Citrus Sinensis ID: 036435

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370--
Protein Sequence
MCQIICLPLSDGSELCYGLIVGIIGITTACITICIFTSKKFSLTLSAAVRRKITKSDKDLEAFIRNYGPLPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQIPPTPFLSSPPRAPIDSFTFS
Secondary Structure (PSIPRED)
ccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccHHHHHHHHHccccccccccHHHHHHHHHHHHHHccccccEEEEEccccHHHHHHHHHHHcccccccccEEEEEccccEEEEEEEccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHcccccccEEEEccccccccccccccccccccccccccccccccEEEcccccccccccccHHccccccccccccccccHHHHHHHHHccccccccccccccccccHHHHHHHHHHcccccccccccHHHHHHHHHHHHHHHccccccccccccHHHHHHHHccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccHHHHHHHcccccccccEcHHHHHHHHHccHHccccccccccEcccccHHHHHHHHHHHHHHHHHHHHHHcEEcccccEEEEEEEcccccHHHHHcccccccccccccHHHHHHHHHHHHHHHHHHHcccccEEEcccccHHHEEEcccccEEEccccccHHccccccEEEccEEEEEEEccccHHHHHHccccEEEcccHHHHHEEEEEEHcccccccccccccccccHHHHHHHHHHcccccccccccccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHccccccccccccccEcccccccccccccc
Coil and Loop (DISEMBL)
mcqiiclplsdgselcYGLIVGIIGITTACITICIFTSKKFSLTLSAAVRRKITKSDKDLEAFIRNygplplkrynfsdvkKLTNSFkdklgqggfggvykgrLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIyefmpngslekfvyngdtskpcqylRWEKMYEIVIGIAKGLEYlhhgcstkilhfdikphnilldedfcpkisdfglaklcttkeGIVSSLLGargiigyiapevfsrnfgevshksdvySFGMMIMELVGCknnldsgvdsssevyfphwiyrhveqdrefklpgvvtrKENEIAKKMIIVGLWCiqarpsdrppmNEVIEMLQgstealqipptpflsspprapidsftfs
Flexible Loop (DISEMBL)
MCQIICLPLSDGSELCYGLIVGIIGITTACITICIFTSKKFSLTLSAAVRRkitksdkdleafirnygplplkrynfSDVKKLTNsfkdklgqggFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPevfsrnfgeVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQIPPtpflsspprapidsftfs
Low Complexity Region (SEG)
MCQIICLPLSDGSELCYGLivgiigittaciticiftSKKFSLTLSAAVRRKITKSDKDLEAFIRNYGPLPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQIPPTPFLSSPPRAPIDSFTFS
Disordered region (IsUnstruct)
*CQIICLPLSDGSELCYGLIVGIIGITTACITICIFTSKKFSLTLSAAVRRKITKSDKDLEAFIRNYGPLPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQA********************************************
Disordered Region (DISOPRED)
**************LCYGLIVGIIGITTACITICIFTSKKFSLTLSAAVRRKITK*****EAFIRNYGPLPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNL******SS*VYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQIPPTPFL**************
Disordered Region (DISEMBL)
MCQIICLPLSDGSELCYGLIVGIIGITTACITICIFTSKKFSLTLSAAVRRKITKSDKDLEAFIRNYGPLPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQIPPTPFLSSPPRAPIDSFTFS
Disordered Region (DISPRO)
*CQIICLPLSDGSELCYGLIVGIIGITTACITICIFTSKKFSLTLSAAVRR*****DKDLEAFIRNYGPLPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQIPPTPFLSS************
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSiiHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MCQIICLPLSDGSELCYGLIVGIIGITTACITICIFTSKKFSLTLSAAVRRKITKSDKDLEAFIRNYGPLPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQIPPTPFLSSPPRAPIDSFTFS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	372	2.2.26 [Sep-21-2011]
Q3ECH2	892	Probable receptor-like pr	no	no	0.887	0.369	0.473	1e-91
Q9FID6	813	Probable receptor-like pr	no	no	0.857	0.392	0.459	9e-91
Q9FID5	806	Probable receptor-like pr	no	no	0.75	0.346	0.532	7e-89
Q9FLV4	872	G-type lectin S-receptor-	no	no	0.731	0.311	0.383	2e-58
Q8RWZ5	821	G-type lectin S-receptor-	no	no	0.768	0.348	0.386	3e-56
Q9XID3	829	G-type lectin S-receptor-	no	no	0.720	0.323	0.395	5e-56
C0LGH2	1032	Probable LRR receptor-lik	no	no	0.846	0.305	0.365	2e-53
C0LGH3	1033	Probable LRR receptor-lik	no	no	0.873	0.314	0.356	3e-53
O64477	828	G-type lectin S-receptor-	no	no	0.752	0.338	0.378	2e-50
Q39203	797	G-type lectin S-receptor-	no	no	0.720	0.336	0.388	2e-50

>sp|Q3ECH2|Y1670_ARATH Probable receptor-like protein kinase At1g67000 OS=Arabidopsis thaliana GN=At1g67000 PE=2 SV=2

 Score =  337 bits (863), Expect = 1e-91,   Method: Compositional matrix adjust.
 Identities = 182/384 (47%), Positives = 252/384 (65%), Gaps = 54/384 (14%)

Query: 18  GLIVGIIGITTACITICIFTSKKFSLTLSAAVRRKITKSDKDLEAFIRNYGPLPLKRYNF 77
           G+++  + +   C  + IF  +K     S  VR +       L+A I      PLK Y +
Sbjct: 505 GVVIVFLVLLCPCFRVQIFRKRK----TSDEVRLQ------KLKALI------PLKHYTY 548

Query: 78  SDVKKLTNSFKDKLGQGGFGGVYKGRLLD------------------DFVNEVASISRTS 119
           ++VKK+T SF + +G+GGFG VY G L D                  DF+NEVAS+S+TS
Sbjct: 549 AEVKKMTKSFTEVVGRGGFGIVYSGTLSDSSMVAVKVLKDSKGTDGEDFINEVASMSQTS 608

Query: 120 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
           HVN+V+LLGFC EG+ RA+IYEF+ NGSL+KF+    + K    L  + +Y I +G+A+G
Sbjct: 609 HVNIVSLLGFCCEGSRRAIIYEFLGNGSLDKFI----SDKSSVNLDLKTLYGIALGVARG 664

Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
           LEYLH+GC T+I+HFDIKP N+LLD++ CPK+SDFGLAKLC  KE I+ SLL  RG IGY
Sbjct: 665 LEYLHYGCKTRIVHFDIKPQNVLLDDNLCPKVSDFGLAKLCEKKESIL-SLLDTRGTIGY 723

Query: 240 IAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKN----NLDSGVDSSSEVYFPHWIYRHV 295
           IAPE+ SR +G VSHKSDVYS+GM+++E++G +     + +S  D SS +YFP WIY+ +
Sbjct: 724 IAPEMISRLYGSVSHKSDVYSYGMLVLEMIGARKKERFDQNSRSDGSS-IYFPEWIYKDL 782

Query: 296 E----QDREFKLPG-----VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGS 346
           E    +D E    G      ++ +E EIA+KM +VGLWCIQ+ PSDRPPMN+V+EM++GS
Sbjct: 783 EKANIKDIEKTENGGLIENGISSEEEEIARKMTLVGLWCIQSSPSDRPPMNKVVEMMEGS 842

Query: 347 TEALQIPPTPFLSSPPRAPI-DSF 369
            +AL++PP P L     + + DSF
Sbjct: 843 LDALEVPPRPVLQQISASSVSDSF 866

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9FID6|Y5392_ARATH Probable receptor-like protein kinase At5g39020 OS=Arabidopsis thaliana GN=At5g39020 PE=2 SV=1

 Score =  333 bits (855), Expect = 9e-91,   Method: Compositional matrix adjust.
 Identities = 164/357 (45%), Positives = 242/357 (67%), Gaps = 38/357 (10%)

Query: 19  LIVG-IIGITTACITICIFTSKKFSLTLSAAVRRKITKSDKDLEAFIRNYGPLPLKRYNF 77
           ++VG +IG+ T  + I +   +         ++RK  K +  +  F      L LK+Y +
Sbjct: 443 IVVGSVIGLATFIVIIMLLIRQ---------MKRKKNKKENSVIMF-----KLLLKQYIY 488

Query: 78  SDVKKLTNSFKDKLGQGGFGGVYKGRLL-----------------DDFVNEVASISRTSH 120
           +++KK+T SF   +G+GGFG VY+G L                  DDF+NEV S+S+TSH
Sbjct: 489 AELKKITKSFSHTVGKGGFGTVYRGNLSNGRTVAVKVLKDLKGNGDDFINEVTSMSQTSH 548

Query: 121 VNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGL 180
           VN+V+LLGFC EG+ RA+I EF+ +GSL++F+    +  P        +Y I +GIA+GL
Sbjct: 549 VNIVSLLGFCYEGSKRAIISEFLEHGSLDQFISRNKSLTP----NVTTLYGIALGIARGL 604

Query: 181 EYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYI 240
           EYLH+GC T+I+HFDIKP NILLD++FCPK++DFGLAKLC  +E I+ SL+  RG IGYI
Sbjct: 605 EYLHYGCKTRIVHFDIKPQNILLDDNFCPKVADFGLAKLCEKRESIL-SLIDTRGTIGYI 663

Query: 241 APEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQ-DR 299
           APEV SR +G +SHKSDVYS+GM++++++G +N +++   + S  YFP WIY+ +E  D+
Sbjct: 664 APEVVSRMYGGISHKSDVYSYGMLVLDMIGARNKVETTTCNGSTAYFPDWIYKDLENGDQ 723

Query: 300 EFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQIPPTP 356
            + +   +  ++N+I KKMI+V LWCI+  PSDRPPMN+V+EM++GS +AL++PP P
Sbjct: 724 TWIIGDEINEEDNKIVKKMILVSLWCIRPCPSDRPPMNKVVEMIEGSLDALELPPKP 780

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9FID5|Y5393_ARATH Probable receptor-like protein kinase At5g39030 OS=Arabidopsis thaliana GN=At5g39030 PE=2 SV=1

 Score =  327 bits (839), Expect = 7e-89,   Method: Compositional matrix adjust.
 Identities = 163/306 (53%), Positives = 220/306 (71%), Gaps = 27/306 (8%)

Query: 72  LKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRL-----------------LDDFVNEVAS 114
           L  Y ++++KK+T SF   +G+GGFG VY G L                  +DF+NEVAS
Sbjct: 485 LNMYTYAELKKITKSFSYIIGKGGFGTVYGGNLSNGRKVAVKVLKDLKGSAEDFINEVAS 544

Query: 115 ISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIV 173
           +S+TSHVN+V+LLGFC EG+ RA++YEF+ NGSL++F+  N   ++    L     Y I 
Sbjct: 545 MSQTSHVNIVSLLGFCFEGSKRAIVYEFLENGSLDQFMSRNKSLTQDVTTL-----YGIA 599

Query: 174 IGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGA 233
           +GIA+GLEYLH+GC T+I+HFDIKP NILLD + CPK+SDFGLAKLC  +E ++ SL+  
Sbjct: 600 LGIARGLEYLHYGCKTRIVHFDIKPQNILLDGNLCPKVSDFGLAKLCEKRESVL-SLMDT 658

Query: 234 RGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKN-NLDSGVDS-SSEVYFPHWI 291
           RG IGYIAPEVFSR +G VSHKSDVYSFGM++++++G ++  +   VDS +S  YFP WI
Sbjct: 659 RGTIGYIAPEVFSRMYGRVSHKSDVYSFGMLVIDMIGARSKEIVETVDSAASSTYFPDWI 718

Query: 292 YRHVEQDREFKLPG-VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEAL 350
           Y+ +E   +  + G  +T++E EIAKKMI+VGLWCIQ  PSDRP MN V+EM++GS +AL
Sbjct: 719 YKDLEDGEQTWIFGDEITKEEKEIAKKMIVVGLWCIQPCPSDRPSMNRVVEMMEGSLDAL 778

Query: 351 QIPPTP 356
           +IPP P
Sbjct: 779 EIPPKP 784

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1

 Score =  226 bits (576), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 117/305 (38%), Positives = 180/305 (59%), Gaps = 33/305 (10%)

Query: 75  YNFSDVKKLTNSFKDKLGQGGFGGVYKG----------RLLD--------DFVNEVASIS 116
           + + D++  TN+F   LG GGFG VYKG          + LD        +F+ EV +I 
Sbjct: 520 FTYRDLQNCTNNFSQLLGSGGFGTVYKGTVAGETLVAVKRLDRALSHGEREFITEVNTIG 579

Query: 117 RTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 176
              H+N+V L G+C E ++R L+YE+M NGSL+K++++ +  +    L W   +EI +  
Sbjct: 580 SMHHMNLVRLCGYCSEDSHRLLVYEYMINGSLDKWIFSSE--QTANLLDWRTRFEIAVAT 637

Query: 177 AKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI 236
           A+G+ Y H  C  +I+H DIKP NILLD++FCPK+SDFGLAK+   +   V +++  RG 
Sbjct: 638 AQGIAYFHEQCRNRIIHCDIKPENILLDDNFCPKVSDFGLAKMMGREHSHVVTMI--RGT 695

Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE 296
            GY+APE  S     ++ K+DVYS+GM+++E+VG + NLD   D + + ++P W Y+ + 
Sbjct: 696 RGYLAPEWVSNR--PITVKADVYSYGMLLLEIVGGRRNLDMSYD-AEDFFYPGWAYKELT 752

Query: 297 QDREFK-----LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQ 351
                K     L GV    E E   K + V  WCIQ   S RP M EV+++L+G+++ + 
Sbjct: 753 NGTSLKAVDKRLQGVA---EEEEVVKALKVAFWCIQDEVSMRPSMGEVVKLLEGTSDEIN 809

Query: 352 IPPTP 356
           +PP P
Sbjct: 810 LPPMP 814

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1

 Score =  219 bits (557), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 126/326 (38%), Positives = 191/326 (58%), Gaps = 40/326 (12%)

Query: 61  EAFIRNYGPLPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLLD-------------- 106
           + F+ N   +P+ R+ + D++  TN+F  KLGQGGFG VY+G L D              
Sbjct: 470 DNFLENLSGMPI-RFAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLAVKKLEGIGQ 528

Query: 107 ---DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVY---NGDTSKP 160
              +F  EV+ I    H+++V L GFC EG +R L YEF+  GSLE++++   +GD    
Sbjct: 529 GKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDV--- 585

Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
              L W+  + I +G AKGL YLH  C  +I+H DIKP NILLD++F  K+SDFGLAKL 
Sbjct: 586 --LLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLM 643

Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVD 280
           T ++  V + +  RG  GY+APE  + N+  +S KSDVYS+GM+++EL+G + N D   +
Sbjct: 644 TREQSHVFTTM--RGTRGYLAPEWIT-NYA-ISEKSDVYSYGMVLLELIGGRKNYDPS-E 698

Query: 281 SSSEVYFPHWIYRHVEQDREFKLPGVVTRK------ENEIAKKMIIVGLWCIQARPSDRP 334
           +S + +FP + ++ +E   E KL  +V  K       +E  ++ +   LWCIQ     RP
Sbjct: 699 TSEKCHFPSFAFKKME---EGKLMDIVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTRP 755

Query: 335 PMNEVIEMLQGSTEALQIPPTPFLSS 360
            M++V++ML+G    +Q P +  + S
Sbjct: 756 SMSKVVQMLEGVFPVVQPPSSSTMGS 781

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1

 Score =  218 bits (556), Expect = 5e-56,   Method: Compositional matrix adjust.
 Identities = 117/296 (39%), Positives = 173/296 (58%), Gaps = 28/296 (9%)

Query: 74  RYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLLD-----------------DFVNEVASIS 116
           ++ + ++++ T SFK+KLG GGFG VY+G L +                  F  EVA+IS
Sbjct: 473 QFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQLEGIEQGEKQFRMEVATIS 532

Query: 117 RTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 176
            T H+N+V L+GFC +G +R L+YEFM NGSL+ F++  D++K   +L WE  + I +G 
Sbjct: 533 STHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAK---FLTWEYRFNIALGT 589

Query: 177 AKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI 236
           AKG+ YLH  C   I+H DIKP NIL+D++F  K+SDFGLAKL   K+    ++   RG 
Sbjct: 590 AKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRY-NMSSVRGT 648

Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE 296
            GY+APE  +     ++ KSDVYS+GM+++ELV  K N D   + ++   F  W Y   E
Sbjct: 649 RGYLAPEWLANL--PITSKSDVYSYGMVLLELVSGKRNFDVS-EKTNHKKFSIWAYEEFE 705

Query: 297 QDREFKLPGVVTRKEN----EIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE 348
           +     +      ++     E   +M+    WCIQ +P  RP M +V++ML+G TE
Sbjct: 706 KGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEGITE 761

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2

 Score =  209 bits (532), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 133/364 (36%), Positives = 195/364 (53%), Gaps = 49/364 (13%)

Query: 18  GLIVGII---GITTACITICIFTSKKFSLTLSAAVRRKITKSDKDLEAF-IRNYGPLPLK 73
           G IVG+I   G+ +    + +FT +K         RRK    D++L    ++ Y      
Sbjct: 636 GTIVGVIVGVGLLSILAGVVMFTIRK---------RRKRYTDDEELLGMDVKPY------ 680

Query: 74  RYNFSDVKKLTNSF--KDKLGQGGFGGVYKGRLLD------------------DFVNEVA 113
            + +S++K  T  F   +KLG+GGFG VYKG L D                   FV E+ 
Sbjct: 681 IFTYSELKSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAVKLLSVGSRQGKGQFVAEIV 740

Query: 114 SISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIV 173
           +IS   H N+V L G C EG +R L+YE++PNGSL++ ++   T     +L W   YEI 
Sbjct: 741 AISSVLHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFGDKT----LHLDWSTRYEIC 796

Query: 174 IGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGA 233
           +G+A+GL YLH   S +I+H D+K  NILLD    P+ISDFGLAKL   K+  +S+ +  
Sbjct: 797 LGVARGLVYLHEEASVRIVHRDVKASNILLDSRLVPQISDFGLAKLYDDKKTHISTRVA- 855

Query: 234 RGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYR 293
            G IGY+APE   R  G ++ K+DVY+FG++ +ELV  + N D  ++   + Y   W + 
Sbjct: 856 -GTIGYLAPEYAMR--GHLTEKTDVYAFGVVALELVSGRPNSDENLEEEKK-YLLEWAWN 911

Query: 294 HVEQDREFKL-PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQI 352
             E+ R+ +L    +T    E AK+MI + L C Q   + RPPM+ V+ ML G  E   +
Sbjct: 912 LHEKSRDIELIDDKLTDFNMEEAKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEIGDV 971

Query: 353 PPTP 356
              P
Sbjct: 972 TSKP 975

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2

 Score =  209 bits (532), Expect = 3e-53,   Method: Compositional matrix adjust.
 Identities = 133/373 (35%), Positives = 196/373 (52%), Gaps = 48/373 (12%)

Query: 8   PLSDGSELCYGLIVGII---GITTACITICIFTSKKFSLTLSAAVRRKITKSDKDLEAFI 64
           P S G  +  G IVG+I   G+ +    + IF  +K         R++ T  ++ L   +
Sbjct: 626 PPSKGKSMT-GTIVGVIVGVGLLSIISGVVIFIIRK--------RRKRYTDDEEILSMDV 676

Query: 65  RNYGPLPLKRYNFSDVKKLTNSF--KDKLGQGGFGGVYKGRLLD---------------- 106
           + Y       + +S++K  T  F   +KLG+GGFG VYKG+L D                
Sbjct: 677 KPY------TFTYSELKSATQDFDPSNKLGEGGFGPVYKGKLNDGREVAVKLLSVGSRQG 730

Query: 107 --DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL 164
              FV E+ +IS   H N+V L G C EG +R L+YE++PNGSL++ ++   T     +L
Sbjct: 731 KGQFVAEIVAISAVQHRNLVKLYGCCYEGEHRLLVYEYLPNGSLDQALFGEKT----LHL 786

Query: 165 RWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE 224
            W   YEI +G+A+GL YLH     +I+H D+K  NILLD    PK+SDFGLAKL   K+
Sbjct: 787 DWSTRYEICLGVARGLVYLHEEARLRIVHRDVKASNILLDSKLVPKVSDFGLAKLYDDKK 846

Query: 225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE 284
             +S+ +   G IGY+APE   R  G ++ K+DVY+FG++ +ELV  + N D  ++    
Sbjct: 847 THISTRVA--GTIGYLAPEYAMR--GHLTEKTDVYAFGVVALELVSGRPNSDENLEDEKR 902

Query: 285 VYFPHWIYRHVEQDREFKL-PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEML 343
            Y   W +   E+ RE +L    +T    E  K+MI + L C Q   + RPPM+ V+ ML
Sbjct: 903 -YLLEWAWNLHEKGREVELIDHQLTEFNMEEGKRMIGIALLCTQTSHALRPPMSRVVAML 961

Query: 344 QGSTEALQIPPTP 356
            G  E   +   P
Sbjct: 962 SGDVEVSDVTSKP 974

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1

 Score =  200 bits (508), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 118/312 (37%), Positives = 169/312 (54%), Gaps = 32/312 (10%)

Query: 68  GPLPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLLD-----------------DFVN 110
           G   L  +++ +++  T +F DKLG GGFG V+KG L D                  F  
Sbjct: 476 GDGTLSAFSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRLEGISQGEKQFRT 535

Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY 170
           EV +I    HVN+V L GFC EG+ + L+Y++MPNGSL+  ++     +    L W+  +
Sbjct: 536 EVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKI-VLGWKLRF 594

Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSL 230
           +I +G A+GL YLH  C   I+H DIKP NILLD  FCPK++DFGLAKL       V  L
Sbjct: 595 QIALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRV--L 652

Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHW 290
              RG  GY+APE  S     ++ K+DVYS+GMM+ ELV  + N +   ++    +FP W
Sbjct: 653 TTMRGTRGYLAPEWISGV--AITAKADVYSYGMMLFELVSGRRNTEQS-ENEKVRFFPSW 709

Query: 291 IYRHVEQDREFKLPGVVTRKEN-----EIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG 345
               + +D + +   V  R E      E   +   V  WCIQ   S RP M++V+++L+G
Sbjct: 710 AATILTKDGDIR-SLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEG 768

Query: 346 STEALQIPPTPF 357
               L++ P PF
Sbjct: 769 ---VLEVNPPPF 777

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1

 Score =  199 bits (507), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 120/309 (38%), Positives = 164/309 (53%), Gaps = 41/309 (13%)

Query: 67  YGPLPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRL------------------LDDF 108
           +  L LK ++F +++  TN F DK+G GGFG V+KG L                    +F
Sbjct: 443 FAVLNLKVFSFKELQSATNGFSDKVGHGGFGAVFKGTLPGSSTFVAVKRLERPGSGESEF 502

Query: 109 VNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEK 168
             EV +I    HVN+V L GFC E  +R L+Y++MP GSL  ++     + P + L WE 
Sbjct: 503 RAEVCTIGNIQHVNLVRLRGFCSENLHRLLVYDYMPQGSLSSYL---SRTSP-KLLSWET 558

Query: 169 MYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVS 228
            + I +G AKG+ YLH GC   I+H DIKP NILLD D+  K+SDFGLAKL       V 
Sbjct: 559 RFRIALGTAKGIAYLHEGCRDCIIHCDIKPENILLDSDYNAKVSDFGLAKLLGRDFSRV- 617

Query: 229 SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE---- 284
            L   RG  GY+APE  S     ++ K+DVYSFGM ++EL+G + N+    D+  E    
Sbjct: 618 -LATMRGTWGYVAPEWISGL--PITTKADVYSFGMTLLELIGGRRNVIVNSDTLGEKETE 674

Query: 285 ---VYFPHWIYRHVEQDREFKLPGVVTRKEN-----EIAKKMIIVGLWCIQARPSDRPPM 336
               +FP W  R + Q     +  VV  + N     E   +M  V +WCIQ     RP M
Sbjct: 675 PEKWFFPPWAAREIIQG---NVDSVVDSRLNGEYNTEEVTRMATVAIWCIQDNEEIRPAM 731

Query: 337 NEVIEMLQG 345
             V++ML+G
Sbjct: 732 GTVVKMLEG 740

Serine/threonine-protein kinase.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	372
147769927	1001	hypothetical protein VITISV_010117 [Viti	0.948	0.352	0.563	1e-121
224108429	365	predicted protein [Populus trichocarpa]	0.922	0.939	0.585	1e-120
147795963	624	hypothetical protein VITISV_039936 [Viti	0.935	0.557	0.568	1e-120
359472674	637	PREDICTED: probable receptor-like protei	0.935	0.546	0.568	1e-120
224133116	415	predicted protein [Populus trichocarpa]	0.956	0.857	0.578	1e-119
224133128	333	predicted protein [Populus trichocarpa]	0.819	0.915	0.647	1e-119
356522799	542	PREDICTED: probable receptor-like protei	0.943	0.647	0.557	1e-118
297734241	667	unnamed protein product [Vitis vinifera]	0.948	0.529	0.576	1e-118
359472676	459	PREDICTED: probable receptor-like protei	0.852	0.690	0.616	1e-117
359491461	1963	PREDICTED: uncharacterized protein LOC10	0.948	0.179	0.576	1e-117

>gi|147769927|emb|CAN76446.1| hypothetical protein VITISV_010117 [Vitis vinifera]

 Score =  439 bits (1130), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 212/376 (56%), Positives = 276/376 (73%), Gaps = 23/376 (6%)

Query: 14  ELCYGLIVGIIGITTACITICIFTSKKFSLTLSAAVRRKITKSDKDLEAFIRNYGPLPLK 73
           +L  GL + I GI    + +  + SKKF     +  + K T +  ++E F+RN+  L  K
Sbjct: 630 KLALGLAISITGIGIP-LALTFYFSKKFR----SIFKEKQTGNHLNVETFLRNHESLAPK 684

Query: 74  RYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLL-----------------DDFVNEVASIS 116
           RY +S+V+K+T+SFKD++G+GG+G VYKG+LL                 ++F+NE+ASIS
Sbjct: 685 RYRYSEVQKMTSSFKDRVGEGGYGAVYKGKLLNGDLVAVKVLSETKGNGEEFINEIASIS 744

Query: 117 RTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 176
           RTSHVN+V+LLGFC +G+ RALIYEFMPNGSLEKF+Y+ ++S     L WE +Y I IGI
Sbjct: 745 RTSHVNIVSLLGFCFQGSKRALIYEFMPNGSLEKFIYDKNSSMTYHKLGWETLYNIAIGI 804

Query: 177 AKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI 236
           A+GLEYLH GC+T+ILH DIKPHNILL++DFCPKISDFGL+KLCT KE I+ S+ GARG 
Sbjct: 805 ARGLEYLHRGCNTRILHLDIKPHNILLNQDFCPKISDFGLSKLCTRKESII-SMSGARGT 863

Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE 296
            GYIAPEVF RNFG+VS KSDVYS+GMM++E+VG + N D G++ +SE+YFPHWIY+ +E
Sbjct: 864 AGYIAPEVFCRNFGDVSPKSDVYSYGMMVLEMVGGRKNTDDGINHTSEIYFPHWIYKRLE 923

Query: 297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQIPPTP 356
            D E  L G +  +E   A+KMIIV LWCIQ  PS+RPPMN V++ML+GS E+LQIPP P
Sbjct: 924 LDEELGLQGFMNEEERTSARKMIIVSLWCIQTNPSNRPPMNGVVDMLEGSLESLQIPPKP 983

Query: 357 FLSSPPRAPIDSFTFS 372
           FL SPPR+  D  T S
Sbjct: 984 FLYSPPRSMRDLSTAS 999

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224108429|ref|XP_002314844.1| predicted protein [Populus trichocarpa] gi|222863884|gb|EEF01015.1| predicted protein [Populus trichocarpa]

 Score =  439 bits (1128), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 212/362 (58%), Positives = 267/362 (73%), Gaps = 19/362 (5%)

Query: 24  IGITTACITICIFTSKKFSLTLSAAVRRKITKSDKDLEAFIRNYGPLPLKRYNFSDVKKL 83
           +GI    ITIC    +K+S     +  RK T+  + +E F+RNYG L  +RY++S++KK+
Sbjct: 2   VGIGVLIITICCVIIRKYSSIHFLSCWRK-TRGSQSIEVFLRNYGTLAPERYSYSELKKM 60

Query: 84  TNSFKDKLGQGGFGGVYKGRLLD-----------------DFVNEVASISRTSHVNVVTL 126
           T +FK+KLGQGGFG V+KG LLD                 +FVNEV+SI RTSHVN+VTL
Sbjct: 61  TKNFKEKLGQGGFGSVFKGNLLDGRLVAVKVLKKSKSNGEEFVNEVSSIGRTSHVNIVTL 120

Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
           LGFC EG  RALIYEFM NGSL+K +Y  + SK    L WE +Y+I +GIA+GLEYLH G
Sbjct: 121 LGFCFEGPKRALIYEFMSNGSLDKHIYEENLSKAHPKLGWETLYQIAVGIARGLEYLHRG 180

Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
           C+T+ILHFDIKPHNILLDE+FCPKISDFGLAK+C +KE IV S+LGARG  GYIAPEVF 
Sbjct: 181 CNTRILHFDIKPHNILLDENFCPKISDFGLAKICPSKESIV-SMLGARGTAGYIAPEVFC 239

Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
           RNFG VSHKSDVYS+GM+++E++G + N   GVD++SE+YFPHWIYR +E   E +L G 
Sbjct: 240 RNFGGVSHKSDVYSYGMLVLEMIGGRKNFRVGVDNTSEIYFPHWIYRRLEIGEELQLRGA 299

Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQIPPTPFLSSPPRAPI 366
               E + A+KMI+  LWCIQ  PS+RPPM+ V++MLQGS E+L IPP P+LSSPPR+P 
Sbjct: 300 GNEVEEQNARKMILASLWCIQTDPSNRPPMSRVVDMLQGSLESLPIPPKPYLSSPPRSPH 359

Query: 367 DS 368
            S
Sbjct: 360 GS 361

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147795963|emb|CAN69599.1| hypothetical protein VITISV_039936 [Vitis vinifera]

 Score =  438 bits (1126), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 211/371 (56%), Positives = 275/371 (74%), Gaps = 23/371 (6%)

Query: 14  ELCYGLIVGIIGITTACITICIFTSKKFSLTLSAAVRRKITKSDKDLEAFIRNYGPLPLK 73
           +L  GL + I GI    + +  + SKKF     +  + K T +  ++E F+RN+  L  K
Sbjct: 253 KLALGLAISITGIGIP-LALTFYFSKKFR----SIFKEKQTGNHLNVETFLRNHESLAPK 307

Query: 74  RYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLL-----------------DDFVNEVASIS 116
           RY +S+V+K+T+SFKD++G+GG+G VYKG+LL                 ++F+NE+ASIS
Sbjct: 308 RYRYSEVQKMTSSFKDRVGEGGYGAVYKGKLLNGDLVAVKVLSETKGNGEEFINEIASIS 367

Query: 117 RTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 176
           RTSHVN+V+LLGFC +G+ RALIYEFMPNGSLEKF+Y+ ++S     L WE +Y I IGI
Sbjct: 368 RTSHVNIVSLLGFCFQGSKRALIYEFMPNGSLEKFIYDKNSSMTYDKLGWETLYNIAIGI 427

Query: 177 AKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI 236
           A+GLEYLH GC+T+ILH DIKPHNILL++DFCPKISDFGL+KLCT KE IV S+ GARG 
Sbjct: 428 ARGLEYLHRGCNTRILHLDIKPHNILLNQDFCPKISDFGLSKLCTRKESIV-SMSGARGT 486

Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE 296
            GYIAPEVF RNFG+VS KSDVYS+GMM++E+VG + N+D G++ +SE+YFPHWIY+ +E
Sbjct: 487 AGYIAPEVFCRNFGDVSPKSDVYSYGMMVLEMVGGRKNIDDGINHTSEIYFPHWIYKRLE 546

Query: 297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQIPPTP 356
            D E  L G +  +E   A+KMIIV LWCIQ  PS+RPPMN V++ML+GS E+LQIPP P
Sbjct: 547 LDEELGLQGFMNEEERTSARKMIIVSLWCIQTNPSNRPPMNGVVDMLEGSLESLQIPPKP 606

Query: 357 FLSSPPRAPID 367
           FL SPPR+  D
Sbjct: 607 FLYSPPRSMRD 617

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359472674|ref|XP_002279652.2| PREDICTED: probable receptor-like protein kinase At1g67000-like [Vitis vinifera]

 Score =  437 bits (1125), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 211/371 (56%), Positives = 275/371 (74%), Gaps = 23/371 (6%)

Query: 14  ELCYGLIVGIIGITTACITICIFTSKKFSLTLSAAVRRKITKSDKDLEAFIRNYGPLPLK 73
           +L  GL + I GI    + +  + SKKF     +  + K T +  ++E F+RN+  L  K
Sbjct: 266 KLALGLAISITGIGIP-LALTFYFSKKFR----SIFKEKQTGNHLNVETFLRNHESLAPK 320

Query: 74  RYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLL-----------------DDFVNEVASIS 116
           RY +S+V+K+T+SFKD++G+GG+G VYKG+LL                 ++F+NE+ASIS
Sbjct: 321 RYRYSEVQKMTSSFKDRVGEGGYGAVYKGKLLNGDLVAVKVLSETKGNGEEFINEIASIS 380

Query: 117 RTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 176
           RTSHVN+V+LLGFC +G+ RALIYEFMPNGSLEKF+Y+ ++S     L WE +Y I IGI
Sbjct: 381 RTSHVNIVSLLGFCFQGSKRALIYEFMPNGSLEKFIYDKNSSMTYDKLGWETLYNIAIGI 440

Query: 177 AKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI 236
           A+GLEYLH GC+T+ILH DIKPHNILL++DFCPKISDFGL+KLCT KE IV S+ GARG 
Sbjct: 441 ARGLEYLHRGCNTRILHLDIKPHNILLNQDFCPKISDFGLSKLCTRKESIV-SMSGARGT 499

Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE 296
            GYIAPEVF RNFG+VS KSDVYS+GMM++E+VG + N+D G++ +SE+YFPHWIY+ +E
Sbjct: 500 AGYIAPEVFCRNFGDVSPKSDVYSYGMMVLEMVGGRKNIDDGINHTSEIYFPHWIYKRLE 559

Query: 297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQIPPTP 356
            D E  L G +  +E   A+KMIIV LWCIQ  PS+RPPMN V++ML+GS E+LQIPP P
Sbjct: 560 LDEELGLQGFMNEEERTSARKMIIVSLWCIQTNPSNRPPMNGVVDMLEGSLESLQIPPKP 619

Query: 357 FLSSPPRAPID 367
           FL SPPR+  D
Sbjct: 620 FLYSPPRSMRD 630

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224133116|ref|XP_002321486.1| predicted protein [Populus trichocarpa] gi|222868482|gb|EEF05613.1| predicted protein [Populus trichocarpa]

 Score =  436 bits (1120), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 221/382 (57%), Positives = 276/382 (72%), Gaps = 26/382 (6%)

Query: 3   QIICL----PLSDGSELCYGLIVGIIGITTACITICIFTSKKFSLTLSAAVRRKITKSDK 58
           + IC     PL+       G++ G  GI   C+ +  ++ +K S T +    +K  K ++
Sbjct: 28  EFICFCRDRPLTHQPPQLAGVVSGSAGILFICVIL--YSRRKASSTTTPIFLKK--KHNQ 83

Query: 59  DLEAFIRNYGPLPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLLD------------ 106
            LE FIRN+GPL LKRYN SDVKK+TN FKDKLGQGG+G VYKG+L D            
Sbjct: 84  HLEVFIRNHGPLALKRYNLSDVKKMTNFFKDKLGQGGYGIVYKGKLQDGHLVAVKVMQAS 143

Query: 107 -----DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPC 161
                +F+NEVASISRTSHVN+VTLLGFCLEG+ R LIY+FM NGSLEKF+ + +  +  
Sbjct: 144 KGDGEEFINEVASISRTSHVNIVTLLGFCLEGDKRVLIYDFMVNGSLEKFINHENALQAN 203

Query: 162 QYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT 221
           Q L W K+Y+I++G+A+GLEYLH GC+T+I+HFDIKPHNILLD DF PKISDFGLAK CT
Sbjct: 204 QQLGWNKLYQILVGVARGLEYLHRGCNTRIVHFDIKPHNILLDADFSPKISDFGLAKPCT 263

Query: 222 TKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDS 281
            KE  V SLL ARG IGYIAPEVFSRNFG+VSHKSDVYS+GMM +E+VG + N ++ + S
Sbjct: 264 RKESNV-SLLEARGTIGYIAPEVFSRNFGQVSHKSDVYSYGMMALEIVGGRKNHEAEMSS 322

Query: 282 SSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
           SSE YFP WIYRH+E D EF+L GV   ++++I +++ IVGLWCI   PSDRP M +VIE
Sbjct: 323 SSEKYFPDWIYRHLELDDEFELNGVTNAEQSDIMRQIAIVGLWCILTNPSDRPSMRKVIE 382

Query: 342 MLQGSTEALQIPPTPFLSSPPR 363
           ML+G   AL+IPP P L SPPR
Sbjct: 383 MLEGPLGALKIPPKPRLYSPPR 404

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224133128|ref|XP_002321489.1| predicted protein [Populus trichocarpa] gi|222868485|gb|EEF05616.1| predicted protein [Populus trichocarpa]

 Score =  432 bits (1112), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 209/323 (64%), Positives = 252/323 (78%), Gaps = 18/323 (5%)

Query: 58  KDLEAFIRNYGPLPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLLD----------- 106
           +DLE FIRN+GPL LKRYN SDVKK+TN FKDKLGQGG+G VYKG+L D           
Sbjct: 1   QDLEVFIRNHGPLALKRYNLSDVKKMTNFFKDKLGQGGYGIVYKGKLQDGHLVAVKVTQA 60

Query: 107 ------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKP 160
                 +F+NEVASISRTSHVN+VTLLGFCLEG+ R LIY+FM NGSLEKF+ + + S+ 
Sbjct: 61  SKGDGEEFINEVASISRTSHVNIVTLLGFCLEGDKRVLIYDFMVNGSLEKFINHKNASQA 120

Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
            Q L W K+Y+I++G+A+GLEYLH GC+T+I+HFDIKPHNILLD DF PKISDFGLAK C
Sbjct: 121 NQQLGWNKLYQILVGVARGLEYLHRGCNTRIVHFDIKPHNILLDADFSPKISDFGLAKPC 180

Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVD 280
           T KE  V SLL ARG IGYIAPEVFSRNFG+VSHKSDVYS+GMM +E+VG + N ++ + 
Sbjct: 181 TRKESNV-SLLEARGTIGYIAPEVFSRNFGQVSHKSDVYSYGMMALEIVGGRKNHEAEMS 239

Query: 281 SSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI 340
           SSSE YFP WIYRH+E D EF+L GV   ++++I +++ IVGLWCI   PSDRP M +VI
Sbjct: 240 SSSEKYFPDWIYRHLELDDEFELNGVTNAEQSDIMRQIAIVGLWCILTNPSDRPSMRKVI 299

Query: 341 EMLQGSTEALQIPPTPFLSSPPR 363
           EML+G   AL+IPP P L SPPR
Sbjct: 300 EMLEGPLGALKIPPKPRLYSPPR 322

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356522799|ref|XP_003530032.1| PREDICTED: probable receptor-like protein kinase At1g67000-like [Glycine max]

 Score =  431 bits (1109), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 208/373 (55%), Positives = 273/373 (73%), Gaps = 22/373 (5%)

Query: 13  SELCYGLIVGIIGITTACITICIFTSKKFSLTLSAAVRRKITKSDKDLEAFIRNYGPLPL 72
           +++  G++  ++G    CI IC F   ++ L +        TKSD+D+EAF++N G +  
Sbjct: 173 TKVVIGVVSAVMGGFMICIIICCF---RYKLLIQPIKLCSTTKSDQDIEAFLKNKGAVAQ 229

Query: 73  KRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLL-----------------DDFVNEVASI 115
           KRY FS+VKK+TNSFK KLGQGGFG VYKG+L                  ++F NEVASI
Sbjct: 230 KRYKFSEVKKMTNSFKVKLGQGGFGAVYKGQLPTGCPVAVKLLNSSKGNGEEFTNEVASI 289

Query: 116 SRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG 175
           SRTSHVN+VTLLGFCL+G  +ALIYEFM NGSL+KF+YN    +    LRW+ +Y+I IG
Sbjct: 290 SRTSHVNIVTLLGFCLKGRKKALIYEFMANGSLDKFIYN-RGPETIASLRWQNLYQISIG 348

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           IA+GLEYLH GC+T+ILHFDIKPHNILLDE+FCPKISDFGLAKLC  KE I+S +   RG
Sbjct: 349 IARGLEYLHRGCNTRILHFDIKPHNILLDENFCPKISDFGLAKLCPRKESIIS-MSNTRG 407

Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV 295
            +GY+APE+++R+FG VSHKSDVYS+GMM++E+VG + N+D+    +SE+YFPH  Y+ +
Sbjct: 408 TLGYVAPEMWNRHFGGVSHKSDVYSYGMMLLEMVGGRKNIDAEASRTSEIYFPHLAYKRL 467

Query: 296 EQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQIPPT 355
           E D + +   V+T +ENEIAK+M IVGLWCIQ  P+DRP M+ VIEML+GS  +L++PP 
Sbjct: 468 ELDNDLRPDEVMTTEENEIAKRMTIVGLWCIQTFPNDRPIMSRVIEMLEGSMNSLEMPPK 527

Query: 356 PFLSSPPRAPIDS 368
           P LSSP R+  +S
Sbjct: 528 PMLSSPTRSATES 540

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297734241|emb|CBI15488.3| unnamed protein product [Vitis vinifera]

 Score =  430 bits (1105), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 214/371 (57%), Positives = 272/371 (73%), Gaps = 18/371 (4%)

Query: 18  GLIVGIIGITTACITICIFTSKKFSLTLSAAVRRKITKSDKDLEAFIRNYGPLPLKRYNF 77
            ++   +G   A I I     +K S      + RK + +D+++E F+RNYG    KRY++
Sbjct: 292 AVVAAGVGTLFASILIIFCFKRKISKHRLMFIWRKRSDADQNIEEFVRNYGSQAPKRYSY 351

Query: 78  SDVKKLTNSFKDKLGQG----------GFGGVYKGRLL-------DDFVNEVASISRTSH 120
           S+VKK+TN+FKDKLGQG          G G +   ++L       D+F+NEVASISRTSH
Sbjct: 352 SNVKKMTNAFKDKLGQGGYGGVYKGKLGDGHLVAVKVLNTSKGNGDEFINEVASISRTSH 411

Query: 121 VNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGL 180
           VN+V LLGFC EG  +ALIYEFM NGSLE F+ + +  K  ++L WEK+Y+I +GIA+GL
Sbjct: 412 VNIVRLLGFCFEGGKKALIYEFMSNGSLENFLGSENPLKVSKHLGWEKLYQIAVGIARGL 471

Query: 181 EYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYI 240
           EYLH GC TKILHFD+KPHNILLD+DF PKISDFGLAKLC  KE I+S +  ARG IGY+
Sbjct: 472 EYLHCGCRTKILHFDVKPHNILLDQDFSPKISDFGLAKLCPPKESIIS-MSAARGTIGYV 530

Query: 241 APEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDRE 300
           APEVF RNFG+VSHKSDVYS+GMM++E+VG + N++  V  +SE YFPHWIY+H+EQ  +
Sbjct: 531 APEVFCRNFGQVSHKSDVYSYGMMVLEMVGGRQNVNGTVGHTSETYFPHWIYKHLEQQED 590

Query: 301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQIPPTPFLSS 360
             L G+  ++ENEI +KMI+VGLWCIQ  PS RP M++VIEML+GS EALQIPP PFLSS
Sbjct: 591 LGLEGIENKEENEITRKMIVVGLWCIQTNPSHRPCMSKVIEMLEGSIEALQIPPKPFLSS 650

Query: 361 PPRAPIDSFTF 371
           PPR PIDS +F
Sbjct: 651 PPRFPIDSSSF 661

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359472676|ref|XP_002279634.2| PREDICTED: probable receptor-like protein kinase At1g67000-like [Vitis vinifera]

 Score =  427 bits (1099), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 207/336 (61%), Positives = 258/336 (76%), Gaps = 19/336 (5%)

Query: 52  KITKSDKDLEAFIRNYGPLPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLLD----- 106
           K TK+  ++EAF+RN+G L LKRY  SDVKK+TNSFKDK+G+GG+G VYKG+LLD     
Sbjct: 122 KRTKNQPNIEAFLRNHGSLALKRYRHSDVKKMTNSFKDKIGEGGYGDVYKGKLLDGQMVA 181

Query: 107 ------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYN 154
                       +F+NEVASI+RTSH+N+V+L GFC EG  RALIYEFMPNGSLEK++ N
Sbjct: 182 VKVLNETKGNGEEFINEVASITRTSHINIVSLRGFCFEGPKRALIYEFMPNGSLEKYICN 241

Query: 155 GDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDF 214
           G  SK    L WE +Y+I +GIA+GLEYLH GC+T+ILHFDIKPHNILL EDFCPKISDF
Sbjct: 242 GHHSKTNCQLGWETLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLSEDFCPKISDF 301

Query: 215 GLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNN 274
           GLAKLCT K+ I+ S+LG RG  GYIAPEVFSR FG VSHKSDVYS+GMM++++VG + +
Sbjct: 302 GLAKLCTRKDSII-SMLGTRGTPGYIAPEVFSRAFGGVSHKSDVYSYGMMVLDMVGGRKD 360

Query: 275 LDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRP 334
           +D G   +SE+YFP  IY+ +E+D +  LP ++   E E  +KMIIV LWCIQ RPSDRP
Sbjct: 361 VDGGSSHTSEIYFPDSIYKCIEEDEDLGLPEIMN-GERECTRKMIIVSLWCIQTRPSDRP 419

Query: 335 PMNEVIEMLQGSTEALQIPPTPFLSSPPRAPIDSFT 370
           PM +V++ML GS ++LQIPP P+L SPPR+  DS T
Sbjct: 420 PMCQVLDMLGGSLQSLQIPPKPYLFSPPRSLQDSST 455

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359491461|ref|XP_002277015.2| PREDICTED: uncharacterized protein LOC100261246 [Vitis vinifera]

 Score =  427 bits (1098), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 214/371 (57%), Positives = 272/371 (73%), Gaps = 18/371 (4%)

Query: 18   GLIVGIIGITTACITICIFTSKKFSLTLSAAVRRKITKSDKDLEAFIRNYGPLPLKRYNF 77
             ++   +G   A I I     +K S      + RK + +D+++E F+RNYG    KRY++
Sbjct: 1588 AVVAAGVGTLFASILIIFCFKRKISKHRLMFIWRKRSDADQNIEEFVRNYGSQAPKRYSY 1647

Query: 78   SDVKKLTNSFKDKLGQG----------GFGGVYKGRLL-------DDFVNEVASISRTSH 120
            S+VKK+TN+FKDKLGQG          G G +   ++L       D+F+NEVASISRTSH
Sbjct: 1648 SNVKKMTNAFKDKLGQGGYGGVYKGKLGDGHLVAVKVLNTSKGNGDEFINEVASISRTSH 1707

Query: 121  VNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGL 180
            VN+V LLGFC EG  +ALIYEFM NGSLE F+ + +  K  ++L WEK+Y+I +GIA+GL
Sbjct: 1708 VNIVRLLGFCFEGGKKALIYEFMSNGSLENFLGSENPLKVSKHLGWEKLYQIAVGIARGL 1767

Query: 181  EYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYI 240
            EYLH GC TKILHFD+KPHNILLD+DF PKISDFGLAKLC  KE I+S +  ARG IGY+
Sbjct: 1768 EYLHCGCRTKILHFDVKPHNILLDQDFSPKISDFGLAKLCPPKESIIS-MSAARGTIGYV 1826

Query: 241  APEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDRE 300
            APEVF RNFG+VSHKSDVYS+GMM++E+VG + N++  V  +SE YFPHWIY+H+EQ  +
Sbjct: 1827 APEVFCRNFGQVSHKSDVYSYGMMVLEMVGGRQNVNGTVGHTSETYFPHWIYKHLEQQED 1886

Query: 301  FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQIPPTPFLSS 360
              L G+  ++ENEI +KMI+VGLWCIQ  PS RP M++VIEML+GS EALQIPP PFLSS
Sbjct: 1887 LGLEGIENKEENEITRKMIVVGLWCIQTNPSHRPCMSKVIEMLEGSIEALQIPPKPFLSS 1946

Query: 361  PPRAPIDSFTF 371
            PPR PIDS +F
Sbjct: 1947 PPRFPIDSSSF 1957

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	372
TAIR|locus:2176737	665	PR5K "PR5-like receptor kinase	0.784	0.439	0.540	1.5e-90
TAIR|locus:2204480	666	AT1G66910 [Arabidopsis thalian	0.801	0.447	0.527	2.8e-89
TAIR|locus:2020583	799	AT1G70250 [Arabidopsis thalian	0.819	0.381	0.522	1.2e-88
TAIR|locus:2141862	853	AT4G18250 [Arabidopsis thalian	0.803	0.350	0.510	2.5e-88
TAIR|locus:2176717	638	AT5G38260 [Arabidopsis thalian	0.801	0.467	0.507	1.3e-86
TAIR|locus:2019713	892	AT1G67000 [Arabidopsis thalian	0.793	0.330	0.516	1.7e-84
TAIR|locus:2019688	674	AT1G66930 [Arabidopsis thalian	0.784	0.433	0.506	1.2e-83
TAIR|locus:2177142	813	AT5G39020 [Arabidopsis thalian	0.817	0.373	0.478	1.3e-82
TAIR|locus:2177152	806	AT5G39030 [Arabidopsis thalian	0.752	0.347	0.531	2.8e-82
TAIR|locus:2176707	579	AT5G38250 [Arabidopsis thalian	0.669	0.430	0.560	8.1e-76

TAIR|locus:2176737 PR5K "PR5-like receptor kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 903 (322.9 bits), Expect = 1.5e-90, P = 1.5e-90
 Identities = 172/318 (54%), Positives = 233/318 (73%)

Query:    72 LKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLLD------------------DFVNEVA 113
             LKRY+++ VKK+TNSF   LG+GGFG VYKG+L D                  +F+NEVA
Sbjct:   318 LKRYSYTRVKKMTNSFAHVLGKGGFGTVYKGKLADSGRDVAVKILKVSEGNGEEFINEVA 377

Query:   114 SISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIV 173
             S+SRTSHVN+V+LLGFC E N RA+IYEFMPNGSL+K++    ++K    + WE++Y++ 
Sbjct:   378 SMSRTSHVNIVSLLGFCYEKNKRAIIYEFMPNGSLDKYISANMSTK----MEWERLYDVA 433

Query:   174 IGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGA 233
             +GI++GLEYLH+ C T+I+HFDIKP NIL+DE+ CPKISDFGLAKLC  KE I+S +L  
Sbjct:   434 VGISRGLEYLHNRCVTRIVHFDIKPQNILMDENLCPKISDFGLAKLCKNKESIIS-MLHM 492

Query:   234 RGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKN--NLDSGVDSSSEVYFPHWI 291
             RG  GYIAPE+FS+NFG VSHKSDVYS+GM+++E++G KN   ++    ++  +YFP W+
Sbjct:   493 RGTFGYIAPEMFSKNFGAVSHKSDVYSYGMVVLEMIGAKNIEKVEYSGSNNGSMYFPEWV 552

Query:   292 YRHVEQDREFKLPG-VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEAL 350
             Y+  E+    ++ G  +T +E +IAKK+++V LWCIQ  PSDRPPM +VIEML+G+ EAL
Sbjct:   553 YKDFEKGEITRIFGDSITDEEEKIAKKLVLVALWCIQMNPSDRPPMIKVIEMLEGNLEAL 612

Query:   351 QIPPTPFLSSPPRAPIDS 368
             Q+PP P L SP     D+
Sbjct:   613 QVPPNPLLFSPEETVPDT 630

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

GO:0009691 "cytokinin biosynthetic process" evidence=RCA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0009620 "response to fungus" evidence=ISS

TAIR|locus:2204480 AT1G66910 [Arabidopsis thaliana (taxid:3702)]

 Score = 891 (318.7 bits), Expect = 2.8e-89, P = 2.8e-89
 Identities = 171/324 (52%), Positives = 232/324 (71%)

Query:    70 LPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLLD-----------------DFVNEV 112
             +PLK Y+++ V  +T SF + +G+GGFG VY+G L D                 DF+NEV
Sbjct:   333 IPLKHYSYAQVTSITKSFAEVIGKGGFGTVYRGTLYDGRSVAVKVLKESQGNGEDFINEV 392

Query:   113 ASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEI 172
             AS+S+TSHVN+VTLLGFC EG  RA+IYEFM NGSL+KF+    +SK    + W ++Y I
Sbjct:   393 ASMSQTSHVNIVTLLGFCSEGYKRAIIYEFMENGSLDKFI----SSKKSSTMDWRELYGI 448

Query:   173 VIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLG 232
              +G+A+GLEYLHHGC T+I+HFDIKP N+LLD++  PK+SDFGLAKLC  KE I+S L+ 
Sbjct:   449 ALGVARGLEYLHHGCRTRIVHFDIKPQNVLLDDNLSPKVSDFGLAKLCERKESILS-LMD 507

Query:   233 ARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKN--NLDSGVDSSSEVYFPHW 290
              RG IGYIAPEVFSR +G VSHKSDVYS+GM++++++G +N  + +    S+S +YFP W
Sbjct:   508 TRGTIGYIAPEVFSRVYGRVSHKSDVYSYGMLVLDIIGARNKTSTEDTTSSTSSMYFPEW 567

Query:   291 IYRHVEQDREFK-LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA 349
             IYR +E+    K +   ++ +E+EIAKKM +VGLWCIQ  P DRP MN V+EM++G+ +A
Sbjct:   568 IYRDLEKAHNGKSIETAISNEEDEIAKKMTLVGLWCIQPWPLDRPAMNRVVEMMEGNLDA 627

Query:   350 LQIPPTPFLSSPPRAPI-DSFTFS 372
             L++PP P L   P A + +S TFS
Sbjct:   628 LEVPPRPVLQQIPTATLQESSTFS 651

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2020583 AT1G70250 [Arabidopsis thaliana (taxid:3702)]

 Score = 885 (316.6 bits), Expect = 1.2e-88, P = 1.2e-88
 Identities = 177/339 (52%), Positives = 237/339 (69%)

Query:    51 RKITKSDKDLEAFIRNYGPLPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLLD---- 106
             RK   ++K++EA +       LKR+++  VKK+T SF++ LG+GGFG VYKG+L D    
Sbjct:   431 RKSDLNEKNMEAVVM------LKRFSYVQVKKMTKSFENVLGKGGFGTVYKGKLPDGSRD 484

Query:   107 --------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV 152
                           DF+NE+AS+SRTSH N+V+LLGFC EG  +A+IYE MPNGSL+KF+
Sbjct:   485 VAVKILKESNEDGEDFINEIASMSRTSHANIVSLLGFCYEGRKKAIIYELMPNGSLDKFI 544

Query:   153 YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKIS 212
                 ++K    + W+ +Y I +G++ GLEYLH  C ++I+HFDIKP NIL+D D CPKIS
Sbjct:   545 SKNMSAK----MEWKTLYNIAVGVSHGLEYLHSHCVSRIVHFDIKPQNILIDGDLCPKIS 600

Query:   213 DFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
             DFGLAKLC   E I+S +L ARG IGYIAPEVFS+NFG VSHKSDVYS+GM+++E++G +
Sbjct:   601 DFGLAKLCKNNESIIS-MLHARGTIGYIAPEVFSQNFGGVSHKSDVYSYGMVVLEMIGAR 659

Query:   273 N--NLDSGVDSSSEVYFPHWIYRHVEQDREFK-LPGVVTRKENE-IAKKMIIVGLWCIQA 328
             N     +   S++ +YFP WIY+ +E+      L   +T +E+E I KKM++VGLWCIQ 
Sbjct:   660 NIGRAQNAGSSNTSMYFPDWIYKDLEKGEIMSFLADQITEEEDEKIVKKMVLVGLWCIQT 719

Query:   329 RPSDRPPMNEVIEMLQGSTEALQIPPTPFLSSPP-RAPI 366
              P DRPPM++V+EML+GS EALQIPP P L  P   API
Sbjct:   720 NPYDRPPMSKVVEMLEGSLEALQIPPKPLLCLPAITAPI 758

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2141862 AT4G18250 [Arabidopsis thaliana (taxid:3702)]

 Score = 882 (315.5 bits), Expect = 2.5e-88, P = 2.5e-88
 Identities = 171/335 (51%), Positives = 235/335 (70%)

Query:    50 RRKITKSDKDLEAFIRNYGPLPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLLD--- 106
             +RK   +D+++EA +       LKRY+F  VKK+TNSF   +G+GGFG VYKG+L D   
Sbjct:   490 KRKSELNDENIEAVVM------LKRYSFEKVKKMTNSFDHVIGKGGFGTVYKGKLPDASG 543

Query:   107 ----------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEK 150
                             +F+NE+ S+SR SHVN+V+L GFC EG+ RA+IYEFMPNGSL+K
Sbjct:   544 RDIALKILKESKGNGEEFINELVSMSRASHVNIVSLFGFCYEGSQRAIIYEFMPNGSLDK 603

Query:   151 FVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPK 210
             F+    ++K    + W+ +Y I +G+A+GLEYLH+ C +KI+HFDIKP NIL+DED CPK
Sbjct:   604 FISENMSTK----IEWKTLYNIAVGVARGLEYLHNSCVSKIVHFDIKPQNILIDEDLCPK 659

Query:   211 ISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG 270
             ISDFGLAKLC  KE I+S +L ARG +GYIAPE+FS+N+G VSHKSDVYS+GM+++E++G
Sbjct:   660 ISDFGLAKLCKKKESIIS-MLDARGTVGYIAPEMFSKNYGGVSHKSDVYSYGMVVLEMIG 718

Query:   271 C--KNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL--PGVVTRKENE-IAKKMIIVGLWC 325
                +  +++     S +YFP W+Y  +E+    +L    ++  +E E I K+M +VGLWC
Sbjct:   719 ATKREEVETSATDKSSMYFPDWVYEDLERKETMRLLEDHIIEEEEEEKIVKRMTLVGLWC 778

Query:   326 IQARPSDRPPMNEVIEMLQGST-EALQIPPTPFLS 359
             IQ  PSDRPPM +V+EML+GS  EALQ+PP P L+
Sbjct:   779 IQTNPSDRPPMRKVVEMLEGSRLEALQVPPKPLLN 813

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2176717 AT5G38260 [Arabidopsis thaliana (taxid:3702)]

 Score = 866 (309.9 bits), Expect = 1.3e-86, P = 1.3e-86
 Identities = 165/325 (50%), Positives = 231/325 (71%)

Query:    68 GPLPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLLD-----------------DFVN 110
             G + LK+Y++++V+K+T  F   LG+GGFG VY G L D                 DF+N
Sbjct:   304 GLVQLKQYSYAEVRKITKLFSHTLGKGGFGTVYGGNLCDGRKVAVKILKDFKSNGEDFIN 363

Query:   111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY 170
             EVAS+S+TSHVN+V+LLGFC EG+ RA++YEF+ NGSL++F+    + K    L    +Y
Sbjct:   364 EVASMSQTSHVNIVSLLGFCYEGSKRAIVYEFLENGSLDQFL----SEKKSLNLDVSTLY 419

Query:   171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSL 230
              I +G+A+GL+YLHHGC T+I+HFDIKP NILLD+ FCPK+SDFGLAKLC  +E I+S L
Sbjct:   420 RIALGVARGLDYLHHGCKTRIVHFDIKPQNILLDDTFCPKVSDFGLAKLCEKRESILS-L 478

Query:   231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNL--DSGVDSSSEVYFP 288
             L ARG IGYIAPEVFS  +G VSHKSDVYS+GM+++E++G KN    ++   +SS  YFP
Sbjct:   479 LDARGTIGYIAPEVFSGMYGRVSHKSDVYSYGMLVLEMIGAKNKEIEETAASNSSSAYFP 538

Query:   289 HWIYRHVEQDRE-FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST 347
              WIY+++E   + +K    ++R++ E+AKKM +VGLWCIQ  P +RPPMN ++EM++GS 
Sbjct:   539 DWIYKNLENGEDTWKFGDEISREDKEVAKKMTLVGLWCIQPSPLNRPPMNRIVEMMEGSL 598

Query:   348 EALQIPPTPFL--SSPPRAPIDSFT 370
             + L++PP P +  S+ P   + SF+
Sbjct:   599 DVLEVPPKPSIHYSAEPLPQLSSFS 623

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2019713 AT1G67000 [Arabidopsis thaliana (taxid:3702)]

 Score = 846 (302.9 bits), Expect = 1.7e-84, P = 1.7e-84
 Identities = 171/331 (51%), Positives = 230/331 (69%)

Query:    70 LPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLLD------------------DFVNE 111
             +PLK Y +++VKK+T SF + +G+GGFG VY G L D                  DF+NE
Sbjct:   541 IPLKHYTYAEVKKMTKSFTEVVGRGGFGIVYSGTLSDSSMVAVKVLKDSKGTDGEDFINE 600

Query:   112 VASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYE 171
             VAS+S+TSHVN+V+LLGFC EG+ RA+IYEF+ NGSL+KF+    + K    L  + +Y 
Sbjct:   601 VASMSQTSHVNIVSLLGFCCEGSRRAIIYEFLGNGSLDKFI----SDKSSVNLDLKTLYG 656

Query:   172 IVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLL 231
             I +G+A+GLEYLH+GC T+I+HFDIKP N+LLD++ CPK+SDFGLAKLC  KE I+S LL
Sbjct:   657 IALGVARGLEYLHYGCKTRIVHFDIKPQNVLLDDNLCPKVSDFGLAKLCEKKESILS-LL 715

Query:   232 GARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGC--KNNLDSGVDSS-SEVYFP 288
               RG IGYIAPE+ SR +G VSHKSDVYS+GM+++E++G   K   D    S  S +YFP
Sbjct:   716 DTRGTIGYIAPEMISRLYGSVSHKSDVYSYGMLVLEMIGARKKERFDQNSRSDGSSIYFP 775

Query:   289 HWIYRHVEQ----DREFKLPGV-----VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEV 339
              WIY+ +E+    D E    G      ++ +E EIA+KM +VGLWCIQ+ PSDRPPMN+V
Sbjct:   776 EWIYKDLEKANIKDIEKTENGGLIENGISSEEEEIARKMTLVGLWCIQSSPSDRPPMNKV 835

Query:   340 IEMLQGSTEALQIPPTPFLSSPPRAPI-DSF 369
             +EM++GS +AL++PP P L     + + DSF
Sbjct:   836 VEMMEGSLDALEVPPRPVLQQISASSVSDSF 866

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2019688 AT1G66930 [Arabidopsis thaliana (taxid:3702)]

 Score = 838 (300.0 bits), Expect = 1.2e-83, P = 1.2e-83
 Identities = 162/320 (50%), Positives = 225/320 (70%)

Query:    70 LPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLLD------------------DFVNE 111
             +PLK Y ++ VK++T SF + +G+GGFG VY+G L D                  DF+NE
Sbjct:   331 IPLKHYTYAQVKRMTKSFAEVVGRGGFGIVYRGTLCDGRMVAVKVLKESKGNNSEDFINE 390

Query:   112 VASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYE 171
             V+S+S+TSHVN+V+LLGFC EG+ RA+IYEF+ NGSL+KF+    + K    L    +Y 
Sbjct:   391 VSSMSQTSHVNIVSLLGFCSEGSRRAIIYEFLENGSLDKFI----SEKTSVILDLTALYG 446

Query:   172 IVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLL 231
             I +G+A+GLEYLH+GC T+I+HFDIKP N+LLD++  PK+SDFGLAKLC  KE ++S L+
Sbjct:   447 IALGVARGLEYLHYGCKTRIVHFDIKPQNVLLDDNLSPKVSDFGLAKLCEKKESVMS-LM 505

Query:   232 GARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSS--SEVYFPH 289
               RG IGYIAPE+ SR +G VSHKSDVYS+GM++ E++G +     G +S+  S +YFP 
Sbjct:   506 DTRGTIGYIAPEMISRVYGSVSHKSDVYSYGMLVFEMIGARKKERFGQNSANGSSMYFPE 565

Query:   290 WIYRHVEQDREFKLPGV---VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGS 346
             WIY+ +E+     L  +   ++ +E EIAKKM +VGLWCIQ+ PSDRPPMN+V+EM++GS
Sbjct:   566 WIYKDLEKADNGDLEHIEIGISSEEEEIAKKMTLVGLWCIQSSPSDRPPMNKVVEMMEGS 625

Query:   347 TEALQIPPTPFLSSPPRAPI 366
              +AL++PP P L      P+
Sbjct:   626 LDALEVPPRPVLQQIHVGPL 645

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2177142 AT5G39020 [Arabidopsis thaliana (taxid:3702)]

 Score = 828 (296.5 bits), Expect = 1.3e-82, P = 1.3e-82
 Identities = 159/332 (47%), Positives = 231/332 (69%)

Query:    43 LTLSAAVRRKITKSDKDLEAFIRNYGPLPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKG 102
             + L   ++RK  K +  +  F      L LK+Y ++++KK+T SF   +G+GGFG VY+G
Sbjct:   459 MLLIRQMKRKKNKKENSVIMF-----KLLLKQYIYAELKKITKSFSHTVGKGGFGTVYRG 513

Query:   103 RLL-----------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 145
              L                  DDF+NEV S+S+TSHVN+V+LLGFC EG+ RA+I EF+ +
Sbjct:   514 NLSNGRTVAVKVLKDLKGNGDDFINEVTSMSQTSHVNIVSLLGFCYEGSKRAIISEFLEH 573

Query:   146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE 205
             GSL++F+    +  P        +Y I +GIA+GLEYLH+GC T+I+HFDIKP NILLD+
Sbjct:   574 GSLDQFISRNKSLTP----NVTTLYGIALGIARGLEYLHYGCKTRIVHFDIKPQNILLDD 629

Query:   206 DFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMI 265
             +FCPK++DFGLAKLC  +E I+S L+  RG IGYIAPEV SR +G +SHKSDVYS+GM++
Sbjct:   630 NFCPKVADFGLAKLCEKRESILS-LIDTRGTIGYIAPEVVSRMYGGISHKSDVYSYGMLV 688

Query:   266 MELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQ-DREFKLPGVVTRKENEIAKKMIIVGLW 324
             ++++G +N +++   + S  YFP WIY+ +E  D+ + +   +  ++N+I KKMI+V LW
Sbjct:   689 LDMIGARNKVETTTCNGSTAYFPDWIYKDLENGDQTWIIGDEINEEDNKIVKKMILVSLW 748

Query:   325 CIQARPSDRPPMNEVIEMLQGSTEALQIPPTP 356
             CI+  PSDRPPMN+V+EM++GS +AL++PP P
Sbjct:   749 CIRPCPSDRPPMNKVVEMIEGSLDALELPPKP 780

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009625 "response to insect" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

TAIR|locus:2177152 AT5G39030 [Arabidopsis thaliana (taxid:3702)]

 Score = 825 (295.5 bits), Expect = 2.8e-82, P = 2.8e-82
 Identities = 162/305 (53%), Positives = 220/305 (72%)

Query:    72 LKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRL-----------------LDDFVNEVAS 114
             L  Y ++++KK+T SF   +G+GGFG VY G L                  +DF+NEVAS
Sbjct:   485 LNMYTYAELKKITKSFSYIIGKGGFGTVYGGNLSNGRKVAVKVLKDLKGSAEDFINEVAS 544

Query:   115 ISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVI 174
             +S+TSHVN+V+LLGFC EG+ RA++YEF+ NGSL++F+    +    Q +    +Y I +
Sbjct:   545 MSQTSHVNIVSLLGFCFEGSKRAIVYEFLENGSLDQFMSRNKSLT--QDVT--TLYGIAL 600

Query:   175 GIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGAR 234
             GIA+GLEYLH+GC T+I+HFDIKP NILLD + CPK+SDFGLAKLC  +E ++S L+  R
Sbjct:   601 GIARGLEYLHYGCKTRIVHFDIKPQNILLDGNLCPKVSDFGLAKLCEKRESVLS-LMDTR 659

Query:   235 GIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNN-LDSGVDSS-SEVYFPHWIY 292
             G IGYIAPEVFSR +G VSHKSDVYSFGM++++++G ++  +   VDS+ S  YFP WIY
Sbjct:   660 GTIGYIAPEVFSRMYGRVSHKSDVYSFGMLVIDMIGARSKEIVETVDSAASSTYFPDWIY 719

Query:   293 RHVEQDREFKLPG-VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQ 351
             + +E   +  + G  +T++E EIAKKMI+VGLWCIQ  PSDRP MN V+EM++GS +AL+
Sbjct:   720 KDLEDGEQTWIFGDEITKEEKEIAKKMIVVGLWCIQPCPSDRPSMNRVVEMMEGSLDALE 779

Query:   352 IPPTP 356
             IPP P
Sbjct:   780 IPPKP 784

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2176707 AT5G38250 [Arabidopsis thaliana (taxid:3702)]

 Score = 764 (274.0 bits), Expect = 8.1e-76, P = 8.1e-76
 Identities = 148/264 (56%), Positives = 198/264 (75%)

Query:   101 KGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKP 160
             KG   +DF+NEVAS+S+TSHVN+VTLLGFC EG+ RA+IYEF+ NGSL++ + N D S  
Sbjct:   307 KGNC-EDFINEVASMSQTSHVNIVTLLGFCYEGSKRAIIYEFLENGSLDQSL-NLDVST- 363

Query:   161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
                     +Y I +G+A+GLEYLH+GC T+I+HFDIKP N+LLDE+  PK++DFGLAKLC
Sbjct:   364 --------LYGIALGVARGLEYLHYGCKTRIVHFDIKPQNVLLDENLRPKVADFGLAKLC 415

Query:   221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNN--LDSG 278
               +E I+S LL  RG IGYIAPE+FSR +G VSHKSDVYS+GM+++E++G +N   + + 
Sbjct:   416 EKQESILS-LLDTRGTIGYIAPELFSRMYGSVSHKSDVYSYGMLVLEMIGARNKERVQNA 474

Query:   279 VDSSSEVYFPHWIYRHVEQDREFKLPGV-VTRKENEIAKKMIIVGLWCIQARPSDRPPMN 337
               ++S  YFP WIY+ +E     +L G  +TR+E + AKKMI+VGLWCIQ RPSDRP MN
Sbjct:   475 DPNNSSAYFPDWIYKDLENFDNTRLLGDGLTREEEKNAKKMILVGLWCIQFRPSDRPSMN 534

Query:   338 EVIEMLQGSTEALQIPPTPFLSSP 361
             +V+EM++GS ++L  PP P L  P
Sbjct:   535 KVVEMMEGSLDSLDPPPKPLLHMP 558

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	372
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-42
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-42
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-42
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-39
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	5e-38
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-37
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	8e-33
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-27
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-26
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	8e-25
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	9e-25
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-24
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-23
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-23
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	7e-23
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-22
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-22
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-22
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-22
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	6e-22
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	9e-22
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	9e-22
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-21
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-21
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-21
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	6e-21
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	7e-21
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-20
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-20
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-20
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-20
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	8e-20
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-19
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	8e-19
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-18
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-18
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-18
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	9e-18
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	9e-18
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-17
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-17
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-17
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-17
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-17
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	5e-17
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-16
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-16
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-16
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-16
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-16
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-16
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-16
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	6e-16
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	6e-16
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	8e-16
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	8e-16
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-15
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-15
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-15
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-15
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-15
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-15
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-15
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-15
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-15
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-15
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-15
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-15
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	5e-15
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	7e-15
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-14
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-14
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-14
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-14
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-14
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-14
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-14
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-14
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-14
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	6e-14
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	7e-14
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	7e-14
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	8e-14
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	9e-14
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-13
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-13
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-13
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-13
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-13
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-13
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-13
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-13
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-13
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-13
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-13
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	5e-13
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	7e-13
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	7e-13
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	9e-13
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-12
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-12
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-12
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-12
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-12
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-12
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-12
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-12
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-12
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-12
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	6e-12
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	8e-12
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	8e-12
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-11
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-11
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-11
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-11
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-11
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-11
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-11
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-11
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-11
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-11
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-11
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-11
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-11
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-11
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-11
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-11
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-11
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	7e-11
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	7e-11
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	9e-11
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-10
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-10
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-10
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-10
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-10
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-10
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-10
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-10
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-10
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-10
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-10
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-10
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-10
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	6e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	6e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	9e-10
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	9e-10
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	9e-10
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-09
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-09
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-09
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-09
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-09
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-09
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-09
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-09
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-09
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-09
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-09
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-09
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-09
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-09
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	6e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	6e-09
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	6e-09
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	6e-09
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	7e-09
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-08
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-08
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-08
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-08
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-08
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-08
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-08
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-08
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-08
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-08
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-08
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-08
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-08
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-08
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-08
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-08
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-08
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-08
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-08
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-08
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	5e-08
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-08
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	6e-08
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	7e-08
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	8e-08
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	8e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-07
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-07
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-07
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-07
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-07
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-07
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-07
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-07
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-07
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-07
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-07
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-07
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-07
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-07
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-07
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	5e-07
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-07
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	6e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	6e-07
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	7e-07
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	7e-07
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	7e-07
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	7e-07
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	8e-07
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	8e-07
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	9e-07
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	9e-07
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-06
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-06
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-06
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-06
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-06
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-06
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-06
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-06
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-06
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	6e-06
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	6e-06
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	7e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	7e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-05
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-05
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-05
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-05
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-05
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-05
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-05
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-05
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-05
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-05
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-05
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-05
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-05
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-05
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	4e-05
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	4e-05
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-05
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	6e-05
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	7e-05
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	7e-05
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	8e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	8e-05
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	9e-05
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	9e-05
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	9e-05
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-04
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-04
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	1e-04
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-04
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-04
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-04
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	5e-04
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	6e-04
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	0.001
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	0.001
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	0.001
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.002
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.002
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	0.002
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.002
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	0.002
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.003
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.004
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  147 bits (374), Expect = 1e-42
 Identities = 68/204 (33%), Positives = 108/204 (52%), Gaps = 33/204 (16%)

Query: 91  LGQGGFGGVYKGR--------------------LLDDFVNEVASISRTSHVNVVTLLGFC 130
           LG+GGFG VY  R                    LL++ + E+  + + +H N+V L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 131 LEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTK 190
            + N+  L+ E+   GSL+  +      +    L  +++  I++ I +GLEYLH   S  
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLK-----ENEGKLSEDEILRILLQILEGLEYLH---SNG 112

Query: 191 ILHFDIKPHNILLDED-FCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNF 249
           I+H D+KP NILLD D    K++DFGL+KL T+ + ++ ++    G   Y+APEV     
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI---VGTPAYMAPEVLLGK- 168

Query: 250 GEVSHKSDVYSFGMMIMELVGCKN 273
           G  S KSD++S G+++ EL   K+
Sbjct: 169 GYYSEKSDIWSLGVILYELPELKD 192

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  148 bits (376), Expect = 2e-42
 Identities = 74/287 (25%), Positives = 123/287 (42%), Gaps = 60/287 (20%)

Query: 86  SFKDKLGQGGFGGVYKGRLLD------------------------DFVNEVASISRTSHV 121
           +   KLG+G FG VYKG+L                          +F+ E   + +  H 
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 122 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGL 180
           NVV LLG C E     ++ E+M  G L  ++  N         L    +    + IA+G+
Sbjct: 62  NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK------LSLSDLLSFALQIARGM 115

Query: 181 EYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYI 240
           EYL    S   +H D+   N L+ E+   KISDFGL++     +       G +  I ++
Sbjct: 116 EYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKR--GGKLPIRWM 170

Query: 241 APEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHW----IYRHVE 296
           APE      G+ + KSDV+SFG+++ E+            +  E  +P      +  +++
Sbjct: 171 APESL--KEGKFTSKSDVWSFGVLLWEIF-----------TLGEQPYPGMSNEEVLEYLK 217

Query: 297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEML 343
               ++LP     +      ++  + L C    P DRP  +E++E+L
Sbjct: 218 NG--YRLP-----QPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  147 bits (373), Expect = 5e-42
 Identities = 75/286 (26%), Positives = 123/286 (43%), Gaps = 57/286 (19%)

Query: 86  SFKDKLGQGGFGGVYKGRL------------------------LDDFVNEVASISRTSHV 121
           +   KLG+G FG VYKG L                        +++F+ E   + +  H 
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 122 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           N+V LLG C E     ++ E+MP G L  ++         + L    +    + IA+G+E
Sbjct: 62  NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYL----RKNRPKELSLSDLLSFALQIARGME 117

Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           YL    S   +H D+   N L+ E+   KISDFGL++     +       G +  I ++A
Sbjct: 118 YLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVK--GGKLPIRWMA 172

Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHW----IYRHVEQ 297
           PE      G+ + KSDV+SFG+++ E+            +  E  +P      +  ++++
Sbjct: 173 PESL--KEGKFTSKSDVWSFGVLLWEIF-----------TLGEEPYPGMSNAEVLEYLKK 219

Query: 298 DREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEML 343
                 P        E+ K M    L C    P DRP  +E++E+L
Sbjct: 220 GYRLPKP---PNCPPELYKLM----LQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  139 bits (353), Expect = 5e-39
 Identities = 80/284 (28%), Positives = 127/284 (44%), Gaps = 55/284 (19%)

Query: 87  FKDKLGQGGFGGVYKGRL------------------------LDDFVNEVASISRTSHVN 122
              KLG+G FG VYKG L                         ++F+ E + + + SH N
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62

Query: 123 VVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 182
           +V LLG C +G    ++ E+MP G L  F+           L  + + ++ + IAKG+EY
Sbjct: 63  IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK-----LTLKDLLQMALQIAKGMEY 117

Query: 183 LHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAP 242
           L    S   +H D+   N L+ E+   KISDFGL++    ++       G +  I ++AP
Sbjct: 118 LE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRD-IYEDDYYRKRGGGKLPIKWMAP 173

Query: 243 EVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK 302
           E      G+ + KSDV+SFG+++ E+        +  +          +   +E     +
Sbjct: 174 ESL--KDGKFTSKSDVWSFGVLLWEIF-------TLGEQPYPGMSNEEVLELLEDGY--R 222

Query: 303 LPGVVTRKEN---EIAKKMIIVGLWCIQARPSDRPPMNEVIEML 343
           LP    R EN   E+ + M    L C    P DRP  +E++E L
Sbjct: 223 LP----RPENCPDELYELM----LQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  136 bits (346), Expect = 5e-38
 Identities = 84/293 (28%), Positives = 124/293 (42%), Gaps = 68/293 (23%)

Query: 89  DKLGQGGFGGVYKGRLLD-----------------------DFVNEVASISRTSHVNVVT 125
            KLG+G FG VYKG+L                         DF+ E   + +  H NVV 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 126 LLGFCLEGNNRALIYEFMPNGSLEKFV---YNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 182
           LLG C E     L+ E+M  G L  ++        S     L  + +    I IAKG+EY
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 183 LHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAP 242
           L    S K +H D+   N L+ ED   KISDFGL++     +       G +  I ++AP
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK-TGGKLPIRWMAP 176

Query: 243 EVFSRNFGEVSHKSDVYSFGMMIMELV--------GCKNNLDSGVDSSSEVYFPHWIYRH 294
           E      G  + KSDV+SFG+++ E+         G  N                 +  +
Sbjct: 177 ESL--KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---------------EEVLEY 219

Query: 295 VEQDREFKLPGVVTRKEN---EIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
           + +   ++LP    + E    E+ + M    L C Q  P DRP  +E++E L+
Sbjct: 220 LRKG--YRLP----KPEYCPDELYELM----LSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  135 bits (341), Expect = 2e-37
 Identities = 77/277 (27%), Positives = 118/277 (42%), Gaps = 45/277 (16%)

Query: 87  FKDKLGQGGFGGVYKGRLLDD---------------------FVNEVASISRTSHVNVVT 125
              KLG G FG VYK +                            E+  + R SH N+V 
Sbjct: 3   LLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVR 62

Query: 126 LLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH 184
           L+    + ++  L+ E+   G L +     G        L  ++  +I + I +GLEYLH
Sbjct: 63  LIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG-------PLSEDEAKKIALQILRGLEYLH 115

Query: 185 HGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV 244
              S  I+H D+KP NILLDE+   KI+DFGLAK        +++ +G      Y+APEV
Sbjct: 116 ---SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTP---WYMAPEV 169

Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
                G    K DV+S G+++ EL+       SG +   +      + R +      +  
Sbjct: 170 LLGGNG-YGPKVDVWSLGVILYELL-TGKPPFSGENILDQ----LQLIRRI-LGPPLEFD 222

Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
                  +E AK +I     C+   PS RP   E+++
Sbjct: 223 EPKWSSGSEEAKDLI---KKCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  122 bits (309), Expect = 8e-33
 Identities = 55/203 (27%), Positives = 88/203 (43%), Gaps = 35/203 (17%)

Query: 87  FKDKLGQGGFGGVYKGRLLDD--------------------FVNEVASISRTSHVNVVTL 126
             +KLG+G FG VY  R                         + E+  + +  H N+V L
Sbjct: 3   ILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRL 62

Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                + +   L+ E+   G L   +         +   +  + +I+      LEYLH  
Sbjct: 63  YDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFY--LRQIL----SALEYLH-- 114

Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            S  I+H D+KP NILLDED   K++DFGLA+     E  +++ +G      Y+APEV  
Sbjct: 115 -SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE-KLTTFVGTP---EYMAPEVLL 169

Query: 247 RNFGEVSHKSDVYSFGMMIMELV 269
                     D++S G+++ EL+
Sbjct: 170 GK--GYGKAVDIWSLGVILYELL 190

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  108 bits (271), Expect = 2e-27
 Identities = 59/210 (28%), Positives = 86/210 (40%), Gaps = 51/210 (24%)

Query: 90  KLGQGGFGGVYKG---------------------RLLDDFVNEVASISRTSHVNVVTLLG 128
            LG+G FG VY                         L+    E+  +S   H N+V   G
Sbjct: 7   LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66

Query: 129 FCL--EGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG-----IAKGLE 181
                E N   +  E++  GSL   +               K+ E VI      I +GL 
Sbjct: 67  SERDEEKNTLNIFLEYVSGGSLSSLLKKFG-----------KLPEPVIRKYTRQILEGLA 115

Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG--- 238
           YLH   S  I+H DIK  NIL+D D   K++DFG AK    + G + +  G   + G   
Sbjct: 116 YLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAK----RLGDIETGEGTGSVRGTPY 168

Query: 239 YIAPEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           ++APEV      E    +D++S G  ++E+
Sbjct: 169 WMAPEVIRG--EEYGRAADIWSLGCTVIEM 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  105 bits (265), Expect = 1e-26
 Identities = 70/278 (25%), Positives = 116/278 (41%), Gaps = 53/278 (19%)

Query: 87  FKDKLGQGGFG----GVYKGR------------LLDDFVNEVASISRTSHVNVVTLLGFC 130
               +G+G FG    G Y+G+                F+ E + ++   H N+V LLG  
Sbjct: 10  LGATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69

Query: 131 LEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTK 190
           L+GN   ++ E+M  GSL  ++     S+    +   +     + + +G+EYL       
Sbjct: 70  LQGNPLYIVTEYMAKGSLVDYL----RSRGRAVITLAQQLGFALDVCEGMEYLE---EKN 122

Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFG 250
            +H D+   N+L+ ED   K+SDFGLAK  +            +  + + APE       
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAKEAS------QGQDSGKLPVKWTAPEALRE--K 174

Query: 251 EVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHW----IYRHVEQDREFKLPGV 306
           + S KSDV+SFG+++ E+            S   V +P      +  HVE+    + P  
Sbjct: 175 KFSTKSDVWSFGILLWEIY-----------SFGRVPYPRIPLKDVVPHVEKGYRMEAPEG 223

Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
                 E+ K M      C +  P+ RP   ++ E L 
Sbjct: 224 CP---PEVYKVM----KDCWELDPAKRPTFKQLREQLA 254

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  101 bits (253), Expect = 8e-25
 Identities = 62/197 (31%), Positives = 100/197 (50%), Gaps = 28/197 (14%)

Query: 90  KLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHVNVVTLLGFCLE 132
           KLG G FG V+ G                    + F+ E   + +  H  +V L   C E
Sbjct: 13  KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72

Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKIL 192
                ++ E+M  GSL  F+ +G+  K    LR  ++ ++   IA+G+ YL    S   +
Sbjct: 73  EEPIYIVTEYMSKGSLLDFLKSGEGKK----LRLPQLVDMAAQIAEGMAYLE---SRNYI 125

Query: 193 HFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEV 252
           H D+   NIL+ E+   KI+DFGLA+L   ++   ++  GA+  I + APE  + N+G  
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARL--IEDDEYTAREGAKFPIKWTAPE--AANYGRF 181

Query: 253 SHKSDVYSFGMMIMELV 269
           + KSDV+SFG+++ E+V
Sbjct: 182 TIKSDVWSFGILLTEIV 198

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  101 bits (254), Expect = 9e-25
 Identities = 82/290 (28%), Positives = 123/290 (42%), Gaps = 52/290 (17%)

Query: 91  LGQGGFGGVYKG----------------RLLDD--------FVNEVASISRTSHVNVVTL 126
           LG G FG VYKG                 L ++         ++E   ++   H +VV L
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNG-DTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
           LG CL  +   LI + MP G L  +V N  D       L W       + IAKG+ YL  
Sbjct: 75  LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYLE- 126

Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVF 245
               +++H D+   N+L+      KI+DFGLAKL    E    +  G +  I ++A E  
Sbjct: 127 --EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAE-GGKVPIKWMALE-- 181

Query: 246 SRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG 305
           S      +HKSDV+S+G+ + EL+        G+ +         I   +E+      P 
Sbjct: 182 SILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-------IPDLLEKGERLPQPP 234

Query: 306 VVTRKENEIAKKMIIVGLWCIQA--RPSDRPPMNEVIEMLQGSTEALQIP 353
           + T     I   M++V  W I A  RP+ +  +NE  +M +     L I 
Sbjct: 235 ICT-----IDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQRYLVIQ 279

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 99.2 bits (248), Expect = 4e-24
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 43/208 (20%)

Query: 86  SFKDKLGQGGFGGVYKGR-------------------LLDDFVNEVASISRTSHVNVVTL 126
              +K+G+GGFG VYK R                     +  +NE+  + +  H N+V  
Sbjct: 3   EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKY 62

Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYE-----IVIGIAKGLE 181
            G  L+ +   ++ EF   GSL+      D  K       + + E     +   + KGLE
Sbjct: 63  YGSYLKKDELWIVMEFCSGGSLK------DLLK----STNQTLTESQIAYVCKELLKGLE 112

Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           YLH   S  I+H DIK  NILL  D   K+ DFGL+    +     ++++G      ++A
Sbjct: 113 YLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSA-QLSDTKARNTMVGTP---YWMA 165

Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELV 269
           PEV +       +K+D++S G+  +EL 
Sbjct: 166 PEVING--KPYDYKADIWSLGITAIELA 191

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 97.8 bits (244), Expect = 2e-23
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 34/200 (17%)

Query: 91  LGQGGFGGVYKGRLL-----------------------DDFVNEVASISRTSHVNVVTLL 127
           +G G FG V +GRL                         DF+ E + + +  H N++ L 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
           G   +     +I E+M NGSL+KF+   D           ++  ++ GIA G++YL    
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDKFLREND-----GKFTVGQLVGMLRGIASGMKYLSEMN 126

Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSR 247
               +H D+   NIL++ +   K+SDFGL++     E   ++  G +  I + APE  + 
Sbjct: 127 Y---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTT-KGGKIPIRWTAPEAIA- 181

Query: 248 NFGEVSHKSDVYSFGMMIME 267
            + + +  SDV+SFG+++ E
Sbjct: 182 -YRKFTSASDVWSFGIVMWE 200

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 99.8 bits (247), Expect = 2e-23
 Identities = 73/277 (26%), Positives = 108/277 (38%), Gaps = 34/277 (12%)

Query: 90  KLGQGGFGGVYKGRLLDDFVNEVASISRTS--------------------HVNVVTLLGF 129
           KLG+G FG VY  R       +V +    S                      N+V L  F
Sbjct: 7   KLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDF 66

Query: 130 CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCST 189
             +  +  L+ E++  GSLE  +       P   L   +   I+  I   LEYLH   S 
Sbjct: 67  FQDEGSLYLVMEYVDGGSLEDLLKKIGRKGP---LSESEALFILAQILSALEYLH---SK 120

Query: 190 KILHFDIKPHNILLDED-FCPKISDFGLAKL---CTTKEGIVSSLLGARGIIGYIAPEVF 245
            I+H DIKP NILLD D    K+ DFGLAKL     +   I +    + G  GY+APEV 
Sbjct: 121 GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180

Query: 246 SR-NFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
              +    S  SD++S G+ + EL+      +   +SS+       I           L 
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLS 240

Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
                  ++ A  ++      +   P +R   +  + 
Sbjct: 241 PSNPELISKAASDLL---KKLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 96.1 bits (240), Expect = 7e-23
 Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 47/207 (22%)

Query: 89  DKLGQGGFGGVYKGR--------------LLDDF------VNEVASISRTSHVNVVTLLG 128
             LGQG  G VYK R              +  D       + E+ ++       VV   G
Sbjct: 7   KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66

Query: 129 -FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG-----IAKGLEY 182
            F  EG   +++ E+M  GSL   +            +  K+ E V+      I KGL+Y
Sbjct: 67  AFYKEGE-ISIVLEYMDGGSLADLLK-----------KVGKIPEPVLAYIARQILKGLDY 114

Query: 183 LHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAP 242
           LH      I+H DIKP N+L++     KI+DFG++K+        ++ +G    + Y++P
Sbjct: 115 LHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGT---VTYMSP 169

Query: 243 EVFSRNFGEV-SHKSDVYSFGMMIMEL 268
           E      GE  S+ +D++S G+ ++E 
Sbjct: 170 ERIQ---GESYSYAADIWSLGLTLLEC 193

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 95.3 bits (237), Expect = 1e-22
 Identities = 72/278 (25%), Positives = 120/278 (43%), Gaps = 45/278 (16%)

Query: 86  SFKDKLGQGGFGGVYKG------------------RLLDDFVNEVASISRTSHVNVVTLL 127
           + K KLG G +G VY+G                    +++F+ E A +    H N+V LL
Sbjct: 9   TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 68

Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVY-NGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
           G C       +I EFM  G+L  ++            L +     +   I+  +EYL   
Sbjct: 69  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE-- 121

Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
                +H D+   N L+ E+   K++DFGL++L        ++  GA+  I + APE  S
Sbjct: 122 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTAPE--S 176

Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
             + + S KSDV++FG+++ E+     +   G+D S        +Y  +E+    + P  
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKGYRMERPEG 229

Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
              K  E+ +        C Q  PSDRP   E+ +  +
Sbjct: 230 CPPKVYELMRA-------CWQWNPSDRPSFAEIHQAFE 260

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 94.4 bits (235), Expect = 3e-22
 Identities = 76/268 (28%), Positives = 119/268 (44%), Gaps = 54/268 (20%)

Query: 90  KLGQGGFGGVYKGR------------------LLDDFVNEVASISRTSHVNVVTLLGFCL 131
           KLG G FG V++G                      DF  EV ++ R  H ++++L   C 
Sbjct: 13  KLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72

Query: 132 EGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKI 191
            G    +I E M  GSL  F+ + +     Q L    + ++   +A+G+ YL        
Sbjct: 73  VGEPVYIITELMEKGSLLAFLRSPEG----QVLPVASLIDMACQVAEGMAYLE---EQNS 125

Query: 192 LHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI-IGYIAPEVFSRNFG 250
           +H D+   NIL+ ED   K++DFGLA+L   KE +  S    + I   + APE  S   G
Sbjct: 126 IHRDLAARNILVGEDLVCKVADFGLARL--IKEDVYLS--SDKKIPYKWTAPEAASH--G 179

Query: 251 EVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFP----HWIYRHVEQDREFKLPGV 306
             S KSDV+SFG+++ E+            +  +V +P    H +Y  +     +++P  
Sbjct: 180 TFSTKSDVWSFGILLYEMF-----------TYGQVPYPGMNNHEVYDQI--TAGYRMP-C 225

Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRP 334
             +   EI K M+    W  +  P DRP
Sbjct: 226 PAKCPQEIYKIML--ECWAAE--PEDRP 249

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 94.1 bits (234), Expect = 3e-22
 Identities = 70/275 (25%), Positives = 114/275 (41%), Gaps = 43/275 (15%)

Query: 86  SFKDKLGQGGFGGVYKGRLL-----------------DDFVNEVASISRTSHVNVVTLLG 128
           +F  +LG G FG V+ G+                   DDF+ E   + + SH N+V L G
Sbjct: 7   TFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66

Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
            C +     ++ E+M NG L  ++           L  E + ++   + + +EYL     
Sbjct: 67  VCTKQRPIFIVTEYMANGCLLNYLRERK-----GKLGTEWLLDMCSDVCEAMEYLESNG- 120

Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRN 248
              +H D+   N L+ ED   K+SDFGLA+     +   S   G +  + +  PEVF  +
Sbjct: 121 --FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ--GTKFPVKWAPPEVF--D 174

Query: 249 FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVT 308
           +   S KSDV+SFG+++ E+      +     S+SEV         V        P +  
Sbjct: 175 YSRFSSKSDVWSFGVLMWEVFSE-GKMPYERFSNSEV------VESVSAGYRLYRPKLAP 227

Query: 309 RKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEML 343
            +   I          C   +P DRP   +++  L
Sbjct: 228 TEVYTIMYS-------CWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 93.6 bits (233), Expect = 5e-22
 Identities = 80/280 (28%), Positives = 119/280 (42%), Gaps = 62/280 (22%)

Query: 91  LGQGGFGGVYKGRLLDD------------------------FVNEVASISRTSHVNVVTL 126
           LG G FG VY+G  LDD                           E+A +S+  H N+V  
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG-----IAKGLE 181
           LG   E +N  +  E +P GSL K              ++    E VI      I  GLE
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAK-----------LLKKYGSFPEPVIRLYTRQILLGLE 116

Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           YLH       +H DIK  NIL+D +   K++DFG+AK         S     +G   ++A
Sbjct: 117 YLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS----FKGSPYWMA 169

Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PEV ++  G     +D++S G  ++E+        +G    S++     +++     R  
Sbjct: 170 PEVIAQQ-GGYGLAADIWSLGCTVLEMA-------TGKPPWSQLEGVAAVFKIG---RSK 218

Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
           +LP +     +E AK  I   L C+Q  PS RP   E++E
Sbjct: 219 ELPPIPDHLSDE-AKDFI---LKCLQRDPSLRPTAAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 93.5 bits (232), Expect = 6e-22
 Identities = 75/283 (26%), Positives = 126/283 (44%), Gaps = 51/283 (18%)

Query: 79  DVKKLTNSFKDKLGQGGFGGVYKGRLLDD---------------FVNEVASISRTSHVNV 123
           +++KLT    + +G+G FG V +G                    F+ E A +++  H N+
Sbjct: 4   NLQKLT--LGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNL 61

Query: 124 VTLLGFCLEGNNRALIYEFMPNGSLEKFVYN-GDTSKPC-QYLRWEKMYEIVIGIAKGLE 181
           V LLG  L  N   ++ E M  G+L  F+   G       Q L++       + +A+G+E
Sbjct: 62  VRLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFS------LDVAEGME 114

Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           YL    S K++H D+   NIL+ ED   K+SDFGLA++     G+ +S L  +    + A
Sbjct: 115 YLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLPVK----WTA 165

Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE       + S KSDV+S+G+++ E           V S     +P    + V++  E 
Sbjct: 166 PEALKHK--KFSSKSDVWSYGVLLWE-----------VFSYGRAPYPKMSLKEVKECVE- 211

Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
              G            + ++   C +  P  RP  +++ E L+
Sbjct: 212 --KGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 92.9 bits (231), Expect = 9e-22
 Identities = 76/289 (26%), Positives = 123/289 (42%), Gaps = 72/289 (24%)

Query: 89  DKLGQGGFGGVYKGRLLDD-------------------FVNEVASISRTSHVNVVTLLGF 129
           +K+G+G FG VYKG L  +                   F+ E   + +  H N+V L+G 
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60

Query: 130 CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCST 189
           C++     ++ E +P GSL  F+      K    L  +K+ ++ +  A G+EYL    S 
Sbjct: 61  CVQKQPIYIVMELVPGGSLLTFL-----RKKKNRLTVKKLLQMSLDAAAGMEYLE---SK 112

Query: 190 KILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI-IGYIAPEVFSRN 248
             +H D+   N L+ E+   KISDFG+++    + GI +   G + I I + APE    N
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKWTAPEAL--N 168

Query: 249 FGEVSHKSDVYSFGMMIMELV--------GCKNN-----LDSGVDSSSEVYFPHWIYRHV 295
           +G  + +SDV+S+G+++ E          G  N      ++SG    +    P  IYR +
Sbjct: 169 YGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLM 228

Query: 296 EQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
            Q                           C    P +RP  +E+   LQ
Sbjct: 229 LQ---------------------------CWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 93.1 bits (231), Expect = 9e-22
 Identities = 74/280 (26%), Positives = 128/280 (45%), Gaps = 53/280 (18%)

Query: 86  SFKDKLGQGGFGGVYKGRLL-----------------DDFVNEVASISRTSHVNVVTLLG 128
           +   ++G G FG V+ G  L                 +DF+ E   + + SH  +V L G
Sbjct: 7   TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66

Query: 129 FCLEGNNRALIYEFMPNGSLEKFV--YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
            C E +   L++EFM +G L  ++    G  S+       E +  + + + +G+ YL   
Sbjct: 67  VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQ-------ETLLGMCLDVCEGMAYLESS 119

Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
               ++H D+   N L+ E+   K+SDFG+ +     +   +S  G +  + + +PEVFS
Sbjct: 120 N---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWSSPEVFS 174

Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQ-DREFKL-- 303
             F + S KSDV+SFG+++ E V  +        S+SEV         VE  +  F+L  
Sbjct: 175 --FSKYSSKSDVWSFGVLMWE-VFSEGKTPYENRSNSEV---------VETINAGFRLYK 222

Query: 304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEML 343
           P + ++   E+ +        C + RP DRP  + ++  L
Sbjct: 223 PRLASQSVYELMQ-------HCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 96.1 bits (239), Expect = 2e-21
 Identities = 71/246 (28%), Positives = 119/246 (48%), Gaps = 39/246 (15%)

Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKM 169
           +E+A + +  H N+V L+G C       LI+E++   +L + + N         L WE+ 
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---------LSWERR 782

Query: 170 YEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSS 229
            +I IGIAK L +LH  CS  ++  ++ P  I++D    P +       LCT  +  +SS
Sbjct: 783 RKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISS 842

Query: 230 LLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLD--SGVDSS----- 282
                    Y+APE  +R   +++ KSD+Y FG++++EL+  K+  D   GV  S     
Sbjct: 843 --------AYVAPE--TRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWA 892

Query: 283 ----SEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNE 338
               S+ +   WI   +  D        V+  +NEI + M +  L C    P+ RP  N+
Sbjct: 893 RYCYSDCHLDMWIDPSIRGD--------VSVNQNEIVEVMNL-ALHCTATDPTARPCAND 943

Query: 339 VIEMLQ 344
           V++ L+
Sbjct: 944 VLKTLE 949

Length = 968

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 92.1 bits (229), Expect = 2e-21
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 28/200 (14%)

Query: 87  FKDKLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHVNVVTLLGF 129
              KLG G FG V++G                     DF+ E   + +  H  ++ L   
Sbjct: 10  LLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69

Query: 130 CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCST 189
           C       ++ E M  GSL +++  G        L+  ++ ++   +A G+ YL    + 
Sbjct: 70  CTLEEPIYIVTELMKYGSLLEYLQGGAGRA----LKLPQLIDMAAQVASGMAYLE---AQ 122

Query: 190 KILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNF 249
             +H D+   N+L+ E+   K++DFGLA++   KE I  +  GA+  I + APE  +  +
Sbjct: 123 NYIHRDLAARNVLVGENNICKVADFGLARV--IKEDIYEAREGAKFPIKWTAPE--AALY 178

Query: 250 GEVSHKSDVYSFGMMIMELV 269
              S KSDV+SFG+++ E+V
Sbjct: 179 NRFSIKSDVWSFGILLTEIV 198

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 92.1 bits (229), Expect = 3e-21
 Identities = 64/222 (28%), Positives = 98/222 (44%), Gaps = 51/222 (22%)

Query: 87  FKDKLGQGGFGGVYKGRLL-------------------------DDFVNEVASISRTSHV 121
           F ++LG+G FG VYKG L                           +F  E   +S   H 
Sbjct: 9   FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68

Query: 122 NVVTLLGFCLEGNNRALIYEFMPNGSLEKF-VYNGDTSKP---------CQYLRWEKMYE 171
           N+V LLG C +     +++E++ +G L +F V N   S              L       
Sbjct: 69  NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128

Query: 172 IVIGIAKGLEYL--HHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE---GI 226
           I I IA G+EYL  HH      +H D+   N L+ E    KISDFGL++   + +     
Sbjct: 129 IAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQ 183

Query: 227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMEL 268
             SLL  R    ++ PE     +G+ + +SD++SFG+++ E+
Sbjct: 184 SKSLLPVR----WMPPEAIL--YGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 91.0 bits (226), Expect = 6e-21
 Identities = 69/288 (23%), Positives = 128/288 (44%), Gaps = 58/288 (20%)

Query: 91  LGQGGFGGVYKGRL------------------------LDDFVNEVASISRTSHVNVVTL 126
           LG+G FG V +G+L                        +++F++E A +    H NV+ L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 127 LGFCLEGNNRA------LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGL 180
           +G C E ++        +I  FM +G L  F+         + L  + + + ++ IA G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 181 EYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT----KEGIVSSLLGARGI 236
           EYL    +   +H D+   N +L ED    ++DFGL+K   +    ++G ++ +      
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM-----P 178

Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE 296
           + +IA E  +      + KSDV++FG+ + E+         GV++       H IY ++ 
Sbjct: 179 VKWIAIESLADRV--YTSKSDVWAFGVTMWEIATRGQTPYPGVEN-------HEIYDYLR 229

Query: 297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
                K P      E+ + +   ++   C +A P DRP   ++ E+L+
Sbjct: 230 HGNRLKQP------EDCLDELYDLM-YSCWRADPKDRPTFTKLREVLE 270

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 91.0 bits (226), Expect = 7e-21
 Identities = 77/301 (25%), Positives = 128/301 (42%), Gaps = 59/301 (19%)

Query: 80  VKKLTNSFKDKLGQGGFGGVYKGRLL-------------------------DDFVNEVAS 114
           V++ T   K +LG+G FG V+ G                             DF  E   
Sbjct: 2   VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAEL 61

Query: 115 ISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSK-------PCQYLRW 166
           ++   H N+V   G C EG+   +++E+M +G L KF+  +G  +        P   L  
Sbjct: 62  LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121

Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK-LCTTKEG 225
            ++ +I + IA G+ YL    S   +H D+   N L+  D   KI DFG+++ + TT   
Sbjct: 122 SQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY 178

Query: 226 IV--SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSS 283
            V   ++L  R    ++ PE  S  + + + +SDV+SFG+++ E+         G+ S+ 
Sbjct: 179 RVGGHTMLPIR----WMPPE--SIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL-SNE 231

Query: 284 EVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEML 343
           EV         + Q R  + P        E+   M    L C +  P  R  + ++ E L
Sbjct: 232 EV------IECITQGRLLQRPRTCPS---EVYDIM----LGCWKRDPQQRINIKDIHERL 278

Query: 344 Q 344
           Q
Sbjct: 279 Q 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 90.0 bits (224), Expect = 1e-20
 Identities = 60/213 (28%), Positives = 93/213 (43%), Gaps = 47/213 (22%)

Query: 87  FKDKLGQGGFGGVYKG--RLLDDFV-------------------NEVASISRTSHVNVVT 125
             D +G+G FG VYKG      DFV                    E+  +    H N+V 
Sbjct: 4   LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVK 63

Query: 126 LLGFCLEGNNRALIYEFMPNGSLEKFVYN-GDTSKP--CQYLRWEKMYEIVIGIAKGLEY 182
            +G     ++  +I E+  NGSL + +   G   +     Y     +Y+++    +GL Y
Sbjct: 64  YIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVY-----VYQVL----QGLAY 114

Query: 183 LHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG---Y 239
           LH      ++H DIK  NIL  +D   K++DFG+A    TK   VS       ++G   +
Sbjct: 115 LH---EQGVIHRDIKAANILTTKDGVVKLADFGVA----TKLNDVSKDD--ASVVGTPYW 165

Query: 240 IAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
           +APEV        S  SD++S G  ++EL+   
Sbjct: 166 MAPEVI--EMSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 89.0 bits (221), Expect = 3e-20
 Identities = 61/207 (29%), Positives = 91/207 (43%), Gaps = 40/207 (19%)

Query: 90  KLGQGGFGGVYKGRL------------------------LDDFVNEVASISRTSHVNVVT 125
           +LG+G FG V   R                           DF  E+  +    H N+V 
Sbjct: 11  QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70

Query: 126 LLGFCLE--GNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 182
             G C +  G +  LI E++P+GSL  ++  + D     + L +         I KG++Y
Sbjct: 71  YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQ------ICKGMDY 124

Query: 183 LHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT-KEGIVSSLLGARGIIGYIA 241
           L    S + +H D+   NIL++ +   KISDFGLAK+    K+       G   I  Y A
Sbjct: 125 LG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-A 180

Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           PE    +  + S  SDV+SFG+ + EL
Sbjct: 181 PECLRTS--KFSSASDVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 88.3 bits (219), Expect = 4e-20
 Identities = 69/276 (25%), Positives = 126/276 (45%), Gaps = 54/276 (19%)

Query: 89  DKLGQGGFGGVYK-GRLLD--------------------DFVNEVASISRTSHVNVVTLL 127
            KLG+G +G VYK  RL D                    D VNE+  ++  +H N+++  
Sbjct: 6   KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYK 65

Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
              L+GN   ++ E+ P G L K +      +  + +  ++++ I I + +GL+ LH   
Sbjct: 66  EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKR--KLIPEQEIWRIFIQLLRGLQALH--- 120

Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG---YIAPEV 244
             KILH D+K  NILL  +   KI D G++K+             A+  IG   Y+APEV
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM--------AKTQIGTPHYMAPEV 172

Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
           +       S+KSD++S G ++ E+       ++   S  ++      Y+ V++ +   +P
Sbjct: 173 WKGR--PYSYKSDIWSLGCLLYEMATFAPPFEA--RSMQDLR-----YK-VQRGKYPPIP 222

Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI 340
            + ++      +         +Q +P  RP  ++++
Sbjct: 223 PIYSQDLQNFIR-------SMLQVKPKLRPNCDKIL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 87.9 bits (219), Expect = 5e-20
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 37/205 (18%)

Query: 88  KDKLGQGGFGGVYKGRLLDD---FV------------------NEVASISRTSHVNVVTL 126
             ++G+G FG VY  R   D   +V                  NEV  + + +H N++  
Sbjct: 5   IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY 64

Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                E     ++ E+   G L + +      K  +    E++ +  + +   L+YLH  
Sbjct: 65  YESFEEKGKLCIVMEYADGGDLSQKIKK--QKKEGKPFPEEQILDWFVQLCLALKYLH-- 120

Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG---YIAPE 243
            S KILH DIKP NI L  +   K+ DFG++K+ +      S++  A+ ++G   Y++PE
Sbjct: 121 -SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS------STVDLAKTVVGTPYYLSPE 173

Query: 244 VFSRNFGEVSHKSDVYSFGMMIMEL 268
           +        ++KSD++S G ++ EL
Sbjct: 174 LCQNK--PYNYKSDIWSLGCVLYEL 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 88.0 bits (219), Expect = 8e-20
 Identities = 60/208 (28%), Positives = 92/208 (44%), Gaps = 43/208 (20%)

Query: 86  SFKDKLGQGGFGGVYKG--------------RLLDD----FVNEVASISRTSHVNVVTLL 127
              +K+G+G  G VYK               RL        +NE+  +    H N+V   
Sbjct: 22  KNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYY 81

Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG-----IAKGLEY 182
              L G+   ++ E+M  GSL   +               +M E  I      + +GLEY
Sbjct: 82  DSYLVGDELWVVMEYMDGGSLTDIITQNFV----------RMNEPQIAYVCREVLQGLEY 131

Query: 183 LHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY-IA 241
           LH   S  ++H DIK  NILL +D   K++DFG A   T ++   +S++G      Y +A
Sbjct: 132 LH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGT----PYWMA 184

Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELV 269
           PEV  R   +   K D++S G+M +E+ 
Sbjct: 185 PEVIKRK--DYGPKVDIWSLGIMCIEMA 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 85.5 bits (211), Expect = 4e-19
 Identities = 56/200 (28%), Positives = 97/200 (48%), Gaps = 33/200 (16%)

Query: 89  DKLGQGGFGGVYKGRLLDD--------------------FVNEVASISRTSHVNVVTLLG 128
           +++G+G FG V+ GRL  D                    F+ E   + + SH N+V L+G
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
            C +     ++ E +  G    F+           L+ +++ ++V   A G+EYL     
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRTEGP-----RLKVKELIQMVENAAAGMEYLESKHC 115

Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI-IGYIAPEVFSR 247
              +H D+   N L+ E    KISDFG+++    ++G+ +S  G + I + + APE    
Sbjct: 116 ---IHRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEAL-- 168

Query: 248 NFGEVSHKSDVYSFGMMIME 267
           N+G  S +SDV+SFG+++ E
Sbjct: 169 NYGRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 84.7 bits (209), Expect = 8e-19
 Identities = 76/278 (27%), Positives = 126/278 (45%), Gaps = 51/278 (18%)

Query: 90  KLGQGGFGGVYKG----------RLL-------DDFVNEVASISRTSHVNVVTLLGFCLE 132
           KLGQG FG V+ G          + L       + F+ E   + +  H  +V L     E
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72

Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKIL 192
                ++ E+M  GSL  F+  G+  K   YLR  ++ ++   IA G+ Y+        +
Sbjct: 73  -EPIYIVTEYMSKGSLLDFL-KGEMGK---YLRLPQLVDMAAQIASGMAYVER---MNYV 124

Query: 193 HFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEV 252
           H D++  NIL+ E+   K++DFGLA+L    E   ++  GA+  I + APE  +  +G  
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAPE--AALYGRF 180

Query: 253 SHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV--EQDREFKLPGVVTRK 310
           + KSDV+SFG+++ EL            +   V +P  + R V  + +R +++P      
Sbjct: 181 TIKSDVWSFGILLTELT-----------TKGRVPYPGMVNREVLDQVERGYRMPC----- 224

Query: 311 ENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE 348
             E  + +  +   C +  P +RP      E LQ   E
Sbjct: 225 PPECPESLHDLMCQCWRKEPEERP----TFEYLQAFLE 258

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 83.9 bits (207), Expect = 2e-18
 Identities = 70/287 (24%), Positives = 116/287 (40%), Gaps = 57/287 (19%)

Query: 91  LGQGGFGGVYKGRL-----------------------LDDFVNEVASISRTSHVNVVTLL 127
           LG+G FG V +G+L                       ++DF++E   +    H NV+ L+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 128 GFCLEGNNR------ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           G CL+           +I  FM +G L  F+         QYL  + + + +  IA G+E
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT----KEGIVSSLLGARGII 237
           YL    S   +H D+   N +L+E+    ++DFGL+K        ++G ++ +      I
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQ 297
             +A  V++        KSDV+SFG+ + E+         GV++S        IY ++ Q
Sbjct: 184 ESLADRVYTT-------KSDVWSFGVTMWEIATRGQTPYPGVENSE-------IYDYLRQ 229

Query: 298 DREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
               K P         +          C    P DRP    +   L+
Sbjct: 230 GNRLKQPPDCLDGLYSLMSS-------CWLLNPKDRPSFETLRCELE 269

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 83.6 bits (206), Expect = 2e-18
 Identities = 69/234 (29%), Positives = 113/234 (48%), Gaps = 42/234 (17%)

Query: 90  KLGQGGFGGVYKGR-----------------LLDDFVNEVASISRTSHVNVVTLLGFCLE 132
           KLGQG FG V+ G                  + + F+ E   + +  H  +V L     E
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72

Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKIL 192
                ++ EFM  GSL  F+  GD     +YL+  ++ ++   IA G+ Y+        +
Sbjct: 73  -EPIYIVTEFMGKGSLLDFLKEGDG----KYLKLPQLVDMAAQIADGMAYIER---MNYI 124

Query: 193 HFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEV 252
           H D++  NIL+ ++   KI+DFGLA+L    E   ++  GA+  I + APE  +  +G  
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNE--YTARQGAKFPIKWTAPE--AALYGRF 180

Query: 253 SHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV-EQ-DREFKLP 304
           + KSDV+SFG+++ ELV           +   V +P  + R V EQ +R +++P
Sbjct: 181 TIKSDVWSFGILLTELV-----------TKGRVPYPGMVNREVLEQVERGYRMP 223

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 83.0 bits (205), Expect = 4e-18
 Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 33/202 (16%)

Query: 86  SFKDKLGQGGFGGVYKGRLL-----------------DDFVNEVASISRTSHVNVVTLLG 128
           +F  +LG G FG V+ G+                   +DF+ E   + + SH  +V L G
Sbjct: 7   TFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66

Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYN--GDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
            C +     ++ EFM NG L  ++    G  SK       + +  +   + +G+EYL   
Sbjct: 67  VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSK-------DMLLSMCQDVCEGMEYLER- 118

Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
                +H D+   N L+      K+SDFG+ +     E   SS  GA+  + +  PEVF 
Sbjct: 119 --NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS--GAKFPVKWSPPEVF- 173

Query: 247 RNFGEVSHKSDVYSFGMMIMEL 268
            NF + S KSDV+SFG+++ E+
Sbjct: 174 -NFSKYSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 81.8 bits (202), Expect = 9e-18
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 31/207 (14%)

Query: 79  DVKKLTNSFKDKLGQGGFG----GVYKGRL-------------LDDFVNEVASISRTSHV 121
           D K LT  F  +LG G FG    G ++G+               D+F+ E   + + SH 
Sbjct: 2   DPKDLT--FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHE 59

Query: 122 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
            +V L G C +     ++ E+M NG L  ++         +  +  ++ E+   + +G+ 
Sbjct: 60  KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHG-----KRFQPSQLLEMCKDVCEGMA 114

Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           YL    S + +H D+   N L+D+  C K+SDFGL++     E   +S +G++  + +  
Sbjct: 115 YLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSP 169

Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           PEV    + + S KSDV++FG+++ E+
Sbjct: 170 PEVL--LYSKFSSKSDVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 81.8 bits (202), Expect = 9e-18
 Identities = 62/200 (31%), Positives = 93/200 (46%), Gaps = 35/200 (17%)

Query: 90  KLGQGGFG----GVYKGRL-------------LDDFVNEVASISRTSHVNVVTLLGFCLE 132
           KLG G FG    G Y G                + F+ E   + +  H  +V L      
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV-- 70

Query: 133 GNNRALIY---EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCST 189
              +  IY   E+M NGSL  F+   +  K    L   K+ ++   IA+G+ ++      
Sbjct: 71  --TQEPIYIITEYMENGSLVDFLKTPEGIK----LTINKLIDMAAQIAEGMAFIE---RK 121

Query: 190 KILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNF 249
             +H D++  NIL+ E  C KI+DFGLA+L    E       GA+  I + APE    N+
Sbjct: 122 NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTARE--GAKFPIKWTAPEAI--NY 177

Query: 250 GEVSHKSDVYSFGMMIMELV 269
           G  + KSDV+SFG+++ E+V
Sbjct: 178 GTFTIKSDVWSFGILLTEIV 197

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 81.6 bits (202), Expect = 1e-17
 Identities = 73/300 (24%), Positives = 115/300 (38%), Gaps = 79/300 (26%)

Query: 89  DKLGQGGFGGVYKGRLLD-------------------------DFVNEVASISR--TSHV 121
            +LGQG FG VY+G                             +F+NE AS+ +    H 
Sbjct: 12  RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNE-ASVMKEFNCH- 69

Query: 122 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVY----NGDTSKPCQYLRWEKMYEIVIGIA 177
           +VV LLG    G    ++ E M  G L+ ++       + +        +K  ++   IA
Sbjct: 70  HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129

Query: 178 KGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT-----KEGIVSSLLG 232
            G+ YL    + K +H D+   N ++ ED   KI DFG+ +         K G    LL 
Sbjct: 130 DGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGG--KGLLP 184

Query: 233 ARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV--------GCKNNLDSGVDSSSE 284
            R    ++APE  S   G  + KSDV+SFG+++ E+         G  N           
Sbjct: 185 VR----WMAPE--SLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN----------- 227

Query: 285 VYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
                      E+  +F + G           K++ +   C Q  P  RP   E++  L+
Sbjct: 228 -----------EEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 80.8 bits (200), Expect = 2e-17
 Identities = 53/212 (25%), Positives = 88/212 (41%), Gaps = 48/212 (22%)

Query: 89  DKLGQGGFGGVYKG---------------------RLLDDFVNEVASISRTSHVNVVTLL 127
           +K+G G FG VY                       + + +  +E+  +    H N+V   
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 128 GFCLEGNNRALIY-EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG-----IAKGLE 181
           G  +    +  I+ E+   G+LE+ + +G             + E VI      + +GL 
Sbjct: 66  GVEVH-REKVYIFMEYCSGGTLEELLEHGRI-----------LDEHVIRVYTLQLLEGLA 113

Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK-LCTTKEGIVSSLLGARGIIGYI 240
           YLH   S  I+H DIKP NI LD +   K+ DFG A  L      +   +    G   Y+
Sbjct: 114 YLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYM 170

Query: 241 APEVFSRNFGEVSHK---SDVYSFGMMIMELV 269
           APEV +    +       +D++S G +++E+ 
Sbjct: 171 APEVITGG--KGKGHGRAADIWSLGCVVLEMA 200

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 80.5 bits (199), Expect = 3e-17
 Identities = 53/202 (26%), Positives = 81/202 (40%), Gaps = 35/202 (17%)

Query: 91  LGQGGFGGVYKGRLL-----------------------DDFVNEVASISRTSHVNVVTLL 127
           LG G FG V KG  L                        +F+ E + +++  H  +V L+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
           G C  G    L+ E  P G L K++                       +A G+ YL    
Sbjct: 63  GVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLE--- 112

Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSR 247
           S   +H D+   N+LL      KISDFG+++          +    R  + + APE    
Sbjct: 113 SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI-- 170

Query: 248 NFGEVSHKSDVYSFGMMIMELV 269
           N+G+ S KSDV+S+G+ + E  
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAF 192

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 80.4 bits (198), Expect = 3e-17
 Identities = 74/278 (26%), Positives = 127/278 (45%), Gaps = 51/278 (18%)

Query: 90  KLGQGGFGGVYKG----------RLL-------DDFVNEVASISRTSHVNVVTLLGFCLE 132
           KLG G FG V+ G          + L       + F+ E   + +  H  +V L     E
Sbjct: 13  KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72

Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKIL 192
                ++ E+M  GSL  F+ +G+     + L+   + ++   +A G+ Y+        +
Sbjct: 73  -EPIYIVTEYMSKGSLLDFLKDGEG----RALKLPNLVDMAAQVAAGMAYIER---MNYI 124

Query: 193 HFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEV 252
           H D++  NIL+ +    KI+DFGLA+L    E   ++  GA+  I + APE  +  +G  
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIEDNE--YTARQGAKFPIKWTAPE--AALYGRF 180

Query: 253 SHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV-EQ-DREFKLPGVVTRK 310
           + KSDV+SFG+++ ELV           +   V +P    R V EQ +R +++P     +
Sbjct: 181 TIKSDVWSFGILLTELV-----------TKGRVPYPGMNNREVLEQVERGYRMP---CPQ 226

Query: 311 ENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE 348
           +  I+   +++  W  +  P +RP      E LQ   E
Sbjct: 227 DCPISLHELMLQCW--KKDPEERP----TFEYLQSFLE 258

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 80.8 bits (199), Expect = 4e-17
 Identities = 72/278 (25%), Positives = 128/278 (46%), Gaps = 38/278 (13%)

Query: 105 LDDFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV---------YN 154
           L D V+E+  +     H N++ LLG C +     ++ E+   G+L +++         Y+
Sbjct: 61  LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYS 120

Query: 155 GDTSK-PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISD 213
            DT K P + L ++ +      +A+G+EYL    S K +H D+   N+L+ ED   KI+D
Sbjct: 121 FDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIAD 177

Query: 214 FGLAKLCTTKEGIVSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
           FGLA+     +    +  G R  + ++APE +F R +   +H+SDV+SFG+++ E+    
Sbjct: 178 FGLARDVHNIDYYKKTTNG-RLPVKWMAPEALFDRVY---THQSDVWSFGVLLWEIFTLG 233

Query: 273 NNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSD 332
            +   G+           +++ +++      P   T +   I ++       C  A PS 
Sbjct: 234 GSPYPGIPVEE-------LFKLLKEGHRMDKPANCTHELYMIMRE-------CWHAVPSQ 279

Query: 333 RPPMNEVIEMLQ-----GSTEALQIPPTPFLSSPPRAP 365
           RP   +++E L       ST+       PF    P  P
Sbjct: 280 RPTFKQLVEDLDRVLTVTSTDEYLDLSVPFEQYSPGCP 317

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 79.3 bits (195), Expect = 5e-17
 Identities = 59/197 (29%), Positives = 96/197 (48%), Gaps = 33/197 (16%)

Query: 91  LGQGGFGGVYKGRLLDD-------------------FVNEVASISRTSHVNVVTLLGFCL 131
           LG+G FG V+KG L D                    F++E   + +  H N+V L+G C 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 132 EGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKI 191
           +     ++ E +P G    F+      K    L+ +++ +  +  A G+ YL    S   
Sbjct: 63  QRQPIYIVMELVPGGDFLSFL-----RKKKDELKTKQLVKFALDAAAGMAYLE---SKNC 114

Query: 192 LHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI-IGYIAPEVFSRNFG 250
           +H D+   N L+ E+   KISDFG+++     +GI SS  G + I I + APE    N+G
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR--QEDDGIYSS-SGLKQIPIKWTAPEAL--NYG 169

Query: 251 EVSHKSDVYSFGMMIME 267
             S +SDV+S+G+++ E
Sbjct: 170 RYSSESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 78.5 bits (194), Expect = 1e-16
 Identities = 49/157 (31%), Positives = 79/157 (50%), Gaps = 22/157 (14%)

Query: 117 RTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 176
           + +   +V   G      + ++  E+M  GSL+K +       P + L      +I + +
Sbjct: 55  KCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAV 109

Query: 177 AKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI 236
            KGL YLH     KI+H D+KP NIL++     K+ DFG++        +V+SL  A+  
Sbjct: 110 LKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQ------LVNSL--AKTF 159

Query: 237 IG---YIAPEVFSRNFGEV-SHKSDVYSFGMMIMELV 269
           +G   Y+APE   R  G   S KSD++S G+ ++EL 
Sbjct: 160 VGTSSYMAPE---RIQGNDYSVKSDIWSLGLSLIELA 193

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 77.9 bits (192), Expect = 2e-16
 Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 41/206 (19%)

Query: 88  KDKLGQGGFGGVYKGRLLDD---------------------FVNEVASISRTSHVNVVTL 126
            +K+G+G FG V+K     D                      ++E   +++     ++  
Sbjct: 5   LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRY 64

Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
               L+     ++ E+  NG L K +      +  + L  ++++   I I  GL +LH  
Sbjct: 65  YESFLDKGKLNIVMEYAENGDLHKLLK----MQRGRPLPEDQVWRFFIQILLGLAHLH-- 118

Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG---YIAPE 243
            S KILH DIK  N+ LD     KI D G+AKL +      ++   A  I+G   Y++PE
Sbjct: 119 -SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD-----NTNF-ANTIVGTPYYLSPE 171

Query: 244 VFS-RNFGEVSHKSDVYSFGMMIMEL 268
           +   + + E   KSDV++ G+++ E 
Sbjct: 172 LCEDKPYNE---KSDVWALGVVLYEC 194

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 78.0 bits (193), Expect = 3e-16
 Identities = 59/209 (28%), Positives = 88/209 (42%), Gaps = 43/209 (20%)

Query: 87  FKDKLGQGGFGGVYKGR-------------LLDDFVNEVASISRT-----------SHVN 122
              KLG+G +  VYK R              L +       I+ T            H N
Sbjct: 4   KGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPN 63

Query: 123 VVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTS-KPCQYLRWEKMYEIVIGIAKGLE 181
           ++ LL      +N  L++EFM    LEK + +      P     +  M        +GLE
Sbjct: 64  IIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLM------TLRGLE 116

Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           YLH   S  ILH D+KP+N+L+  D   K++DFGLA+   +    ++  +  R    Y A
Sbjct: 117 YLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTR---WYRA 170

Query: 242 PEVFSRNFGEVSHKS--DVYSFGMMIMEL 268
           PE+    FG   +    D++S G +  EL
Sbjct: 171 PELL---FGARHYGVGVDMWSVGCIFAEL 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 67/252 (26%), Positives = 120/252 (47%), Gaps = 35/252 (13%)

Query: 105 LDDFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV----------- 152
           L D ++E+  +     H N++ LLG C +     +I E+   G+L +++           
Sbjct: 67  LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYC 126

Query: 153 YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKIS 212
           YN     P + L ++ +      +A+G+EYL    S K +H D+   N+L+ ED   KI+
Sbjct: 127 YNPTQV-PEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIA 182

Query: 213 DFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGC 271
           DFGLA+     +    +  G R  + ++APE +F R +   +H+SDV+SFG+++ E+   
Sbjct: 183 DFGLARDIHHIDYYKKTTNG-RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEIFTL 238

Query: 272 KNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPS 331
             +   GV           +++ +++      P   T   NE+   M++   W   A PS
Sbjct: 239 GGSPYPGVPVEE-------LFKLLKEGHRMDKPSNCT---NELY--MMMRDCW--HAVPS 284

Query: 332 DRPPMNEVIEML 343
            RP   +++E L
Sbjct: 285 QRPTFKQLVEDL 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 77.5 bits (191), Expect = 3e-16
 Identities = 68/208 (32%), Positives = 104/208 (50%), Gaps = 43/208 (20%)

Query: 91  LGQGGFGGVYKGRLLDDFVNE----VASISRT-------------------SHVNVVTLL 127
           +G+G FG VY G L+D    +    V S++R                    SH NV++LL
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 128 GFCLEGNNRALI-YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG----IAKGLEY 182
           G CL      L+   +M +G L  F+ + +T  P          + +IG    +AKG+EY
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRS-ETHNP--------TVKDLIGFGLQVAKGMEY 113

Query: 183 LHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI-VSSLLGARGIIGYIA 241
           L    S K +H D+   N +LDE F  K++DFGLA+    KE   V +  GA+  + ++A
Sbjct: 114 L---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA 170

Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            E  S    + + KSDV+SFG+++ EL+
Sbjct: 171 LE--SLQTQKFTTKSDVWSFGVLLWELM 196

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 77.5 bits (191), Expect = 3e-16
 Identities = 67/218 (30%), Positives = 95/218 (43%), Gaps = 44/218 (20%)

Query: 66  NYGPLPLKRYN-FSD-------VKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISR 117
           N+G + L RY+   D       VKKL +S  + L               DF  E+  +  
Sbjct: 16  NFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHL--------------RDFEREIEILKS 61

Query: 118 TSHVNVVTLLGFCLEG--NNRALIYEFMPNGSLEKFVYNG----DTSKPCQYLRWEKMYE 171
             H N+V   G C      N  L+ E++P GSL  ++       D  K   Y   +    
Sbjct: 62  LQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLY-ASQ---- 116

Query: 172 IVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK-LCTTKEGIVSSL 230
               I KG+EYL    S + +H D+   NIL++ +   KI DFGL K L   KE      
Sbjct: 117 ----ICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVRE 169

Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMEL 268
            G   I  Y APE  + +  + S  SDV+SFG+++ EL
Sbjct: 170 PGESPIFWY-APESLTES--KFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 77.7 bits (191), Expect = 5e-16
 Identities = 85/320 (26%), Positives = 132/320 (41%), Gaps = 55/320 (17%)

Query: 82  KLTNSFKDK-LGQGGFGGVYKGRLLDD------------------------FVNEVASIS 116
           K T   K K LG G FG VYKG  + +                         ++E   ++
Sbjct: 5   KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 64

Query: 117 RTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQY-LRWEKMYEIVIG 175
              + +V  LLG CL    + LI + MP G L  +V     +   QY L W       + 
Sbjct: 65  SVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQ 117

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           IAKG+ YL      +++H D+   N+L+      KI+DFGLAKL    E    +  G + 
Sbjct: 118 IAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHA-EGGKV 173

Query: 236 IIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRH 294
            I ++A E +  R +   +H+SDV+S+G+ + EL+   +    G+ +S        I   
Sbjct: 174 PIKWMALESILHRIY---THQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSI 223

Query: 295 VEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQA--RPSDRPPMNEVIEMLQGSTEALQI 352
           +E+      P + T     I   MI+V  W I A  RP  R  + E  +M +     L I
Sbjct: 224 LEKGERLPQPPICT-----IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI 278

Query: 353 PPTPFLSSPPRAPIDSFTFS 372
                +  P     + +   
Sbjct: 279 QGDERMHLPSPTDSNFYRAL 298

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 76.5 bits (189), Expect = 6e-16
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 40/204 (19%)

Query: 87  FKDKLGQGGFGGVYKGR-----------------LLDDFVNEVASISRTSHVNVVTLLGF 129
             +KLG+G +G VYK                    L + + E++ + +     +V   G 
Sbjct: 7   ILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGS 66

Query: 130 CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQ-YLRWEKMYEIVIGIAKGLEYLHHGCS 188
             +  +  ++ E+   GS+       D  K     L  E++  I+    KGLEYLH   S
Sbjct: 67  YFKNTDLWIVMEYCGAGSVS------DIMKITNKTLTEEEIAAILYQTLKGLEYLH---S 117

Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG-IIG---YIAPEV 244
            K +H DIK  NILL+E+   K++DFG++       G ++  +  R  +IG   ++APEV
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVS-------GQLTDTMAKRNTVIGTPFWMAPEV 170

Query: 245 FSRNFGEVSHKSDVYSFGMMIMEL 268
                   ++K+D++S G+  +E+
Sbjct: 171 IQEI--GYNNKADIWSLGITAIEM 192

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 77.4 bits (190), Expect = 6e-16
 Identities = 65/251 (25%), Positives = 123/251 (49%), Gaps = 33/251 (13%)

Query: 105 LDDFVNEVASISRTS-HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV---------YN 154
           L D V+E+  +     H N++ LLG C +     +I E+   G+L +++         Y+
Sbjct: 64  LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 123

Query: 155 GDTSK-PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISD 213
            D ++ P + + ++ +      +A+G+EYL    S K +H D+   N+L+ E+   KI+D
Sbjct: 124 YDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIAD 180

Query: 214 FGLAKLCTTKEGIVSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
           FGLA+     +    +  G R  + ++APE +F R +   +H+SDV+SFG+++ E+    
Sbjct: 181 FGLARDVNNIDYYKKTTNG-RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEIFTLG 236

Query: 273 NNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSD 332
            +   G+           +++ +++      P   T   NE+   M++   W   A PS 
Sbjct: 237 GSPYPGIPVEE-------LFKLLKEGHRMDKPANCT---NELY--MMMRDCW--HAIPSH 282

Query: 333 RPPMNEVIEML 343
           RP   +++E L
Sbjct: 283 RPTFKQLVEDL 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 76.4 bits (188), Expect = 8e-16
 Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 52/214 (24%)

Query: 91  LGQGGFGGVY----------------------------KGRLLDDFVNEVASISRTSHVN 122
           +G G FG VY                            K  +LD    E+A +    H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 123 VVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEK--MYEIVIGIAKGL 180
           +V  LG  L+ ++  +  E++P GS+   + N        Y  +E+  +   V  I KGL
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNN--------YGAFEETLVRNFVRQILKGL 119

Query: 181 EYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK------LCTTKEGIVSSLLGAR 234
            YLH   +  I+H DIK  NIL+D     KISDFG++K      L T   G   SL G+ 
Sbjct: 120 NYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS- 175

Query: 235 GIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMEL 268
             + ++APEV  +     + K+D++S G +++E+
Sbjct: 176 --VFWMAPEVVKQTS--YTRKADIWSLGCLVVEM 205

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 75.9 bits (187), Expect = 8e-16
 Identities = 56/204 (27%), Positives = 82/204 (40%), Gaps = 35/204 (17%)

Query: 89  DKLGQGGFGGVYKG-----------------------RLLDDFVNEVASISRTSHVNVVT 125
            KLG G FG V +G                        ++DDF+ E A +    H N++ 
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60

Query: 126 LLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH 184
           L G  L  +   ++ E  P GSL ++   +         L      +  + IA G+ YL 
Sbjct: 61  LYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTL-----CDYAVQIANGMRYLE 114

Query: 185 HGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV 244
              S + +H D+   NILL  D   KI DFGL +     E         +    + APE 
Sbjct: 115 ---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE- 170

Query: 245 FSRNFGEVSHKSDVYSFGMMIMEL 268
            S      SH SDV+ FG+ + E+
Sbjct: 171 -SLRTRTFSHASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 71/288 (24%), Positives = 126/288 (43%), Gaps = 57/288 (19%)

Query: 90  KLGQGGFGGVYKG------------RLLDDFVNEVASI-SRTSHVN------------VV 124
           +LGQG FG VY+G            R+    VNE AS+  R   +N            VV
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72

Query: 125 TLLGFCLEGNNRALIYEFMPNGSLEKFVYN------GDTSKPCQYLRWEKMYEIVIGIAK 178
            LLG   +G    ++ E M +G L+ ++ +       +  +P   L+  +M ++   IA 
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ--EMIQMAAEIAD 130

Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI-- 236
           G+ YL+   + K +H D+   N ++  DF  KI DFG+ +     +       G +G+  
Sbjct: 131 GMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK---GGKGLLP 184

Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE 296
           + ++APE  S   G  +  SD++SFG+++ E+         G+ +              E
Sbjct: 185 VRWMAPE--SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--------------E 228

Query: 297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
           Q  +F + G    + +   +++  +   C Q  P  RP   E++ +L+
Sbjct: 229 QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 61/227 (26%), Positives = 105/227 (46%), Gaps = 47/227 (20%)

Query: 76  NFSDVKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTS---------------- 119
            ++D+K     F+D +G+G FG V K R+  D +   A+I R                  
Sbjct: 5   EWNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE 59

Query: 120 -------HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF-----VYNGDTS-----KPCQ 162
                  H N++ LLG C       L  E+ P+G+L  F     V   D +         
Sbjct: 60  VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 119

Query: 163 YLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT 222
            L  +++      +A+G++YL      + +H D+   NIL+ E++  KI+DFGL++    
Sbjct: 120 TLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---G 173

Query: 223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
           +E  V   +G R  + ++A E  S N+   +  SDV+S+G+++ E+V
Sbjct: 174 QEVYVKKTMG-RLPVRWMAIE--SLNYSVYTTNSDVWSYGVLLWEIV 217

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 75.7 bits (186), Expect = 2e-15
 Identities = 61/216 (28%), Positives = 93/216 (43%), Gaps = 48/216 (22%)

Query: 91  LGQGGFGGVYKGRLLD--------------------------DFVNEVASISRTSHVNVV 124
           LG G FG VY+G   D                          +F+ E   +S  +H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 125 TLLGFCLEGNNRALIYEFMPNGSLEKFVYNGD-TSKPCQYLRWEKMYEIVIGIAKGLEYL 183
            LLG CL    + +I E M  G L  ++ +          L  +++ +I + +AKG  YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 184 HHGCSTKILHFDIKPHNILLDED--FCP---KISDFGLAKLCTT-----KEGIVSSLLGA 233
                   +H D+   N L+ E         KI DFGLA+         KEG    LL  
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEG--EGLLPV 177

Query: 234 RGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
           R    ++APE      G+ + +SDV+SFG+++ E++
Sbjct: 178 R----WMAPESLLD--GKFTTQSDVWSFGVLMWEIL 207

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 74/300 (24%), Positives = 132/300 (44%), Gaps = 62/300 (20%)

Query: 86  SFKDKLGQGGFGGVYKG-------------RLLD---------DFVNEVASISRTS-HVN 122
            F+D +G+G FG V +              ++L          DF  E+  + +   H N
Sbjct: 5   KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPN 64

Query: 123 VVTLLGFCLEGNNRALIY---EFMPNGSLEKF-----VYNGDTSKPCQY-----LRWEKM 169
           ++ LLG C    NR  +Y   E+ P G+L  F     V   D +   ++     L  +++
Sbjct: 65  IINLLGAC---ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121

Query: 170 YEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSS 229
            +    +A G++YL      + +H D+   N+L+ E+   KI+DFGL++    +E  V  
Sbjct: 122 LQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKK 175

Query: 230 LLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPH 289
            +G R  + ++A E  S N+   + KSDV+SFG+++ E+V        G+  +       
Sbjct: 176 TMG-RLPVRWMAIE--SLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE------ 226

Query: 290 WIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA 349
            +Y  + Q    + P     +  E+ ++       C + RP +RPP  ++   L    EA
Sbjct: 227 -LYEKLPQGYRMEKPRNCDDEVYELMRQ-------CWRDRPYERPPFAQISVQLSRMLEA 278

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 75.2 bits (185), Expect = 2e-15
 Identities = 76/292 (26%), Positives = 116/292 (39%), Gaps = 67/292 (22%)

Query: 91  LGQGGFG----GVYKGRLLD---------------------DFVNEVASISRTSHVNVVT 125
           LG G FG    G+Y+GR  D                     DF+ E   +S+ +H N+V 
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73

Query: 126 LLGFCLEGNNRALIYEFMPNGSLEKFVYNG--DTSKPCQYLRWEKMYEIVIGIAKGLEYL 183
           L+G   E   R ++ E M  G L+ F+        +P   L  + +      +AKG +YL
Sbjct: 74  LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSS-LTMKDLLFCARDVAKGCKYL 132

Query: 184 HHGCSTKILHFDIKPHNILLDEDFCP------KISDFGLAKLCTTKEGIVSS---LLGAR 234
                   +H DI   N LL    C       KI+DFG+A+       I  +     G R
Sbjct: 133 E---ENHFIHRDIAARNCLLT---CKGPGRVAKIADFGMAR------DIYRASYYRKGGR 180

Query: 235 GI--IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIY 292
            +  I ++ PE F    G  + K+DV+SFG+++ E+              S  Y P +  
Sbjct: 181 AMLPIKWMPPEAFLD--GIFTSKTDVWSFGVLLWEIF-------------SLGYMP-YPG 224

Query: 293 RHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
           R  ++  EF   G            +  +   C Q  P DRP    ++E +Q
Sbjct: 225 RTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 75.2 bits (186), Expect = 2e-15
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 52/212 (24%)

Query: 88  KDKLGQGGFGGVYKGR-------------LLDDF--------VNEVASISRTSHVNVVTL 126
            +KLG+G +G VYK R              LD+         + E++ +    H N+V L
Sbjct: 4   LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKL 63

Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
           L          L++E+     L+K++           ++      I+  + +GL Y H  
Sbjct: 64  LDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIK-----SIMYQLLRGLAYCH-- 115

Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT------TKEGIVSSLLGARGIIGYI 240
            S +ILH D+KP NIL++ D   K++DFGLA+         T E +V+        + Y 
Sbjct: 116 -SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE-VVT--------LWYR 165

Query: 241 APEVF--SRNFG-EVSHKSDVYSFGMMIMELV 269
           APE+   S+++   V    D++S G +  E++
Sbjct: 166 APEILLGSKHYSTAV----DIWSVGCIFAEMI 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 75.5 bits (185), Expect = 3e-15
 Identities = 74/274 (27%), Positives = 123/274 (44%), Gaps = 52/274 (18%)

Query: 91  LGQGGFGGVYKG---------------RLLDD---------FVNEVASISRTSHVNVVTL 126
           LG G FG VYKG               ++L++         F++E   ++   H ++V L
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL-RWEKMYEIVIGIAKGLEYLHH 185
           LG CL    + L+ + MP+G L  +V+    +   Q L  W       + IAKG+ YL  
Sbjct: 75  LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLEE 127

Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVF 245
               +++H D+   N+L+      KI+DFGLA+L    E   ++  G +  I ++A E  
Sbjct: 128 ---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA-DGGKMPIKWMALECI 183

Query: 246 SRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG 305
             ++ + +H+SDV+S+G+ I EL+        G+ +         I   +E+      P 
Sbjct: 184 --HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-------IPDLLEKGERLPQPP 234

Query: 306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEV 339
           + T     I   M++V  W I A    RP   E+
Sbjct: 235 ICT-----IDVYMVMVKCWMIDA--DSRPKFKEL 261

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 74.5 bits (184), Expect = 3e-15
 Identities = 53/228 (23%), Positives = 89/228 (39%), Gaps = 55/228 (24%)

Query: 87  FKDKLGQGGFGGVYKGRLLDDF---------------VNEVASISR--------TSHVNV 123
           F   +G+G F  V   +  +                   +V  +            H  +
Sbjct: 5   FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGI 64

Query: 124 VTLLGFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPC-QYLRWEKMYEIVIGIAKGLE 181
           + L     +  N   + E+ PNG L +++   G   + C ++       EI++     LE
Sbjct: 65  IKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFY----AAEILLA----LE 116

Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG--- 238
           YLH   S  I+H D+KP NILLD+D   KI+DFG AK+        S+   A  I     
Sbjct: 117 YLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173

Query: 239 --------------YIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
                         Y++PE+ +         SD+++ G +I +++  K
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEK--PAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 74.3 bits (183), Expect = 3e-15
 Identities = 55/174 (31%), Positives = 83/174 (47%), Gaps = 26/174 (14%)

Query: 105 LDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLE---KFVYNG---DTS 158
           +D+   EV ++S+ +H NVV      + G+   L+  ++  GSL    K  Y     D +
Sbjct: 43  VDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEA 102

Query: 159 KPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK 218
                L+          + KGLEYLH   S   +H DIK  NILL ED   KI+DFG++ 
Sbjct: 103 IIATVLK---------EVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSA 150

Query: 219 LCTTKEGIVSSLLGAR-GIIG---YIAPEVFSRNFGEVSHKSDVYSFGMMIMEL 268
                 G  +     R   +G   ++APEV  +  G    K+D++SFG+  +EL
Sbjct: 151 -SLADGGDRTR--KVRKTFVGTPCWMAPEVMEQVHG-YDFKADIWSFGITAIEL 200

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 74.2 bits (182), Expect = 4e-15
 Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 37/204 (18%)

Query: 91  LGQGGFGGVYKGRL-----------------------LDDFVNEVASISRTSHVNVVTLL 127
           +G G FG V++G L                         DF++E + + + SH N++ L 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTS-KPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
           G   +     +I E+M NG+L+K++ + D      Q      +  ++ GIA G++YL   
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQ------LVGMLRGIAAGMKYL--- 123

Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
                +H D+   NIL++ +   K+SDFGL+++         +  G +  I + APE  +
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIA 183

Query: 247 -RNFGEVSHKSDVYSFGMMIMELV 269
            R F   +  SDV+SFG+++ E++
Sbjct: 184 YRKF---TSASDVWSFGIVMWEVM 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 74.3 bits (182), Expect = 4e-15
 Identities = 57/197 (28%), Positives = 92/197 (46%), Gaps = 28/197 (14%)

Query: 90  KLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHVNVVTLLGFCLE 132
           KLG G FG V+ G                   +  F+ E   +    H  +V L     +
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72

Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKIL 192
                +I E+M  GSL  F+ + +  K    +   K+ +    IA+G+ Y+        +
Sbjct: 73  EEPIYIITEYMAKGSLLDFLKSDEGGK----VLLPKLIDFSAQIAEGMAYIE---RKNYI 125

Query: 193 HFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEV 252
           H D++  N+L+ E    KI+DFGLA++    E   ++  GA+  I + APE    NFG  
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEAI--NFGSF 181

Query: 253 SHKSDVYSFGMMIMELV 269
           + KSDV+SFG+++ E+V
Sbjct: 182 TIKSDVWSFGILLYEIV 198

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 74.1 bits (182), Expect = 4e-15
 Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 35/204 (17%)

Query: 91  LGQGGFGGVYKGRL-----------------------LDDFVNEVASISRTSHVNVVTLL 127
           +G G FG V +GRL                         DF++E + + +  H N++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
           G   +     +I EFM NG+L+ F+   D       L       ++ GIA G++YL    
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL-----VGMLRGIAAGMKYL---S 123

Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLC--TTKEGIVSSLLGARGIIGYIAPEVF 245
               +H D+   NIL++ +   K+SDFGL++     T +   +S LG +  I + APE  
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183

Query: 246 SRNFGEVSHKSDVYSFGMMIMELV 269
           +  + + +  SDV+S+G+++ E++
Sbjct: 184 A--YRKFTSASDVWSYGIVMWEVM 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 74.2 bits (182), Expect = 5e-15
 Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 54/213 (25%)

Query: 91  LGQGGFGGVYKG------------------------RLLDDFVNEVASISRTSHVNVVTL 126
           LG+G +G VY G                        +  +    EV  +    HVN+V  
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYN-GDTSKP--CQYLRWEKMYEIVIGIAKGLEYL 183
           LG CL+ N  ++  EF+P GS+   +   G   +P  C+Y +          I  G+ YL
Sbjct: 68  LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK---------QILDGVAYL 118

Query: 184 HHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK------LCTTKEGIVSSLLGARGII 237
           H+ C   ++H DIK +N++L  +   K+ DFG A+      L  T   ++ S+    G  
Sbjct: 119 HNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSM---HGTP 172

Query: 238 GYIAPEVFSRNFGEVSH--KSDVYSFGMMIMEL 268
            ++APEV +    E  +  KSD++S G  + E+
Sbjct: 173 YWMAPEVIN----ESGYGRKSDIWSIGCTVFEM 201

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 73.9 bits (181), Expect = 7e-15
 Identities = 75/286 (26%), Positives = 122/286 (42%), Gaps = 53/286 (18%)

Query: 90  KLGQGGFGGVYKG------------RLLDDFVNEVASI-SRTSHVN------------VV 124
           +LGQG FG VY+G            R+    VNE AS+  R   +N            VV
Sbjct: 13  ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72

Query: 125 TLLGFCLEGNNRALIYEFMPNGSLEKFVYN---GDTSKPCQYL-RWEKMYEIVIGIAKGL 180
            LLG   +G    +I E M  G L+ ++ +      + P Q     +KM ++   IA G+
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 181 EYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI--IG 238
            YL+   + K +H D+   N ++ EDF  KI DFG+ +     +       G +G+  + 
Sbjct: 133 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK---GGKGLLPVR 186

Query: 239 YIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQD 298
           +++PE  S   G  +  SDV+SFG+++ E+         G+ +              EQ 
Sbjct: 187 WMSPE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--------------EQV 230

Query: 299 REFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
             F + G +  K +     +  +   C Q  P  RP   E+I  ++
Sbjct: 231 LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 49/204 (24%), Positives = 86/204 (42%), Gaps = 38/204 (18%)

Query: 89  DKLGQGGFGGVYKGRLLDDFVN---------------------EVASISRTSHVNVVTLL 127
            K+G+G +G VYK R                            E+  +   +H N++ LL
Sbjct: 5   GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64

Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
                  +  L++EFM +  L K +   D  +    L    +   +  + +GL + H   
Sbjct: 65  DVFRHKGDLYLVFEFM-DTDLYKLI--KDRQRG---LPESLIKSYLYQLLQGLAFCH--- 115

Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVF-- 245
           S  ILH D+KP N+L++ +   K++DFGLA+   +     +  +  R    Y APE+   
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR---WYRAPELLLG 172

Query: 246 SRNFGEVSHKSDVYSFGMMIMELV 269
            + +       D++S G +  EL+
Sbjct: 173 DKGYST---PVDIWSVGCIFAELL 193

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 73.3 bits (180), Expect = 1e-14
 Identities = 48/162 (29%), Positives = 82/162 (50%), Gaps = 18/162 (11%)

Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEK-- 168
           E+ ++    H+N+V  LGF       ++  E++P GS+   +          Y R+E+  
Sbjct: 58  EIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRT--------YGRFEEQL 109

Query: 169 MYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVS 228
           +      + +GL YLH   S  ILH D+K  N+L+D D   KISDFG++K     + I  
Sbjct: 110 VRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISK---KSDDIYD 163

Query: 229 SL--LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           +   +  +G + ++APEV        S K D++S G +++E+
Sbjct: 164 NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEM 205

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 75/281 (26%), Positives = 121/281 (43%), Gaps = 56/281 (19%)

Query: 91  LGQGGFGGVYKG---------------RLLDD---------FVNEVASISRTSHVNVVTL 126
           LG G FG V+KG               + + D           + + ++    H  +V L
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
           LG C  G +  L+ +  P GSL   V  + D+  P + L W       + IAKG+ YL  
Sbjct: 75  LGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMYYLEE 127

Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC--TTKEGIVSSLLGARGIIGYIAPE 243
                ++H ++   NILL  D   +I+DFG+A L     K+   S     +  I ++A E
Sbjct: 128 HR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSE---HKTPIKWMALE 181

Query: 244 VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL 303
             S  FG  +H+SDV+S+G+ + E+      +  G +  + +  PH +   +E+      
Sbjct: 182 --SILFGRYTHQSDVWSYGVTVWEM------MSYGAEPYAGMR-PHEVPDLLEKGERLAQ 232

Query: 304 PGVVTRKENEIAKKMIIVGLWCI--QARPSDRPPMNEVIEM 342
           P + T     I   M++V  W I    RP+ +   NE   M
Sbjct: 233 PQICT-----IDVYMVMVKCWMIDENVRPTFKELANEFTRM 268

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 72.7 bits (178), Expect = 1e-14
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 25/207 (12%)

Query: 138 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIK 197
           +I EFM  GSL  F+ + + SK        K+ +    IA+G+ ++        +H D++
Sbjct: 77  IITEFMAKGSLLDFLKSDEGSK----QPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLR 129

Query: 198 PHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSD 257
             NIL+      KI+DFGLA++    E       GA+  I + APE    NFG  + KSD
Sbjct: 130 AANILVSASLVCKIADFGLARVIEDNEYTARE--GAKFPIKWTAPEAI--NFGSFTIKSD 185

Query: 258 VYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKK 317
           V+SFG+++ME+V        G+ S+ EV       R +E  R +++P     +     ++
Sbjct: 186 VWSFGILLMEIVTYGRIPYPGM-SNPEV------IRALE--RGYRMP-----RPENCPEE 231

Query: 318 MIIVGLWCIQARPSDRPPMNEVIEMLQ 344
           +  + + C + RP +RP    +  +L 
Sbjct: 232 LYNIMMRCWKNRPEERPTFEYIQSVLD 258

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 72.8 bits (179), Expect = 2e-14
 Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 62/225 (27%)

Query: 91  LGQGGFGGVYKGRL-------------------------LDDFVNEVASISRT-SHVNVV 124
           LG+G FG V K                            L D V+E+  +     H N++
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 125 TLLGFCLEGNNRALIYEFMPNGSLEKFV---------YNGDTSK-PCQYLRWEKMYEIVI 174
            LLG C +     ++ E+  +G+L  F+          + D  + P + L  + +     
Sbjct: 80  NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139

Query: 175 GIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLA---------KLCTTKEG 225
            +A+G+E+L    S K +H D+   N+L+ ED   KI+DFGLA         +  T    
Sbjct: 140 QVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN--- 193

Query: 226 IVSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELV 269
                   R  + ++APE +F R +   +H+SDV+SFG+++ E+ 
Sbjct: 194 -------GRLPVKWMAPEALFDRVY---THQSDVWSFGVLLWEIF 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 72.3 bits (178), Expect = 2e-14
 Identities = 53/205 (25%), Positives = 84/205 (40%), Gaps = 32/205 (15%)

Query: 89  DKLGQGGFGGVYK------GRLL---------------DDFVNEVASISRTSHVNVVTLL 127
           + +G+G FG V K      G++L                  V+EV  +    H N+V   
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 128 G-FCLEGNNRALIY-EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
                  N    I  E+   G L + +      K  +Y+  E ++ I+  +   L   H+
Sbjct: 66  DRIIDRSNQTLYIVMEYCEGGDLAQLIQK--CKKERKYIEEEFIWRILTQLLLALYECHN 123

Query: 186 GC--STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE 243
                  +LH D+KP NI LD +   K+ DFGLAK+         + +G      Y++PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTP---YYMSPE 180

Query: 244 VFSRNFGEVSHKSDVYSFGMMIMEL 268
             +        KSD++S G +I EL
Sbjct: 181 QLNHM--SYDEKSDIWSLGCLIYEL 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 71.6 bits (176), Expect = 3e-14
 Identities = 38/93 (40%), Positives = 45/93 (48%), Gaps = 9/93 (9%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           I   LEYLH   S  I+H DIKP NILLDE     I+DF +A   T      S+     G
Sbjct: 109 IVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST----SG 161

Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMEL 268
             GY+APEV  R     S   D +S G+   E 
Sbjct: 162 TPGYMAPEVLCRQ--GYSVAVDWWSLGVTAYEC 192

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 71.6 bits (175), Expect = 4e-14
 Identities = 57/228 (25%), Positives = 99/228 (43%), Gaps = 51/228 (22%)

Query: 80  VKKLTNSFKDKLGQGGFGGVY----------KGRLL--------------DDFVNEVASI 115
           +K+     K +LG+G FG V+          + ++L               DF  E   +
Sbjct: 2   IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELL 61

Query: 116 SRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF---------VYNGDTSKPCQYLRW 166
           +   H ++V   G C EG    +++E+M +G L +F         +  G        L  
Sbjct: 62  TVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTL 121

Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
            +M  I   IA G+ YL    S   +H D+   N L+ +    KI DFG+++       I
Sbjct: 122 GQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR------DI 172

Query: 227 VSS---LLGARGI--IGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMEL 268
            S+    +G R +  I ++ PE +  R F   + +SD++SFG+++ E+
Sbjct: 173 YSTDYYRVGGRTMLPIRWMPPESILYRKF---TTESDIWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 71.0 bits (174), Expect = 5e-14
 Identities = 57/205 (27%), Positives = 84/205 (40%), Gaps = 43/205 (20%)

Query: 91  LGQGGFGGVYKGRLLDDFVN-------------------EVASISRTSHVNVVTLLGFCL 131
           LG+G +G VY  R L   V                    E+A  S   H N+V  LG   
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 132 EGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY--EIVIG-----IAKGLEYLH 184
           E     +  E +P GSL   + +          +W  +   E  I      I +GL+YLH
Sbjct: 76  ENGFFKIFMEQVPGGSLSALLRS----------KWGPLKDNEQTIIFYTKQILEGLKYLH 125

Query: 185 HGCSTKILHFDIKPHNILLDE-DFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE 243
                +I+H DIK  N+L++      KISDFG +K          +     G + Y+APE
Sbjct: 126 ---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF---TGTLQYMAPE 179

Query: 244 VFSRNFGEVSHKSDVYSFGMMIMEL 268
           V  +        +D++S G  I+E+
Sbjct: 180 VIDKGPRGYGAPADIWSLGCTIVEM 204

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 71.1 bits (174), Expect = 6e-14
 Identities = 62/232 (26%), Positives = 95/232 (40%), Gaps = 24/232 (10%)

Query: 120 HVNVVTLLGFCLEGNNRA--LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIA 177
           H N+V   G C E   +   LI E++P GSL  ++       P   L   ++      I 
Sbjct: 65  HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-------PKHKLNLAQLLLFAQQIC 117

Query: 178 KGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGII 237
           +G+ YLH   S   +H D+   N+LLD D   KI DFGLAK                  +
Sbjct: 118 EGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 174

Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQ 297
            + A E    N  + S+ SDV+SFG+ + EL+    + DS    S    F   I     Q
Sbjct: 175 FWYAVECLKEN--KFSYASDVWSFGVTLYELL---THCDS--KQSPPKKFEEMIGPKQGQ 227

Query: 298 DREFKLPGVVTRKE-----NEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
               +L  ++ R           +++ I+   C +     RP    +I +L+
Sbjct: 228 MTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 70.6 bits (173), Expect = 7e-14
 Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 43/213 (20%)

Query: 89  DKLGQGGFGGVYKGRL------------------------------LDDFVNEVASISRT 118
           + LG G FG VYK R                               + D V+EV  I   
Sbjct: 6   EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65

Query: 119 -SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIA 177
             H N+V      LE +   ++ + +    L +   +    K  Q    E+++ I + + 
Sbjct: 66  LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKK--QRFTEERIWNIFVQMV 123

Query: 178 KGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGII 237
             L YLH     +I+H D+ P+NI+L ED    I+DFGLAK    ++   S L    G I
Sbjct: 124 LALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK----QKQPESKLTSVVGTI 177

Query: 238 GYIAPEVF-SRNFGEVSHKSDVYSFGMMIMELV 269
            Y  PE+  +  +GE   K+DV++FG ++ ++ 
Sbjct: 178 LYSCPEIVKNEPYGE---KADVWAFGCILYQMC 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 70.7 bits (173), Expect = 7e-14
 Identities = 60/242 (24%), Positives = 107/242 (44%), Gaps = 38/242 (15%)

Query: 108 FVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWE 167
           F+ E  ++ +  H N+V L G    GN   ++ E+M NG+L+ F+   +       L   
Sbjct: 53  FLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ-----LVAG 107

Query: 168 KMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV 227
           ++  ++ G+A G++YL        +H  +  H +L++ D   KIS F   +L   K   +
Sbjct: 108 QLMGMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAI 162

Query: 228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYF 287
            + +  +  + + APE     +   S  SDV+SFG+++ E           V S  E   
Sbjct: 163 YTTMSGKSPVLWAAPEAI--QYHHFSSASDVWSFGIVMWE-----------VMSYGER-- 207

Query: 288 PHW------IYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
           P+W      + + VE    F+LP       N + + M    L C Q    +RP  +++  
Sbjct: 208 PYWDMSGQDVIKAVEDG--FRLPAPR-NCPNLLHQLM----LDCWQKERGERPRFSQIHS 260

Query: 342 ML 343
           +L
Sbjct: 261 IL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 70.4 bits (172), Expect = 8e-14
 Identities = 52/194 (26%), Positives = 92/194 (47%), Gaps = 31/194 (15%)

Query: 91  LGQGGFGGV----YKGRLL-----------DDFVNEVASISRTSHVNVVTLLGFCLEGNN 135
           +G+G FG V    Y+G  +             F+ E + +++  H N+V LLG  +E   
Sbjct: 14  IGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 73

Query: 136 RALIY-EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHF 194
              I  E+M  GSL  ++     S+    L  + + +  + + + +EYL    +   +H 
Sbjct: 74  GLYIVTEYMAKGSLVDYL----RSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHR 126

Query: 195 DIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSH 254
           D+   N+L+ ED   K+SDFGL K  ++ +         +  + + APE       + S 
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDT------GKLPVKWTAPEALREK--KFST 178

Query: 255 KSDVYSFGMMIMEL 268
           KSDV+SFG+++ E+
Sbjct: 179 KSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 70.6 bits (174), Expect = 9e-14
 Identities = 56/210 (26%), Positives = 88/210 (41%), Gaps = 46/210 (21%)

Query: 90  KLGQGGFGGVYKGRL------------------LDDFVN--EVASISR-TSHVNVVTLLG 128
           +LG G FG VY  R                    ++ +N  EV S+ +   H N+V L  
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKE 65

Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH-HGC 187
              E +    ++E+M  G+L +        KP        +  I+  I +GL ++H HG 
Sbjct: 66  VFRENDELYFVFEYM-EGNLYQL-MKDRKGKPFSE---SVIRSIIYQILQGLAHIHKHG- 119

Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSL-----LGARGIIGYIAP 242
                H D+KP N+L+      KI+DFGLA+       I S       +  R    Y AP
Sbjct: 120 ---FFHRDLKPENLLVSGPEVVKIADFGLAR------EIRSRPPYTDYVSTR---WYRAP 167

Query: 243 EVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
           E+  R+    S   D+++ G ++ EL   +
Sbjct: 168 EILLRS-TSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 70.2 bits (172), Expect = 1e-13
 Identities = 49/162 (30%), Positives = 83/162 (51%), Gaps = 19/162 (11%)

Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKM 169
           NEV  +    H N+V +    L G+   ++ EF+  G+L   V +   ++       E++
Sbjct: 65  NEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNE-------EQI 117

Query: 170 YEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSS 229
             + + + K L +LH   +  ++H DIK  +ILL  D   K+SDFG     + +     S
Sbjct: 118 ATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS 174

Query: 230 LLGARGIIGYIAPEVFSRN-FG-EVSHKSDVYSFGMMIMELV 269
           L+G      ++APEV SR  +G EV    D++S G+M++E+V
Sbjct: 175 LVGTP---YWMAPEVISRLPYGTEV----DIWSLGIMVIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 53/176 (30%), Positives = 94/176 (53%), Gaps = 19/176 (10%)

Query: 105 LDDFVNEVASISRTS-HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV---------YN 154
           L D ++E+  +     H N++ LLG C +     +I E+   G+L +F+         Y 
Sbjct: 61  LADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYT 120

Query: 155 GDTSK-PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISD 213
            D +K P + L ++ +      +A+G+EYL    S + +H D+   N+L+ ED   KI+D
Sbjct: 121 FDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIAD 177

Query: 214 FGLAKLCTTKEGIVSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMEL 268
           FGLA+     +    +  G R  + ++APE +F R +   +H+SDV+SFG+++ E+
Sbjct: 178 FGLARGVHDIDYYKKTSNG-RLPVKWMAPEALFDRVY---THQSDVWSFGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 69.9 bits (171), Expect = 1e-13
 Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 33/202 (16%)

Query: 91  LGQGGFGGVYKGRL-----------------------LDDFVNEVASISRTSHVNVVTLL 127
           +G G FG V  GRL                         DF++E + + +  H N++ L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
           G   +     ++ E+M NGSL+ F+   D           ++  ++ GIA G++YL    
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ-----FTVIQLVGMLRGIASGMKYL---S 123

Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSR 247
               +H D+   NIL++ +   K+SDFGL+++         +  G +  I + APE  + 
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA- 182

Query: 248 NFGEVSHKSDVYSFGMMIMELV 269
            + + +  SDV+S+G+++ E++
Sbjct: 183 -YRKFTSASDVWSYGIVMWEVM 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 69.6 bits (170), Expect = 2e-13
 Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 35/201 (17%)

Query: 90  KLGQGGFGGVYKG-----------------------RLLDDFVNEVASISRTSHVNVVTL 126
           +LG G FG V KG                        L D+ + E   + +  +  +V +
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
           +G C E  +  L+ E    G L KF+         +++  + + E+V  ++ G++YL   
Sbjct: 62  IGIC-EAESWMLVMELAELGPLNKFLQKN------KHVTEKNITELVHQVSMGMKYLEE- 113

Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
             T  +H D+   N+LL      KISDFGL+K     E    +    +  + + APE   
Sbjct: 114 --TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM- 170

Query: 247 RNFGEVSHKSDVYSFGMMIME 267
            N+ + S KSDV+SFG+++ E
Sbjct: 171 -NYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 69.1 bits (169), Expect = 2e-13
 Identities = 68/214 (31%), Positives = 96/214 (44%), Gaps = 51/214 (23%)

Query: 91  LGQGGFGGVY------KGRLL-----------DDFVNEVASI-------SRTSHVNVVTL 126
           LGQG FG VY       GR L            +   EV ++           H  +V  
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 127 LGFCLEGNNRALIY-EFMPNGSLEKFV--YNGDT-SKPCQYLRWEKMYEIVIGIAKGLEY 182
            G CL  +    I+ E+MP GS++  +  Y   T +   +Y R          I +G+EY
Sbjct: 70  YG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR---------QILEGVEY 119

Query: 183 LHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG---Y 239
           LH   S  I+H DIK  NIL D     K+ DFG +K   T   I SS  G + + G   +
Sbjct: 120 LH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT---ICSSGTGMKSVTGTPYW 173

Query: 240 IAPEVFSRNFGE-VSHKSDVYSFGMMIMELVGCK 272
           ++PEV S   GE    K+DV+S G  ++E++  K
Sbjct: 174 MSPEVIS---GEGYGRKADVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 68.9 bits (168), Expect = 3e-13
 Identities = 58/247 (23%), Positives = 113/247 (45%), Gaps = 40/247 (16%)

Query: 107 DFVNEVASISRTSH-VNVVTLLGFCLEGNNRALIY---EFMPNGSLEKF-----VYNGDT 157
           DF  E+  + +  H  N++ LLG C    +R  +Y   E+ P+G+L  F     V   D 
Sbjct: 41  DFAGELEVLCKLGHHPNIINLLGAC---EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDP 97

Query: 158 SKPCQY-----LRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKIS 212
           +          L  +++      +A+G++YL      + +H D+   NIL+ E++  KI+
Sbjct: 98  AFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIA 154

Query: 213 DFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
           DFGL++    +E  V   +G R  + ++A E  S N+   +  SDV+S+G+++ E+V   
Sbjct: 155 DFGLSR---GQEVYVKKTMG-RLPVRWMAIE--SLNYSVYTTNSDVWSYGVLLWEIVSLG 208

Query: 273 NNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSD 332
                G+  +        +Y  + Q    + P     +  ++ ++       C + +P +
Sbjct: 209 GTPYCGMTCAE-------LYEKLPQGYRLEKPLNCDDEVYDLMRQ-------CWREKPYE 254

Query: 333 RPPMNEV 339
           RP   ++
Sbjct: 255 RPSFAQI 261

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 68.9 bits (169), Expect = 3e-13
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 47/210 (22%)

Query: 90  KLGQGGFGGVYKGRLL---------------------DDFVNEVASISRTSHVNVVTLLG 128
           ++G+G  G V+K +                       +  + E+ ++    H  VV LL 
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQ----YLRWEKMYEIVIGIAKGLEYLH 184
               G+   L+ E+MP   L + + + +   P      Y+R   M      + KG+ Y+H
Sbjct: 67  VFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMR---M------LLKGVAYMH 116

Query: 185 HGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV-SSLLGARGIIGYIAPE 243
              +  I+H D+KP N+L+  D   KI+DFGLA+L + +E  + S  +  R    Y APE
Sbjct: 117 ---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATR---WYRAPE 170

Query: 244 VF--SRNFGEVSHKSDVYSFGMMIMELVGC 271
           +   +R +       D+++ G +  EL+  
Sbjct: 171 LLYGARKYDP---GVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 68.3 bits (167), Expect = 4e-13
 Identities = 59/243 (24%), Positives = 104/243 (42%), Gaps = 51/243 (20%)

Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKM 169
           NE   +   SH N++      LE     ++ E+ P G+L +++      K C  L  E  
Sbjct: 48  NECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYI-----QKRCNSLLDED- 101

Query: 170 YEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE-DFCPKISDFGLAKLCTTKEGIVS 228
             I+    + L  LHH  +  ILH D+K  NILLD+     KI DFG++K+ ++K    S
Sbjct: 102 -TILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK----S 156

Query: 229 SLLGARGIIGYIAPEVF-SRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYF 287
                 G   YI+PE+   + + +   KSD+++ G ++ EL   K   ++          
Sbjct: 157 KAYTVVGTPCYISPELCEGKPYNQ---KSDIWALGCVLYELASLKRAFEAA--------- 204

Query: 288 PHWIYRHVEQDREFKLPGVVTR----KENEIAK------KMIIVGLWCIQARPSDRPPMN 337
                          LP +V +        I+       + +I+ +  +   PS RP ++
Sbjct: 205 --------------NLPALVLKIMSGTFAPISDRYSPDLRQLILSM--LNLDPSKRPQLS 248

Query: 338 EVI 340
           +++
Sbjct: 249 QIM 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 68.6 bits (168), Expect = 4e-13
 Identities = 51/170 (30%), Positives = 75/170 (44%), Gaps = 30/170 (17%)

Query: 111 EVASISRTSHVNVVTLLGFCLE--GNNRALIYEFMPNGSLEKFVY------NGDTSKPCQ 162
           E+          +V   G  L+   ++  +  E+   GSL+  +Y       G       
Sbjct: 49  ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIG---- 103

Query: 163 YLRWEKMY-EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT 221
               EK+  +I   + KGL YLH   S KI+H DIKP NILL      K+ DFG++    
Sbjct: 104 ----EKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSG--- 153

Query: 222 TKEGIVSSLLGA-RGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG 270
               +V+SL G   G   Y+APE         S  SDV+S G+ ++E+  
Sbjct: 154 ---ELVNSLAGTFTGTSFYMAPERIQG--KPYSITSDVWSLGLTLLEVAQ 198

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 68.3 bits (168), Expect = 5e-13
 Identities = 68/254 (26%), Positives = 101/254 (39%), Gaps = 86/254 (33%)

Query: 87  FKDKLGQGGFGGV----YKG------------------RLLDDFVNEVASISRTSHVNVV 124
           F   LG G FG V    +KG                  + ++  +NE   +    H  +V
Sbjct: 5   FIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLV 64

Query: 125 TLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLR--------WEKMY--EIVI 174
            L G   + +N  L+ E++P G L  F           +LR          + Y  ++V+
Sbjct: 65  NLYGSFQDDSNLYLVMEYVPGGEL--F----------SHLRKSGRFPEPVARFYAAQVVL 112

Query: 175 GIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK--------LCTTKEGI 226
                LEYLH      I++ D+KP N+LLD D   KI+DFG AK        LC T E  
Sbjct: 113 A----LEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGTPE-- 163

Query: 227 VSSLLGARGIIGYIAPEVF-SRNFGEVSHKS-DVYSFGMMIME-LVGCKNNLDSGVDS-- 281
                       Y+APE+  S+ +G    K+ D ++ G++I E L G     D       
Sbjct: 164 ------------YLAPEIILSKGYG----KAVDWWALGILIYEMLAGYPPFFDDNPIQIY 207

Query: 282 ----SSEVYFPHWI 291
                 +V FP + 
Sbjct: 208 EKILEGKVRFPSFF 221

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 68.2 bits (166), Expect = 5e-13
 Identities = 67/273 (24%), Positives = 120/273 (43%), Gaps = 50/273 (18%)

Query: 89  DKLGQGGFGGVYKG-----------RLLD---------DFVNEVASISRTSHVNVVTLLG 128
           +++G+G FG V+KG           +++D         D   E+  +S+     V    G
Sbjct: 10  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69

Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
             L+G    +I E++  GS    +  G    P    +   M + ++   KGL+YLH   S
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLLRAG----PFDEFQIATMLKEIL---KGLDYLH---S 119

Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRN 248
            K +H DIK  N+LL E    K++DFG+A   T  +   ++ +G      ++APEV  ++
Sbjct: 120 EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTP---FWMAPEVIQQS 176

Query: 249 FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVT 308
                 K+D++S G+  +EL         G   +S+++ P  +   + ++    L G  +
Sbjct: 177 --AYDSKADIWSLGITAIELA-------KGEPPNSDMH-PMRVLFLIPKNNPPTLTGEFS 226

Query: 309 RKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
           +   E           C+   PS RP   E+++
Sbjct: 227 KPFKEFIDA-------CLNKDPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 67.9 bits (167), Expect = 5e-13
 Identities = 58/208 (27%), Positives = 85/208 (40%), Gaps = 52/208 (25%)

Query: 91  LGQGGFGGVYKGRLLDD----------------------FVNEVASISRTSHVNVVTLLG 128
           LG+G FG V   R  D                        + E   +SR +H  +V L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59

Query: 129 FCLEGNNRA-LIYEFMPNGSLEKFVYNGDTSKPCQYLR----WEKMY--EIVIGIAKGLE 181
           +  +   +  L+ E+ P G L   +         +  R      + Y  EIV+     LE
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHLS--------KEGRFSEERARFYAAEIVLA----LE 107

Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK-LCTTKEGIVSSLLGARGIIGYI 240
           YLH   S  I++ D+KP NILLD D   K++DFGLAK L +      +      G   Y+
Sbjct: 108 YLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC----GTPEYL 160

Query: 241 APEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           APEV            D +S G+++ E+
Sbjct: 161 APEVLLG--KGYGKAVDWWSLGVLLYEM 186

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 67.5 bits (165), Expect = 7e-13
 Identities = 52/239 (21%), Positives = 109/239 (45%), Gaps = 29/239 (12%)

Query: 106 DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQYL 164
            D +NE+  +S   H N++      ++ N   +  E+   G+L +K V         + +
Sbjct: 44  RDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMV 103

Query: 165 RWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE 224
            W  +++IV  ++    Y+H      ILH DIK  NI L +    K+ DFG++K+  ++ 
Sbjct: 104 LW-YLFQIVSAVS----YIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155

Query: 225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE 284
            +  +++G      Y++PE+      + + KSD+++ G ++ EL+  K   D+   +   
Sbjct: 156 SMAETVVGT---PYYMSPELCQGV--KYNFKSDIWALGCVLYELLTLKRTFDA--TNPLN 208

Query: 285 VYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEML 343
           +     + + V+ +    +  V +        ++I +    +Q  P  RP  +EV++  
Sbjct: 209 L-----VVKIVQGNYT-PVVSVYS-------SELISLVHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 68.0 bits (166), Expect = 7e-13
 Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 50/208 (24%)

Query: 89  DKLGQGGFGGVY----------------------KGRLLDDFVNEVASISRTSHVNVVTL 126
           +K+GQG  G VY                      K  L+   +NE+  +    H N+V  
Sbjct: 25  EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELI---INEILVMRENKHPNIVNY 81

Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG-----IAKGLE 181
           L   L G+   ++ E++  GSL   V     ++ C       M E  I        + LE
Sbjct: 82  LDSYLVGDELWVVMEYLAGGSLTDVV-----TETC-------MDEGQIAAVCRECLQALE 129

Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           +LH   S +++H DIK  NILL  D   K++DFG     T ++   S+++G      ++A
Sbjct: 130 FLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP---YWMA 183

Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELV 269
           PEV +R       K D++S G+M +E+V
Sbjct: 184 PEVVTRK--AYGPKVDIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 67.7 bits (165), Expect = 9e-13
 Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 47/223 (21%)

Query: 84  TNSFKDKLGQGGFGGVYKGRLL-------------------------DDFVNEVASISRT 118
           T  F ++LG+  FG VYKG L                          ++F +E    SR 
Sbjct: 6   TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL 65

Query: 119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF---------VYNGDTSKPCQ-YLRWEK 168
            H N+V LLG   +    ++I+ +  +  L +F         V + D  K  +  L    
Sbjct: 66  QHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPAD 125

Query: 169 MYEIVIGIAKGLEYL--HHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
              IV  IA G+E+L  HH       H D+   N+L+ +    KISD GL +     +  
Sbjct: 126 FVHIVTQIAAGMEFLSSHHVV-----HKDLATRNVLVFDKLNVKISDLGLFREVYAAD-- 178

Query: 227 VSSLLGARGI-IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMEL 268
              L+G   + I +++PE     +G+ S  SD++S+G+++ E+
Sbjct: 179 YYKLMGNSLLPIRWMSPEAIM--YGKFSIDSDIWSYGVVLWEV 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 63/234 (26%), Positives = 108/234 (46%), Gaps = 59/234 (25%)

Query: 87  FKDKLGQGGFGGVY--------------------KGRLL----------------DDFVN 110
           FK+KLG+G FG V+                    KGR L                +DF+ 
Sbjct: 9   FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68

Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVY---------NGDTSKPC 161
           EV  +SR    N++ LLG C++ +   +I E+M NG L +F+          NG+ + P 
Sbjct: 69  EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128

Query: 162 QY----LRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLA 217
            +    + +  +  + + IA G++YL    S   +H D+   N L+ E+   KI+DFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185

Query: 218 KLCTTKEGIVSSLLGARGI--IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
           +      G    + G R +  I ++A E      G+ +  SDV++FG+ + E++
Sbjct: 186 R--NLYAGDYYRIQG-RAVLPIRWMAWECIL--MGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 49/178 (27%), Positives = 89/178 (50%), Gaps = 21/178 (11%)

Query: 106 DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV--------YNGDT 157
           +DF+ E+  +SR  + N++ LLG C+  +   +I E+M NG L +F+        +    
Sbjct: 62  NDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHAN 121

Query: 158 SKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLA 217
           + P   +    +  + + IA G++YL    S   +H D+   N L+   +  KI+DFG++
Sbjct: 122 NIPS--VSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176

Query: 218 KLCTTKEGIVSSLLGARGI--IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CK 272
           +      G    + G R +  I ++A E  S   G+ +  SDV++FG+ + E+   CK
Sbjct: 177 R--NLYSGDYYRIQG-RAVLPIRWMAWE--SILLGKFTTASDVWAFGVTLWEMFTLCK 229

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 66.5 bits (163), Expect = 2e-12
 Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 51/209 (24%)

Query: 90  KLGQGGFGGVYKGRLL----------------DDF---VNEVASISRTSHVNVVTLLGFC 130
           ++G G +G VYK R +                DDF     E++ +    H N+V   G  
Sbjct: 10  RIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY 69

Query: 131 LEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIA-------KGLEYL 183
           L  +   ++ E+   GSL+  +Y   T  P   L+          IA       KGL YL
Sbjct: 70  LRRDKLWIVMEYCGGGSLQD-IYQ-VTRGPLSELQ----------IAYVCRETLKGLAYL 117

Query: 184 HHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG---YI 240
           H    T  +H DIK  NILL ED   K++DFG++        + +++   +  IG   ++
Sbjct: 118 HE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQ------LTATIAKRKSFIGTPYWM 168

Query: 241 APEVFSRNF-GEVSHKSDVYSFGMMIMEL 268
           APEV +    G    K D+++ G+  +EL
Sbjct: 169 APEVAAVERKGGYDGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 65/281 (23%), Positives = 114/281 (40%), Gaps = 58/281 (20%)

Query: 90  KLGQGGFGGVYKGRLL----------------------DDFVNEVASISRTSHVNVVTLL 127
           K+G+G F  VYK   L                       D + E+  + +  H NV+  L
Sbjct: 9   KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYL 68

Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
              +E N   ++ E    G L + + +    K  + +    +++  + +   LE++H   
Sbjct: 69  ASFIENNELNIVLELADAGDLSRMIKH--FKKQKRLIPERTIWKYFVQLCSALEHMH--- 123

Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSR 247
           S +I+H DIKP N+ +      K+ D GL +  ++K     SL+G      Y++PE    
Sbjct: 124 SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTP---YYMSPERIHE 180

Query: 248 NFGEVSHKSDVYSFGMMIMELV-------GCKNNLDSGVDSSSEVYFPHWIYRHVEQDRE 300
           N    + KSD++S G ++ E+        G K NL S      +  +P     H  +   
Sbjct: 181 N--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSE--- 235

Query: 301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
            +L  +V+R               CI   P  RP ++ V++
Sbjct: 236 -ELRDLVSR---------------CINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 47/220 (21%)

Query: 87  FKDKLGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVN 122
           F ++LG+  FG +YKG L                          +F  E + ++   H N
Sbjct: 9   FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68

Query: 123 VVTLLGFCLEGNNRALIYEFMPNGSLEKFVY-----------NGDTSKPCQYLRWEKMYE 171
           +V LLG   +     +++E++  G L +F+            + +       L       
Sbjct: 69  IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128

Query: 172 IVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI---VS 228
           I I IA G+EYL    S   +H D+   NIL+ E    KISD GL++   + +       
Sbjct: 129 IAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185

Query: 229 SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           SLL  R    ++ PE     +G+ S  SD++SFG+++ E+
Sbjct: 186 SLLPIR----WMPPEAIM--YGKFSSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 43/223 (19%)

Query: 80  VKKLTNSFKDKLGQGGFGGVY----------KGRLL--------------DDFVNEVASI 115
           +K+     K +LG+G FG V+          + ++L               DF  E   +
Sbjct: 2   IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELL 61

Query: 116 SRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV--YNGDT-----SKPCQYLRWEK 168
           +   H ++V   G C+EG+   +++E+M +G L KF+  +  D            L   +
Sbjct: 62  TNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQ 121

Query: 169 MYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVS 228
           M  I   IA G+ YL    S   +H D+   N L+ E+   KI DFG+++   + +    
Sbjct: 122 MLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD---Y 175

Query: 229 SLLGARGI--IGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMEL 268
             +G   +  I ++ PE +  R F   + +SDV+S G+++ E+
Sbjct: 176 YRVGGHTMLPIRWMPPESIMYRKF---TTESDVWSLGVVLWEI 215

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 73/277 (26%), Positives = 113/277 (40%), Gaps = 54/277 (19%)

Query: 91  LGQGGFGGVYKGRLLDD------------------------FVNEVASISRTSHVNVVTL 126
           LG G FG VYKG  + D                         ++E   ++      V  L
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL-RWEKMYEIVIGIAKGLEYLHH 185
           LG CL    + L+ + MP G L  +V         Q L  W       + IAKG+ YL  
Sbjct: 75  LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYLE- 126

Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
               +++H D+   N+L+      KI+DFGLA+L    E    +  G +  I ++A E +
Sbjct: 127 --EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHA-DGGKVPIKWMALESI 183

Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
             R F   +H+SDV+S+G+ + EL+        G+ +         I   +E+      P
Sbjct: 184 LHRRF---THQSDVWSYGVTVWELMTFGAKPYDGIPARE-------IPDLLEKGERLPQP 233

Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
            + T     I   MI+V  W I      RP   E+++
Sbjct: 234 PICT-----IDVYMIMVKCWMID--SECRPRFRELVD 263

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 65.9 bits (161), Expect = 3e-12
 Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 39/203 (19%)

Query: 91  LGQGGFGGVYKGR-------------------LLDDFVNEVASISRTSHVNVVTLLGFCL 131
           LG G FG VYK +                    L+DF+ E+  +S   H N+V L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 132 EGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKI 191
             N   ++ EF   G+L+  +   +  +    L   ++  +   + + L +LH   S K+
Sbjct: 73  YENKLWILIEFCDGGALDSIML--ELERG---LTEPQIRYVCRQMLEALNFLH---SHKV 124

Query: 192 LHFDIKPHNILLDEDFCPKISDFGL-AKLCTTKEGIVSSLLGARGIIGYIAPEV-----F 245
           +H D+K  NILL  D   K++DFG+ AK  +T +    + +G      ++APEV     F
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK-RDTFIGTP---YWMAPEVVACETF 180

Query: 246 SRNFGEVSHKSDVYSFGMMIMEL 268
             N     +K+D++S G+ ++EL
Sbjct: 181 KDN--PYDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 65.9 bits (161), Expect = 4e-12
 Identities = 43/151 (28%), Positives = 77/151 (50%), Gaps = 28/151 (18%)

Query: 89  DKLGQGGFGGVYKG--------------RLLDD-------FVNEVASISRTSHVNVVTLL 127
           +K+G+G +G VYKG              RL  +        + E++ +    H N+V L 
Sbjct: 6   EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQ 65

Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
              ++ +   LI+EF+ +  L+K++   D+    QY+  E +   +  I +G+ + H   
Sbjct: 66  DVLMQESRLYLIFEFL-SMDLKKYL---DSLPKGQYMDAELVKSYLYQILQGILFCH--- 118

Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAK 218
           S ++LH D+KP N+L+D     K++DFGLA+
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLAR 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 66.3 bits (161), Expect = 4e-12
 Identities = 73/288 (25%), Positives = 123/288 (42%), Gaps = 54/288 (18%)

Query: 79  DVKKLTNSFKDKLGQGGFGGVYKGRLL----------------------DDFVNEVASIS 116
           D +KL    ++ +G G FG VY  R +                       D + EV  + 
Sbjct: 22  DPEKLFTDLRE-IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQ 80

Query: 117 RTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 176
           R  H N +   G  L  +   L+ E+    + +    +    KP Q +   ++  I  G 
Sbjct: 81  RIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVH---KKPLQEV---EIAAITHGA 134

Query: 177 AKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI 236
            +GL YLH   S  ++H DIK  NILL E    K++DFG A + +     V       G 
Sbjct: 135 LQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-------GT 184

Query: 237 IGYIAPEV-FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV 295
             ++APEV  + + G+   K DV+S G+  +EL   K  L   +++ S +Y       H+
Sbjct: 185 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL-FNMNAMSALY-------HI 236

Query: 296 EQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEML 343
            Q+     P + + + ++  +  +     C+Q  P DRP   E+++ +
Sbjct: 237 AQNES---PTLQSNEWSDYFRNFVDS---CLQKIPQDRPTSEELLKHM 278

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 65.2 bits (159), Expect = 6e-12
 Identities = 54/225 (24%), Positives = 87/225 (38%), Gaps = 59/225 (26%)

Query: 91  LGQGGFGGVYKGRLL-------------------------DDFVNEVASISRTSHVNVVT 125
           +GQG FG V++ R                            DF  E A ++   H N+V 
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 126 LLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEK----------------M 169
           LLG C  G    L++E+M  G L +F+ +      C                        
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 170 YEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGL------AKLCTTK 223
             I   +A G+ YL      K +H D+   N L+ E+   KI+DFGL      A      
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           E   +  +  R    ++ PE  S  +   + +SDV+++G+++ E+
Sbjct: 190 E---NDAIPIR----WMPPE--SIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 65.2 bits (159), Expect = 8e-12
 Identities = 62/224 (27%), Positives = 100/224 (44%), Gaps = 46/224 (20%)

Query: 68  GPLPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYK------GRLL---------DDFV--- 109
           G  P    + S+++++     +++G G  G VYK      GRL          +D V   
Sbjct: 64  GSAPSAAKSLSELERV-----NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQ 118

Query: 110 --NEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWE 167
              E+  +   +H NVV             ++ EFM  GSLE      +     Q+L   
Sbjct: 119 ICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADE-----QFLA-- 171

Query: 168 KMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK-LCTTKEGI 226
              ++   I  G+ YLH      I+H DIKP N+L++     KI+DFG+++ L  T +  
Sbjct: 172 ---DVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC 225

Query: 227 VSSLLGARGIIGYIAPEVFSR--NFGEVS-HKSDVYSFGMMIME 267
            SS+    G I Y++PE  +   N G    +  D++S G+ I+E
Sbjct: 226 NSSV----GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILE 265

Length = 353

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 65.0 bits (158), Expect = 8e-12
 Identities = 71/313 (22%), Positives = 130/313 (41%), Gaps = 66/313 (21%)

Query: 80  VKKLTNSFKDKLGQGGFGGVY----------KGRLL--------------DDFVNEVASI 115
           +K+     K +LG+G FG V+          K ++L               DF  E   +
Sbjct: 2   IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELL 61

Query: 116 SRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF----------VYNGDTSKPCQYLR 165
           +   H ++V   G C +G+   +++E+M +G L KF          + +G   +    L 
Sbjct: 62  TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 121

Query: 166 WEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG 225
             +M  I   IA G+ YL    S   +H D+   N L+  +   KI DFG+++   + + 
Sbjct: 122 LSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD- 177

Query: 226 IVSSLLGARGI--IGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSS 282
                +G   +  I ++ PE +  R F   + +SDV+SFG+++ E+              
Sbjct: 178 --YYRVGGHTMLPIRWMPPESIMYRKF---TTESDVWSFGVILWEI----------FTYG 222

Query: 283 SEVYF---PHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEV 339
            + +F      +   + Q R  + P V  ++  +     I++G W  Q  P  R  + E+
Sbjct: 223 KQPWFQLSNTEVIECITQGRVLERPRVCPKEVYD-----IMLGCW--QREPQQRLNIKEI 275

Query: 340 IEMLQGSTEALQI 352
            ++L    +A  I
Sbjct: 276 YKILHALGKATPI 288

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 46/170 (27%), Positives = 82/170 (48%), Gaps = 12/170 (7%)

Query: 102 GRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRA--LIYEFMPNGSLEKFVYNGDTSK 159
           G  + D   E+  +    H N+V   G C E       LI EF+P+GSL++++      +
Sbjct: 47  GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-----PR 101

Query: 160 PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL 219
               +  ++  +  + I KG++YL    S + +H D+   N+L++ +   KI DFGL K 
Sbjct: 102 NKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 158

Query: 220 CTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             T +   +        + + APE   ++  +    SDV+SFG+ + EL+
Sbjct: 159 IETDKEYYTVKDDLDSPVFWYAPECLIQS--KFYIASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 37/211 (17%)

Query: 79  DVKKLTNSFKDKLGQGGFGGVYKGRLL-------------------DDFVNEVASISRTS 119
           D KK    F +K+GQG  G VY    +                   +  +NE+  +    
Sbjct: 17  DPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK 75

Query: 120 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
           + N+V  L   L G+   ++ E++  GSL   V     ++ C  +   ++  +     + 
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETC--MDEGQIAAVCRECLQA 128

Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
           LE+LH   S +++H DIK  NILL  D   K++DFG     T ++   S+++G      +
Sbjct: 129 LEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP---YW 182

Query: 240 IAPEVFSRN-FGEVSHKSDVYSFGMMIMELV 269
           +APEV +R  +G    K D++S G+M +E++
Sbjct: 183 MAPEVVTRKAYGP---KVDIWSLGIMAIEMI 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 41/209 (19%)

Query: 91  LGQGGFGGVYKGR-------------------------LLDDFVNEVASISRTSHVNVVT 125
           LG+G FG V+  +                         L  +F  E+    + SH NVV 
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 126 LLGFCLEGNNRALIYEFMPNGSLEKFV----YNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           LLG C E     +I E+   G L++F+       +  KP   L  ++   +   IA G++
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKP-PPLSTKQKVALCTQIALGMD 131

Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE--GIVSSLLGARGIIGY 239
           +L +    + +H D+   N L+      K+S   L+K     E   + ++L+  R    +
Sbjct: 132 HLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR----W 184

Query: 240 IAPEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           +APE    +  + S KSDV+SFG+++ E+
Sbjct: 185 LAPEAVQED--DFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 58/230 (25%), Positives = 102/230 (44%), Gaps = 45/230 (19%)

Query: 91  LGQGGFGGVYKGRL------------------------LDDFVNEVASISRTSHVNVVTL 126
           LG+G FG V + +L                        +++F+ E A +    H NV+ L
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66

Query: 127 LGFCLEGNNRA------LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGL 180
           +G  L    +       +I  FM +G L  F+      +    L  + +   +I IA G+
Sbjct: 67  IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126

Query: 181 EYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT----KEGIVSSLLGARGI 236
           EYL    S   +H D+   N +L+E+    ++DFGL+K   +    ++G  S L      
Sbjct: 127 EYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL-----P 178

Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVY 286
           + ++A E  + N       SDV++FG+ + E++       +GV+ +SE+Y
Sbjct: 179 VKWLALESLADNVYTT--HSDVWAFGVTMWEIMTRGQTPYAGVE-NSEIY 225

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 47/161 (29%), Positives = 82/161 (50%), Gaps = 17/161 (10%)

Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKM 169
           NEV  +    H NVV +    L G+   ++ EF+  G+L   V +   ++       E++
Sbjct: 68  NEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE-------EQI 120

Query: 170 YEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSS 229
             + + + + L YLH   +  ++H DIK  +ILL  D   K+SDFG     + +     S
Sbjct: 121 ATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS 177

Query: 230 LLGARGIIGYIAPEVFSR-NFGEVSHKSDVYSFGMMIMELV 269
           L+G      ++APEV SR  +G    + D++S G+M++E++
Sbjct: 178 LVGTP---YWMAPEVISRLPYGT---EVDIWSLGIMVIEMI 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 64.0 bits (155), Expect = 2e-11
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 35/210 (16%)

Query: 79  DVKKLTNSFKDKLGQGGFGGVYKGRLL-------------------DDFVNEVASISRTS 119
           D KK    F +K+GQG  G VY    +                   +  +NE+  +    
Sbjct: 16  DPKKKYTRF-EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENK 74

Query: 120 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
           + N+V  L   L G+   ++ E++  GSL   V     ++ C  +   ++  +     + 
Sbjct: 75  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETC--MDEGQIAAVCRECLQA 127

Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
           L++LH   S +++H DIK  NILL  D   K++DFG     T ++   S+++G      +
Sbjct: 128 LDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP---YW 181

Query: 240 IAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
           +APEV +R       K D++S G+M +E+V
Sbjct: 182 MAPEVVTRK--AYGPKVDIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 63.4 bits (155), Expect = 2e-11
 Identities = 52/152 (34%), Positives = 74/152 (48%), Gaps = 33/152 (21%)

Query: 134 NNRALIYEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMY--EIVIGIAKGLEYLHHGCSTK 190
            N  L+ E++P G L   + N G   +        ++Y  EIV+     LEYLH   S  
Sbjct: 66  KNLYLVMEYLPGGDLASLLENVGSLDE-----DVARIYIAEIVLA----LEYLH---SNG 113

Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGA-------RGIIG---YI 240
           I+H D+KP NIL+D +   K++DFGL     +K G+V   +         + I+G   YI
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGL-----SKVGLVRRQINLNDDEKEDKRIVGTPDYI 168

Query: 241 APEVFSRNFGEVSHKSDVYSFGMMIME-LVGC 271
           APEV     G  S   D +S G ++ E LVG 
Sbjct: 169 APEVI-LGQGH-SKTVDWWSLGCILYEFLVGI 198

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 35/200 (17%)

Query: 89  DKLGQGGFGGVYKG-----------RLLD---------DFVNEVASISRTSHVNVVTLLG 128
           +++G+G FG VYKG           +++D         D   E+  +S+     +    G
Sbjct: 10  ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69

Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
             L+G    +I E++  GS    +  G        L    +  I+  I KGL+YLH   S
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLLKPGP-------LEETYIATILREILKGLDYLH---S 119

Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRN 248
            + +H DIK  N+LL E    K++DFG+A   T  +   ++ +G      ++APEV  ++
Sbjct: 120 ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTP---FWMAPEVIKQS 176

Query: 249 FGEVSHKSDVYSFGMMIMEL 268
                 K+D++S G+  +EL
Sbjct: 177 --AYDFKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 63.6 bits (154), Expect = 2e-11
 Identities = 69/273 (25%), Positives = 119/273 (43%), Gaps = 50/273 (18%)

Query: 89  DKLGQGGFGGVYKG-----------RLLD---------DFVNEVASISRTSHVNVVTLLG 128
           +K+G+G FG V+KG           +++D         D   E+  +S+     V    G
Sbjct: 10  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69

Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
             L+     +I E++  GS    +  G        L   ++  I+  I KGL+YLH   S
Sbjct: 70  SYLKDTKLWIIMEYLGGGSALDLLEPGP-------LDETQIATILREILKGLDYLH---S 119

Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRN 248
            K +H DIK  N+LL E    K++DFG+A   T  +   ++ +G      ++APEV  ++
Sbjct: 120 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTP---FWMAPEVIKQS 176

Query: 249 FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVT 308
                 K+D++S G+  +EL         G    SE++ P  +   + ++    L G  +
Sbjct: 177 --AYDSKADIWSLGITAIELA-------KGEPPHSELH-PMKVLFLIPKNNPPTLEGNYS 226

Query: 309 RKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
           +   E  +        C+   PS RP   E+++
Sbjct: 227 KPLKEFVEA-------CLNKEPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 63.4 bits (154), Expect = 2e-11
 Identities = 51/200 (25%), Positives = 85/200 (42%), Gaps = 33/200 (16%)

Query: 90  KLGQGGFG----GVYKGR------------------LLDDFVNEVASISRTSHVNVVTLL 127
           +LG G FG    GVYK R                  + D+ + E   + +  +  +V ++
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
           G C E     L+ E    G L KF+                + E++  ++ G++YL    
Sbjct: 62  GVC-EAEALMLVMEMASGGPLNKFLSGKKDEITV-----SNVVELMHQVSMGMKYLE--- 112

Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSR 247
               +H D+   N+LL      KISDFGL+K     +    +    +  + + APE    
Sbjct: 113 GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECI-- 170

Query: 248 NFGEVSHKSDVYSFGMMIME 267
           NF + S +SDV+S+G+ + E
Sbjct: 171 NFRKFSSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 63.4 bits (155), Expect = 2e-11
 Identities = 56/208 (26%), Positives = 87/208 (41%), Gaps = 53/208 (25%)

Query: 90  KLGQGGFGGVYKGRL--------------------LDDFVNEVASISRTSHVNVVTLLGF 129
            +G+G FG VYK                       ++D   E+  +S+     +    G 
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67

Query: 130 CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG-----IAKGLEYLH 184
            L+G+   +I E+   GS        D  KP       K+ E  I      +  GLEYLH
Sbjct: 68  FLKGSKLWIIMEYCGGGSCL------DLLKPG------KLDETYIAFILREVLLGLEYLH 115

Query: 185 HGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGAR----GIIGYI 240
                  +H DIK  NILL E+   K++DFG++       G ++S +  R    G   ++
Sbjct: 116 ---EEGKIHRDIKAANILLSEEGDVKLADFGVS-------GQLTSTMSKRNTFVGTPFWM 165

Query: 241 APEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           APEV  +       K+D++S G+  +EL
Sbjct: 166 APEVIKQ--SGYDEKADIWSLGITAIEL 191

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 40/116 (34%), Positives = 63/116 (54%), Gaps = 15/116 (12%)

Query: 157 TSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGL 216
           +   CQY     +Y+++    +GL+Y+H   S  +LH D+KP N+LL+ +   KI DFGL
Sbjct: 106 SDDHCQYF----LYQLL----RGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGL 154

Query: 217 AKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
           A+  + K   ++  +  R    Y APE+   N  E +   DV+S G +  EL+G K
Sbjct: 155 ARTTSEKGDFMTEYVVTR---WYRAPELL-LNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 63.4 bits (154), Expect = 3e-11
 Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 49/222 (22%)

Query: 91  LGQGGFGGVYKG---RL----------------------LDDFVNEVASISRTSHVNVVT 125
           LG+G FG V K    RL                      L D ++E   + + +H +V+ 
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 126 LLGFCLEGNNRALIYEFMPNGSLEKFV----------YNGDTSKPCQYLRWEKMYEIVIG 175
           L G C +     LI E+   GSL  F+             D ++   YL       + +G
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 176 --------IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV 227
                   I++G++YL      K++H D+   N+L+ E    KISDFGL++    ++  V
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
               G R  + ++A E    +    + +SDV+SFG+++ E+V
Sbjct: 185 KRSKG-RIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIV 223

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 47/161 (29%), Positives = 81/161 (50%), Gaps = 17/161 (10%)

Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKM 169
           NEV  +    H NVV +    L G+   ++ EF+  G+L   V +   ++       E++
Sbjct: 66  NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE-------EQI 118

Query: 170 YEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSS 229
             + + + K L  LH   +  ++H DIK  +ILL  D   K+SDFG     + +     S
Sbjct: 119 AAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 175

Query: 230 LLGARGIIGYIAPEVFSR-NFGEVSHKSDVYSFGMMIMELV 269
           L+G      ++APE+ SR  +G    + D++S G+M++E+V
Sbjct: 176 LVGTP---YWMAPELISRLPYGP---EVDIWSLGIMVIEMV 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 63.0 bits (153), Expect = 3e-11
 Identities = 55/235 (23%), Positives = 100/235 (42%), Gaps = 30/235 (12%)

Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY 170
           E+  ++R +H +++ +LG   E ++  L  E+M  GS+   +      K    + +    
Sbjct: 53  EIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINY---- 108

Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLD---EDFCPKISDFGLAKLCTTKEGIV 227
                + +GL YLH     +I+H D+K  N+L+D   +    +I+DFG A     K    
Sbjct: 109 --TEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGA 161

Query: 228 SSLLGAR-GIIGYIAPEVF-SRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
               G   G I ++APEV     +G      DV+S G +I+E+           +  S  
Sbjct: 162 GEFQGQLLGTIAFMAPEVLRGEQYGR---SCDVWSVGCVIIEM--ATAKPPWNAEKHSNH 216

Query: 286 YFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI 340
                I++         +P  ++    ++        L C++ +P DRPP  E++
Sbjct: 217 L--ALIFKIASATTAPSIPEHLSPGLRDVT-------LRCLELQPEDRPPSRELL 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 62.7 bits (152), Expect = 3e-11
 Identities = 59/244 (24%), Positives = 105/244 (43%), Gaps = 54/244 (22%)

Query: 111 EVASISRTSHVNVVT--------------LLGFCLEGNNRALIYEFMPNGSLEKFVYNGD 156
           E   +S+  H N+V               ++GFC  G+                 +Y+  
Sbjct: 49  EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGD-----------------LYHKL 91

Query: 157 TSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGL 216
             +  + L   ++ E  + IA  L+YLH      ILH D+K  N+ L      K+ D G+
Sbjct: 92  KEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGI 148

Query: 217 AKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLD 276
           A++   +  + S+L+G      Y++PE+FS      ++KSDV++ G  + E+   K+  +
Sbjct: 149 ARVLENQCDMASTLIGTP---YYMSPELFSNK--PYNYKSDVWALGCCVYEMATLKHAFN 203

Query: 277 SGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPM 336
           +  D +S V      YR +E     KLP +      E+ +  +I  +     RP  RP +
Sbjct: 204 AK-DMNSLV------YRIIEG----KLPPMPKDYSPELGE--LIATMLS--KRPEKRPSV 248

Query: 337 NEVI 340
             ++
Sbjct: 249 KSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 62.7 bits (152), Expect = 4e-11
 Identities = 61/286 (21%), Positives = 117/286 (40%), Gaps = 58/286 (20%)

Query: 86  SFKDKLGQGGFGGVYKGR-LLD---------------------DFVNEVASISRTSHVNV 123
             + K+G+G F  VY+   LLD                     D + E+  + + +H NV
Sbjct: 5   RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNV 64

Query: 124 VTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYL 183
           +      +E N   ++ E    G L + + +    K  + +  + +++  + +   LE++
Sbjct: 65  IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQK--RLIPEKTVWKYFVQLCSALEHM 122

Query: 184 HHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE 243
           H   S +++H DIKP N+ +      K+ D GL +  ++K     SL+G      Y++PE
Sbjct: 123 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTP---YYMSPE 176

Query: 244 VFSRNFGEVSHKSDVYSFGMMIMELV-------GCKNNLDSGVDSSSEVYFPHWIYRHVE 296
               N    + KSD++S G ++ E+        G K NL S      +  +P     H  
Sbjct: 177 RIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS 234

Query: 297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM 342
           ++                 ++++ +   CI   P  RP +  V ++
Sbjct: 235 EE----------------LRQLVNM---CINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 62.6 bits (153), Expect = 4e-11
 Identities = 40/154 (25%), Positives = 66/154 (42%), Gaps = 34/154 (22%)

Query: 89  DKLGQGGFGGVYKGRLLDD----------FVNEVASISRTS-----------HVNVVTLL 127
            ++G+G +G VYK R                NE      T+           H N+V L 
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 128 GFCLE--GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLR-WEKMYEIVIGIAKGLEYLH 184
                    +  +++E+M +  L   + + +       ++ + K       + +GL+YLH
Sbjct: 65  EIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQ------LLEGLQYLH 117

Query: 185 HGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK 218
              S  ILH DIK  NIL++ D   K++DFGLA+
Sbjct: 118 ---SNGILHRDIKGSNILINNDGVLKLADFGLAR 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 62.0 bits (150), Expect = 7e-11
 Identities = 52/201 (25%), Positives = 92/201 (45%), Gaps = 33/201 (16%)

Query: 90  KLGQGGFGGVYKGR-------------------LLDDFVNEVASISRTSHVNVVTLLGFC 130
           +LG G FG VYK +                    L+D++ E+  ++  +H  +V LLG  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 131 LEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTK 190
                  ++ EF P G+++  +   D       L   ++  I   + + L+YLH   S K
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLELDRG-----LTEPQIQVICRQMLEALQYLH---SMK 130

Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVF---SR 247
           I+H D+K  N+LL  D   K++DFG++           S +G      ++APEV    + 
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTP---YWMAPEVVMCETM 187

Query: 248 NFGEVSHKSDVYSFGMMIMEL 268
                 +K+D++S G+ ++E+
Sbjct: 188 KDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 61.7 bits (150), Expect = 7e-11
 Identities = 50/206 (24%), Positives = 85/206 (41%), Gaps = 36/206 (17%)

Query: 86  SFKDKLGQGGFGGVYKGRLLD-----------------------DFVNEVASISRTSHVN 122
           +    +G+G FG VY+G  +                         F+ E   + +  H +
Sbjct: 9   TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPH 68

Query: 123 VVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 182
           +V L+G   E N   ++ E  P G L  ++     S     L    +      ++  L Y
Sbjct: 69  IVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYS-----LDLASLILYSYQLSTALAY 122

Query: 183 LHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAP 242
           L    S + +H DI   N+L+    C K+ DFGL++    +    +S    +  I ++AP
Sbjct: 123 LE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASK--GKLPIKWMAP 177

Query: 243 EVFSRNFGEVSHKSDVYSFGMMIMEL 268
           E  S NF   +  SDV+ FG+ + E+
Sbjct: 178 E--SINFRRFTSASDVWMFGVCMWEI 201

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 61.6 bits (149), Expect = 9e-11
 Identities = 49/160 (30%), Positives = 75/160 (46%), Gaps = 15/160 (9%)

Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKM 169
           NEV  +    H NVV +    L G    ++ EF+  G+L   V           L  E++
Sbjct: 67  NEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-------TRLNEEQI 119

Query: 170 YEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSS 229
             +   + + L YLH   S  ++H DIK  +ILL  D   K+SDFG     +       S
Sbjct: 120 ATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 176

Query: 230 LLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
           L+G      ++APEV SR       + D++S G+M++E+V
Sbjct: 177 LVGTP---YWMAPEVISRT--PYGTEVDIWSLGIMVIEMV 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 61.4 bits (149), Expect = 1e-10
 Identities = 33/94 (35%), Positives = 48/94 (51%), Gaps = 9/94 (9%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           I  GLE+LH     +I++ D+KP N+LLD+    +ISD GLA     K G    + G  G
Sbjct: 104 IICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGG--KKIKGRAG 156

Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             GY+APEV            D ++ G  + E++
Sbjct: 157 TPGYMAPEVLQG--EVYDFSVDWFALGCTLYEMI 188

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 49/201 (24%), Positives = 90/201 (44%), Gaps = 32/201 (15%)

Query: 90  KLGQGGFGGVYKGR-LLD---------------------DFVNEVASISRTSHVNVVTLL 127
           K+G+G F  VY+   LLD                     D V E+  + + +H NV+  L
Sbjct: 9   KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYL 68

Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
              +E N   ++ E    G L + +      K  + +    +++  + +   +E++H   
Sbjct: 69  DSFIEDNELNIVLELADAGDLSQMIKYFKKQK--RLIPERTVWKYFVQLCSAVEHMH--- 123

Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSR 247
           S +++H DIKP N+ +      K+ D GL +  ++K     SL+G      Y++PE    
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTP---YYMSPERIHE 180

Query: 248 NFGEVSHKSDVYSFGMMIMEL 268
           N    + KSD++S G ++ E+
Sbjct: 181 N--GYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 36/94 (38%), Positives = 57/94 (60%), Gaps = 8/94 (8%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           +A  L++LH   S  I++ D+KP NILLDE+   K++DFGL+K     E    S  G   
Sbjct: 107 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGT-- 161

Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            + Y+APEV +R  G  +  +D +SFG+++ E++
Sbjct: 162 -VEYMAPEVVNRR-GH-TQSADWWSFGVLMFEML 192

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 69/274 (25%), Positives = 113/274 (41%), Gaps = 53/274 (19%)

Query: 90  KLGQGGFGGVY------------------KGRLLD----DFVNEVASISRTSHVNVVTLL 127
           ++G G FG VY                   G+  +    D + EV  + +  H N +   
Sbjct: 28  EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87

Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
           G  L+ +   L+ E+    + +    +    KP Q +   ++  I  G  +GL YLH   
Sbjct: 88  GCYLKEHTAWLVMEYCLGSASDLLEVH---KKPLQEV---EIAAITHGALQGLAYLHSHN 141

Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV-FS 246
              ++H DIK  NILL E    K++DFG A   +     V       G   ++APEV  +
Sbjct: 142 ---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-------GTPYWMAPEVILA 191

Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
            + G+   K DV+S G+  +EL   K  L   +++ S +Y       H+ Q+        
Sbjct: 192 MDEGQYDGKVDVWSLGITCIELAERKPPL-FNMNAMSALY-------HIAQNDS------ 237

Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI 340
            T + NE          +C+Q  P +RP   E++
Sbjct: 238 PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 73/311 (23%), Positives = 128/311 (41%), Gaps = 69/311 (22%)

Query: 79  DVKKLTNSFKDKLGQGGFGGVYKGRLL----------------------DDFVNEVASIS 116
           D +KL +  ++ +G G FG VY  R +                       D + EV  + 
Sbjct: 12  DPEKLFSDLRE-IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70

Query: 117 RTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 176
           +  H N +   G  L  +   L+ E+    + +    +    KP Q +   ++  +  G 
Sbjct: 71  KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH---KKPLQEV---EIAAVTHGA 124

Query: 177 AKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI 236
            +GL YLH   S  ++H D+K  NILL E    K+ DFG A +       V       G 
Sbjct: 125 LQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-------GT 174

Query: 237 IGYIAPEV-FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV 295
             ++APEV  + + G+   K DV+S G+  +EL   K  L   +++ S +Y       H+
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL-FNMNAMSALY-------HI 226

Query: 296 EQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRP---------------PMNEVI 340
            Q+     P + +   +E  +  +     C+Q  P DRP               P   ++
Sbjct: 227 AQNES---PALQSGHWSEYFRNFVDS---CLQKIPQDRPTSEVLLKHRFVLRERPPTVIM 280

Query: 341 EMLQGSTEALQ 351
           +++Q + +A++
Sbjct: 281 DLIQRTKDAVR 291

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 60.7 bits (147), Expect = 2e-10
 Identities = 67/287 (23%), Positives = 117/287 (40%), Gaps = 52/287 (18%)

Query: 89  DKLGQGGFGGVYKGRL----------------------LDDFVNEVASISRTSHVNVVTL 126
           D++G G FG V  G                           F+ EV      +H NV+  
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYN--GDTSKPCQYLRWEKMYEIVIGIAKGLEYLH 184
           LG C+E     L+ EF P G L+ ++ +  G  ++  Q    ++M      +A GL +LH
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM---ACEVASGLLWLH 117

Query: 185 HGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV 244
                  +H D+   N  L  D   KI D+GLA L    E    +       + ++APE+
Sbjct: 118 Q---ADFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPEL 173

Query: 245 ---FSRNF--GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPH---WIYRHVE 296
                ++    + + KS+++S G+ + EL            ++ + Y       + + V 
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWEL----------FTAADQPYPDLSDEQVLKQVV 223

Query: 297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEML 343
           ++++ KLP    + + + + +   V  +C    P  RP   EV E+L
Sbjct: 224 REQDIKLPK--PQLDLKYSDRWYEVMQFC-WLDPETRPTAEEVHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 60.7 bits (147), Expect = 2e-10
 Identities = 59/231 (25%), Positives = 104/231 (45%), Gaps = 52/231 (22%)

Query: 86  SFKDKLGQGGFGGVY------------KGRLLD------------------------DFV 109
           +FK+KLG+G FG V+            K   LD                        DF+
Sbjct: 8   TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFL 67

Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQ-----YL 164
            E+  +SR    N++ LL  C+  +   +I E+M NG L +F+   +  +  +      +
Sbjct: 68  KEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127

Query: 165 RWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE 224
            +  +  +   IA G++YL    S   +H D+   N L+ +++  KI+DFG+++      
Sbjct: 128 SYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSR--NLYS 182

Query: 225 GIVSSLLGARGI--IGYIAPEVFSRNFGEVSHKSDVYSFGMMIME-LVGCK 272
           G    + G R +  I +++ E  S   G+ +  SDV++FG+ + E L  CK
Sbjct: 183 GDYYRIQG-RAVLPIRWMSWE--SILLGKFTTASDVWAFGVTLWEILTLCK 230

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 60.9 bits (147), Expect = 2e-10
 Identities = 44/161 (27%), Positives = 82/161 (50%), Gaps = 15/161 (9%)

Query: 109 VNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEK 168
           +NE+  +    + N+V  L   L G+   ++ E++  GSL   V     ++ C  +   +
Sbjct: 64  INEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV-----TETC--MDEAQ 116

Query: 169 MYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVS 228
           +  +     + LE+LH   + +++H DIK  N+LL  D   K++DFG     T ++   S
Sbjct: 117 IAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS 173

Query: 229 SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
           +++G      ++APEV +R       K D++S G+M +E+V
Sbjct: 174 TMVGTP---YWMAPEVVTRK--AYGPKVDIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 49/149 (32%), Positives = 73/149 (48%), Gaps = 21/149 (14%)

Query: 123 VVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 182
           +V+  G  L  NN  +  EFM  GSL++        K    +  E + +I + + +GL Y
Sbjct: 65  IVSFYGAFLNENNICMCMEFMDCGSLDRI------YKKGGPIPVEILGKIAVAVVEGLTY 118

Query: 183 L---HHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
           L   H      I+H DIKP NIL++     K+ DFG+     + E I S      G   Y
Sbjct: 119 LYNVHR-----IMHRDIKPSNILVNSRGQIKLCDFGV-----SGELINSIADTFVGTSTY 168

Query: 240 IAPEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           ++PE      G+ + KSDV+S G+ I+EL
Sbjct: 169 MSPERIQG--GKYTVKSDVWSLGISIIEL 195

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 71/274 (25%), Positives = 117/274 (42%), Gaps = 53/274 (19%)

Query: 90  KLGQGGFGGVYKGRLL----------------------DDFVNEVASISRTSHVNVVTLL 127
           ++G G FG VY  R +                       D + EV  + +  H N +   
Sbjct: 22  EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81

Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
           G  L  +   L+ E+   GS    +   +  K  + L+  ++  I  G  +GL YLH   
Sbjct: 82  GCYLREHTAWLVMEYCL-GSASDIL---EVHK--KPLQEVEIAAICHGALQGLAYLH--- 132

Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV-FS 246
           S + +H DIK  NILL E    K++DFG A L +     V       G   ++APEV  +
Sbjct: 133 SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-------GTPYWMAPEVILA 185

Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
            + G+   K DV+S G+  +EL   K  L + +++ S +Y       H+ Q+     P +
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFN-MNAMSALY-------HIAQNDS---PTL 234

Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI 340
            +   ++  +  +     C+Q  P DRP   E++
Sbjct: 235 SSNDWSDYFRNFVDS---CLQKIPQDRPSSEELL 265

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 60.2 bits (146), Expect = 3e-10
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 37/204 (18%)

Query: 89  DKLGQGGFGGVYKG--RLLDDFV------------------NEVASISRTSHVNVVTLLG 128
           +KLG+G +  VYKG  R   + V                   E++ +    H N+V L  
Sbjct: 6   EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHD 65

Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
                N   L++E+M +  L+K++   DT      L    +      + KG+ + H    
Sbjct: 66  VIHTENKLMLVFEYM-DKDLKKYM---DTHGVRGALDPNTVKSFTYQLLKGIAFCH---E 118

Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI-VSSLLGARGIIGYIAPEVF-- 245
            ++LH D+KP N+L+++    K++DFGLA+      GI V++       + Y AP+V   
Sbjct: 119 NRVLHRDLKPQNLLINKRGELKLADFGLARAF----GIPVNTFSNEVVTLWYRAPDVLLG 174

Query: 246 SRNFGEVSHKSDVYSFGMMIMELV 269
           SR +   S   D++S G ++ E++
Sbjct: 175 SRTY---STSIDIWSVGCIMAEMI 195

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 52/172 (30%), Positives = 84/172 (48%), Gaps = 27/172 (15%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           +A+G+E+L    S K +H D+   NILL E+   KI DFGLA+        V     AR 
Sbjct: 182 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK-GDARL 237

Query: 236 IIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRH 294
            + ++APE +F + +   + +SDV+SFG+++ E+          + +S         Y  
Sbjct: 238 PLKWMAPESIFDKVY---TTQSDVWSFGVLLWEIF--------SLGASP--------YPG 278

Query: 295 VEQDREF--KLP-GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEML 343
           V+ D EF  +L  G   R       ++  + L C    P DRP  +E++E+L
Sbjct: 279 VQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 53/169 (31%), Positives = 82/169 (48%), Gaps = 21/169 (12%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           +AKG+E+L    S K +H D+   NILL E+   KI DFGLA+        V     AR 
Sbjct: 188 VAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK-GDARL 243

Query: 236 IIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRH 294
            + ++APE +F R +   + +SDV+SFG+++ E+     +   GV    E        R 
Sbjct: 244 PLKWMAPETIFDRVY---TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRR 294

Query: 295 VEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEML 343
           +++    + P   T    E+ + M    L C    PS RP  +E++E L
Sbjct: 295 LKEGTRMRAPDYTT---PEMYQTM----LDCWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 60.2 bits (146), Expect = 3e-10
 Identities = 45/150 (30%), Positives = 69/150 (46%), Gaps = 10/150 (6%)

Query: 119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
           +H N+V LLG C  G    +I E+   G L  F+      K   +L  E +      +AK
Sbjct: 97  NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLR----RKRESFLTLEDLLSFSYQVAK 152

Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG 238
           G+ +L    S   +H D+   N+LL      KI DFGLA+        V     AR  + 
Sbjct: 153 GMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVK-GNARLPVK 208

Query: 239 YIAPEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           ++APE           +SDV+S+G+++ E+
Sbjct: 209 WMAPESIFNCVYTF--ESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 59.6 bits (145), Expect = 4e-10
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 55/213 (25%)

Query: 89  DKLGQGGFGGVYKGRLL----------------DDFV-----NEVASISRTSHVNVVTLL 127
           +K+G+G +G VYK R                  D+ V      E++ +   +H N+V LL
Sbjct: 5   EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLL 64

Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEK----MYEIVIGIAKGLEYL 183
                 N   L++EF+ +  L+K++     S P   L        +Y+++ GIA    Y 
Sbjct: 65  DVVHSENKLYLVFEFL-DLDLKKYM----DSSPLTGLDPPLIKSYLYQLLQGIA----YC 115

Query: 184 HHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK-----LCTTKEGIVSSLLGARGIIG 238
           H   S ++LH D+KP N+L+D +   K++DFGLA+     + T    +V+        + 
Sbjct: 116 H---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVT--------LW 164

Query: 239 YIAPEVF--SRNFGEVSHKSDVYSFGMMIMELV 269
           Y APE+   SR +   S   D++S G +  E+V
Sbjct: 165 YRAPEILLGSRQY---STPVDIWSIGCIFAEMV 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 59.4 bits (144), Expect = 6e-10
 Identities = 60/275 (21%), Positives = 110/275 (40%), Gaps = 51/275 (18%)

Query: 91  LGQGGFGGVYKG-----------RLLD---------DFVNEVASISRTSHV---NVVTLL 127
           +G+G +G VY+G           ++++         D   EVA +S+       N+    
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
           G  L+G    +I E+   GS+   +  G  ++    +       I+  +   L+Y+H   
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-------IIREVLVALKYIHK-- 119

Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSR 247
              ++H DIK  NIL+      K+ DFG+A L        S+ +G      ++APEV   
Sbjct: 120 -VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTP---YWMAPEVI-T 174

Query: 248 NFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVV 307
                  K+D++S G+ I E+    N   S VD+   +         + + +  +L    
Sbjct: 175 EGKYYDTKADIWSLGITIYEMA-TGNPPYSDVDAFRAMML-------IPKSKPPRLED-- 224

Query: 308 TRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM 342
               N  +K +      C+   P +R    E+++ 
Sbjct: 225 ----NGYSKLLREFVAACLDEEPKERLSAEELLKS 255

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 59.3 bits (143), Expect = 6e-10
 Identities = 64/246 (26%), Positives = 111/246 (45%), Gaps = 43/246 (17%)

Query: 89  DKLGQGGFGGVYKGR--LLDDFV------------------NEVASISRTSHVNVVTLLG 128
           DKLG+G +  V+KGR  L ++ V                   EV+ +    H N+VTL  
Sbjct: 11  DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70

Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVI---GIAKGLEYLHH 185
                    L++E++ +  L++++ N      C  L    M+ + I    + +GL Y H 
Sbjct: 71  IIHTERCLTLVFEYLDS-DLKQYLDN------CGNLM--SMHNVKIFMFQLLRGLSYCHK 121

Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVF 245
               KILH D+KP N+L++E    K++DFGLA+  +      S+ +     + Y  P+V 
Sbjct: 122 ---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVT---LWYRPPDVL 175

Query: 246 SRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG 305
             +  E S   D++  G ++ E+   +  +  G     E+   H I+R +    E   PG
Sbjct: 176 LGS-TEYSTPIDMWGVGCILYEMATGR-PMFPGSTVKEEL---HLIFRLLGTPTEETWPG 230

Query: 306 VVTRKE 311
           + + +E
Sbjct: 231 ITSNEE 236

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 58.6 bits (142), Expect = 9e-10
 Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 53/219 (24%)

Query: 88  KDKLGQGGFGGVYKGRLLD-DFVNEVASISRT-----------------------SHVNV 123
            D L +G FG ++ G L+D     E     +T                       SH N+
Sbjct: 11  SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNI 70

Query: 124 VTLLGFCLEGNNRALI-YEFMPNGSLEKFVYN---GDTSKPCQYLRWEKMYEIVIGIAKG 179
           + +L  C+E      + Y +M  G+L+ F+     G+ + P Q L  +++  + I IA G
Sbjct: 71  LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNP-QALSTQQLVHMAIQIACG 129

Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK-------LCTTKEGIVSSLLG 232
           + YLH      ++H DI   N ++DE+   KI+D  L++        C          LG
Sbjct: 130 MSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC----------LG 176

Query: 233 --ARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
                 + ++A E         S  SDV+SFG+++ EL+
Sbjct: 177 DNENRPVKWMALESLVNKE--YSSASDVWSFGVLLWELM 213

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 58.8 bits (142), Expect = 9e-10
 Identities = 61/243 (25%), Positives = 110/243 (45%), Gaps = 37/243 (15%)

Query: 89  DKLGQGGFGGVYKGR--LLDDFV------------------NEVASISRTSHVNVVTLLG 128
           +KLG+G +  V+KGR  L ++ V                   EV+ +    H N+VTL  
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
                 +  L++E++ +  L++++   D       +   K++  +  I +GL Y H    
Sbjct: 72  IVHTDKSLTLVFEYL-DKDLKQYM---DDCGNIMSMHNVKIF--LYQILRGLAYCHR--- 122

Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRN 248
            K+LH D+KP N+L++E    K++DFGLA+  +      S+ +     + Y  P+V   +
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVT---LWYRPPDVLLGS 179

Query: 249 FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVT 308
             E S + D++  G +  E+   +  L  G     E+   H I+R +    E   PG+ +
Sbjct: 180 -SEYSTQIDMWGVGCIFFEMASGR-PLFPGSTVEDEL---HLIFRLLGTPTEETWPGISS 234

Query: 309 RKE 311
             E
Sbjct: 235 NDE 237

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 58.7 bits (142), Expect = 9e-10
 Identities = 68/252 (26%), Positives = 115/252 (45%), Gaps = 53/252 (21%)

Query: 89  DKLGQGGFGGVYKGR-------------LLD--------DFVNEVASISRTSHVNVVTLL 127
           +K+G+G +G VYK R              LD          + E++ +   +H N+V LL
Sbjct: 6   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65

Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQY-LRWEKMYEIVIGIAKGLEYLHHG 186
                 N   L++EF+ +  L+KF+   D S      L   K Y  +  + +GL + H  
Sbjct: 66  DVIHTENKLYLVFEFL-HQDLKKFM---DASPLSGIPLPLIKSY--LFQLLQGLAFCH-- 117

Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAK-----LCTTKEGIVSSLLGARGIIGYIA 241
            S ++LH D+KP N+L++ +   K++DFGLA+     + T    +V+        + Y A
Sbjct: 118 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT--------LWYRA 168

Query: 242 PEVF--SRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDR 299
           PE+    + +   S   D++S G +  E+V  +  L  G DS  +  F   I+R +    
Sbjct: 169 PEILLGCKYY---STAVDIWSLGCIFAEMV-TRRALFPG-DSEIDQLFR--IFRTLGTPD 221

Query: 300 EFKLPGVVTRKE 311
           E   PGV +  +
Sbjct: 222 EVVWPGVTSLPD 233

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 58.3 bits (141), Expect = 1e-09
 Identities = 50/173 (28%), Positives = 83/173 (47%), Gaps = 22/173 (12%)

Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYN--GDTSKPCQYLRWEK 168
           EVA +S   H N+V       E  N  ++ ++   G L K +    G      Q L W  
Sbjct: 49  EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW-- 106

Query: 169 MYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVS 228
                + I   L+++H     KILH DIK  NI L +D   K+ DFG+A++      + S
Sbjct: 107 ----FVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARV------LNS 153

Query: 229 SLLGARGIIG---YIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSG 278
           ++  AR  IG   Y++PE+        ++KSD+++ G ++ E+   K+  ++G
Sbjct: 154 TVELARTCIGTPYYLSPEICENR--PYNNKSDIWALGCVLYEMCTLKHAFEAG 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 58.0 bits (140), Expect = 1e-09
 Identities = 68/284 (23%), Positives = 113/284 (39%), Gaps = 69/284 (24%)

Query: 90  KLGQGGFGGVYKGRLLDD---------------------FVNEVASISRTSHVNVVTLLG 128
           K+G+G FG +Y  +   D                        EV  +++  H N+VT   
Sbjct: 7   KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66

Query: 129 FCLEGNNRALIYEFMPNGSLEKFV--YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
              E     ++ E+   G L K +    G      Q L W       + I+ GL+++H  
Sbjct: 67  SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISLGLKHIH-- 118

Query: 187 CSTKILHFDIKPHNILLDED-FCPKISDFGLAKLCTTKEGIVSSLLGARGIIG---YIAP 242
              KILH DIK  NI L ++    K+ DFG+A+          S+  A   +G   Y++P
Sbjct: 119 -DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN------DSMELAYTCVGTPYYLSP 171

Query: 243 EVFSRNFGEVSHKSDVYSFGMMIMELVGCK-----NNLDSGVDSSSEVYFPHWIYRHVEQ 297
           E+        ++K+D++S G ++ EL   K     NNL   V    + YF   I  +  +
Sbjct: 172 EICQNR--PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF-APISPNFSR 228

Query: 298 DREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
           D                  + +I  L+  +  P DRP +  +++
Sbjct: 229 DL-----------------RSLISQLF--KVSPRDRPSITSILK 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 60/243 (24%), Positives = 113/243 (46%), Gaps = 37/243 (15%)

Query: 89  DKLGQGGFGGVYKGR--LLDDFV------------------NEVASISRTSHVNVVTLLG 128
           DKLG+G +  VYKGR  L D+ V                   EV+ +    H N+VTL  
Sbjct: 12  DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
                 +  L++E++ +  L++++   D       +   K++  +  + +GL Y H    
Sbjct: 72  IIHTEKSLTLVFEYL-DKDLKQYL---DDCGNSINMHNVKLF--LFQLLRGLNYCHR--- 122

Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRN 248
            K+LH D+KP N+L++E    K++DFGLA+  +      S+ +     + Y  P++   +
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVT---LWYRPPDILLGS 179

Query: 249 FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVT 308
             + S + D++  G +  E+   +  L  G     ++   H+I+R +    E   PG+++
Sbjct: 180 -TDYSTQIDMWGVGCIFYEMSTGR-PLFPGSTVEEQL---HFIFRILGTPTEETWPGILS 234

Query: 309 RKE 311
            +E
Sbjct: 235 NEE 237

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 58/212 (27%), Positives = 92/212 (43%), Gaps = 48/212 (22%)

Query: 91  LGQGGFGGVYKGRLLDDFVNEVASISRT---------------------SHVNVVTLLGF 129
           +G+G +G VYK R       ++ +I                        +H N+ T  G 
Sbjct: 14  IGEGTYGKVYKARHKKT--GQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGA 71

Query: 130 CLEGNNRA------LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYL 183
            ++ N         L+ E    GS+   V      K  + L+ E +  I+    +GL YL
Sbjct: 72  FIKKNPPGNDDQLWLVMELCGGGSVTDLVKG--LRKKGKRLKEEWIAYILRETLRGLAYL 129

Query: 184 HHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG-IIG---Y 239
           H     K++H DIK  NILL ++   K+ DFG++         + S LG R   IG   +
Sbjct: 130 H---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ-------LDSTLGRRNTFIGTPYW 179

Query: 240 IAPEVFSRNFG-EVS--HKSDVYSFGMMIMEL 268
           +APEV + +   + S   +SDV+S G+  +EL
Sbjct: 180 MAPEVIACDEQPDASYDARSDVWSLGITAIEL 211

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 52/178 (29%), Positives = 74/178 (41%), Gaps = 50/178 (28%)

Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKM 169
           NE   +   SH  ++ L     +     ++ E++P G L              YLR    
Sbjct: 50  NEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGEL------------FSYLRNSGR 97

Query: 170 YEIVIG------IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK----- 218
           +    G      I   LEYLH   S +I++ D+KP NILLD++   K++DFG AK     
Sbjct: 98  FSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154

Query: 219 ---LCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKS--DVYSFGMMIME-LVG 270
              LC T E              Y+APEV         H    D ++ G++I E LVG
Sbjct: 155 TWTLCGTPE--------------YLAPEVIQSK----GHNKAVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 51/160 (31%), Positives = 74/160 (46%), Gaps = 32/160 (20%)

Query: 120 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY------NGDTSK--PCQYLRWEKM 169
           H NV+ LL              F P  SLE F  VY        D +    CQ L  + +
Sbjct: 73  HENVIGLLDV------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHI 120

Query: 170 YEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSS 229
             +V  I +GL+Y+H   S  I+H D+KP NI ++ED   KI DFGLA+    +      
Sbjct: 121 QFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE------ 171

Query: 230 LLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
           + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 172 MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 210

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 43/164 (26%), Positives = 70/164 (42%), Gaps = 24/164 (14%)

Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSK---PCQYLRWE 167
           EV  + +  H N+V L           L++E++    LE      + S    P   +R  
Sbjct: 50  EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELL----EASPGGLPPDAVR-- 103

Query: 168 KMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV 227
                +  + + + Y H   S  I+H DIKP NIL+ E    K+ DFG A+    +    
Sbjct: 104 ---SYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157

Query: 228 -SSLLGARGIIGYIAPEVF--SRNFGEVSHKSDVYSFGMMIMEL 268
            +  +  R    Y APE+     N+G+     DV++ G ++ EL
Sbjct: 158 LTDYVATR---WYRAPELLVGDTNYGK---PVDVWAIGCIMAEL 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 57.8 bits (140), Expect = 3e-09
 Identities = 36/105 (34%), Positives = 55/105 (52%), Gaps = 22/105 (20%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL------CTTKEGIVSS 229
           I +GL+YLH   S  ILH DIKP N+L++ +   KI DFGLA++          + +V+ 
Sbjct: 112 ILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168

Query: 230 LLGARGIIGYIAPEVF--SRNFGEVSHKSDVYSFGMMIMELVGCK 272
                    Y APE+   SR++       D++S G +  EL+G +
Sbjct: 169 Y--------YRAPEILMGSRHYTS---AVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 57.2 bits (138), Expect = 3e-09
 Identities = 44/142 (30%), Positives = 64/142 (45%), Gaps = 24/142 (16%)

Query: 138 LIYEFMPNGSLEKFVYNGDTSKP-------CQYLRWEKMYEIVIGIAKGLEYLHHGCSTK 190
           L+   M  G L   +YN D   P       C Y            I  GLE+LH     +
Sbjct: 70  LVMTIMNGGDLRYHIYNVDEENPGFPEPRACFY---------TAQIISGLEHLHQ---RR 117

Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFG 250
           I++ D+KP N+LLD D   +ISD GLA     K+G  S   G  G  G++APE+      
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLA--VELKDG-QSKTKGYAGTPGFMAPELLQGE-- 172

Query: 251 EVSHKSDVYSFGMMIMELVGCK 272
           E     D ++ G+ + E++  +
Sbjct: 173 EYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 56.7 bits (137), Expect = 4e-09
 Identities = 40/119 (33%), Positives = 58/119 (48%), Gaps = 15/119 (12%)

Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSL 230
           EIV+     L++LH      I++ DIK  NILLD +    ++DFGL+K    +E      
Sbjct: 113 EIVLA----LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE--ERA 163

Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKS--DVYSFGMMIMELV-GCKN-NLDSGVDSSSEV 285
               G I Y+APEV     G   H    D +S G++  EL+ G     +D   +S SE+
Sbjct: 164 YSFCGTIEYMAPEVIRG--GSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI 220

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 56.8 bits (137), Expect = 4e-09
 Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 46/205 (22%)

Query: 87  FKDKLGQGGFGGVYK------GRLL--------------DDFVNEVASISRTSHVNVVTL 126
           +++ LG G  G VYK       R+L                 ++E+  + +     ++  
Sbjct: 5   YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGF 64

Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
            G     N  ++  EFM  GSL+  VY      P   L       I + + KGL YL   
Sbjct: 65  YGAFFVENRISICTEFMDGGSLD--VYR---KIPEHVLG-----RIAVAVVKGLTYL--- 111

Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG---YIAPE 243
            S KILH D+KP N+L++     K+ DFG++        +V+S+  A+  +G   Y+APE
Sbjct: 112 WSLKILHRDVKPSNMLVNTRGQVKLCDFGVST------QLVNSI--AKTYVGTNAYMAPE 163

Query: 244 VFSRNFGEVSHKSDVYSFGMMIMEL 268
             S    +    SDV+S G+  MEL
Sbjct: 164 RISGE--QYGIHSDVWSLGISFMEL 186

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 57.0 bits (138), Expect = 4e-09
 Identities = 47/171 (27%), Positives = 81/171 (47%), Gaps = 15/171 (8%)

Query: 104 LLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVY-----NGDTS 158
             +DF+ EV  +SR S  N+  LLG C       +I E+M NG L +F+          +
Sbjct: 62  AREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLA 121

Query: 159 KPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK 218
              + L +  +  +   IA G+ YL    S   +H D+   N L+ +++  KI+DFG+++
Sbjct: 122 CNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178

Query: 219 LCTTKEGIVSSLLGARGI--IGYIAPEVFSRNFGEVSHKSDVYSFGMMIME 267
              +        +  R    I ++A E      G+ + KSDV++FG+ + E
Sbjct: 179 NLYSS---DYYRVQGRAPLPIRWMAWESVLL--GKFTTKSDVWAFGVTLWE 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 57.0 bits (138), Expect = 4e-09
 Identities = 32/107 (29%), Positives = 60/107 (56%), Gaps = 17/107 (15%)

Query: 169 MYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK-LCTTKE--- 224
           +Y+++    +GL+Y+H   S  ++H D+KP N+L++ED   +I DFG+A+ L ++     
Sbjct: 113 LYQLL----RGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHK 165

Query: 225 GIVSSLLGARGIIGYIAPEV-FSRNFGEVSHKSDVYSFGMMIMELVG 270
             ++  +  R    Y APE+  S    E +   D++S G +  E++G
Sbjct: 166 YFMTEYVATR---WYRAPELLLS--LPEYTTAIDMWSVGCIFAEMLG 207

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 56.6 bits (136), Expect = 4e-09
 Identities = 55/201 (27%), Positives = 84/201 (41%), Gaps = 36/201 (17%)

Query: 90  KLGQGGFGGVYKGRLL----------------DDFV---NEVASISRTSHVNVVTLLGFC 130
           ++G G +G VYK R L                DDF     E+  +    H N+V   G  
Sbjct: 16  RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75

Query: 131 LEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQ--YLRWEKMYEIVIGIAKGLEYLHHGCS 188
           L      +  E+   GSL+   +        Q  Y+  E +        +GL YLH   S
Sbjct: 76  LSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL--------QGLAYLH---S 124

Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS-R 247
              +H DIK  NILL ++   K++DFG+A   T       S +G      ++APEV +  
Sbjct: 125 KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTP---YWMAPEVAAVE 181

Query: 248 NFGEVSHKSDVYSFGMMIMEL 268
             G  +   D+++ G+  +EL
Sbjct: 182 KNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 56.6 bits (136), Expect = 4e-09
 Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 33/201 (16%)

Query: 90  KLGQGGFGGVYKGR-------------------LLDDFVNEVASISRTSHVNVVTLLGFC 130
           +LG G FG VYK +                    L+D++ E+  ++   H N+V LL   
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 131 LEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTK 190
              NN  ++ EF   G+++  +   +  +P   L   ++  +     + L YLH     K
Sbjct: 72  YYENNLWILIEFCAGGAVDAVML--ELERP---LTEPQIRVVCKQTLEALNYLH---ENK 123

Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVF---SR 247
           I+H D+K  NIL   D   K++DFG++   T       S +G      ++APEV    + 
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTP---YWMAPEVVMCETS 180

Query: 248 NFGEVSHKSDVYSFGMMIMEL 268
                 +K+DV+S G+ ++E+
Sbjct: 181 KDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 56.2 bits (135), Expect = 6e-09
 Identities = 62/209 (29%), Positives = 86/209 (41%), Gaps = 45/209 (21%)

Query: 91  LGQGGFGGVY------KGRLL------------------DDFVNEVASISRTSHVNVVTL 126
           LGQG FG VY       GR L                       E+  +    H  +V  
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 127 LGFCLEGNNRAL--IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH 184
            G   +   + L    E+MP GS++      D  K    L      +    I +G+ YLH
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSVK------DQLKAYGALTESVTRKYTRQILEGMSYLH 123

Query: 185 HGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG---YIA 241
              S  I+H DIK  NIL D     K+ DFG +K   T   I  S  G R + G   +++
Sbjct: 124 ---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT---ICMSGTGIRSVTGTPYWMS 177

Query: 242 PEVFSRNFGE-VSHKSDVYSFGMMIMELV 269
           PEV S   GE    K+DV+S G  ++E++
Sbjct: 178 PEVIS---GEGYGRKADVWSLGCTVVEML 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 56.6 bits (137), Expect = 6e-09
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 5/98 (5%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLL-GAR 234
           I  GL+Y+H   S  +LH D+KP N+L++ D   KI DFGLA+  +   G  +  +    
Sbjct: 114 ILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170

Query: 235 GIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
               Y APE+   +F   +   DV+S G ++ EL+G K
Sbjct: 171 ATRWYRAPEIM-LSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 56.3 bits (135), Expect = 6e-09
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 42/208 (20%)

Query: 91  LGQGGFGGVYKGRLL------------------DDFVNEVASISRTSH-VNVVTLLGFCL 131
           +G G +G VYKGR +                  ++   E+  + + SH  N+ T  G  +
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73

Query: 132 EGNNRA------LIYEFMPNGSLEKFVYN--GDTSKPCQYLRWEKMYEIVIGIAKGLEYL 183
           + N         L+ EF   GS+   + N  G+T      L+ E +  I   I +GL +L
Sbjct: 74  KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT------LKEEWIAYICREILRGLSHL 127

Query: 184 HHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE 243
           H     K++H DIK  N+LL E+   K+ DFG++       G  ++ +G      ++APE
Sbjct: 128 HQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTP---YWMAPE 181

Query: 244 VFSRNF---GEVSHKSDVYSFGMMIMEL 268
           V + +         KSD++S G+  +E+
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEM 209

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 56.5 bits (136), Expect = 6e-09
 Identities = 50/169 (29%), Positives = 83/169 (49%), Gaps = 21/169 (12%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           +A+G+E+L    S K +H D+   NILL E+   KI DFGLA+        V     AR 
Sbjct: 183 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK-GSARL 238

Query: 236 IIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRH 294
            + ++APE +F + +   + +SDV+SFG+++ E+     +   GV  + E        + 
Sbjct: 239 PLKWMAPESIFDKVY---TTQSDVWSFGVLLWEIFSLGASPYPGVQINEE------FCQR 289

Query: 295 VEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEML 343
           ++     + P   T    EI + M    L C Q  P +RP  + ++E+L
Sbjct: 290 LKDGTRMRAPENAT---PEIYRIM----LACWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 56.2 bits (136), Expect = 7e-09
 Identities = 51/213 (23%), Positives = 91/213 (42%), Gaps = 48/213 (22%)

Query: 90  KLGQGGFGGVYKGR--LLDDFV-------------------NEVASISRTSHVNVVTLLG 128
           K+GQG FG V+K R       V                    E+  +    H NVV L+ 
Sbjct: 19  KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 78

Query: 129 FC-----LEGNNRA---LIYEFMPNGSLEKFVYNGDTSKPCQYLRW--EKMYEIVIGIAK 178
            C          +    L++EF  +  L   + N       + +++   ++ +++  +  
Sbjct: 79  ICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSN-------KNVKFTLSEIKKVMKMLLN 130

Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI-I 237
           GL Y+H     KILH D+K  NIL+ +D   K++DFGLA+  +  +    +    R + +
Sbjct: 131 GLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187

Query: 238 GYIAPEVF--SRNFGEVSHKSDVYSFGMMIMEL 268
            Y  PE+    R++G      D++  G ++ E+
Sbjct: 188 WYRPPELLLGERDYGP---PIDMWGAGCIMAEM 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 41/157 (26%), Positives = 65/157 (41%), Gaps = 43/157 (27%)

Query: 89  DKLGQGGFGGVYKGR--LLDDFV------------------NEVASISRTSHVNVVTLLG 128
           DKLG+G +  VYKGR  L    V                   E + +    H N+VTL  
Sbjct: 11  DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHD 70

Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWE----KMYEIVI---GIAKGLE 181
                    L++E++              +   QY+        M+ + +    + +GL 
Sbjct: 71  IIHTKKTLTLVFEYL-------------DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLA 117

Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK 218
           Y H     ++LH D+KP N+L+ E    K++DFGLA+
Sbjct: 118 YCHQ---RRVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 51/215 (23%), Positives = 93/215 (43%), Gaps = 31/215 (14%)

Query: 103 RLLDDFVNEVASISRTSHVNVVTLL--GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKP 160
                F  E A  +R  H N+V LL  G    G   A ++E++P  +L + +        
Sbjct: 20  HQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFA-VFEYVPGRTLREVLAADGALPA 78

Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL---DEDFCPKISDFGLA 217
            +  R   M ++       L+ L    +  I+H D+KP NI++         K+ DFG+ 
Sbjct: 79  GETGRL--MLQV-------LDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIG 129

Query: 218 KLCT-TKEGIVSSLLGARGIIG---YIAPEVFSRNFGE-VSHKSDVYSFGMMIMELVGCK 272
            L    ++  V++L     ++G   Y APE      GE V+  SD+Y++G++ +E +  +
Sbjct: 130 TLLPGVRDADVATLTRTTEVLGTPTYCAPEQLR---GEPVTPNSDLYAWGLIFLECLTGQ 186

Query: 273 NNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVV 307
             +     S +E+      Y+ +    +  LP  +
Sbjct: 187 RVVQGA--SVAEIL-----YQQLSPV-DVSLPPWI 213

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 34/104 (32%), Positives = 51/104 (49%), Gaps = 16/104 (15%)

Query: 172 IVIGIAKGLEYL--HHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSS 229
           + + I K L YL   HG    ++H D+KP NILLD     K+ DFG++        +V S
Sbjct: 119 MTVAIVKALHYLKEKHG----VIHRDVKPSNILLDASGNVKLCDFGISGR------LVDS 168

Query: 230 LLGAR--GIIGYIAPEVFSRN--FGEVSHKSDVYSFGMMIMELV 269
               R  G   Y+APE         +   ++DV+S G+ ++EL 
Sbjct: 169 KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELA 212

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 55.0 bits (133), Expect = 1e-08
 Identities = 45/161 (27%), Positives = 71/161 (44%), Gaps = 43/161 (26%)

Query: 91  LGQGGFGGVYKGRLLDD--FV-------------------NEVA---SISRTSHVNVVTL 126
           +G+G +G VYK R L+   FV                    E+A    +    H N+V L
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66

Query: 127 LGFCL-----EGNNRALIYEFMP---NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
           L  C            L++E +       L K    G   +  + L    M +++    +
Sbjct: 67  LDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDL----MRQLL----R 118

Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL 219
           G+++LH   S +I+H D+KP NIL+  D   KI+DFGLA++
Sbjct: 119 GVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 41/134 (30%), Positives = 68/134 (50%), Gaps = 14/134 (10%)

Query: 138 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIK 197
           ++ E+MP G L   + N D  +     +W + Y   + +A  L+ +H   S   +H D+K
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPE-----KWARFYTAEVVLA--LDAIH---SMGFIHRDVK 169

Query: 198 PHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGE--VSHK 255
           P N+LLD+    K++DFG   +   KEG+V     A G   YI+PEV     G+     +
Sbjct: 170 PDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGDGYYGRE 227

Query: 256 SDVYSFGMMIMELV 269
            D +S G+ + E++
Sbjct: 228 CDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 54.8 bits (132), Expect = 1e-08
 Identities = 40/141 (28%), Positives = 61/141 (43%), Gaps = 26/141 (18%)

Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL--RWEKMY--EIVIGIAKGLEYLHHGCS 188
            +   L+ E++  G     +      K    L   W K Y  E+V+G+    E LH    
Sbjct: 69  KDYLYLVMEYLNGGDCASLI------KTLGGLPEDWAKQYIAEVVLGV----EDLH---Q 115

Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRN 248
             I+H DIKP N+L+D+    K++DFGL++     +  V       G   Y+APE     
Sbjct: 116 RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV-------GTPDYLAPETILGV 168

Query: 249 FGEVSHKSDVYSFGMMIMELV 269
                  SD +S G +I E +
Sbjct: 169 GD--DKMSDWWSLGCVIFEFL 187

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 58/188 (30%), Positives = 85/188 (45%), Gaps = 48/188 (25%)

Query: 91  LGQGGFGGVYKGRLLDD------FVNEV---ASISR----TSHVN-------------VV 124
           LG+GG+G V++ R +        F  +V   A+I R    T+H               +V
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 125 TLLGFCLEGNNRALIYEFMPNGSL-----EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
            L+     G    LI E++  G L      + ++  DT+  C YL      EI +     
Sbjct: 64  DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTA--CFYLS-----EISLA---- 112

Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
           LE+LH      I++ D+KP NILLD     K++DFGL K  +  EG V+      G I Y
Sbjct: 113 LEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKE-SIHEGTVTHTFC--GTIEY 166

Query: 240 IAPEVFSR 247
           +APE+  R
Sbjct: 167 MAPEILMR 174

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 52/169 (30%), Positives = 79/169 (46%), Gaps = 32/169 (18%)

Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY------NGDTSK--P 160
           E+  +    H NV+ LL              F P  SLE+F  VY        D +    
Sbjct: 66  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 113

Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 114 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH- 169

Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
           T  E     + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 170 TDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 212

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 55.2 bits (134), Expect = 2e-08
 Identities = 31/95 (32%), Positives = 47/95 (49%), Gaps = 14/95 (14%)

Query: 138 LIYEFMPNGSLEKFVYNGD--TSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFD 195
           ++ E M    L K + +    T    QY     +Y+I+    +GL+YLH   S  ++H D
Sbjct: 81  IVTELMET-DLHKVIKSPQPLTDDHIQYF----LYQIL----RGLKYLH---SANVIHRD 128

Query: 196 IKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSL 230
           +KP NIL++ +   KI DFGLA+     E     L
Sbjct: 129 LKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL 163

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 36/97 (37%), Positives = 54/97 (55%), Gaps = 11/97 (11%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           I  GL++LH      I++ D+K  N+LLD+D   KI+DFG+ K     EG  S+  G   
Sbjct: 105 IICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTP- 160

Query: 236 IIGYIAPEVFSRNFGE-VSHKSDVYSFGMMIME-LVG 270
              YIAPE+     G+  +   D +SFG+++ E L+G
Sbjct: 161 --DYIAPEILK---GQKYNESVDWWSFGVLLYEMLIG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 43/138 (31%), Positives = 67/138 (48%), Gaps = 19/138 (13%)

Query: 138 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY--EIVIGIAKGLEYLHHGCSTKILHFD 195
           ++ E+MP G L   + N D  +     +W + Y  E+V+     L+ +H   S   +H D
Sbjct: 120 MVMEYMPGGDLVNLMSNYDIPE-----KWARFYTAEVVLA----LDAIH---SMGFIHRD 167

Query: 196 IKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVF--SRNFGEVS 253
           +KP N+LLD+    K++DFG   +     G+V     A G   YI+PEV       G   
Sbjct: 168 VKPDNMLLDKSGHLKLADFGTC-MKMDANGMVRC-DTAVGTPDYISPEVLKSQGGDGYYG 225

Query: 254 HKSDVYSFGMMIME-LVG 270
            + D +S G+ + E LVG
Sbjct: 226 RECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 43/133 (32%), Positives = 62/133 (46%), Gaps = 15/133 (11%)

Query: 138 LIYEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDI 196
           L+   M  G L+  +YN G+          E+       I  GLE LH       ++ D+
Sbjct: 77  LVLTIMNGGDLKFHIYNMGNPG-----FEEERALFYAAEILCGLEDLHR---ENTVYRDL 128

Query: 197 KPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKS 256
           KP NILLD+    +ISD GLA      EG   S+ G  G +GY+APEV +      +   
Sbjct: 129 KPENILLDDYGHIRISDLGLA--VKIPEG--ESIRGRVGTVGYMAPEVLNNQ--RYTLSP 182

Query: 257 DVYSFGMMIMELV 269
           D +  G +I E++
Sbjct: 183 DYWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 54.4 bits (131), Expect = 2e-08
 Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 9/94 (9%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           I  GLE LH     +I++ D+KP NILLD+    +ISD GLA      EG   ++ G  G
Sbjct: 111 ITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEG--ETIRGRVG 163

Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            +GY+APEV        +   D +  G +I E++
Sbjct: 164 TVGYMAPEVVKNE--RYTFSPDWWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 48/203 (23%), Positives = 89/203 (43%), Gaps = 38/203 (18%)

Query: 90  KLGQGGFGGVYK------GRLL----------DDFVN-----EVASISRTSHVNVVTLLG 128
            +G+G +G V K      G+++          D  V      E+  + +  H N+V L+ 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
                    L++EF+ +  L+      D  K    L   ++ + +  I +G+E+ H   S
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLD------DLEKYPNGLDESRVRKYLFQILRGIEFCH---S 118

Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRN 248
             I+H DIKP NIL+ +    K+ DFG A+       + +  +  R    Y APE+    
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR---WYRAPELL--- 172

Query: 249 FGEVSHKS--DVYSFGMMIMELV 269
            G+  +    D+++ G ++ E++
Sbjct: 173 VGDTKYGRAVDIWAVGCLVTEML 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 54.5 bits (132), Expect = 3e-08
 Identities = 63/240 (26%), Positives = 106/240 (44%), Gaps = 74/240 (30%)

Query: 72  LKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGR------------LLDDFVN--------- 110
           L++Y   ++ +       KLG+G +G V+K              + D F N         
Sbjct: 6   LRKY---EILQ-------KLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR 55

Query: 111 EVASISR-TSHVNVVTLLGFCLEGNNRA--LIYEFMPN--------GSLEKFVYNGDTSK 159
           E+  +     H N+V LL      N++   L++E+M            LE      D  K
Sbjct: 56  EIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILE------DVHK 109

Query: 160 PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK- 218
             +Y+    MY+++    K L+Y+H   S  ++H D+KP NILL+ D   K++DFGLA+ 
Sbjct: 110 --RYI----MYQLL----KALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARS 156

Query: 219 LCTTKEGIVSSLL----GARGIIGYIAPEVF--SRNFGEVSHKSDVYSFGMMIMELVGCK 272
           L   +E   + +L      R    Y APE+   S  +   +   D++S G ++ E++  K
Sbjct: 157 LSELEENPENPVLTDYVATR---WYRAPEILLGSTRY---TKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 53.9 bits (129), Expect = 3e-08
 Identities = 62/210 (29%), Positives = 87/210 (41%), Gaps = 47/210 (22%)

Query: 91  LGQGGFGGVY------KGRLL--------------DDFVN----EVASISRTSHVNVVTL 126
           LGQG FG VY       GR L                 VN    E+  +    H  +V  
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 127 LGFCLEGNNRAL--IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH 184
            G   +   R L    E MP GS++      D  K    L      +    I +G+ YLH
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIK------DQLKSYGALTENVTRKYTRQILEGVSYLH 123

Query: 185 HGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK----LCTTKEGIVSSLLGARGIIGYI 240
              S  I+H DIK  NIL D     K+ DFG +K    +C +  G+ S      G   ++
Sbjct: 124 ---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS----VTGTPYWM 176

Query: 241 APEVFSRNFGE-VSHKSDVYSFGMMIMELV 269
           +PEV S   GE    K+D++S G  ++E++
Sbjct: 177 SPEVIS---GEGYGRKADIWSVGCTVVEML 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 54.0 bits (130), Expect = 3e-08
 Identities = 57/221 (25%), Positives = 100/221 (45%), Gaps = 61/221 (27%)

Query: 89  DKLGQGGFGGVYK------GRL---------LDD------FVNEVASISRTSHVN-VVTL 126
           +K+G+G +G VYK      G+L         +D+       + E++ +   S    +V L
Sbjct: 7   EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRL 66

Query: 127 LGF--CLEGNNRALIY---EFMPNGSLEKFV--YNGDTSKPCQYLRWEK-MYEIVIGIAK 178
           L      E N +  +Y   E++ +  L+KF+        +P      +  MY+++ G+A 
Sbjct: 67  LDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA- 124

Query: 179 GLEYLH-HGCSTKILHFDIKPHNILLDED-FCPKISDFGLAKLCT------TKEGIVSSL 230
              + H HG    ++H D+KP N+L+D+     KI+D GL +  +      T E IV+  
Sbjct: 125 ---HCHKHG----VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHE-IVT-- 174

Query: 231 LGARGIIGYIAPEVF--SRNFGEVSHKSDVYSFGMMIMELV 269
                 + Y APEV   S ++   S   D++S G +  E+ 
Sbjct: 175 ------LWYRAPEVLLGSTHY---STPVDIWSVGCIFAEMS 206

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 54.2 bits (131), Expect = 3e-08
 Identities = 53/176 (30%), Positives = 72/176 (40%), Gaps = 47/176 (26%)

Query: 77  FSDVKKLTN-SFKDKLGQGGFGGVYKGRLL-----------------DDF----VNEVAS 114
           F    KL +     KLG+G FG VYK R +                 D F    + E+  
Sbjct: 1   FYGCSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKI 60

Query: 115 ISRTSHVNVVTLLGFCLE-----GNNRALIYEFMP------NGSLEKFVYNGD-TSKPCQ 162
           + +  H NVV L+   +E        R  +Y   P      +G LE    N        Q
Sbjct: 61  LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE----NPSVKLTESQ 116

Query: 163 YLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK 218
                K Y  ++ + +G+ YLH      ILH DIK  NIL+D     KI+DFGLA+
Sbjct: 117 I----KCY--MLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLAR 163

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 53.8 bits (130), Expect = 4e-08
 Identities = 41/140 (29%), Positives = 67/140 (47%), Gaps = 22/140 (15%)

Query: 138 LIYEFMPNGSLEKFVYNGDTSKP-CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDI 196
           ++ E M    L K +     S    QY     +Y+I+    +GL+Y+H   S  +LH D+
Sbjct: 85  IVQELMET-DLYKLIKTQHLSNDHIQYF----LYQIL----RGLKYIH---SANVLHRDL 132

Query: 197 KPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLL----GARGIIGYIAPEVFSRNFGEV 252
           KP N+LL+ +   KI DFGLA++    E   +  L      R    Y APE+   N    
Sbjct: 133 KPSNLLLNTNCDLKICDFGLARI-ADPEHDHTGFLTEYVATR---WYRAPEIM-LNSKGY 187

Query: 253 SHKSDVYSFGMMIMELVGCK 272
           +   D++S G ++ E++  +
Sbjct: 188 TKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 53.5 bits (129), Expect = 4e-08
 Identities = 43/130 (33%), Positives = 65/130 (50%), Gaps = 22/130 (16%)

Query: 147 SLEKF---VYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL 203
           SL+KF   VY          +  E + +I +   K L YL      KI+H D+KP NILL
Sbjct: 88  SLDKFYKYVYE----VLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILL 141

Query: 204 DEDFCPKISDFGLAKLCTTKEGIVSSLLGAR--GIIGYIAPE---VFSRNFGEVSHKSDV 258
           D +   K+ DFG++        +V S+   R  G   Y+APE     +R+  +V  +SDV
Sbjct: 142 DRNGNIKLCDFGISGQ------LVDSIAKTRDAGCRPYMAPERIDPSARDGYDV--RSDV 193

Query: 259 YSFGMMIMEL 268
           +S G+ + E+
Sbjct: 194 WSLGITLYEV 203

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 53.7 bits (129), Expect = 4e-08
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 44/211 (20%)

Query: 89  DKLGQGGFGGVYKGRLLDDFVNEVASISRT-----------------------SHVNVVT 125
           +K+G+G +G VYK R  D   NE  ++ +                         H N+V 
Sbjct: 8   EKIGEGTYGVVYKAR--DRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVR 65

Query: 126 LLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
           L           L++E++ +  L+K + +         L    +Y+I+ GIA    Y H 
Sbjct: 66  LQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA----YCH- 119

Query: 186 GCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGI-VSSLLGARGIIGYIAPE 243
             S ++LH D+KP N+L+D      K++DFGLA+      GI V +       + Y APE
Sbjct: 120 --SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF----GIPVRTFTHEVVTLWYRAPE 173

Query: 244 VF--SRNFGEVSHKSDVYSFGMMIMELVGCK 272
           +   SR++   S   D++S G +  E+V  K
Sbjct: 174 ILLGSRHY---STPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 53.9 bits (129), Expect = 5e-08
 Identities = 43/145 (29%), Positives = 73/145 (50%), Gaps = 16/145 (11%)

Query: 129 FCLEGNNRAL--IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
           FC   +++ L  + E+MP G L   + N D  +     +W K Y   + +A  L+ +H  
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE-----KWAKFYTAEVVLA--LDAIH-- 159

Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            S  ++H D+KP N+LLD+    K++DFG   +   + G+V     A G   YI+PEV  
Sbjct: 160 -SMGLIHRDVKPDNMLLDKHGHLKLADFGTC-MKMDETGMVRCDT-AVGTPDYISPEVLK 216

Query: 247 RNFGE--VSHKSDVYSFGMMIMELV 269
              G+     + D +S G+ + E++
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 53.5 bits (128), Expect = 5e-08
 Identities = 49/172 (28%), Positives = 78/172 (45%), Gaps = 32/172 (18%)

Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY------NGDTSK--P 160
           E+  +    H NV+ LL              F P  S+E F  VY        D +    
Sbjct: 64  ELRLLKHMKHENVIGLLDV------------FTPATSIENFNEVYLVTNLMGADLNNIVK 111

Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  E +  ++  + +GL+Y+H   S  I+H D+KP N+ ++ED   +I DFGLA+  
Sbjct: 112 CQKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQA 168

Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
             +      + G      Y APE+   N+   +   D++S G ++ EL+  K
Sbjct: 169 DDE------MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 53.5 bits (128), Expect = 5e-08
 Identities = 34/94 (36%), Positives = 51/94 (54%), Gaps = 9/94 (9%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           I  GLE LH     +I++ D+KP NILLD+    +ISD GLA      EG   ++ G  G
Sbjct: 111 ICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEG--QTIKGRVG 163

Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            +GY+APEV        +   D ++ G ++ E++
Sbjct: 164 TVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 53.2 bits (128), Expect = 6e-08
 Identities = 60/216 (27%), Positives = 92/216 (42%), Gaps = 58/216 (26%)

Query: 89  DKLGQGGFGGVYK------------------------GRLLDDFVNEVASIS-RTSH-VN 122
           ++LG+G +G V K                         RLL D       IS R+     
Sbjct: 7   EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDL-----DISMRSVDCPY 61

Query: 123 VVTLLGFCLEGNNRALIYEFMPNGSLEKF---VYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
            VT  G      +  +  E M + SL+KF   VY+   + P   L      +I + I K 
Sbjct: 62  TVTFYGALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILG-----KIAVSIVKA 115

Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSL-----LGAR 234
           LEYLH      ++H D+KP N+L++ +   K+ DFG++        +V S+      G +
Sbjct: 116 LEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGY------LVDSVAKTIDAGCK 167

Query: 235 GIIGYIAPEVFS--RNFGEVSHKSDVYSFGMMIMEL 268
               Y+APE  +   N      KSDV+S G+ ++EL
Sbjct: 168 ---PYMAPERINPELNQKGYDVKSDVWSLGITMIEL 200

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 53.0 bits (127), Expect = 7e-08
 Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 43/208 (20%)

Query: 90  KLGQGGFGGVYKGRLLDD---------------------FVNEVASISRTS---HVNVVT 125
           ++G G +G VYK R                          V EVA + R     H N+V 
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 126 LLGFCLEGNNR-----ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGL 180
           L+  C            L++E + +  L  ++       P   L  E + +++    +GL
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL----DKVPPPGLPAETIKDLMRQFLRGL 121

Query: 181 EYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYI 240
           ++LH  C   I+H D+KP NIL+      K++DFGLA++ + +  +   ++     + Y 
Sbjct: 122 DFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV----TLWYR 174

Query: 241 APEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           APEV  ++    +   D++S G +  E+
Sbjct: 175 APEVLLQS--TYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 52.6 bits (126), Expect = 8e-08
 Identities = 53/209 (25%), Positives = 83/209 (39%), Gaps = 38/209 (18%)

Query: 90  KLGQGGFGGVYKGRLLDD----------------------FVNEVASISRTSHVNVVTLL 127
           ++G G FG V  G +                         F+ E        H N++  L
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSK--PCQYLRWEKM-YEIVIGIAKGLEYLH 184
           G C E     L+ EF P G L+ ++ +   ++         ++M  E    IA GL +LH
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACE----IALGLLHLH 117

Query: 185 HGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV 244
                  +H D+   N LL  D   KI D+GL+     KE    +       + +IAPE+
Sbjct: 118 ---KNNFIHSDLALRNCLLTADLTVKIGDYGLSH-NKYKEDYYVTPDQLWVPLRWIAPEL 173

Query: 245 FSRNFGEV-----SHKSDVYSFGMMIMEL 268
                G +     + +S+V+S G+ I EL
Sbjct: 174 VDEVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 53.3 bits (128), Expect = 8e-08
 Identities = 35/100 (35%), Positives = 54/100 (54%), Gaps = 8/100 (8%)

Query: 183 LHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGAR--GIIGYI 240
           +HH  S  ++H DIK  NILL  +   K+ DFG +K+       VS  +G    G   Y+
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAAT---VSDDVGRTFCGTPYYV 212

Query: 241 APEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVD 280
           APE++ R     S K+D++S G+++ EL+  K   D G +
Sbjct: 213 APEIWRRK--PYSKKADMFSLGVLLYELLTLKRPFD-GEN 249

Length = 496

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 32/111 (28%), Positives = 58/111 (52%), Gaps = 9/111 (8%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           I +GL YLH   + +I+H D+K  NI +++     I D G A+          + LG  G
Sbjct: 166 ILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVVA---PAFLGLAG 218

Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVY 286
            +   APEV +R+  + + K+D++S G+++ E++   + +     S+ E Y
Sbjct: 219 TVETNAPEVLARD--KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEY 267

Length = 357

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 33/104 (31%), Positives = 58/104 (55%), Gaps = 20/104 (19%)

Query: 169 MYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK-EGIV 227
           +Y+I+    +GL+Y+H   S  ++H D+KP NIL++E+   KI DFGLA++   +  G V
Sbjct: 114 LYQIL----RGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYV 166

Query: 228 SSLLGARGIIGYIAPEVFS--RNFGEVSHKSDVYSFGMMIMELV 269
           S+         Y APE+    + +     + D++S G +  E++
Sbjct: 167 STRY-------YRAPEIMLTWQKYDV---EVDIWSAGCIFAEML 200

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 55/207 (26%), Positives = 83/207 (40%), Gaps = 46/207 (22%)

Query: 90  KLGQGGFGGVY--KGRLLDDFV-------------NEVASISR-------TSHVNVVTLL 127
           ++GQGG+G V+  K +   + V             NEV  +         T    +V LL
Sbjct: 8   QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67

Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
               +     L  E++P G     + N        + R+  M E+   +      LH   
Sbjct: 68  YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSE-DHARF-YMAEMFEAVDA----LHE-- 119

Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG---YIAPEV 244
               +H D+KP N L+D     K++DFGL+K      GIV+    A  ++G   Y+APEV
Sbjct: 120 -LGYIHRDLKPENFLIDASGHIKLTDFGLSK------GIVTY---ANSVVGSPDYMAPEV 169

Query: 245 FSRNFGEVSHKSDVYSFGMMIME-LVG 270
                       D +S G M+ E L G
Sbjct: 170 L--RGKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 39/163 (23%), Positives = 69/163 (42%), Gaps = 39/163 (23%)

Query: 90  KLGQGGFGGVYKGRLLDDFVN------------------------EVASISRTSHVNVVT 125
            +G+G +G VYK +  +                            E+A +    H NVV+
Sbjct: 7   CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66

Query: 126 LLGFCLEGNNRA--LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEK--MYEIVIGIAKGLE 181
           L+   LE  +++  L++++  +   +   ++    +        K  +++I+ G+     
Sbjct: 67  LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH---- 122

Query: 182 YLHHGCSTKILHFDIKPHNILL----DEDFCPKISDFGLAKLC 220
           YLH   S  +LH D+KP NIL+     E    KI D GLA+L 
Sbjct: 123 YLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 59/235 (25%), Positives = 95/235 (40%), Gaps = 34/235 (14%)

Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL----EKFVYNGDTSKPCQYLRW 166
           E   +S+  H  +V      LE +   +I E+     L    E+  + G T    Q   W
Sbjct: 52  EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111

Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
                  I +  G+ Y+H     +ILH D+K  NI L  +   KI DFG+++L      +
Sbjct: 112 ------FIQLLLGVHYMHQ---RRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDL 161

Query: 227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVY 286
            ++  G      Y++PE           KSD++S G ++ E+  C  +   G +      
Sbjct: 162 ATTFTGTP---YYMSPEALKHQ--GYDSKSDIWSLGCILYEMC-CLAHAFEGQN------ 209

Query: 287 FPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
           F   + R VE      LP   +R+ N I + M       +   PS RP   E++ 
Sbjct: 210 FLSVVLRIVEGPTP-SLPETYSRQLNSIMQSM-------LNKDPSLRPSAAEILR 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 52.1 bits (125), Expect = 1e-07
 Identities = 40/154 (25%), Positives = 72/154 (46%), Gaps = 36/154 (23%)

Query: 89  DKLGQGGFGGVYKGR-------------LLDD--------FVNEVASISRTSHVNVVTLL 127
           +K+G+G +G V+K +              LDD         + E+  +    H N+V L 
Sbjct: 6   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY 65

Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV--YNGDTSKP-CQYLRWEKMYEIVIGIAKGLEYLH 184
                     L++E+  +  L+K+    NGD      +      M++++    KGL + H
Sbjct: 66  DVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSF----MFQLL----KGLAFCH 116

Query: 185 HGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK 218
              S  +LH D+KP N+L++++   K++DFGLA+
Sbjct: 117 ---SHNVLHRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 59/213 (27%), Positives = 91/213 (42%), Gaps = 49/213 (23%)

Query: 66  NYGPLPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVT 125
           ++ P+ +KR+  S + K          Q     V+  R + +++N         H   V 
Sbjct: 55  DFPPVAIKRFEKSKIIK----------QKQVDHVFSERKILNYIN---------HPFCVN 95

Query: 126 LLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG------IAKG 179
           L G   + +   L+ EF+  G    F            LR  K +   +G      I   
Sbjct: 96  LYGSFKDESYLYLVLEFVIGGEFFTF------------LRRNKRFPNDVGCFYAAQIVLI 143

Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
            EYL    S  I++ D+KP N+LLD+D   K++DFG AK+  T+   +       G   Y
Sbjct: 144 FEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC------GTPEY 194

Query: 240 IAPEVFSRNFGEVSHKSDVYSFGMMIME-LVGC 271
           IAPE+   N G     +D ++ G+ I E LVGC
Sbjct: 195 IAPEIL-LNVGH-GKAADWWTLGIFIYEILVGC 225

Length = 340

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 63/210 (30%), Positives = 88/210 (41%), Gaps = 47/210 (22%)

Query: 91  LGQGGFGGVY------KGRLL--------------DDFVN----EVASISRTSHVNVVTL 126
           LG+G FG VY       GR L                 VN    E+  +    H  +V  
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 127 LGFCL---EGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYL 183
            G CL   E    ++  E+MP GS++      D  K    L           I +G+ YL
Sbjct: 70  YG-CLRDPEEKKLSIFVEYMPGGSIK------DQLKAYGALTENVTRRYTRQILQGVSYL 122

Query: 184 HHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG---YI 240
           H   S  I+H DIK  NIL D     K+ DFG +K   T   I  S  G + + G   ++
Sbjct: 123 H---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT---ICMSGTGIKSVTGTPYWM 176

Query: 241 APEVFSRNFGE-VSHKSDVYSFGMMIMELV 269
           +PEV S   GE    K+DV+S    ++E++
Sbjct: 177 SPEVIS---GEGYGRKADVWSVACTVVEML 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 53/219 (24%)

Query: 87  FKDKLGQGGFGGVYKG--------------RL-LDD-----FVNEVASISRTSHVNVVTL 126
             D+LG+G +G VYK               RL LD+      + E+  + +     +V  
Sbjct: 5   VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDF 64

Query: 127 LG-FCLEGNNRALIY--EFMPNGSLEKFVYNGDTS---KPCQYLRWEKMYEIVIGIAKGL 180
            G F +EG   A+    E+M  GSL+K +Y G  +    P   LR      I   + KGL
Sbjct: 65  YGAFFIEG---AVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLR-----RITYAVVKGL 115

Query: 181 EYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG-- 238
           ++L       I+H D+KP N+L++ +   K+ DFG++        +V+SL  A+  IG  
Sbjct: 116 KFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSG------NLVASL--AKTNIGCQ 165

Query: 239 -YIAPEVFS----RNFGEVSHKSDVYSFGMMIMEL-VGC 271
            Y+APE             + +SDV+S G+ I+E+ +G 
Sbjct: 166 SYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 36/101 (35%), Positives = 51/101 (50%), Gaps = 19/101 (18%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGAR- 234
           I  GL++LH      I++ D+K  N+LLD +   KI+DFG   +C  KEGI   L G   
Sbjct: 105 IVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFG---MC--KEGI---LGGVTT 153

Query: 235 ----GIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIME-LVG 270
               G   YIAPE+ S          D ++ G+++ E L G
Sbjct: 154 STFCGTPDYIAPEILSYQ--PYGPAVDWWALGVLLYEMLAG 192

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 51.5 bits (124), Expect = 2e-07
 Identities = 39/154 (25%), Positives = 70/154 (45%), Gaps = 35/154 (22%)

Query: 89  DKLGQGGFGGVYKGR------------LLDDF-----VNEVASI----SRTSHVNVVTLL 127
            K+G+G F  V K +            +   F     VN +  I      + H N++ L+
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLI 64

Query: 128 GFCLE--GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH- 184
               +      AL++E M + +L + +       P + ++   MY+++    K L+++H 
Sbjct: 65  EVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKS-YMYQLL----KSLDHMHR 118

Query: 185 HGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK 218
           +G    I H DIKP NIL+ +D   K++DFG  +
Sbjct: 119 NG----IFHRDIKPENILIKDD-ILKLADFGSCR 147

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 51.1 bits (122), Expect = 3e-07
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 9/91 (9%)

Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG 238
           GLE++H   +  +++ D+KP NILLDE    +ISD GLA   + K+   S      G  G
Sbjct: 109 GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-----GTHG 160

Query: 239 YIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
           Y+APEV  +     S  +D +S G M+ +L+
Sbjct: 161 YMAPEVLQKGVAYDS-SADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 51.4 bits (123), Expect = 3e-07
 Identities = 42/170 (24%), Positives = 79/170 (46%), Gaps = 21/170 (12%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           +AKG+ +L    S   +H D+   NILL      KI DFGLA+        V     AR 
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK-GNARL 278

Query: 236 IIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRH 294
            + ++APE +F+  +   + +SDV+S+G+++ E+    ++   G+   S+       Y+ 
Sbjct: 279 PVKWMAPESIFNCVY---TFESDVWSYGILLWEIFSLGSSPYPGMPVDSK------FYKM 329

Query: 295 VEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
           +++      P     +  +I K        C  A P  RP   +++++++
Sbjct: 330 IKEGYRMLSPECAPSEMYDIMKS-------CWDADPLKRPTFKQIVQLIE 372

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 8/94 (8%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           I   LEYLH   S  +++ DIK  N++LD+D   KI+DFGL K   +    + +  G   
Sbjct: 104 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP- 159

Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
              Y+APEV   N  +     D +  G+++ E++
Sbjct: 160 --EYLAPEVLEDN--DYGRAVDWWGLGVVMYEMM 189

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 51.1 bits (122), Expect = 4e-07
 Identities = 49/172 (28%), Positives = 78/172 (45%), Gaps = 38/172 (22%)

Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--------VYNGDTSKPCQ 162
           E+  +    H NV+ LL              F P+ SL++F            D  K   
Sbjct: 64  ELRLLKHMKHENVIGLLDV------------FTPDLSLDRFHDFYLVMPFMGTDLGK--- 108

Query: 163 YLRWEKMYE-----IVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLA 217
            ++ EK+ E     +V  + KGL+Y+H   +  I+H D+KP N+ ++ED   KI DFGLA
Sbjct: 109 LMKHEKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA 165

Query: 218 KLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
           +         S + G      Y APEV   N+   +   D++S G ++ E++
Sbjct: 166 RQTD------SEMTGYVVTRWYRAPEVI-LNWMHYTQTVDIWSVGCIMAEML 210

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 38/206 (18%)

Query: 91  LGQGGFGGVYKGR-----------LLDDFVNEVASISR--------TSHVNVVTLLGFCL 131
           +G G +G VYKGR           ++D   +E   I          + H N+ T  G  +
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83

Query: 132 E----GNNRAL--IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
           +    G++  L  + EF   GS+   V N  T      L+ + +  I   I +GL +LH 
Sbjct: 84  KKSPPGHDDQLWLVMEFCGAGSVTDLVKN--TKGNA--LKEDWIAYICREILRGLAHLH- 138

Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVF 245
             + K++H DIK  N+LL E+   K+ DFG++       G  ++ +G      ++APEV 
Sbjct: 139 --AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTP---YWMAPEVI 193

Query: 246 SRNFGEVS---HKSDVYSFGMMIMEL 268
           + +    +   ++SD++S G+  +E+
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEM 219

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 50.8 bits (121), Expect = 5e-07
 Identities = 37/132 (28%), Positives = 69/132 (52%), Gaps = 15/132 (11%)

Query: 137 ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDI 196
           ++  E M  GSL++ +      K  + +  E + ++ I + +GL YL      +I+H D+
Sbjct: 79  SICMEHMDGGSLDQVL------KEAKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDV 130

Query: 197 KPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKS 256
           KP NIL++     K+ DFG++      + + +S +G R    Y++PE         S +S
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTR---SYMSPERLQGT--HYSVQS 183

Query: 257 DVYSFGMMIMEL 268
           D++S G+ ++EL
Sbjct: 184 DIWSMGLSLVEL 195

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 50.5 bits (121), Expect = 5e-07
 Identities = 37/128 (28%), Positives = 64/128 (50%), Gaps = 15/128 (11%)

Query: 141 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHN 200
           E M  GSL++ +      K    +    + +I I + +GL YL      KI+H D+KP N
Sbjct: 79  EHMDGGSLDQVL------KKAGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSN 130

Query: 201 ILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYS 260
           IL++     K+ DFG++      + + +S +G R    Y++PE        V   SD++S
Sbjct: 131 ILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTR---SYMSPERLQGTHYTVQ--SDIWS 183

Query: 261 FGMMIMEL 268
            G+ ++E+
Sbjct: 184 LGLSLVEM 191

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 50.4 bits (120), Expect = 5e-07
 Identities = 51/209 (24%), Positives = 97/209 (46%), Gaps = 44/209 (21%)

Query: 90  KLGQGGFGGVYKGRLLDD---FV-------------------NEVASISRT---SHVNVV 124
           ++G+G +G V+K R L +   FV                    EVA +       H NVV
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 125 TLLGFC-LEGNNR----ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
            L   C +   +R     L++E +            +   P + ++ + M++++    +G
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK-DMMFQLL----RG 122

Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
           L++LH   S +++H D+KP NIL+      K++DFGLA++ + +  + S ++     + Y
Sbjct: 123 LDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV----TLWY 175

Query: 240 IAPEVFSRNFGEVSHKSDVYSFGMMIMEL 268
            APEV  ++    +   D++S G +  E+
Sbjct: 176 RAPEVLLQS--SYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 50.5 bits (120), Expect = 6e-07
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 8/94 (8%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           I   L+YLH G   KI++ D+K  N++LD+D   KI+DFGL K   T    + +  G   
Sbjct: 104 IVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTP- 159

Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
              Y+APEV   N  +     D +  G+++ E++
Sbjct: 160 --EYLAPEVLEDN--DYGRAVDWWGLGVVMYEMM 189

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 50.4 bits (120), Expect = 6e-07
 Identities = 45/143 (31%), Positives = 69/143 (48%), Gaps = 20/143 (13%)

Query: 137 ALIYEFMPNGSLEKF-----VYNGDTSKPCQY----LRWEKMYEIVIGIAKGLEYLHHGC 187
           +L+  F P  SLE+F     V     +  CQ     L  E+M  ++  +  G+++LH   
Sbjct: 84  SLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH--- 140

Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV-FS 246
           S  I+H D+KP NI++  D   KI DFGLA+   T   +   ++       Y APEV   
Sbjct: 141 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY----YRAPEVILG 196

Query: 247 RNFGEVSHKSDVYSFGMMIMELV 269
             + E     D++S G ++ ELV
Sbjct: 197 MGYKE---NVDIWSVGCIMGELV 216

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 50.3 bits (120), Expect = 7e-07
 Identities = 31/89 (34%), Positives = 45/89 (50%), Gaps = 7/89 (7%)

Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
           LE+LH      I++ D+KP NILLD      + DFGL+K   T     ++  G      Y
Sbjct: 109 LEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGT---TEY 162

Query: 240 IAPEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           +APEV     G   H  D +S G+++ E+
Sbjct: 163 LAPEVLLDEKGYTKH-VDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 49.9 bits (119), Expect = 7e-07
 Identities = 40/132 (30%), Positives = 63/132 (47%), Gaps = 13/132 (9%)

Query: 138 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIK 197
           L+   M  G L+  +YN         L  E++      I  G+ +LH   S  I++ D+K
Sbjct: 70  LVMSLMNGGDLKYHIYNVGERG----LEMERVIHYSAQITCGILHLH---SMDIVYRDMK 122

Query: 198 PHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSD 257
           P N+LLD+    ++SD GLA     K+G   ++    G  GY+APE+        S+  D
Sbjct: 123 PENVLLDDQGNCRLSDLGLA--VELKDG--KTITQRAGTNGYMAPEILKEE--PYSYPVD 176

Query: 258 VYSFGMMIMELV 269
            ++ G  I E+V
Sbjct: 177 WFAMGCSIYEMV 188

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 50.0 bits (119), Expect = 7e-07
 Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 10/95 (10%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           I  GL++LH   S  I++ D+K  NILLD D   KI+DFG+ K     +    +  G   
Sbjct: 105 IICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP- 160

Query: 236 IIGYIAPEVFSRNFGE-VSHKSDVYSFGMMIMELV 269
              YIAPE+     G+  +   D +SFG+++ E++
Sbjct: 161 --DYIAPEIL---LGQKYNTSVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 50.0 bits (119), Expect = 7e-07
 Identities = 33/91 (36%), Positives = 50/91 (54%), Gaps = 9/91 (9%)

Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG 238
           GLE L      +I++ D+KP NILLD+    +ISD GLA      EG   ++ G  G +G
Sbjct: 114 GLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLA--VQIPEG--ETVRGRVGTVG 166

Query: 239 YIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
           Y+APEV +    + +   D +  G +I E++
Sbjct: 167 YMAPEVINNE--KYTFSPDWWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 50.1 bits (120), Expect = 8e-07
 Identities = 32/107 (29%), Positives = 55/107 (51%), Gaps = 19/107 (17%)

Query: 172 IVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL----CTTKEGIV 227
           +++ + +GL+YLH      I+H D+K  N+LL +  C KI+DFGLA+            V
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKV 169

Query: 228 SSLLGARGIIGYIAPEVFSRNFGEVSHKS--DVYSFGMMIMELVGCK 272
            +L        Y APE+     G  ++ +  D+++ G ++ EL+  K
Sbjct: 170 VTLW-------YRAPELL---LGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 50.5 bits (121), Expect = 8e-07
 Identities = 55/234 (23%), Positives = 86/234 (36%), Gaps = 71/234 (30%)

Query: 90  KLGQGGFGGVYKG----------------------RLLDDFVNEVASISRTSHVNVVTLL 127
            +G+GG G VY                         L   F+ E    +   H  +V + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLR--WEK---------------MY 170
             C +G+    +Y  MP      ++  G T K    L+  W+K                 
Sbjct: 69  SICSDGD---PVYYTMP------YI-EGYTLK--SLLKSVWQKESLSKELAEKTSVGAFL 116

Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE------ 224
            I   I   +EY+H   S  +LH D+KP NILL       I D+G A     +E      
Sbjct: 117 SIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDI 173

Query: 225 -----GIVSSLLGARG-IIG---YIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
                 I  S +   G I+G   Y+APE         S  +D+Y+ G+++ +++
Sbjct: 174 DVDERNICYSSMTIPGKIVGTPDYMAPERLLGV--PASESTDIYALGVILYQML 225

Length = 932

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 49.8 bits (119), Expect = 9e-07
 Identities = 40/130 (30%), Positives = 58/130 (44%), Gaps = 42/130 (32%)

Query: 181 EYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK--------LCTTKEGIVSSLLG 232
           EYLH   S  I++ D+KP N+LLD     K++DFG AK        LC T E        
Sbjct: 132 EYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTPE-------- 180

Query: 233 ARGIIGYIAPEVF-SRNFGEVSHKSDVYSFGMMIME-LVGCKNNLDSGVDSSSEVY---- 286
                 Y+APEV  S+  G+     D ++ G+++ E + G     D   D+   +Y    
Sbjct: 181 ------YLAPEVIQSKGHGKA---VDWWTMGVLLYEFIAGYPPFFD---DTPFRIYEKIL 228

Query: 287 -----FPHWI 291
                FP+W 
Sbjct: 229 AGRLKFPNWF 238

Length = 329

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 50.0 bits (120), Expect = 9e-07
 Identities = 44/164 (26%), Positives = 65/164 (39%), Gaps = 46/164 (28%)

Query: 138 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY--EIVIGIAKGLEYLHH-GCSTKILHF 194
           L+ E+MP G L   +   D           + Y  E+V+ +    + +H  G     +H 
Sbjct: 78  LVMEYMPGGDLMNLLIRKDVFPE----ETARFYIAELVLAL----DSVHKLGF----IHR 125

Query: 195 DIKPHNILLDEDFCPKISDFGLAK------------------LCTTKEGIVSSLLG---- 232
           DIKP NIL+D D   K++DFGL K                  L      +          
Sbjct: 126 DIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRV 185

Query: 233 -ARGIIG---YIAPEVF-SRNFGEVSHKSDVYSFGMMIME-LVG 270
            A   +G   YIAPEV     +G    + D +S G+++ E L G
Sbjct: 186 RANSTVGTPDYIAPEVLRGTPYG---LECDWWSLGVILYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 35/94 (37%), Positives = 52/94 (55%), Gaps = 9/94 (9%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           I  GLE++H   +  +++ D+KP NILLDE    +ISD GLA   + K+   S      G
Sbjct: 106 IILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-----G 157

Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             GY+APEV  +     S  +D +S G M+ +L+
Sbjct: 158 THGYMAPEVLQKGTAYDS-SADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 48.7 bits (116), Expect = 1e-06
 Identities = 67/287 (23%), Positives = 119/287 (41%), Gaps = 68/287 (23%)

Query: 89  DKLGQGGFGGVYKG------------------RLLD--------DFVNEVASISRTSHVN 122
           + LGQG F  ++KG                  ++LD         F    + +S+ SH +
Sbjct: 1   ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60

Query: 123 VVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 182
           +V   G C+ G+   ++ E++  GSL+ ++     +K    + W+      + +AK L +
Sbjct: 61  LVLNYGVCVCGDESIMVQEYVKFGSLDTYL---KKNKNLINISWK------LEVAKQLAW 111

Query: 183 -LHHGCSTKILHFDIKPHNILL--DEDFCP------KISDFGLAKLCTTKEGIVSSLLGA 233
            LH      + H ++   N+LL  +ED         K+SD G++     KE ++      
Sbjct: 112 ALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLER---- 167

Query: 234 RGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYR 293
              I ++ PE    N   +S  +D +SFG  + E+    +   S +DS  ++ F      
Sbjct: 168 ---IPWVPPECI-ENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF------ 217

Query: 294 HVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI 340
              +DR  +LP     K  E+A   +I    C+   P  RP    +I
Sbjct: 218 --YEDRH-QLP---APKWTELA--NLINQ--CMDYEPDFRPSFRAII 254

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 31/93 (33%), Positives = 46/93 (49%), Gaps = 15/93 (16%)

Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG- 238
            EYLH   +  I++ D+KP N+LLD +   K+ DFG AK        + S        G 
Sbjct: 106 FEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAK-------KLKSGQKTWTFCGT 155

Query: 239 --YIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             Y+APE+   N G      D +S G+++ EL+
Sbjct: 156 PEYVAPEIIL-NKGY-DFSVDYWSLGILLYELL 186

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 42/204 (20%)

Query: 90  KLGQGGFGGVYKGRLL----------------DDFV---NEVASISRTSHVNVVTLLGFC 130
           ++G G +G VYK R +                +DF     E+  +    H N+V   G  
Sbjct: 16  RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY 75

Query: 131 LEGNNRALIYEFMPNGSLEKFVY-NGDTSK-PCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
           L  +   +  EF   GSL+   +  G  S+    Y+  E +        +GL YLH   S
Sbjct: 76  LRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL--------QGLYYLH---S 124

Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG---YIAPEVF 245
              +H DIK  NILL ++   K++DFG++        I +++   +  IG   ++APEV 
Sbjct: 125 KGKMHRDIKGANILLTDNGHVKLADFGVSA------QITATIAKRKSFIGTPYWMAPEVA 178

Query: 246 S-RNFGEVSHKSDVYSFGMMIMEL 268
           +    G  +   D+++ G+  +EL
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 64/262 (24%), Positives = 113/262 (43%), Gaps = 47/262 (17%)

Query: 90  KLGQGGFGGVYKGRLLD-----DFV--------------NEVASISRTSHVNVVTLLGFC 130
           K+G+G +G VYK +  D     D+                E+A +    H NV++L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 131 LEGNNRA--LIYEFMPNGSLEKFVYNGDTS---KPCQYLRWEKMYEIVIGIAKGLEYLHH 185
           L   +R   L++++  +       ++  +    KP Q  R   +  ++  I  G+ YLH 
Sbjct: 68  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR-GMVKSLLYQILDGIHYLH- 125

Query: 186 GCSTKILHFDIKPHNILL----DEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
             +  +LH D+KP NIL+     E    KI+D G A+L  +    ++ L        Y A
Sbjct: 126 --ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 242 PEVF--SRNFGEVSHKSDVYSFGMMIMELVGCK---NNLDSGVDSSSEVYFPHWIYRHVE 296
           PE+   +R++   +   D+++ G +  EL+  +   +     + +S+        Y H +
Sbjct: 184 PELLLGARHY---TKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP-------YHHDQ 233

Query: 297 QDREFKLPGVVTRKENEIAKKM 318
            DR F + G    K+ E  KKM
Sbjct: 234 LDRIFNVMGFPADKDWEDIKKM 255

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 61/261 (23%), Positives = 110/261 (42%), Gaps = 45/261 (17%)

Query: 90  KLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFC 130
           K+G+G +G VYK +  D                       E+A +    H NV+ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67

Query: 131 LEGNNRA--LIYEFMPNG--SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
           L  ++R   L++++  +    + KF      +K    L    +  ++  I  G+ YLH  
Sbjct: 68  LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH-- 125

Query: 187 CSTKILHFDIKPHNILL----DEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAP 242
            +  +LH D+KP NIL+     E    KI+D G A+L  +    ++ L        Y AP
Sbjct: 126 -ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184

Query: 243 EVF--SRNFGEVSHKSDVYSFGMMIMELVGCK---NNLDSGVDSSSEVYFPHWIYRHVEQ 297
           E+   +R++   +   D+++ G +  EL+  +   +     + +S+        + H + 
Sbjct: 185 ELLLGARHY---TKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP-------FHHDQL 234

Query: 298 DREFKLPGVVTRKENEIAKKM 318
           DR F + G    K+ E  +KM
Sbjct: 235 DRIFSVMGFPADKDWEDIRKM 255

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 48.4 bits (115), Expect = 3e-06
 Identities = 34/106 (32%), Positives = 56/106 (52%), Gaps = 10/106 (9%)

Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
           +K+  +V  +  GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+        
Sbjct: 117 DKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD----- 168

Query: 227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
            + + G      Y APEV   N+   +   D++S G ++ E++  K
Sbjct: 169 -AEMTGYVVTRWYRAPEVI-LNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 47.9 bits (114), Expect = 3e-06
 Identities = 28/69 (40%), Positives = 35/69 (50%), Gaps = 6/69 (8%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           IA  L YLH   S  I++ D+KP NILLD      ++DFGL K         S+  G   
Sbjct: 105 IASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTP- 160

Query: 236 IIGYIAPEV 244
              Y+APEV
Sbjct: 161 --EYLAPEV 167

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 48.2 bits (114), Expect = 4e-06
 Identities = 47/169 (27%), Positives = 78/169 (46%), Gaps = 32/169 (18%)

Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF-----VYNGDTSKPCQYLR 165
           E+  +   +H N+++LL              F P  SLE+F     V     +  CQ ++
Sbjct: 66  ELVLMKCVNHKNIISLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQ 113

Query: 166 WE----KMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT 221
            E    +M  ++  +  G+++LH   S  I+H D+KP NI++  D   KI DFGLA+   
Sbjct: 114 MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170

Query: 222 TKEGIVSSLLGARGIIGYIAPEV-FSRNFGEVSHKSDVYSFGMMIMELV 269
           T   +   ++       Y APEV     + E     D++S G ++ E+V
Sbjct: 171 TSFMMTPYVVTRY----YRAPEVILGMGYKE---NVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 37/132 (28%), Positives = 68/132 (51%), Gaps = 15/132 (11%)

Query: 137 ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDI 196
           ++  E M  GSL++ +      K    +  + + ++ I + KGL YL      KI+H D+
Sbjct: 79  SICMEHMDGGSLDQVL------KKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDV 130

Query: 197 KPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKS 256
           KP NIL++     K+ DFG++      + + +S +G R    Y++PE         S +S
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTR---SYMSPERLQGT--HYSVQS 183

Query: 257 DVYSFGMMIMEL 268
           D++S G+ ++E+
Sbjct: 184 DIWSMGLSLVEM 195

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 45/154 (29%), Positives = 72/154 (46%), Gaps = 21/154 (13%)

Query: 137 ALIYEFMPNGSLEKF-----VYNGDTSKPCQYLRWE----KMYEIVIGIAKGLEYLHHGC 187
            L+  F P  SLE+F     V     +  CQ ++ E    +M  ++  +  G+++LH   
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH--- 143

Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV-FS 246
           S  I+H D+KP NI++  D   KI DFGLA+   T   +   ++       Y APEV   
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY----YRAPEVILG 199

Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVD 280
             + E     D++S G ++ E++     L  G D
Sbjct: 200 MGYKE---NVDIWSVGCIMGEMI-KGGVLFPGTD 229

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 47.2 bits (112), Expect = 6e-06
 Identities = 31/94 (32%), Positives = 51/94 (54%), Gaps = 8/94 (8%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           I  GL++LH   S  I++ D+K  N++LD D   KI+DFG+ K     +   S+  G   
Sbjct: 105 IVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTP- 160

Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
              YIAPE+      + +   D +SFG+++ E++
Sbjct: 161 --DYIAPEILQGL--KYTFSVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 46.7 bits (111), Expect = 6e-06
 Identities = 58/229 (25%), Positives = 93/229 (40%), Gaps = 52/229 (22%)

Query: 91  LGQGGFGGVYKGRL------------LDDFVN---------------EVASI-SRTSHVN 122
           LGQG F  +YKG L             +  V                E AS+ S+ SH +
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 123 VVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 182
           +V L G C+   N  ++ E++  G L+ F++     K    L W K+  +   +A  L Y
Sbjct: 63  LVKLYGVCVRDEN-IMVEEYVKFGPLDVFLH---REKNNVSLHW-KLD-VAKQLASALHY 116

Query: 183 LHHGCSTKILHFDIKPHNILL----DEDFCP---KISDFGLAKLCTTKEGIVSSLLGARG 235
           L      K++H ++   NIL+      +      K+SD G+     ++E  V        
Sbjct: 117 LE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVER------ 167

Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE 284
            I +IAPE        ++  +D +SFG  ++E+            SSSE
Sbjct: 168 -IPWIAPECIRNGQASLTIAADKWSFGTTLLEIC-SNGEEPLSTLSSSE 214

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 47.0 bits (112), Expect = 7e-06
 Identities = 59/222 (26%), Positives = 88/222 (39%), Gaps = 73/222 (32%)

Query: 91  LGQGGFGGV----YKGR--------LLDDFV---NEVASI----------SRTSHVNVVT 125
           LG+G FG V    YK          L    +   +EV S+          +   H  +V 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 126 LLGFCLEGNNRA-LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY--EIVIGIAKGLEY 182
           L   C +  +    + E+   G L   ++    S+P         Y   +V+G    L+Y
Sbjct: 67  LFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP-----RAVFYAACVVLG----LQY 116

Query: 183 LHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK-----------LCTTKEGIVSSLL 231
           LH     KI++ D+K  N+LLD +   KI+DFGL K            C T E       
Sbjct: 117 LH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPE------- 166

Query: 232 GARGIIGYIAPEVFSRNFGEVSHKSDV--YSFGMMIME-LVG 270
                  ++APEV +    E S+   V  +  G++I E LVG
Sbjct: 167 -------FLAPEVLT----ETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 47.1 bits (112), Expect = 7e-06
 Identities = 27/92 (29%), Positives = 44/92 (47%), Gaps = 3/92 (3%)

Query: 178 KGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGII 237
           + L+Y+H   +  + H D+KP NIL + D   KI DFGLA++                  
Sbjct: 114 RALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            Y APE+    F + +   D++S G +  E++
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 202

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 46.0 bits (109), Expect = 1e-05
 Identities = 47/191 (24%), Positives = 82/191 (42%), Gaps = 20/191 (10%)

Query: 120 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGD-TSKPCQYLRWEKMYEIVIGIAK 178
           H N++  LG C+E     L++E+   G L+ ++       +  Q L  ++M      IA 
Sbjct: 54  HPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRM---ACEIAA 110

Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG 238
           G+ ++H       LH D+   N  L  D   K+ D+G+      KE  + +       + 
Sbjct: 111 GVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLR 166

Query: 239 YIAPEVFSRNFG-----EVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYR 293
           ++APE+     G     E +  S+V++ G+ + EL        S + S  EV        
Sbjct: 167 WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL-SDREV------LN 219

Query: 294 HVEQDREFKLP 304
           HV +D++ KL 
Sbjct: 220 HVIKDQQVKLF 230

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 39/124 (31%), Positives = 61/124 (49%), Gaps = 12/124 (9%)

Query: 167 EKMYEIVIG-IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG 225
           E+  +I  G I   LE+LH      I++ DIK  NILLD +    ++DFGL+K     E 
Sbjct: 104 EQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE- 159

Query: 226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKS--DVYSFGMMIMELV--GCKNNLDSGVDS 281
            V       G I Y+AP++     G+  H    D +S G+++ EL+       +D   +S
Sbjct: 160 -VERAYSFCGTIEYMAPDIVRG--GDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS 216

Query: 282 SSEV 285
            +E+
Sbjct: 217 QAEI 220

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 26/73 (35%), Positives = 38/73 (52%), Gaps = 6/73 (8%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           I   L YLH   S  +++ D+K  N++LD+D   KI+DFGL K   +    + +  G   
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP- 159

Query: 236 IIGYIAPEVFSRN 248
              Y+APEV   N
Sbjct: 160 --EYLAPEVLEDN 170

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 27/72 (37%), Positives = 37/72 (51%), Gaps = 6/72 (8%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           +A  + YLH   S  I++ D+KP NILLD      ++DFGL K     E   S+  G   
Sbjct: 105 VASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTP- 160

Query: 236 IIGYIAPEVFSR 247
              Y+APEV  +
Sbjct: 161 --EYLAPEVLRK 170

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 35/126 (27%), Positives = 61/126 (48%), Gaps = 19/126 (15%)

Query: 169 MYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE--DFCPKISDFGLAKLCTTKEGI 226
           +  I   + + ++YLH     +I+H DIK  NI ++   D C  + DFG A  C   +  
Sbjct: 184 ILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVC--LGDFGAA--CFPVDIN 236

Query: 227 VSSLLGARGIIGYIAPEVFSRN-FGEVSHKSDVYSFGMMIMELVGCKNN------LDSGV 279
            +   G  G I   APE+ +R+ +G      D++S G+++ E+  C ++      LD   
Sbjct: 237 ANKYYGWAGTIATNAPELLARDPYGPAV---DIWSAGIVLFEMATCHDSLFEKDGLDGDC 293

Query: 280 DSSSEV 285
           DS  ++
Sbjct: 294 DSDRQI 299

Length = 391

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 22/52 (42%), Positives = 35/52 (67%), Gaps = 8/52 (15%)

Query: 169 MYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLD-EDFCPKISDFGLAKL 219
           MY+++    +GL+Y+H   S  +LH D+KP N+ ++ ED   KI DFGLA++
Sbjct: 120 MYQLL----RGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARI 164

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 45.9 bits (109), Expect = 1e-05
 Identities = 39/108 (36%), Positives = 56/108 (51%), Gaps = 24/108 (22%)

Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL----CTTK--EGIVSSLLGA 233
           LEYLH   +  I+H D+KP N+L+      K++DFGL+K+     TT   EG +      
Sbjct: 114 LEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK--DT 168

Query: 234 R--------GIIGYIAPEVFSRN-FGEVSHKSDVYSFGMMIME-LVGC 271
           R        G   YIAPEV  R  +G+     D ++ G+++ E LVGC
Sbjct: 169 REFLDKQVCGTPEYIAPEVILRQGYGK---PVDWWAMGIILYEFLVGC 213

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 40/157 (25%), Positives = 66/157 (42%), Gaps = 43/157 (27%)

Query: 89  DKLGQGGFGGVYKG--------------RLLDD------FVNEVASISRTSHVNVVTLLG 128
           +KLG+G +  VYKG              RL ++       + E + +    H N+V L  
Sbjct: 11  EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHD 70

Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQY-------LRWEKMYEIVIGIAKGLE 181
                    L++E++              +  CQY       L  E +   +  + +GL 
Sbjct: 71  IIHTKETLTLVFEYV-------------HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLS 117

Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK 218
           Y+H      ILH D+KP N+L+ +    K++DFGLA+
Sbjct: 118 YIHQ---RYILHRDLKPQNLLISDTGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 45/174 (25%), Positives = 78/174 (44%), Gaps = 28/174 (16%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           +A+G+E+L    S   +H D+   N+LL +    KI DFGLA+        VS   G+  
Sbjct: 246 VARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSK--GSTF 300

Query: 236 I-IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSG--VDSSSEVYFPHWIY 292
           + + ++APE    N    +  SDV+S+G+++ E+         G  VDS+         Y
Sbjct: 301 LPVKWMAPESIFDNL--YTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--------FY 350

Query: 293 RHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPP---MNEVIEML 343
             ++       P   T++  +I  K       C  + P  RP    +++++E L
Sbjct: 351 NKIKSGYRMAKPDHATQEVYDIMVK-------CWNSEPEKRPSFLHLSDIVESL 397

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 56/225 (24%), Positives = 102/225 (45%), Gaps = 50/225 (22%)

Query: 78  SDVKKLTN-SFK--DKLGQGGFGGVYKGRLLD--------------DFVN-EVASISRTS 119
           +D+ +  N S+K  + +G G FG VY+   +D               + N E+  +   +
Sbjct: 58  NDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLN 117

Query: 120 HVNVVTLLGF----CLEGNNRAL----IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYE 171
           H+N++ L  +    C + N + +    + EF+P  ++ K++ +   +     L   K+Y 
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYS 176

Query: 172 IVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDED-FCPKISDFGLAKLCTTKEGIVSSL 230
               + + L Y+H   S  I H D+KP N+L+D +    K+ DFG AK          +L
Sbjct: 177 Y--QLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK----------NL 221

Query: 231 LGARGIIGYI------APEVFSRNFGEVSHKSDVYSFGMMIMELV 269
           L  +  + YI      APE+        +H  D++S G +I E++
Sbjct: 222 LAGQRSVSYICSRFYRAPELMLGATNYTTH-IDLWSLGCIIAEMI 265

Length = 440

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 48/207 (23%), Positives = 83/207 (40%), Gaps = 45/207 (21%)

Query: 89  DKLGQGGFGGVYKG--RLLDDFV------------------NEVASISRTSHVNVVTLLG 128
           +KLG+G +  VYKG  R+    V                   E + +    H N+V L  
Sbjct: 11  EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHD 70

Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
                     ++E+M     +  + +     P     +  M++++    +GL Y+H    
Sbjct: 71  IIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLF--MFQLL----RGLAYIHG--- 121

Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAKL----CTTKEGIVSSLLGARGIIGYIAPEV 244
             ILH D+KP N+L+      K++DFGLA+       T    V +L        Y  P+V
Sbjct: 122 QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLW-------YRPPDV 174

Query: 245 FSRNFGEVSHKS--DVYSFGMMIMELV 269
                G   + S  D++  G + +E++
Sbjct: 175 L---LGATDYSSALDIWGAGCIFIEML 198

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 46/204 (22%), Positives = 85/204 (41%), Gaps = 40/204 (19%)

Query: 90  KLGQGGFGGVYKGRLLDD--------FVN-------------EVASISRTSHVNVVTLLG 128
           K+G+G +G V+K R  +         FV              E+  + +  H N+V L+ 
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67

Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH-HGC 187
                    L++E+  +  L +        K  + +    + +I+    + + + H H C
Sbjct: 68  VFRRKRKLHLVFEYCDHTVLNEL------EKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC 121

Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSR 247
               +H D+KP NIL+ +    K+ DFG A++ T      +  +  R    Y APE+   
Sbjct: 122 ----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR---WYRAPELL-- 172

Query: 248 NFGEVSHKS--DVYSFGMMIMELV 269
             G+  +    DV++ G +  EL+
Sbjct: 173 -VGDTQYGPPVDVWAIGCVFAELL 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 29/72 (40%), Positives = 37/72 (51%), Gaps = 6/72 (8%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           IA  L YLH   S  I++ D+KP NILLD      ++DFGL K      G  S+  G   
Sbjct: 105 IASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTP- 160

Query: 236 IIGYIAPEVFSR 247
              Y+APEV  +
Sbjct: 161 --EYLAPEVLHK 170

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 37/171 (21%), Positives = 68/171 (39%), Gaps = 27/171 (15%)

Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKM 169
            E+ +  +  H N++  +   +  +   ++   M  GS E  +              E +
Sbjct: 48  QEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFP---------EGL 98

Query: 170 YEIVI-----GIAKGLEYLHH-GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT-T 222
            E+ I      +   L+Y+H  G     +H  +K  +ILL  D    +S  GL    +  
Sbjct: 99  PELAIAFILKDVLNALDYIHSKGF----IHRSVKASHILLSGDGKVVLS--GLRYSVSMI 152

Query: 223 KEG-----IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           K G     +      +   + +++PEV  +N    + KSD+YS G+   EL
Sbjct: 153 KHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACEL 203

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 44.9 bits (106), Expect = 3e-05
 Identities = 44/135 (32%), Positives = 62/135 (45%), Gaps = 18/135 (13%)

Query: 138 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG-IAKGLEYLHHGCSTKILHFDI 196
           LI +++  G +   +Y  D          E       G I   LE+LH      I++ DI
Sbjct: 82  LILDYVSGGEMFTHLYQRDNFS-------EDEVRFYSGEIILALEHLH---KLGIVYRDI 131

Query: 197 KPHNILLDEDFCPKISDFGLAK--LCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSH 254
           K  NILLD +    ++DFGL+K  L   KE   S      G I Y+APE+  R  G    
Sbjct: 132 KLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC----GTIEYMAPEII-RGKGGHGK 186

Query: 255 KSDVYSFGMMIMELV 269
             D +S G++I EL+
Sbjct: 187 AVDWWSLGILIFELL 201

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 44.6 bits (105), Expect = 4e-05
 Identities = 29/100 (29%), Positives = 53/100 (53%), Gaps = 8/100 (8%)

Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG 238
           G++++H     ++LH DIK  NI L ++   K+ DFG A+L T+      + +G      
Sbjct: 112 GVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTP---Y 165

Query: 239 YIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSG 278
           Y+ PE++       ++KSD++S G ++ EL   K+   + 
Sbjct: 166 YVPPEIWENM--PYNNKSDIWSLGCILYELCTLKHPFQAN 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 44.7 bits (106), Expect = 4e-05
 Identities = 43/142 (30%), Positives = 68/142 (47%), Gaps = 28/142 (19%)

Query: 142 FMPNGSLEKF-----VYNGDTSKPCQY----LRWEKMYEIVIGIAKGLEYLHHGCSTKIL 192
           F P  SLE+F     V     +  CQ     L  E+M  ++  +  G+++LH   S  I+
Sbjct: 84  FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH---SAGII 140

Query: 193 HFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV-----FSR 247
           H D+KP NI++  D   KI DFGLA+   T   +++  +  R    Y APEV     +  
Sbjct: 141 HRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTR---YYRAPEVILGMGYKE 196

Query: 248 NFGEVSHKSDVYSFGMMIMELV 269
           N        D++S G ++ E++
Sbjct: 197 NV-------DIWSVGCIMGEMI 211

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 44.3 bits (105), Expect = 4e-05
 Identities = 41/182 (22%), Positives = 82/182 (45%), Gaps = 23/182 (12%)

Query: 104 LLDDFVNEVASISRTSHVNVVTLLGFCLEGNNR----ALIYEFMPNGSLEKFVYNGDTSK 159
           L+D   NE+ ++ R    N++ + GF ++  +     +LI E+   G L + +       
Sbjct: 61  LIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE---- 116

Query: 160 PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL 219
             + L ++   ++ I   KGL  L+    T   + ++   + L+ E++  KI       +
Sbjct: 117 --KDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKI-------I 165

Query: 220 CTTKEGIVSSLLGAR-GIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK---NNL 275
           C   E I+SS        + Y + ++ +  F E + K D+YS G+++ E+   K    NL
Sbjct: 166 CHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL 225

Query: 276 DS 277
            +
Sbjct: 226 TT 227

Length = 283

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 44.6 bits (106), Expect = 4e-05
 Identities = 47/187 (25%), Positives = 75/187 (40%), Gaps = 47/187 (25%)

Query: 115 ISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWE--KMY-- 170
           ++   H  + TL           L+ ++ P G L + +      +P + L  E  + Y  
Sbjct: 55  LATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLL----QRQPGKCLSEEVARFYAA 110

Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSL 230
           E+++     LEYLH      I++ D+KP NILL E     +SDF L+K    +   VS  
Sbjct: 111 EVLLA----LEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKA 163

Query: 231 LGAR--------------------------GIIGYIAPEVFSRNFGEVSHKSDV--YSFG 262
           L                             G   YIAPEV S +     H S V  ++ G
Sbjct: 164 LRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD----GHGSAVDWWTLG 219

Query: 263 MMIMELV 269
           +++ E++
Sbjct: 220 ILLYEML 226

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 44.6 bits (105), Expect = 4e-05
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 37/208 (17%)

Query: 89  DKLGQGGFGGVYKG-----------RLLD---DFVNEVAS-----ISRTSHVNVVTLLGF 129
           + +G+G +G VYK            ++LD   D   E+ +      S  +H NVV   G 
Sbjct: 28  ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGM 87

Query: 130 C-----LEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH 184
                 L G    L+ E    GS+ + V         Q L    +  I+ G   GL++LH
Sbjct: 88  FYKADKLVGGQLWLVLELCNGGSVTELVKG--LLICGQRLDEAMISYILYGALLGLQHLH 145

Query: 185 HGCSTKILHFDIKPHNILLDEDFCPKISDFGL-AKLCTTKEGIVSSLLGARGIIGYIAPE 243
              + +I+H D+K +NILL  +   K+ DFG+ A+L +T+    +S+    G   ++APE
Sbjct: 146 ---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV----GTPFWMAPE 198

Query: 244 VFS---RNFGEVSHKSDVYSFGMMIMEL 268
           V +   +       + DV+S G+  +EL
Sbjct: 199 VIACEQQYDYSYDARCDVWSLGITAIEL 226

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 43.9 bits (103), Expect = 6e-05
 Identities = 31/96 (32%), Positives = 51/96 (53%), Gaps = 11/96 (11%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV--SSLLGA 233
           I   L+YLH      +++ D+K  N++LD+D   KI+DFGL      KEGI   +++   
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLC-----KEGIKDGATMKTF 156

Query: 234 RGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            G   Y+APEV   N  +     D +  G+++ E++
Sbjct: 157 CGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMM 190

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 44.1 bits (104), Expect = 7e-05
 Identities = 36/124 (29%), Positives = 63/124 (50%), Gaps = 21/124 (16%)

Query: 180 LEYLH-HGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGAR--GI 236
           L +LH HG    +++ D+K  NILLD +   K++DFG+      KEGI++ +      G 
Sbjct: 109 LMFLHRHG----VIYRDLKLDNILLDAEGHCKLADFGMC-----KEGILNGVTTTTFCGT 159

Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK-----NNLDSGVDS--SSEVYFPH 289
             YIAPE+      E     D ++ G+++ E++  +     +N D   +S    +V +P 
Sbjct: 160 PDYIAPEILQEL--EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV 217

Query: 290 WIYR 293
           W+ +
Sbjct: 218 WLSK 221

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 44.2 bits (104), Expect = 7e-05
 Identities = 33/102 (32%), Positives = 54/102 (52%), Gaps = 14/102 (13%)

Query: 170 YEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG--IV 227
           Y+IV+     L+ +H   S K++H D+K  NI L      K+ DFG +K  +      + 
Sbjct: 176 YQIVLA----LDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVA 228

Query: 228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
           SS  G      Y+APE++ R     S K+D++S G+++ EL+
Sbjct: 229 SSFCGTP---YYLAPELWERK--RYSKKADMWSLGVILYELL 265

Length = 478

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 43.8 bits (103), Expect = 8e-05
 Identities = 31/74 (41%), Positives = 38/74 (51%), Gaps = 10/74 (13%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGAR- 234
           IA  L YLH   S  I++ D+KP NILLD      ++DFGL      KEGI  S      
Sbjct: 105 IASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLC-----KEGIAQSDTTTTF 156

Query: 235 -GIIGYIAPEVFSR 247
            G   Y+APEV  +
Sbjct: 157 CGTPEYLAPEVIRK 170

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 43.9 bits (103), Expect = 8e-05
 Identities = 39/171 (22%), Positives = 80/171 (46%), Gaps = 17/171 (9%)

Query: 103 RLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI---YEFMPNGSLEKFVYNGDTSK 159
           R      NE+ ++ R +H N++ +        N  +I   Y+F     L  F+Y+     
Sbjct: 205 RAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEAFDW 260

Query: 160 PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL 219
             + L  +    I+  +   +EY+H     K++H DIK  NI L+ D    + DFG A  
Sbjct: 261 KDRPLLKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAM- 315

Query: 220 CTTKEGIVSSLLGARGIIGYIAPEVFSRN-FGEVSHKSDVYSFGMMIMELV 269
              ++   +   G  G +   +PE+ + + + E+   +D++S G+++++++
Sbjct: 316 -PFEKEREAFDYGWVGTVATNSPEILAGDGYCEI---TDIWSCGLILLDML 362

Length = 501

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 43.4 bits (102), Expect = 9e-05
 Identities = 46/173 (26%), Positives = 79/173 (45%), Gaps = 38/173 (21%)

Query: 111 EVASI-SRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKM 169
           E AS+ S+ SH+++  + G C+ G+   ++ EF+ +G L+              LR EK 
Sbjct: 65  ETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD------------VCLRKEKG 112

Query: 170 -----YEIVIG--IAKGLEYLHHGCSTKILHFDIKPHNIL-----LDEDFCP--KISDFG 215
                ++I +   +A  L YL       ++H ++   NIL     L E   P  K+SD G
Sbjct: 113 RVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPG 169

Query: 216 LAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           ++    ++E  V         I +IAPE        +S  +D +SFG  ++E+
Sbjct: 170 VSFTALSREERVER-------IPWIAPECV-PGGNSLSTAADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 43.6 bits (103), Expect = 9e-05
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 55/217 (25%)

Query: 89  DKLGQGGFGGVYKGR-------------LLDD--------FVNEVASISRTSHVNVVTL- 126
            ++G+G +G VYK R              LD+         + E+  + + +H N+V L 
Sbjct: 13  GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72

Query: 127 ---------LGFCLEGNNRALIYEFMPN---GSLEKFVYNGDTSKPCQYLRWEKMYEIVI 174
                    L F  +     L++E+M +   G LE  + +        +++         
Sbjct: 73  EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMK--------- 123

Query: 175 GIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGAR 234
            + +GL Y H       LH DIK  NILL+     K++DFGLA+L  ++E   S     +
Sbjct: 124 QLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE---SRPYTNK 177

Query: 235 GI-IGYIAPEVFSRNFGEVSHKS--DVYSFGMMIMEL 268
            I + Y  PE+     GE  +    DV+S G ++ EL
Sbjct: 178 VITLWYRPPELL---LGEERYGPAIDVWSCGCILGEL 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 43.3 bits (102), Expect = 9e-05
 Identities = 40/145 (27%), Positives = 67/145 (46%), Gaps = 25/145 (17%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGAR- 234
           I   L +LH      I++ D+K  N+LLD +   K++DFG+      KEGI +    +  
Sbjct: 105 ITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMC-----KEGIFNGKTTSTF 156

Query: 235 -GIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKN------NLDSGVDS--SSEV 285
            G   YIAPE+        S   D ++ G+++ E++ C +      N D   ++  + EV
Sbjct: 157 CGTPDYIAPEILQEMLYGPS--VDWWAMGVLLYEML-CGHAPFEAENEDDLFEAILNDEV 213

Query: 286 YFPHWIYRHVEQDREFKLPGVVTRK 310
            +P W+     QD    L   +T+ 
Sbjct: 214 VYPTWL----SQDAVDILKAFMTKN 234

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 54/191 (28%), Positives = 91/191 (47%), Gaps = 21/191 (10%)

Query: 132 EGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKI 191
           + NN  L+ ++   G L   +   +   P    R+  + E+VI I   +  LH+      
Sbjct: 72  DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARF-YLAEMVIAI-DSVHQLHY------ 123

Query: 192 LHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSR---N 248
           +H DIKP NIL+D +   +++DFG + L   ++G V S + A G   YI+PE+       
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSV-AVGTPDYISPEILQAMEDG 181

Query: 249 FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVT 308
            G+   + D +S G+ + E++  +    +  +S  E Y    I  H E+   F+ P  VT
Sbjct: 182 KGKYGPECDWWSLGVCMYEMLYGETPFYA--ESLVETYGK--IMNHKER---FQFPAQVT 234

Query: 309 RKENEIAKKMI 319
              +E AK +I
Sbjct: 235 -DVSEDAKDLI 244

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 44.0 bits (103), Expect = 1e-04
 Identities = 61/232 (26%), Positives = 83/232 (35%), Gaps = 60/232 (25%)

Query: 90  KLGQGGFGGVY---------------------KGRLLDDFVNEVASISRTSHVNVVTLLG 128
           K+G G FG V+                     K R     V EV  +    H N+V  + 
Sbjct: 20  KIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYID 79

Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQ--YLRWEKMYE-----IVIGIAKGLE 181
             L   N+ L Y  M      +F   GD S+  Q  Y  + K+ E     I   +   L 
Sbjct: 80  RFLNKANQKL-YILM------EFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALA 132

Query: 182 YLHH----GCSTKILHFDIKPHNILLDEDF-----------------CPKISDFGLAKLC 220
           Y H+        ++LH D+KP NI L                       KI DFGL+K  
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK-- 190

Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
               GI S      G   Y +PE+          KSD+++ G +I EL   K
Sbjct: 191 --NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240

Length = 1021

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 31/80 (38%), Positives = 40/80 (50%), Gaps = 9/80 (11%)

Query: 138 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIK 197
           LI EF+P G L   +   DT       R+  M E V+ I    E +H       +H DIK
Sbjct: 78  LIMEFLPGGDLMTMLIKYDTFSE-DVTRF-YMAECVLAI----EAVH---KLGFIHRDIK 128

Query: 198 PHNILLDEDFCPKISDFGLA 217
           P NIL+D     K+SDFGL+
Sbjct: 129 PDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 12/96 (12%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGAR- 234
           IA GL +LH   S  I++ D+K  N++LD +   KI+DFG   +C  KE I         
Sbjct: 110 IAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFG---MC--KENIFGGKTTRTF 161

Query: 235 -GIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            G   YIAPE+ +  +       D ++FG+++ E++
Sbjct: 162 CGTPDYIAPEIIA--YQPYGKSVDWWAFGVLLYEML 195

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 48/175 (27%), Positives = 81/175 (46%), Gaps = 34/175 (19%)

Query: 111 EVASISR-TSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDT--SKPCQYLRWE 167
           E AS+ R  SH ++V L G C+      ++ EF+  G L+ F++      + P     W+
Sbjct: 53  ETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTP-----WK 107

Query: 168 KMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL-----DEDFCP--KISDFGLAKLC 220
             +++   +A  L YL       ++H ++   NILL     D +  P  K+SD G+    
Sbjct: 108 --FKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV 162

Query: 221 TTKEGIVSSLLGARGIIGYIAPEVF--SRNFGEVSHKSDVYSFGMMIMELVGCKN 273
            +++  V         I +IAPE    S+N   +S  +D +SFG  + E+  C N
Sbjct: 163 LSRQECVER-------IPWIAPECVEDSKN---LSIAADKWSFGTTLWEI--CYN 205

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 47/213 (22%)

Query: 89  DKLGQGGFGGVYKG-----------RLLD---DFVNEVAS-----ISRTSHVNVVTLLGF 129
           + +G+G +G V+K            ++LD   D   E+ +      + + H NVV   G 
Sbjct: 24  ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGM 83

Query: 130 CLE-----GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIA-----KG 179
             +     G+   L+ E    GS+   V            R E+M E +I         G
Sbjct: 84  YYKKDVKNGDQLWLVLELCNGGSVTDLVKG-------FLKRGERMEEPIIAYILHEALMG 136

Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGL-AKLCTTKEGIVSSLLGARGIIG 238
           L++LH     K +H D+K +NILL  +   K+ DFG+ A+L +T+    +S+    G   
Sbjct: 137 LQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV----GTPF 189

Query: 239 YIAPEVFS---RNFGEVSHKSDVYSFGMMIMEL 268
           ++APEV +   +       + DV+S G+  +EL
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 27/81 (33%), Positives = 46/81 (56%), Gaps = 5/81 (6%)

Query: 192 LHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSR---N 248
           +H DIKP N+LLD +   +++DFG + L   ++G V S + A G   YI+PE+       
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSV-AVGTPDYISPEILQAMEDG 181

Query: 249 FGEVSHKSDVYSFGMMIMELV 269
            G+   + D +S G+ + E++
Sbjct: 182 MGKYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 30/95 (31%), Positives = 52/95 (54%), Gaps = 8/95 (8%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           IA GL +LH   S  I++ D+K  N++LD +   KI+DFG+ K     +G+ +      G
Sbjct: 110 IAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NMWDGVTTKTFC--G 163

Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG 270
              YIAPE+ +  +       D ++FG+++ E++ 
Sbjct: 164 TPDYIAPEIIA--YQPYGKSVDWWAFGVLLYEMLA 196

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 8/94 (8%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           +A G+E+L    S   +H D+   N+L+ E    KI DFGLA+        +S   G+  
Sbjct: 248 VANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISK--GSTF 302

Query: 236 I-IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           + + ++APE    N    +  SDV+SFG+++ E+
Sbjct: 303 LPLKWMAPESIFNNL--YTTLSDVWSFGILLWEI 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 42.2 bits (99), Expect = 4e-04
 Identities = 22/57 (38%), Positives = 36/57 (63%), Gaps = 5/57 (8%)

Query: 176 IAKGLEYLH-HGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLL 231
           +A  L+YLH HG    I+H D+KP N+L+  +   K++DFGL+K+   +E  +  +L
Sbjct: 113 VALALDYLHRHG----IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDIL 165

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 41.6 bits (97), Expect = 4e-04
 Identities = 41/153 (26%), Positives = 70/153 (45%), Gaps = 15/153 (9%)

Query: 130 CLEGNNRA-LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
           C +  +R  L+ E++  G L  F        P ++ R+   Y   I IA  L +LH    
Sbjct: 64  CFQTTSRLFLVIEYVNGGDL-MFHMQRQRKLPEEHARF---YAAEICIA--LNFLHE--- 114

Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRN 248
             I++ D+K  N+LLD D   K++D+G+ K         S+  G      YIAPE+    
Sbjct: 115 RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTP---NYIAPEILRGE 171

Query: 249 FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDS 281
             E     D ++ G+++ E++  ++  D   D+
Sbjct: 172 --EYGFSVDWWALGVLMFEMMAGRSPFDIITDN 202

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 41.4 bits (98), Expect = 4e-04
 Identities = 32/98 (32%), Positives = 45/98 (45%), Gaps = 23/98 (23%)

Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT------TKEGIVSSLLG 232
           G+ +LH      ILH D+K  N+LL+     KI DFGLA+         T+  +V +L  
Sbjct: 118 GVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQ--LVVTLW- 171

Query: 233 ARGIIGYIAPEVFSRNFGE--VSHKSDVYSFGMMIMEL 268
                 Y APE+     G    S   D++S G +  EL
Sbjct: 172 ------YRAPELL---LGAKEYSTAIDMWSVGCIFAEL 200

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 41.5 bits (97), Expect = 5e-04
 Identities = 36/147 (24%), Positives = 66/147 (44%), Gaps = 30/147 (20%)

Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH-HGC 187
           F   G+  +L+  + P G  E  + N                 I+ G  +GL YLH +G 
Sbjct: 80  FMAYGSANSLLKTYFPEGMSEALIGN-----------------ILFGALRGLNYLHQNGY 122

Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKL-CTTKEGIVSSLLG-----ARGIIGYIA 241
               +H +IK  +IL+  D    +S  GL+ L    + G  + ++      +  ++ +++
Sbjct: 123 ----IHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLS 176

Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           PE+  ++    + KSD+YS G+   EL
Sbjct: 177 PELLRQDLYGYNVKSDIYSVGITACEL 203

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 40.9 bits (96), Expect = 6e-04
 Identities = 29/106 (27%), Positives = 47/106 (44%), Gaps = 18/106 (16%)

Query: 119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYN----GDTSKPCQYLRWEKMYEIVI 174
            H N++ L+   +EG+   L+ + M    L+K V       ++   C          I++
Sbjct: 78  KHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKC----------ILL 126

Query: 175 GIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
            I  GL  LH       +H D+ P NI ++     KI+DFGLA+  
Sbjct: 127 QILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRY 169

Length = 335

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 40.4 bits (95), Expect = 0.001
 Identities = 28/89 (31%), Positives = 39/89 (43%), Gaps = 14/89 (15%)

Query: 134 NNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG-IAKGLEYLHHGCSTKIL 192
           N   LI E++P G +   +   DT         E+     I      ++ +H       +
Sbjct: 74  NYLYLIMEYLPGGDMMTLLMKKDTFT-------EEETRFYIAETILAIDSIH---KLGYI 123

Query: 193 HFDIKPHNILLDEDFCPKISDFGLAKLCT 221
           H DIKP N+LLD     K+SDFG   LCT
Sbjct: 124 HRDIKPDNLLLDAKGHIKLSDFG---LCT 149

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 39.8 bits (93), Expect = 0.001
 Identities = 44/145 (30%), Positives = 68/145 (46%), Gaps = 24/145 (16%)

Query: 134 NNRALIYEFMPNGSLEKFV--YNG--DTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCST 189
           +N  L+ E+ P G L   +  Y    D      YL      E+V+ I       H     
Sbjct: 74  DNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLA-----ELVLAI-------HSVHQM 121

Query: 190 KILHFDIKPHNILLDEDFCPKISDFG-LAKLCTTKEGIVSSLLGARGIIGYIAPEVFS-- 246
             +H DIKP N+L+D     K++DFG  A+L  T   +V+S L   G   YIAPEV +  
Sbjct: 122 GYVHRDIKPENVLIDRTGHIKLADFGSAARL--TANKMVNSKLPV-GTPDYIAPEVLTTM 178

Query: 247 RNFGEVSH--KSDVYSFGMMIMELV 269
              G+ ++  + D +S G++  E++
Sbjct: 179 NGDGKGTYGVECDWWSLGVIAYEMI 203

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 39.6 bits (92), Expect = 0.001
 Identities = 28/101 (27%), Positives = 53/101 (52%), Gaps = 8/101 (7%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           I+ GL +LH      I++ D+K  N++LD +   KI+DFG+ K     +G+ +      G
Sbjct: 110 ISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-HMVDGVTTRTFC--G 163

Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLD 276
              YIAPE+ +  +       D +++G+++ E++  +   D
Sbjct: 164 TPDYIAPEIIA--YQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 31/89 (34%), Positives = 43/89 (48%), Gaps = 16/89 (17%)

Query: 135 NRALIYEFMPNGSLEKFVYNGDT--SKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKIL 192
           N  LI EF+P G +   +   DT   +  Q+     + E V+ I    + +H       +
Sbjct: 75  NLYLIMEFLPGGDMMTLLMKKDTLSEEATQFY----IAETVLAI----DAIHQ---LGFI 123

Query: 193 HFDIKPHNILLDEDFCPKISDFGLAKLCT 221
           H DIKP N+LLD     K+SDFG   LCT
Sbjct: 124 HRDIKPDNLLLDAKGHVKLSDFG---LCT 149

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 29/87 (33%), Positives = 40/87 (45%), Gaps = 12/87 (13%)

Query: 135 NRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHF 194
           N  LI EF+P G +   +   DT      L  E+    +      ++ +H       +H 
Sbjct: 75  NLYLIMEFLPGGDMMTLLMKKDT------LTEEETQFYIAETVLAIDSIHQ---LGFIHR 125

Query: 195 DIKPHNILLDEDFCPKISDFGLAKLCT 221
           DIKP N+LLD     K+SDFG   LCT
Sbjct: 126 DIKPDNLLLDSKGHVKLSDFG---LCT 149

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 39.7 bits (92), Expect = 0.002
 Identities = 35/150 (23%), Positives = 69/150 (46%), Gaps = 20/150 (13%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           I+  L YLH      I++ D+K  N+LLD +   K++D+G+ K         S+  G   
Sbjct: 105 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP- 160

Query: 236 IIGYIAPEVF-SRNFGEVSHKSDVYSFGMMIMELVGCKNNLD-----SGVDSSSEVYFPH 289
              YIAPE+    ++G      D ++ G+++ E++  ++  D        D ++E Y   
Sbjct: 161 --NYIAPEILRGEDYG---FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ 215

Query: 290 WIYRHVEQDREFKLPGVVTRKENEIAKKMI 319
            I      +++ ++P  ++ K   + K  +
Sbjct: 216 VIL-----EKQIRIPRSLSVKAASVLKSFL 240

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 39.5 bits (92), Expect = 0.002
 Identities = 49/168 (29%), Positives = 77/168 (45%), Gaps = 30/168 (17%)

Query: 109 VNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEK 168
           V+E   + R SH  V+ LL   + G    L+   +P    + + Y G   +P    +   
Sbjct: 208 VHEARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQ--- 261

Query: 169 MYEIVIGIAKGL----EYLHHGCSTKILHFDIKPHNILLD--EDFCPKISDFGLAKLCTT 222
               V  +A+ L    +Y+H      I+H DIK  N+L++  ED C  + DFG A  C  
Sbjct: 262 ----VTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDIC--LGDFGAA--CFA 310

Query: 223 KEGIVSSLL--GARGIIGYIAPEVFSRNFGEVSHKS-DVYSFGMMIME 267
           + G  S+    G  G +   APEV +   G+    S D++S G++I E
Sbjct: 311 R-GSWSTPFHYGIAGTVDTNAPEVLA---GDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 39.4 bits (92), Expect = 0.002
 Identities = 26/74 (35%), Positives = 42/74 (56%), Gaps = 9/74 (12%)

Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSL 230
           E+V+ I   +  L +      +H DIKP N+LLD++   +++DFG + L    +G V S 
Sbjct: 110 EMVLAI-DSVHQLGY------VHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSN 161

Query: 231 LGARGIIGYIAPEV 244
           + A G   YI+PE+
Sbjct: 162 V-AVGTPDYISPEI 174

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 38.6 bits (90), Expect = 0.003
 Identities = 19/42 (45%), Positives = 25/42 (59%), Gaps = 6/42 (14%)

Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT 221
           +E +H       +H DIKP NIL+D D   K++DFG   LCT
Sbjct: 114 IESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFG---LCT 149

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 38.7 bits (90), Expect = 0.004
 Identities = 43/170 (25%), Positives = 80/170 (47%), Gaps = 21/170 (12%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           +A+G+++L    S   +H D+   N+LL +    KI DFGLA+        V     AR 
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK-GNARL 276

Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV 295
            + ++APE        V  +SDV+S+G+++ E+     +   G+  +S+ Y    + R  
Sbjct: 277 PVKWMAPESIFDCVYTV--QSDVWSYGILLWEIFSLGKSPYPGILVNSKFY--KMVKRGY 332

Query: 296 EQDR-EFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
           +  R +F  P + +     I K        C    P++RP  +++ +++Q
Sbjct: 333 QMSRPDFAPPEIYS-----IMKM-------CWNLEPTERPTFSQISQLIQ 370

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 38.4 bits (89), Expect = 0.004
 Identities = 28/91 (30%), Positives = 46/91 (50%), Gaps = 10/91 (10%)

Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
           LE LH      +++ D+KP NILLD      + DFGL KL    +   ++  G      Y
Sbjct: 106 LENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTP---EY 159

Query: 240 IAPEVFSRNFGEVSHKS-DVYSFGMMIMELV 269
           +APE+     G    K+ D ++ G+++ E++
Sbjct: 160 LAPELLL---GHGYTKAVDWWTLGVLLYEML 187

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	372
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
PTZ00284	467	protein kinase; Provisional	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.98
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.98
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.98
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.95
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.94
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.94
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.91
PRK09188	365	serine/threonine protein kinase; Provisional	99.89
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.88
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.88
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.88
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.88
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.87
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.86
PRK12274	218	serine/threonine protein kinase; Provisional	99.83
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.82
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.81
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.81
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.8
PRK10345	210	hypothetical protein; Provisional	99.79
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.78
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.77
PRK14879	211	serine/threonine protein kinase; Provisional	99.74
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.73
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.73
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.71
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.7
smart00090	237	RIO RIO-like kinase.	99.67
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.64
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.64
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.59
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.59
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.56
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.51
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.5
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.41
KOG1243	690	consensus Protein kinase [General function predict	99.4
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.31
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.24
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.16
KOG3087	229	consensus Serine/threonine protein kinase [General	99.14
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.08
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.05
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.02
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.0
COG4248	637	Uncharacterized protein with protein kinase and he	98.91
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.9
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.89
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.86
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.72
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.7
PRK09902	216	hypothetical protein; Provisional	98.68
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.65
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.63
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.43
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.3
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.27
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.08
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.03
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.03
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.92
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.89
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.79
PLN02876	822	acyl-CoA dehydrogenase	97.76
PF01636	239	APH: Phosphotransferase enzyme family This family	97.63
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.57
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.52
PRK10593	297	hypothetical protein; Provisional	97.52
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.39
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.19
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.13
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	96.8
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.74
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	96.63
PRK09550	401	mtnK methylthioribose kinase; Reviewed	96.58
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.41
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.21
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.05
PLN02236	344	choline kinase	95.94
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.72
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	95.44
PLN02756	418	S-methyl-5-thioribose kinase	94.94
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	94.76
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	94.64
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	94.33
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	93.93
PRK05231	319	homoserine kinase; Provisional	93.44
PTZ00384	383	choline kinase; Provisional	93.23
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	93.11
KOG1236	565	consensus Predicted unusual protein kinase [Genera	92.85
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	92.63
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	92.58
PRK10271	188	thiK thiamine kinase; Provisional	92.52
COG2334	331	Putative homoserine kinase type II (protein kinase	92.35
KOG2270	520	consensus Serine/threonine protein kinase involved	92.16
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	91.93
PHA03111	444	Ser/Thr kinase; Provisional	91.6
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	90.56
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	90.37
PF14575	75	EphA2_TM: Ephrin type-A receptor 2 transmembrane d	90.26

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-53  Score=395.15  Aligned_cols=267  Identities=43%  Similarity=0.801  Sum_probs=224.0

Q ss_pred             CCccccHHHHHHHHhhhh--hhcCCCCceEEEEEEecc------------------hHHHHHHHHhccCCCceeeeEeEE
Q 036435           71 PLKRYNFSDVKKLTNSFK--DKLGQGGFGGVYKGRLLD------------------DFVNEVASISRTSHVNVVTLLGFC  130 (372)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~--~~lg~G~~g~V~~~~~~~------------------~~~~E~~~l~~l~h~nIv~l~g~~  130 (372)
                      ....|++.++..+|++|.  ..||+|+||.||+|.+.+                  +|.+|+.++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            467899999999999998  589999999999996632                  599999999999999999999999


Q ss_pred             ecCC-ceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCce
Q 036435          131 LEGN-NRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP  209 (372)
Q Consensus       131 ~~~~-~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~  209 (372)
                      .+.+ +.+||||||++|+|.++|+.....    .++|.+|++|+.++|.||+|||+.+.++|+||||||+|||||+++++
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~----~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a  216 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE----PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA  216 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC----CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence            9999 499999999999999999886543    48999999999999999999999888899999999999999999999


Q ss_pred             EEeecCCcccccC-CCCeeeeeccc-ccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccch
Q 036435          210 KISDFGLAKLCTT-KEGIVSSLLGA-RGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYF  287 (372)
Q Consensus       210 kl~Dfgla~~~~~-~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~  287 (372)
                      ||+|||+|+.... ....    ... .||.+|+|||+...  +..+.|+||||||++++|++||+++.+... +.....+
T Consensus       217 KlsDFGLa~~~~~~~~~~----~~~~~gt~gY~~PEy~~~--g~lt~KsDVySFGVvllElitgr~~~d~~~-~~~~~~l  289 (361)
T KOG1187|consen  217 KLSDFGLAKLGPEGDTSV----STTVMGTFGYLAPEYAST--GKLTEKSDVYSFGVVLLELITGRKAVDQSR-PRGELSL  289 (361)
T ss_pred             EccCccCcccCCccccce----eeecCCCCccCChhhhcc--CCcCcccccccchHHHHHHHhCCcccCCCC-CcccccH
Confidence            9999999976543 2211    111 69999999999976  489999999999999999999998887654 2333447


Q ss_pred             HHHHHHHhhhcc--cccCCccC-CcchH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 036435          288 PHWIYRHVEQDR--EFKLPGVV-TRKEN-EIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE  348 (372)
Q Consensus       288 ~~~~~~~~~~~~--~~~~~~~~-~~~~~-~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~  348 (372)
                      ..|....+....  .+..|... ..... ....++..++.+|++.+|.+||+|.+|++.|+....
T Consensus       290 ~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  290 VEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             HHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            888877666642  22334433 23332 567889999999999999999999999999966553

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-49  Score=367.21  Aligned_cols=242  Identities=29%  Similarity=0.495  Sum_probs=203.8

Q ss_pred             HHHhhhhhhcCCCCceEEEEEEecc-----------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           82 KLTNSFKDKLGQGGFGGVYKGRLLD-----------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      .....+.+.||+|.||.||.|++..                 +|.+|+++|++|+|+|||+++|+|..++.++||||||+
T Consensus       205 r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~  284 (468)
T KOG0197|consen  205 REELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP  284 (468)
T ss_pred             HHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence            3334567889999999999998743                 79999999999999999999999999889999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      .|+|.+||.....    ..+...+.+.++.|||+||+||+   ++++|||||.++|||++++..+||+|||||+...+..
T Consensus       285 ~GsLl~yLr~~~~----~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~  357 (468)
T KOG0197|consen  285 KGSLLDYLRTREG----GLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE  357 (468)
T ss_pred             cCcHHHHhhhcCC----CccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence            9999999987333    23899999999999999999999   8999999999999999999999999999999544333


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                        .........+..|.|||.+..  +.++.|||||||||+|||++| |+.|+.....        ..+.+.++++.++..
T Consensus       358 --Y~~~~~~kfPIkWtAPEa~~~--~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn--------~ev~~~le~GyRlp~  425 (468)
T KOG0197|consen  358 --YTASEGGKFPIKWTAPEALNY--GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN--------EEVLELLERGYRLPR  425 (468)
T ss_pred             --eeecCCCCCCceecCHHHHhh--CCcccccceeehhhhHHHHhccCCCCCCCCCH--------HHHHHHHhccCcCCC
Confidence              222344556788999999976  499999999999999999998 5555554432        226677888877776


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~  349 (372)
                      |..+       +..+.++|..||+.+|++|||++.+...|+.....
T Consensus       426 P~~C-------P~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  426 PEGC-------PDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             CCCC-------CHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            6554       45778899999999999999999999999876643

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-48  Score=360.64  Aligned_cols=238  Identities=31%  Similarity=0.486  Sum_probs=196.5

Q ss_pred             hhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecCC-ceeEEEEecCCC
Q 036435           88 KDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEGN-NRALIYEFMPNG  146 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~-~~~lV~e~~~~g  146 (372)
                      .+.||+|+||+||+|.+..                    +|.+|+.+|.+++|||||+|+|+|.+.. .+++||||+++|
T Consensus        46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G  125 (362)
T KOG0192|consen   46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG  125 (362)
T ss_pred             hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence            4569999999999997632                    6999999999999999999999999988 799999999999


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eeecCCCCCceEECCCC-ceEEeecCCcccccCCC
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTK-ILHFDIKPHNILLDEDF-CPKISDFGLAKLCTTKE  224 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~-ivH~dlk~~Nill~~~~-~~kl~Dfgla~~~~~~~  224 (372)
                      +|.++++....    ..+++..+++++.|||+||.|||   +.+ ||||||||+|||++.++ ++||+|||+++......
T Consensus       126 sL~~~l~~~~~----~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~  198 (362)
T KOG0192|consen  126 SLSVLLHKKRK----RKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK  198 (362)
T ss_pred             cHHHHHhhccc----CCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence            99999987421    23999999999999999999999   677 99999999999999997 99999999998765432


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCC
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP  304 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (372)
                         .......||+.|||||++.+....++.|+||||||+++|||+||+.||......       .-....+..+.+...|
T Consensus       199 ---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~-------~~~~~v~~~~~Rp~~p  268 (362)
T KOG0192|consen  199 ---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV-------QVASAVVVGGLRPPIP  268 (362)
T ss_pred             ---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhcCCCCCCC
Confidence               112235699999999999842137999999999999999999999999875431       1123333344444433


Q ss_pred             ccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 036435          305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       305 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~  349 (372)
                      ..       ....+..++.+||+.||.+||++.+++..|+.+...
T Consensus       269 ~~-------~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~  306 (362)
T KOG0192|consen  269 KE-------CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH  306 (362)
T ss_pred             cc-------CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence            32       456778888899999999999999999999876643

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-48  Score=345.50  Aligned_cols=230  Identities=25%  Similarity=0.383  Sum_probs=190.1

Q ss_pred             hhhcCCCCceEEEEEEec--------------------chHHHHHHHHhccCCCceeeeEeEEecCCc-eeEEEEecCCC
Q 036435           88 KDKLGQGGFGGVYKGRLL--------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNN-RALIYEFMPNG  146 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~--------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~-~~lV~e~~~~g  146 (372)
                      .+.||+|..|+|||+++.                    +++.+|++++++.+|||||++||.|.+++. .+++||||++|
T Consensus        84 ~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgG  163 (364)
T KOG0581|consen   84 LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGG  163 (364)
T ss_pred             hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCC
Confidence            357999999999999774                    278999999999999999999999999995 99999999999


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      ||++++...+.      +++...-+++.++++||.|||+  .++||||||||+|||++..|++||||||.+......   
T Consensus       164 SLd~~~k~~g~------i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---  232 (364)
T KOG0581|consen  164 SLDDILKRVGR------IPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---  232 (364)
T ss_pred             CHHHHHhhcCC------CCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence            99999987643      8999999999999999999995  599999999999999999999999999999876543   


Q ss_pred             eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCcc
Q 036435          227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV  306 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (372)
                        ......||..|||||.+.+.  .++.++||||||+.++|+.+|+-|+........  .... +...+-.+.....|..
T Consensus       233 --~a~tfvGT~~YMsPERi~g~--~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~--~~~~-Ll~~Iv~~ppP~lP~~  305 (364)
T KOG0581|consen  233 --IANTFVGTSAYMSPERISGE--SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYL--DIFE-LLCAIVDEPPPRLPEG  305 (364)
T ss_pred             --hcccccccccccChhhhcCC--cCCcccceecccHHHHHHhhCCCCCCCcCCCCC--CHHH-HHHHHhcCCCCCCCcc
Confidence              23455799999999999986  899999999999999999999999987522111  1111 1111222222222221


Q ss_pred             CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       307 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                            .+..++.+++..||++||.+||+++|+++
T Consensus       306 ------~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  306 ------EFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             ------cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                  35667888999999999999999999986

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.7e-49  Score=333.00  Aligned_cols=241  Identities=23%  Similarity=0.410  Sum_probs=194.4

Q ss_pred             HHhhhhhhcCCCCceEEEEEEec---------------------chHHHHHHHHhccCCCceeeeEe-EEecCCc-eeEE
Q 036435           83 LTNSFKDKLGQGGFGGVYKGRLL---------------------DDFVNEVASISRTSHVNVVTLLG-FCLEGNN-RALI  139 (372)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~---------------------~~~~~E~~~l~~l~h~nIv~l~g-~~~~~~~-~~lV  139 (372)
                      ..+.+.++||+|+||.|||+...                     ++...|+.+|++|+|||||++++ .+.+++. ++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            34456688999999999999653                     26788999999999999999999 5555555 8999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCceEECCCCceEEeecCCc
Q 036435          140 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTK--ILHFDIKPHNILLDEDFCPKISDFGLA  217 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl~Dfgla  217 (372)
                      ||||.+|||...++.....  .+.+++.++++++.|++.||.++|+.. ..  |+||||||.||+||.+|.+||+||||+
T Consensus        99 mE~c~~GDLsqmIk~~K~q--kr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~  175 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQ--KRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLG  175 (375)
T ss_pred             HHhhcccCHHHHHHHHHhc--cccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhH
Confidence            9999999999998765432  245999999999999999999999421 44  999999999999999999999999999


Q ss_pred             ccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhh
Q 036435          218 KLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQ  297 (372)
Q Consensus       218 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (372)
                      +.+.+..+..   ....|||.||+||.+.++  .++.||||||+||++|||+...+||++..-        ..+..++.+
T Consensus       176 r~l~s~~tfA---~S~VGTPyYMSPE~i~~~--~Y~~kSDiWslGCllyEMcaL~~PF~g~n~--------~~L~~KI~q  242 (375)
T KOG0591|consen  176 RFLSSKTTFA---HSLVGTPYYMSPERIHES--GYNFKSDIWSLGCLLYEMCALQSPFYGDNL--------LSLCKKIEQ  242 (375)
T ss_pred             hHhcchhHHH---HhhcCCCcccCHHHHhcC--CCCcchhHHHHHHHHHHHHhcCCCcccccH--------HHHHHHHHc
Confidence            9887765443   344699999999999986  999999999999999999999999987521        113444544


Q ss_pred             cccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 036435          298 DREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG  345 (372)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~  345 (372)
                      +.-...|      ....+.++..++..|+..||+.||+...+++.++.
T Consensus       243 gd~~~~p------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  243 GDYPPLP------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             CCCCCCc------HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence            4222222      24567788889999999999999986555555443

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4.3e-48  Score=373.48  Aligned_cols=250  Identities=27%  Similarity=0.471  Sum_probs=207.5

Q ss_pred             HHHHHHhhhhhhcCCCCceEEEEEEec-------------------------chHHHHHHHHhccCCCceeeeEeEEecC
Q 036435           79 DVKKLTNSFKDKLGQGGFGGVYKGRLL-------------------------DDFVNEVASISRTSHVNVVTLLGFCLEG  133 (372)
Q Consensus        79 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~  133 (372)
                      ++......+.++||+|+||+||+|+..                         .+|.+|+++++.++|||||+|+|+|.++
T Consensus       482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~  561 (774)
T KOG1026|consen  482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG  561 (774)
T ss_pred             EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence            344444566788999999999998652                         2799999999999999999999999999


Q ss_pred             CceeEEEEecCCCChhhhhhcCCCCC----C----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC
Q 036435          134 NNRALIYEFMPNGSLEKFVYNGDTSK----P----CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE  205 (372)
Q Consensus       134 ~~~~lV~e~~~~g~L~~~l~~~~~~~----~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~  205 (372)
                      +.+++|+|||.+|||.+||....+..    .    ...++..+.+.||.|||.||.||.   +..+|||||..+|+|+.+
T Consensus       562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge  638 (774)
T KOG1026|consen  562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGE  638 (774)
T ss_pred             CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceecc
Confidence            99999999999999999997654311    1    223899999999999999999999   899999999999999999


Q ss_pred             CCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCc
Q 036435          206 DFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSE  284 (372)
Q Consensus       206 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~  284 (372)
                      +..|||+||||++...+.+.+... ....-+++|||||.+..  +++|.+||||||||+|||+++ |+.|++.....   
T Consensus       639 ~l~VKIsDfGLsRdiYssDYYk~~-~~t~lPIRWMppEsIly--~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~---  712 (774)
T KOG1026|consen  639 NLVVKISDFGLSRDIYSSDYYKVR-GNTLLPIRWMPPESILY--GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ---  712 (774)
T ss_pred             ceEEEecccccchhhhhhhhhccc-CCceeeeecCCHHHhhc--CcccchhhhhhhhhhhhhhhccccCcccccchH---
Confidence            999999999999988776655442 23345678999999975  599999999999999999996 77777765432   


Q ss_pred             cchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 036435          285 VYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~  349 (372)
                           .+.+.+.++..+.-|       .+.+.++.+||..||+.+|++||+++||-.+|+.....
T Consensus       713 -----EVIe~i~~g~lL~~P-------e~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  713 -----EVIECIRAGQLLSCP-------ENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             -----HHHHHHHcCCcccCC-------CCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence                 245555555444433       44567899999999999999999999999999987654

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.9e-47  Score=339.35  Aligned_cols=232  Identities=27%  Similarity=0.388  Sum_probs=190.6

Q ss_pred             hhhhhcCCCCceEEEEEEecc--------------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD--------------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALI  139 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~--------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV  139 (372)
                      .+.+.||+|+||.|-+|....                          .+.+|+++|++|+|||||++++++...+..|+|
T Consensus       175 ii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmV  254 (475)
T KOG0615|consen  175 IISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMV  254 (475)
T ss_pred             EeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEE
Confidence            345789999999999885422                          357999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC---CceEEeecCC
Q 036435          140 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDED---FCPKISDFGL  216 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfgl  216 (372)
                      +||++||+|.+++-.+..      +.+..-..++.|++.|+.|||   +.||+||||||+|||++.+   ..+||+|||+
T Consensus       255 lE~v~GGeLfd~vv~nk~------l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  255 LEYVEGGELFDKVVANKY------LREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             EEEecCccHHHHHHhccc------cccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccch
Confidence            999999999999987654      677777889999999999999   8999999999999999755   7899999999


Q ss_pred             cccccCCCCeeeeecccccccccccccccccccCCC-CccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHh
Q 036435          217 AKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEV-SHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV  295 (372)
Q Consensus       217 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  295 (372)
                      |+......    -....+||+.|.|||++.+..... ..+.|+||+||+||-+++|.+||.+......       +.+.+
T Consensus       326 AK~~g~~s----fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-------l~eQI  394 (475)
T KOG0615|consen  326 AKVSGEGS----FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-------LKEQI  394 (475)
T ss_pred             hhccccce----ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-------HHHHH
Confidence            99876322    234567999999999998652233 3588999999999999999999986543221       23444


Q ss_pred             hhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          296 EQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ..++-...    +....++.++..+++.++|..||++|||++|+++
T Consensus       395 ~~G~y~f~----p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  395 LKGRYAFG----PLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             hcCccccc----ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            44433222    2345667888999999999999999999999985

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-46  Score=349.39  Aligned_cols=228  Identities=28%  Similarity=0.450  Sum_probs=192.2

Q ss_pred             HhhhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEE
Q 036435           84 TNSFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYE  141 (372)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  141 (372)
                      ++...+.||+|+|+.||+++..+                      .+.+|+++.++|+|||||+++++|++.++.|||.|
T Consensus        19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLE   98 (592)
T KOG0575|consen   19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLE   98 (592)
T ss_pred             eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEE
Confidence            34446789999999999997732                      68899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      +|.+++|..+++.+..      +++.++..++.||+.||.|||   +.+|+|||||..|+||+++.++||+|||||....
T Consensus        99 LC~~~sL~el~Krrk~------ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le  169 (592)
T KOG0575|consen   99 LCHRGSLMELLKRRKP------LTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE  169 (592)
T ss_pred             ecCCccHHHHHHhcCC------CCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeec
Confidence            9999999999985443      999999999999999999999   8999999999999999999999999999999877


Q ss_pred             CCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccc
Q 036435          222 TKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF  301 (372)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (372)
                      ......   ...+|||.|.|||++.+.  ..+..+||||+||++|-|+.|++||+...-        ...+..+... .+
T Consensus       170 ~~~Erk---~TlCGTPNYIAPEVl~k~--gHsfEvDiWSlGcvmYtLL~G~PPFetk~v--------kety~~Ik~~-~Y  235 (592)
T KOG0575|consen  170 YDGERK---KTLCGTPNYIAPEVLNKS--GHSFEVDIWSLGCVMYTLLVGRPPFETKTV--------KETYNKIKLN-EY  235 (592)
T ss_pred             Cccccc---ceecCCCcccChhHhccC--CCCCchhhhhhhhHHHhhhhCCCCcccchH--------HHHHHHHHhc-Cc
Confidence            554333   345799999999999875  789999999999999999999999986421        1133433332 33


Q ss_pred             cCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       302 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ..|..       +.....+|+..+|++||.+|||+++|+.
T Consensus       236 ~~P~~-------ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  236 SMPSH-------LSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             ccccc-------cCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            44443       3344556777788999999999999996

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-46  Score=332.67  Aligned_cols=177  Identities=28%  Similarity=0.466  Sum_probs=159.5

Q ss_pred             hhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           87 FKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      +.++||+|+||+||+|++.+                     ....|+.+|+.++|||||++++++..++..|||||||.|
T Consensus        14 ~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~g   93 (429)
T KOG0595|consen   14 LSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNG   93 (429)
T ss_pred             ehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCC
Confidence            45679999999999998754                     367899999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC------CceEEeecCCccc
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDED------FCPKISDFGLAKL  219 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~------~~~kl~Dfgla~~  219 (372)
                      |||.+|+++.+.      +++.++..++.|+|.||++||   +++||||||||.||||+.+      -.+||+|||+|+.
T Consensus        94 GDLs~yi~~~~~------l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   94 GDLSDYIRRRGR------LPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             CCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            999999988763      899999999999999999999   8999999999999999764      4689999999998


Q ss_pred             ccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCC
Q 036435          220 CTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSG  278 (372)
Q Consensus       220 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~  278 (372)
                      ...+..    ....+|++-|||||++...  +|+.|+|+||+|+++|++++|+.||+..
T Consensus       165 L~~~~~----a~tlcGSplYMAPEV~~~~--~YdAKADLWSiG~Ilyq~l~g~~Pf~a~  217 (429)
T KOG0595|consen  165 LQPGSM----AETLCGSPLYMAPEVIMSQ--QYDAKADLWSIGTILYQCLTGKPPFDAE  217 (429)
T ss_pred             CCchhH----HHHhhCCccccCHHHHHhc--cccchhhHHHHHHHHHHHHhCCCCcccc
Confidence            875432    3456799999999999764  9999999999999999999999999854

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-46  Score=355.31  Aligned_cols=253  Identities=25%  Similarity=0.459  Sum_probs=214.7

Q ss_pred             CccccHHHHHHHHhhhh-----------hhcCCCCceEEEEEEecc-----------------------hHHHHHHHHhc
Q 036435           72 LKRYNFSDVKKLTNSFK-----------DKLGQGGFGGVYKGRLLD-----------------------DFVNEVASISR  117 (372)
Q Consensus        72 ~~~~~~~~~~~~~~~~~-----------~~lg~G~~g~V~~~~~~~-----------------------~~~~E~~~l~~  117 (372)
                      ...++|+|..++...|.           +.||.|.||.|++|++..                       +|+.|+.+|.+
T Consensus       607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQ  686 (996)
T KOG0196|consen  607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQ  686 (996)
T ss_pred             cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhccc
Confidence            34678888777776663           458999999999997742                       79999999999


Q ss_pred             cCCCceeeeEeEEecCCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC
Q 036435          118 TSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIK  197 (372)
Q Consensus       118 l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk  197 (372)
                      ++||||++|.|+........+|+|||+||+|+.||.+++.+     |++.+...++++||.||+||.   +.++|||||.
T Consensus       687 FdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGq-----ftviQLVgMLrGIAsGMkYLs---dm~YVHRDLA  758 (996)
T KOG0196|consen  687 FDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQ-----FTVIQLVGMLRGIASGMKYLS---DMNYVHRDLA  758 (996)
T ss_pred             CCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCc-----eEeehHHHHHHHHHHHhHHHh---hcCchhhhhh
Confidence            99999999999999999999999999999999999988753     999999999999999999999   8999999999


Q ss_pred             CCceEECCCCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHh-cCCCCCC
Q 036435          198 PHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV-GCKNNLD  276 (372)
Q Consensus       198 ~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell-tg~~p~~  276 (372)
                      ++|||++.+...|++||||++...+............-+.+|.|||.+..  .+++.++||||||+++||.+ .|.+||.
T Consensus       759 ARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~--RKFTsASDVWSyGIVmWEVmSyGERPYW  836 (996)
T KOG0196|consen  759 ARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYW  836 (996)
T ss_pred             hhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhh--cccCchhhccccceEEEEecccCCCccc
Confidence            99999999999999999999977655433222333334578999999976  49999999999999999977 4889887


Q ss_pred             CCCCCCCccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 036435          277 SGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~  349 (372)
                      +..+.+        +.+.++++.++..|       .+++..+.+||+.||++|..+||.+.+++..|+++...
T Consensus       837 dmSNQd--------VIkaIe~gyRLPpP-------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  837 DMSNQD--------VIKAIEQGYRLPPP-------MDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             ccchHH--------HHHHHHhccCCCCC-------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence            764422        56667766665444       44567899999999999999999999999999888744

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-44  Score=359.09  Aligned_cols=247  Identities=29%  Similarity=0.493  Sum_probs=200.7

Q ss_pred             HHHhhhhhhcCCCCceEEEEEEecc-------------------------hHHHHHHHHhccCCCceeeeEeEEecCCce
Q 036435           82 KLTNSFKDKLGQGGFGGVYKGRLLD-------------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNR  136 (372)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~-------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~  136 (372)
                      .....+.+.||+|.||.||+|...+                         +|++|..+|++++|||||+++|+|.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            3344456789999999999997643                         799999999999999999999999999999


Q ss_pred             eEEEEecCCCChhhhhhcCCCCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecC
Q 036435          137 ALIYEFMPNGSLEKFVYNGDTSK-PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFG  215 (372)
Q Consensus       137 ~lV~e~~~~g~L~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  215 (372)
                      ++++|||++|||..||.+..... ....++..+.+.++.|||+|+.||+   ++++|||||.++|+||++...+||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccc
Confidence            99999999999999998863211 1234899999999999999999999   8999999999999999999999999999


Q ss_pred             CcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCC-CCCCCCCCCCCccchHHHHHHH
Q 036435          216 LAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK-NNLDSGVDSSSEVYFPHWIYRH  294 (372)
Q Consensus       216 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~  294 (372)
                      +|+.+...+.+... ....-...|||||.+..  +.++.|+|||||||++||++|.. .||.+....+        +...
T Consensus       848 lArDiy~~~yyr~~-~~a~lPvkWm~PEsl~d--~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~--------v~~~  916 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKH-GEAMLPVKWMPPESLKD--GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE--------VLLD  916 (1025)
T ss_pred             hhHhhhhchheecc-CccccceecCCHHHHhh--cccccccchhhhHHHHHHHHhCCCCCCCCcchHH--------HHHH
Confidence            99976655544332 22345678999999986  49999999999999999999855 5554432211        3333


Q ss_pred             hhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 036435          295 VEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~  349 (372)
                      +..+.++..|..       ++..+.++|..||+.+|++||++..+++++..+...
T Consensus       917 ~~~ggRL~~P~~-------CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~  964 (1025)
T KOG1095|consen  917 VLEGGRLDPPSY-------CPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA  964 (1025)
T ss_pred             HHhCCccCCCCC-------CChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence            444445555543       446778899999999999999999999988776644

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-44  Score=318.08  Aligned_cols=220  Identities=24%  Similarity=0.323  Sum_probs=183.1

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      .+.+.||+|+||.||.++..+                      ...+|..+|.+++||.||+++-.|++++.+|+|+||+
T Consensus        28 ~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~  107 (357)
T KOG0598|consen   28 EILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYL  107 (357)
T ss_pred             eeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEecc
Confidence            345789999999999987643                      5788999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      .||.|..+|.+.+.      +++..+.-++.+|+.||.|||   +.+||||||||+|||||++|.++|+||||++.....
T Consensus       108 ~GGeLf~hL~~eg~------F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~  178 (357)
T KOG0598|consen  108 NGGELFYHLQREGR------FSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD  178 (357)
T ss_pred             CCccHHHHHHhcCC------cchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence            99999999987653      899999999999999999999   899999999999999999999999999999865443


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                      ...   ....+||+.|||||++.+.  .++..+|.||+|+++|||++|.+||.......        ..+.+........
T Consensus       179 ~~~---t~tfcGT~eYmAPEil~~~--gy~~~vDWWsLGillYeML~G~pPF~~~~~~~--------~~~~I~~~k~~~~  245 (357)
T KOG0598|consen  179 GDA---TRTFCGTPEYMAPEILLGK--GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK--------MYDKILKGKLPLP  245 (357)
T ss_pred             CCc---cccccCCccccChHHHhcC--CCCcccchHhHHHHHHHHhhCCCCCcCccHHH--------HHHHHhcCcCCCC
Confidence            322   2346799999999999986  89999999999999999999999998653221        3344444332333


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCC
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRP  334 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP  334 (372)
                      |...+       ....+++.+.|++||++|.
T Consensus       246 p~~ls-------~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  246 PGYLS-------EEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             CccCC-------HHHHHHHHHHhccCHHHhc
Confidence            33233       4455666778899999996

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-44  Score=321.26  Aligned_cols=236  Identities=30%  Similarity=0.424  Sum_probs=186.5

Q ss_pred             hhhhhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEecCC--ceeEEEEecC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLEGN--NRALIYEFMP  144 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~--~~~lV~e~~~  144 (372)
                      ...+.||+|+||.||++...+                   .+.+|+.+|++++|||||+++|......  .++++|||++
T Consensus        20 ~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~   99 (313)
T KOG0198|consen   20 SKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAP   99 (313)
T ss_pred             hhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccC
Confidence            345779999999999997742                   2689999999999999999999754444  6899999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC-CCceEEeecCCcccccCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE-DFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgla~~~~~~  223 (372)
                      +|+|.+++.+.+. +    +++..+..+.+|+++||+|||   +++++|+||||+|||++. ++.+||+|||+++.....
T Consensus       100 ~GsL~~~~~~~g~-~----l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen  100 GGSLSDLIKRYGG-K----LPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             CCcHHHHHHHcCC-C----CCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            9999999988764 2    999999999999999999999   899999999999999999 799999999999876642


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                      ...........||+.|||||++... .....++||||+||++.||+||+.||....      ....+........   ..
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g-~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~------~~~~~~~~ig~~~---~~  241 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNG-EVARRESDIWSLGCTVVEMLTGKPPWSEFF------EEAEALLLIGRED---SL  241 (313)
T ss_pred             cccccccccccCCccccCchhhcCC-CcCCccchhhhcCCEEEeccCCCCcchhhc------chHHHHHHHhccC---CC
Confidence            2222223456799999999999841 133469999999999999999999998631      1112222222222   22


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEML  343 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L  343 (372)
                      |    ..+..++....+++..|+..||++|||++++++..
T Consensus       242 P----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  242 P----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             C----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence            2    12222456667788889999999999999999754

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-42  Score=317.77  Aligned_cols=231  Identities=23%  Similarity=0.365  Sum_probs=190.8

Q ss_pred             hhhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhcc-CCCceeeeEeEEecCCceeEEEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYE  141 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e  141 (372)
                      +.|.+.||.|+|++|++++..+                      -+.+|-..|.+| .||.|++|+..|.++..+|+|+|
T Consensus        75 F~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe  154 (604)
T KOG0592|consen   75 FKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLE  154 (604)
T ss_pred             cchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEE
Confidence            4567899999999999997643                      366788999999 89999999999999999999999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      |+++|+|.+++++.+.      |++....-++.||+.||+|||   +.|||||||||+|||||.++++||+|||.|+.+.
T Consensus       155 ~A~nGdll~~i~K~Gs------fde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~  225 (604)
T KOG0592|consen  155 YAPNGDLLDLIKKYGS------FDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKILS  225 (604)
T ss_pred             ecCCCcHHHHHHHhCc------chHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence            9999999999988764      899999999999999999999   8999999999999999999999999999999775


Q ss_pred             CCCCe----------eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHH
Q 036435          222 TKEGI----------VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWI  291 (372)
Q Consensus       222 ~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  291 (372)
                      .....          ........||..|.+||++...  ..+..+|+|+|||++|+|+.|.+||....+--        +
T Consensus       226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~--~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl--------i  295 (604)
T KOG0592|consen  226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS--PAGPSSDLWALGCILYQMLAGQPPFRAANEYL--------I  295 (604)
T ss_pred             hhhccccCccCcccccCcccceeeeecccCHHHhcCC--CCCcccchHHHHHHHHHHhcCCCCCccccHHH--------H
Confidence            43221          1111346799999999999875  88999999999999999999999998754311        2


Q ss_pred             HHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          292 YRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                      .+.+.. ..+..|...+       +.+.+|+.+.|..||.+|++.+++-+.
T Consensus       296 FqkI~~-l~y~fp~~fp-------~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  296 FQKIQA-LDYEFPEGFP-------EDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             HHHHHH-hcccCCCCCC-------HHHHHHHHHHHccCccccccHHHHhhC
Confidence            233222 2334444333       455567777889999999999998864

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-43  Score=329.27  Aligned_cols=240  Identities=30%  Similarity=0.502  Sum_probs=191.7

Q ss_pred             hhhhcCCCCceEEEEEEecc------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCCh
Q 036435           87 FKDKLGQGGFGGVYKGRLLD------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL  148 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L  148 (372)
                      +.+.||+|.||+||+|++-.                  .|.+|+..+++-+|.||+=|.|+|..... .+|+.+|+|.+|
T Consensus       396 l~~rIGsGsFGtV~Rg~whGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSL  474 (678)
T KOG0193|consen  396 LGERIGSGSFGTVYRGRWHGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSL  474 (678)
T ss_pred             ccceeccccccceeecccccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchh
Confidence            35679999999999998732                  69999999999999999999999998877 999999999999


Q ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeee
Q 036435          149 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVS  228 (372)
Q Consensus       149 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  228 (372)
                      ..+++.....     |...+.++|++||++||.|||   .++|||||||..||||.+++.|||+||||+........ ..
T Consensus       475 Y~hlHv~etk-----fdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g-~~  545 (678)
T KOG0193|consen  475 YTHLHVQETK-----FDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG-EQ  545 (678)
T ss_pred             hhhccchhhh-----hhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeeeeeecc-cc
Confidence            9999886632     899999999999999999999   89999999999999999999999999999975443311 11


Q ss_pred             eecccccccccccccccccc-cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccC
Q 036435          229 SLLGARGIIGYIAPEVFSRN-FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVV  307 (372)
Q Consensus       229 ~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (372)
                      ......|...|||||++... ...++..+||||||+++|||++|..||.. ...+ .+.        ...++.+..+.. 
T Consensus       546 q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~d-qIi--------fmVGrG~l~pd~-  614 (678)
T KOG0193|consen  546 QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRD-QII--------FMVGRGYLMPDL-  614 (678)
T ss_pred             ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChh-heE--------EEecccccCccc-
Confidence            12334477889999998642 34789999999999999999999999983 2221 110        011122111111 


Q ss_pred             CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          308 TRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       308 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                      .....+..++|.+|+..||..++++||.+.+|+..|+.+.
T Consensus       615 s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~  654 (678)
T KOG0193|consen  615 SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL  654 (678)
T ss_pred             hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence            1222345677888999999999999999999999887665

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-42  Score=312.47  Aligned_cols=243  Identities=23%  Similarity=0.350  Sum_probs=196.2

Q ss_pred             hhhhhhcCCCCceEEEEEEec--------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL--------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~--------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      |++.++||.|.-++||+|+..                    +.+.+|+..++.++||||++++..|..++.+++||.||.
T Consensus        28 YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa  107 (516)
T KOG0582|consen   28 YELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMA  107 (516)
T ss_pred             eeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhc
Confidence            455678999999999999653                    268899999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      +|++.+.++..-+..    +++..+..|++++++||.|||   .+|.||||||+.||||+.+|.+||+|||.+.......
T Consensus       108 ~GS~ldIik~~~~~G----l~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  108 GGSLLDIIKTYYPDG----LEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             CCcHHHHHHHHcccc----ccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            999999998765433    999999999999999999999   8999999999999999999999999999987665544


Q ss_pred             Ceeeee-cccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcc-ccc
Q 036435          225 GIVSSL-LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDR-EFK  302 (372)
Q Consensus       225 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  302 (372)
                      ...... ....||+.|||||++..+...|+.|+||||||+...||.+|..||.......       .+...+.... .+.
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk-------vLl~tLqn~pp~~~  253 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK-------VLLLTLQNDPPTLL  253 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH-------HHHHHhcCCCCCcc
Confidence            322222 5567999999999977666789999999999999999999999998643211       1112221111 111


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .............+.+.+++..||++||++|||++++++
T Consensus       254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            111122233345567888999999999999999999996

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.2e-43  Score=304.70  Aligned_cols=240  Identities=21%  Similarity=0.320  Sum_probs=187.7

Q ss_pred             hhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           88 KDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      ..++|+|+||+|||.+..+                     -.+||+++|++++|+|+|.++++|.....++||+|||+. 
T Consensus         7 LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-   85 (396)
T KOG0593|consen    7 LGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-   85 (396)
T ss_pred             hhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-
Confidence            3579999999999997754                     368999999999999999999999999999999999987 


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      ++.+-|.....     .++...+.+++.|+++|+.|+|   +++++||||||+|||++.++.+||||||.|+........
T Consensus        86 TvL~eLe~~p~-----G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~  157 (396)
T KOG0593|consen   86 TVLHELERYPN-----GVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN  157 (396)
T ss_pred             HHHHHHHhccC-----CCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCcch
Confidence            65556655442     2889999999999999999999   899999999999999999999999999999988743333


Q ss_pred             eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHH--------HHHhhhc
Q 036435          227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWI--------YRHVEQD  298 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~  298 (372)
                      ..   ....|.-|.|||.+.+. ..|....||||+||++.||++|.+.|.+..+-+.. +.....        .+....+
T Consensus       158 YT---DYVATRWYRaPELLvGD-tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQL-y~I~ktLG~L~prhq~iF~~N  232 (396)
T KOG0593|consen  158 YT---DYVATRWYRAPELLVGD-TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQL-YLIRKTLGNLIPRHQSIFSSN  232 (396)
T ss_pred             hh---hhhhhhhccChhhhccc-CcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHH-HHHHHHHcccCHHHHHHhccC
Confidence            22   23456779999999985 48999999999999999999999999876554321 111111        1111111


Q ss_pred             c---cccCCccC-----CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          299 R---EFKLPGVV-----TRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       299 ~---~~~~~~~~-----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .   ...+|...     .........-+++++..||+.||.+|++.++++.
T Consensus       233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            1   11222222     1222334557889999999999999999999884

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-43  Score=330.71  Aligned_cols=239  Identities=28%  Similarity=0.449  Sum_probs=194.3

Q ss_pred             hhhhhhcCCCCceEEEEEEecc--------------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD--------------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRAL  138 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~--------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~l  138 (372)
                      ..+.++||+|+||.||+|++..                          +|.+|++++++++|||||++||++.....+++
T Consensus       159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~i  238 (474)
T KOG0194|consen  159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLML  238 (474)
T ss_pred             ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEE
Confidence            3445789999999999997631                          68999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          139 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       139 V~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      |||+|+||+|.++|.+...     .++..+.+.++.+.|.||+|||   +.+++||||.++|+|++.++.+||+|||+++
T Consensus       239 vmEl~~gGsL~~~L~k~~~-----~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~  310 (474)
T KOG0194|consen  239 VMELCNGGSLDDYLKKNKK-----SLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSR  310 (474)
T ss_pred             EEEecCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCcccccc
Confidence            9999999999999988764     2899999999999999999999   8999999999999999999999999999988


Q ss_pred             cccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHh-h
Q 036435          219 LCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHV-E  296 (372)
Q Consensus       219 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~-~  296 (372)
                      ....   +........-+..|+|||.+...  .++.++|||||||++||+++ |..||......        .+...+ .
T Consensus       311 ~~~~---~~~~~~~~klPirWLAPEtl~~~--~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--------~v~~kI~~  377 (474)
T KOG0194|consen  311 AGSQ---YVMKKFLKKLPIRWLAPETLNTG--IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--------EVKAKIVK  377 (474)
T ss_pred             CCcc---eeeccccccCcceecChhhhccC--ccccccchhheeeeEEeeeccCCCCCCCCCHH--------HHHHHHHh
Confidence            6431   11111112345789999999864  89999999999999999998 67777654321        233333 3


Q ss_pred             hcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccCC
Q 036435          297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQ  351 (372)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~  351 (372)
                      .+.+...|.       ..+..+..++..||..+|++||+|.++.+.|+.+.....
T Consensus       378 ~~~r~~~~~-------~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  378 NGYRMPIPS-------KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             cCccCCCCC-------CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence            333333332       224556667789999999999999999999988776543

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=4e-42  Score=320.88  Aligned_cols=244  Identities=27%  Similarity=0.418  Sum_probs=187.7

Q ss_pred             hhhhhhcCCCCceEEEEEEec-------------------------chHHHHHHHHhcc-CCCceeeeEeEEecCC-cee
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL-------------------------DDFVNEVASISRT-SHVNVVTLLGFCLEGN-NRA  137 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-------------------------~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~-~~~  137 (372)
                      +.+.+.||+|+||.||+|.+.                         ..+.+|+.++.++ +||||++++++|...+ ..+
T Consensus         9 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~   88 (338)
T cd05102           9 LRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLM   88 (338)
T ss_pred             ceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceE
Confidence            445678999999999998631                         1477899999999 8999999999987654 578


Q ss_pred             EEEEecCCCChhhhhhcCCCCC--------------------------------------------------------CC
Q 036435          138 LIYEFMPNGSLEKFVYNGDTSK--------------------------------------------------------PC  161 (372)
Q Consensus       138 lV~e~~~~g~L~~~l~~~~~~~--------------------------------------------------------~~  161 (372)
                      +||||+++|+|.+++.......                                                        ..
T Consensus        89 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (338)
T cd05102          89 VIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWK  168 (338)
T ss_pred             EEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccccc
Confidence            9999999999999997532100                                                        01


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeeeeeccccccccccc
Q 036435          162 QYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA  241 (372)
Q Consensus       162 ~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~a  241 (372)
                      ..+++.+++.++.|+++||+|||   +.+++||||||+|||++.++.+||+|||+++.......... .....++..|+|
T Consensus       169 ~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~-~~~~~~~~~y~a  244 (338)
T cd05102         169 SPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR-KGSARLPLKWMA  244 (338)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhc-ccCCCCCccccC
Confidence            34888999999999999999999   79999999999999999999999999999986543322111 122345678999


Q ss_pred             ccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHH
Q 036435          242 PEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMII  320 (372)
Q Consensus       242 PE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  320 (372)
                      ||.+.+.  .++.++|||||||++|||++ |..||.......       ..............+.       .....+.+
T Consensus       245 PE~~~~~--~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-------~~~~~~~~~~~~~~~~-------~~~~~l~~  308 (338)
T cd05102         245 PESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-------EFCQRLKDGTRMRAPE-------NATPEIYR  308 (338)
T ss_pred             cHHhhcC--CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-------HHHHHHhcCCCCCCCC-------CCCHHHHH
Confidence            9998764  78999999999999999997 999987532211       1122222222222221       23456788


Q ss_pred             HHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 036435          321 VGLWCIQARPSDRPPMNEVIEMLQGSTE  348 (372)
Q Consensus       321 l~~~cl~~~p~~RPs~~evl~~L~~~~~  348 (372)
                      ++.+||+.||.+|||+.++++.|+.+..
T Consensus       309 li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         309 IMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            9999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-43  Score=315.86  Aligned_cols=245  Identities=23%  Similarity=0.362  Sum_probs=195.6

Q ss_pred             HhhhhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccC-CCceeeeEeEEecCC-ceeEEEE
Q 036435           84 TNSFKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTS-HVNVVTLLGFCLEGN-NRALIYE  141 (372)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~-h~nIv~l~g~~~~~~-~~~lV~e  141 (372)
                      .|...++||.|+||.||+|+..+                    .-+||++.|++++ ||||+++.+++.+++ .+++|||
T Consensus        11 RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE   90 (538)
T KOG0661|consen   11 RYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFE   90 (538)
T ss_pred             HHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHH
Confidence            45567899999999999997643                    2478999999999 999999999999988 9999999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      ||+. +|.+.++.++     ..|++.++..|+.||++||+|+|   .+|+.|||+||+|||+..+..+||+|||+|+.+.
T Consensus        91 ~Md~-NLYqLmK~R~-----r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   91 FMDC-NLYQLMKDRN-----RLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             hhhh-hHHHHHhhcC-----CcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccc
Confidence            9965 9999998874     34999999999999999999999   8999999999999999999999999999999887


Q ss_pred             CCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCcc---------chHHHHH
Q 036435          222 TKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV---------YFPHWIY  292 (372)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~---------~~~~~~~  292 (372)
                      +...+.    ....|.-|.|||++... +.|+.+.|+||+|||++|+.+-++.|.+..+.+.-.         ....|..
T Consensus       162 SkpPYT----eYVSTRWYRAPEvLLrs-~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e  236 (538)
T KOG0661|consen  162 SKPPYT----EYVSTRWYRAPEVLLRS-GYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE  236 (538)
T ss_pred             cCCCcc----hhhhcccccchHHhhhc-cccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence            665432    23467779999999876 689999999999999999999999998765433100         0011111


Q ss_pred             -HHhhhcccccCCccCCcc----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          293 -RHVEQDREFKLPGVVTRK----ENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       293 -~~~~~~~~~~~~~~~~~~----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                       ..+.....+..|......    ......+.++++.+|+..||.+|||++|.++.
T Consensus       237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence             112222233333333222    22356778899999999999999999999974

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.5e-43  Score=318.01  Aligned_cols=238  Identities=25%  Similarity=0.367  Sum_probs=188.0

Q ss_pred             hhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecC--CceeEEEEecC
Q 036435           88 KDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEG--NNRALIYEFMP  144 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~--~~~~lV~e~~~  144 (372)
                      .++||+|.||.|||++...                     -..+|+.+|++|+||||++|.+...+.  ..+|||+|||+
T Consensus       122 i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd  201 (560)
T KOG0600|consen  122 IEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD  201 (560)
T ss_pred             HHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEeccc
Confidence            4679999999999997643                     367899999999999999999999876  68999999998


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      + ||..++....     -.|++.++.-++.|++.||+|+|   .++|+|||||.+|||||++|.+||+|||||+++....
T Consensus       202 h-DL~GLl~~p~-----vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~  272 (560)
T KOG0600|consen  202 H-DLSGLLSSPG-----VKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG  272 (560)
T ss_pred             c-hhhhhhcCCC-----cccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence            7 9998887643     23999999999999999999999   8999999999999999999999999999999876554


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccc----
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDRE----  300 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----  300 (372)
                      ...  .....-|.-|.|||.+.|. ..|+.+.|+||.|||+.||++|++.|....+..    ..+.++.....-..    
T Consensus       273 ~~~--~T~rVvTLWYRpPELLLG~-t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve----Ql~kIfklcGSP~e~~W~  345 (560)
T KOG0600|consen  273 SAP--YTSRVVTLWYRPPELLLGA-TSYGTAVDLWSVGCILAELFLGKPILQGRTEVE----QLHKIFKLCGSPTEDYWP  345 (560)
T ss_pred             Ccc--cccceEEeeccChHHhcCC-cccccceeehhhhHHHHHHHcCCCCcCCccHHH----HHHHHHHHhCCCChhccc
Confidence            332  2334467889999999997 589999999999999999999999998754422    11111211111000    


Q ss_pred             -ccCCc------------cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          301 -FKLPG------------VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       301 -~~~~~------------~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                       .++|.            .+......+....++|+..+|..||.+|.|+.++++
T Consensus       346 ~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  346 VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence             01111            011112234556788999999999999999999885

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-43  Score=320.87  Aligned_cols=238  Identities=27%  Similarity=0.478  Sum_probs=194.0

Q ss_pred             ccHHHHHHHHhhhhhhcCCCCceEEEEEEecc----------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           75 YNFSDVKKLTNSFKDKLGQGGFGGVYKGRLLD----------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        75 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~----------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      ..|+++...     +-||+|+.|.||+|++.+          .-..+++-|++|+||||+.|.|+|.....+|||||||.
T Consensus       121 iPFe~IsEL-----eWlGSGaQGAVF~Grl~netVAVKKV~elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa  195 (904)
T KOG4721|consen  121 IPFEEISEL-----EWLGSGAQGAVFLGRLHNETVAVKKVRELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCA  195 (904)
T ss_pred             CCHHHhhhh-----hhhccCcccceeeeeccCceehhHHHhhhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence            345555443     339999999999998865          23457899999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      .|-|...|+....      ++.....++..+||.||.|||   .++|||||||.-||||+.+..+||+|||-++......
T Consensus       196 ~GqL~~VLka~~~------itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S  266 (904)
T KOG4721|consen  196 QGQLYEVLKAGRP------ITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS  266 (904)
T ss_pred             cccHHHHHhccCc------cCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhhh
Confidence            9999999987654      888899999999999999999   8999999999999999999999999999998765542


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCC
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP  304 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (372)
                      +    .....||..|||||++.+.  ..++|.||||||||||||+||.-||.+-....       .+|..-.....+..|
T Consensus       267 T----kMSFaGTVaWMAPEvIrne--PcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-------IIwGVGsNsL~LpvP  333 (904)
T KOG4721|consen  267 T----KMSFAGTVAWMAPEVIRNE--PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-------IIWGVGSNSLHLPVP  333 (904)
T ss_pred             h----hhhhhhhHhhhCHHHhhcC--CcccccceehhHHHHHHHHhcCCCccccchhe-------eEEeccCCcccccCc
Confidence            2    2345799999999999986  88999999999999999999999987643321       122222222233333


Q ss_pred             ccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 036435          305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGS  346 (372)
Q Consensus       305 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~  346 (372)
                      .       .+++.+.-|+..||+-.|..||++.+++..|+=.
T Consensus       334 s-------tcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  334 S-------TCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             c-------cCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            2       2345566688889999999999999999988643

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-41  Score=290.59  Aligned_cols=223  Identities=27%  Similarity=0.422  Sum_probs=185.4

Q ss_pred             ccccHHHHHHHHhhhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEE
Q 036435           73 KRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFC  130 (372)
Q Consensus        73 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~  130 (372)
                      +.+++++.+     +.+.||.|+||.|..++...                      ...+|..+|+.+.||+++++++.|
T Consensus        39 ~~~~l~dfe-----~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~  113 (355)
T KOG0616|consen   39 NPYSLQDFE-----RLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF  113 (355)
T ss_pred             CCcchhhhh-----heeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee
Confidence            336666553     34679999999999987642                      577899999999999999999999


Q ss_pred             ecCCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceE
Q 036435          131 LEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPK  210 (372)
Q Consensus       131 ~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  210 (372)
                      .+.+++|+||||++||.|.+++++.+.      +++..+..++.||+.||+|||   +.+|++|||||+|||+|.+|.+|
T Consensus       114 ~d~~~lymvmeyv~GGElFS~Lrk~~r------F~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iK  184 (355)
T KOG0616|consen  114 KDNSNLYMVMEYVPGGELFSYLRKSGR------FSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIK  184 (355)
T ss_pred             ccCCeEEEEEeccCCccHHHHHHhcCC------CCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEE
Confidence            999999999999999999999987654      999999999999999999999   89999999999999999999999


Q ss_pred             EeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHH
Q 036435          211 ISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHW  290 (372)
Q Consensus       211 l~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~  290 (372)
                      |+|||.|+......      ...+|||.|+|||.+...  .++.++|.|||||++|||+.|.+||.+....        .
T Consensus       185 itDFGFAK~v~~rT------~TlCGTPeYLAPEii~sk--~ynkavDWWalGVLIYEMlaG~pPF~~~~~~--------~  248 (355)
T KOG0616|consen  185 ITDFGFAKRVSGRT------WTLCGTPEYLAPEIIQSK--GYNKAVDWWALGVLIYEMLAGYPPFYDDNPI--------Q  248 (355)
T ss_pred             EEeccceEEecCcE------EEecCCccccChHHhhcC--CCCcchhHHHHHHHHHHHHcCCCCCcCCChH--------H
Confidence            99999999876542      455799999999999886  8899999999999999999999999976542        2


Q ss_pred             HHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCC
Q 036435          291 IYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDR  333 (372)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R  333 (372)
                      +++.+-++ ....|...+....++...+       |+.|-.+|
T Consensus       249 iY~KI~~~-~v~fP~~fs~~~kdLl~~L-------L~vD~t~R  283 (355)
T KOG0616|consen  249 IYEKILEG-KVKFPSYFSSDAKDLLKKL-------LQVDLTKR  283 (355)
T ss_pred             HHHHHHhC-cccCCcccCHHHHHHHHHH-------HhhhhHhh
Confidence            44554433 4456666666555555554       45555555

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-42  Score=317.97  Aligned_cols=251  Identities=26%  Similarity=0.401  Sum_probs=195.6

Q ss_pred             HHHHHHhhhhhhcCCCCceEEEEEEe-------------------cchHHHHHHHHhccCCCceeeeEeEEecCCceeEE
Q 036435           79 DVKKLTNSFKDKLGQGGFGGVYKGRL-------------------LDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI  139 (372)
Q Consensus        79 ~~~~~~~~~~~~lg~G~~g~V~~~~~-------------------~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV  139 (372)
                      |.....-.|.++||+|.||.|.....                   +++|.+|+++|.+|+||||++++|+|..++.+++|
T Consensus       534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI  613 (807)
T KOG1094|consen  534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI  613 (807)
T ss_pred             hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence            33333445678999999999998644                   23799999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccc
Q 036435          140 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL  219 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  219 (372)
                      +|||++|+|..|+..+....    +.....+.|+.||+.||+||.   +.++|||||.++|+|+|.++++||+|||+++.
T Consensus       614 ~EYmEnGDLnqFl~aheapt----~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~  686 (807)
T KOG1094|consen  614 TEYMENGDLNQFLSAHELPT----AETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRN  686 (807)
T ss_pred             HHHHhcCcHHHHHHhccCcc----cccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccc
Confidence            99999999999998874321    445666789999999999999   89999999999999999999999999999998


Q ss_pred             ccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc--CCCCCCCCCCCCCccchHHHHHHHhhh
Q 036435          220 CTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG--CKNNLDSGVDSSSEVYFPHWIYRHVEQ  297 (372)
Q Consensus       220 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (372)
                      ..+++.+... ....-+++|||+|.+..  ++++.++|+|+||+++||+++  ...||....+..        +.+....
T Consensus       687 lysg~yy~vq-gr~vlpiRwmawEsill--gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~--------vven~~~  755 (807)
T KOG1094|consen  687 LYSGDYYRVQ-GRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ--------VVENAGE  755 (807)
T ss_pred             cccCCceeee-cceeeeeeehhHHHHHh--ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH--------HHHhhhh
Confidence            8777665542 23345678999999876  499999999999999999874  556665443211        1111111


Q ss_pred             cccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          298 DREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                      ...-.-.......+.-+...+++++.+||..+-.+||+++++...|++..
T Consensus       756 ~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~  805 (807)
T KOG1094|consen  756 FFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA  805 (807)
T ss_pred             hcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence            11111111122233345677889999999999999999999999887643

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.3e-41  Score=312.86  Aligned_cols=247  Identities=24%  Similarity=0.382  Sum_probs=185.1

Q ss_pred             hhhhhhcCCCCceEEEEEEec------------------------------------chHHHHHHHHhccCCCceeeeEe
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL------------------------------------DDFVNEVASISRTSHVNVVTLLG  128 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~------------------------------------~~~~~E~~~l~~l~h~nIv~l~g  128 (372)
                      +.+.++||+|+||.||++.+.                                    .++.+|+.++.+++||||+++++
T Consensus         7 ~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~   86 (304)
T cd05096           7 LLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLG   86 (304)
T ss_pred             CeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEE
Confidence            445678999999999998521                                    15788999999999999999999


Q ss_pred             EEecCCceeEEEEecCCCChhhhhhcCCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecC
Q 036435          129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTS-------------KPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFD  195 (372)
Q Consensus       129 ~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~-------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~d  195 (372)
                      ++.+.+..++||||+++|+|.+++......             .....+++.+++.++.|++.||+|||   +.+++|||
T Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH~d  163 (304)
T cd05096          87 VCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRD  163 (304)
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccccC
Confidence            999999999999999999999998653211             11124788999999999999999999   79999999


Q ss_pred             CCCCceEECCCCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcC--CC
Q 036435          196 IKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGC--KN  273 (372)
Q Consensus       196 lk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg--~~  273 (372)
                      |||+|||++.++.+||+|||+++.......... .....++..|+|||++.+.  .++.++||||||+++|||+++  ..
T Consensus       164 lkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRI-QGRAVLPIRWMAWECILMG--KFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             cchhheEEcCCccEEECCCccceecccCceeEe-cCcCCCCccccCHHHHhcC--CCCchhhhHHHHHHHHHHHHccCCC
Confidence            999999999999999999999986544332211 1223457789999998764  789999999999999999874  45


Q ss_pred             CCCCCCCCCCccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 036435          274 NLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG  345 (372)
Q Consensus       274 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~  345 (372)
                      ||.......    ...................    .....+..+.+++.+||+.||.+|||+.++.+.|++
T Consensus       241 p~~~~~~~~----~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         241 PYGELTDEQ----VIENAGEFFRDQGRQVYLF----RPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCCcCCHHH----HHHHHHHHhhhcccccccc----CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            555432111    1111111111110000000    011234568889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.6e-41  Score=307.59  Aligned_cols=231  Identities=20%  Similarity=0.315  Sum_probs=185.3

Q ss_pred             hhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEec----CCceeEEEEecC
Q 036435           89 DKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLE----GNNRALIYEFMP  144 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~----~~~~~lV~e~~~  144 (372)
                      ..||+|++|.||+|++.+                    .+.+|+.+|++++||||++++|++.+    ....++||||++
T Consensus        26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~  105 (283)
T PHA02988         26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT  105 (283)
T ss_pred             eEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCC
Confidence            459999999999997632                    46699999999999999999999977    347889999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      +|+|.+++....      .+++...++++.|++.||.|||+  ..+++||||||+|||+++++.+||+|||+++......
T Consensus       106 ~g~L~~~l~~~~------~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~  177 (283)
T PHA02988        106 RGYLREVLDKEK------DLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP  177 (283)
T ss_pred             CCcHHHHHhhCC------CCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence            999999997643      28899999999999999999993  2488899999999999999999999999998654322


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCC
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP  304 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (372)
                            ....++..|+|||.+.+....++.++|||||||++|||++|+.||......       ...............+
T Consensus       178 ------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~-------~~~~~i~~~~~~~~~~  244 (283)
T PHA02988        178 ------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK-------EIYDLIINKNNSLKLP  244 (283)
T ss_pred             ------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhcCCCCCCC
Confidence                  123477889999999764347899999999999999999999999754211       1111222222222222


Q ss_pred             ccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       305 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                             ......+.+++.+||+.||.+|||++++++.|+...
T Consensus       245 -------~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        245 -------LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             -------CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence                   123456788999999999999999999999998754

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=5.3e-41  Score=283.75  Aligned_cols=239  Identities=25%  Similarity=0.353  Sum_probs=190.0

Q ss_pred             hhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           87 FKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      -.++||+|.||+||+|++.+                     ...||++.|+.++|+||+.++++|.+.+++.||+|||+.
T Consensus         6 ~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t   85 (318)
T KOG0659|consen    6 KLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT   85 (318)
T ss_pred             hhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc
Confidence            35679999999999997743                     578999999999999999999999999999999999976


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                       +|+..++....     .++..++..++.++++|++|||   .+.|+||||||.|+|++++|.+||+|||+|+.+.+...
T Consensus        86 -dLe~vIkd~~i-----~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~  156 (318)
T KOG0659|consen   86 -DLEVVIKDKNI-----ILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR  156 (318)
T ss_pred             -cHHHHhccccc-----ccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence             99999987653     3899999999999999999999   89999999999999999999999999999998876554


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                      ....   ..-|.-|.|||.+.|. ..|+...|+||.|||+.||+-|.+.|.+..+-+    ....+.+.+..-..-.+|+
T Consensus       157 ~~~~---~V~TRWYRAPELLfGs-r~Yg~~VDmWavGCI~AELllr~P~fpG~sDid----QL~~If~~LGTP~~~~WP~  228 (318)
T KOG0659|consen  157 IQTH---QVVTRWYRAPELLFGS-RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID----QLSKIFRALGTPTPDQWPE  228 (318)
T ss_pred             cccc---ceeeeeccChHHhccc-hhcCCcchhhhHHHHHHHHHccCCCCCCCchHH----HHHHHHHHcCCCCcccCcc
Confidence            3322   1456779999999987 689999999999999999998887776544322    1111122211111111111


Q ss_pred             ---------------c-CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          306 ---------------V-VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       306 ---------------~-~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                                     . ..........+.++++..++..||.+|++++|+++.
T Consensus       229 ~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  229 MTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             ccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence                           0 011223345667899999999999999999999874

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.8e-41  Score=305.95  Aligned_cols=235  Identities=24%  Similarity=0.413  Sum_probs=186.8

Q ss_pred             hhhhhhcCCCCceEEEEEEec-----------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL-----------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYE  141 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-----------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  141 (372)
                      +.+.+.||+|+||.||+|.+.                       ..+.+|+..+++++||||++++|++..++..++|||
T Consensus         7 ~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   86 (266)
T cd05064           7 IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTE   86 (266)
T ss_pred             eEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEE
Confidence            455678999999999998642                       147889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      |+++|+|.+++.....     .+++.+++.++.|++.||+|||   +.+++||||||+|||++.++.+|++|||.+....
T Consensus        87 ~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          87 YMSNGALDSFLRKHEG-----QLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             eCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            9999999999976432     2899999999999999999999   8999999999999999999999999999876543


Q ss_pred             CCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhccc
Q 036435          222 TKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDRE  300 (372)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (372)
                      .....  ......++..|+|||.+.+.  .++.++|||||||++||+++ |..||......        .....+.....
T Consensus       159 ~~~~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--------~~~~~~~~~~~  226 (266)
T cd05064         159 SEAIY--TTMSGKSPVLWAAPEAIQYH--HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--------DVIKAVEDGFR  226 (266)
T ss_pred             ccchh--cccCCCCceeecCHHHHhhC--CccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHHCCCC
Confidence            22111  11122356789999998764  78999999999999999775 99998754221        11222222222


Q ss_pred             ccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 036435          301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGS  346 (372)
Q Consensus       301 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~  346 (372)
                      ...+       ...+..+.+++..||+.+|.+||+++++++.|+++
T Consensus       227 ~~~~-------~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         227 LPAP-------RNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CCCC-------CCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            1111       22445678899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=6e-42  Score=315.68  Aligned_cols=223  Identities=27%  Similarity=0.417  Sum_probs=188.5

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      .+.+.||+|+||+||||+-..                     .+.+|++++++++||||+.++++|++..++++|+||+.
T Consensus         5 hv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~   84 (808)
T KOG0597|consen    5 HVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAV   84 (808)
T ss_pred             hHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhh
Confidence            345789999999999996532                     48899999999999999999999999999999999997


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      | +|..+|.....      ++++.+..++.++..||.|||   +.+|+|||+||.|||++.++.+|++|||+|+....+.
T Consensus        85 g-~L~~il~~d~~------lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t  154 (808)
T KOG0597|consen   85 G-DLFTILEQDGK------LPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT  154 (808)
T ss_pred             h-hHHHHHHhccC------CCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence            7 99999987654      999999999999999999999   8999999999999999999999999999999876644


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhc--cccc
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQD--REFK  302 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  302 (372)
                      ..   .....|||-|||||.+.+.  .++..+|+||+||++||+++|++||....           +.+.+...  ....
T Consensus       155 ~v---ltsikGtPlYmAPElv~e~--pyd~~sDlWslGcilYE~~~G~PPF~a~s-----------i~~Lv~~I~~d~v~  218 (808)
T KOG0597|consen  155 SV---LTSIKGTPLYMAPELVEEQ--PYDHTSDLWSLGCILYELYVGQPPFYARS-----------ITQLVKSILKDPVK  218 (808)
T ss_pred             ee---eeeccCcccccCHHHHcCC--CccchhhHHHHHHHHHHHhcCCCCchHHH-----------HHHHHHHHhcCCCC
Confidence            33   3456799999999999975  89999999999999999999999998531           22222211  1112


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .|       ......+.+++...|++||.+|.+..+++.
T Consensus       219 ~p-------~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  219 PP-------STASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             Cc-------ccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            22       244566777888889999999999999985

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-41  Score=314.60  Aligned_cols=229  Identities=27%  Similarity=0.438  Sum_probs=187.8

Q ss_pred             hhhhhhcCCCCceEEEEEEec------------------------chHHHHHHHHhccC-CCceeeeEeEEecCCceeEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL------------------------DDFVNEVASISRTS-HVNVVTLLGFCLEGNNRALI  139 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~------------------------~~~~~E~~~l~~l~-h~nIv~l~g~~~~~~~~~lV  139 (372)
                      +.+.+.||+|+||.|+.|+..                        +.+.+|+.++++++ ||||++++.++......++|
T Consensus        19 y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~iv   98 (370)
T KOG0583|consen   19 YELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIV   98 (370)
T ss_pred             eeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEE
Confidence            445678999999999998542                        13457999999998 99999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC-CceEEeecCCcc
Q 036435          140 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDED-FCPKISDFGLAK  218 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgla~  218 (372)
                      |||+.+|+|.+++.+.+.      +.+..+..++.|++.|++|+|   +.+|+||||||+|+|+|.+ +++||+|||++.
T Consensus        99 mEy~~gGdL~~~i~~~g~------l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~  169 (370)
T KOG0583|consen   99 MEYCSGGDLFDYIVNKGR------LKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSA  169 (370)
T ss_pred             EEecCCccHHHHHHHcCC------CChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence            999999999999988433      888999999999999999999   8999999999999999999 999999999998


Q ss_pred             cccCCCCeeeeecccccccccccccccccccCCC-CccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhh
Q 036435          219 LCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEV-SHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQ  297 (372)
Q Consensus       219 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (372)
                      ......   ......+||+.|+|||++.+. ..+ ..++||||+||+||.|++|+.||++.....        +...+. 
T Consensus       170 ~~~~~~---~~l~t~cGsp~Y~aPEvl~~~-~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~--------l~~ki~-  236 (370)
T KOG0583|consen  170 ISPGED---GLLKTFCGSPAYAAPEVLSGK-GTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN--------LYRKIR-  236 (370)
T ss_pred             ccCCCC---CcccCCCCCcccCCHHHhCCC-CCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH--------HHHHHh-
Confidence            774111   123456799999999999986 215 589999999999999999999999733211        222222 


Q ss_pred             cccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          298 DREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ...+..|....      ..++..++.+||..||.+|+++.++++
T Consensus       237 ~~~~~~p~~~~------S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  237 KGEFKIPSYLL------SPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             cCCccCCCCcC------CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence            22334443331      456777889999999999999999993

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=315.41  Aligned_cols=225  Identities=28%  Similarity=0.424  Sum_probs=189.5

Q ss_pred             hhcCCCCceEEEEEEec-------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCChh
Q 036435           89 DKLGQGGFGGVYKGRLL-------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLE  149 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~-------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~  149 (372)
                      .+||+|+-|.||.++..                   +-+.+|+.+|+..+|+|||+++..+..++.++.|||||+||+|.
T Consensus       279 ~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLT  358 (550)
T KOG0578|consen  279 KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLT  358 (550)
T ss_pred             hhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchh
Confidence            57999999999988542                   24789999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeeee
Q 036435          150 KFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSS  229 (372)
Q Consensus       150 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  229 (372)
                      +.+....       +++.++..|+++++.||+|||   ..+|+|||||.+|||++.+|.+||+|||++..+.......  
T Consensus       359 DvVt~~~-------~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR--  426 (550)
T KOG0578|consen  359 DVVTKTR-------MTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR--  426 (550)
T ss_pred             hhhhccc-------ccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcc--
Confidence            9997654       899999999999999999999   8999999999999999999999999999998876655422  


Q ss_pred             ecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCCc
Q 036435          230 LLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTR  309 (372)
Q Consensus       230 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (372)
                       ....||+.|||||++...  .|.+|.||||||++++||+-|.+||.....-.        ....+..+...++.     
T Consensus       427 -~TmVGTPYWMAPEVvtrk--~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr--------AlyLIa~ng~P~lk-----  490 (550)
T KOG0578|consen  427 -STMVGTPYWMAPEVVTRK--PYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--------ALYLIATNGTPKLK-----  490 (550)
T ss_pred             -ccccCCCCccchhhhhhc--ccCccccchhhhhHHHHHhcCCCCccCCChHH--------HHHHHhhcCCCCcC-----
Confidence             344699999999999886  89999999999999999999999998643211        22233333222221     


Q ss_pred             chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          310 KENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       310 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ....+...+.+++.+||+.|+.+|++++|+|+
T Consensus       491 ~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  491 NPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             CccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            22334567778889999999999999999997

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=9.2e-41  Score=315.70  Aligned_cols=241  Identities=27%  Similarity=0.431  Sum_probs=187.4

Q ss_pred             hhhhhhcCCCCceEEEEEEec-------------------------chHHHHHHHHhcc-CCCceeeeEeEEecCCceeE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL-------------------------DDFVNEVASISRT-SHVNVVTLLGFCLEGNNRAL  138 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-------------------------~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~l  138 (372)
                      +.+.+.||+|+||.||+++..                         +.+.+|+.+++.+ +||||++++++|.+++..++
T Consensus        37 ~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~l  116 (375)
T cd05104          37 LSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLV  116 (375)
T ss_pred             eehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCccee
Confidence            455788999999999998531                         1477899999999 89999999999999999999


Q ss_pred             EEEecCCCChhhhhhcCCCC------------------------------------------------------------
Q 036435          139 IYEFMPNGSLEKFVYNGDTS------------------------------------------------------------  158 (372)
Q Consensus       139 V~e~~~~g~L~~~l~~~~~~------------------------------------------------------------  158 (372)
                      ||||+++|+|.+++......                                                            
T Consensus       117 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (375)
T cd05104         117 ITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYID  196 (375)
T ss_pred             eehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecc
Confidence            99999999999999653210                                                            


Q ss_pred             ---------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeeee
Q 036435          159 ---------KPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSS  229 (372)
Q Consensus       159 ---------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  229 (372)
                               .....+++..+++++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++.......... 
T Consensus       197 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~-  272 (375)
T cd05104         197 QDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV-  272 (375)
T ss_pred             cccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccc-
Confidence                     00124789999999999999999999   79999999999999999999999999999986544332111 


Q ss_pred             ecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCC
Q 036435          230 LLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVT  308 (372)
Q Consensus       230 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (372)
                      .....++..|+|||.+.+.  .++.++|||||||++|||++ |..||.......       .....+........+.   
T Consensus       273 ~~~~~~~~~y~aPE~~~~~--~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~---  340 (375)
T cd05104         273 KGNARLPVKWMAPESIFNC--VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-------KFYKMIKEGYRMLSPE---  340 (375)
T ss_pred             cCCCCCCcceeChhHhcCC--CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-------HHHHHHHhCccCCCCC---
Confidence            1223355679999999764  78999999999999999997 778876432211       1122222222211121   


Q ss_pred             cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 036435          309 RKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG  345 (372)
Q Consensus       309 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~  345 (372)
                          ....++.+++.+||+.||++||+++++++.|++
T Consensus       341 ----~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         341 ----CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             ----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence                123567889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.3e-40  Score=289.64  Aligned_cols=237  Identities=20%  Similarity=0.280  Sum_probs=187.9

Q ss_pred             hhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecC--CceeEEEEecCC
Q 036435           89 DKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEG--NNRALIYEFMPN  145 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~--~~~~lV~e~~~~  145 (372)
                      +.|++|+||.||+|++..                     ..+||+.+|.+++|||||.+-.+....  +..|+|||||++
T Consensus        82 nrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh  161 (419)
T KOG0663|consen   82 NRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH  161 (419)
T ss_pred             hhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh
Confidence            569999999999998743                     478999999999999999999988754  579999999988


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                       ||.+.+.+..     +.|...++.-+..|+++|++|||   ...|+|||||++|+|+++.|.+||+|||+|+.+.+...
T Consensus       162 -DLksl~d~m~-----q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k  232 (419)
T KOG0663|consen  162 -DLKSLMETMK-----QPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK  232 (419)
T ss_pred             -hHHHHHHhcc-----CCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcCCcc
Confidence             9999998765     23899999999999999999999   89999999999999999999999999999998877643


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                      ..   ....-|.-|.|||.+.+. ..++...|+||+|||+.|++++++.|.+..+.+    ..+.+...+..-.+..+|+
T Consensus       233 ~~---T~lVVTLWYRaPELLLG~-~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d----Ql~~If~llGtPte~iwpg  304 (419)
T KOG0663|consen  233 PY---TPLVVTLWYRAPELLLGA-KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID----QLDKIFKLLGTPSEAIWPG  304 (419)
T ss_pred             cC---cceEEEeeecCHHHhcCC-cccCcchhhhhHHHHHHHHHhcCCCCCCCchHH----HHHHHHHHhCCCccccCCC
Confidence            22   233457779999999987 589999999999999999999999988765433    1222333332222222222


Q ss_pred             cCCc------------------chHH--HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          306 VVTR------------------KENE--IAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       306 ~~~~------------------~~~~--~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                      ....                  ....  +.+.-++++...|..||.+|.|++|.++.
T Consensus       305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence            1100                  0001  33566778888999999999999998863

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4.1e-41  Score=302.38  Aligned_cols=231  Identities=32%  Similarity=0.586  Sum_probs=179.8

Q ss_pred             hhhcCCCCceEEEEEEec------------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           88 KDKLGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      .+.||.|.||.||+|++.                        +.+.+|++.+++++||||++++|++.+.+..++|+||+
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~   83 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC   83 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence            467999999999999876                        16889999999999999999999999888899999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      ++|+|.+++.....    ..+++.++..++.|+++||+|||   +.+++|+||+++||++++++.+||+|||++......
T Consensus        84 ~~g~L~~~L~~~~~----~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~  156 (259)
T PF07714_consen   84 PGGSLDDYLKSKNK----EPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK  156 (259)
T ss_dssp             TTEBHHHHHHHTCT----TTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred             cccccccccccccc----ccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence            99999999988722    22899999999999999999999   789999999999999999999999999999876333


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      ... ...........|+|||.+.+.  .++.++||||||+++||+++ |+.|+.....        ..+...+.......
T Consensus       157 ~~~-~~~~~~~~~~~~~aPE~~~~~--~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--------~~~~~~~~~~~~~~  225 (259)
T PF07714_consen  157 SKY-KNDSSQQLPLRYLAPEVLKDG--EYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--------EEIIEKLKQGQRLP  225 (259)
T ss_dssp             SSE-EESTTSESGGGGS-HHHHHHS--EESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--------HHHHHHHHTTEETT
T ss_pred             ccc-ccccccccccccccccccccc--ccccccccccccccccccccccccccccccc--------ccccccccccccce
Confidence            222 222334466789999999775  68999999999999999999 6677654311        11223333333322


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEML  343 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L  343 (372)
                      .+.       .....+.+++..||+.+|.+|||+.++++.|
T Consensus       226 ~~~-------~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  226 IPD-------NCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             SBT-------TSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ecc-------chhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            222       1245677899999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.9e-40  Score=301.75  Aligned_cols=239  Identities=25%  Similarity=0.463  Sum_probs=189.5

Q ss_pred             hhhhhcCCCCceEEEEEEec-------------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLL-------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIY  140 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~-------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~  140 (372)
                      .+.+.||+|+||.||+|...                         .++.+|+.++++++||||+++++++.+.+..++++
T Consensus         8 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   87 (283)
T cd05048           8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLF   87 (283)
T ss_pred             chhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEE
Confidence            45678999999999998641                         14788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhcCCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceE
Q 036435          141 EFMPNGSLEKFVYNGDTSK----------PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPK  210 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  210 (372)
                      ||+++|+|.+++.......          ....+++.+++.++.|++.||+|||   ..+++|+||||+||++++++.+|
T Consensus        88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~~~~  164 (283)
T cd05048          88 EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVK  164 (283)
T ss_pred             ecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCCcEE
Confidence            9999999999997643211          1134889999999999999999999   79999999999999999999999


Q ss_pred             EeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHH
Q 036435          211 ISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPH  289 (372)
Q Consensus       211 l~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~  289 (372)
                      |+|||++........... .....+++.|+|||.+.+.  .++.++|||||||++|||++ |..||......        
T Consensus       165 L~dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--------  233 (283)
T cd05048         165 ISDFGLSRDIYSADYYRV-QSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--------  233 (283)
T ss_pred             ECCCcceeeccccccccc-cCCCcccccccCHHHhccC--cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--------
Confidence            999999986543322111 1223457789999998764  78999999999999999998 98888753221        


Q ss_pred             HHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 036435          290 WIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG  345 (372)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~  345 (372)
                      .....+........       ....+..+.+++.+||+.||.+||+++++++.|+.
T Consensus       234 ~~~~~i~~~~~~~~-------~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         234 EVIEMIRSRQLLPC-------PEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHHHcCCcCCC-------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            12222222211111       22345678889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.9e-40  Score=296.21  Aligned_cols=232  Identities=26%  Similarity=0.471  Sum_probs=185.0

Q ss_pred             hhhhhcCCCCceEEEEEEecc-----------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCCh
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD-----------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL  148 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~-----------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L  148 (372)
                      .+.+.||+|+||.||++++.+                 ++.+|+.++++++||||+++++++.+++..++||||+++|+|
T Consensus         7 ~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L   86 (256)
T cd05114           7 TFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCL   86 (256)
T ss_pred             EEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcH
Confidence            445789999999999986632                 678899999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeee
Q 036435          149 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVS  228 (372)
Q Consensus       149 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  228 (372)
                      .+++.....     .+++..+..++.|++.||+|||   +.+++|+||||+||++++++.+||+|||+++......... 
T Consensus        87 ~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~-  157 (256)
T cd05114          87 LNYLRQRQG-----KLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS-  157 (256)
T ss_pred             HHHHHhCcc-----CCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec-
Confidence            999875432     2889999999999999999999   8999999999999999999999999999998654322111 


Q ss_pred             eecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccC
Q 036435          229 SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVV  307 (372)
Q Consensus       229 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (372)
                       .....++..|+|||.+.+.  .++.++|+||||+++|||++ |+.||......       + ....+........+.. 
T Consensus       158 -~~~~~~~~~y~aPE~~~~~--~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~-------~-~~~~i~~~~~~~~~~~-  225 (256)
T cd05114         158 -SSGAKFPVKWSPPEVFNFS--KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-------E-VVEMISRGFRLYRPKL-  225 (256)
T ss_pred             -cCCCCCchhhCChhhcccC--ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH-------H-HHHHHHCCCCCCCCCC-
Confidence             1222345679999998764  78899999999999999999 88888653211       1 1122222222212211 


Q ss_pred             CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 036435          308 TRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ  344 (372)
Q Consensus       308 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~  344 (372)
                            ....+.+++.+||+.+|.+||+++++++.|.
T Consensus       226 ------~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         226 ------ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             ------CCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                  2356788999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.3e-40  Score=314.38  Aligned_cols=243  Identities=25%  Similarity=0.447  Sum_probs=188.2

Q ss_pred             HhhhhhhcCCCCceEEEEEEec-------------------------chHHHHHHHHhcc-CCCceeeeEeEEecCCcee
Q 036435           84 TNSFKDKLGQGGFGGVYKGRLL-------------------------DDFVNEVASISRT-SHVNVVTLLGFCLEGNNRA  137 (372)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-------------------------~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~  137 (372)
                      .+.+.+.||+|+||.||+++..                         ..+.+|+.+++.+ +|+||++++++|.+++..+
T Consensus        39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~  118 (374)
T cd05106          39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVL  118 (374)
T ss_pred             HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeE
Confidence            3455788999999999987631                         1477899999999 8999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCCC------------------------------------------------------------
Q 036435          138 LIYEFMPNGSLEKFVYNGDT------------------------------------------------------------  157 (372)
Q Consensus       138 lV~e~~~~g~L~~~l~~~~~------------------------------------------------------------  157 (372)
                      +||||+++|+|.+++.....                                                            
T Consensus       119 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (374)
T cd05106         119 VITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSK  198 (374)
T ss_pred             EeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccccc
Confidence            99999999999999864311                                                            


Q ss_pred             ----CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeeeeeccc
Q 036435          158 ----SKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGA  233 (372)
Q Consensus       158 ----~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  233 (372)
                          ......+++.++++++.|+++||+|||   +.+++||||||+|||+++++.+||+|||+++.......... ....
T Consensus       199 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~-~~~~  274 (374)
T cd05106         199 DEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV-KGNA  274 (374)
T ss_pred             chhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee-ccCC
Confidence                001124788999999999999999999   79999999999999999999999999999986543322111 1222


Q ss_pred             ccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCCcchH
Q 036435          234 RGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKEN  312 (372)
Q Consensus       234 ~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (372)
                      .++..|+|||++.+.  .++.++|||||||++|||++ |+.||.......       ..............+..      
T Consensus       275 ~~~~~y~aPE~~~~~--~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-------~~~~~~~~~~~~~~~~~------  339 (374)
T cd05106         275 RLPVKWMAPESIFDC--VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-------KFYKMVKRGYQMSRPDF------  339 (374)
T ss_pred             CCccceeCHHHhcCC--CCCccccHHHHHHHHHHHHhCCCCCCccccccH-------HHHHHHHcccCccCCCC------
Confidence            356679999998764  78999999999999999997 999987543211       01122222211111211      


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 036435          313 EIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGS  346 (372)
Q Consensus       313 ~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~  346 (372)
                       ....+.+++.+||+.||.+|||+.++++.|+++
T Consensus       340 -~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         340 -APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             -CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence             235678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=7.6e-41  Score=304.90  Aligned_cols=230  Identities=24%  Similarity=0.345  Sum_probs=182.6

Q ss_pred             hhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           87 FKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      ..+.||+|+||.||++....                      .+.+|+.++++++|+||+++++++.+++..++|+||++
T Consensus         4 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~   83 (285)
T cd05631           4 HYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMN   83 (285)
T ss_pred             EEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecC
Confidence            35679999999999986521                      36679999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      +|+|.+++......    .+++..+..++.|++.||+|||   +.+++||||||+|||+++++.+||+|||++.......
T Consensus        84 ~g~L~~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          84 GGDLKFHIYNMGNP----GFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             CCcHHHHHHhhCCC----CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            99999888654321    2899999999999999999999   8999999999999999999999999999998654322


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCC
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP  304 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (372)
                      .    .....||..|+|||.+.+.  .++.++|||||||++|||++|+.||.........    ......... ....  
T Consensus       157 ~----~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~----~~~~~~~~~-~~~~--  223 (285)
T cd05631         157 T----VRGRVGTVGYMAPEVINNE--KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR----EEVDRRVKE-DQEE--  223 (285)
T ss_pred             e----ecCCCCCCCccCHhhhcCC--CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH----HHHHHHhhc-cccc--
Confidence            1    1234588999999999874  7899999999999999999999999865332110    111111111 0011  


Q ss_pred             ccCCcchHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 036435          305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPP-----MNEVIE  341 (372)
Q Consensus       305 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~  341 (372)
                           ........+.+++.+||+.||.+||+     ++++++
T Consensus       224 -----~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         224 -----YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             -----CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence                 11223456778999999999999997     788886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.3e-40  Score=309.48  Aligned_cols=224  Identities=22%  Similarity=0.333  Sum_probs=182.9

Q ss_pred             hhhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEe
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      +.+.+.||+|+||.||+++...                      .+.+|+.++++++||||+++++++.+++..++||||
T Consensus        20 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   99 (329)
T PTZ00263         20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEF   99 (329)
T ss_pred             eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcC
Confidence            3456789999999999997632                      467899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      +++|+|.+++.....      +++..+..++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++....
T Consensus       100 ~~~~~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263        100 VVGGELFTHLRKAGR------FPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             CCCChHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            999999999976542      788999999999999999999   89999999999999999999999999999986543


Q ss_pred             CCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      ..      ....||+.|+|||.+.+.  .++.++|||||||++|||++|+.||.....        ......+... ...
T Consensus       171 ~~------~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~i~~~-~~~  233 (329)
T PTZ00263        171 RT------FTLCGTPEYLAPEVIQSK--GHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--------FRIYEKILAG-RLK  233 (329)
T ss_pred             Cc------ceecCChhhcCHHHHcCC--CCCCcceeechHHHHHHHHcCCCCCCCCCH--------HHHHHHHhcC-CcC
Confidence            22      123588999999999875  678999999999999999999999975321        1112222221 222


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPP-----MNEVIE  341 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~  341 (372)
                      .|..       ....+.+++.+||+.||.+||+     +++++.
T Consensus       234 ~p~~-------~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        234 FPNW-------FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             CCCC-------CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            2322       2345678999999999999997     677774

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3.6e-40  Score=296.79  Aligned_cols=235  Identities=30%  Similarity=0.469  Sum_probs=187.7

Q ss_pred             hhhhhcCCCCceEEEEEEecc------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS  147 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~  147 (372)
                      .+.+.||+|+||.||+|...+                  ++.+|++++++++||||+++++++..++..++||||+++++
T Consensus         9 ~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   88 (263)
T cd05052           9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN   88 (263)
T ss_pred             EEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCc
Confidence            445789999999999987532                  57889999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCee
Q 036435          148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV  227 (372)
Q Consensus       148 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  227 (372)
                      |.+++.....    ..+++..++.++.|+++||+|||   +.+++|+||||+||++++++.+||+|||++..........
T Consensus        89 L~~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~  161 (263)
T cd05052          89 LLDYLRECNR----QEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA  161 (263)
T ss_pred             HHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence            9999976432    23899999999999999999999   7999999999999999999999999999998764432111


Q ss_pred             eeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCcc
Q 036435          228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV  306 (372)
Q Consensus       228 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (372)
                        .....++..|+|||.+.+.  .++.++|||||||++|||++ |..||......        ..............+  
T Consensus       162 --~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~~--  227 (263)
T cd05052         162 --HAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------QVYELLEKGYRMERP--  227 (263)
T ss_pred             --cCCCCCccccCCHHHhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHCCCCCCCC--
Confidence              1122345679999998764  78899999999999999998 88887643211        112222222111111  


Q ss_pred             CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 036435          307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGS  346 (372)
Q Consensus       307 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~  346 (372)
                           ...+..+.+++.+||+.||++||++.++++.|+.+
T Consensus       228 -----~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         228 -----EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             -----CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence                 12346688899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-41  Score=282.50  Aligned_cols=239  Identities=25%  Similarity=0.410  Sum_probs=196.8

Q ss_pred             CCCCccccHHHHHHHHhhhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeee
Q 036435           69 PLPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTL  126 (372)
Q Consensus        69 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l  126 (372)
                      ....+.++++++     ++.+.||+|.||.||.|+..+                      ++.+|+++-+.|+||||+++
T Consensus        13 ~~~~~~~~l~df-----eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrl   87 (281)
T KOG0580|consen   13 SRATKTWTLDDF-----EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRL   87 (281)
T ss_pred             cccccccchhhc-----cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhh
Confidence            334456666655     456789999999999997643                      68899999999999999999


Q ss_pred             EeEEecCCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC
Q 036435          127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDED  206 (372)
Q Consensus       127 ~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~  206 (372)
                      |++|.++...||++||.++|+|...|......+    +++.....+..|+|.|+.|+|   .++|+||||||+|+|++..
T Consensus        88 Y~~fhd~~riyLilEya~~gel~k~L~~~~~~~----f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~  160 (281)
T KOG0580|consen   88 YGYFHDSKRIYLILEYAPRGELYKDLQEGRMKR----FDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSA  160 (281)
T ss_pred             hhheeccceeEEEEEecCCchHHHHHHhccccc----ccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCC
Confidence            999999999999999999999999998655433    788888899999999999999   8999999999999999999


Q ss_pred             CceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccc
Q 036435          207 FCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVY  286 (372)
Q Consensus       207 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~  286 (372)
                      +.+|++|||-+.....+.     ....+||..|.+||...+.  ..+...|+|++|++.||++.|.+||......     
T Consensus       161 ~~lkiAdfGwsV~~p~~k-----R~tlcgt~dyl~pEmv~~~--~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~-----  228 (281)
T KOG0580|consen  161 GELKIADFGWSVHAPSNK-----RKTLCGTLDYLPPEMVEGR--GHDKFVDLWSLGVLCYEFLVGLPPFESQSHS-----  228 (281)
T ss_pred             CCeeccCCCceeecCCCC-----ceeeecccccCCHhhcCCC--CccchhhHHHHHHHHHHHHhcCCchhhhhhH-----
Confidence            999999999987654222     1334699999999999886  8899999999999999999999999865421     


Q ss_pred             hHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          287 FPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                         ..++.+... ++..|.       .+.....+++.+|+..+|.+|.+..|+++.
T Consensus       229 ---etYkrI~k~-~~~~p~-------~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  229 ---ETYKRIRKV-DLKFPS-------TISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             ---HHHHHHHHc-cccCCc-------ccChhHHHHHHHHhccCccccccHHHHhhh
Confidence               134444332 333343       234566778888999999999999998863

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=4.2e-40  Score=304.44  Aligned_cols=238  Identities=27%  Similarity=0.428  Sum_probs=186.6

Q ss_pred             hhhhhhcCCCCceEEEEEEec------------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIY  140 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~  140 (372)
                      +...+.||+|+||.||+|++.                        +++.+|+.+++.++||||++++|+|..+ ..++|+
T Consensus         9 f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~   87 (316)
T cd05108           9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT   87 (316)
T ss_pred             ceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceeee
Confidence            344578999999999998641                        1577899999999999999999999865 578999


Q ss_pred             EecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccc
Q 036435          141 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC  220 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~  220 (372)
                      ||+++|+|.+++.....     .+++..++.++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++..
T Consensus        88 e~~~~g~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          88 QLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             ecCCCCCHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccc
Confidence            99999999999976532     2889999999999999999999   899999999999999999999999999999876


Q ss_pred             cCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcc
Q 036435          221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDR  299 (372)
Q Consensus       221 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (372)
                      ........ .....++..|+|||.+.+.  .++.++||||||+++|||++ |+.||......        ..........
T Consensus       160 ~~~~~~~~-~~~~~~~~~y~apE~~~~~--~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~  228 (316)
T cd05108         160 GADEKEYH-AEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------EISSILEKGE  228 (316)
T ss_pred             cCCCccee-ccCCccceeecChHHhccC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHhCCC
Confidence            54332211 1222346789999998764  78999999999999999997 88888643211        1122222222


Q ss_pred             cccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 036435          300 EFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~  349 (372)
                      ....+.       .....+.+++.+||+.+|.+||++.+++..|..+...
T Consensus       229 ~~~~~~-------~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         229 RLPQPP-------ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             CCCCCC-------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence            222221       1234577899999999999999999999998776643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.9e-40  Score=307.70  Aligned_cols=223  Identities=22%  Similarity=0.306  Sum_probs=180.1

Q ss_pred             hhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           89 DKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      +.||+|+||.||+++...                      .+.+|+.++++++||||+++++++.+++..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            358999999999986532                      4667999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      +|.+++.....      +++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++........
T Consensus        81 ~L~~~l~~~~~------~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  151 (323)
T cd05571          81 ELFFHLSRERV------FSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT  151 (323)
T ss_pred             cHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCc
Confidence            99999976432      899999999999999999999   899999999999999999999999999998753322211


Q ss_pred             eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCcc
Q 036435          227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV  306 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (372)
                         .....||+.|+|||.+.+.  .++.++|||||||++|||++|+.||......        .....+.. .....+. 
T Consensus       152 ---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--------~~~~~~~~-~~~~~p~-  216 (323)
T cd05571         152 ---MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFELILM-EEIRFPR-  216 (323)
T ss_pred             ---ccceecCccccChhhhcCC--CCCccccCcccchhhhhhhcCCCCCCCCCHH--------HHHHHHHc-CCCCCCC-
Confidence               1234589999999999775  7899999999999999999999999753211        01111111 1122222 


Q ss_pred             CCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 036435          307 VTRKENEIAKKMIIVGLWCIQARPSDRP-----PMNEVIE  341 (372)
Q Consensus       307 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~  341 (372)
                            .....+.+++.+||+.||++||     +++++++
T Consensus       217 ------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         217 ------TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             ------CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence                  2345677899999999999999     7898875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-41  Score=311.04  Aligned_cols=231  Identities=20%  Similarity=0.297  Sum_probs=185.4

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      .+.+.||+|+||.||+++..+                      .+.+|+.++.+++||||+++++++.+++..++||||+
T Consensus         4 ~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~   83 (333)
T cd05600           4 QILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYV   83 (333)
T ss_pred             EEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCC
Confidence            345789999999999997632                      4677999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      ++|+|.+++.....      +++..+..++.|++.||.|||   +.+++||||||+|||++.++.+||+|||++......
T Consensus        84 ~g~~L~~~l~~~~~------l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~  154 (333)
T cd05600          84 PGGDFRTLLNNLGV------LSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY  154 (333)
T ss_pred             CCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCcccccc
Confidence            99999999976432      889999999999999999999   899999999999999999999999999999865431


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhh-ccccc
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQ-DREFK  302 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  302 (372)
                            .....||+.|+|||.+.+.  .++.++|||||||++|||++|..||.......        ....+.. .....
T Consensus       155 ------~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--------~~~~i~~~~~~~~  218 (333)
T cd05600         155 ------ANSVVGSPDYMAPEVLRGK--GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE--------TWENLKYWKETLQ  218 (333)
T ss_pred             ------cCCcccCccccChhHhcCC--CCCCccceecchHHHhhhhhCCCCCCCCCHHH--------HHHHHHhcccccc
Confidence                  1334588999999999875  78999999999999999999999997542211        1111111 11111


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                      .+.... ....+...+.+++.+||+.+|.+||+++++++.
T Consensus       219 ~~~~~~-~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         219 RPVYDD-PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCCCCc-cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            111111 012345677889999999999999999999964

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-40  Score=296.74  Aligned_cols=235  Identities=27%  Similarity=0.484  Sum_probs=188.5

Q ss_pred             hhhhhcCCCCceEEEEEEec-----------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEe
Q 036435           86 SFKDKLGQGGFGGVYKGRLL-----------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~-----------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      .+.+.||+|+||.||+|++.                       .++.+|+.++++++||||+++++++.+++..++||||
T Consensus         7 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   86 (266)
T cd05033           7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEY   86 (266)
T ss_pred             eeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEc
Confidence            45678999999999998652                       1477899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      +++++|.+++.....     .+++.+++.++.|++.||+|||   +.+++|+||||+||++++++.++|+|||+++....
T Consensus        87 ~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          87 MENGSLDKFLRENDG-----KFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             CCCCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            999999999976432     3899999999999999999999   89999999999999999999999999999987752


Q ss_pred             CCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREF  301 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (372)
                      ...... .....++..|+|||.+.+.  .++.++||||||+++|++++ |..||......        ............
T Consensus       159 ~~~~~~-~~~~~~~~~y~~Pe~~~~~--~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~  227 (266)
T cd05033         159 SEATYT-TKGGKIPIRWTAPEAIAYR--KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--------DVIKAVEDGYRL  227 (266)
T ss_pred             ccccee-ccCCCCCccccChhhhccC--CCccccchHHHHHHHHHHHccCCCCCCCCCHH--------HHHHHHHcCCCC
Confidence            222211 1223356789999998764  78999999999999999998 88888643211        112222222111


Q ss_pred             cCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 036435          302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGS  346 (372)
Q Consensus       302 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~  346 (372)
                      ..+       ......+.+++.+||+.+|++||+++++++.|+++
T Consensus       228 ~~~-------~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         228 PPP-------MDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             CCC-------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            111       12345678899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.2e-40  Score=312.25  Aligned_cols=243  Identities=19%  Similarity=0.256  Sum_probs=183.4

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCChhhh
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF  151 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~~~  151 (372)
                      +.+.+.||+|+||.||++....             .+.+|+.++++++||||+++++++..+...++|+|++. ++|.++
T Consensus        94 y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~  172 (391)
T PHA03212         94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCY  172 (391)
T ss_pred             cEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHH
Confidence            4445789999999999987632             57889999999999999999999999999999999995 689888


Q ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeeeeec
Q 036435          152 VYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLL  231 (372)
Q Consensus       152 l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~  231 (372)
                      +.....      +++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++.........  ...
T Consensus       173 l~~~~~------l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~--~~~  241 (391)
T PHA03212        173 LAAKRN------IAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN--KYY  241 (391)
T ss_pred             HHhcCC------CCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc--ccc
Confidence            865432      889999999999999999999   789999999999999999999999999999754322111  123


Q ss_pred             ccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccc---hHHHHHHHhh------------
Q 036435          232 GARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVY---FPHWIYRHVE------------  296 (372)
Q Consensus       232 ~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~---~~~~~~~~~~------------  296 (372)
                      ...||+.|+|||++.+.  .++.++|||||||++|||++|+.|+...........   ....+.....            
T Consensus       242 ~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~  319 (391)
T PHA03212        242 GWAGTIATNAPELLARD--PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA  319 (391)
T ss_pred             cccCccCCCChhhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence            34689999999999774  789999999999999999999988764332111100   0000000000            


Q ss_pred             --------h-cccccCCccCC--cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          297 --------Q-DREFKLPGVVT--RKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       297 --------~-~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                              . ......+....  .........+.+++.+||+.||.+|||++|+++
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                    0 00000111111  111234567889999999999999999999985

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-40  Score=305.00  Aligned_cols=224  Identities=24%  Similarity=0.287  Sum_probs=182.4

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      .+.+.||+|+||.||+++...                      .+.+|+.++++++||||+++++++.+++..++||||+
T Consensus         4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   83 (291)
T cd05612           4 ERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYV   83 (291)
T ss_pred             eeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCC
Confidence            345789999999999997631                      3677999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      ++|+|.+++.....      +++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++......
T Consensus        84 ~~~~L~~~~~~~~~------~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          84 PGGELFSYLRNSGR------FSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             CCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            99999999976542      889999999999999999999   899999999999999999999999999999865432


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                      .      ....||+.|+|||.+.+.  .++.++|||||||++|+|++|+.||......        .....+... ....
T Consensus       155 ~------~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~--------~~~~~i~~~-~~~~  217 (291)
T cd05612         155 T------WTLCGTPEYLAPEVIQSK--GHNKAVDWWALGILIYEMLVGYPPFFDDNPF--------GIYEKILAG-KLEF  217 (291)
T ss_pred             c------ccccCChhhcCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhC-CcCC
Confidence            2      223588999999999875  6789999999999999999999999754211        112222211 1222


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPP-----MNEVIEM  342 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~~  342 (372)
                      +..       ....+.+++.+||+.||.+||+     ++++++.
T Consensus       218 ~~~-------~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         218 PRH-------LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             Ccc-------CCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence            221       2345778999999999999995     8888764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=9.5e-40  Score=293.05  Aligned_cols=229  Identities=26%  Similarity=0.424  Sum_probs=182.5

Q ss_pred             hcCCCCceEEEEEEec-----------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           90 KLGQGGFGGVYKGRLL-----------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        90 ~lg~G~~g~V~~~~~~-----------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      +||+|+||.||+|.+.                       +++.+|+.++++++||||+++++++. ++..++|+||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            5899999999998541                       15788999999999999999999985 45678999999999


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      +|.+++....      .+++..+..++.|++.||+|||   +.+++|+||||+||++++++.+||+|||++.........
T Consensus        81 ~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~  151 (257)
T cd05116          81 PLNKFLQKNK------HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY  151 (257)
T ss_pred             cHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence            9999996543      2889999999999999999999   899999999999999999999999999999876544433


Q ss_pred             eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                      ........++..|+|||.+.+.  .++.++|+|||||++|||++ |..||......        .....+........|.
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~i~~~~~~~~~~  221 (257)
T cd05116         152 YKAKTHGKWPVKWYAPECMNYY--KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--------EVTQMIESGERMECPQ  221 (257)
T ss_pred             eeecCCCCCCccccCHhHhccC--CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHCCCCCCCCC
Confidence            2222223345789999998654  78889999999999999998 88898753221        1222333332222222


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG  345 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~  345 (372)
                             .....+.+++.+||+.||++||++++|.+.|++
T Consensus       222 -------~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         222 -------RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             -------CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence                   234567789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.2e-40  Score=308.20  Aligned_cols=177  Identities=24%  Similarity=0.379  Sum_probs=154.3

Q ss_pred             hhhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      ...+.||+|+||.||+++...                    ++.+|++++++++||||+++++++.+++..++||||+++
T Consensus         8 ~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   87 (331)
T cd06649           8 ERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG   87 (331)
T ss_pred             eEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCC
Confidence            345679999999999987631                    588899999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      |+|.+++.....      +++..+..++.|++.||.|||+  ..+++||||||+|||++.++.+||+|||++....... 
T Consensus        88 ~~L~~~l~~~~~------~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  158 (331)
T cd06649          88 GSLDQVLKEAKR------IPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  158 (331)
T ss_pred             CcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence            999999976432      8899999999999999999993  3469999999999999999999999999997653322 


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCC
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDS  277 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~  277 (372)
                          .....||..|+|||.+.+.  .++.++|||||||++|||++|+.||..
T Consensus       159 ----~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~  204 (331)
T cd06649         159 ----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVELAIGRYPIPP  204 (331)
T ss_pred             ----cccCCCCcCcCCHhHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence                1233588999999999875  789999999999999999999999964

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=9.4e-40  Score=296.57  Aligned_cols=242  Identities=27%  Similarity=0.461  Sum_probs=190.1

Q ss_pred             HHhhhhhhcCCCCceEEEEEEec-------------------------chHHHHHHHHhccCCCceeeeEeEEecCCcee
Q 036435           83 LTNSFKDKLGQGGFGGVYKGRLL-------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRA  137 (372)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~  137 (372)
                      .++.+.+.||+|+||.||+|+..                         +.+.+|++++++++|+||+++++++..+...+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            34556788999999999998641                         15788999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCce
Q 036435          138 LIYEFMPNGSLEKFVYNGDT--------SKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP  209 (372)
Q Consensus       138 lV~e~~~~g~L~~~l~~~~~--------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~  209 (372)
                      +||||+++++|.+++.....        ......+++.++..++.|++.|++|||   +.+++|+||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeE
Confidence            99999999999999976532        112234889999999999999999999   8999999999999999999999


Q ss_pred             EEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchH
Q 036435          210 KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFP  288 (372)
Q Consensus       210 kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~  288 (372)
                      ||+|||++........... .....+++.|+|||.+.+.  .++.++||||||+++|||++ |..||.......      
T Consensus       162 kl~d~g~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~------  232 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRV-GGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE------  232 (280)
T ss_pred             EECCcccceecccCcceec-CCCCcccceecChhhhccC--CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH------
Confidence            9999999976533221111 1222356789999999764  78999999999999999998 999986532211      


Q ss_pred             HHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 036435          289 HWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG  345 (372)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~  345 (372)
                        .......+.....+       ......+.+++.+||+.||++||++.|+++.|++
T Consensus       233 --~~~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         233 --VIECITQGRLLQRP-------RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             --HHHHHHcCCcCCCC-------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence              11111111111111       1234668889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-41  Score=311.56  Aligned_cols=243  Identities=28%  Similarity=0.436  Sum_probs=203.1

Q ss_pred             HHHHHHhhhhhhcCCCCceEEEEEEecc------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEE
Q 036435           79 DVKKLTNSFKDKLGQGGFGGVYKGRLLD------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIY  140 (372)
Q Consensus        79 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~  140 (372)
                      |++.....+..+||-|.||.||.|.|.+                  +|+.|+.+|+.++|||+|+++|+|..+..+|||+
T Consensus       263 EmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiT  342 (1157)
T KOG4278|consen  263 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIIT  342 (1157)
T ss_pred             hccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEE
Confidence            3444444456789999999999998853                  7999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccc
Q 036435          141 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC  220 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~  220 (372)
                      |||.+|+|.+||.+.+...    ++..-.+.++.||..||.||.   .+++|||||.++|+|+.++..+|++||||++++
T Consensus       343 EfM~yGNLLdYLRecnr~e----v~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlM  415 (1157)
T KOG4278|consen  343 EFMCYGNLLDYLRECNRSE----VPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLM  415 (1157)
T ss_pred             ecccCccHHHHHHHhchhh----cchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence            9999999999998876543    777888999999999999999   899999999999999999999999999999988


Q ss_pred             cCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcc
Q 036435          221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDR  299 (372)
Q Consensus       221 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (372)
                      .......  .......+.|.|||-+.-+  .++.|+|||+|||+|||+.| |-.||....-        ..++..++.+.
T Consensus       416 tgDTYTA--HAGAKFPIKWTAPEsLAyN--tFSiKSDVWAFGVLLWEIATYGMsPYPGidl--------SqVY~LLEkgy  483 (1157)
T KOG4278|consen  416 TGDTYTA--HAGAKFPIKWTAPESLAYN--TFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQVYGLLEKGY  483 (1157)
T ss_pred             cCCceec--ccCccCcccccCccccccc--ccccchhhHHHHHHHHHHHhcCCCCCCCccH--------HHHHHHHhccc
Confidence            6544322  2334456789999999754  89999999999999999987 5555554221        23677777777


Q ss_pred             cccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          300 EFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                      +.+.|..       ++..+++||+.||+.+|.+||++.|+-+.++.+.
T Consensus       484 RM~~PeG-------CPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf  524 (1157)
T KOG4278|consen  484 RMDGPEG-------CPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF  524 (1157)
T ss_pred             cccCCCC-------CCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence            6666644       3467888999999999999999999998876554

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=6.5e-40  Score=299.61  Aligned_cols=242  Identities=25%  Similarity=0.435  Sum_probs=191.1

Q ss_pred             hhhhhcCCCCceEEEEEEec------------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYE  141 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  141 (372)
                      .+.+.||+|+||.||+++..                        +.+.+|+.++++++|+||+++++++.+++..++|||
T Consensus         8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   87 (291)
T cd05094           8 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFE   87 (291)
T ss_pred             EEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEe
Confidence            34578999999999998631                        157889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhcCCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEE
Q 036435          142 FMPNGSLEKFVYNGDTS----------KPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKI  211 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  211 (372)
                      |+++++|.+++......          .....+++..++.++.|++.||+|||   +.+++||||||+||+++.++.++|
T Consensus        88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~~~l  164 (291)
T cd05094          88 YMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKI  164 (291)
T ss_pred             cCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEE
Confidence            99999999999764321          11234899999999999999999999   899999999999999999999999


Q ss_pred             eecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHH
Q 036435          212 SDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHW  290 (372)
Q Consensus       212 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~  290 (372)
                      +|||++.......... ......++..|+|||.+.+.  .++.++||||||+++|||++ |+.||.......        
T Consensus       165 ~dfg~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--------  233 (291)
T cd05094         165 GDFGMSRDVYSTDYYR-VGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--------  233 (291)
T ss_pred             CCCCcccccCCCceee-cCCCCCcceeecChHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--------
Confidence            9999997654432211 11233457789999998764  78899999999999999998 898886532211        


Q ss_pred             HHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 036435          291 IYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE  348 (372)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~  348 (372)
                      ..+..........+       ...+..+.+++.+||+.+|.+||+++++++.|+.+..
T Consensus       234 ~~~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         234 VIECITQGRVLERP-------RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             HHHHHhCCCCCCCC-------ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            11222222111111       1234567889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.8e-39  Score=291.37  Aligned_cols=231  Identities=25%  Similarity=0.425  Sum_probs=182.7

Q ss_pred             hcCCCCceEEEEEEec----------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCC
Q 036435           90 KLGQGGFGGVYKGRLL----------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS  147 (372)
Q Consensus        90 ~lg~G~~g~V~~~~~~----------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~  147 (372)
                      .||+|+||.||+|.+.                      +.+.+|+.++++++||||+++++++. ....++|+||+++|+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999998542                      14788999999999999999999885 457899999999999


Q ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCee
Q 036435          148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV  227 (372)
Q Consensus       148 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  227 (372)
                      |.+++.....     .+++.++++++.|++.||+|||   ..+++|+||||+||+++.++.+||+|||++..........
T Consensus        81 L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~  152 (257)
T cd05115          81 LNKFLSGKKD-----EITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY  152 (257)
T ss_pred             HHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence            9999875332     2899999999999999999999   7899999999999999999999999999998654433322


Q ss_pred             eeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCcc
Q 036435          228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV  306 (372)
Q Consensus       228 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (372)
                      .......++..|+|||.+.+.  .++.++|+||||+++||+++ |..||......        .+...+........+. 
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~-  221 (257)
T cd05115         153 KARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--------EVMSFIEQGKRLDCPA-  221 (257)
T ss_pred             eccCCCCCCcccCCHHHHccC--CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHHCCCCCCCCC-
Confidence            222222345789999998764  68899999999999999996 99998754221        1223333332222221 


Q ss_pred             CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 036435          307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGS  346 (372)
Q Consensus       307 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~  346 (372)
                            .....+.+++..||+.+|++||++.+|.+.|+..
T Consensus       222 ------~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         222 ------ECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             ------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence                  2245677899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.5e-40  Score=310.13  Aligned_cols=246  Identities=21%  Similarity=0.296  Sum_probs=180.1

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCC-----ceeEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGN-----NRALI  139 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~-----~~~lV  139 (372)
                      .+.+.||+|+||.||+|+...                     ++.+|+.++++++||||+++++++...+     ..++|
T Consensus         3 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv   82 (338)
T cd07859           3 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV   82 (338)
T ss_pred             EEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEE
Confidence            345789999999999996532                     4778999999999999999999886432     47999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccc
Q 036435          140 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL  219 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  219 (372)
                      |||+. ++|.+++.....      +++..+..++.|+++||+|||   +.+++||||||+|||++.++.+||+|||+++.
T Consensus        83 ~e~~~-~~L~~~l~~~~~------~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~  152 (338)
T cd07859          83 FELME-SDLHQVIKANDD------LTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARV  152 (338)
T ss_pred             EecCC-CCHHHHHHhccc------CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCccccc
Confidence            99995 699998875432      899999999999999999999   89999999999999999999999999999986


Q ss_pred             ccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCcc--------chHHHH
Q 036435          220 CTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV--------YFPHWI  291 (372)
Q Consensus       220 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~--------~~~~~~  291 (372)
                      ...............||..|+|||++.+....++.++|||||||++|||++|+.||..........        ....+ 
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~-  231 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET-  231 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHH-
Confidence            533222212123345889999999986533478899999999999999999999996543210000        00000 


Q ss_pred             HHHhh--------hcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          292 YRHVE--------QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       292 ~~~~~--------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                      ...+.        .......+.............+.+++.+||+.||++|||++|+++.
T Consensus       232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            00000        0000000111111111223567789999999999999999999963

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-39  Score=293.49  Aligned_cols=237  Identities=27%  Similarity=0.444  Sum_probs=188.6

Q ss_pred             HhhhhhhcCCCCceEEEEEEec-----------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           84 TNSFKDKLGQGGFGGVYKGRLL-----------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      ...+.+.||+|+||.||+|...                 +++.+|+.++++++||||+++++++..++..++|+||++++
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   86 (261)
T cd05068           7 SIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYG   86 (261)
T ss_pred             heeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCC
Confidence            3455688999999999998642                 25888999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      +|.+++.....    ..+++.++..++.|++.||.|||   +.+++|+||||+||++++++.+||+|||++.........
T Consensus        87 ~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05068          87 SLLEYLQGGAG----RALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE  159 (261)
T ss_pred             cHHHHHhccCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence            99999976542    23899999999999999999999   799999999999999999999999999999876532211


Q ss_pred             eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                        .......+..|+|||.+.+.  .++.++|+||||+++|||++ |+.||.....        ......+........+ 
T Consensus       160 --~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~-  226 (261)
T cd05068         160 --AREGAKFPIKWTAPEAALYN--RFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--------AEVLQQVDQGYRMPCP-  226 (261)
T ss_pred             --ccCCCcCceeccCccccccC--CCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCCCCC-
Confidence              11122234579999998764  78999999999999999999 8888864321        1122222222111111 


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGS  346 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~  346 (372)
                            ......+.+++.+||+.+|.+||+++++++.|+.+
T Consensus       227 ------~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         227 ------PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             ------CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence                  12346788899999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=5.5e-40  Score=311.83  Aligned_cols=243  Identities=23%  Similarity=0.395  Sum_probs=189.7

Q ss_pred             hhhhhhcCCCCceEEEEEEec-------------------------chHHHHHHHHhccC-CCceeeeEeEEecCCceeE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL-------------------------DDFVNEVASISRTS-HVNVVTLLGFCLEGNNRAL  138 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-------------------------~~~~~E~~~l~~l~-h~nIv~l~g~~~~~~~~~l  138 (372)
                      +.+.+.||+|+||.||+|+..                         +.+.+|++++++++ ||||++++++|.+.+..++
T Consensus        39 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~l  118 (400)
T cd05105          39 LVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYI  118 (400)
T ss_pred             eehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEE
Confidence            345688999999999998641                         15788999999996 9999999999999999999


Q ss_pred             EEEecCCCChhhhhhcCCCC------------------------------------------------------------
Q 036435          139 IYEFMPNGSLEKFVYNGDTS------------------------------------------------------------  158 (372)
Q Consensus       139 V~e~~~~g~L~~~l~~~~~~------------------------------------------------------------  158 (372)
                      ||||+++|+|.+++......                                                            
T Consensus       119 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (400)
T cd05105         119 ITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEAS  198 (400)
T ss_pred             EEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhh
Confidence            99999999999998653210                                                            


Q ss_pred             ------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCc
Q 036435          159 ------------------------------KPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFC  208 (372)
Q Consensus       159 ------------------------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~  208 (372)
                                                    .....+++.+++.++.|++.||+|||   ..+++|+||||+|||+++++.
T Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~~~~  275 (400)
T cd05105         199 KYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGKI  275 (400)
T ss_pred             hhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeCCCE
Confidence                                          01124788999999999999999999   799999999999999999999


Q ss_pred             eEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccch
Q 036435          209 PKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYF  287 (372)
Q Consensus       209 ~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~  287 (372)
                      +||+|||+++......... ......++..|+|||.+.+.  .++.++|||||||++|||++ |..||.......     
T Consensus       276 ~kL~DfGla~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~-----  347 (400)
T cd05105         276 VKICDFGLARDIMHDSNYV-SKGSTFLPVKWMAPESIFDN--LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS-----  347 (400)
T ss_pred             EEEEeCCcceecccccccc-ccCCcCCCcceEChhhhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-----
Confidence            9999999998654332211 11223466789999998764  78999999999999999996 888887542211     


Q ss_pred             HHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          288 PHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                        .....+........+       ......+.+++.+||+.||++||++.++.+.|+++.
T Consensus       348 --~~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         348 --TFYNKIKSGYRMAKP-------DHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             --HHHHHHhcCCCCCCC-------ccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence              112222222111111       234567888999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.4e-39  Score=341.03  Aligned_cols=240  Identities=26%  Similarity=0.496  Sum_probs=187.5

Q ss_pred             hhhcCCCCceEEEEEEecc---------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCChhhhh
Q 036435           88 KDKLGQGGFGGVYKGRLLD---------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV  152 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~---------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~~~l  152 (372)
                      .+.||+|+||.||+|+...               ...+|++.+++++||||++++|+|.+++..++||||+++|+|.+++
T Consensus       695 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l  774 (968)
T PLN00113        695 ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL  774 (968)
T ss_pred             ccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHH
Confidence            3579999999999997631               2356799999999999999999999999999999999999999999


Q ss_pred             hcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeeeeecc
Q 036435          153 YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLG  232 (372)
Q Consensus       153 ~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  232 (372)
                      +.         ++|.++.+++.|+++||+|||+.++.+++||||||+||+++.++..++. ||.+......       ..
T Consensus       775 ~~---------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-------~~  837 (968)
T PLN00113        775 RN---------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-------TK  837 (968)
T ss_pred             hc---------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-------CC
Confidence            52         8899999999999999999997767899999999999999999888875 6655433221       11


Q ss_pred             cccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcc--cccCCcc--CC
Q 036435          233 ARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDR--EFKLPGV--VT  308 (372)
Q Consensus       233 ~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~--~~  308 (372)
                      ..+|..|+|||++.+.  .++.++|||||||++|||+||+.||+.....  ......|.........  ....+..  ..
T Consensus       838 ~~~t~~y~aPE~~~~~--~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  913 (968)
T PLN00113        838 CFISSAYVAPETRETK--DITEKSDIYGFGLILIELLTGKSPADAEFGV--HGSIVEWARYCYSDCHLDMWIDPSIRGDV  913 (968)
T ss_pred             ccccccccCcccccCC--CCCcccchhhHHHHHHHHHhCCCCCCcccCC--CCcHHHHHHHhcCccchhheeCccccCCC
Confidence            2477899999998764  7899999999999999999999999643222  2234444433221110  0111111  11


Q ss_pred             cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 036435          309 RKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE  348 (372)
Q Consensus       309 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~  348 (372)
                      ....+...++.+++.+||+.||++||+|+|+++.|++...
T Consensus       914 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            1233456678899999999999999999999999988764

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=9.5e-40  Score=293.61  Aligned_cols=235  Identities=26%  Similarity=0.434  Sum_probs=187.0

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-----------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-----------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS  147 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-----------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~  147 (372)
                      +.+.++||+|+||.||+|...+                 .+.+|+.++++++|+||+++++.+.+++..++|+||+++|+
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   87 (261)
T cd05072           8 IKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGS   87 (261)
T ss_pred             eEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCc
Confidence            3456789999999999986532                 57789999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCee
Q 036435          148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV  227 (372)
Q Consensus       148 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  227 (372)
                      |.+++......    .+++.+++.++.|++.||+|||   ..+++|+||||+||++++++.+||+|||++..........
T Consensus        88 L~~~l~~~~~~----~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (261)
T cd05072          88 LLDFLKSDEGG----KVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA  160 (261)
T ss_pred             HHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence            99999764322    2889999999999999999999   7999999999999999999999999999998754322111


Q ss_pred             eeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCcc
Q 036435          228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV  306 (372)
Q Consensus       228 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (372)
                        .....++..|+|||++.+.  .++.++|+|||||++|+|++ |..||......        .....+.....  .+..
T Consensus       161 --~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--------~~~~~~~~~~~--~~~~  226 (261)
T cd05072         161 --REGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--------DVMSALQRGYR--MPRM  226 (261)
T ss_pred             --cCCCccceecCCHHHhccC--CCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--------HHHHHHHcCCC--CCCC
Confidence              1223356779999998764  78899999999999999998 88888643211        11222222211  1111


Q ss_pred             CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 036435          307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG  345 (372)
Q Consensus       307 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~  345 (372)
                           ......+.+++.+||+.+|++||+++++.+.|+.
T Consensus       227 -----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         227 -----ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             -----CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                 1234567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.9e-40  Score=306.77  Aligned_cols=232  Identities=24%  Similarity=0.306  Sum_probs=181.2

Q ss_pred             hhhhhcCCCCceEEEEEEec--------------------------chHHHHHHHHhcc-CCCceeeeEeEEecCCceeE
Q 036435           86 SFKDKLGQGGFGGVYKGRLL--------------------------DDFVNEVASISRT-SHVNVVTLLGFCLEGNNRAL  138 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~--------------------------~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~l  138 (372)
                      .+.+.||+|+||.||+++..                          +.+.+|+.++.++ +||||+++++++.+++..++
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (332)
T cd05614           3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHL   82 (332)
T ss_pred             eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEE
Confidence            34578999999999987541                          1356799999999 59999999999999999999


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          139 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       139 V~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      ||||+++|+|.+++.....      +++.++..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++
T Consensus        83 v~e~~~~g~L~~~l~~~~~------~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~  153 (332)
T cd05614          83 ILDYVSGGEMFTHLYQRDN------FSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSK  153 (332)
T ss_pred             EEeCCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence            9999999999999976432      889999999999999999999   8999999999999999999999999999998


Q ss_pred             cccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhc
Q 036435          219 LCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQD  298 (372)
Q Consensus       219 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (372)
                      .........  .....||..|+|||.+.+. ..++.++|||||||++|||++|+.||.........    ..+...+.. 
T Consensus       154 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~----~~~~~~~~~-  225 (332)
T cd05614         154 EFLSEEKER--TYSFCGTIEYMAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ----SEVSRRILK-  225 (332)
T ss_pred             cccccCCCc--cccccCCccccCHHHhcCC-CCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH----HHHHHHHhc-
Confidence            654332211  1234589999999998764 24788999999999999999999999754322211    111111111 


Q ss_pred             ccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 036435          299 REFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRP-----PMNEVIE  341 (372)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~  341 (372)
                      .....+.       .....+.+++.+||+.||++||     +++++++
T Consensus       226 ~~~~~~~-------~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         226 CDPPFPS-------FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             CCCCCCC-------CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            1111111       2345567889999999999999     7778875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-40  Score=312.24  Aligned_cols=232  Identities=26%  Similarity=0.375  Sum_probs=192.3

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      ++.+.||.|+-|.|-.|++..                      .+.+|+-+|+.+.|||++++|+++.++.++|+|.||+
T Consensus        15 kLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv   94 (786)
T KOG0588|consen   15 KLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYV   94 (786)
T ss_pred             eccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEec
Confidence            345679999999999886632                      5899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      ++|.|.+++...+.      +++.++..++.||+.|+.|+|   ..+|+||||||+|+|||..+++||+|||+|.....+
T Consensus        95 ~gGELFdylv~kG~------l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g  165 (786)
T KOG0588|consen   95 PGGELFDYLVRKGP------LPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG  165 (786)
T ss_pred             CCchhHHHHHhhCC------CCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence            99999999988765      889999999999999999999   899999999999999999999999999999875544


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                      .-    ....+|.+.|.+||++.|. .--..++||||+|||||.|+||+.||+++.-       . -+..++.. ..+.+
T Consensus       166 kl----LeTSCGSPHYA~PEIV~G~-pYdG~~sDVWSCGVILfALLtG~LPFdDdNi-------r-~LLlKV~~-G~f~M  231 (786)
T KOG0588|consen  166 KL----LETSCGSPHYAAPEIVSGR-PYDGRPSDVWSCGVILFALLTGKLPFDDDNI-------R-VLLLKVQR-GVFEM  231 (786)
T ss_pred             cc----ccccCCCcccCCchhhcCC-CCCCCccccchhHHHHHHHHhCCCCCCCccH-------H-HHHHHHHc-CcccC
Confidence            32    3445799999999999986 2336899999999999999999999985421       1 12333332 35566


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hhcCc
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM--LQGST  347 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~--L~~~~  347 (372)
                      |..++.       +..+|+.+|+..||++|.|++||++.  |.+-.
T Consensus       232 Ps~Is~-------eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~  270 (786)
T KOG0588|consen  232 PSNISS-------EAQDLLRRMLDVDPSTRITTEEILKHPFLSGYT  270 (786)
T ss_pred             CCcCCH-------HHHHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence            655544       44556777889999999999999984  44444

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-40  Score=305.68  Aligned_cols=221  Identities=21%  Similarity=0.308  Sum_probs=177.3

Q ss_pred             cCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCCh
Q 036435           91 LGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL  148 (372)
Q Consensus        91 lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L  148 (372)
                      ||+|+||.||+++..+                      .+.+|+.++++++||||+++++++.+++..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            7999999999987632                      366799999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeee
Q 036435          149 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVS  228 (372)
Q Consensus       149 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  228 (372)
                      .+++.....      +++..+..++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++........  
T Consensus        81 ~~~l~~~~~------~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~--  149 (312)
T cd05585          81 FHHLQREGR------FDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--  149 (312)
T ss_pred             HHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCc--
Confidence            999976432      889999999999999999999   899999999999999999999999999999754322211  


Q ss_pred             eecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCC
Q 036435          229 SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVT  308 (372)
Q Consensus       229 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (372)
                       .....||+.|+|||.+.+.  .++.++|||||||++|||++|+.||.....       .. ........ ....+.   
T Consensus       150 -~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~el~tg~~pf~~~~~-------~~-~~~~~~~~-~~~~~~---  214 (312)
T cd05585         150 -TNTFCGTPEYLAPELLLGH--GYTKAVDWWTLGVLLYEMLTGLPPFYDENV-------NE-MYRKILQE-PLRFPD---  214 (312)
T ss_pred             -cccccCCcccCCHHHHcCC--CCCCccceechhHHHHHHHhCCCCcCCCCH-------HH-HHHHHHcC-CCCCCC---
Confidence             1234589999999999875  789999999999999999999999975321       11 11111111 112221   


Q ss_pred             cchHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 036435          309 RKENEIAKKMIIVGLWCIQARPSDRPP---MNEVIE  341 (372)
Q Consensus       309 ~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~evl~  341 (372)
                          .....+.+++.+||+.||.+||+   +.+++.
T Consensus       215 ----~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         215 ----GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             ----cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence                23456778889999999999985   555554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.1e-39  Score=297.94  Aligned_cols=240  Identities=25%  Similarity=0.427  Sum_probs=189.2

Q ss_pred             hhhhcCCCCceEEEEEEec-------------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEE
Q 036435           87 FKDKLGQGGFGGVYKGRLL-------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYE  141 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~-------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  141 (372)
                      +.+.||+|+||.||+|+..                         +++.+|+.+++.++||||+++++.+..++..++|+|
T Consensus         4 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (290)
T cd05045           4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVE   83 (290)
T ss_pred             ccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEE
Confidence            4578999999999998642                         147789999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhcCCCC------------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE
Q 036435          142 FMPNGSLEKFVYNGDTS------------------KPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL  203 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~------------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill  203 (372)
                      |+.+|+|.+++......                  .....+++.+++.++.|++.||+|||   +.+++||||||+|||+
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~nill  160 (290)
T cd05045          84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLV  160 (290)
T ss_pred             ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhheEEE
Confidence            99999999998653211                  11234889999999999999999999   8999999999999999


Q ss_pred             CCCCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCC
Q 036435          204 DEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSS  282 (372)
Q Consensus       204 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~  282 (372)
                      ++++.+||+|||+++.......... .....++..|+|||.+.+.  .++.++||||||+++|||++ |..||.....  
T Consensus       161 ~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--  235 (290)
T cd05045         161 AEGRKMKISDFGLSRDVYEEDSYVK-RSKGRIPVKWMAIESLFDH--IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP--  235 (290)
T ss_pred             cCCCcEEeccccccccccCccchhc-ccCCCCCccccCHHHHccC--CcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence            9999999999999986543332211 1223456789999988764  78999999999999999998 8888854321  


Q ss_pred             CccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          283 SEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                            ..+............+       ......+.+++.+||+.+|.+||+++++++.|+++.
T Consensus       236 ------~~~~~~~~~~~~~~~~-------~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         236 ------ERLFNLLKTGYRMERP-------ENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             ------HHHHHHHhCCCCCCCC-------CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence                  1122333222222112       123456788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.7e-41  Score=308.11  Aligned_cols=231  Identities=22%  Similarity=0.362  Sum_probs=192.3

Q ss_pred             hhhhhhcCCCCceEEEEEEec---------------------chHHHHHHHHhccCCCceeeeEeEEecCCc-eeEEEEe
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL---------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNN-RALIYEF  142 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~---------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~-~~lV~e~  142 (372)
                      +.+.+.+|+|+||.++..+..                     +...+|+.++++++|||||.+.+.|.+++. .+|||+|
T Consensus         6 Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y   85 (426)
T KOG0589|consen    6 YEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEY   85 (426)
T ss_pred             hhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEee
Confidence            445678999999999876442                     257889999999999999999999999988 9999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      |+||+|.+.+.+...    ..++++++.+++.|++.|+.|||   ...|+|||||+.|||++.++.+||+|||+|+..+.
T Consensus        86 ~eGg~l~~~i~~~k~----~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   86 CEGGDLAQLIKEQKG----VLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             cCCCCHHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence            999999999987663    34999999999999999999999   89999999999999999999999999999998876


Q ss_pred             CCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      .....   ....||+.||+||.+.+.  .|+.|+|+|||||++|||++-+++|.......        +...+....   
T Consensus       159 ~~~~a---~tvvGTp~YmcPEil~d~--pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~--------Li~ki~~~~---  222 (426)
T KOG0589|consen  159 EDSLA---STVVGTPYYMCPEILSDI--PYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE--------LILKINRGL---  222 (426)
T ss_pred             chhhh---heecCCCcccCHHHhCCC--CCCccCcchhhcchHHHHHhcccccCccchHH--------HHHHHhhcc---
Confidence            65332   344699999999999986  89999999999999999999999998653221        112222221   


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                          ..+.......++..++..|++.+|+.||++.+++..
T Consensus       223 ----~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 ----YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ----CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence                122223345677788899999999999999999864

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-40  Score=307.95  Aligned_cols=235  Identities=26%  Similarity=0.474  Sum_probs=199.6

Q ss_pred             hhhhhhcCCCCceEEEEEEecc------------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD------------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIY  140 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~  140 (372)
                      ....+.||.|.||.||+|...+                        .|+.|..++++++||||++++|+|.+. ..++||
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wivm  469 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVM  469 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEE
Confidence            3446789999999999997632                        699999999999999999999999764 679999


Q ss_pred             EecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccc
Q 036435          141 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC  220 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~  220 (372)
                      |.++-|.|..||..+...     ++......++.||+.||+|||   +.+.|||||..+|||+.+...+||+|||+++..
T Consensus       470 EL~~~GELr~yLq~nk~s-----L~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~  541 (974)
T KOG4257|consen  470 ELAPLGELREYLQQNKDS-----LPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYL  541 (974)
T ss_pred             ecccchhHHHHHHhcccc-----chHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhc
Confidence            999999999999887643     888999999999999999999   899999999999999999999999999999998


Q ss_pred             cCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcc
Q 036435          221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDR  299 (372)
Q Consensus       221 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (372)
                      .+...+...  ...-++.|||||.+.-  ..++.++|||=|||++||++. |..||..-...+        +..+++.+.
T Consensus       542 ed~~yYkaS--~~kLPIKWmaPESINf--RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD--------VI~~iEnGe  609 (974)
T KOG4257|consen  542 EDDAYYKAS--RGKLPIKWMAPESINF--RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD--------VIGHIENGE  609 (974)
T ss_pred             cccchhhcc--ccccceeecCccccch--hcccchhhHHHHHHHHHHHHHhcCCccccccccc--------eEEEecCCC
Confidence            776655442  3445688999999864  599999999999999999874 889998765544        345566676


Q ss_pred             cccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          300 EFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                      ++..|..       ++..+..++.+||+.+|.+||++.++...|+.+.
T Consensus       610 RlP~P~n-------CPp~LYslmskcWayeP~kRPrftei~~~lsdv~  650 (974)
T KOG4257|consen  610 RLPCPPN-------CPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL  650 (974)
T ss_pred             CCCCCCC-------CChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence            7666644       3456778999999999999999999987775443

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.9e-40  Score=308.13  Aligned_cols=225  Identities=24%  Similarity=0.318  Sum_probs=183.3

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYE  141 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  141 (372)
                      +.+.+.||+|+||.||+|+...                       .+.+|+.+++.++||||+++++++.+++..++|||
T Consensus        32 y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~E  111 (340)
T PTZ00426         32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLE  111 (340)
T ss_pred             cEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEe
Confidence            4556789999999999986421                       35679999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      |+++|+|.+++.....      +++..+..++.|++.||.|||   +.+++||||||+|||++.++.+||+|||++....
T Consensus       112 y~~~g~L~~~i~~~~~------~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        112 FVIGGEFFTFLRRNKR------FPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             CCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            9999999999976542      889999999999999999999   8999999999999999999999999999998654


Q ss_pred             CCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccc
Q 036435          222 TKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF  301 (372)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (372)
                      ...      ....||+.|+|||++.+.  .++.++|+|||||++|||++|+.||.....        ......+... ..
T Consensus       183 ~~~------~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--------~~~~~~i~~~-~~  245 (340)
T PTZ00426        183 TRT------YTLCGTPEYIAPEILLNV--GHGKAADWWTLGIFIYEILVGCPPFYANEP--------LLIYQKILEG-II  245 (340)
T ss_pred             CCc------ceecCChhhcCHHHHhCC--CCCccccccchhhHHHHHhcCCCCCCCCCH--------HHHHHHHhcC-CC
Confidence            322      233589999999999764  678999999999999999999999975421        1122222221 11


Q ss_pred             cCCccCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 036435          302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRP-----PMNEVIEM  342 (372)
Q Consensus       302 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~~  342 (372)
                      ..|..       ....+.+++.+||+.||++|+     +++++++.
T Consensus       246 ~~p~~-------~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        246 YFPKF-------LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             CCCCC-------CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            22222       234567788999999999995     88888764

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.3e-39  Score=292.13  Aligned_cols=232  Identities=26%  Similarity=0.489  Sum_probs=185.7

Q ss_pred             hhhhhcCCCCceEEEEEEecc-----------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCCh
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD-----------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL  148 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~-----------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L  148 (372)
                      .+.+.||+|+||.||+++..+                 ++.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus         7 ~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l   86 (256)
T cd05113           7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCL   86 (256)
T ss_pred             EEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcH
Confidence            456789999999999986532                 578899999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeee
Q 036435          149 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVS  228 (372)
Q Consensus       149 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  228 (372)
                      .+++.....     .+++.+++.++.|++.||+|||   +.+++|+||||+||++++++.+||+|||.++........  
T Consensus        87 ~~~i~~~~~-----~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~--  156 (256)
T cd05113          87 LNYLREHGK-----RFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT--  156 (256)
T ss_pred             HHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee--
Confidence            999976432     2899999999999999999999   899999999999999999999999999999865443211  


Q ss_pred             eecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccC
Q 036435          229 SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVV  307 (372)
Q Consensus       229 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (372)
                      ......++..|+|||.+.+.  .++.++|+||||+++|+|++ |..||.......        .............+.  
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~--~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~--  224 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYS--KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--------TVEKVSQGLRLYRPH--  224 (256)
T ss_pred             ecCCCccChhhCCHHHHhcC--cccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--------HHHHHhcCCCCCCCC--
Confidence            11223356779999999764  78899999999999999998 888886432211        122222222211111  


Q ss_pred             CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 036435          308 TRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ  344 (372)
Q Consensus       308 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~  344 (372)
                           .....+.+++.+||+.+|.+||++.++++.|+
T Consensus       225 -----~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         225 -----LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             -----CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                 12467788999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.8e-40  Score=299.17  Aligned_cols=243  Identities=26%  Similarity=0.369  Sum_probs=183.3

Q ss_pred             hhhhhcCCCCceEEEEEEec------------------------chHHHHHHHHhccCCCceeeeEeEEecC--CceeEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTLLGFCLEG--NNRALI  139 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~--~~~~lV  139 (372)
                      .+.+.||+|+||+||++...                        ..+.+|++++++++||||+++++++...  ...++|
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            34578999999999775320                        1467899999999999999999988754  357899


Q ss_pred             EEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccc
Q 036435          140 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL  219 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  219 (372)
                      |||+++|+|.+++....       +++.++..++.|++.||+|||   +.+++|+||||+||++++++.+||+|||++..
T Consensus        87 ~e~~~~~~l~~~~~~~~-------l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  156 (283)
T cd05080          87 MEYVPLGSLRDYLPKHK-------LNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  156 (283)
T ss_pred             ecCCCCCCHHHHHHHcC-------CCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccc
Confidence            99999999999996532       899999999999999999999   79999999999999999999999999999986


Q ss_pred             ccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCcc-------chHHHHH
Q 036435          220 CTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV-------YFPHWIY  292 (372)
Q Consensus       220 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~-------~~~~~~~  292 (372)
                      ...............++..|+|||.+.+.  .++.++||||||+++|||++|+.|+..........       .......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd05080         157 VPEGHEYYRVREDGDSPVFWYAVECLKEN--KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLI  234 (283)
T ss_pred             cCCcchhhccCCCCCCCceeeCHhHhccc--CCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhh
Confidence            65433221111222355679999998764  78899999999999999999999986532211000       0000001


Q ss_pred             HHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          293 RHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                      ..........       ........+.+++..||+.+|++|||++++++.|+.+.
T Consensus       235 ~~~~~~~~~~-------~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         235 ELLERGMRLP-------CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhhcCCCCC-------CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            1111111111       11223467888999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.2e-39  Score=295.96  Aligned_cols=235  Identities=24%  Similarity=0.384  Sum_probs=183.7

Q ss_pred             hhhhcCCCCceEEEEEEecc------------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEe
Q 036435           87 FKDKLGQGGFGGVYKGRLLD------------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      +.+.||+|+||.||+|++..                        ++..|+..+++++||||+++++++.. ...++++||
T Consensus        11 ~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~   89 (279)
T cd05111          11 KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQL   89 (279)
T ss_pred             eccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEe
Confidence            35779999999999987521                        35667778899999999999999854 567899999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      +++|+|.+++.....     .+++..+..++.|++.||+|||   +.+++|+||||+||++++++.+||+|||+++....
T Consensus        90 ~~~gsL~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          90 SPLGSLLDHVRQHRD-----SLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             CCCCcHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            999999999976432     2899999999999999999999   78999999999999999999999999999986543


Q ss_pred             CCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREF  301 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (372)
                      ..... ......++..|+|||.+.+.  .++.++||||||+++||+++ |..||.....        ......+..+...
T Consensus       162 ~~~~~-~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~  230 (279)
T cd05111         162 DDKKY-FYSEHKTPIKWMALESILFG--RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--------HEVPDLLEKGERL  230 (279)
T ss_pred             CCccc-ccCCCCCcccccCHHHhccC--CcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHCCCcC
Confidence            32211 12233466789999998764  78999999999999999998 8888865321        1112222222222


Q ss_pred             cCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 036435          302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE  348 (372)
Q Consensus       302 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~  348 (372)
                      ..+..       ....+.+++.+||..||++|||+.|+++.|..+..
T Consensus       231 ~~~~~-------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         231 AQPQI-------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             CCCCC-------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence            22221       22456778889999999999999999999987664

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.3e-39  Score=291.08  Aligned_cols=230  Identities=27%  Similarity=0.432  Sum_probs=181.1

Q ss_pred             hhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCCh
Q 036435           89 DKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL  148 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L  148 (372)
                      +.||+|+||.||+|+...                    .+.+|++++++++||||+++++++.+++..++|+||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            369999999999986531                    478899999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeee
Q 036435          149 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVS  228 (372)
Q Consensus       149 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  228 (372)
                      .+++.....     .+++.+++.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++......... .
T Consensus        81 ~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-~  151 (252)
T cd05084          81 LTFLRTEGP-----RLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA-S  151 (252)
T ss_pred             HHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCccccccccc-c
Confidence            999965432     2889999999999999999999   899999999999999999999999999998754322111 1


Q ss_pred             eecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccC
Q 036435          229 SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVV  307 (372)
Q Consensus       229 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (372)
                      .......+..|+|||.+.+.  .++.++|+||||+++|||++ |..||.....        ...............+   
T Consensus       152 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~--------~~~~~~~~~~~~~~~~---  218 (252)
T cd05084         152 TGGMKQIPVKWTAPEALNYG--RYSSESDVWSFGILLWEAFSLGAVPYANLSN--------QQTREAIEQGVRLPCP---  218 (252)
T ss_pred             cCCCCCCceeecCchhhcCC--CCChHHHHHHHHHHHHHHHhCCCCCccccCH--------HHHHHHHHcCCCCCCc---
Confidence            01111234569999998764  78899999999999999997 7777754321        1112222222111111   


Q ss_pred             CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 036435          308 TRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ  344 (372)
Q Consensus       308 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~  344 (372)
                          ...+..+.+++.+||+.+|++|||++++++.|+
T Consensus       219 ----~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         219 ----ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             ----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence                123457888999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-39  Score=290.97  Aligned_cols=231  Identities=29%  Similarity=0.496  Sum_probs=184.6

Q ss_pred             hhhhhcCCCCceEEEEEEec-----------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCCh
Q 036435           86 SFKDKLGQGGFGGVYKGRLL-----------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL  148 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~-----------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L  148 (372)
                      .+.+.||+|+||.||++++.                 +++.+|++++++++||||+++++++.+.+..++|+||+++++|
T Consensus         7 ~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   86 (256)
T cd05059           7 TFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCL   86 (256)
T ss_pred             chhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCH
Confidence            45678999999999998652                 1578899999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeee
Q 036435          149 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVS  228 (372)
Q Consensus       149 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  228 (372)
                      .+++.....     .+++..++.++.|++.||+|||   +.+++|+||||+||++++++.+||+|||+++......... 
T Consensus        87 ~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~-  157 (256)
T cd05059          87 LNYLRERKG-----KLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS-  157 (256)
T ss_pred             HHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccccccc-
Confidence            999976432     2899999999999999999999   8999999999999999999999999999998654322111 


Q ss_pred             eecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccC
Q 036435          229 SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVV  307 (372)
Q Consensus       229 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (372)
                       .....++..|+|||.+.+.  .++.++|+||||+++||+++ |+.||.......        .............+.  
T Consensus       158 -~~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~--  224 (256)
T cd05059         158 -SQGTKFPVKWAPPEVFDYS--RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--------VVESVSAGYRLYRPK--  224 (256)
T ss_pred             -cCCCCCCccccCHHHhccC--CCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--------HHHHHHcCCcCCCCC--
Confidence             1122234579999998764  78899999999999999998 788886432211        122222221111121  


Q ss_pred             CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 036435          308 TRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEML  343 (372)
Q Consensus       308 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L  343 (372)
                           ..+..+.+++.+||+.+|++|||+.++++.|
T Consensus       225 -----~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         225 -----LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             -----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence                 1345788899999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-39  Score=289.90  Aligned_cols=232  Identities=27%  Similarity=0.478  Sum_probs=183.8

Q ss_pred             hhcCCCCceEEEEEEec-----------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           89 DKLGQGGFGGVYKGRLL-----------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~-----------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      ++||+|+||.||+|+..                       +++.+|+.++++++||||+++++++. .+..++|+||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            36999999999998541                       14778999999999999999999876 4568999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      |+|.+++....      .+++..++.++.|++.||+|||   ..+++|+||||+||+++.++.+||+|||+++.......
T Consensus        80 ~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~  150 (257)
T cd05060          80 GPLLKYLKKRR------EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD  150 (257)
T ss_pred             CcHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence            99999997654      2899999999999999999999   78999999999999999999999999999987654443


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCC
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP  304 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (372)
                      .........++..|+|||.+.+.  .++.++|+||||+++|++++ |..||......        .....+........+
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~  220 (257)
T cd05060         151 YYRATTAGRWPLKWYAPECINYG--KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA--------EVIAMLESGERLPRP  220 (257)
T ss_pred             ccccccCccccccccCHHHhcCC--CCCccchHHHHHHHHHHHHcCCCCCcccCCHH--------HHHHHHHcCCcCCCC
Confidence            22222222345679999998764  78999999999999999998 89988653211        112222222221112


Q ss_pred             ccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       305 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                             ......+.+++.+||+.+|.+||++.++++.|++..
T Consensus       221 -------~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         221 -------EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             -------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence                   123456788999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.9e-39  Score=296.05  Aligned_cols=243  Identities=26%  Similarity=0.421  Sum_probs=190.3

Q ss_pred             hhhhhhcCCCCceEEEEEEec------------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIY  140 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~  140 (372)
                      +.+.+.||+|+||.||++...                        +.+.+|+.++++++||||+++++++.+++..++|+
T Consensus         7 ~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   86 (288)
T cd05093           7 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVF   86 (288)
T ss_pred             eeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence            345678999999999998631                        14788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhcCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEee
Q 036435          141 EFMPNGSLEKFVYNGDT-------SKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISD  213 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~-------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  213 (372)
                      ||+++++|.+++.....       ......+++.+++.++.|++.||+|||   +.+++||||||+||++++++.+||+|
T Consensus        87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl~d  163 (288)
T cd05093          87 EYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGD  163 (288)
T ss_pred             EcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEecc
Confidence            99999999999975431       011124899999999999999999999   89999999999999999999999999


Q ss_pred             cCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHH
Q 036435          214 FGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIY  292 (372)
Q Consensus       214 fgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  292 (372)
                      ||++........... .....++..|+|||.+.+.  .++.++|+|||||++|+|++ |..||......        ...
T Consensus       164 fg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~--------~~~  232 (288)
T cd05093         164 FGMSRDVYSTDYYRV-GGHTMLPIRWMPPESIMYR--KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--------EVI  232 (288)
T ss_pred             CCccccccCCceeec-CCCCCccccccCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------HHH
Confidence            999986543322111 1223356789999998764  78899999999999999998 88887643211        112


Q ss_pred             HHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 036435          293 RHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE  348 (372)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~  348 (372)
                      ..+..+.....+.       .....+.+++.+||+.||.+|||++++++.|+.+..
T Consensus       233 ~~i~~~~~~~~~~-------~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         233 ECITQGRVLQRPR-------TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             HHHHcCCcCCCCC-------CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            2222222111111       123568889999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-39  Score=292.71  Aligned_cols=239  Identities=27%  Similarity=0.473  Sum_probs=186.4

Q ss_pred             hhhhcCCCCceEEEEEEecc------------------------hHHHHHHHHhccCCCceeeeEeEEecCCc------e
Q 036435           87 FKDKLGQGGFGGVYKGRLLD------------------------DFVNEVASISRTSHVNVVTLLGFCLEGNN------R  136 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~------~  136 (372)
                      +.+.||+|+||.||+|++.+                        .+.+|+..++.++||||+++++++.+...      .
T Consensus         3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   82 (273)
T cd05035           3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP   82 (273)
T ss_pred             cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence            45789999999999986421                        47789999999999999999999876554      7


Q ss_pred             eEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCC
Q 036435          137 ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGL  216 (372)
Q Consensus       137 ~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  216 (372)
                      ++|+||+++|+|.+++...........+++..+..++.|++.||+|||   +.+++|+||||+||++++++.+||+|||+
T Consensus        83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  159 (273)
T cd05035          83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGL  159 (273)
T ss_pred             EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCccc
Confidence            899999999999999865432222345899999999999999999999   79999999999999999999999999999


Q ss_pred             cccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHh
Q 036435          217 AKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHV  295 (372)
Q Consensus       217 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  295 (372)
                      ++.......... .....++..|+|||.+.+.  .++.++|||||||++|||++ |..||......        ......
T Consensus       160 ~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--------~~~~~~  228 (273)
T cd05035         160 SKKIYSGDYYRQ-GRIAKMPVKWIAIESLADR--VYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--------EIYDYL  228 (273)
T ss_pred             eeeccccccccc-cccccCCccccCHhhcccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHH
Confidence            987654332211 1122345679999998764  78899999999999999999 77887543211        112222


Q ss_pred             hhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 036435          296 EQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGS  346 (372)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~  346 (372)
                      ........+       ......+.+++.+||+.||.+||++.++++.|+++
T Consensus       229 ~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         229 RHGNRLKQP-------EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             HcCCCCCCC-------cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            222222222       12345788899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.4e-39  Score=292.65  Aligned_cols=239  Identities=28%  Similarity=0.453  Sum_probs=183.7

Q ss_pred             hhhhcCCCCceEEEEEEecc-----------------------hHHHHHHHHhccCCCceeeeEeEEecC------Ccee
Q 036435           87 FKDKLGQGGFGGVYKGRLLD-----------------------DFVNEVASISRTSHVNVVTLLGFCLEG------NNRA  137 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~-----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~------~~~~  137 (372)
                      +.+.||+|+||.||+|++.+                       .+.+|+.+++.++|+||+++++++...      ...+
T Consensus         3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   82 (272)
T cd05075           3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV   82 (272)
T ss_pred             cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence            45789999999999986421                       477899999999999999999987532      2468


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCc
Q 036435          138 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLA  217 (372)
Q Consensus       138 lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla  217 (372)
                      +++||+++|+|.+++...........+++.....++.|++.||+|||   +.+++||||||+|||+++++.+||+|||++
T Consensus        83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCCcc
Confidence            99999999999998854322122234899999999999999999999   799999999999999999999999999999


Q ss_pred             ccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhh
Q 036435          218 KLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVE  296 (372)
Q Consensus       218 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  296 (372)
                      ........... .....+++.|++||.+.+.  .++.++|+||||+++|||++ |..||.....        ........
T Consensus       160 ~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~~~~~~  228 (272)
T cd05075         160 KKIYNGDYYRQ-GRIAKMPVKWIAIESLADR--VYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--------SEIYDYLR  228 (272)
T ss_pred             cccCcccceec-CCcccCCcccCCHHHccCC--CcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHH
Confidence            87654332111 1222356789999998764  78999999999999999999 7788764221        11222222


Q ss_pred             hcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 036435          297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGS  346 (372)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~  346 (372)
                      .......+       ......+.+++.+||+.||++|||+.++++.|+++
T Consensus       229 ~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         229 QGNRLKQP-------PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             cCCCCCCC-------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            22221111       12345678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.1e-39  Score=302.98  Aligned_cols=223  Identities=23%  Similarity=0.313  Sum_probs=179.5

Q ss_pred             hcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCC
Q 036435           90 KLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS  147 (372)
Q Consensus        90 ~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~  147 (372)
                      .||+|+||.||+++...                      .+.+|+.+++.++||||+++++++.+++..++||||+++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~   81 (328)
T cd05593           2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE   81 (328)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence            58999999999986532                      46779999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCee
Q 036435          148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV  227 (372)
Q Consensus       148 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  227 (372)
                      |.+++....      .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++........ 
T Consensus        82 L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~-  151 (328)
T cd05593          82 LFFHLSRER------VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT-  151 (328)
T ss_pred             HHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccc-
Confidence            999886543      2899999999999999999999   899999999999999999999999999998754322211 


Q ss_pred             eeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccC
Q 036435          228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVV  307 (372)
Q Consensus       228 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (372)
                        .....||+.|+|||.+.+.  .++.++|||||||++|+|++|+.||......       . ....+.. .....|.  
T Consensus       152 --~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~Pf~~~~~~-------~-~~~~~~~-~~~~~p~--  216 (328)
T cd05593         152 --MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------K-LFELILM-EDIKFPR--  216 (328)
T ss_pred             --cccccCCcCccChhhhcCC--CCCccCCccccchHHHHHhhCCCCCCCCCHH-------H-HHHHhcc-CCccCCC--
Confidence              1234589999999999764  7889999999999999999999999753211       1 1111111 1112222  


Q ss_pred             CcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 036435          308 TRKENEIAKKMIIVGLWCIQARPSDRP-----PMNEVIEM  342 (372)
Q Consensus       308 ~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~~  342 (372)
                           .....+.+++.+||+.||.+||     ++.++++.
T Consensus       217 -----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         217 -----TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             -----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence                 2345677888999999999997     88988853

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=4.4e-40  Score=302.64  Aligned_cols=229  Identities=24%  Similarity=0.314  Sum_probs=183.8

Q ss_pred             hhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           88 KDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      ...||+|+||.||.++-.+                      .++.|-.+|....+|+||+++-.|.+..++||||||++|
T Consensus       146 Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPG  225 (550)
T KOG0605|consen  146 LKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPG  225 (550)
T ss_pred             heeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCC
Confidence            3679999999999997543                      578899999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC-
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE-  224 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~-  224 (372)
                      ||+...|.+.+.      |++..+..++.+++.|+.-||   +.|+|||||||+|+|||..|++||+||||+.-..... 
T Consensus       226 GD~mTLL~~~~~------L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~  296 (550)
T KOG0605|consen  226 GDMMTLLMRKDT------LTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR  296 (550)
T ss_pred             ccHHHHHHhcCc------CchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence            999999988765      899999999999999999999   8999999999999999999999999999995321100 


Q ss_pred             --------------------Cee-----e------------------eecccccccccccccccccccCCCCccccchhH
Q 036435          225 --------------------GIV-----S------------------SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSF  261 (372)
Q Consensus       225 --------------------~~~-----~------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dvwsl  261 (372)
                                          ...     .                  ......|||.|||||++.+.  .++..+|.||+
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k--gY~~~cDwWSL  374 (550)
T KOG0605|consen  297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK--GYGKECDWWSL  374 (550)
T ss_pred             hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC--CCCccccHHHH
Confidence                                000     0                  00123499999999999987  79999999999


Q ss_pred             HHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhc-ccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCC---HH
Q 036435          262 GMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQD-REFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPP---MN  337 (372)
Q Consensus       262 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~  337 (372)
                      |||+||||.|-+||.......        .++.+..- ..+..|.....     ..+..+++.+|+. ||++|..   ++
T Consensus       375 G~ImyEmLvGyPPF~s~tp~~--------T~rkI~nwr~~l~fP~~~~~-----s~eA~DLI~rll~-d~~~RLG~~G~~  440 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSETPQE--------TYRKIVNWRETLKFPEEVDL-----SDEAKDLITRLLC-DPENRLGSKGAE  440 (550)
T ss_pred             HHHHHHHHhCCCCCCCCCHHH--------HHHHHHHHhhhccCCCcCcc-----cHHHHHHHHHHhc-CHHHhcCcccHH
Confidence            999999999999998764432        34443322 22334433332     2566678888888 9999986   55


Q ss_pred             HHHH
Q 036435          338 EVIE  341 (372)
Q Consensus       338 evl~  341 (372)
                      ||-+
T Consensus       441 EIK~  444 (550)
T KOG0605|consen  441 EIKK  444 (550)
T ss_pred             HHhc
Confidence            5543

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1e-39  Score=303.87  Aligned_cols=180  Identities=24%  Similarity=0.372  Sum_probs=155.5

Q ss_pred             HhhhhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           84 TNSFKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      .+.+.++||+|+||.||+++...                    .+.+|++++++++||||++++++|.+++..++||||+
T Consensus         6 ~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   85 (333)
T cd06650           6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM   85 (333)
T ss_pred             hhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecC
Confidence            34556789999999999986531                    4788999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      ++|+|.+++.....      +++..+..++.|++.||.|||+  ..+++|+||||+|||+++++.+||+|||++......
T Consensus        86 ~~~~L~~~l~~~~~------~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~  157 (333)
T cd06650          86 DGGSLDQVLKKAGR------IPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (333)
T ss_pred             CCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence            99999999976432      7889999999999999999994  357999999999999999999999999998755332


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCC
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSG  278 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~  278 (372)
                      .     .....||..|+|||.+.+.  .++.++|+|||||++|||++|+.||...
T Consensus       158 ~-----~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         158 M-----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             c-----cccCCCCccccCHHHhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            1     1223578899999999774  7889999999999999999999998753

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.7e-39  Score=295.59  Aligned_cols=240  Identities=26%  Similarity=0.429  Sum_probs=187.2

Q ss_pred             hhhhhhcCCCCceEEEEEEec------------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIY  140 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~  140 (372)
                      ..+.+.||+|+||.||+|++.                        ..+.+|+.++++++||||+++++++..++..++||
T Consensus         7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   86 (283)
T cd05090           7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLF   86 (283)
T ss_pred             ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEE
Confidence            345678999999999998641                        14778999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhcCCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCce
Q 036435          141 EFMPNGSLEKFVYNGDT-----------SKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP  209 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~-----------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~  209 (372)
                      ||+++++|.+++.....           ......+++.+.+.++.|++.||+|||   +.+++|+||||+|||+++++.+
T Consensus        87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~~~  163 (283)
T cd05090          87 EYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQLHV  163 (283)
T ss_pred             EcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCCcE
Confidence            99999999999864321           011234889999999999999999999   7899999999999999999999


Q ss_pred             EEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchH
Q 036435          210 KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFP  288 (372)
Q Consensus       210 kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~  288 (372)
                      ||+|||+++.......... .....++..|+|||.+.+.  .++.++|+||||+++|||++ |..||.....        
T Consensus       164 kl~dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--------  232 (283)
T cd05090         164 KISDLGLSREIYSADYYRV-QPKSLLPIRWMPPEAIMYG--KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--------  232 (283)
T ss_pred             EeccccccccccCCcceec-ccCCCccceecChHHhccC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--------
Confidence            9999999986644332211 1223356779999998764  78999999999999999998 8888764321        


Q ss_pred             HHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 036435          289 HWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG  345 (372)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~  345 (372)
                      ..+.+..........+.       .....+.+++.+||+.||++||++.++++.|..
T Consensus       233 ~~~~~~~~~~~~~~~~~-------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         233 QEVIEMVRKRQLLPCSE-------DCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHHHHcCCcCCCCC-------CCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            11222222222222221       234567788999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3.1e-39  Score=290.14  Aligned_cols=235  Identities=29%  Similarity=0.488  Sum_probs=188.7

Q ss_pred             hhhhhhcCCCCceEEEEEEec------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      +.+.+.||.|+||.||+|+..                  +++.+|+.+++.++|+||+++++++.+.+..++||||+++|
T Consensus         8 y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (261)
T cd05148           8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKG   87 (261)
T ss_pred             HHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccC
Confidence            455688999999999998753                  25788999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      +|.+++.....    ..+++.++..++.|++.||+|||   +.+++|+||||+||++++++.+||+|||.+.........
T Consensus        88 ~L~~~~~~~~~----~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~  160 (261)
T cd05148          88 SLLAFLRSPEG----QVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL  160 (261)
T ss_pred             CHHHHHhcCCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence            99999976443    23899999999999999999999   799999999999999999999999999999865432211


Q ss_pred             eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                         .....++..|+|||.+.+.  .++.++|+||||+++|+|++ |+.||......        ..............+ 
T Consensus       161 ---~~~~~~~~~~~~PE~~~~~--~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~-  226 (261)
T cd05148         161 ---SSDKKIPYKWTAPEAASHG--TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH--------EVYDQITAGYRMPCP-  226 (261)
T ss_pred             ---ccCCCCceEecCHHHHccC--CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH--------HHHHHHHhCCcCCCC-
Confidence               1133456789999998764  78899999999999999998 78888643211        112222222111111 


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGS  346 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~  346 (372)
                            ......+.+++.+||+.||.+|||++++++.|+.+
T Consensus       227 ------~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         227 ------AKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             ------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence                  22345678899999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.7e-39  Score=303.57  Aligned_cols=228  Identities=22%  Similarity=0.357  Sum_probs=176.3

Q ss_pred             hhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           87 FKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      +.+.||+|+||.||+++...                    .+.+|++++++++|+||+++++++.+++..++||||+++|
T Consensus        78 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  157 (353)
T PLN00034         78 RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG  157 (353)
T ss_pred             hhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCC
Confidence            45779999999999997531                    4788999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      +|.+..          ..++..+..++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++........
T Consensus       158 ~L~~~~----------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~  224 (353)
T PLN00034        158 SLEGTH----------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP  224 (353)
T ss_pred             cccccc----------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence            986532          1566778899999999999999   899999999999999999999999999999865432211


Q ss_pred             eeeeccccccccccccccccccc---CCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          227 VSSLLGARGIIGYIAPEVFSRNF---GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                         .....||..|+|||.+....   ...+.++|||||||++|||++|+.||.......    ... ............ 
T Consensus       225 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~----~~~-~~~~~~~~~~~~-  295 (353)
T PLN00034        225 ---CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD----WAS-LMCAICMSQPPE-  295 (353)
T ss_pred             ---ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc----HHH-HHHHHhccCCCC-
Confidence               12345889999999885321   123568999999999999999999997432211    000 011111111111 


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                            ........+.+++.+||+.||++|||++|+++.
T Consensus       296 ------~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        296 ------APATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             ------CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                  111234568889999999999999999999974

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=8.9e-40  Score=303.10  Aligned_cols=223  Identities=24%  Similarity=0.321  Sum_probs=179.0

Q ss_pred             hhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           89 DKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      +.||+|+||.||+++...                      .+.+|+.++++++||||+++++++.+++..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            358999999999986532                      3567999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      +|.+++.....      +++..+..++.|++.||+|||   +.+++||||||+|||+++++.+||+|||++.........
T Consensus        81 ~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  151 (323)
T cd05595          81 ELFFHLSRERV------FTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  151 (323)
T ss_pred             cHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc
Confidence            99998876432      899999999999999999999   899999999999999999999999999998753322211


Q ss_pred             eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCcc
Q 036435          227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV  306 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (372)
                         .....||+.|+|||.+.+.  .++.++|||||||++|||++|+.||.......        ...... ......|. 
T Consensus       152 ---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--------~~~~~~-~~~~~~p~-  216 (323)
T cd05595         152 ---MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--------LFELIL-MEEIRFPR-  216 (323)
T ss_pred             ---cccccCCcCcCCcccccCC--CCCchhchhhhHHHHHHHHhCCCCCCCCCHHH--------HHHHHh-cCCCCCCC-
Confidence               1234588999999999764  78999999999999999999999997542211        111111 11112222 


Q ss_pred             CCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 036435          307 VTRKENEIAKKMIIVGLWCIQARPSDRP-----PMNEVIE  341 (372)
Q Consensus       307 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~  341 (372)
                            .+...+.+++.+||+.||.+||     ++.++++
T Consensus       217 ------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         217 ------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             ------CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence                  2345677888999999999998     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.2e-39  Score=294.04  Aligned_cols=235  Identities=26%  Similarity=0.465  Sum_probs=186.2

Q ss_pred             hhhhcCCCCceEEEEEEec-----------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           87 FKDKLGQGGFGGVYKGRLL-----------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~-----------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      ..+.||+|+||.||+|+..                       +++.+|++++++++||||+++++++.+.+..++||||+
T Consensus         9 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (268)
T cd05063           9 KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYM   88 (268)
T ss_pred             EeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcC
Confidence            4578999999999998652                       14778999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      ++++|.+++.....     .+++.++..++.|++.||+|||   +.+++|+||||+||++++++.+||+|||++......
T Consensus        89 ~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          89 ENGALDKYLRDHDG-----EFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             CCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            99999999975432     2899999999999999999999   789999999999999999999999999999866433


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      ............+..|+|||++.+.  .++.++|+|||||++||+++ |+.||......       . ....+.....  
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-------~-~~~~i~~~~~--  228 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYR--KFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-------E-VMKAINDGFR--  228 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcC--CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-------H-HHHHHhcCCC--
Confidence            2221111122234579999998764  78999999999999999997 99998643211       1 1222222111  


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGS  346 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~  346 (372)
                      .+.     ..+....+.+++.+||+.+|++||++.++++.|+++
T Consensus       229 ~~~-----~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         229 LPA-----PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             CCC-----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            111     112346678899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.2e-39  Score=293.98  Aligned_cols=240  Identities=25%  Similarity=0.403  Sum_probs=185.5

Q ss_pred             hhhhhhcCCCCceEEEEEEec-------------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL-------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI  139 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV  139 (372)
                      +.+.+.||+|+||.||+|...                         .++.+|+.+++.++||||+++++++.++...++|
T Consensus         8 ~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv   87 (277)
T cd05062           8 ITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI   87 (277)
T ss_pred             ceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEE
Confidence            344678999999999987532                         1477899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecC
Q 036435          140 YEFMPNGSLEKFVYNGDTSK----PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFG  215 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~----~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  215 (372)
                      +||+++|+|.+++.......    ....+++..++.++.|+++||+|||   +.+++|+||||+||++++++.++|+|||
T Consensus        88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l~dfg  164 (277)
T cd05062          88 MELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFG  164 (277)
T ss_pred             EecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEECCCC
Confidence            99999999999997533211    1123688999999999999999999   7899999999999999999999999999


Q ss_pred             CcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHH
Q 036435          216 LAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRH  294 (372)
Q Consensus       216 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  294 (372)
                      +++.......... .....++..|+|||.+.+.  .++.++|+|||||++|||++ |..||......        .....
T Consensus       165 ~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--------~~~~~  233 (277)
T cd05062         165 MTRDIYETDYYRK-GGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--------QVLRF  233 (277)
T ss_pred             CccccCCcceeec-CCCCccCHhhcChhHhhcC--CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHH
Confidence            9986544332211 1122356789999998764  78999999999999999998 67777543211        11122


Q ss_pred             hhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 036435          295 VEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG  345 (372)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~  345 (372)
                      .........+.       .....+.+++.+||+.||++|||+.|+++.|++
T Consensus       234 ~~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         234 VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HHcCCcCCCCC-------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            22221111121       123567889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.1e-39  Score=317.33  Aligned_cols=234  Identities=20%  Similarity=0.261  Sum_probs=184.8

Q ss_pred             hhhhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      +.+.+.||+|+||.||++....                    .+.+|+.+++.++||||+++++++.+++..++||||++
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~  148 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS  148 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence            4456789999999999985421                    46779999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      +|+|.+++......  ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus       149 gg~L~~~l~~~~~~--~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        149 GGDLNKQIKQRLKE--HLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             CCCHHHHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            99999988653211  123889999999999999999999   8999999999999999999999999999998764432


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCC
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP  304 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (372)
                      ... ......||+.|+|||.+.+.  .++.++|||||||++|||++|+.||.....       .. +......+.....+
T Consensus       224 ~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-------~~-~~~~~~~~~~~~~~  292 (478)
T PTZ00267        224 SLD-VASSFCGTPYYLAPELWERK--RYSKKADMWSLGVILYELLTLHRPFKGPSQ-------RE-IMQQVLYGKYDPFP  292 (478)
T ss_pred             ccc-cccccCCCccccCHhHhCCC--CCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-------HH-HHHHHHhCCCCCCC
Confidence            211 12234589999999999774  789999999999999999999999864321       11 11111111111111


Q ss_pred             ccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       305 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                             ..+...+.+++.+||+.||++||+++++++
T Consensus       293 -------~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        293 -------CPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             -------ccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence                   123456788999999999999999999874

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.9e-40  Score=300.32  Aligned_cols=243  Identities=19%  Similarity=0.259  Sum_probs=181.3

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      .+.+.||+|+||.||+++...                     .+.+|+.++++++||||+++++++.+++..++||||++
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   83 (287)
T cd07848           4 EVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVE   83 (287)
T ss_pred             eEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCC
Confidence            345789999999999987632                     46789999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      ++.+..+.....      .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.......
T Consensus        84 ~~~l~~~~~~~~------~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          84 KNMLELLEEMPN------GVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             CCHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            877765443221      2889999999999999999999   8999999999999999999999999999998754322


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccch-------HHHHHHHhhh
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYF-------PHWIYRHVEQ  297 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~-------~~~~~~~~~~  297 (372)
                      ...  .....||..|+|||++.+.  .++.++|+|||||++|||++|+.||............       +.........
T Consensus       155 ~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07848         155 NAN--YTEYVATRWYRSPELLLGA--PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS  230 (287)
T ss_pred             ccc--ccccccccccCCcHHHcCC--CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence            111  1233578899999999775  6889999999999999999999999764321100000       0000000000


Q ss_pred             cc---cccCCccCCc------chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          298 DR---EFKLPGVVTR------KENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       298 ~~---~~~~~~~~~~------~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ..   ....+.....      ........+.+++.+||+.||++|||++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00   0011111000      01123456889999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.1e-39  Score=297.05  Aligned_cols=244  Identities=26%  Similarity=0.420  Sum_probs=186.6

Q ss_pred             hhhhhhcCCCCceEEEEEEec------------------------chHHHHHHHHhccCCCceeeeEeEEecC--CceeE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTLLGFCLEG--NNRAL  138 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~--~~~~l  138 (372)
                      +...+.||+|+||.||+++..                        +.+.+|+.++++++||||+++++++.+.  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (284)
T cd05079           6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL   85 (284)
T ss_pred             hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEE
Confidence            344678999999999988631                        1578899999999999999999999875  56889


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          139 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       139 V~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      ||||+++++|.+++.....     .+++.+++.++.|++.||+|||   +.+++||||||+||++++++.++|+|||++.
T Consensus        86 v~e~~~g~~L~~~l~~~~~-----~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          86 IMEFLPSGSLKEYLPRNKN-----KINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             EEEccCCCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccc
Confidence            9999999999999865432     2899999999999999999999   8999999999999999999999999999998


Q ss_pred             cccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCC--------CccchHHH
Q 036435          219 LCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSS--------SEVYFPHW  290 (372)
Q Consensus       219 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~--------~~~~~~~~  290 (372)
                      ................++..|+|||.+.+.  .++.++|+||||+++|||++++.|........        ..... ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~-~~  234 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQS--KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTV-TR  234 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccC--CCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccH-HH
Confidence            765443322222234466779999998764  78899999999999999999877654321100        00011 11


Q ss_pred             HHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 036435          291 IYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGS  346 (372)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~  346 (372)
                      .............+       ......+.+++.+||+.+|.+||+++++++.|+.+
T Consensus       235 ~~~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         235 LVRVLEEGKRLPRP-------PNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHHHHcCccCCCC-------CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            11111111111111       12356788899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3e-39  Score=296.09  Aligned_cols=241  Identities=25%  Similarity=0.461  Sum_probs=187.2

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhcc-CCCceeeeEeEEecCCceeEEEEe
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      .+.+.||+|+||.||+|...+                      .+.+|+.++.++ +||||+++++++.+.+..++|+||
T Consensus         5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~   84 (297)
T cd05089           5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEY   84 (297)
T ss_pred             eeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEe
Confidence            446789999999999986421                      477899999999 799999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEe
Q 036435          143 MPNGSLEKFVYNGDTSK----------PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKIS  212 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  212 (372)
                      +++|+|.+++.......          ....+++..++.++.|++.||+|||   +.+++||||||+|||+++++.+||+
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~  161 (297)
T cd05089          85 APYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIA  161 (297)
T ss_pred             cCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeEEEC
Confidence            99999999997643111          1134889999999999999999999   7999999999999999999999999


Q ss_pred             ecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHH
Q 036435          213 DFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWI  291 (372)
Q Consensus       213 Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  291 (372)
                      |||++......    ........+..|+|||.+.+.  .++.++|||||||++|||++ |..||......       . .
T Consensus       162 dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~-------~-~  227 (297)
T cd05089         162 DFGLSRGEEVY----VKKTMGRLPVRWMAIESLNYS--VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA-------E-L  227 (297)
T ss_pred             CcCCCccccce----eccCCCCcCccccCchhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------H-H
Confidence            99998643211    111112234569999998764  68899999999999999997 98998653221       1 1


Q ss_pred             HHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccC
Q 036435          292 YRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEAL  350 (372)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~  350 (372)
                      ............+       ..+...+.+++.+||+.+|.+|||++++++.|+.+....
T Consensus       228 ~~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         228 YEKLPQGYRMEKP-------RNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             HHHHhcCCCCCCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            2222222111112       123456778999999999999999999999998777543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=3.8e-39  Score=293.24  Aligned_cols=241  Identities=25%  Similarity=0.412  Sum_probs=187.1

Q ss_pred             HhhhhhhcCCCCceEEEEEEec-------------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeE
Q 036435           84 TNSFKDKLGQGGFGGVYKGRLL-------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRAL  138 (372)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~l  138 (372)
                      .+.+.+.||+|+||.||+|+..                         +.+.+|+.++.+++||||+++++++.+.+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            3456788999999999998642                         147789999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhcCCC----------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCc
Q 036435          139 IYEFMPNGSLEKFVYNGDT----------SKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFC  208 (372)
Q Consensus       139 V~e~~~~g~L~~~l~~~~~----------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~  208 (372)
                      ++||+++++|.+++.....          ......+++..+..++.|++.||+|||   +.+++||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCc
Confidence            9999999999999864211          011234888999999999999999999   899999999999999999999


Q ss_pred             eEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccch
Q 036435          209 PKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYF  287 (372)
Q Consensus       209 ~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~  287 (372)
                      +||+|||+++......... ......+++.|+|||.+.+.  .++.++|||||||++|||++ |..||......      
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------  233 (283)
T cd05091         163 VKISDLGLFREVYAADYYK-LMGNSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------  233 (283)
T ss_pred             eEecccccccccccchhee-eccCccCCccccCHHHHhcC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH------
Confidence            9999999988654332211 12233456789999998764  78899999999999999998 77777543211      


Q ss_pred             HHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 036435          288 PHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG  345 (372)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~  345 (372)
                       . ....+........+       .+....+.+++..||+.+|.+||+++++++.|+.
T Consensus       234 -~-~~~~i~~~~~~~~~-------~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         234 -D-VIEMIRNRQVLPCP-------DDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             -H-HHHHHHcCCcCCCC-------CCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence             1 12222222111111       2234567889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-39  Score=293.58  Aligned_cols=240  Identities=25%  Similarity=0.420  Sum_probs=187.9

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-------------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-------------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALI  139 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV  139 (372)
                      +.+.+.||+|+||.||+|....                         .+.+|+.+++.++||||+++++++.++...++|
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v   87 (277)
T cd05032           8 ITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVV   87 (277)
T ss_pred             eeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEE
Confidence            3445789999999999986521                         477899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecC
Q 036435          140 YEFMPNGSLEKFVYNGDTSK----PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFG  215 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~----~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  215 (372)
                      |||+++|+|.+++.......    ....+++..++.++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~dfg  164 (277)
T cd05032          88 MELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFG  164 (277)
T ss_pred             EecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEECCcc
Confidence            99999999999997543211    1224789999999999999999999   8999999999999999999999999999


Q ss_pred             CcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHH
Q 036435          216 LAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRH  294 (372)
Q Consensus       216 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  294 (372)
                      +++......... ......++..|+|||.+.+.  .++.++|||||||++||+++ |..||......        .....
T Consensus       165 ~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--------~~~~~  233 (277)
T cd05032         165 MTRDIYETDYYR-KGGKGLLPVRWMAPESLKDG--VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--------EVLKF  233 (277)
T ss_pred             cchhhccCcccc-cCCCCCccccccCHHHHhcC--CCCcccchHHHHHHHHHhhccCCCCCccCCHH--------HHHHH
Confidence            998654432211 11223457789999998764  78999999999999999998 88887643211        11222


Q ss_pred             hhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 036435          295 VEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG  345 (372)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~  345 (372)
                      .........+..       ....+.+++.+||+.+|++|||+.++++.|++
T Consensus       234 ~~~~~~~~~~~~-------~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         234 VIDGGHLDLPEN-------CPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             HhcCCCCCCCCC-------CCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            222222222221       24678889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=9.8e-40  Score=298.04  Aligned_cols=240  Identities=23%  Similarity=0.371  Sum_probs=181.0

Q ss_pred             hhhhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      +.+.+.||+|+||.||+|+...                    .+.+|+.++++++||||+++++++.+++..++||||++
T Consensus         7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   86 (288)
T cd07871           7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD   86 (288)
T ss_pred             ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence            3445789999999999986531                    46789999999999999999999999999999999997


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      + +|.+++.....     .+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++......
T Consensus        87 ~-~l~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~  157 (288)
T cd07871          87 S-DLKQYLDNCGN-----LMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT  157 (288)
T ss_pred             c-CHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence            5 99998865432     2788999999999999999999   8999999999999999999999999999997644322


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHh---------
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV---------  295 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---------  295 (372)
                      ..   .....+++.|+|||.+.+. ..++.++||||+||++|||++|+.||........    ........         
T Consensus       158 ~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~  229 (288)
T cd07871         158 KT---YSNEVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE----LHLIFRLLGTPTEETWP  229 (288)
T ss_pred             cc---ccCceecccccChHHhcCC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHhCCCChHHhh
Confidence            11   1233578899999998653 3678999999999999999999999975432110    00000000         


Q ss_pred             --hhc---ccccCCccCCcc----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          296 --EQD---REFKLPGVVTRK----ENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       296 --~~~---~~~~~~~~~~~~----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                        ...   .....+......    ......+..+++.+||+.||.+|||++|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         230 GITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             ccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence              000   000011110000    0112356788999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.8e-39  Score=300.52  Aligned_cols=231  Identities=20%  Similarity=0.306  Sum_probs=178.9

Q ss_pred             hhcCCCCceEEEEEEecc----------------------hHHHHHHHHhcc-CCCceeeeEeEEecCCceeEEEEecCC
Q 036435           89 DKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      +.||+|+||.||+++...                      .+.+|+.++.++ +||||+++++++.+++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            359999999999987532                      356788888776 899999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      |+|..++.....      +++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.......
T Consensus        81 ~~L~~~~~~~~~------l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~  151 (329)
T cd05618          81 GDLMFHMQRQRK------LPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD  151 (329)
T ss_pred             CCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC
Confidence            999998865432      899999999999999999999   89999999999999999999999999999875332221


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCC-ccchHHHHHHHhhhcccccCC
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSS-EVYFPHWIYRHVEQDREFKLP  304 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  304 (372)
                      .   .....||..|+|||++.+.  .++.++|+|||||++|||++|+.||........ ......+....... .....|
T Consensus       152 ~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~-~~~~~p  225 (329)
T cd05618         152 T---TSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-KQIRIP  225 (329)
T ss_pred             c---cccccCCccccCHHHHcCC--CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc-CCCCCC
Confidence            1   1234588999999999875  788999999999999999999999964322111 11112223332222 122223


Q ss_pred             ccCCcchHHHHHHHHHHHHHcccCCCCCCCC------HHHHHH
Q 036435          305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPP------MNEVIE  341 (372)
Q Consensus       305 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs------~~evl~  341 (372)
                      .       .....+.+++.+||+.||.+||+      +.++++
T Consensus       226 ~-------~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05618         226 R-------SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  261 (329)
T ss_pred             C-------CCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence            2       22355678899999999999998      466654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.9e-39  Score=295.48  Aligned_cols=241  Identities=25%  Similarity=0.454  Sum_probs=188.8

Q ss_pred             hhhhhcCCCCceEEEEEEecc-------------------------hHHHHHHHHhcc-CCCceeeeEeEEecCCceeEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD-------------------------DFVNEVASISRT-SHVNVVTLLGFCLEGNNRALI  139 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~-------------------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV  139 (372)
                      .+.+.||+|+||.||++...+                         ++.+|+.+++++ +|+||+++++++.+++..+++
T Consensus        15 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li   94 (293)
T cd05053          15 TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVV   94 (293)
T ss_pred             EEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEE
Confidence            345789999999999986421                         477899999999 899999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCC----------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCce
Q 036435          140 YEFMPNGSLEKFVYNGDT----------SKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP  209 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~----------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~  209 (372)
                      |||+++|+|.+++.....          ......+++..++.++.|++.||+|||   +.+++|+||||+||++++++.+
T Consensus        95 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~~~~~~  171 (293)
T cd05053          95 VEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVM  171 (293)
T ss_pred             EEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEcCCCeE
Confidence            999999999999975321          012235899999999999999999999   8999999999999999999999


Q ss_pred             EEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchH
Q 036435          210 KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFP  288 (372)
Q Consensus       210 kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~  288 (372)
                      ||+|||+++.......... .....++..|+|||.+.+.  .++.++|||||||++||+++ |..||......       
T Consensus       172 kL~Dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------  241 (293)
T cd05053         172 KIADFGLARDIHHIDYYRK-TTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-------  241 (293)
T ss_pred             EeCccccccccccccceec-cCCCCCCccccCHHHhccC--CcCcccceeehhhHHHHHhcCCCCCCCCCCHH-------
Confidence            9999999987654332211 1223356789999998764  78899999999999999997 88887643211       


Q ss_pred             HHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          289 HWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                       ..............+       ......+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       242 -~~~~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         242 -ELFKLLKEGYRMEKP-------QNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             -HHHHHHHcCCcCCCC-------CCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence             122222222221111       122456788999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-41  Score=302.78  Aligned_cols=224  Identities=28%  Similarity=0.400  Sum_probs=186.4

Q ss_pred             hhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCC
Q 036435           88 KDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS  147 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~  147 (372)
                      .+.||+|+||.||||....                    ++.+|+.+|.+++++||.++||.+..+..++++||||.+|+
T Consensus        18 ~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGs   97 (467)
T KOG0201|consen   18 LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGS   97 (467)
T ss_pred             chhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcc
Confidence            3679999999999997632                    67889999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCee
Q 036435          148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV  227 (372)
Q Consensus       148 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  227 (372)
                      +.+.+.....      +.+..+.-++++++.|+.|||   ..+.+|||||+.|||+..+|.+|++|||++..........
T Consensus        98 v~~lL~~~~~------~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr  168 (467)
T KOG0201|consen   98 VLDLLKSGNI------LDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR  168 (467)
T ss_pred             hhhhhccCCC------CccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence            9999976553      467777788999999999999   8999999999999999999999999999998766544332


Q ss_pred             eeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccC
Q 036435          228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVV  307 (372)
Q Consensus       228 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (372)
                         ....||+-|||||++.+.  .|+.|+||||||++.+||.+|.+|+.........                +.+|...
T Consensus       169 ---~tfvGTPfwMAPEVI~~~--~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl----------------flIpk~~  227 (467)
T KOG0201|consen  169 ---KTFVGTPFWMAPEVIKQS--GYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL----------------FLIPKSA  227 (467)
T ss_pred             ---ccccccccccchhhhccc--cccchhhhhhhhHHHHHHhcCCCCCcccCcceEE----------------EeccCCC
Confidence               456799999999999865  8999999999999999999999999765443211                1111111


Q ss_pred             Cc-chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          308 TR-KENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       308 ~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ++ ....+...+.+++..||++||+.||+++++++
T Consensus       228 PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  228 PPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             CCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            11 11134566778888999999999999999985

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=5.6e-39  Score=289.67  Aligned_cols=236  Identities=25%  Similarity=0.474  Sum_probs=187.9

Q ss_pred             hhhhhcCCCCceEEEEEEec-----------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEe
Q 036435           86 SFKDKLGQGGFGGVYKGRLL-----------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~-----------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      ++.+.||+|+||.||+|+..                       ..+.+|+.++++++||||+++++++.+++..++||||
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (267)
T cd05066           7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEY   86 (267)
T ss_pred             EeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEc
Confidence            45678999999999998652                       1478899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      +++++|.+++.....     .+++.+++.++.|++.||+|||   +.+++|+||||+|||++.++.++|+|||++.....
T Consensus        87 ~~~~~L~~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          87 MENGSLDAFLRKHDG-----QFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             CCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            999999999976432     2899999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREF  301 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (372)
                      ............++..|+|||.+.+.  .++.++|+||||+++||+++ |..||.......        ....+......
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--------~~~~~~~~~~~  228 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--------VIKAIEEGYRL  228 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccC--ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--------HHHHHhCCCcC
Confidence            43322222222345679999999764  78999999999999999886 999886542211        11222222111


Q ss_pred             cCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 036435          302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGS  346 (372)
Q Consensus       302 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~  346 (372)
                      ..+       ...+..+.+++.+||+.+|.+||++.++++.|++.
T Consensus       229 ~~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         229 PAP-------MDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             CCC-------CCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            111       12345678899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.5e-39  Score=296.97  Aligned_cols=238  Identities=24%  Similarity=0.399  Sum_probs=176.5

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhcc---CCCceeeeEeEEec-----CCc
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRT---SHVNVVTLLGFCLE-----GNN  135 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l---~h~nIv~l~g~~~~-----~~~  135 (372)
                      .+.+.||+|+||.||+++...                      .+.+|+.+++++   +||||++++++|..     ...
T Consensus         4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~   83 (290)
T cd07862           4 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK   83 (290)
T ss_pred             ceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCc
Confidence            446789999999999986521                      356687777766   69999999999862     456


Q ss_pred             eeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecC
Q 036435          136 RALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFG  215 (372)
Q Consensus       136 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  215 (372)
                      .++|+||++ ++|.+++......    .+++.++..++.|++.||+|||   +.+++||||||+|||+++++.+||+|||
T Consensus        84 ~~lv~e~~~-~~l~~~~~~~~~~----~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          84 LTLVFEHVD-QDLTTYLDKVPEP----GVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             EEEEEccCC-CCHHHHHHhCCCC----CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEcccc
Confidence            899999996 6999998764322    2899999999999999999999   8999999999999999999999999999


Q ss_pred             CcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHh
Q 036435          216 LAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV  295 (372)
Q Consensus       216 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  295 (372)
                      +++......    ......||+.|+|||.+.+.  .++.++|||||||++|||++|++||........   + ..+....
T Consensus       156 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~---~-~~i~~~~  225 (290)
T cd07862         156 LARIYSFQM----ALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---L-GKILDVI  225 (290)
T ss_pred             ceEeccCCc----ccccccccccccChHHHhCC--CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH---H-HHHHHHh
Confidence            997654331    12234588999999998764  788999999999999999999999976432110   0 0010000


Q ss_pred             hhcccccCCc-----------cCC----cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          296 EQDREFKLPG-----------VVT----RKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       296 ~~~~~~~~~~-----------~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ........+.           ...    ....+....+.+++.+||+.||++|||+.|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         226 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             CCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            0000000000           000    001123456678999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=5.2e-39  Score=291.99  Aligned_cols=239  Identities=25%  Similarity=0.413  Sum_probs=186.7

Q ss_pred             hhhhhcCCCCceEEEEEEec------------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYE  141 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  141 (372)
                      .+.++||+|+||.||+++..                        +.+.+|+++++.++|+||+++++++.+++..++|+|
T Consensus         8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   87 (280)
T cd05092           8 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFE   87 (280)
T ss_pred             eeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEe
Confidence            34678999999999998521                        158889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhcCCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEe
Q 036435          142 FMPNGSLEKFVYNGDTS---------KPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKIS  212 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~---------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  212 (372)
                      |+++|+|.+++......         .....+++.+++.++.|++.||+|||   +.+++|+||||+|||+++++.+||+
T Consensus        88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~kL~  164 (280)
T cd05092          88 YMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVVKIG  164 (280)
T ss_pred             cCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCEEEC
Confidence            99999999999764321         11134899999999999999999999   8999999999999999999999999


Q ss_pred             ecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHH
Q 036435          213 DFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWI  291 (372)
Q Consensus       213 Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  291 (372)
                      |||++........... .....+++.|+|||.+.+.  .++.++|||||||++|||++ |..||.......        .
T Consensus       165 dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--------~  233 (280)
T cd05092         165 DFGMSRDIYSTDYYRV-GGRTMLPIRWMPPESILYR--KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE--------A  233 (280)
T ss_pred             CCCceeEcCCCceeec-CCCccccccccCHHHhccC--CcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--------H
Confidence            9999976543322111 1222346789999998765  78999999999999999998 888886432211        1


Q ss_pred             HHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 036435          292 YRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG  345 (372)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~  345 (372)
                      ............+.       .....+.+++.+||+.||++||+++++++.|++
T Consensus       234 ~~~~~~~~~~~~~~-------~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         234 IECITQGRELERPR-------TCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             HHHHHcCccCCCCC-------CCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            12222222221121       223567789999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=4e-39  Score=299.49  Aligned_cols=230  Identities=20%  Similarity=0.290  Sum_probs=179.9

Q ss_pred             hcCCCCceEEEEEEecc----------------------hHHHHHHHHhcc-CCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           90 KLGQGGFGGVYKGRLLD----------------------DFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        90 ~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      .||+|+||.||+++...                      .+.+|..++.++ +||||+++++++.+++..++||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g   81 (329)
T cd05588           2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG   81 (329)
T ss_pred             eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            58999999999986532                      356788889888 7999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      +|.+++.....      +++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++........
T Consensus        82 ~L~~~~~~~~~------l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~  152 (329)
T cd05588          82 DLMFHMQRQRK------LPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT  152 (329)
T ss_pred             CHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCc
Confidence            99998865432      899999999999999999999   899999999999999999999999999998753221111


Q ss_pred             eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCC-CccchHHHHHHHhhhcccccCCc
Q 036435          227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSS-SEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                         .....||+.|+|||++.+.  .++.++|+|||||++|+|++|+.||....... .......+..+.+... ....|.
T Consensus       153 ---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~p~  226 (329)
T cd05588         153 ---TSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK-QIRIPR  226 (329)
T ss_pred             ---cccccCCccccCHHHHcCC--CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC-CCCCCC
Confidence               1234588999999999875  78899999999999999999999997432211 1111222333322221 222232


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCC------HHHHHH
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPP------MNEVIE  341 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs------~~evl~  341 (372)
                      .       +...+.+++.+||+.||.+||+      ++++++
T Consensus       227 ~-------~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         227 S-------LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             C-------CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            2       2346778899999999999997      677764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.7e-39  Score=292.05  Aligned_cols=239  Identities=26%  Similarity=0.415  Sum_probs=177.0

Q ss_pred             hcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCC
Q 036435           90 KLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS  147 (372)
Q Consensus        90 ~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~  147 (372)
                      +||+|+||.||+|+...                      .+.+|+.+++.++||||+++++.+.+....++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            59999999999985421                      46789999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCee
Q 036435          148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV  227 (372)
Q Consensus       148 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  227 (372)
                      |.+++....... ....++...+.++.|++.||+|||   +.+++||||||+|||+++++.+||+|||++..........
T Consensus        82 L~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          82 LKNYLRSNRGMV-AQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             HHHHHHhccccc-cccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            999997654311 123567888999999999999999   7999999999999999999999999999987543322211


Q ss_pred             eeecccccccccccccccccc-----cCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccc
Q 036435          228 SSLLGARGIIGYIAPEVFSRN-----FGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREF  301 (372)
Q Consensus       228 ~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (372)
                      . .....++..|+|||++...     ...++.++|||||||++|||++ |..||.......       ....... ....
T Consensus       158 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-------~~~~~~~-~~~~  228 (269)
T cd05042         158 T-KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-------VLKQVVR-EQDI  228 (269)
T ss_pred             c-cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-------HHHHHhh-ccCc
Confidence            1 1223356779999987531     1256789999999999999998 667775432111       0111111 1111


Q ss_pred             cCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 036435          302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ  344 (372)
Q Consensus       302 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~  344 (372)
                      ..+..  .........+.+++..|| .||++|||+++|++.|.
T Consensus       229 ~~~~~--~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         229 KLPKP--QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             cCCCC--cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            11111  111223445566777788 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.2e-39  Score=297.82  Aligned_cols=240  Identities=25%  Similarity=0.464  Sum_probs=185.9

Q ss_pred             hhhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhcc-CCCceeeeEeEEecCCceeEEEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYE  141 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e  141 (372)
                      +.+.+.||+|+||.||+|.+.+                      .+.+|+.++.++ +||||+++++++.+++..++|+|
T Consensus         9 ~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e   88 (303)
T cd05088           9 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE   88 (303)
T ss_pred             ceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEE
Confidence            3456789999999999996421                      467799999999 89999999999999999999999


Q ss_pred             ecCCCChhhhhhcCCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEE
Q 036435          142 FMPNGSLEKFVYNGDTS----------KPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKI  211 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  211 (372)
                      |+++|+|.+++......          .....+++.+++.++.|++.||+|||   +.+++||||||+|||+++++.+||
T Consensus        89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~~kl  165 (303)
T cd05088          89 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKI  165 (303)
T ss_pred             eCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCcEEe
Confidence            99999999999764321          11124899999999999999999999   899999999999999999999999


Q ss_pred             eecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHH
Q 036435          212 SDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHW  290 (372)
Q Consensus       212 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~  290 (372)
                      +|||++.......    ......++..|+|||.+.+.  .++.++|||||||++|||+| |..||.......        
T Consensus       166 ~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------  231 (303)
T cd05088         166 ADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------  231 (303)
T ss_pred             CccccCcccchhh----hcccCCCcccccCHHHHhcc--CCcccccchhhhhHHHHHHhcCCCCcccCChHH--------
Confidence            9999986432111    01112245679999988764  68899999999999999998 999886432211        


Q ss_pred             HHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 036435          291 IYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE  348 (372)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~  348 (372)
                      .............+       ......+.+++.+||+.+|++||+++++++.|.++..
T Consensus       232 ~~~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~  282 (303)
T cd05088         232 LYEKLPQGYRLEKP-------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  282 (303)
T ss_pred             HHHHHhcCCcCCCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            11112111111111       1123567889999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.9e-39  Score=293.28  Aligned_cols=229  Identities=25%  Similarity=0.349  Sum_probs=179.1

Q ss_pred             cCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCCh
Q 036435           91 LGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL  148 (372)
Q Consensus        91 lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L  148 (372)
                      ||+|+||.||+++...                      .+..|++++++++||||+++++++.++...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            7999999999986531                      245699999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeee
Q 036435          149 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVS  228 (372)
Q Consensus       149 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  228 (372)
                      .+++......    .+++..+..++.|++.||+|||   +.+++||||||+||++++++.++|+|||++.........  
T Consensus        81 ~~~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~--  151 (277)
T cd05607          81 KYHIYNVGER----GLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI--  151 (277)
T ss_pred             HHHHHhcccc----CCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCcee--
Confidence            9988654432    2889999999999999999999   899999999999999999999999999999866443211  


Q ss_pred             eecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCC
Q 036435          229 SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVT  308 (372)
Q Consensus       229 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (372)
                        ....|+..|+|||++.+.  .++.++|+||+||++|||++|+.||.........    ..+....... ....     
T Consensus       152 --~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~----~~~~~~~~~~-~~~~-----  217 (277)
T cd05607         152 --TQRAGTNGYMAPEILKEE--PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK----EELKRRTLED-EVKF-----  217 (277)
T ss_pred             --eccCCCCCccCHHHHccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH----HHHHHHhhcc-cccc-----
Confidence              223578899999999775  6899999999999999999999998754321110    0011111100 0000     


Q ss_pred             cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 036435          309 RKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEML  343 (372)
Q Consensus       309 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L  343 (372)
                       ........+.+++.+||+.||++||++.|+++.+
T Consensus       218 -~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         218 -EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             -ccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence             1112345678899999999999999997766433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.1e-39  Score=299.95  Aligned_cols=240  Identities=21%  Similarity=0.320  Sum_probs=179.3

Q ss_pred             hhhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      .+.+.||+|+||.||+|+...                    .+.+|+.++++++||||+++++++.++...++||||++ 
T Consensus         8 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-   86 (303)
T cd07869           8 EKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-   86 (303)
T ss_pred             eEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-
Confidence            446789999999999997631                    46789999999999999999999999999999999995 


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      ++|.+++.....     .+++..+..++.|++.||+|||   +.+++||||||+|||+++++.+||+|||++........
T Consensus        87 ~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  158 (303)
T cd07869          87 TDLCQYMDKHPG-----GLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH  158 (303)
T ss_pred             cCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc
Confidence            688888865432     2888999999999999999999   89999999999999999999999999999875432221


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccc----
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF----  301 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----  301 (372)
                         ......+|+.|+|||.+.+. ..++.++|+||+||++|||++|..||....+....   ..............    
T Consensus       159 ---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~  231 (303)
T cd07869         159 ---TYSNEVVTLWYRPPDVLLGS-TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ---LERIFLVLGTPNEDTWPG  231 (303)
T ss_pred             ---cCCCCcccCCCCChHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH---HHHHHHHhCCCChhhccc
Confidence               11234578899999998654 36788999999999999999999999754321100   00000000000000    


Q ss_pred             --c----CCcc----CCcchH------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          302 --K----LPGV----VTRKEN------EIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       302 --~----~~~~----~~~~~~------~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                        .    .+..    ......      .....+.+++.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence              0    0000    000000      01245678999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.1e-39  Score=295.64  Aligned_cols=247  Identities=26%  Similarity=0.384  Sum_probs=186.0

Q ss_pred             hhhhhhcCCCCceEEEEEEec------------------------------------chHHHHHHHHhccCCCceeeeEe
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL------------------------------------DDFVNEVASISRTSHVNVVTLLG  128 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~------------------------------------~~~~~E~~~l~~l~h~nIv~l~g  128 (372)
                      +.+.+.||+|+||.||+++..                                    +++.+|++++++++||||+++++
T Consensus         7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~   86 (296)
T cd05051           7 LNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLG   86 (296)
T ss_pred             CcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence            345678999999999986532                                    15678999999999999999999


Q ss_pred             EEecCCceeEEEEecCCCChhhhhhcCCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE
Q 036435          129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSK-----PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL  203 (372)
Q Consensus       129 ~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~-----~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill  203 (372)
                      ++..++..++|+||+++++|.+++.......     ....+++..++.++.|++.||+|||   +.+++|+||||+||++
T Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~Nili  163 (296)
T cd05051          87 VCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLV  163 (296)
T ss_pred             EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhceee
Confidence            9999999999999999999999997654211     1124899999999999999999999   7999999999999999


Q ss_pred             CCCCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc--CCCCCCCCCCC
Q 036435          204 DEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG--CKNNLDSGVDS  281 (372)
Q Consensus       204 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt--g~~p~~~~~~~  281 (372)
                      ++++.++|+|||+++.......... .....++..|+|||.+.+.  .++.++|||||||++|||++  +..||..... 
T Consensus       164 ~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~-  239 (296)
T cd05051         164 GKNYTIKIADFGMSRNLYSSDYYRV-QGRAPLPIRWMAWESVLLG--KFTTKSDVWAFGVTLWEILTLCREQPYEHLTD-  239 (296)
T ss_pred             cCCCceEEccccceeecccCcceee-cCcCCCCceecCHHHhhcC--CCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence            9999999999999986544332211 1233456789999998764  78999999999999999998  5566643221 


Q ss_pred             CCccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 036435          282 SSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG  345 (372)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~  345 (372)
                             ..........................+.++.+++.+||+.||++|||++++++.|++
T Consensus       240 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         240 -------QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             -------HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence                   111111111100000000000111234578899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=8.2e-39  Score=289.15  Aligned_cols=234  Identities=25%  Similarity=0.465  Sum_probs=182.5

Q ss_pred             hhcCCCCceEEEEEEecc----------------------hHHHHHHHHhcc-CCCceeeeEeEEecCCceeEEEEecCC
Q 036435           89 DKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      +.||+|+||.||+|++.+                      .+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            358999999999996521                      466799999999 899999999999999999999999999


Q ss_pred             CChhhhhhcCCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecC
Q 036435          146 GSLEKFVYNGDTS----------KPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFG  215 (372)
Q Consensus       146 g~L~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  215 (372)
                      |+|.+++......          .....+++.+++.++.|++.||+|||   +.+++|+||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence            9999999764321          11234889999999999999999999   7999999999999999999999999999


Q ss_pred             CcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHH
Q 036435          216 LAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRH  294 (372)
Q Consensus       216 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  294 (372)
                      ++.......    .......+..|+|||++.+.  .++.++|+||||+++|||++ |..||......       . ....
T Consensus       158 l~~~~~~~~----~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-------~-~~~~  223 (270)
T cd05047         158 LSRGQEVYV----KKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------E-LYEK  223 (270)
T ss_pred             Cccccchhh----hccCCCCccccCChHHHccC--CCCchhhHHHHHHHHHHHHcCCCCCccccCHH-------H-HHHH
Confidence            986322111    01112235679999998764  78899999999999999997 99998643211       1 1222


Q ss_pred             hhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 036435          295 VEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGS  346 (372)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~  346 (372)
                      .........+       ......+.+++.+||+.||.+|||+.++++.|+++
T Consensus       224 ~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         224 LPQGYRLEKP-------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             HhCCCCCCCC-------CcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence            2222111111       11335678899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-39  Score=290.01  Aligned_cols=234  Identities=21%  Similarity=0.353  Sum_probs=192.5

Q ss_pred             HHHHHHhhhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCce
Q 036435           79 DVKKLTNSFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNR  136 (372)
Q Consensus        79 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~  136 (372)
                      ...+..+.+.+.||+|.||.|-++....                      .+.+|+++|+.|+||||+.+|.+|++.+..
T Consensus        49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKI  128 (668)
T KOG0611|consen   49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKI  128 (668)
T ss_pred             cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence            3445667788899999999999875411                      588999999999999999999999999999


Q ss_pred             eEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCC
Q 036435          137 ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGL  216 (372)
Q Consensus       137 ~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  216 (372)
                      .|||||..+|.|.+|+...+.      +++.++..+++||..|+.|+|   .++++|||||.+|||+|.++++||+||||
T Consensus       129 vivMEYaS~GeLYDYiSer~~------LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGL  199 (668)
T KOG0611|consen  129 VIVMEYASGGELYDYISERGS------LSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGL  199 (668)
T ss_pred             EEEEEecCCccHHHHHHHhcc------ccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccch
Confidence            999999999999999988764      999999999999999999999   89999999999999999999999999999


Q ss_pred             cccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhh
Q 036435          217 AKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE  296 (372)
Q Consensus       217 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  296 (372)
                      +-.+....-    ....+|++-|.+||.+.|. .--.+..|.|||||+||-|+.|..||++....       . +...+.
T Consensus       200 SNly~~~kf----LqTFCGSPLYASPEIvNG~-PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-------~-lvrQIs  266 (668)
T KOG0611|consen  200 SNLYADKKF----LQTFCGSPLYASPEIVNGT-PYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK-------R-LVRQIS  266 (668)
T ss_pred             hhhhccccH----HHHhcCCcccCCccccCCC-CCCCCccchhhHHHHHHHHhhcccccCCchHH-------H-HHHHhh
Confidence            987655432    3456799999999999886 23368999999999999999999999864321       1 222232


Q ss_pred             hcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 036435          297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEML  343 (372)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L  343 (372)
                      .+. +..|..        +....-++.|+|..||++|.|+.+|....
T Consensus       267 ~Ga-YrEP~~--------PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  267 RGA-YREPET--------PSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             ccc-ccCCCC--------CchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence            221 222211        23344578899999999999999998753

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.8e-39  Score=291.45  Aligned_cols=240  Identities=23%  Similarity=0.408  Sum_probs=189.7

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      .+.+.||+|+||.||+|+...                      ++.+|++++++++||||+++++++.+.+..++|+||+
T Consensus         5 ~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   84 (267)
T cd08228           5 QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELA   84 (267)
T ss_pred             eeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEec
Confidence            345789999999999996521                      4778999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      ++|+|.+++......  ...++...+..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++......
T Consensus        85 ~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~  159 (267)
T cd08228          85 DAGDLSQMIKYFKKQ--KRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             CCCcHHHHHHHhhhc--cCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence            999999988643221  123788999999999999999999   899999999999999999999999999998875433


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                      ...   .....++..|+|||.+.+.  .++.++|+||||+++|||++|+.||.......     .. ....+....   .
T Consensus       160 ~~~---~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-----~~-~~~~~~~~~---~  225 (267)
T cd08228         160 TTA---AHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-----FS-LCQKIEQCD---Y  225 (267)
T ss_pred             hHH---HhcCCCCccccChhhhccC--CCCchhhHHHHHHHHHHHhcCCCCCccccccH-----HH-HHHHHhcCC---C
Confidence            211   1123477889999998765  67899999999999999999999986543211     11 112221111   1


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                      +..   ........+.+++.+||+.+|++||++.++++.|+++.
T Consensus       226 ~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         226 PPL---PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             CCC---ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            111   12234567888999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=5.5e-39  Score=290.04  Aligned_cols=239  Identities=26%  Similarity=0.378  Sum_probs=177.8

Q ss_pred             hcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCC
Q 036435           90 KLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS  147 (372)
Q Consensus        90 ~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~  147 (372)
                      .||+|+||.||+|+..+                      .+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD   81 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence            58999999999986421                      47789999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCee
Q 036435          148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV  227 (372)
Q Consensus       148 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  227 (372)
                      |.+++....... ....++..+..++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++..........
T Consensus        82 L~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          82 LKGYLRSCRKAE-LMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             HHHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            999997543211 123677888899999999999999   7999999999999999999999999999997543322211


Q ss_pred             eeeccccccccccccccccccc-----CCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccc
Q 036435          228 SSLLGARGIIGYIAPEVFSRNF-----GEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREF  301 (372)
Q Consensus       228 ~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (372)
                       ......++..|+|||++.+..     ..++.++|+||||+++|||++ |+.||.......      .............
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~~~~  230 (269)
T cd05087         158 -TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ------VLTYTVREQQLKL  230 (269)
T ss_pred             -cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH------HHHHHhhcccCCC
Confidence             112234677899999986421     135789999999999999996 999986532211      0001001111111


Q ss_pred             cCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 036435          302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ  344 (372)
Q Consensus       302 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~  344 (372)
                      ..+.....    ....+.+++..|+ .+|++|||+++|++.|+
T Consensus       231 ~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPRLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            11211111    2334666888898 58999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-39  Score=295.65  Aligned_cols=248  Identities=23%  Similarity=0.362  Sum_probs=184.0

Q ss_pred             HhhhhhhcCCCCceEEEEEEec----------------------------------chHHHHHHHHhccCCCceeeeEeE
Q 036435           84 TNSFKDKLGQGGFGGVYKGRLL----------------------------------DDFVNEVASISRTSHVNVVTLLGF  129 (372)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~----------------------------------~~~~~E~~~l~~l~h~nIv~l~g~  129 (372)
                      .+.+.+.||+|+||.||+++..                                  +.+.+|++++++++|+|+++++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~   85 (295)
T cd05097           6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGV   85 (295)
T ss_pred             hCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEE
Confidence            3455678999999999976421                                  147789999999999999999999


Q ss_pred             EecCCceeEEEEecCCCChhhhhhcCCCC------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE
Q 036435          130 CLEGNNRALIYEFMPNGSLEKFVYNGDTS------KPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL  203 (372)
Q Consensus       130 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~~------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill  203 (372)
                      +..++..++||||+++++|.+++......      .....+++.+++.++.|++.||+|||   +.+++|+||||+||++
T Consensus        86 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nill  162 (295)
T cd05097          86 CVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLV  162 (295)
T ss_pred             EcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEEE
Confidence            99999999999999999999999654311      11123788999999999999999999   8999999999999999


Q ss_pred             CCCCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc--CCCCCCCCCCC
Q 036435          204 DEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG--CKNNLDSGVDS  281 (372)
Q Consensus       204 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt--g~~p~~~~~~~  281 (372)
                      ++++.+||+|||++.......... ......++..|+|||.+.+.  .++.++|+||||+++|+|++  +..||......
T Consensus       163 ~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~  239 (295)
T cd05097         163 GNHYTIKIADFGMSRNLYSGDYYR-IQGRAVLPIRWMAWESILLG--KFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE  239 (295)
T ss_pred             cCCCcEEecccccccccccCccee-ccCcCcCceeecChhhhccC--CcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence            999999999999998654332211 11222346789999998764  78999999999999999998  44555432211


Q ss_pred             CCccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 036435          282 SSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG  345 (372)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~  345 (372)
                      .    ...................    .....+..+.+++.+||+.||.+||++++|++.|++
T Consensus       240 ~----~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         240 Q----VIENTGEFFRNQGRQIYLS----QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             H----HHHHHHHhhhhccccccCC----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            0    0000111111100000000    011134578899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.7e-39  Score=301.56  Aligned_cols=224  Identities=21%  Similarity=0.298  Sum_probs=178.7

Q ss_pred             hhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           89 DKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      +.||+|+||.||+++...                      .+.+|+++++.++||||+++++++.+++..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            358999999999986521                      3567889999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS-TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      +|.+++....      .+++.++..++.|++.||+|||   + .+++||||||+|||+++++.+||+|||+++.......
T Consensus        81 ~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~  151 (325)
T cd05594          81 ELFFHLSRER------VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA  151 (325)
T ss_pred             cHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc
Confidence            9999886543      2899999999999999999999   5 7999999999999999999999999999875432221


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                      .   .....||+.|+|||.+.+.  .++.++|||||||++|||++|+.||......       . ...... ......|.
T Consensus       152 ~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-------~-~~~~i~-~~~~~~p~  217 (325)
T cd05594         152 T---MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------K-LFELIL-MEEIRFPR  217 (325)
T ss_pred             c---cccccCCcccCCHHHHccC--CCCCccccccccceeeeeccCCCCCCCCCHH-------H-HHHHHh-cCCCCCCC
Confidence            1   1233588999999999764  7889999999999999999999999753211       0 111111 11122222


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRP-----PMNEVIEM  342 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~~  342 (372)
                      .       ....+.+++.+||+.||++|+     ++.++++.
T Consensus       218 ~-------~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         218 T-------LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             C-------CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            1       235677888999999999997     89998853

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.8e-39  Score=299.82  Aligned_cols=223  Identities=24%  Similarity=0.343  Sum_probs=178.6

Q ss_pred             hhcCCCCceEEEEEEecc--------------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEe
Q 036435           89 DKLGQGGFGGVYKGRLLD--------------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~--------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      +.||+|+||.||+++...                          .+.+|+.++++++||||+++++++.+++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            469999999999976410                          356799999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      +++|+|.+++.....      +++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++....
T Consensus        82 ~~~~~L~~~~~~~~~------~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  152 (323)
T cd05584          82 LSGGELFMHLEREGI------FMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH  152 (323)
T ss_pred             CCCchHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence            999999999976542      788889999999999999999   89999999999999999999999999999875432


Q ss_pred             CCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      ....   .....||+.|+|||.+.+.  .++.++|||||||++|||++|+.||......       . ....+... ...
T Consensus       153 ~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~pf~~~~~~-------~-~~~~~~~~-~~~  218 (323)
T cd05584         153 EGTV---THTFCGTIEYMAPEILMRS--GHGKAVDWWSLGALMYDMLTGAPPFTAENRK-------K-TIDKILKG-KLN  218 (323)
T ss_pred             CCCc---ccccCCCccccChhhccCC--CCCCcceecccHHHHHHHhcCCCCCCCCCHH-------H-HHHHHHcC-CCC
Confidence            2211   1234588999999999775  6789999999999999999999999753211       1 11111111 122


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRP-----PMNEVIE  341 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~  341 (372)
                      .+..       ....+.+++.+||+.||++||     +++++++
T Consensus       219 ~~~~-------~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         219 LPPY-------LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CCCC-------CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            2221       235677899999999999999     7888775

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=8.9e-39  Score=287.36  Aligned_cols=234  Identities=31%  Similarity=0.503  Sum_probs=179.0

Q ss_pred             hhcCCCCceEEEEEEecc-----------------------hHHHHHHHHhccCCCceeeeEeEEe-cCCceeEEEEecC
Q 036435           89 DKLGQGGFGGVYKGRLLD-----------------------DFVNEVASISRTSHVNVVTLLGFCL-EGNNRALIYEFMP  144 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~-----------------------~~~~E~~~l~~l~h~nIv~l~g~~~-~~~~~~lV~e~~~  144 (372)
                      +.||+|+||.||+|++.+                       .+.+|+.+++.++||||+++++++. .++..++|+||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            358999999999986421                       4677999999999999999999876 4556899999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      +|+|.+++.....     .+++..++.++.|+++||+|||   +.+++|+||||+|||+++++.+||+|||+++......
T Consensus        81 ~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~  152 (262)
T cd05058          81 HGDLRNFIRSETH-----NPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE  152 (262)
T ss_pred             CCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence            9999999975432     2678888999999999999999   7999999999999999999999999999997654322


Q ss_pred             Ceee-eecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCC-CCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          225 GIVS-SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKN-NLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       225 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      .... ......++..|+|||.+.+.  .++.++||||||+++|||++|+. ||... ..      .. ............
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~~~~~~-~~------~~-~~~~~~~~~~~~  222 (262)
T cd05058         153 YYSVHNHTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDV-DS------FD-ITVYLLQGRRLL  222 (262)
T ss_pred             ceeecccccCcCCccccChhHhccC--ccchHHHHHHHHHHHHHHHcCCCCCCCCC-CH------HH-HHHHHhcCCCCC
Confidence            1111 11223456789999998764  78999999999999999999654 44322 11      01 111222221111


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                      .+.       ..+..+.+++..||+.+|++||++.++++.|+++.
T Consensus       223 ~~~-------~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         223 QPE-------YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             CCC-------cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence            111       12356788999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.4e-39  Score=290.56  Aligned_cols=222  Identities=25%  Similarity=0.420  Sum_probs=174.5

Q ss_pred             hcCCCCceEEEEEEec-------------------------------------------chHHHHHHHHhccCCCceeee
Q 036435           90 KLGQGGFGGVYKGRLL-------------------------------------------DDFVNEVASISRTSHVNVVTL  126 (372)
Q Consensus        90 ~lg~G~~g~V~~~~~~-------------------------------------------~~~~~E~~~l~~l~h~nIv~l  126 (372)
                      .||+|+||.||+|.+.                                           ..+.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            5999999999998641                                           146778999999999999999


Q ss_pred             EeEEecCCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC
Q 036435          127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDED  206 (372)
Q Consensus       127 ~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~  206 (372)
                      +++|.++...++||||+++|+|..++.....     .+++..++.++.|++.||+|||   +.+++||||||+|||++..
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~  153 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKG-----RVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARL  153 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEecc
Confidence            9999999999999999999999999865332     2889999999999999999999   7999999999999999754


Q ss_pred             C-------ceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHh-cCCCCCCCC
Q 036435          207 F-------CPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV-GCKNNLDSG  278 (372)
Q Consensus       207 ~-------~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell-tg~~p~~~~  278 (372)
                      +       .+|++|||++.......       ...++..|+|||.+.+. ..++.++|+||||+++||++ +|..||...
T Consensus       154 ~~~~~~~~~~kl~d~g~~~~~~~~~-------~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~  225 (274)
T cd05076         154 GLAEGTSPFIKLSDPGVSFTALSRE-------ERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKER  225 (274)
T ss_pred             CcccCccceeeecCCcccccccccc-------ccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence            3       48999999886443221       12366779999988653 46799999999999999984 788888654


Q ss_pred             CCCCCccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 036435          279 VDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ  344 (372)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~  344 (372)
                      ....        ........  ...+..       ....+.+++.+||+.+|++|||++++++.|.
T Consensus       226 ~~~~--------~~~~~~~~--~~~~~~-------~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         226 TPSE--------KERFYEKK--HRLPEP-------SCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             ChHH--------HHHHHHhc--cCCCCC-------CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            2211        11111111  111111       1245788999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.5e-39  Score=293.20  Aligned_cols=229  Identities=22%  Similarity=0.328  Sum_probs=179.1

Q ss_pred             cCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCCh
Q 036435           91 LGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL  148 (372)
Q Consensus        91 lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L  148 (372)
                      ||+|+||+||+++...                      .+..|+.++++++|+||+++.+++.+++..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            7999999999986531                      356799999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeee
Q 036435          149 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVS  228 (372)
Q Consensus       149 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  228 (372)
                      .+++......  ...+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|||++.........  
T Consensus        81 ~~~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--  153 (280)
T cd05608          81 RYHIYNVDEE--NPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--  153 (280)
T ss_pred             HHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--
Confidence            9888543221  123899999999999999999999   899999999999999999999999999999765443321  


Q ss_pred             eecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCC
Q 036435          229 SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVT  308 (372)
Q Consensus       229 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (372)
                       .....||+.|+|||.+.+.  .++.++|+|||||++|||++|+.||.........    .......... ...      
T Consensus       154 -~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~----~~~~~~~~~~-~~~------  219 (280)
T cd05608         154 -TKGYAGTPGFMAPELLQGE--EYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN----KELKQRILND-SVT------  219 (280)
T ss_pred             -ccccCCCcCccCHHHhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH----HHHHHhhccc-CCC------
Confidence             1233588999999999875  7889999999999999999999999754322110    0011111000 011      


Q ss_pred             cchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 036435          309 RKENEIAKKMIIVGLWCIQARPSDRP-----PMNEVIE  341 (372)
Q Consensus       309 ~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~  341 (372)
                       ........+.+++.+||+.||++||     +++++++
T Consensus       220 -~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         220 -YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             -CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence             1122446678899999999999999     6677775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=6.1e-39  Score=287.62  Aligned_cols=231  Identities=28%  Similarity=0.453  Sum_probs=185.2

Q ss_pred             hhcCCCCceEEEEEEecc-----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           89 DKLGQGGFGGVYKGRLLD-----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~-----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      +.||+|++|.||+|.+.+                       ++.+|+.++++++||||+++++++.+ ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            368999999999986522                       47789999999999999999999988 889999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      |+|.+++.+...    ..+++..+..++.|+++||+|||   +.+++|+||||+||+++.++.+||+|||++........
T Consensus        80 ~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (257)
T cd05040          80 GSLLDRLRKDAL----GHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED  152 (257)
T ss_pred             CcHHHHHHhccc----ccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEecccccccccccccc
Confidence            999999987542    23899999999999999999999   89999999999999999999999999999987755433


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhh-cccccC
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQ-DREFKL  303 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  303 (372)
                      .........++..|+|||.+.+.  .++.++|+|||||++|||++ |+.||......       + ....... ......
T Consensus       153 ~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~-~~~~~~~~~~~~~~  222 (257)
T cd05040         153 HYVMEEHLKVPFAWCAPESLRTR--TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-------Q-ILKKIDKEGERLER  222 (257)
T ss_pred             ceecccCCCCCceecCHHHhccc--CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-------H-HHHHHHhcCCcCCC
Confidence            22222234467789999998765  78899999999999999998 99998643211       1 1111111 111111


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ  344 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~  344 (372)
                      +       ...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       223 ~-------~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         223 P-------EACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             C-------ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            1       123467888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=7.8e-39  Score=290.36  Aligned_cols=237  Identities=27%  Similarity=0.414  Sum_probs=184.5

Q ss_pred             hhhhcCCCCceEEEEEEecc-------------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEE
Q 036435           87 FKDKLGQGGFGGVYKGRLLD-------------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYE  141 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~-------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  141 (372)
                      +.+.||+|+||.||+|.+.+                         .+.+|+.++++++|+||+++++++.+.+..++|+|
T Consensus        10 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   89 (277)
T cd05036          10 LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLE   89 (277)
T ss_pred             eeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEe
Confidence            45789999999999987632                         47889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhcCCCCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC---ceEEeecCCc
Q 036435          142 FMPNGSLEKFVYNGDTSK-PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDF---CPKISDFGLA  217 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfgla  217 (372)
                      |+++++|.+++....... ....+++.+++.++.|++.||+|||   +.+++|+||||+||+++.++   .+||+|||++
T Consensus        90 ~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~  166 (277)
T cd05036          90 LMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA  166 (277)
T ss_pred             cCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEeccCccc
Confidence            999999999997654211 1224899999999999999999999   78999999999999998654   5999999999


Q ss_pred             ccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhh
Q 036435          218 KLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVE  296 (372)
Q Consensus       218 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  296 (372)
                      +......... .......+..|+|||++.+.  .++.++|||||||++|||++ |..||.......        ....+.
T Consensus       167 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--------~~~~~~  235 (277)
T cd05036         167 RDIYRASYYR-KGGRAMLPIKWMPPEAFLDG--IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--------VMEFVT  235 (277)
T ss_pred             cccCCcccee-cCCCCCccHhhCCHHHHhcC--CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHH
Confidence            8763322111 11122235679999999764  78999999999999999997 888886532211        122222


Q ss_pred             hcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 036435          297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ  344 (372)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~  344 (372)
                      .......+       ...+..+.+++.+||+.+|++||++.++++.|+
T Consensus       236 ~~~~~~~~-------~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         236 GGGRLDPP-------KGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             cCCcCCCC-------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            22222222       123456788999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=294.26  Aligned_cols=235  Identities=23%  Similarity=0.337  Sum_probs=183.1

Q ss_pred             hhhhhcCCCCceEEEEEEec---------------------------------chHHHHHHHHhccCCCceeeeEeEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLL---------------------------------DDFVNEVASISRTSHVNVVTLLGFCLE  132 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~---------------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~  132 (372)
                      .+.+.||+|.||.|-+++..                                 +.+.+|+.+|++++|||||+|+.+..+
T Consensus       100 ~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDD  179 (576)
T KOG0585|consen  100 ELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDD  179 (576)
T ss_pred             ehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecC
Confidence            44578999999999988542                                 268899999999999999999999876


Q ss_pred             C--CceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceE
Q 036435          133 G--NNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPK  210 (372)
Q Consensus       133 ~--~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  210 (372)
                      .  +.+|||+|||..|.+...-...      ..+++.++.++++++..||+|||   ..+|+||||||+|+||+++|.+|
T Consensus       180 P~s~~~YlVley~s~G~v~w~p~d~------~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~VK  250 (576)
T KOG0585|consen  180 PESDKLYLVLEYCSKGEVKWCPPDK------PELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGTVK  250 (576)
T ss_pred             cccCceEEEEEeccCCccccCCCCc------ccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCcEE
Confidence            4  5899999999988875432211      12899999999999999999999   89999999999999999999999


Q ss_pred             EeecCCcccccCCCCe--eeeeccccccccccccccccccc--CCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccc
Q 036435          211 ISDFGLAKLCTTKEGI--VSSLLGARGIIGYIAPEVFSRNF--GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVY  286 (372)
Q Consensus       211 l~Dfgla~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~  286 (372)
                      |+|||.+.........  ........|||.|+|||...+..  ...+.+.||||+||+||-|+.|+.||.+.....    
T Consensus       251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~----  326 (576)
T KOG0585|consen  251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE----  326 (576)
T ss_pred             eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH----
Confidence            9999999876433211  11133467999999999987631  133578899999999999999999998653211    


Q ss_pred             hHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 036435          287 FPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEML  343 (372)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L  343 (372)
                          ++..+... .+..|     ...++.+.+.+++.++|++||++|.+..+|....
T Consensus       327 ----l~~KIvn~-pL~fP-----~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  327 ----LFDKIVND-PLEFP-----ENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             ----HHHHHhcC-cccCC-----CcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence                22222211 12222     2235567788899999999999999999987644

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.5e-39  Score=308.72  Aligned_cols=244  Identities=20%  Similarity=0.270  Sum_probs=182.8

Q ss_pred             hhhhcCCCCceEEEEEEecc-------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCChhhhhh
Q 036435           87 FKDKLGQGGFGGVYKGRLLD-------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVY  153 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~-------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~~~l~  153 (372)
                      +.+.||+|+||.||++...+             .+.+|+++|++++|+||+++++++..++..++|+|++. ++|.+++.
T Consensus       173 i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~  251 (461)
T PHA03211        173 IHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLG  251 (461)
T ss_pred             EEEEEccCCCeEEEEEEECCCCCEEEEecccccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHH
Confidence            34679999999999997743             46789999999999999999999999999999999994 69999886


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeeeeeccc
Q 036435          154 NGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGA  233 (372)
Q Consensus       154 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  233 (372)
                      ....     .+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.......... ....
T Consensus       252 ~~~~-----~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~-~~~~  322 (461)
T PHA03211        252 ARLR-----PLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF-HYGI  322 (461)
T ss_pred             hcCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc-cccc
Confidence            5432     3899999999999999999999   89999999999999999999999999999986543221111 1234


Q ss_pred             ccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccc--ccCC-------
Q 036435          234 RGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDRE--FKLP-------  304 (372)
Q Consensus       234 ~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-------  304 (372)
                      .||..|+|||++.+.  .++.++|||||||++|||++|..++...............+.+.+.....  ...+       
T Consensus       323 ~GT~~Y~APE~~~~~--~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l  400 (461)
T PHA03211        323 AGTVDTNAPEVLAGD--PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRL  400 (461)
T ss_pred             CCCcCCcCHHHHcCC--CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHH
Confidence            589999999999875  78999999999999999999887665433221111111112221111100  0000       


Q ss_pred             --------------ccCCcc---hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          305 --------------GVVTRK---ENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       305 --------------~~~~~~---~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                                    ......   .......+.+++.+||+.||.+|||+.|+++.
T Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        401 VSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             HHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                          000000   01122367789999999999999999999963

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.2e-38  Score=286.41  Aligned_cols=237  Identities=27%  Similarity=0.475  Sum_probs=187.0

Q ss_pred             HHHhhhhhhcCCCCceEEEEEEecc-----------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           82 KLTNSFKDKLGQGGFGGVYKGRLLD-----------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      ..++++.++||+|+||.||++...+                 ++.+|+.++++++|+||+++++++. .+..++++||++
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME   83 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence            3445667889999999999986522                 6889999999999999999999874 457899999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      +++|.+++......    .+++.++..++.|++.||+|||   +.+++|+||||+||++++++.++|+|||++.......
T Consensus        84 ~~~L~~~~~~~~~~----~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05067          84 NGSLVDFLKTPEGI----KLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE  156 (260)
T ss_pred             CCCHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence            99999998764322    3899999999999999999999   8999999999999999999999999999997654322


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                      ...  .....++..|+|||.+.+.  .++.++|+||||+++||+++ |+.||.......        ....+........
T Consensus       157 ~~~--~~~~~~~~~y~~pe~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~  224 (260)
T cd05067         157 YTA--REGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--------VIQNLERGYRMPR  224 (260)
T ss_pred             ccc--ccCCcccccccCHHHhccC--CcCcccchHHHHHHHHHHHhCCCCCCCCCChHH--------HHHHHHcCCCCCC
Confidence            111  1222356789999998764  78899999999999999998 999986542211        1222222222221


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG  345 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~  345 (372)
                      +.       .....+.+++.+||+.+|++||+++++++.|+.
T Consensus       225 ~~-------~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         225 PD-------NCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CC-------CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            11       123568889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-39  Score=290.78  Aligned_cols=254  Identities=25%  Similarity=0.378  Sum_probs=193.6

Q ss_pred             hhhhhcCCCCceEEEEEEecc--------------hHHHHHHHHh--ccCCCceeeeEeEEecCC----ceeEEEEecCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD--------------DFVNEVASIS--RTSHVNVVTLLGFCLEGN----NRALIYEFMPN  145 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~--------------~~~~E~~~l~--~l~h~nIv~l~g~~~~~~----~~~lV~e~~~~  145 (372)
                      ++.+.||+|.||.||||++.+              .|..|-++.+  .++|+||++|++.-....    .++||+||.+.
T Consensus       213 ~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~k  292 (534)
T KOG3653|consen  213 QLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPK  292 (534)
T ss_pred             hhHHHhhcCccceeehhhccCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccC
Confidence            346789999999999998864              4666766665  458999999999877655    88999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCCeeecCCCCCceEECCCCceEEeecCCccc
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG------CSTKILHFDIKPHNILLDEDFCPKISDFGLAKL  219 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~------~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  219 (372)
                      |+|.+||+.+-       ++|....+++..+++||+|||+.      ..++|+|||||++|||+.+|++.-|+|||+|..
T Consensus       293 GsL~dyL~~nt-------isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~  365 (534)
T KOG3653|consen  293 GSLCDYLKANT-------ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR  365 (534)
T ss_pred             CcHHHHHHhcc-------ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence            99999998765       89999999999999999999973      357899999999999999999999999999998


Q ss_pred             ccCCCCeeeeecccccccccccccccccccCCCC-----ccccchhHHHHHHHHhcCCCCCCCCCCCCCccch-------
Q 036435          220 CTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVS-----HKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYF-------  287 (372)
Q Consensus       220 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-----~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~-------  287 (372)
                      +........ ..+..||.+|||||++.+.. .+.     .+.||||+|.++||+++...-++.+..+.....+       
T Consensus       366 ~~p~~~~~d-~~~qVGT~RYMAPEvLEgai-nl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h  443 (534)
T KOG3653|consen  366 LEPGKPQGD-THGQVGTRRYMAPEVLEGAI-NLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH  443 (534)
T ss_pred             ecCCCCCcc-hhhhhhhhhhcCHHHHhhhc-ccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence            775443333 23467999999999998752 222     4689999999999999887766532222221111       


Q ss_pred             ---HHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccC
Q 036435          288 ---PHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEAL  350 (372)
Q Consensus       288 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~  350 (372)
                         .+.-...+.+..+..+|......  .-+..+.+.+..||+.||+.|.|+.=+-+++..+....
T Consensus       444 Pt~e~mq~~VV~kK~RP~~p~~W~~h--~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  444 PTLEEMQELVVRKKQRPKIPDAWRKH--AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             CCHHHHHHHHHhhccCCCChhhhhcC--ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence               11112223333344443322222  23566778889999999999999999988888777543

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=8e-39  Score=287.96  Aligned_cols=235  Identities=28%  Similarity=0.444  Sum_probs=185.4

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-----------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-----------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS  147 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-----------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~  147 (372)
                      +.+.++||+|+||.||+|++.+                 ++.+|+.++++++||||+++++++. ....++||||+++|+
T Consensus         8 ~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~   86 (262)
T cd05071           8 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGS   86 (262)
T ss_pred             eeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCc
Confidence            4566889999999999996532                 5788999999999999999999875 456799999999999


Q ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCee
Q 036435          148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV  227 (372)
Q Consensus       148 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  227 (372)
                      |.+++.....    ..+++..++.++.|+++||+|||   +.+++|+||||+||++++++.+||+|||.+..........
T Consensus        87 L~~~~~~~~~----~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~  159 (262)
T cd05071          87 LLDFLKGEMG----KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  159 (262)
T ss_pred             HHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence            9999975432    23789999999999999999999   8999999999999999999999999999997654332211


Q ss_pred             eeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCcc
Q 036435          228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV  306 (372)
Q Consensus       228 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (372)
                        .....++..|+|||.+.+.  .++.++|+||||+++||+++ |..||.....        ..............    
T Consensus       160 --~~~~~~~~~y~~PE~~~~~--~~~~~~DvwslG~~l~ellt~g~~p~~~~~~--------~~~~~~~~~~~~~~----  223 (262)
T cd05071         160 --RQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVERGYRMP----  223 (262)
T ss_pred             --ccCCcccceecCHhHhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCh--------HHHHHHHhcCCCCC----
Confidence              1223356779999988764  78999999999999999999 7777754321        11122222211111    


Q ss_pred             CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 036435          307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGS  346 (372)
Q Consensus       307 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~  346 (372)
                         ...+....+.+++.+|++++|++||++.++++.|+..
T Consensus       224 ---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         224 ---CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             ---CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence               1223456788999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.5e-38  Score=285.80  Aligned_cols=234  Identities=27%  Similarity=0.473  Sum_probs=184.1

Q ss_pred             hhhhhhcCCCCceEEEEEEec-----------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL-----------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS  147 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-----------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~  147 (372)
                      +.+.++||+|+||.||++...                 +++.+|+.++++++|+|++++++++. ....+++|||+++++
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~   86 (260)
T cd05070           8 LQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGS   86 (260)
T ss_pred             hhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCc
Confidence            455678999999999998652                 25789999999999999999999885 456899999999999


Q ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCee
Q 036435          148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV  227 (372)
Q Consensus       148 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  227 (372)
                      |.+++.....    ..+++.+++.++.|++.||+|||   +.+++|+||||+||++++++.++|+|||++..........
T Consensus        87 L~~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05070          87 LLDFLKDGEG----RALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             HHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence            9999976432    23899999999999999999999   7899999999999999999999999999998654332111


Q ss_pred             eeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCcc
Q 036435          228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV  306 (372)
Q Consensus       228 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (372)
                        .....++..|+|||.+.+.  .++.++|+||||+++|+|++ |..||......       . ....+........+  
T Consensus       160 --~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-------~-~~~~~~~~~~~~~~--  225 (260)
T cd05070         160 --RQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMNNR-------E-VLEQVERGYRMPCP--  225 (260)
T ss_pred             --ccCCCCCccccChHHHhcC--CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH-------H-HHHHHHcCCCCCCC--
Confidence              1122345679999998764  78899999999999999999 88888643211       1 11222211111111  


Q ss_pred             CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 036435          307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG  345 (372)
Q Consensus       307 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~  345 (372)
                           ......+.+++.+||+.+|.+|||+.++.+.|+.
T Consensus       226 -----~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         226 -----QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             -----CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                 2234568889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=7.2e-39  Score=301.77  Aligned_cols=181  Identities=27%  Similarity=0.360  Sum_probs=155.2

Q ss_pred             hhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           87 FKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      +.+.||+|+||+||+++...                      .+.+|+.++.+++|+||+++++.+.++...++||||++
T Consensus         5 ~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~   84 (363)
T cd05628           5 SLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLP   84 (363)
T ss_pred             EeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCC
Confidence            45789999999999986532                      36679999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      +|+|.+++.+...      +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        85 gg~L~~~l~~~~~------l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~  155 (363)
T cd05628          85 GGDMMTLLMKKDT------LTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH  155 (363)
T ss_pred             CCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence            9999999976532      899999999999999999999   8999999999999999999999999999997543211


Q ss_pred             Ce--------------------------------eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCC
Q 036435          225 GI--------------------------------VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK  272 (372)
Q Consensus       225 ~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~  272 (372)
                      ..                                ........||+.|+|||++.+.  .++.++|||||||++|||++|+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~~DvwSlGvil~ell~G~  233 (363)
T cd05628         156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIGY  233 (363)
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC--CCCCchhhhhhHHHHHHHHhCC
Confidence            00                                0001234589999999999875  7889999999999999999999


Q ss_pred             CCCCCC
Q 036435          273 NNLDSG  278 (372)
Q Consensus       273 ~p~~~~  278 (372)
                      .||...
T Consensus       234 ~Pf~~~  239 (363)
T cd05628         234 PPFCSE  239 (363)
T ss_pred             CCCCCC
Confidence            999754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=4.3e-39  Score=305.20  Aligned_cols=233  Identities=20%  Similarity=0.285  Sum_probs=177.5

Q ss_pred             hhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           87 FKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      +.+.||+|+||.||+|+..+                      .+.+|+.++++++||||+++++++.+++..++||||++
T Consensus         5 ~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~   84 (381)
T cd05626           5 KIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP   84 (381)
T ss_pred             EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCC
Confidence            45679999999999996532                      36789999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      +|+|.+++.....      +++..+..++.|++.||+|||   ..+|+||||||+|||++.++.+||+|||++.......
T Consensus        85 gg~L~~~l~~~~~------~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          85 GGDMMSLLIRMEV------FPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             CCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            9999999976542      888999999999999999999   8999999999999999999999999999986432100


Q ss_pred             Ce--------------------------------------------eeeecccccccccccccccccccCCCCccccchh
Q 036435          225 GI--------------------------------------------VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYS  260 (372)
Q Consensus       225 ~~--------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dvws  260 (372)
                      ..                                            ........||+.|+|||.+.+.  .++.++||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwS  233 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK--GYTQLCDWWS  233 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC--CCCCccceee
Confidence            00                                            0001123589999999999764  7889999999


Q ss_pred             HHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHH--cccCCCCCCCCHHH
Q 036435          261 FGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLW--CIQARPSDRPPMNE  338 (372)
Q Consensus       261 lG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~~p~~RPs~~e  338 (372)
                      |||++|||++|..||.......       ..............+...     .+..++.+++.+  |+..+|..||++++
T Consensus       234 lG~il~elltG~~Pf~~~~~~~-------~~~~i~~~~~~~~~~~~~-----~~s~~~~dli~~ll~~~~~~~~R~~~~~  301 (381)
T cd05626         234 VGVILFEMLVGQPPFLAPTPTE-------TQLKVINWENTLHIPPQV-----KLSPEAVDLITKLCCSAEERLGRNGADD  301 (381)
T ss_pred             hhhHHHHHHhCCCCCcCCCHHH-------HHHHHHccccccCCCCCC-----CCCHHHHHHHHHHccCcccccCCCCHHH
Confidence            9999999999999997643211       011111111122222211     112344445544  66777888999999


Q ss_pred             HHHH
Q 036435          339 VIEM  342 (372)
Q Consensus       339 vl~~  342 (372)
                      +++.
T Consensus       302 ~l~h  305 (381)
T cd05626         302 IKAH  305 (381)
T ss_pred             HhcC
Confidence            9863

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=8.4e-39  Score=288.63  Aligned_cols=235  Identities=28%  Similarity=0.490  Sum_probs=184.2

Q ss_pred             hcCCCCceEEEEEEecc--------------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           90 KLGQGGFGGVYKGRLLD--------------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        90 ~lg~G~~g~V~~~~~~~--------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      .||+|+||.||+|+..+                          .+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM   81 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence            58999999999987521                          4678999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC-----ceEEeecCCc
Q 036435          144 PNGSLEKFVYNGDTSK-PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDF-----CPKISDFGLA  217 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-----~~kl~Dfgla  217 (372)
                      ++++|.+++....... ....+++.+++.++.|++.||+|||   +.+++|+||||+||+++.++     .++++|||++
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            9999999997643221 2234889999999999999999999   78999999999999999877     8999999999


Q ss_pred             ccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhh
Q 036435          218 KLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVE  296 (372)
Q Consensus       218 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  296 (372)
                      ........... .....++..|+|||.+.+.  .++.++||||||+++|||++ |..||.......        ....+.
T Consensus       159 ~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~--------~~~~~~  227 (269)
T cd05044         159 RDIYKSDYYRK-EGEGLLPVRWMAPESLLDG--KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE--------VLQHVT  227 (269)
T ss_pred             ccccccccccc-CcccCCCccccCHHHHccC--CcccchhHHHHHHHHHHHHHcCCCCCcccCHHH--------HHHHHh
Confidence            76543322111 1122356789999998764  78999999999999999998 888886432110        112222


Q ss_pred             hcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 036435          297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG  345 (372)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~  345 (372)
                      .......+       ...+..+.+++.+||+.+|.+||+++++++.|++
T Consensus       228 ~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         228 AGGRLQKP-------ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             cCCccCCc-------ccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            22222111       2235677889999999999999999999998863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=8.7e-39  Score=287.33  Aligned_cols=234  Identities=29%  Similarity=0.481  Sum_probs=184.3

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-----------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-----------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS  147 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-----------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~  147 (372)
                      +.+.+.||+|+||.||++....                 .+.+|+.++++++|+|++++++++. .+..++||||+++|+
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~   86 (260)
T cd05069           8 LRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGS   86 (260)
T ss_pred             eeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCC
Confidence            3456789999999999986521                 5788999999999999999999885 456899999999999


Q ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCee
Q 036435          148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV  227 (372)
Q Consensus       148 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  227 (372)
                      |.+++.....    ..+++..+..++.|++.||+|||   +.+++|+||||+||++++++.++|+|||++..........
T Consensus        87 L~~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05069          87 LLDFLKEGDG----KYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             HHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence            9999976432    23789999999999999999999   7899999999999999999999999999997654332111


Q ss_pred             eeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCcc
Q 036435          228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV  306 (372)
Q Consensus       228 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (372)
                        .....++..|+|||.+.+.  .++.++|+||||+++|||++ |..||.......        .............   
T Consensus       160 --~~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~~~---  224 (260)
T cd05069         160 --RQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--------VLEQVERGYRMPC---  224 (260)
T ss_pred             --cCCCccchhhCCHHHhccC--CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCCC---
Confidence              1222356779999988764  78999999999999999999 888886532211        1122222111111   


Q ss_pred             CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 036435          307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG  345 (372)
Q Consensus       307 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~  345 (372)
                          ..+....+.+++.+||+.||.+||+++++++.|+.
T Consensus       225 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         225 ----PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ----CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                12345678889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3e-39  Score=299.13  Aligned_cols=223  Identities=21%  Similarity=0.295  Sum_probs=177.3

Q ss_pred             hhcCCCCceEEEEEEecc----------------------hHHHHHHHHhcc-CCCceeeeEeEEecCCceeEEEEecCC
Q 036435           89 DKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      +.||+|+||.||+++..+                      .+.+|..++..+ +||||+++++++.+++..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            358999999999987532                      345677888776 799999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      |+|.+++.....      +++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++.......
T Consensus        81 g~L~~~i~~~~~------l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~  151 (320)
T cd05590          81 GDLMFHIQKSRR------FDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK  151 (320)
T ss_pred             chHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC
Confidence            999999876532      889999999999999999999   89999999999999999999999999999875432221


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                      .   .....||+.|+|||.+.+.  .++.++|+|||||++|||++|+.||......        .....+... ....+.
T Consensus       152 ~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--------~~~~~i~~~-~~~~~~  217 (320)
T cd05590         152 T---TSTFCGTPDYIAPEILQEM--LYGPSVDWWAMGVLLYEMLCGHAPFEAENED--------DLFEAILND-EVVYPT  217 (320)
T ss_pred             c---ccccccCccccCHHHHcCC--CCCCccchhhhHHHHHHHhhCCCCCCCCCHH--------HHHHHHhcC-CCCCCC
Confidence            1   1234589999999999764  7889999999999999999999999754221        112222211 111221


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPM------NEVIE  341 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~------~evl~  341 (372)
                             .....+.+++.+||+.||.+||++      +++++
T Consensus       218 -------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~  252 (320)
T cd05590         218 -------WLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILR  252 (320)
T ss_pred             -------CCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHc
Confidence                   134567788999999999999998      66654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.7e-38  Score=283.60  Aligned_cols=229  Identities=26%  Similarity=0.445  Sum_probs=181.9

Q ss_pred             hhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCChh
Q 036435           89 DKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLE  149 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~  149 (372)
                      +.||+|+||.||+|...+                   .+.+|+.++++++||||+++++++.+.+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            368999999999986522                   4778999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeeee
Q 036435          150 KFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSS  229 (372)
Q Consensus       150 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  229 (372)
                      +++.....     .+++..++.++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++..........  
T Consensus        81 ~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~--  150 (250)
T cd05085          81 SFLRKKKD-----ELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS--  150 (250)
T ss_pred             HHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceecccccccc--
Confidence            99865432     2789999999999999999999   8999999999999999999999999999987543322111  


Q ss_pred             ecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCC
Q 036435          230 LLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVT  308 (372)
Q Consensus       230 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (372)
                      .....++..|+|||++.+.  .++.++|+||||+++|++++ |..||......        ..............+    
T Consensus       151 ~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~----  216 (250)
T cd05085         151 SGLKQIPIKWTAPEALNYG--RYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--------QAREQVEKGYRMSCP----  216 (250)
T ss_pred             CCCCCCcccccCHHHhccC--CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--------HHHHHHHcCCCCCCC----
Confidence            1112345679999998764  78999999999999999998 88888643211        112222222111111    


Q ss_pred             cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 036435          309 RKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ  344 (372)
Q Consensus       309 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~  344 (372)
                         ......+.+++.+||+.+|++||++.++++.|.
T Consensus       217 ---~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         217 ---QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             ---CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence               123467888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.1e-38  Score=297.23  Aligned_cols=245  Identities=27%  Similarity=0.428  Sum_probs=187.0

Q ss_pred             HhhhhhhcCCCCceEEEEEEec-------------------------chHHHHHHHHhcc-CCCceeeeEeEEecC-Cce
Q 036435           84 TNSFKDKLGQGGFGGVYKGRLL-------------------------DDFVNEVASISRT-SHVNVVTLLGFCLEG-NNR  136 (372)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-------------------------~~~~~E~~~l~~l-~h~nIv~l~g~~~~~-~~~  136 (372)
                      .+.+.+.||+|+||.||+|...                         +.+.+|+.++.++ +|+||++++++|... ...
T Consensus         8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~   87 (337)
T cd05054           8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPL   87 (337)
T ss_pred             HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCE
Confidence            3456788999999999988421                         1366799999999 899999999988754 568


Q ss_pred             eEEEEecCCCChhhhhhcCCCC-------------------------------------------------------CCC
Q 036435          137 ALIYEFMPNGSLEKFVYNGDTS-------------------------------------------------------KPC  161 (372)
Q Consensus       137 ~lV~e~~~~g~L~~~l~~~~~~-------------------------------------------------------~~~  161 (372)
                      ++++||+++|+|.+++......                                                       ...
T Consensus        88 ~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (337)
T cd05054          88 MVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYK  167 (337)
T ss_pred             EEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhh
Confidence            8999999999999998643210                                                       001


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeeeeeccccccccccc
Q 036435          162 QYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA  241 (372)
Q Consensus       162 ~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~a  241 (372)
                      ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++........... .....++..|+|
T Consensus       168 ~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~-~~~~~~~~~y~a  243 (337)
T cd05054         168 EPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR-KGDARLPLKWMA  243 (337)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhh-ccCCCCCccccC
Confidence            24899999999999999999999   89999999999999999999999999999987543322111 122345678999


Q ss_pred             ccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHH
Q 036435          242 PEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMII  320 (372)
Q Consensus       242 PE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  320 (372)
                      ||++.+.  .++.++|||||||++|||++ |..||.......       ..............+       ......+.+
T Consensus       244 PE~~~~~--~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~-------~~~~~~~~~  307 (337)
T cd05054         244 PESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-------EFCRRLKEGTRMRAP-------EYATPEIYS  307 (337)
T ss_pred             cHHhcCC--CCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-------HHHHHHhccCCCCCC-------ccCCHHHHH
Confidence            9998774  78999999999999999997 988886432111       111222222111111       123456888


Q ss_pred             HHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 036435          321 VGLWCIQARPSDRPPMNEVIEMLQGSTE  348 (372)
Q Consensus       321 l~~~cl~~~p~~RPs~~evl~~L~~~~~  348 (372)
                      ++.+||+.+|++||+++|+++.|+++.+
T Consensus       308 l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         308 IMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            9999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=6.7e-39  Score=294.77  Aligned_cols=245  Identities=25%  Similarity=0.444  Sum_probs=190.4

Q ss_pred             HHHhhhhhhcCCCCceEEEEEEec---------------------------chHHHHHHHHhcc-CCCceeeeEeEEecC
Q 036435           82 KLTNSFKDKLGQGGFGGVYKGRLL---------------------------DDFVNEVASISRT-SHVNVVTLLGFCLEG  133 (372)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~---------------------------~~~~~E~~~l~~l-~h~nIv~l~g~~~~~  133 (372)
                      ...+.+.+.||+|+||.||+++..                           .++.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            334455678999999999988531                           1477899999999 899999999999999


Q ss_pred             CceeEEEEecCCCChhhhhhcCCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE
Q 036435          134 NNRALIYEFMPNGSLEKFVYNGDTSK----------PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL  203 (372)
Q Consensus       134 ~~~~lV~e~~~~g~L~~~l~~~~~~~----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill  203 (372)
                      +..++||||+++|+|.+++.......          ....+++.+++.++.|++.||+|||   +.+++|+||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEE
Confidence            99999999999999999997643211          1234889999999999999999999   7999999999999999


Q ss_pred             CCCCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCC
Q 036435          204 DEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSS  282 (372)
Q Consensus       204 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~  282 (372)
                      ++++.+||+|||+++.......... .....++..|+|||.+.+.  .++.++||||||+++|++++ |..||.....  
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--  245 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKK-TTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--  245 (304)
T ss_pred             cCCCcEEECCCccceeccccccccc-ccCCCCCceeeCchhhccC--CCCchhhHHHHHHHHHHHHcCCCCCcccCCH--
Confidence            9999999999999987644322211 1223456789999998764  78899999999999999998 6777653211  


Q ss_pred             CccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          283 SEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                            ...............+       ......+.+++.+||+.+|.+|||+.++++.|+++.
T Consensus       246 ------~~~~~~~~~~~~~~~~-------~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~  297 (304)
T cd05101         246 ------EELFKLLKEGHRMDKP-------ANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL  297 (304)
T ss_pred             ------HHHHHHHHcCCcCCCC-------CCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence                  1122222222222111       123466788999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3.9e-39  Score=298.60  Aligned_cols=224  Identities=19%  Similarity=0.291  Sum_probs=178.3

Q ss_pred             hhcCCCCceEEEEEEecc----------------------hHHHHHHHHhcc-CCCceeeeEeEEecCCceeEEEEecCC
Q 036435           89 DKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      +.||+|+||.||+|+...                      .+..|.+++..+ +||||+++++++.+++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            359999999999996532                      255688888766 799999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      |+|.+++.....      +++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++........
T Consensus        81 ~~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~  151 (321)
T cd05591          81 GDLMFQIQRSRK------FDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV  151 (321)
T ss_pred             CcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc
Confidence            999999875432      889999999999999999999   89999999999999999999999999999875432221


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                      .   .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.......        ....+... ....|.
T Consensus       152 ~---~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~--------~~~~i~~~-~~~~p~  217 (321)
T cd05591         152 T---TTTFCGTPDYIAPEILQEL--EYGPSVDWWALGVLMYEMMAGQPPFEADNEDD--------LFESILHD-DVLYPV  217 (321)
T ss_pred             c---ccccccCccccCHHHHcCC--CCCCccceechhHHHHHHhcCCCCCCCCCHHH--------HHHHHHcC-CCCCCC
Confidence            1   1234588999999998764  78999999999999999999999997543211        11222111 111121


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCC-------CHHHHHHH
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRP-------PMNEVIEM  342 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-------s~~evl~~  342 (372)
                      .       ....+.+++.+||+.||++||       +++++++.
T Consensus       218 ~-------~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         218 W-------LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             C-------CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            1       235677889999999999999       78888753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.4e-38  Score=285.33  Aligned_cols=232  Identities=25%  Similarity=0.439  Sum_probs=183.0

Q ss_pred             hhhhhhcCCCCceEEEEEEecc---------------hHHHHHHHHhccCCCceeeeEeEEe-cCCceeEEEEecCCCCh
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD---------------DFVNEVASISRTSHVNVVTLLGFCL-EGNNRALIYEFMPNGSL  148 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~---------------~~~~E~~~l~~l~h~nIv~l~g~~~-~~~~~~lV~e~~~~g~L  148 (372)
                      +.+.+.||+|+||.||++....               .+.+|+.++++++|+|++++++++. +++..++|+||+++++|
T Consensus         8 ~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L   87 (256)
T cd05082           8 LKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL   87 (256)
T ss_pred             CeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcH
Confidence            3456789999999999986532               5788999999999999999999765 45678999999999999


Q ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeee
Q 036435          149 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVS  228 (372)
Q Consensus       149 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  228 (372)
                      .+++......    .+++..++.++.|++.||+|||   +.+++|+||||+||++++++.+||+|||++........   
T Consensus        88 ~~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~---  157 (256)
T cd05082          88 VDYLRSRGRS----VLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD---  157 (256)
T ss_pred             HHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccCC---
Confidence            9999765432    2889999999999999999999   89999999999999999999999999999875433221   


Q ss_pred             eecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccC
Q 036435          229 SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVV  307 (372)
Q Consensus       229 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (372)
                         ...++..|+|||++.+.  .++.++|||||||++|||++ |+.||.....       .. ....+........+   
T Consensus       158 ---~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-------~~-~~~~~~~~~~~~~~---  221 (256)
T cd05082         158 ---TGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-------KD-VVPRVEKGYKMDAP---  221 (256)
T ss_pred             ---CCccceeecCHHHHccC--CCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-------HH-HHHHHhcCCCCCCC---
Confidence               12245679999998764  78899999999999999997 8888764311       11 11222221111111   


Q ss_pred             CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 036435          308 TRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGS  346 (372)
Q Consensus       308 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~  346 (372)
                          ......+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       222 ----~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         222 ----DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             ----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                12345678899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.2e-38  Score=287.24  Aligned_cols=244  Identities=26%  Similarity=0.417  Sum_probs=182.7

Q ss_pred             hhhhhcCCCCceEEEEEEec-----------------------chHHHHHHHHhccCCCceeeeEeEEec--CCceeEEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLL-----------------------DDFVNEVASISRTSHVNVVTLLGFCLE--GNNRALIY  140 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~-----------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~--~~~~~lV~  140 (372)
                      .+.+.||+|+||.||++...                       +.+.+|++++++++||||+++++++..  ....++|+
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   86 (284)
T cd05081           7 KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVM   86 (284)
T ss_pred             eeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEE
Confidence            34577999999999998631                       157889999999999999999998754  34688999


Q ss_pred             EecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccc
Q 036435          141 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC  220 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~  220 (372)
                      ||+++|+|.+++.....     .+++..+..++.|++.||+|||   ..+++|+||||+||++++++.+||+|||++...
T Consensus        87 e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          87 EYLPYGSLRDYLQKHRE-----RLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EecCCCCHHHHHHhcCc-----CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            99999999999965432     2899999999999999999999   899999999999999999999999999999876


Q ss_pred             cCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCC-----Cc---cchHHHHH
Q 036435          221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSS-----SE---VYFPHWIY  292 (372)
Q Consensus       221 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~-----~~---~~~~~~~~  292 (372)
                      ..............++..|+|||.+.+.  .++.++|+||||+++|||++|..++.......     ..   ........
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI  236 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccC--CcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence            5433222111122234469999998764  78899999999999999999887654321110     00   00000011


Q ss_pred             HHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 036435          293 RHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGS  346 (372)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~  346 (372)
                      ..........       ........+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       237 ~~~~~~~~~~-------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         237 ELLKNNGRLP-------APPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHhcCCcCC-------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            1111111111       1112345688899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.8e-38  Score=285.72  Aligned_cols=222  Identities=24%  Similarity=0.389  Sum_probs=173.9

Q ss_pred             hhcCCCCceEEEEEEec-------------------------------chHHHHHHHHhccCCCceeeeEeEEecCCcee
Q 036435           89 DKLGQGGFGGVYKGRLL-------------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRA  137 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~-------------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~  137 (372)
                      +.||+|+||.||+|+..                               ..+.+|+.+++.++||||+++++++.++...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            35899999999999631                               04677889999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCc-------eE
Q 036435          138 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFC-------PK  210 (372)
Q Consensus       138 lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-------~k  210 (372)
                      +||||+++|+|..++.....     .+++..++.++.|+++||+|||   +.+++||||||+|||++.++.       ++
T Consensus        81 lv~e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~  152 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSD-----VLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIK  152 (262)
T ss_pred             EEEecccCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeE
Confidence            99999999999998865432     2899999999999999999999   899999999999999986654       89


Q ss_pred             EeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHh-cCCCCCCCCCCCCCccchHH
Q 036435          211 ISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV-GCKNNLDSGVDSSSEVYFPH  289 (372)
Q Consensus       211 l~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell-tg~~p~~~~~~~~~~~~~~~  289 (372)
                      ++|||++.......       ...++..|+|||.+.+. ..++.++|||||||++|||+ +|..|+.......       
T Consensus       153 l~d~g~~~~~~~~~-------~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-------  217 (262)
T cd05077         153 LSDPGIPITVLSRQ-------ECVERIPWIAPECVEDS-KNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-------  217 (262)
T ss_pred             eCCCCCCccccCcc-------cccccccccChhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-------
Confidence            99999987553321       22467789999988643 36889999999999999997 5777765432111       


Q ss_pred             HHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 036435          290 WIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEML  343 (372)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L  343 (372)
                       ........  ...   ...    ....+.+++.+||+.||.+||++.++++.+
T Consensus       218 -~~~~~~~~--~~~---~~~----~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         218 -KERFYEGQ--CML---VTP----SCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             -HHHHHhcC--ccC---CCC----ChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence             01111111  000   111    134678899999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-39  Score=303.63  Aligned_cols=227  Identities=26%  Similarity=0.406  Sum_probs=189.1

Q ss_pred             hhhhhcCCCCceEEEEEEec-----------------------chHHHHHHHHhccCCCceeeeEeEEecCCc--eeEEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLL-----------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNN--RALIY  140 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~-----------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~--~~lV~  140 (372)
                      +|..+||+|+|-+||||.+.                       ++|..|+.+|+.|+||||+++|.++.+..+  ..+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            34678999999999999663                       268999999999999999999999998765  77999


Q ss_pred             EecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC-CCCceEEeecCCccc
Q 036435          141 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLD-EDFCPKISDFGLAKL  219 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgla~~  219 (372)
                      |.+..|+|..|+++...      ++...+.+|++||++||.|||+. .++|+|||||.+||+|+ ..|.|||+|+|||..
T Consensus       123 EL~TSGtLr~Y~kk~~~------vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl  195 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHRR------VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL  195 (632)
T ss_pred             ecccCCcHHHHHHHhcc------CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHH
Confidence            99999999999988764      78889999999999999999964 78999999999999997 568999999999987


Q ss_pred             ccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcc
Q 036435          220 CTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDR  299 (372)
Q Consensus       220 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (372)
                      .......     ...|||.|||||+...   .|++..||||||.+++||+|+..||.....       +..++.++..+.
T Consensus       196 ~r~s~ak-----svIGTPEFMAPEmYEE---~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n-------~AQIYKKV~SGi  260 (632)
T KOG0584|consen  196 LRKSHAK-----SVIGTPEFMAPEMYEE---NYNELVDVYAFGMCMLEMVTSEYPYSECTN-------PAQIYKKVTSGI  260 (632)
T ss_pred             hhccccc-----eeccCccccChHHHhh---hcchhhhhhhhhHHHHHHHhccCChhhhCC-------HHHHHHHHHcCC
Confidence            7654422     2469999999999875   789999999999999999999999976543       234677776664


Q ss_pred             cccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          300 EFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ....-..+.      ..++.+++.+|+.. .++|||+.|+|+
T Consensus       261 KP~sl~kV~------dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  261 KPAALSKVK------DPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             CHHHhhccC------CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence            432211111      23566788899999 999999999996

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=8.5e-39  Score=294.49  Aligned_cols=245  Identities=25%  Similarity=0.439  Sum_probs=189.4

Q ss_pred             HHhhhhhhcCCCCceEEEEEEec---------------------------chHHHHHHHHhcc-CCCceeeeEeEEecCC
Q 036435           83 LTNSFKDKLGQGGFGGVYKGRLL---------------------------DDFVNEVASISRT-SHVNVVTLLGFCLEGN  134 (372)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~---------------------------~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~  134 (372)
                      ..+.+.+.||+|+||.||+++..                           .++.+|+.+++++ +||||+++++++.+++
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            34556788999999999988531                           1467799999999 7999999999999999


Q ss_pred             ceeEEEEecCCCChhhhhhcCCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC
Q 036435          135 NRALIYEFMPNGSLEKFVYNGDTS----------KPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLD  204 (372)
Q Consensus       135 ~~~lV~e~~~~g~L~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~  204 (372)
                      ..++|+||+++|+|.+++......          .....+++.+++.++.|++.||+|||   +.+++|+||||+||+++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEc
Confidence            999999999999999999764321          11234899999999999999999999   79999999999999999


Q ss_pred             CCCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCC
Q 036435          205 EDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSS  283 (372)
Q Consensus       205 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~  283 (372)
                      .++.+||+|||++........... .....++..|+|||.+.+.  .++.++|+|||||++|||++ |..||.....   
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~~~g~~p~~~~~~---  248 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKK-TTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---  248 (307)
T ss_pred             CCCcEEECCCcccccccccchhhc-cccCCCccceeChHHhccC--CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH---
Confidence            999999999999876543221111 1122245679999998764  78899999999999999998 7777753211   


Q ss_pred             ccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 036435          284 EVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE  348 (372)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~  348 (372)
                           ..+............+       ......+.+++.+||+.+|.+||++.++++.|+++..
T Consensus       249 -----~~~~~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~  301 (307)
T cd05098         249 -----EELFKLLKEGHRMDKP-------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA  301 (307)
T ss_pred             -----HHHHHHHHcCCCCCCC-------CcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence                 1122222222221211       1234577789999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.7e-38  Score=288.48  Aligned_cols=237  Identities=26%  Similarity=0.433  Sum_probs=185.1

Q ss_pred             hhhhhcCCCCceEEEEEEec------------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYE  141 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  141 (372)
                      .+.+.||+|+||+||+|++.                        ..+.+|+.+++.++||||+++++++... ..++++|
T Consensus        10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~   88 (279)
T cd05109          10 KKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQ   88 (279)
T ss_pred             eeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEE
Confidence            34578999999999998641                        1467899999999999999999999754 5789999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      |+++|+|.+++.....     .+++..++.++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++...
T Consensus        89 ~~~~g~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          89 LMPYGCLLDYVRENKD-----RIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             cCCCCCHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence            9999999999976432     2899999999999999999999   8999999999999999999999999999998765


Q ss_pred             CCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhccc
Q 036435          222 TKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDRE  300 (372)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (372)
                      ....... .....++..|+|||.+.+.  .++.++|||||||++|||++ |..||......        .....+.....
T Consensus       161 ~~~~~~~-~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~  229 (279)
T cd05109         161 IDETEYH-ADGGKVPIKWMALESILHR--RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--------EIPDLLEKGER  229 (279)
T ss_pred             cccceee-cCCCccchhhCCHHHhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHCCCc
Confidence            4332211 1222346779999998764  78999999999999999998 88887643211        11122222211


Q ss_pred             ccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 036435          301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       301 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~  349 (372)
                      ...+       ......+.+++..||+.||++||++.++++.|+.+...
T Consensus       230 ~~~~-------~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05109         230 LPQP-------PICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD  271 (279)
T ss_pred             CCCC-------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence            1111       12345678899999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-40  Score=276.77  Aligned_cols=229  Identities=22%  Similarity=0.382  Sum_probs=185.6

Q ss_pred             hhhhhcCCCCceEEEEEEe---------------------cchHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           86 SFKDKLGQGGFGGVYKGRL---------------------LDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~---------------------~~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      .+.+.||+|.|+.||+...                     .+++.+|+.+.+.|+||||+++.....+.+..|+|+|+|+
T Consensus        14 ~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~   93 (355)
T KOG0033|consen   14 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVT   93 (355)
T ss_pred             hHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEeccc
Confidence            4457899999999987422                     2368899999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC---CCCceEEeecCCccccc
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLD---EDFCPKISDFGLAKLCT  221 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgla~~~~  221 (372)
                      |++|..-+-.+.      .+++..+--..+||+++|.|+|   .++|||||+||+|+|+.   ...-+||+|||+|...+
T Consensus        94 G~dl~~eIV~R~------~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   94 GGELFEDIVARE------FYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             chHHHHHHHHHH------HHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            999976665432      3788888889999999999999   89999999999999994   44568999999999887


Q ss_pred             CCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccc
Q 036435          222 TKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF  301 (372)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (372)
                      .+.    ......|||+|||||++...  .++..+|||+.||+||-|+.|.+||.+.....        +++.+..+. .
T Consensus       165 ~g~----~~~G~~GtP~fmaPEvvrkd--py~kpvDiW~cGViLfiLL~G~~PF~~~~~~r--------lye~I~~g~-y  229 (355)
T KOG0033|consen  165 DGE----AWHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQHR--------LYEQIKAGA-Y  229 (355)
T ss_pred             Ccc----ccccccCCCcccCHHHhhcC--CCCCcchhhhhhHHHHHHHhCCCCCCCccHHH--------HHHHHhccc-c
Confidence            332    23456799999999999875  89999999999999999999999998743322        444444332 2


Q ss_pred             cCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       302 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      +.+.   +....+.++..+++.+||..||.+|.|++|.+.
T Consensus       230 d~~~---~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  230 DYPS---PEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             CCCC---cccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            2222   233345566777889999999999999998874

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=8.6e-39  Score=292.90  Aligned_cols=246  Identities=24%  Similarity=0.396  Sum_probs=184.2

Q ss_pred             hhhhhhcCCCCceEEEEEEec------------------------------------chHHHHHHHHhccCCCceeeeEe
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL------------------------------------DDFVNEVASISRTSHVNVVTLLG  128 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~------------------------------------~~~~~E~~~l~~l~h~nIv~l~g  128 (372)
                      +.+.+.||+|+||.||+++..                                    +++.+|+.++++++|+||+++++
T Consensus         7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~   86 (296)
T cd05095           7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLA   86 (296)
T ss_pred             ceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence            345678999999999986310                                    25788999999999999999999


Q ss_pred             EEecCCceeEEEEecCCCChhhhhhcCCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE
Q 036435          129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTS-----KPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL  203 (372)
Q Consensus       129 ~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~-----~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill  203 (372)
                      ++.+++..++||||+++|+|.+++......     .....+++.++..++.|++.||+|||   +.+++|+||||+|||+
T Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Nili  163 (296)
T cd05095          87 VCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLV  163 (296)
T ss_pred             EEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheEEE
Confidence            999999999999999999999999764321     11234888999999999999999999   7899999999999999


Q ss_pred             CCCCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc--CCCCCCCCCCC
Q 036435          204 DEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG--CKNNLDSGVDS  281 (372)
Q Consensus       204 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt--g~~p~~~~~~~  281 (372)
                      +.++.++|+|||++........... .....++..|++||...+.  .++.++|+|||||++|||++  |..||......
T Consensus       164 ~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~--~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         164 GKNYTIKIADFGMSRNLYSGDYYRI-QGRAVLPIRWMSWESILLG--KFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             cCCCCEEeccCcccccccCCcceec-cCcCcCccccCCHHHHhcC--CccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            9999999999999986543322111 1122345679999987664  78999999999999999998  66676543221


Q ss_pred             CCccchHHHHHHHhhh-cccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 036435          282 SSEVYFPHWIYRHVEQ-DREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG  345 (372)
Q Consensus       282 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~  345 (372)
                      .    ........... ......+.     .......+.+++.+||+.||.+||++.++++.|++
T Consensus       241 ~----~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         241 Q----VIENTGEFFRDQGRQVYLPK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             H----HHHHHHHHHhhccccccCCC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            1    00000010000 00111111     11123577889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2e-38  Score=301.11  Aligned_cols=244  Identities=23%  Similarity=0.377  Sum_probs=188.8

Q ss_pred             HhhhhhhcCCCCceEEEEEEec-------------------------chHHHHHHHHhccC-CCceeeeEeEEecCCcee
Q 036435           84 TNSFKDKLGQGGFGGVYKGRLL-------------------------DDFVNEVASISRTS-HVNVVTLLGFCLEGNNRA  137 (372)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-------------------------~~~~~E~~~l~~l~-h~nIv~l~g~~~~~~~~~  137 (372)
                      ...+.+.||+|+||.||+|++.                         +.+.+|+.+|.++. ||||++++++|.+++..+
T Consensus        38 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~  117 (401)
T cd05107          38 NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIY  117 (401)
T ss_pred             HeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcE
Confidence            3345678999999999999741                         14778999999997 999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCCCC-----------------------------------------------------------
Q 036435          138 LIYEFMPNGSLEKFVYNGDTS-----------------------------------------------------------  158 (372)
Q Consensus       138 lV~e~~~~g~L~~~l~~~~~~-----------------------------------------------------------  158 (372)
                      +|+||+++|+|.++++.....                                                           
T Consensus       118 iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (401)
T cd05107         118 IITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKG  197 (401)
T ss_pred             EEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchh
Confidence            999999999999999754210                                                           


Q ss_pred             ---------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC
Q 036435          159 ---------------------------------KPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE  205 (372)
Q Consensus       159 ---------------------------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~  205 (372)
                                                       .....+++..++.++.|++.||+|||   +.+++||||||+|||+++
T Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl~~  274 (401)
T cd05107         198 TVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLICE  274 (401)
T ss_pred             hhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEEeC
Confidence                                             01124788899999999999999999   799999999999999999


Q ss_pred             CCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCc
Q 036435          206 DFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSE  284 (372)
Q Consensus       206 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~  284 (372)
                      ++.+||+|||+++......... ......++..|+|||.+.+.  .++.++|+||||+++|||++ |+.||......   
T Consensus       275 ~~~~kL~DfGla~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~---  348 (401)
T cd05107         275 GKLVKICDFGLARDIMRDSNYI-SKGSTFLPLKWMAPESIFNN--LYTTLSDVWSFGILLWEIFTLGGTPYPELPMN---  348 (401)
T ss_pred             CCEEEEEecCcceecccccccc-cCCCcCCCCceeChHHhcCC--CCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch---
Confidence            9999999999998654322111 11223467789999999764  68899999999999999998 78887543211   


Q ss_pred             cchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          285 VYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                          ......+........+.       .....+.+++..||+.+|.+||+++++++.|+++.
T Consensus       349 ----~~~~~~~~~~~~~~~p~-------~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         349 ----EQFYNAIKRGYRMAKPA-------HASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             ----HHHHHHHHcCCCCCCCC-------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                11222222222222221       13457788999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.6e-38  Score=293.66  Aligned_cols=244  Identities=25%  Similarity=0.458  Sum_probs=188.8

Q ss_pred             hhhhhhcCCCCceEEEEEEec---------------------------chHHHHHHHHhcc-CCCceeeeEeEEecCCce
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL---------------------------DDFVNEVASISRT-SHVNVVTLLGFCLEGNNR  136 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~---------------------------~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~  136 (372)
                      +.+.+.||+|+||.||+++..                           .++.+|+.+++++ +||||+++++++.+++..
T Consensus        14 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~   93 (314)
T cd05099          14 LVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPL   93 (314)
T ss_pred             eeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCce
Confidence            345678999999999998531                           1467899999999 699999999999999999


Q ss_pred             eEEEEecCCCChhhhhhcCCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC
Q 036435          137 ALIYEFMPNGSLEKFVYNGDTS----------KPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDED  206 (372)
Q Consensus       137 ~lV~e~~~~g~L~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~  206 (372)
                      ++|+||+++|+|.+++......          .....+++.+++.++.|++.||.|||   +.+++|+||||+|||++++
T Consensus        94 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~~~  170 (314)
T cd05099          94 YVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTED  170 (314)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEEcCC
Confidence            9999999999999999764321          11234899999999999999999999   8999999999999999999


Q ss_pred             CceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCcc
Q 036435          207 FCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEV  285 (372)
Q Consensus       207 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~  285 (372)
                      +.+||+|||+++.......... .....++..|+|||.+.+.  .++.++|+||||+++|||++ |..||.....     
T Consensus       171 ~~~kL~Dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~~g~~p~~~~~~-----  242 (314)
T cd05099         171 NVMKIADFGLARGVHDIDYYKK-TSNGRLPVKWMAPEALFDR--VYTHQSDVWSFGILMWEIFTLGGSPYPGIPV-----  242 (314)
T ss_pred             CcEEEccccccccccccccccc-cccCCCCccccCHHHHccC--CcCccchhhHHHHHHHHHHhCCCCCCCCCCH-----
Confidence            9999999999986543222111 1122244679999998764  78899999999999999998 7888754321     


Q ss_pred             chHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 036435          286 YFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~  349 (372)
                         ...............+       ......+.+++.+||+.+|++||++.++++.|+++...
T Consensus       243 ---~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~  296 (314)
T cd05099         243 ---EELFKLLREGHRMDKP-------SNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA  296 (314)
T ss_pred             ---HHHHHHHHcCCCCCCC-------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence               1122222222111111       12245677899999999999999999999999887644

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.6e-39  Score=303.60  Aligned_cols=233  Identities=22%  Similarity=0.284  Sum_probs=183.6

Q ss_pred             hhhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEe
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      +.+.+.||+|+||.||+++...                      .+.+|+.+++.++||||+++++++.+++..++||||
T Consensus        45 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey  124 (370)
T cd05596          45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEY  124 (370)
T ss_pred             cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcC
Confidence            3456789999999999986532                      256799999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      +++|+|.+++.+..       ++...+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||++.....
T Consensus       125 ~~gg~L~~~l~~~~-------l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~  194 (370)
T cd05596         125 MPGGDLVNLMSNYD-------IPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA  194 (370)
T ss_pred             CCCCcHHHHHHhcC-------CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence            99999999986542       788889999999999999999   89999999999999999999999999999986543


Q ss_pred             CCCeeeeeccccccccccccccccccc--CCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhh-cc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNF--GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQ-DR  299 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~  299 (372)
                      ....  ......||+.|+|||.+.+..  ..++.++|+|||||++|||++|+.||......       . ....+.. ..
T Consensus       195 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~-~~~~i~~~~~  264 (370)
T cd05596         195 NGMV--RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------G-TYSKIMDHKN  264 (370)
T ss_pred             CCcc--cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-------H-HHHHHHcCCC
Confidence            2211  112346899999999986531  24788999999999999999999999754321       1 1122211 11


Q ss_pred             cccCCccCCcchHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 036435          300 EFKLPGVVTRKENEIAKKMIIVGLWCIQARPSD--RPPMNEVIEM  342 (372)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~evl~~  342 (372)
                      ....+..     ......+.+++.+||+.+|.+  |++++++++.
T Consensus       265 ~~~~~~~-----~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         265 SLTFPDD-----IEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             cCCCCCc-----CCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            2222221     123456778889999999988  9999999763

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.1e-38  Score=295.28  Aligned_cols=246  Identities=25%  Similarity=0.456  Sum_probs=190.4

Q ss_pred             HHHhhhhhhcCCCCceEEEEEEec---------------------------chHHHHHHHHhcc-CCCceeeeEeEEecC
Q 036435           82 KLTNSFKDKLGQGGFGGVYKGRLL---------------------------DDFVNEVASISRT-SHVNVVTLLGFCLEG  133 (372)
Q Consensus        82 ~~~~~~~~~lg~G~~g~V~~~~~~---------------------------~~~~~E~~~l~~l-~h~nIv~l~g~~~~~  133 (372)
                      ...+.+.+.||+|+||.||+++..                           +++.+|+.+++++ +||||++++++|.++
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            344566788999999999988531                           1477899999999 899999999999999


Q ss_pred             CceeEEEEecCCCChhhhhhcCCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE
Q 036435          134 NNRALIYEFMPNGSLEKFVYNGDTS----------KPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL  203 (372)
Q Consensus       134 ~~~~lV~e~~~~g~L~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill  203 (372)
                      +..++++||+++|+|.+++......          .....+++.+++.++.|++.||+|||   +.+++||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill  167 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLV  167 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEE
Confidence            9999999999999999999764311          11234889999999999999999999   8999999999999999


Q ss_pred             CCCCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCC
Q 036435          204 DEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSS  282 (372)
Q Consensus       204 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~  282 (372)
                      +.++.+||+|||+++.......... .....++..|+|||.+.+.  .++.++||||||+++|||++ |..||.....  
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~--  242 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKK-TTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--  242 (334)
T ss_pred             cCCCcEEECCcccceeccccccccc-ccCCCcCceEcCHHHhccC--CcCchhhhHHHHHHHHHHHhcCCCCCCCCCH--
Confidence            9999999999999986543221111 1222345679999998764  78899999999999999998 7777754321  


Q ss_pred             CccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 036435          283 SEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE  348 (372)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~  348 (372)
                           .. ....+........+       ......+.+++.+||+.+|.+||++.++++.|+.+..
T Consensus       243 -----~~-~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         243 -----EE-LFKLLKEGHRMDKP-------ANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             -----HH-HHHHHHcCCCCCCC-------CCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence                 11 12222222111111       1224567789999999999999999999999987763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.6e-38  Score=294.02  Aligned_cols=186  Identities=26%  Similarity=0.382  Sum_probs=151.0

Q ss_pred             hhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEec--CCceeEEEEecCCCC
Q 036435           89 DKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLE--GNNRALIYEFMPNGS  147 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~--~~~~~lV~e~~~~g~  147 (372)
                      .+||+|+||+||+|+..+                   .+.+|+.++++++||||+++++++.+  +...++|+||+. ++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~   85 (317)
T cd07868           7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HD   85 (317)
T ss_pred             cccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CC
Confidence            579999999999997531                   47889999999999999999998864  456789999995 58


Q ss_pred             hhhhhhcCCCC---CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE----CCCCceEEeecCCcccc
Q 036435          148 LEKFVYNGDTS---KPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL----DEDFCPKISDFGLAKLC  220 (372)
Q Consensus       148 L~~~l~~~~~~---~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfgla~~~  220 (372)
                      |.+++......   .....+++..+..++.|++.||+|||   +.+++||||||+|||+    +.++.+||+|||+++..
T Consensus        86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~  162 (317)
T cd07868          86 LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF  162 (317)
T ss_pred             HHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence            88887543211   11224889999999999999999999   8999999999999999    45678999999999876


Q ss_pred             cCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCC
Q 036435          221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGV  279 (372)
Q Consensus       221 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~  279 (372)
                      ..............+|+.|+|||++.+. ..++.++|+||+||++|||++|++||....
T Consensus       163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         163 NSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             CCCCccccccCCccccccccCCHHHcCC-CCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            5433222223345688999999998764 357899999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=8.2e-39  Score=293.92  Aligned_cols=238  Identities=26%  Similarity=0.445  Sum_probs=187.5

Q ss_pred             hhhhhhcCCCCceEEEEEEec-------------------------chHHHHHHHHhcc-CCCceeeeEeEEecCCceeE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL-------------------------DDFVNEVASISRT-SHVNVVTLLGFCLEGNNRAL  138 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-------------------------~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~l  138 (372)
                      ..+.+.||+|+||.||+++..                         +.+.+|+.+++++ +||||+++++++..++..++
T Consensus        37 ~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l  116 (302)
T cd05055          37 LSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILV  116 (302)
T ss_pred             eEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEE
Confidence            445678999999999988531                         1477899999999 79999999999999999999


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          139 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       139 V~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      |+||+++|+|.+++.....    ..+++.++..++.|++.||+|||   +.+++|+||||+|||++.++.++++|||++.
T Consensus       117 v~e~~~~~~L~~~i~~~~~----~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         117 ITEYCCYGDLLNFLRRKRE----SFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             EEEcCCCCcHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence            9999999999999975432    12899999999999999999999   7999999999999999999999999999998


Q ss_pred             cccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhh
Q 036435          219 LCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQ  297 (372)
Q Consensus       219 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (372)
                      .......... .....++..|+|||.+.+.  .++.++||||+||++|||++ |..||.......       ........
T Consensus       190 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-------~~~~~~~~  259 (302)
T cd05055         190 DIMNDSNYVV-KGNARLPVKWMAPESIFNC--VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-------KFYKLIKE  259 (302)
T ss_pred             cccCCCceee-cCCCCcccccCCHhhhccC--CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-------HHHHHHHc
Confidence            6544332111 1223456789999998764  78899999999999999998 888886542211       11122222


Q ss_pred             cccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 036435          298 DREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGS  346 (372)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~  346 (372)
                      ......+       ......+.+++.+||+.+|++|||+.++++.|+++
T Consensus       260 ~~~~~~~-------~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         260 GYRMAQP-------EHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             CCcCCCC-------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            2111111       11245688899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=7.7e-39  Score=295.93  Aligned_cols=223  Identities=23%  Similarity=0.319  Sum_probs=174.6

Q ss_pred             hhcCCCCceEEEEEEecc----------------------hHHHHHHHHhc-cCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           89 DKLGQGGFGGVYKGRLLD----------------------DFVNEVASISR-TSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~-l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      +.||+|+||.||+++..+                      .+..|..++.. .+||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            359999999999997632                      23456666664 4899999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      |+|.+++.....      +++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus        81 g~L~~~~~~~~~------~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  151 (316)
T cd05592          81 GDLMFHIQSSGR------FDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG  151 (316)
T ss_pred             CcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC
Confidence            999999876432      889999999999999999999   79999999999999999999999999999976433221


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                      .   .....||+.|+|||.+.+.  .++.++|||||||++|||++|+.||......        .....+... ....+.
T Consensus       152 ~---~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~G~~Pf~~~~~~--------~~~~~i~~~-~~~~~~  217 (316)
T cd05592         152 K---ASTFCGTPDYIAPEILKGQ--KYNESVDWWSFGVLLYEMLIGQSPFHGEDED--------ELFDSILND-RPHFPR  217 (316)
T ss_pred             c---cccccCCccccCHHHHcCC--CCCCcccchhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHcC-CCCCCC
Confidence            1   1234589999999999875  7899999999999999999999999754211        111212111 111121


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMN-EVIE  341 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-evl~  341 (372)
                             .....+.+++.+||+.||.+||++. ++++
T Consensus       218 -------~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         218 -------WISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             -------CCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence                   1345567888999999999999876 4543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.5e-38  Score=285.56  Aligned_cols=224  Identities=24%  Similarity=0.388  Sum_probs=175.5

Q ss_pred             hhcCCCCceEEEEEEec--------------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEe
Q 036435           89 DKLGQGGFGGVYKGRLL--------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~--------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      +.||+|+||.||+|...                          +.+.+|+.+++.++||||+++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            36999999999998642                          1467799999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCc--------eEEeec
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFC--------PKISDF  214 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--------~kl~Df  214 (372)
                      +++|+|.+++.....     .+++..++.++.|++.||+|||   +.+++||||||+||+++.++.        ++++||
T Consensus        81 ~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~  152 (258)
T cd05078          81 VKFGSLDTYLKKNKN-----LINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP  152 (258)
T ss_pred             CCCCcHHHHHhcCCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEeccc
Confidence            999999999976542     2889999999999999999999   899999999999999987665        699999


Q ss_pred             CCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHH
Q 036435          215 GLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRH  294 (372)
Q Consensus       215 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  294 (372)
                      |++.......       ...++..|+|||++.+. ..++.++|+||||+++|||++|..++........       ....
T Consensus       153 g~~~~~~~~~-------~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~-------~~~~  217 (258)
T cd05078         153 GISITVLPKE-------ILLERIPWVPPECIENP-QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK-------KLQF  217 (258)
T ss_pred             ccccccCCch-------hccccCCccCchhccCC-CCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH-------HHHH
Confidence            9887543321       22467789999998763 3578899999999999999999644332221110       0111


Q ss_pred             hhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 036435          295 VEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ  344 (372)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~  344 (372)
                      ...  ....|..       ...++.+++.+||+.||++|||++++++.|+
T Consensus       218 ~~~--~~~~~~~-------~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         218 YED--RHQLPAP-------KWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             HHc--cccCCCC-------CcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            111  1112211       1246788999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.3e-38  Score=287.65  Aligned_cols=237  Identities=26%  Similarity=0.455  Sum_probs=185.9

Q ss_pred             hhhhhhcCCCCceEEEEEEec-----------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL-----------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYE  141 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-----------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  141 (372)
                      +++.+.||+|+||.||+|+..                       .+|..|+.++++++||||+++++++.++...++|+|
T Consensus         6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   85 (269)
T cd05065           6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE   85 (269)
T ss_pred             eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEe
Confidence            345678999999999998652                       157789999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      |+++|+|.+++.....     .+++.+++.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++....
T Consensus        86 ~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          86 FMENGALDSFLRQNDG-----QFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             cCCCCcHHHHHhhCCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccc
Confidence            9999999999976432     2899999999999999999999   7999999999999999999999999999987654


Q ss_pred             CCCCeeeeeccc--ccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhc
Q 036435          222 TKEGIVSSLLGA--RGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQD  298 (372)
Q Consensus       222 ~~~~~~~~~~~~--~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (372)
                      ............  ..+..|+|||.+.+.  .++.++|||||||++||+++ |..||......        .....+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--------~~~~~i~~~  227 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--------DVINAIEQD  227 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccC--cccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--------HHHHHHHcC
Confidence            332211111111  124579999998764  78999999999999999886 88888653211        011222221


Q ss_pred             ccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 036435          299 REFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGS  346 (372)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~  346 (372)
                      .....+       .+.+..+.+++.+||+.+|.+||+++++++.|+++
T Consensus       228 ~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         228 YRLPPP-------MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             CcCCCc-------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            111111       12345677899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-38  Score=283.77  Aligned_cols=235  Identities=32%  Similarity=0.537  Sum_probs=187.8

Q ss_pred             hhcCCCCceEEEEEEecc-----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           89 DKLGQGGFGGVYKGRLLD-----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~-----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      +.||+|+||.||++....                       .+.+|++.++.++|+||+++++++.++...++|+||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            369999999999997641                       567899999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCC---CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          146 GSLEKFVYNGDTS---KPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       146 g~L~~~l~~~~~~---~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      ++|.+++......   .....+++.++..++.|++.||+|||   +.+++|+||||+||++++++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999875211   00123899999999999999999999   89999999999999999999999999999987665


Q ss_pred             CCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREF  301 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (372)
                      .... .......++..|+|||.+.+.  .++.++|+||+|+++|||++ |..||.....        .............
T Consensus       158 ~~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~  226 (262)
T cd00192         158 DDYY-RKKTGGKLPIRWMAPESLKDG--IFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--------EEVLEYLRKGYRL  226 (262)
T ss_pred             cccc-ccccCCCcCccccCHHHhccC--CcchhhccHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCC
Confidence            4321 112334567889999998765  78999999999999999998 5888875421        1122223222222


Q ss_pred             cCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 036435          302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ  344 (372)
Q Consensus       302 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~  344 (372)
                      ..+       ......+.+++.+||+.+|++|||+.++++.|+
T Consensus       227 ~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         227 PKP-------EYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             CCC-------ccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            222       222567888999999999999999999998874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-39  Score=292.76  Aligned_cols=231  Identities=27%  Similarity=0.348  Sum_probs=182.4

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      ...+.||+|+||.||++....                      .+.+|+.++++++||||+++++.+.+++..++||||+
T Consensus         3 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (285)
T cd05605           3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM   82 (285)
T ss_pred             eEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEecc
Confidence            345779999999999986531                      3567999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      ++|+|.+++.....    ..+++..+..++.|++.||.|||   +.+++|+||||+||++++++.++|+|||++......
T Consensus        83 ~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          83 NGGDLKFHIYNMGN----PGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             CCCcHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            99999998865432    22899999999999999999999   799999999999999999999999999999865432


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                      ...    ....|+..|+|||.+.+.  .++.++|+||+||++||+++|+.||........    ...+...+... ..  
T Consensus       156 ~~~----~~~~~~~~y~aPE~~~~~--~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~----~~~~~~~~~~~-~~--  222 (285)
T cd05605         156 ETI----RGRVGTVGYMAPEVVKNE--RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK----REEVERRVKED-QE--  222 (285)
T ss_pred             Ccc----ccccCCCCccCcHHhcCC--CCCccccchhHHHHHHHHHHCCCCCCCCchhhH----HHHHHHHhhhc-cc--
Confidence            211    223578899999999764  788999999999999999999999975432110    01111111110 00  


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRP-----PMNEVIE  341 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~  341 (372)
                           .........+.+++.+||+.||.+||     +++++++
T Consensus       223 -----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         223 -----EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             -----ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence                 11122456678899999999999999     8888865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.3e-38  Score=287.03  Aligned_cols=240  Identities=22%  Similarity=0.423  Sum_probs=189.1

Q ss_pred             hhhhhhcCCCCceEEEEEEec----------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEe
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL----------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~----------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      +.+.+.||+|+||.||+++..                      .++.+|+.+++.++||||+++++++.+++..++++||
T Consensus         4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   83 (267)
T cd08229           4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL   83 (267)
T ss_pred             hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEe
Confidence            345678999999999998742                      1577899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      +++++|.+++......  ...+++.++..++.|+++||+|||   +.+++|+||||+||+++.++.++|+|||++.....
T Consensus        84 ~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          84 ADAGDLSRMIKHFKKQ--KRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             cCCCCHHHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            9999999998753221  134899999999999999999999   89999999999999999999999999999876543


Q ss_pred             CCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      .....   ....++..|+|||.+.+.  .++.++|+||||+++|+|++|..||.......     .. ........   .
T Consensus       159 ~~~~~---~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~-~~~~~~~~---~  224 (267)
T cd08229         159 KTTAA---HSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-----YS-LCKKIEQC---D  224 (267)
T ss_pred             CCccc---ccccCCcCccCHHHhcCC--CccchhhHHHHHHHHHHHHhCCCCcccccchH-----HH-HhhhhhcC---C
Confidence            32211   223477889999999765  78899999999999999999999986532211     00 11111111   1


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGS  346 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~  346 (372)
                      .+..   ........+.+++.+||+.||++|||+.+|++.++++
T Consensus       225 ~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         225 YPPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             CCCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            1111   1123456788899999999999999999999988764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=305.17  Aligned_cols=232  Identities=25%  Similarity=0.450  Sum_probs=195.0

Q ss_pred             hhhhcCCCCceEEEEEEec-----------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           87 FKDKLGQGGFGGVYKGRLL-----------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~-----------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      ..++||+|.||+|++|.|.                       ++|++|+.+|.+|+|||+++|||+..+ ....+|+|++
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa  192 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA  192 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence            3578999999999999774                       279999999999999999999999988 6788999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      +.|+|.+.|++...    ..|-......++.|||.||.||.   .++.|||||..+|+|+-....+||+||||.+....+
T Consensus       193 plGSLldrLrka~~----~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n  265 (1039)
T KOG0199|consen  193 PLGSLLDRLRKAKK----AILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN  265 (1039)
T ss_pred             ccchHHHHHhhccc----cceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence            99999999988222    23788889999999999999999   899999999999999999999999999999998887


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      +..+.......-...|.|||.+...  +++.++|||+|||++|||+| |..||-+...        ..+.+.++++..+.
T Consensus       266 ed~Yvm~p~rkvPfAWCaPEsLrh~--kFShaSDvWmyGVTiWEMFtyGEePW~G~~g--------~qIL~~iD~~erLp  335 (1039)
T KOG0199|consen  266 EDMYVMAPQRKVPFAWCAPESLRHR--KFSHASDVWMYGVTIWEMFTYGEEPWVGCRG--------IQILKNIDAGERLP  335 (1039)
T ss_pred             CcceEecCCCcCcccccCHhHhccc--cccccchhhhhhhhHHhhhccCCCCCCCCCH--------HHHHHhccccccCC
Confidence            7666544444455679999999874  99999999999999999997 5577765322        22455566555554


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEML  343 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L  343 (372)
                      .|       +.+.+++++++..||..+|++|||+..+.+.+
T Consensus       336 RP-------k~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  336 RP-------KYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             CC-------CCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            44       34568899999999999999999999998543

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-39  Score=302.18  Aligned_cols=233  Identities=23%  Similarity=0.310  Sum_probs=185.1

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      .+.+.||+|+||.||+++...                      .+.+|+.++..++||||+++++++.+++..++||||+
T Consensus         4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   83 (350)
T cd05573           4 EVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYM   83 (350)
T ss_pred             eEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCC
Confidence            345789999999999997641                      3677999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      ++|+|.+++....      .+++..+..++.|++.||+|||   ..+++||||||+|||++.++.+||+|||++......
T Consensus        84 ~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          84 PGGDLMNLLIRKD------VFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             CCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            9999999997653      2889999999999999999999   899999999999999999999999999999865443


Q ss_pred             CC--------------------------eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCC
Q 036435          224 EG--------------------------IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDS  277 (372)
Q Consensus       224 ~~--------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~  277 (372)
                      ..                          .........||+.|+|||.+.+.  .++.++|||||||++|||++|+.||..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~Pf~~  232 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT--PYGLECDWWSLGVILYEMLYGFPPFYS  232 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC--CCCCceeeEecchhhhhhccCCCCCCC
Confidence            20                          00112234589999999999875  789999999999999999999999976


Q ss_pred             CCCCCCccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHH
Q 036435          278 GVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPP-MNEVIEM  342 (372)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~evl~~  342 (372)
                      .....       ..............|....     +...+.+++.+|++ ||.+||+ ++++++.
T Consensus       233 ~~~~~-------~~~~i~~~~~~~~~p~~~~-----~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         233 DTLQE-------TYNKIINWKESLRFPPDPP-----VSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CCHHH-------HHHHHhccCCcccCCCCCC-----CCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            43211       1111111111222222111     34667788889997 9999999 9999974

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-39  Score=304.37  Aligned_cols=231  Identities=23%  Similarity=0.287  Sum_probs=179.7

Q ss_pred             hhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           87 FKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      +.+.||+|+||.||+++...                      .+.+|+.++..++||||+++++++.+++..++||||++
T Consensus         5 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~   84 (364)
T cd05599           5 SIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLP   84 (364)
T ss_pred             EEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCC
Confidence            45789999999999987632                      35679999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      +|+|.+++.....      +++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++.......
T Consensus        85 ~g~L~~~l~~~~~------l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  155 (364)
T cd05599          85 GGDMMTLLMKKDT------FTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH  155 (364)
T ss_pred             CcHHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence            9999999976432      899999999999999999999   8999999999999999999999999999987543211


Q ss_pred             Cee-----------------------------------eeecccccccccccccccccccCCCCccccchhHHHHHHHHh
Q 036435          225 GIV-----------------------------------SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV  269 (372)
Q Consensus       225 ~~~-----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell  269 (372)
                      ...                                   .......||+.|+|||++.+.  .++.++|||||||++|||+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~  233 (364)
T cd05599         156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT--GYNKECDWWSLGVIMYEML  233 (364)
T ss_pred             cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC--CCCCeeeeecchhHHHHhh
Confidence            000                                   001123589999999998764  7899999999999999999


Q ss_pred             cCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 036435          270 GCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPP---MNEVIE  341 (372)
Q Consensus       270 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~evl~  341 (372)
                      +|..||.......       ...........+..+...     .....+.+++.+|+. +|.+|++   ++++++
T Consensus       234 ~G~~Pf~~~~~~~-------~~~~i~~~~~~~~~~~~~-----~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         234 VGYPPFCSDNPQE-------TYRKIINWKETLQFPDEV-----PLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             cCCCCCCCCCHHH-------HHHHHHcCCCccCCCCCC-----CCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            9999997542210       111111111112222211     123456677788886 8999998   888876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.4e-38  Score=284.85  Aligned_cols=229  Identities=24%  Similarity=0.369  Sum_probs=185.0

Q ss_pred             hhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           87 FKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      +.+.||+|++|.||+++...                     .+.+|++++++++||||+++++++.+++..++|+||+++
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd08529           4 ILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAEN   83 (256)
T ss_pred             EeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCC
Confidence            45779999999999996532                     577899999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      ++|.+++.....    ..+++.++..++.|++.||.|||   +.+++|+||||+||++++++.++|+|||++........
T Consensus        84 ~~L~~~l~~~~~----~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          84 GDLHKLLKMQRG----RPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            999999976432    23899999999999999999999   79999999999999999999999999999986654332


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                      ..   ....++..|+|||+..+.  .++.++|+||||+++|+|++|+.||......        ...........   + 
T Consensus       157 ~~---~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~---~-  219 (256)
T cd08529         157 FA---NTIVGTPYYLSPELCEDK--PYNEKSDVWALGVVLYECCTGKHPFDANNQG--------ALILKIIRGVF---P-  219 (256)
T ss_pred             hh---hccccCccccCHHHhcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCCC---C-
Confidence            21   223477889999998764  6889999999999999999999998754311        11111111111   1 


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                         .........+.+++.+||+.+|++||++.++++.
T Consensus       220 ---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         220 ---PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ---CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence               1111345678889999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.8e-38  Score=288.37  Aligned_cols=242  Identities=24%  Similarity=0.426  Sum_probs=186.4

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-------------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-------------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALI  139 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV  139 (372)
                      +.+.+.||+|+||.||+|...+                         .+.+|+.+++.++||||+++++++.+++..++|
T Consensus         8 ~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   87 (288)
T cd05061           8 ITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVV   87 (288)
T ss_pred             ceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence            4456789999999999985321                         467799999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCC----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecC
Q 036435          140 YEFMPNGSLEKFVYNGDTS----KPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFG  215 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~----~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  215 (372)
                      |||+++|+|.+++......    .....+++..+..++.|++.||.|||   +.+++||||||+||++++++.+||+|||
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L~Dfg  164 (288)
T cd05061          88 MELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFG  164 (288)
T ss_pred             EeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEECcCC
Confidence            9999999999999753321    11123678889999999999999999   8999999999999999999999999999


Q ss_pred             CcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHH
Q 036435          216 LAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRH  294 (372)
Q Consensus       216 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  294 (372)
                      +++.......... .....++..|+|||.+.+.  .++.++|+|||||++|||++ |..||......       . ....
T Consensus       165 ~~~~~~~~~~~~~-~~~~~~~~~y~~pE~~~~~--~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~-------~-~~~~  233 (288)
T cd05061         165 MTRDIYETDYYRK-GGKGLLPVRWMAPESLKDG--VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-------Q-VLKF  233 (288)
T ss_pred             ccccccccccccc-cCCCcccccccCHHHhccC--CCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-------H-HHHH
Confidence            9986543322111 1122346679999998764  78999999999999999998 67777542211       1 1111


Q ss_pred             hhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          295 VEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                      .........+       ......+.+++.+||+.||++|||+.++++.|+...
T Consensus       234 ~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         234 VMDGGYLDQP-------DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             HHcCCCCCCC-------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            1111111111       122457888999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.1e-38  Score=280.04  Aligned_cols=242  Identities=26%  Similarity=0.369  Sum_probs=186.9

Q ss_pred             hhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCc-eeeeEeEEecCC------ceeE
Q 036435           87 FKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVN-VVTLLGFCLEGN------NRAL  138 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~n-Iv~l~g~~~~~~------~~~l  138 (372)
                      ..++||+|+||+||+|+...                     ...+|+.+|++++|+| |+++++++.+.+      .+++
T Consensus        15 ~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~l   94 (323)
T KOG0594|consen   15 KVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYL   94 (323)
T ss_pred             HHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEE
Confidence            34679999999999997632                     4689999999999999 999999999887      7899


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          139 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       139 V~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      |+||++. +|..++.......  +.++...+..+..|++.||+|||   +++|+||||||.|||++++|.+||+|||+|+
T Consensus        95 vfe~~d~-DL~~ymd~~~~~~--~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr  168 (323)
T KOG0594|consen   95 VFEFLDR-DLKKYMDSLPKKP--QGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGLAR  168 (323)
T ss_pred             EEEeecc-cHHHHHHhccccc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccchHH
Confidence            9999965 9999998765321  33777899999999999999999   8999999999999999999999999999999


Q ss_pred             cccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhc
Q 036435          219 LCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQD  298 (372)
Q Consensus       219 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (372)
                      ...-....   .....+|.-|.|||++.+. ..++...||||+||++.||+++++-|....+.+    ....+.+.+...
T Consensus       169 a~~ip~~~---yt~evvTlWYRaPEvLlGs-~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~----ql~~If~~lGtP  240 (323)
T KOG0594|consen  169 AFSIPMRT---YTPEVVTLWYRAPEVLLGS-TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID----QLFRIFRLLGTP  240 (323)
T ss_pred             HhcCCccc---ccccEEEeeccCHHHhcCC-CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH----HHHHHHHHcCCC
Confidence            66533221   2334577789999999986 479999999999999999999999888765422    111122222221


Q ss_pred             ccccCCcc------------------CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          299 REFKLPGV------------------VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       299 ~~~~~~~~------------------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                      ..-.+|+.                  .....+.......+++.+||+.+|.+|.|++..++.
T Consensus       241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            11111111                  011111112367889999999999999999999875

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.4e-38  Score=285.97  Aligned_cols=235  Identities=27%  Similarity=0.464  Sum_probs=185.7

Q ss_pred             HhhhhhhcCCCCceEEEEEEecc-----------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           84 TNSFKDKLGQGGFGGVYKGRLLD-----------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      .+.+.++||+|+||.||++...+                 .+.+|+.++++++|+||+++++++.+ ...++++||++++
T Consensus         7 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~   85 (260)
T cd05073           7 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKG   85 (260)
T ss_pred             ceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCC
Confidence            34556789999999999986521                 57889999999999999999999887 7789999999999


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      +|.+++......    .+++.+++.++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++.........
T Consensus        86 ~L~~~~~~~~~~----~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  158 (260)
T cd05073          86 SLLDFLKSDEGS----KQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT  158 (260)
T ss_pred             cHHHHHHhCCcc----ccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence            999999764322    2789999999999999999999   789999999999999999999999999999765432211


Q ss_pred             eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                      .  .....++..|+|||++.+.  .++.++|+||||+++|++++ |..||.......        .............+ 
T Consensus       159 ~--~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--------~~~~~~~~~~~~~~-  225 (260)
T cd05073         159 A--REGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--------VIRALERGYRMPRP-  225 (260)
T ss_pred             c--ccCCcccccccCHhHhccC--CcCccccchHHHHHHHHHHhcCCCCCCCCCHHH--------HHHHHhCCCCCCCc-
Confidence            1  1222355679999998764  78899999999999999998 888886432111        12222222111111 


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG  345 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~  345 (372)
                            ......+.+++.+||+.+|++||+++++.+.|+.
T Consensus       226 ------~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         226 ------ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ------ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                  2234568889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-38  Score=285.67  Aligned_cols=231  Identities=26%  Similarity=0.342  Sum_probs=182.1

Q ss_pred             hhhhcCCCCceEEEEEEecc------------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEe
Q 036435           87 FKDKLGQGGFGGVYKGRLLD------------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      ..+.||+|++|.||++...+                        .+.+|+.++++++||||+++++++.++...++|+||
T Consensus         6 ~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   85 (263)
T cd06625           6 RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEY   85 (263)
T ss_pred             ccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEE
Confidence            35789999999999985421                        467799999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      +++++|.+++.....      +++..+..++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||++.....
T Consensus        86 ~~~~~l~~~~~~~~~------~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          86 MPGGSVKDQLKAYGA------LTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             CCCCcHHHHHHHhCC------CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence            999999999876432      788999999999999999999   89999999999999999999999999999976543


Q ss_pred             CCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      ............++..|+|||.+.+.  ..+.++||||||+++||+++|+.||.......       .............
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~~~~~~  227 (263)
T cd06625         157 ICSSGTGMKSVTGTPYWMSPEVISGE--GYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA-------AIFKIATQPTNPQ  227 (263)
T ss_pred             cccccccccCCCcCccccCcceeccC--CCCchhhhHHHHHHHHHHHhCCCCccccchHH-------HHHHHhccCCCCC
Confidence            22111111223467789999999875  68899999999999999999999986532110       0111111111111


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                      .+       ......+.+++.+||+.+|.+|||+.++++.
T Consensus       228 ~~-------~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         228 LP-------SHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             CC-------ccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            11       2234567788999999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=7.7e-39  Score=297.02  Aligned_cols=224  Identities=22%  Similarity=0.343  Sum_probs=175.3

Q ss_pred             hhhhcCCCCceEEEEEEecc----------------------hHHHHHHHH---hccCCCceeeeEeEEecCCceeEEEE
Q 036435           87 FKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASI---SRTSHVNVVTLLGFCLEGNNRALIYE  141 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l---~~l~h~nIv~l~g~~~~~~~~~lV~e  141 (372)
                      +.+.||+|+||.||++....                      .+.+|..++   ++++||||+++++++.+++..++|||
T Consensus         3 i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E   82 (324)
T cd05589           3 CLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVME   82 (324)
T ss_pred             EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEc
Confidence            45679999999999986532                      244455444   56789999999999999999999999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      |+++|+|..++...       .+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|||++....
T Consensus        83 ~~~~~~L~~~~~~~-------~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05589          83 YAAGGDLMMHIHTD-------VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM  152 (324)
T ss_pred             CCCCCcHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence            99999999888543       2899999999999999999999   8999999999999999999999999999987533


Q ss_pred             CCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccc
Q 036435          222 TKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF  301 (372)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (372)
                      .....   .....||+.|+|||.+.+.  .++.++|+|||||++|||++|+.||......       . ....+... ..
T Consensus       153 ~~~~~---~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~G~~pf~~~~~~-------~-~~~~i~~~-~~  218 (324)
T cd05589         153 GFGDR---TSTFCGTPEFLAPEVLTET--SYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-------E-VFDSIVND-EV  218 (324)
T ss_pred             CCCCc---ccccccCccccCHhHhcCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCHH-------H-HHHHHHhC-CC
Confidence            22211   1234588999999999875  7889999999999999999999999754221       1 11111111 11


Q ss_pred             cCCccCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 036435          302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRP-----PMNEVIE  341 (372)
Q Consensus       302 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~  341 (372)
                      ..|.       .+...+.+++.+||+.||.+||     ++.++++
T Consensus       219 ~~p~-------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         219 RYPR-------FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             CCCC-------CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            1221       2345677899999999999999     5667665

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.3e-38  Score=294.44  Aligned_cols=223  Identities=23%  Similarity=0.311  Sum_probs=175.8

Q ss_pred             hhcCCCCceEEEEEEecc----------------------hHHHHHHHHhc-cCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           89 DKLGQGGFGGVYKGRLLD----------------------DFVNEVASISR-TSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~-l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      +.||+|+||.||+|+..+                      .+..|..++.. ++||||+++++++.+++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            358999999999997632                      24557777775 4899999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      |+|.+++.....      +++.++..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++........
T Consensus        81 g~L~~~l~~~~~------~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  151 (316)
T cd05619          81 GDLMFHIQSCHK------FDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA  151 (316)
T ss_pred             CcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC
Confidence            999999975432      889999999999999999999   89999999999999999999999999999875332221


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                      .   .....||..|+|||.+.+.  .++.++|||||||++|||++|+.||......        .....+... ....+.
T Consensus       152 ~---~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~~~~~--------~~~~~i~~~-~~~~~~  217 (316)
T cd05619         152 K---TCTFCGTPDYIAPEILLGQ--KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--------ELFQSIRMD-NPCYPR  217 (316)
T ss_pred             c---eeeecCCccccCHHHHcCC--CCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhC-CCCCCc
Confidence            1   1233588999999999775  7899999999999999999999999753211        112222111 111121


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMN-EVIE  341 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-evl~  341 (372)
                             .....+.+++.+||+.||++||++. ++.+
T Consensus       218 -------~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         218 -------WLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             -------cCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence                   1335677889999999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.2e-39  Score=299.89  Aligned_cols=220  Identities=25%  Similarity=0.322  Sum_probs=176.2

Q ss_pred             hhcCCCCceEEEEEEec------------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           89 DKLGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      +.||+|+||.||+++..                        ..+.+|++++++++||||+++++++.+++..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            46999999999987541                        135679999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      +|+|.+++....      .+++..+..++.|++.||+|||   +.+++||||||+|||+++++.+||+|||++.......
T Consensus        82 ~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~  152 (318)
T cd05582          82 GGDLFTRLSKEV------MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  152 (318)
T ss_pred             CCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence            999999996543      2899999999999999999999   8999999999999999999999999999998654332


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCC
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP  304 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (372)
                      ..   .....||+.|+|||.+.+.  .++.++|||||||++|||++|+.||......        .....+.. .....|
T Consensus       153 ~~---~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~~~--------~~~~~i~~-~~~~~p  218 (318)
T cd05582         153 KK---AYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGSLPFQGKDRK--------ETMTMILK-AKLGMP  218 (318)
T ss_pred             Cc---eecccCChhhcCHHHHcCC--CCCCccceeccceEeeeeccCCCCCCCCCHH--------HHHHHHHc-CCCCCC
Confidence            11   1234588999999999764  6789999999999999999999999753211        11111111 111222


Q ss_pred             ccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 036435          305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNE  338 (372)
Q Consensus       305 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  338 (372)
                      .       .....+.+++.+||+.||++||++.+
T Consensus       219 ~-------~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         219 Q-------FLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             C-------CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            2       23456778889999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=9.9e-39  Score=295.48  Aligned_cols=223  Identities=21%  Similarity=0.314  Sum_probs=178.2

Q ss_pred             hhcCCCCceEEEEEEecc----------------------hHHHHHHHHhcc-CCCceeeeEeEEecCCceeEEEEecCC
Q 036435           89 DKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      +.||+|+||.||+++...                      .+.+|..+++.+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            359999999999986532                      345688888877 799999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      |+|.+++.....      +++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++.......
T Consensus        81 ~~L~~~~~~~~~------l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  151 (318)
T cd05570          81 GDLMFHIQRSGR------FDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV  151 (318)
T ss_pred             CCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC
Confidence            999999876532      899999999999999999999   89999999999999999999999999999875322221


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                      .   .....||+.|+|||.+.+.  .++.++|+|||||++|+|++|+.||......        .....+... ....+.
T Consensus       152 ~---~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslGvil~~l~~G~~pf~~~~~~--------~~~~~i~~~-~~~~~~  217 (318)
T cd05570         152 T---TSTFCGTPDYIAPEILSYQ--PYGPAVDWWALGVLLYEMLAGQSPFEGDDED--------ELFQSILED-EVRYPR  217 (318)
T ss_pred             c---ccceecCccccCHHHhcCC--CCCcchhhhhHHHHHHHHhhCCCCCCCCCHH--------HHHHHHHcC-CCCCCC
Confidence            1   1223588999999999875  7899999999999999999999999753211        111111111 111221


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPM-----NEVIE  341 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~-----~evl~  341 (372)
                             .....+.+++.+||+.||.+||++     .++++
T Consensus       218 -------~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         218 -------WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             -------cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence                   234567889999999999999999     88875

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=6.9e-39  Score=302.18  Aligned_cols=234  Identities=22%  Similarity=0.277  Sum_probs=181.1

Q ss_pred             hhhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEe
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      +.+.+.||+|+||.||+++...                      .+.+|+.+++.++||||+++++++.+++..++||||
T Consensus        45 y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey  124 (370)
T cd05621          45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEY  124 (370)
T ss_pred             CeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcC
Confidence            3445789999999999987632                      366899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      +++|+|.+++....       +++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||++.....
T Consensus       125 ~~gg~L~~~l~~~~-------~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~  194 (370)
T cd05621         125 MPGGDLVNLMSNYD-------VPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE  194 (370)
T ss_pred             CCCCcHHHHHHhcC-------CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence            99999999996532       788899999999999999999   89999999999999999999999999999987543


Q ss_pred             CCCeeeeeccccccccccccccccccc--CCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNF--GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDRE  300 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (372)
                      ....  ......||+.|+|||.+.+..  ..++.++|+||+||++|||++|+.||......       ............
T Consensus       195 ~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-------~~~~~i~~~~~~  265 (370)
T cd05621         195 TGMV--RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-------GTYSKIMDHKNS  265 (370)
T ss_pred             CCce--ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCcc
Confidence            2221  123446899999999987531  23788999999999999999999999754221       111112221122


Q ss_pred             ccCCccCCcchHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 036435          301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSD--RPPMNEVIEM  342 (372)
Q Consensus       301 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~evl~~  342 (372)
                      ...|..     ......+.+++.+|++.++.+  |++++|+++.
T Consensus       266 ~~~p~~-----~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         266 LNFPED-----VEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             cCCCCc-----ccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            222221     123455666777888755543  8899999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.2e-38  Score=282.74  Aligned_cols=232  Identities=27%  Similarity=0.533  Sum_probs=184.3

Q ss_pred             hhhhhcCCCCceEEEEEEec-----------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCCh
Q 036435           86 SFKDKLGQGGFGGVYKGRLL-----------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL  148 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~-----------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L  148 (372)
                      .+.+.||+|+||.||++.+.                 +++.+|++++++++|||++++++++......++|+||+++++|
T Consensus         7 ~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L   86 (256)
T cd05112           7 TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCL   86 (256)
T ss_pred             EEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcH
Confidence            44678999999999998653                 2688999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeee
Q 036435          149 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVS  228 (372)
Q Consensus       149 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  228 (372)
                      .+++.....     .+++..+..++.|++.|++|||   +.+++|+||||+||+++.++.+||+|||++.......... 
T Consensus        87 ~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~-  157 (256)
T cd05112          87 SDYLRAQRG-----KFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS-  157 (256)
T ss_pred             HHHHHhCcc-----CCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCcccc-
Confidence            999875432     2789999999999999999999   7899999999999999999999999999987654322111 


Q ss_pred             eecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccC
Q 036435          229 SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVV  307 (372)
Q Consensus       229 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (372)
                       .....++.+|+|||.+.+.  .++.++|+||||+++|||++ |..||......       . .......+.....+.. 
T Consensus       158 -~~~~~~~~~~~aPe~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-------~-~~~~~~~~~~~~~~~~-  225 (256)
T cd05112         158 -STGTKFPVKWSSPEVFSFS--KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-------E-VVETINAGFRLYKPRL-  225 (256)
T ss_pred             -cCCCccchhhcCHhHhccC--CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-------H-HHHHHhCCCCCCCCCC-
Confidence             1122345689999998764  78899999999999999998 88888643211       1 1122222211111211 


Q ss_pred             CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 036435          308 TRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ  344 (372)
Q Consensus       308 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~  344 (372)
                            ....+.+++.+||+.+|++||++.++++.|+
T Consensus       226 ------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         226 ------ASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             ------CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence                  2356888999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.3e-38  Score=294.38  Aligned_cols=222  Identities=22%  Similarity=0.292  Sum_probs=174.9

Q ss_pred             hhcCCCCceEEEEEEecc----------------------hHHHHHHHHhcc-CCCceeeeEeEEecCCceeEEEEecCC
Q 036435           89 DKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      +.||+|+||.||+++...                      ....|..++... +||||+++++++.+++..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            359999999999987632                      245577777654 899999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      |+|.+++.....      +++.++..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++.......
T Consensus        81 g~L~~~i~~~~~------~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  151 (316)
T cd05620          81 GDLMFHIQDKGR------FDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN  151 (316)
T ss_pred             CcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC
Confidence            999999876432      889999999999999999999   89999999999999999999999999999875322221


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                      .   .....||+.|+|||.+.+.  .++.++|||||||++|||++|+.||......        ...+.+... ....+.
T Consensus       152 ~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--------~~~~~~~~~-~~~~~~  217 (316)
T cd05620         152 R---ASTFCGTPDYIAPEILQGL--KYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--------ELFESIRVD-TPHYPR  217 (316)
T ss_pred             c---eeccCCCcCccCHHHHcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhC-CCCCCC
Confidence            1   1234589999999999875  7899999999999999999999999754211        111222111 111121


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMN-EVI  340 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-evl  340 (372)
                             .....+.+++.+||+.||++||++. +++
T Consensus       218 -------~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         218 -------WITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             -------CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                   1235677889999999999999985 555

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.7e-38  Score=293.72  Aligned_cols=225  Identities=21%  Similarity=0.301  Sum_probs=176.2

Q ss_pred             hhcCCCCceEEEEEEecc----------------------hHHHHHHHHhcc-CCCceeeeEeEEecCCceeEEEEecCC
Q 036435           89 DKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      +.||+|+||.||+++..+                      .+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            359999999999987532                      366788888888 699999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      |+|..++....      .+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++........
T Consensus        81 ~~L~~~~~~~~------~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~  151 (327)
T cd05617          81 GDLMFHMQRQR------KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD  151 (327)
T ss_pred             CcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC
Confidence            99999886543      2899999999999999999999   79999999999999999999999999999875322221


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                      .   .....||+.|+|||++.+.  .++.++|+|||||++|||++|+.||........ .....+....... .....|.
T Consensus       152 ~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~-~~~~~p~  224 (327)
T cd05617         152 T---TSTFCGTPNYIAPEILRGE--EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPD-MNTEDYLFQVILE-KPIRIPR  224 (327)
T ss_pred             c---eecccCCcccCCHHHHCCC--CCCchheeehhHHHHHHHHhCCCCCCccCCCcc-cccHHHHHHHHHh-CCCCCCC
Confidence            1   1234588999999999774  788999999999999999999999975332211 1112222332222 1122222


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCCH
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPM  336 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  336 (372)
                      .       ....+.+++.+||+.||.+|+++
T Consensus       225 ~-------~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         225 F-------LSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             C-------CCHHHHHHHHHHhccCHHHcCCC
Confidence            2       23456778899999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-38  Score=282.55  Aligned_cols=231  Identities=27%  Similarity=0.482  Sum_probs=186.7

Q ss_pred             hhhhhhcCCCCceEEEEEEecc----------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCCh
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD----------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL  148 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~----------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L  148 (372)
                      +.+.+.||+|+||.||++...+                ++.+|+.++++++|+||+++++++.+.+..++|+||+++++|
T Consensus         8 ~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L   87 (256)
T cd05039           8 LKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSL   87 (256)
T ss_pred             ccceeeeecCCCceEEEEEecCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcH
Confidence            3456789999999999986532                578899999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeee
Q 036435          149 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVS  228 (372)
Q Consensus       149 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  228 (372)
                      .+++......    .+++..+..++.|++.||.|||   ..+++|+||||+||+++.++.+||+|||.++.......   
T Consensus        88 ~~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~---  157 (256)
T cd05039          88 VDYLRSRGRA----VITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD---  157 (256)
T ss_pred             HHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccccc---
Confidence            9999765432    3899999999999999999999   89999999999999999999999999999986633221   


Q ss_pred             eecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccC
Q 036435          229 SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVV  307 (372)
Q Consensus       229 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (372)
                         ....+..|+|||.+.+.  .++.++|+||||+++||+++ |..||.....        ..+............+   
T Consensus       158 ---~~~~~~~~~ape~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~---  221 (256)
T cd05039         158 ---SGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVPHVEKGYRMEAP---  221 (256)
T ss_pred             ---cCCCcccccCchhhcCC--cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHhcCCCCCCc---
Confidence               22345679999998764  78899999999999999997 8888864321        1122222222111111   


Q ss_pred             CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 036435          308 TRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG  345 (372)
Q Consensus       308 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~  345 (372)
                          ...+..+.+++.+||+.+|++||+++++++.|++
T Consensus       222 ----~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         222 ----EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             ----cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence                1234678889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-39  Score=307.64  Aligned_cols=234  Identities=29%  Similarity=0.474  Sum_probs=193.4

Q ss_pred             hhhcCCCCceEEEEEEec------------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           88 KDKLGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      .++||+|+||+||||.+.                        +++++|+..|.+++|||+++++|+|..+. ..||++|+
T Consensus       701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m  779 (1177)
T KOG1025|consen  701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM  779 (1177)
T ss_pred             hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence            467999999999999762                        27999999999999999999999998876 88999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      +.|+|.+|++.+...     +.....+.|..|||+||.|||   ..++|||||.++|||+.+...+|+.|||+++.....
T Consensus       780 P~G~LlDyvr~hr~~-----igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  780 PLGCLLDYVREHRDN-----IGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             ccchHHHHHHHhhcc-----ccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            999999999875532     888999999999999999999   899999999999999999999999999999987765


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      ...... ....-.+.|||-|.+...  .++.++|||||||.+||++| |..|++.....        .+...++.+.++.
T Consensus       852 ~~ey~~-~~gK~pikwmale~i~~~--~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~--------eI~dlle~geRLs  920 (1177)
T KOG1025|consen  852 EKEYSA-PGGKVPIKWMALESIRIR--KYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE--------EIPDLLEKGERLS  920 (1177)
T ss_pred             cccccc-cccccCcHHHHHHHhhcc--CCCchhhhhhhhhhHHHHHhcCCCccCCCCHH--------HhhHHHhccccCC
Confidence            544332 222345779999999764  89999999999999999987 77777654322        1344455555555


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE  348 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~  348 (372)
                      .|..       ...++..++.+||..|+..||+++++...+.+...
T Consensus       921 qPpi-------CtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  921 QPPI-------CTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             CCCC-------ccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence            4433       34577888999999999999999999988766543

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3e-38  Score=287.60  Aligned_cols=243  Identities=25%  Similarity=0.334  Sum_probs=186.9

Q ss_pred             HHhhhhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEe
Q 036435           83 LTNSFKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      ..+++.+.||+|+||+||++...+                    .+.+|+++++.++||||+++++++.+.+..++|+||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            344566889999999999986531                    578899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      +++++|.+++....      .+++..+..++.+++.||.|||+  ..+++|+||||+||++++++.++|+|||++.....
T Consensus        85 ~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~  156 (284)
T cd06620          85 MDCGSLDRIYKKGG------PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN  156 (284)
T ss_pred             CCCCCHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence            99999999986643      28899999999999999999994  36899999999999999999999999999875432


Q ss_pred             CCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      ...     ....|+..|+|||.+.+.  .++.++|+|||||++|++++|+.||...............+...........
T Consensus       157 ~~~-----~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd06620         157 SIA-----DTFVGTSTYMSPERIQGG--KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP  229 (284)
T ss_pred             hcc-----CccccCcccCCHHHHccC--CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc
Confidence            211     123578899999998764  7889999999999999999999999865432111111111111111111000


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEML  343 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L  343 (372)
                      .+..   ...+....+.+++.+||+.||.+|||++|+++..
T Consensus       230 ~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         230 PPRL---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             CCCC---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            1110   1112446788899999999999999999999753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.8e-38  Score=293.56  Aligned_cols=186  Identities=26%  Similarity=0.385  Sum_probs=150.6

Q ss_pred             hhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEec--CCceeEEEEecCCCC
Q 036435           89 DKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLE--GNNRALIYEFMPNGS  147 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~--~~~~~lV~e~~~~g~  147 (372)
                      .+||+|+||.||+++..+                   .+.+|+.++++++||||+++++++..  +...++|+||+.+ +
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~   85 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-D   85 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-c
Confidence            469999999999997531                   47889999999999999999998854  4577899999964 8


Q ss_pred             hhhhhhcCCC---CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE----CCCCceEEeecCCcccc
Q 036435          148 LEKFVYNGDT---SKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL----DEDFCPKISDFGLAKLC  220 (372)
Q Consensus       148 L~~~l~~~~~---~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfgla~~~  220 (372)
                      |.+++.....   ......+++..+..++.|++.||+|||   +.+++||||||+|||+    +.++.+||+|||+++..
T Consensus        86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~  162 (317)
T cd07867          86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF  162 (317)
T ss_pred             HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence            8887753221   111234889999999999999999999   8999999999999999    56678999999999876


Q ss_pred             cCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCC
Q 036435          221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGV  279 (372)
Q Consensus       221 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~  279 (372)
                      ..............+|..|+|||.+.+. ..++.++|||||||++|||+||+.||....
T Consensus       163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         163 NSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             CCCcccccccCcceecccccCcHHhcCC-CccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            5433222222334578899999998764 357899999999999999999999997543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.7e-38  Score=286.38  Aligned_cols=237  Identities=23%  Similarity=0.323  Sum_probs=183.9

Q ss_pred             HhhhhhhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           84 TNSFKDKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      .+.+.+.||+|+||.||+|+...                   .+.+|+.++++++||||+++++++..++..++|+||++
T Consensus        10 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~   89 (267)
T cd06646          10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCG   89 (267)
T ss_pred             hcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCC
Confidence            34556789999999999997521                   36789999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      +++|.+++.....      +++.++..++.|+++||+|||   +.+++|+||||+||++++++.+||+|||++.......
T Consensus        90 ~~~L~~~~~~~~~------~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          90 GGSLQDIYHVTGP------LSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI  160 (267)
T ss_pred             CCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence            9999999865432      889999999999999999999   7999999999999999999999999999998654322


Q ss_pred             Ceeeeecccccccccccccccccc-cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRN-FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                      ..   .....++..|+|||.+... ...++.++|+|||||++|||++|+.||.........        ... .......
T Consensus       161 ~~---~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~--------~~~-~~~~~~~  228 (267)
T cd06646         161 AK---RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--------FLM-SKSNFQP  228 (267)
T ss_pred             cc---cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh--------eee-ecCCCCC
Confidence            11   1223477889999987532 135788999999999999999999998643221100        000 0011111


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEML  343 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L  343 (372)
                      +...  ....+...+.+++.+||+.+|++|||++++++.|
T Consensus       229 ~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         229 PKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            1111  1122346788899999999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-38  Score=283.91  Aligned_cols=235  Identities=29%  Similarity=0.499  Sum_probs=186.4

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-----------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-----------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS  147 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-----------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~  147 (372)
                      +.+.+.||+|+||.||++...+                 ++.+|+.++++++|+||+++++++.++...++|+||+++++
T Consensus         8 ~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~   87 (261)
T cd05034           8 LKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGS   87 (261)
T ss_pred             eeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCC
Confidence            3456789999999999986532                 58899999999999999999999999899999999999999


Q ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCee
Q 036435          148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV  227 (372)
Q Consensus       148 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  227 (372)
                      |.+++.....    ..+++.++..++.|++.||+|||   +.+++|+||||+||++++++.+||+|||++..........
T Consensus        88 L~~~i~~~~~----~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  160 (261)
T cd05034          88 LLDFLKSGEG----KKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA  160 (261)
T ss_pred             HHHHHhcccc----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence            9999976542    23899999999999999999999   7899999999999999999999999999987654321111


Q ss_pred             eeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCcc
Q 036435          228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV  306 (372)
Q Consensus       228 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (372)
                        .....++..|+|||.+.+.  .++.++|+||+|+++|++++ |+.||.....        ...............+. 
T Consensus       161 --~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~-  227 (261)
T cd05034         161 --REGAKFPIKWTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--------REVLEQVERGYRMPRPP-  227 (261)
T ss_pred             --hhccCCCccccCHHHhccC--CcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCCCCC-
Confidence              1122245679999998764  78899999999999999998 8888854321        11122222221111111 


Q ss_pred             CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 036435          307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG  345 (372)
Q Consensus       307 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~  345 (372)
                            ..+..+.+++.+||+.+|++||+++++.+.|+.
T Consensus       228 ------~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         228 ------NCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ------CCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                  124568889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4.8e-38  Score=283.82  Aligned_cols=237  Identities=20%  Similarity=0.344  Sum_probs=174.6

Q ss_pred             hcCCCCceEEEEEEec----------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCC
Q 036435           90 KLGQGGFGGVYKGRLL----------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS  147 (372)
Q Consensus        90 ~lg~G~~g~V~~~~~~----------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~  147 (372)
                      +||+|+||.||+|+..                      +.+.+|+.+++.++||||+++++.|.+....++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            5999999999998531                      158889999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCee
Q 036435          148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV  227 (372)
Q Consensus       148 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  227 (372)
                      |.+++.+....  ...+++..+..++.|++.||+|||   +.+++|+||||+|||++.++.+||+|||++........ .
T Consensus        82 L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~-~  155 (268)
T cd05086          82 LKSYLSQEQWH--RRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY-I  155 (268)
T ss_pred             HHHHHHhhhcc--cccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchh-h
Confidence            99999764321  122677788899999999999999   79999999999999999999999999999864322111 1


Q ss_pred             eeecccccccccccccccccc-----cCCCCccccchhHHHHHHHHhcC-CCCCCCCCCCCCccchHHHHHHHhhhc-cc
Q 036435          228 SSLLGARGIIGYIAPEVFSRN-----FGEVSHKSDVYSFGMMIMELVGC-KNNLDSGVDSSSEVYFPHWIYRHVEQD-RE  300 (372)
Q Consensus       228 ~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~DvwslG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~  300 (372)
                      .......++..|+|||++...     ....+.++||||||+++|||+++ ..||......       .......... ..
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-------~~~~~~~~~~~~~  228 (268)
T cd05086         156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR-------EVLNHVIKDQQVK  228 (268)
T ss_pred             hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHhhcccc
Confidence            111233467889999987532     12457899999999999999975 5566432211       1111111111 11


Q ss_pred             ccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 036435          301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ  344 (372)
Q Consensus       301 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~  344 (372)
                      ...+....    .....+.+++..|| .+|.+||+++++++.|.
T Consensus       229 ~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         229 LFKPQLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             cCCCccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            11121111    13345666788899 57999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-38  Score=297.93  Aligned_cols=178  Identities=22%  Similarity=0.377  Sum_probs=152.0

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCChhhh
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF  151 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~~~  151 (372)
                      +.+.+.||+|+||.||+|+...             ....|+.++++++||||+++++++.+++..++|+||+. ++|.++
T Consensus        68 y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~  146 (357)
T PHA03209         68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTY  146 (357)
T ss_pred             cEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHH
Confidence            4556789999999999997643             45789999999999999999999999999999999994 699998


Q ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeeeeec
Q 036435          152 VYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLL  231 (372)
Q Consensus       152 l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~  231 (372)
                      +.....     .+++..+..++.|++.||.|||   ..+|+||||||+|||++.++.+||+|||+++.......    ..
T Consensus       147 l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~----~~  214 (357)
T PHA03209        147 LTKRSR-----PLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA----FL  214 (357)
T ss_pred             HHhccC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccCcc----cc
Confidence            865432     3899999999999999999999   79999999999999999999999999999975332211    12


Q ss_pred             ccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCC
Q 036435          232 GARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDS  277 (372)
Q Consensus       232 ~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~  277 (372)
                      ...||..|+|||++.+.  .++.++|||||||++|||+++..++..
T Consensus       215 ~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvvl~ell~~~~~~f~  258 (357)
T PHA03209        215 GLAGTVETNAPEVLARD--KYNSKADIWSAGIVLFEMLAYPSTIFE  258 (357)
T ss_pred             cccccccccCCeecCCC--CCCchhhHHHHHHHHHHHHHcCCcccc
Confidence            34588999999999875  789999999999999999987666543

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-38  Score=285.05  Aligned_cols=236  Identities=29%  Similarity=0.460  Sum_probs=187.1

Q ss_pred             hhhhhcCCCCceEEEEEEec------------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYE  141 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  141 (372)
                      .+.+.||+|+||.||+|...                        .++.+|+.++++++||||+++++++.. ...++|+|
T Consensus        10 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e   88 (279)
T cd05057          10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQ   88 (279)
T ss_pred             EEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEe
Confidence            45678999999999998642                        157789999999999999999999987 78899999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      |+++|+|.+++.....     .+++..++.++.|++.||+|||   +.+++|+||||+||++++++.+||+|||+++...
T Consensus        89 ~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          89 LMPLGCLLDYVRNHKD-----NIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             cCCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence            9999999999976432     2899999999999999999999   7999999999999999999999999999998765


Q ss_pred             CCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhccc
Q 036435          222 TKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDRE  300 (372)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (372)
                      ....... .....++..|+|||.+...  .++.++|+||||+++||+++ |+.||.....        ..+...+.....
T Consensus       161 ~~~~~~~-~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~~~  229 (279)
T cd05057         161 VDEKEYH-AEGGKVPIKWMALESILHR--IYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--------VEIPDLLEKGER  229 (279)
T ss_pred             Cccccee-cCCCcccccccCHHHhhcC--CcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--------HHHHHHHhCCCC
Confidence            4332221 1222345679999988654  78899999999999999998 9999865321        112222222222


Q ss_pred             ccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 036435          301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE  348 (372)
Q Consensus       301 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~  348 (372)
                      ...+..       ....+.+++.+||..+|.+||++.++++.|.++..
T Consensus       230 ~~~~~~-------~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         230 LPQPPI-------CTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             CCCCCC-------CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            222211       22456778899999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.5e-38  Score=289.06  Aligned_cols=243  Identities=27%  Similarity=0.453  Sum_probs=187.9

Q ss_pred             hhhhhcCCCCceEEEEEEec------------------------chHHHHHHHHhccCCCceeeeEeEEec--CCceeEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTLLGFCLE--GNNRALI  139 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~--~~~~~lV  139 (372)
                      .+.+.||+|+||.||++++.                        +.+.+|++++++++||||+++++++..  +...++|
T Consensus         7 ~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   86 (284)
T cd05038           7 KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLI   86 (284)
T ss_pred             hhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEE
Confidence            44578999999999998742                        157889999999999999999999987  5578999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccc
Q 036435          140 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL  219 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  219 (372)
                      +||+++++|.+++.....     .+++.++..++.|++.||+|||   ..+++|+||||+||+++.++.++|+|||++..
T Consensus        87 ~e~~~~~~l~~~l~~~~~-----~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          87 MEYLPSGSLRDYLQRHRD-----QINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EecCCCCCHHHHHHhCcc-----ccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            999999999999976542     2899999999999999999999   79999999999999999999999999999987


Q ss_pred             ccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCc--------cchHHHH
Q 036435          220 CTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE--------VYFPHWI  291 (372)
Q Consensus       220 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~--------~~~~~~~  291 (372)
                      ...............++..|++||.+.+.  .++.++|+||||+++|||++|+.|+.........        ..... .
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~  235 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTS--KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR-L  235 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccC--CCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHH-H
Confidence            65433222211222345669999998764  7889999999999999999999987653221100        00111 1


Q ss_pred             HHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 036435          292 YRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGS  346 (372)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~  346 (372)
                      ............+       ......+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus       236 ~~~~~~~~~~~~~-------~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         236 LELLKEGERLPRP-------PSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHHcCCcCCCC-------ccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            1111111111111       12335688899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-39  Score=271.98  Aligned_cols=248  Identities=22%  Similarity=0.349  Sum_probs=190.1

Q ss_pred             hhhhhhcCCCCceEEEEEEec-------------------chHHHHHHHHhccCCCceeeeEeEEecCC-----ceeEEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL-------------------DDFVNEVASISRTSHVNVVTLLGFCLEGN-----NRALIY  140 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~-----~~~lV~  140 (372)
                      +.+.+.||+|||+-||.++..                   +..++|++.-++++|||+++++++...+.     ..|+++
T Consensus        23 yri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~  102 (302)
T KOG2345|consen   23 YRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLL  102 (302)
T ss_pred             EEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEe
Confidence            345678999999999998732                   25789999999999999999999887543     489999


Q ss_pred             EecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccc
Q 036435          141 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC  220 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~  220 (372)
                      +|...|+|.+.+....-.  +..+++.+.+.|+.++++||++||+. ..++.||||||.|||+++++.+++.|||.+...
T Consensus       103 Pyy~~Gsl~d~i~~~k~k--g~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a  179 (302)
T KOG2345|consen  103 PYYKRGSLLDEIERLKIK--GNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQA  179 (302)
T ss_pred             ehhccccHHHHHHHHhhc--CCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcccc
Confidence            999999999999775432  24599999999999999999999942 335999999999999999999999999998754


Q ss_pred             cCCCCe------eeeecccccccccccccccccc-cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHH
Q 036435          221 TTKEGI------VSSLLGARGIIGYIAPEVFSRN-FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYR  293 (372)
Q Consensus       221 ~~~~~~------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  293 (372)
                      .-.-..      .........|..|.|||.+.-. ...+++++|||||||++|+|+.|..||+......+...+.     
T Consensus       180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA-----  254 (302)
T KOG2345|consen  180 PIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA-----  254 (302)
T ss_pred             ceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe-----
Confidence            321110      0111223467889999998643 2367899999999999999999999998643322211110     


Q ss_pred             HhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          294 HVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                        -.+..+..|..     ...++.+.+++.+|++.||.+||++.+++..++.+.
T Consensus       255 --v~n~q~s~P~~-----~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  255 --VQNAQISIPNS-----SRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             --eeccccccCCC-----CCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence              01111222221     226788999999999999999999999999988754

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.7e-38  Score=288.40  Aligned_cols=239  Identities=26%  Similarity=0.442  Sum_probs=184.8

Q ss_pred             hhhhhcCCCCceEEEEEEec-------------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLL-------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIY  140 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~-------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~  140 (372)
                      .+.+.||+|+||.||+++..                         +++.+|+.++++++||||+++++++.++...++|+
T Consensus         8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~   87 (288)
T cd05050           8 EYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLF   87 (288)
T ss_pred             eecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEE
Confidence            34578999999999998641                         14778999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhcCCCC----------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC
Q 036435          141 EFMPNGSLEKFVYNGDTS----------------KPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLD  204 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~~----------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~  204 (372)
                      ||+++|+|.+++......                .....+++.+++.++.|++.||+|||   ..+++||||||+||+++
T Consensus        88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~nil~~  164 (288)
T cd05050          88 EYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVG  164 (288)
T ss_pred             ecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhheEec
Confidence            999999999999753210                11123788999999999999999999   79999999999999999


Q ss_pred             CCCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCC
Q 036435          205 EDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSS  283 (372)
Q Consensus       205 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~  283 (372)
                      +++.++|+|||++........... ......+..|+|||.+.+.  .++.++|||||||++|||++ |..||......  
T Consensus       165 ~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~--  239 (288)
T cd05050         165 ENMVVKIADFGLSRNIYSADYYKA-SENDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE--  239 (288)
T ss_pred             CCCceEECccccceecccCccccc-cCCCccChhhcCHHHHhcC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--
Confidence            999999999999876543321111 1122245679999998764  78999999999999999997 77777543211  


Q ss_pred             ccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 036435          284 EVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG  345 (372)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~  345 (372)
                           . .............+       ......+.+++.+||+.+|++|||+.|+++.|++
T Consensus       240 -----~-~~~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 -----E-VIYYVRDGNVLSCP-------DNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             -----H-HHHHHhcCCCCCCC-------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                 1 11222222111111       1234678889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=4.3e-38  Score=285.85  Aligned_cols=242  Identities=24%  Similarity=0.394  Sum_probs=188.7

Q ss_pred             hhhhhhcCCCCceEEEEEEecc------------------------hHHHHHHHHhccCCCceeeeEeEEec-CCceeEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD------------------------DFVNEVASISRTSHVNVVTLLGFCLE-GNNRALI  139 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~-~~~~~lV  139 (372)
                      +.+.+.||+|+||.||+|...+                        .+.+|+.++++++|+||+++++++.+ +...+++
T Consensus         8 ~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   87 (280)
T cd05043           8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVL   87 (280)
T ss_pred             eEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEE
Confidence            3456789999999999997532                        37789999999999999999998876 4678999


Q ss_pred             EEecCCCChhhhhhcCCCC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCc
Q 036435          140 YEFMPNGSLEKFVYNGDTS--KPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLA  217 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla  217 (372)
                      +||+++|+|.+++......  .....+++.+++.++.|++.||+|||   +.+++|+||||+||++++++.+||+|||++
T Consensus        88 ~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~g~~  164 (280)
T cd05043          88 YPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALS  164 (280)
T ss_pred             EEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCCCCc
Confidence            9999999999998764321  11234899999999999999999999   899999999999999999999999999999


Q ss_pred             ccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhh
Q 036435          218 KLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVE  296 (372)
Q Consensus       218 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  296 (372)
                      +.......... .....++..|+|||++.+.  .++.++||||||+++||+++ |+.||......       . ......
T Consensus       165 ~~~~~~~~~~~-~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~-~~~~~~  233 (280)
T cd05043         165 RDLFPMDYHCL-GDNENRPVKWMALESLVNK--EYSSASDVWSFGVLLWELMTLGQTPYVEIDPF-------E-MAAYLK  233 (280)
T ss_pred             ccccCCceEEe-CCCCCcchhccCHHHHhcC--CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH-------H-HHHHHH
Confidence            86544332211 1223356779999998765  78999999999999999998 99988653211       1 122222


Q ss_pred             hcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                      ....+..+       ......+.+++.+||+.+|++|||+.++++.|+.+.
T Consensus       234 ~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         234 DGYRLAQP-------INCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             cCCCCCCC-------CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            22111111       113456788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=6.2e-38  Score=281.16  Aligned_cols=223  Identities=24%  Similarity=0.426  Sum_probs=176.1

Q ss_pred             hhcCCCCceEEEEEEecc----------------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEE
Q 036435           89 DKLGQGGFGGVYKGRLLD----------------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIY  140 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~----------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~  140 (372)
                      +.||+|+||.||+|.+.+                            .+.+|+.++++++||||+++++++.. ...++|+
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            368999999999986621                            47789999999999999999999988 7789999


Q ss_pred             EecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC-------ceEEee
Q 036435          141 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDF-------CPKISD  213 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-------~~kl~D  213 (372)
                      ||+++|+|.+++.....     .+++..++.++.|++.||+|||   +.+++|+||||+||+++.++       .+||+|
T Consensus        80 e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D  151 (259)
T cd05037          80 EYVKFGPLDVFLHREKN-----NVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD  151 (259)
T ss_pred             EcCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCC
Confidence            99999999999976542     2889999999999999999999   89999999999999999887       799999


Q ss_pred             cCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcC-CCCCCCCCCCCCccchHHHHH
Q 036435          214 FGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGC-KNNLDSGVDSSSEVYFPHWIY  292 (372)
Q Consensus       214 fgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg-~~p~~~~~~~~~~~~~~~~~~  292 (372)
                      ||++.......       ...++..|+|||.+.+....++.++|+||||+++|||++| ..|+.......        ..
T Consensus       152 fg~a~~~~~~~-------~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~--------~~  216 (259)
T cd05037         152 PGIPITVLSRE-------ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE--------KE  216 (259)
T ss_pred             CCccccccccc-------ccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh--------HH
Confidence            99998654311       1235567999999876423678999999999999999995 66665432111        01


Q ss_pred             HHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 036435          293 RHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ  344 (372)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~  344 (372)
                      ...........+.         ...+.+++.+||+.+|.+|||+.++++.|.
T Consensus       217 ~~~~~~~~~~~~~---------~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         217 RFYQDQHRLPMPD---------CAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             HHHhcCCCCCCCC---------chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            1111111111111         157788999999999999999999998773

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.5e-38  Score=294.97  Aligned_cols=219  Identities=21%  Similarity=0.276  Sum_probs=172.1

Q ss_pred             hhcCCCCceEEEEEEecc----------------------hHHHHHH-HHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           89 DKLGQGGFGGVYKGRLLD----------------------DFVNEVA-SISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~----------------------~~~~E~~-~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      +.||+|+||+||+++...                      ++.+|.. +++.++||||+++++.+.+++..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            358999999999997632                      2334443 56788999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      |+|.+++.....      +++..+..++.|++.||+|||   +.+++||||||+|||+++++.+||+|||++........
T Consensus        81 g~L~~~l~~~~~------~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  151 (323)
T cd05575          81 GELFFHLQRERS------FPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK  151 (323)
T ss_pred             CCHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC
Confidence            999999876432      889999999999999999999   89999999999999999999999999999875322221


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                      .   .....||+.|+|||.+.+.  .++.++|||||||++|||++|+.||......       . ....+... ....+.
T Consensus       152 ~---~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~-------~-~~~~i~~~-~~~~~~  217 (323)
T cd05575         152 T---TSTFCGTPEYLAPEVLRKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA-------E-MYDNILNK-PLRLKP  217 (323)
T ss_pred             c---cccccCChhhcChhhhcCC--CCCccccccccchhhhhhhcCCCCCCCCCHH-------H-HHHHHHcC-CCCCCC
Confidence            1   1234589999999999774  7889999999999999999999999753211       1 11111111 111111


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCCHH
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMN  337 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  337 (372)
                             .....+.+++.+||+.||.+||++.
T Consensus       218 -------~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         218 -------NISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             -------CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence                   1245677889999999999999884

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.9e-39  Score=286.44  Aligned_cols=250  Identities=26%  Similarity=0.352  Sum_probs=185.1

Q ss_pred             hhcCCCCceEEEEEEecc---------------hHHHHHHHHhccCCCceeeeEeEEecCC-----ceeEEEEecCCCCh
Q 036435           89 DKLGQGGFGGVYKGRLLD---------------DFVNEVASISRTSHVNVVTLLGFCLEGN-----NRALIYEFMPNGSL  148 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~---------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~-----~~~lV~e~~~~g~L  148 (372)
                      +.+|+|+||.||+|++.+               --.+|+++|+++.|||||++.-+|....     ...+|||||+. +|
T Consensus        30 ~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL  108 (364)
T KOG0658|consen   30 RLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TL  108 (364)
T ss_pred             EEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HH
Confidence            579999999999998754               2357999999999999999998887432     45699999987 99


Q ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC-CceEEeecCCcccccCCCCee
Q 036435          149 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDED-FCPKISDFGLAKLCTTKEGIV  227 (372)
Q Consensus       149 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgla~~~~~~~~~~  227 (372)
                      .+.++.....  .+.++...+.-+..|+.+||+|||   ..+|+||||||.|+|+|.+ |.+||||||.|+....++...
T Consensus       109 ~~~~r~~~~~--~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epni  183 (364)
T KOG0658|consen  109 YRVIRHYTRA--NQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNI  183 (364)
T ss_pred             HHHHHHHhhc--CCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCce
Confidence            9998752111  123777788889999999999999   8999999999999999955 999999999999887666543


Q ss_pred             eeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHH----HHHhhhc----c
Q 036435          228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWI----YRHVEQD----R  299 (372)
Q Consensus       228 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~----~~~~~~~----~  299 (372)
                      ...    -|.-|.|||.+.|. ..++.+.||||.||++.||+-|++-|.+....+....+...+    .+.+...    .
T Consensus       184 SYi----cSRyYRaPELifga-~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~  258 (364)
T KOG0658|consen  184 SYI----CSRYYRAPELIFGA-TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYT  258 (364)
T ss_pred             eEE----EeccccCHHHHcCc-cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccc
Confidence            322    34569999999986 589999999999999999999999998743322111100000    0001000    1


Q ss_pred             cccCCccCCc-----chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhhcCccc
Q 036435          300 EFKLPGVVTR-----KENEIAKKMIIVGLWCIQARPSDRPPMNEVIE--MLQGSTEA  349 (372)
Q Consensus       300 ~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~--~L~~~~~~  349 (372)
                      ....|.....     .......+.++++.++|+.+|.+|.++.|++.  ..+.++++
T Consensus       259 ~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  259 EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence            1122222111     12234567889999999999999999999885  45555554

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.2e-38  Score=295.71  Aligned_cols=226  Identities=21%  Similarity=0.303  Sum_probs=177.6

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCC-ceeeeEeEEecCCceeEEEEe
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHV-NVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~-nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      .+.+.||+|+||.||+|+..+                      .+..|..++..++|+ +|+++++++.+.+..++||||
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~   82 (324)
T cd05587           3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY   82 (324)
T ss_pred             eEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcC
Confidence            346789999999999996532                      356788899988765 588899999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      +++|+|.+++.....      +++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++.....
T Consensus        83 ~~~g~L~~~~~~~~~------~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05587          83 VNGGDLMYHIQQVGK------FKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF  153 (324)
T ss_pred             CCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence            999999999876432      889999999999999999999   79999999999999999999999999999875332


Q ss_pred             CCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      ....   .....||+.|+|||++.+.  .++.++|+||+||++|||++|+.||......        .....+... ...
T Consensus       154 ~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~pf~~~~~~--------~~~~~i~~~-~~~  219 (324)
T cd05587         154 GGKT---TRTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--------ELFQSIMEH-NVS  219 (324)
T ss_pred             CCCc---eeeecCCccccChhhhcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHcC-CCC
Confidence            2211   1233588999999999875  7889999999999999999999999754211        111111111 111


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPM-----NEVIE  341 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~-----~evl~  341 (372)
                      .+.       .....+.+++.+||+.||.+|++.     +++.+
T Consensus       220 ~~~-------~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  256 (324)
T cd05587         220 YPK-------SLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE  256 (324)
T ss_pred             CCC-------CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            221       234567788999999999999976     55554

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=4.3e-38  Score=284.31  Aligned_cols=236  Identities=23%  Similarity=0.413  Sum_probs=186.1

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYE  141 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  141 (372)
                      +.+.+.||+|+||.||+|...+                       .+.+|+.++++++||||+++++++.+ ...++|||
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e   86 (270)
T cd05056           8 ITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVME   86 (270)
T ss_pred             ceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEE
Confidence            4456789999999999986421                       47789999999999999999999875 45789999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      |+++|+|.+++.....     .+++.+++.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++....
T Consensus        87 ~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          87 LAPLGELRSYLQVNKY-----SLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             cCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeecc
Confidence            9999999999976432     2899999999999999999999   7999999999999999999999999999998654


Q ss_pred             CCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhccc
Q 036435          222 TKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDRE  300 (372)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (372)
                      .......  ....++..|+|||.+.+.  .++.++||||||+++||+++ |..||.......        ..........
T Consensus       159 ~~~~~~~--~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--------~~~~~~~~~~  226 (270)
T cd05056         159 DESYYKA--SKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--------VIGRIENGER  226 (270)
T ss_pred             cccceec--CCCCccccccChhhhccC--CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHHHcCCc
Confidence            4322111  122345679999998764  78899999999999999886 999986543211        1122222222


Q ss_pred             ccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 036435          301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE  348 (372)
Q Consensus       301 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~  348 (372)
                      ...+.       .....+.+++.+|+..+|.+|||+.++++.|+.+..
T Consensus       227 ~~~~~-------~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         227 LPMPP-------NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             CCCCC-------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            22221       234567788999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.2e-38  Score=293.72  Aligned_cols=236  Identities=18%  Similarity=0.255  Sum_probs=179.6

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      .+.+.||+|+||.||+++...                      .+.+|..++..++|+||+++++++.+++..++||||+
T Consensus         4 ~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~   83 (331)
T cd05624           4 EIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYY   83 (331)
T ss_pred             eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence            345789999999999987632                      2667889999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      ++|+|.+++.....     .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++......
T Consensus        84 ~gg~L~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          84 VGGDLLTLLSKFED-----RLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             CCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            99999999976432     2889999999999999999999   899999999999999999999999999999865443


Q ss_pred             CCeeeeecccccccccccccccccc---cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccc
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRN---FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDRE  300 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (372)
                      ....  .....||+.|+|||++.+.   .+.++.++|+|||||++|||++|+.||......       ............
T Consensus       156 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-------~~~~~i~~~~~~  226 (331)
T cd05624         156 GTVQ--SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-------ETYGKIMNHEER  226 (331)
T ss_pred             Ccee--eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH-------HHHHHHHcCCCc
Confidence            3221  1234589999999998642   125788999999999999999999999753211       111111111122


Q ss_pred             ccCCccCCcchHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 036435          301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSD--RPPMNEVIEM  342 (372)
Q Consensus       301 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~evl~~  342 (372)
                      ...|....    ++...+.+++.+|+..++++  |++++++++.
T Consensus       227 ~~~p~~~~----~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         227 FQFPSHIT----DVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             ccCCCccc----cCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            22232221    23456667777887765543  5688888753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-39  Score=283.17  Aligned_cols=250  Identities=20%  Similarity=0.253  Sum_probs=186.5

Q ss_pred             hhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEec-----CCceeEEEE
Q 036435           88 KDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLE-----GNNRALIYE  141 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~-----~~~~~lV~e  141 (372)
                      .+.||+|+||.|..+....                     +..+|+++|+.++|+||+.+++++..     -+..|+|+|
T Consensus        27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e  106 (359)
T KOG0660|consen   27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE  106 (359)
T ss_pred             cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence            3679999999999987642                     57899999999999999999999876     357899999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      +|+ -+|...++.+..      ++.....-++.|++.||+|+|   +.+|+||||||+|+|++.+..+||+|||+|+...
T Consensus       107 lMe-tDL~~iik~~~~------L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~  176 (359)
T KOG0660|consen  107 LME-TDLHQIIKSQQD------LTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARYLD  176 (359)
T ss_pred             HHh-hHHHHHHHcCcc------ccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceeecc
Confidence            995 499999987653      888889999999999999999   8999999999999999999999999999999875


Q ss_pred             CCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccch-------HHHHHHH
Q 036435          222 TKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYF-------PHWIYRH  294 (372)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~-------~~~~~~~  294 (372)
                      .. ..........-|.-|.|||.+... ..++...||||.|||+.||++|++-|.+...-..-..+       .......
T Consensus       177 ~~-~~~~~mTeYVaTRWYRAPElll~~-~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~  254 (359)
T KOG0660|consen  177 KF-FEDGFMTEYVATRWYRAPELLLNS-SEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK  254 (359)
T ss_pred             cc-CcccchhcceeeeeecCHHHHhcc-ccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence            43 222222334467789999998654 69999999999999999999999999865432110000       0000111


Q ss_pred             hhh--------cccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hhcCccc
Q 036435          295 VEQ--------DREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM--LQGSTEA  349 (372)
Q Consensus       295 ~~~--------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~--L~~~~~~  349 (372)
                      +..        ......+..............++++.++|..||.+|+|++|.++.  |+...++
T Consensus       255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp  319 (359)
T KOG0660|consen  255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDP  319 (359)
T ss_pred             hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCC
Confidence            110        000000111111122334567889999999999999999999863  4444443

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.3e-38  Score=300.49  Aligned_cols=234  Identities=23%  Similarity=0.297  Sum_probs=180.8

Q ss_pred             HhhhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEE
Q 036435           84 TNSFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYE  141 (372)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  141 (372)
                      .+.+.+.||+|+||.||+++...                      .+.+|..+++.++||||+++++.+.+++..++|||
T Consensus        44 ~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~E  123 (371)
T cd05622          44 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVME  123 (371)
T ss_pred             hcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence            34445789999999999987632                      35678999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      |+++|+|.+++....       ++...+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++....
T Consensus       124 y~~gg~L~~~~~~~~-------~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~  193 (371)
T cd05622         124 YMPGGDLVNLMSNYD-------VPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN  193 (371)
T ss_pred             CCCCCcHHHHHHhcC-------CCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence            999999999986542       788889999999999999999   8999999999999999999999999999998654


Q ss_pred             CCCCeeeeeccccccccccccccccccc--CCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhh-c
Q 036435          222 TKEGIVSSLLGARGIIGYIAPEVFSRNF--GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQ-D  298 (372)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~  298 (372)
                      ......  .....||+.|+|||++.+..  +.++.++|||||||++|||++|+.||......       . ....+.. .
T Consensus       194 ~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~-~~~~i~~~~  263 (371)
T cd05622         194 KEGMVR--CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------G-TYSKIMNHK  263 (371)
T ss_pred             cCCccc--ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-------H-HHHHHHcCC
Confidence            332111  12346899999999987531  23788999999999999999999999754221       1 1122211 1


Q ss_pred             ccccCCccCCcchHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 036435          299 REFKLPGVVTRKENEIAKKMIIVGLWCIQARPSD--RPPMNEVIEM  342 (372)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~evl~~  342 (372)
                      .....+.     .......+.+++.+||+.++.+  |++++++++.
T Consensus       264 ~~~~~~~-----~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         264 NSLTFPD-----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             CcccCCC-----cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            1122221     1234456677888899844433  7899998874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=6.4e-38  Score=282.37  Aligned_cols=240  Identities=23%  Similarity=0.429  Sum_probs=189.8

Q ss_pred             hhhhhcCCCCceEEEEEEec----------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLL----------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~----------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      .+.+.||+|+||.||+|...                      +.+.+|++++++++|+|++++++++.+++..++||||+
T Consensus         5 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   84 (267)
T cd08224           5 KIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELA   84 (267)
T ss_pred             eeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecC
Confidence            45678999999999998663                      15778999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      ++|+|.+++......  ...+++.+++.++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++......
T Consensus        85 ~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  159 (267)
T cd08224          85 DAGDLSRMIKHFKKQ--KRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             CCCCHHHHHHHhccc--CCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence            999999998653221  234899999999999999999999   899999999999999999999999999998765433


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                      ....   ....++..|+|||.+.+.  .++.++|+||||+++|+|++|+.||......     ... .............
T Consensus       160 ~~~~---~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~-~~~~~~~~~~~~~  228 (267)
T cd08224         160 TTAA---HSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LYS-LCKKIEKCDYPPL  228 (267)
T ss_pred             Cccc---ceecCCccccCHHHhccC--CCCchhcHHHHHHHHHHHHHCCCCcccCCcc-----HHH-HHhhhhcCCCCCC
Confidence            2211   223477889999998764  7889999999999999999999998654311     111 1111111111111


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                      +      .......+.+++.+||+.+|++|||+.++++.|+++.
T Consensus       229 ~------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         229 P------ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             C------hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            1      1234557788999999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.2e-38  Score=308.72  Aligned_cols=234  Identities=22%  Similarity=0.307  Sum_probs=182.0

Q ss_pred             hhhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCC--------c
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGN--------N  135 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~--------~  135 (372)
                      +.+.+.||+|+||+||+++...                     .+.+|+..+..++|+||+++++.+...+        .
T Consensus        34 Y~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~  113 (496)
T PTZ00283         34 YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLM  113 (496)
T ss_pred             EEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceE
Confidence            3456789999999999986521                     4678999999999999999988775432        3


Q ss_pred             eeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecC
Q 036435          136 RALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFG  215 (372)
Q Consensus       136 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  215 (372)
                      .++||||+++|+|.+++......  ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||
T Consensus       114 i~lV~Ey~~~gsL~~~l~~~~~~--~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~DFG  188 (496)
T PTZ00283        114 IALVLDYANAGDLRQEIKSRAKT--NRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFG  188 (496)
T ss_pred             EEEEEeCCCCCcHHHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence            67999999999999999764321  234899999999999999999999   8999999999999999999999999999


Q ss_pred             CcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHh
Q 036435          216 LAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV  295 (372)
Q Consensus       216 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  295 (372)
                      +++.......... .....||+.|+|||.+.+.  .++.++|||||||++|||++|+.||.....       .. +....
T Consensus       189 ls~~~~~~~~~~~-~~~~~Gt~~Y~aPE~~~~~--~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-------~~-~~~~~  257 (496)
T PTZ00283        189 FSKMYAATVSDDV-GRTFCGTPYYVAPEIWRRK--PYSKKADMFSLGVLLYELLTLKRPFDGENM-------EE-VMHKT  257 (496)
T ss_pred             cCeeccccccccc-cccccCCcceeCHHHhCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-------HH-HHHHH
Confidence            9986543221111 1234589999999999874  789999999999999999999999975321       11 11111


Q ss_pred             hhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          296 EQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ........+       ......+.+++.+||+.||.+||++.++++
T Consensus       258 ~~~~~~~~~-------~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        258 LAGRYDPLP-------PSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             hcCCCCCCC-------CCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence            111111111       223456888999999999999999999875

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-38  Score=301.69  Aligned_cols=231  Identities=23%  Similarity=0.286  Sum_probs=177.2

Q ss_pred             hhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           87 FKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      +.+.||+|+||.||+++...                      .+.+|++++++++||||+++++++.+++..|+||||++
T Consensus         5 ~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~   84 (377)
T cd05629           5 TVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLP   84 (377)
T ss_pred             EeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCC
Confidence            45789999999999986521                      46779999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      +|+|.+++.....      +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        85 gg~L~~~l~~~~~------~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  155 (377)
T cd05629          85 GGDLMTMLIKYDT------FSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH  155 (377)
T ss_pred             CCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            9999999976432      888999999999999999999   8999999999999999999999999999996332110


Q ss_pred             Ce------------e--------------------------------eeecccccccccccccccccccCCCCccccchh
Q 036435          225 GI------------V--------------------------------SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYS  260 (372)
Q Consensus       225 ~~------------~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dvws  260 (372)
                      ..            .                                .......||+.|+|||++.+.  .++.++||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwS  233 (377)
T cd05629         156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ--GYGQECDWWS  233 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC--CCCCceeeEe
Confidence            00            0                                000123589999999999775  7899999999


Q ss_pred             HHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhh-cccccCCccCCcchHHHHHHHHHHHHHcccCCCCCC---CCH
Q 036435          261 FGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQ-DREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDR---PPM  336 (372)
Q Consensus       261 lG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R---Ps~  336 (372)
                      |||++|||++|..||.......        ....+.. ...+..|..     ......+.+++.+|++ +|.+|   +++
T Consensus       234 lGvil~elltG~~Pf~~~~~~~--------~~~~i~~~~~~~~~p~~-----~~~s~~~~dli~~lL~-~~~~r~~r~~~  299 (377)
T cd05629         234 LGAIMFECLIGWPPFCSENSHE--------TYRKIINWRETLYFPDD-----IHLSVEAEDLIRRLIT-NAENRLGRGGA  299 (377)
T ss_pred             cchhhhhhhcCCCCCCCCCHHH--------HHHHHHccCCccCCCCC-----CCCCHHHHHHHHHHhc-CHhhcCCCCCH
Confidence            9999999999999997542211        1111111 112222221     1123456678888887 66665   599


Q ss_pred             HHHHHH
Q 036435          337 NEVIEM  342 (372)
Q Consensus       337 ~evl~~  342 (372)
                      .++++.
T Consensus       300 ~~~l~h  305 (377)
T cd05629         300 HEIKSH  305 (377)
T ss_pred             HHHhcC
Confidence            998864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=5.2e-39  Score=298.95  Aligned_cols=233  Identities=21%  Similarity=0.257  Sum_probs=182.9

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      .+.+.||+|+||.||+++...                      .+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus         4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   83 (330)
T cd05601           4 DVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQ   83 (330)
T ss_pred             eEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCC
Confidence            345789999999999986532                      3677899999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      ++|+|.+++.....     .+++..+..++.|++.||.|||   +.+++||||||+|||++.++.+||+|||++......
T Consensus        84 ~~~~L~~~l~~~~~-----~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          84 PGGDLLSLLNRYED-----QFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            99999999976532     2899999999999999999999   899999999999999999999999999999876543


Q ss_pred             CCeeeeecccccccccccccccccc----cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcc
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRN----FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDR  299 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (372)
                      ....  .....||+.|+|||++...    ...++.++|||||||++|||++|+.||......       ...........
T Consensus       156 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-------~~~~~i~~~~~  226 (330)
T cd05601         156 KMVN--SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-------KTYNNIMNFQR  226 (330)
T ss_pred             Ccee--eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-------HHHHHHHcCCC
Confidence            3221  1234588999999998631    135788999999999999999999999754321       11111111111


Q ss_pred             cccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          300 EFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ....+..     ......+.+++..|++ +|.+||+++++++
T Consensus       227 ~~~~~~~-----~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         227 FLKFPED-----PKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             ccCCCCC-----CCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            1122211     1234567778888998 9999999999885

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-38  Score=301.64  Aligned_cols=246  Identities=20%  Similarity=0.228  Sum_probs=183.6

Q ss_pred             HhhhhhhcCCCCceEEEEEEecc----------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCC
Q 036435           84 TNSFKDKLGQGGFGGVYKGRLLD----------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS  147 (372)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~~----------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~  147 (372)
                      .+.+.+.||+|+||.||++...+                ...+|+.++++++||||+++++++...+..++|||++. ++
T Consensus        93 ~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~  171 (392)
T PHA03207         93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CD  171 (392)
T ss_pred             ceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CC
Confidence            35556789999999999985421                45789999999999999999999999999999999995 68


Q ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCee
Q 036435          148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV  227 (372)
Q Consensus       148 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  227 (372)
                      |.+++....      .+++.+++.++.|++.||.|||   ..+|+||||||+|||++.++.+||+|||++..........
T Consensus       172 l~~~l~~~~------~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~  242 (392)
T PHA03207        172 LFTYVDRSG------PLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP  242 (392)
T ss_pred             HHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccc
Confidence            999884432      2899999999999999999999   7999999999999999999999999999997654432211


Q ss_pred             eeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHH---------------
Q 036435          228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIY---------------  292 (372)
Q Consensus       228 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~---------------  292 (372)
                       ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||...........+.....               
T Consensus       243 -~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~  319 (392)
T PHA03207        243 -QCYGWSGTLETNSPELLALD--PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST  319 (392)
T ss_pred             -cccccccccCccCHhHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence             12334689999999999764  789999999999999999999999976543221111111000               


Q ss_pred             ---HHhhhcccccCCcc-CCcc--hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          293 ---RHVEQDREFKLPGV-VTRK--ENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       293 ---~~~~~~~~~~~~~~-~~~~--~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                         ...........+.. ....  .......+.+++.+||+.||++|||+.|++..
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence               00000000000000 0000  01123456778899999999999999999864

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.4e-38  Score=295.50  Aligned_cols=222  Identities=22%  Similarity=0.288  Sum_probs=172.9

Q ss_pred             hhcCCCCceEEEEEEecc----------------------hHHHHH-HHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           89 DKLGQGGFGGVYKGRLLD----------------------DFVNEV-ASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~----------------------~~~~E~-~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      +.||+|+||+||+++...                      .+.+|. .+++.++||||+++++++.+++..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            359999999999997632                      223333 346778999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      |+|.+++.....      ++...+..++.|+++||+|||   +.+++||||||+|||++.++.+||+|||+++.......
T Consensus        81 ~~L~~~~~~~~~------~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~  151 (325)
T cd05602          81 GELFYHLQRERC------FLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG  151 (325)
T ss_pred             CcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC
Confidence            999999976432      778888999999999999999   89999999999999999999999999999975432221


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                      .   .....||+.|+|||.+.+.  .++.++|||||||++|||++|+.||......       . ....+... ....+ 
T Consensus       152 ~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~-~~~~i~~~-~~~~~-  216 (325)
T cd05602         152 T---TSTFCGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-------E-MYDNILNK-PLQLK-  216 (325)
T ss_pred             C---cccccCCccccCHHHHcCC--CCCCccccccccHHHHHHhcCCCCCCCCCHH-------H-HHHHHHhC-CcCCC-
Confidence            1   1234589999999999875  7889999999999999999999999753211       1 11111111 11111 


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI  340 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl  340 (372)
                            ......+.+++.+||+.||.+||++.+.+
T Consensus       217 ------~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         217 ------PNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             ------CCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence                  12345677888999999999999887433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-38  Score=292.34  Aligned_cols=236  Identities=19%  Similarity=0.247  Sum_probs=177.5

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      .+.+.||+|+||.||+++...                      .+.+|..++..++|+||+++++++.+++..++||||+
T Consensus         4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   83 (331)
T cd05597           4 EILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYY   83 (331)
T ss_pred             eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecC
Confidence            346789999999999987532                      3677899999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      ++|+|.+++.+...     .+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++......
T Consensus        84 ~g~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          84 VGGDLLTLLSKFED-----RLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             CCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            99999999975332     2889999999999999999999   899999999999999999999999999998765433


Q ss_pred             CCeeeeecccccccccccccccccc---cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccc
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRN---FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDRE  300 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (372)
                      .....  ....||+.|+|||++.+.   ...++.++|||||||++|||++|+.||......       ............
T Consensus       156 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~-------~~~~~i~~~~~~  226 (331)
T cd05597         156 GTVQS--NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-------ETYGKIMNHKEH  226 (331)
T ss_pred             CCccc--cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH-------HHHHHHHcCCCc
Confidence            22111  223589999999998631   135788999999999999999999999753211       111111111112


Q ss_pred             ccCCccCCcchHHHHHHHHHHHHHcc--cCCCCCCCCHHHHHHH
Q 036435          301 FKLPGVVTRKENEIAKKMIIVGLWCI--QARPSDRPPMNEVIEM  342 (372)
Q Consensus       301 ~~~~~~~~~~~~~~~~~l~~l~~~cl--~~~p~~RPs~~evl~~  342 (372)
                      ...+.....    ....+.+++.+|+  ..++..|++++++++.
T Consensus       227 ~~~~~~~~~----~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         227 FQFPPDVTD----VSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             ccCCCccCC----CCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            222222111    2344555666655  4444558899998864

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.8e-39  Score=274.30  Aligned_cols=210  Identities=24%  Similarity=0.361  Sum_probs=176.2

Q ss_pred             hHHHHHHHHhcc-CCCceeeeEeEEecCCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 036435          107 DFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH  185 (372)
Q Consensus       107 ~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~  185 (372)
                      .-.+|+.+|+++ .||||+++.++++++...++|+|.|+.|.|.|+|...-.      ++++...+|.+|+.+|++||| 
T Consensus        68 aT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~Vt------lSEK~tR~iMrqlfegVeylH-  140 (411)
T KOG0599|consen   68 ATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVT------LSEKETRRIMRQLFEGVEYLH-  140 (411)
T ss_pred             HHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhhee------ecHHHHHHHHHHHHHHHHHHH-
Confidence            467799999999 699999999999999999999999999999999976543      899999999999999999999 


Q ss_pred             CCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeeeeecccccccccccccccccc----cCCCCccccchhH
Q 036435          186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRN----FGEVSHKSDVYSF  261 (372)
Q Consensus       186 ~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~Dvwsl  261 (372)
                        ..+||||||||+|||+|++.++||+|||.+.....+..    ....+|||+|+|||.+..+    ...++...|+||+
T Consensus       141 --a~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~Gek----LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~  214 (411)
T KOG0599|consen  141 --ARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGEK----LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWAC  214 (411)
T ss_pred             --HhhhhhcccChhheeeccccceEEeccceeeccCCchh----HHHhcCCCcccChhheeeecccCCCCccchhhHHHH
Confidence              89999999999999999999999999999998776653    3455799999999998642    2467889999999


Q ss_pred             HHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          262 GMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       262 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ||++|.|+.|.+||......        .+.+.+.++.    -...++...++.....+++.+||+.||++|.|++|+++
T Consensus       215 GVImyTLLaGcpPFwHRkQm--------lMLR~ImeGk----yqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  215 GVIMYTLLAGCPPFWHRKQM--------LMLRMIMEGK----YQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             HHHHHHHHcCCCchhHHHHH--------HHHHHHHhcc----cccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            99999999999999753210        1122222221    12234456677788899999999999999999999986

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=8e-38  Score=284.41  Aligned_cols=232  Identities=23%  Similarity=0.323  Sum_probs=181.2

Q ss_pred             hhhhhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      .+.+.||+|+||.||+|+...                   .+.+|+++++.++||||+++++++..++..++|+||++++
T Consensus         8 ~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~   87 (282)
T cd06643           8 EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG   87 (282)
T ss_pred             HHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCC
Confidence            345779999999999987632                   4778999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      +|.+++.+...     .+++..+..++.|+++||+|||   +.+++|+||||+||+++.++.+||+|||++.........
T Consensus        88 ~l~~~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~  159 (282)
T cd06643          88 AVDAVMLELER-----PLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR  159 (282)
T ss_pred             cHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccccccc
Confidence            99998865321     2899999999999999999999   799999999999999999999999999998765332211


Q ss_pred             eeeecccccccccccccccccc---cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          227 VSSLLGARGIIGYIAPEVFSRN---FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                         .....++..|+|||++...   ...++.++|+|||||++|||++|+.||.......       .... .........
T Consensus       160 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-------~~~~-~~~~~~~~~  228 (282)
T cd06643         160 ---RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-------VLLK-IAKSEPPTL  228 (282)
T ss_pred             ---cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-------HHHH-HhhcCCCCC
Confidence               1233578899999998521   1356789999999999999999999986532110       0111 111111111


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      +     ....+...+.+++.+||+.||.+||++.++++
T Consensus       229 ~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         229 A-----QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             C-----CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0     11123456788999999999999999999885

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.4e-38  Score=292.29  Aligned_cols=219  Identities=21%  Similarity=0.277  Sum_probs=171.5

Q ss_pred             hhcCCCCceEEEEEEecc----------------------hHHHHHH-HHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           89 DKLGQGGFGGVYKGRLLD----------------------DFVNEVA-SISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~----------------------~~~~E~~-~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      +.||+|+||.||+++...                      .+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            369999999999997632                      2344443 57888999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      |+|..++.....      +++..+..++.|+++||+|||   +.+++||||||+||+++.++.+||+|||+++.......
T Consensus        81 ~~L~~~l~~~~~------~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  151 (321)
T cd05603          81 GELFFHLQRERC------FLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE  151 (321)
T ss_pred             CCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC
Confidence            999988865432      788899999999999999999   89999999999999999999999999999875322221


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                      .   .....||+.|+|||.+.+.  .++.++|||||||++|||++|..||.....       .. ....+... ....+.
T Consensus       152 ~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~-~~~~i~~~-~~~~~~  217 (321)
T cd05603         152 T---TSTFCGTPEYLAPEVLRKE--PYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-------SQ-MYDNILHK-PLQLPG  217 (321)
T ss_pred             c---cccccCCcccCCHHHhcCC--CCCCcCcccccchhhhhhhcCCCCCCCCCH-------HH-HHHHHhcC-CCCCCC
Confidence            1   1234588999999999764  788999999999999999999999975421       11 11111111 111121


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCCHH
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMN  337 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  337 (372)
                             .....+.+++.+||+.||.+||+..
T Consensus       218 -------~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         218 -------GKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             -------CCCHHHHHHHHHHccCCHhhcCCCC
Confidence                   1234677889999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.5e-38  Score=301.72  Aligned_cols=231  Identities=21%  Similarity=0.287  Sum_probs=174.4

Q ss_pred             hhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           87 FKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      +.+.||+|+||.||+++...                      .+.+|+.++++++||||+++++.+.+++..++||||++
T Consensus         5 ~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~   84 (382)
T cd05625           5 KIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIP   84 (382)
T ss_pred             EEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCC
Confidence            35789999999999997532                      46779999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      +|+|.+++.+...      +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++.......
T Consensus        85 gg~L~~~l~~~~~------~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          85 GGDMMSLLIRMGI------FPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            9999999976432      788899999999999999999   7999999999999999999999999999975321100


Q ss_pred             C--------------------------------------------eeeeecccccccccccccccccccCCCCccccchh
Q 036435          225 G--------------------------------------------IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYS  260 (372)
Q Consensus       225 ~--------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dvws  260 (372)
                      .                                            .........||+.|+|||++.+.  .++.++||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwS  233 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWS  233 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC--CCCCeeeEEe
Confidence            0                                            00001123589999999999775  7899999999


Q ss_pred             HHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCC---HH
Q 036435          261 FGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPP---MN  337 (372)
Q Consensus       261 lG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~  337 (372)
                      |||++|||++|+.||.......       ..............|..     ........+++.+++ .+|.+|++   ++
T Consensus       234 lGvil~elltG~~Pf~~~~~~~-------~~~~i~~~~~~~~~p~~-----~~~s~~~~~li~~l~-~~p~~R~~~~~~~  300 (382)
T cd05625         234 VGVILYEMLVGQPPFLAQTPLE-------TQMKVINWQTSLHIPPQ-----AKLSPEASDLIIKLC-RGPEDRLGKNGAD  300 (382)
T ss_pred             chHHHHHHHhCCCCCCCCCHHH-------HHHHHHccCCCcCCCCc-----ccCCHHHHHHHHHHc-cCHhHcCCCCCHH
Confidence            9999999999999997542211       01111111111222211     112234445555554 48999997   88


Q ss_pred             HHHH
Q 036435          338 EVIE  341 (372)
Q Consensus       338 evl~  341 (372)
                      ++++
T Consensus       301 ei~~  304 (382)
T cd05625         301 EIKA  304 (382)
T ss_pred             HHhc
Confidence            8775

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=5.9e-38  Score=293.30  Aligned_cols=245  Identities=28%  Similarity=0.417  Sum_probs=185.9

Q ss_pred             HhhhhhhcCCCCceEEEEEEec-------------------------chHHHHHHHHhcc-CCCceeeeEeEEecC-Cce
Q 036435           84 TNSFKDKLGQGGFGGVYKGRLL-------------------------DDFVNEVASISRT-SHVNVVTLLGFCLEG-NNR  136 (372)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-------------------------~~~~~E~~~l~~l-~h~nIv~l~g~~~~~-~~~  136 (372)
                      .+.+.+.||+|+||.||+|...                         +.+.+|+.++.++ +||||+++++++... ...
T Consensus         8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~   87 (343)
T cd05103           8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL   87 (343)
T ss_pred             HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCce
Confidence            4556788999999999998521                         1467899999999 789999999988654 467


Q ss_pred             eEEEEecCCCChhhhhhcCCCCC---------------------------------------------------------
Q 036435          137 ALIYEFMPNGSLEKFVYNGDTSK---------------------------------------------------------  159 (372)
Q Consensus       137 ~lV~e~~~~g~L~~~l~~~~~~~---------------------------------------------------------  159 (372)
                      ++|+||+++|+|.+++.......                                                         
T Consensus        88 ~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (343)
T cd05103          88 MVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAE  167 (343)
T ss_pred             EEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhh
Confidence            89999999999999986532100                                                         


Q ss_pred             ----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeeeeeccccc
Q 036435          160 ----PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG  235 (372)
Q Consensus       160 ----~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  235 (372)
                          ....+++.++..++.|+++||+|||   +.+++||||||+||++++++.+||+|||++........... .....+
T Consensus       168 ~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~  243 (343)
T cd05103         168 QEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR-KGDARL  243 (343)
T ss_pred             hhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhh-cCCCCC
Confidence                0123788999999999999999999   89999999999999999999999999999986533221111 122335


Q ss_pred             ccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCCcchHHH
Q 036435          236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEI  314 (372)
Q Consensus       236 t~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (372)
                      +..|+|||.+.+.  .++.++|+||||+++|++++ |..||......       ...............+..       .
T Consensus       244 ~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~-------~  307 (343)
T cd05103         244 PLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-------EEFCRRLKEGTRMRAPDY-------T  307 (343)
T ss_pred             CcceECcHHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-------HHHHHHHhccCCCCCCCC-------C
Confidence            6779999998764  78999999999999999996 88887643211       111222222222222221       2


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 036435          315 AKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE  348 (372)
Q Consensus       315 ~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~  348 (372)
                      ...+.+++..||+.||++|||+.++++.|+.+.+
T Consensus       308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            3467889999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.3e-37  Score=282.70  Aligned_cols=230  Identities=25%  Similarity=0.410  Sum_probs=179.3

Q ss_pred             hhhhhcCCCCceEEEEEEec--------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLL--------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~--------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      .+.+.||+|+||.||++...                    .++.+|++++++++||||+++++++...+..++|+||+++
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   83 (279)
T cd06619           4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDG   83 (279)
T ss_pred             hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCC
Confidence            34578999999999999652                    1477899999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      ++|..+.          .+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++....... 
T Consensus        84 ~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-  149 (279)
T cd06619          84 GSLDVYR----------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-  149 (279)
T ss_pred             CChHHhh----------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence            9997552          1678889999999999999999   8999999999999999999999999999997654322 


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                          .....+|..|+|||.+.+.  .++.++|+||||+++|+|++|+.||............... ............+ 
T Consensus       150 ----~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~-  221 (279)
T cd06619         150 ----AKTYVGTNAYMAPERISGE--QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL-LQCIVDEDPPVLP-  221 (279)
T ss_pred             ----ccCCCCChhhcCceeecCC--CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHH-HHHHhccCCCCCC-
Confidence                1233578899999999875  7899999999999999999999999753322211111111 1111111111111 


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                           .......+.+++.+||+.+|++||+++++++.
T Consensus       222 -----~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         222 -----VGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             -----CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence                 11123567889999999999999999999863

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=7.4e-39  Score=303.19  Aligned_cols=233  Identities=21%  Similarity=0.288  Sum_probs=176.8

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      .+.+.||+|+||.||+++...                      .+.+|+.++++++||||+++++.+.+++..++||||+
T Consensus         4 ~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~   83 (376)
T cd05598           4 VKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI   83 (376)
T ss_pred             eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCC
Confidence            345789999999999987532                      3667999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      ++|+|.+++....      .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++..+...
T Consensus        84 ~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~  154 (376)
T cd05598          84 PGGDMMSLLIRLG------IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (376)
T ss_pred             CCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence            9999999997643      2788889999999999999999   899999999999999999999999999998532100


Q ss_pred             CC----------------------------------------eeeeecccccccccccccccccccCCCCccccchhHHH
Q 036435          224 EG----------------------------------------IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGM  263 (372)
Q Consensus       224 ~~----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~  263 (372)
                      ..                                        .........||+.|+|||++.+.  .++.++|||||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGv  232 (376)
T cd05598         155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWSVGV  232 (376)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC--CCCcceeeeeccc
Confidence            00                                        00001123589999999999875  7889999999999


Q ss_pred             HHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCC---CHHHHH
Q 036435          264 MIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRP---PMNEVI  340 (372)
Q Consensus       264 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP---s~~evl  340 (372)
                      ++|||++|+.||.......       ..............+..     ..+...+.+++.+|+ .+|.+|+   ++.+++
T Consensus       233 ilyell~G~~Pf~~~~~~~-------~~~~i~~~~~~~~~~~~-----~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell  299 (376)
T cd05598         233 ILYEMLVGQPPFLADTPAE-------TQLKVINWETTLHIPSQ-----AKLSREASDLILRLC-CGAEDRLGKNGADEIK  299 (376)
T ss_pred             eeeehhhCCCCCCCCCHHH-------HHHHHhccCccccCCCC-----CCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence            9999999999997643211       11111111111111111     112334555666655 4999999   889988


Q ss_pred             HH
Q 036435          341 EM  342 (372)
Q Consensus       341 ~~  342 (372)
                      +.
T Consensus       300 ~h  301 (376)
T cd05598         300 AH  301 (376)
T ss_pred             CC
Confidence            64

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.6e-38  Score=294.69  Aligned_cols=221  Identities=20%  Similarity=0.288  Sum_probs=175.4

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhcc-CCCceeeeEeEEecCCceeEEEEe
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      .+.+.||+|+||.||+++...                      .+..|..++..+ +|++|+++++++.+.+..++||||
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~   82 (323)
T cd05616           3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEY   82 (323)
T ss_pred             eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcC
Confidence            345789999999999986532                      245577777776 589999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      +++|+|.+++.....      +++.++..++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++....
T Consensus        83 ~~~g~L~~~~~~~~~------~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~  153 (323)
T cd05616          83 VNGGDLMYQIQQVGR------FKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW  153 (323)
T ss_pred             CCCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence            999999999876432      889999999999999999999   89999999999999999999999999999975432


Q ss_pred             CCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      ....   .....||+.|+|||.+.+.  .++.++|+|||||++|||++|+.||......        .....+... ...
T Consensus       154 ~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--------~~~~~i~~~-~~~  219 (323)
T cd05616         154 DGVT---TKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--------ELFQSIMEH-NVA  219 (323)
T ss_pred             CCCc---cccCCCChhhcCHHHhcCC--CCCCccchhchhHHHHHHHhCCCCCCCCCHH--------HHHHHHHhC-CCC
Confidence            2211   1234589999999999874  7899999999999999999999999754221        111222111 112


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCCH
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPM  336 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  336 (372)
                      .|.       .....+.+++.+||+.||.+|++.
T Consensus       220 ~p~-------~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         220 YPK-------SMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             CCC-------cCCHHHHHHHHHHcccCHHhcCCC
Confidence            222       234567789999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-39  Score=301.85  Aligned_cols=220  Identities=21%  Similarity=0.352  Sum_probs=179.4

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhcc-CCCceeeeEeEEecCCceeEEEEe
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      .|.+.||+|+||+|+++....                      ....|.+++... +||.+++++..|.+.+++|+||||
T Consensus       371 ~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey  450 (694)
T KOG0694|consen  371 RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEY  450 (694)
T ss_pred             EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEe
Confidence            446789999999999986632                      467788888777 599999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      +.||++..+.+..       .|++..+.-++..|+.||+|||   +++||+||||.+|||||.+|.+||+|||+++..-.
T Consensus       451 ~~Ggdm~~~~~~~-------~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~  520 (694)
T KOG0694|consen  451 VAGGDLMHHIHTD-------VFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG  520 (694)
T ss_pred             cCCCcEEEEEecc-------cccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccCC
Confidence            9999955444332       2999999999999999999999   89999999999999999999999999999986432


Q ss_pred             CCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      ..   ......+||+.|||||++.+.  .|+...|.|||||++|||+.|..||..+.+.+        +...+..+ +..
T Consensus       521 ~g---~~TsTfCGTpey~aPEil~e~--~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee--------~FdsI~~d-~~~  586 (694)
T KOG0694|consen  521 QG---DRTSTFCGTPEFLAPEVLTEQ--SYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE--------VFDSIVND-EVR  586 (694)
T ss_pred             CC---CccccccCChhhcChhhhccC--cccchhhHHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHHhcC-CCC
Confidence            22   234567899999999999986  99999999999999999999999998765432        22222111 112


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCCH
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPM  336 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  336 (372)
                      .|       ..++.+.++++.+.|.++|++|.-+
T Consensus       587 yP-------~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  587 YP-------RFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             CC-------CcccHHHHHHHHHHhccCcccccCC
Confidence            22       2345677788888999999999966

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.5e-38  Score=295.27  Aligned_cols=220  Identities=21%  Similarity=0.250  Sum_probs=172.1

Q ss_pred             hhcCCCCceEEEEEEecc----------------------hHHHHHH-HHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           89 DKLGQGGFGGVYKGRLLD----------------------DFVNEVA-SISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~----------------------~~~~E~~-~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      +.||+|+||.||+++...                      .+..|.. +++.++||||+++++++.+++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            359999999999986532                      2344444 46778999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      |+|..++.....      +++.++..++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++.......
T Consensus        81 ~~L~~~l~~~~~------~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  151 (325)
T cd05604          81 GELFFHLQRERS------FPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD  151 (325)
T ss_pred             CCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC
Confidence            999998865432      889999999999999999999   89999999999999999999999999999875332221


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                      .   .....||+.|+|||.+.+.  .++.++|||||||++|||++|..||......       . ....+.... ...+.
T Consensus       152 ~---~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~~~~~-------~-~~~~~~~~~-~~~~~  217 (325)
T cd05604         152 T---TTTFCGTPEYLAPEVIRKQ--PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-------E-MYDNILHKP-LVLRP  217 (325)
T ss_pred             C---cccccCChhhCCHHHHcCC--CCCCcCccccccceehhhhcCCCCCCCCCHH-------H-HHHHHHcCC-ccCCC
Confidence            1   1234588999999999774  7889999999999999999999999754211       1 112221111 11111


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNE  338 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  338 (372)
                             .....+.+++.+|++.+|.+||++.+
T Consensus       218 -------~~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         218 -------GASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             -------CCCHHHHHHHHHHhccCHHhcCCCCC
Confidence                   12345677889999999999998863

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.1e-38  Score=292.13  Aligned_cols=243  Identities=21%  Similarity=0.352  Sum_probs=181.2

Q ss_pred             hhhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      ...+.||+|+||.||+|+...                    .+.+|+.++++++||||+++++++.+++..++||||+++
T Consensus         9 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   88 (309)
T cd07872           9 IKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK   88 (309)
T ss_pred             EEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC
Confidence            345789999999999986531                    467899999999999999999999999999999999975


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                       +|.+++.....     .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++........
T Consensus        89 -~l~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          89 -DLKQYMDDCGN-----IMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             -CHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence             89888865432     2788999999999999999999   89999999999999999999999999999976433221


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchH-------HHHHHHhhhc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFP-------HWIYRHVEQD  298 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~-------~~~~~~~~~~  298 (372)
                      .   .....+|..|+|||.+.+. ..++.++|||||||++|+|++|+.||...........+.       ...+......
T Consensus       160 ~---~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
T cd07872         160 T---YSNEVVTLWYRPPDVLLGS-SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN  235 (309)
T ss_pred             c---cccccccccccCCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcch
Confidence            1   1223468889999998654 367899999999999999999999997643221000000       0000000000


Q ss_pred             c---cccCCccCC----cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          299 R---EFKLPGVVT----RKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       299 ~---~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .   ....+....    .....+...+.+++.+||+.||.+|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            0   000111000    011123456788999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=4.1e-38  Score=288.49  Aligned_cols=228  Identities=24%  Similarity=0.366  Sum_probs=182.2

Q ss_pred             hhhhhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      .+.+.||+|+||.||+|....                   .+.+|+.+++.++|+||+++++.+..+...++||||++++
T Consensus        23 ~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~  102 (296)
T cd06654          23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG  102 (296)
T ss_pred             eeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCC
Confidence            345679999999999996421                   5778999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      +|.+++.+..       +++.++..++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++.........
T Consensus       103 ~L~~~~~~~~-------~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  172 (296)
T cd06654         103 SLTDVVTETC-------MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (296)
T ss_pred             CHHHHHHhcC-------CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence            9999986532       788999999999999999999   899999999999999999999999999998765433211


Q ss_pred             eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCcc
Q 036435          227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV  306 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (372)
                         .....+++.|+|||.+.+.  ..+.++|+|||||++|+|++|+.||.......       ...... .......   
T Consensus       173 ---~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-------~~~~~~-~~~~~~~---  236 (296)
T cd06654         173 ---RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-------ALYLIA-TNGTPEL---  236 (296)
T ss_pred             ---cCcccCCccccCHHHHcCC--CCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-------hHHHHh-cCCCCCC---
Confidence               1223477889999998764  67899999999999999999999997543211       011111 1111010   


Q ss_pred             CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       307 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                        .........+.+++.+||+.+|++||+++++++
T Consensus       237 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         237 --QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             --CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence              111234466788999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=8.9e-38  Score=279.70  Aligned_cols=230  Identities=27%  Similarity=0.497  Sum_probs=182.0

Q ss_pred             hhhhhhcCCCCceEEEEEEecc---------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCChh
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD---------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLE  149 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~---------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~  149 (372)
                      +.+.+.||+|+||.||+++..+               .+.+|+.++++++|||++++++++..+ ..++|+||+++++|.
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~   86 (254)
T cd05083           8 LTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLV   86 (254)
T ss_pred             ceeeeeeccCCCCceEecccCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHH
Confidence            3456789999999999986432               578899999999999999999998765 579999999999999


Q ss_pred             hhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeeee
Q 036435          150 KFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSS  229 (372)
Q Consensus       150 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  229 (372)
                      +++......    .+++.+++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++.......     
T Consensus        87 ~~l~~~~~~----~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-----  154 (254)
T cd05083          87 NFLRTRGRA----LVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-----  154 (254)
T ss_pred             HHHHhcCcC----CCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccC-----
Confidence            999765432    3889999999999999999999   8999999999999999999999999999987543221     


Q ss_pred             ecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCC
Q 036435          230 LLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVT  308 (372)
Q Consensus       230 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (372)
                       .....+..|+|||.+.+.  .++.++|+||||+++|||++ |+.||......       . .............+    
T Consensus       155 -~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-------~-~~~~~~~~~~~~~~----  219 (254)
T cd05083         155 -DNSKLPVKWTAPEALKHK--KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-------E-VKECVEKGYRMEPP----  219 (254)
T ss_pred             -CCCCCCceecCHHHhccC--CcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-------H-HHHHHhCCCCCCCC----
Confidence             112234679999998764  78899999999999999997 88888643211       1 12222222111111    


Q ss_pred             cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 036435          309 RKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG  345 (372)
Q Consensus       309 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~  345 (372)
                         ...+..+.+++.+||+.+|.+||+++++++.|+.
T Consensus       220 ---~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         220 ---EGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             ---CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence               1234567789999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.6e-38  Score=300.43  Aligned_cols=242  Identities=22%  Similarity=0.312  Sum_probs=179.3

Q ss_pred             hhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCC-----ceeEEE
Q 036435           87 FKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGN-----NRALIY  140 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~-----~~~lV~  140 (372)
                      ..+.||+|+||.||+++...                     ++.+|+.+++.++||||+++++++...+     ..++|+
T Consensus         4 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~   83 (372)
T cd07853           4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT   83 (372)
T ss_pred             ccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEe
Confidence            35779999999999987521                     4678999999999999999999998776     789999


Q ss_pred             EecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccc
Q 036435          141 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC  220 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~  220 (372)
                      ||+. ++|.+++....      .+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++...
T Consensus        84 e~~~-~~l~~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          84 ELMQ-SDLHKIIVSPQ------PLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             eccc-cCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9996 58888876543      2899999999999999999999   899999999999999999999999999999865


Q ss_pred             cCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCcc---------chHHH-
Q 036435          221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV---------YFPHW-  290 (372)
Q Consensus       221 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~---------~~~~~-  290 (372)
                      .......  .....+|..|+|||.+.+. ..++.++||||+||++|||++|+.||..........         ....+ 
T Consensus       154 ~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~  230 (372)
T cd07853         154 EPDESKH--MTQEVVTQYYRAPEILMGS-RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMR  230 (372)
T ss_pred             ccCcccc--CCCCCcCCCcCCHHHHcCC-CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            4322111  1223467889999998764 357899999999999999999999997543211000         00000 


Q ss_pred             -----HHHHhhhcccccCCcc--CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          291 -----IYRHVEQDREFKLPGV--VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       291 -----~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                           ....+... ....+..  ...........+.+++.+||+.||.+|||++|+++.
T Consensus       231 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         231 SACEGARAHILRG-PHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HhhHHHHHHHHhC-CCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                 00000000 0000000  000011124567889999999999999999999863

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.7e-38  Score=288.95  Aligned_cols=235  Identities=21%  Similarity=0.341  Sum_probs=185.1

Q ss_pred             HhhhhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhcc-CCCceeeeEeEEecCCceeEEEEe
Q 036435           84 TNSFKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      .+...+.||+||.+.||++...+                    .|.+|+.+|.+| .|.+|+++++|-..++.+|+||||
T Consensus       362 ~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~  441 (677)
T KOG0596|consen  362 EYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMEC  441 (677)
T ss_pred             hhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeec
Confidence            34456789999999999986532                    589999999999 599999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      =+. ||..+|.+.....    ..| .+..+..|++.++.++|   ..+|||.||||.|+|+-. |.+||+|||+|..+..
T Consensus       442 Gd~-DL~kiL~k~~~~~----~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  442 GDI-DLNKILKKKKSID----PDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP  511 (677)
T ss_pred             ccc-cHHHHHHhccCCC----chH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence            854 9999998766432    334 67889999999999999   899999999999999854 6899999999998877


Q ss_pred             CCCeeeeeccccccccccccccccccc---------CCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHH
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNF---------GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYR  293 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~---------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  293 (372)
                      ..+... .....||+.||+||.+....         -+.+.++||||+|||||+|+.|+.||.....      ....+..
T Consensus       512 DTTsI~-kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n------~~aKl~a  584 (677)
T KOG0596|consen  512 DTTSIV-KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN------QIAKLHA  584 (677)
T ss_pred             ccccee-eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH------HHHHHHh
Confidence            665544 34567999999999986421         1367899999999999999999999975321      0111112


Q ss_pred             HhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          294 HVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ..+.+..+..|.....      ..+++++..||+.||.+||++.++|+
T Consensus       585 I~~P~~~Iefp~~~~~------~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  585 ITDPNHEIEFPDIPEN------DELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             hcCCCccccccCCCCc------hHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            2222333344433322      22888999999999999999999996

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1e-37  Score=290.58  Aligned_cols=230  Identities=26%  Similarity=0.360  Sum_probs=191.3

Q ss_pred             HhhhhhhcCCCCceEEEEEEec----------------------chHHHHHHHHhccC-CCceeeeEeEEecCCceeEEE
Q 036435           84 TNSFKDKLGQGGFGGVYKGRLL----------------------DDFVNEVASISRTS-HVNVVTLLGFCLEGNNRALIY  140 (372)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~----------------------~~~~~E~~~l~~l~-h~nIv~l~g~~~~~~~~~lV~  140 (372)
                      .+.+.+.||+|.||.||+++..                      ..+.+|+.+|+++. ||||+.+++++.+....++||
T Consensus        36 ~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvm  115 (382)
T KOG0032|consen   36 KYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVM  115 (382)
T ss_pred             cEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEE
Confidence            3455688999999999998653                      26889999999998 999999999999999999999


Q ss_pred             EecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC----CCceEEeecCC
Q 036435          141 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE----DFCPKISDFGL  216 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~Dfgl  216 (372)
                      |++.||.|.+.+...       .+++.++..++.|++++++|||   +.+++||||||+|+|+..    ++.+|++|||+
T Consensus       116 EL~~GGeLfd~i~~~-------~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  116 ELCEGGELFDRIVKK-------HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EecCCchHHHHHHHc-------cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            999999999999776       1899999999999999999999   899999999999999953    35799999999


Q ss_pred             cccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhh
Q 036435          217 AKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE  296 (372)
Q Consensus       217 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  296 (372)
                      +.......    ......||+.|+|||++...  .++..+||||+|+++|.|++|.+||.......        ....+.
T Consensus       186 a~~~~~~~----~~~~~~Gtp~y~APEvl~~~--~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~--------~~~~i~  251 (382)
T KOG0032|consen  186 AKFIKPGE----RLHTIVGTPEYVAPEVLGGR--PYGDEVDVWSIGVILYILLSGVPPFWGETEFE--------IFLAIL  251 (382)
T ss_pred             ceEccCCc----eEeeecCCccccCchhhcCC--CCCcccchhHHHHHHHHHhhCCCCCcCCChhH--------HHHHHH
Confidence            99877622    23456799999999999864  89999999999999999999999998765432        111222


Q ss_pred             hcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .+ .+   .........+...+.+++..++..||.+|+|+.++++
T Consensus       252 ~~-~~---~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  252 RG-DF---DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             cC-CC---CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence            11 11   2223334455677888999999999999999999998

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=7.8e-38  Score=287.56  Aligned_cols=234  Identities=28%  Similarity=0.455  Sum_probs=182.8

Q ss_pred             hhhcCCCCceEEEEEEecc------------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           88 KDKLGQGGFGGVYKGRLLD------------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      .+.||+|+||.||+|++..                        ++.+|+.++++++||||++++|+|... ..++++||+
T Consensus        12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~   90 (303)
T cd05110          12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLM   90 (303)
T ss_pred             ccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehhc
Confidence            4679999999999986411                        467899999999999999999999764 467999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      ++|+|.+++.....     .+++..++.++.|++.||+|||   +.+++|+||||+||++++++.+||+|||+++.....
T Consensus        91 ~~g~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~  162 (303)
T cd05110          91 PHGCLLDYVHEHKD-----NIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD  162 (303)
T ss_pred             CCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccCc
Confidence            99999999876432     2889999999999999999999   899999999999999999999999999999865433


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      ..... .....++..|+|||.+.+.  .++.++||||||+++||+++ |+.||.....        ..............
T Consensus       163 ~~~~~-~~~~~~~~~y~~PE~~~~~--~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~~  231 (303)
T cd05110         163 EKEYN-ADGGKMPIKWMALECIHYR--KFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--------REIPDLLEKGERLP  231 (303)
T ss_pred             ccccc-cCCCccccccCCHHHhccC--CCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHCCCCCC
Confidence            22111 1223356789999998764  78999999999999999997 8888864321        11122222222221


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE  348 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~  348 (372)
                      .+.       .....+.+++..||..+|++||+++++++.|+.+..
T Consensus       232 ~~~-------~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~  270 (303)
T cd05110         232 QPP-------ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR  270 (303)
T ss_pred             CCC-------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            111       123467788999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4.8e-38  Score=289.66  Aligned_cols=239  Identities=21%  Similarity=0.316  Sum_probs=181.0

Q ss_pred             hhhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      .+.+.||+|+||.||+++...                    ++.+|++++++++||||+++++++.+++..++|+||+++
T Consensus         4 ~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~   83 (308)
T cd06615           4 EKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDG   83 (308)
T ss_pred             eEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCC
Confidence            345779999999999986521                    477899999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      ++|.+++....      .+++..+..++.|+++||.|||+  ..+++|+||||+|||+++++.+||+|||++....... 
T Consensus        84 ~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  154 (308)
T cd06615          84 GSLDQVLKKAG------RIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  154 (308)
T ss_pred             CcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence            99999997653      28899999999999999999993  3689999999999999999999999999987543221 


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHH---------------
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHW---------------  290 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~---------------  290 (372)
                          .....++..|+|||.+.+.  .++.++|+||||+++|+|++|+.||...........+...               
T Consensus       155 ----~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (308)
T cd06615         155 ----ANSFVGTRSYMSPERLQGT--HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSG  228 (308)
T ss_pred             ----cccCCCCcCccChhHhcCC--CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccC
Confidence                1223578889999998764  6889999999999999999999998643211100000000               


Q ss_pred             ----------HHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          291 ----------IYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       291 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                                .............+.. .  .......+.+++.+||+.+|++||+++++++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         229 HPPDSPRPMAIFELLDYIVNEPPPKL-P--SGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CCCCccchhhHHHHHHHHhcCCCccC-c--CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                      0000000000000000 0  01134568899999999999999999999874

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=5.7e-38  Score=285.96  Aligned_cols=229  Identities=25%  Similarity=0.340  Sum_probs=180.1

Q ss_pred             hhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           88 KDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      .+.||+|+||+||+++...                      .+.+|++++++++|+||+++.+.+.+++..++|+||+++
T Consensus         5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   84 (285)
T cd05632           5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG   84 (285)
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccC
Confidence            4679999999999986631                      256799999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      ++|.+++......    .+++..+..++.|++.||.|||   +.+|+||||||+||++++++.+||+|||++........
T Consensus        85 ~~L~~~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          85 GDLKFHIYNMGNP----GFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES  157 (285)
T ss_pred             ccHHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence            9999988754322    2899999999999999999999   89999999999999999999999999999976533221


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                          .....|+..|+|||.+.+.  .++.++|+||||+++|||++|..||........    ...+........ ...  
T Consensus       158 ----~~~~~g~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~----~~~~~~~~~~~~-~~~--  224 (285)
T cd05632         158 ----IRGRVGTVGYMAPEVLNNQ--RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK----REEVDRRVLETE-EVY--  224 (285)
T ss_pred             ----ccCCCCCcCccChHHhcCC--CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHhhhccc-ccc--
Confidence                1233578999999999764  788999999999999999999999975422110    011111111110 011  


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPP-----MNEVIE  341 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~  341 (372)
                           .......+.+++..||+.||++||+     ++++++
T Consensus       225 -----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         225 -----SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             -----CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence                 1123456678899999999999999     667765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.1e-38  Score=286.14  Aligned_cols=233  Identities=29%  Similarity=0.459  Sum_probs=181.8

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      .+.+.||+|+||+||+++...                     ...+|+.++++++||||+++++++.+....++||||++
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~   81 (260)
T PF00069_consen    2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP   81 (260)
T ss_dssp             EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred             EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccc
Confidence            346789999999999997743                     23458999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      +++|.+++....      .+++..+..++.|+++||++||   +.+++|+||||+||++++++.++|+|||.+.......
T Consensus        82 ~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~  152 (260)
T PF00069_consen   82 GGSLQDYLQKNK------PLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN  152 (260)
T ss_dssp             TEBHHHHHHHHS------SBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT
T ss_pred             cccccccccccc------cccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence            999999998322      2899999999999999999999   7899999999999999999999999999997642111


Q ss_pred             Ceeeeecccccccccccccccc-cccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          225 GIVSSLLGARGIIGYIAPEVFS-RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                         .......++..|+|||.+. +  ...+.++|+||+|+++|+|++|..||.......    .................
T Consensus       153 ---~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~----~~~~~~~~~~~~~~~~~  223 (260)
T PF00069_consen  153 ---ENFNPFVGTPEYMAPEVLQQG--KKYTRKSDIWSLGIILYELLTGKLPFEESNSDD----QLEIIEKILKRPLPSSS  223 (260)
T ss_dssp             ---SEBSSSSSSGGGSCHHHHTTT--SSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH----HHHHHHHHHHTHHHHHT
T ss_pred             ---ccccccccccccccccccccc--ccccccccccccccccccccccccccccccchh----hhhhhhhcccccccccc
Confidence               1223445788999999987 4  378999999999999999999999998641101    00011111110000000


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .     ........+.+++.+||+.||++||+++++++
T Consensus       224 ~-----~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  224 Q-----QSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             T-----SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             c-----ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0     00001267889999999999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=6e-38  Score=280.92  Aligned_cols=230  Identities=21%  Similarity=0.338  Sum_probs=183.3

Q ss_pred             hhhhhcCCCCceEEEEEEec--------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLL--------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~--------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      .+.+.||+|+||.||+++..                    +.+.+|+.++++++|+||+++++.+.+++..++|+||+++
T Consensus         3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   82 (255)
T cd08219           3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDG   82 (255)
T ss_pred             eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCC
Confidence            34578999999999998653                    1577899999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      |+|.+++.....    ..+++..++.++.|++.||.|||   +.+++|+||||+||++++++.++++|||++........
T Consensus        83 ~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  155 (255)
T cd08219          83 GDLMQKIKLQRG----KLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA  155 (255)
T ss_pred             CcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence            999998865332    23789999999999999999999   89999999999999999999999999999976543222


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                      ..   ....++..|+|||++.+.  ..+.++|+||||+++|+|++|..||......       . .............+ 
T Consensus       156 ~~---~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-------~-~~~~~~~~~~~~~~-  221 (255)
T cd08219         156 YA---CTYVGTPYYVPPEIWENM--PYNNKSDIWSLGCILYELCTLKHPFQANSWK-------N-LILKVCQGSYKPLP-  221 (255)
T ss_pred             cc---ccccCCccccCHHHHccC--CcCchhhhhhhchhheehhhccCCCCCCCHH-------H-HHHHHhcCCCCCCC-
Confidence            11   223477889999998764  7889999999999999999999999753211       1 11111111111111 


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                            ......+.+++.+||+.||++||++++++..
T Consensus       222 ------~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         222 ------SHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ------cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                  1234567789999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.2e-37  Score=289.95  Aligned_cols=236  Identities=19%  Similarity=0.246  Sum_probs=179.0

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      .+.+.||+|+||.||+++...                      .+.+|..++..++|+||+++++.+.+++..++||||+
T Consensus         4 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~   83 (332)
T cd05623           4 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYY   83 (332)
T ss_pred             eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEecc
Confidence            345789999999999987632                      2677889999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      ++|+|.+++.+...     .+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++......
T Consensus        84 ~~g~L~~~l~~~~~-----~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          84 VGGDLLTLLSKFED-----RLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             CCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            99999999976432     2889999999999999999999   899999999999999999999999999999765332


Q ss_pred             CCeeeeecccccccccccccccccc---cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccc
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRN---FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDRE  300 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (372)
                      ....  .....||+.|+|||++.+.   ...++.++|||||||++|||++|+.||......       ............
T Consensus       156 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~-------~~~~~i~~~~~~  226 (332)
T cd05623         156 GTVQ--SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-------ETYGKIMNHKER  226 (332)
T ss_pred             Ccce--ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH-------HHHHHHhCCCcc
Confidence            2211  1234589999999998631   135788999999999999999999999754211       111111222222


Q ss_pred             ccCCccCCcchHHHHHHHHHHHHHcccC--CCCCCCCHHHHHHH
Q 036435          301 FKLPGVVTRKENEIAKKMIIVGLWCIQA--RPSDRPPMNEVIEM  342 (372)
Q Consensus       301 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~--~p~~RPs~~evl~~  342 (372)
                      ...|...    ..+...+.+++.+|+..  ++..|++++++++.
T Consensus       227 ~~~p~~~----~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         227 FQFPAQV----TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             ccCCCcc----ccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            2222221    12334556667776644  44447899998865

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=4.7e-38  Score=292.14  Aligned_cols=245  Identities=18%  Similarity=0.212  Sum_probs=178.8

Q ss_pred             hhhhcCCC--CceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           87 FKDKLGQG--GFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        87 ~~~~lg~G--~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      +.++||+|  +|++||+++...                     .+.+|+.+++.++||||+++++++.+++..++|+||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45679999  688999986532                     3567999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      ++|+|.+++......    .+++..++.++.|++.||+|||   +.+++||||||+|||++.++.++++||+.+......
T Consensus        82 ~~~~l~~~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~  154 (327)
T cd08227          82 AYGSAKDLICTHFMD----GMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINH  154 (327)
T ss_pred             CCCcHHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccc
Confidence            999999999654321    2899999999999999999999   799999999999999999999999999865443221


Q ss_pred             CCeee----eecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhh---
Q 036435          224 EGIVS----SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE---  296 (372)
Q Consensus       224 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---  296 (372)
                      .....    ......++..|+|||++.+....++.++|||||||++|||++|+.||........   ..........   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~  231 (327)
T cd08227         155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM---LLEKLNGTVPCLL  231 (327)
T ss_pred             cccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH---HHHHhcCCccccc
Confidence            11000    0011235677999999876433678999999999999999999999975322110   0000000000   


Q ss_pred             -------------h---cccc--------------cCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          297 -------------Q---DREF--------------KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       297 -------------~---~~~~--------------~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                                   .   ....              ................+.+++.+||+.||++|||++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence                         0   0000              0000001112233457888999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=5e-38  Score=286.33  Aligned_cols=230  Identities=25%  Similarity=0.340  Sum_probs=181.3

Q ss_pred             hhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           87 FKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      ..+.||+|+||.||++....                      .+.+|+.++++++|+||+++++.+.+++..++||||++
T Consensus         4 ~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   83 (285)
T cd05630           4 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN   83 (285)
T ss_pred             eeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecC
Confidence            34679999999999976531                      35679999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      +++|.+++.....    ..+++.+++.++.|++.||.|||   +.+++|+||||+||++++++.++|+|||++.......
T Consensus        84 g~~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          84 GGDLKFHIYHMGE----AGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             CCcHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            9999999865432    22899999999999999999999   8999999999999999999999999999987654332


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCC
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP  304 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (372)
                      ..    ....|+..|+|||.+.+.  .++.++|+||||+++|+|++|+.||.........    .......... ....+
T Consensus       157 ~~----~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~----~~~~~~~~~~-~~~~~  225 (285)
T cd05630         157 TI----KGRVGTVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR----EEVERLVKEV-QEEYS  225 (285)
T ss_pred             cc----cCCCCCccccChHHHcCC--CCCCccccHHHHHHHHHHHhCCCCCCCCCccchH----HHHHhhhhhh-hhhcC
Confidence            11    223588999999999764  7899999999999999999999999764322110    0011111100 00111


Q ss_pred             ccCCcchHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 036435          305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPP-----MNEVIE  341 (372)
Q Consensus       305 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~  341 (372)
                             ......+.+++..||+.||++|||     ++|+++
T Consensus       226 -------~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         226 -------EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             -------ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence                   123355778899999999999999     888886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-38  Score=307.98  Aligned_cols=239  Identities=20%  Similarity=0.306  Sum_probs=186.8

Q ss_pred             hhhhhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccC-CCceeeeEeEEe-c---C---CceeE
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTS-HVNVVTLLGFCL-E---G---NNRAL  138 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~-h~nIv~l~g~~~-~---~---~~~~l  138 (372)
                      .+.+.|.+|||+.||.++...                   .+.+|+.+|++|+ |+|||.+++... .   +   -+.+|
T Consensus        40 ~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evll  119 (738)
T KOG1989|consen   40 TVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLL  119 (738)
T ss_pred             EEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEe
Confidence            345679999999999997643                   5789999999996 999999999332 1   1   25679


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          139 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       139 V~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      .||||.+|.|-+++..+-..+    |++.++++|+.|+++|+++||. +..+|||||||-+||||+.+++.||||||.|.
T Consensus       120 LmEyC~gg~Lvd~mn~Rlq~~----lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSat  194 (738)
T KOG1989|consen  120 LMEYCKGGSLVDFMNTRLQTR----LTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSAT  194 (738)
T ss_pred             ehhhccCCcHHHHHHHHHhcc----CChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence            999999999999998765433    9999999999999999999994 46789999999999999999999999999997


Q ss_pred             cccCCCCeee------eecccccccccccccccccc-cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHH
Q 036435          219 LCTTKEGIVS------SLLGARGIIGYIAPEVFSRN-FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWI  291 (372)
Q Consensus       219 ~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  291 (372)
                      ..........      ..-...-|+.|.|||++.-. .-.+++|+|||+|||+||-|+....||+......         
T Consensus       195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la---------  265 (738)
T KOG1989|consen  195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA---------  265 (738)
T ss_pred             cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee---------
Confidence            5432221100      00112367889999998521 1378999999999999999999999998652211         


Q ss_pred             HHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          292 YRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                          .-...+..|.     ...+...+.+|+..||+.||.+||++-+|+..+..+.
T Consensus       266 ----Ilng~Y~~P~-----~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~  312 (738)
T KOG1989|consen  266 ----ILNGNYSFPP-----FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA  312 (738)
T ss_pred             ----EEeccccCCC-----CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence                0112223332     2456788999999999999999999999999886665

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=7.2e-38  Score=282.99  Aligned_cols=232  Identities=26%  Similarity=0.385  Sum_probs=179.1

Q ss_pred             hhhhhcCCCCceEEEEEEecc------------------hHHHHHHHHhcc-CCCceeeeEeEEecC------CceeEEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD------------------DFVNEVASISRT-SHVNVVTLLGFCLEG------NNRALIY  140 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~------------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~------~~~~lV~  140 (372)
                      .+.+.||+|+||.||+|...+                  .+.+|+.+++++ +|+||+++++++...      ...++||
T Consensus         9 ~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~   88 (272)
T cd06637           9 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVM   88 (272)
T ss_pred             hHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEE
Confidence            445779999999999997632                  578899999998 799999999998753      3578999


Q ss_pred             EecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccc
Q 036435          141 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC  220 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~  220 (372)
                      ||+++|+|.+++.....    ..+++..+..++.|++.||+|||   +.+++|+||||+||++++++.+||+|||++...
T Consensus        89 e~~~~~~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~  161 (272)
T cd06637          89 EFCGAGSVTDLIKNTKG----NTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  161 (272)
T ss_pred             EcCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence            99999999999976432    23899999999999999999999   789999999999999999999999999999765


Q ss_pred             cCCCCeeeeecccccccccccccccccc---cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhh
Q 036435          221 TTKEGIVSSLLGARGIIGYIAPEVFSRN---FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQ  297 (372)
Q Consensus       221 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (372)
                      ......   .....|+..|+|||++.+.   ...++.++|+|||||++|||++|+.||.......        .......
T Consensus       162 ~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~--------~~~~~~~  230 (272)
T cd06637         162 DRTVGR---RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR--------ALFLIPR  230 (272)
T ss_pred             cccccc---CCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH--------HHHHHhc
Confidence            332211   1234578889999998632   1357889999999999999999999986432211        0111111


Q ss_pred             cccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          298 DREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .   ..+...   .......+.+++.+||+.+|.+|||++++++
T Consensus       231 ~---~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         231 N---PAPRLK---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             C---CCCCCC---CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            1   001011   1123456788999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.7e-37  Score=279.86  Aligned_cols=234  Identities=23%  Similarity=0.349  Sum_probs=181.8

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      +.+.+.||+|+||.||+++..+                   .+.+|+.+++.++||||+++++.+.+++..++|+||+++
T Consensus        11 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~   90 (267)
T cd06645          11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGG   90 (267)
T ss_pred             HHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCC
Confidence            4556789999999999987532                   367799999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      ++|.+++.....      +++.+++.++.|++.||.|||   ..+++|+||||+||+++.++.+||+|||++........
T Consensus        91 ~~L~~~~~~~~~------~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06645          91 GSLQDIYHVTGP------LSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA  161 (267)
T ss_pred             CcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence            999999865432      899999999999999999999   78999999999999999999999999999876543221


Q ss_pred             eeeeecccccccccccccccccc-cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCC
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRN-FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP  304 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (372)
                         ......|+..|+|||.+... ...++.++|+|||||++|+|++|+.||........       .......  ....+
T Consensus       162 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-------~~~~~~~--~~~~~  229 (267)
T cd06645         162 ---KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-------LFLMTKS--NFQPP  229 (267)
T ss_pred             ---ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-------HHhhhcc--CCCCC
Confidence               11233578899999987421 13578899999999999999999999865432110       0111111  11111


Q ss_pred             ccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       305 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ....  ...+...+.+++.+||+.+|++||+++++++
T Consensus       230 ~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         230 KLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             cccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            1100  1123356778999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.6e-37  Score=278.21  Aligned_cols=230  Identities=24%  Similarity=0.354  Sum_probs=184.2

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      .+.+.||.|+||.||.++..+                     ++.+|+.++++++|+||+++++++.+++..+++|||++
T Consensus         3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~   82 (256)
T cd08221           3 IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYAN   82 (256)
T ss_pred             eEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecC
Confidence            345789999999888775421                     57889999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      +|+|.+++.....    ..+++.++..++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||++.......
T Consensus        83 ~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          83 GGTLYDKIVRQKG----QLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             CCcHHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            9999999976532    23899999999999999999999   7899999999999999999999999999998664433


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCC
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP  304 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (372)
                      ..   .....++..|+|||.+.+.  .++.++|+||||+++|||++|..||......       . ...........   
T Consensus       156 ~~---~~~~~~~~~y~ape~~~~~--~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-------~-~~~~~~~~~~~---  219 (256)
T cd08221         156 SM---AETVVGTPYYMSPELCQGV--KYNFKSDIWALGCVLYELLTLKRTFDATNPL-------N-LVVKIVQGNYT---  219 (256)
T ss_pred             cc---ccccCCCccccCHhhcCCC--CCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-------H-HHHHHHcCCCC---
Confidence            21   1233578899999998765  6788999999999999999999998643211       1 11111111111   


Q ss_pred             ccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       305 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                          .........+.+++.+||+.+|.+||+++++++.
T Consensus       220 ----~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         220 ----PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             ----CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence                1112334667889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=9e-38  Score=281.93  Aligned_cols=231  Identities=25%  Similarity=0.341  Sum_probs=178.7

Q ss_pred             hhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCChh
Q 036435           89 DKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLE  149 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~  149 (372)
                      ..||+|+||.||+|+..+                   .+.+|+.++++++|+||+++++++..++..++|+||+++++|.
T Consensus        14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~   93 (268)
T cd06624          14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS   93 (268)
T ss_pred             EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence            469999999999997532                   5788999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC-CCceEEeecCCcccccCCCCeee
Q 036435          150 KFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE-DFCPKISDFGLAKLCTTKEGIVS  228 (372)
Q Consensus       150 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgla~~~~~~~~~~~  228 (372)
                      +++......   ...++..+..++.|++.||+|||   ..+++|+||||+||+++. ++.++|+|||++.........  
T Consensus        94 ~~l~~~~~~---~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~--  165 (268)
T cd06624          94 ALLRSKWGP---LKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC--  165 (268)
T ss_pred             HHHHHhccc---CCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc--
Confidence            999764221   01278888999999999999999   799999999999999986 679999999998765432211  


Q ss_pred             eecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCC
Q 036435          229 SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVT  308 (372)
Q Consensus       229 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (372)
                       .....++..|+|||.+.+....++.++|+||||+++|+|++|+.||.........      .............     
T Consensus       166 -~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~------~~~~~~~~~~~~~-----  233 (268)
T cd06624         166 -TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA------MFKVGMFKIHPEI-----  233 (268)
T ss_pred             -cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh------HhhhhhhccCCCC-----
Confidence             1223477889999998654235788999999999999999999998653221100      0000000001111     


Q ss_pred             cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          309 RKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       309 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                        .......+.+++.+||+.+|.+|||+.++++
T Consensus       234 --~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         234 --PESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             --CcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence              1223456788999999999999999999886

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.4e-37  Score=276.91  Aligned_cols=230  Identities=24%  Similarity=0.389  Sum_probs=184.5

Q ss_pred             hhhhhcCCCCceEEEEEEecc-----------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCCh
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD-----------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL  148 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~-----------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L  148 (372)
                      .+.+.||+|+||.||+|+..+                 ++.+|++++++++||||+++++++.++...++++||+++++|
T Consensus         6 ~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L   85 (256)
T cd06612           6 DILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSV   85 (256)
T ss_pred             hhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcH
Confidence            445779999999999997642                 588999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeee
Q 036435          149 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVS  228 (372)
Q Consensus       149 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  228 (372)
                      .+++....     ..+++..+..++.|+++||.|||   +.+++|+||+|+||++++++.+||+|||++.........  
T Consensus        86 ~~~l~~~~-----~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~--  155 (256)
T cd06612          86 SDIMKITN-----KTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK--  155 (256)
T ss_pred             HHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCccc--
Confidence            99986543     23899999999999999999999   789999999999999999999999999999876543211  


Q ss_pred             eecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCC
Q 036435          229 SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVT  308 (372)
Q Consensus       229 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (372)
                       .....++..|+|||.+.+.  .++.++||||||+++|+|++|+.||........        .......   ..+  ..
T Consensus       156 -~~~~~~~~~y~~PE~~~~~--~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~--------~~~~~~~---~~~--~~  219 (256)
T cd06612         156 -RNTVIGTPFWMAPEVIQEI--GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA--------IFMIPNK---PPP--TL  219 (256)
T ss_pred             -cccccCCccccCHHHHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh--------hhhhccC---CCC--CC
Confidence             1223367889999998775  788999999999999999999999875322110        0000000   000  01


Q ss_pred             cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          309 RKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       309 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .........+.+++.+||+.||.+|||++++++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            112234467888999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.7e-37  Score=274.38  Aligned_cols=230  Identities=28%  Similarity=0.479  Sum_probs=181.8

Q ss_pred             hhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCChh
Q 036435           89 DKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLE  149 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~  149 (372)
                      ++||+|+||.||++...+                   .+.+|++++++++|+||+++++++.+....++|+||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            369999999999987531                   5788999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeeee
Q 036435          150 KFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSS  229 (372)
Q Consensus       150 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  229 (372)
                      +++.....     .+++..++.++.+++.||+|||   +.+++|+||||+||+++.++.+||+|||++........... 
T Consensus        81 ~~l~~~~~-----~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~-  151 (251)
T cd05041          81 TFLRKKKN-----RLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVS-  151 (251)
T ss_pred             HHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceec-
Confidence            99965432     2789999999999999999999   89999999999999999999999999999986543221111 


Q ss_pred             ecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCC
Q 036435          230 LLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVT  308 (372)
Q Consensus       230 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (372)
                      ......+..|+|||.+.+.  .++.++|+||||+++|||++ |..||.......        .............+    
T Consensus       152 ~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~--------~~~~~~~~~~~~~~----  217 (251)
T cd05041         152 DGLKQIPIKWTAPEALNYG--RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ--------TRERIESGYRMPAP----  217 (251)
T ss_pred             cccCcceeccCChHhhccC--CCCcchhHHHHHHHHHHHHhccCCCCccCCHHH--------HHHHHhcCCCCCCC----
Confidence            1112235679999998764  78999999999999999998 777775432211        11222221111111    


Q ss_pred             cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 036435          309 RKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ  344 (372)
Q Consensus       309 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~  344 (372)
                         ......+.+++.+||+.+|.+||++.|+++.|+
T Consensus       218 ---~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         218 ---QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             ---ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence               223457888999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.5e-38  Score=315.79  Aligned_cols=237  Identities=22%  Similarity=0.333  Sum_probs=180.1

Q ss_pred             HhhhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecC--CceeEEE
Q 036435           84 TNSFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEG--NNRALIY  140 (372)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~--~~~~lV~  140 (372)
                      .+.+.+.||+|+||.||+++...                     .+.+|+.++++++||||++++++|.+.  ..+++||
T Consensus        14 ~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVM   93 (1021)
T PTZ00266         14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILM   93 (1021)
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEE
Confidence            34556789999999999986532                     478899999999999999999988653  5689999


Q ss_pred             EecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC----CCCeeecCCCCCceEECC-----------
Q 036435          141 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC----STKILHFDIKPHNILLDE-----------  205 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~----~~~ivH~dlk~~Nill~~-----------  205 (372)
                      ||+++|+|.+++......  ...+++..++.|+.||+.||+|||+..    ..+|+|+||||+||||+.           
T Consensus        94 EY~~gGSL~~lL~k~~~~--~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~  171 (1021)
T PTZ00266         94 EFCDAGDLSRNIQKCYKM--FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ  171 (1021)
T ss_pred             eCCCCCcHHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence            999999999999753211  123899999999999999999999421    145999999999999964           


Q ss_pred             ------CCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCC
Q 036435          206 ------DFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGV  279 (372)
Q Consensus       206 ------~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~  279 (372)
                            .+.+||+|||++........    .....||+.|+|||++.+....++.++|||||||++|||++|..||....
T Consensus       172 ~~n~ng~~iVKLsDFGlAr~l~~~s~----~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        172 ANNLNGRPIAKIGDFGLSKNIGIESM----AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             ccccCCCCceEEccCCcccccccccc----ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                  23489999999986543221    12335899999999986543467899999999999999999999997532


Q ss_pred             CCCCccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          280 DSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ..       ..+...+.....+..        ......+.+++..||+.+|.+||++.+++.
T Consensus       248 ~~-------~qli~~lk~~p~lpi--------~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        248 NF-------SQLISELKRGPDLPI--------KGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             cH-------HHHHHHHhcCCCCCc--------CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            21       111222222111111        112456788999999999999999999984

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4.1e-37  Score=281.24  Aligned_cols=233  Identities=24%  Similarity=0.349  Sum_probs=181.1

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      +.+.++||+|+||.||+|+...                   .+.+|+.++++++||||+++++.+..++..++||||+++
T Consensus        14 y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   93 (292)
T cd06644          14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPG   93 (292)
T ss_pred             hhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCC
Confidence            3456789999999999997632                   477899999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      ++|..++.+...     .+++..+..++.|++.||+|||   ..+++|+||||+||+++.++.+||+|||++........
T Consensus        94 ~~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~  165 (292)
T cd06644          94 GAVDAIMLELDR-----GLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ  165 (292)
T ss_pred             CcHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence            999988765432     2899999999999999999999   89999999999999999999999999999875432211


Q ss_pred             eeeeecccccccccccccccccc---cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRN---FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      .   .....++..|+|||.+.+.   ...++.++|+|||||++|||++|+.||......        ..........   
T Consensus       166 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~~---  231 (292)
T cd06644         166 R---RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--------RVLLKIAKSE---  231 (292)
T ss_pred             c---cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH--------HHHHHHhcCC---
Confidence            1   1223467889999998532   135678999999999999999999998653211        0111111111   


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .+..  .....+...+.+++.+||+.+|++||+++++++
T Consensus       232 ~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         232 PPTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             CccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            1110  011223456788999999999999999999986

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2e-37  Score=281.05  Aligned_cols=226  Identities=27%  Similarity=0.399  Sum_probs=181.8

Q ss_pred             hhhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      ...+.||+|+||.||+|.+..                    .+.+|+.++++++||||+++++++..++..++|+||+++
T Consensus         7 ~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   86 (277)
T cd06642           7 TKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGG   86 (277)
T ss_pred             HHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCC
Confidence            345679999999999996521                    478899999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      ++|.+++...       .+++..+..++.|+++|+.|||   ..+++|+||+|+||++++++.++|+|||++........
T Consensus        87 ~~L~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06642          87 GSALDLLKPG-------PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CcHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence            9999998643       2889999999999999999999   79999999999999999999999999999976543221


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                      .   .....++..|+|||.+.+.  .++.++|+||||+++|||++|+.|+.......        ..........   + 
T Consensus       157 ~---~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------~~~~~~~~~~---~-  219 (277)
T cd06642         157 K---RNTFVGTPFWMAPEVIKQS--AYDFKADIWSLGITAIELAKGEPPNSDLHPMR--------VLFLIPKNSP---P-  219 (277)
T ss_pred             h---hhcccCcccccCHHHhCcC--CCchhhhHHHHHHHHHHHHhCCCCCcccchhh--------HHhhhhcCCC---C-
Confidence            1   1223467889999999775  78899999999999999999999986432211        0111111111   1 


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                         .........+.+++.+||+.+|.+||++.++++
T Consensus       220 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         220 ---TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             ---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence               111223466788999999999999999999997

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=9.1e-38  Score=300.74  Aligned_cols=249  Identities=20%  Similarity=0.295  Sum_probs=178.7

Q ss_pred             hhhhhhcCCCCceEEEEEEecc---------------hHHHHHHHHhccCCCceeeeEeEEecC--------CceeEEEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD---------------DFVNEVASISRTSHVNVVTLLGFCLEG--------NNRALIYE  141 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~---------------~~~~E~~~l~~l~h~nIv~l~g~~~~~--------~~~~lV~e  141 (372)
                      +.+.+.||+|+||.||+|...+               ...+|+.++++++||||+++++++...        ..+++|||
T Consensus        68 y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE  147 (440)
T PTZ00036         68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVME  147 (440)
T ss_pred             EEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEe
Confidence            3445789999999999997632               356799999999999999999887532        24678999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC-ceEEeecCCcccc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDF-CPKISDFGLAKLC  220 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgla~~~  220 (372)
                      |+++ +|.+++.....  ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++ .+||+|||+++..
T Consensus       148 ~~~~-~l~~~~~~~~~--~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~  221 (440)
T PTZ00036        148 FIPQ-TVHKYMKHYAR--NNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL  221 (440)
T ss_pred             cCCc-cHHHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccccchhc
Confidence            9975 78777654221  1123899999999999999999999   89999999999999998654 7999999999865


Q ss_pred             cCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhh---
Q 036435          221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQ---  297 (372)
Q Consensus       221 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---  297 (372)
                      ......    ....||+.|+|||++.+. ..++.++|||||||++|||++|.+||........   +.. .......   
T Consensus       222 ~~~~~~----~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~---~~~-i~~~~~~p~~  292 (440)
T PTZ00036        222 LAGQRS----VSYICSRFYRAPELMLGA-TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ---LVR-IIQVLGTPTE  292 (440)
T ss_pred             cCCCCc----ccCCCCcCccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHH-HHHHhCCCCH
Confidence            433211    223578899999998654 3688999999999999999999999975432110   000 0000000   


Q ss_pred             ---------cccccCCccCCcc-----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhhcCcc
Q 036435          298 ---------DREFKLPGVVTRK-----ENEIAKKMIIVGLWCIQARPSDRPPMNEVIE--MLQGSTE  348 (372)
Q Consensus       298 ---------~~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~--~L~~~~~  348 (372)
                               -.....+......     ......++.+++.+||+.||.+|||+.|+++  .++.+..
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~  359 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD  359 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence                     0011111111110     0112357889999999999999999999985  3444443

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.8e-37  Score=291.97  Aligned_cols=239  Identities=23%  Similarity=0.270  Sum_probs=175.0

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCC------ceeE
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGN------NRAL  138 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~------~~~l  138 (372)
                      .+.+.||+|+||.||+++...                     .+.+|+.+++.++||||+++++++...+      ..++
T Consensus        24 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l  103 (359)
T cd07876          24 QQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYL  103 (359)
T ss_pred             EEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEE
Confidence            345789999999999986521                     4678999999999999999999987543      4699


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          139 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       139 V~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      ||||+++ +|.+.+..        .+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++
T Consensus       104 v~e~~~~-~l~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~  171 (359)
T cd07876         104 VMELMDA-NLCQVIHM--------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  171 (359)
T ss_pred             EEeCCCc-CHHHHHhc--------cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence            9999965 67666632        1788899999999999999999   8999999999999999999999999999997


Q ss_pred             cccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCc-----------cch
Q 036435          219 LCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE-----------VYF  287 (372)
Q Consensus       219 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~-----------~~~  287 (372)
                      .......    .....+|+.|+|||.+.+.  .++.++|||||||++|+|++|+.||.........           ..+
T Consensus       172 ~~~~~~~----~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  245 (359)
T cd07876         172 TACTNFM----MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF  245 (359)
T ss_pred             ccccCcc----CCCCcccCCCCCchhccCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence            5433221    1234578899999999875  7899999999999999999999999754321100           000


Q ss_pred             HHHHHHHhhh--cccccCCccC-------------CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          288 PHWIYRHVEQ--DREFKLPGVV-------------TRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       288 ~~~~~~~~~~--~~~~~~~~~~-------------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                      ..........  ......+...             ..........+.+++.+||+.||++|||++|+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0000000000  0000000000             00011123567889999999999999999999973

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.1e-37  Score=279.22  Aligned_cols=229  Identities=27%  Similarity=0.352  Sum_probs=174.8

Q ss_pred             hhhhcCCCCceEEEEEEecc------------------------hHHHHHHHHhccCCCceeeeEeEEecC--CceeEEE
Q 036435           87 FKDKLGQGGFGGVYKGRLLD------------------------DFVNEVASISRTSHVNVVTLLGFCLEG--NNRALIY  140 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~--~~~~lV~  140 (372)
                      ..+.||+|+||.||++...+                        .+.+|+.++++++||||+++++++.+.  ...++++
T Consensus         6 ~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~   85 (266)
T cd06651           6 RGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFM   85 (266)
T ss_pred             ccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEE
Confidence            35789999999999986421                        367799999999999999999998763  5678999


Q ss_pred             EecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccc
Q 036435          141 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC  220 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~  220 (372)
                      ||+++++|.+++.....      +++...+.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++...
T Consensus        86 e~~~~~~L~~~l~~~~~------l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~  156 (266)
T cd06651          86 EYMPGGSVKDQLKAYGA------LTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL  156 (266)
T ss_pred             eCCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence            99999999999976432      788999999999999999999   899999999999999999999999999999765


Q ss_pred             cCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccc
Q 036435          221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDRE  300 (372)
Q Consensus       221 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (372)
                      ..............++..|+|||.+.+.  .++.++|+|||||++||+++|+.||......       ..........  
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-------~~~~~~~~~~--  225 (266)
T cd06651         157 QTICMSGTGIRSVTGTPYWMSPEVISGE--GYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-------AAIFKIATQP--  225 (266)
T ss_pred             ccccccCCccccCCccccccCHHHhCCC--CCCchhhhHHHHHHHHHHHHCCCCccccchH-------HHHHHHhcCC--
Confidence            3321111111223477889999999764  7889999999999999999999998753211       0111111111  


Q ss_pred             ccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       301 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                       ..+..    .......+.+++ +||..+|++||+++|+++
T Consensus       226 -~~~~~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         226 -TNPQL----PSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             -CCCCC----chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence             11111    112233444454 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.4e-37  Score=283.10  Aligned_cols=244  Identities=23%  Similarity=0.351  Sum_probs=179.9

Q ss_pred             hhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           87 FKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      +.+.||+|++|.||+|+...                     .+.+|+.++++++||||+++++++.+++..++|+||++ 
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-   82 (285)
T cd07861           4 KIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-   82 (285)
T ss_pred             EeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-
Confidence            45679999999999996531                     46789999999999999999999999999999999997 


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      ++|.+++......   ..+++..+..++.|++.||+|||   +.+++|+||||+||++++++.+||+|||++........
T Consensus        83 ~~l~~~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          83 MDLKKYLDSLPKG---QYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             CCHHHHHhcCCCC---CcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            6898888654321   23899999999999999999999   89999999999999999999999999999976543221


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHH-------HHHHHhhh-
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPH-------WIYRHVEQ-  297 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~-------~~~~~~~~-  297 (372)
                      .   .....+++.|+|||.+.+. ..++.++|+||||+++|+|++|+.||..............       ..+..... 
T Consensus       157 ~---~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (285)
T cd07861         157 V---YTHEVVTLWYRAPEVLLGS-PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL  232 (285)
T ss_pred             c---ccCCcccccccChHHhcCC-CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhh
Confidence            1   1223467889999988654 3578899999999999999999999875432110000000       00000000 


Q ss_pred             -cccccCCccC----CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          298 -DREFKLPGVV----TRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       298 -~~~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                       ......+...    .........++.+++.+||+.||++|||++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence             0000000000    0011123456778999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.3e-37  Score=312.72  Aligned_cols=245  Identities=21%  Similarity=0.296  Sum_probs=185.8

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      .+.++||+|+||.||+|+...                      ++.+|++++++++||||+++++++.+++..++||||+
T Consensus         5 eIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~   84 (932)
T PRK13184          5 DIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYI   84 (932)
T ss_pred             EEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcC
Confidence            345789999999999996521                      5788999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          144 PNGSLEKFVYNGDTS-----KPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~-----~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      ++|+|.+++......     .....+++..++.++.|+++||+|||   +.+++||||||+||+++.++.+||+|||+++
T Consensus        85 eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFGLAk  161 (932)
T PRK13184         85 EGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAI  161 (932)
T ss_pred             CCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecCcce
Confidence            999999998652110     11123677889999999999999999   7999999999999999999999999999998


Q ss_pred             cccCCCCe---------------eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCC
Q 036435          219 LCTTKEGI---------------VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSS  283 (372)
Q Consensus       219 ~~~~~~~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~  283 (372)
                      ........               ........||+.|+|||.+.+.  .++.++|||||||++|||+||+.||....... 
T Consensus       162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~--~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k-  238 (932)
T PRK13184        162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV--PASESTDIYALGVILYQMLTLSFPYRRKKGRK-  238 (932)
T ss_pred             ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC--CCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh-
Confidence            66221110               0001123589999999999775  78999999999999999999999997532111 


Q ss_pred             ccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhhcCcc
Q 036435          284 EVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRP-PMNEVIEMLQGSTE  348 (372)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~evl~~L~~~~~  348 (372)
                       .     ...     .....+.... ...+.+..+.+++.+|++.||++|| +++++.+.|+....
T Consensus       239 -i-----~~~-----~~i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        239 -I-----SYR-----DVILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             -h-----hhh-----hhccChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence             0     000     0001111110 1123445678899999999999996 56777777766543

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-37  Score=278.86  Aligned_cols=227  Identities=26%  Similarity=0.376  Sum_probs=183.5

Q ss_pred             hhhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      .+.+.||.|+||.||+|+...                    .+.+|+.+++.++|+||+++++++.++...++|+||+++
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~   83 (274)
T cd06609           4 TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGG   83 (274)
T ss_pred             hhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCC
Confidence            445779999999999997532                    477899999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      ++|.+++...       .+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.++|+|||++........
T Consensus        84 ~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  153 (274)
T cd06609          84 GSCLDLLKPG-------KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS  153 (274)
T ss_pred             CcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence            9999999754       2899999999999999999999   89999999999999999999999999999987654321


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                      .   .....++..|+|||.+.+.  .++.++|+||||+++|+|++|..||.......        ....+........+ 
T Consensus       154 ~---~~~~~~~~~y~~PE~~~~~--~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--------~~~~~~~~~~~~~~-  219 (274)
T cd06609         154 K---RNTFVGTPFWMAPEVIKQS--GYDEKADIWSLGITAIELAKGEPPLSDLHPMR--------VLFLIPKNNPPSLE-  219 (274)
T ss_pred             c---cccccCCccccChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCcccCchHH--------HHHHhhhcCCCCCc-
Confidence            1   1233477889999999875  68999999999999999999999996532111        11111111111111 


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                        ..   .....+.+++.+||..+|++|||++++++
T Consensus       220 --~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         220 --GN---KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             --cc---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence              11   13456778999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.2e-37  Score=280.96  Aligned_cols=235  Identities=23%  Similarity=0.363  Sum_probs=182.7

Q ss_pred             hhhhhhcCCCCceEEEEEEec--------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL--------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~--------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      +++.+.||+|+||.||+++..                    +.+.+|+.++++++||||+++++.+..++..++|+||++
T Consensus         3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (286)
T cd06622           3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD   82 (286)
T ss_pred             hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence            345678999999999998763                    157789999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      +++|.+++.....   ...+++..+..++.|++.||.|||+  ..+++|+||||+||+++.++.+||+|||++.......
T Consensus        83 ~~~l~~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          83 AGSLDKLYAGGVA---TEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             CCCHHHHHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            9999998876421   1238999999999999999999994  3699999999999999999999999999987653322


Q ss_pred             Ceeeeeccccccccccccccccccc----CCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccc
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNF----GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDRE  300 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (372)
                      .     ....++..|+|||.+.+..    ..++.++|+|||||++|+|++|+.||.......        ..........
T Consensus       158 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--------~~~~~~~~~~  224 (286)
T cd06622         158 A-----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--------IFAQLSAIVD  224 (286)
T ss_pred             c-----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh--------HHHHHHHHhh
Confidence            1     1234677899999985431    135789999999999999999999996532211        1111111111


Q ss_pred             ccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       301 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ...+.    ...++...+.+++.+||+.+|++||+++++++
T Consensus       225 ~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         225 GDPPT----LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             cCCCC----CCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            11111    11224567788999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=6.6e-38  Score=285.72  Aligned_cols=238  Identities=25%  Similarity=0.392  Sum_probs=175.9

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhcc---CCCceeeeEeEEecC-----Cce
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRT---SHVNVVTLLGFCLEG-----NNR  136 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l---~h~nIv~l~g~~~~~-----~~~  136 (372)
                      .+.+.||+|+||.||+++..+                     .+.+|+.+++++   +||||+++++++.+.     ...
T Consensus         3 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~   82 (288)
T cd07863           3 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKV   82 (288)
T ss_pred             eEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceE
Confidence            345779999999999996532                     356788777766   699999999988653     357


Q ss_pred             eEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCC
Q 036435          137 ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGL  216 (372)
Q Consensus       137 ~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  216 (372)
                      ++|+||++ ++|.+++......    .+++..+..++.|++.||.|||   +.+++||||||+||++++++.+||+|||+
T Consensus        83 ~lv~e~~~-~~l~~~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~  154 (288)
T cd07863          83 TLVFEHVD-QDLRTYLDKVPPP----GLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGL  154 (288)
T ss_pred             EEEEcccc-cCHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCc
Confidence            89999997 4899988764332    2899999999999999999999   89999999999999999999999999999


Q ss_pred             cccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhh
Q 036435          217 AKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE  296 (372)
Q Consensus       217 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  296 (372)
                      +........    .....+|..|+|||.+.+.  .++.++||||+||++|+|++|++||........   +.. +.....
T Consensus       155 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~---~~~-~~~~~~  224 (288)
T cd07863         155 ARIYSCQMA----LTPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ---LGK-IFDLIG  224 (288)
T ss_pred             cccccCccc----CCCccccccccCchHhhCC--CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH---HHH-HHHHhC
Confidence            986543221    1223478889999999764  789999999999999999999999865422110   000 000000


Q ss_pred             hccc------cc-----C----CccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          297 QDRE------FK-----L----PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       297 ~~~~------~~-----~----~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ....      ..     .    +........+....+.+++.+||+.||++|||++|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         225 LPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             CCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0000      00     0    00000111223456788999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.4e-37  Score=281.61  Aligned_cols=236  Identities=26%  Similarity=0.423  Sum_probs=183.1

Q ss_pred             hhhcCCCCceEEEEEEec-------------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEe
Q 036435           88 KDKLGQGGFGGVYKGRLL-------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~-------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      .+.||+|+||.||+++..                         +.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   89 (275)
T cd05046          10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEY   89 (275)
T ss_pred             eeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEe
Confidence            467999999999998742                         1478899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccc
Q 036435          143 MPNGSLEKFVYNGDTSK---PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL  219 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  219 (372)
                      +++|+|.+++.......   ....+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.++++|||++..
T Consensus        90 ~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~  166 (275)
T cd05046          90 TDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKD  166 (275)
T ss_pred             cCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEcccccccc
Confidence            99999999997654211   0123899999999999999999999   89999999999999999999999999999875


Q ss_pred             ccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhc
Q 036435          220 CTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQD  298 (372)
Q Consensus       220 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (372)
                      .......  ......++..|+|||.+.+.  ..+.++||||||+++|++++ |..||......       . ........
T Consensus       167 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~-------~-~~~~~~~~  234 (275)
T cd05046         167 VYNSEYY--KLRNALIPLRWLAPEAVQED--DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-------E-VLNRLQAG  234 (275)
T ss_pred             cCccccc--ccCCceeEEeecChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCccccchH-------H-HHHHHHcC
Confidence            4322211  11223456779999998764  67889999999999999998 67777543211       1 11111111


Q ss_pred             ccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 036435          299 REFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ  344 (372)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~  344 (372)
                       ....+.     .......+.+++.+||+.+|++||++.++++.|.
T Consensus       235 -~~~~~~-----~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         235 -KLELPV-----PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             -CcCCCC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence             111110     1123457888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=6.6e-37  Score=277.73  Aligned_cols=226  Identities=27%  Similarity=0.381  Sum_probs=183.1

Q ss_pred             hhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           87 FKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      ..+.||.|+||.||+|....                    .+.+|+.++++++||||+++++++.+++..++||||+++|
T Consensus         8 ~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (277)
T cd06640           8 KLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGG   87 (277)
T ss_pred             hhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCC
Confidence            35679999999999997532                    4788999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      +|.+++....       +++.++..++.|++.||+|||   +.+++|+||+|+||+++.++.++++|||++.........
T Consensus        88 ~L~~~i~~~~-------l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06640          88 SALDLLRAGP-------FDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             cHHHHHhcCC-------CCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccc
Confidence            9999986432       788999999999999999999   899999999999999999999999999999765433211


Q ss_pred             eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCcc
Q 036435          227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV  306 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (372)
                         .....++..|+|||.+.+.  .++.++|+||||+++|||++|..||.......        .........       
T Consensus       158 ---~~~~~~~~~y~apE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------~~~~~~~~~-------  217 (277)
T cd06640         158 ---RNTFVGTPFWMAPEVIQQS--AYDSKADIWSLGITAIELAKGEPPNSDMHPMR--------VLFLIPKNN-------  217 (277)
T ss_pred             ---cccccCcccccCHhHhccC--CCccHHHHHHHHHHHHHHHHCCCCCCCcChHh--------HhhhhhcCC-------
Confidence               1223467789999998764  78999999999999999999999987543211        011111110       


Q ss_pred             CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       307 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                      ...........+.+++.+||+.+|++||+++++++.
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            111223456778899999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=6.5e-38  Score=290.64  Aligned_cols=221  Identities=20%  Similarity=0.294  Sum_probs=174.9

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccC-CCceeeeEeEEecCCceeEEEEe
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTS-HVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~-h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      ++.+.||+|+||.||+++...                      .+..|..++..+. |++|+++++++.+++..++||||
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey   82 (323)
T cd05615           3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEY   82 (323)
T ss_pred             eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcC
Confidence            456789999999999986532                      3566888888775 57788899999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      +++|+|.+++.....      +++.++..++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++....
T Consensus        83 ~~~g~L~~~i~~~~~------l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~  153 (323)
T cd05615          83 VNGGDLMYHIQQVGK------FKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV  153 (323)
T ss_pred             CCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence            999999999876432      899999999999999999999   89999999999999999999999999999875432


Q ss_pred             CCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      ....   .....||+.|+|||++.+.  .++.++|+||+||++|||++|+.||......        .....+.. ....
T Consensus       154 ~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~pf~~~~~~--------~~~~~i~~-~~~~  219 (323)
T cd05615         154 DGVT---TRTFCGTPDYIAPEIIAYQ--PYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--------ELFQSIME-HNVS  219 (323)
T ss_pred             CCcc---ccCccCCccccCHHHHcCC--CCCCccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHh-CCCC
Confidence            2211   1234588999999999764  7889999999999999999999999754211        11122211 1112


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCCH
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPM  336 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  336 (372)
                      .|.       .....+.+++.+||+++|.+|++.
T Consensus       220 ~p~-------~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         220 YPK-------SLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             CCc-------cCCHHHHHHHHHHcccCHhhCCCC
Confidence            222       233567788999999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.9e-37  Score=276.43  Aligned_cols=231  Identities=29%  Similarity=0.557  Sum_probs=184.7

Q ss_pred             hhhhcCCCCceEEEEEEecc------------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEe
Q 036435           87 FKDKLGQGGFGGVYKGRLLD------------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      +.+.||+|+||.||+++..+                        .+.+|+..+++++|+||+++++++.+.+..+++|||
T Consensus         3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~   82 (258)
T smart00219        3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY   82 (258)
T ss_pred             ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence            45779999999999986642                        577899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      +++++|.+++.......    +++.++..++.|++.||+|||   +.+++|+||||+||++++++.++|+|||++.....
T Consensus        83 ~~~~~l~~~~~~~~~~~----~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       83 MEGGDLLDYLRKNRPKE----LSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             cCCCCHHHHHHhhhhcc----CCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence            99999999997644321    899999999999999999999   89999999999999999999999999999987655


Q ss_pred             CCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREF  301 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (372)
                      .......  ...++..|+|||.+.+.  .++.++|+||+|+++++|++ |..||.....        .............
T Consensus       156 ~~~~~~~--~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~  223 (258)
T smart00219      156 DDYYKKK--GGKLPIRWMAPESLKDG--KFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--------EEVLEYLKKGYRL  223 (258)
T ss_pred             ccccccc--cCCCcccccChHHhccC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHhcCCCC
Confidence            4322221  23367889999998653  78999999999999999998 6777654211        1112222222222


Q ss_pred             cCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 036435          302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEML  343 (372)
Q Consensus       302 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L  343 (372)
                      ..+.       .....+.+++.+|++.+|++|||+.++++.|
T Consensus       224 ~~~~-------~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      224 PKPE-------NCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CCCC-------cCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            1111       1356788899999999999999999999864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.3e-37  Score=278.89  Aligned_cols=229  Identities=27%  Similarity=0.441  Sum_probs=181.6

Q ss_pred             hhhhcCCCCceEEEEEEecc----------------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeE
Q 036435           87 FKDKLGQGGFGGVYKGRLLD----------------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRAL  138 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~----------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~l  138 (372)
                      +.+.||+|+||.||+|....                            .+.+|+.++++++||||+++++++.+++..++
T Consensus         4 ~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (267)
T cd06628           4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNI   83 (267)
T ss_pred             ccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEE
Confidence            45679999999999986421                            36789999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          139 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       139 V~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      |+||+++++|.+++.....      +++..+..++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||+++
T Consensus        84 v~e~~~~~~L~~~l~~~~~------l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          84 FLEYVPGGSVAALLNNYGA------FEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             EEEecCCCCHHHHHHhccC------ccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCc
Confidence            9999999999999976432      788999999999999999999   7999999999999999999999999999998


Q ss_pred             cccCCCCeee---eecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHh
Q 036435          219 LCTTKEGIVS---SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV  295 (372)
Q Consensus       219 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  295 (372)
                      ..........   ......++..|+|||.+.+.  .++.++|+||||+++|+|++|+.||.......       .... .
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~-~  224 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT--SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-------AIFK-I  224 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccC--CCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-------HHHH-H
Confidence            7653221111   11123477889999998764  77899999999999999999999997532110       0111 1


Q ss_pred             hhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          296 EQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ...   ..+.    ........+.+++.+||+.||.+||++.++++
T Consensus       225 ~~~---~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         225 GEN---ASPE----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             hcc---CCCc----CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            111   1111    11223467788999999999999999999886

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.9e-37  Score=273.87  Aligned_cols=233  Identities=24%  Similarity=0.288  Sum_probs=188.0

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      ++.+.||.|.-|+||++++.+                      +...|-++|+.++||.+..||+.+..++..|+|||||
T Consensus        80 ~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyC  159 (459)
T KOG0610|consen   80 RLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYC  159 (459)
T ss_pred             HHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecC
Confidence            345679999999999997753                      5677999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      +||+|...++++...    .+++..+..++.+++.||+|||   ..|||+|||||+||||.++|++.|+||.|+......
T Consensus       160 pGGdL~~LrqkQp~~----~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  160 PGGDLHSLRQKQPGK----RFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             CCccHHHHHhhCCCC----ccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            999999998876543    3999999999999999999999   899999999999999999999999999998543210


Q ss_pred             CC------------------------------e-e----------------------eeecccccccccccccccccccC
Q 036435          224 EG------------------------------I-V----------------------SSLLGARGIIGYIAPEVFSRNFG  250 (372)
Q Consensus       224 ~~------------------------------~-~----------------------~~~~~~~gt~~y~aPE~~~~~~~  250 (372)
                      .+                              . .                      .......||-+|+|||++.|.  
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~--  310 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE--  310 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC--
Confidence            00                              0 0                      001123488999999999997  


Q ss_pred             CCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCC
Q 036435          251 EVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARP  330 (372)
Q Consensus       251 ~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p  330 (372)
                      ..+.+.|.|+|||++|||+.|..||.+......       +.+.+.+...+  |+.     .+....+.+|+.+.|.+||
T Consensus       311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T-------l~NIv~~~l~F--p~~-----~~vs~~akDLIr~LLvKdP  376 (459)
T KOG0610|consen  311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET-------LRNIVGQPLKF--PEE-----PEVSSAAKDLIRKLLVKDP  376 (459)
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh-------HHHHhcCCCcC--CCC-----CcchhHHHHHHHHHhccCh
Confidence            778999999999999999999999987654321       23333332222  211     1456677888899999999


Q ss_pred             CCCCC----HHHHHH
Q 036435          331 SDRPP----MNEVIE  341 (372)
Q Consensus       331 ~~RPs----~~evl~  341 (372)
                      ++|..    +.||-+
T Consensus       377 ~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  377 SKRLGSKRGAAEIKR  391 (459)
T ss_pred             hhhhccccchHHhhc
Confidence            99998    777764

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.8e-37  Score=279.27  Aligned_cols=239  Identities=25%  Similarity=0.424  Sum_probs=181.6

Q ss_pred             hhhhcCCCCceEEEEEEec------------------------chHHHHHHHHhccCCCceeeeEeEEecCC------ce
Q 036435           87 FKDKLGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGN------NR  136 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~------~~  136 (372)
                      +.+.||+|+||.||+|.+.                        +++.+|+.++++++||||+++++++....      ..
T Consensus         3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   82 (273)
T cd05074           3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP   82 (273)
T ss_pred             chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence            4567999999999998642                        14778999999999999999999886542      23


Q ss_pred             eEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCC
Q 036435          137 ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGL  216 (372)
Q Consensus       137 ~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  216 (372)
                      ++++||+++|+|.+++...........+++...++++.|++.||+|||   +.+++|+||||+||++++++.+||+|||+
T Consensus        83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg~  159 (273)
T cd05074          83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGL  159 (273)
T ss_pred             EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcccc
Confidence            688999999999988754322111223789999999999999999999   78999999999999999999999999999


Q ss_pred             cccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHh
Q 036435          217 AKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHV  295 (372)
Q Consensus       217 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  295 (372)
                      ++.......... .....++..|++||.+.+.  .++.++||||||+++|||++ |+.||......        ......
T Consensus       160 ~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~--~~~~~sDi~slG~il~el~~~g~~p~~~~~~~--------~~~~~~  228 (273)
T cd05074         160 SKKIYSGDYYRQ-GCASKLPVKWLALESLADN--VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS--------EIYNYL  228 (273)
T ss_pred             cccccCCcceec-CCCccCchhhcCHhHHhcC--ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH--------HHHHHH
Confidence            986543322111 1122345679999998764  67889999999999999999 77877643211        011222


Q ss_pred             hhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 036435          296 EQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGS  346 (372)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~  346 (372)
                      ........+       ......+.+++.+||+.+|.+||++.++++.|+++
T Consensus       229 ~~~~~~~~~-------~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         229 IKGNRLKQP-------PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             HcCCcCCCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            222111111       12346788899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-37  Score=279.51  Aligned_cols=233  Identities=24%  Similarity=0.361  Sum_probs=182.9

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      +.+.+.||+|+||.||+++...                   .+.+|++++++++||||+++++++.++...++||||+++
T Consensus         7 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   86 (280)
T cd06611           7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDG   86 (280)
T ss_pred             HHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCC
Confidence            4456789999999999997632                   577899999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      ++|.+++.....     .+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++........
T Consensus        87 ~~L~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (280)
T cd06611          87 GALDSIMLELER-----GLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ  158 (280)
T ss_pred             CcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence            999999876432     2899999999999999999999   89999999999999999999999999999876433221


Q ss_pred             eeeeecccccccccccccccccc---cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRN---FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      .   .....++..|+|||.+...   ...++.++|+||||+++|||++|+.||.......        ..........  
T Consensus       159 ~---~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~--  225 (280)
T cd06611         159 K---RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--------VLLKILKSEP--  225 (280)
T ss_pred             c---cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--------HHHHHhcCCC--
Confidence            1   1223478889999997532   1246789999999999999999999987532110        1111111111  


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                       +..  .........+.+++..||+.+|.+||++.++++
T Consensus       226 -~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         226 -PTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             -CCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence             100  011123456778899999999999999999986

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=7.1e-38  Score=294.72  Aligned_cols=230  Identities=26%  Similarity=0.325  Sum_probs=175.9

Q ss_pred             hhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           87 FKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      +.+.||+|+||.||+++..+                      .+.+|+.++.+++||||+++++.+.+++..++||||++
T Consensus         5 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~   84 (360)
T cd05627           5 SLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLP   84 (360)
T ss_pred             EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence            35679999999999986532                      46679999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      +|+|.+++.+...      +++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++.......
T Consensus        85 gg~L~~~l~~~~~------l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          85 GGDMMTLLMKKDT------LSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             CccHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence            9999999976532      889999999999999999999   8999999999999999999999999999987543211


Q ss_pred             Ce--------------------------------eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCC
Q 036435          225 GI--------------------------------VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK  272 (372)
Q Consensus       225 ~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~  272 (372)
                      ..                                ........||+.|+|||++.+.  .++.++|+|||||++|||++|+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyel~tG~  233 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIGY  233 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC--CCCCcceeccccceeeecccCC
Confidence            00                                0001123589999999999875  7889999999999999999999


Q ss_pred             CCCCCCCCCCCccchHHHHHHHhhh-cccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 036435          273 NNLDSGVDSSSEVYFPHWIYRHVEQ-DREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPP---MNEVIE  341 (372)
Q Consensus       273 ~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~evl~  341 (372)
                      .||......        .....+.. ......|....     ....+.+++.+++ .||.+|++   ++++++
T Consensus       234 ~Pf~~~~~~--------~~~~~i~~~~~~~~~p~~~~-----~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         234 PPFCSETPQ--------ETYRKVMNWKETLVFPPEVP-----ISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCCCCCCHH--------HHHHHHHcCCCceecCCCCC-----CCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            999754321        11122211 11222222111     2334555666655 49999985   566665

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.9e-37  Score=282.98  Aligned_cols=229  Identities=24%  Similarity=0.372  Sum_probs=182.2

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      +.+.+.||+|+||.||++...+                   .+.+|+.+++.++|+||+++++++..++..++|+||+++
T Consensus        21 y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~  100 (297)
T cd06656          21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG  100 (297)
T ss_pred             ceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCC
Confidence            3445789999999999997531                   477899999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      ++|.+++.+..       +++.++..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++........
T Consensus       101 ~~L~~~~~~~~-------~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~  170 (297)
T cd06656         101 GSLTDVVTETC-------MDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (297)
T ss_pred             CCHHHHHHhCC-------CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence            99999986532       788999999999999999999   79999999999999999999999999999876543321


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                      ..   ....+++.|+|||.+.+.  .++.++|+|||||++|++++|+.||.........       .. ....   ..+.
T Consensus       171 ~~---~~~~~~~~y~aPE~~~~~--~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~-------~~-~~~~---~~~~  234 (297)
T cd06656         171 KR---STMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-------YL-IATN---GTPE  234 (297)
T ss_pred             Cc---CcccCCccccCHHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe-------ee-eccC---CCCC
Confidence            11   223477889999999764  7789999999999999999999999654321100       00 0000   0000


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                        ..........+.+++.+||+.+|.+||+++++++
T Consensus       235 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         235 --LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             --CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              0011223456778899999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-38  Score=290.65  Aligned_cols=223  Identities=24%  Similarity=0.323  Sum_probs=172.8

Q ss_pred             cCCCCceEEEEEEecc----------------------hHHHHHHHHhcc---CCCceeeeEeEEecCCceeEEEEecCC
Q 036435           91 LGQGGFGGVYKGRLLD----------------------DFVNEVASISRT---SHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        91 lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l---~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      ||+|+||+||+++...                      .+..|..++.+.   +||||+++++++.+++..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            7999999999987632                      233456666655   699999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      |+|.+++.....      +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++........
T Consensus        81 g~L~~~l~~~~~------~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~  151 (330)
T cd05586          81 GELFWHLQKEGR------FSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK  151 (330)
T ss_pred             ChHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC
Confidence            999999875432      889999999999999999999   89999999999999999999999999999875433221


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                      .   .....||..|+|||.+.+. ..++.++|||||||++|+|++|+.||.....        ......+... ....+.
T Consensus       152 ~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~elltG~~Pf~~~~~--------~~~~~~i~~~-~~~~~~  218 (330)
T cd05586         152 T---TNTFCGTTEYLAPEVLLDE-KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT--------QQMYRNIAFG-KVRFPK  218 (330)
T ss_pred             C---ccCccCCccccCHHHHcCC-CCCCCccceeccccEEEEeccCCCCCCCCCH--------HHHHHHHHcC-CCCCCC
Confidence            1   1234589999999998754 2578999999999999999999999975321        1112222211 111221


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCC----CHHHHHH
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRP----PMNEVIE  341 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RP----s~~evl~  341 (372)
                            ......+.+++.+||+.||.+||    ++.++++
T Consensus       219 ------~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         219 ------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             ------ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence                  11345667888999999999998    4666654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.7e-37  Score=300.89  Aligned_cols=249  Identities=18%  Similarity=0.216  Sum_probs=176.9

Q ss_pred             HhhhhhhcCCCCceEEEEEEec-------------------------------------chHHHHHHHHhccCCCceeee
Q 036435           84 TNSFKDKLGQGGFGGVYKGRLL-------------------------------------DDFVNEVASISRTSHVNVVTL  126 (372)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-------------------------------------~~~~~E~~~l~~l~h~nIv~l  126 (372)
                      .+.+.+.||+|+||.||++...                                     ..+.+|+.+|++++||||+++
T Consensus       149 ~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l  228 (501)
T PHA03210        149 HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKI  228 (501)
T ss_pred             ccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcE
Confidence            3455678999999999987531                                     146789999999999999999


Q ss_pred             EeEEecCCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC
Q 036435          127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDED  206 (372)
Q Consensus       127 ~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~  206 (372)
                      ++++.+.+..++|+|++. ++|.+++........ ......++..++.|++.||+|||   +.+|+||||||+|||++.+
T Consensus       229 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~-~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~~~  303 (501)
T PHA03210        229 EEILRSEANTYMITQKYD-FDLYSFMYDEAFDWK-DRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCD  303 (501)
T ss_pred             eEEEEECCeeEEEEeccc-cCHHHHHhhcccccc-ccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCC
Confidence            999999999999999994 588888765432111 11345677889999999999999   8999999999999999999


Q ss_pred             CceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccc
Q 036435          207 FCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVY  286 (372)
Q Consensus       207 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~  286 (372)
                      +.+||+|||+++.........  .....||..|+|||++.+.  .++.++|||||||++|||++|+.++...........
T Consensus       304 ~~vkL~DFGla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~  379 (501)
T PHA03210        304 GKIVLGDFGTAMPFEKEREAF--DYGWVGTVATNSPEILAGD--GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ  379 (501)
T ss_pred             CCEEEEeCCCceecCcccccc--cccccCCcCCCCchhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence            999999999998765432211  1234589999999999875  789999999999999999998865433221111000


Q ss_pred             hHHH-----------------HHHHhhhcccccCCccCCcch--HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          287 FPHW-----------------IYRHVEQDREFKLPGVVTRKE--NEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       287 ~~~~-----------------~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      +...                 .+..+........+.......  ......+.+++.+||+.||.+|||+.|+++
T Consensus       380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            0000                 000000000000000000000  011234667788999999999999999986

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.5e-37  Score=291.46  Aligned_cols=240  Identities=22%  Similarity=0.265  Sum_probs=175.7

Q ss_pred             hhhhhhcCCCCceEEEEEEec---------------------chHHHHHHHHhccCCCceeeeEeEEecC------Ccee
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL---------------------DDFVNEVASISRTSHVNVVTLLGFCLEG------NNRA  137 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~---------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~------~~~~  137 (372)
                      +.+.+.||+|+||.||++...                     ..+.+|+.+++.++||||+++++++...      ...+
T Consensus        26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~  105 (364)
T cd07875          26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY  105 (364)
T ss_pred             eeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEE
Confidence            344578999999999998642                     1467899999999999999999988643      3579


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCc
Q 036435          138 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLA  217 (372)
Q Consensus       138 lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla  217 (372)
                      +||||+++ +|.+++...        +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       106 lv~e~~~~-~l~~~~~~~--------~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875         106 IVMELMDA-NLCQVIQME--------LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             EEEeCCCC-CHHHHHHhc--------CCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence            99999965 787777431        788999999999999999999   899999999999999999999999999999


Q ss_pred             ccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCcc--------chHH
Q 036435          218 KLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV--------YFPH  289 (372)
Q Consensus       218 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~--------~~~~  289 (372)
                      +.......    .....+|..|+|||.+.+.  .++.++|||||||++|+|++|+.||..........        ..+.
T Consensus       174 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  247 (364)
T cd07875         174 RTAGTSFM----MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE  247 (364)
T ss_pred             cccCCCCc----ccCCcccCCcCCHHHHhCC--CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            86543221    1233578899999999875  78999999999999999999999997543211000        0000


Q ss_pred             H-------HHHHhhhccccc-------CCccC----CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          290 W-------IYRHVEQDREFK-------LPGVV----TRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       290 ~-------~~~~~~~~~~~~-------~~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                      +       ............       .+...    ..........+.+++.+||+.||.+|||++++++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0       000000000000       00000    00011123467889999999999999999999873

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3e-37  Score=277.93  Aligned_cols=231  Identities=26%  Similarity=0.419  Sum_probs=181.2

Q ss_pred             hhhhcCCCCceEEEEEEec------------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEe
Q 036435           87 FKDKLGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      ..+.||+|+||.||+|...                        ..+.+|++++++++|+||+++++++.+++..++|+||
T Consensus         4 ~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (265)
T cd06631           4 KGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEF   83 (265)
T ss_pred             ccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEec
Confidence            3567999999999998542                        1367899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      +++++|.+++.+...      +++..+..++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||++.....
T Consensus        84 ~~~~~L~~~l~~~~~------~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          84 VPGGSISSILNRFGP------LPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             CCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            999999999976432      788999999999999999999   78999999999999999999999999999976532


Q ss_pred             CCC---eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcc
Q 036435          223 KEG---IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDR  299 (372)
Q Consensus       223 ~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (372)
                      ...   .........++..|+|||.+.+.  .++.++|+||||+++|+|++|..||.......      . .. ......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~-~~-~~~~~~  224 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINES--GYGRKSDIWSIGCTVFEMATGKPPLASMDRLA------A-MF-YIGAHR  224 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCC--CCcchhhHHHHHHHHHHHHhCCCccccCChHH------H-HH-Hhhhcc
Confidence            111   11111233578899999998764  67899999999999999999999997532111      0 01 111110


Q ss_pred             cccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          300 EFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      . ..+..    .......+.+++.+||+.+|.+||++.++++
T Consensus       225 ~-~~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         225 G-LMPRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             C-CCCCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0 11111    1123456788999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-37  Score=280.04  Aligned_cols=250  Identities=24%  Similarity=0.365  Sum_probs=188.1

Q ss_pred             hhhhcCCCCceEEEEEEecc--------------hHHHHHHHHhcc--CCCceeeeEeEEecCC----ceeEEEEecCCC
Q 036435           87 FKDKLGQGGFGGVYKGRLLD--------------DFVNEVASISRT--SHVNVVTLLGFCLEGN----NRALIYEFMPNG  146 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~--------------~~~~E~~~l~~l--~h~nIv~l~g~~~~~~----~~~lV~e~~~~g  146 (372)
                      +.+.||+|.||.||+|+++.              .+.+|.++.+..  +|+||+.|++.-..++    +++||++|.++|
T Consensus       215 L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~G  294 (513)
T KOG2052|consen  215 LQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHG  294 (513)
T ss_pred             EEEEecCccccceeeccccCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCC
Confidence            35679999999999998864              578888888764  9999999998765443    689999999999


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG-----CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-----~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      ||.|||....       ++....++++..+|.||++||.+     -.+.|.|||||+.|||+..++..-|+|+|||....
T Consensus       295 SL~DyL~r~t-------v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~  367 (513)
T KOG2052|consen  295 SLYDYLNRNT-------VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD  367 (513)
T ss_pred             cHHHHHhhcc-------CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEec
Confidence            9999998743       89999999999999999999952     25679999999999999999999999999998766


Q ss_pred             CCC-CeeeeecccccccccccccccccccC--CC--CccccchhHHHHHHHHhc----------CCCCCCCCCCCCCccc
Q 036435          222 TKE-GIVSSLLGARGIIGYIAPEVFSRNFG--EV--SHKSDVYSFGMMIMELVG----------CKNNLDSGVDSSSEVY  286 (372)
Q Consensus       222 ~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~--~~--~~~~DvwslG~il~ellt----------g~~p~~~~~~~~~~~~  286 (372)
                      ... ..........||.+|||||++.....  .+  -..+||||||.++||+.-          -+.||++..+.+..  
T Consensus       368 ~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs--  445 (513)
T KOG2052|consen  368 SDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPS--  445 (513)
T ss_pred             ccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCC--
Confidence            553 33333455679999999999976311  11  146799999999999873          23566655443321  


Q ss_pred             hHHHHHHHhh-hcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 036435          287 FPHWIYRHVE-QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE  348 (372)
Q Consensus       287 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~  348 (372)
                      +.+ +...+- +..+...|+.-  ...+....+.+++..||..||.-|.|+=-+-+.|.++..
T Consensus       446 ~ee-MrkVVCv~~~RP~ipnrW--~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  446 FEE-MRKVVCVQKLRPNIPNRW--KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             HHH-HhcceeecccCCCCCccc--ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            111 111111 11112222221  223467889999999999999999999888888877664

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=8.4e-38  Score=287.04  Aligned_cols=243  Identities=20%  Similarity=0.330  Sum_probs=180.9

Q ss_pred             hhhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      .+.+.||+|+||.||+++...                    .+.+|+.++++++||||+++++++.+++..++|+||++ 
T Consensus         9 ~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-   87 (301)
T cd07873           9 IKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-   87 (301)
T ss_pred             EEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-
Confidence            345779999999999986531                    46789999999999999999999999999999999997 


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      ++|.+++.....     .+++..+..++.|++.||+|||   +.+++|+||||+||++++++.+||+|||++........
T Consensus        88 ~~l~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          88 KDLKQYLDDCGN-----SINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             cCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            599998876432     2889999999999999999999   89999999999999999999999999999976433221


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchH-------HHHHHHhhhc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFP-------HWIYRHVEQD  298 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~-------~~~~~~~~~~  298 (372)
                      .   .....+++.|+|||.+.+. ..++.++|||||||++|||++|+.||...........+.       ...+......
T Consensus       160 ~---~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (301)
T cd07873         160 T---YSNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN  235 (301)
T ss_pred             c---ccccceeecccCcHHHhCC-CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcc
Confidence            1   1223467889999998654 357889999999999999999999997543211000000       0000000000


Q ss_pred             c---cccCCccCCc----chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          299 R---EFKLPGVVTR----KENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       299 ~---~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .   ....+.....    ........+.+++.+||+.||.+|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0   0111111110    11123456788999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.8e-37  Score=282.90  Aligned_cols=227  Identities=23%  Similarity=0.376  Sum_probs=181.3

Q ss_pred             hhhhcCCCCceEEEEEEec-------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCC
Q 036435           87 FKDKLGQGGFGGVYKGRLL-------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS  147 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~-------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~  147 (372)
                      +.+.||.|+||.||+|...                   +.+.+|+.+++.++||||+++++++.+++..++|+||+++++
T Consensus        23 ~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  102 (296)
T cd06655          23 RYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGS  102 (296)
T ss_pred             EEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCc
Confidence            4567999999999998642                   157789999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCee
Q 036435          148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV  227 (372)
Q Consensus       148 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  227 (372)
                      |.+++....       +++.++..++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++......... 
T Consensus       103 L~~~~~~~~-------l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-  171 (296)
T cd06655         103 LTDVVTETC-------MDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-  171 (296)
T ss_pred             HHHHHHhcC-------CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc-
Confidence            999886432       899999999999999999999   899999999999999999999999999998865433221 


Q ss_pred             eeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccC
Q 036435          228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVV  307 (372)
Q Consensus       228 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (372)
                        .....++..|+|||.+.+.  .++.++|+|||||++|++++|+.||.......       .... .........    
T Consensus       172 --~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~-------~~~~-~~~~~~~~~----  235 (296)
T cd06655         172 --RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-------ALYL-IATNGTPEL----  235 (296)
T ss_pred             --CCCcCCCccccCcchhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHH-HHhcCCccc----
Confidence              1223477889999998764  78899999999999999999999997543211       0111 111111000    


Q ss_pred             CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          308 TRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       308 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                       .........+.+++.+||..||.+||++.++++
T Consensus       236 -~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         236 -QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             -CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence             011223456778899999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=9e-37  Score=275.93  Aligned_cols=234  Identities=24%  Similarity=0.393  Sum_probs=181.9

Q ss_pred             hhhcCCCCceEEEEEEecc-----------------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeE
Q 036435           88 KDKLGQGGFGGVYKGRLLD-----------------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRAL  138 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~-----------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~l  138 (372)
                      .+.||+|+||.||+|....                             .+.+|+.++++++|||++++++++...+..++
T Consensus         6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   85 (272)
T cd06629           6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI   85 (272)
T ss_pred             cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEE
Confidence            4679999999999985421                             35679999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          139 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       139 V~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      |+||+++++|.+++....      .+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.
T Consensus        86 v~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~  156 (272)
T cd06629          86 FLEYVPGGSIGSCLRTYG------RFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISK  156 (272)
T ss_pred             EEecCCCCcHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence            999999999999997653      2889999999999999999999   7899999999999999999999999999997


Q ss_pred             cccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhc
Q 036435          219 LCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQD  298 (372)
Q Consensus       219 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (372)
                      ......... ......++..|+|||.+.+....++.++|+||||+++|++++|..||......       ..........
T Consensus       157 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~  228 (272)
T cd06629         157 KSDDIYDND-QNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-------AAMFKLGNKR  228 (272)
T ss_pred             ccccccccc-ccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-------HHHHHhhccc
Confidence            643321111 11233578889999998764224789999999999999999999998643211       0011111111


Q ss_pred             ccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          299 REFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .....+   .....++...+.+++.+||+.+|.+||+++++++
T Consensus       229 ~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         229 SAPPIP---PDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             cCCcCC---ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            111111   1112234567888999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-38  Score=292.99  Aligned_cols=223  Identities=30%  Similarity=0.422  Sum_probs=185.2

Q ss_pred             hhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           89 DKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      +.||.|+||.||-+++..                      ++.+|+..|++++|||++.+.|+|..+...+||||||- |
T Consensus        32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-G  110 (948)
T KOG0577|consen   32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-G  110 (948)
T ss_pred             HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-c
Confidence            569999999999987632                      79999999999999999999999999999999999994 5


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      +-.|.+.-...     ++.+.++..|..+.+.||+|||   +.+.||||||+.|||+++.|.|||+|||.|......   
T Consensus       111 SAsDlleVhkK-----plqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA---  179 (948)
T KOG0577|consen  111 SASDLLEVHKK-----PLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA---  179 (948)
T ss_pred             cHHHHHHHHhc-----cchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCch---
Confidence            87777765432     3888999999999999999999   899999999999999999999999999999876543   


Q ss_pred             eeeecccccccccccccccccc-cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          227 VSSLLGARGIIGYIAPEVFSRN-FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                          ....|||.|||||++... -+.|+-+.||||||++..||.-.++|+......+        ..-++..+..   |.
T Consensus       180 ----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS--------ALYHIAQNes---Pt  244 (948)
T KOG0577|consen  180 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQNES---PT  244 (948)
T ss_pred             ----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH--------HHHHHHhcCC---CC
Confidence                345699999999998532 2689999999999999999999999987654322        2233333332   22


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      +.   ..++...+.+++..||++-|.+|||.+++++
T Consensus       245 Lq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  245 LQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             CC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            22   3456677888999999999999999998875

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.4e-37  Score=281.61  Aligned_cols=243  Identities=21%  Similarity=0.320  Sum_probs=181.5

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      .+.+.||+|+||.||+++...                     .+.+|+.++++++|||++++++++..+...++|+||++
T Consensus         4 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~   83 (286)
T cd07847           4 EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCD   83 (286)
T ss_pred             eeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccC
Confidence            345679999999999986531                     36789999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      +++|..+.....      .+++.+++.++.|++.||+|||   +.+++|+||||+||++++++.+||+|||++.......
T Consensus        84 ~~~l~~~~~~~~------~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          84 HTVLNELEKNPR------GVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccHHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            988887765432      2899999999999999999999   7999999999999999999999999999998765433


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHH-------HHHhhh
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWI-------YRHVEQ  297 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~  297 (372)
                      ..   .....++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||................       ......
T Consensus       155 ~~---~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07847         155 DD---YTDYVATRWYRAPELLVGD-TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFST  230 (286)
T ss_pred             cc---ccCcccccccCCHHHHhCC-CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccc
Confidence            21   1123467789999998653 357889999999999999999999997543221100000000       000000


Q ss_pred             cc---cccCCccCCc-----chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          298 DR---EFKLPGVVTR-----KENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       298 ~~---~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ..   ....+.....     ........+.+++.+||+.+|++||++.|++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         231 NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            00   0001111000     01123467889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-37  Score=273.94  Aligned_cols=234  Identities=24%  Similarity=0.364  Sum_probs=183.5

Q ss_pred             hhhhhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      .+.+.||+|+||.||++....                   .+.+|+.++++++||||+++++++.+++..+++|||++++
T Consensus         6 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~   85 (262)
T cd06613           6 ELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGG   85 (262)
T ss_pred             EEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCC
Confidence            345779999999999997532                   5788999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      +|.+++.....     .+++.++..++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||++.........
T Consensus        86 ~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  157 (262)
T cd06613          86 SLQDIYQVTRG-----PLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK  157 (262)
T ss_pred             cHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence            99999876421     2889999999999999999999   899999999999999999999999999998765432211


Q ss_pred             eeeecccccccccccccccccc-cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          227 VSSLLGARGIIGYIAPEVFSRN-FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                         .....++..|+|||.+.+. ...++.++|+||||+++|||++|+.||.......       .... ... ..+..+.
T Consensus       158 ---~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~-------~~~~-~~~-~~~~~~~  225 (262)
T cd06613         158 ---RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR-------ALFL-ISK-SNFPPPK  225 (262)
T ss_pred             ---cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-------HHHH-HHh-ccCCCcc
Confidence               1223477789999998652 1267889999999999999999999987533211       0011 111 1111111


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                        ..........+.+++.+||+.+|.+|||+++++.
T Consensus       226 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         226 --LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             --ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence              1122334567889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=6.4e-37  Score=274.39  Aligned_cols=229  Identities=23%  Similarity=0.360  Sum_probs=181.0

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecC-CceeEEEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEG-NNRALIYEFM  143 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~-~~~~lV~e~~  143 (372)
                      .+.+.||+|++|.||+++...                     .+.+|++++++++|+|++++++.+... ...++|+||+
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (257)
T cd08223           3 CFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFC   82 (257)
T ss_pred             eEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEeccc
Confidence            456789999999999886521                     467799999999999999999987644 4678999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      ++++|.+++.....    ..+++.++..++.|++.|+++||   +.+++|+||||+||++++++.++|+|||++......
T Consensus        83 ~~~~l~~~l~~~~~----~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          83 EGGDLYHKLKEQKG----KLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             CCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence            99999999976432    23899999999999999999999   899999999999999999999999999999866433


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                      ...   .....+++.|+|||.+.+.  .++.++|+||||+++++|++|+.||.....       ...... ...+..   
T Consensus       156 ~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-------~~~~~~-~~~~~~---  219 (257)
T cd08223         156 CDM---ASTLIGTPYYMSPELFSNK--PYNYKSDVWALGCCVYEMATLKHAFNAKDM-------NSLVYR-IIEGKL---  219 (257)
T ss_pred             CCc---cccccCCcCccChhHhcCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCH-------HHHHHH-HHhcCC---
Confidence            221   1223477889999998764  788999999999999999999999864321       111111 111111   


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      +.    ........+.+++.+||+.+|++||++.++++
T Consensus       220 ~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         220 PP----MPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             CC----CccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            11    11234567888999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=6.7e-37  Score=274.20  Aligned_cols=229  Identities=23%  Similarity=0.374  Sum_probs=183.3

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      .+.+.||+|+||.||+++...                     ++.+|+.++++++||||+++++++.+++..++|+||++
T Consensus         3 ~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd08218           3 VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCE   82 (256)
T ss_pred             eEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCC
Confidence            345789999999999976521                     57889999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      +++|.+++......    .+++.++++++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus        83 ~~~l~~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          83 GGDLYKKINAQRGV----LFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             CCcHHHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence            99999998754321    2789999999999999999999   7999999999999999999999999999997654322


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCC
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP  304 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (372)
                      ...   ....++..|+|||.+.+.  ..+.++|+||||++++++++|+.||.....       ........ .+....  
T Consensus       156 ~~~---~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------~~~~~~~~-~~~~~~--  220 (256)
T cd08218         156 ELA---RTCIGTPYYLSPEICENR--PYNNKSDIWALGCVLYEMCTLKHAFEAGNM-------KNLVLKII-RGSYPP--  220 (256)
T ss_pred             hhh---hhccCCccccCHHHhCCC--CCCCccchhHHHHHHHHHHcCCCCccCCCH-------HHHHHHHh-cCCCCC--
Confidence            111   123467889999998764  788999999999999999999999864321       11111111 111111  


Q ss_pred             ccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       305 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                           ........+.+++.+||+.+|.+||+++++++
T Consensus       221 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         221 -----VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             -----CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                 11233567888999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.7e-37  Score=282.50  Aligned_cols=243  Identities=21%  Similarity=0.317  Sum_probs=180.0

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      .+.+.||+|+||.||+++...                     .+.+|+.++++++||||+++++++.+.+..++|+||++
T Consensus         3 ~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (284)
T cd07839           3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD   82 (284)
T ss_pred             eeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC
Confidence            345779999999999987631                     46789999999999999999999999999999999996


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                       ++|.+++.....     .+++..++.++.|+++||.|||   ..+++|+||||+||+++.++.+||+|||+++......
T Consensus        83 -~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          83 -QDLKKYFDSCNG-----DIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             -CCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence             588888765332     2899999999999999999999   7999999999999999999999999999998654322


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccch--------HHHHHHHhh
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYF--------PHWIYRHVE  296 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~--------~~~~~~~~~  296 (372)
                      ..   .....++..|+|||.+.+. ..++.++|||||||++|+|++|+.|+............        ....+....
T Consensus       154 ~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07839         154 RC---YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVS  229 (284)
T ss_pred             CC---cCCCccccCCcChHHHhCC-cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhh
Confidence            11   1223467889999998664 35688999999999999999999987643321100000        000000011


Q ss_pred             hccccc-CCccCC-----cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          297 QDREFK-LPGVVT-----RKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       297 ~~~~~~-~~~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ...... .+....     .........+.+++.+||+.||.+|||++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             hcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            100000 000000     011123467788999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-37  Score=289.61  Aligned_cols=239  Identities=22%  Similarity=0.279  Sum_probs=174.7

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecC------CceeE
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEG------NNRAL  138 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~------~~~~l  138 (372)
                      ...+.||+|+||.||++....                     .+.+|+.++++++||||+++++++...      ...++
T Consensus        18 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~   97 (343)
T cd07878          18 QNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYL   97 (343)
T ss_pred             hhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEE
Confidence            345779999999999996531                     366899999999999999999988643      35689


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          139 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       139 V~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      ++|++ +++|.+++....       +++..+..++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++
T Consensus        98 ~~~~~-~~~l~~~~~~~~-------l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~  166 (343)
T cd07878          98 VTNLM-GADLNNIVKCQK-------LSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR  166 (343)
T ss_pred             EeecC-CCCHHHHHhcCC-------CCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCccce
Confidence            99998 779988875432       899999999999999999999   8999999999999999999999999999998


Q ss_pred             cccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchH-------HHH
Q 036435          219 LCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFP-------HWI  291 (372)
Q Consensus       219 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~-------~~~  291 (372)
                      ......      ....||..|+|||.+.+. ..++.++|||||||++|+|++|+.||...........+.       ...
T Consensus       167 ~~~~~~------~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07878         167 QADDEM------TGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV  239 (343)
T ss_pred             ecCCCc------CCccccccccCchHhcCC-ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            654322      233578899999998763 367899999999999999999999996532111000000       000


Q ss_pred             HHHhhhc----ccccCCccCCcch----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          292 YRHVEQD----REFKLPGVVTRKE----NEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       292 ~~~~~~~----~~~~~~~~~~~~~----~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                      ...+...    .....+.......    ......+.+++.+||+.||.+|||++|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000000    0000000000000    0112346789999999999999999999963

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=7.5e-37  Score=275.45  Aligned_cols=229  Identities=24%  Similarity=0.288  Sum_probs=176.1

Q ss_pred             hhhhcCCCCceEEEEEEecc------------------------hHHHHHHHHhccCCCceeeeEeEEecC--CceeEEE
Q 036435           87 FKDKLGQGGFGGVYKGRLLD------------------------DFVNEVASISRTSHVNVVTLLGFCLEG--NNRALIY  140 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~--~~~~lV~  140 (372)
                      +.+.||+|+||.||+|...+                        .+.+|+.++++++||||+++++++.+.  ...++|+
T Consensus         6 ~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~   85 (265)
T cd06652           6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFM   85 (265)
T ss_pred             EeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEE
Confidence            35679999999999986421                        356799999999999999999998764  4678999


Q ss_pred             EecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccc
Q 036435          141 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC  220 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~  220 (372)
                      ||+++++|.+++.....      +++...++++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++...
T Consensus        86 e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652          86 EHMPGGSIKDQLKSYGA------LTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRL  156 (265)
T ss_pred             EecCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence            99999999999875432      788889999999999999999   799999999999999999999999999999865


Q ss_pred             cCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccc
Q 036435          221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDRE  300 (372)
Q Consensus       221 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (372)
                      ..............++..|+|||.+.+.  .++.++|+||||+++|||++|+.||......       ..........  
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~--  225 (265)
T cd06652         157 QTICLSGTGMKSVTGTPYWMSPEVISGE--GYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-------AAIFKIATQP--  225 (265)
T ss_pred             ccccccccccccCCCCccccChhhhcCC--CCCcchhHHHHHHHHHHHhhCCCCCCccchH-------HHHHHHhcCC--
Confidence            4321111111223477889999998764  7889999999999999999999998643111       0011111111  


Q ss_pred             ccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       301 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                       ..    ..........+.+++.+|+. +|++||+++++++
T Consensus       226 -~~----~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         226 -TN----PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             -CC----CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence             01    11223344567778888885 8999999999885

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.1e-37  Score=291.06  Aligned_cols=239  Identities=23%  Similarity=0.272  Sum_probs=175.5

Q ss_pred             hhhhhcCCCCceEEEEEEec---------------------chHHHHHHHHhccCCCceeeeEeEEecCC------ceeE
Q 036435           86 SFKDKLGQGGFGGVYKGRLL---------------------DDFVNEVASISRTSHVNVVTLLGFCLEGN------NRAL  138 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~---------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~------~~~l  138 (372)
                      ...+.||+|+||.||++...                     ..+.+|+.+++.++||||+++++++....      ..++
T Consensus        20 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l   99 (355)
T cd07874          20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYL   99 (355)
T ss_pred             eEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEE
Confidence            34578999999999998542                     14678999999999999999999886543      4699


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          139 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       139 V~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      ||||+++ +|.+.+..        .+++..+..++.|+++||+|||   +.+++||||||+|||++.++.+||+|||+++
T Consensus       100 v~e~~~~-~l~~~~~~--------~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~~  167 (355)
T cd07874         100 VMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_pred             Ehhhhcc-cHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence            9999965 77776643        1788999999999999999999   8999999999999999999999999999998


Q ss_pred             cccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCcc--------chHHH
Q 036435          219 LCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV--------YFPHW  290 (372)
Q Consensus       219 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~--------~~~~~  290 (372)
                      .......    .....+|..|+|||.+.+.  .++.++|||||||++|+|++|+.||..........        ..+.+
T Consensus       168 ~~~~~~~----~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (355)
T cd07874         168 TAGTSFM----MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  241 (355)
T ss_pred             cCCCccc----cCCccccCCccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            6543221    1233578899999999775  78999999999999999999999997542111000        00000


Q ss_pred             -------HHHHhhhccc---ccCCccC--------CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          291 -------IYRHVEQDRE---FKLPGVV--------TRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       291 -------~~~~~~~~~~---~~~~~~~--------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                             ..........   ...+...        ..........+.+++.+||+.||++|||++|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                   0000000000   0000000        00111124567889999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-38  Score=295.12  Aligned_cols=230  Identities=28%  Similarity=0.400  Sum_probs=186.4

Q ss_pred             hcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCChhh
Q 036435           90 KLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEK  150 (372)
Q Consensus        90 ~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~~  150 (372)
                      .||+|.||+||-|++.+                   -+..|+.+-++|+|.|||+++|.|-+++.+-+.||-++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            59999999999997743                   36789999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC-CCCceEEeecCCcccccCCCCeeee
Q 036435          151 FVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLD-EDFCPKISDFGLAKLCTTKEGIVSS  229 (372)
Q Consensus       151 ~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgla~~~~~~~~~~~~  229 (372)
                      .|...-+.-   +=++.++-.+..||++||.|||   ...|||||||-+|||++ -.|.+||+|||-++....-..-   
T Consensus       662 LLrskWGPl---KDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~---  732 (1226)
T KOG4279|consen  662 LLRSKWGPL---KDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC---  732 (1226)
T ss_pred             HHHhccCCC---ccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCCcc---
Confidence            997643210   1267788889999999999999   89999999999999995 7899999999999865432211   


Q ss_pred             ecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCCc
Q 036435          230 LLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTR  309 (372)
Q Consensus       230 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (372)
                      .....||..|||||++......|..++|||||||.+.||.||++||.....+...      +.+    ...++   .-++
T Consensus       733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA------MFk----VGmyK---vHP~  799 (1226)
T KOG4279|consen  733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA------MFK----VGMYK---VHPP  799 (1226)
T ss_pred             ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh------hhh----hccee---cCCC
Confidence            1334599999999999865568899999999999999999999999866544311      111    11111   1223


Q ss_pred             chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          310 KENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       310 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .+.++..+..+++++|+.++|.+||+++++++
T Consensus       800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            44566778888999999999999999999986

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=6.5e-37  Score=278.37  Aligned_cols=232  Identities=26%  Similarity=0.380  Sum_probs=178.6

Q ss_pred             hhhhhcCCCCceEEEEEEecc------------------hHHHHHHHHhcc-CCCceeeeEeEEec------CCceeEEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD------------------DFVNEVASISRT-SHVNVVTLLGFCLE------GNNRALIY  140 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~------------------~~~~E~~~l~~l-~h~nIv~l~g~~~~------~~~~~lV~  140 (372)
                      .+.+.||+|+||.||+|+..+                  ++..|+.+++++ +|+||+++++++..      .+..+++|
T Consensus        19 ~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~   98 (282)
T cd06636          19 ELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVM   98 (282)
T ss_pred             hhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEE
Confidence            445789999999999987632                  567788999998 79999999999853      45789999


Q ss_pred             EecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccc
Q 036435          141 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC  220 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~  220 (372)
                      ||+++|+|.+++......    .+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||++...
T Consensus        99 e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~  171 (282)
T cd06636          99 EFCGAGSVTDLVKNTKGN----ALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  171 (282)
T ss_pred             EeCCCCcHHHHHHHccCC----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence            999999999999764322    2788889999999999999999   799999999999999999999999999998755


Q ss_pred             cCCCCeeeeecccccccccccccccccc---cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhh
Q 036435          221 TTKEGIVSSLLGARGIIGYIAPEVFSRN---FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQ  297 (372)
Q Consensus       221 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (372)
                      ......   .....|+..|+|||.+...   ...++.++|+|||||++|||++|+.||........        ......
T Consensus       172 ~~~~~~---~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~--------~~~~~~  240 (282)
T cd06636         172 DRTVGR---RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA--------LFLIPR  240 (282)
T ss_pred             hccccC---CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh--------hhhHhh
Confidence            322111   1233478889999987531   13578899999999999999999999975432110        000111


Q ss_pred             cccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          298 DREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .   ..+   ..........+.+++.+||+.||.+||++.|+++
T Consensus       241 ~---~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         241 N---PPP---KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             C---CCC---CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            1   001   1111224567888999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.1e-36  Score=274.22  Aligned_cols=232  Identities=25%  Similarity=0.403  Sum_probs=183.9

Q ss_pred             hhhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      .+.+.||+|+||.||++....                    ++.+|++++++++||||+++++.+..++..++|+||+++
T Consensus         4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (265)
T cd06605           4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDG   83 (265)
T ss_pred             hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCC
Confidence            346789999999999997641                    478899999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS-TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      ++|.+++....     ..+++..+..++.|++.||+|||   + .+++|+||||+||++++++.++|+|||.+.......
T Consensus        84 ~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          84 GSLDKILKEVQ-----GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             CcHHHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            99999997653     22889999999999999999999   7 899999999999999999999999999987654322


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCC
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP  304 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (372)
                      ..     ...++..|+|||.+.+.  .++.++|+||||+++|++++|+.||.........  ....... .........+
T Consensus       156 ~~-----~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--~~~~~~~-~~~~~~~~~~  225 (265)
T cd06605         156 AK-----TFVGTSSYMAPERIQGN--DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG--IFELLQY-IVNEPPPRLP  225 (265)
T ss_pred             hh-----cccCChhccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCcccccccc--HHHHHHH-HhcCCCCCCC
Confidence            11     14477889999999775  7889999999999999999999999765321111  1111111 1111111111


Q ss_pred             ccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       305 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                         .   ......+.+++.+||..||.+|||+.+++.
T Consensus       226 ---~---~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         226 ---S---GKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             ---h---hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence               1   114566888999999999999999999885

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.1e-36  Score=274.80  Aligned_cols=235  Identities=27%  Similarity=0.427  Sum_probs=182.6

Q ss_pred             hhhhhcCCCCceEEEEEEecc------------------------------hHHHHHHHHhc-cCCCceeeeEeEEecCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD------------------------------DFVNEVASISR-TSHVNVVTLLGFCLEGN  134 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~------------------------------~~~~E~~~l~~-l~h~nIv~l~g~~~~~~  134 (372)
                      .+.+.||+|+||.||+|....                              ++.+|+.++.+ ++||||+++++++.+++
T Consensus         3 ~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   82 (269)
T cd08528           3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEND   82 (269)
T ss_pred             hhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCC
Confidence            345789999999999987532                              25668887765 79999999999999999


Q ss_pred             ceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeec
Q 036435          135 NRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDF  214 (372)
Q Consensus       135 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  214 (372)
                      ..++||||+++++|.+++......  ...+++..++.++.|++.||.|||+  ..+++|+||+|+||++++++.+||+||
T Consensus        83 ~~~lv~e~~~~~~l~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          83 RLYIVMDLIEGAPLGEHFNSLKEK--KQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             eEEEEEecCCCCcHHHHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence            999999999999999988542211  1238999999999999999999993  368999999999999999999999999


Q ss_pred             CCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHH
Q 036435          215 GLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRH  294 (372)
Q Consensus       215 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  294 (372)
                      |++.......    ......++..|++||.+.+.  .++.++|+||||+++|+|++|+.||......       ... ..
T Consensus       159 g~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~--~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~-------~~~-~~  224 (269)
T cd08528         159 GLAKQKQPES----KLTSVVGTILYSCPEIVKNE--PYGEKADVWAFGCILYQMCTLQPPFYSTNML-------SLA-TK  224 (269)
T ss_pred             cceeeccccc----ccccccCcccCcChhhhcCC--CCchHHHHHHHHHHHHHHHhCCCcccccCHH-------HHH-HH
Confidence            9998755433    12234578889999999764  6899999999999999999999998643211       111 11


Q ss_pred             hhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 036435          295 VEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ  344 (372)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~  344 (372)
                      .........+      .......+.+++.+||+.||++||++.|+..+++
T Consensus       225 ~~~~~~~~~~------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         225 IVEAVYEPLP------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             HhhccCCcCC------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            1111111111      1123456788999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=6e-37  Score=280.21  Aligned_cols=226  Identities=24%  Similarity=0.360  Sum_probs=178.5

Q ss_pred             hhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCChh
Q 036435           89 DKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLE  149 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~  149 (372)
                      ..||+|+||.||++....                   .+.+|+..+++++|+||+++++.+..++..++||||+++++|.
T Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~  107 (292)
T cd06658          28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT  107 (292)
T ss_pred             hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence            469999999999986521                   4778999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeeee
Q 036435          150 KFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSS  229 (372)
Q Consensus       150 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  229 (372)
                      +++....       +++.++..++.|++.||+|||   +.+++||||||+||++++++.++|+|||++..........  
T Consensus       108 ~~~~~~~-------l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~--  175 (292)
T cd06658         108 DIVTHTR-------MNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR--  175 (292)
T ss_pred             HHHhcCC-------CCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC--
Confidence            9885432       889999999999999999999   7899999999999999999999999999987543322111  


Q ss_pred             ecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCCc
Q 036435          230 LLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTR  309 (372)
Q Consensus       230 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (372)
                       ....++..|+|||.+.+.  .++.++|+||||+++|||++|+.||.......        .............+     
T Consensus       176 -~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~-----  239 (292)
T cd06658         176 -KSLVGTPYWMAPEVISRL--PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ--------AMRRIRDNLPPRVK-----  239 (292)
T ss_pred             -ceeecCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhcCCCccc-----
Confidence             123477889999998764  78899999999999999999999987532110        11111111010111     


Q ss_pred             chHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          310 KENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       310 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                      ........+.+++.+||+.||.+|||++++++.
T Consensus       240 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         240 DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            111233457778889999999999999999963

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.9e-36  Score=272.71  Aligned_cols=239  Identities=26%  Similarity=0.360  Sum_probs=186.2

Q ss_pred             hhhhhcCCCCceEEEEEEec--------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLL--------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~--------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      ++.+.||.|+||.||+|...                    +.+.+|++.++.++|+||+++++.+..++..++|+|++++
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~   83 (267)
T cd06610           4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSG   83 (267)
T ss_pred             eeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCC
Confidence            44678999999999999652                    2578899999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      ++|.+++......   ..+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||++........
T Consensus        84 ~~l~~~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          84 GSLLDIMKSSYPR---GGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             CcHHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            9999999764321   23899999999999999999999   89999999999999999999999999999986654432


Q ss_pred             ee-eeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCC
Q 036435          226 IV-SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP  304 (372)
Q Consensus       226 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (372)
                      .. .......++..|+|||.+... ...+.++|+||||+++|+|++|+.||.......   .    ....... .....+
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~----~~~~~~~-~~~~~~  228 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPMK---V----LMLTLQN-DPPSLE  228 (267)
T ss_pred             ccccccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccChhh---h----HHHHhcC-CCCCcC
Confidence            21 111223478889999998764 367899999999999999999999997543211   0    1111111 000010


Q ss_pred             ccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       305 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .  ..........+.+++.+||+.||++||+++++++
T Consensus       229 ~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         229 T--GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             C--ccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            0  0011234567888999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-36  Score=274.97  Aligned_cols=228  Identities=24%  Similarity=0.378  Sum_probs=181.5

Q ss_pred             hhhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccC---CCceeeeEeEEecCCceeEEEEe
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTS---HVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~---h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      .+.+.||+|+||.||+|....                    ++.+|+.++++++   |||++++++++.++...++||||
T Consensus         4 ~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~   83 (277)
T cd06917           4 QRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEY   83 (277)
T ss_pred             hhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEec
Confidence            345679999999999987521                    4778999999996   99999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      +++++|.+++...       .+++..++.++.|++.||.|||   +.+++|+||+|+||++++++.++|+|||++.....
T Consensus        84 ~~~~~L~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06917          84 AEGGSVRTLMKAG-------PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ  153 (277)
T ss_pred             CCCCcHHHHHHcc-------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence            9999999998653       2899999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      ....   .....|+..|+|||.+.+. ..++.++|+||||+++|+|++|..||.......       . .......   .
T Consensus       154 ~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-------~-~~~~~~~---~  218 (277)
T cd06917         154 NSSK---RSTFVGTPYWMAPEVITEG-KYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-------A-MMLIPKS---K  218 (277)
T ss_pred             Cccc---cccccCCcceeCHHHhccC-CccccchhHHHHHHHHHHHHhCCCCCCCCChhh-------h-hhccccC---C
Confidence            3321   1233578889999988653 356889999999999999999999997542211       0 0111111   1


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .+.....   .....+.+++.+||+.||.+||++.++++
T Consensus       219 ~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         219 PPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             CCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            1111111   13457888999999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1e-36  Score=277.62  Aligned_cols=235  Identities=22%  Similarity=0.292  Sum_probs=178.2

Q ss_pred             hhhhcCCCCceEEEEEEecc------------------hHHHHHHHHhcc-CCCceeeeEeEEe-----cCCceeEEEEe
Q 036435           87 FKDKLGQGGFGGVYKGRLLD------------------DFVNEVASISRT-SHVNVVTLLGFCL-----EGNNRALIYEF  142 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~------------------~~~~E~~~l~~l-~h~nIv~l~g~~~-----~~~~~~lV~e~  142 (372)
                      +.+.||+|+||.||+++...                  ++.+|+.+++++ +||||+++++++.     +++..++||||
T Consensus        22 ~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~  101 (286)
T cd06638          22 IIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLEL  101 (286)
T ss_pred             eeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEee
Confidence            34779999999999986521                  467799999999 6999999999884     34568999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      +++++|.+++......  ...+++..+..++.|+++||.|||   +.+++||||||+||++++++.+||+|||++.....
T Consensus       102 ~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  176 (286)
T cd06638         102 CNGGSVTDLVKGFLKR--GERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS  176 (286)
T ss_pred             cCCCCHHHHHHHhhcc--CccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEEEccCCceeeccc
Confidence            9999999988643211  123889999999999999999999   79999999999999999999999999999876543


Q ss_pred             CCCeeeeecccccccccccccccccc---cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRN---FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDR  299 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (372)
                      ....   .....|+..|+|||.+...   ...++.++|+||+||++|||++|+.||........       . .......
T Consensus       177 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-------~-~~~~~~~  245 (286)
T cd06638         177 TRLR---RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-------L-FKIPRNP  245 (286)
T ss_pred             CCCc---cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-------H-hhccccC
Confidence            2211   1223588899999988532   13578899999999999999999999875432110       0 0011110


Q ss_pred             cccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          300 EFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                      .   +....  .......+.+++.+||+.||++|||+.|+++.
T Consensus       246 ~---~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         246 P---PTLHQ--PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             C---CcccC--CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            0   11000  11123467889999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=281.39  Aligned_cols=232  Identities=24%  Similarity=0.295  Sum_probs=181.9

Q ss_pred             hhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           87 FKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      +.+.||+|+||.||++...+                      .+.+|++++++++|+||+++++.+.++...++||||+.
T Consensus         5 ~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   84 (316)
T cd05574           5 KIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCP   84 (316)
T ss_pred             EeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecC
Confidence            35679999999999986532                      36779999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      +++|.+++.....    ..+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++.......
T Consensus        85 ~~~L~~~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          85 GGELFRLLQRQPG----KCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             CCCHHHHHHhCCC----CccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            9999999875432    23899999999999999999999   8999999999999999999999999999987553221


Q ss_pred             Ceee--------------------------eecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCC
Q 036435          225 GIVS--------------------------SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSG  278 (372)
Q Consensus       225 ~~~~--------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~  278 (372)
                      ....                          ......||..|+|||++.+.  .++.++||||||+++|+|++|+.||...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD--GHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC--CCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence            1100                          01123478889999999775  6789999999999999999999998754


Q ss_pred             CCCCCccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCC----HHHHHH
Q 036435          279 VDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPP----MNEVIE  341 (372)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs----~~evl~  341 (372)
                      ....       ........  ....+.     .......+.+++.+||+.||++||+    ++++++
T Consensus       236 ~~~~-------~~~~~~~~--~~~~~~-----~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         236 NRDE-------TFSNILKK--EVTFPG-----SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             chHH-------HHHHHhcC--CccCCC-----ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            3211       01111111  111111     1114577888999999999999999    777665

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.3e-36  Score=270.52  Aligned_cols=228  Identities=24%  Similarity=0.402  Sum_probs=181.1

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      .+.+.||+|+||.||++...+                     .+.+|++++++++||||+++++.+..++..++|+||++
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd08220           3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAP   82 (256)
T ss_pred             eEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCC
Confidence            345779999999999876521                     57889999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC-CceEEeecCCcccccCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDED-FCPKISDFGLAKLCTTK  223 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgla~~~~~~  223 (372)
                      +++|.+++.....    ..+++..+..++.|+++||+|||   +.+++|+||+|+||+++++ +.+||+|||++......
T Consensus        83 ~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          83 GGTLAEYIQKRCN----SLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             CCCHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            9999999976432    23889999999999999999999   8999999999999999854 46899999999866443


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                      ...    ....++..|+|||.+.+.  .++.++|+||||+++|+|++|+.||......       ....... .......
T Consensus       156 ~~~----~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-------~~~~~~~-~~~~~~~  221 (256)
T cd08220         156 SKA----YTVVGTPCYISPELCEGK--PYNQKSDIWALGCVLYELASLKRAFEAANLP-------ALVLKIM-SGTFAPI  221 (256)
T ss_pred             ccc----cccccCCcccCchhccCC--CCCcccchHHHHHHHHHHHhCCCCcccCchH-------HHHHHHH-hcCCCCC
Confidence            211    223477889999999764  6789999999999999999999998654221       1111111 1111111


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      +       ......+.+++.+||+.+|.+|||++|+++
T Consensus       222 ~-------~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         222 S-------DRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             C-------CCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            1       123456788999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=8.4e-37  Score=273.58  Aligned_cols=227  Identities=30%  Similarity=0.438  Sum_probs=181.3

Q ss_pred             hhhhcCCCCceEEEEEEec------------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEe
Q 036435           87 FKDKLGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      ..+.||+|+||.||+|...                        +.+.+|+.++++++|+||+++++++.++...++|+||
T Consensus         4 ~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   83 (258)
T cd06632           4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLEL   83 (258)
T ss_pred             ccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEe
Confidence            3467999999999998653                        1477899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      +++++|.+++.+...      +++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||++.....
T Consensus        84 ~~~~~L~~~~~~~~~------~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          84 VPGGSLAKLLKKYGS------FPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             cCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            999999999976432      789999999999999999999   79999999999999999999999999999886543


Q ss_pred             CCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      ...    .....++..|++||.+... ..++.++|+||||+++|+|++|+.||......       ..........   .
T Consensus       155 ~~~----~~~~~~~~~y~~pe~~~~~-~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~~~---~  219 (258)
T cd06632         155 FSF----AKSFKGSPYWMAPEVIAQQ-GGYGLAADIWSLGCTVLEMATGKPPWSQLEGV-------AAVFKIGRSK---E  219 (258)
T ss_pred             ccc----ccccCCCcceeCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcccCcHH-------HHHHHHHhcc---c
Confidence            321    1233477889999998764 23889999999999999999999998754311       1111111101   1


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .+.    ........+.+++.+||+.+|.+||+++++++
T Consensus       220 ~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         220 LPP----IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             CCC----cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            111    11123456778899999999999999999885

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.6e-37  Score=281.46  Aligned_cols=243  Identities=21%  Similarity=0.361  Sum_probs=181.3

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      .+.+.||+|+||.||++...+                     .+.+|++++++++||||+++++++.+++..++|+||++
T Consensus         4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   83 (286)
T cd07846           4 ENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVD   83 (286)
T ss_pred             eEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCC
Confidence            345789999999999987632                     36789999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      +++|.++.....      .+++.+++.++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||++.......
T Consensus        84 ~~~l~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          84 HTVLDDLEKYPN------GLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             ccHHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            988888765432      2899999999999999999999   7899999999999999999999999999998654432


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHH-------HHHHHhhh
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPH-------WIYRHVEQ  297 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~-------~~~~~~~~  297 (372)
                      ..   .....++..|+|||++.+. ..++.++||||||+++|||++|++||...........+..       ........
T Consensus       155 ~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07846         155 EV---YTDYVATRWYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQK  230 (286)
T ss_pred             cc---cCcccceeeccCcHHhccc-cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhcc
Confidence            11   1223467889999998753 3577899999999999999999988864432110000000       00000000


Q ss_pred             cc---cccCCccCC-----cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          298 DR---EFKLPGVVT-----RKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       298 ~~---~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ..   ....+....     .....+...+.+++.+||+.+|++||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             chHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            00   000011000     001123567889999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3e-36  Score=274.85  Aligned_cols=239  Identities=24%  Similarity=0.307  Sum_probs=181.8

Q ss_pred             hhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecC--CceeEEEEecC
Q 036435           87 FKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEG--NNRALIYEFMP  144 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~--~~~~lV~e~~~  144 (372)
                      +.+.||.|++|.||++...+                    ++.+|++++++++||||+++++++.+.  +..++||||++
T Consensus         5 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~   84 (287)
T cd06621           5 ELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCE   84 (287)
T ss_pred             EEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecC
Confidence            34679999999999997632                    578999999999999999999998654  46899999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      +++|.+++......  ...++...+..++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||++.......
T Consensus        85 ~~~L~~~l~~~~~~--~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  159 (287)
T cd06621          85 GGSLDSIYKKVKKR--GGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL  159 (287)
T ss_pred             CCCHHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence            99999987643211  123888999999999999999999   8999999999999999999999999999987543322


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCC
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP  304 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (372)
                      .     ....++..|+|||.+.+.  .++.++|+||||+++|+|++|+.||.........  ..+ .............+
T Consensus       160 ~-----~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~~~-~~~~~~~~~~~~~~  229 (287)
T cd06621         160 A-----GTFTGTSFYMAPERIQGK--PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG--PIE-LLSYIVNMPNPELK  229 (287)
T ss_pred             c-----ccccCCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCC--hHH-HHHHHhcCCchhhc
Confidence            1     122367789999998764  7889999999999999999999999865331110  011 11111111111111


Q ss_pred             ccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       305 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .... ........+.+++.+||+.+|++|||+.|+++
T Consensus       230 ~~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         230 DEPG-NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             cCCC-CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            1111 11124567889999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=8.8e-37  Score=279.77  Aligned_cols=226  Identities=26%  Similarity=0.358  Sum_probs=179.6

Q ss_pred             hhcCCCCceEEEEEEec-------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCChh
Q 036435           89 DKLGQGGFGGVYKGRLL-------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLE  149 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~-------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~  149 (372)
                      ..||+|+||.||++...                   +.+.+|+.+++.++||||+++++++..++..++|+||+++++|.
T Consensus        27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~  106 (297)
T cd06659          27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT  106 (297)
T ss_pred             hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence            46999999999998652                   15778999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeeee
Q 036435          150 KFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSS  229 (372)
Q Consensus       150 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  229 (372)
                      +++....       +++.++..++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++.........   
T Consensus       107 ~~~~~~~-------~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~---  173 (297)
T cd06659         107 DIVSQTR-------LNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK---  173 (297)
T ss_pred             HHHhhcC-------CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc---
Confidence            9875422       889999999999999999999   899999999999999999999999999998754432211   


Q ss_pred             ecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCCc
Q 036435          230 LLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTR  309 (372)
Q Consensus       230 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (372)
                      .....++..|+|||.+.+.  .++.++|+|||||++|||++|+.||.......        ....+..... ...    .
T Consensus       174 ~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--------~~~~~~~~~~-~~~----~  238 (297)
T cd06659         174 RKSLVGTPYWMAPEVISRT--PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--------AMKRLRDSPP-PKL----K  238 (297)
T ss_pred             ccceecCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHhccCC-CCc----c
Confidence            1223478899999999764  78899999999999999999999987432111        1111111100 000    1


Q ss_pred             chHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          310 KENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       310 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                      ........+.+++.+||+.+|.+||+++++++.
T Consensus       239 ~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         239 NAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            111234567788999999999999999999983

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=5.6e-36  Score=271.63  Aligned_cols=227  Identities=28%  Similarity=0.392  Sum_probs=181.7

Q ss_pred             hhhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      .+.+.||+|+||.||+|....                    .+.+|+.++++++||||+++++++.+++..++|+||+++
T Consensus         7 ~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   86 (277)
T cd06641           7 TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGG   86 (277)
T ss_pred             hhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCC
Confidence            345679999999999986521                    477899999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      ++|.+++....       +++..+..++.|++.|+.|||   ..+++|+||+|+||++++++.++|+|||++........
T Consensus        87 ~~l~~~i~~~~-------~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06641          87 GSALDLLEPGP-------LDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CcHHHHHhcCC-------CCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence            99999986432       889999999999999999999   89999999999999999999999999999876543221


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                      .   .....++..|+|||.+.+.  .++.++|+|||||++|+|++|..|+......        .....+.....   +.
T Consensus       157 ~---~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~~---~~  220 (277)
T cd06641         157 K---RNTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIELAKGEPPHSELHPM--------KVLFLIPKNNP---PT  220 (277)
T ss_pred             h---hccccCCccccChhhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCccchH--------HHHHHHhcCCC---CC
Confidence            1   1223467889999998764  7789999999999999999999998643211        11111111111   11


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                          ........+.+++.+||+.+|.+||++.++++.
T Consensus       221 ----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         221 ----LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             ----CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                112234667789999999999999999999973

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-38  Score=315.69  Aligned_cols=232  Identities=25%  Similarity=0.340  Sum_probs=188.4

Q ss_pred             hhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCC
Q 036435           89 DKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS  147 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~  147 (372)
                      ..||.|.||.||-+...+                     .+.+|..+|..++|||+|+++|+-.+.+..+|.||||++|+
T Consensus      1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred             cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence            469999999999886533                     57889999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC-Ce
Q 036435          148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE-GI  226 (372)
Q Consensus       148 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~-~~  226 (372)
                      |.+.+.....      .++.-...+..|++.|++|||   ..+||||||||+||+|+.+|.+|++|||.|..+.... +.
T Consensus      1321 La~ll~~gri------~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1321 LASLLEHGRI------EDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred             HHHHHHhcch------hhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence            9999976543      445555667899999999999   8999999999999999999999999999998876553 22


Q ss_pred             eeeeccccccccccccccccccc-CCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          227 VSSLLGARGIIGYIAPEVFSRNF-GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                      ........||+.|||||++.+.. .....+.||||+|||+.||+||++||......-       .+.-++..+.....|.
T Consensus      1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~-------aIMy~V~~gh~Pq~P~ 1464 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW-------AIMYHVAAGHKPQIPE 1464 (1509)
T ss_pred             CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh-------HHHhHHhccCCCCCch
Confidence            22344567999999999998753 234568999999999999999999997643321       1234455555655554


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEML  343 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L  343 (372)
                      .       +...-.+++.+||+.||.+|.++.|+++.-
T Consensus      1465 ~-------ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1465 R-------LSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred             h-------hhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence            4       445556677889999999999999888753

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.3e-36  Score=278.60  Aligned_cols=239  Identities=25%  Similarity=0.344  Sum_probs=180.3

Q ss_pred             hhhhcCCCCceEEEEEEecc------------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEe
Q 036435           87 FKDKLGQGGFGGVYKGRLLD------------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      +.+.||+|+||.||+|....                        .+..|++++++++|+||+++++++.+++..++||||
T Consensus         4 ~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   83 (298)
T cd07841           4 KGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEF   83 (298)
T ss_pred             eeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEcc
Confidence            45679999999999997531                        245799999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      + +|+|.+++....     ..+++..++.++.|+++||+|||   +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        84 ~-~~~L~~~i~~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          84 M-ETDLEKVIKDKS-----IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             c-CCCHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9 899999997643     12899999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhh------
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE------  296 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------  296 (372)
                      ....   .....++..|+|||.+.+. ..++.++|+|||||++|||++|.++|.......   .+.. ......      
T Consensus       155 ~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~---~~~~-~~~~~~~~~~~~  226 (298)
T cd07841         155 PNRK---MTHQVVTRWYRAPELLFGA-RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID---QLGK-IFEALGTPTEEN  226 (298)
T ss_pred             CCcc---ccccccceeeeCHHHHhCC-CCCCcHHHHHHHHHHHHHHHcCCccccCCccHH---HHHH-HHHHcCCCchhh
Confidence            3211   1222456789999988653 367899999999999999999977776432211   0000 000000      


Q ss_pred             -----hcccccC-----CccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          297 -----QDREFKL-----PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       297 -----~~~~~~~-----~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                           .......     +.............+.+++.+||+.+|.+|||++|+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         227 WPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             hhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence                 0000000     000001112235678899999999999999999999973

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=5.6e-37  Score=264.58  Aligned_cols=254  Identities=23%  Similarity=0.297  Sum_probs=190.1

Q ss_pred             hhhhhcCCCCceEEEEEEecc-------------------------hHHHHHHHHhccCCCceeeeEeEEec-CCceeEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD-------------------------DFVNEVASISRTSHVNVVTLLGFCLE-GNNRALI  139 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~-------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~-~~~~~lV  139 (372)
                      +..+.||+|.||.|||+.-.+                         ...+|+.+++.++|||++.+..++.+ +...+++
T Consensus        27 e~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~  106 (438)
T KOG0666|consen   27 EGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLL  106 (438)
T ss_pred             hccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEE
Confidence            445789999999999994321                         47899999999999999999999988 7789999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC----CceEEeecC
Q 036435          140 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDED----FCPKISDFG  215 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg  215 (372)
                      +||.++ +|...++-....+. +.++...+..|+.||++|+.|||   ++-|+||||||+|||+..+    |.+||+|||
T Consensus       107 fdYAEh-DL~~II~fHr~~~~-~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG  181 (438)
T KOG0666|consen  107 FDYAEH-DLWHIIKFHRASKA-KQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIADLG  181 (438)
T ss_pred             ehhhhh-hHHHHHHHhccchh-ccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence            999988 99988876554333 45899999999999999999999   8999999999999999866    899999999


Q ss_pred             CcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCc--cchHHH---
Q 036435          216 LAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE--VYFPHW---  290 (372)
Q Consensus       216 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~--~~~~~~---  290 (372)
                      +++.+...-..........-|.-|.|||.+.|. ..+|.+.||||.|||+.||+|-.+.|.........  .+..+.   
T Consensus       182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa-~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r  260 (438)
T KOG0666|consen  182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGA-RHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR  260 (438)
T ss_pred             HHHHhhccccccccCCceEEEEEecChHHhccc-ccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence            999887654433333444567889999999987 68999999999999999999999888764332211  111111   


Q ss_pred             HHHHhhhcccccCCccCCcc------------------hHHH-------HHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 036435          291 IYRHVEQDREFKLPGVVTRK------------------ENEI-------AKKMIIVGLWCIQARPSDRPPMNEVIEMLQG  345 (372)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~------------------~~~~-------~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~  345 (372)
                      +.+.+..-....+|......                  ...+       ....+++..++|+.||.+|.|+++.++..--
T Consensus       261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF  340 (438)
T KOG0666|consen  261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF  340 (438)
T ss_pred             HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence            12222111111111111000                  0000       1236678889999999999999998875443

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-37  Score=289.96  Aligned_cols=232  Identities=22%  Similarity=0.365  Sum_probs=186.3

Q ss_pred             hhhhhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      ++...||.|+||.|||+...+                   +++-|+++|..+.||+||++++.|..++.++++.|||.||
T Consensus        35 eIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GG  114 (1187)
T KOG0579|consen   35 EIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGG  114 (1187)
T ss_pred             HHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCc
Confidence            345779999999999987643                   6888999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      -.+..+..-+.     .+++.++.-++.|+++||.|||   +.+|||||||+.|||++-+|.++|+|||.+-......  
T Consensus       115 AVDaimlEL~r-----~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~--  184 (1187)
T KOG0579|consen  115 AVDAIMLELGR-----VLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR--  184 (1187)
T ss_pred             hHhHHHHHhcc-----ccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhHH--
Confidence            99988876543     3999999999999999999999   8999999999999999999999999999986432211  


Q ss_pred             eeeecccccccccccccccccc---cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          227 VSSLLGARGIIGYIAPEVFSRN---FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                       .......|||.|||||++...   ...|+.++||||||+.|.||..+.+|-.......        +.-.+.   ....
T Consensus       185 -qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR--------VllKia---KSeP  252 (1187)
T KOG0579|consen  185 -QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--------VLLKIA---KSEP  252 (1187)
T ss_pred             -hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH--------HHHHHh---hcCC
Confidence             122345699999999998542   2478899999999999999999988865432211        111222   1222


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      |.+..+  ..+...+.+++.+||.+||..||++.++++
T Consensus       253 PTLlqP--S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  253 PTLLQP--SHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             CcccCc--chhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            333322  234567788889999999999999999885

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.8e-36  Score=271.21  Aligned_cols=234  Identities=25%  Similarity=0.424  Sum_probs=183.5

Q ss_pred             hhhhcCCCCceEEEEEEec---------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           87 FKDKLGQGGFGGVYKGRLL---------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~---------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      ..+.||+|+||.||+|...                     +.+.+|+.++++++|+||+++++++.+.+..++|+||+++
T Consensus         4 ~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (264)
T cd06626           4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSG   83 (264)
T ss_pred             eeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCC
Confidence            4578999999999999652                     1577899999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      ++|.+++....      .+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||++........
T Consensus        84 ~~L~~~~~~~~------~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          84 GTLEELLEHGR------ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CcHHHHHhhcC------CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            99999997643      2788999999999999999999   89999999999999999999999999999987654433


Q ss_pred             eeee-eccccccccccccccccccc-CCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          226 IVSS-LLGARGIIGYIAPEVFSRNF-GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       226 ~~~~-~~~~~gt~~y~aPE~~~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                      .... .....++..|+|||.+.+.. ...+.++||||||+++|++++|+.||.......      ..... .........
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~------~~~~~-~~~~~~~~~  227 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF------QIMFH-VGAGHKPPI  227 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH------HHHHH-HhcCCCCCC
Confidence            2211 12345778899999987642 237899999999999999999999997542111      11111 111111111


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      |.     .......+.+++.+||+.+|.+||++.+++.
T Consensus       228 ~~-----~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         228 PD-----SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             Cc-----ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            21     1123456778999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-36  Score=278.06  Aligned_cols=242  Identities=23%  Similarity=0.359  Sum_probs=177.7

Q ss_pred             hhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           87 FKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      +.+.||+|++|.||+|+...                    .+.+|++++++++|+||+++++++.+++..++||||+++ 
T Consensus         9 ~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-   87 (291)
T cd07844           9 KLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-   87 (291)
T ss_pred             EEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-
Confidence            45789999999999997531                    357799999999999999999999999999999999975 


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      +|.+++.....     .+++..+..++.|+++||.|||   +.+++|+||||+||+++.++.+||+|||+++........
T Consensus        88 ~L~~~~~~~~~-----~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  159 (291)
T cd07844          88 DLKQYMDDCGG-----GLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT  159 (291)
T ss_pred             CHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence            99998876542     2889999999999999999999   799999999999999999999999999998754322111


Q ss_pred             eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchH--------HHHHHHhhhc
Q 036435          227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFP--------HWIYRHVEQD  298 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~--------~~~~~~~~~~  298 (372)
                         .....++..|+|||.+.+. ..++.++||||+|+++|+|++|+.||.............        ...+......
T Consensus       160 ---~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07844         160 ---YSNEVVTLWYRPPDVLLGS-TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN  235 (291)
T ss_pred             ---ccccccccccCCcHHhhcC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence               1122357789999988653 357889999999999999999999996543211000000        0000000000


Q ss_pred             c---cccCCccCCcc----hHHH--HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          299 R---EFKLPGVVTRK----ENEI--AKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       299 ~---~~~~~~~~~~~----~~~~--~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .   ....+......    ....  ...+.+++.+||+.+|++|||++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            0   00000000000    0011  256778999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.1e-36  Score=278.32  Aligned_cols=235  Identities=20%  Similarity=0.263  Sum_probs=180.7

Q ss_pred             hhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           87 FKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      +.+.||+|+||.||++....                      .+.+|+.+++.++||||+++++.+.+++..++||||++
T Consensus         5 ~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   84 (305)
T cd05609           5 TIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVE   84 (305)
T ss_pred             EeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCC
Confidence            45779999999999986532                      46679999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      +++|.+++.....      +++..+..++.|++.||+|||   +.+++|+||||+||++++++.+||+|||+++......
T Consensus        85 g~~L~~~l~~~~~------~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~  155 (305)
T cd05609          85 GGDCATLLKNIGA------LPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL  155 (305)
T ss_pred             CCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence            9999999966432      889999999999999999999   7999999999999999999999999999987421110


Q ss_pred             Ce------------eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHH
Q 036435          225 GI------------VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIY  292 (372)
Q Consensus       225 ~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  292 (372)
                      ..            ........++..|+|||.+.+.  .++.++|+||||+++||+++|..||......       . +.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~vl~el~~g~~pf~~~~~~-------~-~~  225 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ--GYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-------E-LF  225 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------H-HH
Confidence            00            0001123467889999998764  7899999999999999999999998643211       1 11


Q ss_pred             HHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 036435          293 RHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG  345 (372)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~  345 (372)
                      ...... ....+...    ......+.+++.+||+.+|++||++.++.+.|+.
T Consensus       226 ~~~~~~-~~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         226 GQVISD-DIEWPEGD----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             HHHHhc-ccCCCCcc----ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            111111 11111111    1234567889999999999999997666666654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.8e-36  Score=275.80  Aligned_cols=240  Identities=22%  Similarity=0.339  Sum_probs=182.6

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      .+.+.||+|+||.||+|+...                     .+.+|+.++++++||||+++++++.+++..++|+||+ 
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-   81 (286)
T cd07832           3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-   81 (286)
T ss_pred             eEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-
Confidence            345789999999999987531                     5788999999999999999999999999999999999 


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      +++|.+++....     ..+++.++..++.|+++||+|||   +.+++|+||||+||+++.++.++|+|||++.......
T Consensus        82 ~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          82 PSDLSEVLRDEE-----RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            999999987544     22899999999999999999999   7999999999999999999999999999998765433


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhc------
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQD------  298 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------  298 (372)
                      .  .......++..|+|||.+.+. ..++.++||||+|+++|||++|.++|.......    ............      
T Consensus       154 ~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~  226 (286)
T cd07832         154 P--RLYSHQVATRWYRAPELLYGA-RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE----QLAIVFRTLGTPNEETWP  226 (286)
T ss_pred             C--CccccccCcccccCceeeecc-ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH----HHHHHHHHcCCCChHHHh
Confidence            2  111234578889999998654 356899999999999999999977775432211    000011100000      


Q ss_pred             --------ccccCCccCC----cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          299 --------REFKLPGVVT----RKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       299 --------~~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                              .....+....    ....+....+.+++.+||+.+|++||+++++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         227 GLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             hccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                    0000000000    011123467889999999999999999999986

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=7.4e-36  Score=268.43  Aligned_cols=224  Identities=21%  Similarity=0.319  Sum_probs=180.0

Q ss_pred             cCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCCh
Q 036435           91 LGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL  148 (372)
Q Consensus        91 lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L  148 (372)
                      ||.|+||.||+++...                      .+.+|+.++++++||||+++++++.+++..++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            6999999999997642                      477899999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeee
Q 036435          149 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVS  228 (372)
Q Consensus       149 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  228 (372)
                      .+++.+...      +++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++........   
T Consensus        81 ~~~l~~~~~------l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~---  148 (262)
T cd05572          81 WTILRDRGL------FDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---  148 (262)
T ss_pred             HHHHhhcCC------CCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc---
Confidence            999976532      889999999999999999999   89999999999999999999999999999987654321   


Q ss_pred             eecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCC
Q 036435          229 SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVT  308 (372)
Q Consensus       229 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (372)
                       .....++..|++||.+.+.  .++.++|+||+|+++|+|++|..||.......     ................|.   
T Consensus       149 -~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~---  217 (262)
T cd05572         149 -TWTFCGTPEYVAPEIILNK--GYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-----MEIYNDILKGNGKLEFPN---  217 (262)
T ss_pred             -cccccCCcCccChhHhcCC--CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-----HHHHHHHhccCCCCCCCc---
Confidence             1223477889999998764  78899999999999999999999997654211     111111111111112221   


Q ss_pred             cchHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 036435          309 RKENEIAKKMIIVGLWCIQARPSDRPP-----MNEVIE  341 (372)
Q Consensus       309 ~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~  341 (372)
                          .....+.+++.+||+.+|++||+     ++|+++
T Consensus       218 ----~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         218 ----YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             ----ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence                12457888999999999999999     677665

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.1e-36  Score=274.76  Aligned_cols=233  Identities=25%  Similarity=0.352  Sum_probs=176.3

Q ss_pred             hhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccC-CCceeeeEeEEecCCceeEEEEecCCC
Q 036435           88 KDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTS-HVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~-h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      .+.||+|+||.||+++...                    .+.+|+.++.++. |+||+++++++..++..++++||+.. 
T Consensus         9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-   87 (288)
T cd06616           9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-   87 (288)
T ss_pred             HHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-
Confidence            4679999999999986532                    4678999999996 99999999999999999999999864 


Q ss_pred             Chhhhhh---cCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          147 SLEKFVY---NGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       147 ~L~~~l~---~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      +|.++..   ....    ..+++..+..++.|++.||+|||+  ..+++||||||+||+++.++.+||+|||++......
T Consensus        88 ~l~~l~~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          88 SLDKFYKYVYEVLK----SVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             CHHHHHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            6655432   2111    238999999999999999999994  359999999999999999999999999999765432


Q ss_pred             CCeeeeeccccccccccccccccccc-CCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNF-GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      ...    ....++..|+|||.+.+.. ..++.++||||||+++|||++|+.||.....          ............
T Consensus       162 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----------~~~~~~~~~~~~  227 (288)
T cd06616         162 IAK----TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----------VFDQLTQVVKGD  227 (288)
T ss_pred             Ccc----ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----------HHHHHhhhcCCC
Confidence            211    2224778899999986531 2578899999999999999999999865321          111111111111


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .+.............+.+++.+||+.+|++|||++++++
T Consensus       228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            111112222335567889999999999999999999986

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.8e-36  Score=275.96  Aligned_cols=230  Identities=25%  Similarity=0.382  Sum_probs=183.1

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      +.+.+.||+|+||.||++....                   .+.+|+.++++++||||+++++++..++..++|+||+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~  100 (293)
T cd06647          21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAG  100 (293)
T ss_pred             ceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCC
Confidence            3456789999999999996421                   477899999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      ++|.+++.+..       +++.++..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++........
T Consensus       101 ~~L~~~~~~~~-------l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647         101 GSLTDVVTETC-------MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             CcHHHHHhhcC-------CCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence            99999986532       788999999999999999999   89999999999999999999999999999876544332


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                      ..   ....+++.|++||.+.+.  .++.++|+||||+++|++++|+.||.........       .. .....   .+.
T Consensus       171 ~~---~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~-------~~-~~~~~---~~~  234 (293)
T cd06647         171 KR---STMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-------YL-IATNG---TPE  234 (293)
T ss_pred             cc---ccccCChhhcCchhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe-------ee-hhcCC---CCC
Confidence            11   223477889999998764  7889999999999999999999999754321110       00 00000   011


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                      .  .........+.+++.+||+.+|++||++++++..
T Consensus       235 ~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         235 L--QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             C--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1  1122234567789999999999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.8e-36  Score=275.69  Aligned_cols=243  Identities=22%  Similarity=0.318  Sum_probs=179.2

Q ss_pred             hhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           87 FKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      ..+.||+|++|.||+|+...                     .+.+|++++++++||||+++++++.+++..++||||+. 
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-   82 (284)
T cd07860           4 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-   82 (284)
T ss_pred             eeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-
Confidence            34679999999999996531                     47789999999999999999999999999999999995 


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      ++|.+++......    .+++..+..++.|++.||+|||   ..+++|+||+|+||++++++.+||+|||++........
T Consensus        83 ~~l~~~~~~~~~~----~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          83 QDLKKFMDASPLS----GIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             cCHHHHHHhCCCC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            6899988664322    3899999999999999999999   79999999999999999999999999999876543221


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHH-------HHHHHhhhc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPH-------WIYRHVEQD  298 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~-------~~~~~~~~~  298 (372)
                      .   .....++..|+|||.+.+. ..++.++|+||||+++|||+||+.||..............       ..+......
T Consensus       156 ~---~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07860         156 T---YTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL  231 (284)
T ss_pred             c---cccccccccccCCeEEecC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence            1   1222367789999988664 3468899999999999999999999875432110000000       000000000


Q ss_pred             --ccccCCccCCcc----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          299 --REFKLPGVVTRK----ENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       299 --~~~~~~~~~~~~----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                        .....+......    .......+.+++.+||+.||++|||++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence              000000000000    1123355778999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-36  Score=299.58  Aligned_cols=243  Identities=26%  Similarity=0.444  Sum_probs=195.9

Q ss_pred             hhhhhcCCCCceEEEEEEec---------------------------chHHHHHHHHhcc-CCCceeeeEeEEecCCcee
Q 036435           86 SFKDKLGQGGFGGVYKGRLL---------------------------DDFVNEVASISRT-SHVNVVTLLGFCLEGNNRA  137 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~---------------------------~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~  137 (372)
                      .+.+.||+|.||.|++|...                           +.+..|+++|+.+ +|+||+.++|+|...+..+
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~  378 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY  378 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence            34568999999999998642                           2688999999999 6999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCC---CCCC-----C--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC
Q 036435          138 LIYEFMPNGSLEKFVYNGD---TSKP-----C--QYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDF  207 (372)
Q Consensus       138 lV~e~~~~g~L~~~l~~~~---~~~~-----~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~  207 (372)
                      +|.||+.+|+|.++|....   ....     .  ..++..+.+.++.|||.||+||+   +.++|||||.++|||++++.
T Consensus       379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~~~~  455 (609)
T KOG0200|consen  379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLITKNK  455 (609)
T ss_pred             EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEecCCC
Confidence            9999999999999998766   1110     1  23899999999999999999999   89999999999999999999


Q ss_pred             ceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccch
Q 036435          208 CPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYF  287 (372)
Q Consensus       208 ~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~  287 (372)
                      .+||+|||+|+.......+........-...|||||.+...  .++.++||||||++|||++|...+.+.+...      
T Consensus       456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~--~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~------  527 (609)
T KOG0200|consen  456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDR--VFTSKSDVWSFGILLWEIFTLGGTPYPGIPP------  527 (609)
T ss_pred             EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccC--cccccchhhHHHHHHHHHhhCCCCCCCCCCc------
Confidence            99999999999766655554322221134569999999874  8999999999999999999855443333211      


Q ss_pred             HHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 036435          288 PHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGS  346 (372)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~  346 (372)
                      ...+.+.+..+.+...|...       ..++.++|..||+.+|++||++.++.+.++..
T Consensus       528 ~~~l~~~l~~G~r~~~P~~c-------~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  528 TEELLEFLKEGNRMEQPEHC-------SDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             HHHHHHHHhcCCCCCCCCCC-------CHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            11234566666666666544       45777899999999999999999999998873

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.2e-36  Score=295.86  Aligned_cols=238  Identities=17%  Similarity=0.229  Sum_probs=170.9

Q ss_pred             hhhhhhcCCCCceEEEEEEecc------------------hHHHHHHHHhccCC------CceeeeEeEEecC-CceeEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD------------------DFVNEVASISRTSH------VNVVTLLGFCLEG-NNRALI  139 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~------------------~~~~E~~~l~~l~h------~nIv~l~g~~~~~-~~~~lV  139 (372)
                      +.+.+.||+|+||+||++....                  ++..|+.++.+++|      .+++++++++..+ ...++|
T Consensus       131 y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv  210 (467)
T PTZ00284        131 FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIV  210 (467)
T ss_pred             EEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEE
Confidence            3445789999999999996532                  34567888877755      4588999988765 468899


Q ss_pred             EEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCceEECCCC-----------
Q 036435          140 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS-TKILHFDIKPHNILLDEDF-----------  207 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~-~~ivH~dlk~~Nill~~~~-----------  207 (372)
                      ||++ +++|.+++.+...      +++..+..++.|++.||+|||   . .+|+||||||+|||++.++           
T Consensus       211 ~~~~-g~~l~~~l~~~~~------l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~  280 (467)
T PTZ00284        211 MPKY-GPCLLDWIMKHGP------FSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVTNRAL  280 (467)
T ss_pred             Eecc-CCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCccccccccccc
Confidence            9988 7799998876532      899999999999999999999   5 5999999999999998665           


Q ss_pred             -----ceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCC
Q 036435          208 -----CPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSS  282 (372)
Q Consensus       208 -----~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~  282 (372)
                           .+||+|||.+.......      ....||+.|+|||++.+.  .++.++|||||||++|||++|+.||.......
T Consensus       281 ~~~~~~vkl~DfG~~~~~~~~~------~~~~gt~~Y~APE~~~~~--~~~~~~DiwSlGvil~elltG~~pf~~~~~~~  352 (467)
T PTZ00284        281 PPDPCRVRICDLGGCCDERHSR------TAIVSTRHYRSPEVVLGL--GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE  352 (467)
T ss_pred             CCCCceEEECCCCccccCcccc------ccccCCccccCcHHhhcC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence                 49999999886432221      234589999999999875  78999999999999999999999997543211


Q ss_pred             Cccc-------hH-HHHHH--------HhhhcccccCCccCC-----------cchHHHHHHHHHHHHHcccCCCCCCCC
Q 036435          283 SEVY-------FP-HWIYR--------HVEQDREFKLPGVVT-----------RKENEIAKKMIIVGLWCIQARPSDRPP  335 (372)
Q Consensus       283 ~~~~-------~~-~~~~~--------~~~~~~~~~~~~~~~-----------~~~~~~~~~l~~l~~~cl~~~p~~RPs  335 (372)
                      ....       ++ .|...        .......+ .+....           .........+.+++.+||+.||.+|||
T Consensus       353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t  431 (467)
T PTZ00284        353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQL-RPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN  431 (467)
T ss_pred             HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccc-cccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence            0000       00 00000        00000000 000000           000001245678999999999999999


Q ss_pred             HHHHHH
Q 036435          336 MNEVIE  341 (372)
Q Consensus       336 ~~evl~  341 (372)
                      ++|+++
T Consensus       432 a~e~L~  437 (467)
T PTZ00284        432 ARQMTT  437 (467)
T ss_pred             HHHHhc
Confidence            999997

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.5e-36  Score=277.81  Aligned_cols=239  Identities=19%  Similarity=0.256  Sum_probs=171.2

Q ss_pred             hhhhhhcCCCCceEEEEEEecch------------------HH---------------HHHHHHhccCCCceeeeEeEEe
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLDD------------------FV---------------NEVASISRTSHVNVVTLLGFCL  131 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~~------------------~~---------------~E~~~l~~l~h~nIv~l~g~~~  131 (372)
                      +.+.+.||+|+||.||+|+..+.                  +.               .+...+..+.|+|++++++++.
T Consensus        14 y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~   93 (294)
T PHA02882         14 WKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGS   93 (294)
T ss_pred             eEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeee
Confidence            44567899999999999975321                  11               1223445668999999999776


Q ss_pred             cCC----ceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC
Q 036435          132 EGN----NRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDF  207 (372)
Q Consensus       132 ~~~----~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~  207 (372)
                      ...    ..++++|++. .++.+.+.....      .++..+..++.|++.||+|||   +.+++||||||+|||++.++
T Consensus        94 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~------~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         94 FKRCRMYYRFILLEKLV-ENTKEIFKRIKC------KNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNN  163 (294)
T ss_pred             EecCCceEEEEEEehhc-cCHHHHHHhhcc------CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCC
Confidence            543    3467778774 367666654321      567888999999999999999   79999999999999999999


Q ss_pred             ceEEeecCCcccccCCCCee----eeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCC
Q 036435          208 CPKISDFGLAKLCTTKEGIV----SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSS  283 (372)
Q Consensus       208 ~~kl~Dfgla~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~  283 (372)
                      .++|+|||+++.........    .......||+.|+|||.+.+.  .++.++|||||||++|||++|+.||........
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~--~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~  241 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA--CVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN  241 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC--CCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence            99999999998664322111    111223589999999998875  789999999999999999999999976532221


Q ss_pred             ccchHH-HHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 036435          284 EVYFPH-WIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ  344 (372)
Q Consensus       284 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~  344 (372)
                      ...... .....+... ....        ......+.+++..|++.+|++||+++++++.|+
T Consensus       242 ~~~~~~~~~~~~~~~~-~~~~--------~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        242 LIHAAKCDFIKRLHEG-KIKI--------KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHHHhHHHHHHHhhhh-hhcc--------CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            110000 001111111 0111        112466788999999999999999999998763

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.1e-36  Score=270.85  Aligned_cols=232  Identities=25%  Similarity=0.448  Sum_probs=181.3

Q ss_pred             hhhcCCCCceEEEEEEec-------------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEe
Q 036435           88 KDKLGQGGFGGVYKGRLL-------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~-------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      .+.||+|+||.||+++..                         +.+.+|+.++++++|+||+++++++.+++..++|+||
T Consensus         5 ~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~   84 (268)
T cd06630           5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW   84 (268)
T ss_pred             cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEec
Confidence            467999999999998642                         1477899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC-ceEEeecCCccccc
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDF-CPKISDFGLAKLCT  221 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgla~~~~  221 (372)
                      +++++|.+++.+..      .+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++ .+||+|||++....
T Consensus        85 ~~~~~L~~~l~~~~------~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          85 MAGGSVSHLLSKYG------AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             cCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            99999999997643      2889999999999999999999   79999999999999998765 59999999997665


Q ss_pred             CCCCeee-eecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccc
Q 036435          222 TKEGIVS-SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDRE  300 (372)
Q Consensus       222 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (372)
                      ....... ......++..|+|||.+.+.  .++.++|+||+|+++|+|++|..||........    ............ 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~-  228 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRGE--QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH----LALIFKIASATT-  228 (268)
T ss_pred             cccccCCccccccccccceeCHhHhccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCcch----HHHHHHHhccCC-
Confidence            4321111 01123477889999998764  778999999999999999999999864432110    111111111110 


Q ss_pred             ccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       301 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                            ...........+.+++.+||+.+|.+||++.++++
T Consensus       229 ------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         229 ------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             ------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                  11122334567888999999999999999999885

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.9e-36  Score=274.50  Aligned_cols=223  Identities=26%  Similarity=0.365  Sum_probs=181.1

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      .+.+.||+|+||.||++...+                      .+.+|++++++++||||+++++++.+++..++||||+
T Consensus         4 ~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (290)
T cd05580           4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYV   83 (290)
T ss_pred             EEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecC
Confidence            345789999999999986632                      4677999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      ++++|.+++.....      +++..+..++.|+++||.|||   +.+++|+||+|+||++++++.+||+|||++......
T Consensus        84 ~~~~L~~~~~~~~~------l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          84 PGGELFSHLRKSGR------FPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             CCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            99999999976532      889999999999999999999   799999999999999999999999999999876443


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                      .      ....+++.|+|||.+.+.  ..+.++|+||||+++|+|++|+.||.....        ......... .....
T Consensus       155 ~------~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~-~~~~~  217 (290)
T cd05580         155 T------YTLCGTPEYLAPEIILSK--GYGKAVDWWALGILIYEMLAGYPPFFDDNP--------IQIYEKILE-GKVRF  217 (290)
T ss_pred             C------CCCCCCccccChhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhc-CCccC
Confidence            1      233478899999998764  678999999999999999999999875431        111122211 11222


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRP-----PMNEVIE  341 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~  341 (372)
                      +..       ....+.+++.+||+.||.+|+     +++|+++
T Consensus       218 ~~~-------~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         218 PSF-------FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             Ccc-------CCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence            211       245677888999999999999     7777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=8.9e-36  Score=270.32  Aligned_cols=226  Identities=25%  Similarity=0.361  Sum_probs=177.1

Q ss_pred             cCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCCh
Q 036435           91 LGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL  148 (372)
Q Consensus        91 lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L  148 (372)
                      ||+|+||+||++....                      .+.+|++++++++||||+++++.+...+..++|+||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            6999999999986431                      356799999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeee
Q 036435          149 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVS  228 (372)
Q Consensus       149 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  228 (372)
                      .+++.....    ..+++.++..++.|++.||.|||   ..+++|+||+|+||++++++.+||+|||++........   
T Consensus        81 ~~~l~~~~~----~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---  150 (277)
T cd05577          81 KYHIYNVGE----PGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---  150 (277)
T ss_pred             HHHHHHcCc----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---
Confidence            999976543    23899999999999999999999   89999999999999999999999999999876543211   


Q ss_pred             eecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCC
Q 036435          229 SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVT  308 (372)
Q Consensus       229 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (372)
                       .....++..|+|||.+.+.  .++.++|+||||+++|+|++|+.||.........    ..+..... ......+    
T Consensus       151 -~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~-~~~~~~~----  218 (277)
T cd05577         151 -IKGRAGTPGYMAPEVLQGE--VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK----EELKRRTL-EMAVEYP----  218 (277)
T ss_pred             -cccccCCCCcCCHHHhcCC--CCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH----HHHHhccc-cccccCC----
Confidence             1223467789999998764  6889999999999999999999999754332110    00111100 0011111    


Q ss_pred             cchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 036435          309 RKENEIAKKMIIVGLWCIQARPSDRP-----PMNEVIE  341 (372)
Q Consensus       309 ~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~  341 (372)
                         ......+.+++.+||+.||.+||     ++.++++
T Consensus       219 ---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         219 ---DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             ---ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence               12245677899999999999999     6666764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-36  Score=271.00  Aligned_cols=235  Identities=27%  Similarity=0.372  Sum_probs=180.8

Q ss_pred             hhhhhcCCCCceEEEEEEecc------------------hHHHHHHHHhcc-CCCceeeeEeEEecCC------ceeEEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD------------------DFVNEVASISRT-SHVNVVTLLGFCLEGN------NRALIY  140 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~------------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~~------~~~lV~  140 (372)
                      .+.+.||+|+||.||+|+...                  ++.+|+.+++++ +|+||+++++++.+..      ..++|+
T Consensus         9 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~   88 (275)
T cd06608           9 ELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVM   88 (275)
T ss_pred             eheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEE
Confidence            445789999999999997632                  578899999999 7999999999997654      489999


Q ss_pred             EecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccc
Q 036435          141 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC  220 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~  220 (372)
                      ||+++++|.+++......  ...+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.+||+|||++...
T Consensus        89 e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~  163 (275)
T cd06608          89 ELCGGGSVTDLVKGLRKK--GKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL  163 (275)
T ss_pred             EcCCCCcHHHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCccceec
Confidence            999999999998653311  123899999999999999999999   899999999999999999999999999998765


Q ss_pred             cCCCCeeeeecccccccccccccccccc---cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhh
Q 036435          221 TTKEGIVSSLLGARGIIGYIAPEVFSRN---FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQ  297 (372)
Q Consensus       221 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (372)
                      ......   .....++..|+|||.+...   ...++.++||||||+++|+|++|..||.......        .......
T Consensus       164 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~  232 (275)
T cd06608         164 DSTLGR---RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--------ALFKIPR  232 (275)
T ss_pred             ccchhh---hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--------HHHHhhc
Confidence            432211   1233478889999987542   1256789999999999999999999996432111        0111111


Q ss_pred             cccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          298 DREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ..   .+.  ..........+.+++.+||+.||++|||++++++
T Consensus       233 ~~---~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         233 NP---PPT--LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             cC---CCC--CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            11   111  1112234567888999999999999999999985

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.7e-36  Score=275.85  Aligned_cols=244  Identities=19%  Similarity=0.247  Sum_probs=180.1

Q ss_pred             hhhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecC--CceeEEEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEG--NNRALIYE  141 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~--~~~~lV~e  141 (372)
                      +.+.+.||+|+||.||+|+...                     .+.+|+.++++++||||+++++++..+  +..++|+|
T Consensus         7 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e   86 (293)
T cd07843           7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVME   86 (293)
T ss_pred             hhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEeh
Confidence            3445789999999999997632                     356899999999999999999999877  89999999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      |++ ++|.+++.....     .+++.+++.++.|++.||+|||   +.+++|+||||+||++++++.+||+|||++....
T Consensus        87 ~~~-~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          87 YVE-HDLKSLMETMKQ-----PFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             hcC-cCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            997 499998876432     3899999999999999999999   7899999999999999999999999999998765


Q ss_pred             CCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHH-------HHHH
Q 036435          222 TKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHW-------IYRH  294 (372)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~-------~~~~  294 (372)
                      .....   .....++..|+|||.+.+. ..++.++|+||+|+++|+|++|..||...........+...       .+..
T Consensus       158 ~~~~~---~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (293)
T cd07843         158 SPLKP---YTQLVVTLWYRAPELLLGA-KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPG  233 (293)
T ss_pred             CCccc---cccccccccccCchhhcCC-ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHH
Confidence            43211   1223467889999998764 24688999999999999999999998754321100000000       0000


Q ss_pred             h---hhcccccC----CccCCcchHH--HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          295 V---EQDREFKL----PGVVTRKENE--IAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       295 ~---~~~~~~~~----~~~~~~~~~~--~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .   ........    ..........  ....+.+++.+||+.+|++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             hhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            0   00000000    0000000111  2456778999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-36  Score=267.33  Aligned_cols=238  Identities=21%  Similarity=0.306  Sum_probs=191.8

Q ss_pred             hhhcCCCCceEEEEEEecc-------------------------hHHHHHHHHhccCCCceeeeEeEEecCC-ceeEEEE
Q 036435           88 KDKLGQGGFGGVYKGRLLD-------------------------DFVNEVASISRTSHVNVVTLLGFCLEGN-NRALIYE  141 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~-------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~-~~~lV~e  141 (372)
                      ...+-+|.||.||+|.+++                         .++.|.-++..+.|||++++.|++.++. ..+.+|.
T Consensus       289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~  368 (563)
T KOG1024|consen  289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYP  368 (563)
T ss_pred             hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEe
Confidence            3468899999999997754                         4778888899999999999999998754 6678899


Q ss_pred             ecCCCChhhhhhcC--CCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccc
Q 036435          142 FMPNGSLEKFVYNG--DTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL  219 (372)
Q Consensus       142 ~~~~g~L~~~l~~~--~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  219 (372)
                      ++.-|+|..||...  ...+..+.++..+...++.|++.|++|||   ..++||.||.++|++||+..++||+|=.+++.
T Consensus       369 ~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRD  445 (563)
T KOG1024|consen  369 ATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQVKLTDSALSRD  445 (563)
T ss_pred             ccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhheeEEeccchhccc
Confidence            99999999999732  22233355888999999999999999999   89999999999999999999999999999998


Q ss_pred             ccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhc
Q 036435          220 CTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQD  298 (372)
Q Consensus       220 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (372)
                      ....+..-.. .+...+..||+||.+.++  .++.++|+|||||++|||+| |+.|+-..+.        ..+...+..+
T Consensus       446 LFP~DYhcLG-DnEnRPvkWMslEal~n~--~yssasDvWsfGVllWELmtlg~~PyaeIDP--------fEm~~ylkdG  514 (563)
T KOG1024|consen  446 LFPGDYHCLG-DNENRPVKWMSLEALQNS--HYSSASDVWSFGVLLWELMTLGKLPYAEIDP--------FEMEHYLKDG  514 (563)
T ss_pred             cCcccccccC-CCCCCcccccCHHHHhhh--hhcchhhhHHHHHHHHHHHhcCCCCccccCH--------HHHHHHHhcc
Confidence            7765543221 222345679999999886  99999999999999999997 5555543221        2244555566


Q ss_pred             ccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 036435          299 REFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGS  346 (372)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~  346 (372)
                      .++..|.       +++.++..++..||..+|++||++++++..|.+-
T Consensus       515 yRlaQP~-------NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  515 YRLAQPF-------NCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             ceecCCC-------CCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence            6665553       3456788899999999999999999999988654

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=9.8e-36  Score=274.10  Aligned_cols=228  Identities=31%  Similarity=0.435  Sum_probs=178.5

Q ss_pred             hhhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEe
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      +...+.||+|+||.||+|+...                      ++.+|+++++.++||||++++++|.+++..++|+||
T Consensus        17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   96 (307)
T cd06607          17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY   96 (307)
T ss_pred             hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHh
Confidence            3445779999999999986521                      477899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      ++ |+|.+++.....     .+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.+||+|||++.....
T Consensus        97 ~~-g~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          97 CL-GSASDILEVHKK-----PLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             hC-CCHHHHHHHccc-----CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            96 588777754321     2899999999999999999999   79999999999999999999999999999876533


Q ss_pred             CCCeeeeeccccccccccccccccc-ccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSR-NFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF  301 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (372)
                      ..       ...++..|+|||.+.+ ....++.++||||||+++|||++|..||.......       ... ....... 
T Consensus       168 ~~-------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~-------~~~-~~~~~~~-  231 (307)
T cd06607         168 AN-------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALY-HIAQNDS-  231 (307)
T ss_pred             CC-------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH-------HHH-HHhcCCC-
Confidence            22       2246778999998742 12367889999999999999999999986532111       011 1111111 


Q ss_pred             cCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       302 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                        +..   ........+.+++.+||+.+|++||++.+++..
T Consensus       232 --~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         232 --PTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             --CCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence              111   112345678889999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4.7e-36  Score=269.54  Aligned_cols=234  Identities=23%  Similarity=0.380  Sum_probs=183.1

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEec--CCceeEEEEe
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLE--GNNRALIYEF  142 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~--~~~~~lV~e~  142 (372)
                      .+.+.||.|+||.||++....                     .+.+|+.++++++||||+++++++..  +...++++||
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~   82 (265)
T cd08217           3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEY   82 (265)
T ss_pred             eeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehh
Confidence            345679999999999986521                     46779999999999999999998764  3467899999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeeecCCCCCceEECCCCceEEeecCCcccc
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC--STKILHFDIKPHNILLDEDFCPKISDFGLAKLC  220 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~  220 (372)
                      +++++|.+++.....  ....+++..++.++.|++.||+|||..+  +.+++|+||+|+||++++++.+||+|||++...
T Consensus        83 ~~~~~L~~~l~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          83 CEGGDLAQLIQKCKK--ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             ccCCCHHHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999976421  1134899999999999999999999432  578999999999999999999999999999876


Q ss_pred             cCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccc
Q 036435          221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDRE  300 (372)
Q Consensus       221 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (372)
                      .......   ....++..|+|||.+.+.  .++.++|+||||+++|+|++|+.||......        ...........
T Consensus       161 ~~~~~~~---~~~~~~~~~~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~  227 (265)
T cd08217         161 GHDSSFA---KTYVGTPYYMSPEQLNHM--SYDEKSDIWSLGCLIYELCALSPPFTARNQL--------QLASKIKEGKF  227 (265)
T ss_pred             cCCcccc---cccccCCCccChhhhcCC--CCCchhHHHHHHHHHHHHHHCCCcccCcCHH--------HHHHHHhcCCC
Confidence            5443211   223478889999998764  6889999999999999999999998754211        11122222111


Q ss_pred             ccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       301 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ..       ........+.+++.+||+.+|.+||+++++++
T Consensus       228 ~~-------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         228 RR-------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             CC-------CccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            11       11234567888999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-36  Score=282.75  Aligned_cols=246  Identities=22%  Similarity=0.314  Sum_probs=180.2

Q ss_pred             hhhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecCC-----ceeEEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEGN-----NRALIY  140 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~-----~~~lV~  140 (372)
                      .+.+.||+|+||.||+|+...                    .+.+|+.++++++||||+++++++....     ..++|+
T Consensus         8 ~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~   87 (336)
T cd07849           8 QNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQ   87 (336)
T ss_pred             EEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEe
Confidence            345789999999999986521                    4677999999999999999999876543     579999


Q ss_pred             EecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccc
Q 036435          141 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC  220 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~  220 (372)
                      ||+++ +|.+++....       +++..+..++.|+++||+|||   +.+++||||||+||+++.++.+||+|||++...
T Consensus        88 e~~~~-~l~~~~~~~~-------l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  156 (336)
T cd07849          88 ELMET-DLYKLIKTQH-------LSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIA  156 (336)
T ss_pred             hhccc-CHHHHHhcCC-------CCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence            99964 8888875432       899999999999999999999   899999999999999999999999999999865


Q ss_pred             cCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhh---
Q 036435          221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQ---  297 (372)
Q Consensus       221 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---  297 (372)
                      ..............+|..|+|||.+.+. ..++.++||||+||++|+|++|+.||.......    ....+......   
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~----~~~~~~~~~~~~~~  231 (336)
T cd07849         157 DPEHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH----QLNLILGVLGTPSQ  231 (336)
T ss_pred             cccccccCCcCCcCcCCCccChHHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHcCCCCH
Confidence            4433222212234578889999987543 367899999999999999999999996532110    00000000000   


Q ss_pred             ---------c-cc-cc-CCccCC----cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hhcCc
Q 036435          298 ---------D-RE-FK-LPGVVT----RKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM--LQGST  347 (372)
Q Consensus       298 ---------~-~~-~~-~~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~--L~~~~  347 (372)
                               . .. .. .+....    .........+.+++.+||+.+|++|||+.++++.  +....
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence                     0 00 00 000000    0011234668899999999999999999999975  55444

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3.5e-36  Score=269.93  Aligned_cols=227  Identities=26%  Similarity=0.319  Sum_probs=183.1

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      .+.+.||.|+||.||+++..+                      .+.+|++++++++||||+++++++.++...++|+||+
T Consensus         3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   82 (258)
T cd05578           3 ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLL   82 (258)
T ss_pred             eEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCC
Confidence            345789999999999997631                      5778999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      ++++|.+++....      .+++.++..++.|+++||.|||   +.+++|+||+|+||++++++.++|+|||++......
T Consensus        83 ~~~~L~~~l~~~~------~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          83 LGGDLRYHLSQKV------KFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             CCCCHHHHHHhcC------CcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            9999999997652      2889999999999999999999   789999999999999999999999999999866543


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                      ..    .....++..|+|||.+.+.  ..+.++|+||||+++|+|++|..||.......     ..+....... .....
T Consensus       154 ~~----~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~~-~~~~~  221 (258)
T cd05578         154 TL----TTSTSGTPGYMAPEVLCRQ--GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI-----RDQIRAKQET-ADVLY  221 (258)
T ss_pred             cc----ccccCCChhhcCHHHHccc--CCCCcccchhhHHHHHHHHhCCCCCCCCCccH-----HHHHHHHhcc-ccccC
Confidence            21    1233477889999999775  68899999999999999999999988654321     1112221111 11111


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCCCH--HHHH
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPM--NEVI  340 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~--~evl  340 (372)
                      +       ......+.+++.+||+.||.+||++  +|++
T Consensus       222 ~-------~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         222 P-------ATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             c-------ccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            1       1234678889999999999999999  6654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=7e-36  Score=272.20  Aligned_cols=225  Identities=24%  Similarity=0.366  Sum_probs=180.0

Q ss_pred             hhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCChh
Q 036435           89 DKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLE  149 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~  149 (372)
                      +.||+|++|.||++....                   .+.+|+.++++++||||+++++++..++..++|+||+++++|.
T Consensus        25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~  104 (285)
T cd06648          25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT  104 (285)
T ss_pred             eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence            579999999999986531                   4678999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeeee
Q 036435          150 KFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSS  229 (372)
Q Consensus       150 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  229 (372)
                      +++....       +++.++..++.|++.||+|||   +.+++||||+|+||+++.++.++|+|||.+.........   
T Consensus       105 ~~~~~~~-------~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~---  171 (285)
T cd06648         105 DIVTHTR-------MNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR---  171 (285)
T ss_pred             HHHHhCC-------CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc---
Confidence            9987622       889999999999999999999   899999999999999999999999999988754432211   


Q ss_pred             ecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCCc
Q 036435          230 LLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTR  309 (372)
Q Consensus       230 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (372)
                      .....|+..|+|||.+.+.  .++.++|+||||+++|+|++|+.||......       . .........   .+...  
T Consensus       172 ~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-------~-~~~~~~~~~---~~~~~--  236 (285)
T cd06648         172 RKSLVGTPYWMAPEVISRL--PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-------Q-AMKRIRDNL---PPKLK--  236 (285)
T ss_pred             cccccCCccccCHHHhcCC--CCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-------H-HHHHHHhcC---CCCCc--
Confidence            1223478889999998764  6889999999999999999999998653211       1 111111111   11110  


Q ss_pred             chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          310 KENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       310 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ........+.+++.+||+.+|++||++.++++
T Consensus       237 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         237 NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            11123457888999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=7.9e-36  Score=271.02  Aligned_cols=225  Identities=28%  Similarity=0.348  Sum_probs=172.9

Q ss_pred             hcCCCCceEEEEEEecc----------------------hHHHHHHHHh---ccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           90 KLGQGGFGGVYKGRLLD----------------------DFVNEVASIS---RTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        90 ~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~---~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      .||+|+||.||+++..+                      .+.+|..+++   ..+||||+.+++++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            38999999999986532                      1234443333   3479999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      +|+|.+++.....      +++..+..++.|++.||+|||   +.+++|+||||+|||+++++.++|+|||++.......
T Consensus        81 ~~~L~~~i~~~~~------l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~  151 (279)
T cd05633          81 GGDLHYHLSQHGV------FSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  151 (279)
T ss_pred             CCCHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC
Confidence            9999999875432      899999999999999999999   8999999999999999999999999999987543322


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCC
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP  304 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (372)
                      .     ....||..|+|||.+.+. ..++.++|+||+||++|+|++|..||........     ....... .......+
T Consensus       152 ~-----~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~~~~~~-~~~~~~~~  219 (279)
T cd05633         152 P-----HASVGTHGYMAPEVLQKG-TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRMT-LTVNVELP  219 (279)
T ss_pred             c-----cCcCCCcCccCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-----HHHHHHh-hcCCcCCc
Confidence            1     223588899999988642 2578999999999999999999999975433221     1111111 01111111


Q ss_pred             ccCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 036435          305 GVVTRKENEIAKKMIIVGLWCIQARPSDRP-----PMNEVIEM  342 (372)
Q Consensus       305 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~~  342 (372)
                             ......+.+++.+||+.||++||     +++++++.
T Consensus       220 -------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         220 -------DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             -------cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence                   22345677888999999999999     59999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=6.6e-36  Score=273.07  Aligned_cols=233  Identities=24%  Similarity=0.330  Sum_probs=177.5

Q ss_pred             hhhcCCCCceEEEEEEecc------------------hHHHHHHHHhcc-CCCceeeeEeEEecC-----CceeEEEEec
Q 036435           88 KDKLGQGGFGGVYKGRLLD------------------DFVNEVASISRT-SHVNVVTLLGFCLEG-----NNRALIYEFM  143 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~------------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~-----~~~~lV~e~~  143 (372)
                      .+.||+|+||.||++...+                  .+.+|+.+++++ +|||++++++++...     +..++|+||+
T Consensus        27 ~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~  106 (291)
T cd06639          27 IETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELC  106 (291)
T ss_pred             EEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEEC
Confidence            4679999999999986532                  466799999999 899999999998754     3589999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      ++|+|.+++......  ...+++..+..++.|++.||+|||   ..+++|+||||+||++++++.+||+|||++......
T Consensus       107 ~~~sL~~~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~  181 (291)
T cd06639         107 NGGSVTELVKGLLIC--GQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST  181 (291)
T ss_pred             CCCcHHHHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEeecccchhcccc
Confidence            999999988643211  123899999999999999999999   789999999999999999999999999998865432


Q ss_pred             CCeeeeeccccccccccccccccccc---CCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccc
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNF---GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDRE  300 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (372)
                      ....   ....++..|+|||.+....   ..++.++|+|||||++|||++|+.||.......       .... ......
T Consensus       182 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~-------~~~~-~~~~~~  250 (291)
T cd06639         182 RLRR---NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK-------TLFK-IPRNPP  250 (291)
T ss_pred             cccc---cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH-------HHHH-HhcCCC
Confidence            2111   2234778899999986431   136889999999999999999999987542211       0111 111111


Q ss_pred             ccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       301 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                         +...  ........+.+++.+||+.+|++||++.++++
T Consensus       251 ---~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         251 ---PTLL--HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             ---CCCC--cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence               1111  11223456888999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=9.3e-36  Score=277.88  Aligned_cols=249  Identities=22%  Similarity=0.264  Sum_probs=180.9

Q ss_pred             hhhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhcc-CCCceeeeEeEEecC--CceeEEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRT-SHVNVVTLLGFCLEG--NNRALIY  140 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~--~~~~lV~  140 (372)
                      +.+.+.||+|+||.||+|....                     .+.+|+.+++++ +||||+++++++...  ...++|+
T Consensus         9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~   88 (337)
T cd07852           9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVF   88 (337)
T ss_pred             HHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEe
Confidence            4456789999999999996531                     366799999999 999999999998654  3679999


Q ss_pred             EecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccc
Q 036435          141 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC  220 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~  220 (372)
                      ||++ ++|.+++...       .+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++...
T Consensus        89 e~~~-~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          89 EYME-TDLHAVIRAN-------ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             cccc-cCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence            9997 5999988654       2889999999999999999999   799999999999999999999999999999866


Q ss_pred             cCCCCe--eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccch--------HHH
Q 036435          221 TTKEGI--VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYF--------PHW  290 (372)
Q Consensus       221 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~--------~~~  290 (372)
                      ......  ........++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||...........+        ...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07852         158 SELEENPENPVLTDYVATRWYRAPEILLGS-TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED  236 (337)
T ss_pred             ccccccccCcchhcccccccccCceeeecc-ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            443321  0111223478889999988653 36788999999999999999999998653321100000        000


Q ss_pred             HH--------HHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hhcC
Q 036435          291 IY--------RHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM--LQGS  346 (372)
Q Consensus       291 ~~--------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~--L~~~  346 (372)
                      ..        ..+......... ............+.+++.+||+.||++|||+.++++.  +++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         237 IESIKSPFAATMLDSLPSRPRK-PLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             HHHHHhhhHHHhhhhccccccc-chhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence            00        000000000000 0001111135678899999999999999999999964  4444

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-36  Score=275.92  Aligned_cols=244  Identities=21%  Similarity=0.312  Sum_probs=181.0

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      ++.+.||+|+||.||++...+                     .+.+|++++++++|+||+++++++.+++..++|+||++
T Consensus         4 ~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~   83 (288)
T cd07833           4 EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVE   83 (288)
T ss_pred             eEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCC
Confidence            446789999999999986632                     47889999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      ++.+..+.....      .+++.++..++.|++.||+|||   ..+++|+||+|+||++++++.+||+|||++.......
T Consensus        84 ~~~l~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          84 RTLLELLEASPG------GLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             CCHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            877766554332      2889999999999999999999   7899999999999999999999999999998765443


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHH-------HHHHHhhh
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPH-------WIYRHVEQ  297 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~-------~~~~~~~~  297 (372)
                      ...  .....++..|+|||++.+. ..++.++|+||||+++|+|++|+.||..............       ........
T Consensus       155 ~~~--~~~~~~~~~~~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd07833         155 ASP--LTDYVATRWYRAPELLVGD-TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS  231 (288)
T ss_pred             ccc--ccCcccccCCcCCchhcCC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhccc
Confidence            211  1223467889999998764 3678999999999999999999999875422110000000       00000000


Q ss_pred             cccc---cCCccCCc------chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          298 DREF---KLPGVVTR------KENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       298 ~~~~---~~~~~~~~------~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ....   ..+.....      ....+...+.+++.+||+.+|++||+++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            0000   00000000      01112567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-38  Score=270.49  Aligned_cols=230  Identities=23%  Similarity=0.339  Sum_probs=190.6

Q ss_pred             hhhhhcCCCCceEEEEEEec-----------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCCh
Q 036435           86 SFKDKLGQGGFGGVYKGRLL-----------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL  148 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~-----------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L  148 (372)
                      ++.++||+|+||.|||+.++                 +++.+|+.+++++..|++|++||.+..+..+++|||||..|+.
T Consensus        36 Di~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSi  115 (502)
T KOG0574|consen   36 DIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSI  115 (502)
T ss_pred             HHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcH
Confidence            44678999999999987543                 3788999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeee
Q 036435          149 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVS  228 (372)
Q Consensus       149 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  228 (372)
                      .+.+..+..     .+++.++..+++..++||+|||   ...-+|||||+.|||++.+|.+||+|||.|....+.-.   
T Consensus       116 SDI~R~R~K-----~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA---  184 (502)
T KOG0574|consen  116 SDIMRARRK-----PLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA---  184 (502)
T ss_pred             HHHHHHhcC-----CccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH---
Confidence            999977653     3999999999999999999999   78899999999999999999999999999986654322   


Q ss_pred             eecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCC
Q 036435          229 SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVT  308 (372)
Q Consensus       229 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (372)
                      ......||+-|||||++..-  .|+.++||||+|+...||.-|++||.+......- .            ...-.|....
T Consensus       185 KRNTVIGTPFWMAPEVI~EI--GY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI-F------------MIPT~PPPTF  249 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEI--GYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI-F------------MIPTKPPPTF  249 (502)
T ss_pred             hhCccccCcccccHHHHHHh--ccchhhhHhhhcchhhhhhcCCCCccccccccee-E------------eccCCCCCCC
Confidence            22345699999999999875  7899999999999999999999999765432210 0            0001111222


Q ss_pred             cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          309 RKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       309 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ..+..+..++-+++..||-++|++|-|+-++++
T Consensus       250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            345567788899999999999999999988876

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.6e-35  Score=266.09  Aligned_cols=229  Identities=26%  Similarity=0.383  Sum_probs=184.9

Q ss_pred             hhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           87 FKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      +.+.||+|++|.||+++..+                    .+.+|+..+++++|+||+++++++..++..++|+||++++
T Consensus         5 ~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (264)
T cd06623           5 RVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGG   84 (264)
T ss_pred             eeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCC
Confidence            45789999999999996642                    5788999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS-TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      +|.+++....      .+++..++.++.|+++||+|||   + .+++|+||+|+||+++.++.++|+|||++........
T Consensus        85 ~L~~~l~~~~------~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          85 SLADLLKKVG------KIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD  155 (264)
T ss_pred             cHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence            9999997653      2899999999999999999999   7 9999999999999999999999999999987654332


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                      ..   ....++..|+|||.+.+.  .++.++|+||||+++|+|++|..||.......    ..+. ...+.....   +.
T Consensus       156 ~~---~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~----~~~~-~~~~~~~~~---~~  222 (264)
T cd06623         156 QC---NTFVGTVTYMSPERIQGE--SYSYAADIWSLGLTLLECALGKFPFLPPGQPS----FFEL-MQAICDGPP---PS  222 (264)
T ss_pred             cc---cceeecccccCHhhhCCC--CCCchhhHHHHHHHHHHHHhCCCCCccccccC----HHHH-HHHHhcCCC---CC
Confidence            21   123467889999998764  78899999999999999999999987654211    1111 111111111   11


Q ss_pred             cCCcchHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          306 VVTRKENE-IAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       306 ~~~~~~~~-~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                          .... ....+.+++.+||+.+|++||++.++++
T Consensus       223 ----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         223 ----LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             ----CCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence                1111 4567888999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.3e-36  Score=270.70  Aligned_cols=228  Identities=22%  Similarity=0.407  Sum_probs=181.3

Q ss_pred             hhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           87 FKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      +.+.||+|+||.||++....                     .+.+|+.++++++|+||+++++.+.+++..++|+||+++
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   83 (257)
T cd08225           4 IIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDG   83 (257)
T ss_pred             EEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCC
Confidence            45779999999999987632                     467899999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC-ceEEeecCCcccccCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDF-CPKISDFGLAKLCTTKE  224 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgla~~~~~~~  224 (372)
                      ++|.+++......    .+++..+..++.|+++||+|||   +.+++|+||||+||++++++ .+||+|||.+.......
T Consensus        84 ~~L~~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          84 GDLMKRINRQRGV----LFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CcHHHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            9999999764432    2799999999999999999999   79999999999999998875 46999999997654332


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCC
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP  304 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (372)
                      ...   ....|++.|+|||.+.+.  .++.++|+||||+++||+++|..||.....       ..+........    .+
T Consensus       157 ~~~---~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~----~~  220 (257)
T cd08225         157 ELA---YTCVGTPYYLSPEICQNR--PYNNKTDIWSLGCVLYELCTLKHPFEGNNL-------HQLVLKICQGY----FA  220 (257)
T ss_pred             ccc---cccCCCccccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHhccc----CC
Confidence            211   223478889999988764  788999999999999999999999864321       11222211111    11


Q ss_pred             ccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       305 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                          .........+.+++.+||+.+|++|||++++++
T Consensus       221 ----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         221 ----PISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             ----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence                111123456888999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.4e-35  Score=269.33  Aligned_cols=239  Identities=20%  Similarity=0.291  Sum_probs=177.6

Q ss_pred             hhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccC-CCceeeeEeEEecC--CceeEEEEec
Q 036435           87 FKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTS-HVNVVTLLGFCLEG--NNRALIYEFM  143 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~-h~nIv~l~g~~~~~--~~~~lV~e~~  143 (372)
                      +.+.||+|+||.||+++...                    ...+|+..+.++. |+|++++++++.++  +..++|+||+
T Consensus         3 ~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~   82 (282)
T cd07831           3 ILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELM   82 (282)
T ss_pred             eEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecC
Confidence            45679999999999997531                    2356888898885 99999999999987  8899999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      + |+|.+++.....     .+++.++..++.|++.||+|||   +.+++|+||+|+||+++. +.+||+|||++......
T Consensus        83 ~-~~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          83 D-MNLYELIKGRKR-----PLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK  152 (282)
T ss_pred             C-ccHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence            6 588888865431     3899999999999999999999   799999999999999999 99999999999866433


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCcc--------chHHHHHHHh
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV--------YFPHWIYRHV  295 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~--------~~~~~~~~~~  295 (372)
                      ...    ....++..|+|||.+... ..++.++|+|||||++|||++|..||......+...        ....+ ....
T Consensus       153 ~~~----~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  226 (282)
T cd07831         153 PPY----TEYISTRWYRAPECLLTD-GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV-LKKF  226 (282)
T ss_pred             CCc----CCCCCCcccCChhHhhcC-CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHH-HHhh
Confidence            221    122467889999987543 357889999999999999999999996543211000        00000 0011


Q ss_pred             hhc--ccccCCccCCc----chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          296 EQD--REFKLPGVVTR----KENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       296 ~~~--~~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ...  .....+.....    ........+.+++.+||+++|++||+++++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            000  01111111111    11234678899999999999999999999985

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.5e-35  Score=272.67  Aligned_cols=232  Identities=30%  Similarity=0.400  Sum_probs=180.6

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      ...+.||+|+||.||+++...                      ++.+|+.++++++|||++++++++.+++..++|+||+
T Consensus        28 ~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  107 (317)
T cd06635          28 TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC  107 (317)
T ss_pred             hhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCC
Confidence            345679999999999987521                      4778999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      . |+|.+.+....     ..+++.++..++.|++.||.|||   ..+++|+||+|+||+++.++.+||+|||++......
T Consensus       108 ~-g~l~~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (317)
T cd06635         108 L-GSASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA  178 (317)
T ss_pred             C-CCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence            6 58888775432     22899999999999999999999   799999999999999999999999999998754322


Q ss_pred             CCeeeeeccccccccccccccccc-ccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSR-NFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                             ....++..|+|||.+.. ..+.++.++|+|||||++|||++|+.||.......        ............
T Consensus       179 -------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--------~~~~~~~~~~~~  243 (317)
T cd06635         179 -------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQNESPT  243 (317)
T ss_pred             -------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH--------HHHHHHhccCCC
Confidence                   12347788999999742 12367899999999999999999999986532110        111111111111


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                            .........+.+++.+||+.+|.+||++.++++.+-...
T Consensus       244 ------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         244 ------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             ------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence                  111223456788999999999999999999998654433

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-36  Score=272.69  Aligned_cols=243  Identities=22%  Similarity=0.336  Sum_probs=179.8

Q ss_pred             hhhhcCCCCceEEEEEEec---------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           87 FKDKLGQGGFGGVYKGRLL---------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~---------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      +.+.||.|++|.||+|...                     +.+.+|++.+++++|||++++++++.+++..++++||++ 
T Consensus         3 ~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-   81 (283)
T cd07835           3 KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-   81 (283)
T ss_pred             hheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-
Confidence            4567999999999998652                     147789999999999999999999999999999999995 


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      ++|.+++.....    ..+++..++.++.|+++||+|||   +.+++|+||+|+||+++.++.++|+|||++........
T Consensus        82 ~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          82 LDLKKYMDSSPL----TGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             cCHHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence            699999876542    23899999999999999999999   78999999999999999999999999999976533221


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHH-------HHHHHhhhc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPH-------WIYRHVEQD  298 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~-------~~~~~~~~~  298 (372)
                      .   .....++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||..............       +.+......
T Consensus       155 ~---~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd07835         155 T---YTHEVVTLWYRAPEILLGS-RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL  230 (283)
T ss_pred             c---cCccccccCCCCCceeecC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhc
Confidence            1   1222357789999988653 3568899999999999999999999875422110000000       000000000


Q ss_pred             cc--ccCCc----cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          299 RE--FKLPG----VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       299 ~~--~~~~~----~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ..  ...+.    ............+.+++.+||+.+|++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            00  00000    000111223457888999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2e-35  Score=274.59  Aligned_cols=239  Identities=20%  Similarity=0.278  Sum_probs=177.9

Q ss_pred             hhcCCC--CceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           89 DKLGQG--GFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        89 ~~lg~G--~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      ..||+|  +||+||+++...                     .+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            356776  899999997631                     467889999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      ++|.+++.+....    .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++++||+.+........
T Consensus        84 ~~l~~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~  156 (328)
T cd08226          84 GSANSLLKTYFPE----GMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ  156 (328)
T ss_pred             CCHHHHHHhhccc----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc
Confidence            9999998775432    2889999999999999999999   89999999999999999999999999986543322111


Q ss_pred             eee----eecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcc--
Q 036435          226 IVS----SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDR--  299 (372)
Q Consensus       226 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--  299 (372)
                      ...    ......++..|+|||++.+....++.++|||||||++|||++|+.||........       .........  
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~-------~~~~~~~~~~~  229 (328)
T cd08226         157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM-------LLQKLKGPPYS  229 (328)
T ss_pred             cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH-------HHHHhcCCCCC
Confidence            100    0011124556999999976434578999999999999999999999975432110       000000000  


Q ss_pred             ------------------------------------cccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          300 ------------------------------------EFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       300 ------------------------------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                                                          ..................+.+++.+||+.||++|||++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         230 PLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             CccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                                                000000111123345677899999999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.3e-35  Score=269.78  Aligned_cols=232  Identities=25%  Similarity=0.356  Sum_probs=175.5

Q ss_pred             hhhhcCCCCceEEEEEEecc--------------------hHHHHHHH-HhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           87 FKDKLGQGGFGGVYKGRLLD--------------------DFVNEVAS-ISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~-l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      +.+.||+|+||.||+++...                    ++..|+.. ++.++||||+++++++..++..++|+||++ 
T Consensus         5 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-   83 (283)
T cd06617           5 VIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-   83 (283)
T ss_pred             EEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-
Confidence            45679999999999987632                    34556654 566689999999999999999999999996 


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCST-KILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      |+|.+++......  ...+++..++.++.|++.||+|||   +. +++||||||+||+++.++.+||+|||++.......
T Consensus        84 ~~l~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (283)
T cd06617          84 TSLDKFYKKVYDK--GLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV  158 (283)
T ss_pred             ccHHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            6898887653221  134899999999999999999999   65 99999999999999999999999999998653321


Q ss_pred             Ceeeeecccccccccccccccccc--cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRN--FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      .    .....++..|+|||.+.+.  ...++.++|+|||||++|+|++|+.||.......     . ...... ......
T Consensus       159 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~-~~~~~~-~~~~~~  227 (283)
T cd06617         159 A----KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-----Q-QLKQVV-EEPSPQ  227 (283)
T ss_pred             c----cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-----H-HHHHHH-hcCCCC
Confidence            1    1123477889999988652  1246889999999999999999999986432211     0 011111 111111


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .+      ...+...+.+++.+||+.+|.+||+++++++
T Consensus       228 ~~------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         228 LP------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             CC------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11      1123467888999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-36  Score=275.80  Aligned_cols=250  Identities=23%  Similarity=0.315  Sum_probs=180.8

Q ss_pred             hhhhhcCCCCceEEEEEEecc------------------------hHHHHHHHHhccCCCceeeeEeEEecC--CceeEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD------------------------DFVNEVASISRTSHVNVVTLLGFCLEG--NNRALI  139 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~--~~~~lV  139 (372)
                      .+.+.||+|+||.||+|+...                        .+.+|+.++++++||||+++++++.+.  ...++|
T Consensus         3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   82 (316)
T cd07842           3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLL   82 (316)
T ss_pred             eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEE
Confidence            345679999999999987632                        356799999999999999999999988  789999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC----CCceEEeecC
Q 036435          140 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE----DFCPKISDFG  215 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~Dfg  215 (372)
                      +||+++ +|.+.+....... ...++...+..++.|++.||+|||   +.+++||||||+||+++.    ++.+||+|||
T Consensus        83 ~e~~~~-~l~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          83 FDYAEH-DLWQIIKFHRQAK-RVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EeCCCc-CHHHHHHhhccCC-CcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            999975 7777765432211 124889999999999999999999   899999999999999999    9999999999


Q ss_pred             CcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCc-cchHH----H
Q 036435          216 LAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE-VYFPH----W  290 (372)
Q Consensus       216 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~-~~~~~----~  290 (372)
                      ++.................++..|+|||.+.+. ..++.++|+||||+++++|++|+.||......... .....    .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            998764433221122233567889999988653 35788999999999999999999999765433200 00000    0


Q ss_pred             HHHHhh-----------hcc-------cccCCccCCcchH-------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          291 IYRHVE-----------QDR-------EFKLPGVVTRKEN-------EIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       291 ~~~~~~-----------~~~-------~~~~~~~~~~~~~-------~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      +...+.           ...       .............       .....+.+++.+||+.||++|||+.|+++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000000           000       0000000000111       22346889999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-35  Score=266.64  Aligned_cols=230  Identities=23%  Similarity=0.282  Sum_probs=177.6

Q ss_pred             hhhhhcCCCCceEEEEEEecc------------------------hHHHHHHHHhccCCCceeeeEeEEecC--CceeEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD------------------------DFVNEVASISRTSHVNVVTLLGFCLEG--NNRALI  139 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~--~~~~lV  139 (372)
                      .+.+.||+|+||.||+++...                        .+.+|++++++++|+||+++++++.+.  +..++|
T Consensus         5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v   84 (264)
T cd06653           5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIF   84 (264)
T ss_pred             eeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEE
Confidence            345789999999999986421                        467799999999999999999998764  457899


Q ss_pred             EEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccc
Q 036435          140 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL  219 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  219 (372)
                      +||+++++|.+++.....      +++.....++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||+++.
T Consensus        85 ~e~~~~~~L~~~~~~~~~------l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          85 VEYMPGGSIKDQLKAYGA------LTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEeCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccc
Confidence            999999999999875432      788999999999999999999   89999999999999999999999999999986


Q ss_pred             ccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcc
Q 036435          220 CTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDR  299 (372)
Q Consensus       220 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (372)
                      ...............++..|+|||.+.+.  .++.++|+|||||++|++++|+.||......       ...........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~  226 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGE--GYGRKADVWSVACTVVEMLTEKPPWAEYEAM-------AAIFKIATQPT  226 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCccCHH-------HHHHHHHcCCC
Confidence            53321111111223478889999999875  6889999999999999999999998753211       11111111111


Q ss_pred             cccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          300 EFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ...       .+......+.+++..||+ +|.+||++.+++.
T Consensus       227 ~~~-------~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         227 KPM-------LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             CCC-------CCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            111       122344667788889999 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=7.6e-36  Score=272.63  Aligned_cols=241  Identities=20%  Similarity=0.285  Sum_probs=175.4

Q ss_pred             hhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           87 FKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      +.+.||+|+||.||+|....                    .+.+|+.+++.++|+||+++++++.+++..++|+||+. +
T Consensus         9 ~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~   87 (291)
T cd07870           9 NLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-T   87 (291)
T ss_pred             EEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-C
Confidence            35779999999999986421                    46789999999999999999999999999999999995 6


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      +|.+++.....     .+++..+..++.|++.||+|||   ..+++|+||||+||+++.++.+||+|||+++........
T Consensus        88 ~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  159 (291)
T cd07870          88 DLAQYMIQHPG-----GLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT  159 (291)
T ss_pred             CHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC
Confidence            88777754332     2778889999999999999999   789999999999999999999999999999754332211


Q ss_pred             eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHH---------HHHHhhh
Q 036435          227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHW---------IYRHVEQ  297 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~---------~~~~~~~  297 (372)
                         .....++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||........ .....|         .......
T Consensus       160 ---~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07870         160 ---YSSEVVTLWYRPPDVLLGA-TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE-QLEKIWTVLGVPTEDTWPGVSK  234 (291)
T ss_pred             ---CCCccccccccCCceeecC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH-HHHHHHHHcCCCChhhhhhhhh
Confidence               1223467889999998753 3578899999999999999999999975432100 000000         0000000


Q ss_pred             ccc---ccCCccCCcchH------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          298 DRE---FKLPGVVTRKEN------EIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       298 ~~~---~~~~~~~~~~~~------~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ...   ...+........      .....+.+++.+|++.||++|||+++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            000   000000000000      01345678899999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=7.4e-36  Score=271.57  Aligned_cols=244  Identities=22%  Similarity=0.333  Sum_probs=180.8

Q ss_pred             hhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           87 FKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      +.+.||.|++|.||+|+...                    .+.+|+.++++++|+||+++++++.+.+..++|+||+++ 
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-   82 (284)
T cd07836           4 QLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-   82 (284)
T ss_pred             EeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-
Confidence            45789999999999997631                    466899999999999999999999999999999999975 


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      +|.+++......   ..+++.++..++.|+++||+|||   +.+++|+||||+||++++++.++|+|||++.........
T Consensus        83 ~l~~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~  156 (284)
T cd07836          83 DLKKYMDTHGVR---GALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT  156 (284)
T ss_pred             cHHHHHHhcCCC---CCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence            898888654421   23899999999999999999999   789999999999999999999999999999765432211


Q ss_pred             eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHH-------HHHHhhhcc
Q 036435          227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHW-------IYRHVEQDR  299 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~  299 (372)
                         .....++..|++||.+.+. ..++.++|+||||+++|+|++|+.||...............       .++.+....
T Consensus       157 ---~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07836         157 ---FSNEVVTLWYRAPDVLLGS-RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP  232 (284)
T ss_pred             ---cccccccccccChHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCc
Confidence               1223467889999998654 35688999999999999999999998754321100000000       000000000


Q ss_pred             cc--cCCccCCc----chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          300 EF--KLPGVVTR----KENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       300 ~~--~~~~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .+  ..+.....    ........+.+++.+|++.||.+||+++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00  00100000    11123456788999999999999999999885

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.9e-35  Score=268.15  Aligned_cols=229  Identities=26%  Similarity=0.418  Sum_probs=182.9

Q ss_pred             hhhhcCCCCceEEEEEEec------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCCh
Q 036435           87 FKDKLGQGGFGGVYKGRLL------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL  148 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L  148 (372)
                      +.+.||+|+||.||++...                  ..+.+|++.+++++|+|++++++.+..++..++|+||+++++|
T Consensus        23 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L  102 (286)
T cd06614          23 NLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL  102 (286)
T ss_pred             HhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcH
Confidence            3467999999999998764                  1577899999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeee
Q 036435          149 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVS  228 (372)
Q Consensus       149 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  228 (372)
                      .+++....     ..+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++.........  
T Consensus       103 ~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--  172 (286)
T cd06614         103 TDIITQNF-----VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK--  172 (286)
T ss_pred             HHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh--
Confidence            99998754     12899999999999999999999   899999999999999999999999999998755433211  


Q ss_pred             eecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCC
Q 036435          229 SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVT  308 (372)
Q Consensus       229 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (372)
                       .....++..|++||.+.+.  .++.++|+||||+++|+|++|+.||.......       .... .....   .+..  
T Consensus       173 -~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~-------~~~~-~~~~~---~~~~--  236 (286)
T cd06614         173 -RNSVVGTPYWMAPEVIKRK--DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-------ALFL-ITTKG---IPPL--  236 (286)
T ss_pred             -hccccCCcccCCHhHhcCC--CCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-------HHHH-HHhcC---CCCC--
Confidence             1222467789999998764  68899999999999999999999986432110       0111 11111   1111  


Q ss_pred             cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          309 RKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       309 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .....+...+.+++.+||+.+|.+||++.++++
T Consensus       237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         237 KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            111224567888999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-35  Score=269.61  Aligned_cols=239  Identities=21%  Similarity=0.317  Sum_probs=180.1

Q ss_pred             hhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecC--CceeEEEEec
Q 036435           87 FKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEG--NNRALIYEFM  143 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~--~~~~lV~e~~  143 (372)
                      +.+.||+|+||.||+|+..+                     .+.+|+.++++++|+|++++++++.+.  +..++|+||+
T Consensus         3 ~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~   82 (287)
T cd07840           3 KIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYM   82 (287)
T ss_pred             eeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccc
Confidence            45679999999999997532                     477899999999999999999999988  8999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      ++ +|.+++....     ..+++..++.++.|+++||+|||   ..+++|+||+|+||++++++.+||+|||++......
T Consensus        83 ~~-~l~~~~~~~~-----~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          83 DH-DLTGLLDSPE-----VKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             cc-cHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            75 8998886543     13899999999999999999999   789999999999999999999999999999866543


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccc---
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDRE---  300 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---  300 (372)
                      ...  ......++..|+|||.+.+. ..++.++||||||+++|||++|+.||.......    ....+.........   
T Consensus       154 ~~~--~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~----~~~~~~~~~~~~~~~~~  226 (287)
T cd07840         154 NSA--DYTNRVITLWYRPPELLLGA-TRYGPEVDMWSVGCILAELFLGKPIFQGSTELE----QLEKIFELCGSPTDENW  226 (287)
T ss_pred             Ccc--cccccccccccCCceeeEcc-ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCchhhc
Confidence            321  11223456789999987654 357899999999999999999999987543211    00000000000000   


Q ss_pred             -----------c----cCCccCCcchHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          301 -----------F----KLPGVVTRKENE-IAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       301 -----------~----~~~~~~~~~~~~-~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                                 .    ..+......... ....+.+++.+||+.+|++||+++++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         227 PGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             cccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                       0    000000000111 2567889999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=5.4e-36  Score=282.52  Aligned_cols=180  Identities=24%  Similarity=0.337  Sum_probs=153.3

Q ss_pred             hhhhhhcCCCCceEEEEEEecc------------------hHHHHHHHHhccC-C-----CceeeeEeEEecCCceeEEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD------------------DFVNEVASISRTS-H-----VNVVTLLGFCLEGNNRALIY  140 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~------------------~~~~E~~~l~~l~-h-----~nIv~l~g~~~~~~~~~lV~  140 (372)
                      +.+.+.||+|+||.|-|+...+                  +...|+.+|..|+ |     -|+|+++++|...+++|||+
T Consensus       188 Y~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVf  267 (586)
T KOG0667|consen  188 YEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVF  267 (586)
T ss_pred             EEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeee
Confidence            3446789999999999986643                  5667999999997 3     38999999999999999999


Q ss_pred             EecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC--CCceEEeecCCcc
Q 036435          141 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE--DFCPKISDFGLAK  218 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgla~  218 (372)
                      |.+.. +|.++++.+.-..    ++...+..++.||+.||.+||   ..+|||+||||+||||.+  ...+||+|||.|.
T Consensus       268 ELL~~-NLYellK~n~f~G----lsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc  339 (586)
T KOG0667|consen  268 ELLST-NLYELLKNNKFRG----LSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSC  339 (586)
T ss_pred             hhhhh-hHHHHHHhcCCCC----CCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccccc
Confidence            99955 9999999876543    999999999999999999999   899999999999999964  3479999999998


Q ss_pred             cccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCC
Q 036435          219 LCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVD  280 (372)
Q Consensus       219 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~  280 (372)
                      .....-..      ..-+.-|.|||++.|-  .++.+.||||||||+.||++|.+.|.+..+
T Consensus       340 ~~~q~vyt------YiQSRfYRAPEVILGl--pY~~~IDmWSLGCIlAEL~tG~PLfpG~ne  393 (586)
T KOG0667|consen  340 FESQRVYT------YIQSRFYRAPEVILGL--PYDTAIDMWSLGCILAELFTGEPLFPGDNE  393 (586)
T ss_pred             ccCCccee------eeeccccccchhhccC--CCCCccceeehhhhHHhHhcCccccCCCCH
Confidence            76554321      1234569999999985  999999999999999999999877776544

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.2e-35  Score=272.03  Aligned_cols=243  Identities=22%  Similarity=0.326  Sum_probs=177.8

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecC--CceeEEEEe
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEG--NNRALIYEF  142 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~--~~~~lV~e~  142 (372)
                      ++.+.||+|+||.||+|+...                     .+.+|+.++++++|+||+++++++.+.  +..++|+||
T Consensus        10 ~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~   89 (309)
T cd07845          10 EKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEY   89 (309)
T ss_pred             eEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEec
Confidence            345679999999999997632                     356899999999999999999998765  468999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      +.+ +|.+++....     ..+++.++..++.|++.||+|||   +.+++|+||||+||++++++.+||+|||++.....
T Consensus        90 ~~~-~l~~~l~~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          90 CEQ-DLASLLDNMP-----TPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             CCC-CHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            964 8988886543     23899999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHH-------HHHHHh
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPH-------WIYRHV  295 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~-------~~~~~~  295 (372)
                      ....   .....++..|+|||.+.+. ..++.++|+||+||++|||++|+.||...........+..       ..+...
T Consensus       161 ~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07845         161 PAKP---MTPKVVTLWYRAPELLLGC-TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF  236 (309)
T ss_pred             ccCC---CCcccccccccChhhhcCC-CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence            3211   1222356779999998653 3678999999999999999999999975432110000000       000000


Q ss_pred             hh---cccccCCccCC----cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          296 EQ---DREFKLPGVVT----RKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       296 ~~---~~~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ..   ......+....    .........+.+++.+||+.||++|||++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            00   00000000000    001113456778999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.3e-35  Score=271.58  Aligned_cols=242  Identities=21%  Similarity=0.344  Sum_probs=177.9

Q ss_pred             hhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccC-CCceeeeEeEEecCCc-----eeEE
Q 036435           87 FKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTS-HVNVVTLLGFCLEGNN-----RALI  139 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~-h~nIv~l~g~~~~~~~-----~~lV  139 (372)
                      ..+.||+|+||.||+|....                     .+.+|+.+++.++ ||||+++++++...+.     .++|
T Consensus         5 ~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv   84 (295)
T cd07837           5 KLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLV   84 (295)
T ss_pred             EeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEE
Confidence            45679999999999997532                     4678999999995 6999999999987665     8999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC-CCceEEeecCCcc
Q 036435          140 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE-DFCPKISDFGLAK  218 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgla~  218 (372)
                      |||+++ +|.+++...... ....+++..++.++.||++||.|||   ..+++|+||||+||+++. ++.+||+|||++.
T Consensus        85 ~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~  159 (295)
T cd07837          85 FEYLDS-DLKKFMDSNGRG-PGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR  159 (295)
T ss_pred             eeccCc-CHHHHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence            999985 899888654322 1234899999999999999999999   899999999999999998 8999999999987


Q ss_pred             cccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhc
Q 036435          219 LCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQD  298 (372)
Q Consensus       219 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (372)
                      ........   .....+++.|+|||.+.+. ..++.++|+||||+++|+|++|..||.........   .. +.......
T Consensus       160 ~~~~~~~~---~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~---~~-~~~~~~~~  231 (295)
T cd07837         160 AFSIPVKS---YTHEIVTLWYRAPEVLLGS-THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL---LH-IFKLLGTP  231 (295)
T ss_pred             ecCCCccc---cCCcccccCCCChHHhhCC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH---HH-HHHHhCCC
Confidence            65332211   1122357789999988653 35789999999999999999999998754321100   00 00000000


Q ss_pred             cc------------ccCCcc----CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          299 RE------------FKLPGV----VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       299 ~~------------~~~~~~----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ..            ...+..    ...........+.+++.+||+.||.+||+++|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            00            000000    00111234567888999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.7e-35  Score=269.22  Aligned_cols=225  Identities=24%  Similarity=0.346  Sum_probs=178.5

Q ss_pred             hhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCChh
Q 036435           89 DKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLE  149 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~  149 (372)
                      .+||+|+||.||++....                   .+.+|+.+++.++|+||+++++.+..++..++||||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            579999999999986632                   4778999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeeee
Q 036435          150 KFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSS  229 (372)
Q Consensus       150 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  229 (372)
                      +++....       +++.....++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||++..........  
T Consensus       106 ~~~~~~~-------~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~--  173 (292)
T cd06657         106 DIVTHTR-------MNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--  173 (292)
T ss_pred             HHHhcCC-------CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccccc--
Confidence            9875432       789999999999999999999   7899999999999999999999999999987654322111  


Q ss_pred             ecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCCc
Q 036435          230 LLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTR  309 (372)
Q Consensus       230 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (372)
                       ....++..|+|||.+.+.  .++.++|+||+|+++|+|++|..||.......        ..............     
T Consensus       174 -~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~--------~~~~~~~~~~~~~~-----  237 (292)
T cd06657         174 -KSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--------AMKMIRDNLPPKLK-----  237 (292)
T ss_pred             -cccccCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhhCCcccC-----
Confidence             223477889999998764  77899999999999999999999987532110        11111111110110     


Q ss_pred             chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          310 KENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       310 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ........+.+++.+||+.+|.+||++.++++
T Consensus       238 ~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         238 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            01123445778889999999999999999886

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=5e-35  Score=260.54  Aligned_cols=228  Identities=29%  Similarity=0.476  Sum_probs=183.1

Q ss_pred             hhhhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCC
Q 036435           87 FKDKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS  147 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~  147 (372)
                      ..+.||+|++|.||+++...                   .+.+|+..+++++|+|++++++++..+...++++||+++++
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~   83 (253)
T cd05122           4 ILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGS   83 (253)
T ss_pred             eeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCc
Confidence            34679999999999997641                   47889999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCee
Q 036435          148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV  227 (372)
Q Consensus       148 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  227 (372)
                      |.+++....     ..+++..+..++.|+++||+|||   ..+++|+||+|+||++++++.++|+|||.+........  
T Consensus        84 L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          84 LKDLLKSTN-----QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             HHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            999987653     22899999999999999999999   79999999999999999999999999999987655432  


Q ss_pred             eeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccC
Q 036435          228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVV  307 (372)
Q Consensus       228 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (372)
                        .....++..|+|||.+.+.  ..+.++|+||||+++|+|++|+.||.......       .... ....   ..+...
T Consensus       154 --~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~-~~~~---~~~~~~  218 (253)
T cd05122         154 --RNTMVGTPYWMAPEVINGK--PYDYKADIWSLGITAIELAEGKPPYSELPPMK-------ALFK-IATN---GPPGLR  218 (253)
T ss_pred             --ccceecCCcccCHHHHcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCchHH-------HHHH-HHhc---CCCCcC
Confidence              1223477889999998765  68899999999999999999999987542111       0111 1111   111111


Q ss_pred             CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          308 TRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       308 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .  .......+.+++.+||+.||++|||+.++++
T Consensus       219 ~--~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         219 N--PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             c--ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1  1112466888999999999999999999885

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=7.1e-35  Score=264.59  Aligned_cols=224  Identities=27%  Similarity=0.328  Sum_probs=173.0

Q ss_pred             hcCCCCceEEEEEEecc----------------------hHHHHHH---HHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           90 KLGQGGFGGVYKGRLLD----------------------DFVNEVA---SISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        90 ~lg~G~~g~V~~~~~~~----------------------~~~~E~~---~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      .||+|+||.||++...+                      .+..|..   .++...||||+++++++.+++..++|+||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            38999999999886521                      1233433   3444579999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      +|+|.+++....      .+++..+..++.|++.||+|||   +.+++|+||||+||++++++.+||+|||++.......
T Consensus        81 g~~L~~~l~~~~------~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~  151 (278)
T cd05606          81 GGDLHYHLSQHG------VFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  151 (278)
T ss_pred             CCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC
Confidence            999999886543      2899999999999999999999   7999999999999999999999999999987554322


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCC
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP  304 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (372)
                      .     ....|+..|+|||.+.+. ..++.++|+||+|+++|||++|+.||.........     ...... .......+
T Consensus       152 ~-----~~~~~~~~y~aPE~~~~~-~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~-----~~~~~~-~~~~~~~~  219 (278)
T cd05606         152 P-----HASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-----EIDRMT-LTMAVELP  219 (278)
T ss_pred             C-----cCcCCCcCCcCcHHhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH-----HHHHHh-hccCCCCC
Confidence            1     223578899999998743 25789999999999999999999999765322210     011111 11111122


Q ss_pred             ccCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 036435          305 GVVTRKENEIAKKMIIVGLWCIQARPSDRP-----PMNEVIE  341 (372)
Q Consensus       305 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~  341 (372)
                      .       .....+.+++.+|+..+|.+||     ++.++++
T Consensus       220 ~-------~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         220 D-------SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             C-------cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            1       1245677888999999999999     9999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.2e-35  Score=266.97  Aligned_cols=229  Identities=26%  Similarity=0.373  Sum_probs=180.3

Q ss_pred             cCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCCh
Q 036435           91 LGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL  148 (372)
Q Consensus        91 lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L  148 (372)
                      ||+|+||.||+++..+                      .+.+|++++++++||||+++++.+.+++..++|+||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999987642                      477789999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe--
Q 036435          149 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI--  226 (372)
Q Consensus       149 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~--  226 (372)
                      .+++....      .+++..+..++.|+++||+|||   +.+++|+||+|+||++++++.++|+|||++.........  
T Consensus        81 ~~~l~~~~------~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  151 (265)
T cd05579          81 ASLLENVG------SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL  151 (265)
T ss_pred             HHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc
Confidence            99997644      2899999999999999999999   899999999999999999999999999998765433211  


Q ss_pred             ---eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          227 ---VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       227 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                         ........++..|++||...+.  ..+.++|+||||+++|++++|..||......       . ........ ....
T Consensus       152 ~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-------~-~~~~~~~~-~~~~  220 (265)
T cd05579         152 NDDEKEDKRIVGTPDYIAPEVILGQ--GHSKTVDWWSLGCILYEFLVGIPPFHGETPE-------E-IFQNILNG-KIEW  220 (265)
T ss_pred             ccccccccCcccCccccCHHHhcCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-------H-HHHHHhcC-CcCC
Confidence               0111223467789999998764  6788999999999999999999998754311       1 11111111 1111


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ  344 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~  344 (372)
                      +...     .....+.+++.+||+.+|.+|||+.++.+.|+
T Consensus       221 ~~~~-----~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         221 PEDV-----EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             Cccc-----cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            2111     12567788999999999999999966666554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.6e-35  Score=271.26  Aligned_cols=242  Identities=22%  Similarity=0.329  Sum_probs=175.7

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCC--------ce
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGN--------NR  136 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~--------~~  136 (372)
                      .+.+.||+|+||.||+++...                     .+.+|+.++++++||||+++++++....        ..
T Consensus        15 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~   94 (310)
T cd07865          15 EKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSF   94 (310)
T ss_pred             EEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceE
Confidence            445789999999999997531                     3567999999999999999999987654        34


Q ss_pred             eEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCC
Q 036435          137 ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGL  216 (372)
Q Consensus       137 ~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  216 (372)
                      ++|+||+. ++|.+++.....     .+++.++..++.|+++||+|||   +.+++|+||||+||+++.++.+||+|||+
T Consensus        95 ~lv~e~~~-~~l~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          95 YLVFEFCE-HDLAGLLSNKNV-----KFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             EEEEcCCC-cCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence            99999996 488888865431     2899999999999999999999   78999999999999999999999999999


Q ss_pred             cccccCCCCee-eeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHh
Q 036435          217 AKLCTTKEGIV-SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV  295 (372)
Q Consensus       217 a~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  295 (372)
                      +.......... .......++..|+|||.+.+. ..++.++|+||||+++|||++|..||........    ...+....
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~----~~~~~~~~  240 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ----LTLISQLC  240 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHhcCC-cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHh
Confidence            98654332211 111223467789999988664 3468899999999999999999999865432110    00000000


Q ss_pred             hh--------------cccccCCccCCcchH------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          296 EQ--------------DREFKLPGVVTRKEN------EIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       296 ~~--------------~~~~~~~~~~~~~~~------~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ..              ......+........      .....+.+++.+||+.||.+|||++++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             CCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            00              000001111000000      01235678999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-35  Score=264.36  Aligned_cols=226  Identities=21%  Similarity=0.284  Sum_probs=173.7

Q ss_pred             hhcCCCCceEEEEEEecc----------------------hHHHHHHH-HhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           89 DKLGQGGFGGVYKGRLLD----------------------DFVNEVAS-ISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~-l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      +.||+|+||.||+++...                      .+..|..+ ....+|+|++++++++.+++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            458999999999986532                      12334433 3445899999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      ++|.+++.....      +++..+..++.|+++||.|||   +.+++|+||+|+||++++++.+||+|||++......  
T Consensus        82 ~~L~~~l~~~~~------~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  150 (260)
T cd05611          82 GDCASLIKTLGG------LPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN--  150 (260)
T ss_pred             CCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceecccc--
Confidence            999999976432      889999999999999999999   799999999999999999999999999998754331  


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                           ....++..|+|||.+.+.  .++.++|+||||+++|+|++|..||......       . ........ ....+.
T Consensus       151 -----~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~-~~~~~~~~-~~~~~~  214 (260)
T cd05611         151 -----KKFVGTPDYLAPETILGV--GDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-------A-VFDNILSR-RINWPE  214 (260)
T ss_pred             -----ccCCCCcCccChhhhcCC--CCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-------H-HHHHHHhc-ccCCCC
Confidence                 123467889999998875  5789999999999999999999999643211       1 11211111 111111


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ  344 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~  344 (372)
                      ..   ...+...+.+++.+||+.+|++||++.++.+.|.
T Consensus       215 ~~---~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         215 EV---KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             cc---cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence            11   1124567888999999999999998766655543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=4.8e-35  Score=270.29  Aligned_cols=240  Identities=17%  Similarity=0.209  Sum_probs=178.3

Q ss_pred             hhhcCCCCceEEEEEEec-------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCCh
Q 036435           88 KDKLGQGGFGGVYKGRLL-------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL  148 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~-------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L  148 (372)
                      .+.+|.|+++.||+++..                   +.+.+|+.++++++|+||+++++++.+++..+++|||+++|+|
T Consensus         7 ~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l   86 (314)
T cd08216           7 GKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC   86 (314)
T ss_pred             hHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence            344666677777765331                   1678899999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe--
Q 036435          149 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI--  226 (372)
Q Consensus       149 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~--  226 (372)
                      .+++......    .+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||.+.........  
T Consensus        87 ~~~l~~~~~~----~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~  159 (314)
T cd08216          87 EDLLKTHFPE----GLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR  159 (314)
T ss_pred             HHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence            9999764322    2888999999999999999999   899999999999999999999999999988755332211  


Q ss_pred             --eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhc------
Q 036435          227 --VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQD------  298 (372)
Q Consensus       227 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------  298 (372)
                        ........++..|+|||.+.+....++.++|+|||||++|||++|+.||.......       ...+.....      
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~-------~~~~~~~~~~~~~~~  232 (314)
T cd08216         160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ-------MLLEKVRGTVPCLLD  232 (314)
T ss_pred             ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhccCccccc
Confidence              01112234667899999987643457889999999999999999999997543211       000100000      


Q ss_pred             ----------cc-----ccCC----ccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          299 ----------RE-----FKLP----GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       299 ----------~~-----~~~~----~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                                ..     ...+    .............+.+++.+||+.||++|||++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         233 KSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             cCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence                      00     0000    0001112234467888999999999999999999996

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-36  Score=269.40  Aligned_cols=224  Identities=25%  Similarity=0.373  Sum_probs=182.8

Q ss_pred             hhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           89 DKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      +.||+|+||.||-.+...                      ..+.|-.+|.+++.+.||.+--.|++.+.+++|+..|.||
T Consensus       191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGG  270 (591)
T KOG0986|consen  191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGG  270 (591)
T ss_pred             EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCC
Confidence            579999999999876543                      3678999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      ||.-++.+.++..    +++..++.++.+|+.||++||   ..+||+|||||+|||||+.|+++|+|+|||..+..+...
T Consensus       271 DLkfHiyn~g~~g----F~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~  343 (591)
T KOG0986|consen  271 DLKFHIYNHGNPG----FDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI  343 (591)
T ss_pred             ceeEEeeccCCCC----CchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCCCCcc
Confidence            9999999877533    999999999999999999999   899999999999999999999999999999987765533


Q ss_pred             eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCcc
Q 036435          227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV  306 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (372)
                          ....||.+|||||++.+.  .|+...|.||+||++|||+.|+.||....+....        +.++.. ....+..
T Consensus       344 ----~~rvGT~GYMAPEvl~ne--~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~--------eEvdrr-~~~~~~e  408 (591)
T KOG0986|consen  344 ----RGRVGTVGYMAPEVLQNE--VYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR--------EEVDRR-TLEDPEE  408 (591)
T ss_pred             ----ccccCcccccCHHHHcCC--cccCCccHHHHHhHHHHHHcccCchhhhhhhhhH--------HHHHHH-Hhcchhh
Confidence                333699999999999886  7999999999999999999999999865443321        111111 1111222


Q ss_pred             CCcchHHHHHHHHHHHHHcccCCCCCCCCHH
Q 036435          307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMN  337 (372)
Q Consensus       307 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  337 (372)
                      .+   ....++..++....|++||.+|....
T Consensus       409 y~---~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  409 YS---DKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             cc---cccCHHHHHHHHHHHccCHHHhccCC
Confidence            22   22345556677778899999997644

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=4e-35  Score=270.20  Aligned_cols=227  Identities=29%  Similarity=0.417  Sum_probs=177.5

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      ...+.||+|+||.||+|+...                      ++.+|+++++.++|+|++++++++.+++..++|+||+
T Consensus        18 ~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   97 (308)
T cd06634          18 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC   97 (308)
T ss_pred             HHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEcc
Confidence            335679999999999987521                      4668999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      . |+|.+.+.....     .+++.++..++.|++.||.|||   ..+++|+||+|+||+++.++.+||+|||++......
T Consensus        98 ~-~~l~~~~~~~~~-----~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          98 L-GSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             C-CCHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            6 688887754331     2889999999999999999999   799999999999999999999999999998765432


Q ss_pred             CCeeeeeccccccccccccccccc-ccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSR-NFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      .       ...++..|+|||.+.+ .....+.++|||||||++|+|++|+.||.......       .. ........  
T Consensus       169 ~-------~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~~-~~~~~~~~--  231 (308)
T cd06634         169 N-------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------AL-YHIAQNES--  231 (308)
T ss_pred             c-------cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-------HH-HHHhhcCC--
Confidence            1       2246788999998753 11357889999999999999999999986532110       01 11111111  


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                       +..   ........+.+++.+||+.+|.+||+++++++.
T Consensus       232 -~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         232 -PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             -CCc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence             111   112234567889999999999999999999965

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.4e-35  Score=269.62  Aligned_cols=241  Identities=24%  Similarity=0.326  Sum_probs=177.6

Q ss_pred             hhhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCC---------
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGN---------  134 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~---------  134 (372)
                      +.+.+.||+|+||.||+|....                     .+.+|+.++++++||||+++++++.+..         
T Consensus         9 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~   88 (302)
T cd07864           9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDK   88 (302)
T ss_pred             hheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccC
Confidence            3446789999999999997632                     3567999999999999999999998655         


Q ss_pred             -ceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEee
Q 036435          135 -NRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISD  213 (372)
Q Consensus       135 -~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  213 (372)
                       ..++|+||+++ +|.+.+....     ..+++..+..++.|++.||+|||   +.+++|+||||+||++++++.+||+|
T Consensus        89 ~~~~lv~e~~~~-~l~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          89 GAFYLVFEYMDH-DLMGLLESGL-----VHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             CcEEEEEcccCc-cHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCc
Confidence             78999999976 7777776542     12899999999999999999999   79999999999999999999999999


Q ss_pred             cCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHH
Q 036435          214 FGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYR  293 (372)
Q Consensus       214 fgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  293 (372)
                      ||++..........  .....++..|+|||.+.+. ...+.++|||||||++|||++|+.||.......   .+ ..+..
T Consensus       160 fg~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~---~~-~~~~~  232 (302)
T cd07864         160 FGLARLYNSEESRP--YTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFTKKPIFQANQELA---QL-ELISR  232 (302)
T ss_pred             ccccccccCCcccc--cccceeccCccChHHhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH---HH-HHHHH
Confidence            99998664433211  1122356779999988653 356889999999999999999999987532211   00 00011


Q ss_pred             HhhhcccccCCc------------------cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          294 HVEQDREFKLPG------------------VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       294 ~~~~~~~~~~~~------------------~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ..........+.                  ............+.+++..||+.+|.+||+++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            000000000000                  000011123467889999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-35  Score=268.80  Aligned_cols=242  Identities=23%  Similarity=0.362  Sum_probs=180.9

Q ss_pred             hhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccC-CCceeeeEeEEecCCceeEEEEecCC
Q 036435           87 FKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTS-HVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~-h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      +.+.||+|+||.||+|+..+                    ...+|+..+++++ |+||+++++++.+++..++||||+ +
T Consensus         3 ~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~   81 (283)
T cd07830           3 VIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-E   81 (283)
T ss_pred             eheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-C
Confidence            45789999999999997632                    2356889999998 999999999999999999999999 8


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      |+|.+++.....    ..+++.+++.++.|++.+|.|||   +.+++|+||+|+||++++++.++|+|||++........
T Consensus        82 ~~l~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (283)
T cd07830          82 GNLYQLMKDRKG----KPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP  154 (283)
T ss_pred             CCHHHHHHhccc----ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence            899999876542    23899999999999999999999   79999999999999999999999999999986544322


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCcc---------chHHHHHHH-h
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV---------YFPHWIYRH-V  295 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~---------~~~~~~~~~-~  295 (372)
                      .    ....++..|+|||.+.+. ..++.++|+||||++++||++|+.||..........         .-..|.... .
T Consensus       155 ~----~~~~~~~~~~aPE~~~~~-~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd07830         155 Y----TDYVSTRWYRAPEILLRS-TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL  229 (283)
T ss_pred             c----CCCCCcccccCceeeecC-cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence            1    123467789999988653 367899999999999999999999986543211000         000010000 0


Q ss_pred             hhcccccCCccCCcch----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          296 EQDREFKLPGVVTRKE----NEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       296 ~~~~~~~~~~~~~~~~----~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ........+.......    ......+.+++.+||+.+|++|||++|++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            0001111111111111    111356889999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.2e-35  Score=271.72  Aligned_cols=237  Identities=22%  Similarity=0.328  Sum_probs=177.0

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      .+.+.||+|++|.||+|+...                     .+.+|++++++++||||+++++++.++...++|+||++
T Consensus         5 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (294)
T PLN00009          5 EKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD   84 (294)
T ss_pred             EEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc
Confidence            345679999999999997531                     46789999999999999999999999999999999996


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC-CCceEEeecCCcccccCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE-DFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgla~~~~~~  223 (372)
                       ++|.+++......    .+++..+..++.|++.||+|||   +.+++|+||+|+||+++. ++.+||+|||++......
T Consensus        85 -~~l~~~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         85 -LDLKKHMDSSPDF----AKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             -ccHHHHHHhCCCC----CcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence             5888888654432    2678888999999999999999   789999999999999985 567999999999765432


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhh---cc-
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQ---DR-  299 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~-  299 (372)
                      ...   .....++..|+|||++.+. ..++.++|+||+|+++|+|+||+.||........       .......   .. 
T Consensus       157 ~~~---~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~-------~~~~~~~~~~~~~  225 (294)
T PLN00009        157 VRT---FTHEVVTLWYRAPEILLGS-RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE-------LFKIFRILGTPNE  225 (294)
T ss_pred             ccc---cccCceeecccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHHHhCCCCh
Confidence            211   1223467889999998653 3578899999999999999999999975432110       0110000   00 


Q ss_pred             ------------cccCCccCCc----chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          300 ------------EFKLPGVVTR----KENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       300 ------------~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                                  ....+.....    ........+.+++.+|++.+|++||++.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        226 ETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence                        0000000000    01123456788999999999999999999986

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.9e-35  Score=269.58  Aligned_cols=237  Identities=23%  Similarity=0.292  Sum_probs=182.6

Q ss_pred             hhhhcCCCCceEEEEEEec--------------------------chHHHHHHHHhcc-CCCceeeeEeEEecCCceeEE
Q 036435           87 FKDKLGQGGFGGVYKGRLL--------------------------DDFVNEVASISRT-SHVNVVTLLGFCLEGNNRALI  139 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~--------------------------~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV  139 (372)
                      +.+.||+|+||.||+++..                          +.+.+|+.++.++ +||||+++++.+..+...++|
T Consensus         4 ~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   83 (288)
T cd05583           4 LLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLI   83 (288)
T ss_pred             EEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEE
Confidence            4577999999999987632                          1366799999999 699999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccc
Q 036435          140 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL  219 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  219 (372)
                      |||+++|+|.+++....      .+++..+..++.|+++||.|||   +.+++|+||+|+||+++.++.++|+|||+++.
T Consensus        84 ~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          84 LDYVNGGELFTHLYQRE------HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EecCCCCcHHHHHhhcC------CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccc
Confidence            99999999999986543      2889999999999999999999   79999999999999999999999999999876


Q ss_pred             ccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcc
Q 036435          220 CTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDR  299 (372)
Q Consensus       220 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (372)
                      ........  .....++..|+|||.+.+.....+.++|+||||+++|||++|..||........   ... ........ 
T Consensus       155 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~~-~~~~~~~~-  227 (288)
T cd05583         155 FLAEEEER--AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS---QSE-ISRRILKS-  227 (288)
T ss_pred             cccccccc--cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch---HHH-HHHHHHcc-
Confidence            54332211  122347788999999876422478899999999999999999999864322111   011 11111111 


Q ss_pred             cccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 036435          300 EFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGS  346 (372)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~  346 (372)
                      ....+       ......+.+++.+||+.||++|||+.++.+.|+..
T Consensus       228 ~~~~~-------~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         228 KPPFP-------KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             CCCCC-------cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence            11111       11335677889999999999999998888777653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=5.7e-35  Score=261.25  Aligned_cols=229  Identities=27%  Similarity=0.380  Sum_probs=184.0

Q ss_pred             hhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecC--CceeEEEEecC
Q 036435           88 KDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEG--NNRALIYEFMP  144 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~--~~~~lV~e~~~  144 (372)
                      .+.||+|++|.||+|...+                     .+.+|+..+++++||||+++++.+.+.  +..++|+||++
T Consensus         5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~   84 (260)
T cd06606           5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVS   84 (260)
T ss_pred             eeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecC
Confidence            4679999999999997641                     478899999999999999999999988  88999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      +++|.+++.+..      .+++.++..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus        85 ~~~L~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  155 (260)
T cd06606          85 GGSLSSLLKKFG------KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE  155 (260)
T ss_pred             CCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence            999999997654      2899999999999999999999   7999999999999999999999999999998765543


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCC
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP  304 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (372)
                      ... ......++..|+|||.+.+.  ..+.++|+||||+++++|++|..||.......      ............    
T Consensus       156 ~~~-~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~----  222 (260)
T cd06606         156 TGE-GTGSVRGTPYWMAPEVIRGE--EYGRAADIWSLGCTVIEMATGKPPWSELGNPM------AALYKIGSSGEP----  222 (260)
T ss_pred             ccc-cccCCCCCccccCHhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCchH------HHHHhccccCCC----
Confidence            210 01223477889999998775  68999999999999999999999997654110      111111110111    


Q ss_pred             ccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       305 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                         ..........+.+++.+|++.+|.+||++.++++
T Consensus       223 ---~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         223 ---PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             ---cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence               1111223567888999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.3e-35  Score=266.46  Aligned_cols=230  Identities=23%  Similarity=0.360  Sum_probs=179.7

Q ss_pred             hhhhhcCCCCceEEEEEEecc------------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD------------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYE  141 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  141 (372)
                      .+.+.||+|+||.||+++...                        ++.+|+.++++++||||+++++++.+....++|+|
T Consensus         3 ~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (260)
T cd08222           3 ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITE   82 (260)
T ss_pred             eeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEE
Confidence            456789999999999885531                        35678899999999999999999999999999999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      |+++++|.+++......  ...+++.+++.++.|+++||.|||   +.+++|+||+|+||++++ +.+||+|||++....
T Consensus        83 ~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          83 YCEGRDLDCKLEELKHT--GKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             eCCCCCHHHHHHHHhhc--ccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence            99999999988653211  123899999999999999999999   899999999999999975 569999999987654


Q ss_pred             CCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccc
Q 036435          222 TKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF  301 (372)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (372)
                      .....   .....++..|+|||.+.+.  .++.++|+||||+++|+|++|..||.....       .. .........  
T Consensus       157 ~~~~~---~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-------~~-~~~~~~~~~--  221 (260)
T cd08222         157 GSCDL---ATTFTGTPYYMSPEALKHQ--GYDSKSDIWSLGCILYEMCCLAHAFEGQNF-------LS-VVLRIVEGP--  221 (260)
T ss_pred             CCccc---ccCCCCCcCccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HH-HHHHHHcCC--
Confidence            33221   1223477889999988654  678899999999999999999999864211       01 111111111  


Q ss_pred             cCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       302 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                       .+.    ........+.+++.+||+.+|++||++.++++
T Consensus       222 -~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         222 -TPS----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             -CCC----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence             111    12234567888999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.1e-35  Score=264.24  Aligned_cols=228  Identities=28%  Similarity=0.463  Sum_probs=183.7

Q ss_pred             hhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           87 FKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      +.+.||+|+||.||+++...                     ++.+|+.++++++|+||+++++++.++...++|+||+++
T Consensus         4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   83 (256)
T cd08530           4 VLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPF   83 (256)
T ss_pred             EeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCC
Confidence            45779999999999986531                     467899999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      ++|.+++......  ...+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||++........
T Consensus        84 ~~L~~~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~  158 (256)
T cd08530          84 GDLSKAISKRKKK--RKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA  158 (256)
T ss_pred             CCHHHHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccCCc
Confidence            9999998763321  123899999999999999999999   89999999999999999999999999999987654411


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                           ....++..|++||.+.+.  .++.++|+||+|+++|+|++|+.||.......        .........   .+ 
T Consensus       159 -----~~~~~~~~~~~Pe~~~~~--~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--------~~~~~~~~~---~~-  219 (256)
T cd08530         159 -----KTQIGTPHYMAPEVWKGR--PYSYKSDIWSLGCLLYEMATFAPPFEARSMQD--------LRYKVQRGK---YP-  219 (256)
T ss_pred             -----ccccCCccccCHHHHCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHhcCC---CC-
Confidence                 123477889999999764  78889999999999999999999986532110        111111111   11 


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                         ........++.+++.+||+.+|.+||++.++++
T Consensus       220 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         220 ---PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             ---CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence               111234567889999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.1e-35  Score=275.46  Aligned_cols=248  Identities=23%  Similarity=0.296  Sum_probs=180.8

Q ss_pred             hhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecC-----CceeEEE
Q 036435           87 FKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEG-----NNRALIY  140 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~-----~~~~lV~  140 (372)
                      ..+.||+|+||+||+++...                     .+.+|+.+++.++|+||+++++++...     ...++|+
T Consensus         9 ~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~   88 (337)
T cd07858           9 PIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVY   88 (337)
T ss_pred             EEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEE
Confidence            34679999999999986521                     466799999999999999999988754     3479999


Q ss_pred             EecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccc
Q 036435          141 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC  220 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~  220 (372)
                      ||+. ++|.+++.....      +++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++...
T Consensus        89 e~~~-~~L~~~~~~~~~------l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  158 (337)
T cd07858          89 ELMD-TDLHQIIRSSQT------LSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTT  158 (337)
T ss_pred             eCCC-CCHHHHHhcCCC------CCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence            9995 689988865432      899999999999999999999   799999999999999999999999999999866


Q ss_pred             cCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchH--------H---
Q 036435          221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFP--------H---  289 (372)
Q Consensus       221 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~--------~---  289 (372)
                      ......   .....++..|+|||.+.+. ..++.++|+|||||++|+|++|+.||...........+.        .   
T Consensus       159 ~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07858         159 SEKGDF---MTEYVVTRWYRAPELLLNC-SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG  234 (337)
T ss_pred             CCCccc---ccccccccCccChHHHhcC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence            443211   1223467889999988653 257899999999999999999999986532100000000        0   


Q ss_pred             -----HHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hhcCccc
Q 036435          290 -----WIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM--LQGSTEA  349 (372)
Q Consensus       290 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~--L~~~~~~  349 (372)
                           ..............+ .......+....+.+++.+||+.+|++|||++++++.  +.....+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~  300 (337)
T cd07858         235 FIRNEKARRYIRSLPYTPRQ-SFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP  300 (337)
T ss_pred             hcCchhhhHHHHhcCccccc-CHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence                 000000000000000 0000112345678899999999999999999999975  6655443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-35  Score=259.72  Aligned_cols=227  Identities=28%  Similarity=0.425  Sum_probs=183.0

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      .+.+.||+|++|.||+++...                     .+.+|++++++++|+|++++++++.+++..++|+||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (254)
T cd06627           3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAE   82 (254)
T ss_pred             eeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCC
Confidence            345789999999999986531                     47889999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      +++|.+++....      .+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus        83 ~~~L~~~~~~~~------~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          83 NGSLRQIIKKFG------PFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             CCcHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence            999999997653      2899999999999999999999   8999999999999999999999999999998765543


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCC
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP  304 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (372)
                      ..   .....++..|+|||...+.  ..+.++|+||+|+++|+|++|..||......      .. ... .........+
T Consensus       154 ~~---~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~------~~-~~~-~~~~~~~~~~  220 (254)
T cd06627         154 KD---DASVVGTPYWMAPEVIEMS--GASTASDIWSLGCTVIELLTGNPPYYDLNPM------AA-LFR-IVQDDHPPLP  220 (254)
T ss_pred             cc---ccccccchhhcCHhhhcCC--CCCcchhHHHHHHHHHHHHhCCCCCCCccHH------HH-HHH-HhccCCCCCC
Confidence            22   1223477889999998764  5789999999999999999999998753211      00 111 1111111111


Q ss_pred             ccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       305 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                             ......+.+++.+||+.+|++||++.+++.
T Consensus       221 -------~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         221 -------EGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             -------CCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence                   123456778999999999999999999884

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=7.9e-35  Score=260.36  Aligned_cols=230  Identities=24%  Similarity=0.418  Sum_probs=184.2

Q ss_pred             hhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           87 FKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      +.+.||+|+||.||++...+                     .+.+|++++++++|||++++++.+..++..++|+||+++
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~   83 (258)
T cd08215           4 IIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADG   83 (258)
T ss_pred             EEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCC
Confidence            45679999999999987641                     477899999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      ++|.+++.....  ....+++.++..++.++++||.|||   +.+++|+||+|+||++++++.++|+|||.+........
T Consensus        84 ~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~  158 (258)
T cd08215          84 GDLSQKIKKQKK--EGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD  158 (258)
T ss_pred             CcHHHHHHHhhc--cCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCcc
Confidence            999999977531  1133899999999999999999999   78999999999999999999999999999986654331


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                      .   .....+++.|+|||.+.+.  .++.++|+||+|+++++|++|+.||......       . .............+.
T Consensus       159 ~---~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-------~-~~~~~~~~~~~~~~~  225 (258)
T cd08215         159 L---AKTVVGTPYYLSPELCQNK--PYNYKSDIWSLGCVLYELCTLKHPFEGENLL-------E-LALKILKGQYPPIPS  225 (258)
T ss_pred             e---ecceeeeecccChhHhccC--CCCccccHHHHHHHHHHHHcCCCCCCCCcHH-------H-HHHHHhcCCCCCCCC
Confidence            1   1223477889999998764  6889999999999999999999998654211       1 111111111111111


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                             .....+.+++.+||+.+|++|||+.++++
T Consensus       226 -------~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         226 -------QYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             -------CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                   23466788999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4e-35  Score=266.43  Aligned_cols=242  Identities=21%  Similarity=0.308  Sum_probs=181.9

Q ss_pred             hhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           87 FKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      ..+.||+|++|.||+++...                     .+.+|+..+++++|+||+++++++.+++..++|+||+++
T Consensus         3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (283)
T cd05118           3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT   82 (283)
T ss_pred             cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC
Confidence            34679999999999996531                     467899999999999999999999999999999999975


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                       +|.+++.....     .+++..+..++.|+++||.|||   +.+++|+||||+||+++.++.++|+|||.+........
T Consensus        83 -~l~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~  153 (283)
T cd05118          83 -DLYKLIKDRQR-----GLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR  153 (283)
T ss_pred             -CHHHHHHhhcc-----cCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence             89888876431     2899999999999999999999   89999999999999999999999999999987654431


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchH-------HHHHHHhhh-
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFP-------HWIYRHVEQ-  297 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~-------~~~~~~~~~-  297 (372)
                      .   .....++..|+|||.+.+. ..++.++|+||+|+++|+|++|+.||.............       ...+..... 
T Consensus       154 ~---~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd05118         154 P---YTHYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL  229 (283)
T ss_pred             c---ccCccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhh
Confidence            1   1223467789999998763 367899999999999999999999886543211000000       000000000 


Q ss_pred             --cccccCCccC----CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          298 --DREFKLPGVV----TRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       298 --~~~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                        ......+...    .....+....+.+++.+||+.||.+||++++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence              0000011111    1112335678899999999999999999999885

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=5.8e-35  Score=266.71  Aligned_cols=232  Identities=23%  Similarity=0.283  Sum_probs=178.6

Q ss_pred             hhhhcCCCCceEEEEEEec--------------------------chHHHHHHHHhcc-CCCceeeeEeEEecCCceeEE
Q 036435           87 FKDKLGQGGFGGVYKGRLL--------------------------DDFVNEVASISRT-SHVNVVTLLGFCLEGNNRALI  139 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~--------------------------~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV  139 (372)
                      +.+.||+|+||.||+++..                          +.+.+|+.++.++ +|+||+++++.+..+...++|
T Consensus         4 ~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (290)
T cd05613           4 LLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLI   83 (290)
T ss_pred             eeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEE
Confidence            4567999999999987642                          1366799999999 699999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccc
Q 036435          140 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL  219 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  219 (372)
                      +||+++++|.+++.....      +++..+..++.|+++||.|||   +.+++||||+|+|||+++++.+||+|||++..
T Consensus        84 ~e~~~~~~L~~~l~~~~~------l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          84 LDYINGGELFTHLSQRER------FKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EecCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            999999999999976432      788999999999999999999   89999999999999999999999999999986


Q ss_pred             ccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcc
Q 036435          220 CTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDR  299 (372)
Q Consensus       220 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (372)
                      ........  .....|+..|+|||.+.+.....+.++||||||+++|+|++|..||........   ..... ...... 
T Consensus       155 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~---~~~~~-~~~~~~-  227 (290)
T cd05613         155 FHEDEVER--AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS---QAEIS-RRILKS-  227 (290)
T ss_pred             cccccccc--cccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc---HHHHH-HHhhcc-
Confidence            54322111  122347788999999875433567899999999999999999999864322111   11111 111111 


Q ss_pred             cccCCccCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 036435          300 EFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRP-----PMNEVIE  341 (372)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~  341 (372)
                      ....+       ......+.+++.+||+.||.+||     ++++++.
T Consensus       228 ~~~~~-------~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         228 EPPYP-------QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             CCCCC-------ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            11111       12345677899999999999997     6777765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.4e-34  Score=261.18  Aligned_cols=221  Identities=21%  Similarity=0.289  Sum_probs=170.6

Q ss_pred             cCCCCceEEEEEEecc-------------hH-HHHHHHHhcc-CCCceeeeEeEEecCCceeEEEEecCCCChhhhhhcC
Q 036435           91 LGQGGFGGVYKGRLLD-------------DF-VNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNG  155 (372)
Q Consensus        91 lg~G~~g~V~~~~~~~-------------~~-~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~~  155 (372)
                      ||+|+||.||+++...             .+ ..|+.....+ +||||+++++.+..++..++||||+++|+|.+++...
T Consensus        24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~  103 (267)
T PHA03390         24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE  103 (267)
T ss_pred             ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhc
Confidence            5999999999987532             11 1233333323 7999999999999999999999999999999999765


Q ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC-ceEEeecCCcccccCCCCeeeeecccc
Q 036435          156 DTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDF-CPKISDFGLAKLCTTKEGIVSSLLGAR  234 (372)
Q Consensus       156 ~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgla~~~~~~~~~~~~~~~~~  234 (372)
                      .      .+++.++..++.|+++||.|||   +.+++|+||||+||+++.++ .++|+|||++.......       ...
T Consensus       104 ~------~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-------~~~  167 (267)
T PHA03390        104 G------KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS-------CYD  167 (267)
T ss_pred             C------CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc-------cCC
Confidence            3      2899999999999999999999   78999999999999999888 99999999987654322       224


Q ss_pred             cccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCCcchHHH
Q 036435          235 GIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEI  314 (372)
Q Consensus       235 gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (372)
                      ++..|+|||++.+.  .++.++|+||||+++|+|++|+.||.......  .....+... .  ......       ....
T Consensus       168 ~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~-~--~~~~~~-------~~~~  233 (267)
T PHA03390        168 GTLDYFSPEKIKGH--NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE--LDLESLLKR-Q--QKKLPF-------IKNV  233 (267)
T ss_pred             CCCcccChhhhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCcch--hhHHHHHHh-h--cccCCc-------cccc
Confidence            77889999999764  77899999999999999999999997432211  111111111 1  111111       1134


Q ss_pred             HHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 036435          315 AKKMIIVGLWCIQARPSDRPP-MNEVIE  341 (372)
Q Consensus       315 ~~~l~~l~~~cl~~~p~~RPs-~~evl~  341 (372)
                      ...+.+++.+||+.+|.+||+ ++++++
T Consensus       234 ~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        234 SKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             CHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            567788899999999999995 688874

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=5.4e-35  Score=272.46  Aligned_cols=239  Identities=22%  Similarity=0.274  Sum_probs=178.6

Q ss_pred             hhhcCCCCceEEEEEEecc---------------------------------hHHHHHHHHhccCCCceeeeEeEEecCC
Q 036435           88 KDKLGQGGFGGVYKGRLLD---------------------------------DFVNEVASISRTSHVNVVTLLGFCLEGN  134 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~---------------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~  134 (372)
                      .+.||+|+||+||++....                                 .+.+|++++++++|+||+++++++..++
T Consensus        14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   93 (335)
T PTZ00024         14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD   93 (335)
T ss_pred             hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence            4569999999999996421                                 2568999999999999999999999999


Q ss_pred             ceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeec
Q 036435          135 NRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDF  214 (372)
Q Consensus       135 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  214 (372)
                      ..++||||+. |+|.+++....      .+++.....++.|++.||+|||   +.+++|+||+|+||+++.++.+||+||
T Consensus        94 ~~~lv~e~~~-~~l~~~l~~~~------~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~df  163 (335)
T PTZ00024         94 FINLVMDIMA-SDLKKVVDRKI------RLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADF  163 (335)
T ss_pred             cEEEEEeccc-cCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECCc
Confidence            9999999996 69999986543      2889999999999999999999   899999999999999999999999999


Q ss_pred             CCcccccCCCC-----------eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCC
Q 036435          215 GLAKLCTTKEG-----------IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSS  283 (372)
Q Consensus       215 gla~~~~~~~~-----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~  283 (372)
                      |++........           .........++..|+|||.+.+. ..++.++|+|||||++|||++|+.||....... 
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~-  241 (335)
T PTZ00024        164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA-EKYHFAVDMWSVGCIFAELLTGKPLFPGENEID-  241 (335)
T ss_pred             cceeecccccccccccccccccccccccccccccCCCCChhcccC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence            99976541110           00111223357789999998764 357889999999999999999999987543211 


Q ss_pred             ccchHHHHHHHhhhcccc----------------cCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          284 EVYFPHWIYRHVEQDREF----------------KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                         ....+..........                ..+.............+.+++.+||+.+|++||++++++.
T Consensus       242 ---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        242 ---QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             ---HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence               001111111000000                0000000011122456788999999999999999999996

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=252.23  Aligned_cols=230  Identities=23%  Similarity=0.363  Sum_probs=178.9

Q ss_pred             hhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccC-CCceeeeEeEEecCCceeEEEEecCCC
Q 036435           88 KDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTS-HVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~-h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      ...||.|+.|.|++.+.+.                    +++..+.++.+-+ .|.||+.+|+|..+...++.||.|.. 
T Consensus        97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-  175 (391)
T KOG0983|consen   97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-  175 (391)
T ss_pred             HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-
Confidence            4569999999999987643                    4666777766654 89999999999999999999999943 


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      .++..+.....     .+++.-+=++...+.+||.||-+  .++|+|||+||+|||+|+.|++|+||||++.........
T Consensus       176 C~ekLlkrik~-----piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh  248 (391)
T KOG0983|consen  176 CAEKLLKRIKG-----PIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH  248 (391)
T ss_pred             HHHHHHHHhcC-----CchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccccc
Confidence            66666655432     27777777889999999999997  889999999999999999999999999999876554433


Q ss_pred             eeeecccccccccccccccccc-cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          227 VSSLLGARGIIGYIAPEVFSRN-FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                          ....|-+.|||||.+.-. ..+|+.++||||||+.++||.||..||......-.       +...+.......++.
T Consensus       249 ----trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe-------~ltkvln~ePP~L~~  317 (391)
T KOG0983|consen  249 ----TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE-------VLTKVLNEEPPLLPG  317 (391)
T ss_pred             ----ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH-------HHHHHHhcCCCCCCc
Confidence                233477889999999643 35789999999999999999999999987543211       222222222222222


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ...     +...+.+++..||++|+.+||...++++
T Consensus       318 ~~g-----FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  318 HMG-----FSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             ccC-----cCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            221     4567788889999999999999999886

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-34  Score=263.25  Aligned_cols=237  Identities=24%  Similarity=0.401  Sum_probs=177.7

Q ss_pred             hhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhcc---CCCceeeeEeEEecCCc-----ee
Q 036435           87 FKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRT---SHVNVVTLLGFCLEGNN-----RA  137 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l---~h~nIv~l~g~~~~~~~-----~~  137 (372)
                      +.+.||+|+||.||+|+...                     .+.+|+.+++++   +|||++++++++.+.+.     .+
T Consensus         3 ~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~   82 (287)
T cd07838           3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLT   82 (287)
T ss_pred             EEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeE
Confidence            45679999999999997632                     355687777666   59999999999998776     89


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCc
Q 036435          138 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLA  217 (372)
Q Consensus       138 lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla  217 (372)
                      +++||+. ++|.+++......    .+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||++
T Consensus        83 l~~e~~~-~~l~~~l~~~~~~----~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~  154 (287)
T cd07838          83 LVFEHVD-QDLATYLSKCPKP----GLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLA  154 (287)
T ss_pred             EEehhcc-cCHHHHHHHccCC----CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCcc
Confidence            9999996 4899988764322    3899999999999999999999   789999999999999999999999999999


Q ss_pred             ccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhh
Q 036435          218 KLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQ  297 (372)
Q Consensus       218 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (372)
                      .........    ....++..|+|||.+.+.  .++.++|+|||||++|||++|.+||.......   .+... ......
T Consensus       155 ~~~~~~~~~----~~~~~~~~~~~PE~~~~~--~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~---~~~~~-~~~~~~  224 (287)
T cd07838         155 RIYSFEMAL----TSVVVTLWYRAPEVLLQS--SYATPVDMWSVGCIFAELFRRRPLFRGTSEAD---QLDKI-FDVIGL  224 (287)
T ss_pred             eeccCCccc----ccccccccccChHHhccC--CCCCcchhhhHHHHHHHHHhCCCcccCCChHH---HHHHH-HHHcCC
Confidence            775433211    222367789999999775  78899999999999999999998887543211   00000 000000


Q ss_pred             ccccc-----------CCcc----CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          298 DREFK-----------LPGV----VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       298 ~~~~~-----------~~~~----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .....           .+..    ......+....+.+++.+||+.||.+||+++++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         225 PSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            00000           0000    11112234567788999999999999999999884

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=7.8e-35  Score=273.38  Aligned_cols=238  Identities=21%  Similarity=0.246  Sum_probs=175.6

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecC------CceeE
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEG------NNRAL  138 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~------~~~~l  138 (372)
                      ...+.||+|+||.||+++...                     .+.+|+.++++++||||+++++++...      ...++
T Consensus        19 ~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l   98 (353)
T cd07850          19 QNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYL   98 (353)
T ss_pred             EEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEE
Confidence            335789999999999986521                     456799999999999999999998644      35699


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          139 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       139 V~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      |+||+. ++|.+.+...        ++...+..++.|++.||+|||   ..+++|+||||+||+++.++.+||+|||+++
T Consensus        99 v~e~~~-~~l~~~~~~~--------l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~  166 (353)
T cd07850          99 VMELMD-ANLCQVIQMD--------LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  166 (353)
T ss_pred             EEeccC-CCHHHHHhhc--------CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence            999995 5888887532        788899999999999999999   7999999999999999999999999999998


Q ss_pred             cccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCc--------cchHHH
Q 036435          219 LCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE--------VYFPHW  290 (372)
Q Consensus       219 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~--------~~~~~~  290 (372)
                      .......    .....++..|+|||.+.+.  .++.++|||||||++|+|++|+.||.........        .....+
T Consensus       167 ~~~~~~~----~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
T cd07850         167 TAGTSFM----MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF  240 (353)
T ss_pred             eCCCCCC----CCCCcccccccCHHHHhCC--CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            6543221    1223467889999999775  7899999999999999999999999754311000        000000


Q ss_pred             H-------HHHhhhcccc------------cCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          291 I-------YRHVEQDREF------------KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       291 ~-------~~~~~~~~~~------------~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .       ..........            ..+.............+.+++.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            0       0000000000            0000001111123556788999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-35  Score=268.70  Aligned_cols=227  Identities=20%  Similarity=0.355  Sum_probs=187.5

Q ss_pred             hhhhhhcCCCCceEEEEEEec---------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL---------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~---------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      |++.+.||+|.|++|-.+++.                     ..+.+|++.|+.++|||||++|.+......+|||+|.-
T Consensus        20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG   99 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG   99 (864)
T ss_pred             ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence            345577999999998766431                     26889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE-CCCCceEEeecCCcccccC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL-DEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill-~~~~~~kl~Dfgla~~~~~  222 (372)
                      ++|+|.+|+-++...     +.+..+.+++.||+.|+.|+|   +..+|||||||+||.+ ..-|-+||.|||.+-.+..
T Consensus       100 D~GDl~DyImKHe~G-----l~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen  100 DGGDLFDYIMKHEEG-----LNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             CCchHHHHHHhhhcc-----ccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            999999999877642     899999999999999999999   8999999999999886 5678999999999987766


Q ss_pred             CCCeeeeecccccccccccccccccccCCC-CccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEV-SHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF  301 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (372)
                      +...    ...+|...|-|||.+.|.  .| .++.||||||||||.|++|++||+...+...       +...++.  .+
T Consensus       172 G~kL----~TsCGSLAYSAPEILLGD--sYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET-------LTmImDC--KY  236 (864)
T KOG4717|consen  172 GKKL----TTSCGSLAYSAPEILLGD--SYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET-------LTMIMDC--KY  236 (864)
T ss_pred             cchh----hcccchhhccCchhhhcC--ccCCcchhhhHHHHHHHHHHhCCCccccccchhh-------hhhhhcc--cc
Confidence            5533    345688999999999986  44 5789999999999999999999987654321       1111111  11


Q ss_pred             cCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       302 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      -       -+..+..++.+++..||..||.+|.+.++|+.
T Consensus       237 t-------vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  237 T-------VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             c-------CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            1       23456678888999999999999999999885

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.3e-34  Score=267.47  Aligned_cols=223  Identities=30%  Similarity=0.421  Sum_probs=175.1

Q ss_pred             hhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           89 DKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      +.||+|+||.||+|+...                      .+.+|++++++++|||++++++++.+++..++|+||+. |
T Consensus        27 ~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~  105 (313)
T cd06633          27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-G  105 (313)
T ss_pred             eeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-C
Confidence            569999999999996521                      46789999999999999999999999999999999995 5


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      +|.+++.....     .+++.+++.++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||++......   
T Consensus       106 ~l~~~l~~~~~-----~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~---  174 (313)
T cd06633         106 SASDLLEVHKK-----PLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA---  174 (313)
T ss_pred             CHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCCC---
Confidence            88888765332     2899999999999999999999   789999999999999999999999999998643221   


Q ss_pred             eeeecccccccccccccccccc-cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          227 VSSLLGARGIIGYIAPEVFSRN-FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                          ....|+..|+|||.+... .+.++.++|+||||+++|+|++|..||.......       ...... ..   ..+.
T Consensus       175 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~-------~~~~~~-~~---~~~~  239 (313)
T cd06633         175 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIA-QN---DSPT  239 (313)
T ss_pred             ----CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-------HHHHHH-hc---CCCC
Confidence                123477889999998531 1367889999999999999999999987542211       011111 11   1111


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ..   .......+.+++.+||+.+|.+||++.++++
T Consensus       240 ~~---~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         240 LQ---SNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             CC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11   1123345778999999999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=251.37  Aligned_cols=252  Identities=21%  Similarity=0.332  Sum_probs=192.9

Q ss_pred             cccHHHHHHHHhhhhhhcCCCCceEEEEEEe-------------------cchHHHHHHHHhcc-CCCceeeeEeEEecC
Q 036435           74 RYNFSDVKKLTNSFKDKLGQGGFGGVYKGRL-------------------LDDFVNEVASISRT-SHVNVVTLLGFCLEG  133 (372)
Q Consensus        74 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-------------------~~~~~~E~~~l~~l-~h~nIv~l~g~~~~~  133 (372)
                      ..+|+|+.+.|.   +.||+|+|+.|--...                   +.++.+|++++.+. .|+||+.++++|+++
T Consensus        72 ~g~F~d~YkLt~---e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   72 SGKFEDMYKLTS---ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             cchHHHHHHhHH---HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            346788888774   6799999999975533                   23789999999999 599999999999999


Q ss_pred             CceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC---ceE
Q 036435          134 NNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDF---CPK  210 (372)
Q Consensus       134 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~k  210 (372)
                      ..+|||||.|.||+|..++.++.      .|++.++.++..+|+.||.+||   .++|.||||||+|||.....   -+|
T Consensus       149 ~~FYLVfEKm~GGplLshI~~~~------~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvK  219 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQKRK------HFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVK  219 (463)
T ss_pred             ceEEEEEecccCchHHHHHHHhh------hccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCcee
Confidence            99999999999999999998764      3999999999999999999999   89999999999999997554   479


Q ss_pred             EeecCCcccccCCCCe----eeeecccccccccccccccc---cccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCC
Q 036435          211 ISDFGLAKLCTTKEGI----VSSLLGARGIIGYIAPEVFS---RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSS  283 (372)
Q Consensus       211 l~Dfgla~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~  283 (372)
                      |+||.|..-......-    ........|+..|||||++.   ++...|+.++|.||||+|+|-|++|-+||.+....+-
T Consensus       220 iCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC  299 (463)
T KOG0607|consen  220 ICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC  299 (463)
T ss_pred             eeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC
Confidence            9999988654322211    11233456888999999864   3334688999999999999999999999986544321


Q ss_pred             cc-------chHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          284 EV-------YFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       284 ~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ..       .-.+.+.+.+.++ .+..|.   .....+.....+++...+..|+.+|.++.+++.
T Consensus       300 GWdrGe~Cr~CQ~~LFesIQEG-kYeFPd---kdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  300 GWDRGEVCRVCQNKLFESIQEG-KYEFPD---KDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CccCCCccHHHHHHHHHHHhcc-CCcCCh---hhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            11       1122233333332 233332   233445566667777788899999999999886

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=3.7e-35  Score=273.50  Aligned_cols=243  Identities=18%  Similarity=0.265  Sum_probs=178.0

Q ss_pred             hhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEec----CCceeEEEE
Q 036435           87 FKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLE----GNNRALIYE  141 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~----~~~~~lV~e  141 (372)
                      +.+.||+|+||.||+++..+                     .+.+|+.++++++||||+++++++..    ....++|+|
T Consensus         9 ~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e   88 (334)
T cd07855           9 PIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMD   88 (334)
T ss_pred             eeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEe
Confidence            34679999999999986532                     46779999999999999999998763    346899999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      |+. |+|.+++....      .+++..+..++.|++.||+|||   ..+++|+||||+||++++++.+||+|||++....
T Consensus        89 ~~~-~~l~~~~~~~~------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855          89 LME-SDLHHIIHSDQ------PLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS  158 (334)
T ss_pred             hhh-hhHHHHhccCC------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence            995 69999886543      2899999999999999999999   7999999999999999999999999999997654


Q ss_pred             CCCCee-eeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCcc--------c---h--
Q 036435          222 TKEGIV-SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV--------Y---F--  287 (372)
Q Consensus       222 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~--------~---~--  287 (372)
                      ...... .......++..|+|||.+.+. ..++.++|+||||+++|||++|+.||..........        .   .  
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         159 SSPTEHKYFMTEYVATRWYRAPELLLSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             ccCcCCCcccccccccccccChHHhcCC-cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence            332211 111233578889999998653 367899999999999999999999996542211000        0   0  


Q ss_pred             ---HHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          288 ---PHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       288 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                         ........... ....+.............+.+++.+||+.+|++||++++++.
T Consensus       238 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         238 RIGSDRVRKYIQNL-PRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hhchhhHHHHHhhc-ccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence               00000000000 000000000011223567889999999999999999999886

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=4.4e-35  Score=269.87  Aligned_cols=242  Identities=23%  Similarity=0.347  Sum_probs=175.6

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCC--------ce
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGN--------NR  136 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~--------~~  136 (372)
                      .+.+.||+|+||.||+++...                     .+.+|++++++++||||+++++++.+..        ..
T Consensus        11 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   90 (311)
T cd07866          11 EILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSV   90 (311)
T ss_pred             EEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceE
Confidence            345789999999999997531                     4678999999999999999999876543        46


Q ss_pred             eEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCC
Q 036435          137 ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGL  216 (372)
Q Consensus       137 ~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  216 (372)
                      ++|+||+.+ +|...+....     ..+++.++..++.|+++||+|||   +.+++|+||||+||++++++.+||+|||+
T Consensus        91 ~lv~~~~~~-~l~~~~~~~~-----~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~  161 (311)
T cd07866          91 YMVTPYMDH-DLSGLLENPS-----VKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGL  161 (311)
T ss_pred             EEEEecCCc-CHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCcc
Confidence            999999965 7877776432     13899999999999999999999   89999999999999999999999999999


Q ss_pred             cccccCCCCeee--------eecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchH
Q 036435          217 AKLCTTKEGIVS--------SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFP  288 (372)
Q Consensus       217 a~~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~  288 (372)
                      +...........        ......++..|+|||.+.+. ..++.++||||||+++|||++|++||........    .
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~----~  236 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE-RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ----L  236 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCC-CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH----H
Confidence            986543221111        11223467789999988653 3578899999999999999999999865332110    0


Q ss_pred             HHHHHHhh--------------hcc----cccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          289 HWIYRHVE--------------QDR----EFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       289 ~~~~~~~~--------------~~~----~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ..+.....              ...    ....+.............+.+++.+||+.||.+|||+.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            00000000              000    000000000001122356888999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.6e-35  Score=272.32  Aligned_cols=249  Identities=22%  Similarity=0.268  Sum_probs=185.6

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCC-----ceeEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGN-----NRALI  139 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~-----~~~lV  139 (372)
                      .+.+.||+|+||.||+++..+                     .+.+|+.+++.++|+||+++++++....     ..++|
T Consensus         3 ~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv   82 (330)
T cd07834           3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIV   82 (330)
T ss_pred             eeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEE
Confidence            345789999999999997532                     5778999999999999999999998775     78999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccc
Q 036435          140 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL  219 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  219 (372)
                      +||++ ++|.+++....      .+++..+..++.|+++||+|||   +.+++|+||||+||+++.++.++|+|||++..
T Consensus        83 ~e~~~-~~l~~~l~~~~------~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~  152 (330)
T cd07834          83 TELME-TDLHKVIKSPQ------PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARG  152 (330)
T ss_pred             ecchh-hhHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence            99997 58999887643      2899999999999999999999   89999999999999999999999999999987


Q ss_pred             ccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhh--
Q 036435          220 CTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQ--  297 (372)
Q Consensus       220 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--  297 (372)
                      ...............++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||.......    ....+......  
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~----~~~~i~~~~~~~~  227 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPELLLSS-SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID----QLNLIVEVLGTPS  227 (330)
T ss_pred             ecccccccccccccccccCcCCceeeecc-cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH----HHHHHHHhcCCCC
Confidence            65543211112233467889999999764 367899999999999999999999997543211    00000000000  


Q ss_pred             ---------c--------ccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hhcCccc
Q 036435          298 ---------D--------REFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM--LQGSTEA  349 (372)
Q Consensus       298 ---------~--------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~--L~~~~~~  349 (372)
                               .        .....+.............+.+++.+||+.+|.+||+++++++.  +++....
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             hhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence                     0        00000000000011235668889999999999999999999973  5555543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.1e-35  Score=272.04  Aligned_cols=239  Identities=23%  Similarity=0.295  Sum_probs=174.9

Q ss_pred             hhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCC------ceeEEE
Q 036435           88 KDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGN------NRALIY  140 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~------~~~lV~  140 (372)
                      .+.||+|+||.||+|+...                     .+.+|+.++++++||||+++++++....      ..++|+
T Consensus        20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~   99 (342)
T cd07879          20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM   99 (342)
T ss_pred             EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEe
Confidence            4679999999999986521                     3678999999999999999999987543      458999


Q ss_pred             EecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccc
Q 036435          141 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC  220 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~  220 (372)
                      ||+.. +|.++...        .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++..
T Consensus       100 e~~~~-~l~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~  167 (342)
T cd07879         100 PYMQT-DLQKIMGH--------PLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHA  167 (342)
T ss_pred             ccccc-CHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence            99964 77766521        2889999999999999999999   789999999999999999999999999998764


Q ss_pred             cCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHH---------
Q 036435          221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWI---------  291 (372)
Q Consensus       221 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~---------  291 (372)
                      ....      ....++..|+|||.+.+. ..++.++|+|||||++|||++|+.||.......   .+....         
T Consensus       168 ~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~  237 (342)
T cd07879         168 DAEM------TGYVVTRWYRAPEVILNW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGPE  237 (342)
T ss_pred             CCCC------CCceeeecccChhhhcCc-cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCHH
Confidence            3221      123467789999998653 357889999999999999999999997542110   000000         


Q ss_pred             -HHHhhhc----ccccCCccC----CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hhcCcc
Q 036435          292 -YRHVEQD----REFKLPGVV----TRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM--LQGSTE  348 (372)
Q Consensus       292 -~~~~~~~----~~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~--L~~~~~  348 (372)
                       .......    .....+...    ..........+.+++.+||+.||.+||++++++..  +++..+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence             0000000    000000000    00001123567889999999999999999999954  666554

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-35  Score=275.98  Aligned_cols=183  Identities=26%  Similarity=0.445  Sum_probs=157.5

Q ss_pred             hhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecCC------ceeEEEE
Q 036435           88 KDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEGN------NRALIYE  141 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~------~~~lV~e  141 (372)
                      .+.||+|+||.||+|+..+                    ...+|+++|++++|+|||+++++-.+..      ...+|||
T Consensus        18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE   97 (732)
T KOG4250|consen   18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME   97 (732)
T ss_pred             hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence            4679999999999998643                    5788999999999999999999866543      5679999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC--CCC--ceEEeecCCc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLD--EDF--CPKISDFGLA  217 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~--~~kl~Dfgla  217 (372)
                      ||.+|||...|.+..+..   .+++.+.+.++.++..||.|||   .++|+||||||.||++-  ++|  .-||+|||.|
T Consensus        98 yC~gGsL~~~L~~PEN~~---GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   98 YCSGGSLRKVLNSPENAY---GLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             ecCCCcHHHHhcCccccc---CCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            999999999998765543   3999999999999999999999   89999999999999983  334  4699999999


Q ss_pred             ccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCC
Q 036435          218 KLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDS  281 (372)
Q Consensus       218 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~  281 (372)
                      +...++.    ......||..|.+||...++ ..++...|.|||||++|+..||..||.....+
T Consensus       172 rel~d~s----~~~S~vGT~~YLhPel~E~q-~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  172 RELDDNS----LFTSLVGTEEYLHPELYERQ-KKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             ccCCCCC----eeeeecCchhhcChHHHhhc-cCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence            9876655    34556799999999999853 48899999999999999999999999876554

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.1e-34  Score=265.68  Aligned_cols=233  Identities=21%  Similarity=0.350  Sum_probs=175.8

Q ss_pred             hhhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccC-CCceeeeEeEEecCCceeEEEEecC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTS-HVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~-h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      .+.+.||+|+||.||+++..+                    ++.+|+.++.+.. ||||+++++++.++...++||||++
T Consensus        18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   97 (296)
T cd06618          18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS   97 (296)
T ss_pred             eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC
Confidence            446789999999999997642                    3556777666664 9999999999999999999999985


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                       ++|.+.+.....     .+++..+..++.|++.||+|||+  ..+++|+||+|+||++++++.+||+|||++.......
T Consensus        98 -~~l~~l~~~~~~-----~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          98 -TCLDKLLKRIQG-----PIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             -cCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence             478777655332     38999999999999999999993  2589999999999999999999999999987654322


Q ss_pred             Ceeeeeccccccccccccccccccc--CCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNF--GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      ..    ....++..|+|||.+.+..  +.++.++|+||||+++|+|++|+.||.......      +........ ....
T Consensus       170 ~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~-~~~~  238 (296)
T cd06618         170 AK----TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF------EVLTKILQE-EPPS  238 (296)
T ss_pred             cc----cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH------HHHHHHhcC-CCCC
Confidence            11    1224677899999987541  347889999999999999999999986431110      111111111 1111


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                      .+.     .......+.+++.+||+.||.+||+++++++.
T Consensus       239 ~~~-----~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         239 LPP-----NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CCC-----CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            111     01234567889999999999999999999863

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-35  Score=249.72  Aligned_cols=232  Identities=21%  Similarity=0.279  Sum_probs=184.6

Q ss_pred             hhcCCCCceEEEEEEecc--------------hHHHHHHHHhcc-CCCceeeeEeEEecC----CceeEEEEecCCCChh
Q 036435           89 DKLGQGGFGGVYKGRLLD--------------DFVNEVASISRT-SHVNVVTLLGFCLEG----NNRALIYEFMPNGSLE  149 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~--------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~----~~~~lV~e~~~~g~L~  149 (372)
                      ++||-|-.|.|-....+.              ...+|+++--.. .|||||++++++.+.    ..+.+|||.|+||.|.
T Consensus        68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLf  147 (400)
T KOG0604|consen   68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELF  147 (400)
T ss_pred             hhhccccCCceEEEEeccchhhhHHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHH
Confidence            679999999998765432              467788875555 599999999998753    4678999999999999


Q ss_pred             hhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC---CCCceEEeecCCcccccCCCCe
Q 036435          150 KFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLD---EDFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       150 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      +.+.+++..    .+++.++-.|..||+.|+.|||   +.+|.||||||+|+|.+   .+..+||+|||.|+....... 
T Consensus       148 sriq~~g~~----afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~-  219 (400)
T KOG0604|consen  148 SRIQDRGDQ----AFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGD-  219 (400)
T ss_pred             HHHHHcccc----cchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccccccccCCCcc-
Confidence            999887653    4999999999999999999999   89999999999999996   456799999999987554332 


Q ss_pred             eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCcc
Q 036435          227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV  306 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (372)
                         ....+-|+.|.|||++...  +++..+|+||+||++|-|++|-+||+.....    .+..-+...+..+ .+..   
T Consensus       220 ---L~TPc~TPyYvaPevlg~e--KydkscdmwSlgVimYIlLCGyPPFYS~hg~----aispgMk~rI~~g-qy~F---  286 (400)
T KOG0604|consen  220 ---LMTPCFTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGL----AISPGMKRRIRTG-QYEF---  286 (400)
T ss_pred             ---ccCCcccccccCHHHhCch--hcCCCCCccchhHHHHHhhcCCCcccccCCc----cCChhHHhHhhcc-CccC---
Confidence               3445678999999999775  8999999999999999999999999975431    1111122222221 2222   


Q ss_pred             CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       307 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ..++...+++...+++...|..+|++|.|+.+++.
T Consensus       287 P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  287 PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            23455667788888999999999999999999885

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1e-34  Score=271.33  Aligned_cols=244  Identities=21%  Similarity=0.268  Sum_probs=174.1

Q ss_pred             hhhhhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEecC-------------
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLEG-------------  133 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~-------------  133 (372)
                      .+.+.||.|+||.||+|...+                   .+.+|++++++++||||+++++++...             
T Consensus         8 ~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~   87 (342)
T cd07854           8 MDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTE   87 (342)
T ss_pred             EEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccc
Confidence            345789999999999986532                   477899999999999999999876654             


Q ss_pred             -CceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC-CCCceEE
Q 036435          134 -NNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLD-EDFCPKI  211 (372)
Q Consensus       134 -~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl  211 (372)
                       ...++|+||++ ++|.+++....       +++..+..++.|+++||.|||   +.+++||||||+||+++ +++.+|+
T Consensus        88 ~~~~~lv~e~~~-~~L~~~~~~~~-------l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          88 LNSVYIVQEYME-TDLANVLEQGP-------LSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             cceEEEEeeccc-ccHHHHHHcCC-------CCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEE
Confidence             35789999997 59988885432       889999999999999999999   79999999999999997 5567899


Q ss_pred             eecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccch----
Q 036435          212 SDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYF----  287 (372)
Q Consensus       212 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~----  287 (372)
                      +|||++.................++..|+|||.+.+. ..++.++|+|||||++|+|++|+.||............    
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~  235 (342)
T cd07854         157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV  235 (342)
T ss_pred             CCcccceecCCccccccccccccccccccCHHHHhCc-cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            9999997654322211111223467789999987543 36788999999999999999999999754321100000    


Q ss_pred             ----H---HHHHHHhhhccc--ccCCc-cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          288 ----P---HWIYRHVEQDRE--FKLPG-VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       288 ----~---~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                          .   ............  ...+. ............+.+++.+||+.||.+|||++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence                0   000000000000  00000 000001123456788999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=261.06  Aligned_cols=240  Identities=22%  Similarity=0.329  Sum_probs=185.0

Q ss_pred             hhhhhhcCCCCceEEEEEEecc--------------------------hHHHHHHHHhccCCCceeeeEeEEe-cCCcee
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD--------------------------DFVNEVASISRTSHVNVVTLLGFCL-EGNNRA  137 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~--------------------------~~~~E~~~l~~l~h~nIv~l~g~~~-~~~~~~  137 (372)
                      +-+...||+|+|+.|||+.+..                          ...+|-.+-+.|.||.||++|+++. +.+.+|
T Consensus       465 YLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFC  544 (775)
T KOG1151|consen  465 YLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFC  544 (775)
T ss_pred             HHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccce
Confidence            3345789999999999985421                          5788999999999999999999886 567889


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC---CCCceEEeec
Q 036435          138 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLD---EDFCPKISDF  214 (372)
Q Consensus       138 lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Df  214 (372)
                      -|+|||+|.+|+-||+.+..      +++.++..|+.||.+||.||.+- ..+|||.||||.|||+.   ..|.+||.||
T Consensus       545 TVLEYceGNDLDFYLKQhkl------mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF  617 (775)
T KOG1151|consen  545 TVLEYCEGNDLDFYLKQHKL------MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF  617 (775)
T ss_pred             eeeeecCCCchhHHHHhhhh------hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence            99999999999999987653      89999999999999999999853 78999999999999994   5688999999


Q ss_pred             CCcccccCCCCe----eeeeccccccccccccccccc--ccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchH
Q 036435          215 GLAKLCTTKEGI----VSSLLGARGIIGYIAPEVFSR--NFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFP  288 (372)
Q Consensus       215 gla~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~  288 (372)
                      ||++.+......    ........||.-|++||++.-  ...+++.|.||||+|||+|+.+.|+.||.......      
T Consensus       618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ------  691 (775)
T KOG1151|consen  618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ------  691 (775)
T ss_pred             chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH------
Confidence            999987654322    122345669999999998753  24578999999999999999999999998753321      


Q ss_pred             HHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          289 HWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                          ..+..+..+.......+.-+.+..+..+++.+||+..-++|....++..
T Consensus       692 ----dILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  692 ----DILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             ----HHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence                1111221111111111112223455667888999999999988777664

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.1e-34  Score=262.92  Aligned_cols=229  Identities=24%  Similarity=0.388  Sum_probs=182.1

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccC-CCceeeeEeEEecCCceeEEEEe
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTS-HVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~-h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      .+.+.||+|+||.||+++...                      .+.+|..++++++ ||||+++++++.+++..++||||
T Consensus         4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd05581           4 KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEY   83 (280)
T ss_pred             eEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcC
Confidence            345679999999999997631                      4677899999998 99999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      +++++|.+++.+..      .+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++++|||++.....
T Consensus        84 ~~~~~L~~~l~~~~------~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          84 APNGELLQYIRKYG------SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             CCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            99999999997654      2899999999999999999999   89999999999999999999999999999986543


Q ss_pred             CCCe-----------------eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCcc
Q 036435          223 KEGI-----------------VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV  285 (372)
Q Consensus       223 ~~~~-----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~  285 (372)
                      ....                 ........++..|+|||.+.+.  .++.++|+||||++++++++|..||......    
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----  228 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK--PAGKSSDLWALGCIIYQMLTGKPPFRGSNEY----  228 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCC--CCChhhhHHHHHHHHHHHHhCCCCCCCccHH----
Confidence            3211                 0111223467889999998764  6889999999999999999999998754311    


Q ss_pred             chHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCH----HHHHH
Q 036435          286 YFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPM----NEVIE  341 (372)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~----~evl~  341 (372)
                          ....... ......+       ..+...+.+++.+||+.+|.+||++    +++++
T Consensus       229 ----~~~~~~~-~~~~~~~-------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         229 ----LTFQKIL-KLEYSFP-------PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             ----HHHHHHH-hcCCCCC-------CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence                0111111 1111112       1225678889999999999999999    77664

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-34  Score=255.13  Aligned_cols=218  Identities=28%  Similarity=0.360  Sum_probs=176.3

Q ss_pred             cCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCCh
Q 036435           91 LGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL  148 (372)
Q Consensus        91 lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L  148 (372)
                      ||+|+||.||+++..+                      .+.+|+.++++++||||+++++.+.+++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            6999999999986531                      577899999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeee
Q 036435          149 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVS  228 (372)
Q Consensus       149 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  228 (372)
                      .+++....      .+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.........  
T Consensus        81 ~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~--  149 (250)
T cd05123          81 FSHLSKEG------RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR--  149 (250)
T ss_pred             HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCc--
Confidence            99997653      2899999999999999999999   799999999999999999999999999999865443211  


Q ss_pred             eecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCC
Q 036435          229 SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVT  308 (372)
Q Consensus       229 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (372)
                       .....++..|++||...+.  ..+.++|+||||+++|++++|..||.....       .. ....... .....+..  
T Consensus       150 -~~~~~~~~~~~~Pe~~~~~--~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-------~~-~~~~~~~-~~~~~~~~--  215 (250)
T cd05123         150 -TNTFCGTPEYLAPEVLLGK--GYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-------KE-IYEKILK-DPLRFPEF--  215 (250)
T ss_pred             -ccCCcCCccccChHHhCCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HH-HHHHHhc-CCCCCCCC--
Confidence             1233477889999998764  678899999999999999999999864322       01 1111111 12222222  


Q ss_pred             cchHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 036435          309 RKENEIAKKMIIVGLWCIQARPSDRPPMNE  338 (372)
Q Consensus       309 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  338 (372)
                           ....+.+++.+||..||++||++.+
T Consensus       216 -----~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         216 -----LSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             -----CCHHHHHHHHHHhcCCHhhCCCccc
Confidence                 2456778999999999999999944

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-34  Score=284.74  Aligned_cols=232  Identities=22%  Similarity=0.270  Sum_probs=183.5

Q ss_pred             hhhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEe
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      +.+.+.||+|+||.|..+++..                      -|..|-.+|..-+.+-|+.++-.|.+++++|+||||
T Consensus        77 feilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY  156 (1317)
T KOG0612|consen   77 FEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDY  156 (1317)
T ss_pred             hHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEec
Confidence            3456789999999999998743                      377788899988999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      |+||||-..+.+.+.      +++..+..++..|..||.-||   +.|+|||||||+|||||..|++||+|||.+.....
T Consensus       157 ~pGGDlltLlSk~~~------~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~  227 (1317)
T KOG0612|consen  157 MPGGDLLTLLSKFDR------LPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA  227 (1317)
T ss_pred             ccCchHHHHHhhcCC------ChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence            999999999988762      899999999999999999999   89999999999999999999999999999987765


Q ss_pred             CCCeeeeecccccccccccccccccc--c-CCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHh-hhc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRN--F-GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV-EQD  298 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~  298 (372)
                      .....  .....|||.|.+||++...  . +.|...+|.||+||++|||+.|..||+.+.-..        .+..+ ...
T Consensus       228 dG~V~--s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslve--------TY~KIm~hk  297 (1317)
T KOG0612|consen  228 DGTVR--SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVE--------TYGKIMNHK  297 (1317)
T ss_pred             CCcEE--eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHH--------HHHHHhchh
Confidence            44333  3566799999999998632  2 578999999999999999999999998643211        22222 223


Q ss_pred             ccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 036435          299 REFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPP---MNEVIE  341 (372)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~evl~  341 (372)
                      ..+..|....     +++...+++.+.+ -+|+.|..   ++++-.
T Consensus       298 ~~l~FP~~~~-----VSeeakdLI~~ll-~~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  298 ESLSFPDETD-----VSEEAKDLIEALL-CDREVRLGRNGIEDIKN  337 (1317)
T ss_pred             hhcCCCcccc-----cCHHHHHHHHHHh-cChhhhcccccHHHHHh
Confidence            3444452211     2333334444333 36778887   888765

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=4.1e-34  Score=266.22  Aligned_cols=245  Identities=24%  Similarity=0.302  Sum_probs=174.8

Q ss_pred             hhhhhcCCCCceEEEEEEecc-----------------------hHHHHHHHHhcc-CCCceeeeEeEEecC----Ccee
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD-----------------------DFVNEVASISRT-SHVNVVTLLGFCLEG----NNRA  137 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~-----------------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~----~~~~  137 (372)
                      .+.+.||+|+||.||+++...                       .+.+|+.+++++ +||||+++++.+...    ...+
T Consensus         3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~   82 (332)
T cd07857           3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELY   82 (332)
T ss_pred             eEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEE
Confidence            345779999999999987532                       357799999999 599999999976432    4568


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCc
Q 036435          138 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLA  217 (372)
Q Consensus       138 lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla  217 (372)
                      +++||+. ++|.+++....      .+++..+..++.|++.||+|||   ..+++|+||||+||++++++.+||+|||++
T Consensus        83 ~~~e~~~-~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a  152 (332)
T cd07857          83 LYEELME-ADLHQIIRSGQ------PLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLA  152 (332)
T ss_pred             EEEeccc-CCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence            8889885 69999886543      2899999999999999999999   799999999999999999999999999999


Q ss_pred             ccccCCCCee-eeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCcc--------chH
Q 036435          218 KLCTTKEGIV-SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV--------YFP  288 (372)
Q Consensus       218 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~--------~~~  288 (372)
                      .......... .......||..|+|||.+.+. ..++.++|+||+|+++|++++|+.||..........        ...
T Consensus       153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  231 (332)
T cd07857         153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE  231 (332)
T ss_pred             eecccccccccccccCcccCccccCcHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence            8654322111 111233578899999987653 367899999999999999999999987543110000        000


Q ss_pred             HHHHHHhhhc-----ccc-cCC-ccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          289 HWIYRHVEQD-----REF-KLP-GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       289 ~~~~~~~~~~-----~~~-~~~-~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .+........     ... ..+ .............+.+++.+||+.||++|||++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0000000000     000 000 0000000112456788999999999999999999885

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.6e-34  Score=267.22  Aligned_cols=246  Identities=20%  Similarity=0.289  Sum_probs=175.5

Q ss_pred             HHHHHHhhh--hhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecC--
Q 036435           79 DVKKLTNSF--KDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEG--  133 (372)
Q Consensus        79 ~~~~~~~~~--~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~--  133 (372)
                      ++...+.+|  .+.||+|+||.||++....                     .+.+|+.++++++||||+++++++...  
T Consensus        11 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~   90 (345)
T cd07877          11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS   90 (345)
T ss_pred             HHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence            333344443  4679999999999986421                     466799999999999999999988643  


Q ss_pred             ----CceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCce
Q 036435          134 ----NNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP  209 (372)
Q Consensus       134 ----~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~  209 (372)
                          ...+++++++ +++|.+++....       +++..+..++.|++.||+|||   +.+++|+||||+||++++++.+
T Consensus        91 ~~~~~~~~lv~~~~-~~~L~~~~~~~~-------l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~  159 (345)
T cd07877          91 LEEFNDVYLVTHLM-GADLNNIVKCQK-------LTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCEL  159 (345)
T ss_pred             ccccccEEEEehhc-ccCHHHHHhcCC-------CCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCE
Confidence                3467888887 789988875432       899999999999999999999   8999999999999999999999


Q ss_pred             EEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccch--
Q 036435          210 KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYF--  287 (372)
Q Consensus       210 kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~--  287 (372)
                      ||+|||++.......      ....++..|+|||.+.+. ..++.++|+|||||++|||++|+.||...........+  
T Consensus       160 kl~dfg~~~~~~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~  232 (345)
T cd07877         160 KILDFGLARHTDDEM------TGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR  232 (345)
T ss_pred             EEecccccccccccc------cccccCCCccCHHHHhCc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            999999987643221      223477889999988653 36788999999999999999999998643221100000  


Q ss_pred             -----HHHHHHHhhhcc------c-ccCCcc-CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          288 -----PHWIYRHVEQDR------E-FKLPGV-VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       288 -----~~~~~~~~~~~~------~-~~~~~~-~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                           .......+....      . ...+.. ...........+.+++.+|++.||.+||++.++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence                 000000000000      0 000000 000000123467889999999999999999998863

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4e-34  Score=265.75  Aligned_cols=237  Identities=22%  Similarity=0.296  Sum_probs=174.2

Q ss_pred             hhhcCCCCceEEEEEEec---------------------chHHHHHHHHhccCCCceeeeEeEEec-CCceeEEEEecCC
Q 036435           88 KDKLGQGGFGGVYKGRLL---------------------DDFVNEVASISRTSHVNVVTLLGFCLE-GNNRALIYEFMPN  145 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~---------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~-~~~~~lV~e~~~~  145 (372)
                      .+.||+|+||.||++...                     ..+.+|+.++++++||||+++++++.. +...++|+||+ +
T Consensus        15 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~   93 (328)
T cd07856          15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-G   93 (328)
T ss_pred             EEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-c
Confidence            478999999999998542                     157789999999999999999999876 56789999999 5


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      ++|.+++....       +++.....++.|+++||+|||   +.+++|+||+|+||++++++.+||+|||++....... 
T Consensus        94 ~~L~~~~~~~~-------~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~-  162 (328)
T cd07856          94 TDLHRLLTSRP-------LEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM-  162 (328)
T ss_pred             cCHHHHHhcCC-------CCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccccCCCc-
Confidence            69998886432       788888899999999999999   8999999999999999999999999999987543221 


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccch--------HHHHHHHhhh
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYF--------PHWIYRHVEQ  297 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~--------~~~~~~~~~~  297 (372)
                           ....++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||...........+        .++.......
T Consensus       163 -----~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (328)
T cd07856         163 -----TGYVSTRYYRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSE  236 (328)
T ss_pred             -----CCCcccccccCceeeecc-CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccch
Confidence                 122467789999987652 36789999999999999999999998653211000000        0000000000


Q ss_pred             c-----ccccC--CccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          298 D-----REFKL--PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       298 ~-----~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                      .     .....  +.............+.+++.+||+.+|++||++++++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         237 NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0     00000  000000111234678889999999999999999998763

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-34  Score=259.58  Aligned_cols=241  Identities=24%  Similarity=0.339  Sum_probs=180.3

Q ss_pred             hhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           88 KDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      .+.||+|+||.||+|+..+                     .+.+|+.++++++|+|++++++++.+.+..++|+||++ +
T Consensus         4 ~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~   82 (282)
T cd07829           4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-M   82 (282)
T ss_pred             ehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-c
Confidence            4679999999999986642                     46779999999999999999999999999999999997 5


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      +|.+++.....     .+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||++.........
T Consensus        83 ~l~~~i~~~~~-----~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~  154 (282)
T cd07829          83 DLKKYLDKRPG-----PLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT  154 (282)
T ss_pred             CHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence            99999976531     2899999999999999999999   789999999999999999999999999999866443221


Q ss_pred             eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccch-------HHHHHHHhhhc-
Q 036435          227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYF-------PHWIYRHVEQD-  298 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~-------~~~~~~~~~~~-  298 (372)
                         .....++..|+|||.+.+. ..++.++|+||||+++||+++|+.||...........+       ....+...... 
T Consensus       155 ---~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07829         155 ---YTHEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP  230 (282)
T ss_pred             ---cCccccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence               1222356679999998654 36789999999999999999999988654321100000       00000000000 


Q ss_pred             -ccccCCccCC----cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          299 -REFKLPGVVT----RKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       299 -~~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                       .....+....    .........+.+++.+||+.||++||++++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence             0000111100    111123567899999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.6e-34  Score=268.74  Aligned_cols=226  Identities=24%  Similarity=0.346  Sum_probs=185.5

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      .+...||+|.|+.|..++...                     .+.+|+++|..++|||||+++.+......+|+||||+.
T Consensus        59 ~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~  138 (596)
T KOG0586|consen   59 VIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYAS  138 (596)
T ss_pred             eeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEecc
Confidence            445789999999999997632                     47899999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      +|.+.+|+.+.+.      .....+..++.|+..|++|||   +..|+|||||++||||+.+.++||+|||++..+....
T Consensus       139 ~ge~~~yl~~~gr------~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~  209 (596)
T KOG0586|consen  139 GGELFDYLVKHGR------MKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL  209 (596)
T ss_pred             CchhHHHHHhccc------chhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeecccc
Confidence            9999999988764      555888899999999999999   8999999999999999999999999999998876433


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCC
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP  304 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (372)
                      .    ....+|++.|.|||+..+. ....+++|+||+|+++|-|+.|..||++..-....        .... ...+.+|
T Consensus       210 ~----lqt~cgsppyAaPEl~~g~-~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr--------~rvl-~gk~rIp  275 (596)
T KOG0586|consen  210 M----LQTFCGSPPYAAPELFNGK-KYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR--------PRVL-RGKYRIP  275 (596)
T ss_pred             c----ccccCCCCCccChHhhcCc-ccCCcceehhhhhhhheeeeecccccCCccccccc--------chhe-eeeeccc
Confidence            2    3455799999999999886 35578999999999999999999999865332211        1111 1123334


Q ss_pred             ccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       305 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      -..+.       ++-+++++.|-.+|.+|++++++.+
T Consensus       276 ~~ms~-------dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  276 FYMSC-------DCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             ceeec-------hhHHHHHHhhccCccccCCHHHhhh
Confidence            33333       4445666677999999999999886

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3e-34  Score=268.24  Aligned_cols=237  Identities=23%  Similarity=0.272  Sum_probs=174.8

Q ss_pred             hhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCC------ceeEE
Q 036435           87 FKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGN------NRALI  139 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~------~~~lV  139 (372)
                      ..+.||+|+||.||++....                     .+.+|+.++++++||||+++++++..+.      ..++|
T Consensus        19 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv   98 (343)
T cd07880          19 DLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLV   98 (343)
T ss_pred             EEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEE
Confidence            35679999999999986421                     4678999999999999999999987654      35899


Q ss_pred             EEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccc
Q 036435          140 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL  219 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  219 (372)
                      +||+ +++|.+++....       +++..+..++.|+++||+|||   +.+++||||||+||++++++.+||+|||++..
T Consensus        99 ~e~~-~~~l~~~~~~~~-------l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~  167 (343)
T cd07880          99 MPFM-GTDLGKLMKHEK-------LSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  167 (343)
T ss_pred             EecC-CCCHHHHHhcCC-------CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence            9999 779988886432       899999999999999999999   89999999999999999999999999999986


Q ss_pred             ccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccc-------hHHHHH
Q 036435          220 CTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVY-------FPHWIY  292 (372)
Q Consensus       220 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~-------~~~~~~  292 (372)
                      .....      ....++..|+|||.+.+. ..++.++|+||+|+++|++++|+.||...........       .+....
T Consensus       168 ~~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  240 (343)
T cd07880         168 TDSEM------TGYVVTRWYRAPEVILNW-MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV  240 (343)
T ss_pred             cccCc------cccccCCcccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            54322      223467889999998653 3578899999999999999999999975422100000       000000


Q ss_pred             HHhhhc----ccccCCccC----CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          293 RHVEQD----REFKLPGVV----TRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       293 ~~~~~~----~~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ..+...    .....+...    ..........+.+++.+|++.||++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            000000    000001000    0011123446788999999999999999999994

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.9e-34  Score=285.09  Aligned_cols=183  Identities=24%  Similarity=0.402  Sum_probs=127.0

Q ss_pred             eEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCC
Q 036435          137 ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGL  216 (372)
Q Consensus       137 ~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  216 (372)
                      ||=||||+.-.|.+++..+...     -.....++++++|++||+|+|   +.++|||||||.||++|+++.|||+|||+
T Consensus       672 YIQMEyCE~~ll~~iI~~N~~~-----~~~d~~wrLFreIlEGLaYIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGL  743 (1351)
T KOG1035|consen  672 YIQMEYCEKTLLRDIIRRNHFN-----SQRDEAWRLFREILEGLAYIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGL  743 (1351)
T ss_pred             EEEHhhhhhhHHHHHHHhcccc-----hhhHHHHHHHHHHHHHHHHHH---hCceeeccCCcceeEEcCCCCeeeccccc
Confidence            4567777775566665544311     035678899999999999999   89999999999999999999999999999


Q ss_pred             ccccc----C-------C----CCeeeeeccccccccccccccccccc-CCCCccccchhHHHHHHHHhcCCCCCCCCCC
Q 036435          217 AKLCT----T-------K----EGIVSSLLGARGIIGYIAPEVFSRNF-GEVSHKSDVYSFGMMIMELVGCKNNLDSGVD  280 (372)
Q Consensus       217 a~~~~----~-------~----~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~  280 (372)
                      |....    .       .    ...........||.-|+|||.+.+.. ..++.|+|+||+|+|++||+.   ||....+
T Consensus       744 At~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME  820 (1351)
T KOG1035|consen  744 ATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME  820 (1351)
T ss_pred             chhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHH
Confidence            98721    0       0    00111223456899999999998752 269999999999999999983   3443221


Q ss_pred             CCCccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          281 SSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .          ...+..-+...+|...+.... ....-..++.++++.||.+|||+.|++.
T Consensus       821 R----------a~iL~~LR~g~iP~~~~f~~~-~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  821 R----------ASILTNLRKGSIPEPADFFDP-EHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             H----------HHHHHhcccCCCCCCcccccc-cchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence            0          111222222233332111222 2334456889999999999999999985

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-34  Score=269.64  Aligned_cols=237  Identities=23%  Similarity=0.290  Sum_probs=175.5

Q ss_pred             hhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCc------eeEE
Q 036435           87 FKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNN------RALI  139 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~------~~lV  139 (372)
                      +.+.||+|+||.||+|+...                     .+.+|+.++++++||||+++++++...+.      .++|
T Consensus        19 ~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv   98 (343)
T cd07851          19 NLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLV   98 (343)
T ss_pred             EEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEE
Confidence            34679999999999986631                     35679999999999999999998876554      8999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccc
Q 036435          140 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL  219 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  219 (372)
                      +||+ +++|.+++...       .+++..+..++.|+++||+|||   +.+++|+||||+||++++++.+||+|||++..
T Consensus        99 ~e~~-~~~L~~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~  167 (343)
T cd07851          99 THLM-GADLNNIVKCQ-------KLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARH  167 (343)
T ss_pred             EecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccccccc
Confidence            9999 66999988652       2899999999999999999999   79999999999999999999999999999986


Q ss_pred             ccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccc--------hHHHH
Q 036435          220 CTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVY--------FPHWI  291 (372)
Q Consensus       220 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~--------~~~~~  291 (372)
                      .....      ....++..|+|||.+.+. ..++.++||||||+++|++++|+.||...........        -..+.
T Consensus       168 ~~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  240 (343)
T cd07851         168 TDDEM------TGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL  240 (343)
T ss_pred             ccccc------cCCcccccccCHHHHhCC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence            54321      223467789999998653 3678899999999999999999999975422110000        00000


Q ss_pred             HHHhhhcc-cc--cCCccC----CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          292 YRHVEQDR-EF--KLPGVV----TRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       292 ~~~~~~~~-~~--~~~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ........ .+  ..+...    ..........+.+++.+||+.||.+|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            00000000 00  000000    0000112467889999999999999999999986

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-34  Score=248.60  Aligned_cols=219  Identities=22%  Similarity=0.293  Sum_probs=177.8

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      +|.+.||+|.||.|-..+-..                      .-+.|-++|+..+||.+..+.-.|+..+.+|+||||.
T Consensus       171 dfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeya  250 (516)
T KOG0690|consen  171 DFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYA  250 (516)
T ss_pred             hHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEc
Confidence            566889999999998775421                      3466888999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      .||.|.-+|.+..      .+++.....+-..|..||.|||   +.+||.||||.+|.|+|.+|.+||+|||+++..-..
T Consensus       251 nGGeLf~HLsrer------~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~  321 (516)
T KOG0690|consen  251 NGGELFFHLSRER------VFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY  321 (516)
T ss_pred             cCceEeeehhhhh------cccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhcccc
Confidence            9999999997643      3888888999999999999999   899999999999999999999999999999854322


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                      .   ......+|||.|+|||++..+  .+....|.|.+||++|||++|+.||+......        +.+.+ -...++.
T Consensus       322 g---~t~kTFCGTPEYLAPEVleDn--DYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k--------LFeLI-l~ed~kF  387 (516)
T KOG0690|consen  322 G---DTTKTFCGTPEYLAPEVLEDN--DYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK--------LFELI-LMEDLKF  387 (516)
T ss_pred             c---ceeccccCChhhcCchhhccc--cccceeehhhhhHHHHHHHhccCcccccchhH--------HHHHH-HhhhccC
Confidence            2   234566899999999999886  89999999999999999999999998653321        12221 1234455


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCC
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRP  334 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP  334 (372)
                      |...++..       ..+....|.+||.+|.
T Consensus       388 Pr~ls~eA-------ktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  388 PRTLSPEA-------KTLLSGLLKKDPKKRL  411 (516)
T ss_pred             CccCCHHH-------HHHHHHHhhcChHhhc
Confidence            55555433       3455557799999996

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.3e-35  Score=246.20  Aligned_cols=243  Identities=23%  Similarity=0.374  Sum_probs=181.8

Q ss_pred             hhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecC--------CceeEE
Q 036435           89 DKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEG--------NNRALI  139 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~--------~~~~lV  139 (372)
                      .+||+|.||.||+++..+                     ...+|+++|..++|+|++.+++.|...        ..+|+|
T Consensus        23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylV  102 (376)
T KOG0669|consen   23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLV  102 (376)
T ss_pred             HhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeee
Confidence            579999999999986533                     578999999999999999999998742        247999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccc
Q 036435          140 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL  219 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  219 (372)
                      |++|++ +|...|.+..-     .++..++.++..++.+||.|+|   ...|+|||+|++|+||+.++.+||+|||+++.
T Consensus       103 f~~ceh-DLaGlLsn~~v-----r~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar~  173 (376)
T KOG0669|consen  103 FDFCEH-DLAGLLSNRKV-----RFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLARA  173 (376)
T ss_pred             HHHhhh-hHHHHhcCccc-----cccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence            999987 99999976532     3899999999999999999999   89999999999999999999999999999976


Q ss_pred             ccCCCCe-eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhc
Q 036435          220 CTTKEGI-VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQD  298 (372)
Q Consensus       220 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (372)
                      +...... .....+..-|.-|.+||.+.|. ..++++.|+|+.||++.||+|+.+-+....+... ..+...+...+...
T Consensus       174 fs~~~n~~kprytnrvvTLwYrppEllLG~-r~yg~~iDiWgAgCimaeMwtrspimqgnteqqq-l~~Is~LcGs~tke  251 (376)
T KOG0669|consen  174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGD-REYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQ-LHLISQLCGSITKE  251 (376)
T ss_pred             eecccccCCCCcccceeeeecCCHHHhhcc-cccCCcchhHhHHHHHHHHHccCccccCChHHHH-HHHHHHHhccCCcc
Confidence            6543322 2222333457889999999986 6899999999999999999999988876543211 11111111000000


Q ss_pred             -------------c-cccCCccCCcchHHHHH------HHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          299 -------------R-EFKLPGVVTRKENEIAK------KMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       299 -------------~-~~~~~~~~~~~~~~~~~------~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                                   . ....+........+..+      ..++++..++..||.+|+++++++..
T Consensus       252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence                         0 00011111112222222      56788888999999999999999864

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.3e-33  Score=250.18  Aligned_cols=206  Identities=19%  Similarity=0.200  Sum_probs=163.9

Q ss_pred             CCceEEEEEEecc--------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCChhhhhhcCCCCC
Q 036435           94 GGFGGVYKGRLLD--------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSK  159 (372)
Q Consensus        94 G~~g~V~~~~~~~--------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~  159 (372)
                      |.||.||+++...              .+.+|...+....||||+++++++.+++..++||||+++|+|.+++.....  
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--   81 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLN--   81 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhhhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcC--
Confidence            7899999887632              355666666667899999999999999999999999999999999876432  


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeeeeeccccccccc
Q 036435          160 PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY  239 (372)
Q Consensus       160 ~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  239 (372)
                          +++..+..++.|+++||+|||   +.+++|+||||+||+++.++.++++|||.+.......      ....++..|
T Consensus        82 ----l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~------~~~~~~~~y  148 (237)
T cd05576          82 ----IPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC------DGEAVENMY  148 (237)
T ss_pred             ----CCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc------ccCCcCccc
Confidence                899999999999999999999   8999999999999999999999999999886554321      122356679


Q ss_pred             ccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCCcchHHHHHHHH
Q 036435          240 IAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMI  319 (372)
Q Consensus       240 ~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  319 (372)
                      +|||.+.+.  .++.++|+||+|+++|||++|..|+.......             ........|       ......+.
T Consensus       149 ~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------------~~~~~~~~~-------~~~~~~~~  206 (237)
T cd05576         149 CAPEVGGIS--EETEACDWWSLGAILFELLTGKTLVECHPSGI-------------NTHTTLNIP-------EWVSEEAR  206 (237)
T ss_pred             cCCcccCCC--CCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------------ccccccCCc-------ccCCHHHH
Confidence            999998664  67899999999999999999998765321110             000111112       12345677


Q ss_pred             HHHHHcccCCCCCCCCH
Q 036435          320 IVGLWCIQARPSDRPPM  336 (372)
Q Consensus       320 ~l~~~cl~~~p~~RPs~  336 (372)
                      +++.+|++.||++||++
T Consensus       207 ~li~~~l~~dp~~R~~~  223 (237)
T cd05576         207 SLLQQLLQFNPTERLGA  223 (237)
T ss_pred             HHHHHHccCCHHHhcCC
Confidence            89999999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-33  Score=266.09  Aligned_cols=221  Identities=20%  Similarity=0.304  Sum_probs=176.2

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------hHHHHHHHHhcc-CCCceeeeEeEEecCCceeEEEEecCCCChh
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------DFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNGSLE  149 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~  149 (372)
                      .+...+|.|+|+.|-++....               +..+|+.++... +||||+++.+.+.++.+.|+|||.+.++-|.
T Consensus       325 ~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell  404 (612)
T KOG0603|consen  325 EFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELL  404 (612)
T ss_pred             ccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHH
Confidence            445679999999998875532               356677665555 7999999999999999999999999999888


Q ss_pred             hhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE-CCCCceEEeecCCcccccCCCCeee
Q 036435          150 KFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL-DEDFCPKISDFGLAKLCTTKEGIVS  228 (372)
Q Consensus       150 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill-~~~~~~kl~Dfgla~~~~~~~~~~~  228 (372)
                      +.+.....      +. .++..|+.+|+.|+.|||   ..++|||||||+|||+ ++.++++|+|||.++.....     
T Consensus       405 ~ri~~~~~------~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----  469 (612)
T KOG0603|consen  405 RRIRSKPE------FC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----  469 (612)
T ss_pred             HHHHhcch------hH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-----
Confidence            87765431      33 677889999999999999   8999999999999999 59999999999999876654     


Q ss_pred             eecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCC
Q 036435          229 SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVT  308 (372)
Q Consensus       229 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (372)
                       ....+-|..|.|||++...  .+++++|+||||++||+|++|+.||.......       .+...+..      +    
T Consensus       470 -~~tp~~t~~y~APEvl~~~--~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~-------ei~~~i~~------~----  529 (612)
T KOG0603|consen  470 -CDTPALTLQYVAPEVLAIQ--EYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI-------EIHTRIQM------P----  529 (612)
T ss_pred             -hcccchhhcccChhhhccC--CCCcchhhHHHHHHHHHHHhCCCccccCCchH-------HHHHhhcC------C----
Confidence             2334567889999999865  89999999999999999999999998653320       01111111      1    


Q ss_pred             cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          309 RKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       309 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .....++....+|+.+||+.||.+||+++++..
T Consensus       530 ~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  530 KFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             ccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            111345566777888999999999999999885

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-35  Score=250.13  Aligned_cols=242  Identities=22%  Similarity=0.311  Sum_probs=178.8

Q ss_pred             cccHHHHHHHHhhhhhhcCCCCceEEEEEEec--------------------chHHHHHHHHhcc-CCCceeeeEeEEec
Q 036435           74 RYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLL--------------------DDFVNEVASISRT-SHVNVVTLLGFCLE  132 (372)
Q Consensus        74 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--------------------~~~~~E~~~l~~l-~h~nIv~l~g~~~~  132 (372)
                      .|+-.+++..     ..||.|+||+|+|-.+.                    .+++.|.+...+- +.||||++||.+..
T Consensus        60 ~F~~~~Lqdl-----g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~  134 (361)
T KOG1006|consen   60 TFTSDNLQDL-----GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS  134 (361)
T ss_pred             ccccchHHHH-----HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc
Confidence            4555555443     46999999999986442                    2577777755544 79999999999999


Q ss_pred             CCceeEEEEecCCCChhhhhh---cCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCce
Q 036435          133 GNNRALIYEFMPNGSLEKFVY---NGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP  209 (372)
Q Consensus       133 ~~~~~lV~e~~~~g~L~~~l~---~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~  209 (372)
                      ++..++.||.|+- ||+.+-+   .-..    ..+++.-.-.|..-..+||.||-+  ...|+|||+||+|||+|..|.+
T Consensus       135 EGdcWiCMELMd~-SlDklYk~vy~vq~----~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~v  207 (361)
T KOG1006|consen  135 EGDCWICMELMDI-SLDKLYKRVYSVQK----SRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDV  207 (361)
T ss_pred             CCceeeeHHHHhh-hHHHHHHHHHHHHh----ccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCE
Confidence            9999999999954 7654432   2221    227777777788888999999997  7899999999999999999999


Q ss_pred             EEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHH
Q 036435          210 KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPH  289 (372)
Q Consensus       210 kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~  289 (372)
                      ||||||++......-..    ....|-..|||||.+......++.+|||||||++|||+.||+-|+.....         
T Consensus       208 KLCDFGIcGqLv~SiAk----T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s---------  274 (361)
T KOG1006|consen  208 KLCDFGICGQLVDSIAK----TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS---------  274 (361)
T ss_pred             eeecccchHhHHHHHHh----hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH---------
Confidence            99999999765433211    12236667999999987644589999999999999999999999875322         


Q ss_pred             HHHHHhhhcccccCCccC-CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          290 WIYRHVEQDREFKLPGVV-TRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                       +.+++.....-..|.+. +....+....+..++..|+.+|-..||..+++.+
T Consensus       275 -vfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  275 -VFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             -HHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence             22222221111122222 2223456678888999999999999999999875

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-33  Score=222.87  Aligned_cols=180  Identities=27%  Similarity=0.429  Sum_probs=153.3

Q ss_pred             hhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           88 KDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      .++||+|.||+||||+..+                     ..++|+-+|+.++|.|||+++++...++.+-+|+|||.. 
T Consensus         7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-   85 (292)
T KOG0662|consen    7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-   85 (292)
T ss_pred             HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-
Confidence            4679999999999997643                     589999999999999999999999999999999999954 


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      +|..|.....+.     ++.+.+..++.|+++||.++|   +.++.|||+||.|.|++.+|++|++|||+++.+.-.-.-
T Consensus        86 dlkkyfdslng~-----~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipvrc  157 (292)
T KOG0662|consen   86 DLKKYFDSLNGD-----LDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC  157 (292)
T ss_pred             HHHHHHHhcCCc-----CCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence            999888665432     888999999999999999999   899999999999999999999999999999976543311


Q ss_pred             eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCC
Q 036435          227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVD  280 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~  280 (372)
                         .....-|.-|.+|+++.+. .-++...|+||.||++.|+.....|...+.+
T Consensus       158 ---ysaevvtlwyrppdvlfga-kly~tsidmwsagcifaelanagrplfpg~d  207 (292)
T KOG0662|consen  158 ---YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGND  207 (292)
T ss_pred             ---eeceeeeeeccCcceeeee-ehhccchHhhhcchHHHHHhhcCCCCCCCCc
Confidence               1122356779999999886 4789999999999999999976666555443

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-32  Score=265.91  Aligned_cols=233  Identities=27%  Similarity=0.374  Sum_probs=188.9

Q ss_pred             hhhhhcCCCCceEEEEEEecc------------------hHHHHHHHHhcc-CCCceeeeEeEEe-----cCCceeEEEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD------------------DFVNEVASISRT-SHVNVVTLLGFCL-----EGNNRALIYE  141 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~------------------~~~~E~~~l~~l-~h~nIv~l~g~~~-----~~~~~~lV~e  141 (372)
                      .|.+.||.|.+|.||+++..+                  ++..|.++|+.. .|||++.++|++.     .+++++||||
T Consensus        22 ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVME  101 (953)
T KOG0587|consen   22 EIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVME  101 (953)
T ss_pred             EEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEee
Confidence            446789999999999987643                  577788888877 7999999999987     3568999999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      ||.+||..|.+++...    ..+.|..+.-|++.++.|+.+||   ...++|||+|-.|||++.++.+||+|||++....
T Consensus       102 fC~gGSVTDLVKn~~g----~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld  174 (953)
T KOG0587|consen  102 FCGGGSVTDLVKNTKG----NRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  174 (953)
T ss_pred             ccCCccHHHHHhhhcc----cchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence            9999999999987653    34999999999999999999999   8999999999999999999999999999998765


Q ss_pred             CCCCeeeeecccccccccccccccccc---cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhc
Q 036435          222 TKEGIVSSLLGARGIIGYIAPEVFSRN---FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQD  298 (372)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (372)
                      ....   ......||+.|||||++...   ...++.++|+||||++..||--|.+|+.+.......          . . 
T Consensus       175 sT~g---rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL----------F-~-  239 (953)
T KOG0587|consen  175 STVG---RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL----------F-L-  239 (953)
T ss_pred             cccc---cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh----------c-c-
Confidence            4332   22445699999999999743   235778999999999999999999998876443211          0 0 


Q ss_pred             ccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          299 REFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                       ..+-|......+..+.+++.+++..||.+|-.+||++.++++
T Consensus       240 -IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  240 -IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             -CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence             111122222334567888999999999999999999999885

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2.3e-32  Score=275.26  Aligned_cols=124  Identities=28%  Similarity=0.454  Sum_probs=112.5

Q ss_pred             hhhhhcCCCCceEEEEEEec----------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLL----------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~----------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      .+.++||+|+||.||+|...                      ..+.+|+.++..++||||+++++++...+..++||||+
T Consensus         7 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~   86 (669)
T cd05610           7 VIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYL   86 (669)
T ss_pred             EEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCC
Confidence            34578999999999999764                      24778999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      .+++|.+++....      .+++..++.++.||+.||+|||   ..+|+||||||+|||++.++.+||+|||+++
T Consensus        87 ~g~~L~~li~~~~------~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          87 IGGDVKSLLHIYG------YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999997543      2788999999999999999999   7899999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.8e-32  Score=250.34  Aligned_cols=223  Identities=22%  Similarity=0.293  Sum_probs=185.1

Q ss_pred             hhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           89 DKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      ..||-|+||.|=.++...                      .+..|-.+|...+.|.||++|..|.++...|+.||.|-||
T Consensus       426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGG  505 (732)
T KOG0614|consen  426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGG  505 (732)
T ss_pred             hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCc
Confidence            359999999998776532                      4677999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      .|+..|..++.      |...+...++..+++|++|||   .++||+|||||+|.++|.+|.+||.|||.|+.+..+...
T Consensus       506 ElWTiLrdRg~------Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT  576 (732)
T KOG0614|consen  506 ELWTILRDRGS------FDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT  576 (732)
T ss_pred             hhhhhhhhcCC------cccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCCce
Confidence            99999988765      888889999999999999999   899999999999999999999999999999988776643


Q ss_pred             eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcc-cccCCc
Q 036435          227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDR-EFKLPG  305 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  305 (372)
                          ...+||+.|.|||.+.+.  ..+.+.|.||||+++|||++|.+||.......        .+..+-.+. .+.+|.
T Consensus       577 ----wTFcGTpEYVAPEIILnK--GHD~avDyWaLGIli~ELL~G~pPFs~~dpmk--------tYn~ILkGid~i~~Pr  642 (732)
T KOG0614|consen  577 ----WTFCGTPEYVAPEIILNK--GHDRAVDYWALGILIYELLTGSPPFSGVDPMK--------TYNLILKGIDKIEFPR  642 (732)
T ss_pred             ----eeecCCcccccchhhhcc--CcchhhHHHHHHHHHHHHHcCCCCCCCCchHH--------HHHHHHhhhhhhhccc
Confidence                456799999999999876  67889999999999999999999998754432        344443332 334454


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPP-----MNEVIE  341 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~  341 (372)
                      .++       +...+++.+.+..+|.+|..     +.++-+
T Consensus       643 ~I~-------k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk  676 (732)
T KOG0614|consen  643 RIT-------KTATDLIKKLCRDNPTERLGYQKGGINDIKK  676 (732)
T ss_pred             ccc-------hhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence            444       44455666666889999986     556554

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=1.6e-31  Score=249.62  Aligned_cols=191  Identities=23%  Similarity=0.354  Sum_probs=160.3

Q ss_pred             hhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           89 DKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      +.||-|+||.|.++.-.+                      .+..|-.+|..-..+-||+||-.|.+.+++|+||||++||
T Consensus       635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG  714 (1034)
T KOG0608|consen  635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG  714 (1034)
T ss_pred             eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence            459999999999986543                      4667889999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC----
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT----  222 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~----  222 (372)
                      ++-+.|.+.+-      |.+..+..++.++..|+++.|   ..|+|||||||+|||||.+|.+||.||||+.-+..    
T Consensus       715 DmMSLLIrmgI------FeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds  785 (1034)
T KOG0608|consen  715 DMMSLLIRMGI------FEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  785 (1034)
T ss_pred             cHHHHHHHhcc------CHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceecccc
Confidence            99999987653      888899999999999999999   89999999999999999999999999999964321    


Q ss_pred             -----CCCeee------------------------------eecccccccccccccccccccCCCCccccchhHHHHHHH
Q 036435          223 -----KEGIVS------------------------------SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIME  267 (372)
Q Consensus       223 -----~~~~~~------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~e  267 (372)
                           ++....                              ......||+.|+|||++...  .++.-+|.||.||||||
T Consensus       786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~--g~~q~cdwws~gvil~e  863 (1034)
T KOG0608|consen  786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART--GYTQLCDWWSVGVILYE  863 (1034)
T ss_pred             ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc--CccccchhhHhhHHHHH
Confidence                 000000                              00112499999999999875  88999999999999999


Q ss_pred             HhcCCCCCCCCCCCCCccchHHH
Q 036435          268 LVGCKNNLDSGVDSSSEVYFPHW  290 (372)
Q Consensus       268 lltg~~p~~~~~~~~~~~~~~~~  290 (372)
                      |+.|+.||.............+|
T Consensus       864 m~~g~~pf~~~tp~~tq~kv~nw  886 (1034)
T KOG0608|consen  864 MLVGQPPFLADTPGETQYKVINW  886 (1034)
T ss_pred             HhhCCCCccCCCCCcceeeeeeh
Confidence            99999999987766544444444

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.98  E-value=3.6e-32  Score=241.00  Aligned_cols=250  Identities=19%  Similarity=0.281  Sum_probs=187.2

Q ss_pred             ccHHHHHHHHhhhhhhcCCCCceEEEEEEecc------------------hHHHHHHHHhccC--CC----ceeeeEeEE
Q 036435           75 YNFSDVKKLTNSFKDKLGQGGFGGVYKGRLLD------------------DFVNEVASISRTS--HV----NVVTLLGFC  130 (372)
Q Consensus        75 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------------------~~~~E~~~l~~l~--h~----nIv~l~g~~  130 (372)
                      +...|.....+.+...+|+|.||.|-...+.+                  ..+-|+++|+++.  .|    -++.+.++|
T Consensus        81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF  160 (415)
T KOG0671|consen   81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF  160 (415)
T ss_pred             EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence            44445555556667889999999998875533                  4566999999994  22    378888899


Q ss_pred             ecCCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC-----
Q 036435          131 LEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE-----  205 (372)
Q Consensus       131 ~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~-----  205 (372)
                      .-.++.++|+|.+ |.|+.+++.++....    ++...+..++.|+++++++||   +.+++|.||||+|||+.+     
T Consensus       161 dyrghiCivfell-G~S~~dFlk~N~y~~----fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~  232 (415)
T KOG0671|consen  161 DYRGHICIVFELL-GLSTFDFLKENNYIP----FPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFK  232 (415)
T ss_pred             hccCceEEEEecc-ChhHHHHhccCCccc----cchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEE
Confidence            9999999999999 669999998876543    899999999999999999999   899999999999999932     


Q ss_pred             ---------------CCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc
Q 036435          206 ---------------DFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG  270 (372)
Q Consensus       206 ---------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt  270 (372)
                                     +..++++|||.|.......      .....|..|.|||++.+-  .++.++||||+||||.|+.|
T Consensus       233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h------s~iVsTRHYRAPEViLgL--GwS~pCDvWSiGCIL~Elyt  304 (415)
T KOG0671|consen  233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH------STIVSTRHYRAPEVILGL--GWSQPCDVWSIGCILVELYT  304 (415)
T ss_pred             EeccCCccceeccCCCcceEEEecCCcceeccCc------ceeeeccccCCchheecc--CcCCccCceeeeeEEEEeec
Confidence                           2358999999998765444      223467889999999986  89999999999999999999


Q ss_pred             CCCCCCCCCCCCCc-------cchHHHHHHHh------hhcccccCCccCC------------------cchHHHHHHHH
Q 036435          271 CKNNLDSGVDSSSE-------VYFPHWIYRHV------EQDREFKLPGVVT------------------RKENEIAKKMI  319 (372)
Q Consensus       271 g~~p~~~~~~~~~~-------~~~~~~~~~~~------~~~~~~~~~~~~~------------------~~~~~~~~~l~  319 (372)
                      |...|+...+....       ..++..+....      ..+ .+.+++...                  ........+++
T Consensus       305 G~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~-rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~Lf  383 (415)
T KOG0671|consen  305 GETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRG-RLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLF  383 (415)
T ss_pred             cceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcc-cccCccccccccchhhhcCCccHHHHhccCcHHHhHHH
Confidence            99999865422100       01111111111      111 222222111                  11223356799


Q ss_pred             HHHHHcccCCCCCCCCHHHHHH
Q 036435          320 IVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       320 ~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      +|+.++|..||.+|+|+.|+++
T Consensus       384 DLl~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  384 DLLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             HHHHHHHccCccccccHHHHhc
Confidence            9999999999999999999886

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=1e-32  Score=252.82  Aligned_cols=224  Identities=25%  Similarity=0.385  Sum_probs=178.3

Q ss_pred             hhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCC
Q 036435           89 DKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS  147 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~  147 (372)
                      +.||+|.||+||-|++++                     +..+|+.+|++++||.||.+...|+..+..+.|||.+ +|+
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~GD  648 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HGD  648 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cch
Confidence            679999999999987643                     6889999999999999999999999999999999999 557


Q ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC---CceEEeecCCcccccCCC
Q 036435          148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDED---FCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       148 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfgla~~~~~~~  224 (372)
                      ..+.+-.....+    +++..-..++.||+.||.|||   -.+|+|+||||+|||+.+.   .++||||||.|+.+....
T Consensus       649 MLEMILSsEkgR----L~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks  721 (888)
T KOG4236|consen  649 MLEMILSSEKGR----LPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS  721 (888)
T ss_pred             HHHHHHHhhccc----chHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence            666654443322    888888889999999999999   7999999999999999643   479999999999886543


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCC
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP  304 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (372)
                      -.    ....||+.|+|||++.+.  .++..-|+||.|||+|--++|.-||..+.+..+          .+ ++..+..|
T Consensus       722 FR----rsVVGTPAYLaPEVLrnk--GyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd----------QI-QNAaFMyP  784 (888)
T KOG4236|consen  722 FR----RSVVGTPAYLAPEVLRNK--GYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND----------QI-QNAAFMYP  784 (888)
T ss_pred             hh----hhhcCCccccCHHHHhhc--cccccccceeeeEEEEEEecccccCCCccchhH----------Hh-hccccccC
Confidence            21    234699999999999886  889999999999999999999999987644321          12 22222233


Q ss_pred             ccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 036435          305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI  340 (372)
Q Consensus       305 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl  340 (372)
                      .   ....++....++++...|+..-++|-|.+.-+
T Consensus       785 p---~PW~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  785 P---NPWSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             C---CchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence            2   22344556667777778888888888877654

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-32  Score=244.69  Aligned_cols=225  Identities=22%  Similarity=0.313  Sum_probs=178.1

Q ss_pred             HHHHHhhhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhcc-CCCceeeeEeEEecCCce
Q 036435           80 VKKLTNSFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRT-SHVNVVTLLGFCLEGNNR  136 (372)
Q Consensus        80 ~~~~~~~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~  136 (372)
                      ++....+|...||+|+||.|-++....                      --+.|-++|... +-|.+++++.+|..-+.+
T Consensus       346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL  425 (683)
T KOG0696|consen  346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL  425 (683)
T ss_pred             eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence            334445778899999999999875422                      123466666655 577899999999999999


Q ss_pred             eEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCC
Q 036435          137 ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGL  216 (372)
Q Consensus       137 ~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  216 (372)
                      |+||||+.||+|-.++.+-+.      +.+..+..++.+||-||-+||   +.+|+.||||.+||++|.+|.+||+|||+
T Consensus       426 yFVMEyvnGGDLMyhiQQ~Gk------FKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGm  496 (683)
T KOG0696|consen  426 YFVMEYVNGGDLMYHIQQVGK------FKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGM  496 (683)
T ss_pred             eeEEEEecCchhhhHHHHhcc------cCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccc
Confidence            999999999999999987664      777889999999999999999   89999999999999999999999999999


Q ss_pred             cccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHh-
Q 036435          217 AKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV-  295 (372)
Q Consensus       217 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-  295 (372)
                      ++.--....   .....+||+.|+|||.+.-+  .|+...|.|||||+||||+.|.+||+...+..        +.+.+ 
T Consensus       497 cKEni~~~~---TTkTFCGTPdYiAPEIi~Yq--PYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e--------lF~aI~  563 (683)
T KOG0696|consen  497 CKENIFDGV---TTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--------LFQAIM  563 (683)
T ss_pred             ccccccCCc---ceeeecCCCcccccceEEec--ccccchhHHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHHH
Confidence            985433322   23456799999999999764  89999999999999999999999999765432        22222 


Q ss_pred             hhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCC
Q 036435          296 EQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPP  335 (372)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs  335 (372)
                      +.+.  ..|       ..++.+..++....+.+.|.+|..
T Consensus       564 ehnv--syP-------KslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  564 EHNV--SYP-------KSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             HccC--cCc-------ccccHHHHHHHHHHhhcCCccccC
Confidence            2221  122       334566677777888999999864

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=2.3e-31  Score=235.23  Aligned_cols=209  Identities=26%  Similarity=0.370  Sum_probs=167.4

Q ss_pred             chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 036435          106 DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH  185 (372)
Q Consensus       106 ~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~  185 (372)
                      +.+.+|++.+++++|+||+++++++......++++||+++++|.+++.....      +++..+..++.+++.++.||| 
T Consensus        32 ~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~------~~~~~~~~~~~~l~~~l~~lh-  104 (244)
T smart00220       32 ERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGR------LSEDEARFYARQILSALEYLH-  104 (244)
T ss_pred             HHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccC------CCHHHHHHHHHHHHHHHHHHH-
Confidence            3678999999999999999999999999999999999999999999876432      788999999999999999999 


Q ss_pred             CCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHH
Q 036435          186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMI  265 (372)
Q Consensus       186 ~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il  265 (372)
                        ..+++|+||+|+||++++++.++|+|||.+.......    ......++..|++||.+.+.  .++.++|+||||+++
T Consensus       105 --~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~pE~~~~~--~~~~~~Di~slG~~l  176 (244)
T smart00220      105 --SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----LLTTFVGTPEYMAPEVLLGK--GYGKAVDVWSLGVIL  176 (244)
T ss_pred             --HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc----ccccccCCcCCCCHHHHccC--CCCchhhHHHHHHHH
Confidence              7899999999999999999999999999998765432    11233477889999998754  778899999999999


Q ss_pred             HHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          266 MELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       266 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      +++++|..||.......       ............ .    ..........+.+++.+|+..+|++||++.++++
T Consensus       177 ~~l~~~~~p~~~~~~~~-------~~~~~~~~~~~~-~----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      177 YELLTGKPPFPGDDQLL-------ELFKKIGKPKPP-F----PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHhCCCCCCCCCcHH-------HHHHHHhccCCC-C----ccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            99999999987532111       111111111110 0    0000014467888999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-31  Score=256.85  Aligned_cols=229  Identities=24%  Similarity=0.345  Sum_probs=175.2

Q ss_pred             hhcCCCCce-EEEEEEecc--------------hHHHHHHHHhcc-CCCceeeeEeEEecCCceeEEEEecCCCChhhhh
Q 036435           89 DKLGQGGFG-GVYKGRLLD--------------DFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV  152 (372)
Q Consensus        89 ~~lg~G~~g-~V~~~~~~~--------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~~~l  152 (372)
                      +.+|.|+-| .||+|...+              -..+|+..|+.- .||||+++++.-.+....|+..|.|.. +|.+++
T Consensus       515 eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL~dli  593 (903)
T KOG1027|consen  515 EILGYGSNGTVVFRGVYEGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SLQDLI  593 (903)
T ss_pred             HHcccCCCCcEEEEEeeCCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hHHHHH
Confidence            568898876 479997754              356899999888 699999999999999999999999955 999999


Q ss_pred             hcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC---C--CceEEeecCCcccccCCCCee
Q 036435          153 YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE---D--FCPKISDFGLAKLCTTKEGIV  227 (372)
Q Consensus       153 ~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~--~~~kl~Dfgla~~~~~~~~~~  227 (372)
                      .......  ....-...+.++.|+++||++||   +.+||||||||.||||+.   +  ..++|+|||+++....+....
T Consensus       594 e~~~~d~--~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~  668 (903)
T KOG1027|consen  594 ESSGLDV--EMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSF  668 (903)
T ss_pred             hccccch--hhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchh
Confidence            8741111  11111445778999999999999   899999999999999975   2  478999999999888777665


Q ss_pred             eeecccccccccccccccccccCCCCccccchhHHHHHHHHhcC-CCCCCCCCCCCCccchHHHHHHHhhhcccccCCcc
Q 036435          228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGC-KNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV  306 (372)
Q Consensus       228 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (372)
                      .......||-+|+|||.+...  .-+.+.||||+||++|+.++| ..||.+....+..+         +.....  ....
T Consensus       669 ~r~s~~sGt~GW~APE~L~~~--~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NI---------l~~~~~--L~~L  735 (903)
T KOG1027|consen  669 SRLSGGSGTSGWQAPEQLRED--RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANI---------LTGNYT--LVHL  735 (903)
T ss_pred             hcccCCCCcccccCHHHHhcc--ccCcccchhhcCceEEEEecCCccCCCchHHhhhhh---------hcCccc--eeee
Confidence            556777899999999999875  567799999999999998886 79998654322111         111111  1111


Q ss_pred             CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 036435          307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI  340 (372)
Q Consensus       307 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl  340 (372)
                      .+.  .+.  ...+|+.+|++++|..||++.+|+
T Consensus       736 ~~~--~d~--eA~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  736 EPL--PDC--EAKDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             ccC--chH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence            111  111  566788889999999999999998

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=1.8e-31  Score=262.70  Aligned_cols=249  Identities=20%  Similarity=0.189  Sum_probs=152.9

Q ss_pred             hhhhhcCCCCceEEEEEEecch----------------HHHHHHHHhcc---CCCceeeeEeE------EecCCceeEEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLLDD----------------FVNEVASISRT---SHVNVVTLLGF------CLEGNNRALIY  140 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~~----------------~~~E~~~l~~l---~h~nIv~l~g~------~~~~~~~~lV~  140 (372)
                      .+.+.||+|+||.||+|++.+.                -..|.....++   .+.++..+...      +.++...++|+
T Consensus       135 ~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~LV~  214 (566)
T PLN03225        135 VLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDEYWLVW  214 (566)
T ss_pred             EEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCceEEEE
Confidence            3457899999999999987432                12233333333   23333333222      24566889999


Q ss_pred             EecCCCChhhhhhcCCCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC-
Q 036435          141 EFMPNGSLEKFVYNGDTSK--------------PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE-  205 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~--------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~-  205 (372)
                      ||+.+++|.+++.......              .........+..++.|++.||+|||   +.+|+||||||+|||+++ 
T Consensus       215 ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLKP~NILl~~~  291 (566)
T PLN03225        215 RYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVKPQNIIFSEG  291 (566)
T ss_pred             EecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCCHHHEEEeCC
Confidence            9999999999987543100              0001223445679999999999999   799999999999999985 


Q ss_pred             CCceEEeecCCcccccCCCCeeeeecccccccccccccccccccC--------------------CCCccccchhHHHHH
Q 036435          206 DFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFG--------------------EVSHKSDVYSFGMMI  265 (372)
Q Consensus       206 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--------------------~~~~~~DvwslG~il  265 (372)
                      ++.+||+|||+++..........  ....+|+.|+|||.+.....                    .++.++|||||||++
T Consensus       292 ~~~~KL~DFGlA~~l~~~~~~~~--~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL  369 (566)
T PLN03225        292 SGSFKIIDLGAAADLRVGINYIP--KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF  369 (566)
T ss_pred             CCcEEEEeCCCccccccccccCC--cccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHH
Confidence            67999999999986543322211  23457889999996532110                    234567999999999


Q ss_pred             HHHhcCCCCCCCCCCC------CCccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 036435          266 MELVGCKNNLDSGVDS------SSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEV  339 (372)
Q Consensus       266 ~elltg~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev  339 (372)
                      |||+++..+.+.....      ........|... .............. ..........+++.+||+.||++|||++++
T Consensus       370 ~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~-~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~  447 (566)
T PLN03225        370 LQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKL-VEPRASPDLRRGFE-VLDLDGGAGWELLKSMMRFKGRQRISAKAA  447 (566)
T ss_pred             HHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHh-hccccchhhhhhhh-hccccchHHHHHHHHHccCCcccCCCHHHH
Confidence            9999876554321000      000001111000 00000000000000 000011234579999999999999999999


Q ss_pred             HH
Q 036435          340 IE  341 (372)
Q Consensus       340 l~  341 (372)
                      ++
T Consensus       448 L~  449 (566)
T PLN03225        448 LA  449 (566)
T ss_pred             hC
Confidence            97

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=5.2e-30  Score=246.72  Aligned_cols=218  Identities=19%  Similarity=0.205  Sum_probs=145.3

Q ss_pred             HHHHHhccCCCce-----eeeEeEEec--------CCceeEEEEecCCCChhhhhhcCCCC------------------C
Q 036435          111 EVASISRTSHVNV-----VTLLGFCLE--------GNNRALIYEFMPNGSLEKFVYNGDTS------------------K  159 (372)
Q Consensus       111 E~~~l~~l~h~nI-----v~l~g~~~~--------~~~~~lV~e~~~~g~L~~~l~~~~~~------------------~  159 (372)
                      |+..+.+++|.|+     ++++++|..        .+..+|||||+++|+|.++++.....                  .
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            6666777766654     677887753        35689999999999999998753210                  0


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeeeeeccccccccc
Q 036435          160 PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY  239 (372)
Q Consensus       160 ~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y  239 (372)
                      ....+++..+..++.|++.||.|||   ..+++||||||+|||++.++.+||+|||++..........  .....+|+.|
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~--~~~g~~tp~Y  376 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN--PLYGMLDPRY  376 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC--ccccCCCcce
Confidence            1123578889999999999999999   7899999999999999999999999999997654322111  1122357899


Q ss_pred             ccccccccccC--------------------CCCccccchhHHHHHHHHhcCCC-CCCCCCCCCCc-----cchHHHHHH
Q 036435          240 IAPEVFSRNFG--------------------EVSHKSDVYSFGMMIMELVGCKN-NLDSGVDSSSE-----VYFPHWIYR  293 (372)
Q Consensus       240 ~aPE~~~~~~~--------------------~~~~~~DvwslG~il~elltg~~-p~~~~~~~~~~-----~~~~~~~~~  293 (372)
                      +|||.+.....                    ....+.|+||+||++++|++|.. |+........+     .....|  .
T Consensus       377 ~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~--r  454 (507)
T PLN03224        377 SPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRW--R  454 (507)
T ss_pred             eChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHH--H
Confidence            99998753210                    11235799999999999999875 55432111100     001111  1


Q ss_pred             HhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCC---CCCCCHHHHHH
Q 036435          294 HVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARP---SDRPPMNEVIE  341 (372)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p---~~RPs~~evl~  341 (372)
                      .. .......+     ..........+++.++|..+|   .+|+|++|+++
T Consensus       455 ~~-~~~~~~~~-----~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        455 MY-KGQKYDFS-----LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             hh-cccCCCcc-----cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            11 11111111     111234556677778888765   68999999985

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=8.1e-31  Score=217.65  Aligned_cols=240  Identities=18%  Similarity=0.310  Sum_probs=180.6

Q ss_pred             hhhhhhcCCCCceEEEEEEec----------------chHHHHHHHHhccC-CCceeeeEeEEecC--CceeEEEEecCC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL----------------DDFVNEVASISRTS-HVNVVTLLGFCLEG--NNRALIYEFMPN  145 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~----------------~~~~~E~~~l~~l~-h~nIv~l~g~~~~~--~~~~lV~e~~~~  145 (372)
                      +.+.+++|+|.|+.||.|...                +.+.+|+.+|+.|+ ||||++++++..+.  ....||+||+.+
T Consensus        40 Yeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n  119 (338)
T KOG0668|consen   40 YEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNN  119 (338)
T ss_pred             HHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhcc
Confidence            455678999999999999642                26899999999997 99999999999875  456899999998


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC-CCceEEeecCCcccccCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE-DFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgla~~~~~~~  224 (372)
                      -+.......         ++-.++.....+++.||.|+|   +.||.|||+||.|+++|. .-.++|+|+|+|.+...+.
T Consensus       120 ~Dfk~ly~t---------l~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~  187 (338)
T KOG0668|consen  120 TDFKQLYPT---------LTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  187 (338)
T ss_pred             ccHHHHhhh---------hchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence            777655422         677788899999999999999   899999999999999984 5679999999999988776


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHH------HHHH----
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHW------IYRH----  294 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~------~~~~----  294 (372)
                      .+....    .+.-|--||.+.. +..++..-|+|||||++..|+..+.||..+.+..+...-...      +...    
T Consensus       188 eYnVRV----ASRyfKGPELLVd-y~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY  262 (338)
T KOG0668|consen  188 EYNVRV----ASRYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY  262 (338)
T ss_pred             eeeeee----ehhhcCCchheee-chhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence            655432    2344788999876 357889999999999999999999999887654432110000      0000    


Q ss_pred             -----------hhhcccccCCccCCcchHHH-HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          295 -----------VEQDREFKLPGVVTRKENEI-AKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       295 -----------~~~~~~~~~~~~~~~~~~~~-~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                                 +....+..+..........+ ..+.++++...|..|-++|+|++|...
T Consensus       263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence                       11111111111222222222 266788899999999999999999774

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.5e-30  Score=222.74  Aligned_cols=226  Identities=19%  Similarity=0.278  Sum_probs=178.5

Q ss_pred             hhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhcc-CCCceeeeEeEEecCCceeEEEEecC
Q 036435           88 KDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      ...||+|+|+.|..+++.+                      =...|-.+..+. +||.+|.++.+|..+..+++|.||++
T Consensus       255 l~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~  334 (593)
T KOG0695|consen  255 LRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVN  334 (593)
T ss_pred             eeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEec
Confidence            4679999999998886643                      134566666665 79999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      ||+|.-++.+...      ++++.+..+...|+.||.|||   +.+|+.||||.+|||+|..|.+||.|+|+++.--...
T Consensus       335 ggdlmfhmqrqrk------lpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~~g  405 (593)
T KOG0695|consen  335 GGDLMFHMQRQRK------LPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG  405 (593)
T ss_pred             Ccceeeehhhhhc------CcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCCCC
Confidence            9999888766543      899999999999999999999   8999999999999999999999999999998643332


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCC
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP  304 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (372)
                      ..   .+..+||+.|.|||.+.+.  .+....|.|++||+++||+.|+.||+--.....+....+++.+.+.+. .+.+|
T Consensus       406 d~---tstfcgtpnyiapeilrge--eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek-qirip  479 (593)
T KOG0695|consen  406 DT---TSTFCGTPNYIAPEILRGE--EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK-QIRIP  479 (593)
T ss_pred             cc---cccccCCCcccchhhhccc--ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh-ccccc
Confidence            22   3456799999999999986  899999999999999999999999985443333344455555554332 23344


Q ss_pred             ccCCcchHHHHHHHHHHHHHcccCCCCCCCC
Q 036435          305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPP  335 (372)
Q Consensus       305 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs  335 (372)
                      ...+-       +...+...-|++||.+|..
T Consensus       480 rslsv-------kas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  480 RSLSV-------KASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             ceeeh-------hhHHHHHHhhcCCcHHhcC
Confidence            33333       3334555667999999864

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=1.7e-30  Score=212.57  Aligned_cols=184  Identities=27%  Similarity=0.381  Sum_probs=146.1

Q ss_pred             hhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhcc-CCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           88 KDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      ...||+|+||.|-+-++..                    +.++|+.+..+. ..|.+|.+||........++.||.|.. 
T Consensus        51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t-  129 (282)
T KOG0984|consen   51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT-  129 (282)
T ss_pred             hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-
Confidence            3579999999987655422                    466677765554 699999999999999999999999965 


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      ||..+-.+--.  ....+++.-.=+|+..+..||.|||+  ...++|||+||+|||++.+|++|+||||++....+.-..
T Consensus       130 Sldkfy~~v~~--~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk  205 (282)
T KOG0984|consen  130 SLDKFYRKVLK--KGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK  205 (282)
T ss_pred             hHHHHHHHHHh--cCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHH
Confidence            88766543211  11338888888999999999999997  789999999999999999999999999999876543321


Q ss_pred             eeeeccccccccccccccccccc--CCCCccccchhHHHHHHHHhcCCCCCCCCCC
Q 036435          227 VSSLLGARGIIGYIAPEVFSRNF--GEVSHKSDVYSFGMMIMELVGCKNNLDSGVD  280 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~  280 (372)
                      .    ...|-..|||||.+....  ..|+.|+||||||+.+.||.+++.||+....
T Consensus       206 t----~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  206 T----MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             H----HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence            1    123556799999986431  3688999999999999999999999986543

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.6e-31  Score=225.96  Aligned_cols=178  Identities=29%  Similarity=0.423  Sum_probs=148.8

Q ss_pred             hhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCC-----ceeEEEE
Q 036435           88 KDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGN-----NRALIYE  141 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~-----~~~lV~e  141 (372)
                      .+.||-|+||+||..++..                     .+.+|+++|.-++|.|++..+++..-.+     +.|.++|
T Consensus        58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE  137 (449)
T KOG0664|consen   58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE  137 (449)
T ss_pred             CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence            4579999999999876532                     6889999999999999999999876543     5678899


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      .|.. +|...+...      +.++...+.-++.||++||+|||   +.+|.||||||.|.|++++..+||||||+++...
T Consensus       138 LmQS-DLHKIIVSP------Q~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  138 LMQS-DLHKIIVSP------QALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHh-hhhheeccC------CCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccc
Confidence            9954 888877543      33888888899999999999999   8999999999999999999999999999999766


Q ss_pred             CCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCC
Q 036435          222 TKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSG  278 (372)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~  278 (372)
                      ..+....  ....-|..|.|||.+.|. ..++.+.||||.||++.|++..+-.|..-
T Consensus       208 ~d~~~hM--TqEVVTQYYRAPEiLMGa-RhYs~AvDiWSVGCIFaELLgRrILFQAq  261 (449)
T KOG0664|consen  208 QRDRLNM--THEVVTQYYRAPELLMGA-RRYTGAVDIWSVGCIFAELLQRKILFQAA  261 (449)
T ss_pred             hhhhhhh--HHHHHHHHhccHHHhhcc-hhhcCccceehhhHHHHHHHhhhhhhhcc
Confidence            5443322  223356779999999987 68999999999999999999888777643

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=3e-28  Score=210.13  Aligned_cols=193  Identities=37%  Similarity=0.618  Sum_probs=165.9

Q ss_pred             cCCCCceEEEEEEec--------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCChhh
Q 036435           91 LGQGGFGGVYKGRLL--------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEK  150 (372)
Q Consensus        91 lg~G~~g~V~~~~~~--------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~~  150 (372)
                      ||+|.+|.||+++..                    +.+.+|+..++.++|++++++++++......++++|++++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            689999999999764                    238899999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC-CCceEEeecCCcccccCCCCeeee
Q 036435          151 FVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE-DFCPKISDFGLAKLCTTKEGIVSS  229 (372)
Q Consensus       151 ~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgla~~~~~~~~~~~~  229 (372)
                      ++....     ..+++..+..++.++++++++||   ..+++|+||+|.||+++. ++.++|+|||.+........   .
T Consensus        81 ~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---~  149 (215)
T cd00180          81 LLKENE-----GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---L  149 (215)
T ss_pred             HHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---h
Confidence            997653     12889999999999999999999   789999999999999999 89999999999986654321   1


Q ss_pred             ecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCCc
Q 036435          230 LLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTR  309 (372)
Q Consensus       230 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (372)
                      .....+...|++||..... ...+.++|+|++|++++++                                         
T Consensus       150 ~~~~~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l-----------------------------------------  187 (215)
T cd00180         150 LKTIVGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL-----------------------------------------  187 (215)
T ss_pred             hhcccCCCCccChhHhccc-CCCCchhhhHHHHHHHHHH-----------------------------------------
Confidence            1223366779999988653 3678899999999999998                                         


Q ss_pred             chHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          310 KENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       310 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                            ..+.+++..|++.+|.+||++.++++.
T Consensus       188 ------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 ------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             ------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                  456778888999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=7.8e-30  Score=236.33  Aligned_cols=175  Identities=23%  Similarity=0.344  Sum_probs=153.1

Q ss_pred             hhhcCCCCceEEEEEEecc---------------------------hHHHHHHHHhccC---CCceeeeEeEEecCCcee
Q 036435           88 KDKLGQGGFGGVYKGRLLD---------------------------DFVNEVASISRTS---HVNVVTLLGFCLEGNNRA  137 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~---------------------------~~~~E~~~l~~l~---h~nIv~l~g~~~~~~~~~  137 (372)
                      .+.+|.|+||.|+.+.+.+                           .+-.|+.+|..++   |+||++++++|++++++|
T Consensus       566 lq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yy  645 (772)
T KOG1152|consen  566 LQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYY  645 (772)
T ss_pred             eeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeE
Confidence            3579999999999986643                           3556999999997   999999999999999999


Q ss_pred             EEEEec-CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCC
Q 036435          138 LIYEFM-PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGL  216 (372)
Q Consensus       138 lV~e~~-~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  216 (372)
                      |++|-. ++-+|.+++.....      +++.++.-|+.|++.|+++||   +.+|||||||-+||.++.+|-+||+|||.
T Consensus       646 l~te~hg~gIDLFd~IE~kp~------m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfgs  716 (772)
T KOG1152|consen  646 LETEVHGEGIDLFDFIEFKPR------MDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFGS  716 (772)
T ss_pred             EEecCCCCCcchhhhhhccCc------cchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeeccc
Confidence            999986 45689999976654      899999999999999999999   89999999999999999999999999999


Q ss_pred             cccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCC
Q 036435          217 AKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDS  277 (372)
Q Consensus       217 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~  277 (372)
                      |....++.     ....+||.+|.|||++.|. .-....-|||++|++||.++....||+.
T Consensus       717 aa~~ksgp-----fd~f~gtv~~aapevl~g~-~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  717 AAYTKSGP-----FDVFVGTVDYAAPEVLGGE-KYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhhhcCCC-----cceeeeeccccchhhhCCC-ccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            98766544     3345799999999999986 2336778999999999999999999864

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=3.4e-28  Score=250.53  Aligned_cols=199  Identities=21%  Similarity=0.264  Sum_probs=138.4

Q ss_pred             HhccCC-CceeeeEeEE-------ecCCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 036435          115 ISRTSH-VNVVTLLGFC-------LEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG  186 (372)
Q Consensus       115 l~~l~h-~nIv~l~g~~-------~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~  186 (372)
                      .+.++| +||++++++|       .+...+++++||+ +++|.+++....     ..+++.+++.++.||++||+|||  
T Consensus        26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH--   97 (793)
T PLN00181         26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-----RSVDAFECFHVFRQIVEIVNAAH--   97 (793)
T ss_pred             cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-----ccccHHHHHHHHHHHHHHHHHHH--
Confidence            445667 6899999988       3334677888988 569999997532     23899999999999999999999  


Q ss_pred             CCCCeeecCCCCCceEECCC-------------------CceEEeecCCcccccCCCC--------e-----eeeecccc
Q 036435          187 CSTKILHFDIKPHNILLDED-------------------FCPKISDFGLAKLCTTKEG--------I-----VSSLLGAR  234 (372)
Q Consensus       187 ~~~~ivH~dlk~~Nill~~~-------------------~~~kl~Dfgla~~~~~~~~--------~-----~~~~~~~~  234 (372)
                       +.+|+||||||+||||+..                   +.+|++|||+++.......        .     ........
T Consensus        98 -~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (793)
T PLN00181         98 -SQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAM  176 (793)
T ss_pred             -hCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccC
Confidence             8999999999999999654                   4455666666553211000        0     00001134


Q ss_pred             cccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCCcchHHH
Q 036435          235 GIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEI  314 (372)
Q Consensus       235 gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (372)
                      ||+.|||||++.+.  .++.++|||||||++|||++|..|+.....          ....+...   ..+...    ...
T Consensus       177 gt~~Y~APE~~~~~--~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----------~~~~~~~~---~~~~~~----~~~  237 (793)
T PLN00181        177 EMSWYTSPEEDNGS--SSNCASDVYRLGVLLFELFCPVSSREEKSR----------TMSSLRHR---VLPPQI----LLN  237 (793)
T ss_pred             CCcceEChhhhccC--CCCchhhhhhHHHHHHHHhhCCCchhhHHH----------HHHHHHHh---hcChhh----hhc
Confidence            78889999998875  789999999999999999998877542110          01111110   011110    011


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          315 AKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       315 ~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ......++.+||+++|.+||++.|+++
T Consensus       238 ~~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        238 WPKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             CHHHHHHHHHhCCCChhhCcChHHHhh
Confidence            233457788999999999999999986

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=4.5e-27  Score=198.54  Aligned_cols=167  Identities=20%  Similarity=0.216  Sum_probs=124.2

Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      |+|.+++.....     .+++.+++.++.|++.||+|||   ..+      ||+|||++.++.+|+  ||++....... 
T Consensus         1 GsL~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-   63 (176)
T smart00750        1 VSLADILEVRGR-----PLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-   63 (176)
T ss_pred             CcHHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc-
Confidence            689999976432     2999999999999999999999   455      999999999999999  99987654322 


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                             ..||+.|||||++.+.  .++.++|||||||++|||++|+.||.......      ............ ..+.
T Consensus        64 -------~~g~~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~p~~~~~~~~------~~~~~~~~~~~~-~~~~  127 (176)
T smart00750       64 -------SRVDPYFMAPEVIQGQ--SYTEKADIYSLGITLYEALDYELPYNEERELS------AILEILLNGMPA-DDPR  127 (176)
T ss_pred             -------CCCcccccChHHhcCC--CCcchhhHHHHHHHHHHHHhCCCCccccchhc------HHHHHHHHHhcc-CCcc
Confidence                   2478999999999875  78899999999999999999999986543211      111111111111 1111


Q ss_pred             cCCcchHHHHH--HHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 036435          306 VVTRKENEIAK--KMIIVGLWCIQARPSDRPPMNEVIEMLQGS  346 (372)
Q Consensus       306 ~~~~~~~~~~~--~l~~l~~~cl~~~p~~RPs~~evl~~L~~~  346 (372)
                      . .........  .+.+++.+||+.+|.+||++.++++.+...
T Consensus       128 ~-~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      128 D-RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             c-cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            0 111223333  688999999999999999999999987544

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3.1e-27  Score=215.37  Aligned_cols=121  Identities=27%  Similarity=0.429  Sum_probs=101.2

Q ss_pred             cHHHHHH-HHhhhhhhcCCCCceEEEEEEecc------------------hHHHHHHHHhccC-----C---CceeeeEe
Q 036435           76 NFSDVKK-LTNSFKDKLGQGGFGGVYKGRLLD------------------DFVNEVASISRTS-----H---VNVVTLLG  128 (372)
Q Consensus        76 ~~~~~~~-~~~~~~~~lg~G~~g~V~~~~~~~------------------~~~~E~~~l~~l~-----h---~nIv~l~g  128 (372)
                      .+.|+.. ..|.+.++||-|.|++||++.+..                  ..+.|+++|++++     |   ..||+|++
T Consensus        70 ~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD  149 (590)
T KOG1290|consen   70 RIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLD  149 (590)
T ss_pred             eccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeec
Confidence            3344444 556667899999999999986532                  5788999999984     3   36999999


Q ss_pred             EEec----CCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE
Q 036435          129 FCLE----GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL  203 (372)
Q Consensus       129 ~~~~----~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill  203 (372)
                      .|..    +.+.++|+|++ |.+|..++.....+.    ++...+.+|+.||+.||.|||.  ..+|||.||||+|||+
T Consensus       150 ~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrG----lpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  150 HFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRG----LPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL  221 (590)
T ss_pred             cceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCC----CcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence            9974    45889999999 679999998876544    9999999999999999999998  6799999999999999

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=8.6e-28  Score=204.31  Aligned_cols=226  Identities=21%  Similarity=0.322  Sum_probs=167.4

Q ss_pred             hhhhhhcCCCCceEEEEEEecc------------------hHHHHHHHHhcc-CCCceeeeEe-EEecCCceeEEEEecC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD------------------DFVNEVASISRT-SHVNVVTLLG-FCLEGNNRALIYEFMP  144 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~------------------~~~~E~~~l~~l-~h~nIv~l~g-~~~~~~~~~lV~e~~~  144 (372)
                      +++.+.||+|.||.+-+++++.                  +|.+|..---.| .|.||+.-|+ .|+..+.+.+++||++
T Consensus        26 y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP  105 (378)
T KOG1345|consen   26 YTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAP  105 (378)
T ss_pred             hhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCc
Confidence            4556789999999999887753                  678887655555 5999998775 5566778889999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE-C-CCCceEEeecCCcccccC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL-D-EDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill-~-~~~~~kl~Dfgla~~~~~  222 (372)
                      .|+|.+-+...+       +.+....+++.|+++||.|+|   +.++||||||.+|||+ + +...+||||||+.+..+.
T Consensus       106 ~gdL~snv~~~G-------igE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~  175 (378)
T KOG1345|consen  106 RGDLRSNVEAAG-------IGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT  175 (378)
T ss_pred             cchhhhhcCccc-------ccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence            999998886644       778888899999999999999   8999999999999999 3 344799999999886543


Q ss_pred             CCCeeeeecccccccccccccccccc---cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRN---FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDR  299 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (372)
                      .-...      ..+..|.+||.....   .-...+.+|+|.||++++.++||+.||+.....+  ..  -|-+..+....
T Consensus       176 tV~~~------~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d--~~--Y~~~~~w~~rk  245 (378)
T KOG1345|consen  176 TVKYL------EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD--KP--YWEWEQWLKRK  245 (378)
T ss_pred             eehhh------hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC--ch--HHHHHHHhccc
Confidence            22211      134458999876421   1245678999999999999999999999543322  22  33344444544


Q ss_pred             cccCCccCCcchHHHHHHHHHHHHHcccCCCCCCC
Q 036435          300 EFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRP  334 (372)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP  334 (372)
                      ....|......    .+.+..+-.+-+.+++.+|-
T Consensus       246 ~~~~P~~F~~f----s~~a~r~Fkk~lt~~~~drc  276 (378)
T KOG1345|consen  246 NPALPKKFNPF----SEKALRLFKKSLTPRFKDRC  276 (378)
T ss_pred             CccCchhhccc----CHHHHHHHHHhcCCcccccc
Confidence            44555554443    34455566677888998883

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-28  Score=231.04  Aligned_cols=232  Identities=23%  Similarity=0.326  Sum_probs=182.7

Q ss_pred             hhhhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCC
Q 036435           87 FKDKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS  147 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~  147 (372)
                      ....+|+|+||.|||+++..                   -..+|+-+++..+||||+.++|.+.....++++||||.+|+
T Consensus        19 llqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggs   98 (829)
T KOG0576|consen   19 LLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGS   98 (829)
T ss_pred             heeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCc
Confidence            34679999999999997743                   36779999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCee
Q 036435          148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV  227 (372)
Q Consensus       148 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  227 (372)
                      |.+.-+-.+.      +++.++.-+.+..+.|++|||   +.+=+|||||-.|||+++.|.+|++|||.+-.+...-.  
T Consensus        99 lQdiy~~Tgp------lselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~--  167 (829)
T KOG0576|consen   99 LQDIYHVTGP------LSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA--  167 (829)
T ss_pred             ccceeeeccc------chhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhhhh--
Confidence            9998776554      888999999999999999999   89999999999999999999999999999976654322  


Q ss_pred             eeeccccccccccccccccc-ccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCcc
Q 036435          228 SSLLGARGIIGYIAPEVFSR-NFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV  306 (372)
Q Consensus       228 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (372)
                       +.....||+.|||||+..- ..+.+...+|+|++|+...|+--..+|..+.....        + ..+.....+..|.+
T Consensus       168 -KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr--------~-l~LmTkS~~qpp~l  237 (829)
T KOG0576|consen  168 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR--------A-LFLMTKSGFQPPTL  237 (829)
T ss_pred             -hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH--------H-HHHhhccCCCCCcc
Confidence             2234569999999998642 22578999999999999999987777765432211        1 11222223333333


Q ss_pred             CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       307 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .+..  ...+.+-+++..|+.++|.+||+++.+++
T Consensus       238 kDk~--kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  238 KDKT--KWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             cCCc--cchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            3221  23456778888999999999999987663

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.94  E-value=1.4e-27  Score=214.66  Aligned_cols=180  Identities=26%  Similarity=0.427  Sum_probs=150.9

Q ss_pred             hhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhcc-CCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           88 KDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      .++||.|+|++||++.+..                    .+..|++.|..+ .+.||+++.+++..++...+|+||+++.
T Consensus        41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~  120 (418)
T KOG1167|consen   41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHD  120 (418)
T ss_pred             hccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCcc
Confidence            4689999999999986532                    688999999999 5999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC-CCCceEEeecCCcccccC-C-
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLD-EDFCPKISDFGLAKLCTT-K-  223 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgla~~~~~-~-  223 (372)
                      +..++...         ++...+..++..++.||+++|   ..|||||||||+|+|.+ ..+.-.|.|||+|..... . 
T Consensus       121 ~f~~l~~~---------l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~  188 (418)
T KOG1167|consen  121 RFRDLYRS---------LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ  188 (418)
T ss_pred             CHHHHHhc---------CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence            99888854         778889999999999999999   89999999999999998 557789999999972110 0 


Q ss_pred             -------------------------------CCee--------eeecccccccccccccccccccCCCCccccchhHHHH
Q 036435          224 -------------------------------EGIV--------SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMM  264 (372)
Q Consensus       224 -------------------------------~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~i  264 (372)
                                                     ..+.        .......||+||.|||++.+. +.-+++.||||.|||
T Consensus       189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~-~~QttaiDiws~GVI  267 (418)
T KOG1167|consen  189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC-PRQTTAIDIWSAGVI  267 (418)
T ss_pred             hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc-cCcCCccceeeccce
Confidence                                           0000        001223499999999999875 677899999999999


Q ss_pred             HHHHhcCCCCCCCCCC
Q 036435          265 IMELVGCKNNLDSGVD  280 (372)
Q Consensus       265 l~elltg~~p~~~~~~  280 (372)
                      ++-+++++.||....+
T Consensus       268 ~Lslls~~~PFf~a~d  283 (418)
T KOG1167|consen  268 LLSLLSRRYPFFKAKD  283 (418)
T ss_pred             eehhhccccccccCcc
Confidence            9999999999986543

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.94  E-value=1.7e-27  Score=206.91  Aligned_cols=155  Identities=27%  Similarity=0.344  Sum_probs=133.5

Q ss_pred             chHHHHHHHHhccCCCceeeeEeEEecC------CceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHH
Q 036435          106 DDFVNEVASISRTSHVNVVTLLGFCLEG------NNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG  179 (372)
Q Consensus       106 ~~~~~E~~~l~~l~h~nIv~l~g~~~~~------~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~  179 (372)
                      .+..+|..++..++|+||++++.++.-.      .+.|+|||+|. .+|...+...        ++..++..++.|++.|
T Consensus        60 kra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~~e--------lDH~tis~i~yq~~~~  130 (369)
T KOG0665|consen   60 KRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD-ANLCQVILME--------LDHETISYILYQMLCG  130 (369)
T ss_pred             hhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhh-hHHHHHHHHh--------cchHHHHHHHHHHHHH
Confidence            3678999999999999999999998743      46799999995 5998887622        7788999999999999


Q ss_pred             HHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccch
Q 036435          180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVY  259 (372)
Q Consensus       180 l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dvw  259 (372)
                      ++|||   +.+|+||||||+||++..++.+||.|||+|+.....    ........|.-|.|||++-+.  .+.+..|||
T Consensus       131 ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~----~~mtpyVvtRyyrapevil~~--~~ke~vdiw  201 (369)
T KOG0665|consen  131 IKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD----FMMTPYVVTRYYRAPEVILGM--GYKENVDIW  201 (369)
T ss_pred             HHHHH---hcceeecccCcccceecchhheeeccchhhcccCcc----cccCchhheeeccCchheecc--CCcccchhh
Confidence            99999   899999999999999999999999999999865433    122344567789999999986  599999999


Q ss_pred             hHHHHHHHHhcCCCCCCCC
Q 036435          260 SFGMMIMELVGCKNNLDSG  278 (372)
Q Consensus       260 slG~il~elltg~~p~~~~  278 (372)
                      |+||++.||++|+-.|.+.
T Consensus       202 SvGci~gEli~~~Vlf~g~  220 (369)
T KOG0665|consen  202 SVGCIMGELILGTVLFPGK  220 (369)
T ss_pred             hhhhHHHHHhhceEEecCc
Confidence            9999999999999888743

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.94  E-value=5.7e-28  Score=221.49  Aligned_cols=254  Identities=20%  Similarity=0.255  Sum_probs=191.2

Q ss_pred             cccHHHHHHHHhhhhhhcCCCCceEEEEEEecc------------------hHHHHHHHHhccC------CCceeeeEeE
Q 036435           74 RYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLLD------------------DFVNEVASISRTS------HVNVVTLLGF  129 (372)
Q Consensus        74 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------------------~~~~E~~~l~~l~------h~nIv~l~g~  129 (372)
                      ++.+.|+....|.+....|+|-|++|.+|....                  .=++|+++|.+|+      --+.++|+..
T Consensus       423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~  502 (752)
T KOG0670|consen  423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRH  502 (752)
T ss_pred             EEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence            455667777777777789999999999987642                  3467999999995      3478999999


Q ss_pred             EecCCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC-Cc
Q 036435          130 CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDED-FC  208 (372)
Q Consensus       130 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~  208 (372)
                      |...+++|||+|-+ ..+|.+.|+..+..-   .|....+..++.|+.-||..|-   ..+|+|.||||.|||+++. ..
T Consensus       503 F~hknHLClVFE~L-slNLRevLKKyG~nv---GL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~i  575 (752)
T KOG0670|consen  503 FKHKNHLCLVFEPL-SLNLREVLKKYGRNV---GLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNI  575 (752)
T ss_pred             hhhcceeEEEehhh-hchHHHHHHHhCccc---ceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcce
Confidence            99999999999999 569999998865432   2788889999999999999999   8999999999999999865 45


Q ss_pred             eEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCC------
Q 036435          209 PKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSS------  282 (372)
Q Consensus       209 ~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~------  282 (372)
                      +||||||.|.....++....     .-+..|.|||.+.|-  .|+...|+||.||+||||.||+-.|.+.....      
T Consensus       576 LKLCDfGSA~~~~eneitPY-----LVSRFYRaPEIiLG~--~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~m  648 (752)
T KOG0670|consen  576 LKLCDFGSASFASENEITPY-----LVSRFYRAPEIILGL--PYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFM  648 (752)
T ss_pred             eeeccCccccccccccccHH-----HHHHhccCcceeecC--cccCCccceeeceeeEEeeccceecCCCCcHHHHHHHH
Confidence            79999999987765442211     123459999999986  89999999999999999999999887654321      


Q ss_pred             -CccchHHHH-------HHHhhhcccc-------------------cCC-----------ccCCcchHHHHHHHHHHHHH
Q 036435          283 -SEVYFPHWI-------YRHVEQDREF-------------------KLP-----------GVVTRKENEIAKKMIIVGLW  324 (372)
Q Consensus       283 -~~~~~~~~~-------~~~~~~~~~~-------------------~~~-----------~~~~~~~~~~~~~l~~l~~~  324 (372)
                       ....+++.+       .++.+.+..+                   ..|           ...+.........+.+|+..
T Consensus       649 e~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdk  728 (752)
T KOG0670|consen  649 ELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDK  728 (752)
T ss_pred             HhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHH
Confidence             011111111       1111111000                   001           11233344566788899999


Q ss_pred             cccCCCCCCCCHHHHHH
Q 036435          325 CIQARPSDRPPMNEVIE  341 (372)
Q Consensus       325 cl~~~p~~RPs~~evl~  341 (372)
                      |+..||++|.|..+.|+
T Consensus       729 ml~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  729 MLILDPEKRITVNQALK  745 (752)
T ss_pred             HhccChhhcCCHHHHhc
Confidence            99999999999999875

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=2.2e-26  Score=201.32  Aligned_cols=180  Identities=32%  Similarity=0.480  Sum_probs=152.3

Q ss_pred             hhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           87 FKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      +.+.||+|++|.||++...+                    .+.+|++.+++++|+|++++++++......++++||++++
T Consensus         3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~   82 (225)
T smart00221        3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGG   82 (225)
T ss_pred             eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCC
Confidence            35679999999999996632                    5677999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      +|.+++......     +++.....++.+++.++.+||   +.+++|+|++|+||+++.++.++|+|||.+.........
T Consensus        83 ~L~~~~~~~~~~-----~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~  154 (225)
T smart00221       83 DLFDYLRKKGGK-----LSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA  154 (225)
T ss_pred             CHHHHHHhcccC-----CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence            999999764321     688999999999999999999   789999999999999999999999999999876544210


Q ss_pred             eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCC
Q 036435          227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDS  277 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~  277 (372)
                        ......++..|++||... ....++.++|+|+||+++++|++|+.||..
T Consensus       155 --~~~~~~~~~~~~~pe~~~-~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 --LLKTVKGTPFYLAPEVLL-GGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             --cccceeccCCcCCHhHhc-CCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence              112234667799999984 223777899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=2.3e-26  Score=195.81  Aligned_cols=235  Identities=22%  Similarity=0.397  Sum_probs=180.4

Q ss_pred             hhhhhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      ++..+|.....|..|+|+++.                   +|..|.-.|+-+.||||+.++|.|....++.++..||+.|
T Consensus       193 nl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g  272 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG  272 (448)
T ss_pred             hhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence            345678889999999998853                   6888999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      +|...|+...+.    ..+..++.+++.++++|++|||+- .+-|...-|.+..|++|++.+++|.- +-+++...    
T Consensus       273 slynvlhe~t~v----vvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfsfq----  342 (448)
T KOG0195|consen  273 SLYNVLHEQTSV----VVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFSFQ----  342 (448)
T ss_pred             HHHHHHhcCccE----EEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceeeee----
Confidence            999999886542    367789999999999999999952 33355557899999999999888752 22221111    


Q ss_pred             eeeecccccccccccccccccccCCC-CccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          227 VSSLLGARGIIGYIAPEVFSRNFGEV-SHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                         .....-.+.||+||.+....... -.++|+|||.+++||+.|...||.+.....              .+....+.+
T Consensus       343 ---e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme--------------cgmkialeg  405 (448)
T KOG0195|consen  343 ---EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME--------------CGMKIALEG  405 (448)
T ss_pred             ---ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh--------------hhhhhhhcc
Confidence               11222456799999998752222 357899999999999999999998654432              222233333


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                      +....++.....+.+++.-|.+.||.+||.++.++-.|++..
T Consensus       406 lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  406 LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            333344455667788888899999999999999999998753

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=3.4e-23  Score=191.63  Aligned_cols=244  Identities=20%  Similarity=0.259  Sum_probs=179.2

Q ss_pred             hhhhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCC----CceeeeEeEE-ecCCceeEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSH----VNVVTLLGFC-LEGNNRALI  139 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h----~nIv~l~g~~-~~~~~~~lV  139 (372)
                      +.+.++||+|+||.||++...+                    .+..|..++..+..    +++..+++.. ..+...++|
T Consensus        20 ~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iV   99 (322)
T KOG1164|consen   20 YKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIV   99 (322)
T ss_pred             eEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEE
Confidence            4456789999999999987422                    36779999999873    6899999988 477788999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC-----CceEEeec
Q 036435          140 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDED-----FCPKISDF  214 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-----~~~kl~Df  214 (372)
                      |+.+ |.+|.+.......    +.++..+++.++.|++.+|++||   +.+++||||||+|+++...     ..+.|.||
T Consensus       100 M~l~-G~sL~dl~~~~~~----~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen  100 MSLL-GPSLEDLRKRNPP----GRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             Eecc-CccHHHHHHhCCC----CCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence            9999 7899998866552    23999999999999999999999   8999999999999999754     46999999


Q ss_pred             CCccccc--CCCCe----eee-ecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccch
Q 036435          215 GLAKLCT--TKEGI----VSS-LLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYF  287 (372)
Q Consensus       215 gla~~~~--~~~~~----~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~  287 (372)
                      |+++...  .....    ... ....+||..|++++...+.  ..+.+.|+||++.++.|++.|..||.........   
T Consensus       172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~--e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~---  246 (322)
T KOG1164|consen  172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI--EQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK---  246 (322)
T ss_pred             CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCC--ccCCchhhhhHHHHHHHHhcCCCCCccccccchH---
Confidence            9998332  22111    111 1345699999999998875  8899999999999999999999999665433211   


Q ss_pred             HHHHHHHhhhc-ccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccC
Q 036435          288 PHWIYRHVEQD-REFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEAL  350 (372)
Q Consensus       288 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~  350 (372)
                           ...... ....... .....   ...+.++...+-..+...+|....+...|++.....
T Consensus       247 -----~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  247 -----SKFEKDPRKLLTDR-FGDLK---PEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             -----HHHHHHhhhhcccc-ccCCC---hHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence                 111111 0111110 11111   233344444444688999999999999887766543

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=6e-23  Score=190.05  Aligned_cols=143  Identities=20%  Similarity=0.207  Sum_probs=110.9

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-------------------------hHHHHHHHHhccCCCceee-eEeEEecCCceeE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-------------------------DFVNEVASISRTSHVNVVT-LLGFCLEGNNRAL  138 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-------------------------~~~~E~~~l~~l~h~nIv~-l~g~~~~~~~~~l  138 (372)
                      +.+.+.||+|+||+||+|.+..                         .+.+|+++|++++|+|+++ ++++    +..++
T Consensus        20 Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~~L   95 (365)
T PRK09188         20 FVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GKDGL   95 (365)
T ss_pred             ceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CCcEE
Confidence            3456789999999999985421                         2789999999999999985 4432    46799


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCC-CCCceEECCCCceEEeecCCc
Q 036435          139 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDI-KPHNILLDEDFCPKISDFGLA  217 (372)
Q Consensus       139 V~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dl-k~~Nill~~~~~~kl~Dfgla  217 (372)
                      ||||++|++|.. +.  .       ..   ...++.|+++||+|||   +.+|+|||| ||+|||++.++.+||+|||+|
T Consensus        96 VmE~~~G~~L~~-~~--~-------~~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA  159 (365)
T PRK09188         96 VRGWTEGVPLHL-AR--P-------HG---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLA  159 (365)
T ss_pred             EEEccCCCCHHH-hC--c-------cc---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence            999999999962 21  1       11   1467889999999999   899999999 999999999999999999999


Q ss_pred             ccccCCCCeee-----eeccccccccccccccccc
Q 036435          218 KLCTTKEGIVS-----SLLGARGIIGYIAPEVFSR  247 (372)
Q Consensus       218 ~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~  247 (372)
                      +..........     ......++..|+|||++.-
T Consensus       160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             eecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            97654332211     1134457788999999864

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.88  E-value=2.5e-22  Score=189.29  Aligned_cols=219  Identities=24%  Similarity=0.382  Sum_probs=163.8

Q ss_pred             HhccCCCceeeeEeEEecCCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 036435          115 ISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHF  194 (372)
Q Consensus       115 l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~  194 (372)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+....     ..++|.-...+.++++.||+|||+  +.-..|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-----~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg   73 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-----IKLDYFFILSFIRDISKGLAYLHN--SPIGYHG   73 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-----cCccHHHHHHHHHHHHHHHHHHhc--Ccceeee
Confidence            467899999999999999999999999999999999998743     238888889999999999999995  3334999


Q ss_pred             CCCCCceEECCCCceEEeecCCcccccCCCCeeeeecccccccccccccccccc--cCC---CCccccchhHHHHHHHHh
Q 036435          195 DIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRN--FGE---VSHKSDVYSFGMMIMELV  269 (372)
Q Consensus       195 dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~---~~~~~DvwslG~il~ell  269 (372)
                      .++++|+++|....+||+|||+.......... .......-..-|.|||.+.+.  ...   .+.+.|+||||++++|++
T Consensus        74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~-~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~  152 (484)
T KOG1023|consen   74 ALKSSNCLVDSRWVLKLTDFGLNSLLEETAEP-EAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL  152 (484)
T ss_pred             eeccccceeeeeEEEEechhhhcccccccccc-cccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence            99999999999999999999998776431100 001111123459999999763  112   577899999999999999


Q ss_pred             cCCCCCCCCCCCCCccchHHHHHHHhhh-cccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          270 GCKNNLDSGVDSSSEVYFPHWIYRHVEQ-DREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       270 tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                      +.+.||+..........    +...+.. ......|......  +....+..++..||..+|.+||+++.+-..++...
T Consensus       153 ~r~~~~~~~~~~~~~~e----ii~~~~~~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~  225 (484)
T KOG1023|consen  153 FRSGPFDLRNLVEDPDE----IILRVKKGGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN  225 (484)
T ss_pred             hccCccccccccCChHH----HHHHHHhcCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence            99999987544333211    1222222 2222223222221  44457889999999999999999999998876554

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=8.5e-22  Score=172.39  Aligned_cols=187  Identities=20%  Similarity=0.298  Sum_probs=157.5

Q ss_pred             hhhhhhcCCCCceEEEEEEec-----------------chHHHHHHHHhcc-CCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL-----------------DDFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-----------------~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      +.+.++||+|+||+.+.|+..                 -++..|-+..+.| ..++|...|-|-.++.+-.||+|.+ |.
T Consensus        30 yrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GP  108 (449)
T KOG1165|consen   30 YRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GP  108 (449)
T ss_pred             ceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-Cc
Confidence            456789999999999999752                 1678888888888 5789999998888888889999999 78


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC-----CCceEEeecCCccccc
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE-----DFCPKISDFGLAKLCT  221 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfgla~~~~  221 (372)
                      ||+|.+.-.+.     .|+..++..+|.|++.-++|+|   .+.+|.|||||+|+||..     ...+.++|||+|+.+.
T Consensus       109 SLEDLFD~CgR-----~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr  180 (449)
T KOG1165|consen  109 SLEDLFDLCGR-----RFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR  180 (449)
T ss_pred             CHHHHHHHhcC-----cccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence            99998866553     2999999999999999999999   899999999999999964     3458999999999887


Q ss_pred             CCCCeee----eecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCC
Q 036435          222 TKEGIVS----SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSS  282 (372)
Q Consensus       222 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~  282 (372)
                      +..+...    ......||.+||+-....|.  .-+.+.|+-|+|.++++.+-|..||+....+.
T Consensus       181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGr--EQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t  243 (449)
T KOG1165|consen  181 DPKTKQHIPYREHKSLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKADT  243 (449)
T ss_pred             CccccccCccccccccccceeeeEeeccccc--hhhhhhhHHHhhhhhhhhccCCCccccccCcc
Confidence            6554322    22334599999999988875  78999999999999999999999999865443

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.88  E-value=4.1e-21  Score=176.72  Aligned_cols=246  Identities=29%  Similarity=0.370  Sum_probs=180.6

Q ss_pred             hhhhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCC-ceeeeEeEEecCCceeEEEEecCCC
Q 036435           87 FKDKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHV-NVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~-nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      ..+.||.|+||.||++....                   .+.+|+.+++.+.|+ |++++++.+......+++++++.++
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~   83 (384)
T COG0515           4 ILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGG   83 (384)
T ss_pred             eEEeecCCCCeEEEEEEeccEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCC
Confidence            34679999999999986541                   488899999999988 7999999997777789999999999


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC-ceEEeecCCcccccCCCC
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDF-CPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgla~~~~~~~~  225 (372)
                      ++.+++......   ..+.......+..|++.++.|+|   ..+++|||+||+||+++..+ .++++|||.+........
T Consensus        84 ~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~  157 (384)
T COG0515          84 SLEDLLKKIGRK---GPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS  157 (384)
T ss_pred             cHHHHHHhcccc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence            999777654321   13888999999999999999999   78999999999999999888 799999999985544332


Q ss_pred             eee---eeccccccccccccccccccc-CCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccc
Q 036435          226 IVS---SLLGARGIIGYIAPEVFSRNF-GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF  301 (372)
Q Consensus       226 ~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (372)
                      ...   ......||..|++||.+.+.. ...+...|+||+|++++++++|..|+.......    ........+......
T Consensus       158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~----~~~~~~~~~~~~~~~  233 (384)
T COG0515         158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSS----ATSQTLKIILELPTP  233 (384)
T ss_pred             cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccc----cHHHHHHHHHhcCCc
Confidence            211   224456899999999997631 367889999999999999999999965543210    001112222111110


Q ss_pred             -cCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          302 -KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       302 -~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                       ................+.+++..|+..+|..|.+..+....
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence             00000000001223466778888999999999998886653

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.88  E-value=4.3e-23  Score=203.05  Aligned_cols=235  Identities=22%  Similarity=0.289  Sum_probs=174.5

Q ss_pred             hhhcCCCCceEEEEEEecc--------h-----------------HHHHHHHHhccCCCceeeeEeEEecCCceeEEEEe
Q 036435           88 KDKLGQGGFGGVYKGRLLD--------D-----------------FVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~--------~-----------------~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      ...+|.|++|.|+......        .                 +..|.-+-..++|+|++..+..+.+....+-+|||
T Consensus       323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~  402 (601)
T KOG0590|consen  323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY  402 (601)
T ss_pred             cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence            3568999999666553321        1                 22233344567899998888877777666666999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      |++ +|..++....      .++..++..++.|++.|++|+|   ..++.|||+|++|++++.+|.+||+|||.+..+..
T Consensus       403 ~~~-Dlf~~~~~~~------~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~  472 (601)
T KOG0590|consen  403 CPY-DLFSLVMSNG------KLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRY  472 (601)
T ss_pred             ccH-HHHHHHhccc------ccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeecc
Confidence            999 9999997752      2788889999999999999999   89999999999999999999999999999987654


Q ss_pred             CCCe-eeeecccccccccccccccccccCCCC-ccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccc
Q 036435          223 KEGI-VSSLLGARGIIGYIAPEVFSRNFGEVS-HKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDRE  300 (372)
Q Consensus       223 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (372)
                      .... ........|...|+|||.+.+.  .+. ...||||.|+++..|.+|+.||......+...       ........
T Consensus       473 ~~e~~~~~~~g~~gS~pY~apE~~~~~--~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-------~~~~~~~~  543 (601)
T KOG0590|consen  473 PWEKNIHESSGIVGSDPYLAPEVLTGK--EYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-------KTNNYSDQ  543 (601)
T ss_pred             CcchhhhhhcCcccCCcCcCccccccc--ccCcchhhhhhccceEEEEecCCCccccccccccch-------hhhccccc
Confidence            3322 2234556788899999999875  665 46799999999999999999997654433211       00000111


Q ss_pred             ccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       301 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .............++.....++.++|+.||.+|.|+++|++
T Consensus       544 ~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  544 RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            11122222334456677788999999999999999999986

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=3.9e-22  Score=167.33  Aligned_cols=188  Identities=20%  Similarity=0.270  Sum_probs=153.9

Q ss_pred             HhhhhhhcCCCCceEEEEEEecc-----------------hHHHHHHHHhccCC-CceeeeEeEEecCCceeEEEEecCC
Q 036435           84 TNSFKDKLGQGGFGGVYKGRLLD-----------------DFVNEVASISRTSH-VNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~~E~~~l~~l~h-~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      .+.+.++||+|+||.+|.|....                 ++..|..+.+.|++ ..|..+..+..+.+.-.+|||.+ |
T Consensus        16 ky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-G   94 (341)
T KOG1163|consen   16 KYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-G   94 (341)
T ss_pred             ceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-C
Confidence            34556889999999999986532                 68889999999964 56777788888888889999999 8


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC---CCCceEEeecCCcccccC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLD---EDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgla~~~~~  222 (372)
                      .+|++.+.-...     .++..+++.++-|++.-++|+|   ..+++||||||+|+|..   ....+.++|||+|+.+.+
T Consensus        95 PsLEdLfnfC~R-----~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   95 PSLEDLFNFCSR-----RFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             ccHHHHHHHHhh-----hhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            899998865432     2899999999999999999999   89999999999999985   456799999999987765


Q ss_pred             CCCe----eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCC
Q 036435          223 KEGI----VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSS  282 (372)
Q Consensus       223 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~  282 (372)
                      ..+.    .....+..||..|.+-....+.  .-+.+.|+-|+|.++.++--|..||++.....
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~--eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t  228 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHLGI--EQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT  228 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhhhh--hhhhhhhhhhhcceeeeeecCCCcccccchhh
Confidence            4332    1122345589999998877664  66889999999999999999999999865543

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=1.3e-21  Score=175.06  Aligned_cols=197  Identities=20%  Similarity=0.255  Sum_probs=137.3

Q ss_pred             CCCceeeeEeEEec---------------------------CCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHH
Q 036435          119 SHVNVVTLLGFCLE---------------------------GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYE  171 (372)
Q Consensus       119 ~h~nIv~l~g~~~~---------------------------~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~  171 (372)
                      +|||||++.++|.+                           +..+|+||...+. +|..++..+.       .+.....-
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-------~s~r~~~~  345 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-------RSYRTGRV  345 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-------CchHHHHH
Confidence            49999999998863                           2356899988865 9999997765       56677788


Q ss_pred             HHHHHHHHHHHHhcCCCCCeeecCCCCCceEE--CCC--CceEEeecCCcccccC---CCCeeeeecccccccccccccc
Q 036435          172 IVIGIAKGLEYLHHGCSTKILHFDIKPHNILL--DED--FCPKISDFGLAKLCTT---KEGIVSSLLGARGIIGYIAPEV  244 (372)
Q Consensus       172 i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill--~~~--~~~kl~Dfgla~~~~~---~~~~~~~~~~~~gt~~y~aPE~  244 (372)
                      ++.|+++|+.|||   .++|.|||+|++|||+  |++  ..+.++|||.+---..   .-.+........|...-||||+
T Consensus       346 ~laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi  422 (598)
T KOG4158|consen  346 ILAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEI  422 (598)
T ss_pred             HHHHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhh
Confidence            9999999999999   8999999999999998  333  3578999998853222   1112222334456777999998


Q ss_pred             cccccCCC----CccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHH
Q 036435          245 FSRNFGEV----SHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMII  320 (372)
Q Consensus       245 ~~~~~~~~----~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  320 (372)
                      .....+..    -.|.|.|+.|.+.||+++...||+...+...+    .   ....+..-..+|..+.       ..+.+
T Consensus       423 ~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~----~---r~Yqe~qLPalp~~vp-------p~~rq  488 (598)
T KOG4158|consen  423 ATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD----T---RTYQESQLPALPSRVP-------PVARQ  488 (598)
T ss_pred             hhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec----h---hhhhhhhCCCCcccCC-------hHHHH
Confidence            76432222    25899999999999999999999873322111    0   0011111222233222       33445


Q ss_pred             HHHHcccCCCCCCCCHHHHH
Q 036435          321 VGLWCIQARPSDRPPMNEVI  340 (372)
Q Consensus       321 l~~~cl~~~p~~RPs~~evl  340 (372)
                      ++...|++||++|++.+-..
T Consensus       489 lV~~lL~r~pskRvsp~iAA  508 (598)
T KOG4158|consen  489 LVFDLLKRDPSKRVSPNIAA  508 (598)
T ss_pred             HHHHHhcCCccccCCccHHH
Confidence            66667899999999865433

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=2e-20  Score=158.24  Aligned_cols=173  Identities=16%  Similarity=0.113  Sum_probs=127.8

Q ss_pred             hhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccC-CCceeeeEeEEecCCceeEEEEecCC
Q 036435           88 KDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTS-HVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~-h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      ...|++|+||+||.+...+                     .+.+|+++|++|+ |+++.+++++    +..+++|||+.|
T Consensus         7 ~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G   82 (218)
T PRK12274          7 NEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAG   82 (218)
T ss_pred             ceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecC
Confidence            3569999999999764321                     3788999999995 5889999886    456999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCC-CCCceEECCCCceEEeecCCcccccCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDI-KPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dl-k~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      .+|...+..             ....++.|++.+|+++|   ..+|+|||| ||+|||++.++.++|+|||++.......
T Consensus        83 ~~L~~~~~~-------------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         83 AAMYQRPPR-------------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             ccHHhhhhh-------------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            888654311             11357789999999999   899999999 7999999999999999999998554332


Q ss_pred             Ce----e-ee-----ecccccccccccccccccccCCCC-ccccchhHHHHHHHHhcCCCCCCCCCCC
Q 036435          225 GI----V-SS-----LLGARGIIGYIAPEVFSRNFGEVS-HKSDVYSFGMMIMELVGCKNNLDSGVDS  281 (372)
Q Consensus       225 ~~----~-~~-----~~~~~gt~~y~aPE~~~~~~~~~~-~~~DvwslG~il~elltg~~p~~~~~~~  281 (372)
                      ..    . ..     ......++.|++|+.-.-- ...+ .+.+.++.|+-+|.++|++.+...+.+.
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l-~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~~  213 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVL-KRTSWIRELWFATGKPVYRFVTRRVLHWEDNEG  213 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhh-ccchhHHHHHHHhcchHHHHHhccCCccccCCC
Confidence            11    0 00     0112256677777643221 1233 5678899999999999999887665443

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.82  E-value=3.7e-21  Score=190.64  Aligned_cols=232  Identities=20%  Similarity=0.207  Sum_probs=162.3

Q ss_pred             hhhcCCCCceEEEEEEecc------------------hHHHHHHH--HhccCCCceeeeEeEEecCCceeEEEEecCCCC
Q 036435           88 KDKLGQGGFGGVYKGRLLD------------------DFVNEVAS--ISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS  147 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~------------------~~~~E~~~--l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~  147 (372)
                      .+.||++.|=+|.+++..+                  .|.++++-  ...++|||.+++.-+-..++..|||=+|..+ +
T Consensus        28 ~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-n  106 (1431)
T KOG1240|consen   28 VENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-N  106 (1431)
T ss_pred             ecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHhh-h
Confidence            4557777776666655432                  34444433  4455899999999988888888999999976 9


Q ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe-
Q 036435          148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI-  226 (372)
Q Consensus       148 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-  226 (372)
                      |.|.+..+.      ++...+..-|+.|++.||.-+|   ..+|+|||||.+|||++.=+.+.|+||...+...-.+.. 
T Consensus       107 LyDRlSTRP------FL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP  177 (1431)
T KOG1240|consen  107 LYDRLSTRP------FLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP  177 (1431)
T ss_pred             hhhhhccch------HHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence            999997654      3777788889999999999999   899999999999999999999999999877644322211 


Q ss_pred             ---eeeeccccccccccccccccccc---------CCCCccccchhHHHHHHHHhcC-CCCCCCCCC---CCCccchHHH
Q 036435          227 ---VSSLLGARGIIGYIAPEVFSRNF---------GEVSHKSDVYSFGMMIMELVGC-KNNLDSGVD---SSSEVYFPHW  290 (372)
Q Consensus       227 ---~~~~~~~~gt~~y~aPE~~~~~~---------~~~~~~~DvwslG~il~elltg-~~p~~~~~~---~~~~~~~~~~  290 (372)
                         ..-....+.-.+|.|||.+....         ...+++-||||+||++.||++- +++|....-   .......++.
T Consensus       178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~  257 (1431)
T KOG1240|consen  178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQ  257 (1431)
T ss_pred             ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHH
Confidence               11112222335799999875421         1257788999999999999874 666642100   0000011111


Q ss_pred             HHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          291 IYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                      +.+.++                  ...+.+++..|++.||++|.++++.++.-.+..
T Consensus       258 ~Le~Ie------------------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~  296 (1431)
T KOG1240|consen  258 LLEKIE------------------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLV  296 (1431)
T ss_pred             HHHhCc------------------CccHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence            111110                  124667888899999999999999999866655

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.81  E-value=7.7e-21  Score=179.59  Aligned_cols=151  Identities=23%  Similarity=0.224  Sum_probs=133.8

Q ss_pred             hHHHHHHHHhccC-CCceeeeEeEEecCCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 036435          107 DFVNEVASISRTS-HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH  185 (372)
Q Consensus       107 ~~~~E~~~l~~l~-h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~  185 (372)
                      ....|..++...+ ||.++++.-.+..+...+++.+|..+|+|...+.+...      +...........++-+++++| 
T Consensus        42 ~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~------f~~~~~~~~~aelaLald~lh-  114 (612)
T KOG0603|consen   42 HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVM------FDELDVAFYLAELALALDHLH-  114 (612)
T ss_pred             ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCCc------hHHHHHHHHHHHHHHHHhhcc-
Confidence            4556888888886 99999999999999999999999999999999877654      777788888999999999999 


Q ss_pred             CCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHH
Q 036435          186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMI  265 (372)
Q Consensus       186 ~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il  265 (372)
                        +.+++|||+|++||+++.+|.+++.|||+++..-..+..       +||..|||||.+.+    .....|.||||+++
T Consensus       115 --~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-------cgt~eymApEI~~g----h~~a~D~ws~gvl~  181 (612)
T KOG0603|consen  115 --KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-------CGTYEYRAPEIING----HLSAADWWSFGVLA  181 (612)
T ss_pred             --hhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc-------ccchhhhhhHhhhc----cCCcccchhhhhhH
Confidence              899999999999999999999999999999876543322       68999999999863    46789999999999


Q ss_pred             HHHhcCCCCCCC
Q 036435          266 MELVGCKNNLDS  277 (372)
Q Consensus       266 ~elltg~~p~~~  277 (372)
                      +||+||..||..
T Consensus       182 felltg~~pf~~  193 (612)
T KOG0603|consen  182 FELLTGTLPFGG  193 (612)
T ss_pred             HHHhhCCCCCch
Confidence            999999999986

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.81  E-value=1.2e-19  Score=154.50  Aligned_cols=120  Identities=18%  Similarity=0.218  Sum_probs=93.4

Q ss_pred             hhcCCCCceEEEEEEecc---------------------------hH-----------------HHHHHHHhccCCCcee
Q 036435           89 DKLGQGGFGGVYKGRLLD---------------------------DF-----------------VNEVASISRTSHVNVV  124 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~---------------------------~~-----------------~~E~~~l~~l~h~nIv  124 (372)
                      +.||+|+||.||+|...+                           .|                 .+|++.+.++.++++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~   82 (190)
T cd05147           3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP   82 (190)
T ss_pred             CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence            579999999999996521                           11                 1288999999887764


Q ss_pred             eeEeEEecCCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeeecCCCCCceEE
Q 036435          125 TLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYL-HHGCSTKILHFDIKPHNILL  203 (372)
Q Consensus       125 ~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~L-H~~~~~~ivH~dlk~~Nill  203 (372)
                      ....+..  ...++||||++++++........      .++..+...++.|++.+|.++ |   ..+|+||||||+|||+
T Consensus        83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~------~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli  151 (190)
T cd05147          83 CPEPILL--KSHVLVMEFIGDDGWAAPRLKDA------PLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLY  151 (190)
T ss_pred             CCcEEEe--cCCEEEEEEeCCCCCcchhhhcC------CCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEE
Confidence            4333222  23489999999887765533221      288899999999999999999 6   7899999999999999


Q ss_pred             CCCCceEEeecCCcccc
Q 036435          204 DEDFCPKISDFGLAKLC  220 (372)
Q Consensus       204 ~~~~~~kl~Dfgla~~~  220 (372)
                      + ++.++|+|||+|...
T Consensus       152 ~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         152 H-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             E-CCcEEEEEccccccC
Confidence            8 478999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.80  E-value=8.4e-20  Score=157.66  Aligned_cols=150  Identities=12%  Similarity=0.114  Sum_probs=113.8

Q ss_pred             hhhhhhcCCCCceEEEEEEecc--------------------h------HHHHHHHHhccCCCceeeeEeEEecC-----
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD--------------------D------FVNEVASISRTSHVNVVTLLGFCLEG-----  133 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~--------------------~------~~~E~~~l~~l~h~nIv~l~g~~~~~-----  133 (372)
                      +...+.||.|+||.||......                    .      +.+|+..+.+++|++|.....++...     
T Consensus        33 y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~  112 (232)
T PRK10359         33 IKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTL  112 (232)
T ss_pred             eEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccc
Confidence            3345689999999999864411                    1      57899999999999999999886633     


Q ss_pred             ---CceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceE
Q 036435          134 ---NNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPK  210 (372)
Q Consensus       134 ---~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  210 (372)
                         +..++||||++|.+|.++..          ++.    ....+++.+|..+|   ..+++|||++|+||+++.++ ++
T Consensus       113 ~~~~~~~lvmEyi~G~tL~~~~~----------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~  174 (232)
T PRK10359        113 RYAHTYIMLIEYIEGVELNDMPE----------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LR  174 (232)
T ss_pred             cccCCeEEEEEEECCccHHHhhh----------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EE
Confidence               35789999999999987731          332    24569999999999   89999999999999999988 99


Q ss_pred             EeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHh
Q 036435          211 ISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV  269 (372)
Q Consensus       211 l~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell  269 (372)
                      |+|||............               .++...  .+..++|+||||+.+..+.
T Consensus       175 liDfg~~~~~~e~~a~d---------------~~vler--~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        175 IIDLSGKRCTAQRKAKD---------------RIDLER--HYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEECCCcccccchhhHH---------------HHHHHh--HhcccccccceeEeehHHH
Confidence            99999886542211110               012221  4557999999999887654

>PRK10345 hypothetical protein; Provisional

Probab=99.79  E-value=7e-19  Score=151.38  Aligned_cols=117  Identities=20%  Similarity=0.266  Sum_probs=92.9

Q ss_pred             hhcCCCCceEEEEEEe----------------cchHHHHHHHHhcc-----CCCceeeeEeEEecCC---cee-EEEEe-
Q 036435           89 DKLGQGGFGGVYKGRL----------------LDDFVNEVASISRT-----SHVNVVTLLGFCLEGN---NRA-LIYEF-  142 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~----------------~~~~~~E~~~l~~l-----~h~nIv~l~g~~~~~~---~~~-lV~e~-  142 (372)
                      +.||+|+||.||....                .+++.+|+.+++++     .||||++++|++.++.   ..+ +|+|| 
T Consensus         8 ~~LG~G~~~~Vy~hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~   87 (210)
T PRK10345          8 SPLGTGRHRKCYAHPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFD   87 (210)
T ss_pred             ceecCCCceEEEECCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCC
Confidence            5799999999996211                12589999999999     5799999999999874   333 78999 


Q ss_pred             -cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCeeecCCCCCceEECC----CCceEEeecCC
Q 036435          143 -MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGL-EYLHHGCSTKILHFDIKPHNILLDE----DFCPKISDFGL  216 (372)
Q Consensus       143 -~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l-~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~Dfgl  216 (372)
                       +++|+|.+++.+..       +++.  ..++.|++.++ +|||   +.+|+||||||+|||++.    +..++|+||+.
T Consensus        88 G~~~~tL~~~l~~~~-------~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         88 GKPSITLTEFAEQCR-------YEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             CCcchhHHHHHHccc-------ccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence             55799999996532       4544  35677888777 8999   899999999999999973    34799999543


Q ss_pred             c
Q 036435          217 A  217 (372)
Q Consensus       217 a  217 (372)
                      +
T Consensus       156 ~  156 (210)
T PRK10345        156 E  156 (210)
T ss_pred             C
Confidence            3

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.78  E-value=1.6e-18  Score=148.10  Aligned_cols=120  Identities=22%  Similarity=0.187  Sum_probs=95.4

Q ss_pred             hhcCCCCceEEEEEEecc--------------------------------------------hHHHHHHHHhccCCCcee
Q 036435           89 DKLGQGGFGGVYKGRLLD--------------------------------------------DFVNEVASISRTSHVNVV  124 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~--------------------------------------------~~~~E~~~l~~l~h~nIv  124 (372)
                      +.||+|+||.||+|+..+                                            .+.+|...+.++.|+++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   82 (190)
T cd05145           3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP   82 (190)
T ss_pred             ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence            569999999999997531                                            024688899999999875


Q ss_pred             eeEeEEecCCceeEEEEecCCCChhhh-hhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCceE
Q 036435          125 TLLGFCLEGNNRALIYEFMPNGSLEKF-VYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS-TKILHFDIKPHNIL  202 (372)
Q Consensus       125 ~l~g~~~~~~~~~lV~e~~~~g~L~~~-l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~-~~ivH~dlk~~Nil  202 (372)
                      ....+...  ..++||||++++++... +...       .++..+...++.|++.++.++|   . .+++||||||+||+
T Consensus        83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~-------~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIl  150 (190)
T cd05145          83 VPEPILLK--KNVLVMEFIGDDGSPAPRLKDV-------PLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNIL  150 (190)
T ss_pred             CceEEEec--CCEEEEEEecCCCchhhhhhhc-------cCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEE
Confidence            54444333  24899999998765433 3322       1677889999999999999999   6 89999999999999


Q ss_pred             ECCCCceEEeecCCccccc
Q 036435          203 LDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       203 l~~~~~~kl~Dfgla~~~~  221 (372)
                      ++ ++.++|+|||++....
T Consensus       151 l~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         151 YH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             EE-CCCEEEEEcccceecC
Confidence            99 8899999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.77  E-value=1e-18  Score=155.36  Aligned_cols=167  Identities=21%  Similarity=0.287  Sum_probs=108.6

Q ss_pred             ceeEEEEecCCCChhhhhhc---CCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEE
Q 036435          135 NRALIYEFMPNGSLEKFVYN---GDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKI  211 (372)
Q Consensus       135 ~~~lV~e~~~~g~L~~~l~~---~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  211 (372)
                      +.+++|+-+ .+||.+.+..   ....  ...+....++.+..|+++.+++||   ..+++|+||+|+|++++.+|.++|
T Consensus       113 n~~~l~P~~-~~dL~~~~~~l~~~~~~--~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHgdi~~~nfll~~~G~v~L  186 (288)
T PF14531_consen  113 NRFLLMPRA-QGDLQDLVEALFSRAQT--HSPLAFAARLSLTVQMIRLVANLH---SYGLVHGDIKPENFLLDQDGGVFL  186 (288)
T ss_dssp             SEEEEEE---SEEHHHHHHHHHHHTTT--SHHHHHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEE-TTS-EEE
T ss_pred             hhhhccchh-hhcHHHHHHHHhhcccc--cchhHHHHHHHHHHHHHHHHHHHh---hcceEecccceeeEEEcCCCCEEE
Confidence            346788888 4588887543   2211  122455666778899999999999   899999999999999999999999


Q ss_pred             eecCCcccccCCCCeeeeecccccccccccccccccc------cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCcc
Q 036435          212 SDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRN------FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV  285 (372)
Q Consensus       212 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~  285 (372)
                      +||+.....+...      .....+..|.+||.....      .-.++.+.|.|++|+++|.|.+++.||+.........
T Consensus       187 g~F~~~~r~g~~~------~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~  260 (288)
T PF14531_consen  187 GDFSSLVRAGTRY------RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPE  260 (288)
T ss_dssp             --GGGEEETTEEE------EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSG
T ss_pred             cChHHHeecCcee------eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCcccccc
Confidence            9998776543211      112345679999976432      1256889999999999999999999998653322110


Q ss_pred             chHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCC
Q 036435          286 YFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDR  333 (372)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R  333 (372)
                          |               ...... +.++.+..++...|+.||.+|
T Consensus       261 ----~---------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  261 ----W---------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             ----G---------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             ----c---------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence                0               122223 667788889999999999988

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.74  E-value=9.8e-18  Score=145.72  Aligned_cols=117  Identities=22%  Similarity=0.346  Sum_probs=101.6

Q ss_pred             hhcCCCCceEEEEEEecc-------------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           89 DKLGQGGFGGVYKGRLLD-------------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~-------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      +.||+|++|.||+|...+                         .+.+|+.++..++|+|+.....++.+.+..++||||+
T Consensus         2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   81 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI   81 (211)
T ss_pred             cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence            468999999999995321                         3667999999999999988777777788889999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccc
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL  219 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  219 (372)
                      +|++|.+++...         .+ .+..++.+++.+|.++|   ..+++|+|++|+|||++ ++.++++|||++..
T Consensus        82 ~G~~L~~~~~~~---------~~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         82 EGEPLKDLINSN---------GM-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CCcCHHHHHHhc---------cH-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999998542         12 77899999999999999   89999999999999999 78999999999875

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.73  E-value=1.6e-17  Score=163.95  Aligned_cols=114  Identities=22%  Similarity=0.337  Sum_probs=100.1

Q ss_pred             hhhcCCCCceEEEEEEecc-------------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEe
Q 036435           88 KDKLGQGGFGGVYKGRLLD-------------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~-------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      .+.||+|+||.||+|.+..                         .+.+|++++++++|+|++....++.+....++||||
T Consensus       338 ~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~  417 (535)
T PRK09605        338 DHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEY  417 (535)
T ss_pred             cceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEe
Confidence            4679999999999965421                         367899999999999999888888887788999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccc
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL  219 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  219 (372)
                      +++++|.+++.              ....++.|++++|.+||   +.+++||||||+|||+ +++.++|+|||+++.
T Consensus       418 ~~g~~L~~~l~--------------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        418 IGGKDLKDVLE--------------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             cCCCcHHHHHH--------------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            99999998884              34578999999999999   8999999999999999 678999999999875

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.73  E-value=1.1e-17  Score=168.75  Aligned_cols=178  Identities=17%  Similarity=0.214  Sum_probs=136.6

Q ss_pred             HhhhhhhcCCCCceEEEEEEecc---------------hHHHHHHHHhccC---CCceeeeEeEEecCCceeEEEEecCC
Q 036435           84 TNSFKDKLGQGGFGGVYKGRLLD---------------DFVNEVASISRTS---HVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~~---------------~~~~E~~~l~~l~---h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      ++.+.+.||+|+||.||+|...+               +|.-=.+++.+|+   -+-|+.+.....-.+.-+||+||.+.
T Consensus       699 ~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~  778 (974)
T KOG1166|consen  699 KFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPY  778 (974)
T ss_pred             eEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeecccc
Confidence            34456789999999999997654               2322334444444   23344444444556677899999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC-------CCCceEEeecCCcc
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLD-------EDFCPKISDFGLAK  218 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~-------~~~~~kl~Dfgla~  218 (372)
                      |+|.+++...      +.++|.-.+.+..|++..++.||   ..+|||+||||+|+||.       +...++|+|||.+.
T Consensus       779 Gtlld~~N~~------~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si  849 (974)
T KOG1166|consen  779 GTLLDLINTN------KVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI  849 (974)
T ss_pred             ccHHHhhccC------CCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence            9999999733      23899999999999999999999   89999999999999994       34568999999997


Q ss_pred             cccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCC
Q 036435          219 LCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKN  273 (372)
Q Consensus       219 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~  273 (372)
                      .+..-... .......+|-.+-.+|+..|.  .++...|.|.+..+++-|+.|+.
T Consensus       850 Dm~lfp~~-~~F~~~~~td~f~C~EM~~gr--pWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  850 DMKLFPDG-TKFKAVWHTDLFDCIEMREGR--PWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             eeeEcCCC-cEEeeeeccccchhHHHhcCC--CCchhhhhHHHHHHHHHHHHHHH
Confidence            65432222 123344577789999999986  89999999999999999998863

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.71  E-value=4.9e-17  Score=140.01  Aligned_cols=113  Identities=26%  Similarity=0.411  Sum_probs=94.9

Q ss_pred             hcCCCCceEEEEEEecc-------------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           90 KLGQGGFGGVYKGRLLD-------------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        90 ~lg~G~~g~V~~~~~~~-------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      .||+|+||.||+|.+..                         ++.+|+++++.++|+++.....++...+..++||||++
T Consensus         1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~   80 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE   80 (199)
T ss_pred             CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence            38999999999997321                         34579999999998876655555666777899999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccc
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL  219 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  219 (372)
                      |++|.+.+....       .      .++.+++.+|.+||   ..+++|+|++|+||+++ ++.++++|||++..
T Consensus        81 g~~l~~~~~~~~-------~------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        81 GKPLKDVIEEGN-------D------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CccHHHHHhhcH-------H------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999998875421       1      78999999999999   89999999999999999 88999999999864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.70  E-value=5.3e-18  Score=157.55  Aligned_cols=175  Identities=23%  Similarity=0.363  Sum_probs=126.1

Q ss_pred             ceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeec
Q 036435          135 NRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDF  214 (372)
Q Consensus       135 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  214 (372)
                      ++|+.|++|.-.+|.+|+.......   ..++...+.++.|++.|++|      ++.+|+|+||.||+...+..+||+||
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e---~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDF  400 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGE---ERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDF  400 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCccc---ccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhh
Confidence            5789999999999999997654332   27788899999999999998      68999999999999999999999999


Q ss_pred             CCcccccCCCCe---eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHH
Q 036435          215 GLAKLCTTKEGI---VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHW  290 (372)
Q Consensus       215 gla~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~  290 (372)
                      |+........+.   ........||.-||+||.+.++  .++.++||||||++++|++. -...++              
T Consensus       401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~--~y~~kvdIyaLGlil~EL~~~f~T~~e--------------  464 (516)
T KOG1033|consen  401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ--QYSEKVDIYALGLILAELLIQFSTQFE--------------  464 (516)
T ss_pred             hheeecccCCcccchhhhhhhcccccccCCHHHHhhh--hhhhhcchhhHHHHHHHHHHHhccHHH--------------
Confidence            998765443311   1122345689999999999986  99999999999999999985 111111              


Q ss_pred             HHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 036435          291 IYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNE  338 (372)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  338 (372)
                      -.......+.-.+|....   .+. ..=..++.+++.+.|.+||++.+
T Consensus       465 r~~t~~d~r~g~ip~~~~---~d~-p~e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  465 RIATLTDIRDGIIPPEFL---QDY-PEEYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             HHHhhhhhhcCCCChHHh---hcC-cHHHHHHHHhcCCCcccCchHHH
Confidence            011111122222221111   111 22245777899999999995544

>smart00090 RIO RIO-like kinase

Probab=99.67  E-value=2.2e-16  Score=139.09  Aligned_cols=121  Identities=18%  Similarity=0.164  Sum_probs=93.8

Q ss_pred             hhhhhcCCCCceEEEEEE-e-cc------------------------------------------hHHHHHHHHhccCCC
Q 036435           86 SFKDKLGQGGFGGVYKGR-L-LD------------------------------------------DFVNEVASISRTSHV  121 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~-~-~~------------------------------------------~~~~E~~~l~~l~h~  121 (372)
                      .+.+.||+|+||.||+|. . .+                                          .+.+|+..+.++.+.
T Consensus        31 ~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~  110 (237)
T smart00090       31 AIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEA  110 (237)
T ss_pred             HhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhc
Confidence            445789999999999997 2 10                                          034799999999753


Q ss_pred             c--eeeeEeEEecCCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eeecCCCC
Q 036435          122 N--VVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTK-ILHFDIKP  198 (372)
Q Consensus       122 n--Iv~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~-ivH~dlk~  198 (372)
                      +  +.+.+++    ...++||||+++++|........      .+...+...++.|++.++++||   ..+ ++|+||||
T Consensus       111 ~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp  177 (237)
T smart00090      111 GVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV------EPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSE  177 (237)
T ss_pred             CCCCCeeeEe----cCceEEEEEecCCcccccccccC------CcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCCh
Confidence            3  3444443    23589999999988876543222      1555667899999999999999   788 99999999


Q ss_pred             CceEECCCCceEEeecCCcccc
Q 036435          199 HNILLDEDFCPKISDFGLAKLC  220 (372)
Q Consensus       199 ~Nill~~~~~~kl~Dfgla~~~  220 (372)
                      +||+++ ++.++|+|||.+...
T Consensus       178 ~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      178 YNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             hhEEEE-CCCEEEEEChhhhcc
Confidence            999999 889999999998743

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.64  E-value=9e-17  Score=159.65  Aligned_cols=202  Identities=22%  Similarity=0.305  Sum_probs=134.2

Q ss_pred             hhhcCCCCceEEEEEEecc---hHHHHHHHHhccCCCceeee-EeEEecCCceeEEEEecCCCChhhhhhcCCCCCCCCC
Q 036435           88 KDKLGQGGFGGVYKGRLLD---DFVNEVASISRTSHVNVVTL-LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQY  163 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~---~~~~E~~~l~~l~h~nIv~l-~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~  163 (372)
                      .+.|..|+||.||..++..   .|..      +++-.|++-= +.-+.  ++.+.|      ||-.+.++..+.      
T Consensus        88 IklisngAygavylvrh~~trqrfa~------kiNkq~lilRnilt~a--~npfvv------gDc~tllk~~g~------  147 (1205)
T KOG0606|consen   88 IKLISNGAYGAVYLVRHKETRQRFAM------KINKQNLILRNILTFA--GNPFVV------GDCATLLKNIGP------  147 (1205)
T ss_pred             eEeeccCCCCceeeeeccccccchhh------cccccchhhhcccccc--CCccee------chhhhhcccCCC------
Confidence            4678999999999997753   3332      3443333311 12222  223333      566666665443      


Q ss_pred             CCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe------------eeeec
Q 036435          164 LRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI------------VSSLL  231 (372)
Q Consensus       164 l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~------------~~~~~  231 (372)
                      ++.        +++.+++|||   ..+|+|||+||+|.+|+.-|.+|+.|||+++........            .....
T Consensus       148 lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dK  216 (1205)
T KOG0606|consen  148 LPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDK  216 (1205)
T ss_pred             Ccc--------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhc
Confidence            332        2378899999   899999999999999999999999999999754321111            01112


Q ss_pred             ccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCCcch
Q 036435          232 GARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKE  311 (372)
Q Consensus       232 ~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (372)
                      ..+||+.|.|||++..+  .|....|.|++|+|+||.+-|+.||+.+....        +...+..+ ...+++.    .
T Consensus       217 qvcgTPeyiaPeVilrq--gygkpvdwwamGiIlyeFLVgcvpffGdtpee--------lfg~visd-~i~wpE~----d  281 (1205)
T KOG0606|consen  217 QVCGTPEYIAPEVILRQ--GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE--------LFGQVISD-DIEWPEE----D  281 (1205)
T ss_pred             cccCCccccChhhhhhh--ccCCCccHHHHHHHHHHHheeeeeccCCCHHH--------HHhhhhhh-hcccccc----C
Confidence            34699999999999876  78899999999999999999999998764322        22222211 1122222    2


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCC
Q 036435          312 NEIAKKMIIVGLWCIQARPSDRPP  335 (372)
Q Consensus       312 ~~~~~~l~~l~~~cl~~~p~~RPs  335 (372)
                      .....+..+++...|+.+|..|--
T Consensus       282 ea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  282 EALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             cCCCHHHHHHHHHHHHhChHhhcc
Confidence            223445566777788999999963

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.64  E-value=1.1e-15  Score=131.50  Aligned_cols=119  Identities=22%  Similarity=0.205  Sum_probs=93.9

Q ss_pred             hhhhhhcCCCCceEEEEEEecc----------------------------------------hHHHHHHHHhccCCCc--
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD----------------------------------------DFVNEVASISRTSHVN--  122 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~----------------------------------------~~~~E~~~l~~l~h~n--  122 (372)
                      +.+.+.||+|+||.||++...+                                        .+.+|..++..+.|++  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            3445789999999999986631                                        1466888888888874  


Q ss_pred             eeeeEeEEecCCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceE
Q 036435          123 VVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNIL  202 (372)
Q Consensus       123 Iv~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nil  202 (372)
                      +...++    ....++||||+++++|.+....            .....++.+++.++.++|   ..+++|+||||+||+
T Consensus        97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nil  157 (198)
T cd05144          97 VPKPID----WNRHAVVMEYIDGVELYRVRVL------------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNIL  157 (198)
T ss_pred             CCceee----cCCceEEEEEeCCcchhhcccc------------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEE
Confidence            444443    2455899999999998765321            234578899999999999   799999999999999


Q ss_pred             ECCCCceEEeecCCcccccC
Q 036435          203 LDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       203 l~~~~~~kl~Dfgla~~~~~  222 (372)
                      +++++.++|+|||++.....
T Consensus       158 l~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         158 VDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             EcCCCcEEEEECCccccCCC
Confidence            99999999999999965443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.59  E-value=9.5e-15  Score=128.94  Aligned_cols=99  Identities=19%  Similarity=0.217  Sum_probs=79.7

Q ss_pred             hHHHHHHHHhccCCCce--eeeEeEEecCCc----eeEEEEecCC-CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHH
Q 036435          107 DFVNEVASISRTSHVNV--VTLLGFCLEGNN----RALIYEFMPN-GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG  179 (372)
Q Consensus       107 ~~~~E~~~l~~l~h~nI--v~l~g~~~~~~~----~~lV~e~~~~-g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~  179 (372)
                      .+.+|+.++.+++|++|  +..+++......    .++|+|++++ .+|.+++....       ++..    .+.+++.+
T Consensus        86 r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~~-------l~~~----~~~~i~~~  154 (239)
T PRK01723         86 RAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEAP-------LSEE----QWQAIGQL  154 (239)
T ss_pred             HHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcCC-------CCHH----HHHHHHHH
Confidence            36779999999998885  667776544322    2599999997 68998885432       4443    36789999


Q ss_pred             HHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccc
Q 036435          180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL  219 (372)
Q Consensus       180 l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  219 (372)
                      |.+||   +.+|+|+||||+|||++.++.++|+|||.+..
T Consensus       155 l~~lH---~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        155 IARFH---DAGVYHADLNAHNILLDPDGKFWLIDFDRGEL  191 (239)
T ss_pred             HHHHH---HCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence            99999   89999999999999999988999999998875

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.59  E-value=1.6e-16  Score=156.81  Aligned_cols=238  Identities=24%  Similarity=0.305  Sum_probs=173.3

Q ss_pred             hhhhhcCCCCceEEEEEEec----------------------chHHHHHHHHhccC-CCceeeeEeEEecCCceeEEEEe
Q 036435           86 SFKDKLGQGGFGGVYKGRLL----------------------DDFVNEVASISRTS-HVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~----------------------~~~~~E~~~l~~l~-h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      .+.+.||+|+|+.|-.....                      .+...|..+-..++ |+|++.+++...+.+..+++.+|
T Consensus        23 ~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~  102 (601)
T KOG0590|consen   23 KLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSY  102 (601)
T ss_pred             cccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCc
Confidence            33456889999888654331                      13344677767776 99999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC-ceEEeecCCccccc
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDF-CPKISDFGLAKLCT  221 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgla~~~~  221 (372)
                      ..++++.+.+...+.    ...+....-.++.|+..++.|+|.  ..++.|+|+||+|.+++..+ ..+++|||+|..+.
T Consensus       103 s~g~~~f~~i~~~~~----~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen  103 SDGGSLFSKISHPDS----TGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             ccccccccccccCCc----cCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            999999988842221    115556677889999999999995  58999999999999999999 99999999998776


Q ss_pred             CCCCeeeeeccccc-ccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccc
Q 036435          222 TKEGIVSSLLGARG-IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDRE  300 (372)
Q Consensus       222 ~~~~~~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (372)
                      .............| ++.|+|||...+. ....+..|+||.|+++.-+++|..|+.........  +..|....    ..
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~--~~~~~~~~----~~  249 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGK-AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR--YSSWKSNK----GR  249 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccch-hhcCCCcccccccccccccccCCCCcccccccccc--ceeecccc----cc
Confidence            63333333445567 9999999998874 24568899999999999999999999866543321  11111110    00


Q ss_pred             ccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       301 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .     .............++..+++..+|..|.+.+++-.
T Consensus       250 ~-----~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  250 F-----TQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             c-----ccCccccCChhhhhcccccccCCchhccccccccc
Confidence            0     00111223445666777788899999999888764

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.56  E-value=2.4e-14  Score=116.91  Aligned_cols=118  Identities=25%  Similarity=0.205  Sum_probs=100.1

Q ss_pred             hhcCCCCceEEEEEEec---------------chHHHHHHHHhccCC--CceeeeEeEEecCCceeEEEEecCCCChhhh
Q 036435           89 DKLGQGGFGGVYKGRLL---------------DDFVNEVASISRTSH--VNVVTLLGFCLEGNNRALIYEFMPNGSLEKF  151 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~---------------~~~~~E~~~l~~l~h--~nIv~l~g~~~~~~~~~lV~e~~~~g~L~~~  151 (372)
                      +.||+|.++.||+++..               .++.+|+..++.++|  .++.+++++....+..++++||++++++..+
T Consensus         4 ~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~   83 (155)
T cd05120           4 KLLKGGLTNRVYLLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV   83 (155)
T ss_pred             eecccccccceEEEEecCCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC
Confidence            56899999999998752               158899999999977  5999999998888889999999998777643


Q ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccc
Q 036435          152 VYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL  219 (372)
Q Consensus       152 l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  219 (372)
                                   +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.+..
T Consensus        84 -------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          84 -------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             -------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence                         3456677899999999999953335799999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.51  E-value=8.6e-14  Score=118.50  Aligned_cols=118  Identities=23%  Similarity=0.218  Sum_probs=83.4

Q ss_pred             hhhcCCCCceEEEEEEecc--------------------hH----------------------HHHHHHHhccCCCc--e
Q 036435           88 KDKLGQGGFGGVYKGRLLD--------------------DF----------------------VNEVASISRTSHVN--V  123 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~--------------------~~----------------------~~E~~~l~~l~h~n--I  123 (372)
                      .+.||+|+||.||++...+                    ..                      ..|...+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            3579999999999987641                    00                      23444444443332  3


Q ss_pred             eeeEeEEecCCceeEEEEecCCCChhhh-hhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCce
Q 036435          124 VTLLGFCLEGNNRALIYEFMPNGSLEKF-VYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS-TKILHFDIKPHNI  201 (372)
Q Consensus       124 v~l~g~~~~~~~~~lV~e~~~~g~L~~~-l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~-~~ivH~dlk~~Ni  201 (372)
                      .+.++.    ...++||||++++++... +....       .. .+...++.+++.++.++|   . .+++|+||||+||
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-------~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Ni  146 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-------LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNI  146 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh-------hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhE
Confidence            334432    245899999998654322 11110       11 567789999999999999   6 9999999999999


Q ss_pred             EECCCCceEEeecCCccccc
Q 036435          202 LLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       202 ll~~~~~~kl~Dfgla~~~~  221 (372)
                      +++ ++.++++|||.+....
T Consensus       147 li~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         147 LVD-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             EEE-CCcEEEEECccccccc
Confidence            999 8999999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.50  E-value=1.4e-14  Score=127.40  Aligned_cols=206  Identities=18%  Similarity=0.261  Sum_probs=135.6

Q ss_pred             HHHhccCCCceeeeEeEEecCC-----ceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 036435          113 ASISRTSHVNVVTLLGFCLEGN-----NRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC  187 (372)
Q Consensus       113 ~~l~~l~h~nIv~l~g~~~~~~-----~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~  187 (372)
                      .-|-++-|.|||+++.|+.+..     ...++.|||..|+|..+|++.....  ..+......+|+.||+.||.|||+ |
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~--~a~~~~~wkkw~tqIlsal~yLhs-~  195 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ--KALFQKAWKKWCTQILSALSYLHS-C  195 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh--hhhhHHHHHHHHHHHHhhhhhhhc-c
Confidence            3455667999999999987654     4678999999999999998754322  237778889999999999999995 5


Q ss_pred             CCCeeecCCCCCceEECCCCceEEeecCCcccccCCC-CeeeeecccccccccccccccccccCCCCccccchhHHHHHH
Q 036435          188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE-GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIM  266 (372)
Q Consensus       188 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~  266 (372)
                      +++++|+++..+.|++..++-+|++--.-...-..-. ..........+-++|.+||+=..  ...+.++|||+||...+
T Consensus       196 ~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~--tn~~~a~dIy~fgmcAl  273 (458)
T KOG1266|consen  196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT--TNTTGASDIYKFGMCAL  273 (458)
T ss_pred             CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcc--cccccchhhhhhhHHHH
Confidence            8999999999999999999988876422111100000 00000112235678999996443  26678999999999999


Q ss_pred             HHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          267 ELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       267 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ||.-+.-.........    ..   ...+. ...+...   ....       ...+..|++..|..||+|.+++.
T Consensus       274 emailEiq~tnseS~~----~~---ee~ia-~~i~~le---n~lq-------r~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  274 EMAILEIQSTNSESKV----EV---EENIA-NVIIGLE---NGLQ-------RGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             HHHHheeccCCCccee----eh---hhhhh-hheeecc---Cccc-------cCcCcccccCCCCCCcchhhhhc
Confidence            9987664322211100    00   00000 0000000   0000       12445699999999999998874

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.41  E-value=4.4e-13  Score=127.18  Aligned_cols=238  Identities=22%  Similarity=0.246  Sum_probs=169.3

Q ss_pred             HHHHHHHHhhhhhhcCC--CCceEEEEEEe--cc---------------------hHHHHHHHHhcc-CCCceeeeEeEE
Q 036435           77 FSDVKKLTNSFKDKLGQ--GGFGGVYKGRL--LD---------------------DFVNEVASISRT-SHVNVVTLLGFC  130 (372)
Q Consensus        77 ~~~~~~~~~~~~~~lg~--G~~g~V~~~~~--~~---------------------~~~~E~~~l~~l-~h~nIv~l~g~~  130 (372)
                      +.+.......+.+.+|.  |.+|.||.++.  ..                     .=.+|+....++ .|+|.++.+..+
T Consensus       108 ~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~  187 (524)
T KOG0601|consen  108 FDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW  187 (524)
T ss_pred             ccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc
Confidence            44555555566778999  99999999877  21                     234566666666 499999999999


Q ss_pred             ecCCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCeeecCCCCCceEECCC
Q 036435          131 LEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK----GLEYLHHGCSTKILHFDIKPHNILLDED  206 (372)
Q Consensus       131 ~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~----~l~~LH~~~~~~ivH~dlk~~Nill~~~  206 (372)
                      .+.+..++-+|++. .+|.++.+....     .++....+..+.+...    |+.++|   ...++|-|+||.||+...+
T Consensus       188 e~~~~lfiqtE~~~-~sl~~~~~~~~~-----~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~  258 (524)
T KOG0601|consen  188 EGSGILFIQTELCG-ESLQSYCHTPCN-----FLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSD  258 (524)
T ss_pred             ccCCcceeeecccc-chhHHhhhcccc-----cCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccc
Confidence            99999999999994 688888876543     2566667777777777    999999   8999999999999999988


Q ss_pred             -CceEEeecCCcccccCCCCeeee--ecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCC
Q 036435          207 -FCPKISDFGLAKLCTTKEGIVSS--LLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSS  283 (372)
Q Consensus       207 -~~~kl~Dfgla~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~  283 (372)
                       ...+++|||+...+....-....  .....|...|++||.+.+   .++...|+|++|-+..+..++-.....+.... 
T Consensus       259 ~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~---l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-  334 (524)
T KOG0601|consen  259 WTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG---LATFASDIFSLGEVILEAILGSHLPSVGKNSS-  334 (524)
T ss_pred             cceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc---ccchHhhhcchhhhhHhhHhhcccccCCCCCC-
Confidence             88999999999987765522111  122246677999999876   67889999999999999888776554332111 


Q ss_pred             ccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          284 EVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                            |  ......  +.....+...    ..++......+++.+|..|++...+..
T Consensus       335 ------W--~~~r~~--~ip~e~~~~~----s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  335 ------W--SQLRQG--YIPLEFCEGG----SSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             ------c--cccccc--cCchhhhcCc----chhhhhHHHHhcCcchhhhhHHHHHhc
Confidence                  1  111110  0111111111    122333666788999999998777653

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.40  E-value=9.7e-12  Score=119.45  Aligned_cols=161  Identities=17%  Similarity=0.199  Sum_probs=122.7

Q ss_pred             CCCCceEEEEEEecch-----HHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCChhhhhhcCCCCCCCCCCCH
Q 036435           92 GQGGFGGVYKGRLLDD-----FVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRW  166 (372)
Q Consensus        92 g~G~~g~V~~~~~~~~-----~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~  166 (372)
                      -.|++-.||..+....     ..+-++.|+.++||||++++..+..++..|+|+|.+.  .|..++.+.         +.
T Consensus        35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l---------~~  103 (690)
T KOG1243|consen   35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL---------GK  103 (690)
T ss_pred             ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh---------HH
Confidence            3467777777666544     6778899999999999999999999999999999994  677787653         33


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeeeeecccccccccccccccc
Q 036435          167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS  246 (372)
Q Consensus       167 ~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  246 (372)
                      ....-.+.||+.||.|||+  +.+++|++|.-+.|++++.|..||++|.++...........   ....-..|..|+.+.
T Consensus       104 ~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~---~~~~~~s~~~P~~~~  178 (690)
T KOG1243|consen  104 EEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAK---SLYLIESFDDPEEID  178 (690)
T ss_pred             HHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccc---cchhhhcccChhhcC
Confidence            4555678999999999997  78999999999999999999999999988764332221000   001112366676543


Q ss_pred             cccCCCCccccchhHHHHHHHHhcCC
Q 036435          247 RNFGEVSHKSDVYSFGMMIMELVGCK  272 (372)
Q Consensus       247 ~~~~~~~~~~DvwslG~il~elltg~  272 (372)
                      ..    ....|.|-|||+++|++.|.
T Consensus       179 ~s----~~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  179 PS----EWSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             cc----ccchhhhhHHHHHHHHhCcc
Confidence            21    24569999999999999983

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.31  E-value=6.3e-12  Score=120.50  Aligned_cols=103  Identities=19%  Similarity=0.205  Sum_probs=71.1

Q ss_pred             HHHHHHHHhccC----CCceeeeEeEEe-cCCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHH-HHH
Q 036435          108 FVNEVASISRTS----HVNVVTLLGFCL-EGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK-GLE  181 (372)
Q Consensus       108 ~~~E~~~l~~l~----h~nIv~l~g~~~-~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~-~l~  181 (372)
                      |.+|+..+.+++    |.+-+.+-.++. .....+|||||++|++|.+........     .   .+.+++.+++. .+.
T Consensus       200 f~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~-----~---~~~~ia~~~~~~~l~  271 (437)
T TIGR01982       200 LRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG-----L---DRKALAENLARSFLN  271 (437)
T ss_pred             HHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC-----C---CHHHHHHHHHHHHHH
Confidence            445555555552    222233322332 234578999999999998876532110     2   23456666665 467


Q ss_pred             HHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       182 ~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      .+|   ..+++|+|++|.||+++.++.++++|||++....
T Consensus       272 ql~---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       272 QVL---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHH---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            888   7899999999999999999999999999997654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.24  E-value=4.7e-11  Score=99.82  Aligned_cols=110  Identities=28%  Similarity=0.256  Sum_probs=82.0

Q ss_pred             hhcCCCCceEEEEEEecc----------------hHHHHHHHHhccCCCcee-eeEeEEecCCceeEEEEecCCCChhhh
Q 036435           89 DKLGQGGFGGVYKGRLLD----------------DFVNEVASISRTSHVNVV-TLLGFCLEGNNRALIYEFMPNGSLEKF  151 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~----------------~~~~E~~~l~~l~h~nIv-~l~g~~~~~~~~~lV~e~~~~g~L~~~  151 (372)
                      +.|+.|.++.||+.+..+                .+.+|+..++.+.+.+++ +++.+.  ....++||||++|.++.+.
T Consensus         4 ~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~~   81 (170)
T cd05151           4 SPLKGGMTNKNYRVEVANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLTE   81 (170)
T ss_pred             eecCCcccCceEEEEECCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccccc
Confidence            457888888999865421                367899999999766554 455443  3345899999999887643


Q ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----eeecCCCCCceEECCCCceEEeecCCcc
Q 036435          152 VYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTK-----ILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       152 l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~-----ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                          .       ..   ....+.+++++|+.||   ..+     ++|+|++|.||+++ ++.++++|||.+.
T Consensus        82 ----~-------~~---~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          82 ----D-------FS---DPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ----c-------cc---CHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence                0       11   1235678999999999   555     59999999999999 6789999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.16  E-value=3.5e-10  Score=92.88  Aligned_cols=96  Identities=18%  Similarity=0.299  Sum_probs=78.2

Q ss_pred             hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 036435          107 DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG  186 (372)
Q Consensus       107 ~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~  186 (372)
                      +..+|+.++.+++--.|..-+=+..+.+...|+|||++|..|.+.+...             ...++..+-.-+.-||  
T Consensus        45 Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~-------------~~~~~r~vG~~vg~lH--  109 (204)
T COG3642          45 RTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA-------------RPDLLREVGRLVGKLH--  109 (204)
T ss_pred             HHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc-------------chHHHHHHHHHHHHHH--
Confidence            5678999999987555554444556777788999999998999888654             2356777788888999  


Q ss_pred             CCCCeeecCCCCCceEECCCCceEEeecCCccc
Q 036435          187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKL  219 (372)
Q Consensus       187 ~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  219 (372)
                       ..+|+|+||.++||+++.++ +.++||||+..
T Consensus       110 -~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642         110 -KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             -hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence             89999999999999998765 99999999874

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.14  E-value=5.7e-10  Score=91.28  Aligned_cols=125  Identities=21%  Similarity=0.320  Sum_probs=93.7

Q ss_pred             hhcCCCCceEEEEEEecc-------------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           89 DKLGQGGFGGVYKGRLLD-------------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~-------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      ..+-+|+-+.|+++.+..                         +..+|++.|.++.--.|.--.=++.+...-.|+|||+
T Consensus        13 ~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~   92 (229)
T KOG3087|consen   13 ELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFI   92 (229)
T ss_pred             eeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEec
Confidence            457888888888876532                         5788999999987555544444566667778999999


Q ss_pred             CC-CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC---ceEEeecCCccc
Q 036435          144 PN-GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDF---CPKISDFGLAKL  219 (372)
Q Consensus       144 ~~-g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfgla~~  219 (372)
                      ++ .++.+++.......    ........++.+|-+.+.-||   ..+++|+||..+||++..++   .+.++|||++..
T Consensus        93 ~g~~~vk~~i~~~~~~~----~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   93 DGASTVKDFILSTMEDE----SEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             cchhHHHHHHHHHccCc----ccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            76 47888886654321    222223688999999999999   89999999999999996443   358999999875


Q ss_pred             c
Q 036435          220 C  220 (372)
Q Consensus       220 ~  220 (372)
                      .
T Consensus       166 s  166 (229)
T KOG3087|consen  166 S  166 (229)
T ss_pred             c
Confidence            4

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.08  E-value=3.6e-10  Score=109.98  Aligned_cols=103  Identities=16%  Similarity=0.196  Sum_probs=62.6

Q ss_pred             HHHHHHHHhccC----CCceeeeEeEEec-CCceeEEEEecCCCChhhh--hhcCCCCCCCCCCCHHHHHHHHHHHHHHH
Q 036435          108 FVNEVASISRTS----HVNVVTLLGFCLE-GNNRALIYEFMPNGSLEKF--VYNGDTSKPCQYLRWEKMYEIVIGIAKGL  180 (372)
Q Consensus       108 ~~~E~~~l~~l~----h~nIv~l~g~~~~-~~~~~lV~e~~~~g~L~~~--l~~~~~~~~~~~l~~~~~~~i~~qi~~~l  180 (372)
                      +.+|+..+.+++    +.+.+.+-.++.+ ....+|||||++|+.+.+.  +...+..  ...+....+..++.|+    
T Consensus       203 ~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d--~~~la~~~v~~~~~Qi----  276 (537)
T PRK04750        203 LMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTD--MKLLAERGVEVFFTQV----  276 (537)
T ss_pred             HHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCC--HHHHHHHHHHHHHHHH----
Confidence            344444444442    3333333333332 3456799999999999874  2222100  0012222222333333    


Q ss_pred             HHHhcCCCCCeeecCCCCCceEECCCC----ceEEeecCCcccccC
Q 036435          181 EYLHHGCSTKILHFDIKPHNILLDEDF----CPKISDFGLAKLCTT  222 (372)
Q Consensus       181 ~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfgla~~~~~  222 (372)
                         .   ..+++|+|++|.||+++.++    .++++|||++.....
T Consensus       277 ---f---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 ---F---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ---H---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence               3   57999999999999999887    999999999986643

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.05  E-value=1.3e-09  Score=92.33  Aligned_cols=99  Identities=15%  Similarity=0.179  Sum_probs=74.3

Q ss_pred             HHHHHHHHhccCC--CceeeeEeEEecCCceeEEEEecCCCChhh-hhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHH-
Q 036435          108 FVNEVASISRTSH--VNVVTLLGFCLEGNNRALIYEFMPNGSLEK-FVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYL-  183 (372)
Q Consensus       108 ~~~E~~~l~~l~h--~nIv~l~g~~~~~~~~~lV~e~~~~g~L~~-~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~L-  183 (372)
                      ..+|...|+++..  -++...+++    ...++||||+.++.+.. .+.+.       .++..+...+..+++.+|..| 
T Consensus        73 a~kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~-------~~~~~~~~~i~~~i~~~l~~l~  141 (197)
T cd05146          73 AEKEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA-------KLNDEEMKNAYYQVLSMMKQLY  141 (197)
T ss_pred             HHHHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc-------ccCHHHHHHHHHHHHHHHHHHH
Confidence            3489999999953  456666654    45689999997654422 22221       145556677889999999999 


Q ss_pred             hcCCCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          184 HHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       184 H~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      |   ..+++|+||++.||+++ ++.+.|+|||.+....
T Consensus       142 H---~~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         142 K---ECNLVHADLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             H---hCCeecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence            7   78999999999999997 4689999999887543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.02  E-value=2.1e-10  Score=109.25  Aligned_cols=222  Identities=23%  Similarity=0.268  Sum_probs=150.7

Q ss_pred             hhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhcc-CCCceeeeEeEEecCCceeEEEEecC
Q 036435           88 KDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      ...||.|.|+.|++.....                      .-..|+.+...+ .|.++++++..+...++.|+=-|||+
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~  349 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCE  349 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhc
Confidence            3569999999998854321                      123455555555 59999999988888888899999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC-CceEEeecCCcccccCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDED-FCPKISDFGLAKLCTTK  223 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgla~~~~~~  223 (372)
                      ++++.....-.      +.+....++.+..|++.++.++|   ++..+|+|+||+||++.++ +.-++.|||.+..+...
T Consensus       350 ~~s~~l~~~~~------~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~  420 (524)
T KOG0601|consen  350 GGSSSLRSVTS------QMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS  420 (524)
T ss_pred             CcchhhhhHHH------HhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccccccccee
Confidence            99987666222      22777888999999999999999   8999999999999999876 78899999998642211


Q ss_pred             CCeeeeecccccccccc-cccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          224 EGIVSSLLGARGIIGYI-APEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~-aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      ..      ....+-++. ..|.+... ..+..+.|++|||.-+.+..++...-.....         |  ..+..+....
T Consensus       421 ~~------~~~~~~r~~p~~~~~~e~-~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---------~--~~i~~~~~p~  482 (524)
T KOG0601|consen  421 SG------VFHHIDRLYPIAEILLED-YPHLSKADIFSLGLSVDEAITGSPLSESGVQ---------S--LTIRSGDTPN  482 (524)
T ss_pred             cc------cccccccccccchhhccc-cccccccccccccccccccccCcccCccccc---------c--eeeecccccC
Confidence            11      111222344 24554443 3678899999999999999988754332211         0  0111111111


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ  344 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~  344 (372)
                      .++        ....+..+...+..+++..||.+.++....+
T Consensus       483 ~~~--------~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  483 LPG--------LKLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             CCc--------hHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence            111        1133344555577899999999888765443

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.00  E-value=4.5e-09  Score=91.67  Aligned_cols=123  Identities=20%  Similarity=0.198  Sum_probs=93.1

Q ss_pred             hcCCCCceEEEEEEec-------------------chHHHHHHHHhccCC--CceeeeEeEEecCC---ceeEEEEecCC
Q 036435           90 KLGQGGFGGVYKGRLL-------------------DDFVNEVASISRTSH--VNVVTLLGFCLEGN---NRALIYEFMPN  145 (372)
Q Consensus        90 ~lg~G~~g~V~~~~~~-------------------~~~~~E~~~l~~l~h--~nIv~l~g~~~~~~---~~~lV~e~~~~  145 (372)
                      .|+.|..+.||+++..                   .++.+|.++++.+++  .++.+++.+..+..   ..++||||++|
T Consensus         5 ~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G   84 (223)
T cd05154           5 QLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDG   84 (223)
T ss_pred             ecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCC
Confidence            4777888888875432                   257889999999976  44677888776643   56899999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--------------------------------------
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC--------------------------------------  187 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--------------------------------------  187 (372)
                      .++.+.+...       .++..+...++.+++++|..||+..                                      
T Consensus        85 ~~l~~~~~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (223)
T cd05154          85 RVLRDRLLRP-------ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM  157 (223)
T ss_pred             EecCCCCCCC-------CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence            8887765321       1667777788888888888888521                                      


Q ss_pred             ---------------CCCeeecCCCCCceEECC--CCceEEeecCCccc
Q 036435          188 ---------------STKILHFDIKPHNILLDE--DFCPKISDFGLAKL  219 (372)
Q Consensus       188 ---------------~~~ivH~dlk~~Nill~~--~~~~kl~Dfgla~~  219 (372)
                                     ...++|+|+.+.||+++.  ++.+.|+||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                           246799999999999998  66789999987753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.91  E-value=1.6e-08  Score=92.77  Aligned_cols=255  Identities=13%  Similarity=0.140  Sum_probs=149.3

Q ss_pred             hhhcCCCCceEEEEE-Eecc------------hHHHHHHHHhcc-CCCceeeeEeEEe------cC-CceeEEEEecCCC
Q 036435           88 KDKLGQGGFGGVYKG-RLLD------------DFVNEVASISRT-SHVNVVTLLGFCL------EG-NNRALIYEFMPNG  146 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~-~~~~------------~~~~E~~~l~~l-~h~nIv~l~g~~~------~~-~~~~lV~e~~~~g  146 (372)
                      ...||+|+-+.+|-- ...+            .-.+.+..|... .||-+-.=+.+=.      +. ...-+.|..+++.
T Consensus        16 gr~LgqGgea~ly~l~e~~d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~v~g~   95 (637)
T COG4248          16 GRPLGQGGEADLYTLGEVRDQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPKVSGK   95 (637)
T ss_pred             CccccCCccceeeecchhhchhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecccCCCc
Confidence            456999999999853 2211            112223333333 4554433111111      11 1245777777664


Q ss_pred             C-hhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          147 S-LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       147 ~-L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      . ...++.............|.-.+..++.++.+.+-||   ..|.+-+|+.++|+|+++++.+.|.|-........+. 
T Consensus        96 ~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng~-  171 (637)
T COG4248          96 EPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINANGT-  171 (637)
T ss_pred             cchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceeeccCCc-
Confidence            3 3333332223334455899999999999999999999   7999999999999999999999999854333222221 


Q ss_pred             eeeeecccccccccccccccc-cc--cCCCCccccchhHHHHHHHHhcC-CCCCCCCCCCC-----CccchHHHHHHHhh
Q 036435          226 IVSSLLGARGIIGYIAPEVFS-RN--FGEVSHKSDVYSFGMMIMELVGC-KNNLDSGVDSS-----SEVYFPHWIYRHVE  296 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~-~~--~~~~~~~~DvwslG~il~elltg-~~p~~~~~~~~-----~~~~~~~~~~~~~~  296 (372)
                         ......|...|.+||.-. +.  ...-+...|.|.+|+++++++.| +.||.+.-...     .+..+....+-...
T Consensus       172 ---~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~  248 (637)
T COG4248         172 ---LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYAS  248 (637)
T ss_pred             ---eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeech
Confidence               223455788999999754 11  01446789999999999998876 88887532111     11001000000000


Q ss_pred             hcccccCCccCCcchHHHHHHHHHHHHHcccC--CCCCCCCHHHHHHHhhcCccc
Q 036435          297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQA--RPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~--~p~~RPs~~evl~~L~~~~~~  349 (372)
                      +...-..|...+....-+...+-.+-.+|+..  ++.-|||++..+..|..+.+.
T Consensus       249 ~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~  303 (637)
T COG4248         249 DQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ  303 (637)
T ss_pred             hccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence            11111112222222233344555566667753  367899999998887665533

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.90  E-value=1.7e-09  Score=108.79  Aligned_cols=194  Identities=19%  Similarity=0.228  Sum_probs=130.7

Q ss_pred             CCceeeeEeEEecCCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCC
Q 036435          120 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPH  199 (372)
Q Consensus       120 h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~  199 (372)
                      ||-+++..--+......+||++|..+++|...|++...      .+.+-.......+..+++|||   ...+.|+|++|.
T Consensus       863 ~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~------~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~  933 (1205)
T KOG0606|consen  863 SPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGC------LSAEPARSPILERVQSLESLH---SSLRKHRDLKPD  933 (1205)
T ss_pred             CCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCC------cccccccchhHHHHhhhhccc---cchhhccccccc
Confidence            45555544444456678999999999999999987653      333334455667778899999   677999999999


Q ss_pred             ceEECCCCceEEeecCCcccccCC------------------------CCee----eeecccccccccccccccccccCC
Q 036435          200 NILLDEDFCPKISDFGLAKLCTTK------------------------EGIV----SSLLGARGIIGYIAPEVFSRNFGE  251 (372)
Q Consensus       200 Nill~~~~~~kl~Dfgla~~~~~~------------------------~~~~----~~~~~~~gt~~y~aPE~~~~~~~~  251 (372)
                      |.|...++..++.|||.......-                        ....    .......+|+.|.+||.+.+.  .
T Consensus       934 ~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~--~ 1011 (1205)
T KOG0606|consen  934 SLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR--R 1011 (1205)
T ss_pred             chhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccc--c
Confidence            999999999999999844322100                        0000    111234589999999999885  7


Q ss_pred             CCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCC
Q 036435          252 VSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPS  331 (372)
Q Consensus       252 ~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~  331 (372)
                      .....|.|++|++++|.++|.+||.......        +.+.+.. +...+|......    .....++....+..+|.
T Consensus      1012 hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~--------~f~ni~~-~~~~~p~g~~~~----s~~aq~~~~~ll~~~~~ 1078 (1205)
T KOG0606|consen 1012 HGSAADWWSSGVCLFEVLTGIPPFNAETPQQ--------IFENILN-RDIPWPEGPEEG----SYEAQDLINRLLTEEPT 1078 (1205)
T ss_pred             CCCcchhhhhhhhhhhhhcCCCCCCCcchhh--------hhhcccc-CCCCCCCCcccc----ChhhhhhhhhhhccCch
Confidence            7788999999999999999999998654322        2222211 222222222111    12233344445678889


Q ss_pred             CCCCHH
Q 036435          332 DRPPMN  337 (372)
Q Consensus       332 ~RPs~~  337 (372)
                      +|-.+.
T Consensus      1079 qr~~a~ 1084 (1205)
T KOG0606|consen 1079 QRLGAK 1084 (1205)
T ss_pred             hccCcc
Confidence            998776

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.89  E-value=4.5e-10  Score=108.57  Aligned_cols=156  Identities=18%  Similarity=0.275  Sum_probs=103.1

Q ss_pred             HHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeeeeecc------ccccccccccccc
Q 036435          172 IVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLG------ARGIIGYIAPEVF  245 (372)
Q Consensus       172 i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~------~~gt~~y~aPE~~  245 (372)
                      =+.++++|+.|+|.  +.++||++|.|++|.++.++..||+.|+.+........+......      ......|.|||++
T Consensus       104 nl~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~  181 (700)
T KOG2137|consen  104 NLGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL  181 (700)
T ss_pred             hhhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence            35566799999997  789999999999999999999999999988765543222111111      1234579999999


Q ss_pred             ccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHc
Q 036435          246 SRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWC  325 (372)
Q Consensus       246 ~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  325 (372)
                      .+.  ..+.++|+||+|+++|-+..|+.+.-..........    ............       ...+++.++.+-+.+.
T Consensus       182 ~~~--~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~----~~~~~~~~~~~~-------~s~~~p~el~~~l~k~  248 (700)
T KOG2137|consen  182 LGT--TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS----FSRNLLNAGAFG-------YSNNLPSELRESLKKL  248 (700)
T ss_pred             ccc--cccccccceeeeeEEEEEecCCcchhhccCCcchhh----hhhccccccccc-------ccccCcHHHHHHHHHH
Confidence            875  778999999999999999955444332211110000    000000101111       1133455666666678


Q ss_pred             ccCCCCCCCCHHHHHHH
Q 036435          326 IQARPSDRPPMNEVIEM  342 (372)
Q Consensus       326 l~~~p~~RPs~~evl~~  342 (372)
                      +..++.-||++.++...
T Consensus       249 l~~~~~~rp~~~~l~~~  265 (700)
T KOG2137|consen  249 LNGDSAVRPTLDLLLSI  265 (700)
T ss_pred             hcCCcccCcchhhhhcc
Confidence            89999999988887753

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.86  E-value=1.3e-08  Score=90.94  Aligned_cols=105  Identities=22%  Similarity=0.154  Sum_probs=80.5

Q ss_pred             hHHHHHHHHhccCCCce--eeeEeEEec-----CCceeEEEEecCCC-ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHH
Q 036435          107 DFVNEVASISRTSHVNV--VTLLGFCLE-----GNNRALIYEFMPNG-SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK  178 (372)
Q Consensus       107 ~~~~E~~~l~~l~h~nI--v~l~g~~~~-----~~~~~lV~e~~~~g-~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~  178 (372)
                      .+.+|...+.++...+|  ...+++...     ...-++|+|++++. +|.+++......    ..+......++.+++.
T Consensus        74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~----~~~~~~~~~ll~~la~  149 (268)
T PRK15123         74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATN----PPDPRLKRMLIKRVAT  149 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhccc----CCCHHHHHHHHHHHHH
Confidence            37899999998854443  344555443     23568999999876 799988543211    1455677789999999


Q ss_pred             HHHHHhcCCCCCeeecCCCCCceEECC-------CCceEEeecCCcc
Q 036435          179 GLEYLHHGCSTKILHFDIKPHNILLDE-------DFCPKISDFGLAK  218 (372)
Q Consensus       179 ~l~~LH~~~~~~ivH~dlk~~Nill~~-------~~~~kl~Dfgla~  218 (372)
                      .+.-||   ..+++|+|++++|||++.       +..+.++||+.+.
T Consensus       150 ~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        150 MVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             HHHHHH---HCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            999999   899999999999999975       4689999999875

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.72  E-value=4.3e-08  Score=82.78  Aligned_cols=99  Identities=24%  Similarity=0.281  Sum_probs=66.0

Q ss_pred             hHHHHHHHHhccCCC--ceeeeEeEEecCCceeEEEEecC--CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 036435          107 DFVNEVASISRTSHV--NVVTLLGFCLEGNNRALIYEFMP--NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY  182 (372)
Q Consensus       107 ~~~~E~~~l~~l~h~--nIv~l~g~~~~~~~~~lV~e~~~--~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~  182 (372)
                      ...+|.+.|.++..-  ++.+.+.+-    ...+||||++  |..+.. +....       ++......++.+++..+..
T Consensus        54 ~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~-l~~~~-------~~~~~~~~~~~~il~~~~~  121 (188)
T PF01163_consen   54 WAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPR-LKDVD-------LSPEEPKELLEEILEEIIK  121 (188)
T ss_dssp             HHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGC-HHHCG-------GGGSTHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhh-HHhcc-------ccchhHHHHHHHHHHHHHH
Confidence            577899999999766  456666552    4479999998  544433 33322       2223445677788876655


Q ss_pred             -HhcCCCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          183 -LHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       183 -LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                       +|   ..+++|+||.+.||+++++ .+.++|||.+....
T Consensus       122 ~~~---~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  122 MLH---KAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             HHH---CTTEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred             HHH---hcCceecCCChhhEEeecc-eEEEEecCcceecC
Confidence             57   8999999999999999988 99999999887543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.70  E-value=1.2e-07  Score=81.86  Aligned_cols=104  Identities=21%  Similarity=0.266  Sum_probs=81.9

Q ss_pred             hHHHHHHHHhccCCC--ceeeeEeEEecCC----ceeEEEEecCCC-ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHH
Q 036435          107 DFVNEVASISRTSHV--NVVTLLGFCLEGN----NRALIYEFMPNG-SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG  179 (372)
Q Consensus       107 ~~~~E~~~l~~l~h~--nIv~l~g~~~~~~----~~~lV~e~~~~g-~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~  179 (372)
                      ...+|...+..+...  ...+.+++.....    ..++|+|++++. +|.+++.....      .+......++.+++..
T Consensus        57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~------~~~~~~~~ll~~l~~~  130 (206)
T PF06293_consen   57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ------LDPSQRRELLRALARL  130 (206)
T ss_pred             HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc------cchhhHHHHHHHHHHH
Confidence            678899988888533  3445556555422    347999999874 79999876432      4456678899999999


Q ss_pred             HHHHhcCCCCCeeecCCCCCceEECCCC---ceEEeecCCccc
Q 036435          180 LEYLHHGCSTKILHFDIKPHNILLDEDF---CPKISDFGLAKL  219 (372)
Q Consensus       180 l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfgla~~  219 (372)
                      ++-||   ..+++|+|+++.|||++.+.   .+.++||+.++.
T Consensus       131 i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  131 IAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            99999   89999999999999998877   899999987764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.68  E-value=4.5e-07  Score=77.24  Aligned_cols=121  Identities=18%  Similarity=0.110  Sum_probs=89.5

Q ss_pred             cCCCCceEEEEEEec-----------------------chHHHHHHHHhccCCC--ceeeeEeEEe---cC--CceeEEE
Q 036435           91 LGQGGFGGVYKGRLL-----------------------DDFVNEVASISRTSHV--NVVTLLGFCL---EG--NNRALIY  140 (372)
Q Consensus        91 lg~G~~g~V~~~~~~-----------------------~~~~~E~~~l~~l~h~--nIv~l~g~~~---~~--~~~~lV~  140 (372)
                      -|+||.+.|++-.+.                       ..|.+|+..|.++..-  ++.+.+ ++.   .+  ..-+||+
T Consensus        26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence            466888888775521                       1689999999999532  244444 332   11  2457999


Q ss_pred             EecCC-CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCc--eEEeecCCc
Q 036435          141 EFMPN-GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFC--PKISDFGLA  217 (372)
Q Consensus       141 e~~~~-g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfgla  217 (372)
                      |-+++ -+|.+++.+.....    .+......++.+++..++-||   +.++.|+|+.+.||+++.++.  ++++||.-+
T Consensus       105 e~L~g~~~L~~~l~~~~~~~----~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~  177 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSP----YSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKS  177 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCC----cchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence            98863 58999986644222    566777899999999999999   899999999999999986666  999999766


Q ss_pred             cc
Q 036435          218 KL  219 (372)
Q Consensus       218 ~~  219 (372)
                      +.
T Consensus       178 r~  179 (216)
T PRK09902        178 RR  179 (216)
T ss_pred             ch
Confidence            53

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.65  E-value=1.4e-07  Score=82.33  Aligned_cols=116  Identities=23%  Similarity=0.231  Sum_probs=84.2

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------------------------hHHHHHHHHhccCCC--ce
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------------------------DFVNEVASISRTSHV--NV  123 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------------------------~~~~E~~~l~~l~h~--nI  123 (372)
                      .+...||-|.=+.||.|...+                                        ...+|.+.|++|.-.  .+
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            345789999999999986532                                        467899999998654  55


Q ss_pred             eeeEeEEecCCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE
Q 036435          124 VTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL  203 (372)
Q Consensus       124 v~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill  203 (372)
                      .+-+++    +...+||||++|-.|...-           ++....-.++..|++-+.-+-   ..|+||+|+++=||++
T Consensus       174 P~P~~~----nRHaVvMe~ieG~eL~~~r-----------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV  235 (304)
T COG0478         174 PKPIAW----NRHAVVMEYIEGVELYRLR-----------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILV  235 (304)
T ss_pred             CCcccc----ccceeeeehcccceeeccc-----------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEE
Confidence            555544    5678999999886664332           112223344555555555444   5899999999999999


Q ss_pred             CCCCceEEeecCCccc
Q 036435          204 DEDFCPKISDFGLAKL  219 (372)
Q Consensus       204 ~~~~~~kl~Dfgla~~  219 (372)
                      +++|.+.++||-.+..
T Consensus       236 ~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         236 TEDGDIVVIDWPQAVP  251 (304)
T ss_pred             ecCCCEEEEeCccccc
Confidence            9999999999976653

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.63  E-value=1.9e-07  Score=87.88  Aligned_cols=141  Identities=17%  Similarity=0.298  Sum_probs=108.5

Q ss_pred             HHHHHHHhccCCCceeeeEeEEec----CCceeEEEEecCC-CChhhhhhcCCCCC---------CCCCCCHHHHHHHHH
Q 036435          109 VNEVASISRTSHVNVVTLLGFCLE----GNNRALIYEFMPN-GSLEKFVYNGDTSK---------PCQYLRWEKMYEIVI  174 (372)
Q Consensus       109 ~~E~~~l~~l~h~nIv~l~g~~~~----~~~~~lV~e~~~~-g~L~~~l~~~~~~~---------~~~~l~~~~~~~i~~  174 (372)
                      ..-++.++++.|+|+|++..++..    +..+++||+|.++ ++|.++-.......         .....++..++.++.
T Consensus       321 t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~  400 (655)
T KOG3741|consen  321 TSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYIS  400 (655)
T ss_pred             hHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHH
Confidence            344788999999999999998873    4578999999985 57776654432211         123478889999999


Q ss_pred             HHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCc
Q 036435          175 GIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSH  254 (372)
Q Consensus       175 qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  254 (372)
                      |+..||.++|   +.|..-+-|.+.+||++.+.+++|+..|.........                 -|.+.+     -.
T Consensus       401 QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~-----------------~~~le~-----~Q  455 (655)
T KOG3741|consen  401 QLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP-----------------TEPLES-----QQ  455 (655)
T ss_pred             HHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecCCC-----------------CcchhH-----Hh
Confidence            9999999999   7899999999999999999899999888776544322                 022221     24


Q ss_pred             cccchhHHHHHHHHhcCCCC
Q 036435          255 KSDVYSFGMMIMELVGCKNN  274 (372)
Q Consensus       255 ~~DvwslG~il~elltg~~p  274 (372)
                      +-|.-.||.+++.|.||..-
T Consensus       456 q~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  456 QNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             hhhHHHHHHHHHHHhhcccc
Confidence            77899999999999999643

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.43  E-value=1.3e-06  Score=74.10  Aligned_cols=102  Identities=25%  Similarity=0.261  Sum_probs=82.7

Q ss_pred             HHHHHHHhccCC-CceeeeEeEEecCCceeEEEEecCCCChhhh---hhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 036435          109 VNEVASISRTSH-VNVVTLLGFCLEGNNRALIYEFMPNGSLEKF---VYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH  184 (372)
Q Consensus       109 ~~E~~~l~~l~h-~nIv~l~g~~~~~~~~~lV~e~~~~g~L~~~---l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH  184 (372)
                      ..|.-+++.+++ +++.+++|+|    ..++|.||...+++...   +.+..      .-+|..+.+|+.++++.+.+|+
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~------~~~w~~R~~iA~~lL~~l~~l~   76 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFL------QSPWEQRAKIALQLLELLEELD   76 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCcccccccccccccc------ccCHHHHHHHHHHHHHHHHHHh
Confidence            357888888876 6999999999    34789999987766432   11111      1689999999999999999999


Q ss_pred             cCCCCCeeecCCCCCceEECCCCceEEeecCCcccc
Q 036435          185 HGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC  220 (372)
Q Consensus       185 ~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~  220 (372)
                      +.....+.-.|++++|+-+++++.+|++|...+...
T Consensus        77 ~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   77 HGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             cCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            766667889999999999999999999999877654

Proteins in this uncharacterised family are described as transmembrane proteins.

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.30  E-value=9.2e-06  Score=71.13  Aligned_cols=125  Identities=15%  Similarity=0.238  Sum_probs=75.4

Q ss_pred             hhcCCCCceEEEEEEe-------------cchHHHHHHHHhccCCCc--eeeeEeEEecCCceeEEEEecCCCC-hhhh-
Q 036435           89 DKLGQGGFGGVYKGRL-------------LDDFVNEVASISRTSHVN--VVTLLGFCLEGNNRALIYEFMPNGS-LEKF-  151 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~-------------~~~~~~E~~~l~~l~h~n--Iv~l~g~~~~~~~~~lV~e~~~~g~-L~~~-  151 (372)
                      ..||+|..+.||+...             .....+|.++++.+..-+  +.+.+++...++...+|||+++|.+ +... 
T Consensus         7 ~~i~~G~t~~~y~~~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~   86 (226)
T TIGR02172         7 TQTGEGGNGESYTHKTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRII   86 (226)
T ss_pred             eeecCCCCcceeEecCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhh
Confidence            3588999999998311             125788999999986444  4677888777777889999998863 1111 


Q ss_pred             --------------------hhcCCCCCCCCCCCHHHHHH-HHH----------HHHH-HHHHHhc-CCCCCeeecCCCC
Q 036435          152 --------------------VYNGDTSKPCQYLRWEKMYE-IVI----------GIAK-GLEYLHH-GCSTKILHFDIKP  198 (372)
Q Consensus       152 --------------------l~~~~~~~~~~~l~~~~~~~-i~~----------qi~~-~l~~LH~-~~~~~ivH~dlk~  198 (372)
                                          ++......    ........ +..          .+.+ ...+|.. .....++|+|+.|
T Consensus        87 ~~~~~~~~~l~~~la~~l~~lH~~~~~~----~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~  162 (226)
T TIGR02172        87 SDNPSRLEEIAKIFAEMAKKLHSTKCDT----STFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQI  162 (226)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHhCCCCCC----CcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCC
Confidence                                11111000    11111000 000          0111 1122221 1134678999999


Q ss_pred             CceEECCCCceEEeecCCcc
Q 036435          199 HNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       199 ~Nill~~~~~~kl~Dfgla~  218 (372)
                      .||++++++ +.++||+.+.
T Consensus       163 ~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       163 GNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CcEEEcCCC-cEEEechhcC
Confidence            999999888 9999998765

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.27  E-value=2e-07  Score=89.85  Aligned_cols=169  Identities=20%  Similarity=0.106  Sum_probs=122.1

Q ss_pred             hhcCCCCceEEEEEEecc-------------hHHHHHHHHhccCCCc-eeeeEeEEecCCceeEEEEecCCC-Chhhhhh
Q 036435           89 DKLGQGGFGGVYKGRLLD-------------DFVNEVASISRTSHVN-VVTLLGFCLEGNNRALIYEFMPNG-SLEKFVY  153 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~-------------~~~~E~~~l~~l~h~n-Iv~l~g~~~~~~~~~lV~e~~~~g-~L~~~l~  153 (372)
                      ...++|+++.++|.+-..             ...-++++|.+++||| .+..++-+..+....++++++.+| +-..-..
T Consensus       248 h~fvK~altknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~  327 (829)
T KOG0576|consen  248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMT  327 (829)
T ss_pred             HHHHHHHhcCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCC
Confidence            457889999999975432             3556899999999999 778888887788899999999876 2211111


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeeeeeccc
Q 036435          154 NGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGA  233 (372)
Q Consensus       154 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  233 (372)
                      ...     ..+...+...+.+.-+++++++|   +..=+|+|    ||+.++ +..+..||+.........    .....
T Consensus       328 ~se-----~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~----~~~t~  390 (829)
T KOG0576|consen  328 VSE-----IALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM----KPRTA  390 (829)
T ss_pred             hhh-----Hhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcccCccc----ccccC
Confidence            100     11333444556667788999999   45457888    777766 678999999887665443    22344


Q ss_pred             ccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCC
Q 036435          234 RGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLD  276 (372)
Q Consensus       234 ~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~  276 (372)
                      .+|+.|+|||+..++  .+....|+|+.|+-..++--|-+|-.
T Consensus       391 ~~~~~~~~pev~~~~--~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  391 IGTPEPLAPEVIQEN--TIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             CCCCCCCCchhhccc--ccccCCCccCCCcchhhcCCCCCCCC
Confidence            588999999988775  78889999999987777776666543

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.08  E-value=2.6e-05  Score=75.82  Aligned_cols=104  Identities=19%  Similarity=0.240  Sum_probs=66.6

Q ss_pred             hHHHHHHHHhccC-----CCceeeeEeEEe-cCCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHH-
Q 036435          107 DFVNEVASISRTS-----HVNVVTLLGFCL-EGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG-  179 (372)
Q Consensus       107 ~~~~E~~~l~~l~-----h~nIv~l~g~~~-~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~-  179 (372)
                      ++.+|+..+.+++     .+++ .+=.++. -.+...|+|||++|-.+.+........     ++...+   +..++.+ 
T Consensus       207 Dy~~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g-----~d~k~i---a~~~~~~f  277 (517)
T COG0661         207 DYRREAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG-----IDRKEL---AELLVRAF  277 (517)
T ss_pred             CHHHHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhcC-----CCHHHH---HHHHHHHH
Confidence            4677777777663     3332 2222333 245678999999998888874322211     443332   2222221 


Q ss_pred             HHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       180 l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      +..+-   ..+++|.|..|.||+++.+|.+.+.|||+......
T Consensus       278 ~~q~~---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         278 LRQLL---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHHHH---hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            12222   36899999999999999999999999999976653

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.03  E-value=2.1e-05  Score=81.07  Aligned_cols=198  Identities=19%  Similarity=0.204  Sum_probs=133.2

Q ss_pred             HHHHHHHHhccCCCceeeeEeEEecCCce----eEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 036435          108 FVNEVASISRTSHVNVVTLLGFCLEGNNR----ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYL  183 (372)
Q Consensus       108 ~~~E~~~l~~l~h~nIv~l~g~~~~~~~~----~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~L  183 (372)
                      ...|...+.+..|+|++.+++|-.+....    .+..+++..-++.+.+..-..      ++..+.+.+..+..+|++|+
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~------i~~~~~r~~~~~~~~GL~~~  302 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS------IPLETLRILHQKLLEGLAYL  302 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc------cCHHHHHHHHHHHhhhHHHH
Confidence            34577788888999999999988765433    344688888888888866543      78888999999999999999


Q ss_pred             hcCCCCCeeecCCCCC---ceEECCCCceEEe--ecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccc
Q 036435          184 HHGCSTKILHFDIKPH---NILLDEDFCPKIS--DFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDV  258 (372)
Q Consensus       184 H~~~~~~ivH~dlk~~---Nill~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv  258 (372)
                      |   .....|.-+..+   +.-.+..+.+..+  ||+.+............    ..+..+.++|....+....+...|+
T Consensus       303 h---~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~----~~~~~~~~~e~~~~~~~~~~r~~dL  375 (1351)
T KOG1035|consen  303 H---SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSD----LLAEIRNADEDLKENTAKKSRLTDL  375 (1351)
T ss_pred             H---HhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhh----cCccccccccccccccchhhhhhHH
Confidence            9   455555544444   3334555666666  88887765544322221    1234577888877654455566899


Q ss_pred             hhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 036435          259 YSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNE  338 (372)
Q Consensus       259 wslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  338 (372)
                      |.+|.....+..|..+-.......          ..        ++    ..   ....+.+....|+..++++|++..+
T Consensus       376 ~~lgll~~~~~~~~~i~~~~~~~~----------~~--------l~----~~---~~~~~~d~~~~~~~~~~~~Rl~~~~  430 (1351)
T KOG1035|consen  376 WCLGLLLLQLSQGEDISEKSAVPV----------SL--------LD----VL---STSELLDALPKCLDEDSEERLSALE  430 (1351)
T ss_pred             HHHHHHHhhhhhcCcccccccchh----------hh--------hc----cc---cchhhhhhhhhhcchhhhhccchhh
Confidence            999999999887765432211100          00        00    00   0114556677899999999999999


Q ss_pred             HHHHh
Q 036435          339 VIEML  343 (372)
Q Consensus       339 vl~~L  343 (372)
                      ++...
T Consensus       431 ll~~~  435 (1351)
T KOG1035|consen  431 LLTHP  435 (1351)
T ss_pred             hhhch
Confidence            99753

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.03  E-value=1.3e-05  Score=68.62  Aligned_cols=67  Identities=19%  Similarity=0.283  Sum_probs=52.8

Q ss_pred             ceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeec
Q 036435          135 NRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDF  214 (372)
Q Consensus       135 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  214 (372)
                      ..+++|||++|..|.+...          ++.    .++..+.+++.-||   ..|++|+|..|.|+++++++ ++++||
T Consensus       117 ~~~ll~EYIeG~~l~d~~~----------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~~-i~iID~  178 (229)
T PF06176_consen  117 SYVLLMEYIEGVELNDIED----------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNNG-IRIIDT  178 (229)
T ss_pred             EEEEEEEEecCeecccchh----------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECCc-EEEEEC
Confidence            4568999999988866542          222    24566778899999   89999999999999998654 999999


Q ss_pred             CCccc
Q 036435          215 GLAKL  219 (372)
Q Consensus       215 gla~~  219 (372)
                      +..+.
T Consensus       179 ~~k~~  183 (229)
T PF06176_consen  179 QGKRM  183 (229)
T ss_pred             ccccc
Confidence            86653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.92  E-value=0.00015  Score=61.79  Aligned_cols=98  Identities=20%  Similarity=0.302  Sum_probs=70.5

Q ss_pred             hHHHHHHHHhccC------CCceeeeEeEEecCCceeEEEEecCC------CChhhhhhcCCCCCCCCCCCHHHHHHHHH
Q 036435          107 DFVNEVASISRTS------HVNVVTLLGFCLEGNNRALIYEFMPN------GSLEKFVYNGDTSKPCQYLRWEKMYEIVI  174 (372)
Q Consensus       107 ~~~~E~~~l~~l~------h~nIv~l~g~~~~~~~~~lV~e~~~~------g~L~~~l~~~~~~~~~~~l~~~~~~~i~~  174 (372)
                      +..+|+.-...+.      +.+|.+++|+..++...-+|+|.+.+      .+|.+++.+..       ++. ...+.+.
T Consensus        57 ~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-------~~~-~~~~~L~  128 (199)
T PF10707_consen   57 QNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG-------LTE-ELRQALD  128 (199)
T ss_pred             HHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC-------ccH-HHHHHHH
Confidence            5677777666665      88999999999999999999998864      25888885543       554 3333333


Q ss_pred             HHHHHHHHHhcCCCCCeeecCCCCCceEECCC---C-ceEEee-cCCcc
Q 036435          175 GIAKGLEYLHHGCSTKILHFDIKPHNILLDED---F-CPKISD-FGLAK  218 (372)
Q Consensus       175 qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~-~~kl~D-fgla~  218 (372)
                         +-..||-   ...|+.+|++|.||++...   . .+.|+| ||-..
T Consensus       129 ---~f~~~l~---~~~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~~~  171 (199)
T PF10707_consen  129 ---EFKRYLL---DHHIVIRDLNPHNIVVQRRDSGEFRLVLIDGLGEKE  171 (199)
T ss_pred             ---HHHHHHH---HcCCeecCCCcccEEEEecCCCceEEEEEeCCCCcc
Confidence               3345666   6889999999999999522   2 577777 55443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.89  E-value=0.00016  Score=64.15  Aligned_cols=110  Identities=11%  Similarity=0.069  Sum_probs=66.8

Q ss_pred             hHHHHHHHHhccC-CCceeeeEeEEecCCceeEEEEecCCCChhhhh-------------------hcCCCCCCCCCCC-
Q 036435          107 DFVNEVASISRTS-HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV-------------------YNGDTSKPCQYLR-  165 (372)
Q Consensus       107 ~~~~E~~~l~~l~-h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~~~l-------------------~~~~~~~~~~~l~-  165 (372)
                      +..+|+++++.+. +-.+.+++++...++..++|||+++|.+|....                   +......  ..+. 
T Consensus        37 ~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~--~~~~~  114 (244)
T cd05150          37 ELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWEELEPERLVDALAEALRRLHALPVAD--CPFDR  114 (244)
T ss_pred             chHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCccc--CCcch
Confidence            5788999999884 445667888877777789999999987776432                   1111000  0011 


Q ss_pred             -HHHHHHHHH--------------------HHHHHHHHHhc----CCCCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          166 -WEKMYEIVI--------------------GIAKGLEYLHH----GCSTKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       166 -~~~~~~i~~--------------------qi~~~l~~LH~----~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                       ....+....                    .+.+.+..|-.    .....++|+|+.|.|||+++++.+.|+||+.+.
T Consensus       115 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         115 RLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             hHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence             001110000                    01111222211    114569999999999999998778899998764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.79  E-value=0.00014  Score=70.70  Aligned_cols=102  Identities=19%  Similarity=0.239  Sum_probs=65.0

Q ss_pred             hHHHHHHHHhcc----CCCc------eeeeEeEEecCCceeEEEEecCCCChhhh--hhcCCCCCCCCCCCHHHHHHHHH
Q 036435          107 DFVNEVASISRT----SHVN------VVTLLGFCLEGNNRALIYEFMPNGSLEKF--VYNGDTSKPCQYLRWEKMYEIVI  174 (372)
Q Consensus       107 ~~~~E~~~l~~l----~h~n------Iv~l~g~~~~~~~~~lV~e~~~~g~L~~~--l~~~~~~~~~~~l~~~~~~~i~~  174 (372)
                      +|.+|++-..++    .|-+      |.+++-.+  .....|+||||+|..+.+.  +.+.+       ++...+..-+.
T Consensus       240 DF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~g-------i~~~~i~~~l~  310 (538)
T KOG1235|consen  240 DFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRG-------ISPHDILNKLV  310 (538)
T ss_pred             chHHHHHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcC-------CCHHHHHHHHH
Confidence            467776655544    3555      33333222  3467899999999877654  33333       55554444333


Q ss_pred             HHHHHHHHHhcCCCCCeeecCCCCCceEECC----CCceEEeecCCcccccC
Q 036435          175 GIAKGLEYLHHGCSTKILHFDIKPHNILLDE----DFCPKISDFGLAKLCTT  222 (372)
Q Consensus       175 qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~Dfgla~~~~~  222 (372)
                      +...-+-+     ..|.+|+|-.|.||+++.    ++.+.+-|||+......
T Consensus       311 ~~~~~qIf-----~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  311 EAYLEQIF-----KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHHHHHHH-----hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            33222222     357999999999999983    67899999999876543

>PLN02876 acyl-CoA dehydrogenase

Probab=97.76  E-value=0.00029  Score=73.57  Aligned_cols=42  Identities=14%  Similarity=0.304  Sum_probs=33.3

Q ss_pred             hHHHHHHHHhccC-CCce--eeeEeEEecC---CceeEEEEecCCCCh
Q 036435          107 DFVNEVASISRTS-HVNV--VTLLGFCLEG---NNRALIYEFMPNGSL  148 (372)
Q Consensus       107 ~~~~E~~~l~~l~-h~nI--v~l~g~~~~~---~~~~lV~e~~~~g~L  148 (372)
                      .+.+|.++++.+. |.++  .+++++|.+.   +..|+||||++|..+
T Consensus        84 ~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~  131 (822)
T PLN02876         84 AVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIF  131 (822)
T ss_pred             HHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCccc
Confidence            5789999999995 6665  7888888764   467899999987643

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.63  E-value=0.0003  Score=61.48  Aligned_cols=128  Identities=21%  Similarity=0.190  Sum_probs=69.9

Q ss_pred             hhcCCCCceEEEEEEec---------------chHHHHHHHHhccCCC--ceeeeEeEEec---CCceeEEEEecCCCCh
Q 036435           89 DKLGQGGFGGVYKGRLL---------------DDFVNEVASISRTSHV--NVVTLLGFCLE---GNNRALIYEFMPNGSL  148 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~---------------~~~~~E~~~l~~l~h~--nIv~l~g~~~~---~~~~~lV~e~~~~g~L  148 (372)
                      +.|+.|..+.||+....               ..+.+|..+++.+...  .+.+++.+...   ....+++|+++++.++
T Consensus         3 ~~l~~G~~n~~~~v~~~~~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~   82 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDDGRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPL   82 (239)
T ss_dssp             EEEEESSSSEEEEEEETTSEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEH
T ss_pred             ccCCCCCeeeEEEEEECCcEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccc
Confidence            35778888888887552               2577888998888533  35566664433   2346899999999877


Q ss_pred             hh----------------hh---hcCCCCCCCCCCCHHH---------HHHH------------HHHHHH-HHHHHhc--
Q 036435          149 EK----------------FV---YNGDTSKPCQYLRWEK---------MYEI------------VIGIAK-GLEYLHH--  185 (372)
Q Consensus       149 ~~----------------~l---~~~~~~~~~~~l~~~~---------~~~i------------~~qi~~-~l~~LH~--  185 (372)
                      ..                .+   +.... .. ..+.+..         ....            ...+.+ .+..++.  
T Consensus        83 ~~~~~~~~~~~~~~~~~~~l~~lh~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (239)
T PF01636_consen   83 DDELSPEQRPELLRQLGRALAQLHQVPP-PF-SPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL  160 (239)
T ss_dssp             HHTSTHHHHHHHHHHHHHHHHHHHHSHT-TC-CCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccchhhhhhcccccc-cc-cccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence            77                11   11110 00 0011100         0000            111222 2333331  


Q ss_pred             --CCCCCeeecCCCCCceEEC-CCCceEEeecCCcc
Q 036435          186 --GCSTKILHFDIKPHNILLD-EDFCPKISDFGLAK  218 (372)
Q Consensus       186 --~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgla~  218 (372)
                        .....++|+|+.+.||+++ +++.+-|+||+.+.
T Consensus       161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             ccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence              1257799999999999999 66666799998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.57  E-value=0.00054  Score=60.39  Aligned_cols=31  Identities=26%  Similarity=0.434  Sum_probs=26.1

Q ss_pred             CCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          188 STKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       188 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      ...++|+|+.+.||+++++...-|+||+.+.
T Consensus       163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~  193 (235)
T cd05155         163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLG  193 (235)
T ss_pred             CceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence            4559999999999999877666799999764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.52  E-value=0.00088  Score=58.33  Aligned_cols=99  Identities=22%  Similarity=0.233  Sum_probs=66.0

Q ss_pred             HHHHHHHHhccC--CCceeeeEeEEecCCceeEEEEecCCCC-hhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 036435          108 FVNEVASISRTS--HVNVVTLLGFCLEGNNRALIYEFMPNGS-LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH  184 (372)
Q Consensus       108 ~~~E~~~l~~l~--h~nIv~l~g~~~~~~~~~lV~e~~~~g~-L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH  184 (372)
                      ..+|..-|.++.  +-.+.+-+++.    +-.|||||+.... -.=.|+.-       .+...+...+..++++.+.-|-
T Consensus       115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv-------~~e~~e~~~~~~~~v~~~~~l~  183 (268)
T COG1718         115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV-------PLELEEAEGLYEDVVEYMRRLY  183 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccC-------CcCchhHHHHHHHHHHHHHHHH
Confidence            355777777763  33333334432    2369999996431 11111111       1333356777888888888887


Q ss_pred             cCCCCCeeecCCCCCceEECCCCceEEeecCCcccc
Q 036435          185 HGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC  220 (372)
Q Consensus       185 ~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~  220 (372)
                      .  ..++||+||+.=|||+. ++.+.++|||.|...
T Consensus       184 ~--~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         184 K--EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             H--hcCcccccchhhheEEE-CCeEEEEECcccccc
Confidence            3  48999999999999999 889999999988654

>PRK10593 hypothetical protein; Provisional

Probab=97.52  E-value=0.0015  Score=59.81  Aligned_cols=60  Identities=13%  Similarity=0.117  Sum_probs=44.8

Q ss_pred             hhcCCCCceEEEEEEe---------------cchHHHHHHHHhccCC---CceeeeEeEEecC---CceeEEEEecCCCC
Q 036435           89 DKLGQGGFGGVYKGRL---------------LDDFVNEVASISRTSH---VNVVTLLGFCLEG---NNRALIYEFMPNGS  147 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~---------------~~~~~~E~~~l~~l~h---~nIv~l~g~~~~~---~~~~lV~e~~~~g~  147 (372)
                      +.||.|..+.||+-..               .+.+..|...|+.+.-   -.+.+++++|..+   +..++|||++++++
T Consensus        20 ~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~   99 (297)
T PRK10593         20 ECISEQPYAALWALYDSQGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVS   99 (297)
T ss_pred             eecCCccceeEEEEEcCCCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEe
Confidence            4588888888887321               1367899999998853   3678888887643   56899999999876


Q ss_pred             h
Q 036435          148 L  148 (372)
Q Consensus       148 L  148 (372)
                      +
T Consensus       100 ~  100 (297)
T PRK10593        100 V  100 (297)
T ss_pred             c
Confidence            5

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.39  E-value=0.0011  Score=54.63  Aligned_cols=112  Identities=19%  Similarity=0.222  Sum_probs=76.7

Q ss_pred             hhhcCCCCceEEEEEEecc---------------hHHHHHHHHhccCCCceee-eEeEEecCCceeEEEEecCCCChhhh
Q 036435           88 KDKLGQGGFGGVYKGRLLD---------------DFVNEVASISRTSHVNVVT-LLGFCLEGNNRALIYEFMPNGSLEKF  151 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~---------------~~~~E~~~l~~l~h~nIv~-l~g~~~~~~~~~lV~e~~~~g~L~~~  151 (372)
                      .+.|++|.+|.||+|.+..               .+..|+++|..+.--++-+ ++.+-.    -++.|||+.|-.|.+.
T Consensus        27 ~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~L~~~  102 (201)
T COG2112          27 EKELAKGTTSVVYLGEWRGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRPLGKL  102 (201)
T ss_pred             hhhhhcccccEEEEeeccCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcchhhh
Confidence            4679999999999987752               6889999999998766654 444432    2456999998888776


Q ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC-CCceEECCCCceEEeecCCccc
Q 036435          152 VYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIK-PHNILLDEDFCPKISDFGLAKL  219 (372)
Q Consensus       152 l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk-~~Nill~~~~~~kl~Dfgla~~  219 (372)
                      ....         +-..    +..+++.---|-   ..+|-|+.|+ |...++.+++.+.|+||.-|..
T Consensus       103 ~~~~---------~rk~----l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112         103 EIGG---------DRKH----LLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhcc---------cHHH----HHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            5422         1122    334444422344   6788999886 4455555555999999988763

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.19  E-value=0.0034  Score=56.08  Aligned_cols=29  Identities=24%  Similarity=0.359  Sum_probs=25.5

Q ss_pred             CCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          189 TKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       189 ~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      ..++|+|+.|.||++++++ +.++||..+.
T Consensus       146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             CeeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence            4689999999999999876 7899998775

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.13  E-value=0.0065  Score=53.36  Aligned_cols=31  Identities=26%  Similarity=0.321  Sum_probs=26.9

Q ss_pred             CCCeeecCCCCCceEECC-CCceEEeecCCcc
Q 036435          188 STKILHFDIKPHNILLDE-DFCPKISDFGLAK  218 (372)
Q Consensus       188 ~~~ivH~dlk~~Nill~~-~~~~kl~Dfgla~  218 (372)
                      ...++|+|+.+.|||++. ++.+.++||..|.
T Consensus       169 ~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         169 PIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             CEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            457999999999999997 5789999997664

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=96.80  E-value=0.015  Score=49.49  Aligned_cols=116  Identities=26%  Similarity=0.398  Sum_probs=80.9

Q ss_pred             CccccHHHHHHHHhhhhhhcCCCCc-eEEEEEEecc--------------------------------------hHHHHH
Q 036435           72 LKRYNFSDVKKLTNSFKDKLGQGGF-GGVYKGRLLD--------------------------------------DFVNEV  112 (372)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~~lg~G~~-g~V~~~~~~~--------------------------------------~~~~E~  112 (372)
                      +.+|+..   ....+|.+.||.|.- |.|||.+...                                      .|..|.
T Consensus        29 L~~F~~h---~~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~EC  105 (207)
T PF13095_consen   29 LEPFTHH---GDDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCEC  105 (207)
T ss_pred             cCCcCCC---CCcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHH
Confidence            4455551   144566788999999 9999986522                                      377788


Q ss_pred             HHHhccC---CCce--eeeEeEEecC------------------CceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHH
Q 036435          113 ASISRTS---HVNV--VTLLGFCLEG------------------NNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKM  169 (372)
Q Consensus       113 ~~l~~l~---h~nI--v~l~g~~~~~------------------~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~  169 (372)
                      +...+|+   +.++  ++.+||..=.                  ....||.||.+...               .++... 
T Consensus       106 RAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------------~~~~~~-  169 (207)
T PF13095_consen  106 RAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------------PLQIRD-  169 (207)
T ss_pred             HhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------------ccchhH-
Confidence            8777774   5566  8999988421                  12357788776533               023333 


Q ss_pred             HHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCc
Q 036435          170 YEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLA  217 (372)
Q Consensus       170 ~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla  217 (372)
                         +.++.+-|..+|   ..+|+-+|+++.|..     .-||+|||.+
T Consensus       170 ---~~~~~~dl~~~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  170 ---IPQMLRDLKILH---KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             ---HHHHHHHHHHHH---HCCeeeccCcccccc-----CCEEEecccC
Confidence               456667788899   899999999999976     5689999864

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.74  E-value=0.0074  Score=55.22  Aligned_cols=34  Identities=26%  Similarity=0.426  Sum_probs=29.6

Q ss_pred             CCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       188 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      ...++|+|+.+.|++++.++.+-+.||+++..-.
T Consensus       197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             CceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence            3569999999999999988889999999987543

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=96.63  E-value=0.0091  Score=54.49  Aligned_cols=112  Identities=18%  Similarity=0.179  Sum_probs=62.8

Q ss_pred             hHHHHHHHHhccCCCc--eeeeEeE------EecCCceeEEEEecCCCChhh----h----------hhcCCC----C-C
Q 036435          107 DFVNEVASISRTSHVN--VVTLLGF------CLEGNNRALIYEFMPNGSLEK----F----------VYNGDT----S-K  159 (372)
Q Consensus       107 ~~~~E~~~l~~l~h~n--Iv~l~g~------~~~~~~~~lV~e~~~~g~L~~----~----------l~~~~~----~-~  159 (372)
                      +...|+.++..+.+.+  +.+.+..      ...++..++|++|++|..+..    .          ++....    . .
T Consensus        52 ~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~  131 (296)
T cd05153          52 ELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERN  131 (296)
T ss_pred             hccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCC
Confidence            5667888888885433  4444432      122346689999999876532    0          111100    0 0


Q ss_pred             CCCCCCHHHHH----------HHHHHHHHHHHHHhc----CCCCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          160 PCQYLRWEKMY----------EIVIGIAKGLEYLHH----GCSTKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       160 ~~~~l~~~~~~----------~i~~qi~~~l~~LH~----~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      ......|....          .....+..++.++..    ....+++|+|+.|.||++++++.+.|+||+.+.
T Consensus       132 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         132 NLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            00112222211          011123334444442    123579999999999999998777899998765

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=96.58  E-value=0.03  Score=53.13  Aligned_cols=31  Identities=26%  Similarity=0.354  Sum_probs=26.5

Q ss_pred             CCCeeecCCCCCceEECCCCceEEeecCCccc
Q 036435          188 STKILHFDIKPHNILLDEDFCPKISDFGLAKL  219 (372)
Q Consensus       188 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  219 (372)
                      ...++|||+.+.||+++++ .++++||-.+..
T Consensus       222 ~~~l~HgDl~~gni~~~~~-~~~viD~E~a~~  252 (401)
T PRK09550        222 AEALLHGDLHTGSIFVTEE-ETKVIDPEFAFY  252 (401)
T ss_pred             CCceeeccCCcccEEeeCC-CcEEEecccccc
Confidence            5679999999999999776 599999987653

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.41  E-value=0.00052  Score=73.08  Aligned_cols=160  Identities=9%  Similarity=-0.023  Sum_probs=107.3

Q ss_pred             HHHHHHHhccCCCceeeeEeEEec--CCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-
Q 036435          109 VNEVASISRTSHVNVVTLLGFCLE--GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH-  185 (372)
Q Consensus       109 ~~E~~~l~~l~h~nIv~l~g~~~~--~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-  185 (372)
                      ..|...++...|+++.....-...  +...+.+++|+.+|.+.+.+.++-...  ..+...-+...-.+...+..-+|. 
T Consensus      1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~--~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEES--PDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred             hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccC--CcchhchHHHHHHHHHhccchhhhc
Confidence            345555666789988876655443  346689999999999999987654322  112222222222222444444442 


Q ss_pred             -CCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHH
Q 036435          186 -GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMM  264 (372)
Q Consensus       186 -~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~i  264 (372)
                       ..+.-.+|++||+-|.+|+.+.++|++++|+.+.........   ....+++-|+.|+....-  +++.++|+|+.|+-
T Consensus      1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~---Gl~l~sp~~v~qli~N~i--k~t~rsdilr~s~~ 1429 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFF---GLELCSPIYVLQLIKNEI--KFTKRSDILRRSLS 1429 (2724)
T ss_pred             ccCCccchhhhhhhhccceecCCcccccccccccccCchHhhh---hhhhCCHHHHHHHHHHHH--hhhhHHHHHHHHHH
Confidence             224558999999999999999999999999998333222111   122356678888877654  77888999999999


Q ss_pred             HHHHhcCCCCC
Q 036435          265 IMELVGCKNNL  275 (372)
Q Consensus       265 l~elltg~~p~  275 (372)
                      +|+..-|..+|
T Consensus      1430 ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1430 LYLRSDGNAYF 1440 (2724)
T ss_pred             HHHHhcccHHH
Confidence            99988776654

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.21  E-value=0.0053  Score=58.86  Aligned_cols=49  Identities=18%  Similarity=0.300  Sum_probs=39.6

Q ss_pred             hHHHHHHHHhccCCCceeeeEeEEecCC-ceeEEEEecCCCChhhhhhcCC
Q 036435          107 DFVNEVASISRTSHVNVVTLLGFCLEGN-NRALIYEFMPNGSLEKFVYNGD  156 (372)
Q Consensus       107 ~~~~E~~~l~~l~h~nIv~l~g~~~~~~-~~~lV~e~~~~g~L~~~l~~~~  156 (372)
                      +++-....++.+.|+|...++.+..... ...+|+|++ +.||++.+..+.
T Consensus        28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~   77 (725)
T KOG1093|consen   28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN   77 (725)
T ss_pred             HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc
Confidence            4666788899999999999999887654 456789999 669999987654

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.05  E-value=0.02  Score=52.11  Aligned_cols=96  Identities=16%  Similarity=0.131  Sum_probs=63.6

Q ss_pred             hHHHHHHHHhccC-CC-ceeeeEeEEecCCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 036435          107 DFVNEVASISRTS-HV-NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH  184 (372)
Q Consensus       107 ~~~~E~~~l~~l~-h~-nIv~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH  184 (372)
                      ...+|...|+.|. |. -+.+-+    +.+..++|||++.+-.|...-+-         .+..++.   ..+..-+.-|.
T Consensus       156 aa~kEfafmkaL~e~gfpVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v---------~d~~~ly---~~lm~~Iv~la  219 (465)
T KOG2268|consen  156 AATKEFAFMKALYERGFPVPKPI----DHNRHCVVMELVDGYPLRQVRHV---------EDPPTLY---DDLMGLIVRLA  219 (465)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCcc----cccceeeHHHhhcccceeeeeec---------CChHHHH---HHHHHHHHHHH
Confidence            3566777777774 22 122323    33567899999988777544322         2223332   33333345555


Q ss_pred             cCCCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          185 HGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       185 ~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                         ..|+||+|..-=||++++++.++++||-......
T Consensus       220 ---~~GlIHgDFNEFNimv~dd~~i~vIDFPQmvS~s  253 (465)
T KOG2268|consen  220 ---NHGLIHGDFNEFNIMVKDDDKIVVIDFPQMVSTS  253 (465)
T ss_pred             ---HcCceecccchheeEEecCCCEEEeechHhhccC
Confidence               6899999999999999999999999997665443

>PLN02236 choline kinase

Probab=95.94  E-value=0.052  Score=50.73  Aligned_cols=107  Identities=21%  Similarity=0.272  Sum_probs=61.2

Q ss_pred             HHHHHHHHhccCCCcee-eeEeEEecCCceeEEEEecCCCChhhh-----------------hhcCCCCCCCCCCCHHHH
Q 036435          108 FVNEVASISRTSHVNVV-TLLGFCLEGNNRALIYEFMPNGSLEKF-----------------VYNGDTSKPCQYLRWEKM  169 (372)
Q Consensus       108 ~~~E~~~l~~l~h~nIv-~l~g~~~~~~~~~lV~e~~~~g~L~~~-----------------l~~~~~~~~~~~l~~~~~  169 (372)
                      -.+|..+++.+..-++. ++++.+..+    .|+||+++.+|...                 +++...........|.++
T Consensus        83 R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i  158 (344)
T PLN02236         83 RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRL  158 (344)
T ss_pred             hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Confidence            36799999988655444 556665433    58999987666421                 222221111111223333


Q ss_pred             HHHHHHH-----------------HHHHHHH----hc-CCCCCeeecCCCCCceEECC-CCceEEeecCCcc
Q 036435          170 YEIVIGI-----------------AKGLEYL----HH-GCSTKILHFDIKPHNILLDE-DFCPKISDFGLAK  218 (372)
Q Consensus       170 ~~i~~qi-----------------~~~l~~L----H~-~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgla~  218 (372)
                      .++..++                 ...+..|    .. .....++|+|+++.||++++ ++.+.++||..+.
T Consensus       159 ~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        159 RNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             HHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            3332221                 1112222    21 12457999999999999986 4789999998775

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.72  E-value=0.037  Score=51.15  Aligned_cols=55  Identities=24%  Similarity=0.251  Sum_probs=48.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          164 LRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       164 l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      -.+++.+.++.+.+..+.-+..  ..+.=|||+.-.||||+ +|++-|+||-+++...
T Consensus       318 ~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfklsRl~~  372 (488)
T COG5072         318 DRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKLSRLSY  372 (488)
T ss_pred             ccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeeeeeccc
Confidence            5789999999999888887775  67899999999999999 9999999999999543

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=95.44  E-value=0.18  Score=47.02  Aligned_cols=31  Identities=26%  Similarity=0.343  Sum_probs=26.0

Q ss_pred             CCCeeecCCCCCceEECCCCceEEeecCCccc
Q 036435          188 STKILHFDIKPHNILLDEDFCPKISDFGLAKL  219 (372)
Q Consensus       188 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  219 (372)
                      ...++|||+.+.||+++++ .++++|+..+..
T Consensus       191 ~~~llHGDl~~gNi~~~~~-~~~~iD~e~~~~  221 (370)
T TIGR01767       191 AETLLHGDLHSGSIFVSEH-ETKVIDPEFAFY  221 (370)
T ss_pred             cceeeeccCCcccEEEcCC-CCEEEcCccccc
Confidence            5679999999999999775 478999987654

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02756 S-methyl-5-thioribose kinase

Probab=94.94  E-value=0.44  Score=45.29  Aligned_cols=30  Identities=17%  Similarity=0.301  Sum_probs=25.3

Q ss_pred             CCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          188 STKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       188 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      ....+|+|+.+.||+++.++ .+++|...+.
T Consensus       229 ~~~L~HGDl~~g~i~~~~~~-~~~id~ef~~  258 (418)
T PLN02756        229 AQALVHGDLHTGSVMVTPDS-TQVIDPEFAF  258 (418)
T ss_pred             ccceeecCCCCCcEEEcCCC-ceEecchhhc
Confidence            67899999999999999875 8888876554

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=94.76  E-value=0.13  Score=47.88  Aligned_cols=31  Identities=23%  Similarity=0.277  Sum_probs=26.2

Q ss_pred             CCeeecCCCCCceEECC-CCceEEeecCCccc
Q 036435          189 TKILHFDIKPHNILLDE-DFCPKISDFGLAKL  219 (372)
Q Consensus       189 ~~ivH~dlk~~Nill~~-~~~~kl~Dfgla~~  219 (372)
                      ...+|+|+.+.||++++ ++.++++||..|..
T Consensus       182 ~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        182 VVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             eEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            45899999999999974 57899999987753

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=94.64  E-value=0.18  Score=45.72  Aligned_cols=127  Identities=20%  Similarity=0.263  Sum_probs=61.0

Q ss_pred             hhcCCCCceEEEEEEe--------------cchHHHHHHHHhccC---CCceeeeEeEEecCCceeEEEEecCCC--C--
Q 036435           89 DKLGQGGFGGVYKGRL--------------LDDFVNEVASISRTS---HVNVVTLLGFCLEGNNRALIYEFMPNG--S--  147 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~--------------~~~~~~E~~~l~~l~---h~nIv~l~g~~~~~~~~~lV~e~~~~g--~--  147 (372)
                      +.++.|....+|+.+.              .+.|..|.+-|+.|.   --.+.+.+++...++..+||+||++.+  +  
T Consensus        23 ~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~~~~~~  102 (288)
T PF03881_consen   23 EPVSGGDINEAYRLDTDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMGSPSPP  102 (288)
T ss_dssp             EEE--SSSSEEEEEETTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--------CC
T ss_pred             EecCCCChhheEEEECCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCCCCCch
Confidence            3467777777776532              125889999998883   445778888888777789999999876  1  


Q ss_pred             ----hhh---hhhc-CCCCCCC-----------C----CCCHHH-----HHHH--------------HHHHHHHHH-HHh
Q 036435          148 ----LEK---FVYN-GDTSKPC-----------Q----YLRWEK-----MYEI--------------VIGIAKGLE-YLH  184 (372)
Q Consensus       148 ----L~~---~l~~-~~~~~~~-----------~----~l~~~~-----~~~i--------------~~qi~~~l~-~LH  184 (372)
                          |..   .+++ .....-+           +    .-+|.+     ++.-              ..++.+.+. .|+
T Consensus       103 ~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~~~~~~~l~  182 (288)
T PF03881_consen  103 DWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLVERLPSLLP  182 (288)
T ss_dssp             HHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHHHHHHHCCT
T ss_pred             hHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHHHHHHHHhc
Confidence                111   1333 1110000           0    012221     1111              112222222 233


Q ss_pred             c-CCCCCeeecCCCCCceEECCCCceEEeecC
Q 036435          185 H-GCSTKILHFDIKPHNILLDEDFCPKISDFG  215 (372)
Q Consensus       185 ~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  215 (372)
                      . ...+..+|+||-+.|++.+.+|.+.|.|-.
T Consensus       183 ~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa  214 (288)
T PF03881_consen  183 GREPKPSLLHGDLWSGNVGFDADGEPVLFDPA  214 (288)
T ss_dssp             TS----EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred             CCCCCceeeEcCccccceeecCCCCceeeccc
Confidence            1 224679999999999999999989998864

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=94.33  E-value=0.1  Score=47.68  Aligned_cols=31  Identities=29%  Similarity=0.265  Sum_probs=27.4

Q ss_pred             CCCeeecCCCCCceEECCC----CceEEeecCCcc
Q 036435          188 STKILHFDIKPHNILLDED----FCPKISDFGLAK  218 (372)
Q Consensus       188 ~~~ivH~dlk~~Nill~~~----~~~kl~Dfgla~  218 (372)
                      ...++|+|+.+.||+++++    +.+.++||..|.
T Consensus       178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            5689999999999999975    889999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=93.93  E-value=0.094  Score=48.13  Aligned_cols=31  Identities=32%  Similarity=0.522  Sum_probs=27.5

Q ss_pred             CCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          188 STKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       188 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      ..+++|+|+.+.||+++.++...|+||+.+.
T Consensus       186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            5789999999999999988777899998764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=93.44  E-value=0.16  Score=46.89  Aligned_cols=31  Identities=26%  Similarity=0.378  Sum_probs=26.5

Q ss_pred             CCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          188 STKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       188 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      ..+++|+|+.+.||+++.+...-|+||+.+.
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            4689999999999999976656899998764

>PTZ00384 choline kinase; Provisional

Probab=93.23  E-value=0.49  Score=44.84  Aligned_cols=29  Identities=28%  Similarity=0.113  Sum_probs=23.9

Q ss_pred             CCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          189 TKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       189 ~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      ...+|.|+-+.||+.++ ..+.++||..|.
T Consensus       227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~  255 (383)
T PTZ00384        227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAG  255 (383)
T ss_pred             eeeeeccCCcccEEecC-CCEEEEEecccc
Confidence            57899999999999765 459999996553

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=93.11  E-value=0.2  Score=45.96  Aligned_cols=30  Identities=30%  Similarity=0.324  Sum_probs=25.9

Q ss_pred             CCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          188 STKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       188 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      ..+++|+|+.+.||+++. +.+.++||+.+.
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            467999999999999987 678999998664

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=92.85  E-value=0.21  Score=47.07  Aligned_cols=61  Identities=16%  Similarity=0.154  Sum_probs=42.7

Q ss_pred             ceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC
Q 036435          135 NRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLD  204 (372)
Q Consensus       135 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~  204 (372)
                      ...+|-+|..|-++..++....       .++.-..+++.-.++|+--+--  --+.+|.|+.|.||++.
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~~~-------~pe~l~kkva~lg~~AllkMl~--vDNFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKWKS-------QPEALVKKVAKLGVNALLKMLI--VDNFVHADLHPGNVLIR  379 (565)
T ss_pred             cceeeeeccccccHHhhhhccc-------ChHHHHHHHHHHHHHHHHHHHH--hhcceecccCCCcEEEE
Confidence            3457778888889998887644       3344455566656666643332  46899999999999994

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=92.63  E-value=0.64  Score=40.44  Aligned_cols=43  Identities=19%  Similarity=0.433  Sum_probs=34.5

Q ss_pred             hHHHHHHHHhccC---CCceeeeEeEEecCCceeEEEEecCCCChh
Q 036435          107 DFVNEVASISRTS---HVNVVTLLGFCLEGNNRALIYEFMPNGSLE  149 (372)
Q Consensus       107 ~~~~E~~~l~~l~---h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~  149 (372)
                      .|..|+.-|..+.   --++.+.+.+-.+.+..|+|+||++-|.+.
T Consensus        54 ~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          54 MFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             HHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            5778887777763   456788888888899999999999986665

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=92.58  E-value=0.13  Score=44.39  Aligned_cols=31  Identities=35%  Similarity=0.468  Sum_probs=22.1

Q ss_pred             CCCeeecCCCCCceEE-CCCCceEEeecCCcc
Q 036435          188 STKILHFDIKPHNILL-DEDFCPKISDFGLAK  218 (372)
Q Consensus       188 ~~~ivH~dlk~~Nill-~~~~~~kl~Dfgla~  218 (372)
                      ...++|+|+.+.||++ +.++.++++||..|.
T Consensus       142 ~~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  142 PLVFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             GEEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             CceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            3579999999999999 889999999998775

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK10271 thiK thiamine kinase; Provisional

Probab=92.52  E-value=0.1  Score=43.95  Aligned_cols=31  Identities=19%  Similarity=0.248  Sum_probs=26.6

Q ss_pred             CCCeeecCCCCCceEECCCCceEEeecCCccc
Q 036435          188 STKILHFDIKPHNILLDEDFCPKISDFGLAKL  219 (372)
Q Consensus       188 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  219 (372)
                      ....+|+|+.|.|+++++++ ++++||+.+..
T Consensus        76 ~~~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~  106 (188)
T PRK10271         76 RLAPLHMDVHAGNLVHSASG-LRLIDWEYAGD  106 (188)
T ss_pred             CeeeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence            45679999999999998877 99999998753

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=92.35  E-value=0.32  Score=45.02  Aligned_cols=28  Identities=39%  Similarity=0.606  Sum_probs=25.4

Q ss_pred             eeecCCCCCceEECCCCc-eEEeecCCcc
Q 036435          191 ILHFDIKPHNILLDEDFC-PKISDFGLAK  218 (372)
Q Consensus       191 ivH~dlk~~Nill~~~~~-~kl~Dfgla~  218 (372)
                      +||+|+.|.||+++.+.. ..++||+-+.
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEccccc
Confidence            999999999999998875 8999998765

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=92.16  E-value=0.89  Score=42.47  Aligned_cols=101  Identities=18%  Similarity=0.188  Sum_probs=67.7

Q ss_pred             HHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCCh-hhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 036435          108 FVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG  186 (372)
Q Consensus       108 ~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L-~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~  186 (372)
                      ...|++-|.+++...|.----+..  ....|||+|+..... .-.|+..       .++...+..+-.|++.-|.-|.+ 
T Consensus       213 AEKE~RNLkRl~~aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~-------~ls~~ka~~~Y~~~v~~MR~lY~-  282 (520)
T KOG2270|consen  213 AEKEMRNLKRLNNAGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDA-------SLSTSKARELYQQCVRIMRRLYQ-  282 (520)
T ss_pred             HHHHHHHHHHHHhcCCCCCCceee--ecceEeeeeccCCCCcCcccccc-------cCChHHHHHHHHHHHHHHHHHHH-
Confidence            456888888886544331111111  244799999953111 1112221       27777788888889888888886 


Q ss_pred             CCCCeeecCCCCCceEECCCCceEEeecCCcccc
Q 036435          187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC  220 (372)
Q Consensus       187 ~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~  220 (372)
                       ..++||.||+-=|+|+. +|.+.++|.+.+...
T Consensus       283 -~c~LVHADLSEfN~Lyh-dG~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  283 -KCRLVHADLSEFNLLYH-DGKLYIIDVSQSVEH  314 (520)
T ss_pred             -HhceeccchhhhhheEE-CCEEEEEEccccccC
Confidence             67899999999999985 468999998877543

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=91.93  E-value=0.32  Score=43.75  Aligned_cols=50  Identities=20%  Similarity=0.230  Sum_probs=38.0

Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          168 KMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       168 ~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      ...+.+..+-.++.-.+.. ..-++|+|+.|+|++.++.+.++|+||.-|.
T Consensus       133 ~~~~~~~~l~~~l~~~~~~-~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg  182 (269)
T COG0510         133 LLRKKLKELRRALEEVPKD-DLVPCHNDLNPGNLLLTDKGGLFLIDWEYAG  182 (269)
T ss_pred             HHHHHHHHHHHHhhhcCCC-ceeeecCCCCccceEEcCCCcEEEEecccCC
Confidence            3444566666666666631 1469999999999999999999999997665

>PHA03111 Ser/Thr kinase; Provisional

Probab=91.60  E-value=0.24  Score=45.36  Aligned_cols=37  Identities=32%  Similarity=0.425  Sum_probs=25.9

Q ss_pred             HHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCceEEC
Q 036435          168 KMYEIVIGIAKGLEYLHH-GCSTKILHFDIKPHNILLD  204 (372)
Q Consensus       168 ~~~~i~~qi~~~l~~LH~-~~~~~ivH~dlk~~Nill~  204 (372)
                      -+.-++.|++.-.-.+.+ .+....+|-||||+|||+-
T Consensus       280 YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiF  317 (444)
T PHA03111        280 YIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIF  317 (444)
T ss_pred             HHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEe
Confidence            345577888765534432 2356799999999999993

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=90.56  E-value=0.43  Score=43.82  Aligned_cols=31  Identities=23%  Similarity=0.222  Sum_probs=28.0

Q ss_pred             CCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          188 STKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       188 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      ..+++|+|+.+.|+|++.++.+.++||..+.
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            4589999999999999999999999998765

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=90.37  E-value=0.42  Score=41.34  Aligned_cols=120  Identities=18%  Similarity=0.150  Sum_probs=73.7

Q ss_pred             hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 036435          107 DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG  186 (372)
Q Consensus       107 ~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~  186 (372)
                      -|..+..++.+++  .|+++..=  ++...-++.|+|-....               ..    ..++.--+++|.-.|++
T Consensus       104 ~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i---------------~~----~N~i~agi~~L~~fH~~  160 (308)
T PF07387_consen  104 LYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI---------------NF----SNFITAGIKDLMDFHSE  160 (308)
T ss_pred             hhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc---------------ch----hHHHHHhHHHHHHhhcc
Confidence            3556777777653  45665521  33455688899843110               00    12222224567778844


Q ss_pred             CCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHH
Q 036435          187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIM  266 (372)
Q Consensus       187 ~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~  266 (372)
                       ..+.+|+|-.|+||+-|..|.+||.|-+....               .+..|.--|+     ...+.++.+-+|=.-++
T Consensus       161 -~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~---------------~~V~~vN~~Y-----~~lT~~aE~~~fv~s~l  219 (308)
T PF07387_consen  161 -NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE---------------NQVNMVNIEY-----ESLTQEAEVKVFVKSCL  219 (308)
T ss_pred             -CCCeecCCCChhheeecCCCCEEecChhhhhh---------------heeeEEeeec-----cccChHHHHHHHHHHHH
Confidence             67899999999999999999999999764321               0111322222     25567777777776667


Q ss_pred             HHhc
Q 036435          267 ELVG  270 (372)
Q Consensus       267 ellt  270 (372)
                      ++..
T Consensus       220 ~~v~  223 (308)
T PF07387_consen  220 KLVE  223 (308)
T ss_pred             HHHH
Confidence            6664

The function of this family is unknown.

>PF14575 EphA2_TM: Ephrin type-A receptor 2 transmembrane domain; PDB: 3KUL_A 2XVD_A 2VX1_A 2VWV_A 2VX0_A 2VWY_A 2VWZ_A 2VWW_A 2VWU_A 2VWX_A

Probab=90.26  E-value=0.12  Score=36.45  Aligned_cols=20  Identities=10%  Similarity=0.361  Sum_probs=14.5

Q ss_pred             CccccHHHHHHHHhhhhhhc
Q 036435           72 LKRYNFSDVKKLTNSFKDKL   91 (372)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~~l   91 (372)
                      ...++|+|..++-.+|.++|
T Consensus        54 IDP~TYEDP~qAV~eFAkEI   73 (75)
T PF14575_consen   54 IDPHTYEDPNQAVREFAKEI   73 (75)
T ss_dssp             --GGGSSSHHHHHHHCSSB-
T ss_pred             cCcccccCHHHHHHHHHhhc
Confidence            45678999999988887765

...

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	372
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-45
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-45
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		6e-35
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-34
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-30
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-30
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-30
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		7e-28
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		6e-20
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-19
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-19
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-19
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-19
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-19
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-19
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-19
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-19
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-19
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-19
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-19
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-19
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-19
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-19
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-19
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-19
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-19
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-19
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-19
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-19
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-19
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		7e-19
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-18
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-18
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-18
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-18
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-18
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-18
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-18
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		5e-18
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-18
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-18
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		8e-18
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		8e-18
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		8e-18
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		9e-18
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		9e-18
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		9e-18
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-17
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-17
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-17
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-17
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-17
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-17
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-17
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-17
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-17
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-17
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-17
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-17
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-17
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		5e-17
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-17
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-17
4h58_A	275	Braf In Complex With Compound 3 Length = 275		6e-17
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		6e-17
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		6e-17
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		6e-17
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		7e-17
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		7e-17
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-16
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-16
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-16
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-16
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-16
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-16
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-16
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-16
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-16
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		6e-16
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		7e-16
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		7e-16
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		8e-16
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		9e-16
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-15
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-15
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-15
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-15
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-15
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-15
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-15
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-15
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-15
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-15
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-15
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-15
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-15
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-15
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-15
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-15
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-15
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-15
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-15
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-15
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		5e-15
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-15
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-15
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-15
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		7e-15
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		7e-15
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		7e-15
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		8e-15
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		8e-15
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		8e-15
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		8e-15
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		9e-15
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-14
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-14
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-14
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-14
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-14
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-14
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-14
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-14
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-14
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-14
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-14
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-14
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-14
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-14
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-14
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-14
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-14
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-14
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-14
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-14
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-14
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-14
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-14
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-14
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-14
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-14
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-14
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-14
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-14
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-14
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-14
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-14
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-14
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-14
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-14
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-14
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-14
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-14
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-14
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-14
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-14
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-14
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-14
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-14
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-14
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-14
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-14
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		5e-14
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		5e-14
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		6e-14
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		6e-14
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		7e-14
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		7e-14
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		8e-14
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		8e-14
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-14
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		9e-14
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		9e-14
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-14
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-13
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-13
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-13
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-13
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-13
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-13
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-13
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-13
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-13
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-13
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-13
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-13
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-13
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-13
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-13
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-13
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-13
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-13
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-13
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-13
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-13
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-13
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-13
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-13
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-13
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-13
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-13
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-13
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		4e-13
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-13
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-13
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		4e-13
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-13
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		5e-13
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		5e-13
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		5e-13
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		5e-13
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-13
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		5e-13
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-13
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-13
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		5e-13
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-13
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		6e-13
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		7e-13
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		8e-13
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		8e-13
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		9e-13
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		9e-13
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-12
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-12
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-12
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-12
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-12
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-12
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-12
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-12
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-12
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-12
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-12
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-12
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-12
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-12
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-12
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-12
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-12
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-12
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-12
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-12
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-12
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-12
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-12
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-12
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-12
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-12
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-12
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-12
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-12
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-12
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-12
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-12
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-12
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		5e-12
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		7e-12
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		8e-12
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		9e-12
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-11
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-11
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-11
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-11
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-11
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-11
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-11
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-11
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-11
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-11
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-11
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-11
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		4e-11
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-11
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-11
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-11
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		4e-11
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-11
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-11
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-11
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-11
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		5e-11
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-11
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		5e-11
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		5e-11
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-11
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		5e-11
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-11
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		6e-11
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		6e-11
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		6e-11
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-11
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		8e-11
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		8e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-11
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		9e-11
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-10
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-10
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-10
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-10
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-10
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-10
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-10
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-10
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-10
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-10
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-10
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-10
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-10
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-10
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-10
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-10
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-10
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-10
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-10
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-10
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-10
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-10
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-10
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-10
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-10
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-10
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-10
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-10
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-10
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-10
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		5e-10
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		5e-10
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		5e-10
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-10
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		5e-10
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-10
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-10
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		5e-10
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-10
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		6e-10
4fie_A	423	Full-Length Human Pak4 Length = 423		6e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-10
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		6e-10
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		6e-10
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		6e-10
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		6e-10
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		6e-10
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-10
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		7e-10
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		7e-10
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		7e-10
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		7e-10
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		7e-10
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		7e-10
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		7e-10
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		7e-10
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		7e-10
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-10
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		7e-10
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		7e-10
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		7e-10
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-10
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		7e-10
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		7e-10
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		7e-10
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-10
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-10
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		8e-10
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		8e-10
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		8e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		8e-10
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		8e-10
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		8e-10
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		8e-10
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		8e-10
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		8e-10
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		8e-10
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-10
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		8e-10
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		8e-10
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		8e-10
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		8e-10
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		8e-10
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		8e-10
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		8e-10
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		8e-10
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		8e-10
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		8e-10
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		9e-10
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		9e-10
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		9e-10
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		9e-10
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		9e-10
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		9e-10
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		9e-10
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		9e-10
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-10
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		9e-10
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-09
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-09
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-09
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-09
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-09
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-09
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-09
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-09
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-09
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-09
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-09
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-09
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-09
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-09
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-09
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-09
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-09
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-09
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-09
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-09
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-09
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-09
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-09
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-09
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-09
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-09
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-09
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-09
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-09
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-09
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-09
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-09
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-09
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-09
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-09
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-09
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-09
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-09
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-09
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-09
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-09
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-09
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-09
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-09
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-09
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-09
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-09
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-09
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		4e-09
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-09
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-09
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-09
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-09
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		4e-09
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-09
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-09
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-09
3g51_A	325	Structural Diversity Of The Active Conformation Of		4e-09
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-09
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-09
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-09
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		5e-09
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		5e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-09
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		5e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-09
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		5e-09
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		5e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		6e-09
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		6e-09
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		6e-09
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		6e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		6e-09
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		6e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		6e-09
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		7e-09
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		7e-09
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		7e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		7e-09
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		8e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		8e-09
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		8e-09
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-09
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-09
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		9e-09
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		9e-09
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		9e-09
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-08
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-08
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-08
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-08
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-08
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-08
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-08
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-08
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-08
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-08
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-08
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-08
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-08
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-08
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-08
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-08
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-08
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-08
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-08
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-08
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-08
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-08
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-08
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-08
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-08
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-08
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-08
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-08
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-08
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-08
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-08
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-08
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-08
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-08
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-08
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-08
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-08
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-08
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-08
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-08
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-08
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-08
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-08
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-08
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-08
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-08
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-08
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-08
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		5e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-08
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		6e-08
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-08
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		6e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		6e-08
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		7e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-08
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-08
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		9e-08
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		9e-08
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-08
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		9e-08
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		9e-08
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-07
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-07
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-07
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-07
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-07
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-07
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-07
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-07
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-07
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-07
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-07
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-07
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-07
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-07
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		4e-07
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-07
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-07
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-07
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		4e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-07
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		4e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-07
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		4e-07
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-07
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		5e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-07
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-07
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-07
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-07
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		5e-07
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		5e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		6e-07
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		6e-07
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		6e-07
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		6e-07
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-07
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		6e-07
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		6e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		6e-07
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		6e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		7e-07
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		7e-07
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		7e-07
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		7e-07
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		7e-07
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		7e-07
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		7e-07
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		7e-07
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		7e-07
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		7e-07
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		7e-07
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		7e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		7e-07
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		7e-07
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-07
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		8e-07
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		8e-07
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		8e-07
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		9e-07
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		9e-07
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-06
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-06
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-06
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-06
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-06
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-06
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-06
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-06
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-06
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-06
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-06
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-06
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-06
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-06
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-06
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-06
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-06
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-06
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-06
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-06
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-06
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-06
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-06
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-06
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-06
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-06
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-06
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-06
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-06
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-06
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-06
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-06
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-06
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-06
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-06
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-06
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-06
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-06
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-06
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-06
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-06
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-06
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-06
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		4e-06
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		4e-06
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		4e-06
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		4e-06
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-06
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		4e-06
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-06
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		4e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-06
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-06
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		4e-06
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-06
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		4e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		5e-06
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		5e-06
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		5e-06
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-06
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-06
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		5e-06
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		6e-06
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-06
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		6e-06
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		6e-06
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		7e-06
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		7e-06
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		7e-06
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		7e-06
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-06
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-05
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-05
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-05
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-05
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-05
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-05
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-05
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-05
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-05
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-05
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-05
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-05
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		2e-05
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-05
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-05
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-05
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		2e-05
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-05
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-05
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-05
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-05
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-05
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-05
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-05
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-05
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-05
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-05
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-05
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-05
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-05
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-05
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-05
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-05
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-05
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		4e-05
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-05
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		4e-05
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-05
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-05
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		5e-05
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		5e-05
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		5e-05
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		6e-05
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		6e-05
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		6e-05
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		6e-05
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		6e-05
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		6e-05
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		6e-05
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		6e-05
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		6e-05
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		6e-05
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		6e-05
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		7e-05
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		7e-05
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		7e-05
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		7e-05
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		7e-05
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		7e-05
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		7e-05
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		7e-05
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		8e-05
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		8e-05
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		8e-05
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		9e-05
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		9e-05
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		9e-05
4ae6_A	343	Structure And Function Of The Human Sperm-specific		9e-05
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		9e-05
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		9e-05
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		9e-05
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		9e-05
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		9e-05
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-04
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-04
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-04
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-04
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		1e-04
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		1e-04
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		1e-04
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-04
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		1e-04
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		1e-04
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-04
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		1e-04
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-04
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-04
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-04
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-04
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-04
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		1e-04
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-04
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-04
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		1e-04
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-04
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-04
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-04
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-04
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-04
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-04
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-04
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-04
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-04
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-04
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-04
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-04
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-04
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-04
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-04
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-04
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-04
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-04
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-04
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-04
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-04
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-04
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-04
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-04
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-04
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-04
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-04
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-04
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-04
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-04
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-04
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-04
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-04
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-04
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-04
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-04
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-04
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-04
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-04
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-04
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-04
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-04
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-04
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-04
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-04
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-04
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-04
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-04
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-04
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-04
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-04
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-04
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-04
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-04
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-04
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-04
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		4e-04
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-04
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		4e-04
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		4e-04
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-04
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-04
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-04
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-04
3soa_A	444	Full-Length Human Camkii Length = 444		5e-04
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		6e-04
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		6e-04
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		6e-04
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		6e-04
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-04
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-04
3kk8_A	284	Camkii Substrate Complex A Length = 284		6e-04
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		6e-04
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		7e-04
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		7e-04
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		7e-04
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		7e-04
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		7e-04
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		7e-04
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		7e-04
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		7e-04
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		8e-04
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		8e-04
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		8e-04
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		8e-04
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		8e-04
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		8e-04
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-04
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		9e-04
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  179 bits (454), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 164/302 (54%), Gaps = 36/302 (11%)
Query: 72  LKRYNFSDVKKLTNSFKDK--LGQGGFGGVYKGRLLD-------------------DFVN 110
           LKR++  +++  +++F +K  LG+GGFG VYKGRL D                    F  
Sbjct: 25  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQT 84
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY 170
           EV  IS   H N++ L GFC+    R L+Y +M NGS+   +     S+P   L W K  
Sbjct: 85  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPP--LDWPKRQ 142
Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSL 230
            I +G A+GL YLH  C  KI+H D+K  NILLDE+F   + DFGLAKL   K+  V   
Sbjct: 143 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXX- 201
Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLD-SGVDSSSEVYFPH 289
              RG IG+IAPE  S   G+ S K+DV+ +G+M++EL+  +   D + + +  +V    
Sbjct: 202 -AVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 258
Query: 290 WIYRHVEQDREFKLPGVVT-----RKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
           W+   +   +E KL  +V        ++E  +++I V L C Q+ P +RP M+EV+ ML+
Sbjct: 259 WVKGLL---KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315
Query: 345 GS 346
           G 
Sbjct: 316 GD 317

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  179 bits (453), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 164/302 (54%), Gaps = 36/302 (11%)
Query: 72  LKRYNFSDVKKLTNSFKDK--LGQGGFGGVYKGRLLD-------------------DFVN 110
           LKR++  +++  +++F +K  LG+GGFG VYKGRL D                    F  
Sbjct: 17  LKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQT 76
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY 170
           EV  IS   H N++ L GFC+    R L+Y +M NGS+   +     S+P   L W K  
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPP--LDWPKRQ 134
Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSL 230
            I +G A+GL YLH  C  KI+H D+K  NILLDE+F   + DFGLAKL   K+  V   
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXX- 193
Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLD-SGVDSSSEVYFPH 289
              RG IG+IAPE  S   G+ S K+DV+ +G+M++EL+  +   D + + +  +V    
Sbjct: 194 -AVRGXIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250
Query: 290 WIYRHVEQDREFKLPGVVT-----RKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
           W+   +   +E KL  +V        ++E  +++I V L C Q+ P +RP M+EV+ ML+
Sbjct: 251 WVKGLL---KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
Query: 345 GS 346
           G 
Sbjct: 308 GD 309

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  144 bits (364), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 103/303 (33%), Positives = 153/303 (50%), Gaps = 41/303 (13%)
Query: 69  PLPLKRYNFSDVKKLTNSFKDK--LGQGGFGGVYKGRLLDDFVNEVASISRT-------- 118
           P    R    D+++ TN+F  K  +G G FG VYKG L D    +VA   RT        
Sbjct: 23  PFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG--AKVALKRRTPESSQGIE 80
Query: 119 ------------SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRW 166
                        H ++V+L+GFC E N   LIY++M NG+L++ +Y  D   P   + W
Sbjct: 81  EFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL--PTMSMSW 138
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
           E+  EI IG A+GL YLH   +  I+H D+K  NILLDE+F PKI+DFG++K   T+ G 
Sbjct: 139 EQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISK-KGTELGQ 194
Query: 227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVY 286
                  +G +GYI PE F +  G ++ KSDVYSFG+++ E++  ++ +   +     V 
Sbjct: 195 THLXXVVKGTLGYIDPEYFIK--GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREM-VN 251
Query: 287 FPHWIYRHVEQDREFKL-----PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
              W    VE     +L     P +  +   E  +K     + C+     DRP M +V+ 
Sbjct: 252 LAEWA---VESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLW 308
Query: 342 MLQ 344
            L+
Sbjct: 309 KLE 311

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 102/303 (33%), Positives = 153/303 (50%), Gaps = 41/303 (13%)
Query: 69  PLPLKRYNFSDVKKLTNSFKDK--LGQGGFGGVYKGRLLDDFVNEVASISRT-------- 118
           P    R    D+++ TN+F  K  +G G FG VYKG L D    +VA   RT        
Sbjct: 23  PFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG--AKVALKRRTPESSQGIE 80
Query: 119 ------------SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRW 166
                        H ++V+L+GFC E N   LIY++M NG+L++ +Y  D   P   + W
Sbjct: 81  EFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL--PTMSMSW 138
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
           E+  EI IG A+GL YLH   +  I+H D+K  NILLDE+F PKI+DFG++K  T  +  
Sbjct: 139 EQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQT 195
Query: 227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVY 286
               +  +G +GYI PE F +  G ++ KSDVYSFG+++ E++  ++ +   +     V 
Sbjct: 196 HLXXV-VKGTLGYIDPEYFIK--GRLTEKSDVYSFGVVLFEVLCARSAIVQSL-PREMVN 251
Query: 287 FPHWIYRHVEQDREFKL-----PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
              W    VE     +L     P +  +   E  +K     + C+     DRP M +V+ 
Sbjct: 252 LAEWA---VESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLW 308
Query: 342 MLQ 344
            L+
Sbjct: 309 KLE 311

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  130 bits (326), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 95/310 (30%), Positives = 153/310 (49%), Gaps = 56/310 (18%)
Query: 75  YNFSDVKKLTNSFKD--------KLGQGGFGGVYKG---------------------RLL 105
           ++F ++K +TN+F +        K+G+GGFG VYKG                      L 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 106 DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLR 165
             F  E+  +++  H N+V LLGF  +G++  L+Y +MPNGSL   +   D + P   L 
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP---LS 131
Query: 166 WEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG 225
           W    +I  G A G+ +LH       +H DIK  NILLDE F  KISDFGLA+     E 
Sbjct: 132 WHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR---ASEK 185
Query: 226 IVSSLLGAR--GIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSS 283
              +++ +R  G   Y+APE      GE++ KSD+YSFG++++E++       +G+ +  
Sbjct: 186 FAQTVMXSRIVGTTAYMAPEALR---GEITPKSDIYSFGVVLLEII-------TGLPAVD 235
Query: 284 EVYFPHWIYRHVEQDREFKLPGV--VTRKENEI----AKKMIIVGLWCIQARPSDRPPMN 337
           E   P  +    E+  + +      + +K N+      + M  V   C+  + + RP + 
Sbjct: 236 EHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIK 295
Query: 338 EVIEMLQGST 347
           +V ++LQ  T
Sbjct: 296 KVQQLLQEMT 305

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 95/310 (30%), Positives = 152/310 (49%), Gaps = 56/310 (18%)
Query: 75  YNFSDVKKLTNSFKD--------KLGQGGFGGVYKG---------------------RLL 105
           ++F ++K +TN+F +        K+G+GGFG VYKG                      L 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 106 DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLR 165
             F  E+  +++  H N+V LLGF  +G++  L+Y +MPNGSL   +   D + P   L 
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP---LS 131
Query: 166 WEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG 225
           W    +I  G A G+ +LH       +H DIK  NILLDE F  KISDFGLA+     E 
Sbjct: 132 WHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR---ASEK 185
Query: 226 IVSSLLGAR--GIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSS 283
              +++  R  G   Y+APE      GE++ KSD+YSFG++++E++       +G+ +  
Sbjct: 186 FAQTVMXXRIVGTTAYMAPEALR---GEITPKSDIYSFGVVLLEII-------TGLPAVD 235
Query: 284 EVYFPHWIYRHVEQDREFKLPGV--VTRKENEI----AKKMIIVGLWCIQARPSDRPPMN 337
           E   P  +    E+  + +      + +K N+      + M  V   C+  + + RP + 
Sbjct: 236 EHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIK 295
Query: 338 EVIEMLQGST 347
           +V ++LQ  T
Sbjct: 296 KVQQLLQEMT 305

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 95/312 (30%), Positives = 152/312 (48%), Gaps = 56/312 (17%)
Query: 75  YNFSDVKKLTNSFKD--------KLGQGGFGGVYKG---------------------RLL 105
           ++F ++K +TN+F +        K+G+GGFG VYKG                      L 
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 68
Query: 106 DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLR 165
             F  E+  +++  H N+V LLGF  +G++  L+Y +MPNGSL   +   D + P   L 
Sbjct: 69  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP---LS 125
Query: 166 WEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG 225
           W    +I  G A G+ +LH       +H DIK  NILLDE F  KISDFGLA+     E 
Sbjct: 126 WHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR---ASEK 179
Query: 226 IVSSLLGAR--GIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSS 283
               ++  R  G   Y+APE      GE++ KSD+YSFG++++E++       +G+ +  
Sbjct: 180 FAQXVMXXRIVGTTAYMAPEALR---GEITPKSDIYSFGVVLLEII-------TGLPAVD 229
Query: 284 EVYFPHWIYRHVEQDREFKLPGV--VTRKENEI----AKKMIIVGLWCIQARPSDRPPMN 337
           E   P  +    E+  + +      + +K N+      + M  V   C+  + + RP + 
Sbjct: 230 EHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIK 289
Query: 338 EVIEMLQGSTEA 349
           +V ++LQ  T +
Sbjct: 290 KVQQLLQEMTAS 301

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  121 bits (303), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 93/310 (30%), Positives = 146/310 (47%), Gaps = 56/310 (18%)
Query: 75  YNFSDVKKLTNSFKD--------KLGQGGFGGVYKG---------------------RLL 105
           ++F ++K +TN+F +        K G+GGFG VYKG                      L 
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 65
Query: 106 DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLR 165
             F  E+   ++  H N+V LLGF  +G++  L+Y + PNGSL   +   D + P   L 
Sbjct: 66  QQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPP---LS 122
Query: 166 WEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG 225
           W    +I  G A G+ +LH       +H DIK  NILLDE F  KISDFGLA+     E 
Sbjct: 123 WHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR---ASEK 176
Query: 226 IVSSLLGAR--GIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSS 283
               +  +R  G   Y APE      GE++ KSD+YSFG++++E++       +G+ +  
Sbjct: 177 FAQXVXXSRIVGTTAYXAPEALR---GEITPKSDIYSFGVVLLEII-------TGLPAVD 226
Query: 284 EVYFPHWIYRHVEQDREFKLPGV--VTRKENEIAKKMI----IVGLWCIQARPSDRPPMN 337
           E   P  +    E+  + +      + +K N+     +     V   C+  + + RP + 
Sbjct: 227 EHREPQLLLDIKEEIEDEEKTIEDYIDKKXNDADSTSVEAXYSVASQCLHEKKNKRPDIK 286
Query: 338 EVIEMLQGST 347
           +V ++LQ  T
Sbjct: 287 KVQQLLQEXT 296

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 133/295 (45%), Gaps = 45/295 (15%)
Query: 68  GPLPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRL------------------LDDFV 109
           GP P   Y+  ++++   + K KLG G +G VY+G                    +++F+
Sbjct: 1   GPSP--NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL 58
Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKM 169
            E A +    H N+V LLG C       +I EFM  G+L  ++   +  +    +    +
Sbjct: 59  KEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVV----L 114
Query: 170 YEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSS 229
             +   I+  +EYL        +H D+   N L+ E+   K++DFGL++L T      ++
Sbjct: 115 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD--TXTA 169
Query: 230 LLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPH 289
             GA+  I + APE  + N  + S KSDV++FG+++ E+     +   G+D S       
Sbjct: 170 HAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------ 221
Query: 290 WIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
            +Y  +E+D   + P     K  E+ +        C Q  PSDRP   E+ +  +
Sbjct: 222 -VYELLEKDYRMERPEGCPEKVYELMRA-------CWQWNPSDRPSFAEIHQAFE 268

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 131/292 (44%), Gaps = 43/292 (14%)
Query: 71  PLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRL------------------LDDFVNEV 112
           P   Y+  ++++   + K KLG G +G VY+G                    +++F+ E 
Sbjct: 5   PSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEA 64
Query: 113 ASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEI 172
           A +    H N+V LLG C       +I EFM  G+L  ++   +  +    +    +  +
Sbjct: 65  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV----LLYM 120
Query: 173 VIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLG 232
              I+  +EYL        +H D+   N L+ E+   K++DFGL++L T      ++  G
Sbjct: 121 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD--TYTAHAG 175
Query: 233 ARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIY 292
           A+  I + APE  + N  + S KSDV++FG+++ E+     +   G+D S        +Y
Sbjct: 176 AKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VY 226
Query: 293 RHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
             +E+D   + P     K  E+ +        C Q  PSDRP   E+ +  +
Sbjct: 227 ELLEKDYRMERPEGCPEKVYELMRA-------CWQWNPSDRPSFAEIHQAFE 271

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 126/279 (45%), Gaps = 43/279 (15%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKGRL------------------LDDFVNEVASISRTSH 120
           ++++   + K KLG G FG VY+G                    +++F+ E A +    H
Sbjct: 7   EMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 66
Query: 121 VNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGL 180
            N+V LLG C       +I EFM  G+L  ++   +  +    +    +  +   I+  +
Sbjct: 67  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV----LLYMATQISSAM 122
Query: 181 EYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYI 240
           EYL        +H D+   N L+ E+   K++DFGL++L T      ++  GA+  I + 
Sbjct: 123 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD--TXTAHAGAKFPIKWT 177
Query: 241 APEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDRE 300
           APE  + N  + S KSDV++FG+++ E+     +   G+D       P  +Y  +E+D  
Sbjct: 178 APESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGID-------PSQVYELLEKDYR 228
Query: 301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEV 339
            + P     K  E+ +        C Q  PSDRP   E+
Sbjct: 229 MERPEGCPEKVYELMRA-------CWQWNPSDRPSFAEI 260

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 130/288 (45%), Gaps = 43/288 (14%)
Query: 75  YNFSDVKKLTNSFKDKLGQGGFGGVYKGRL------------------LDDFVNEVASIS 116
           Y+  ++++   + K KLG G +G VY+G                    +++F+ E A + 
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 64
Query: 117 RTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 176
              H N+V LLG C       +I EFM  G+L  ++   +  +    +    +  +   I
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV----LLYMATQI 120
Query: 177 AKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI 236
           +  +EYL        +H D+   N L+ E+   K++DFGL++L T      ++  GA+  
Sbjct: 121 SSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFP 175
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE 296
           I + APE  + N  + S KSDV++FG+++ E+     +   G+D S        +Y  +E
Sbjct: 176 IKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLE 226
Query: 297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
           +D   + P     K  E+ +        C Q  PSDRP   E+ +  +
Sbjct: 227 KDYRMERPEGCPEKVYELMRA-------CWQWNPSDRPSFAEIHQAFE 267

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 130/288 (45%), Gaps = 43/288 (14%)
Query: 75  YNFSDVKKLTNSFKDKLGQGGFGGVYKGRL------------------LDDFVNEVASIS 116
           Y+  ++++   + K KLG G +G VY+G                    +++F+ E A + 
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 69
Query: 117 RTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 176
              H N+V LLG C       +I EFM  G+L  ++   +  +    +    +  +   I
Sbjct: 70  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV----LLYMATQI 125
Query: 177 AKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI 236
           +  +EYL        +H D+   N L+ E+   K++DFGL++L T      ++  GA+  
Sbjct: 126 SSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFP 180
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE 296
           I + APE  + N  + S KSDV++FG+++ E+     +   G+D S        +Y  +E
Sbjct: 181 IKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLE 231
Query: 297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
           +D   + P     K  E+ +        C Q  PSDRP   E+ +  +
Sbjct: 232 KDYRMERPEGCPEKVYELMRA-------CWQWNPSDRPSFAEIHQAFE 272

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 130/288 (45%), Gaps = 43/288 (14%)
Query: 75  YNFSDVKKLTNSFKDKLGQGGFGGVYKGRL------------------LDDFVNEVASIS 116
           Y+  ++++   + K KLG G +G VY+G                    +++F+ E A + 
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 64
Query: 117 RTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 176
              H N+V LLG C       +I EFM  G+L  ++   +  +    +    +  +   I
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVV----LLYMATQI 120
Query: 177 AKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI 236
           +  +EYL        +H D+   N L+ E+   K++DFGL++L T      ++  GA+  
Sbjct: 121 SSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFP 175
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE 296
           I + APE  + N  + S KSDV++FG+++ E+     +   G+D S        +Y  +E
Sbjct: 176 IKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLE 226
Query: 297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
           +D   + P     K  E+ +        C Q  PSDRP   E+ +  +
Sbjct: 227 KDYRMERPEGCPEKVYELMRA-------CWQWNPSDRPSFAEIHQAFE 267

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 130/288 (45%), Gaps = 43/288 (14%)
Query: 75  YNFSDVKKLTNSFKDKLGQGGFGGVYKGRL------------------LDDFVNEVASIS 116
           Y+  ++++   + K KLG G +G VY+G                    +++F+ E A + 
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 64
Query: 117 RTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 176
              H N+V LLG C       +I EFM  G+L  ++   +  +    +    +  +   I
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVV----LLYMATQI 120
Query: 177 AKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI 236
           +  +EYL        +H D+   N L+ E+   K++DFGL++L T      ++  GA+  
Sbjct: 121 SSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFP 175
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE 296
           I + APE  + N  + S KSDV++FG+++ E+     +   G+D S        +Y  +E
Sbjct: 176 IKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLE 226
Query: 297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
           +D   + P     K  E+ +        C Q  PSDRP   E+ +  +
Sbjct: 227 KDYRMERPEGCPEKVYELMRA-------CWQWNPSDRPSFAEIHQAFE 267

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 130/288 (45%), Gaps = 43/288 (14%)
Query: 75  YNFSDVKKLTNSFKDKLGQGGFGGVYKGRL------------------LDDFVNEVASIS 116
           Y+  ++++   + K KLG G +G VY+G                    +++F+ E A + 
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 69
Query: 117 RTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 176
              H N+V LLG C       +I EFM  G+L  ++   +  +    +    +  +   I
Sbjct: 70  EIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQI 125
Query: 177 AKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI 236
           +  +EYL        +H D+   N L+ E+   K++DFGL++L T      ++  GA+  
Sbjct: 126 SSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFP 180
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE 296
           I + APE  + N  + S KSDV++FG+++ E+     +   G+D S        +Y  +E
Sbjct: 181 IKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLE 231
Query: 297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
           +D   + P     K  E+ +        C Q  PSDRP   E+ +  +
Sbjct: 232 KDYRMERPEGCPEKVYELMRA-------CWQWNPSDRPSFAEIHQAFE 272

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 130/288 (45%), Gaps = 43/288 (14%)
Query: 75  YNFSDVKKLTNSFKDKLGQGGFGGVYKGRL------------------LDDFVNEVASIS 116
           Y+  ++++   + K KLG G +G VY+G                    +++F+ E A + 
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 64
Query: 117 RTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 176
              H N+V LLG C       +I EFM  G+L  ++   +  +    +    +  +   I
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV----LLYMATQI 120
Query: 177 AKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI 236
           +  +EYL        +H D+   N L+ E+   K++DFGL++L T      ++  GA+  
Sbjct: 121 SSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFP 175
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE 296
           I + APE  + N  + S KSDV++FG+++ E+     +   G+D S        +Y  +E
Sbjct: 176 IKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLE 226
Query: 297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
           +D   + P     K  E+ +        C Q  PSDRP   E+ +  +
Sbjct: 227 KDYRMERPEGCPEKVYELMRA-------CWQWNPSDRPSFAEIHQAFE 267

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 130/288 (45%), Gaps = 43/288 (14%)
Query: 75  YNFSDVKKLTNSFKDKLGQGGFGGVYKGRL------------------LDDFVNEVASIS 116
           Y+  ++++   + K KLG G +G VY+G                    +++F+ E A + 
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 69
Query: 117 RTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 176
              H N+V LLG C       +I EFM  G+L  ++   +  +    +    +  +   I
Sbjct: 70  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQI 125
Query: 177 AKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI 236
           +  +EYL        +H D+   N L+ E+   K++DFGL++L T      ++  GA+  
Sbjct: 126 SSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD--TXTAHAGAKFP 180
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE 296
           I + APE  + N  + S KSDV++FG+++ E+     +   G+D S        +Y  +E
Sbjct: 181 IKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLE 231
Query: 297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
           +D   + P     K  E+ +        C Q  PSDRP   E+ +  +
Sbjct: 232 KDYRMERPEGCPEKVYELMRA-------CWQWNPSDRPSFAEIHQAFE 272

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 130/288 (45%), Gaps = 43/288 (14%)
Query: 75  YNFSDVKKLTNSFKDKLGQGGFGGVYKGRL------------------LDDFVNEVASIS 116
           Y+  ++++   + K KLG G +G VY+G                    +++F+ E A + 
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 69
Query: 117 RTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 176
              H N+V LLG C       +I EFM  G+L  ++   +  +    +    +  +   I
Sbjct: 70  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQI 125
Query: 177 AKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI 236
           +  +EYL        +H D+   N L+ E+   K++DFGL++L T      ++  GA+  
Sbjct: 126 SSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFP 180
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE 296
           I + APE  + N  + S KSDV++FG+++ E+     +   G+D S        +Y  +E
Sbjct: 181 IKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLE 231
Query: 297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
           +D   + P     K  E+ +        C Q  PSDRP   E+ +  +
Sbjct: 232 KDYRMERPEGCPEKVYELMRA-------CWQWNPSDRPSFAEIHQAFE 272

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 128/284 (45%), Gaps = 43/284 (15%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKGRL------------------LDDFVNEVASISRTSH 120
           ++++   + K KLG G +G VY+G                    +++F+ E A +    H
Sbjct: 7   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 66
Query: 121 VNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGL 180
            N+V LLG C       +I EFM  G+L  ++   +  +    +    +  +   I+  +
Sbjct: 67  PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVV----LLYMATQISSAM 122
Query: 181 EYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYI 240
           EYL        +H D+   N L+ E+   K++DFGL++L T      ++  GA+  I + 
Sbjct: 123 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD--TXTAHAGAKFPIKWT 177
Query: 241 APEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDRE 300
           APE  + N  + S KSDV++FG+++ E+     +   G+D       P  +Y  +E+D  
Sbjct: 178 APESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGID-------PSQVYELLEKDYR 228
Query: 301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
            + P     K  E+ +        C Q  PSDRP   E+ +  +
Sbjct: 229 MERPEGCPEKVYELMRA-------CWQWNPSDRPSFAEIHQAFE 265

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 130/288 (45%), Gaps = 43/288 (14%)
Query: 75  YNFSDVKKLTNSFKDKLGQGGFGGVYKGRL------------------LDDFVNEVASIS 116
           Y+  ++++   + K KLG G +G VY+G                    +++F+ E A + 
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 64
Query: 117 RTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 176
              H N+V LLG C       +I EFM  G+L  ++   +  +    +    +  +   I
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQI 120
Query: 177 AKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI 236
           +  +EYL        +H D+   N L+ E+   K++DFGL++L T      ++  GA+  
Sbjct: 121 SSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFP 175
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE 296
           I + APE  + N  + S KSDV++FG+++ E+     +   G+D S        +Y  +E
Sbjct: 176 IKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLE 226
Query: 297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
           +D   + P     K  E+ +        C Q  PSDRP   E+ +  +
Sbjct: 227 KDYRMERPEGCPEKVYELMRA-------CWQWNPSDRPSFAEIHQAFE 267

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 130/288 (45%), Gaps = 43/288 (14%)
Query: 75  YNFSDVKKLTNSFKDKLGQGGFGGVYKGRL------------------LDDFVNEVASIS 116
           Y+  ++++   + K KLG G +G VY+G                    +++F+ E A + 
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 64
Query: 117 RTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 176
              H N+V LLG C       +I EFM  G+L  ++   +  +    +    +  +   I
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQI 120
Query: 177 AKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI 236
           +  +EYL        +H D+   N L+ E+   K++DFGL++L T      ++  GA+  
Sbjct: 121 SSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFP 175
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE 296
           I + APE  + N  + S KSDV++FG+++ E+     +   G+D S        +Y  +E
Sbjct: 176 IKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLE 226
Query: 297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
           +D   + P     K  E+ +        C Q  PSDRP   E+ +  +
Sbjct: 227 KDYRMERPEGCPEKVYELMRA-------CWQWNPSDRPSFAEIHQAFE 267

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 126/279 (45%), Gaps = 43/279 (15%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKGRL------------------LDDFVNEVASISRTSH 120
           ++++   + K KLG G +G VY+G                    +++F+ E A +    H
Sbjct: 7   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 66
Query: 121 VNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGL 180
            N+V LLG C       +I EFM  G+L  ++   +  +    +    +  +   I+  +
Sbjct: 67  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV----LLYMATQISSAM 122
Query: 181 EYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYI 240
           EYL        +H D+   N L+ E+   K++DFGL++L T      ++  GA+  I + 
Sbjct: 123 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD--TFTAHAGAKFPIKWT 177
Query: 241 APEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDRE 300
           APE  + N  + S KSDV++FG+++ E+     +   G+D       P  +Y  +E+D  
Sbjct: 178 APESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGID-------PSQVYELLEKDYR 228
Query: 301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEV 339
            + P     K  E+ +        C Q  PSDRP   E+
Sbjct: 229 MERPEGCPEKVYELMRA-------CWQWNPSDRPSFAEI 260

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 128/283 (45%), Gaps = 43/283 (15%)
Query: 75  YNFSDVKKLTNSFKDKLGQGGFGGVYKGRL------------------LDDFVNEVASIS 116
           Y+  ++++   + K KLG G +G VY+G                    +++F+ E A + 
Sbjct: 6   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 65
Query: 117 RTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 176
              H N+V LLG C       +I EFM  G+L  ++   +  +    +    +  +   I
Sbjct: 66  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQI 121
Query: 177 AKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI 236
           +  +EYL        +H D+   N L+ E+   K++DFGL++L T      ++  GA+  
Sbjct: 122 SSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAPAGAKFP 176
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE 296
           I + APE  + N  + S KSDV++FG+++ E+     +   G+D S        +Y  +E
Sbjct: 177 IKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLE 227
Query: 297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEV 339
           +D   + P     K  E+ +        C Q  PSDRP   E+
Sbjct: 228 KDYRMERPEGCPEKVYELMRA-------CWQWNPSDRPSFAEI 263

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 130/288 (45%), Gaps = 43/288 (14%)
Query: 75  YNFSDVKKLTNSFKDKLGQGGFGGVYKGRL------------------LDDFVNEVASIS 116
           Y+  ++++   + K KLG G +G VY+G                    +++F+ E A + 
Sbjct: 7   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 66
Query: 117 RTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 176
              H N+V LLG C       +I EFM  G+L  ++   +  +    +    +  +   I
Sbjct: 67  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQI 122
Query: 177 AKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI 236
           +  +EYL        +H D+   N L+ E+   K++DFGL++L T      ++  GA+  
Sbjct: 123 SSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFP 177
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE 296
           I + APE  + N  + S KSDV++FG+++ E+     +   G+D S        +Y  +E
Sbjct: 178 IKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLE 228
Query: 297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
           +D   + P     K  E+ +        C Q  PSDRP   E+ +  +
Sbjct: 229 KDYRMERPEGCPEKVYELMRA-------CWQWNPSDRPSFAEIHQAFE 269

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 130/288 (45%), Gaps = 43/288 (14%)
Query: 75  YNFSDVKKLTNSFKDKLGQGGFGGVYKGRL------------------LDDFVNEVASIS 116
           Y+  ++++   + K KLG G +G VY+G                    +++F+ E A + 
Sbjct: 7   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 66
Query: 117 RTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 176
              H N+V LLG C       +I EFM  G+L  ++   +  +    +    +  +   I
Sbjct: 67  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQI 122
Query: 177 AKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI 236
           +  +EYL        +H D+   N L+ E+   K++DFGL++L T      ++  GA+  
Sbjct: 123 SSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFP 177
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE 296
           I + APE  + N  + S KSDV++FG+++ E+     +   G+D S        +Y  +E
Sbjct: 178 IKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLE 228
Query: 297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
           +D   + P     K  E+ +        C Q  PSDRP   E+ +  +
Sbjct: 229 KDYRMERPEGCPEKVYELMRA-------CWQWNPSDRPSFAEIHQAFE 269

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 130/288 (45%), Gaps = 43/288 (14%)
Query: 75  YNFSDVKKLTNSFKDKLGQGGFGGVYKGRL------------------LDDFVNEVASIS 116
           Y+  ++++   + K KLG G +G VY+G                    +++F+ E A + 
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 69
Query: 117 RTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 176
              H N+V LLG C       +I EFM  G+L  ++   +  +    +    +  +   I
Sbjct: 70  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQI 125
Query: 177 AKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI 236
           +  +EYL        +H D+   N L+ E+   K++DFGL++L T      ++  GA+  
Sbjct: 126 SSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFP 180
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE 296
           I + APE  + N  + S KSDV++FG+++ E+     +   G+D S        +Y  +E
Sbjct: 181 IKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLE 231
Query: 297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
           +D   + P     K  E+ +        C Q  PSDRP   E+ +  +
Sbjct: 232 KDYRMERPEGCPEKVYELMRA-------CWQWNPSDRPSFAEIHQAFE 272

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 130/288 (45%), Gaps = 43/288 (14%)
Query: 75  YNFSDVKKLTNSFKDKLGQGGFGGVYKGRL------------------LDDFVNEVASIS 116
           Y+  ++++   + K KLG G +G VY+G                    +++F+ E A + 
Sbjct: 7   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 66
Query: 117 RTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 176
              H N+V LLG C       +I EFM  G+L  ++   +  +    +    +  +   I
Sbjct: 67  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQI 122
Query: 177 AKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI 236
           +  +EYL        +H D+   N L+ E+   K++DFGL++L T      ++  GA+  
Sbjct: 123 SSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD--TYTAPAGAKFP 177
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE 296
           I + APE  + N  + S KSDV++FG+++ E+     +   G+D S        +Y  +E
Sbjct: 178 IKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLE 228
Query: 297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
           +D   + P     K  E+ +        C Q  PSDRP   E+ +  +
Sbjct: 229 KDYRMERPEGCPEKVYELMRA-------CWQWNPSDRPSFAEIHQAFE 269

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 130/288 (45%), Gaps = 43/288 (14%)
Query: 75  YNFSDVKKLTNSFKDKLGQGGFGGVYKGRL------------------LDDFVNEVASIS 116
           Y+  ++++   + K KLG G +G VY+G                    +++F+ E A + 
Sbjct: 18  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 77
Query: 117 RTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 176
              H N+V LLG C       +I EFM  G+L  ++   +  +    +    +  +   I
Sbjct: 78  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQI 133
Query: 177 AKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI 236
           +  +EYL        +H D+   N L+ E+   K++DFGL++L T      ++  GA+  
Sbjct: 134 SSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFP 188
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE 296
           I + APE  + N  + S KSDV++FG+++ E+     +   G+D S        +Y  +E
Sbjct: 189 IKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLE 239
Query: 297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
           +D   + P     K  E+ +        C Q  PSDRP   E+ +  +
Sbjct: 240 KDYRMERPEGCPEKVYELMRA-------CWQWNPSDRPSFAEIHQAFE 280

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 133/296 (44%), Gaps = 45/296 (15%)
Query: 67  YGPLPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRL------------------LDDF 108
           YG  P   Y+  ++++   + K KLG G +G VY+G                    +++F
Sbjct: 206 YGVSP--NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF 263
Query: 109 VNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEK 168
           + E A +    H N+V LLG C       +I EFM  G+L  ++   +  +    +    
Sbjct: 264 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV---- 319
Query: 169 MYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVS 228
           +  +   I+  +EYL        +H ++   N L+ E+   K++DFGL++L T      +
Sbjct: 320 LLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD--TYT 374
Query: 229 SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFP 288
           +  GA+  I + APE  + N  + S KSDV++FG+++ E+     +   G+D S      
Sbjct: 375 AHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----- 427
Query: 289 HWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
             +Y  +E+D   + P     K  E+ +        C Q  PSDRP   E+ +  +
Sbjct: 428 --VYELLEKDYRMERPEGCPEKVYELMRA-------CWQWNPSDRPSFAEIHQAFE 474

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 102/203 (50%), Gaps = 28/203 (13%)
Query: 86  SFKDKLGQGGFGGVYKGRL-------------------LDDFVNEVASISRTSHVNVVTL 126
           + K+K+G G FG V++                      +++F+ EVA + R  H N+V  
Sbjct: 40  NIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
           +G   +  N +++ E++  GSL + ++        + L   +   +   +AKG+ YLH+ 
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAR---EQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            +  I+H ++K  N+L+D+ +  K+ DFGL++L   K     S   A G   ++APEV  
Sbjct: 157 -NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL---KASTFLSSKSAAGTPEWMAPEVLR 212
Query: 247 RNFGEVSHKSDVYSFGMMIMELV 269
                 + KSDVYSFG+++ EL 
Sbjct: 213 DE--PSNEKSDVYSFGVILWELA 233

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 28/207 (13%)
Query: 86  SFKDKLGQGGFGGVYKGRL-------------------LDDFVNEVASISRTSHVNVVTL 126
           + K+K+G G FG V++                      +++F+ EVA + R  H N+V  
Sbjct: 40  NIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
           +G   +  N +++ E++  GSL + ++        + L   +   +   +AKG+ YLH+ 
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAR---EQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            +  I+H D+K  N+L+D+ +  K+ DFGL++L   K         A G   ++APEV  
Sbjct: 157 -NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL---KASXFLXSKXAAGTPEWMAPEVLR 212
Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKN 273
                 + KSDVYSFG+++ EL   + 
Sbjct: 213 DE--PSNEKSDVYSFGVILWELATLQQ 237

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 122/281 (43%), Gaps = 43/281 (15%)
Query: 86  SFKDKLGQGGFGGVYKGRLL-----------------DDFVNEVASISRTSHVNVVTLLG 128
           +F  ++G G FG V+ G  L                 DDF+ E   + + SH  +V L G
Sbjct: 30  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYG 89
Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
            CLE     L++EFM +G L  ++              E +  + + + +G+ YL   C 
Sbjct: 90  VCLEQAPICLVFEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEAC- 143
Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRN 248
             ++H D+   N L+ E+   K+SDFG+ +     +   +S  G +  + + +PEVFS  
Sbjct: 144 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASPEVFS-- 197
Query: 249 FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVT 308
           F   S KSDV+SFG+++ E V  +  +     S+SEV         +        P + +
Sbjct: 198 FSRYSSKSDVWSFGVLMWE-VFSEGKIPYENRSNSEV------VEDISTGFRLYKPRLAS 250
Query: 309 RKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA 349
               +I          C + RP DRP  + ++  L    E+
Sbjct: 251 THVYQIMNH-------CWKERPEDRPAFSRLLRQLAEIAES 284

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 134/298 (44%), Gaps = 49/298 (16%)
Query: 67  YGPLPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRL------------------LDDF 108
           YG  P   Y+  ++++   + K KLG G +G VY+G                    +++F
Sbjct: 245 YGVSP--NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF 302
Query: 109 VNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPC--QYLRW 166
           + E A +    H N+V LLG C       +I EFM  G+L  ++      + C  Q +  
Sbjct: 303 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL------RECNRQEVNA 356
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
             +  +   I+  +EYL        +H ++   N L+ E+   K++DFGL++L T     
Sbjct: 357 VVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD--T 411
Query: 227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVY 286
            ++  GA+  I + APE  + N  + S KSDV++FG+++ E+     +   G+D S    
Sbjct: 412 YTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--- 466
Query: 287 FPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
               +Y  +E+D   + P     K  E+ +        C Q  PSDRP   E+ +  +
Sbjct: 467 ----VYELLEKDYRMERPEGCPEKVYELMRA-------CWQWNPSDRPSFAEIHQAFE 513

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 104/199 (52%), Gaps = 29/199 (14%)
Query: 90  KLGQGGFGGVYKGRLLDD------------------FVNEVASISRTSHVNVVTLLGFCL 131
           ++G G FG VYKG+   D                  F NEVA + +T HVN++  +G+ +
Sbjct: 43  RIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY-M 101
Query: 132 EGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKI 191
             +N A++ ++    SL K ++  +T       +  ++ +I    A+G++YLH   +  I
Sbjct: 102 TKDNLAIVTQWCEGSSLYKHLHVQETK-----FQMFQLIDIARQTAQGMDYLH---AKNI 153
Query: 192 LHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS-RNFG 250
           +H D+K +NI L E    KI DFGLA + +   G    +    G + ++APEV   ++  
Sbjct: 154 IHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG-SQQVEQPTGSVLWMAPEVIRMQDNN 212
Query: 251 EVSHKSDVYSFGMMIMELV 269
             S +SDVYS+G+++ EL+
Sbjct: 213 PFSFQSDVYSYGIVLYELM 231

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 122/281 (43%), Gaps = 43/281 (15%)
Query: 86  SFKDKLGQGGFGGVYKGRLL-----------------DDFVNEVASISRTSHVNVVTLLG 128
           +F  ++G G FG V+ G  L                 +DF+ E   + + SH  +V L G
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
            CLE     L++EFM +G L  ++              E +  + + + +G+ YL   C 
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEAC- 123
Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRN 248
             ++H D+   N L+ E+   K+SDFG+ +     +   +S  G +  + + +PEVFS  
Sbjct: 124 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASPEVFS-- 177
Query: 249 FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVT 308
           F   S KSDV+SFG+++ E+   +  +     S+SEV         +        P + +
Sbjct: 178 FSRYSSKSDVWSFGVLMWEVFS-EGKIPYENRSNSEV------VEDISTGFRLYKPRLAS 230
Query: 309 RKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA 349
               +I          C + RP DRP  + ++  L    E+
Sbjct: 231 THVYQIMNH-------CWKERPEDRPAFSRLLRQLAEIAES 264

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 122/281 (43%), Gaps = 43/281 (15%)
Query: 86  SFKDKLGQGGFGGVYKGRLL-----------------DDFVNEVASISRTSHVNVVTLLG 128
           +F  ++G G FG V+ G  L                 +DF+ E   + + SH  +V L G
Sbjct: 8   TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 67
Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
            CLE     L++EFM +G L  ++              E +  + + + +G+ YL   C 
Sbjct: 68  VCLEQAPICLVFEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEAC- 121
Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRN 248
             ++H D+   N L+ E+   K+SDFG+ +     +   +S  G +  + + +PEVFS  
Sbjct: 122 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASPEVFS-- 175
Query: 249 FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVT 308
           F   S KSDV+SFG+++ E+   +  +     S+SEV         +        P + +
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFS-EGKIPYENRSNSEV------VEDISTGFRLYKPRLAS 228
Query: 309 RKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA 349
               +I          C + RP DRP  + ++  L    E+
Sbjct: 229 THVYQIMNH-------CWKERPEDRPAFSRLLRQLAEIAES 262

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 105/212 (49%), Gaps = 35/212 (16%)
Query: 83  LTNSFKDKLGQGGFGGVYKGRLLDD-----------------------FVNEVASISRTS 119
           L   F + +G+G FG VY G LLD+                       F+ E   +   S
Sbjct: 29  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 88
Query: 120 HVNVVTLLGFCLEGNNRALI-YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
           H NV++LLG CL      L+   +M +G L  F+ N +T  P      + +    + +AK
Sbjct: 89  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTV----KDLIGFGLQVAK 143
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI-VSSLLGARGII 237
           G++YL    S K +H D+   N +LDE F  K++DFGLA+    KE   V +  GA+  +
Sbjct: 144 GMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPV 200
Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            ++A E  S    + + KSDV+SFG+++ EL+
Sbjct: 201 KWMALE--SLQTQKFTTKSDVWSFGVLLWELM 230

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 122/281 (43%), Gaps = 43/281 (15%)
Query: 86  SFKDKLGQGGFGGVYKGRLL-----------------DDFVNEVASISRTSHVNVVTLLG 128
           +F  ++G G FG V+ G  L                 +DF+ E   + + SH  +V L G
Sbjct: 13  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 72
Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
            CLE     L++EFM +G L  ++              E +  + + + +G+ YL   C 
Sbjct: 73  VCLEQAPICLVFEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEAC- 126
Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRN 248
             ++H D+   N L+ E+   K+SDFG+ +     +   +S  G +  + + +PEVFS  
Sbjct: 127 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASPEVFS-- 180
Query: 249 FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVT 308
           F   S KSDV+SFG+++ E+   +  +     S+SEV         +        P + +
Sbjct: 181 FSRYSSKSDVWSFGVLMWEVFS-EGKIPYENRSNSEV------VEDISTGFRLYKPRLAS 233
Query: 309 RKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA 349
               +I          C + RP DRP  + ++  L    E+
Sbjct: 234 THVYQIMNH-------CWRERPEDRPAFSRLLRQLAEIAES 267

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 100/199 (50%), Gaps = 29/199 (14%)
Query: 90  KLGQGGFGGVYKGRL------------------LDDFVNEVASISRTSHVNVVTLLGFCL 131
           ++G G FG VYKG+                   L  F NEV  + +T HVN++  +G+  
Sbjct: 19  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 78
Query: 132 EGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKI 191
           +    A++ ++    SL   ++  +T         +K+ +I    A+G++YLH   +  I
Sbjct: 79  KPQ-LAIVTQWCEGSSLYHHLHASETK-----FEMKKLIDIARQTARGMDYLH---AKSI 129
Query: 192 LHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS-RNFG 250
           +H D+K +NI L ED   KI DFGLA + +   G         G I ++APEV   ++  
Sbjct: 130 IHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSG-SHQFEQLSGSILWMAPEVIRMQDSN 188
Query: 251 EVSHKSDVYSFGMMIMELV 269
             S +SDVY+FG+++ EL+
Sbjct: 189 PYSFQSDVYAFGIVLYELM 207

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 105/212 (49%), Gaps = 35/212 (16%)
Query: 83  LTNSFKDKLGQGGFGGVYKGRLLDD-----------------------FVNEVASISRTS 119
           L   F + +G+G FG VY G LLD+                       F+ E   +   S
Sbjct: 30  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 89
Query: 120 HVNVVTLLGFCLEGNNRALI-YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
           H NV++LLG CL      L+   +M +G L  F+ N +T  P      + +    + +AK
Sbjct: 90  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTV----KDLIGFGLQVAK 144
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI-VSSLLGARGII 237
           G++YL    S K +H D+   N +LDE F  K++DFGLA+    KE   V +  GA+  +
Sbjct: 145 GMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 201
Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            ++A E  S    + + KSDV+SFG+++ EL+
Sbjct: 202 KWMALE--SLQTQKFTTKSDVWSFGVLLWELM 231

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 105/212 (49%), Gaps = 35/212 (16%)
Query: 83  LTNSFKDKLGQGGFGGVYKGRLLDD-----------------------FVNEVASISRTS 119
           L   F + +G+G FG VY G LLD+                       F+ E   +   S
Sbjct: 25  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 84
Query: 120 HVNVVTLLGFCLEGNNRALI-YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
           H NV++LLG CL      L+   +M +G L  F+ N +T  P      + +    + +AK
Sbjct: 85  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTV----KDLIGFGLQVAK 139
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI-VSSLLGARGII 237
           G++YL    S K +H D+   N +LDE F  K++DFGLA+    KE   V +  GA+  +
Sbjct: 140 GMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 196
Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            ++A E  S    + + KSDV+SFG+++ EL+
Sbjct: 197 KWMALE--SLQTQKFTTKSDVWSFGVLLWELM 226

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 105/212 (49%), Gaps = 35/212 (16%)
Query: 83  LTNSFKDKLGQGGFGGVYKGRLLDD-----------------------FVNEVASISRTS 119
           L   F + +G+G FG VY G LLD+                       F+ E   +   S
Sbjct: 29  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 88
Query: 120 HVNVVTLLGFCLEGNNRALI-YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
           H NV++LLG CL      L+   +M +G L  F+ N +T  P      + +    + +AK
Sbjct: 89  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTV----KDLIGFGLQVAK 143
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI-VSSLLGARGII 237
           G++YL    S K +H D+   N +LDE F  K++DFGLA+    KE   V +  GA+  +
Sbjct: 144 GMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 200
Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            ++A E  S    + + KSDV+SFG+++ EL+
Sbjct: 201 KWMALE--SLQTQKFTTKSDVWSFGVLLWELM 230

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 105/212 (49%), Gaps = 35/212 (16%)
Query: 83  LTNSFKDKLGQGGFGGVYKGRLLDD-----------------------FVNEVASISRTS 119
           L   F + +G+G FG VY G LLD+                       F+ E   +   S
Sbjct: 27  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 86
Query: 120 HVNVVTLLGFCLEGNNRALI-YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
           H NV++LLG CL      L+   +M +G L  F+ N +T  P      + +    + +AK
Sbjct: 87  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTV----KDLIGFGLQVAK 141
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI-VSSLLGARGII 237
           G++YL    S K +H D+   N +LDE F  K++DFGLA+    KE   V +  GA+  +
Sbjct: 142 GMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 198
Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            ++A E  S    + + KSDV+SFG+++ EL+
Sbjct: 199 KWMALE--SLQTQKFTTKSDVWSFGVLLWELM 228

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 105/212 (49%), Gaps = 35/212 (16%)
Query: 83  LTNSFKDKLGQGGFGGVYKGRLLDD-----------------------FVNEVASISRTS 119
           L   F + +G+G FG VY G LLD+                       F+ E   +   S
Sbjct: 30  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 89
Query: 120 HVNVVTLLGFCLEGNNRALI-YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
           H NV++LLG CL      L+   +M +G L  F+ N +T  P      + +    + +AK
Sbjct: 90  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTV----KDLIGFGLQVAK 144
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI-VSSLLGARGII 237
           G++YL    S K +H D+   N +LDE F  K++DFGLA+    KE   V +  GA+  +
Sbjct: 145 GMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 201
Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            ++A E  S    + + KSDV+SFG+++ EL+
Sbjct: 202 KWMALE--SLQTQKFTTKSDVWSFGVLLWELM 231

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 104/208 (50%), Gaps = 35/208 (16%)
Query: 87  FKDKLGQGGFGGVYKGRLLDD-----------------------FVNEVASISRTSHVNV 123
           F + +G+G FG VY G LLD+                       F+ E   +   SH NV
Sbjct: 52  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 111
Query: 124 VTLLGFCLEGNNRALI-YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 182
           ++LLG CL      L+   +M +G L  F+ N +T  P      + +    + +AKG++Y
Sbjct: 112 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTV----KDLIGFGLQVAKGMKY 166
Query: 183 LHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI-VSSLLGARGIIGYIA 241
           L    S K +H D+   N +LDE F  K++DFGLA+    KE   V +  GA+  + ++A
Sbjct: 167 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 223
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            E  S    + + KSDV+SFG+++ EL+
Sbjct: 224 LE--SLQTQKFTTKSDVWSFGVLLWELM 249

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 105/212 (49%), Gaps = 35/212 (16%)
Query: 83  LTNSFKDKLGQGGFGGVYKGRLLDD-----------------------FVNEVASISRTS 119
           L   F + +G+G FG VY G LLD+                       F+ E   +   S
Sbjct: 49  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 108
Query: 120 HVNVVTLLGFCLEGNNRALI-YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
           H NV++LLG CL      L+   +M +G L  F+ N +T  P      + +    + +AK
Sbjct: 109 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTV----KDLIGFGLQVAK 163
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI-VSSLLGARGII 237
           G++YL    S K +H D+   N +LDE F  K++DFGLA+    KE   V +  GA+  +
Sbjct: 164 GMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 220
Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            ++A E  S    + + KSDV+SFG+++ EL+
Sbjct: 221 KWMALE--SLQTQKFTTKSDVWSFGVLLWELM 250

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 105/212 (49%), Gaps = 35/212 (16%)
Query: 83  LTNSFKDKLGQGGFGGVYKGRLLDD-----------------------FVNEVASISRTS 119
           L   F + +G+G FG VY G LLD+                       F+ E   +   S
Sbjct: 22  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 81
Query: 120 HVNVVTLLGFCLEGNNRALI-YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
           H NV++LLG CL      L+   +M +G L  F+ N +T  P      + +    + +AK
Sbjct: 82  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTV----KDLIGFGLQVAK 136
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI-VSSLLGARGII 237
           G++YL    S K +H D+   N +LDE F  K++DFGLA+    KE   V +  GA+  +
Sbjct: 137 GMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 193
Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            ++A E  S    + + KSDV+SFG+++ EL+
Sbjct: 194 KWMALE--SLQTQKFTTKSDVWSFGVLLWELM 223

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 105/212 (49%), Gaps = 35/212 (16%)
Query: 83  LTNSFKDKLGQGGFGGVYKGRLLDD-----------------------FVNEVASISRTS 119
           L   F + +G+G FG VY G LLD+                       F+ E   +   S
Sbjct: 28  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 87
Query: 120 HVNVVTLLGFCLEGNNRALI-YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
           H NV++LLG CL      L+   +M +G L  F+ N +T  P      + +    + +AK
Sbjct: 88  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTV----KDLIGFGLQVAK 142
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI-VSSLLGARGII 237
           G++YL    S K +H D+   N +LDE F  K++DFGLA+    KE   V +  GA+  +
Sbjct: 143 GMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 199
Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            ++A E  S    + + KSDV+SFG+++ EL+
Sbjct: 200 KWMALE--SLQTQKFTTKSDVWSFGVLLWELM 229

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 121/281 (43%), Gaps = 43/281 (15%)
Query: 86  SFKDKLGQGGFGGVYKGRLL-----------------DDFVNEVASISRTSHVNVVTLLG 128
           +F  ++G G FG V+ G  L                 +DF+ E   + + SH  +V L G
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
            CLE     L+ EFM +G L  ++              E +  + + + +G+ YL   C 
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEAC- 124
Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRN 248
             ++H D+   N L+ E+   K+SDFG+ +     +   +S  G +  + + +PEVFS  
Sbjct: 125 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASPEVFS-- 178
Query: 249 FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVT 308
           F   S KSDV+SFG+++ E+   +  +     S+SEV         +        P + +
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFS-EGKIPYENRSNSEV------VEDISTGFRLYKPRLAS 231
Query: 309 RKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA 349
               +I          C + RP DRP  + ++  L    E+
Sbjct: 232 THVYQIMNH-------CWRERPEDRPAFSRLLRQLAEIAES 265

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 98/199 (49%), Gaps = 29/199 (14%)
Query: 90  KLGQGGFGGVYKGRL------------------LDDFVNEVASISRTSHVNVVTLLGFCL 131
           ++G G FG VYKG+                   L  F NEV  + +T HVN++  +G+  
Sbjct: 31  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 90
Query: 132 EGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKI 191
                A++ ++    SL   ++  +T         +K+ +I    A+G++YLH   +  I
Sbjct: 91  -APQLAIVTQWCEGSSLYHHLHASETK-----FEMKKLIDIARQTARGMDYLH---AKSI 141
Query: 192 LHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS-RNFG 250
           +H D+K +NI L ED   KI DFGLA   +   G         G I ++APEV   ++  
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG-SHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 251 EVSHKSDVYSFGMMIMELV 269
             S +SDVY+FG+++ EL+
Sbjct: 201 PYSFQSDVYAFGIVLYELM 219

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 29/199 (14%)
Query: 90  KLGQGGFGGVYKGRL------------------LDDFVNEVASISRTSHVNVVTLLGFCL 131
           ++G G FG VYKG+                   L  F NEV  + +T HVN++  +G+  
Sbjct: 31  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 90
Query: 132 EGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKI 191
           +    A++ ++    SL   ++  +T         +K+ +I    A+G++YLH   +  I
Sbjct: 91  K-PQLAIVTQWCEGSSLYHHLHASETK-----FEMKKLIDIARQTARGMDYLH---AKSI 141
Query: 192 LHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS-RNFG 250
           +H D+K +NI L ED   KI DFGLA   +   G         G I ++APEV   ++  
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG-SHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 251 EVSHKSDVYSFGMMIMELV 269
             S +SDVY+FG+++ EL+
Sbjct: 201 PYSFQSDVYAFGIVLYELM 219

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 105/212 (49%), Gaps = 35/212 (16%)
Query: 83  LTNSFKDKLGQGGFGGVYKGRLLDD-----------------------FVNEVASISRTS 119
           L   F + +G+G FG VY G LLD+                       F+ E   +   S
Sbjct: 28  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 87
Query: 120 HVNVVTLLGFCLEGNNRALI-YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
           H NV++LLG CL      L+   +M +G L  F+ N +T  P      + +    + +AK
Sbjct: 88  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTV----KDLIGFGLQVAK 142
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE-GIVSSLLGARGII 237
           G+++L    S K +H D+   N +LDE F  K++DFGLA+    KE   V +  GA+  +
Sbjct: 143 GMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 199
Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            ++A E  S    + + KSDV+SFG+++ EL+
Sbjct: 200 KWMALE--SLQTQKFTTKSDVWSFGVLLWELM 229

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 105/212 (49%), Gaps = 35/212 (16%)
Query: 83  LTNSFKDKLGQGGFGGVYKGRLLDD-----------------------FVNEVASISRTS 119
           L   F + +G+G FG VY G LLD+                       F+ E   +   S
Sbjct: 30  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 89
Query: 120 HVNVVTLLGFCLEGNNRALI-YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
           H NV++LLG CL      L+   +M +G L  F+ N +T  P      + +    + +AK
Sbjct: 90  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTV----KDLIGFGLQVAK 144
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE-GIVSSLLGARGII 237
           G+++L    S K +H D+   N +LDE F  K++DFGLA+    KE   V +  GA+  +
Sbjct: 145 GMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 201
Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            ++A E  S    + + KSDV+SFG+++ EL+
Sbjct: 202 KWMALE--SLQTQKFTTKSDVWSFGVLLWELM 231

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 35/208 (16%)
Query: 87  FKDKLGQGGFGGVYKGRLLDD-----------------------FVNEVASISRTSHVNV 123
           F + +G+G FG VY G LLD+                       F+ E   +   SH NV
Sbjct: 35  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 94
Query: 124 VTLLGFCLEGNNRALI-YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 182
           ++LLG CL      L+   +M +G L  F+ N +T  P      + +    + +AKG+++
Sbjct: 95  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTV----KDLIGFGLQVAKGMKF 149
Query: 183 LHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE-GIVSSLLGARGIIGYIA 241
           L    S K +H D+   N +LDE F  K++DFGLA+    KE   V +  GA+  + ++A
Sbjct: 150 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMA 206
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            E  S    + + KSDV+SFG+++ EL+
Sbjct: 207 LE--SLQTQKFTTKSDVWSFGVLLWELM 232

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 105/212 (49%), Gaps = 35/212 (16%)
Query: 83  LTNSFKDKLGQGGFGGVYKGRLLDD-----------------------FVNEVASISRTS 119
           L   F + +G+G FG VY G LLD+                       F+ E   +   S
Sbjct: 35  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 94
Query: 120 HVNVVTLLGFCLEGNNRALI-YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
           H NV++LLG CL      L+   +M +G L  F+ N +T  P      + +    + +AK
Sbjct: 95  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTV----KDLIGFGLQVAK 149
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE-GIVSSLLGARGII 237
           G+++L    S K +H D+   N +LDE F  K++DFGLA+    KE   V +  GA+  +
Sbjct: 150 GMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 206
Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            ++A E  S    + + KSDV+SFG+++ EL+
Sbjct: 207 KWMALE--SLQTQKFTTKSDVWSFGVLLWELM 236

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 105/212 (49%), Gaps = 35/212 (16%)
Query: 83  LTNSFKDKLGQGGFGGVYKGRLLDD-----------------------FVNEVASISRTS 119
           L   F + +G+G FG VY G LLD+                       F+ E   +   S
Sbjct: 30  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 89
Query: 120 HVNVVTLLGFCLEGNNRALI-YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
           H NV++LLG CL      L+   +M +G L  F+ N +T  P      + +    + +AK
Sbjct: 90  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTV----KDLIGFGLQVAK 144
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE-GIVSSLLGARGII 237
           G+++L    S K +H D+   N +LDE F  K++DFGLA+    KE   V +  GA+  +
Sbjct: 145 GMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 201
Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            ++A E  S    + + KSDV+SFG+++ EL+
Sbjct: 202 KWMALE--SLQTQKFTTKSDVWSFGVLLWELM 231

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 105/212 (49%), Gaps = 35/212 (16%)
Query: 83  LTNSFKDKLGQGGFGGVYKGRLLDD-----------------------FVNEVASISRTS 119
           L   F + +G+G FG VY G LLD+                       F+ E   +   S
Sbjct: 31  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 90
Query: 120 HVNVVTLLGFCLEGNNRALI-YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
           H NV++LLG CL      L+   +M +G L  F+ N +T  P      + +    + +AK
Sbjct: 91  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTV----KDLIGFGLQVAK 145
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE-GIVSSLLGARGII 237
           G+++L    S K +H D+   N +LDE F  K++DFGLA+    KE   V +  GA+  +
Sbjct: 146 GMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 202
Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            ++A E  S    + + KSDV+SFG+++ EL+
Sbjct: 203 KWMALE--SLQTQKFTTKSDVWSFGVLLWELM 232

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 35/208 (16%)
Query: 87  FKDKLGQGGFGGVYKGRLLDD-----------------------FVNEVASISRTSHVNV 123
           F + +G+G FG VY G LLD+                       F+ E   +   SH NV
Sbjct: 93  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 152
Query: 124 VTLLGFCLEGNNRALI-YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 182
           ++LLG CL      L+   +M +G L  F+ N +T  P      + +    + +AKG+++
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTV----KDLIGFGLQVAKGMKF 207
Query: 183 LHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE-GIVSSLLGARGIIGYIA 241
           L    S K +H D+   N +LDE F  K++DFGLA+    KE   V +  GA+  + ++A
Sbjct: 208 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 264
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            E  S    + + KSDV+SFG+++ EL+
Sbjct: 265 LE--SLQTQKFTTKSDVWSFGVLLWELM 290

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 99/200 (49%), Gaps = 29/200 (14%)
Query: 89  DKLGQGGFGGVYKGRL------------------LDDFVNEVASISRTSHVNVVTLLGFC 130
            ++G G FG VYKG+                   L  F NEV  + +T HVN++  +G+ 
Sbjct: 16  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 131 LEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTK 190
            +    A++ ++    SL   ++  +T          K+ +I    A+G++YLH   +  
Sbjct: 76  TK-PQLAIVTQWCEGSSLYHHLHIIETK-----FEMIKLIDIARQTAQGMDYLH---AKS 126
Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS-RNF 249
           I+H D+K +NI L ED   KI DFGLA + +   G         G I ++APEV   ++ 
Sbjct: 127 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG-SHQFEQLSGSILWMAPEVIRMQDK 185
Query: 250 GEVSHKSDVYSFGMMIMELV 269
              S +SDVY+FG+++ EL+
Sbjct: 186 NPYSFQSDVYAFGIVLYELM 205

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 29/200 (14%)
Query: 89  DKLGQGGFGGVYKGRL------------------LDDFVNEVASISRTSHVNVVTLLGFC 130
            ++G G FG VYKG+                   L  F NEV  + +T HVN++  +G+ 
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 131 LEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTK 190
                 A++ ++    SL   ++  +T          K+ +I    A+G++YLH   +  
Sbjct: 74  -TAPQLAIVTQWCEGSSLYHHLHIIETK-----FEMIKLIDIARQTAQGMDYLH---AKS 124
Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS-RNF 249
           I+H D+K +NI L ED   KI DFGLA + +   G         G I ++APEV   ++ 
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG-SHQFEQLSGSILWMAPEVIRMQDK 183
Query: 250 GEVSHKSDVYSFGMMIMELV 269
              S +SDVY+FG+++ EL+
Sbjct: 184 NPYSFQSDVYAFGIVLYELM 203

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 29/199 (14%)
Query: 90  KLGQGGFGGVYKGRL------------------LDDFVNEVASISRTSHVNVVTLLGFCL 131
           ++G G FG VYKG+                   L  F NEV  + +T HVN++  +G+  
Sbjct: 20  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 79
Query: 132 EGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKI 191
           +    A++ ++    SL   ++  +T          K+ +I    A+G++YLH   +  I
Sbjct: 80  K-PQLAIVTQWCEGSSLYHHLHIIETK-----FEMIKLIDIARQTAQGMDYLH---AKSI 130
Query: 192 LHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS-RNFG 250
           +H D+K +NI L ED   KI DFGLA + +   G         G I ++APEV   ++  
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG-SHQFEQLSGSILWMAPEVIRMQDKN 189
Query: 251 EVSHKSDVYSFGMMIMELV 269
             S +SDVY+FG+++ EL+
Sbjct: 190 PYSFQSDVYAFGIVLYELM 208

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 29/199 (14%)
Query: 90  KLGQGGFGGVYKGRL------------------LDDFVNEVASISRTSHVNVVTLLGFCL 131
           ++G G FG VYKG+                   L  F NEV  + +T HVN++  +G+  
Sbjct: 42  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 101
Query: 132 EGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKI 191
           +    A++ ++    SL   ++  +T          K+ +I    A+G++YLH   +  I
Sbjct: 102 KPQ-LAIVTQWCEGSSLYHHLHIIETK-----FEMIKLIDIARQTAQGMDYLH---AKSI 152
Query: 192 LHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS-RNFG 250
           +H D+K +NI L ED   KI DFGLA + +   G         G I ++APEV   ++  
Sbjct: 153 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG-SHQFEQLSGSILWMAPEVIRMQDKN 211
Query: 251 EVSHKSDVYSFGMMIMELV 269
             S +SDVY+FG+++ EL+
Sbjct: 212 PYSFQSDVYAFGIVLYELM 230

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 99/200 (49%), Gaps = 29/200 (14%)
Query: 89  DKLGQGGFGGVYKGRL------------------LDDFVNEVASISRTSHVNVVTLLGFC 130
            ++G G FG VYKG+                   L  F NEV  + +T HVN++  +G+ 
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 131 LEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTK 190
            +    A++ ++    SL   ++  +T          K+ +I    A+G++YLH   +  
Sbjct: 74  TK-PQLAIVTQWCEGSSLYHHLHIIETK-----FEMIKLIDIARQTAQGMDYLH---AKS 124
Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS-RNF 249
           I+H D+K +NI L ED   KI DFGLA + +   G         G I ++APEV   ++ 
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG-SHQFEQLSGSILWMAPEVIRMQDK 183
Query: 250 GEVSHKSDVYSFGMMIMELV 269
              S +SDVY+FG+++ EL+
Sbjct: 184 NPYSFQSDVYAFGIVLYELM 203

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 29/199 (14%)
Query: 90  KLGQGGFGGVYKGRL------------------LDDFVNEVASISRTSHVNVVTLLGFCL 131
           ++G G FG VYKG+                   L  F NEV  + +T HVN++  +G+  
Sbjct: 20  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 79
Query: 132 EGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKI 191
           +    A++ ++    SL   ++  +T          K+ +I    A+G++YLH   +  I
Sbjct: 80  K-PQLAIVTQWCEGSSLYHHLHIIETK-----FEMIKLIDIARQTAQGMDYLH---AKSI 130
Query: 192 LHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS-RNFG 250
           +H D+K +NI L ED   KI DFGLA + +   G         G I ++APEV   ++  
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG-SHQFEQLSGSILWMAPEVIRMQDKN 189
Query: 251 EVSHKSDVYSFGMMIMELV 269
             S +SDVY+FG+++ EL+
Sbjct: 190 PYSFQSDVYAFGIVLYELM 208

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 29/199 (14%)
Query: 90  KLGQGGFGGVYKGRL------------------LDDFVNEVASISRTSHVNVVTLLGFCL 131
           ++G G FG VYKG+                   L  F NEV  + +T HVN++  +G+  
Sbjct: 43  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 102
Query: 132 EGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKI 191
           +    A++ ++    SL   ++  +T          K+ +I    A+G++YLH   +  I
Sbjct: 103 K-PQLAIVTQWCEGSSLYHHLHIIETK-----FEMIKLIDIARQTAQGMDYLH---AKSI 153
Query: 192 LHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS-RNFG 250
           +H D+K +NI L ED   KI DFGLA + +   G         G I ++APEV   ++  
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG-SHQFEQLSGSILWMAPEVIRMQDKN 212
Query: 251 EVSHKSDVYSFGMMIMELV 269
             S +SDVY+FG+++ EL+
Sbjct: 213 PYSFQSDVYAFGIVLYELM 231

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 119/277 (42%), Gaps = 43/277 (15%)
Query: 86  SFKDKLGQGGFGGVYKGRLL-----------------DDFVNEVASISRTSHVNVVTLLG 128
           +F  ++G G FG V+ G  L                 +DF+ E   + + SH  +V L G
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
            CLE     L++EFM +G L  ++              E +  + + + +G+ YL     
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEA-- 122
Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRN 248
             ++H D+   N L+ E+   K+SDFG+ +     +   +S  G +  + + +PEVFS  
Sbjct: 123 -SVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASPEVFS-- 177
Query: 249 FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVT 308
           F   S KSDV+SFG+++ E V  +  +     S+SEV         +        P + +
Sbjct: 178 FSRYSSKSDVWSFGVLMWE-VFSEGKIPYENRSNSEV------VEDISTGFRLYKPRLAS 230
Query: 309 RKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG 345
               +I          C + RP DRP  + ++  L  
Sbjct: 231 THVYQIMNH-------CWKERPEDRPAFSRLLRQLAA 260

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 33/200 (16%)
Query: 89  DKLGQGGFGGVYKGRLLDD--------------------FVNEVASISRTSHVNVVTLLG 128
           +++G+G FG V+ GRL  D                    F+ E   + + SH N+V L+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
            C +     ++ E +  G    F+           LR + + ++V   A G+EYL   C 
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGAR-----LRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI-IGYIAPEVFSR 247
              +H D+   N L+ E    KISDFG+++     +G+ ++  G R + + + APE    
Sbjct: 235 ---IHRDLAARNCLVTEKNVLKISDFGMSR--EEADGVXAASGGLRQVPVKWTAPEAL-- 287
Query: 248 NFGEVSHKSDVYSFGMMIME 267
           N+G  S +SDV+SFG+++ E
Sbjct: 288 NYGRYSSESDVWSFGILLWE 307

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 33/200 (16%)
Query: 89  DKLGQGGFGGVYKGRLLDD--------------------FVNEVASISRTSHVNVVTLLG 128
           +++G+G FG V+ GRL  D                    F+ E   + + SH N+V L+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
            C +     ++ E +  G    F+           LR + + ++V   A G+EYL   C 
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGAR-----LRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI-IGYIAPEVFSR 247
              +H D+   N L+ E    KISDFG+++     +G+ ++  G R + + + APE    
Sbjct: 235 ---IHRDLAARNCLVTEKNVLKISDFGMSR--EEADGVYAASGGLRQVPVKWTAPEAL-- 287
Query: 248 NFGEVSHKSDVYSFGMMIME 267
           N+G  S +SDV+SFG+++ E
Sbjct: 288 NYGRYSSESDVWSFGILLWE 307

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 98/199 (49%), Gaps = 29/199 (14%)
Query: 90  KLGQGGFGGVYKGRL------------------LDDFVNEVASISRTSHVNVVTLLGFCL 131
           ++G G FG VYKG+                   L  F NEV  + +T HVN++  +G+  
Sbjct: 35  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 94
Query: 132 EGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKI 191
           +    A++ ++    SL   ++  +T          K+ +I    A+G++YLH   +  I
Sbjct: 95  KPQ-LAIVTQWCEGSSLYHHLHIIETK-----FEMIKLIDIARQTAQGMDYLH---AKSI 145
Query: 192 LHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS-RNFG 250
           +H D+K +NI L ED   KI DFGLA   +   G         G I ++APEV   ++  
Sbjct: 146 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSG-SHQFEQLSGSILWMAPEVIRMQDKN 204
Query: 251 EVSHKSDVYSFGMMIMELV 269
             S +SDVY+FG+++ EL+
Sbjct: 205 PYSFQSDVYAFGIVLYELM 223

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 111/234 (47%), Gaps = 42/234 (17%)
Query: 90  KLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHVNVVTLLGFCLE 132
           KLGQG FG V+ G                    + F+ E   + +  H  +V L     E
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 74
Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKIL 192
                ++ E+M  GSL  F+  G+T K   YLR  ++ ++   IA G+ Y+        +
Sbjct: 75  -EPIXIVTEYMSKGSLLDFL-KGETGK---YLRLPQLVDMAAQIASGMAYVER---MNYV 126
Query: 193 HFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEV 252
           H D++  NIL+ E+   K++DFGLA+L    E   ++  GA+  I + APE  +  +G  
Sbjct: 127 HRDLRAANILVGENLVCKVADFGLARLIEDNE--XTARQGAKFPIKWTAPE--AALYGRF 182
Query: 253 SHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV--EQDREFKLP 304
           + KSDV+SFG+++ EL            +   V +P  + R V  + +R +++P
Sbjct: 183 TIKSDVWSFGILLTELT-----------TKGRVPYPGMVNREVLDQVERGYRMP 225

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 98/199 (49%), Gaps = 29/199 (14%)
Query: 90  KLGQGGFGGVYKGRL------------------LDDFVNEVASISRTSHVNVVTLLGFCL 131
           ++G G FG VYKG+                   L  F NEV  + +T HVN++  +G+  
Sbjct: 43  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 102
Query: 132 EGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKI 191
           +    A++ ++    SL   ++  +T          K+ +I    A+G++YLH   +  I
Sbjct: 103 K-PQLAIVTQWCEGSSLYHHLHIIETK-----FEMIKLIDIARQTAQGMDYLH---AKSI 153
Query: 192 LHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS-RNFG 250
           +H D+K +NI L ED   KI DFGLA   +   G         G I ++APEV   ++  
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSG-SHQFEQLSGSILWMAPEVIRMQDKN 212
Query: 251 EVSHKSDVYSFGMMIMELV 269
             S +SDVY+FG+++ EL+
Sbjct: 213 PYSFQSDVYAFGIVLYELM 231

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 29/200 (14%)
Query: 89  DKLGQGGFGGVYKGRL------------------LDDFVNEVASISRTSHVNVVTLLGFC 130
            ++G G FG VYKG+                   L  F NEV  + +T HVN++  +G+ 
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 131 LEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTK 190
            +    A++ ++    SL   ++  +T          K+ +I    A+G++YLH   +  
Sbjct: 74  TK-PQLAIVTQWCEGSSLYHHLHIIETK-----FEMIKLIDIARQTAQGMDYLH---AKS 124
Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS-RNF 249
           I+H D+K +NI L ED   KI DFGLA   +   G         G I ++APEV   ++ 
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSG-SHQFEQLSGSILWMAPEVIRMQDK 183
Query: 250 GEVSHKSDVYSFGMMIMELV 269
              S +SDVY+FG+++ EL+
Sbjct: 184 NPYSFQSDVYAFGIVLYELM 203

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 125/284 (44%), Gaps = 43/284 (15%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKGRL------------------LDDFVNEVASISRTSH 120
           ++++   + K KLG G +G VY G                    +++F+ E A +    H
Sbjct: 28  EMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 87
Query: 121 VNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGL 180
            N+V LLG C       ++ E+MP G+L  ++   +  +    +    +  +   I+  +
Sbjct: 88  PNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVV----LLYMATQISSAM 143
Query: 181 EYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYI 240
           EYL        +H D+   N L+ E+   K++DFGL++L T      ++  GA+  I + 
Sbjct: 144 EYLE---KKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGD--TYTAHAGAKFPIKWT 198
Query: 241 APEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDRE 300
           APE  + N    S KSDV++FG+++ E+     +   G+D S        +Y  +E+   
Sbjct: 199 APESLAYN--TFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYDLLEKGYR 249
Query: 301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
            + P     K  E+ +        C +  P+DRP   E  +  +
Sbjct: 250 MEQPEGCPPKVYELMRA-------CWKWSPADRPSFAETHQAFE 286

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 121/264 (45%), Gaps = 47/264 (17%)
Query: 90  KLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHVNVVTLLGFCLE 132
           KLGQG FG V+ G                    + F+ E   + +  H  +V L     E
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 77
Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKIL 192
                ++ E+M  GSL  F+  G+T K   YLR  ++ ++   IA G+ Y+        +
Sbjct: 78  -EPIYIVTEYMSKGSLLDFL-KGETGK---YLRLPQLVDMAAQIASGMAYVER---MNYV 129
Query: 193 HFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEV 252
           H D++  NIL+ E+   K++DFGLA+L    E   ++  GA+  I + APE  +  +G  
Sbjct: 130 HRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAPE--AALYGRF 185
Query: 253 SHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV--EQDREFKLPGVVTRK 310
           + KSDV+SFG+++ EL            +   V +P  + R V  + +R +++P      
Sbjct: 186 TIKSDVWSFGILLTELT-----------TKGRVPYPGMVNREVLDQVERGYRMPC----- 229
Query: 311 ENEIAKKMIIVGLWCIQARPSDRP 334
             E  + +  +   C +  P +RP
Sbjct: 230 PPECPESLHDLMCQCWRKEPEERP 253

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 121/264 (45%), Gaps = 47/264 (17%)
Query: 90  KLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHVNVVTLLGFCLE 132
           KLGQG FG V+ G                    + F+ E   + +  H  +V L     E
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKIL 192
                ++ E+M  GSL  F+  G+T K   YLR  ++ ++   IA G+ Y+        +
Sbjct: 334 -EPIYIVTEYMSKGSLLDFL-KGETGK---YLRLPQLVDMAAQIASGMAYVER---MNYV 385
Query: 193 HFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEV 252
           H D++  NIL+ E+   K++DFGLA+L    E   ++  GA+  I + APE  +  +G  
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAPE--AALYGRF 441
Query: 253 SHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV--EQDREFKLPGVVTRK 310
           + KSDV+SFG+++ EL            +   V +P  + R V  + +R +++P      
Sbjct: 442 TIKSDVWSFGILLTELT-----------TKGRVPYPGMVNREVLDQVERGYRMPC----- 485
Query: 311 ENEIAKKMIIVGLWCIQARPSDRP 334
             E  + +  +   C +  P +RP
Sbjct: 486 PPECPESLHDLMCQCWRKEPEERP 509

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 121/264 (45%), Gaps = 47/264 (17%)
Query: 90  KLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHVNVVTLLGFCLE 132
           KLGQG FG V+ G                    + F+ E   + +  H  +V L     E
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKIL 192
                ++ E+M  GSL  F+  G+T K   YLR  ++ ++   IA G+ Y+        +
Sbjct: 251 -EPIYIVTEYMSKGSLLDFL-KGETGK---YLRLPQLVDMAAQIASGMAYVER---MNYV 302
Query: 193 HFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEV 252
           H D++  NIL+ E+   K++DFGLA+L    E   ++  GA+  I + APE  +  +G  
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAPE--AALYGRF 358
Query: 253 SHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV--EQDREFKLPGVVTRK 310
           + KSDV+SFG+++ EL            +   V +P  + R V  + +R +++P      
Sbjct: 359 TIKSDVWSFGILLTELT-----------TKGRVPYPGMVNREVLDQVERGYRMPC----- 402
Query: 311 ENEIAKKMIIVGLWCIQARPSDRP 334
             E  + +  +   C +  P +RP
Sbjct: 403 PPECPESLHDLMCQCWRKEPEERP 426

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/278 (27%), Positives = 125/278 (44%), Gaps = 51/278 (18%)
Query: 90  KLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHVNVVTLLGFCLE 132
           KLGQG FG V+ G                    + F+ E   + +  H  +V L     E
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKIL 192
                ++ E+M  GSL  F+  G+T K   YLR  ++ ++   IA G+ Y+        +
Sbjct: 251 -EPIYIVTEYMSKGSLLDFL-KGETGK---YLRLPQLVDMAAQIASGMAYVER---MNYV 302
Query: 193 HFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEV 252
           H D++  NIL+ E+   K++DFGLA+L    E   ++  GA+  I + APE  +  +G  
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAPE--AALYGRF 358
Query: 253 SHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV--EQDREFKLPGVVTRK 310
           + KSDV+SFG+++ EL            +   V +P  + R V  + +R +++P      
Sbjct: 359 TIKSDVWSFGILLTELT-----------TKGRVPYPGMVNREVLDQVERGYRMPC----- 402
Query: 311 ENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE 348
             E  + +  +   C +  P +RP      E LQ   E
Sbjct: 403 PPECPESLHDLMCQCWRKEPEERP----TFEYLQAFLE 436

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 109/234 (46%), Gaps = 42/234 (17%)
Query: 90  KLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHVNVVTLLGFCLE 132
           KLGQG FG V+ G                    + F+ E   + +  H  +V L     E
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKIL 192
                ++ E+M  GSL  F+  G+T K   YLR  ++ ++   IA G+ Y+        +
Sbjct: 82  -EPIYIVTEYMNKGSLLDFL-KGETGK---YLRLPQLVDMSAQIASGMAYVER---MNYV 133
Query: 193 HFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEV 252
           H D++  NIL+ E+   K++DFGLA+L    E       GA+  I + APE  +  +G  
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQ--GAKFPIKWTAPE--AALYGRF 189
Query: 253 SHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV--EQDREFKLP 304
           + KSDV+SFG+++ EL            +   V +P  + R V  + +R +++P
Sbjct: 190 TIKSDVWSFGILLTELT-----------TKGRVPYPGMVNREVLDQVERGYRMP 232

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 121/264 (45%), Gaps = 47/264 (17%)
Query: 90  KLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHVNVVTLLGFCLE 132
           KLGQG FG V+ G                    + F+ E   + +  H  +V L     E
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKIL 192
                ++ E+M  GSL  F+  G+T K   YLR  ++ ++   IA G+ Y+        +
Sbjct: 82  -EPIYIVTEYMNKGSLLDFL-KGETGK---YLRLPQLVDMSAQIASGMAYVER---MNYV 133
Query: 193 HFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEV 252
           H D++  NIL+ E+   K++DFGLA+L    E   ++  GA+  I + APE  +  +G  
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAPE--AALYGRF 189
Query: 253 SHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV--EQDREFKLPGVVTRK 310
           + KSDV+SFG+++ EL            +   V +P  + R V  + +R +++P      
Sbjct: 190 TIKSDVWSFGILLTELT-----------TKGRVPYPGMVNREVLDQVERGYRMPC----- 233
Query: 311 ENEIAKKMIIVGLWCIQARPSDRP 334
             E  + +  +   C +  P +RP
Sbjct: 234 PPECPESLHDLMCQCWRKEPEERP 257

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 121/264 (45%), Gaps = 47/264 (17%)
Query: 90  KLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHVNVVTLLGFCLE 132
           KLGQG FG V+ G                    + F+ E   + +  H  +V L     E
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKIL 192
                ++ E+M  GSL  F+  G+T K   YLR  ++ ++   IA G+ Y+        +
Sbjct: 251 -EPIYIVGEYMSKGSLLDFL-KGETGK---YLRLPQLVDMAAQIASGMAYVER---MNYV 302
Query: 193 HFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEV 252
           H D++  NIL+ E+   K++DFGLA+L    E   ++  GA+  I + APE  +  +G  
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAPE--AALYGRF 358
Query: 253 SHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV--EQDREFKLPGVVTRK 310
           + KSDV+SFG+++ EL            +   V +P  + R V  + +R +++P      
Sbjct: 359 TIKSDVWSFGILLTELT-----------TKGRVPYPGMVNREVLDQVERGYRMPC----- 402
Query: 311 ENEIAKKMIIVGLWCIQARPSDRP 334
             E  + +  +   C +  P +RP
Sbjct: 403 PPECPESLHDLMCQCWRKEPEERP 426

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 43/213 (20%)
Query: 86  SFKDKLGQGGFGGVYKGRLLDDFVNEVAS-------ISRT--------------SHVNVV 124
           + ++ +G GGFG VY+   + D V   A+       IS+T               H N++
Sbjct: 10  TLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 125 TLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH 184
            L G CL+  N  L+ EF   G L + V +G    P   + W       + IA+G+ YLH
Sbjct: 70  ALRGVCLKEPNLCLVMEFARGGPLNR-VLSGKRIPPDILVNW------AVQIARGMNYLH 122
Query: 185 HGCSTKILHFDIKPHNILLDEDF--------CPKISDFGLAKLCTTKEGIVSSLLGARGI 236
                 I+H D+K  NIL+ +            KI+DFGLA     +E   ++ + A G 
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA-----REWHRTTKMSAAGA 177
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             ++APEV   +    S  SDV+S+G+++ EL+
Sbjct: 178 YAWMAPEVIRASM--FSKGSDVWSYGVLLWELL 208

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 100/202 (49%), Gaps = 25/202 (12%)
Query: 70  LPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGF 129
           LP KR  F  +K L + + +K  +             DF++E + + +  H NV+ L G 
Sbjct: 56  LPGKREIFVAIKTLKSGYTEKQRR-------------DFLSEASIMGQFDHPNVIHLEGV 102
Query: 130 CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCST 189
             +     +I EFM NGSL+ F+   D           ++  ++ GIA G++YL      
Sbjct: 103 VTKSTPVMIITEFMENGSLDSFLRQNDGQ-----FTVIQLVGMLRGIAAGMKYL---ADM 154
Query: 190 KILHFDIKPHNILLDEDFCPKISDFGLAKLCT--TKEGIVSSLLGARGIIGYIAPEVFSR 247
             +H D+   NIL++ +   K+SDFGL++     T +   +S LG +  I + APE    
Sbjct: 155 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI-- 212
Query: 248 NFGEVSHKSDVYSFGMMIMELV 269
            + + +  SDV+S+G+++ E++
Sbjct: 213 QYRKFTSASDVWSYGIVMWEVM 234

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 110/234 (47%), Gaps = 42/234 (17%)
Query: 90  KLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHVNVVTLLGFCLE 132
           KLGQG FG V+ G                    + F+ E   + +  H  +V L     E
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 73
Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKIL 192
                ++ E+M  GSL  F+  G+  K   YLR  ++ ++   IA G+ Y+        +
Sbjct: 74  -EPIYIVTEYMSKGSLLDFL-KGEMGK---YLRLPQLVDMAAQIASGMAYVER---MNYV 125
Query: 193 HFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEV 252
           H D++  NIL+ E+   K++DFGLA+L    E   ++  GA+  I + APE  +  +G  
Sbjct: 126 HRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAPE--AALYGRF 181
Query: 253 SHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV--EQDREFKLP 304
           + KSDV+SFG+++ EL            +   V +P  + R V  + +R +++P
Sbjct: 182 TIKSDVWSFGILLTELT-----------TKGRVPYPGMVNREVLDQVERGYRMP 224

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 110/234 (47%), Gaps = 42/234 (17%)
Query: 90  KLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHVNVVTLLGFCLE 132
           KLGQG FG V+ G                    + F+ E   + +  H  +V L     E
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVSE 84
Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKIL 192
                ++ E+M  GSL  F+  G+  K   YLR  ++ ++   IA G+ Y+        +
Sbjct: 85  -EPIYIVTEYMSKGSLLDFL-KGEMGK---YLRLPQLVDMAAQIASGMAYVER---MNYV 136
Query: 193 HFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEV 252
           H D++  NIL+ E+   K++DFGLA+L    E   ++  GA+  I + APE  +  +G  
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAPE--AALYGRF 192
Query: 253 SHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV--EQDREFKLP 304
           + KSDV+SFG+++ EL            +   V +P  + R V  + +R +++P
Sbjct: 193 TIKSDVWSFGILLTELT-----------TKGRVPYPGMVNREVLDQVERGYRMP 235

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 110/234 (47%), Gaps = 42/234 (17%)
Query: 90  KLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHVNVVTLLGFCLE 132
           KLGQG FG V+ G                    + F+ E   + +  H  +V L     E
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKIL 192
                ++ E+M  GSL  F+  G+  K   YLR  ++ ++   IA G+ Y+        +
Sbjct: 85  -EPIYIVIEYMSKGSLLDFL-KGEMGK---YLRLPQLVDMAAQIASGMAYVER---MNYV 136
Query: 193 HFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEV 252
           H D++  NIL+ E+   K++DFGLA+L    E   ++  GA+  I + APE  +  +G  
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNE--XTARQGAKFPIKWTAPE--AALYGRF 192
Query: 253 SHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV--EQDREFKLP 304
           + KSDV+SFG+++ EL            +   V +P  + R V  + +R +++P
Sbjct: 193 TIKSDVWSFGILLTELT-----------TKGRVPYPGMVNREVLDQVERGYRMP 235

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 84/171 (49%), Gaps = 10/171 (5%)
Query: 100 YKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSK 159
           Y  R   DF++E + + +  H N++ L G    G    ++ E+M NGSL+ F+   D   
Sbjct: 89  YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQF 148
Query: 160 PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL 219
                   ++  ++ G+  G+ YL        +H D+   N+L+D +   K+SDFGL+++
Sbjct: 149 TIM-----QLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200
Query: 220 CTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG 270
                    +  G +  I + APE  +  F   S  SDV+SFG+++ E++ 
Sbjct: 201 LEDDPDAAXTTTGGKIPIRWTAPEAIA--FRTFSSASDVWSFGVVMWEVLA 249

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 110/234 (47%), Gaps = 42/234 (17%)
Query: 90  KLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHVNVVTLLGFCLE 132
           KLGQG FG V+ G                    + F+ E   + +  H  +V L     E
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 75
Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKIL 192
                ++ E+M  GSL  F+  G+  K   YLR  ++ ++   IA G+ Y+        +
Sbjct: 76  -EPIYIVTEYMSKGSLLDFL-KGEMGK---YLRLPQLVDMAAQIASGMAYVER---MNYV 127
Query: 193 HFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEV 252
           H D++  NIL+ E+   K++DFGLA+L    E   ++  GA+  I + APE  +  +G  
Sbjct: 128 HRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAPE--AALYGRF 183
Query: 253 SHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV--EQDREFKLP 304
           + KSDV+SFG+++ EL            +   V +P  + R V  + +R +++P
Sbjct: 184 TIKSDVWSFGILLTELT-----------TKGRVPYPGMVNREVLDQVERGYRMP 226

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 125/290 (43%), Gaps = 51/290 (17%)
Query: 88  KDKLGQGGFGGVYKGRLLDD---------------FVNEVASISRTSHVNVVTLLGFCLE 132
           ++ +G+G FG V K +                   F+ E+  +SR +H N+V L G CL 
Sbjct: 14  EEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL- 72
Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKIL 192
            N   L+ E+   GSL   ++  +   P  Y          +  ++G+ YLH      ++
Sbjct: 73  -NPVCLVMEYAEGGSLYNVLHGAE---PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 128
Query: 193 HFDIKPHNILL-DEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS-RNFG 250
           H D+KP N+LL       KI DFG A  C     I + +   +G   ++APEVF   N+ 
Sbjct: 129 HRDLKPPNLLLVAGGTVLKICDFGTA--CD----IQTHMTNNKGSAAWMAPEVFEGSNYS 182
Query: 251 EVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRK 310
           E   K DV+S+G+++ E++  +   D       E+  P   +R +        P ++   
Sbjct: 183 E---KCDVFSWGIILWEVITRRKPFD-------EIGGP--AFRIMWAVHNGTRPPLIKNL 230
Query: 311 ENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ-------GSTEALQIP 353
              I   M      C    PS RP M E+++++        G+ E LQ P
Sbjct: 231 PKPIESLMTR----CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYP 276

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 125/290 (43%), Gaps = 51/290 (17%)
Query: 88  KDKLGQGGFGGVYKGRLLDD---------------FVNEVASISRTSHVNVVTLLGFCLE 132
           ++ +G+G FG V K +                   F+ E+  +SR +H N+V L G CL 
Sbjct: 13  EEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL- 71
Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKIL 192
            N   L+ E+   GSL   ++  +   P  Y          +  ++G+ YLH      ++
Sbjct: 72  -NPVCLVMEYAEGGSLYNVLHGAE---PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 193 HFDIKPHNILL-DEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS-RNFG 250
           H D+KP N+LL       KI DFG A  C     I + +   +G   ++APEVF   N+ 
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTA--CD----IQTHMTNNKGSAAWMAPEVFEGSNYS 181
Query: 251 EVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRK 310
           E   K DV+S+G+++ E++  +   D       E+  P   +R +        P ++   
Sbjct: 182 E---KCDVFSWGIILWEVITRRKPFD-------EIGGP--AFRIMWAVHNGTRPPLIKNL 229
Query: 311 ENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ-------GSTEALQIP 353
              I   M      C    PS RP M E+++++        G+ E LQ P
Sbjct: 230 PKPIESLMTR----CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYP 275

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 110/234 (47%), Gaps = 42/234 (17%)
Query: 90  KLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHVNVVTLLGFCLE 132
           KLGQG FG V+ G                    + F+ E   + +  H  +V L     E
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKIL 192
                ++ E+M  GSL  F+  G+  K   YLR  ++ ++   IA G+ Y+        +
Sbjct: 85  -EPIYIVIEYMSKGSLLDFL-KGEMGK---YLRLPQLVDMAAQIASGMAYVER---MNYV 136
Query: 193 HFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEV 252
           H D++  NIL+ E+   K++DFGLA+L    E   ++  GA+  I + APE  +  +G  
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAPE--AALYGRF 192
Query: 253 SHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV--EQDREFKLP 304
           + KSDV+SFG+++ EL            +   V +P  + R V  + +R +++P
Sbjct: 193 TIKSDVWSFGILLTELT-----------TKGRVPYPGMVNREVLDQVERGYRMP 235

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 110/234 (47%), Gaps = 42/234 (17%)
Query: 90  KLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHVNVVTLLGFCLE 132
           KLGQG FG V+ G                    + F+ E   + +  H  +V L     E
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKIL 192
                ++ E+M  GSL  F+  G+  K   YLR  ++ ++   IA G+ Y+        +
Sbjct: 85  -EPIYIVTEYMSKGSLLDFL-KGEMGK---YLRLPQLVDMAAQIASGMAYVER---MNYV 136
Query: 193 HFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEV 252
           H D++  NIL+ E+   K++DFGLA+L    E   ++  GA+  I + APE  +  +G  
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAPE--AALYGRF 192
Query: 253 SHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV--EQDREFKLP 304
           + KSDV+SFG+++ EL            +   V +P  + R V  + +R +++P
Sbjct: 193 TIKSDVWSFGILLTELT-----------TKGRVPYPGMVNREVLDQVERGYRMP 235

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 110/234 (47%), Gaps = 42/234 (17%)
Query: 90  KLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHVNVVTLLGFCLE 132
           KLGQG FG V+ G                    + F+ E   + +  H  +V L     E
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKIL 192
                ++ E+M  GSL  F+  G+  K   YLR  ++ ++   IA G+ Y+        +
Sbjct: 85  -EPIYIVCEYMSKGSLLDFL-KGEMGK---YLRLPQLVDMAAQIASGMAYVER---MNYV 136
Query: 193 HFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEV 252
           H D++  NIL+ E+   K++DFGLA+L    E   ++  GA+  I + APE  +  +G  
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAPE--AALYGRF 192
Query: 253 SHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV--EQDREFKLP 304
           + KSDV+SFG+++ EL            +   V +P  + R V  + +R +++P
Sbjct: 193 TIKSDVWSFGILLTELT-----------TKGRVPYPGMVNREVLDQVERGYRMP 235

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 84/171 (49%), Gaps = 10/171 (5%)
Query: 100 YKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSK 159
           Y  R   DF++E + + +  H N++ L G    G    ++ E+M NGSL+ F+   D   
Sbjct: 89  YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQF 148
Query: 160 PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL 219
                   ++  ++ G+  G+ YL        +H D+   N+L+D +   K+SDFGL+++
Sbjct: 149 TIM-----QLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200
Query: 220 CTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG 270
                    +  G +  I + APE  +  F   S  SDV+SFG+++ E++ 
Sbjct: 201 LEDDPDAAYTTTGGKIPIRWTAPEAIA--FRTFSSASDVWSFGVVMWEVLA 249

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 128/298 (42%), Gaps = 47/298 (15%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHV 121
           +V + T    ++LG G FG V+ G                    D F+ E   + +  H 
Sbjct: 18  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 77
Query: 122 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
            +V L     +     +I E+M NGSL  F+      K    L   K+ ++   IA+G+ 
Sbjct: 78  RLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK----LTINKLLDMAAQIAEGMA 132
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           ++        +H D++  NIL+ +    KI+DFGLA+L    E       GA+  I + A
Sbjct: 133 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTARE--GAKFPIKWTA 187
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE    N+G  + KSDV+SFG+++ E+V           +   + +P      V Q+ E 
Sbjct: 188 PEAI--NYGTFTIKSDVWSFGILLTEIV-----------THGRIPYPGMTNPEVIQNLE- 233
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPP---MNEVIEMLQGSTEALQIPPTP 356
              G    + +   +++  +   C + RP DRP    +  V+E    +TE  Q  P P
Sbjct: 234 --RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG-QFQPQP 288

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 124/259 (47%), Gaps = 45/259 (17%)
Query: 68  GPLPLKRYNFSDVKKLTNSFKDKLGQGGFG----GVYKGRL-------------LDDFVN 110
           G + LKR   + +K+L        G G FG    G +KG+               D+F  
Sbjct: 1   GHMELKREEITLLKEL--------GSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQ 52
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVY-NGDTSKPCQYLRWEKM 169
           E  ++ + SH  +V   G C +     ++ E++ NG L  ++  +G   +P Q L     
Sbjct: 53  EAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLL----- 107
Query: 170 YEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSS 229
            E+   + +G+ +L    S + +H D+   N L+D D C K+SDFG+ +     + + S 
Sbjct: 108 -EMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS- 162
Query: 230 LLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFP- 288
            +G +  + + APEVF  ++ + S KSDV++FG+++ E+      +   + ++SEV    
Sbjct: 163 -VGTKFPVKWSAPEVF--HYFKYSSKSDVWAFGILMWEVFSL-GKMPYDLYTNSEVVLKV 218
Query: 289 ---HWIYR-HVEQDREFKL 303
              H +YR H+  D  +++
Sbjct: 219 SQGHRLYRPHLASDTIYQI 237

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 105/221 (47%), Gaps = 45/221 (20%)
Query: 87  FKDKLGQGGFGGVYKGRLLDD--------------------------FVNEVASISRTSH 120
           ++ ++G+GGFG V+KGRL+ D                          F  EV  +S  +H
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 121 VNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGL 180
            N+V L G  L  N   ++ EF+P G L   +   D + P   ++W     +++ IA G+
Sbjct: 83  PNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLL--DKAHP---IKWSVKLRLMLDIALGI 135
Query: 181 EYLHHGCSTKILHFDIKPHNIL---LDED--FCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           EY+ +  +  I+H D++  NI    LDE+   C K++DFGL++        V S+ G  G
Sbjct: 136 EYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS------VHSVSGLLG 188
Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLD 276
              ++APE         + K+D YSF M++  ++  +   D
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 128/298 (42%), Gaps = 47/298 (15%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHV 121
           +V + T    ++LG G FG V+ G                    D F+ E   + +  H 
Sbjct: 15  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 74
Query: 122 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
            +V L     +     +I E+M NGSL  F+      K    L   K+ ++   IA+G+ 
Sbjct: 75  RLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK----LTINKLLDMAAQIAEGMA 129
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           ++        +H D++  NIL+ +    KI+DFGLA+L    E       GA+  I + A
Sbjct: 130 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTARE--GAKFPIKWTA 184
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE    N+G  + KSDV+SFG+++ E+V           +   + +P      V Q+ E 
Sbjct: 185 PEAI--NYGTFTIKSDVWSFGILLTEIV-----------THGRIPYPGMTNPEVIQNLER 231
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPP---MNEVIEMLQGSTEALQIPPTP 356
              G    + +   +++  +   C + RP DRP    +  V+E    +TE  Q  P P
Sbjct: 232 ---GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG-QYQPQP 285

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 128/298 (42%), Gaps = 47/298 (15%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHV 121
           +V + T    ++LG G FG V+ G                    D F+ E   + +  H 
Sbjct: 17  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 76
Query: 122 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
            +V L     +     +I E+M NGSL  F+      K    L   K+ ++   IA+G+ 
Sbjct: 77  RLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK----LTINKLLDMAAQIAEGMA 131
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           ++        +H D++  NIL+ +    KI+DFGLA+L    E       GA+  I + A
Sbjct: 132 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTARE--GAKFPIKWTA 186
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE    N+G  + KSDV+SFG+++ E+V           +   + +P      V Q+ E 
Sbjct: 187 PEAI--NYGTFTIKSDVWSFGILLTEIV-----------THGRIPYPGMTNPEVIQNLER 233
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPP---MNEVIEMLQGSTEALQIPPTP 356
              G    + +   +++  +   C + RP DRP    +  V+E    +TE  Q  P P
Sbjct: 234 ---GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG-QYQPQP 287

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 128/298 (42%), Gaps = 47/298 (15%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHV 121
           +V + T    ++LG G FG V+ G                    D F+ E   + +  H 
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 122 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
            +V L     +     +I E+M NGSL  F+      K    L   K+ ++   IA+G+ 
Sbjct: 69  RLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK----LTINKLLDMAAQIAEGMA 123
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           ++        +H D++  NIL+ +    KI+DFGLA+L    E       GA+  I + A
Sbjct: 124 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTARE--GAKFPIKWTA 178
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE    N+G  + KSDV+SFG+++ E+V           +   + +P      V Q+ E 
Sbjct: 179 PEAI--NYGTFTIKSDVWSFGILLTEIV-----------THGRIPYPGMTNPEVIQNLE- 224
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPP---MNEVIEMLQGSTEALQIPPTP 356
              G    + +   +++  +   C + RP DRP    +  V+E    +TE  Q  P P
Sbjct: 225 --RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG-QYQPQP 279

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 109/234 (46%), Gaps = 42/234 (17%)
Query: 90  KLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHVNVVTLLGFCLE 132
           KLGQG FG V+ G                    + F+ E   + +  H  +V L     E
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKIL 192
                ++ E+M  GSL  F+  G+  K   YLR  ++ ++   IA G+ Y+        +
Sbjct: 85  -EPIYIVTEYMSKGSLLDFL-KGEMGK---YLRLPQLVDMAAQIASGMAYVER---MNYV 136
Query: 193 HFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEV 252
           H D+   NIL+ E+   K++DFGLA+L    E   ++  GA+  I + APE  +  +G  
Sbjct: 137 HRDLAAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAPE--AALYGRF 192
Query: 253 SHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV--EQDREFKLP 304
           + KSDV+SFG+++ EL            +   V +P  + R V  + +R +++P
Sbjct: 193 TIKSDVWSFGILLTELT-----------TKGRVPYPGMVNREVLDQVERGYRMP 235

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 34/203 (16%)
Query: 91  LGQGGFGGVYKGRLLD------------------------DFVNEVASISRTSHVNVVTL 126
           +G G FG VYKG L                          DF+ E   + + SH N++ L
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
            G   +     +I E+M NG+L+KF+   D           ++  ++ GIA G++YL   
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVL-----QLVGMLRGIAAGMKYL--- 163
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            +   +H D+   NIL++ +   K+SDFGL+++         +  G +  I + APE  S
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 247 RNFGEVSHKSDVYSFGMMIMELV 269
             + + +  SDV+SFG+++ E++
Sbjct: 224 --YRKFTSASDVWSFGIVMWEVM 244

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 130/298 (43%), Gaps = 47/298 (15%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHV 121
           +V + T    ++LG G FG V+ G                    D F+ E   + +  H 
Sbjct: 19  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 78
Query: 122 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
            +V L     +     +I E+M NGSL  F+      K    L   K+ ++   IA+G+ 
Sbjct: 79  RLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK----LTINKLLDMAAQIAEGMA 133
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           ++        +H D++  NIL+ +    KI+DFGLA+L    E   ++  GA+  I + A
Sbjct: 134 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE--YTAREGAKFPIKWTA 188
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE    N+G  + KSDV+SFG+++ E+V           +   + +P      V Q+ E 
Sbjct: 189 PEAI--NYGTFTIKSDVWSFGILLTEIV-----------THGRIPYPGMTNPEVIQNLE- 234
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPP---MNEVIEMLQGSTEALQIPPTP 356
              G    + +   +++  +   C + RP DRP    +  V+E    +TE  Q  P P
Sbjct: 235 --RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG-QYQPQP 289

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 104/221 (47%), Gaps = 45/221 (20%)
Query: 87  FKDKLGQGGFGGVYKGRLLDD--------------------------FVNEVASISRTSH 120
           ++ ++G+GGFG V+KGRL+ D                          F  EV  +S  +H
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 121 VNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGL 180
            N+V L G  L  N   ++ EF+P G L   +   D + P   ++W     +++ IA G+
Sbjct: 83  PNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLL--DKAHP---IKWSVKLRLMLDIALGI 135
Query: 181 EYLHHGCSTKILHFDIKPHNIL---LDED--FCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           EY+ +  +  I+H D++  NI    LDE+   C K++DFG      T +  V S+ G  G
Sbjct: 136 EYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG------TSQQSVHSVSGLLG 188
Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLD 276
              ++APE         + K+D YSF M++  ++  +   D
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 109/234 (46%), Gaps = 42/234 (17%)
Query: 90  KLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHVNVVTLLGFCLE 132
           KLGQG FG V+ G                    + F+ E   + +  H  +V L     E
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKIL 192
                ++ E+M  G L  F+  G+  K   YLR  ++ ++   IA G+ Y+        +
Sbjct: 85  -EPIYIVMEYMSKGCLLDFL-KGEMGK---YLRLPQLVDMAAQIASGMAYVER---MNYV 136
Query: 193 HFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEV 252
           H D++  NIL+ E+   K++DFGLA+L    E   ++  GA+  I + APE  +  +G  
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAPE--AALYGRF 192
Query: 253 SHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV--EQDREFKLP 304
           + KSDV+SFG+++ EL            +   V +P  + R V  + +R +++P
Sbjct: 193 TIKSDVWSFGILLTELT-----------TKGRVPYPGMVNREVLDQVERGYRMP 235

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 109/234 (46%), Gaps = 42/234 (17%)
Query: 90  KLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHVNVVTLLGFCLE 132
           KLGQG FG V+ G                    + F+ E   + +  H  +V L     E
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKIL 192
                ++ E+M  G L  F+  G+  K   YLR  ++ ++   IA G+ Y+        +
Sbjct: 85  -EPIYIVTEYMSKGCLLDFL-KGEMGK---YLRLPQLVDMAAQIASGMAYVER---MNYV 136
Query: 193 HFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEV 252
           H D++  NIL+ E+   K++DFGLA+L    E   ++  GA+  I + APE  +  +G  
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAPE--AALYGRF 192
Query: 253 SHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV--EQDREFKLP 304
           + KSDV+SFG+++ EL            +   V +P  + R V  + +R +++P
Sbjct: 193 TIKSDVWSFGILLTELT-----------TKGRVPYPGMVNREVLDQVERGYRMP 235

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 122/251 (48%), Gaps = 33/251 (13%)
Query: 105 LDDFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV---------YN 154
           L D V+E+  +     H N++TLLG C +     +I E+   G+L +++         Y+
Sbjct: 84  LSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 143
Query: 155 GDTSK-PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISD 213
            D ++ P + + ++ +      +A+G+EYL    S K +H D+   N+L+ E+   KI+D
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIAD 200
Query: 214 FGLAKLCTTKEGIVSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
           FGLA+     +    +  G R  + ++APE +F R +   +H+SDV+SFG+++ E+    
Sbjct: 201 FGLARDINNIDYYKKTTNG-RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEIFTLG 256
Query: 273 NNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSD 332
            +   G+           +++ +++      P   T   NE+   M      C  A PS 
Sbjct: 257 GSPYPGIPVEE-------LFKLLKEGHRMDKPANCT---NELYMMMRD----CWHAVPSQ 302
Query: 333 RPPMNEVIEML 343
           RP   +++E L
Sbjct: 303 RPTFKQLVEDL 313

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 109/234 (46%), Gaps = 42/234 (17%)
Query: 90  KLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHVNVVTLLGFCLE 132
           KLGQG FG V+ G                    + F+ E   + +  H  +V L     E
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 251
Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKIL 192
                ++ E+M  GSL  F+  G+  K   YLR  ++ ++   IA G+ Y+        +
Sbjct: 252 -EPIYIVTEYMSKGSLLDFL-KGEMGK---YLRLPQLVDMAAQIASGMAYVER---MNYV 303
Query: 193 HFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEV 252
           H D++  NIL+ E+   K++DFGL +L    E   ++  GA+  I + APE  +  +G  
Sbjct: 304 HRDLRAANILVGENLVCKVADFGLGRLIEDNE--YTARQGAKFPIKWTAPE--AALYGRF 359
Query: 253 SHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV--EQDREFKLP 304
           + KSDV+SFG+++ EL            +   V +P  + R V  + +R +++P
Sbjct: 360 TIKSDVWSFGILLTELT-----------TKGRVPYPGMVNREVLDQVERGYRMP 402

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 25/202 (12%)
Query: 70  LPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGF 129
           LP KR  F  +K L + + +K  +             DF++E + + +  H NV+ L G 
Sbjct: 30  LPGKREIFVAIKTLKSGYTEKQRR-------------DFLSEASIMGQFDHPNVIHLEGV 76
Query: 130 CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCST 189
             +     +I EFM NGSL+ F+   D           ++  ++ GIA G++YL      
Sbjct: 77  VTKSTPVMIITEFMENGSLDSFLRQNDGQ-----FTVIQLVGMLRGIAAGMKYL---ADM 128
Query: 190 KILHFDIKPHNILLDEDFCPKISDFGLAKLCT--TKEGIVSSLLGARGIIGYIAPEVFSR 247
             +H  +   NIL++ +   K+SDFGL++     T +   +S LG +  I + APE    
Sbjct: 129 NYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI-- 186
Query: 248 NFGEVSHKSDVYSFGMMIMELV 269
            + + +  SDV+S+G+++ E++
Sbjct: 187 QYRKFTSASDVWSYGIVMWEVM 208

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 123/283 (43%), Gaps = 43/283 (15%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHV 121
           +V + T    ++LG G FG V+ G                    D F+ E   + +  H 
Sbjct: 11  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 70
Query: 122 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
            +V L     +     +I E+M NGSL  F+      K    L   K+ ++   IA+G+ 
Sbjct: 71  RLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK----LTINKLLDMAAQIAEGMA 125
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           ++        +H D++  NIL+ +    KI+DFGLA+L    E       GA+  I + A
Sbjct: 126 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTARE--GAKFPIKWTA 180
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE    N+G  + KSDV+SFG+++ E+V           +   + +P      V Q+ E 
Sbjct: 181 PEAI--NYGTFTIKSDVWSFGILLTEIV-----------THGRIPYPGMTNPEVIQNLE- 226
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
              G    + +   +++  +   C + RP DRP  + +  +L+
Sbjct: 227 --RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 267

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 123/283 (43%), Gaps = 43/283 (15%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHV 121
           +V + T    ++LG G FG V+ G                    D F+ E   + +  H 
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 122 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
            +V L     +     +I E+M NGSL  F+      K    L   K+ ++   IA+G+ 
Sbjct: 69  RLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK----LTINKLLDMAAQIAEGMA 123
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           ++        +H D++  NIL+ +    KI+DFGLA+L    E       GA+  I + A
Sbjct: 124 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTARE--GAKFPIKWTA 178
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE    N+G  + KSDV+SFG+++ E+V           +   + +P      V Q+ E 
Sbjct: 179 PEAI--NYGTFTIKSDVWSFGILLTEIV-----------THGRIPYPGMTNPEVIQNLE- 224
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
              G    + +   +++  +   C + RP DRP  + +  +L+
Sbjct: 225 --RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 123/283 (43%), Gaps = 43/283 (15%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHV 121
           +V + T    ++LG G FG V+ G                    D F+ E   + +  H 
Sbjct: 10  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 69
Query: 122 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
            +V L     +     +I E+M NGSL  F+      K    L   K+ ++   IA+G+ 
Sbjct: 70  RLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK----LTINKLLDMAAQIAEGMA 124
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           ++        +H D++  NIL+ +    KI+DFGLA+L    E       GA+  I + A
Sbjct: 125 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTARE--GAKFPIKWTA 179
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE    N+G  + KSDV+SFG+++ E+V           +   + +P      V Q+ E 
Sbjct: 180 PEAI--NYGTFTIKSDVWSFGILLTEIV-----------THGRIPYPGMTNPEVIQNLE- 225
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
              G    + +   +++  +   C + RP DRP  + +  +L+
Sbjct: 226 --RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 266

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 125/283 (44%), Gaps = 43/283 (15%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHV 121
           +V + T    ++LG G FG V+ G                    D F+ E   + +  H 
Sbjct: 15  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 74
Query: 122 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
            +V L     +     +I E+M NGSL  F+      K    L   K+ ++   IA+G+ 
Sbjct: 75  RLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK----LTINKLLDMAAQIAEGMA 129
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           ++        +H D++  NIL+ +    KI+DFGLA+L    E   ++  GA+  I + A
Sbjct: 130 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE--YTAREGAKFPIKWTA 184
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE    N+G  + KSDV+SFG+++ E+V           +   + +P      V Q+ E 
Sbjct: 185 PEAI--NYGTFTIKSDVWSFGILLTEIV-----------THGRIPYPGMTNPEVIQNLE- 230
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
              G    + +   +++  +   C + RP DRP  + +  +L+
Sbjct: 231 --RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 271

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 125/283 (44%), Gaps = 43/283 (15%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHV 121
           +V + T    ++LG G FG V+ G                    D F+ E   + +  H 
Sbjct: 14  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 73
Query: 122 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
            +V L     +     +I E+M NGSL  F+      K    L   K+ ++   IA+G+ 
Sbjct: 74  RLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK----LTINKLLDMAAQIAEGMA 128
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           ++        +H D++  NIL+ +    KI+DFGLA+L    E   ++  GA+  I + A
Sbjct: 129 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE--YTAREGAKFPIKWTA 183
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE    N+G  + KSDV+SFG+++ E+V           +   + +P      V Q+ E 
Sbjct: 184 PEAI--NYGTFTIKSDVWSFGILLTEIV-----------THGRIPYPGMTNPEVIQNLE- 229
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
              G    + +   +++  +   C + RP DRP  + +  +L+
Sbjct: 230 --RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 270

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 125/283 (44%), Gaps = 43/283 (15%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHV 121
           +V + T    ++LG G FG V+ G                    D F+ E   + +  H 
Sbjct: 4   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 63
Query: 122 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
            +V L     +     +I E+M NGSL  F+      K    L   K+ ++   IA+G+ 
Sbjct: 64  RLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK----LTINKLLDMAAQIAEGMA 118
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           ++        +H D++  NIL+ +    KI+DFGLA+L    E   ++  GA+  I + A
Sbjct: 119 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE--YTAREGAKFPIKWTA 173
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE    N+G  + KSDV+SFG+++ E+V           +   + +P      V Q+ E 
Sbjct: 174 PEAI--NYGTFTIKSDVWSFGILLTEIV-----------THGRIPYPGMTNPEVIQNLE- 219
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
              G    + +   +++  +   C + RP DRP  + +  +L+
Sbjct: 220 --RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 260

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 125/283 (44%), Gaps = 43/283 (15%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHV 121
           +V + T    ++LG G FG V+ G                    D F+ E   + +  H 
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 122 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
            +V L     +     +I E+M NGSL  F+      K    L   K+ ++   IA+G+ 
Sbjct: 69  RLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK----LTINKLLDMAAQIAEGMA 123
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           ++        +H D++  NIL+ +    KI+DFGLA+L    E   ++  GA+  I + A
Sbjct: 124 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE--YTAREGAKFPIKWTA 178
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE    N+G  + KSDV+SFG+++ E+V           +   + +P      V Q+ E 
Sbjct: 179 PEAI--NYGTFTIKSDVWSFGILLTEIV-----------THGRIPYPGMTNPEVIQNLE- 224
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
              G    + +   +++  +   C + RP DRP  + +  +L+
Sbjct: 225 --RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 120/276 (43%), Gaps = 54/276 (19%)
Query: 91  LGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTL 126
           LG G FG VYKG  +                         + ++E   ++   + +V  L
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL-RWEKMYEIVIGIAKGLEYLHH 185
           LG CL    + LI + MP G L  +V     +   QYL  W       + IAKG+ YL  
Sbjct: 84  LGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE- 135
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
               +++H D+   N+L+      KI+DFGLAKL   +E    +  G +  I ++A E +
Sbjct: 136 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIKWMALESI 192
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
             R +   +H+SDV+S+G+ + EL+   +    G+ +S        I   +E+      P
Sbjct: 193 LHRIY---THQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERLPQP 242
Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI 340
            + T     I   MI+V  W I A    RP   E+I
Sbjct: 243 PICT-----IDVYMIMVKCWMIDA--DSRPKFRELI 271

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 121/251 (48%), Gaps = 33/251 (13%)
Query: 105 LDDFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV---------YN 154
           L D V+E+  +     H N++ LLG C +     +I E+   G+L +++         Y+
Sbjct: 84  LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 143
Query: 155 GDTSK-PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISD 213
            D ++ P + + ++ +      +A+G+EYL    S K +H D+   N+L+ E+   KI+D
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIAD 200
Query: 214 FGLAKLCTTKEGIVSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
           FGLA+     +    +  G R  + ++APE +F R +   +H+SDV+SFG+++ E+    
Sbjct: 201 FGLARDINNIDXXKKTTNG-RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEIFTLG 256
Query: 273 NNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSD 332
            +   G+           +++ +++      P   T   NE+   M      C  A PS 
Sbjct: 257 GSPYPGIPVEE-------LFKLLKEGHRMDKPANCT---NELYMMMRD----CWHAVPSQ 302
Query: 333 RPPMNEVIEML 343
           RP   +++E L
Sbjct: 303 RPTFKQLVEDL 313

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 104/221 (47%), Gaps = 45/221 (20%)
Query: 87  FKDKLGQGGFGGVYKGRLLDD--------------------------FVNEVASISRTSH 120
           ++ ++G+GGFG V+KGRL+ D                          F  EV  +S  +H
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 121 VNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGL 180
            N+V L G  L  N   ++ EF+P G L   +   D + P   ++W     +++ IA G+
Sbjct: 83  PNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLL--DKAHP---IKWSVKLRLMLDIALGI 135
Query: 181 EYLHHGCSTKILHFDIKPHNIL---LDED--FCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           EY+ +  +  I+H D++  NI    LDE+   C K++DF L++        V S+ G  G
Sbjct: 136 EYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQS------VHSVSGLLG 188
Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLD 276
              ++APE         + K+D YSF M++  ++  +   D
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 124/274 (45%), Gaps = 52/274 (18%)
Query: 91  LGQGGFGGVYKG---------------RLLDD---------FVNEVASISRTSHVNVVTL 126
           LG G FG VYKG               ++L++         F++E   ++   H ++V L
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL-RWEKMYEIVIGIAKGLEYLHH 185
           LG CL    + L+ + MP+G L ++V+    +   Q L  W       + IAKG+ YL  
Sbjct: 106 LGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAKGMMYLE- 157
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVF 245
               +++H D+   N+L+      KI+DFGLA+L    E   ++  G +  I ++A E  
Sbjct: 158 --ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA-DGGKMPIKWMALECI 214
Query: 246 SRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG 305
             ++ + +H+SDV+S+G+ I EL+        G+ +         I   +E+      P 
Sbjct: 215 --HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-------IPDLLEKGERLPQPP 265
Query: 306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEV 339
           + T     I   M++V  W I A    RP   E+
Sbjct: 266 ICT-----IDVYMVMVKCWMIDA--DSRPKFKEL 292

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 124/274 (45%), Gaps = 52/274 (18%)
Query: 91  LGQGGFGGVYKG---------------RLLDD---------FVNEVASISRTSHVNVVTL 126
           LG G FG VYKG               ++L++         F++E   ++   H ++V L
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL-RWEKMYEIVIGIAKGLEYLHH 185
           LG CL    + L+ + MP+G L ++V+    +   Q L  W       + IAKG+ YL  
Sbjct: 83  LGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAKGMMYLE- 134
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVF 245
               +++H D+   N+L+      KI+DFGLA+L    E   ++  G +  I ++A E  
Sbjct: 135 --ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA-DGGKMPIKWMALECI 191
Query: 246 SRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG 305
             ++ + +H+SDV+S+G+ I EL+        G+ +         I   +E+      P 
Sbjct: 192 --HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-------IPDLLEKGERLPQPP 242
Query: 306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEV 339
           + T     I   M++V  W I A    RP   E+
Sbjct: 243 ICT-----IDVYMVMVKCWMIDA--DSRPKFKEL 269

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 120/276 (43%), Gaps = 54/276 (19%)
Query: 91  LGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTL 126
           LG G FG VYKG  +                         + ++E   ++   + +V  L
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL-RWEKMYEIVIGIAKGLEYLHH 185
           LG CL    + LI + MP G L  +V     +   QYL  W       + IAKG+ YL  
Sbjct: 84  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE- 135
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
               +++H D+   N+L+      KI+DFGLAKL   +E    +  G +  I ++A E +
Sbjct: 136 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIKWMALESI 192
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
             R +   +H+SDV+S+G+ + EL+   +    G+ +S        I   +E+      P
Sbjct: 193 LHRIY---THQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERLPQP 242
Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI 340
            + T     I   MI+V  W I A    RP   E+I
Sbjct: 243 PICT-----IDVYMIMVKCWMIDA--DSRPKFRELI 271

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 120/276 (43%), Gaps = 54/276 (19%)
Query: 91  LGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTL 126
           LG G FG VYKG  +                         + ++E   ++   + +V  L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL-RWEKMYEIVIGIAKGLEYLHH 185
           LG CL    + LI + MP G L  +V     +   QYL  W       + IAKG+ YL  
Sbjct: 83  LGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE- 134
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
               +++H D+   N+L+      KI+DFGLAKL   +E    +  G +  I ++A E +
Sbjct: 135 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIKWMALESI 191
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
             R +   +H+SDV+S+G+ + EL+   +    G+ +S        I   +E+      P
Sbjct: 192 LHRIY---THQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERLPQP 241
Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI 340
            + T     I   MI+V  W I A    RP   E+I
Sbjct: 242 PICT-----IDVYMIMVKCWMIDA--DSRPKFRELI 270

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 120/276 (43%), Gaps = 54/276 (19%)
Query: 91  LGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTL 126
           LG G FG VYKG  +                         + ++E   ++   + +V  L
Sbjct: 57  LGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRL 116
Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL-RWEKMYEIVIGIAKGLEYLHH 185
           LG CL    + LI + MP G L  +V     +   QYL  W       + IAKG+ YL  
Sbjct: 117 LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE- 168
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
               +++H D+   N+L+      KI+DFGLAKL   +E    +  G +  I ++A E +
Sbjct: 169 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIKWMALESI 225
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
             R +   +H+SDV+S+G+ + EL+   +    G+ +S        I   +E+      P
Sbjct: 226 LHRIY---THQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERLPQP 275
Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI 340
            + T     I   MI+V  W I A    RP   E+I
Sbjct: 276 PICT-----IDVYMIMVKCWMIDA--DSRPKFRELI 304

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 120/276 (43%), Gaps = 54/276 (19%)
Query: 91  LGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTL 126
           LG G FG VYKG  +                         + ++E   ++   + +V  L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL-RWEKMYEIVIGIAKGLEYLHH 185
           LG CL    + LI + MP G L  +V     +   QYL  W       + IAKG+ YL  
Sbjct: 83  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE- 134
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
               +++H D+   N+L+      KI+DFGLAKL   +E    +  G +  I ++A E +
Sbjct: 135 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIKWMALESI 191
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
             R +   +H+SDV+S+G+ + EL+   +    G+ +S        I   +E+      P
Sbjct: 192 LHRIY---THQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERLPQP 241
Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI 340
            + T     I   MI+V  W I A    RP   E+I
Sbjct: 242 PICT-----IDVYMIMVKCWMIDA--DSRPKFRELI 270

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 120/276 (43%), Gaps = 54/276 (19%)
Query: 91  LGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTL 126
           LG G FG VYKG  +                         + ++E   ++   + +V  L
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL-RWEKMYEIVIGIAKGLEYLHH 185
           LG CL    + LI + MP G L  +V     +   QYL  W       + IAKG+ YL  
Sbjct: 87  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE- 138
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
               +++H D+   N+L+      KI+DFGLAKL   +E    +  G +  I ++A E +
Sbjct: 139 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIKWMALESI 195
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
             R +   +H+SDV+S+G+ + EL+   +    G+ +S        I   +E+      P
Sbjct: 196 LHRIY---THQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERLPQP 245
Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI 340
            + T     I   MI+V  W I A    RP   E+I
Sbjct: 246 PICT-----IDVYMIMVKCWMIDA--DSRPKFRELI 274

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 120/276 (43%), Gaps = 54/276 (19%)
Query: 91  LGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTL 126
           LG G FG VYKG  +                         + ++E   ++   + +V  L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL-RWEKMYEIVIGIAKGLEYLHH 185
           LG CL    + LI + MP G L  +V     +   QYL  W       + IAKG+ YL  
Sbjct: 86  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE- 137
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
               +++H D+   N+L+      KI+DFGLAKL   +E    +  G +  I ++A E +
Sbjct: 138 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIKWMALESI 194
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
             R +   +H+SDV+S+G+ + EL+   +    G+ +S        I   +E+      P
Sbjct: 195 LHRIY---THQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERLPQP 244
Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI 340
            + T     I   MI+V  W I A    RP   E+I
Sbjct: 245 PICT-----IDVYMIMVKCWMIDA--DSRPKFRELI 273

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 120/276 (43%), Gaps = 54/276 (19%)
Query: 91  LGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTL 126
           LG G FG VYKG  +                         + ++E   ++   + +V  L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL-RWEKMYEIVIGIAKGLEYLHH 185
           LG CL    + LI + MP G L  +V     +   QYL  W       + IAKG+ YL  
Sbjct: 85  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE- 136
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
               +++H D+   N+L+      KI+DFGLAKL   +E    +  G +  I ++A E +
Sbjct: 137 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIKWMALESI 193
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
             R +   +H+SDV+S+G+ + EL+   +    G+ +S        I   +E+      P
Sbjct: 194 LHRIY---THQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERLPQP 243
Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI 340
            + T     I   MI+V  W I A    RP   E+I
Sbjct: 244 PICT-----IDVYMIMVKCWMIDA--DSRPKFRELI 272

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 120/276 (43%), Gaps = 54/276 (19%)
Query: 91  LGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTL 126
           LG G FG VYKG  +                         + ++E   ++   + +V  L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL-RWEKMYEIVIGIAKGLEYLHH 185
           LG CL    + LI + MP G L  +V     +   QYL  W       + IAKG+ YL  
Sbjct: 85  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE- 136
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
               +++H D+   N+L+      KI+DFGLAKL   +E    +  G +  I ++A E +
Sbjct: 137 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIKWMALESI 193
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
             R +   +H+SDV+S+G+ + EL+   +    G+ +S        I   +E+      P
Sbjct: 194 LHRIY---THQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERLPQP 243
Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI 340
            + T     I   MI+V  W I A    RP   E+I
Sbjct: 244 PICT-----IDVYMIMVKCWMIDA--DSRPKFRELI 272

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 120/276 (43%), Gaps = 54/276 (19%)
Query: 91  LGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTL 126
           LG G FG VYKG  +                         + ++E   ++   + +V  L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL-RWEKMYEIVIGIAKGLEYLHH 185
           LG CL    + LI + MP G L  +V     +   QYL  W       + IAKG+ YL  
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE- 134
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
               +++H D+   N+L+      KI+DFGLAKL   +E    +  G +  I ++A E +
Sbjct: 135 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIKWMALESI 191
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
             R +   +H+SDV+S+G+ + EL+   +    G+ +S        I   +E+      P
Sbjct: 192 LHRIY---THQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERLPQP 241
Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI 340
            + T     I   MI+V  W I A    RP   E+I
Sbjct: 242 PICT-----IDVYMIMVKCWMIDA--DSRPKFRELI 270

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 126/273 (46%), Gaps = 43/273 (15%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHV 121
           ++ + +   + KLG G FG V+                     ++ F+ E   +    H 
Sbjct: 11  EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD 70
Query: 122 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
            +V L    +      +I EFM  GSL  F+ + + SK  Q L   K+ +    IA+G+ 
Sbjct: 71  KLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSK--QPL--PKLIDFSAQIAEGMA 125
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           ++        +H D++  NIL+      KI+DFGLA++    E   ++  GA+  I + A
Sbjct: 126 FIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTA 180
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE    NFG  + KSDV+SFG+++ME+V        G+ +         + R +E  R +
Sbjct: 181 PEAI--NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-------VIRALE--RGY 229
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRP 334
           ++P    R EN   +++  + + C + RP +RP
Sbjct: 230 RMP----RPEN-CPEELYNIMMRCWKNRPEERP 257

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 120/276 (43%), Gaps = 54/276 (19%)
Query: 91  LGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTL 126
           LG G FG VYKG  +                         + ++E   ++   + +V  L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL-RWEKMYEIVIGIAKGLEYLHH 185
           LG CL    + LI + MP G L  +V     +   QYL  W       + IAKG+ YL  
Sbjct: 86  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE- 137
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
               +++H D+   N+L+      KI+DFGLAKL   +E    +  G +  I ++A E +
Sbjct: 138 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIKWMALESI 194
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
             R +   +H+SDV+S+G+ + EL+   +    G+ +S        I   +E+      P
Sbjct: 195 LHRIY---THQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERLPQP 244
Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI 340
            + T     I   MI+V  W I A    RP   E+I
Sbjct: 245 PICT-----IDVYMIMVKCWMIDA--DSRPKFRELI 273

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 122/251 (48%), Gaps = 33/251 (13%)
Query: 105 LDDFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV---------YN 154
           L D V+E+  +     H N++ LLG C +     +I E+   G+L +++         Y+
Sbjct: 84  LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 143
Query: 155 GDTSK-PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISD 213
            D ++ P + + ++ +      +A+G+EYL    S K +H D+   N+L+ E+   KI+D
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIAD 200
Query: 214 FGLAKLCTTKEGIVSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
           FGLA+     +   ++  G R  + ++APE +F R +   +H+SDV+SFG+++ E+    
Sbjct: 201 FGLARDINNIDYYKNTTNG-RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEIFTLG 256
Query: 273 NNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSD 332
            +   G+           +++ +++      P   T   NE+   M      C  A PS 
Sbjct: 257 GSPYPGIPVEE-------LFKLLKEGHRMDKPANCT---NELYMMMRD----CWHAVPSQ 302
Query: 333 RPPMNEVIEML 343
           RP   +++E L
Sbjct: 303 RPTFKQLVEDL 313

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 120/276 (43%), Gaps = 54/276 (19%)
Query: 91  LGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTL 126
           LG G FG VYKG  +                         + ++E   ++   + +V  L
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76
Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL-RWEKMYEIVIGIAKGLEYLHH 185
           LG CL    + LI + MP G L  +V     +   QYL  W       + IAKG+ YL  
Sbjct: 77  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE- 128
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
               +++H D+   N+L+      KI+DFGLAKL   +E    +  G +  I ++A E +
Sbjct: 129 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIKWMALESI 185
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
             R +   +H+SDV+S+G+ + EL+   +    G+ +S        I   +E+      P
Sbjct: 186 LHRIY---THQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERLPQP 235
Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI 340
            + T     I   MI+V  W I A    RP   E+I
Sbjct: 236 PICT-----IDVYMIMVKCWMIDA--DSRPKFRELI 264

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 120/276 (43%), Gaps = 54/276 (19%)
Query: 91  LGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTL 126
           LG G FG VYKG  +                         + ++E   ++   + +V  L
Sbjct: 48  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 107
Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL-RWEKMYEIVIGIAKGLEYLHH 185
           LG CL    + LI + MP G L  +V     +   QYL  W       + IAKG+ YL  
Sbjct: 108 LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE- 159
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
               +++H D+   N+L+      KI+DFGLAKL   +E    +  G +  I ++A E +
Sbjct: 160 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIKWMALESI 216
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
             R +   +H+SDV+S+G+ + EL+   +    G+ +S        I   +E+      P
Sbjct: 217 LHRIY---THQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERLPQP 266
Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI 340
            + T     I   MI+V  W I A    RP   E+I
Sbjct: 267 PICT-----IDVYMIMVKCWMIDA--DSRPKFRELI 295

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/240 (30%), Positives = 108/240 (45%), Gaps = 32/240 (13%)
Query: 120 HVNVVTLLGFCLE-GNNRALIYEFMPNGSL--------EKFVYNGDTSKPCQYLRWEKMY 170
           H+NVV LLG C + G    +I EF   G+L         +FV   D  K   +L  E + 
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYK--DFLTLEHLI 147
Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSL 230
                +AKG+E+L    S K +H D+   NILL E    KI DFGLA+        V   
Sbjct: 148 XYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRK- 203
Query: 231 LGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPH 289
             AR  + ++APE +F R +   + +SDV+SFG+++ E+     +   GV    E     
Sbjct: 204 GDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE----- 255
Query: 290 WIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA 349
              R +++    + P   T        +M    L C    PS RP  +E++E L    +A
Sbjct: 256 -FXRRLKEGTRMRAPDYTT-------PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 307

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/250 (23%), Positives = 114/250 (45%), Gaps = 36/250 (14%)
Query: 100 YKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSK 159
           Y  +   DF+ E + + +  H N++ L G   +     ++ E+M NGSL+ F+   D   
Sbjct: 62  YTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQF 121
Query: 160 PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL 219
                   ++  ++ GI+ G++YL        +H D+   NIL++ +   K+SDFGL+++
Sbjct: 122 TVI-----QLVGMLRGISAGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRV 173
Query: 220 CTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGV 279
                    +  G +  I + APE  +  F + +  SDV+S+G+++ E+V          
Sbjct: 174 LEDDPEAAYTTRGGKIPIRWTAPEAIA--FRKFTSASDVWSYGIVMWEVVSYGER----- 226
Query: 280 DSSSEVYFPHW------IYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDR 333
                   P+W      + + VE+   ++LP  +     +    +  + L C Q   + R
Sbjct: 227 --------PYWEMTNQDVIKAVEEG--YRLPSPM-----DCPAALYQLMLDCWQKERNSR 271
Query: 334 PPMNEVIEML 343
           P  +E++ ML
Sbjct: 272 PKFDEIVNML 281

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 120/276 (43%), Gaps = 54/276 (19%)
Query: 91  LGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTL 126
           LG G FG VYKG  +                         + ++E   ++   + +V  L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL-RWEKMYEIVIGIAKGLEYLHH 185
           LG CL    + LI + MP G L  +V     +   QYL  W       + IAKG+ YL  
Sbjct: 86  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE- 137
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
               +++H D+   N+L+      KI+DFGLAKL   +E    +  G +  I ++A E +
Sbjct: 138 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIKWMALESI 194
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
             R +   +H+SDV+S+G+ + EL+   +    G+ +S        I   +E+      P
Sbjct: 195 LHRIY---THQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERLPQP 244
Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI 340
            + T     I   MI+V  W I A    RP   E+I
Sbjct: 245 PICT-----IDVYMIMVKCWMIDA--DSRPKFRELI 273

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 120/276 (43%), Gaps = 54/276 (19%)
Query: 91  LGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTL 126
           LG G FG VYKG  +                         + ++E   ++   + +V  L
Sbjct: 29  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 88
Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL-RWEKMYEIVIGIAKGLEYLHH 185
           LG CL    + LI + MP G L  +V     +   QYL  W       + IAKG+ YL  
Sbjct: 89  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE- 140
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
               +++H D+   N+L+      KI+DFGLAKL   +E    +  G +  I ++A E +
Sbjct: 141 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIKWMALESI 197
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
             R +   +H+SDV+S+G+ + EL+   +    G+ +S        I   +E+      P
Sbjct: 198 LHRIY---THQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERLPQP 247
Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI 340
            + T     I   MI+V  W I A    RP   E+I
Sbjct: 248 PICT-----IDVYMIMVKCWMIDA--DSRPKFRELI 276

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 121/251 (48%), Gaps = 33/251 (13%)
Query: 105 LDDFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV---------YN 154
           L D V+E+  +     H N++ LLG C +     +I E+   G+L +++         Y+
Sbjct: 71  LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 130
Query: 155 GDTSK-PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISD 213
            D ++ P + + ++ +      +A+G+EYL    S K +H D+   N+L+ E+   KI+D
Sbjct: 131 YDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIAD 187
Query: 214 FGLAKLCTTKEGIVSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
           FGLA+     +    +  G R  + ++APE +F R +   +H+SDV+SFG+++ E+    
Sbjct: 188 FGLARDINNIDYYKKTTNG-RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEIFTLG 243
Query: 273 NNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSD 332
            +   G+           +++ +++      P   T   NE+   M      C  A PS 
Sbjct: 244 GSPYPGIPVEE-------LFKLLKEGHRMDKPANCT---NELYMMMRD----CWHAVPSQ 289
Query: 333 RPPMNEVIEML 343
           RP   +++E L
Sbjct: 290 RPTFKQLVEDL 300

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 121/251 (48%), Gaps = 33/251 (13%)
Query: 105 LDDFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV---------YN 154
           L D V+E+  +     H N++ LLG C +     +I E+   G+L +++         Y+
Sbjct: 73  LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 132
Query: 155 GDTSK-PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISD 213
            D ++ P + + ++ +      +A+G+EYL    S K +H D+   N+L+ E+   KI+D
Sbjct: 133 YDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIAD 189
Query: 214 FGLAKLCTTKEGIVSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
           FGLA+     +    +  G R  + ++APE +F R +   +H+SDV+SFG+++ E+    
Sbjct: 190 FGLARDINNIDYYKKTTNG-RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEIFTLG 245
Query: 273 NNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSD 332
            +   G+           +++ +++      P   T   NE+   M      C  A PS 
Sbjct: 246 GSPYPGIPVEE-------LFKLLKEGHRMDKPANCT---NELYMMMRD----CWHAVPSQ 291
Query: 333 RPPMNEVIEML 343
           RP   +++E L
Sbjct: 292 RPTFKQLVEDL 302

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 120/276 (43%), Gaps = 54/276 (19%)
Query: 91  LGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTL 126
           LG G FG VYKG  +                         + ++E   ++   + +V  L
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL-RWEKMYEIVIGIAKGLEYLHH 185
           LG CL    + LI + MP G L  +V     +   QYL  W       + IAKG+ YL  
Sbjct: 90  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE- 141
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
               +++H D+   N+L+      KI+DFGLAKL   +E    +  G +  I ++A E +
Sbjct: 142 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIKWMALESI 198
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
             R +   +H+SDV+S+G+ + EL+   +    G+ +S        I   +E+      P
Sbjct: 199 LHRIY---THQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERLPQP 248
Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI 340
            + T     I   MI+V  W I A    RP   E+I
Sbjct: 249 PICT-----IDVYMIMVKCWMIDA--DSRPKFRELI 277

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 121/251 (48%), Gaps = 33/251 (13%)
Query: 105 LDDFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV---------YN 154
           L D V+E+  +     H N++ LLG C +     +I E+   G+L +++         Y+
Sbjct: 130 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 189
Query: 155 GDTSK-PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISD 213
            D ++ P + + ++ +      +A+G+EYL    S K +H D+   N+L+ E+   KI+D
Sbjct: 190 YDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIAD 246
Query: 214 FGLAKLCTTKEGIVSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
           FGLA+     +    +  G R  + ++APE +F R +   +H+SDV+SFG+++ E+    
Sbjct: 247 FGLARDINNIDYYKKTTNG-RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEIFTLG 302
Query: 273 NNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSD 332
            +   G+           +++ +++      P   T   NE+   M      C  A PS 
Sbjct: 303 GSPYPGIPVEE-------LFKLLKEGHRMDKPANCT---NELYMMMRD----CWHAVPSQ 348
Query: 333 RPPMNEVIEML 343
           RP   +++E L
Sbjct: 349 RPTFKQLVEDL 359

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 121/251 (48%), Gaps = 33/251 (13%)
Query: 105 LDDFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV---------YN 154
           L D V+E+  +     H N++ LLG C +     +I E+   G+L +++         Y+
Sbjct: 76  LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 135
Query: 155 GDTSK-PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISD 213
            D ++ P + + ++ +      +A+G+EYL    S K +H D+   N+L+ E+   KI+D
Sbjct: 136 YDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIAD 192
Query: 214 FGLAKLCTTKEGIVSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
           FGLA+     +    +  G R  + ++APE +F R +   +H+SDV+SFG+++ E+    
Sbjct: 193 FGLARDINNIDYYKKTTNG-RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEIFTLG 248
Query: 273 NNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSD 332
            +   G+           +++ +++      P   T   NE+   M      C  A PS 
Sbjct: 249 GSPYPGIPVEE-------LFKLLKEGHRMDKPANCT---NELYMMMRD----CWHAVPSQ 294
Query: 333 RPPMNEVIEML 343
           RP   +++E L
Sbjct: 295 RPTFKQLVEDL 305

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 121/251 (48%), Gaps = 33/251 (13%)
Query: 105 LDDFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV---------YN 154
           L D V+E+  +     H N++ LLG C +     +I E+   G+L +++         Y+
Sbjct: 84  LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 143
Query: 155 GDTSK-PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISD 213
            D ++ P + + ++ +      +A+G+EYL    S K +H D+   N+L+ E+   KI+D
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIAD 200
Query: 214 FGLAKLCTTKEGIVSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
           FGLA+     +    +  G R  + ++APE +F R +   +H+SDV+SFG+++ E+    
Sbjct: 201 FGLARDINNIDYYKKTTNG-RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEIFTLG 256
Query: 273 NNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSD 332
            +   G+           +++ +++      P   T   NE+   M      C  A PS 
Sbjct: 257 GSPYPGIPVEE-------LFKLLKEGHRMDKPANCT---NELYMMMRD----CWHAVPSQ 302
Query: 333 RPPMNEVIEML 343
           RP   +++E L
Sbjct: 303 RPTFKQLVEDL 313

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 105/227 (46%), Gaps = 47/227 (20%)
Query: 76  NFSDVKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTS---------------- 119
           +++D+K     F+D +G+G FG V K R+  D +   A+I R                  
Sbjct: 13  DWNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE 67
Query: 120 -------HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGD----------TSKPCQ 162
                  H N++ LLG C       L  E+ P+G+L  F+               +    
Sbjct: 68  VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 127
Query: 163 YLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT 222
            L  +++      +A+G++YL      + +H D+   NIL+ E++  KI+DFGL++    
Sbjct: 128 TLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---G 181
Query: 223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
           +E  V   +G R  + ++A E  S N+   +  SDV+S+G+++ E+V
Sbjct: 182 QEVYVKKTMG-RLPVRWMAIE--SLNYSVYTTNSDVWSYGVLLWEIV 225

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 125/274 (45%), Gaps = 43/274 (15%)
Query: 87  FKDKLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHVNVVTLLGF 129
            + KLG G FG V+                     ++ F+ E   +    H  +V L   
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 130 CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCST 189
             +     +I EFM  GSL  F+ + + SK  Q L   K+ +    IA+G+ ++      
Sbjct: 252 VTK-EPIYIITEFMAKGSLLDFLKSDEGSK--QPL--PKLIDFSAQIAEGMAFIEQ---R 303
Query: 190 KILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNF 249
             +H D++  NIL+      KI+DFGLA++    E   ++  GA+  I + APE    NF
Sbjct: 304 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEAI--NF 359
Query: 250 GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTR 309
           G  + KSDV+SFG+++ME+V        G+ +         + R +E  R +++P    R
Sbjct: 360 GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-------VIRALE--RGYRMP----R 406
Query: 310 KENEIAKKMIIVGLWCIQARPSDRPPMNEVIEML 343
            EN   +++  + + C + RP +RP    +  +L
Sbjct: 407 PEN-CPEELYNIMMRCWKNRPEERPTFEYIQSVL 439

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 105/227 (46%), Gaps = 47/227 (20%)
Query: 76  NFSDVKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTS---------------- 119
           +++D+K     F+D +G+G FG V K R+  D +   A+I R                  
Sbjct: 23  DWNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE 77
Query: 120 -------HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGD----------TSKPCQ 162
                  H N++ LLG C       L  E+ P+G+L  F+               +    
Sbjct: 78  VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 137
Query: 163 YLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT 222
            L  +++      +A+G++YL      + +H D+   NIL+ E++  KI+DFGL++    
Sbjct: 138 TLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---G 191
Query: 223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
           +E  V   +G R  + ++A E  S N+   +  SDV+S+G+++ E+V
Sbjct: 192 QEVYVKKTMG-RLPVRWMAIE--SLNYSVYTTNSDVWSYGVLLWEIV 235

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 127/298 (42%), Gaps = 47/298 (15%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHV 121
           +V + T    ++LG G  G V+ G                    D F+ E   + +  H 
Sbjct: 9   EVPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 122 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
            +V L     +     +I E+M NGSL  F+      K    L   K+ ++   IA+G+ 
Sbjct: 69  RLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK----LTINKLLDMAAQIAEGMA 123
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           ++        +H D++  NIL+ +    KI+DFGLA+L    E       GA+  I + A
Sbjct: 124 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTARE--GAKFPIKWTA 178
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE    N+G  + KSDV+SFG+++ E+V           +   + +P      V Q+ E 
Sbjct: 179 PEAI--NYGTFTIKSDVWSFGILLTEIV-----------THGRIPYPGMTNPEVIQNLE- 224
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPP---MNEVIEMLQGSTEALQIPPTP 356
              G    + +   +++  +   C + RP DRP    +  V+E    +TE  Q  P P
Sbjct: 225 --RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG-QYQPQP 279

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 125/283 (44%), Gaps = 43/283 (15%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHV 121
           +V + T    ++LG G FG V+ G                    D F+ E   + +  H 
Sbjct: 5   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 64
Query: 122 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
            +V L     +     +I E+M NGSL  F+      K    L   K+ ++   IA+G+ 
Sbjct: 65  RLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK----LTINKLLDMAAQIAEGMA 119
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           ++        +H +++  NIL+ +    KI+DFGLA+L    E   ++  GA+  I + A
Sbjct: 120 FIEE---RNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNE--YTAREGAKFPIKWTA 174
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE    N+G  + KSDV+SFG+++ E+V           +   + +P      V Q+ E 
Sbjct: 175 PEAI--NYGTFTIKSDVWSFGILLTEIV-----------THGRIPYPGMTNPEVIQNLE- 220
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
              G    + +   +++  +   C + RP DRP  + +  +L+
Sbjct: 221 --RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 261

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/250 (23%), Positives = 116/250 (46%), Gaps = 36/250 (14%)
Query: 100 YKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSK 159
           Y  +   DF++E + + +  H N++ L G   +     +I E+M NGSL+ F+   D   
Sbjct: 69  YTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGR- 127
Query: 160 PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL 219
                   ++  ++ GI  G++YL        +H D+   NIL++ +   K+SDFG++++
Sbjct: 128 ----FTVIQLVGMLRGIGSGMKYLS---DMSAVHRDLAARNILVNSNLVCKVSDFGMSRV 180
Query: 220 CTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGV 279
                    +  G +  I + APE  +  + + +  SDV+S+G+++ E++          
Sbjct: 181 LEDDPEAAYTTRGGKIPIRWTAPEAIA--YRKFTSASDVWSYGIVMWEVMSYGER----- 233
Query: 280 DSSSEVYFPHW------IYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDR 333
                   P+W      + + +E+   ++LP  +   +  IA   +++  W  Q   SDR
Sbjct: 234 --------PYWDMSNQDVIKAIEEG--YRLPPPM---DCPIALHQLMLDCW--QKERSDR 278
Query: 334 PPMNEVIEML 343
           P   +++ ML
Sbjct: 279 PKFGQIVNML 288

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 108/240 (45%), Gaps = 30/240 (12%)
Query: 120 HVNVVTLLGFCLE-GNNRALIYEFMPNGSLEKFVYNGDTS----KP----CQYLRWEKMY 170
           H+NVV LLG C + G    +I EF   G+L  ++ +        KP      +L  E + 
Sbjct: 92  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLI 151
Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSL 230
                +AKG+E+L    S K +H D+   NILL E    KI DFGLA+        V   
Sbjct: 152 XYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK- 207
Query: 231 LGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPH 289
             AR  + ++APE +F R +   + +SDV+SFG+++ E+     +   GV    E     
Sbjct: 208 GDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE----- 259
Query: 290 WIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA 349
              R +++    + P   T        +M    L C    PS RP  +E++E L    +A
Sbjct: 260 -FCRRLKEGTRMRAPDYTT-------PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 121/251 (48%), Gaps = 33/251 (13%)
Query: 105 LDDFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV---------YN 154
           L D V+E+  +     H N++ LLG C +     +I E+   G+L +++         Y+
Sbjct: 84  LSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 143
Query: 155 GDTSK-PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISD 213
            D ++ P + + ++ +      +A+G+EYL    S K +H D+   N+L+ E+   KI+D
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIAD 200
Query: 214 FGLAKLCTTKEGIVSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
           FGLA+     +    +  G R  + ++APE +F R +   +H+SDV+SFG+++ E+    
Sbjct: 201 FGLARDINNIDYYKKTTNG-RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEIFTLG 256
Query: 273 NNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSD 332
            +   G+           +++ +++      P   T   NE+   M      C  A PS 
Sbjct: 257 GSPYPGIPVEE-------LFKLLKEGHRMDKPANCT---NELYMMMRD----CWHAVPSQ 302
Query: 333 RPPMNEVIEML 343
           RP   +++E L
Sbjct: 303 RPTFKQLVEDL 313

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 118/252 (46%), Gaps = 35/252 (13%)
Query: 105 LDDFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV----------- 152
           L D ++E+  +     H N++ LLG C +     +I E+   G+L +++           
Sbjct: 66  LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYS 125
Query: 153 YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKIS 212
           YN  +  P + L  + +      +A+G+EYL    S K +H D+   N+L+ ED   KI+
Sbjct: 126 YNP-SHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIA 181
Query: 213 DFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGC 271
           DFGLA+     +    +  G R  + ++APE +F R +   +H+SDV+SFG+++ E+   
Sbjct: 182 DFGLARDIHHIDYYKKTTNG-RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEIFTL 237
Query: 272 KNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPS 331
             +   GV           +++ +++      P   T   NE+   M      C  A PS
Sbjct: 238 GGSPYPGVPVEE-------LFKLLKEGHRMDKPSNCT---NELYMMMRD----CWHAVPS 283
Query: 332 DRPPMNEVIEML 343
            RP   +++E L
Sbjct: 284 QRPTFKQLVEDL 295

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 118/252 (46%), Gaps = 35/252 (13%)
Query: 105 LDDFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV----------- 152
           L D ++E+  +     H N++ LLG C +     +I E+   G+L +++           
Sbjct: 77  LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYS 136
Query: 153 YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKIS 212
           YN  +  P + L  + +      +A+G+EYL    S K +H D+   N+L+ ED   KI+
Sbjct: 137 YN-PSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIA 192
Query: 213 DFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGC 271
           DFGLA+     +    +  G R  + ++APE +F R +   +H+SDV+SFG+++ E+   
Sbjct: 193 DFGLARDIHHIDYYKKTTNG-RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEIFTL 248
Query: 272 KNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPS 331
             +   GV           +++ +++      P   T   NE+   M      C  A PS
Sbjct: 249 GGSPYPGVPVEE-------LFKLLKEGHRMDKPSNCT---NELYMMMRD----CWHAVPS 294
Query: 332 DRPPMNEVIEML 343
            RP   +++E L
Sbjct: 295 QRPTFKQLVEDL 306

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 118/252 (46%), Gaps = 35/252 (13%)
Query: 105 LDDFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV----------- 152
           L D ++E+  +     H N++ LLG C +     +I E+   G+L +++           
Sbjct: 62  LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYC 121
Query: 153 YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKIS 212
           YN  +  P + L  + +      +A+G+EYL    S K +H D+   N+L+ ED   KI+
Sbjct: 122 YNP-SHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIA 177
Query: 213 DFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGC 271
           DFGLA+     +    +  G R  + ++APE +F R +   +H+SDV+SFG+++ E+   
Sbjct: 178 DFGLARDIHHIDYYKKTTNG-RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEIFTL 233
Query: 272 KNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPS 331
             +   GV           +++ +++      P   T   NE+   M      C  A PS
Sbjct: 234 GGSPYPGVPVEE-------LFKLLKEGHRMDKPSNCT---NELYMMMRD----CWHAVPS 279
Query: 332 DRPPMNEVIEML 343
            RP   +++E L
Sbjct: 280 QRPTFKQLVEDL 291

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 118/252 (46%), Gaps = 35/252 (13%)
Query: 105 LDDFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV----------- 152
           L D ++E+  +     H N++ LLG C +     +I E+   G+L +++           
Sbjct: 77  LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYC 136
Query: 153 YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKIS 212
           YN  +  P + L  + +      +A+G+EYL    S K +H D+   N+L+ ED   KI+
Sbjct: 137 YNP-SHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIA 192
Query: 213 DFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGC 271
           DFGLA+     +    +  G R  + ++APE +F R +   +H+SDV+SFG+++ E+   
Sbjct: 193 DFGLARDIHHIDYYKKTTNG-RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEIFTL 248
Query: 272 KNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPS 331
             +   GV           +++ +++      P   T   NE+   M      C  A PS
Sbjct: 249 GGSPYPGVPVEE-------LFKLLKEGHRMDKPSNCT---NELYMMMRD----CWHAVPS 294
Query: 332 DRPPMNEVIEML 343
            RP   +++E L
Sbjct: 295 QRPTFKQLVEDL 306

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 118/252 (46%), Gaps = 35/252 (13%)
Query: 105 LDDFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV----------- 152
           L D ++E+  +     H N++ LLG C +     +I E+   G+L +++           
Sbjct: 77  LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYS 136
Query: 153 YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKIS 212
           YN  +  P + L  + +      +A+G+EYL    S K +H D+   N+L+ ED   KI+
Sbjct: 137 YN-PSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIA 192
Query: 213 DFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGC 271
           DFGLA+     +    +  G R  + ++APE +F R +   +H+SDV+SFG+++ E+   
Sbjct: 193 DFGLARDIHHIDYYKKTTNG-RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEIFTL 248
Query: 272 KNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPS 331
             +   GV           +++ +++      P   T   NE+   M      C  A PS
Sbjct: 249 GGSPYPGVPVEE-------LFKLLKEGHRMDKPSNCT---NELYMMMRD----CWHAVPS 294
Query: 332 DRPPMNEVIEML 343
            RP   +++E L
Sbjct: 295 QRPTFKQLVEDL 306

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 118/252 (46%), Gaps = 35/252 (13%)
Query: 105 LDDFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV----------- 152
           L D ++E+  +     H N++ LLG C +     +I E+   G+L +++           
Sbjct: 69  LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYS 128
Query: 153 YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKIS 212
           YN  +  P + L  + +      +A+G+EYL    S K +H D+   N+L+ ED   KI+
Sbjct: 129 YN-PSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIA 184
Query: 213 DFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGC 271
           DFGLA+     +    +  G R  + ++APE +F R +   +H+SDV+SFG+++ E+   
Sbjct: 185 DFGLARDIHHIDYYKKTTNG-RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEIFTL 240
Query: 272 KNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPS 331
             +   GV           +++ +++      P   T   NE+   M      C  A PS
Sbjct: 241 GGSPYPGVPVEE-------LFKLLKEGHRMDKPSNCT---NELYMMMRD----CWHAVPS 286
Query: 332 DRPPMNEVIEML 343
            RP   +++E L
Sbjct: 287 QRPTFKQLVEDL 298

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 118/252 (46%), Gaps = 35/252 (13%)
Query: 105 LDDFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV----------- 152
           L D ++E+  +     H N++ LLG C +     +I E+   G+L +++           
Sbjct: 70  LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYS 129
Query: 153 YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKIS 212
           YN  +  P + L  + +      +A+G+EYL    S K +H D+   N+L+ ED   KI+
Sbjct: 130 YN-PSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIA 185
Query: 213 DFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGC 271
           DFGLA+     +    +  G R  + ++APE +F R +   +H+SDV+SFG+++ E+   
Sbjct: 186 DFGLARDIHHIDYYKKTTNG-RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEIFTL 241
Query: 272 KNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPS 331
             +   GV           +++ +++      P   T   NE+   M      C  A PS
Sbjct: 242 GGSPYPGVPVEE-------LFKLLKEGHRMDKPSNCT---NELYMMMRD----CWHAVPS 287
Query: 332 DRPPMNEVIEML 343
            RP   +++E L
Sbjct: 288 QRPTFKQLVEDL 299

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/250 (23%), Positives = 116/250 (46%), Gaps = 36/250 (14%)
Query: 100 YKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSK 159
           Y  +   DF++E + + +  H N++ L G   +     +I E+M NGSL+ F+   D   
Sbjct: 48  YTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGR- 106
Query: 160 PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL 219
                   ++  ++ GI  G++YL        +H D+   NIL++ +   K+SDFG++++
Sbjct: 107 ----FTVIQLVGMLRGIGSGMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRV 159
Query: 220 CTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGV 279
                    +  G +  I + APE  +  + + +  SDV+S+G+++ E++          
Sbjct: 160 LEDDPEAAYTTRGGKIPIRWTAPEAIA--YRKFTSASDVWSYGIVMWEVMSYGER----- 212
Query: 280 DSSSEVYFPHW------IYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDR 333
                   P+W      + + +E+   ++LP  +   +  IA   +++  W  Q   SDR
Sbjct: 213 --------PYWDMSNQDVIKAIEEG--YRLPPPM---DCPIALHQLMLDCW--QKERSDR 257
Query: 334 PPMNEVIEML 343
           P   +++ ML
Sbjct: 258 PKFGQIVNML 267

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 121/251 (48%), Gaps = 33/251 (13%)
Query: 105 LDDFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV---------YN 154
           L D V+E+  +     H N++ LLG C +     +I E+   G+L +++         Y+
Sbjct: 84  LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 143
Query: 155 GDTSK-PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISD 213
            D ++ P + + ++ +      +A+G+EYL    S K +H D+   N+L+ E+   +I+D
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIAD 200
Query: 214 FGLAKLCTTKEGIVSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
           FGLA+     +    +  G R  + ++APE +F R +   +H+SDV+SFG+++ E+    
Sbjct: 201 FGLARDINNIDYYKKTTNG-RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEIFTLG 256
Query: 273 NNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSD 332
            +   G+           +++ +++      P   T   NE+   M      C  A PS 
Sbjct: 257 GSPYPGIPVEE-------LFKLLKEGHRMDKPANCT---NELYMMMRD----CWHAVPSQ 302
Query: 333 RPPMNEVIEML 343
           RP   +++E L
Sbjct: 303 RPTFKQLVEDL 313

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 118/252 (46%), Gaps = 35/252 (13%)
Query: 105 LDDFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV----------- 152
           L D ++E+  +     H N++ LLG C +     +I E+   G+L +++           
Sbjct: 118 LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYS 177
Query: 153 YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKIS 212
           YN  +  P + L  + +      +A+G+EYL    S K +H D+   N+L+ ED   KI+
Sbjct: 178 YN-PSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIA 233
Query: 213 DFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGC 271
           DFGLA+     +    +  G R  + ++APE +F R +   +H+SDV+SFG+++ E+   
Sbjct: 234 DFGLARDIHHIDYYKKTTNG-RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEIFTL 289
Query: 272 KNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPS 331
             +   GV           +++ +++      P   T   NE+   M      C  A PS
Sbjct: 290 GGSPYPGVPVEE-------LFKLLKEGHRMDKPSNCT---NELYMMMRD----CWHAVPS 335
Query: 332 DRPPMNEVIEML 343
            RP   +++E L
Sbjct: 336 QRPTFKQLVEDL 347

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 116/251 (46%), Gaps = 33/251 (13%)
Query: 105 LDDFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYN--------- 154
           L D ++E+  +     H N++ LLG C +     +I E+   G+L +++           
Sbjct: 77  LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFS 136
Query: 155 -GDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISD 213
              +  P + L  + +      +A+G+EYL    S K +H D+   N+L+ ED   KI+D
Sbjct: 137 FNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIAD 193
Query: 214 FGLAKLCTTKEGIVSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
           FGLA+     +    +  G R  + ++APE +F R +   +H+SDV+SFG+++ E+    
Sbjct: 194 FGLARDIHHIDXXKKTTNG-RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEIFTLG 249
Query: 273 NNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSD 332
            +   GV           +++ +++      P   T   NE+   M      C  A PS 
Sbjct: 250 GSPYPGVPVEE-------LFKLLKEGHRMDKPSNCT---NELYMMMRD----CWHAVPSQ 295
Query: 333 RPPMNEVIEML 343
           RP   +++E L
Sbjct: 296 RPTFKQLVEDL 306

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/250 (23%), Positives = 116/250 (46%), Gaps = 36/250 (14%)
Query: 100 YKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSK 159
           Y  +   DF++E + + +  H N++ L G   +     +I E+M NGSL+ F+   D   
Sbjct: 54  YTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGR- 112
Query: 160 PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL 219
                   ++  ++ GI  G++YL        +H D+   NIL++ +   K+SDFG++++
Sbjct: 113 ----FTVIQLVGMLRGIGSGMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRV 165
Query: 220 CTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGV 279
                    +  G +  I + APE  +  + + +  SDV+S+G+++ E++          
Sbjct: 166 LEDDPEAAYTTRGGKIPIRWTAPEAIA--YRKFTSASDVWSYGIVMWEVMSYGER----- 218
Query: 280 DSSSEVYFPHW------IYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDR 333
                   P+W      + + +E+   ++LP  +   +  IA   +++  W  Q   SDR
Sbjct: 219 --------PYWDMSNQDVIKAIEEG--YRLPPPM---DCPIALHQLMLDCW--QKERSDR 263
Query: 334 PPMNEVIEML 343
           P   +++ ML
Sbjct: 264 PKFGQIVNML 273

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 120/276 (43%), Gaps = 54/276 (19%)
Query: 91  LGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTL 126
           LG G FG VYKG  +                         + ++E   ++   + +V  L
Sbjct: 20  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 79
Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL-RWEKMYEIVIGIAKGLEYLHH 185
           LG CL    + LI + MP G L  +V     +   QYL  W       + IA+G+ YL  
Sbjct: 80  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAEGMNYLE- 131
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
               +++H D+   N+L+      KI+DFGLAKL   +E    +  G +  I ++A E +
Sbjct: 132 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIKWMALESI 188
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
             R +   +H+SDV+S+G+ + EL+   +    G+ +S        I   +E+      P
Sbjct: 189 LHRIY---THQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERLPQP 238
Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI 340
            + T     I   MI+V  W I A    RP   E+I
Sbjct: 239 PICT-----IDVYMIMVKCWMIDA--DSRPKFRELI 267

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 112/242 (46%), Gaps = 36/242 (14%)
Query: 120 HVNVVTLLGFCLE-GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG--- 175
           H+NVV LLG C + G    +I EF   G+L  ++     SK  +++ ++ +Y+  +    
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----RSKRNEFVPYKDLYKDFLTLEH 145
Query: 176 -------IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVS 228
                  +AKG+E+L    S K +H D+   NILL E    KI DFGLA+        V 
Sbjct: 146 LICYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 202
Query: 229 SLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYF 287
               AR  + ++APE +F R +   + +SDV+SFG+++ E+     +   GV    E   
Sbjct: 203 K-GDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--- 255
Query: 288 PHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST 347
                R +++    + P   T        +M    L C    PS RP  +E++E L    
Sbjct: 256 ---FCRRLKEGTRMRAPDYTT-------PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 305
Query: 348 EA 349
           +A
Sbjct: 306 QA 307

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 85/170 (50%), Gaps = 10/170 (5%)
Query: 100 YKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSK 159
           Y  +   DF+ E + + +  H NVV L G    G    ++ EFM NG+L+ F+   D   
Sbjct: 83  YTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQF 142
Query: 160 PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL 219
                   ++  ++ GIA G+ YL        +H D+   NIL++ +   K+SDFGL+++
Sbjct: 143 TVI-----QLVGMLRGIAAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRV 194
Query: 220 CTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
                  V +  G +  + + APE     + + +  SDV+S+G+++ E++
Sbjct: 195 IEDDPEAVYTTTGGKIPVRWTAPEAI--QYRKFTSASDVWSYGIVMWEVM 242

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 126/295 (42%), Gaps = 62/295 (21%)
Query: 72  LKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLL------------------------DD 107
           LK   F  +K L++        G FG VYKG  +                         +
Sbjct: 12  LKETEFKKIKVLSS--------GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 63
Query: 108 FVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL-RW 166
            ++E   ++   + +V  LLG CL    + LI + MP G L  +V     +   QYL  W
Sbjct: 64  ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW 122
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
                  + IAKG+ YL      +++H D+   N+L+      KI+DFGLAKL   +E  
Sbjct: 123 ------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 227 VSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
             +  G +  I ++A E +  R +   +H+SDV+S+G+ + EL+   +    G+ +S   
Sbjct: 174 YHA-EGGKVPIKWMALESILHRIY---THQSDVWSYGVTVWELMTFGSKPYDGIPASE-- 227
Query: 286 YFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI 340
                I   +E+      P + T     I   MI+V  W I A    RP   E+I
Sbjct: 228 -----ISSILEKGERLPQPPICT-----IDVYMIMVKCWMIDA--DSRPKFRELI 270

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 126/295 (42%), Gaps = 62/295 (21%)
Query: 72  LKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLL------------------------DD 107
           LK   F  +K L++        G FG VYKG  +                         +
Sbjct: 19  LKETEFKKIKVLSS--------GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 70
Query: 108 FVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL-RW 166
            ++E   ++   + +V  LLG CL    + LI + MP G L  +V     +   QYL  W
Sbjct: 71  ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW 129
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
                  + IAKG+ YL      +++H D+   N+L+      KI+DFGLAKL   +E  
Sbjct: 130 ------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 180
Query: 227 VSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
             +  G +  I ++A E +  R +   +H+SDV+S+G+ + EL+   +    G+ +S   
Sbjct: 181 YHA-EGGKVPIKWMALESILHRIY---THQSDVWSYGVTVWELMTFGSKPYDGIPASE-- 234
Query: 286 YFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI 340
                I   +E+      P + T     I   MI+V  W I A    RP   E+I
Sbjct: 235 -----ISSILEKGERLPQPPICT-----IDVYMIMVKCWMIDA--DSRPKFRELI 277

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 126/295 (42%), Gaps = 62/295 (21%)
Query: 72  LKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLL------------------------DD 107
           LK   F  +K L++        G FG VYKG  +                         +
Sbjct: 19  LKETEFKKIKVLSS--------GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 70
Query: 108 FVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL-RW 166
            ++E   ++   + +V  LLG CL    + LI + MP G L  +V     +   QYL  W
Sbjct: 71  ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW 129
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
                  + IAKG+ YL      +++H D+   N+L+      KI+DFGLAKL   +E  
Sbjct: 130 ------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 180
Query: 227 VSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
             +  G +  I ++A E +  R +   +H+SDV+S+G+ + EL+   +    G+ +S   
Sbjct: 181 YHA-EGGKVPIKWMALESILHRIY---THQSDVWSYGVTVWELMTFGSKPYDGIPASE-- 234
Query: 286 YFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI 340
                I   +E+      P + T     I   MI+V  W I A    RP   E+I
Sbjct: 235 -----ISSILEKGERLPQPPICT-----IDVYMIMVKCWMIDA--DSRPKFRELI 277

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 119/276 (43%), Gaps = 54/276 (19%)
Query: 91  LGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTL 126
           LG G FG VYKG  +                         + ++E   ++   + +V  L
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL-RWEKMYEIVIGIAKGLEYLHH 185
           LG CL    + LI + MP G L  +V     +   QYL  W       + IAKG+ YL  
Sbjct: 87  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE- 138
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
               +++H D+   N+L+      KI+DFG AKL   +E    +  G +  I ++A E +
Sbjct: 139 --DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA-EGGKVPIKWMALESI 195
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
             R +   +H+SDV+S+G+ + EL+   +    G+ +S        I   +E+      P
Sbjct: 196 LHRIY---THQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERLPQP 245
Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI 340
            + T     I   MI+V  W I A    RP   E+I
Sbjct: 246 PICT-----IDVYMIMVKCWMIDA--DSRPKFRELI 274

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 119/276 (43%), Gaps = 54/276 (19%)
Query: 91  LGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTL 126
           LG G FG VYKG  +                         + ++E   ++   + +V  L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL-RWEKMYEIVIGIAKGLEYLHH 185
           LG CL    + LI + MP G L  +V     +   QYL  W       + IAKG+ YL  
Sbjct: 85  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE- 136
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
               +++H D+   N+L+      KI+DFG AKL   +E    +  G +  I ++A E +
Sbjct: 137 --DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA-EGGKVPIKWMALESI 193
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
             R +   +H+SDV+S+G+ + EL+   +    G+ +S        I   +E+      P
Sbjct: 194 LHRIY---THQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERLPQP 243
Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI 340
            + T     I   MI+V  W I A    RP   E+I
Sbjct: 244 PICT-----IDVYMIMVKCWMIDA--DSRPKFRELI 272

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 119/276 (43%), Gaps = 54/276 (19%)
Query: 91  LGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTL 126
           LG G FG VYKG  +                         + ++E   ++   + +V  L
Sbjct: 33  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 92
Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL-RWEKMYEIVIGIAKGLEYLHH 185
           LG CL    + LI + MP G L  +V     +   QYL  W       + IAKG+ YL  
Sbjct: 93  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE- 144
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
               +++H D+   N+L+      KI+DFGLAKL   +E    +  G +  I ++A E +
Sbjct: 145 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIKWMALESI 201
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
             R +   +H+SDV+S+G+ + EL+   +    G+ +S        I   +E+      P
Sbjct: 202 LHRIY---THQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERLPQP 251
Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI 340
            + T     I   MI+   W I A    RP   E+I
Sbjct: 252 PICT-----IDVYMIMRKCWMIDA--DSRPKFRELI 280

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 119/276 (43%), Gaps = 54/276 (19%)
Query: 91  LGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTL 126
           LG G FG VYKG  +                         + ++E   ++   + +V  L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL-RWEKMYEIVIGIAKGLEYLHH 185
           LG CL    + LI + MP G L  +V     +   QYL  W       + IAKG+ YL  
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE- 134
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
               +++H D+   N+L+      KI+DFG AKL   +E    +  G +  I ++A E +
Sbjct: 135 --DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA-EGGKVPIKWMALESI 191
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
             R +   +H+SDV+S+G+ + EL+   +    G+ +S        I   +E+      P
Sbjct: 192 LHRIY---THQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERLPQP 241
Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI 340
            + T     I   MI+V  W I A    RP   E+I
Sbjct: 242 PICT-----IDVYMIMVKCWMIDA--DSRPKFRELI 270

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 119/276 (43%), Gaps = 54/276 (19%)
Query: 91  LGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTL 126
           LG G FG VYKG  +                         + ++E   ++   + +V  L
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL-RWEKMYEIVIGIAKGLEYLHH 185
           LG CL    + LI + MP G L  +V     +   QYL  W       + IAKG+ YL  
Sbjct: 90  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE- 141
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
               +++H D+   N+L+      KI+DFG AKL   +E    +  G +  I ++A E +
Sbjct: 142 --DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA-EGGKVPIKWMALESI 198
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
             R +   +H+SDV+S+G+ + EL+   +    G+ +S        I   +E+      P
Sbjct: 199 LHRIY---THQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERLPQP 248
Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI 340
            + T     I   MI+V  W I A    RP   E+I
Sbjct: 249 PICT-----IDVYMIMVKCWMIDA--DSRPKFRELI 277

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 120/251 (47%), Gaps = 33/251 (13%)
Query: 105 LDDFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV---------YN 154
           L D V+E+  +     H N++ LLG C +     +I  +   G+L +++         Y+
Sbjct: 84  LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYS 143
Query: 155 GDTSK-PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISD 213
            D ++ P + + ++ +      +A+G+EYL    S K +H D+   N+L+ E+   KI+D
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIAD 200
Query: 214 FGLAKLCTTKEGIVSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
           FGLA+     +    +  G R  + ++APE +F R +   +H+SDV+SFG+++ E+    
Sbjct: 201 FGLARDINNIDYYKKTTNG-RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEIFTLG 256
Query: 273 NNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSD 332
            +   G+           +++ +++      P   T   NE+   M      C  A PS 
Sbjct: 257 GSPYPGIPVEE-------LFKLLKEGHRMDKPANCT---NELYMMMRD----CWHAVPSQ 302
Query: 333 RPPMNEVIEML 343
           RP   +++E L
Sbjct: 303 RPTFKQLVEDL 313

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 119/276 (43%), Gaps = 54/276 (19%)
Query: 91  LGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTL 126
           LG G FG VYKG  +                         + ++E   ++   + +V  L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL-RWEKMYEIVIGIAKGLEYLHH 185
           LG CL    + LI + MP G L  +V     +   QYL  W       + IAKG+ YL  
Sbjct: 86  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE- 137
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
               +++H D+   N+L+      KI+DFGLAKL   +E    +  G +  I ++A E +
Sbjct: 138 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIKWMALESI 194
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
             R +   +H+SDV+S+G+ + EL+   +    G+ +S        I   +E+      P
Sbjct: 195 LHRIY---THQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERLPQP 244
Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI 340
            + T     I   MI+   W I A    RP   E+I
Sbjct: 245 PICT-----IDVYMIMRKCWMIDA--DSRPKFRELI 273

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 105/227 (46%), Gaps = 47/227 (20%)
Query: 76  NFSDVKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTS---------------- 119
           +++D+K     F+D +G+G FG V K R+  D +   A+I R                  
Sbjct: 20  DWNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE 74
Query: 120 -------HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGD----------TSKPCQ 162
                  H N++ LLG C       L  E+ P+G+L  F+               +    
Sbjct: 75  VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 134
Query: 163 YLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT 222
            L  +++      +A+G++YL      + +H ++   NIL+ E++  KI+DFGL++    
Sbjct: 135 TLSSQQLLHFAADVARGMDYLSQ---KQFIHRNLAARNILVGENYVAKIADFGLSR---G 188
Query: 223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
           +E  V   +G R  + ++A E  S N+   +  SDV+S+G+++ E+V
Sbjct: 189 QEVYVKKTMG-RLPVRWMAIE--SLNYSVYTTNSDVWSYGVLLWEIV 232

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 100/219 (45%), Gaps = 34/219 (15%)
Query: 75  YNFSDVKKLTNSFKDKL-GQGGFGGVYKGRL-----------------------LDDFVN 110
           + F+     TN   DK+ G G FG V  GRL                         DF+ 
Sbjct: 36  HEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY 170
           E + + +  H N++ L G   +     ++ E+M NGSL+ F+   D           ++ 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI-----QLV 150
Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSL 230
            ++ GIA G++YL        +H D+   NIL++ +   K+SDFGLA++         + 
Sbjct: 151 GMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTT 207
Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            G +  I + +PE  +  + + +  SDV+S+G+++ E++
Sbjct: 208 RGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVM 244

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/288 (23%), Positives = 126/288 (43%), Gaps = 57/288 (19%)
Query: 90  KLGQGGFGGVYKGRLLD-------------------------DFVNEVASISRTSHVNVV 124
           +LGQG FG VY+G   D                         +F+NE + +   +  +VV
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 125 TLLGFCLEGNNRALIYEFMPNGSLEKFVYN------GDTSKPCQYLRWEKMYEIVIGIAK 178
            LLG   +G    ++ E M +G L+ ++ +       +  +P   L  ++M ++   IA 
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAEIAD 141
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI-- 236
           G+ YL+   + K +H D+   N ++  DF  KI DFG+ +     +       G +G+  
Sbjct: 142 GMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRK---GGKGLLP 195
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE 296
           + ++APE  S   G  +  SD++SFG+++ E+         G+ +              E
Sbjct: 196 VRWMAPE--SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--------------E 239
Query: 297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
           Q  +F + G    + +   +++  +   C Q  P+ RP   E++ +L+
Sbjct: 240 QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 119/276 (43%), Gaps = 54/276 (19%)
Query: 91  LGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTL 126
           LG G FG VYKG  +                         + ++E   ++   + +V  L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL-RWEKMYEIVIGIAKGLEYLHH 185
           LG CL    + LI + MP G L  +V     +   QYL  W       + IAKG+ YL  
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE- 134
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
               +++H D+   N+L+      KI+DFGLAKL   +E    +  G +  I ++A E +
Sbjct: 135 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIKWMALESI 191
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
             R +   +H+SDV+S+G+ + EL+   +    G+ +S        I   +E+      P
Sbjct: 192 LHRIY---THQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERLPQP 241
Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI 340
            + T     I   MI+   W I A    RP   E+I
Sbjct: 242 PICT-----IDVYMIMRKCWMIDA--DSRPKFRELI 270

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 120/251 (47%), Gaps = 33/251 (13%)
Query: 105 LDDFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV---------YN 154
           L D V+E+  +     H N++ LLG C +     +I E+   G+L +++          +
Sbjct: 84  LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXS 143
Query: 155 GDTSK-PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISD 213
            D ++ P + + ++ +      +A+G+EYL    S K +H D+   N+L+ E+   KI+D
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIAD 200
Query: 214 FGLAKLCTTKEGIVSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
           FGLA+     +    +  G R  + ++APE +F R +   +H+SDV+SFG+++ E+    
Sbjct: 201 FGLARDINNIDXXKKTTNG-RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEIFTLG 256
Query: 273 NNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSD 332
            +   G+           +++ +++      P   T   NE+   M      C  A PS 
Sbjct: 257 GSPYPGIPVEE-------LFKLLKEGHRMDKPANCT---NELYMMMRD----CWHAVPSQ 302
Query: 333 RPPMNEVIEML 343
           RP   +++E L
Sbjct: 303 RPTFKQLVEDL 313

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/241 (29%), Positives = 106/241 (43%), Gaps = 31/241 (12%)
Query: 120 HVNVVTLLGFCLE-GNNRALIYEFMPNGSLEKFV---------YNGDTSKPCQYLRWEKM 169
           H+NVV LLG C + G    +I EF   G+L  ++         Y         +L  E +
Sbjct: 91  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHL 150
Query: 170 YEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSS 229
                 +AKG+E+L    S K +H D+   NILL E    KI DFGLA+        V  
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 207
Query: 230 LLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFP 288
              AR  + ++APE +F R +   + +SDV+SFG+++ E+     +   GV    E    
Sbjct: 208 -GDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---- 259
Query: 289 HWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE 348
               R +++    + P   T        +M    L C    PS RP  +E++E L    +
Sbjct: 260 --FCRRLKEGTRMRAPDYTT-------PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310
Query: 349 A 349
           A
Sbjct: 311 A 311

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/288 (23%), Positives = 125/288 (43%), Gaps = 57/288 (19%)
Query: 90  KLGQGGFGGVYKGRLLD-------------------------DFVNEVASISRTSHVNVV 124
           +LGQG FG VY+G   D                         +F+NE + +   +  +VV
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 125 TLLGFCLEGNNRALIYEFMPNGSLEKFVYN------GDTSKPCQYLRWEKMYEIVIGIAK 178
            LLG   +G    ++ E M +G L+ ++ +       +  +P   L  ++M ++   IA 
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAEIAD 141
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI-- 236
           G+ YL+   + K +H D+   N ++  DF  KI DFG+ +     +       G +G+  
Sbjct: 142 GMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRK---GGKGLLP 195
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE 296
           + ++APE  S   G  +  SD++SFG+++ E+         G+ +              E
Sbjct: 196 VRWMAPE--SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--------------E 239
Query: 297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
           Q  +F + G    + +   +++  +   C Q  P  RP   E++ +L+
Sbjct: 240 QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 92/197 (46%), Gaps = 28/197 (14%)
Query: 90  KLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHVNVVTLLGFCLE 132
           KLG G FG V+ G                   +  F+ E   +    H  +V L     +
Sbjct: 19  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKIL 192
                +I EFM  GSL  F+ + +  K    +   K+ +    IA+G+ Y+        +
Sbjct: 79  EEPIYIITEFMAKGSLLDFLKSDEGGK----VLLPKLIDFSAQIAEGMAYIER---KNYI 131
Query: 193 HFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEV 252
           H D++  N+L+ E    KI+DFGLA++    E   ++  GA+  I + APE    NFG  
Sbjct: 132 HRDLRAANVLVSESLMCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEAI--NFGCF 187
Query: 253 SHKSDVYSFGMMIMELV 269
           + KS+V+SFG+++ E+V
Sbjct: 188 TIKSNVWSFGILLYEIV 204

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 120/251 (47%), Gaps = 33/251 (13%)
Query: 105 LDDFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV---------YN 154
           L D V+E+  +     H N++ LLG C +     +I  +   G+L +++         Y+
Sbjct: 84  LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYS 143
Query: 155 GDTSK-PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISD 213
            D ++ P + + ++ +      +A+G+EYL    S K +H D+   N+L+ E+   KI+D
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIAD 200
Query: 214 FGLAKLCTTKEGIVSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
           FGLA+     +    +  G R  + ++APE +F R +   +H+SDV+SFG+++ E+    
Sbjct: 201 FGLARDINNIDYYKKTTNG-RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEIFTLG 256
Query: 273 NNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSD 332
            +   G+           +++ +++      P   T   NE+   M      C  A PS 
Sbjct: 257 GSPYPGIPVEE-------LFKLLKEGHRMDKPANCT---NELYMMMRD----CWHAVPSQ 302
Query: 333 RPPMNEVIEML 343
           RP   +++E L
Sbjct: 303 RPTFKQLVEDL 313

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/288 (23%), Positives = 125/288 (43%), Gaps = 57/288 (19%)
Query: 90  KLGQGGFGGVYKGRLLD-------------------------DFVNEVASISRTSHVNVV 124
           +LGQG FG VY+G   D                         +F+NE + +   +  +VV
Sbjct: 21  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 80
Query: 125 TLLGFCLEGNNRALIYEFMPNGSLEKFVYN------GDTSKPCQYLRWEKMYEIVIGIAK 178
            LLG   +G    ++ E M +G L+ ++ +       +  +P   L  ++M ++   IA 
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAEIAD 138
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI-- 236
           G+ YL+   + K +H D+   N ++  DF  KI DFG+ +     +       G +G+  
Sbjct: 139 GMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRK---GGKGLLP 192
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE 296
           + ++APE  S   G  +  SD++SFG+++ E+         G+ +              E
Sbjct: 193 VRWMAPE--SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--------------E 236
Query: 297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
           Q  +F + G    + +   +++  +   C Q  P  RP   E++ +L+
Sbjct: 237 QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 284

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 91/197 (46%), Gaps = 28/197 (14%)
Query: 90  KLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHVNVVTLLGFCLE 132
           +LG G FG V+ G                   +  F+ E   +    H  +V L      
Sbjct: 20  RLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKIL 192
                +I E+M  GSL  F+ + +  K    +   K+ +    IA+G+ Y+        +
Sbjct: 80  EEPIYIITEYMAKGSLLDFLKSDEGGK----VLLPKLIDFSAQIAEGMAYIER---KNYI 132
Query: 193 HFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEV 252
           H D++  N+L+ E    KI+DFGLA++    E   ++  GA+  I + APE    NFG  
Sbjct: 133 HRDLRAANVLVSESLMCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEAI--NFGCF 188
Query: 253 SHKSDVYSFGMMIMELV 269
           + KSDV+SFG+++ E+V
Sbjct: 189 TIKSDVWSFGILLYEIV 205

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 100/219 (45%), Gaps = 34/219 (15%)
Query: 75  YNFSDVKKLTNSFKDKL-GQGGFGGVYKGRL-----------------------LDDFVN 110
           + F+     TN   DK+ G G FG V  GRL                         DF+ 
Sbjct: 36  HEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY 170
           E + + +  H N++ L G   +     ++ E+M NGSL+ F+   D           ++ 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI-----QLV 150
Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSL 230
            ++ GIA G++YL        +H D+   NIL++ +   K+SDFGL+++         + 
Sbjct: 151 GMLRGIASGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            G +  I + +PE  +  + + +  SDV+S+G+++ E++
Sbjct: 208 RGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVM 244

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 88/174 (50%), Gaps = 12/174 (6%)
Query: 98  GVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDT 157
           G Y  R   +F++E + + +  H N++ L G         ++ EFM NG+L+ F+   D 
Sbjct: 52  GGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDG 111
Query: 158 SKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLA 217
                     ++  ++ GIA G+ YL        +H D+   NIL++ +   K+SDFGL+
Sbjct: 112 QFTVI-----QLVGMLRGIASGMRYL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLS 163
Query: 218 KLC--TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
           +     + +   +S LG +  I + APE  +  F + +  SD +S+G+++ E++
Sbjct: 164 RFLEENSSDPTYTSSLGGKIPIRWTAPEAIA--FRKFTSASDAWSYGIVMWEVM 215

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 31/207 (14%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKGRLL-----------------DDFVNEVASISRTSHV 121
           D K LT  F  +LG G FG V  G+                   D+F+ E   +   SH 
Sbjct: 6   DPKDLT--FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHE 63
Query: 122 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
            +V L G C +     +I E+M NG L  ++         Q     ++ E+   + + +E
Sbjct: 64  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ-----QLLEMCKDVCEAME 118
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           YL    S + LH D+   N L+++    K+SDFGL++     E   +S +G++  + +  
Sbjct: 119 YLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSP 173
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           PEV    + + S KSD+++FG+++ E+
Sbjct: 174 PEVLM--YSKFSSKSDIWAFGVLMWEI 198

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 100/219 (45%), Gaps = 34/219 (15%)
Query: 75  YNFSDVKKLTNSFKDKL-GQGGFGGVYKGRL-----------------------LDDFVN 110
           + F+     TN   DK+ G G FG V  GRL                         DF+ 
Sbjct: 36  HEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY 170
           E + + +  H N++ L G   +     ++ E+M NGSL+ F+   D           ++ 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI-----QLV 150
Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSL 230
            ++ GIA G++YL        +H D+   NIL++ +   K+SDFGL+++         + 
Sbjct: 151 GMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            G +  I + +PE  +  + + +  SDV+S+G+++ E++
Sbjct: 208 RGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVM 244

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 31/207 (14%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKGRLL-----------------DDFVNEVASISRTSHV 121
           D K LT  F  +LG G FG V  G+                   D+F+ E   +   SH 
Sbjct: 2   DPKDLT--FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHE 59
Query: 122 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
            +V L G C +     +I E+M NG L  ++         Q     ++ E+   + + +E
Sbjct: 60  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ-----QLLEMCKDVCEAME 114
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           YL    S + LH D+   N L+++    K+SDFGL++     E   +S +G++  + +  
Sbjct: 115 YLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSP 169
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           PEV    + + S KSD+++FG+++ E+
Sbjct: 170 PEVLM--YSKFSSKSDIWAFGVLMWEI 194

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 100/219 (45%), Gaps = 34/219 (15%)
Query: 75  YNFSDVKKLTNSFKDKL-GQGGFGGVYKGRL-----------------------LDDFVN 110
           + F+     TN   DK+ G G FG V  GRL                         DF+ 
Sbjct: 24  HEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 83
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY 170
           E + + +  H N++ L G   +     ++ E+M NGSL+ F+   D           ++ 
Sbjct: 84  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI-----QLV 138
Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSL 230
            ++ GIA G++YL        +H D+   NIL++ +   K+SDFGL+++         + 
Sbjct: 139 GMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 195
Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            G +  I + +PE  +  + + +  SDV+S+G+++ E++
Sbjct: 196 RGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVM 232

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 100/219 (45%), Gaps = 34/219 (15%)
Query: 75  YNFSDVKKLTNSFKDKL-GQGGFGGVYKGRL-----------------------LDDFVN 110
           + F+     TN   DK+ G G FG V  GRL                         DF+ 
Sbjct: 34  HEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 93
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY 170
           E + + +  H N++ L G   +     ++ E+M NGSL+ F+   D           ++ 
Sbjct: 94  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI-----QLV 148
Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSL 230
            ++ GIA G++YL        +H D+   NIL++ +   K+SDFGL+++         + 
Sbjct: 149 GMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 205
Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            G +  I + +PE  +  + + +  SDV+S+G+++ E++
Sbjct: 206 RGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVM 242

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 31/207 (14%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKGRLL-----------------DDFVNEVASISRTSHV 121
           D K LT  F  +LG G FG V  G+                   D+F+ E   +   SH 
Sbjct: 7   DPKDLT--FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHE 64
Query: 122 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
            +V L G C +     +I E+M NG L  ++         Q     ++ E+   + + +E
Sbjct: 65  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ-----QLLEMCKDVCEAME 119
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           YL    S + LH D+   N L+++    K+SDFGL++     E   +S +G++  + +  
Sbjct: 120 YLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSP 174
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           PEV    + + S KSD+++FG+++ E+
Sbjct: 175 PEVLM--YSKFSSKSDIWAFGVLMWEI 199

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 100/219 (45%), Gaps = 34/219 (15%)
Query: 75  YNFSDVKKLTNSFKDKL-GQGGFGGVYKGRL-----------------------LDDFVN 110
           + F+     TN   DK+ G G FG V  GRL                         DF+ 
Sbjct: 36  HEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY 170
           E + + +  H N++ L G   +     ++ E+M NGSL+ F+   D           ++ 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI-----QLV 150
Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSL 230
            ++ GIA G++YL        +H D+   NIL++ +   K+SDFGL+++         + 
Sbjct: 151 GMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            G +  I + +PE  +  + + +  SDV+S+G+++ E++
Sbjct: 208 RGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 100/219 (45%), Gaps = 34/219 (15%)
Query: 75  YNFSDVKKLTNSFKDKL-GQGGFGGVYKGRL-----------------------LDDFVN 110
           + F+     TN   DK+ G G FG V  GRL                         DF+ 
Sbjct: 36  HEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY 170
           E + + +  H N++ L G   +     ++ E+M NGSL+ F+   D           ++ 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI-----QLV 150
Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSL 230
            ++ GIA G++YL        +H D+   NIL++ +   K+SDFGL+++         + 
Sbjct: 151 GMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            G +  I + +PE  +  + + +  SDV+S+G+++ E++
Sbjct: 208 RGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVM 244

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 31/207 (14%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKGRLL-----------------DDFVNEVASISRTSHV 121
           D K LT  F  +LG G FG V  G+                   D+F+ E   +   SH 
Sbjct: 22  DPKDLT--FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHE 79
Query: 122 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
            +V L G C +     +I E+M NG L  ++      +     + +++ E+   + + +E
Sbjct: 80  KLVQLYGVCTKQRPIFIITEYMANGCLLNYL-----REMRHRFQTQQLLEMCKDVCEAME 134
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           YL    S + LH D+   N L+++    K+SDFGL++     E   +S +G++  + +  
Sbjct: 135 YLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSP 189
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           PEV    + + S KSD+++FG+++ E+
Sbjct: 190 PEVLM--YSKFSSKSDIWAFGVLMWEI 214

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 100/219 (45%), Gaps = 34/219 (15%)
Query: 75  YNFSDVKKLTNSFKDKL-GQGGFGGVYKGRL-----------------------LDDFVN 110
           + F+     TN   DK+ G G FG V  GRL                         DF+ 
Sbjct: 36  HEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY 170
           E + + +  H N++ L G   +     ++ E+M NGSL+ F+   D           ++ 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI-----QLV 150
Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSL 230
            ++ GIA G++YL        +H D+   NIL++ +   K+SDFGL+++         + 
Sbjct: 151 GMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            G +  I + +PE  +  + + +  SDV+S+G+++ E++
Sbjct: 208 RGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 100/219 (45%), Gaps = 34/219 (15%)
Query: 75  YNFSDVKKLTNSFKDKL-GQGGFGGVYKGRL-----------------------LDDFVN 110
           + F+     TN   DK+ G G FG V  GRL                         DF+ 
Sbjct: 7   HEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 66
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY 170
           E + + +  H N++ L G   +     ++ E+M NGSL+ F+   D           ++ 
Sbjct: 67  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI-----QLV 121
Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSL 230
            ++ GIA G++YL        +H D+   NIL++ +   K+SDFGL+++         + 
Sbjct: 122 GMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 178
Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            G +  I + +PE  +  + + +  SDV+S+G+++ E++
Sbjct: 179 RGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVM 215

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 122/274 (44%), Gaps = 53/274 (19%)
Query: 87  FKDKLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHVNVVTLLGF 129
            + KLG G FG V+                     ++ F+ E   +    H  +V L   
Sbjct: 186 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 245
Query: 130 CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCST 189
             +     +I EFM  GSL  F+ + + SK  Q L   K+ +    IA+G+ ++      
Sbjct: 246 VTK-EPIYIITEFMAKGSLLDFLKSDEGSK--QPL--PKLIDFSAQIAEGMAFIEQ---R 297
Query: 190 KILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNF 249
             +H D++  NIL+      KI+DFGLA++            GA+  I + APE    NF
Sbjct: 298 NYIHRDLRAANILVSASLVCKIADFGLARV------------GAKFPIKWTAPEAI--NF 343
Query: 250 GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTR 309
           G  + KSDV+SFG+++ME+V        G+ +         + R +E  R +++P    R
Sbjct: 344 GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-------VIRALE--RGYRMP----R 390
Query: 310 KENEIAKKMIIVGLWCIQARPSDRPPMNEVIEML 343
            EN   +++  + + C + RP +RP    +  +L
Sbjct: 391 PEN-CPEELYNIMMRCWKNRPEERPTFEYIQSVL 423

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 31/207 (14%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKGRLL-----------------DDFVNEVASISRTSHV 121
           D K LT  F  +LG G FG V  G+                   D+F+ E   +   SH 
Sbjct: 13  DPKDLT--FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHE 70
Query: 122 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
            +V L G C +     +I E+M NG L  ++         Q     ++ E+   + + +E
Sbjct: 71  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ-----QLLEMCKDVCEAME 125
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           YL    S + LH D+   N L+++    K+SDFGL++     E   +S +G++  + +  
Sbjct: 126 YLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSP 180
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           PEV    + + S KSD+++FG+++ E+
Sbjct: 181 PEVLM--YSKFSSKSDIWAFGVLMWEI 205

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 31/207 (14%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKGRLL-----------------DDFVNEVASISRTSHV 121
           D K LT  F  +LG G FG V  G+                   D+F+ E   +   SH 
Sbjct: 22  DPKDLT--FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHE 79
Query: 122 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
            +V L G C +     +I E+M NG L  ++      +     + +++ E+   + + +E
Sbjct: 80  KLVQLYGVCTKQRPIFIITEYMANGCLLNYL-----REMRHRFQTQQLLEMCKDVCEAME 134
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           YL    S + LH D+   N L+++    K+SDFGL++     E   +S +G++  + +  
Sbjct: 135 YLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEE--TSSVGSKFPVRWSP 189
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           PEV    + + S KSD+++FG+++ E+
Sbjct: 190 PEVLM--YSKFSSKSDIWAFGVLMWEI 214

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 88/174 (50%), Gaps = 12/174 (6%)
Query: 98  GVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDT 157
           G Y  R   +F++E + + +  H N++ L G         ++ EFM NG+L+ F+   D 
Sbjct: 54  GGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDG 113
Query: 158 SKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLA 217
                     ++  ++ GIA G+ YL        +H D+   NIL++ +   K+SDFGL+
Sbjct: 114 QFTVI-----QLVGMLRGIASGMRYL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLS 165
Query: 218 KLC--TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
           +     + +   +S LG +  I + APE  +  F + +  SD +S+G+++ E++
Sbjct: 166 RFLEENSSDPTETSSLGGKIPIRWTAPEAIA--FRKFTSASDAWSYGIVMWEVM 217

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/288 (23%), Positives = 125/288 (43%), Gaps = 57/288 (19%)
Query: 90  KLGQGGFGGVYKGRLLD-------------------------DFVNEVASISRTSHVNVV 124
           +LGQG FG VY+G   D                         +F+NE + +   +  +VV
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 125 TLLGFCLEGNNRALIYEFMPNGSLEKFVYN------GDTSKPCQYLRWEKMYEIVIGIAK 178
            LLG   +G    ++ E M +G L+ ++ +       +  +P   L  ++M ++   IA 
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAEIAD 141
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI-- 236
           G+ YL+   + K +H D+   N ++  DF  KI DFG+ +     +       G +G+  
Sbjct: 142 GMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK---GGKGLLP 195
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE 296
           + ++APE  S   G  +  SD++SFG+++ E+         G+ +              E
Sbjct: 196 VRWMAPE--SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--------------E 239
Query: 297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
           Q  +F + G    + +   +++  +   C Q  P  RP   E++ +L+
Sbjct: 240 QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 99/219 (45%), Gaps = 34/219 (15%)
Query: 75  YNFSDVKKLTNSFKDKL-GQGGFGGVYKGRL-----------------------LDDFVN 110
           + F+     TN   DK+ G G FG V  GRL                         DF+ 
Sbjct: 36  HEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY 170
           E + + +  H N++ L G   +     ++ E+M NGSL+ F+   D           ++ 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI-----QLV 150
Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSL 230
            ++ GIA G++YL        +H D+   NIL++ +   K+SDFGL ++         + 
Sbjct: 151 GMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTT 207
Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            G +  I + +PE  +  + + +  SDV+S+G+++ E++
Sbjct: 208 RGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVM 244

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 97/226 (42%), Gaps = 35/226 (15%)
Query: 68  GPLPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRL----------------------- 104
           G +P   +N +  ++    F  +LG+G FG V   R                        
Sbjct: 13  GLVPRGSHNMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH 72
Query: 105 LDDFVNEVASISRTSHVNVVTLLGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQ 162
           L DF  E+  +    H N+V   G C     R   LI E++P GSL  ++      K  +
Sbjct: 73  LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-----QKHKE 127
Query: 163 YLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT 222
            +   K+ +    I KG+EYL    + + +H D+   NIL++ +   KI DFGL K+   
Sbjct: 128 RIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 184
Query: 223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMEL 268
            +            I + APE  + +  + S  SDV+SFG+++ EL
Sbjct: 185 DKEXXKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYEL 228

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 97/226 (42%), Gaps = 35/226 (15%)
Query: 68  GPLPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRL----------------------- 104
           G +P   +N +  ++    F  +LG+G FG V   R                        
Sbjct: 13  GLVPRGSHNMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH 72
Query: 105 LDDFVNEVASISRTSHVNVVTLLGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQ 162
           L DF  E+  +    H N+V   G C     R   LI E++P GSL  ++      K  +
Sbjct: 73  LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-----QKHKE 127
Query: 163 YLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT 222
            +   K+ +    I KG+EYL    + + +H D+   NIL++ +   KI DFGL K+   
Sbjct: 128 RIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 184
Query: 223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMEL 268
            +            I + APE  + +  + S  SDV+SFG+++ EL
Sbjct: 185 DKEXXKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYEL 228

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 108/244 (44%), Gaps = 36/244 (14%)
Query: 120 HVNVVTLLGFCLE-GNNRALIYEFMPNGSLEKFVYNG------------DTSKPCQYLRW 166
           H+NVV LLG C + G    +I EF   G+L  ++ +             D  K   +L  
Sbjct: 81  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK--DFLTL 138
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
           E +      +AKG+E+L    S K +H D+   NILL E    KI DFGLA+        
Sbjct: 139 EHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 195
Query: 227 VSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
           V     AR  + ++APE +F R +   + +SDV+SFG+++ E+     +   GV    E 
Sbjct: 196 VRK-GDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE- 250
Query: 286 YFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG 345
                  R +++    + P   T        +M    L C    PS RP  +E++E L  
Sbjct: 251 -----FCRRLKEGTRMRAPDYTT-------PEMYQTMLDCWHGEPSQRPTFSELVEHLGN 298
Query: 346 STEA 349
             +A
Sbjct: 299 LLQA 302

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 125/304 (41%), Gaps = 59/304 (19%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKG------------RLLDDFVNEVASI-SRTSHVN--- 122
           +V +   +   +LGQG FG VY+G            R+    VNE AS+  R   +N   
Sbjct: 6   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 65
Query: 123 ---------VVTLLGFCLEGNNRALIYEFMPNGSLEKFVY-------NGDTSKPCQYLRW 166
                    VV LLG   +G    +I E M  G L+ ++        N     P      
Sbjct: 66  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL--- 122
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
            KM ++   IA G+ YL+   + K +H D+   N ++ EDF  KI DFG+ +     +  
Sbjct: 123 SKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXX 179
Query: 227 VSSLLGARGI--IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE 284
                G +G+  + +++PE  S   G  +  SDV+SFG+++ E+         G+ +   
Sbjct: 180 RK---GGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--- 231
Query: 285 VYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
                      EQ   F + G +  K +     ++ +   C Q  P  RP   E+I  ++
Sbjct: 232 -----------EQVLRFVMEGGLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIK 280
Query: 345 GSTE 348
              E
Sbjct: 281 EEME 284

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 108/244 (44%), Gaps = 36/244 (14%)
Query: 120 HVNVVTLLGFCLE-GNNRALIYEFMPNGSLEKFVYNG------------DTSKPCQYLRW 166
           H+NVV LLG C + G    +I EF   G+L  ++ +             D  K   +L  
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK--DFLTL 138
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
           E +      +AKG+E+L    S K +H D+   NILL E    KI DFGLA+        
Sbjct: 139 EHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 195
Query: 227 VSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
           V     AR  + ++APE +F R +   + +SDV+SFG+++ E+     +   GV    E 
Sbjct: 196 VRK-GDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE- 250
Query: 286 YFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG 345
                  R +++    + P   T        +M    L C    PS RP  +E++E L  
Sbjct: 251 -----FCRRLKEGTRMRAPDYTT-------PEMYQTMLDCWHGEPSQRPTFSELVEHLGN 298
Query: 346 STEA 349
             +A
Sbjct: 299 LLQA 302

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 108/244 (44%), Gaps = 36/244 (14%)
Query: 120 HVNVVTLLGFCLE-GNNRALIYEFMPNGSLEKFVYNG------------DTSKPCQYLRW 166
           H+NVV LLG C + G    +I EF   G+L  ++ +             D  K   +L  
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK--DFLTL 147
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
           E +      +AKG+E+L    S K +H D+   NILL E    KI DFGLA+        
Sbjct: 148 EHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 204
Query: 227 VSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
           V     AR  + ++APE +F R +   + +SDV+SFG+++ E+     +   GV    E 
Sbjct: 205 VRK-GDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE- 259
Query: 286 YFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG 345
                  R +++    + P   T        +M    L C    PS RP  +E++E L  
Sbjct: 260 -----FCRRLKEGTRMRAPDYTT-------PEMYQTMLDCWHGEPSQRPTFSELVEHLGN 307
Query: 346 STEA 349
             +A
Sbjct: 308 LLQA 311

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 89/178 (50%), Gaps = 23/178 (12%)
Query: 108 FVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWE 167
           F+ EV  +    H NV+  +G   +      I E++  G+L   + + D+  P     W 
Sbjct: 54  FLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYP-----WS 108
Query: 168 KMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC----TTK 223
           +       IA G+ YLH   S  I+H D+  HN L+ E+    ++DFGLA+L     T  
Sbjct: 109 QRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165
Query: 224 EGIVSSLLGAR----GIIG---YIAPEVFS-RNFGEVSHKSDVYSFGMMIMELVGCKN 273
           EG+ S     R     ++G   ++APE+ + R++ E   K DV+SFG+++ E++G  N
Sbjct: 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDE---KVDVFSFGIVLCEIIGRVN 220

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 118/276 (42%), Gaps = 54/276 (19%)
Query: 91  LGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTL 126
           LG G FG VYKG  +                         + ++E   ++   + +V  L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL-RWEKMYEIVIGIAKGLEYLHH 185
           LG CL    + LI + MP G L  +V     +   QYL  W       + IAKG+ YL  
Sbjct: 85  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE- 136
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
               +++H D+   N+L+      KI+DFG AKL   +E    +  G +  I ++A E +
Sbjct: 137 --DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA-EGGKVPIKWMALESI 193
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
             R +   +H+SDV+S+G+ + EL+   +    G+ +S        I   +E+      P
Sbjct: 194 LHRIY---THQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERLPQP 243
Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI 340
            + T     I   MI+   W I A    RP   E+I
Sbjct: 244 PICT-----IDVYMIMRKCWMIDA--DSRPKFRELI 272

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 124/289 (42%), Gaps = 49/289 (16%)
Query: 91  LGQGGFGGVYKGRL------------------------LDDFVNEVASISRTSHVNVVTL 126
           LG+G FG V +G L                        +++F++E A +   SH NV+ L
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 127 LGFCLEGNNRAL-----IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           LG C+E +++ +     I  FM  G L  ++         +++  + + + ++ IA G+E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           YL    +   LH D+   N +L +D    ++DFGL+K   + +      + A+  + +IA
Sbjct: 162 YL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRI-AKMPVKWIA 217
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
            E  +      + KSDV++FG+ + E+         GV +       H +Y ++      
Sbjct: 218 IESLADRV--YTSKSDVWAFGVTMWEIATRGMTPYPGVQN-------HEMYDYLLHGHRL 268
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEAL 350
           K P     +  EI          C +  P DRP  + +   L+   E+L
Sbjct: 269 KQPEDCLDELYEIMYS-------CWRTDPLDRPTFSVLRLQLEKLLESL 310

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKGRLL-----------------DDFVNEVASISRTSHV 121
           D K LT  F  +LG G FG V  G+                   D+F+ E   +   SH 
Sbjct: 7   DPKDLT--FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHE 64
Query: 122 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
            +V L G C +     +I E+M NG L  ++         Q     ++ E+   + + +E
Sbjct: 65  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ-----QLLEMCKDVCEAME 119
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           YL    S + LH D+   N L+++    K+SDFGL++     E   +S  G++  + +  
Sbjct: 120 YLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSRGSKFPVRWSP 174
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           PEV    + + S KSD+++FG+++ E+
Sbjct: 175 PEVLM--YSKFSSKSDIWAFGVLMWEI 199

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 118/276 (42%), Gaps = 54/276 (19%)
Query: 91  LGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTL 126
           LG G FG VYKG  +                         + ++E   ++   + +V  L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL-RWEKMYEIVIGIAKGLEYLHH 185
           LG CL    + LI + MP G L  +V     +   QYL  W       + IAKG+ YL  
Sbjct: 85  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE- 136
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
               +++H D+   N+L+      KI+DFG AKL   +E    +  G +  I ++A E +
Sbjct: 137 --DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA-EGGKVPIKWMALESI 193
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
             R +   +H+SDV+S+G+ + EL+   +    G+ +S        I   +E+      P
Sbjct: 194 LHRIY---THQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERLPQP 243
Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI 340
            + T     I   MI+   W I A    RP   E+I
Sbjct: 244 PICT-----IDVYMIMRKCWMIDA--DSRPKFRELI 272

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/288 (23%), Positives = 124/288 (43%), Gaps = 57/288 (19%)
Query: 90  KLGQGGFGGVYKGRLLD-------------------------DFVNEVASISRTSHVNVV 124
           +LGQG FG VY+G   D                         +F+NE + +   +  +VV
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 125 TLLGFCLEGNNRALIYEFMPNGSLEKFVYN------GDTSKPCQYLRWEKMYEIVIGIAK 178
            LLG   +G    ++ E M +G L+ ++ +       +  +P   L  ++M ++   IA 
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAEIAD 141
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI-- 236
           G+ YL+   + K +H D+   N ++  DF  KI DFG+ +             G +G+  
Sbjct: 142 GMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE---TAYYRKGGKGLLP 195
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE 296
           + ++APE  S   G  +  SD++SFG+++ E+         G+ +              E
Sbjct: 196 VRWMAPE--SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--------------E 239
Query: 297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
           Q  +F + G    + +   +++  +   C Q  P  RP   E++ +L+
Sbjct: 240 QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/288 (23%), Positives = 125/288 (43%), Gaps = 57/288 (19%)
Query: 90  KLGQGGFGGVYKGRLLD-------------------------DFVNEVASISRTSHVNVV 124
           +LGQG FG VY+G   D                         +F+NE + +   +  +VV
Sbjct: 23  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 82
Query: 125 TLLGFCLEGNNRALIYEFMPNGSLEKFVYN------GDTSKPCQYLRWEKMYEIVIGIAK 178
            LLG   +G    ++ E M +G L+ ++ +       +  +P   L  ++M ++   IA 
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAEIAD 140
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI-- 236
           G+ YL+   + K +H D+   N ++  DF  KI DFG+ +     +       G +G+  
Sbjct: 141 GMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK---GGKGLLP 194
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE 296
           + ++APE  S   G  +  SD++SFG+++ E+         G+ +              E
Sbjct: 195 VRWMAPE--SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--------------E 238
Query: 297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
           Q  +F + G    + +   +++  +   C Q  P  RP   E++ +L+
Sbjct: 239 QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 286

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 108/244 (44%), Gaps = 36/244 (14%)
Query: 120 HVNVVTLLGFCLE-GNNRALIYEFMPNGSLEKFVYNG------------DTSKPCQYLRW 166
           H+NVV LLG C + G    +I EF   G+L  ++ +             D  K   +L  
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK--DFLTL 147
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
           E +      +AKG+E+L    S K +H D+   NILL E    KI DFGLA+        
Sbjct: 148 EHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDX 204
Query: 227 VSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
           V     AR  + ++APE +F R +   + +SDV+SFG+++ E+     +   GV    E 
Sbjct: 205 VRK-GDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE- 259
Query: 286 YFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG 345
                  R +++    + P   T        +M    L C    PS RP  +E++E L  
Sbjct: 260 -----FCRRLKEGTRMRAPDYTT-------PEMYQTMLDCWHGEPSQRPTFSELVEHLGN 307
Query: 346 STEA 349
             +A
Sbjct: 308 LLQA 311

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 108/244 (44%), Gaps = 36/244 (14%)
Query: 120 HVNVVTLLGFCLE-GNNRALIYEFMPNGSLEKFVYNG------------DTSKPCQYLRW 166
           H+NVV LLG C + G    +I EF   G+L  ++ +             D  K   +L  
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK--DFLTL 147
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
           E +      +AKG+E+L    S K +H D+   NILL E    KI DFGLA+        
Sbjct: 148 EHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 204
Query: 227 VSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
           V     AR  + ++APE +F R +   + +SDV+SFG+++ E+     +   GV    E 
Sbjct: 205 VRK-GDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE- 259
Query: 286 YFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG 345
                  R +++    + P   T        +M    L C    PS RP  +E++E L  
Sbjct: 260 -----FCRRLKEGTRMRAPDYTT-------PEMYQTMLDCWHGEPSQRPTFSELVEHLGN 307
Query: 346 STEA 349
             +A
Sbjct: 308 LLQA 311

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 108/244 (44%), Gaps = 36/244 (14%)
Query: 120 HVNVVTLLGFCLE-GNNRALIYEFMPNGSLEKFVYNG------------DTSKPCQYLRW 166
           H+NVV LLG C + G    +I EF   G+L  ++ +             D  K   +L  
Sbjct: 92  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYK--DFLTL 149
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
           E +      +AKG+E+L    S K +H D+   NILL E    KI DFGLA+        
Sbjct: 150 EHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 206
Query: 227 VSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
           V     AR  + ++APE +F R +   + +SDV+SFG+++ E+     +   GV    E 
Sbjct: 207 VRK-GDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE- 261
Query: 286 YFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG 345
                  R +++    + P   T        +M    L C    PS RP  +E++E L  
Sbjct: 262 -----FCRRLKEGTRMRAPDYTT-------PEMYQTMLDCWHGEPSQRPTFSELVEHLGN 309
Query: 346 STEA 349
             +A
Sbjct: 310 LLQA 313

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 108/244 (44%), Gaps = 36/244 (14%)
Query: 120 HVNVVTLLGFCLE-GNNRALIYEFMPNGSLEKFVYNG------------DTSKPCQYLRW 166
           H+NVV LLG C + G    +I EF   G+L  ++ +             D  K   +L  
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK--DFLTL 138
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
           E +      +AKG+E+L    S K +H D+   NILL E    KI DFGLA+        
Sbjct: 139 EHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 195
Query: 227 VSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
           V     AR  + ++APE +F R +   + +SDV+SFG+++ E+     +   GV    E 
Sbjct: 196 VRK-GDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE- 250
Query: 286 YFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG 345
                  R +++    + P   T        +M    L C    PS RP  +E++E L  
Sbjct: 251 -----FCRRLKEGTRMRAPDYTT-------PEMYQTMLDCWHGEPSQRPTFSELVEHLGN 298
Query: 346 STEA 349
             +A
Sbjct: 299 LLQA 302

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 108/244 (44%), Gaps = 36/244 (14%)
Query: 120 HVNVVTLLGFCLE-GNNRALIYEFMPNGSLEKFVYNG------------DTSKPCQYLRW 166
           H+NVV LLG C + G    +I EF   G+L  ++ +             D  K   +L  
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK--DFLTL 138
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
           E +      +AKG+E+L    S K +H D+   NILL E    KI DFGLA+        
Sbjct: 139 EHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 195
Query: 227 VSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
           V     AR  + ++APE +F R +   + +SDV+SFG+++ E+     +   GV    E 
Sbjct: 196 VRK-GDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE- 250
Query: 286 YFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG 345
                  R +++    + P   T        +M    L C    PS RP  +E++E L  
Sbjct: 251 -----FCRRLKEGTRMRAPDYTT-------PEMYQTMLDCWHGEPSQRPTFSELVEHLGN 298
Query: 346 STEA 349
             +A
Sbjct: 299 LLQA 302

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 108/244 (44%), Gaps = 36/244 (14%)
Query: 120 HVNVVTLLGFCLE-GNNRALIYEFMPNGSLEKFVYNG------------DTSKPCQYLRW 166
           H+NVV LLG C + G    +I EF   G+L  ++ +             D  K   +L  
Sbjct: 127 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK--DFLTL 184
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
           E +      +AKG+E+L    S K +H D+   NILL E    KI DFGLA+        
Sbjct: 185 EHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 241
Query: 227 VSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
           V     AR  + ++APE +F R +   + +SDV+SFG+++ E+     +   GV    E 
Sbjct: 242 VRK-GDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE- 296
Query: 286 YFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG 345
                  R +++    + P   T        +M    L C    PS RP  +E++E L  
Sbjct: 297 -----FCRRLKEGTRMRAPDYTT-------PEMYQTMLDCWHGEPSQRPTFSELVEHLGN 344
Query: 346 STEA 349
             +A
Sbjct: 345 LLQA 348

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 99/219 (45%), Gaps = 34/219 (15%)
Query: 75  YNFSDVKKLTNSFKDKL-GQGGFGGVYKGRL-----------------------LDDFVN 110
           + F+     TN   DK+ G G FG V  GRL                         DF+ 
Sbjct: 36  HEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY 170
           E + + +  H N++ L G   +     ++ E M NGSL+ F+   D           ++ 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVI-----QLV 150
Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSL 230
            ++ GIA G++YL        +H D+   NIL++ +   K+SDFGL+++         + 
Sbjct: 151 GMLRGIASGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            G +  I + +PE  +  + + +  SDV+S+G+++ E++
Sbjct: 208 RGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVM 244

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 124/304 (40%), Gaps = 59/304 (19%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKG------------RLLDDFVNEVASI-SRTSHVN--- 122
           +V +   +   +LGQG FG VY+G            R+    VNE AS+  R   +N   
Sbjct: 15  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 74
Query: 123 ---------VVTLLGFCLEGNNRALIYEFMPNGSLEKFVY-------NGDTSKPCQYLRW 166
                    VV LLG   +G    +I E M  G L+ ++        N     P      
Sbjct: 75  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL--- 131
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
            KM ++   IA G+ YL+   + K +H D+   N ++ EDF  KI DFG+ +     +  
Sbjct: 132 SKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXX 188
Query: 227 VSSLLGARGI--IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE 284
                G +G+  + +++PE  S   G  +  SDV+SFG+++ E+         G+ +   
Sbjct: 189 RK---GGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--- 240
Query: 285 VYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
                      EQ   F + G +  K +     +  +   C Q  P  RP   E+I  ++
Sbjct: 241 -----------EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 289
Query: 345 GSTE 348
              E
Sbjct: 290 EEME 293

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 99/219 (45%), Gaps = 34/219 (15%)
Query: 75  YNFSDVKKLTNSFKDKL-GQGGFGGVYKGRL-----------------------LDDFVN 110
           + F+     TN   DK+ G G FG V  GRL                         DF+ 
Sbjct: 36  HEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY 170
           E + + +  H N++ L G   +     ++ E M NGSL+ F+   D           ++ 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVI-----QLV 150
Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSL 230
            ++ GIA G++YL        +H D+   NIL++ +   K+SDFGL+++         + 
Sbjct: 151 GMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            G +  I + +PE  +  + + +  SDV+S+G+++ E++
Sbjct: 208 RGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 99/219 (45%), Gaps = 34/219 (15%)
Query: 75  YNFSDVKKLTNSFKDKL-GQGGFGGVYKGRL-----------------------LDDFVN 110
           + F+     TN   DK+ G G FG V  GRL                         DF+ 
Sbjct: 7   HEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 66
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY 170
           E + + +  H N++ L G   +     ++ E M NGSL+ F+   D           ++ 
Sbjct: 67  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVI-----QLV 121
Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSL 230
            ++ GIA G++YL        +H D+   NIL++ +   K+SDFGL+++         + 
Sbjct: 122 GMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 178
Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            G +  I + +PE  +  + + +  SDV+S+G+++ E++
Sbjct: 179 RGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVM 215

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 126/288 (43%), Gaps = 57/288 (19%)
Query: 90  KLGQGGFGGVYKGRLLD-------------------------DFVNEVASISRTSHVNVV 124
           +LGQG FG VY+G   D                         +F+NE + +   +  +VV
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 125 TLLGFCLEGNNRALIYEFMPNGSLEKFVYN------GDTSKPCQYLRWEKMYEIVIGIAK 178
            LLG   +G    ++ E M +G L+ ++ +       +  +P   L  ++M ++   IA 
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAEIAD 141
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI-- 236
           G+ YL+   + K +H ++   N ++  DF  KI DFG+ +     +       G +G+  
Sbjct: 142 GMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK---GGKGLLP 195
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE 296
           + ++APE  S   G  +  SD++SFG+++ E+         G+ +              E
Sbjct: 196 VRWMAPE--SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--------------E 239
Query: 297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
           Q  +F + G    + +   +++  +   C Q  P+ RP   E++ +L+
Sbjct: 240 QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 93/197 (47%), Gaps = 29/197 (14%)
Query: 90  KLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHVNVVTLLGFCLE 132
           +LG G FG V+ G                    + F+ E   + +  H  +V L     E
Sbjct: 16  RLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVSE 75
Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKIL 192
                ++ E+M  GSL  F+ +G+     + L+   + ++   +A G+ Y+        +
Sbjct: 76  -EPIYIVTEYMNKGSLLDFLKDGEG----RALKLPNLVDMAAQVAAGMAYIER---MNYI 127
Query: 193 HFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEV 252
           H D++  NIL+      KI+DFGLA+L    E   ++  GA+  I + APE  +  +G  
Sbjct: 128 HRDLRSANILVGNGLICKIADFGLARLIEDNE--XTARQGAKFPIKWTAPE--AALYGRF 183
Query: 253 SHKSDVYSFGMMIMELV 269
           + KSDV+SFG+++ ELV
Sbjct: 184 TIKSDVWSFGILLTELV 200

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 124/304 (40%), Gaps = 59/304 (19%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKG------------RLLDDFVNEVASI-SRTSHVN--- 122
           +V +   +   +LGQG FG VY+G            R+    VNE AS+  R   +N   
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80
Query: 123 ---------VVTLLGFCLEGNNRALIYEFMPNGSLEKFV-------YNGDTSKPCQYLRW 166
                    VV LLG   +G    +I E M  G L+ ++        N     P      
Sbjct: 81  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL--- 137
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
            KM ++   IA G+ YL+   + K +H D+   N ++ EDF  KI DFG+ +     +  
Sbjct: 138 SKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 194
Query: 227 VSSLLGARGI--IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE 284
                G +G+  + +++PE  S   G  +  SDV+SFG+++ E+         G+ +   
Sbjct: 195 RK---GGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--- 246
Query: 285 VYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
                      EQ   F + G +  K +     +  +   C Q  P  RP   E+I  ++
Sbjct: 247 -----------EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295
Query: 345 GSTE 348
              E
Sbjct: 296 EEME 299

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 126/288 (43%), Gaps = 57/288 (19%)
Query: 90  KLGQGGFGGVYKGRLLD-------------------------DFVNEVASISRTSHVNVV 124
           +LGQG FG VY+G   D                         +F+NE + +   +  +VV
Sbjct: 25  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 84
Query: 125 TLLGFCLEGNNRALIYEFMPNGSLEKFVYN------GDTSKPCQYLRWEKMYEIVIGIAK 178
            LLG   +G    ++ E M +G L+ ++ +       +  +P   L  ++M ++   IA 
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAEIAD 142
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI-- 236
           G+ YL+   + K +H ++   N ++  DF  KI DFG+ +     +       G +G+  
Sbjct: 143 GMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK---GGKGLLP 196
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE 296
           + ++APE  S   G  +  SD++SFG+++ E+         G+ +              E
Sbjct: 197 VRWMAPE--SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--------------E 240
Query: 297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
           Q  +F + G    + +   +++  +   C Q  P+ RP   E++ +L+
Sbjct: 241 QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 288

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 85/170 (50%), Gaps = 12/170 (7%)
Query: 102 GRLLDDFVNEVASISRTSHVNVVTLLGFCLE--GNNRALIYEFMPNGSLEKFVYNGDTSK 159
           G  + D   E+  +    H N+V   G C E  GN   LI EF+P+GSL++++      K
Sbjct: 64  GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-----PK 118
Query: 160 PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL 219
               +  ++  +  + I KG++YL    S + +H D+   N+L++ +   KI DFGL K 
Sbjct: 119 NKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175
Query: 220 CTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             T +   +        + + APE   ++   ++  SDV+SFG+ + EL+
Sbjct: 176 IETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIA--SDVWSFGVTLHELL 223

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 85/170 (50%), Gaps = 12/170 (7%)
Query: 102 GRLLDDFVNEVASISRTSHVNVVTLLGFCLE--GNNRALIYEFMPNGSLEKFVYNGDTSK 159
           G  + D   E+  +    H N+V   G C E  GN   LI EF+P+GSL++++      K
Sbjct: 52  GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-----PK 106
Query: 160 PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL 219
               +  ++  +  + I KG++YL    S + +H D+   N+L++ +   KI DFGL K 
Sbjct: 107 NKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 163
Query: 220 CTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             T +   +        + + APE   ++   ++  SDV+SFG+ + EL+
Sbjct: 164 IETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIA--SDVWSFGVTLHELL 211

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 124/304 (40%), Gaps = 59/304 (19%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKG------------RLLDDFVNEVASI-SRTSHVN--- 122
           +V +   +   +LGQG FG VY+G            R+    VNE AS+  R   +N   
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80
Query: 123 ---------VVTLLGFCLEGNNRALIYEFMPNGSLEKFVY-------NGDTSKPCQYLRW 166
                    VV LLG   +G    +I E M  G L+ ++        N     P      
Sbjct: 81  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL--- 137
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
            KM ++   IA G+ YL+   + K +H D+   N ++ EDF  KI DFG+ +     +  
Sbjct: 138 SKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 194
Query: 227 VSSLLGARGI--IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE 284
                G +G+  + +++PE  S   G  +  SDV+SFG+++ E+         G+ +   
Sbjct: 195 RK---GGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--- 246
Query: 285 VYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
                      EQ   F + G +  K +     +  +   C Q  P  RP   E+I  ++
Sbjct: 247 -----------EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295
Query: 345 GSTE 348
              E
Sbjct: 296 EEME 299

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 90/207 (43%), Gaps = 35/207 (16%)
Query: 87  FKDKLGQGGFGGVYKGRL-----------------------LDDFVNEVASISRTSHVNV 123
           F  +LG+G FG V   R                        L DF  E+  +    H N+
Sbjct: 17  FLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 124 VTLLGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           V   G C     R   LI EF+P GSL +++      K  + +   K+ +    I KG+E
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEFLPYGSLREYL-----QKHKERIDHIKLLQYTSQICKGME 131
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           YL    + + +H D+   NIL++ +   KI DFGL K+    +            I + A
Sbjct: 132 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 188
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           PE  + +  + S  SDV+SFG+++ EL
Sbjct: 189 PESLTES--KFSVASDVWSFGVVLYEL 213

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 124/304 (40%), Gaps = 59/304 (19%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKG------------RLLDDFVNEVASI-SRTSHVN--- 122
           +V +   +   +LGQG FG VY+G            R+    VNE AS+  R   +N   
Sbjct: 11  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 70
Query: 123 ---------VVTLLGFCLEGNNRALIYEFMPNGSLEKFV-------YNGDTSKPCQYLRW 166
                    VV LLG   +G    +I E M  G L+ ++        N     P      
Sbjct: 71  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL--- 127
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
            KM ++   IA G+ YL+   + K +H D+   N ++ EDF  KI DFG+ +     +  
Sbjct: 128 SKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 184
Query: 227 VSSLLGARGI--IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE 284
                G +G+  + +++PE  S   G  +  SDV+SFG+++ E+         G+ +   
Sbjct: 185 RK---GGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--- 236
Query: 285 VYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
                      EQ   F + G +  K +     +  +   C Q  P  RP   E+I  ++
Sbjct: 237 -----------EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 285
Query: 345 GSTE 348
              E
Sbjct: 286 EEME 289

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 124/304 (40%), Gaps = 59/304 (19%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKG------------RLLDDFVNEVASI-SRTSHVN--- 122
           +V +   +   +LGQG FG VY+G            R+    VNE AS+  R   +N   
Sbjct: 43  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 102
Query: 123 ---------VVTLLGFCLEGNNRALIYEFMPNGSLEKFVY-------NGDTSKPCQYLRW 166
                    VV LLG   +G    +I E M  G L+ ++        N     P      
Sbjct: 103 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL--- 159
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
            KM ++   IA G+ YL+   + K +H D+   N ++ EDF  KI DFG+ +     +  
Sbjct: 160 SKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 216
Query: 227 VSSLLGARGI--IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE 284
                G +G+  + +++PE  S   G  +  SDV+SFG+++ E+         G+ +   
Sbjct: 217 RK---GGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--- 268
Query: 285 VYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
                      EQ   F + G +  K +     +  +   C Q  P  RP   E+I  ++
Sbjct: 269 -----------EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 317
Query: 345 GSTE 348
              E
Sbjct: 318 EEME 321

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 124/304 (40%), Gaps = 59/304 (19%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKG------------RLLDDFVNEVASI-SRTSHVN--- 122
           +V +   +   +LGQG FG VY+G            R+    VNE AS+  R   +N   
Sbjct: 14  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 73
Query: 123 ---------VVTLLGFCLEGNNRALIYEFMPNGSLEKFVY-------NGDTSKPCQYLRW 166
                    VV LLG   +G    +I E M  G L+ ++        N     P      
Sbjct: 74  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL--- 130
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
            KM ++   IA G+ YL+   + K +H D+   N ++ EDF  KI DFG+ +     +  
Sbjct: 131 SKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 187
Query: 227 VSSLLGARGI--IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE 284
                G +G+  + +++PE  S   G  +  SDV+SFG+++ E+         G+ +   
Sbjct: 188 RK---GGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--- 239
Query: 285 VYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
                      EQ   F + G +  K +     +  +   C Q  P  RP   E+I  ++
Sbjct: 240 -----------EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 288
Query: 345 GSTE 348
              E
Sbjct: 289 EEME 292

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 124/304 (40%), Gaps = 59/304 (19%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKG------------RLLDDFVNEVASI-SRTSHVN--- 122
           +V +   +   +LGQG FG VY+G            R+    VNE AS+  R   +N   
Sbjct: 14  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 73
Query: 123 ---------VVTLLGFCLEGNNRALIYEFMPNGSLEKFVY-------NGDTSKPCQYLRW 166
                    VV LLG   +G    +I E M  G L+ ++        N     P      
Sbjct: 74  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL--- 130
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
            KM ++   IA G+ YL+   + K +H D+   N ++ EDF  KI DFG+ +     +  
Sbjct: 131 SKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 187
Query: 227 VSSLLGARGI--IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE 284
                G +G+  + +++PE  S   G  +  SDV+SFG+++ E+         G+ +   
Sbjct: 188 RK---GGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--- 239
Query: 285 VYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
                      EQ   F + G +  K +     +  +   C Q  P  RP   E+I  ++
Sbjct: 240 -----------EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 288
Query: 345 GSTE 348
              E
Sbjct: 289 EEME 292

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 124/304 (40%), Gaps = 59/304 (19%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKG------------RLLDDFVNEVASI-SRTSHVN--- 122
           +V +   +   +LGQG FG VY+G            R+    VNE AS+  R   +N   
Sbjct: 12  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 71
Query: 123 ---------VVTLLGFCLEGNNRALIYEFMPNGSLEKFVY-------NGDTSKPCQYLRW 166
                    VV LLG   +G    +I E M  G L+ ++        N     P      
Sbjct: 72  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL--- 128
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
            KM ++   IA G+ YL+   + K +H D+   N ++ EDF  KI DFG+ +     +  
Sbjct: 129 SKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 185
Query: 227 VSSLLGARGI--IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE 284
                G +G+  + +++PE  S   G  +  SDV+SFG+++ E+         G+ +   
Sbjct: 186 RK---GGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--- 237
Query: 285 VYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
                      EQ   F + G +  K +     +  +   C Q  P  RP   E+I  ++
Sbjct: 238 -----------EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 286
Query: 345 GSTE 348
              E
Sbjct: 287 EEME 290

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 124/304 (40%), Gaps = 59/304 (19%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKG------------RLLDDFVNEVASI-SRTSHVN--- 122
           +V +   +   +LGQG FG VY+G            R+    VNE AS+  R   +N   
Sbjct: 15  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 74
Query: 123 ---------VVTLLGFCLEGNNRALIYEFMPNGSLEKFVY-------NGDTSKPCQYLRW 166
                    VV LLG   +G    +I E M  G L+ ++        N     P      
Sbjct: 75  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL--- 131
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
            KM ++   IA G+ YL+   + K +H D+   N ++ EDF  KI DFG+ +     +  
Sbjct: 132 SKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 188
Query: 227 VSSLLGARGI--IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE 284
                G +G+  + +++PE  S   G  +  SDV+SFG+++ E+         G+ +   
Sbjct: 189 RK---GGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--- 240
Query: 285 VYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
                      EQ   F + G +  K +     +  +   C Q  P  RP   E+I  ++
Sbjct: 241 -----------EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 289
Query: 345 GSTE 348
              E
Sbjct: 290 EEME 293

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 124/304 (40%), Gaps = 59/304 (19%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKG------------RLLDDFVNEVASI-SRTSHVN--- 122
           +V +   +   +LGQG FG VY+G            R+    VNE AS+  R   +N   
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 67
Query: 123 ---------VVTLLGFCLEGNNRALIYEFMPNGSLEKFVY-------NGDTSKPCQYLRW 166
                    VV LLG   +G    +I E M  G L+ ++        N     P      
Sbjct: 68  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL--- 124
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
            KM ++   IA G+ YL+   + K +H D+   N ++ EDF  KI DFG+ +     +  
Sbjct: 125 SKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 181
Query: 227 VSSLLGARGI--IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE 284
                G +G+  + +++PE  S   G  +  SDV+SFG+++ E+         G+ +   
Sbjct: 182 RK---GGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--- 233
Query: 285 VYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
                      EQ   F + G +  K +     +  +   C Q  P  RP   E+I  ++
Sbjct: 234 -----------EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 282
Query: 345 GSTE 348
              E
Sbjct: 283 EEME 286

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 37/205 (18%)
Query: 91  LGQGGFGGVYKGRLLDDFVNEVA----SISRTS-------------------HVNVVTLL 127
           +G+G FG VY G  +D   N +     S+SR +                   H NV+ L+
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 128 GFCL--EGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
           G  L  EG    L+  +M +G L +F+ +   +   +      +    + +A+G+EYL  
Sbjct: 89  GIMLPPEGLPHVLL-PYMCHGDLLQFIRSPQRNPTVK-----DLISFGLQVARGMEYL-- 140
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI-VSSLLGARGIIGYIAPEV 244
               K +H D+   N +LDE F  K++DFGLA+    +E   V     AR  + + A E 
Sbjct: 141 -AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE- 198
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELV 269
            S      + KSDV+SFG+++ EL+
Sbjct: 199 -SLQTYRFTTKSDVWSFGVLLWELL 222

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 124/304 (40%), Gaps = 59/304 (19%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKG------------RLLDDFVNEVASI-SRTSHVN--- 122
           +V +   +   +LGQG FG VY+G            R+    VNE AS+  R   +N   
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 67
Query: 123 ---------VVTLLGFCLEGNNRALIYEFMPNGSLEKFVY-------NGDTSKPCQYLRW 166
                    VV LLG   +G    +I E M  G L+ ++        N     P      
Sbjct: 68  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL--- 124
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
            KM ++   IA G+ YL+   + K +H D+   N  + EDF  KI DFG+ +     +  
Sbjct: 125 SKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYY 181
Query: 227 VSSLLGARGI--IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE 284
                G +G+  + +++PE  S   G  +  SDV+SFG+++ E+         G+ +   
Sbjct: 182 RK---GGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--- 233
Query: 285 VYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
                      EQ   F + G +  K +     ++ +   C Q  P  RP   E+I  ++
Sbjct: 234 -----------EQVLRFVMEGGLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIK 282
Query: 345 GSTE 348
              E
Sbjct: 283 EEME 286

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 89/207 (42%), Gaps = 35/207 (16%)
Query: 87  FKDKLGQGGFGGVYKGRL-----------------------LDDFVNEVASISRTSHVNV 123
           F  +LG+G FG V   R                        L DF  E+  +    H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 124 VTLLGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           V   G C     R   LI E++P GSL  ++      K  + +   K+ +    I KG+E
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-----QKHKERIDHIKLLQYTSQICKGME 128
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           YL    + + +H D+   NIL++ +   KI DFGL K+    +            I + A
Sbjct: 129 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           PE  + +  + S  SDV+SFG+++ EL
Sbjct: 186 PESLTES--KFSVASDVWSFGVVLYEL 210

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 35/210 (16%)
Query: 81  KKLTNSFKDKLGQGGFGGVYKG-----------------------RLLDDFVNEVASISR 117
           +KL      +LG G FG V KG                        L D+ + E   + +
Sbjct: 25  RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 84
Query: 118 TSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIA 177
             +  +V ++G C E  +  L+ E    G L K++      +  ++++ + + E+V  ++
Sbjct: 85  LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL------QQNRHVKDKNIIELVHQVS 137
Query: 178 KGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGII 237
            G++YL     +  +H D+   N+LL      KISDFGL+K     E    +    +  +
Sbjct: 138 MGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 194
Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIME 267
            + APE    N+ + S KSDV+SFG+++ E
Sbjct: 195 KWYAPECI--NYYKFSSKSDVWSFGVLMWE 222

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 35/210 (16%)
Query: 81  KKLTNSFKDKLGQGGFGGVYKG-----------------------RLLDDFVNEVASISR 117
           +KL      +LG G FG V KG                        L D+ + E   + +
Sbjct: 25  RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 84
Query: 118 TSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIA 177
             +  +V ++G C E  +  L+ E    G L K++      +  ++++ + + E+V  ++
Sbjct: 85  LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL------QQNRHVKDKNIIELVHQVS 137
Query: 178 KGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGII 237
            G++YL     +  +H D+   N+LL      KISDFGL+K     E    +    +  +
Sbjct: 138 MGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 194
Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIME 267
            + APE    N+ + S KSDV+SFG+++ E
Sbjct: 195 KWYAPECI--NYYKFSSKSDVWSFGVLMWE 222

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 35/210 (16%)
Query: 81  KKLTNSFKDKLGQGGFGGVYKG-----------------------RLLDDFVNEVASISR 117
           +KL      +LG G FG V KG                        L D+ + E   + +
Sbjct: 23  RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 82
Query: 118 TSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIA 177
             +  +V ++G C E  +  L+ E    G L K++      +  ++++ + + E+V  ++
Sbjct: 83  LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL------QQNRHVKDKNIIELVHQVS 135
Query: 178 KGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGII 237
            G++YL     +  +H D+   N+LL      KISDFGL+K     E    +    +  +
Sbjct: 136 MGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 192
Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIME 267
            + APE    N+ + S KSDV+SFG+++ E
Sbjct: 193 KWYAPECI--NYYKFSSKSDVWSFGVLMWE 220

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 35/210 (16%)
Query: 81  KKLTNSFKDKLGQGGFGGVYKG-----------------------RLLDDFVNEVASISR 117
           +KL      +LG G FG V KG                        L D+ + E   + +
Sbjct: 367 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 426
Query: 118 TSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIA 177
             +  +V ++G C E  +  L+ E    G L K++      +  ++++ + + E+V  ++
Sbjct: 427 LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL------QQNRHVKDKNIIELVHQVS 479
Query: 178 KGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGII 237
            G++YL     +  +H D+   N+LL      KISDFGL+K     E    +    +  +
Sbjct: 480 MGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 536
Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIME 267
            + APE    N+ + S KSDV+SFG+++ E
Sbjct: 537 KWYAPECI--NYYKFSSKSDVWSFGVLMWE 564

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 89/207 (42%), Gaps = 35/207 (16%)
Query: 87  FKDKLGQGGFGGVYKGRL-----------------------LDDFVNEVASISRTSHVNV 123
           F  +LG+G FG V   R                        L DF  E+  +    H N+
Sbjct: 18  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 77
Query: 124 VTLLGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           V   G C     R   LI E++P GSL  ++      K  + +   K+ +    I KG+E
Sbjct: 78  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-----QKHKERIDHIKLLQYTSQICKGME 132
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           YL    + + +H D+   NIL++ +   KI DFGL K+    +            I + A
Sbjct: 133 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 189
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           PE  + +  + S  SDV+SFG+++ EL
Sbjct: 190 PESLTES--KFSVASDVWSFGVVLYEL 214

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 89/207 (42%), Gaps = 35/207 (16%)
Query: 87  FKDKLGQGGFGGVYKGRL-----------------------LDDFVNEVASISRTSHVNV 123
           F  +LG+G FG V   R                        L DF  E+  +    H N+
Sbjct: 13  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 72
Query: 124 VTLLGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           V   G C     R   LI E++P GSL  ++      K  + +   K+ +    I KG+E
Sbjct: 73  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-----QKHKERIDHIKLLQYTSQICKGME 127
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           YL    + + +H D+   NIL++ +   KI DFGL K+    +            I + A
Sbjct: 128 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 184
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           PE  + +  + S  SDV+SFG+++ EL
Sbjct: 185 PESLTES--KFSVASDVWSFGVVLYEL 209

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 89/207 (42%), Gaps = 35/207 (16%)
Query: 87  FKDKLGQGGFGGVYKGRL-----------------------LDDFVNEVASISRTSHVNV 123
           F  +LG+G FG V   R                        L DF  E+  +    H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 124 VTLLGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           V   G C     R   LI E++P GSL  ++      K  + +   K+ +    I KG+E
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-----QKHKERIDHIKLLQYTSQICKGME 128
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           YL    + + +H D+   NIL++ +   KI DFGL K+    +            I + A
Sbjct: 129 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 185
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           PE  + +  + S  SDV+SFG+++ EL
Sbjct: 186 PESLTES--KFSVASDVWSFGVVLYEL 210

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 35/210 (16%)
Query: 81  KKLTNSFKDKLGQGGFGGVYKG-----------------------RLLDDFVNEVASISR 117
           +KL      +LG G FG V KG                        L D+ + E   + +
Sbjct: 368 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 427
Query: 118 TSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIA 177
             +  +V ++G C E  +  L+ E    G L K++      +  ++++ + + E+V  ++
Sbjct: 428 LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL------QQNRHVKDKNIIELVHQVS 480
Query: 178 KGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGII 237
            G++YL     +  +H D+   N+LL      KISDFGL+K     E    +    +  +
Sbjct: 481 MGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 537
Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIME 267
            + APE    N+ + S KSDV+SFG+++ E
Sbjct: 538 KWYAPECI--NYYKFSSKSDVWSFGVLMWE 565

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 89/207 (42%), Gaps = 35/207 (16%)
Query: 87  FKDKLGQGGFGGVYKGRL-----------------------LDDFVNEVASISRTSHVNV 123
           F  +LG+G FG V   R                        L DF  E+  +    H N+
Sbjct: 12  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 71
Query: 124 VTLLGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           V   G C     R   LI E++P GSL  ++      K  + +   K+ +    I KG+E
Sbjct: 72  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-----QKHKERIDHIKLLQYTSQICKGME 126
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           YL    + + +H D+   NIL++ +   KI DFGL K+    +            I + A
Sbjct: 127 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 183
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           PE  + +  + S  SDV+SFG+++ EL
Sbjct: 184 PESLTES--KFSVASDVWSFGVVLYEL 208

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 89/207 (42%), Gaps = 35/207 (16%)
Query: 87  FKDKLGQGGFGGVYKGRL-----------------------LDDFVNEVASISRTSHVNV 123
           F  +LG+G FG V   R                        L DF  E+  +    H N+
Sbjct: 17  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 124 VTLLGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           V   G C     R   LI E++P GSL  ++      K  + +   K+ +    I KG+E
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-----QKHKERIDHIKLLQYTSQICKGME 131
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           YL    + + +H D+   NIL++ +   KI DFGL K+    +            I + A
Sbjct: 132 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 188
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           PE  + +  + S  SDV+SFG+++ EL
Sbjct: 189 PESLTES--KFSVASDVWSFGVVLYEL 213

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 35/210 (16%)
Query: 81  KKLTNSFKDKLGQGGFGGVYKG-----------------------RLLDDFVNEVASISR 117
           +KL      +LG G FG V KG                        L D+ + E   + +
Sbjct: 9   RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 68
Query: 118 TSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIA 177
             +  +V ++G C E  +  L+ E    G L K++      +  ++++ + + E+V  ++
Sbjct: 69  LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL------QQNRHVKDKNIIELVHQVS 121
Query: 178 KGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGII 237
            G++YL     +  +H D+   N+LL      KISDFGL+K     E    +    +  +
Sbjct: 122 MGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPV 178
Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIME 267
            + APE    N+ + S KSDV+SFG+++ E
Sbjct: 179 KWYAPECI--NYYKFSSKSDVWSFGVLMWE 206

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 35/210 (16%)
Query: 81  KKLTNSFKDKLGQGGFGGVYKG-----------------------RLLDDFVNEVASISR 117
           +KL      +LG G FG V KG                        L D+ + E   + +
Sbjct: 3   RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 62
Query: 118 TSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIA 177
             +  +V ++G C E  +  L+ E    G L K++      +  ++++ + + E+V  ++
Sbjct: 63  LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL------QQNRHVKDKNIIELVHQVS 115
Query: 178 KGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGII 237
            G++YL     +  +H D+   N+LL      KISDFGL+K     E    +    +  +
Sbjct: 116 MGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 172
Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIME 267
            + APE    N+ + S KSDV+SFG+++ E
Sbjct: 173 KWYAPECI--NYYKFSSKSDVWSFGVLMWE 200

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 89/207 (42%), Gaps = 35/207 (16%)
Query: 87  FKDKLGQGGFGGVYKGRL-----------------------LDDFVNEVASISRTSHVNV 123
           F  +LG+G FG V   R                        L DF  E+  +    H N+
Sbjct: 19  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 78
Query: 124 VTLLGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           V   G C     R   LI E++P GSL  ++      K  + +   K+ +    I KG+E
Sbjct: 79  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-----QKHKERIDHIKLLQYTSQICKGME 133
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           YL    + + +H D+   NIL++ +   KI DFGL K+    +            I + A
Sbjct: 134 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 190
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           PE  + +  + S  SDV+SFG+++ EL
Sbjct: 191 PESLTES--KFSVASDVWSFGVVLYEL 215

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 89/207 (42%), Gaps = 35/207 (16%)
Query: 87  FKDKLGQGGFGGVYKGRL-----------------------LDDFVNEVASISRTSHVNV 123
           F  +LG+G FG V   R                        L DF  E+  +    H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 124 VTLLGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           V   G C     R   LI E++P GSL  ++      K  + +   K+ +    I KG+E
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-----QKHKERIDHIKLLQYTSQICKGME 128
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           YL    + + +H D+   NIL++ +   KI DFGL K+    +            I + A
Sbjct: 129 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 185
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           PE  + +  + S  SDV+SFG+++ EL
Sbjct: 186 PESLTES--KFSVASDVWSFGVVLYEL 210

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 35/210 (16%)
Query: 81  KKLTNSFKDKLGQGGFGGVYKG-----------------------RLLDDFVNEVASISR 117
           +KL      +LG G FG V KG                        L D+ + E   + +
Sbjct: 15  RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 74
Query: 118 TSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIA 177
             +  +V ++G C E  +  L+ E    G L K++      +  ++++ + + E+V  ++
Sbjct: 75  LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL------QQNRHVKDKNIIELVHQVS 127
Query: 178 KGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGII 237
            G++YL     +  +H D+   N+LL      KISDFGL+K     E    +    +  +
Sbjct: 128 MGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 184
Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIME 267
            + APE    N+ + S KSDV+SFG+++ E
Sbjct: 185 KWYAPECI--NYYKFSSKSDVWSFGVLMWE 212

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 89/207 (42%), Gaps = 35/207 (16%)
Query: 87  FKDKLGQGGFGGVYKGRL-----------------------LDDFVNEVASISRTSHVNV 123
           F  +LG+G FG V   R                        L DF  E+  +    H N+
Sbjct: 20  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 79
Query: 124 VTLLGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           V   G C     R   LI E++P GSL  ++      K  + +   K+ +    I KG+E
Sbjct: 80  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-----QKHKERIDHIKLLQYTSQICKGME 134
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           YL    + + +H D+   NIL++ +   KI DFGL K+    +            I + A
Sbjct: 135 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 191
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           PE  + +  + S  SDV+SFG+++ EL
Sbjct: 192 PESLTES--KFSVASDVWSFGVVLYEL 216

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 35/210 (16%)
Query: 81  KKLTNSFKDKLGQGGFGGVYKG-----------------------RLLDDFVNEVASISR 117
           +KL      +LG G FG V KG                        L D+ + E   + +
Sbjct: 5   RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 64
Query: 118 TSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIA 177
             +  +V ++G C E  +  L+ E    G L K++      +  ++++ + + E+V  ++
Sbjct: 65  LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL------QQNRHVKDKNIIELVHQVS 117
Query: 178 KGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGII 237
            G++YL     +  +H D+   N+LL      KISDFGL+K     E    +    +  +
Sbjct: 118 MGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 174
Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIME 267
            + APE    N+ + S KSDV+SFG+++ E
Sbjct: 175 KWYAPECI--NYYKFSSKSDVWSFGVLMWE 202

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 89/207 (42%), Gaps = 35/207 (16%)
Query: 87  FKDKLGQGGFGGVYKGRL-----------------------LDDFVNEVASISRTSHVNV 123
           F  +LG+G FG V   R                        L DF  E+  +    H N+
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 124 VTLLGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           V   G C     R   LI E++P GSL  ++      K  + +   K+ +    I KG+E
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-----QKHKERIDHIKLLQYTSQICKGME 159
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           YL    + + +H D+   NIL++ +   KI DFGL K+    +            I + A
Sbjct: 160 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 216
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           PE  + +  + S  SDV+SFG+++ EL
Sbjct: 217 PESLTES--KFSVASDVWSFGVVLYEL 241

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 89/207 (42%), Gaps = 35/207 (16%)
Query: 87  FKDKLGQGGFGGVYKGRL-----------------------LDDFVNEVASISRTSHVNV 123
           F  +LG+G FG V   R                        L DF  E+  +    H N+
Sbjct: 21  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 80
Query: 124 VTLLGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           V   G C     R   LI E++P GSL  ++      K  + +   K+ +    I KG+E
Sbjct: 81  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-----QKHKERIDHIKLLQYTSQICKGME 135
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           YL    + + +H D+   NIL++ +   KI DFGL K+    +            I + A
Sbjct: 136 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 192
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           PE  + +  + S  SDV+SFG+++ EL
Sbjct: 193 PESLTES--KFSVASDVWSFGVVLYEL 217

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 35/210 (16%)
Query: 81  KKLTNSFKDKLGQGGFGGVYKG-----------------------RLLDDFVNEVASISR 117
           +KL      +LG G FG V KG                        L D+ + E   + +
Sbjct: 9   RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 68
Query: 118 TSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIA 177
             +  +V ++G C E  +  L+ E    G L K++      +  ++++ + + E+V  ++
Sbjct: 69  LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL------QQNRHVKDKNIIELVHQVS 121
Query: 178 KGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGII 237
            G++YL     +  +H D+   N+LL      KISDFGL+K     E    +    +  +
Sbjct: 122 MGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 178
Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIME 267
            + APE    N+ + S KSDV+SFG+++ E
Sbjct: 179 KWYAPECI--NYYKFSSKSDVWSFGVLMWE 206

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 88/207 (42%), Gaps = 35/207 (16%)
Query: 87  FKDKLGQGGFGGVYKGRL-----------------------LDDFVNEVASISRTSHVNV 123
           F  +LG+G FG V   R                        L DF  E+  +    H N+
Sbjct: 17  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 124 VTLLGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           V   G C     R   LI E++P GSL  ++         + +   K+ +    I KG+E
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-----QAHAERIDHIKLLQYTSQICKGME 131
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           YL    + + +H D+   NIL++ +   KI DFGL K+    +            I + A
Sbjct: 132 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 188
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           PE  + +  + S  SDV+SFG+++ EL
Sbjct: 189 PESLTES--KFSVASDVWSFGVVLYEL 213

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 103/242 (42%), Gaps = 48/242 (19%)
Query: 63  FIRNYGPLPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLL----------------- 105
            I  +    LK  + S V+     F ++LG+  FG VYKG L                  
Sbjct: 11  LINQHKQAKLKEISLSAVR-----FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK 65
Query: 106 --------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVY---- 153
                   ++F +E    +R  H NVV LLG   +    ++I+ +  +G L +F+     
Sbjct: 66  DKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSP 125
Query: 154 ------NGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDF 207
                   D       L       +V  IA G+EYL    S  ++H D+   N+L+ +  
Sbjct: 126 HSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKL 182
Query: 208 CPKISDFGLAKLCTTKEGIVSSLLGARGI-IGYIAPEVFSRNFGEVSHKSDVYSFGMMIM 266
             KISD GL +     +     LLG   + I ++APE     +G+ S  SD++S+G+++ 
Sbjct: 183 NVKISDLGLFREVYAAD--YYKLLGNSLLPIRWMAPEAIM--YGKFSIDSDIWSYGVVLW 238
Query: 267 EL 268
           E+
Sbjct: 239 EV 240

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 127/282 (45%), Gaps = 58/282 (20%)
Query: 91  LGQGGFGGVYKG---------------RLLDD---------FVNEVASISRTSHVNVVTL 126
           LG G FG V+KG               ++++D           + + +I    H ++V L
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTS-KPCQYLRWEKMYEIVIGIAKGLEYLH- 184
           LG C  G++  L+ +++P GSL   V     +  P   L W       + IAKG+ YL  
Sbjct: 81  LGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG------VQIAKGMYYLEE 133
Query: 185 HGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC--TTKEGIVSSLLGARGIIGYIAP 242
           HG    ++H ++   N+LL      +++DFG+A L     K+ + S    A+  I ++A 
Sbjct: 134 HG----MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE---AKTPIKWMAL 186
Query: 243 EVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK 302
           E  S +FG+ +H+SDV+S+G+ + EL+       +G+  +        +   +E+     
Sbjct: 187 E--SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-------VPDLLEKGERLA 237
Query: 303 LPGVVTRKENEIAKKMIIVGLWCIQA--RPSDRPPMNEVIEM 342
            P + T     I   M++V  W I    RP+ +   NE   M
Sbjct: 238 QPQICT-----IDVYMVMVKCWMIDENIRPTFKELANEFTRM 274

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 127/282 (45%), Gaps = 58/282 (20%)
Query: 91  LGQGGFGGVYKG---------------RLLDD---------FVNEVASISRTSHVNVVTL 126
           LG G FG V+KG               ++++D           + + +I    H ++V L
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTS-KPCQYLRWEKMYEIVIGIAKGLEYLH- 184
           LG C  G++  L+ +++P GSL   V     +  P   L W       + IAKG+ YL  
Sbjct: 99  LGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG------VQIAKGMYYLEE 151
Query: 185 HGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC--TTKEGIVSSLLGARGIIGYIAP 242
           HG    ++H ++   N+LL      +++DFG+A L     K+ + S    A+  I ++A 
Sbjct: 152 HG----MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE---AKTPIKWMAL 204
Query: 243 EVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK 302
           E  S +FG+ +H+SDV+S+G+ + EL+       +G+  +        +   +E+     
Sbjct: 205 E--SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-------VPDLLEKGERLA 255
Query: 303 LPGVVTRKENEIAKKMIIVGLWCIQA--RPSDRPPMNEVIEM 342
            P + T     I   M++V  W I    RP+ +   NE   M
Sbjct: 256 QPQICT-----IDVYMVMVKCWMIDENIRPTFKELANEFTRM 292

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 89/207 (42%), Gaps = 35/207 (16%)
Query: 87  FKDKLGQGGFGGVYKGRL-----------------------LDDFVNEVASISRTSHVNV 123
           F  +LG+G FG V   R                        L DF  E+  +    H N+
Sbjct: 15  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 74
Query: 124 VTLLGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           V   G C     R   LI E++P GSL  ++      K  + +   K+ +    I KG+E
Sbjct: 75  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-----QKHKERIDHIKLLQYTSQICKGME 129
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           YL    + + +H ++   NIL++ +   KI DFGL K+    +            I + A
Sbjct: 130 YL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA 186
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           PE  + +  + S  SDV+SFG+++ EL
Sbjct: 187 PESLTES--KFSVASDVWSFGVVLYEL 211

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 37/204 (18%)
Query: 89  DKLGQGGFGGVY----------------------KGRLLDDFVNEVASISRTSHVNVVTL 126
           DKLG GG   VY                      K   L  F  EV + S+ SH N+V++
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
           +    E +   L+ E++   +L +++   ++  P   L  +        I  G+++ H  
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGP---LSVDTAINFTNQILDGIKHAH-- 128
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
              +I+H DIKP NIL+D +   KI DFG+AK  +  E  ++      G + Y +PE   
Sbjct: 129 -DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS--ETSLTQTNHVLGTVQYFSPE--- 182
Query: 247 RNFGEVSHK-SDVYSFGMMIMELV 269
           +  GE + + +D+YS G+++ E++
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEML 206

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 135/292 (46%), Gaps = 80/292 (27%)
Query: 91  LGQGGFGGVYKGRLLDD---FV------------NEVASISRTSHVNVVTLLGFCLEG-- 133
           +G GGFG V+K +   D   +V             EV ++++  HVN+V   G C +G  
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNG-CWDGFD 77
Query: 134 ---------NNRA------LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
                    ++R+      +  EF   G+LE+++      K  + L      E+   I K
Sbjct: 78  YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL----ALELFEQITK 133
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLG------ 232
           G++Y+H   S K+++ D+KP NI L +    KI DFGL          V+SL        
Sbjct: 134 GVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGL----------VTSLKNDGKRXR 180
Query: 233 ARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWI 291
           ++G + Y++PE + S+++G+   + D+Y+ G+++ EL+      D+  ++S   +F    
Sbjct: 181 SKGTLRYMSPEQISSQDYGK---EVDLYALGLILAELLHV---CDTAFETSK--FFTDL- 231
Query: 292 YRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEML 343
                  R+  +  +  +KE  + +K+       +  +P DRP  +E++  L
Sbjct: 232 -------RDGIISDIFDKKEKTLLQKL-------LSKKPEDRPNTSEILRTL 269

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 93/220 (42%), Gaps = 40/220 (18%)
Query: 92  GQGGFGGVYKGRLLDDFVN----------------EVASISRTSHVNVVTLLGFCLEGN- 134
            +G FG V+K +LL+++V                 EV S+    H N++  +G    G  
Sbjct: 33  ARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS 92
Query: 135 ---NRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH------ 185
              +  LI  F   GSL  F+           + W ++  I   +A+GL YLH       
Sbjct: 93  VDVDLWLITAFHEKGSLSDFL-------KANVVSWNELCHIAETMARGLAYLHEDIPGLK 145
Query: 186 -GCSTKILHFDIKPHNILLDEDFCPKISDFGLA-KLCTTKEGIVSSLLGARGIIGYIAPE 243
            G    I H DIK  N+LL  +    I+DFGLA K    K        G  G   Y+APE
Sbjct: 146 DGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA--GDTHGQVGTRRYMAPE 203
Query: 244 VF--SRNFGEVSH-KSDVYSFGMMIMELVGCKNNLDSGVD 280
           V   + NF   +  + D+Y+ G+++ EL       D  VD
Sbjct: 204 VLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 101/233 (43%), Gaps = 48/233 (20%)
Query: 72  LKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLL-------------------------D 106
           LK  + S V+     F ++LG+  FG VYKG L                          +
Sbjct: 3   LKEISLSAVR-----FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLRE 57
Query: 107 DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVY----------NGD 156
           +F +E    +R  H NVV LLG   +    ++I+ +  +G L +F+             D
Sbjct: 58  EFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDD 117
Query: 157 TSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGL 216
                  L       +V  IA G+EYL    S  ++H D+   N+L+ +    KISD GL
Sbjct: 118 DRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGL 174
Query: 217 AKLCTTKEGIVSSLLGARGI-IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMEL 268
            +     +     LLG   + I ++APE     +G+ S  SD++S+G+++ E+
Sbjct: 175 FREVYAAD--YYKLLGNSLLPIRWMAPEAIM--YGKFSIDSDIWSYGVVLWEV 223

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 78/312 (25%), Positives = 125/312 (40%), Gaps = 60/312 (19%)
Query: 73  KRYNFSDVKKLTN---SFKDKLGQGGFGGVYKGRLLD----------------------- 106
           K  + SD+K++     +    LG G FG VY+G++                         
Sbjct: 35  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 94
Query: 107 --DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQ-- 162
             DF+ E   IS+ +H N+V  +G  L+   R ++ E M  G L+ F+      +P Q  
Sbjct: 95  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRE-TRPRPSQPS 153
Query: 163 YLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP------KISDFGL 216
            L    +  +   IA G +YL        +H DI   N LL    CP      KI DFG+
Sbjct: 154 SLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLT---CPGPGRVAKIGDFGM 207
Query: 217 AKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLD 276
           A+    + G       A   + ++ PE F    G  + K+D +SFG+++ E+      + 
Sbjct: 208 ARD-IYRAGYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSL-GYMP 263
Query: 277 SGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPM 336
               S+ EV    ++      D     PG V R           +   C Q +P DRP  
Sbjct: 264 YPSKSNQEVL--EFVTSGGRMDPPKNCPGPVYR-----------IMTQCWQHQPEDRPNF 310
Query: 337 NEVIEMLQGSTE 348
             ++E ++  T+
Sbjct: 311 AIILERIEYCTQ 322

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 99/224 (44%), Gaps = 45/224 (20%)
Query: 80  VKKLTNSFKDKLGQGGFGGVYKGRLLD------------------------DFVNEVASI 115
           +K+     K +LG+G FG V+     +                        DF  E   +
Sbjct: 10  IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELL 69
Query: 116 SRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--------VYNGDTSKPCQYLRWE 167
           +   H ++V   G C+EG+   +++E+M +G L KF        V   + + P + L   
Sbjct: 70  TNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTE-LTQS 128
Query: 168 KMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV 227
           +M  I   IA G+ YL    S   +H D+   N L+ E+   KI DFG+++   + +   
Sbjct: 129 QMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD--- 182
Query: 228 SSLLGARGI--IGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMEL 268
              +G   +  I ++ PE +  R F   + +SDV+S G+++ E+
Sbjct: 183 YYRVGGHTMLPIRWMPPESIMYRKF---TTESDVWSLGVVLWEI 223

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 78/312 (25%), Positives = 125/312 (40%), Gaps = 60/312 (19%)
Query: 73  KRYNFSDVKKLTN---SFKDKLGQGGFGGVYKGRLLD----------------------- 106
           K  + SD+K++     +    LG G FG VY+G++                         
Sbjct: 58  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 117
Query: 107 --DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQ-- 162
             DF+ E   IS+ +H N+V  +G  L+   R ++ E M  G L+ F+      +P Q  
Sbjct: 118 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRE-TRPRPSQPS 176
Query: 163 YLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP------KISDFGL 216
            L    +  +   IA G +YL        +H DI   N LL    CP      KI DFG+
Sbjct: 177 SLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLT---CPGPGRVAKIGDFGM 230
Query: 217 AKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLD 276
           A+    + G       A   + ++ PE F    G  + K+D +SFG+++ E+      + 
Sbjct: 231 ARD-IYRAGYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSL-GYMP 286
Query: 277 SGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPM 336
               S+ EV    ++      D     PG V R           +   C Q +P DRP  
Sbjct: 287 YPSKSNQEVL--EFVTSGGRMDPPKNCPGPVYR-----------IMTQCWQHQPEDRPNF 333
Query: 337 NEVIEMLQGSTE 348
             ++E ++  T+
Sbjct: 334 AIILERIEYCTQ 345

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 37/211 (17%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKGRLL-------------------DDFVNEVASISRTS 119
           D KK    F +K+GQG  G VY    +                   +  +NE+  +    
Sbjct: 17  DPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK 75
Query: 120 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
           + N+V  L   L G+   ++ E++  GSL   V     ++ C  +   ++  +     + 
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETC--MDEGQIAAVCRECLQA 128
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
           LE+LH   S +++H DIK  NILL  D   K++DFG     T ++   S+++G      +
Sbjct: 129 LEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP---YW 182
Query: 240 IAPEVFSRN-FGEVSHKSDVYSFGMMIMELV 269
           +APEV +R  +G    K D++S G+M +E++
Sbjct: 183 MAPEVVTRKAYGP---KVDIWSLGIMAIEMI 210

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 134/301 (44%), Gaps = 85/301 (28%)
Query: 91  LGQGGFGGVYKGRLLDD---FV------------NEVASISRTSHVNVVTLLGFCLEGNN 135
           +G GGFG V+K +   D   +V             EV ++++  HVN+V   G C +G  
Sbjct: 20  IGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVKALAKLDHVNIVHYNG-CWDG-- 76
Query: 136 RALIYEFMP---NGSLEKFVYNGDTSK-------PCQYL-----------------RWEK 168
               +++ P   + SLE   Y+ + SK        C ++                 R EK
Sbjct: 77  ----FDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 132
Query: 169 M-----YEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK 223
           +      E+   I KG++Y+H   S K++H D+KP NI L +    KI DFGL       
Sbjct: 133 LDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 189
Query: 224 EGIVSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSS 282
                S    +G + Y++PE + S+++G+   + D+Y+ G+++ EL+      D+  ++S
Sbjct: 190 GKRTRS----KGTLRYMSPEQISSQDYGK---EVDLYALGLILAELLHV---CDTAFETS 239
Query: 283 SEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM 342
              +F           R+  +  +  +KE  + +K+       +  +P DRP  +E++  
Sbjct: 240 K--FFTDL--------RDGIISDIFDKKEKTLLQKL-------LSKKPEDRPNTSEILRT 282
Query: 343 L 343
           L
Sbjct: 283 L 283

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 92/206 (44%), Gaps = 32/206 (15%)
Query: 90  KLGQGGFGGVYKGR-LLD---------------------DFVNEVASISRTSHVNVVTLL 127
           K+G+G F  VY+   LLD                     D + E+  + + +H NV+   
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
              +E N   ++ E    G L + + +    K  + +    +++  + +   LE++H   
Sbjct: 99  ASFIEDNELNIVLELADAGDLSRMIKHFKKQK--RLIPERTVWKYFVQLCSALEHMH--- 153
Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSR 247
           S +++H DIKP N+ +      K+ D GL +  ++K     SL+G      Y++PE    
Sbjct: 154 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTP---YYMSPERIHE 210
Query: 248 NFGEVSHKSDVYSFGMMIMELVGCKN 273
           N    + KSD++S G ++ E+   ++
Sbjct: 211 N--GYNFKSDIWSLGCLLYEMAALQS 234

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 37/211 (17%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKGRLL-------------------DDFVNEVASISRTS 119
           D KK    F +K+GQG  G VY    +                   +  +NE+  +    
Sbjct: 17  DPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK 75
Query: 120 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
           + N+V  L   L G+   ++ E++  GSL   V     ++ C  +   ++  +     + 
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETC--MDEGQIAAVCRECLQA 128
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
           LE+LH   S +++H DIK  NILL  D   K++DFG     T ++   S ++G      +
Sbjct: 129 LEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTP---YW 182
Query: 240 IAPEVFSRN-FGEVSHKSDVYSFGMMIMELV 269
           +APEV +R  +G    K D++S G+M +E++
Sbjct: 183 MAPEVVTRKAYGP---KVDIWSLGIMAIEMI 210

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 92/194 (47%), Gaps = 31/194 (15%)
Query: 91  LGQGGFGGV----YKGRLL-----------DDFVNEVASISRTSHVNVVTLLGFCLEGNN 135
           +G+G FG V    Y+G  +             F+ E + +++  H N+V LLG  +E   
Sbjct: 29  IGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 88
Query: 136 RA-LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHF 194
              ++ E+M  GSL  ++     S+    L  + + +  + + + +EYL        +H 
Sbjct: 89  GLYIVTEYMAKGSLVDYL----RSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 141
Query: 195 DIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSH 254
           D+   N+L+ ED   K+SDFGL K  ++ +         +  + + APE       + S 
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDT------GKLPVKWTAPEALREK--KFST 193
Query: 255 KSDVYSFGMMIMEL 268
           KSDV+SFG+++ E+
Sbjct: 194 KSDVWSFGILLWEI 207

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 80/161 (49%), Gaps = 11/161 (6%)
Query: 106 DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF---VYNGDTSKPCQ 162
           DDF NE+  I+   +   +T  G     +   +IYE+M N S+ KF    +  D +  C 
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC- 146
Query: 163 YLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT 222
           ++  + +  I+  +     Y+H+     I H D+KP NIL+D++   K+SDFG ++    
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD 204
Query: 223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGM 263
           K+     + G+RG   ++ PE FS        K D++S G+
Sbjct: 205 KK-----IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGI 240

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 70/311 (22%), Positives = 128/311 (41%), Gaps = 60/311 (19%)
Query: 76  NFSDVKKLTNSFKDKLGQGGFGGVY----------KGRLL--------------DDFVNE 111
           +   +K+     K +LG+G FG V+          K ++L               DF  E
Sbjct: 8   HVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQRE 67
Query: 112 VASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF----------VYNGDTSKPC 161
              ++   H ++V   G C +G+   +++E+M +G L KF          + +G   +  
Sbjct: 68  AELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK 127
Query: 162 QYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT 221
             L   +M  I   IA G+ YL    S   +H D+   N L+  +   KI DFG+++   
Sbjct: 128 GELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVY 184
Query: 222 TKEGIVSSLLGARGI--IGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSG 278
           + +      +G   +  I ++ PE +  R F   + +SDV+SFG+++ E+          
Sbjct: 185 STD---YYRVGGHTMLPIRWMPPESIMYRKF---TTESDVWSFGVILWEIFTYGKQPWFQ 238
Query: 279 VDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNE 338
           + ++        +   + Q R  + P V         K++  V L C Q  P  R  + E
Sbjct: 239 LSNTE-------VIECITQGRVLERPRVC-------PKEVYDVMLGCWQREPQQRLNIKE 284
Query: 339 VIEMLQGSTEA 349
           + ++L    +A
Sbjct: 285 IYKILHALGKA 295

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 92/194 (47%), Gaps = 31/194 (15%)
Query: 91  LGQGGFGGV----YKGRLL-----------DDFVNEVASISRTSHVNVVTLLGFCLE-GN 134
           +G+G FG V    Y+G  +             F+ E + +++  H N+V LLG  +E   
Sbjct: 14  IGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 73
Query: 135 NRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHF 194
              ++ E+M  GSL  ++     S+    L  + + +  + + + +EYL        +H 
Sbjct: 74  GLYIVTEYMAKGSLVDYL----RSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 126
Query: 195 DIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSH 254
           D+   N+L+ ED   K+SDFGL K  ++ +         +  + + APE       + S 
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDT------GKLPVKWTAPEALREK--KFST 178
Query: 255 KSDVYSFGMMIMEL 268
           KSDV+SFG+++ E+
Sbjct: 179 KSDVWSFGILLWEI 192

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 92/194 (47%), Gaps = 31/194 (15%)
Query: 91  LGQGGFGGV----YKGRLL-----------DDFVNEVASISRTSHVNVVTLLGFCLE-GN 134
           +G+G FG V    Y+G  +             F+ E + +++  H N+V LLG  +E   
Sbjct: 201 IGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 260
Query: 135 NRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHF 194
              ++ E+M  GSL  ++     S+    L  + + +  + + + +EYL        +H 
Sbjct: 261 GLYIVTEYMAKGSLVDYL----RSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 313
Query: 195 DIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSH 254
           D+   N+L+ ED   K+SDFGL K  ++ +         +  + + APE       + S 
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDT------GKLPVKWTAPEALREK--KFST 365
Query: 255 KSDVYSFGMMIMEL 268
           KSDV+SFG+++ E+
Sbjct: 366 KSDVWSFGILLWEI 379

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 78/316 (24%), Positives = 127/316 (40%), Gaps = 68/316 (21%)
Query: 73  KRYNFSDVKKLTN---SFKDKLGQGGFGGVYKGRLLD----------------------- 106
           K  + SD+K++     +    LG G FG VY+G++                         
Sbjct: 18  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 77
Query: 107 --DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQ-- 162
             DF+ E   IS+ +H N+V  +G  L+   R ++ E M  G L+ F+      +P Q  
Sbjct: 78  ELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRE-TRPRPSQPS 136
Query: 163 YLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP------KISDFGL 216
            L    +  +   IA G +YL        +H DI   N LL    CP      KI DFG+
Sbjct: 137 SLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLT---CPGPGRVAKIGDFGM 190
Query: 217 A----KLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
           A    +    ++G  + L      + ++ PE F    G  + K+D +SFG+++ E+    
Sbjct: 191 ARDIYRASYYRKGGCAML-----PVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSL- 242
Query: 273 NNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSD 332
             +     S+ EV    ++      D     PG V R           +   C Q +P D
Sbjct: 243 GYMPYPSKSNQEVL--EFVTSGGRMDPPKNCPGPVYR-----------IMTQCWQHQPED 289
Query: 333 RPPMNEVIEMLQGSTE 348
           RP    ++E ++  T+
Sbjct: 290 RPNFAIILERIEYCTQ 305

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 78/316 (24%), Positives = 127/316 (40%), Gaps = 68/316 (21%)
Query: 73  KRYNFSDVKKLTN---SFKDKLGQGGFGGVYKGRLLD----------------------- 106
           K  + SD+K++     +    LG G FG VY+G++                         
Sbjct: 9   KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 68
Query: 107 --DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQ-- 162
             DF+ E   IS+ +H N+V  +G  L+   R ++ E M  G L+ F+      +P Q  
Sbjct: 69  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRE-TRPRPSQPS 127
Query: 163 YLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP------KISDFGL 216
            L    +  +   IA G +YL        +H DI   N LL    CP      KI DFG+
Sbjct: 128 SLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLT---CPGPGRVAKIGDFGM 181
Query: 217 A----KLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
           A    +    ++G  + L      + ++ PE F    G  + K+D +SFG+++ E+    
Sbjct: 182 ARDIYRASYYRKGGCAML-----PVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSL- 233
Query: 273 NNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSD 332
             +     S+ EV    ++      D     PG V R   +           C Q +P D
Sbjct: 234 GYMPYPSKSNQEVL--EFVTSGGRMDPPKNCPGPVYRIMTQ-----------CWQHQPED 280
Query: 333 RPPMNEVIEMLQGSTE 348
           RP    ++E ++  T+
Sbjct: 281 RPNFAIILERIEYCTQ 296

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 78/316 (24%), Positives = 127/316 (40%), Gaps = 68/316 (21%)
Query: 73  KRYNFSDVKKLTN---SFKDKLGQGGFGGVYKGRLLD----------------------- 106
           K  + SD+K++     +    LG G FG VY+G++                         
Sbjct: 32  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 91
Query: 107 --DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQ-- 162
             DF+ E   IS+ +H N+V  +G  L+   R ++ E M  G L+ F+      +P Q  
Sbjct: 92  ELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRE-TRPRPSQPS 150
Query: 163 YLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP------KISDFGL 216
            L    +  +   IA G +YL        +H DI   N LL    CP      KI DFG+
Sbjct: 151 SLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLT---CPGPGRVAKIGDFGM 204
Query: 217 A----KLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
           A    +    ++G  + L      + ++ PE F    G  + K+D +SFG+++ E+    
Sbjct: 205 ARDIYRASYYRKGGCAML-----PVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSL- 256
Query: 273 NNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSD 332
             +     S+ EV    ++      D     PG V R           +   C Q +P D
Sbjct: 257 GYMPYPSKSNQEVL--EFVTSGGRMDPPKNCPGPVYR-----------IMTQCWQHQPED 303
Query: 333 RPPMNEVIEMLQGSTE 348
           RP    ++E ++  T+
Sbjct: 304 RPNFAIILERIEYCTQ 319

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 37/211 (17%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKGRLL-------------------DDFVNEVASISRTS 119
           D KK    F +K+GQG  G VY    +                   +  +NE+  +    
Sbjct: 17  DPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK 75
Query: 120 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
           + N+V  L   L G+   ++ E++  GSL   V     ++ C  +   ++  +     + 
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETC--MDEGQIAAVCRECLQA 128
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
           LE+LH   S +++H DIK  NILL  D   K++DFG     T ++   S ++G      +
Sbjct: 129 LEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTP---YW 182
Query: 240 IAPEVFSRN-FGEVSHKSDVYSFGMMIMELV 269
           +APEV +R  +G    K D++S G+M +E++
Sbjct: 183 MAPEVVTRKAYGP---KVDIWSLGIMAIEMI 210

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 37/211 (17%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKGRLL-------------------DDFVNEVASISRTS 119
           D KK    F +K+GQG  G VY    +                   +  +NE+  +    
Sbjct: 18  DPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK 76
Query: 120 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
           + N+V  L   L G+   ++ E++  GSL   V     ++ C  +   ++  +     + 
Sbjct: 77  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETC--MDEGQIAAVCRECLQA 129
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
           LE+LH   S +++H DIK  NILL  D   K++DFG     T ++   S ++G      +
Sbjct: 130 LEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTP---YW 183
Query: 240 IAPEVFSRN-FGEVSHKSDVYSFGMMIMELV 269
           +APEV +R  +G    K D++S G+M +E++
Sbjct: 184 MAPEVVTRKAYGP---KVDIWSLGIMAIEMI 211

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 78/316 (24%), Positives = 127/316 (40%), Gaps = 68/316 (21%)
Query: 73  KRYNFSDVKKLTN---SFKDKLGQGGFGGVYKGRLLD----------------------- 106
           K  + SD+K++     +    LG G FG VY+G++                         
Sbjct: 17  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 76
Query: 107 --DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQ-- 162
             DF+ E   IS+ +H N+V  +G  L+   R ++ E M  G L+ F+      +P Q  
Sbjct: 77  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRE-TRPRPSQPS 135
Query: 163 YLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP------KISDFGL 216
            L    +  +   IA G +YL        +H DI   N LL    CP      KI DFG+
Sbjct: 136 SLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLT---CPGPGRVAKIGDFGM 189
Query: 217 A----KLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
           A    +    ++G  + L      + ++ PE F    G  + K+D +SFG+++ E+    
Sbjct: 190 ARDIYRASYYRKGGCAML-----PVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSL- 241
Query: 273 NNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSD 332
             +     S+ EV    ++      D     PG V R           +   C Q +P D
Sbjct: 242 GYMPYPSKSNQEVL--EFVTSGGRMDPPKNCPGPVYR-----------IMTQCWQHQPED 288
Query: 333 RPPMNEVIEMLQGSTE 348
           RP    ++E ++  T+
Sbjct: 289 RPNFAIILERIEYCTQ 304

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 78/316 (24%), Positives = 127/316 (40%), Gaps = 68/316 (21%)
Query: 73  KRYNFSDVKKLTN---SFKDKLGQGGFGGVYKGRLLD----------------------- 106
           K  + SD+K++     +    LG G FG VY+G++                         
Sbjct: 17  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 76
Query: 107 --DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQ-- 162
             DF+ E   IS+ +H N+V  +G  L+   R ++ E M  G L+ F+      +P Q  
Sbjct: 77  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRE-TRPRPSQPS 135
Query: 163 YLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP------KISDFGL 216
            L    +  +   IA G +YL        +H DI   N LL    CP      KI DFG+
Sbjct: 136 SLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLT---CPGPGRVAKIGDFGM 189
Query: 217 A----KLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
           A    +    ++G  + L      + ++ PE F    G  + K+D +SFG+++ E+    
Sbjct: 190 ARDIYRASYYRKGGCAML-----PVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSL- 241
Query: 273 NNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSD 332
             +     S+ EV    ++      D     PG V R           +   C Q +P D
Sbjct: 242 GYMPYPSKSNQEVL--EFVTSGGRMDPPKNCPGPVYR-----------IMTQCWQHQPED 288
Query: 333 RPPMNEVIEMLQGSTE 348
           RP    ++E ++  T+
Sbjct: 289 RPNFAIILERIEYCTQ 304

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 78/316 (24%), Positives = 127/316 (40%), Gaps = 68/316 (21%)
Query: 73  KRYNFSDVKKLTN---SFKDKLGQGGFGGVYKGRLLD----------------------- 106
           K  + SD+K++     +    LG G FG VY+G++                         
Sbjct: 18  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 77
Query: 107 --DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQ-- 162
             DF+ E   IS+ +H N+V  +G  L+   R ++ E M  G L+ F+      +P Q  
Sbjct: 78  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRE-TRPRPSQPS 136
Query: 163 YLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP------KISDFGL 216
            L    +  +   IA G +YL        +H DI   N LL    CP      KI DFG+
Sbjct: 137 SLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLT---CPGPGRVAKIGDFGM 190
Query: 217 A----KLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
           A    +    ++G  + L      + ++ PE F    G  + K+D +SFG+++ E+    
Sbjct: 191 ARDIYRASYYRKGGCAML-----PVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSL- 242
Query: 273 NNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSD 332
             +     S+ EV    ++      D     PG V R           +   C Q +P D
Sbjct: 243 GYMPYPSKSNQEVL--EFVTSGGRMDPPKNCPGPVYR-----------IMTQCWQHQPED 289
Query: 333 RPPMNEVIEMLQGSTE 348
           RP    ++E ++  T+
Sbjct: 290 RPNFAIILERIEYCTQ 305

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 78/316 (24%), Positives = 127/316 (40%), Gaps = 68/316 (21%)
Query: 73  KRYNFSDVKKLTN---SFKDKLGQGGFGGVYKGRLLD----------------------- 106
           K  + SD+K++     +    LG G FG VY+G++                         
Sbjct: 34  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 93
Query: 107 --DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQ-- 162
             DF+ E   IS+ +H N+V  +G  L+   R ++ E M  G L+ F+      +P Q  
Sbjct: 94  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRE-TRPRPSQPS 152
Query: 163 YLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP------KISDFGL 216
            L    +  +   IA G +YL        +H DI   N LL    CP      KI DFG+
Sbjct: 153 SLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLT---CPGPGRVAKIGDFGM 206
Query: 217 A----KLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
           A    +    ++G  + L      + ++ PE F    G  + K+D +SFG+++ E+    
Sbjct: 207 ARDIYRASYYRKGGCAML-----PVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSL- 258
Query: 273 NNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSD 332
             +     S+ EV    ++      D     PG V R           +   C Q +P D
Sbjct: 259 GYMPYPSKSNQEVL--EFVTSGGRMDPPKNCPGPVYR-----------IMTQCWQHQPED 305
Query: 333 RPPMNEVIEMLQGSTE 348
           RP    ++E ++  T+
Sbjct: 306 RPNFAIILERIEYCTQ 321

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 91/194 (46%), Gaps = 31/194 (15%)
Query: 91  LGQGGFGGV----YKGRLL-----------DDFVNEVASISRTSHVNVVTLLGFCLEGNN 135
           +G+G FG V    Y+G  +             F+ E + +++  H N+V LLG  +E   
Sbjct: 20  IGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 79
Query: 136 RA-LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHF 194
              ++ E+M  GSL  ++     S+    L  + + +  + + + +EYL        +H 
Sbjct: 80  GLYIVTEYMAKGSLVDYL----RSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 132
Query: 195 DIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSH 254
           D+   N+L+ ED   K+SDFGL K  ++ +         +  + + APE         S 
Sbjct: 133 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDT------GKLPVKWTAPEALRE--AAFST 184
Query: 255 KSDVYSFGMMIMEL 268
           KSDV+SFG+++ E+
Sbjct: 185 KSDVWSFGILLWEI 198

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 78/316 (24%), Positives = 127/316 (40%), Gaps = 68/316 (21%)
Query: 73  KRYNFSDVKKLTN---SFKDKLGQGGFGGVYKGRLLD----------------------- 106
           K  + SD+K++     +    LG G FG VY+G++                         
Sbjct: 24  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 83
Query: 107 --DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQ-- 162
             DF+ E   IS+ +H N+V  +G  L+   R ++ E M  G L+ F+      +P Q  
Sbjct: 84  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRE-TRPRPSQPS 142
Query: 163 YLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP------KISDFGL 216
            L    +  +   IA G +YL        +H DI   N LL    CP      KI DFG+
Sbjct: 143 SLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLT---CPGPGRVAKIGDFGM 196
Query: 217 A----KLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
           A    +    ++G  + L      + ++ PE F    G  + K+D +SFG+++ E+    
Sbjct: 197 ARDIYRASYYRKGGCAML-----PVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSL- 248
Query: 273 NNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSD 332
             +     S+ EV    ++      D     PG V R           +   C Q +P D
Sbjct: 249 GYMPYPSKSNQEVL--EFVTSGGRMDPPKNCPGPVYR-----------IMTQCWQHQPED 295
Query: 333 RPPMNEVIEMLQGSTE 348
           RP    ++E ++  T+
Sbjct: 296 RPNFAIILERIEYCTQ 311

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 78/316 (24%), Positives = 127/316 (40%), Gaps = 68/316 (21%)
Query: 73  KRYNFSDVKKLTN---SFKDKLGQGGFGGVYKGRLLD----------------------- 106
           K  + SD+K++     +    LG G FG VY+G++                         
Sbjct: 18  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 77
Query: 107 --DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQ-- 162
             DF+ E   IS+ +H N+V  +G  L+   R ++ E M  G L+ F+      +P Q  
Sbjct: 78  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRE-TRPRPSQPS 136
Query: 163 YLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP------KISDFGL 216
            L    +  +   IA G +YL        +H DI   N LL    CP      KI DFG+
Sbjct: 137 SLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLT---CPGPGRVAKIGDFGM 190
Query: 217 A----KLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
           A    +    ++G  + L      + ++ PE F    G  + K+D +SFG+++ E+    
Sbjct: 191 AQDIYRASYYRKGGCAML-----PVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSL- 242
Query: 273 NNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSD 332
             +     S+ EV    ++      D     PG V R           +   C Q +P D
Sbjct: 243 GYMPYPSKSNQEVL--EFVTSGGRMDPPKNCPGPVYR-----------IMTQCWQHQPED 289
Query: 333 RPPMNEVIEMLQGSTE 348
           RP    ++E ++  T+
Sbjct: 290 RPNFAIILERIEYCTQ 305

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 78/316 (24%), Positives = 127/316 (40%), Gaps = 68/316 (21%)
Query: 73  KRYNFSDVKKLTN---SFKDKLGQGGFGGVYKGRLLD----------------------- 106
           K  + SD+K++     +    LG G FG VY+G++                         
Sbjct: 32  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 91
Query: 107 --DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQ-- 162
             DF+ E   IS+ +H N+V  +G  L+   R ++ E M  G L+ F+      +P Q  
Sbjct: 92  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRE-TRPRPSQPS 150
Query: 163 YLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP------KISDFGL 216
            L    +  +   IA G +YL        +H DI   N LL    CP      KI DFG+
Sbjct: 151 SLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLT---CPGPGRVAKIGDFGM 204
Query: 217 A----KLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
           A    +    ++G  + L      + ++ PE F    G  + K+D +SFG+++ E+    
Sbjct: 205 ARDIYRASYYRKGGCAML-----PVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSL- 256
Query: 273 NNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSD 332
             +     S+ EV    ++      D     PG V R           +   C Q +P D
Sbjct: 257 GYMPYPSKSNQEVL--EFVTSGGRMDPPKNCPGPVYR-----------IMTQCWQHQPED 303
Query: 333 RPPMNEVIEMLQGSTE 348
           RP    ++E ++  T+
Sbjct: 304 RPNFAIILERIEYCTQ 319

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 123/306 (40%), Gaps = 57/306 (18%)
Query: 91  LGQGGFGGVYKGRLLDD------------------------FVNEVASISRTSHVNVVTL 126
           LG G FG VYKG  + D                         ++E   ++      V  L
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQ-YLRWEKMYEIVIGIAKGLEYLHH 185
           LG CL    + L+ + MP G L   V         Q  L W       + IAKG+ YL  
Sbjct: 85  LGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLNW------CMQIAKGMSYLE- 136
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
               +++H D+   N+L+      KI+DFGLA+L    E    +  G +  I ++A E +
Sbjct: 137 --DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHA-DGGKVPIKWMALESI 193
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
             R F   +H+SDV+S+G+ + EL+        G+ +         I   +E+      P
Sbjct: 194 LRRRF---THQSDVWSYGVTVWELMTFGAKPYDGIPARE-------IPDLLEKGERLPQP 243
Query: 305 GVVTRKENEIAKKMIIVGLWCI--QARPSDRPPMNEVIEMLQGSTEALQIPPTPFLSSPP 362
            + T     I   MI+V  W I  + RP  R  ++E   M +     + I         P
Sbjct: 244 PICT-----IDVYMIMVKCWMIDSECRPRFRELVSEFSRMARDPQRFVVIQNEDL---GP 295
Query: 363 RAPIDS 368
            +P+DS
Sbjct: 296 ASPLDS 301

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 110/280 (39%), Gaps = 68/280 (24%)
Query: 91  LGQGGFGGVYKGR----------------------LLDDFVNEVASISRTSHVNVVTLLG 128
           LG+G FG VY  R                      +      EV   S   H N++ L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 129 FCLEGNNRALIYEFMPNGS-------LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           +  +     LI E+ P G+       L KF    D  +   Y         +  +A  L 
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKF----DEQRTATY---------ITELANALS 123
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           Y H   S +++H DIKP N+LL      KI+DFG +  C       ++L    G + Y+ 
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--CHAPSSRRTTL---SGTLDYLP 175
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE+      +   K D++S G++  E +  K   ++     +        Y+ + +  EF
Sbjct: 176 PEMIEGRMHD--EKVDLWSLGVLCYEFLVGKPPFEANTYQET--------YKRISRV-EF 224
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
             P  VT    ++  ++       ++  PS RP + EV+E
Sbjct: 225 TFPDFVTEGARDLISRL-------LKHNPSQRPMLREVLE 257

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 78/316 (24%), Positives = 127/316 (40%), Gaps = 68/316 (21%)
Query: 73  KRYNFSDVKKLTN---SFKDKLGQGGFGGVYKGRLLD----------------------- 106
           K  + SD+K++     +    LG G FG VY+G++                         
Sbjct: 32  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQD 91
Query: 107 --DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQ-- 162
             DF+ E   IS+ +H N+V  +G  L+   R ++ E M  G L+ F+      +P Q  
Sbjct: 92  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRE-TRPRPSQPS 150
Query: 163 YLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP------KISDFGL 216
            L    +  +   IA G +YL        +H DI   N LL    CP      KI DFG+
Sbjct: 151 SLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLT---CPGPGRVAKIGDFGM 204
Query: 217 A----KLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
           A    +    ++G  + L      + ++ PE F    G  + K+D +SFG+++ E+    
Sbjct: 205 ARDIYRASYYRKGGCAML-----PVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSL- 256
Query: 273 NNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSD 332
             +     S+ EV    ++      D     PG V R           +   C Q +P D
Sbjct: 257 GYMPYPSKSNQEVL--EFVTSGGRMDPPKNCPGPVYR-----------IMTQCWQHQPED 303
Query: 333 RPPMNEVIEMLQGSTE 348
           RP    ++E ++  T+
Sbjct: 304 RPNFAIILERIEYCTQ 319

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 78/316 (24%), Positives = 127/316 (40%), Gaps = 68/316 (21%)
Query: 73  KRYNFSDVKKLTN---SFKDKLGQGGFGGVYKGRLLD----------------------- 106
           K  + SD+K++     +    LG G FG VY+G++                         
Sbjct: 44  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 103
Query: 107 --DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQ-- 162
             DF+ E   IS+ +H N+V  +G  L+   R ++ E M  G L+ F+      +P Q  
Sbjct: 104 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRE-TRPRPSQPS 162
Query: 163 YLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP------KISDFGL 216
            L    +  +   IA G +YL        +H DI   N LL    CP      KI DFG+
Sbjct: 163 SLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLT---CPGPGRVAKIGDFGM 216
Query: 217 A----KLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
           A    +    ++G  + L      + ++ PE F    G  + K+D +SFG+++ E+    
Sbjct: 217 ARDIYRASYYRKGGCAML-----PVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSL- 268
Query: 273 NNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSD 332
             +     S+ EV    ++      D     PG V R           +   C Q +P D
Sbjct: 269 GYMPYPSKSNQEVL--EFVTSGGRMDPPKNCPGPVYR-----------IMTQCWQHQPED 315
Query: 333 RPPMNEVIEMLQGSTE 348
           RP    ++E ++  T+
Sbjct: 316 RPNFAIILERIEYCTQ 331

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 99/211 (46%), Gaps = 37/211 (17%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKGRLL-------------------DDFVNEVASISRTS 119
           D KK    F +K+GQG  G VY    +                   +  +NE+  +    
Sbjct: 18  DPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK 76
Query: 120 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
           + N+V  L   L G+   ++ E++  GSL   V     ++ C  +   ++  +     + 
Sbjct: 77  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETC--MDEGQIAAVCRECLQA 129
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
           LE+LH   S +++H +IK  NILL  D   K++DFG     T ++   S+++G      +
Sbjct: 130 LEFLH---SNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP---YW 183
Query: 240 IAPEVFSRN-FGEVSHKSDVYSFGMMIMELV 269
           +APEV +R  +G    K D++S G+M +E++
Sbjct: 184 MAPEVVTRKAYGP---KVDIWSLGIMAIEMI 211

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 116/279 (41%), Gaps = 54/279 (19%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKGRLL----------------------DDFVNEVASIS 116
           D +KL +  ++ +G G FG VY  R +                       D + EV  + 
Sbjct: 51  DPEKLFSDLRE-IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109
Query: 117 RTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 176
           +  H N +   G  L  +   L+ E+    + +    +    KP Q +   ++  +  G 
Sbjct: 110 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH---KKPLQEV---EIAAVTHGA 163
Query: 177 AKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI 236
            +GL YLH   S  ++H D+K  NILL E    K+ DFG A +       V       G 
Sbjct: 164 LQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-------GT 213
Query: 237 IGYIAPEV-FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV 295
             ++APEV  + + G+   K DV+S G+  +EL   K  L   +++ S +Y       H+
Sbjct: 214 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL-FNMNAMSALY-------HI 265
Query: 296 EQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRP 334
            Q+     P + +   +E  +  +     C+Q  P DRP
Sbjct: 266 AQNES---PALQSGHWSEYFRNFVDS---CLQKIPQDRP 298

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 51/221 (23%)
Query: 91  LGQGGFGGVYKGR------------------LLDDFVNEVASISRTSHVNVVTLLGFCLE 132
           LGQG FG V K R                   L   ++EV  ++  +H  VV      LE
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLE 73
Query: 133 GNN----------RALIY---EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
             N          ++ ++   E+  NG+L   +++ + ++     + ++ + +   I + 
Sbjct: 74  RRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQ-----QRDEYWRLFRQILEA 128
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV-----------S 228
           L Y+H   S  I+H D+KP NI +DE    KI DFGLAK       I+            
Sbjct: 129 LSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 229 SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
           +L  A G   Y+A EV     G  + K D+YS G++  E++
Sbjct: 186 NLTSAIGTAMYVATEVLD-GTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 65/276 (23%), Positives = 107/276 (38%), Gaps = 60/276 (21%)
Query: 91  LGQGGFGGVYKGR----------------------LLDDFVNEVASISRTSHVNVVTLLG 128
           LG+G FG VY  R                      +      EV   S   H N++ L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYN---GDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
           +  +     LI E+ P G + K +      D  +   Y         +  +A  L Y H 
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATY---------ITELANALSYCH- 130
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVF 245
             S +++H DIKP N+LL      KI+DFG +    +     S      G + Y+ PE+ 
Sbjct: 131 --SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-----SRRXXLXGTLDYLPPEMI 183
Query: 246 SRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG 305
                +   K D++S G++  E +  K   ++     +        Y+ + +  EF  P 
Sbjct: 184 EGRMHD--EKVDLWSLGVLCYEFLVGKPPFEANTYQET--------YKRISRV-EFTFPD 232
Query: 306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
            VT    ++  ++       ++  PS RP + EV+E
Sbjct: 233 FVTEGARDLISRL-------LKHNPSQRPMLREVLE 261

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 116/279 (41%), Gaps = 54/279 (19%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVYKGRLL----------------------DDFVNEVASIS 116
           D +KL +  ++ +G G FG VY  R +                       D + EV  + 
Sbjct: 12  DPEKLFSDLRE-IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 117 RTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 176
           +  H N +   G  L  +   L+ E+    + +    +    KP Q +   ++  +  G 
Sbjct: 71  KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH---KKPLQEV---EIAAVTHGA 124
Query: 177 AKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI 236
            +GL YLH   S  ++H D+K  NILL E    K+ DFG A +       V       G 
Sbjct: 125 LQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-------GT 174
Query: 237 IGYIAPEV-FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV 295
             ++APEV  + + G+   K DV+S G+  +EL   K  L   +++ S +Y       H+
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL-FNMNAMSALY-------HI 226
Query: 296 EQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRP 334
            Q+     P + +   +E  +  +     C+Q  P DRP
Sbjct: 227 AQNES---PALQSGHWSEYFRNFVDS---CLQKIPQDRP 259

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 104/220 (47%), Gaps = 36/220 (16%)
Query: 70  LPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKG-----------RLLD---------DFV 109
           +P  + N +D ++L     +++G+G FG V+KG           +++D         D  
Sbjct: 11  VPGMQNNIADPEELFTKL-ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ 69
Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKM 169
            E+  +S+     V    G  L+G+   +I E++  GS    +  G    P    +   M
Sbjct: 70  QEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAG----PFDEFQIATM 125
Query: 170 YEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSS 229
            + ++   KGL+YLH   S K +H DIK  N+LL E    K++DFG+A   T  +   ++
Sbjct: 126 LKEIL---KGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 179
Query: 230 LLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            +G      ++APEV  ++      K+D++S G+  +EL 
Sbjct: 180 FVGTP---FWMAPEVIQQS--AYDSKADIWSLGITAIELA 214

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 47/221 (21%)
Query: 79  DVKKLTNSFK--DKLGQGGFGGVYKGRLLDDFVNEVASISRT------------------ 118
           DVK     ++  D LG+G F  VYK R  D   N++ +I +                   
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKAR--DKNTNQIVAIKKIKLGHRSEAKDGINRTALR 61
Query: 119 --------SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY 170
                   SH N++ LL      +N +L+++FM    LE  + +        ++   K Y
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHI---KAY 117
Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSL 230
            ++    +GLEYLH      ILH D+KP+N+LLDE+   K++DFGLAK   +        
Sbjct: 118 MLMT--LQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQ 172
Query: 231 LGARGIIGYIAPEVF--SRNFGEVSHKSDVYSFGMMIMELV 269
           +  R    Y APE+   +R +G      D+++ G ++ EL+
Sbjct: 173 VVTR---WYRAPELLFGARMYGV---GVDMWAVGCILAELL 207

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 93/222 (41%), Gaps = 43/222 (19%)
Query: 92  GQGGFGGVYKGRLLDDFV----------------NEVASISRTSHVNVVTLLGFCLEGNN 135
            +G FG V+K +L++DFV                 E+ S     H N++  +     G+N
Sbjct: 24  ARGRFGCVWKAQLMNDFVAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQFIAAEKRGSN 83
Query: 136 RA----LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH------ 185
                 LI  F   GSL  ++           + W ++  +   +++GL YLH       
Sbjct: 84  LEVELWLITAFHDKGSLTDYLKG-------NIITWNELCHVAETMSRGLSYLHEDVPWCR 136
Query: 186 --GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE--GIVSSLLGARGIIGYIA 241
             G    I H D K  N+LL  D    ++DFGLA      +  G     +G R    Y+A
Sbjct: 137 GEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTR---RYMA 193
Query: 242 PEVF--SRNFGEVSH-KSDVYSFGMMIMELVGCKNNLDSGVD 280
           PEV   + NF   +  + D+Y+ G+++ ELV      D  VD
Sbjct: 194 PEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVD 235

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 94/198 (47%), Gaps = 28/198 (14%)
Query: 91  LGQGGFGGVY---------KGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI-- 139
           LGQG FG V+          G L    V + A++     V          + N+  ++  
Sbjct: 36  LGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKL 95
Query: 140 -YEFMPNGSLE---KFVYNGDT----SKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKI 191
            Y F   G L     F+  GD     SK   +   E +   +  +A GL++LH   S  I
Sbjct: 96  HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTE-EDVKFYLAELALGLDHLH---SLGI 151
Query: 192 LHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGE 251
           ++ D+KP NILLDE+   K++DFGL+K     E    S  G    + Y+APEV +R  G 
Sbjct: 152 IYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGT---VEYMAPEVVNRQ-GH 207
Query: 252 VSHKSDVYSFGMMIMELV 269
            SH +D +S+G+++ E++
Sbjct: 208 -SHSADWWSYGVLMFEML 224

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 79/161 (49%), Gaps = 17/161 (10%)
Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKM 169
           NEV  +    H NVV +    L G+   ++ EF+  G+L   V +   ++       E++
Sbjct: 91  NEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNE-------EQI 143
Query: 170 YEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSS 229
             + + + + L YLH   +  ++H DIK  +ILL  D   K+SDFG    C      V  
Sbjct: 144 ATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFG---FCAQVSKEVPK 197
Query: 230 LLGARGIIGYIAPEVFSR-NFGEVSHKSDVYSFGMMIMELV 269
                G   ++APEV SR  +G    + D++S G+M++E++
Sbjct: 198 RKXLVGTPYWMAPEVISRLPYGT---EVDIWSLGIMVIEMI 235

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 108/280 (38%), Gaps = 68/280 (24%)
Query: 91  LGQGGFGGVYKGR----------------------LLDDFVNEVASISRTSHVNVVTLLG 128
           LG+G FG VY  R                      +      EV   S   H N++ L G
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 129 FCLEGNNRALIYEFMPNGS-------LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           +  +     LI E+ P G+       L KF    D  +   Y         +  +A  L 
Sbjct: 76  YFHDSTRVYLILEYAPLGTVYRELQKLSKF----DEQRTATY---------ITELANALS 122
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           Y H   S K++H DIKP N+LL      KI+DFG +    +     S      G + Y+ 
Sbjct: 123 YCH---SKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-----SRRAALCGTLDYLP 174
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE+      +   K D++S G++  E +  K   ++     +        Y+ + +  EF
Sbjct: 175 PEMIEGRMHD--EKVDLWSLGVLCYEFLVGKPPFEANTYQDT--------YKRISRV-EF 223
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
             P  VT    ++  ++       ++  PS RP + EV+E
Sbjct: 224 TFPDFVTEGARDLISRL-------LKHNPSQRPMLREVLE 256

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 92/210 (43%), Gaps = 38/210 (18%)
Query: 87  FKDKLGQGGFGGVY-----------------KGRL---LDDFVNEVASISRTSHVNVVTL 126
           FK KLG G FG V+                 K R    ++    E+  +    H N++ +
Sbjct: 26  FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                + +N  ++ E    G L + + +         L    + E++  +   L Y H  
Sbjct: 86  FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKA--LSEGYVAELMKQMMNALAYFH-- 141
Query: 187 CSTKILHFDIKPHNILLDEDFCP----KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAP 242
            S  ++H D+KP NIL  +D  P    KI DFGLA+L  + E   +    A G   Y+AP
Sbjct: 142 -SQHVVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSDEHSTN----AAGTALYMAP 195
Query: 243 EVFSRNFGEVSHKSDVYSFG-MMIMELVGC 271
           EVF R+   V+ K D++S G +M   L GC
Sbjct: 196 EVFKRD---VTFKCDIWSAGVVMYFLLTGC 222

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 106/276 (38%), Gaps = 60/276 (21%)
Query: 91  LGQGGFGGVYKGR----------------------LLDDFVNEVASISRTSHVNVVTLLG 128
           LG+G FG VY  R                      +      EV   S   H N++ L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYN---GDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
           +  +     LI E+ P G + K +      D  +   Y         +  +A  L Y H 
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATY---------ITELANALSYCH- 130
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVF 245
             S +++H DIKP N+LL      KI+DFG +    +            G + Y+ PE+ 
Sbjct: 131 --SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC-----GTLDYLPPEMI 183
Query: 246 SRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG 305
                +   K D++S G++  E +  K   ++     +        Y+ + +  EF  P 
Sbjct: 184 EGRMHD--EKVDLWSLGVLCYEFLVGKPPFEANTYQET--------YKRISRV-EFTFPD 232
Query: 306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
            VT    ++  ++       ++  PS RP + EV+E
Sbjct: 233 FVTEGARDLISRL-------LKHNPSQRPMLREVLE 261

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 108/280 (38%), Gaps = 68/280 (24%)
Query: 91  LGQGGFGGVYKGR----------------------LLDDFVNEVASISRTSHVNVVTLLG 128
           LG+G FG VY  R                      +      EV   S   H N++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 129 FCLEGNNRALIYEFMPNGS-------LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           +  +     LI E+ P G+       L KF    D  +   Y         +  +A  L 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKF----DEQRTATY---------ITELANALS 122
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           Y H   S +++H DIKP N+LL      KI+DFG +    +     S      G + Y+ 
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-----SRRAALCGTLDYLP 174
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE+      +   K D++S G++  E +  K   ++     +        Y+ + +  EF
Sbjct: 175 PEMIEGRMHD--EKVDLWSLGVLCYEFLVGKPPFEANTYQET--------YKRISRV-EF 223
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
             P  VT    ++  ++       ++  PS RP + EV+E
Sbjct: 224 TFPDFVTEGARDLISRL-------LKHNPSQRPMLREVLE 256

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 75/160 (46%), Gaps = 15/160 (9%)
Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKM 169
           NEV  +    H NVV +    L G    ++ EF+  G+L   V           L  E++
Sbjct: 91  NEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-------RLNEEQI 143
Query: 170 YEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSS 229
             +   + + L YLH   +  ++H DIK  +ILL  D   K+SDFG    C      V  
Sbjct: 144 ATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFG---FCAQISKDVPK 197
Query: 230 LLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
                G   ++APEV SR+    + + D++S G+M++E+V
Sbjct: 198 RKXLVGTPYWMAPEVISRSL--YATEVDIWSLGIMVIEMV 235

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 111/247 (44%), Gaps = 28/247 (11%)
Query: 105 LDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS----LEKFVYNGDTSKP 160
           +D+ + E+ ++S+  H N+V+     +  +   L+ + +  GS    ++  V  G+    
Sbjct: 52  MDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSG 111
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
              L    +  I+  + +GLEYLH       +H D+K  NILL ED   +I+DFG++   
Sbjct: 112 V--LDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFL 166
Query: 221 TTKEGIVSSLLGAR--GIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSG 278
            T   I  + +     G   ++APEV  +  G    K+D++SFG+  +EL        +G
Sbjct: 167 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRG-YDFKADIWSFGITAIELA-------TG 218
Query: 279 VDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKE-----NEIAKKMIIVGLWCIQARPSDR 333
             +    Y P  +     Q+    L   V  KE      +  +KMI +   C+Q  P  R
Sbjct: 219 A-APYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISL---CLQKDPEKR 274
Query: 334 PPMNEVI 340
           P   E++
Sbjct: 275 PTAAELL 281

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 84/171 (49%), Gaps = 12/171 (7%)
Query: 105 LDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS----LEKFVYNGDTSKP 160
           +D+ + E+ ++S+  H N+V+     +  +   L+ + +  GS    ++  V  G+    
Sbjct: 57  MDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSG 116
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
              L    +  I+  + +GLEYLH       +H D+K  NILL ED   +I+DFG++   
Sbjct: 117 V--LDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFL 171
Query: 221 TTKEGIVSSLLGAR--GIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            T   I  + +     G   ++APEV  +  G    K+D++SFG+  +EL 
Sbjct: 172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRG-YDFKADIWSFGITAIELA 221

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 108/280 (38%), Gaps = 68/280 (24%)
Query: 91  LGQGGFGGVYKGR----------------------LLDDFVNEVASISRTSHVNVVTLLG 128
           LG+G FG VY  R                      +      EV   S   H N++ L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 129 FCLEGNNRALIYEFMPNGS-------LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           +  +     LI E+ P G+       L KF    D  +   Y         +  +A  L 
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKF----DEQRTATY---------ITELANALS 125
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           Y H   S +++H DIKP N+LL      KI+DFG +    +     S      G + Y+ 
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-----SRRAALCGTLDYLP 177
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE+      +   K D++S G++  E +  K   ++     +        Y+ + +  EF
Sbjct: 178 PEMIEGRMHD--EKVDLWSLGVLCYEFLVGKPPFEANTYQET--------YKRISRV-EF 226
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
             P  VT    ++  ++       ++  PS RP + EV+E
Sbjct: 227 TFPDFVTEGARDLISRL-------LKHNPSQRPMLREVLE 259

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/280 (23%), Positives = 107/280 (38%), Gaps = 68/280 (24%)
Query: 91  LGQGGFGGVYKGR----------------------LLDDFVNEVASISRTSHVNVVTLLG 128
           LG+G FG VY  R                      +      EV   S   H N++ L G
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 129 FCLEGNNRALIYEFMPNGS-------LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           +  +     LI E+ P G+       L KF    D  +   Y         +  +A  L 
Sbjct: 73  YFHDATRVYLILEYAPLGTVYRELQKLSKF----DEQRTATY---------ITELANALS 119
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           Y H   S +++H DIKP N+LL      KI+DFG +    +            G + Y+ 
Sbjct: 120 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC-----GTLDYLP 171
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE+      +   K D++S G++  E +  K   ++     +        Y+ + +  EF
Sbjct: 172 PEMIEGRMHD--EKVDLWSLGVLCYEFLVGKPPFEANTYQET--------YKRISRV-EF 220
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
             P  VT    ++  ++       ++  PS RP + EV+E
Sbjct: 221 TFPDFVTEGARDLISRL-------LKHNPSQRPMLREVLE 253

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/280 (23%), Positives = 107/280 (38%), Gaps = 68/280 (24%)
Query: 91  LGQGGFGGVYKGR----------------------LLDDFVNEVASISRTSHVNVVTLLG 128
           LG+G FG VY  R                      +      EV   S   H N++ L G
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 129 FCLEGNNRALIYEFMPNGS-------LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           +  +     LI E+ P G+       L KF    D  +   Y         +  +A  L 
Sbjct: 75  YFHDATRVYLILEYAPLGTVYRELQKLSKF----DEQRTATY---------ITELANALS 121
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           Y H   S +++H DIKP N+LL      KI+DFG +    +            G + Y+ 
Sbjct: 122 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC-----GTLDYLP 173
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE+      +   K D++S G++  E +  K   ++     +        Y+ + +  EF
Sbjct: 174 PEMIEGRMHD--EKVDLWSLGVLCYEFLVGKPPFEANTYQET--------YKRISRV-EF 222
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
             P  VT    ++  ++       ++  PS RP + EV+E
Sbjct: 223 TFPDFVTEGARDLISRL-------LKHNPSQRPMLREVLE 255

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/280 (23%), Positives = 107/280 (38%), Gaps = 68/280 (24%)
Query: 91  LGQGGFGGVYKGR----------------------LLDDFVNEVASISRTSHVNVVTLLG 128
           LG+G FG VY  R                      +      EV   S   H N++ L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 129 FCLEGNNRALIYEFMPNGS-------LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           +  +     LI E+ P G+       L KF    D  +   Y         +  +A  L 
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKF----DEQRTATY---------ITELANALS 125
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           Y H   S +++H DIKP N+LL      KI+DFG +    +            G + Y+ 
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC-----GTLDYLP 177
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE+      +   K D++S G++  E +  K   ++     +        Y+ + +  EF
Sbjct: 178 PEMIEGRMHD--EKVDLWSLGVLCYEFLVGKPPFEANTYQET--------YKRISRV-EF 226
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
             P  VT    ++  ++       ++  PS RP + EV+E
Sbjct: 227 TFPDFVTEGARDLISRL-------LKHNPSQRPMLREVLE 259

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/280 (23%), Positives = 107/280 (38%), Gaps = 68/280 (24%)
Query: 91  LGQGGFGGVYKGR----------------------LLDDFVNEVASISRTSHVNVVTLLG 128
           LG+G FG VY  R                      +      EV   S   H N++ L G
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 129 FCLEGNNRALIYEFMPNGS-------LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           +  +     LI E+ P G+       L KF    D  +   Y         +  +A  L 
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSKF----DEQRTATY---------ITELANALS 126
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           Y H   S +++H DIKP N+LL      KI+DFG +    +            G + Y+ 
Sbjct: 127 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC-----GTLDYLP 178
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE+      +   K D++S G++  E +  K   ++     +        Y+ + +  EF
Sbjct: 179 PEMIEGRMHD--EKVDLWSLGVLCYEFLVGKPPFEANTYQET--------YKRISRV-EF 227
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
             P  VT    ++  ++       ++  PS RP + EV+E
Sbjct: 228 TFPDFVTEGARDLISRL-------LKHNPSQRPMLREVLE 260

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 108/280 (38%), Gaps = 68/280 (24%)
Query: 91  LGQGGFGGVYKGR----------------------LLDDFVNEVASISRTSHVNVVTLLG 128
           LG+G FG VY  R                      +      EV   S   H N++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 129 FCLEGNNRALIYEFMPNGS-------LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           +  +     LI E+ P G+       L KF    D  +   Y         +  +A  L 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKF----DEQRTATY---------ITELANALS 122
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           Y H   S +++H DIKP N+LL      KI+DFG +    +     S      G + Y+ 
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-----SRRTXLCGTLDYLP 174
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE+      +   K D++S G++  E +  K   ++     +        Y+ + +  EF
Sbjct: 175 PEMIEGRMHD--EKVDLWSLGVLCYEFLVGKPPFEANTYQET--------YKRISRV-EF 223
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
             P  VT    ++  ++       ++  PS RP + EV+E
Sbjct: 224 TFPDFVTEGARDLISRL-------LKHNPSQRPMLREVLE 256

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 108/280 (38%), Gaps = 68/280 (24%)
Query: 91  LGQGGFGGVYKGR----------------------LLDDFVNEVASISRTSHVNVVTLLG 128
           LG+G FG VY  R                      +      EV   S   H N++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 129 FCLEGNNRALIYEFMPNGS-------LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           +  +     LI E+ P G+       L KF    D  +   Y         +  +A  L 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKF----DEQRTATY---------ITELANALS 122
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           Y H   S +++H DIKP N+LL      KI+DFG +    +     S      G + Y+ 
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-----SRRTDLCGTLDYLP 174
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE+      +   K D++S G++  E +  K   ++     +        Y+ + +  EF
Sbjct: 175 PEMIEGRMHD--EKVDLWSLGVLCYEFLVGKPPFEANTYQET--------YKRISRV-EF 223
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
             P  VT    ++  ++       ++  PS RP + EV+E
Sbjct: 224 TFPDFVTEGARDLISRL-------LKHNPSQRPMLREVLE 256

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 108/280 (38%), Gaps = 68/280 (24%)
Query: 91  LGQGGFGGVYKGR----------------------LLDDFVNEVASISRTSHVNVVTLLG 128
           LG+G FG VY  R                      +      EV   S   H N++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 129 FCLEGNNRALIYEFMPNGS-------LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           +  +     LI E+ P G+       L KF    D  +   Y         +  +A  L 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKF----DEQRTATY---------ITELANALS 122
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           Y H   S +++H DIKP N+LL      KI+DFG +    +     S      G + Y+ 
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-----SRRXXLCGTLDYLP 174
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE+      +   K D++S G++  E +  K   ++     +        Y+ + +  EF
Sbjct: 175 PEMIEGRMHD--EKVDLWSLGVLCYEFLVGKPPFEANTYQET--------YKRISRV-EF 223
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
             P  VT    ++  ++       ++  PS RP + EV+E
Sbjct: 224 TFPDFVTEGARDLISRL-------LKHNPSQRPMLREVLE 256

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 108/280 (38%), Gaps = 68/280 (24%)
Query: 91  LGQGGFGGVYKGR----------------------LLDDFVNEVASISRTSHVNVVTLLG 128
           LG+G FG VY  R                      +      EV   S   H N++ L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 129 FCLEGNNRALIYEFMPNGS-------LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           +  +     LI E+ P G+       L KF    D  +   Y         +  +A  L 
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKF----DEQRTATY---------ITELANALS 125
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           Y H   S +++H DIKP N+LL      KI+DFG +    +     S      G + Y+ 
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-----SRRXXLCGTLDYLP 177
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE+      +   K D++S G++  E +  K   ++     +        Y+ + +  EF
Sbjct: 178 PEMIEGRMHD--EKVDLWSLGVLCYEFLVGKPPFEANTYQET--------YKRISRV-EF 226
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
             P  VT    ++  ++       ++  PS RP + EV+E
Sbjct: 227 TFPDFVTEGARDLISRL-------LKHNPSQRPMLREVLE 259

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/280 (23%), Positives = 107/280 (38%), Gaps = 68/280 (24%)
Query: 91  LGQGGFGGVYKGR----------------------LLDDFVNEVASISRTSHVNVVTLLG 128
           LG+G FG VY  R                      +      EV   S   H N++ L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 129 FCLEGNNRALIYEFMPNGS-------LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           +  +     LI E+ P G+       L KF    D  +   Y         +  +A  L 
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKF----DEQRTATY---------ITELANALS 125
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           Y H   S +++H DIKP N+LL      KI+DFG +    +            G + Y+ 
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC-----GTLDYLP 177
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE+      +   K D++S G++  E +  K   ++     +        Y+ + +  EF
Sbjct: 178 PEMIEGRMHD--EKVDLWSLGVLCYEFLVGKPPFEANTYQET--------YKRISRV-EF 226
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
             P  VT    ++  ++       ++  PS RP + EV+E
Sbjct: 227 TFPDFVTEGARDLISRL-------LKHNPSQRPMLREVLE 259

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/280 (23%), Positives = 107/280 (38%), Gaps = 68/280 (24%)
Query: 91  LGQGGFGGVYKGR----------------------LLDDFVNEVASISRTSHVNVVTLLG 128
           LG+G FG VY  R                      +      EV   S   H N++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 129 FCLEGNNRALIYEFMPNGS-------LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           +  +     LI E+ P G+       L KF    D  +   Y         +  +A  L 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKF----DEQRTATY---------ITELANALS 122
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           Y H   S +++H DIKP N+LL      KI+DFG +    +            G + Y+ 
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC-----GTLDYLP 174
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE+      +   K D++S G++  E +  K   ++     +        Y+ + +  EF
Sbjct: 175 PEMIEGRMHD--EKVDLWSLGVLCYEFLVGKPPFEANTYQET--------YKRISRV-EF 223
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
             P  VT    ++  ++       ++  PS RP + EV+E
Sbjct: 224 TFPDFVTEGARDLISRL-------LKHNPSQRPMLREVLE 256

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 108/280 (38%), Gaps = 68/280 (24%)
Query: 91  LGQGGFGGVYKGR----------------------LLDDFVNEVASISRTSHVNVVTLLG 128
           LG+G FG VY  R                      +      EV   S   H N++ L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 129 FCLEGNNRALIYEFMPNGS-------LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           +  +     LI E+ P G+       L KF    D  +   Y         +  +A  L 
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKF----DEQRTATY---------ITELANALS 123
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           Y H   S +++H DIKP N+LL      KI+DFG +    +     S      G + Y+ 
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-----SRRTDLCGTLDYLP 175
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE+      +   K D++S G++  E +  K   ++     +        Y+ + +  EF
Sbjct: 176 PEMIEGRMHD--EKVDLWSLGVLCYEFLVGKPPFEANTYQET--------YKRISRV-EF 224
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
             P  VT    ++  ++       ++  PS RP + EV+E
Sbjct: 225 TFPDFVTEGARDLISRL-------LKHNPSQRPMLREVLE 257

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 108/280 (38%), Gaps = 68/280 (24%)
Query: 91  LGQGGFGGVYKGR----------------------LLDDFVNEVASISRTSHVNVVTLLG 128
           LG+G FG VY  R                      +      EV   S   H N++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 129 FCLEGNNRALIYEFMPNGS-------LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           +  +     LI E+ P G+       L KF    D  +   Y         +  +A  L 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKF----DEQRTATY---------ITELANALS 122
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           Y H   S +++H DIKP N+LL      KI+DFG +    +     S      G + Y+ 
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-----SRRTDLCGTLDYLP 174
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE+      +   K D++S G++  E +  K   ++     +        Y+ + +  EF
Sbjct: 175 PEMIEGRMHD--EKVDLWSLGVLCYEFLVGKPPFEANTYQET--------YKRISRV-EF 223
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
             P  VT    ++  ++       ++  PS RP + EV+E
Sbjct: 224 TFPDFVTEGARDLISRL-------LKHNPSQRPMLREVLE 256

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 81/175 (46%), Gaps = 21/175 (12%)
Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           +AKG+E+L    S K +H D+   NILL E    KI DFGLA+        V     AR 
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK-GDARL 257
Query: 236 IIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRH 294
            + ++APE +F R +   + +SDV+SFG+++ E+     +   GV    E        R 
Sbjct: 258 PLKWMAPETIFDRVY---TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRR 308
Query: 295 VEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA 349
           +++    + P   T        +M    L C    PS RP  +E++E L    +A
Sbjct: 309 LKEGTRMRAPDYTT-------PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 108/280 (38%), Gaps = 68/280 (24%)
Query: 91  LGQGGFGGVYKGR----------------------LLDDFVNEVASISRTSHVNVVTLLG 128
           LG+G FG VY  R                      +      EV   S   H N++ L G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 129 FCLEGNNRALIYEFMPNGS-------LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           +  +     LI E+ P G+       L KF    D  +   Y         +  +A  L 
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKLSKF----DEQRTATY---------ITELANALS 124
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           Y H   S +++H DIKP N+LL      KI+DFG +    +     S      G + Y+ 
Sbjct: 125 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-----SRRXXLCGTLDYLP 176
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE+      +   K D++S G++  E +  K   ++     +        Y+ + +  EF
Sbjct: 177 PEMIEGRMHD--EKVDLWSLGVLCYEFLVGKPPFEANTYQET--------YKRISRV-EF 225
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
             P  VT    ++  ++       ++  PS RP + EV+E
Sbjct: 226 TFPDFVTEGARDLISRL-------LKHNPSQRPMLREVLE 258

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 71/303 (23%), Positives = 116/303 (38%), Gaps = 73/303 (24%)
Query: 68  GPLPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGR----------------------LL 105
           GPL  +++   D +         LG+G FG VY  R                      + 
Sbjct: 1   GPLGSRQWALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE 55
Query: 106 DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS-------LEKFVYNGDTS 158
                EV   S   H N++ L G+  +     LI E+ P G+       L KF    D  
Sbjct: 56  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF----DEQ 111
Query: 159 KPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK 218
           +   Y         +  +A  L Y H   S +++H DIKP N+LL      KI+DFG + 
Sbjct: 112 RTATY---------ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV 159
Query: 219 LCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSG 278
              +     S      G + Y+ PE+      +   K D++S G++  E +  K   ++ 
Sbjct: 160 HAPS-----SRRDDLCGTLDYLPPEMIEGRMHD--EKVDLWSLGVLCYEFLVGKPPFEAN 212
Query: 279 VDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNE 338
               +        Y+ + +  EF  P  VT    ++  ++       ++  PS RP + E
Sbjct: 213 TYQET--------YKRISR-VEFTFPDFVTEGARDLISRL-------LKHNPSQRPMLRE 256
Query: 339 VIE 341
           V+E
Sbjct: 257 VLE 259

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 75/165 (45%), Gaps = 11/165 (6%)
Query: 108 FVNEVASISRTSHVNVVTLLGFCLEGNNRAL--IYEFMPNGSLEKFVYNGDTSKPCQYLR 165
            V+EV  +    H N+V      ++  N  L  + E+   G L   +  G  +K  QYL 
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKG--TKERQYLD 109
Query: 166 WEKMYEIVIGIAKGLEYLHHGCS--TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK 223
            E +  ++  +   L+  H        +LH D+KP N+ LD     K+ DFGLA++    
Sbjct: 110 EEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD 169
Query: 224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           E      +G      Y++PE  +R     + KSD++S G ++ EL
Sbjct: 170 EDFAKEFVGT---PYYMSPEQMNRM--SYNEKSDIWSLGCLLYEL 209

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 108/280 (38%), Gaps = 68/280 (24%)
Query: 91  LGQGGFGGVYKGR----------------------LLDDFVNEVASISRTSHVNVVTLLG 128
           LG+G FG VY  R                      +      EV   S   H N++ L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 129 FCLEGNNRALIYEFMPNGS-------LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           +  +     LI E+ P G+       L KF    D  +   Y         +  +A  L 
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSKF----DEQRTATY---------ITELANALS 127
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           Y H   S +++H DIKP N+LL      KI+DFG +    +     S      G + Y+ 
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-----SRRTDLCGTLDYLP 179
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE+      +   K D++S G++  E +  K   ++     +        Y+ + +  EF
Sbjct: 180 PEMIEGRMHD--EKVDLWSLGVLCYEFLVGKPPFEANTYQET--------YKRISRV-EF 228
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
             P  VT    ++  ++       ++  PS RP + EV+E
Sbjct: 229 TFPDFVTEGARDLISRL-------LKHNPSQRPMLREVLE 261

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/280 (23%), Positives = 107/280 (38%), Gaps = 68/280 (24%)
Query: 91  LGQGGFGGVYKGR----------------------LLDDFVNEVASISRTSHVNVVTLLG 128
           LG+G FG VY  R                      +      EV   S   H N++ L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 129 FCLEGNNRALIYEFMPNGS-------LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           +  +     LI E+ P G+       L KF    D  +   Y         +  +A  L 
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSKF----DEQRTATY---------ITELANALS 127
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           Y H   S +++H DIKP N+LL      KI+DFG +    +            G + Y+ 
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC-----GTLDYLP 179
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE+      +   K D++S G++  E +  K   ++     +        Y+ + +  EF
Sbjct: 180 PEMIEGRMHD--EKVDLWSLGVLCYEFLVGKPPFEANTYQET--------YKRISRV-EF 228
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
             P  VT    ++  ++       ++  PS RP + EV+E
Sbjct: 229 TFPDFVTEGARDLISRL-------LKHNPSQRPMLREVLE 261

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 81/175 (46%), Gaps = 21/175 (12%)
Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           +AKG+E+L    S K +H D+   NILL E    KI DFGLA+        V     AR 
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK-GDARL 255
Query: 236 IIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRH 294
            + ++APE +F R +   + +SDV+SFG+++ E+     +   GV    E        R 
Sbjct: 256 PLKWMAPETIFDRVY---TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRR 306
Query: 295 VEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA 349
           +++    + P   T        +M    L C    PS RP  +E++E L    +A
Sbjct: 307 LKEGTRMRAPDYTT-------PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 354

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 85/188 (45%), Gaps = 21/188 (11%)
Query: 163 YLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT 222
           +L  E +      +AKG+E+L    S K +H D+   NILL E    KI DFGLA+    
Sbjct: 194 FLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 250
Query: 223 KEGIVSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDS 281
               V     AR  + ++APE +F R +   + +SDV+SFG+++ E+     +   GV  
Sbjct: 251 DPDYVRK-GDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEIFSLGASPYPGVKI 306
Query: 282 SSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
             E        R +++    + P   T        +M    L C    PS RP  +E++E
Sbjct: 307 DEE------FCRRLKEGTRMRAPDYTT-------PEMYQTMLDCWHGEPSQRPTFSELVE 353
Query: 342 MLQGSTEA 349
            L    +A
Sbjct: 354 HLGNLLQA 361

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 69/311 (22%), Positives = 124/311 (39%), Gaps = 61/311 (19%)
Query: 91  LGQGGFGGVYKGRL------------------------LDDFVNEVASISRTSHVNVVTL 126
           LG+G FG V + +L                        +++F+ E A +    H +V  L
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 127 LGFCLEGNNRA------LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGL 180
           +G  L    +       +I  FM +G L  F+      +    L  + +   ++ IA G+
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 181 EYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT----KEGIVSSLLGARGI 236
           EYL    S   +H D+   N +L ED    ++DFGL++   +    ++G  S L      
Sbjct: 151 EYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL-----P 202
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE 296
           + ++A E  + N   V   SDV++FG+ + E++       +G++++        IY ++ 
Sbjct: 203 VKWLALESLADNLYTV--HSDVWAFGVTMWEIMTRGQTPYAGIENAE-------IYNYLI 253
Query: 297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPP---MNEVIEMLQGSTEALQIP 353
                K P        E  +++  +   C  A P  RP    +   +E + G    L   
Sbjct: 254 GGNRLKQP-------PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS 306
Query: 354 PTPFLSSPPRA 364
             P   +  RA
Sbjct: 307 QDPLYINIERA 317

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 118/272 (43%), Gaps = 44/272 (16%)
Query: 89  DKLGQGGFGGVYKGR---------------------LLDDFVNEVASISRTSHVNVVTLL 127
           +K+G+G +G VYK R                     +    + E++ +   +H N+V LL
Sbjct: 16  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 75
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                 N   L++EF+ +  L+KF+  +  T  P   ++       +  + +GL + H  
Sbjct: 76  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-----SYLFQLLQGLAFCH-- 127
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            S ++LH D+KP N+L++ +   K++DFGLA+        V +       + Y APE+  
Sbjct: 128 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTYTHEVVTLWYRAPEIL- 182
Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
                 S   D++S G +  E+V  +  L  G DS  +  F   I+R +    E   PGV
Sbjct: 183 LGXKYYSTAVDIWSLGCIFAEMV-TRRALFPG-DSEIDQLFR--IFRTLGTPDEVVWPGV 238
Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNE 338
            +  + + +        W  Q      PP++E
Sbjct: 239 TSMPDYKPS-----FPKWARQDFSKVVPPLDE 265

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 81/175 (46%), Gaps = 21/175 (12%)
Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           +AKG+E+L    S K +H D+   NILL E    KI DFGLA+        V     AR 
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK-GDARL 264
Query: 236 IIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRH 294
            + ++APE +F R +   + +SDV+SFG+++ E+     +   GV    E        R 
Sbjct: 265 PLKWMAPETIFDRVY---TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRR 315
Query: 295 VEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA 349
           +++    + P   T        +M    L C    PS RP  +E++E L    +A
Sbjct: 316 LKEGTRMRAPDYTT-------PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 363

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 118/272 (43%), Gaps = 44/272 (16%)
Query: 89  DKLGQGGFGGVYKGR---------------------LLDDFVNEVASISRTSHVNVVTLL 127
           +K+G+G +G VYK R                     +    + E++ +   +H N+V LL
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                 N   L++EF+ +  L+KF+  +  T  P   ++       +  + +GL + H  
Sbjct: 69  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-----SYLFQLLQGLAFCH-- 120
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            S ++LH D+KP N+L++ +   K++DFGLA+        V +       + Y APE+  
Sbjct: 121 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTYTHEVVTLWYRAPEIL- 175
Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
                 S   D++S G +  E+V  +  L  G DS  +  F   I+R +    E   PGV
Sbjct: 176 LGXKYYSTAVDIWSLGCIFAEMV-TRRALFPG-DSEIDQLFR--IFRTLGTPDEVVWPGV 231
Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNE 338
            +  + + +        W  Q      PP++E
Sbjct: 232 TSMPDYKPS-----FPKWARQDFSKVVPPLDE 258

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 108/280 (38%), Gaps = 68/280 (24%)
Query: 91  LGQGGFGGVYKGR----------------------LLDDFVNEVASISRTSHVNVVTLLG 128
           LG+G FG VY  R                      +      EV   S   H N++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 129 FCLEGNNRALIYEFMPNGS-------LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           +  +     LI E+ P G+       L KF    D  +   Y         +  +A  L 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKF----DEQRTATY---------ITELANALS 122
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           Y H   S +++H DIKP N+LL      KI+DFG +    +     S      G + Y+ 
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-----SRRTELCGTLDYLP 174
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE+      +   K D++S G++  E +  K   ++     +        Y+ + +  EF
Sbjct: 175 PEMIEGRMHD--EKVDLWSLGVLCYEFLVGKPPFEANTYQET--------YKRISRV-EF 223
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
             P  VT    ++  ++       ++  PS RP + EV+E
Sbjct: 224 TFPDFVTEGARDLISRL-------LKHNPSQRPMLREVLE 256

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 39/203 (19%)
Query: 89  DKLGQGGFGGVYKGRLLDDFVNEVASIS----------RTSHVNVVTLLGFC-------- 130
           D++G+G FG VYKG  +D+   EV +I                  +T+L  C        
Sbjct: 25  DRIGKGSFGEVYKG--IDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRY 82
Query: 131 ----LEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
               L+     +I E++  GS    +  G        L    +  I+  I KGL+YLH  
Sbjct: 83  FGSYLKSTKLWIIMEYLGGGSALDLLKPGP-------LEETYIATILREILKGLDYLH-- 133
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            S + +H DIK  N+LL E    K++DFG+A   T  +   +  +G      ++APEV  
Sbjct: 134 -SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTP---FWMAPEVIK 189
Query: 247 RNFGEVSHKSDVYSFGMMIMELV 269
           ++      K+D++S G+  +EL 
Sbjct: 190 QS--AYDFKADIWSLGITAIELA 210

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 108/280 (38%), Gaps = 68/280 (24%)
Query: 91  LGQGGFGGVYKGR----------------------LLDDFVNEVASISRTSHVNVVTLLG 128
           LG+G FG VY  R                      +      EV   S   H N++ L G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 129 FCLEGNNRALIYEFMPNGS-------LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           +  +     LI E+ P G+       L KF    D  +   Y         +  +A  L 
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKLSKF----DEQRTATY---------ITELANALS 148
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           Y H   S +++H DIKP N+LL      KI+DFG +    +     S      G + Y+ 
Sbjct: 149 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-----SRRTTLCGTLDYLP 200
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE+      +   K D++S G++  E +  K   ++     +        Y+ + +  EF
Sbjct: 201 PEMIEGRMHD--EKVDLWSLGVLCYEFLVGKPPFEANTYQET--------YKRISRV-EF 249
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
             P  VT    ++  ++       ++  PS RP + EV+E
Sbjct: 250 TFPDFVTEGARDLISRL-------LKHNPSQRPMLREVLE 282

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/242 (24%), Positives = 98/242 (40%), Gaps = 33/242 (13%)
Query: 119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV-----------YNGDTSKPCQYLRWE 167
            H N+V LLG C  G    +I E+   G L  F+           YN  +  P + L   
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYN-PSHNPEEQLSSR 166
Query: 168 KMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK-LCTTKEGI 226
            +      +A+G+ +L    S   +H D+   N+LL      KI DFGLA+ +      I
Sbjct: 167 DLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 223
Query: 227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVY 286
           V     AR  + ++APE        V  +SDV+S+G+++ E+     N   G+  +S+  
Sbjct: 224 VKG--NARLPVKWMAPESIFDCVYTV--QSDVWSYGILLWEIFSLGLNPYPGILVNSK-- 277
Query: 287 FPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGS 346
                Y+ V+   +   P    +    I +        C    P+ RP   ++   LQ  
Sbjct: 278 ----FYKLVKDGYQMAQPAFAPKNIYSIMQA-------CWALEPTHRPTFQQICSFLQEQ 326
Query: 347 TE 348
            +
Sbjct: 327 AQ 328

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 88/209 (42%), Gaps = 43/209 (20%)
Query: 91  LGQGGFGGVYKGRLLDDFV-------------------NEVASISRTSHVNVVTLLGFCL 131
           LG+G +G VY GR L + V                    E+A      H N+V  LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 132 EGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWE--KMYEIVIG-----IAKGLEYLH 184
           E     +  E +P GSL   + +          +W   K  E  IG     I +GL+YLH
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRS----------KWGPLKDNEQTIGFYTKQILEGLKYLH 139
Query: 185 HGCSTKILHFDIKPHNILLDE-DFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE 243
                +I+H DIK  N+L++      KISDFG +K      GI        G + Y+APE
Sbjct: 140 ---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA---GINPCTETFTGTLQYMAPE 193
Query: 244 VFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
           +  +        +D++S G  I+E+   K
Sbjct: 194 IIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 36/214 (16%)
Query: 66  NYGPLPLKRYN--------FSDVKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISR 117
           N+G + L RY+           VK+L +S  D+                DF  E+  I +
Sbjct: 19  NFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ--------------RDFQREI-QILK 63
Query: 118 TSHVNVVTLLGFCLEGNNRA---LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVI 174
             H + +        G  R    L+ E++P+G L  F+           L   ++     
Sbjct: 64  ALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRAR-----LDASRLLLYSS 118
Query: 175 GIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGAR 234
            I KG+EYL    S + +H D+   NIL++ +   KI+DFGLAKL    +         +
Sbjct: 119 QICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQ 175
Query: 235 GIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMEL 268
             I + APE  S N    S +SDV+SFG+++ EL
Sbjct: 176 SPIFWYAPESLSDNI--FSRQSDVWSFGVVLYEL 207

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 78/161 (48%), Gaps = 17/161 (10%)
Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKM 169
           NEV  +    H NVV +    L G+   ++ EF+  G+L   V +   ++       E++
Sbjct: 197 NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE-------EQI 249
Query: 170 YEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSS 229
             + + + + L  LH   +  ++H DIK  +ILL  D   K+SDFG    C      V  
Sbjct: 250 AAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPR 303
Query: 230 LLGARGIIGYIAPEVFSR-NFGEVSHKSDVYSFGMMIMELV 269
                G   ++APE+ SR  +G    + D++S G+M++E+V
Sbjct: 304 RKXLVGTPYWMAPELISRLPYGP---EVDIWSLGIMVIEMV 341

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 94/221 (42%), Gaps = 51/221 (23%)
Query: 91  LGQGGFGGVYKGR------------------LLDDFVNEVASISRTSHVNVVTLLGFCLE 132
           LGQG FG V K R                   L   ++EV  ++  +H  VV      LE
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLE 73
Query: 133 GNN----------RALIY---EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
             N          ++ ++   E+  N +L   +++ + ++     + ++ + +   I + 
Sbjct: 74  RRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQ-----QRDEYWRLFRQILEA 128
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV-----------S 228
           L Y+H   S  I+H D+KP NI +DE    KI DFGLAK       I+            
Sbjct: 129 LSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 229 SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
           +L  A G   Y+A EV     G  + K D+YS G++  E++
Sbjct: 186 NLTSAIGTAMYVATEVLD-GTGHYNEKIDMYSLGIIFFEMI 225

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 77/168 (45%), Gaps = 15/168 (8%)
Query: 119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
           +H NVV   G   EGN + L  E+   G L       D  +P   +           +  
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLMA 115
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL--CTTKEGIVSSLLGARGI 236
           G+ YLH      I H DIKP N+LLDE    KISDFGLA +     +E +++ + G    
Sbjct: 116 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT--- 169
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE 284
           + Y+APE+  R     +   DV+S G+++  ++  +   D   DS  E
Sbjct: 170 LPYVAPELLKRREFH-AEPVDVWSCGIVLTAMLAGELPWDQPSDSXQE 216

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 108/280 (38%), Gaps = 68/280 (24%)
Query: 91  LGQGGFGGVYKGR----------------------LLDDFVNEVASISRTSHVNVVTLLG 128
           LG+G FG VY  R                      +      EV   S   H N++ L G
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 129 FCLEGNNRALIYEFMPNGS-------LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           +  +     LI E+ P G+       L KF    D  +   Y         +  +A  L 
Sbjct: 93  YFHDATRVYLILEYAPLGTVYRELQKLSKF----DEQRTATY---------ITELANALS 139
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           Y H   S +++H DIKP N+LL      KI+DFG +    +     S      G + Y+ 
Sbjct: 140 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-----SRRTTLCGTLDYLP 191
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE+      +   K D++S G++  E +  K   ++     +        Y+ + +  EF
Sbjct: 192 PEMIEGRMHD--EKVDLWSLGVLCYEFLVGKPPFEANTYQET--------YKRISRV-EF 240
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
             P  VT    ++  ++       ++  PS RP + EV+E
Sbjct: 241 TFPDFVTEGARDLISRL-------LKHNPSQRPMLREVLE 273

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 78/161 (48%), Gaps = 17/161 (10%)
Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKM 169
           NEV  +    H NVV +    L G+   ++ EF+  G+L   V +   ++       E++
Sbjct: 77  NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE-------EQI 129
Query: 170 YEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSS 229
             + + + + L  LH   +  ++H DIK  +ILL  D   K+SDFG    C      V  
Sbjct: 130 AAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPR 183
Query: 230 LLGARGIIGYIAPEVFSR-NFGEVSHKSDVYSFGMMIMELV 269
                G   ++APE+ SR  +G    + D++S G+M++E+V
Sbjct: 184 RKXLVGTPYWMAPELISRLPYGP---EVDIWSLGIMVIEMV 221

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 78/161 (48%), Gaps = 17/161 (10%)
Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKM 169
           NEV  +    H NVV +    L G+   ++ EF+  G+L   V +   ++       E++
Sbjct: 75  NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE-------EQI 127
Query: 170 YEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSS 229
             + + + + L  LH   +  ++H DIK  +ILL  D   K+SDFG    C      V  
Sbjct: 128 AAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPR 181
Query: 230 LLGARGIIGYIAPEVFSR-NFGEVSHKSDVYSFGMMIMELV 269
                G   ++APE+ SR  +G    + D++S G+M++E+V
Sbjct: 182 RKXLVGTPYWMAPELISRLPYGP---EVDIWSLGIMVIEMV 219

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 36/214 (16%)
Query: 66  NYGPLPLKRYN--------FSDVKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISR 117
           N+G + L RY+           VK+L +S  D+                DF  E+  I +
Sbjct: 23  NFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ--------------RDFQREI-QILK 67
Query: 118 TSHVNVVTLLGFCLEGNNRA---LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVI 174
             H + +        G  R    L+ E++P+G L  F+           L   ++     
Sbjct: 68  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-----LDASRLLLYSS 122
Query: 175 GIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGAR 234
            I KG+EYL    S + +H D+   NIL++ +   KI+DFGLAKL    +         +
Sbjct: 123 QICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQ 179
Query: 235 GIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMEL 268
             I + APE  S N    S +SDV+SFG+++ EL
Sbjct: 180 SPIFWYAPESLSDNI--FSRQSDVWSFGVVLYEL 211

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 110/258 (42%), Gaps = 38/258 (14%)
Query: 105 LDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPC--- 161
           L D ++E   + + +H +V+ L G C +     LI E+   GSL  F+       P    
Sbjct: 70  LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLG 129
Query: 162 ---------------QYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDED 206
                          + L    +      I++G++YL      K++H D+   NIL+ E 
Sbjct: 130 SGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEG 186
Query: 207 FCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIM 266
              KISDFGL++    ++  V    G R  + ++A E    +    + +SDV+SFG+++ 
Sbjct: 187 RKMKISDFGLSRDVYEEDSXVKRSQG-RIPVKWMAIESLFDHI--YTTQSDVWSFGVLLW 243
Query: 267 ELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCI 326
           E+V    N   G+        P  ++  ++     + P       +  +++M  + L C 
Sbjct: 244 EIVTLGGNPYPGIP-------PERLFNLLKTGHRMERP-------DNCSEEMYRLMLQCW 289
Query: 327 QARPSDRPPMNEVIEMLQ 344
           +  P  RP   ++ + L+
Sbjct: 290 KQEPDKRPVFADISKDLE 307

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 110/258 (42%), Gaps = 38/258 (14%)
Query: 105 LDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPC--- 161
           L D ++E   + + +H +V+ L G C +     LI E+   GSL  F+       P    
Sbjct: 70  LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLG 129
Query: 162 ---------------QYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDED 206
                          + L    +      I++G++YL      K++H D+   NIL+ E 
Sbjct: 130 SGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEG 186
Query: 207 FCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIM 266
              KISDFGL++    ++  V    G R  + ++A E    +    + +SDV+SFG+++ 
Sbjct: 187 RKMKISDFGLSRDVYEEDSYVKRSQG-RIPVKWMAIESLFDHI--YTTQSDVWSFGVLLW 243
Query: 267 ELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCI 326
           E+V    N   G+        P  ++  ++     + P       +  +++M  + L C 
Sbjct: 244 EIVTLGGNPYPGIP-------PERLFNLLKTGHRMERP-------DNCSEEMYRLMLQCW 289
Query: 327 QARPSDRPPMNEVIEMLQ 344
           +  P  RP   ++ + L+
Sbjct: 290 KQEPDKRPVFADISKDLE 307

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 118/272 (43%), Gaps = 44/272 (16%)
Query: 89  DKLGQGGFGGVYKGR---------------------LLDDFVNEVASISRTSHVNVVTLL 127
           +K+G+G +G VYK R                     +    + E++ +   +H N+V LL
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                 N   L++EF+ +  L+KF+  +  T  P   ++       +  + +GL + H  
Sbjct: 69  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-----SYLFQLLQGLAFCH-- 120
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            S ++LH D+KP N+L++ +   K++DFGLA+        V +       + Y APE+  
Sbjct: 121 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTYXHEVVTLWYRAPEIL- 175
Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
                 S   D++S G +  E+V  +  L  G DS  +  F   I+R +    E   PGV
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMV-TRRALFPG-DSEIDQLFR--IFRTLGTPDEVVWPGV 231
Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNE 338
            +  + + +        W  Q      PP++E
Sbjct: 232 TSMPDYKPS-----FPKWARQDFSKVVPPLDE 258

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 118/272 (43%), Gaps = 44/272 (16%)
Query: 89  DKLGQGGFGGVYKGR---------------------LLDDFVNEVASISRTSHVNVVTLL 127
           +K+G+G +G VYK R                     +    + E++ +   +H N+V LL
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                 N   L++EF+ +  L+KF+  +  T  P   ++       +  + +GL + H  
Sbjct: 69  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-----SYLFQLLQGLAFCH-- 120
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            S ++LH D+KP N+L++ +   K++DFGLA+        V +       + Y APE+  
Sbjct: 121 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTYXHEVVTLWYRAPEIL- 175
Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
                 S   D++S G +  E+V  +  L  G DS  +  F   I+R +    E   PGV
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMV-TRRALFPG-DSEIDQLFR--IFRTLGTPDEVVWPGV 231
Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNE 338
            +  + + +        W  Q      PP++E
Sbjct: 232 TSMPDYKPS-----FPKWARQDFSKVVPPLDE 258

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 68/281 (24%), Positives = 108/281 (38%), Gaps = 70/281 (24%)
Query: 91  LGQGGFGGVYKGR----------------------LLDDFVNEVASISRTSHVNVVTLLG 128
           LG+G FG VY  R                      +      EV   S   H N++ L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 129 FCLEGNNRALIYEFMPNGS-------LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           +  +     LI E+ P G+       L KF    D  +   Y         +  +A  L 
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSKF----DEQRTATY---------ITELANALS 127
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           Y H   S +++H DIKP N+LL      KI+DFG +    +            G + Y+ 
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC-----GTLDYLP 179
Query: 242 PE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDRE 300
           PE +  R   E   K D++S G++  E +  K   ++     +        Y+ + +  E
Sbjct: 180 PEXIEGRXHDE---KVDLWSLGVLCYEFLVGKPPFEANTYQET--------YKRISRV-E 227
Query: 301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
           F  P  VT    ++  ++       ++  PS RP + EV+E
Sbjct: 228 FTFPDFVTEGARDLISRL-------LKHNPSQRPXLREVLE 261

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 118/272 (43%), Gaps = 44/272 (16%)
Query: 89  DKLGQGGFGGVYKGR---------------------LLDDFVNEVASISRTSHVNVVTLL 127
           +K+G+G +G VYK R                     +    + E++ +   +H N+V LL
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                 N   L++EF+ +  L+KF+  +  T  P   ++       +  + +GL + H  
Sbjct: 68  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-----SYLFQLLQGLAFCH-- 119
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            S ++LH D+KP N+L++ +   K++DFGLA+        V +       + Y APE+  
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTYXHEVVTLWYRAPEIL- 174
Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
                 S   D++S G +  E+V  +  L  G DS  +  F   I+R +    E   PGV
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMV-TRRALFPG-DSEIDQLFR--IFRTLGTPDEVVWPGV 230
Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNE 338
            +  + + +        W  Q      PP++E
Sbjct: 231 TSMPDYKPS-----FPKWARQDFSKVVPPLDE 257

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 118/272 (43%), Gaps = 44/272 (16%)
Query: 89  DKLGQGGFGGVYKGR---------------------LLDDFVNEVASISRTSHVNVVTLL 127
           +K+G+G +G VYK R                     +    + E++ +   +H N+V LL
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                 N   L++EF+ +  L+KF+  +  T  P   ++       +  + +GL + H  
Sbjct: 68  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-----SYLFQLLQGLAFCH-- 119
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            S ++LH D+KP N+L++ +   K++DFGLA+        V +       + Y APE+  
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTYXHEVVTLWYRAPEIL- 174
Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
                 S   D++S G +  E+V  +  L  G DS  +  F   I+R +    E   PGV
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMV-TRRALFPG-DSEIDQLFR--IFRTLGTPDEVVWPGV 230
Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNE 338
            +  + + +        W  Q      PP++E
Sbjct: 231 TSMPDYKPS-----FPKWARQDFSKVVPPLDE 257

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 68/313 (21%), Positives = 126/313 (40%), Gaps = 64/313 (20%)
Query: 80  VKKLTNSFKDKLGQGGFGGVY----------KGRLL--------------DDFVNEVASI 115
           +K+     K +LG+G FG V+          + ++L               DF  E   +
Sbjct: 15  IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELL 74
Query: 116 SRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYN----------GDTSKPCQYLR 165
           +   H ++V   G C EG    +++E+M +G L +F+ +          G+   P   L 
Sbjct: 75  TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP-LG 133
Query: 166 WEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG 225
             ++  +   +A G+ YL        +H D+   N L+ +    KI DFG+++   + + 
Sbjct: 134 LGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD- 189
Query: 226 IVSSLLGARGI--IGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSS 282
                +G R +  I ++ PE +  R F   + +SDV+SFG+++ E+          + ++
Sbjct: 190 --YYRVGGRTMLPIRWMPPESILYRKF---TTESDVWSFGVVLWEIFTYGKQPWYQLSNT 244
Query: 283 SEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM 342
             +         + Q RE + P     +   I +        C Q  P  R  + +V   
Sbjct: 245 EAIDC-------ITQGRELERPRACPPEVYAIMRG-------CWQREPQQRHSIKDVHAR 290
Query: 343 LQGSTEALQIPPT 355
           LQ   +A   PP 
Sbjct: 291 LQALAQA---PPV 300

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 78/161 (48%), Gaps = 17/161 (10%)
Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKM 169
           NEV  +    H NVV +    L G+   ++ EF+  G+L   V +   ++       E++
Sbjct: 66  NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE-------EQI 118
Query: 170 YEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSS 229
             + + + + L  LH   +  ++H DIK  +ILL  D   K+SDFG    C      V  
Sbjct: 119 AAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPR 172
Query: 230 LLGARGIIGYIAPEVFSR-NFGEVSHKSDVYSFGMMIMELV 269
                G   ++APE+ SR  +G    + D++S G+M++E+V
Sbjct: 173 RKXLVGTPYWMAPELISRLPYGP---EVDIWSLGIMVIEMV 210

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 77/168 (45%), Gaps = 15/168 (8%)
Query: 119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
           +H NVV   G   EGN + L  E+   G L       D  +P   +           +  
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLMA 116
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL--CTTKEGIVSSLLGARGI 236
           G+ YLH      I H DIKP N+LLDE    KISDFGLA +     +E +++ + G    
Sbjct: 117 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT--- 170
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE 284
           + Y+APE+  R     +   DV+S G+++  ++  +   D   DS  E
Sbjct: 171 LPYVAPELLKRREFH-AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 36/214 (16%)
Query: 66  NYGPLPLKRYN--------FSDVKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISR 117
           N+G + L RY+           VK+L +S  D+                DF  E+  I +
Sbjct: 35  NFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ--------------RDFQREI-QILK 79
Query: 118 TSHVNVVTLLGFCLEGNNRA---LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVI 174
             H + +        G  R    L+ E++P+G L  F+           L   ++     
Sbjct: 80  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-----LDASRLLLYSS 134
Query: 175 GIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGAR 234
            I KG+EYL    S + +H D+   NIL++ +   KI+DFGLAKL    +         +
Sbjct: 135 QICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQ 191
Query: 235 GIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMEL 268
             I + APE  S N    S +SDV+SFG+++ EL
Sbjct: 192 SPIFWYAPESLSDNI--FSRQSDVWSFGVVLYEL 223

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 118/272 (43%), Gaps = 44/272 (16%)
Query: 89  DKLGQGGFGGVYKGR---------------------LLDDFVNEVASISRTSHVNVVTLL 127
           +K+G+G +G VYK R                     +    + E++ +   +H N+V LL
Sbjct: 13  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 72
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                 N   L++EF+ +  L+KF+  +  T  P   ++       +  + +GL + H  
Sbjct: 73  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-----SYLFQLLQGLAFCH-- 124
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            S ++LH D+KP N+L++ +   K++DFGLA+        V +       + Y APE+  
Sbjct: 125 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTYXHEVVTLWYRAPEIL- 179
Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
                 S   D++S G +  E+V  +  L  G DS  +  F   I+R +    E   PGV
Sbjct: 180 LGCKYYSTAVDIWSLGCIFAEMV-TRRALFPG-DSEIDQLFR--IFRTLGTPDEVVWPGV 235
Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNE 338
            +  + + +        W  Q      PP++E
Sbjct: 236 TSMPDYKPS-----FPKWARQDFSKVVPPLDE 262

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 78/161 (48%), Gaps = 17/161 (10%)
Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKM 169
           NEV  +    H NVV +    L G+   ++ EF+  G+L   V +   ++       E++
Sbjct: 120 NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE-------EQI 172
Query: 170 YEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSS 229
             + + + + L  LH   +  ++H DIK  +ILL  D   K+SDFG    C      V  
Sbjct: 173 AAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPR 226
Query: 230 LLGARGIIGYIAPEVFSR-NFGEVSHKSDVYSFGMMIMELV 269
                G   ++APE+ SR  +G    + D++S G+M++E+V
Sbjct: 227 RKXLVGTPYWMAPELISRLPYGP---EVDIWSLGIMVIEMV 264

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 77/168 (45%), Gaps = 15/168 (8%)
Query: 119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
           +H NVV   G   EGN + L  E+   G L       D  +P   +           +  
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLMA 115
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL--CTTKEGIVSSLLGARGI 236
           G+ YLH      I H DIKP N+LLDE    KISDFGLA +     +E +++ + G    
Sbjct: 116 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT--- 169
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE 284
           + Y+APE+  R     +   DV+S G+++  ++  +   D   DS  E
Sbjct: 170 LPYVAPELLKRREFH-AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 118/272 (43%), Gaps = 44/272 (16%)
Query: 89  DKLGQGGFGGVYKGR---------------------LLDDFVNEVASISRTSHVNVVTLL 127
           +K+G+G +G VYK R                     +    + E++ +   +H N+V LL
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                 N   L++EF+ +  L+KF+  +  T  P   ++       +  + +GL + H  
Sbjct: 69  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-----SYLFQLLQGLSFCH-- 120
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            S ++LH D+KP N+L++ +   K++DFGLA+        V +       + Y APE+  
Sbjct: 121 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTYTHEVVTLWYRAPEIL- 175
Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
                 S   D++S G +  E+V  +  L  G DS  +  F   I+R +    E   PGV
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMV-TRRALFPG-DSEIDQLFR--IFRTLGTPDEVVWPGV 231
Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNE 338
            +  + + +        W  Q      PP++E
Sbjct: 232 TSMPDYKPS-----FPKWARQDFSKVVPPLDE 258

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 77/168 (45%), Gaps = 15/168 (8%)
Query: 119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
           +H NVV   G   EGN + L  E+   G L       D  +P   +           +  
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLMA 115
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL--CTTKEGIVSSLLGARGI 236
           G+ YLH      I H DIKP N+LLDE    KISDFGLA +     +E +++ + G    
Sbjct: 116 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT--- 169
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE 284
           + Y+APE+  R     +   DV+S G+++  ++  +   D   DS  E
Sbjct: 170 LPYVAPELLKRREFH-AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 118/272 (43%), Gaps = 44/272 (16%)
Query: 89  DKLGQGGFGGVYKGR---------------------LLDDFVNEVASISRTSHVNVVTLL 127
           +K+G+G +G VYK R                     +    + E++ +   +H N+V LL
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                 N   L++EF+ +  L+KF+  +  T  P   ++       +  + +GL + H  
Sbjct: 69  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-----SYLFQLLQGLAFCH-- 120
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            S ++LH D+KP N+L++ +   K++DFGLA+        V +       + Y APE+  
Sbjct: 121 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTYXHEVVTLWYRAPEIL- 175
Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
                 S   D++S G +  E+V  +  L  G DS  +  F   I+R +    E   PGV
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMV-TRRALFPG-DSEIDQLFR--IFRTLGTPDEVVWPGV 231
Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNE 338
            +  + + +        W  Q      PP++E
Sbjct: 232 TSMPDYKPS-----FPKWARQDFSKVVPPLDE 258

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 77/168 (45%), Gaps = 15/168 (8%)
Query: 119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
           +H NVV   G   EGN + L  E+   G L       D  +P   +           +  
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLMA 115
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL--CTTKEGIVSSLLGARGI 236
           G+ YLH      I H DIKP N+LLDE    KISDFGLA +     +E +++ + G    
Sbjct: 116 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT--- 169
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE 284
           + Y+APE+  R     +   DV+S G+++  ++  +   D   DS  E
Sbjct: 170 LPYVAPELLKRREFH-AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 118/272 (43%), Gaps = 44/272 (16%)
Query: 89  DKLGQGGFGGVYKGR---------------------LLDDFVNEVASISRTSHVNVVTLL 127
           +K+G+G +G VYK R                     +    + E++ +   +H N+V LL
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 70
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                 N   L++EF+ +  L+KF+  +  T  P   ++       +  + +GL + H  
Sbjct: 71  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-----SYLFQLLQGLAFCH-- 122
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            S ++LH D+KP N+L++ +   K++DFGLA+        V +       + Y APE+  
Sbjct: 123 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTYXHEVVTLWYRAPEIL- 177
Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
                 S   D++S G +  E+V  +  L  G DS  +  F   I+R +    E   PGV
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMV-TRRALFPG-DSEIDQLFR--IFRTLGTPDEVVWPGV 233
Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNE 338
            +  + + +        W  Q      PP++E
Sbjct: 234 TSMPDYKPS-----FPKWARQDFSKVVPPLDE 260

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 118/272 (43%), Gaps = 44/272 (16%)
Query: 89  DKLGQGGFGGVYKGR---------------------LLDDFVNEVASISRTSHVNVVTLL 127
           +K+G+G +G VYK R                     +    + E++ +   +H N+V LL
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                 N   L++EF+ +  L+KF+  +  T  P   ++       +  + +GL + H  
Sbjct: 72  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-----SYLFQLLQGLAFCH-- 123
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            S ++LH D+KP N+L++ +   K++DFGLA+        V +       + Y APE+  
Sbjct: 124 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTYXHEVVTLWYRAPEIL- 178
Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
                 S   D++S G +  E+V  +  L  G DS  +  F   I+R +    E   PGV
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMV-TRRALFPG-DSEIDQLFR--IFRTLGTPDEVVWPGV 234
Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNE 338
            +  + + +        W  Q      PP++E
Sbjct: 235 TSMPDYKPS-----FPKWARQDFSKVVPPLDE 261

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 118/272 (43%), Gaps = 44/272 (16%)
Query: 89  DKLGQGGFGGVYKGR---------------------LLDDFVNEVASISRTSHVNVVTLL 127
           +K+G+G +G VYK R                     +    + E++ +   +H N+V LL
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 70
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                 N   L++EF+ +  L+KF+  +  T  P   ++       +  + +GL + H  
Sbjct: 71  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-----SYLFQLLQGLAFCH-- 122
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            S ++LH D+KP N+L++ +   K++DFGLA+        V +       + Y APE+  
Sbjct: 123 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTYXHEVVTLWYRAPEIL- 177
Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
                 S   D++S G +  E+V  +  L  G DS  +  F   I+R +    E   PGV
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMV-TRRALFPG-DSEIDQLFR--IFRTLGTPDEVVWPGV 233
Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNE 338
            +  + + +        W  Q      PP++E
Sbjct: 234 TSMPDYKPS-----FPKWARQDFSKVVPPLDE 260

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 66/280 (23%), Positives = 107/280 (38%), Gaps = 68/280 (24%)
Query: 91  LGQGGFGGVYKGR----------------------LLDDFVNEVASISRTSHVNVVTLLG 128
           LG+G FG VY  R                      +      EV   S   H N++ L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 129 FCLEGNNRALIYEFMPNGS-------LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           +  +     LI E+ P G+       L KF    D  +   Y         +  +A  L 
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKF----DEQRTATY---------ITELANALS 123
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           Y H   S +++H DIKP N+LL      KI+DFG +    +            G + Y+ 
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLC-----GTLDYLP 175
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE+      +   K D++S G++  E +  K   ++     +        Y+ + +  EF
Sbjct: 176 PEMIEGRMHD--EKVDLWSLGVLCYEFLVGKPPFEANTYQET--------YKRISRV-EF 224
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
             P  VT    ++  ++       ++  PS RP + EV+E
Sbjct: 225 TFPDFVTEGARDLISRL-------LKHNPSQRPMLREVLE 257

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 118/272 (43%), Gaps = 44/272 (16%)
Query: 89  DKLGQGGFGGVYKGR---------------------LLDDFVNEVASISRTSHVNVVTLL 127
           +K+G+G +G VYK R                     +    + E++ +   +H N+V LL
Sbjct: 16  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 75
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                 N   L++EF+ +  L+KF+  +  T  P   ++       +  + +GL + H  
Sbjct: 76  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-----SYLFQLLQGLAFCH-- 127
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            S ++LH D+KP N+L++ +   K++DFGLA+        V +       + Y APE+  
Sbjct: 128 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTYTHEVVTLWYRAPEIL- 182
Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
                 S   D++S G +  E+V  +  L  G DS  +  F   I+R +    E   PGV
Sbjct: 183 LGCKYYSTAVDIWSLGCIFAEMV-TRRALFPG-DSEIDQLF--RIFRTLGTPDEVVWPGV 238
Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNE 338
            +  + + +        W  Q      PP++E
Sbjct: 239 TSMPDYKPS-----FPKWARQDFSKVVPPLDE 265

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 83/164 (50%), Gaps = 16/164 (9%)
Query: 105 LDDFVNEVASISRTSHVNVVTLLGFCLEGNNRAL--IYEFMPNGSLEKFVYNGDTSKPCQ 162
           ++    E+A + +  H NVV L+    + N   L  ++E +  G     V    T KP  
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGP----VMEVPTLKPLS 135
Query: 163 YLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT 222
             +    ++ +I   KG+EYLH+    KI+H DIKP N+L+ ED   KI+DFG++     
Sbjct: 136 EDQARFYFQDLI---KGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKS-DVYSFGMMI 265
            + ++S+ +G      ++APE  S      S K+ DV++ G+ +
Sbjct: 190 SDALLSNTVGTP---AFMAPESLSETRKIFSGKALDVWAMGVTL 230

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 118/272 (43%), Gaps = 44/272 (16%)
Query: 89  DKLGQGGFGGVYKGR---------------------LLDDFVNEVASISRTSHVNVVTLL 127
           +K+G+G +G VYK R                     +    + E++ +   +H N+V LL
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                 N   L++EF+ +  L+KF+  +  T  P   ++       +  + +GL + H  
Sbjct: 70  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-----SYLFQLLQGLAFCH-- 121
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            S ++LH D+KP N+L++ +   K++DFGLA+        V +       + Y APE+  
Sbjct: 122 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTYTHEVVTLWYRAPEIL- 176
Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
                 S   D++S G +  E+V  +  L  G DS  +  F   I+R +    E   PGV
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMV-TRRALFPG-DSEIDQLFR--IFRTLGTPDEVVWPGV 232
Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNE 338
            +  + + +        W  Q      PP++E
Sbjct: 233 TSMPDYKPS-----FPKWARQDFSKVVPPLDE 259

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 118/272 (43%), Gaps = 44/272 (16%)
Query: 89  DKLGQGGFGGVYKGR---------------------LLDDFVNEVASISRTSHVNVVTLL 127
           +K+G+G +G VYK R                     +    + E++ +   +H N+V LL
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                 N   L++EF+ +  L+KF+  +  T  P   ++       +  + +GL + H  
Sbjct: 68  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-----SYLFQLLQGLAFCH-- 119
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            S ++LH D+KP N+L++ +   K++DFGLA+        V +       + Y APE+  
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTYTHEVVTLWYRAPEIL- 174
Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
                 S   D++S G +  E+V  +  L  G DS  +  F   I+R +    E   PGV
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMV-TRRALFPG-DSEIDQLFR--IFRTLGTPDEVVWPGV 230
Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNE 338
            +  + + +        W  Q      PP++E
Sbjct: 231 TSMPDYKPS-----FPKWARQDFSKVVPPLDE 257

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 36/214 (16%)
Query: 66  NYGPLPLKRYN--------FSDVKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISR 117
           N+G + L RY+           VK+L +S  D+                DF  E+  I +
Sbjct: 22  NFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ--------------RDFQREI-QILK 66
Query: 118 TSHVNVVTLLGFCLEGNNRA---LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVI 174
             H + +        G  R    L+ E++P+G L  F+           L   ++     
Sbjct: 67  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-----LDASRLLLYSS 121
Query: 175 GIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGAR 234
            I KG+EYL    S + +H D+   NIL++ +   KI+DFGLAKL    +         +
Sbjct: 122 QICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQ 178
Query: 235 GIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMEL 268
             I + APE  S N    S +SDV+SFG+++ EL
Sbjct: 179 SPIFWYAPESLSDNI--FSRQSDVWSFGVVLYEL 210

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 118/272 (43%), Gaps = 44/272 (16%)
Query: 89  DKLGQGGFGGVYKGR---------------------LLDDFVNEVASISRTSHVNVVTLL 127
           +K+G+G +G VYK R                     +    + E++ +   +H N+V LL
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                 N   L++EF+ +  L+KF+  +  T  P   ++       +  + +GL + H  
Sbjct: 69  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-----SYLFQLLQGLAFCH-- 120
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            S ++LH D+KP N+L++ +   K++DFGLA+        V +       + Y APE+  
Sbjct: 121 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTYTHEVVTLWYRAPEIL- 175
Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
                 S   D++S G +  E+V  +  L  G DS  +  F   I+R +    E   PGV
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMV-TRRALFPG-DSEIDQLFR--IFRTLGTPDEVVWPGV 231
Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNE 338
            +  + + +        W  Q      PP++E
Sbjct: 232 TSMPDYKPS-----FPKWARQDFSKVVPPLDE 258

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 118/272 (43%), Gaps = 44/272 (16%)
Query: 89  DKLGQGGFGGVYKGR---------------------LLDDFVNEVASISRTSHVNVVTLL 127
           +K+G+G +G VYK R                     +    + E++ +   +H N+V LL
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                 N   L++EF+ +  L+KF+  +  T  P   ++       +  + +GL + H  
Sbjct: 68  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-----SYLFQLLQGLAFCH-- 119
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            S ++LH D+KP N+L++ +   K++DFGLA+        V +       + Y APE+  
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTYTHEVVTLWYRAPEIL- 174
Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
                 S   D++S G +  E+V  +  L  G DS  +  F   I+R +    E   PGV
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMV-TRRALFPG-DSEIDQLFR--IFRTLGTPDEVVWPGV 230
Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNE 338
            +  + + +        W  Q      PP++E
Sbjct: 231 TSMPDYKPS-----FPKWARQDFSKVVPPLDE 257

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 78/161 (48%), Gaps = 17/161 (10%)
Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKM 169
           NEV  +    H NVV +    L G+   ++ EF+  G+L   V +   ++       E++
Sbjct: 70  NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE-------EQI 122
Query: 170 YEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSS 229
             + + + + L  LH   +  ++H DIK  +ILL  D   K+SDFG    C      V  
Sbjct: 123 AAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPR 176
Query: 230 LLGARGIIGYIAPEVFSR-NFGEVSHKSDVYSFGMMIMELV 269
                G   ++APE+ SR  +G    + D++S G+M++E+V
Sbjct: 177 RKXLVGTPYWMAPELISRLPYGP---EVDIWSLGIMVIEMV 214

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 118/272 (43%), Gaps = 44/272 (16%)
Query: 89  DKLGQGGFGGVYKGR---------------------LLDDFVNEVASISRTSHVNVVTLL 127
           +K+G+G +G VYK R                     +    + E++ +   +H N+V LL
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                 N   L++EF+ +  L+KF+  +  T  P   ++       +  + +GL + H  
Sbjct: 69  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-----SYLFQLLQGLAFCH-- 120
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            S ++LH D+KP N+L++ +   K++DFGLA+        V +       + Y APE+  
Sbjct: 121 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTYTHEVVTLWYRAPEIL- 175
Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
                 S   D++S G +  E+V  +  L  G DS  +  F   I+R +    E   PGV
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMV-TRRALFPG-DSEIDQLFR--IFRTLGTPDEVVWPGV 231
Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNE 338
            +  + + +        W  Q      PP++E
Sbjct: 232 TSMPDYKPS-----FPKWARQDFSKVVPPLDE 258

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 118/272 (43%), Gaps = 44/272 (16%)
Query: 89  DKLGQGGFGGVYKGR---------------------LLDDFVNEVASISRTSHVNVVTLL 127
           +K+G+G +G VYK R                     +    + E++ +   +H N+V LL
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                 N   L++EF+ +  L+KF+  +  T  P   ++       +  + +GL + H  
Sbjct: 68  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-----SYLFQLLQGLAFCH-- 119
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            S ++LH D+KP N+L++ +   K++DFGLA+        V +       + Y APE+  
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTYTHEVVTLWYRAPEIL- 174
Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
                 S   D++S G +  E+V  +  L  G DS  +  F   I+R +    E   PGV
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMV-TRRALFPG-DSEIDQLFR--IFRTLGTPDEVVWPGV 230
Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNE 338
            +  + + +        W  Q      PP++E
Sbjct: 231 TSMPDYKPS-----FPKWARQDFSKVVPPLDE 257

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 118/272 (43%), Gaps = 44/272 (16%)
Query: 89  DKLGQGGFGGVYKGR---------------------LLDDFVNEVASISRTSHVNVVTLL 127
           +K+G+G +G VYK R                     +    + E++ +   +H N+V LL
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                 N   L++EF+ +  L+KF+  +  T  P   ++       +  + +GL + H  
Sbjct: 70  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-----SYLFQLLQGLAFCH-- 121
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            S ++LH D+KP N+L++ +   K++DFGLA+        V +       + Y APE+  
Sbjct: 122 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTYXHEVVTLWYRAPEIL- 176
Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
                 S   D++S G +  E+V  +  L  G DS  +  F   I+R +    E   PGV
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMV-TRRALFPG-DSEIDQLFR--IFRTLGTPDEVVWPGV 232
Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNE 338
            +  + + +        W  Q      PP++E
Sbjct: 233 TSMPDYKPS-----FPKWARQDFSKVVPPLDE 259

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 68/313 (21%), Positives = 126/313 (40%), Gaps = 64/313 (20%)
Query: 80  VKKLTNSFKDKLGQGGFGGVY----------KGRLL--------------DDFVNEVASI 115
           +K+     K +LG+G FG V+          + ++L               DF  E   +
Sbjct: 9   IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELL 68
Query: 116 SRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYN----------GDTSKPCQYLR 165
           +   H ++V   G C EG    +++E+M +G L +F+ +          G+   P   L 
Sbjct: 69  TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP-LG 127
Query: 166 WEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG 225
             ++  +   +A G+ YL        +H D+   N L+ +    KI DFG+++   + + 
Sbjct: 128 LGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD- 183
Query: 226 IVSSLLGARGI--IGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSS 282
                +G R +  I ++ PE +  R F   + +SDV+SFG+++ E+          + ++
Sbjct: 184 --YYRVGGRTMLPIRWMPPESILYRKF---TTESDVWSFGVVLWEIFTYGKQPWYQLSNT 238
Query: 283 SEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM 342
             +         + Q RE + P     +   I +        C Q  P  R  + +V   
Sbjct: 239 EAIDC-------ITQGRELERPRACPPEVYAIMRG-------CWQREPQQRHSIKDVHAR 284
Query: 343 LQGSTEALQIPPT 355
           LQ   +A   PP 
Sbjct: 285 LQALAQA---PPV 294

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 118/272 (43%), Gaps = 44/272 (16%)
Query: 89  DKLGQGGFGGVYKGR---------------------LLDDFVNEVASISRTSHVNVVTLL 127
           +K+G+G +G VYK R                     +    + E++ +   +H N+V LL
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                 N   L++EF+ +  L+KF+  +  T  P   ++       +  + +GL + H  
Sbjct: 70  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-----SYLFQLLQGLAFCH-- 121
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            S ++LH D+KP N+L++ +   K++DFGLA+        V +       + Y APE+  
Sbjct: 122 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTYXHEVVTLWYRAPEIL- 176
Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
                 S   D++S G +  E+V  +  L  G DS  +  F   I+R +    E   PGV
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMV-TRRALFPG-DSEIDQLFR--IFRTLGTPDEVVWPGV 232
Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNE 338
            +  + + +        W  Q      PP++E
Sbjct: 233 TSMPDYKPS-----FPKWARQDFSKVVPPLDE 259

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 118/272 (43%), Gaps = 44/272 (16%)
Query: 89  DKLGQGGFGGVYKGR---------------------LLDDFVNEVASISRTSHVNVVTLL 127
           +K+G+G +G VYK R                     +    + E++ +   +H N+V LL
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                 N   L++EF+ +  L+KF+  +  T  P   ++       +  + +GL + H  
Sbjct: 69  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-----SYLFQLLQGLAFCH-- 120
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            S ++LH D+KP N+L++ +   K++DFGLA+        V +       + Y APE+  
Sbjct: 121 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTYTHEVVTLWYRAPEIL- 175
Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
                 S   D++S G +  E+V  +  L  G DS  +  F   I+R +    E   PGV
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMV-TRRALFPG-DSEIDQLFR--IFRTLGTPDEVVWPGV 231
Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNE 338
            +  + + +        W  Q      PP++E
Sbjct: 232 TSMPDYKPS-----FPKWARQDFSKVVPPLDE 258

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 77/168 (45%), Gaps = 15/168 (8%)
Query: 119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
           +H NVV   G   EGN + L  E+   G L       D  +P   +           +  
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLMA 115
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL--CTTKEGIVSSLLGARGI 236
           G+ YLH      I H DIKP N+LLDE    KISDFGLA +     +E +++ + G    
Sbjct: 116 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT--- 169
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE 284
           + Y+APE+  R     +   DV+S G+++  ++  +   D   DS  E
Sbjct: 170 LPYVAPELLKRREFH-AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 77/168 (45%), Gaps = 15/168 (8%)
Query: 119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
           +H NVV   G   EGN + L  E+   G L       D  +P   +           +  
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLMA 115
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL--CTTKEGIVSSLLGARGI 236
           G+ YLH      I H DIKP N+LLDE    KISDFGLA +     +E +++ + G    
Sbjct: 116 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT--- 169
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE 284
           + Y+APE+  R     +   DV+S G+++  ++  +   D   DS  E
Sbjct: 170 LPYVAPELLKRREFH-AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 77/168 (45%), Gaps = 15/168 (8%)
Query: 119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
           +H NVV   G   EGN + L  E+   G L       D  +P   +           +  
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLMA 115
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL--CTTKEGIVSSLLGARGI 236
           G+ YLH      I H DIKP N+LLDE    KISDFGLA +     +E +++ + G    
Sbjct: 116 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT--- 169
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE 284
           + Y+APE+  R     +   DV+S G+++  ++  +   D   DS  E
Sbjct: 170 LPYVAPELLKRREFH-AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 77/168 (45%), Gaps = 15/168 (8%)
Query: 119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
           +H NVV   G   EGN + L  E+   G L       D  +P   +           +  
Sbjct: 61  NHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLMA 114
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL--CTTKEGIVSSLLGARGI 236
           G+ YLH      I H DIKP N+LLDE    KISDFGLA +     +E +++ + G    
Sbjct: 115 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT--- 168
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE 284
           + Y+APE+  R     +   DV+S G+++  ++  +   D   DS  E
Sbjct: 169 LPYVAPELLKRREFH-AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 215

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 82/181 (45%), Gaps = 15/181 (8%)
Query: 106 DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLR 165
           ++   E+   +  +H NVV   G   EGN + L  E+   G L       D  +P   + 
Sbjct: 50  ENIKKEICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMP 103
Query: 166 WEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL--CTTK 223
                     +  G+ YLH      I H DIKP N+LLDE    KISDFGLA +     +
Sbjct: 104 EPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160
Query: 224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSS 283
           E +++ + G    + Y+APE+  R     +   DV+S G+++  ++  +   D   DS  
Sbjct: 161 ERLLNKMCGT---LPYVAPELLKRREFH-AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 216
Query: 284 E 284
           E
Sbjct: 217 E 217

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 77/168 (45%), Gaps = 15/168 (8%)
Query: 119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
           +H NVV   G   EGN + L  E+   G L       D  +P   +           +  
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLMA 116
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL--CTTKEGIVSSLLGARGI 236
           G+ YLH      I H DIKP N+LLDE    KISDFGLA +     +E +++ + G    
Sbjct: 117 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT--- 170
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE 284
           + Y+APE+  R     +   DV+S G+++  ++  +   D   DS  E
Sbjct: 171 LPYVAPELLKRREFH-AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 118/272 (43%), Gaps = 44/272 (16%)
Query: 89  DKLGQGGFGGVYKGR---------------------LLDDFVNEVASISRTSHVNVVTLL 127
           +K+G+G +G VYK R                     +    + E++ +   +H N+V LL
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                 N   L++EF+ +  L+KF+  +  T  P   ++       +  + +GL + H  
Sbjct: 72  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-----SYLFQLLQGLAFCH-- 123
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            S ++LH D+KP N+L++ +   K++DFGLA+        V +       + Y APE+  
Sbjct: 124 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTYXHEVVTLWYRAPEIL- 178
Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
                 S   D++S G +  E+V  +  L  G DS  +  F   I+R +    E   PGV
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMV-TRRALFPG-DSEIDQLFR--IFRTLGTPDEVVWPGV 234
Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNE 338
            +  + + +        W  Q      PP++E
Sbjct: 235 TSMPDYKPS-----FPKWARQDFSKVVPPLDE 261

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 77/168 (45%), Gaps = 15/168 (8%)
Query: 119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
           +H NVV   G   EGN + L  E+   G L       D  +P   +           +  
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLMA 116
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL--CTTKEGIVSSLLGARGI 236
           G+ YLH      I H DIKP N+LLDE    KISDFGLA +     +E +++ + G    
Sbjct: 117 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT--- 170
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE 284
           + Y+APE+  R     +   DV+S G+++  ++  +   D   DS  E
Sbjct: 171 LPYVAPELLKRREFH-AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 118/272 (43%), Gaps = 44/272 (16%)
Query: 89  DKLGQGGFGGVYKGR---------------------LLDDFVNEVASISRTSHVNVVTLL 127
           +K+G+G +G VYK R                     +    + E++ +   +H N+V LL
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                 N   L++EF+ +  L+KF+  +  T  P   ++       +  + +GL + H  
Sbjct: 69  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-----SYLFQLLQGLAFCH-- 120
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            S ++LH D+KP N+L++ +   K++DFGLA+        V +       + Y APE+  
Sbjct: 121 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTYXHEVVTLWYRAPEIL- 175
Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
                 S   D++S G +  E+V  +  L  G DS  +  F   I+R +    E   PGV
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMV-TRRALFPG-DSEIDQLFR--IFRTLGTPDEVVWPGV 231
Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNE 338
            +  + + +        W  Q      PP++E
Sbjct: 232 TSMPDYKPS-----FPKWARQDFSKVVPPLDE 258

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 77/168 (45%), Gaps = 15/168 (8%)
Query: 119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
           +H NVV   G   EGN + L  E+   G L       D  +P   +           +  
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLMA 116
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL--CTTKEGIVSSLLGARGI 236
           G+ YLH      I H DIKP N+LLDE    KISDFGLA +     +E +++ + G    
Sbjct: 117 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT--- 170
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE 284
           + Y+APE+  R     +   DV+S G+++  ++  +   D   DS  E
Sbjct: 171 LPYVAPELLKRREFH-AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 71/321 (22%), Positives = 129/321 (40%), Gaps = 69/321 (21%)
Query: 77  FSD-----VKKLTNSFKDKLGQGGFGGVY----------KGRLL--------------DD 107
           FSD     +K+     K +LG+G FG V+          + ++L               D
Sbjct: 30  FSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD 89
Query: 108 FVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYN----------GDT 157
           F  E   ++   H ++V   G C EG    +++E+M +G L +F+ +          G+ 
Sbjct: 90  FQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED 149
Query: 158 SKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLA 217
             P   L   ++  +   +A G+ YL        +H D+   N L+ +    KI DFG++
Sbjct: 150 VAPGP-LGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
Query: 218 KLCTTKEGIVSSLLGARGI--IGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNN 274
           +   + +      +G R +  I ++ PE +  R F   + +SDV+SFG+++ E+      
Sbjct: 206 RDIYSTD---YYRVGGRTMLPIRWMPPESILYRKF---TTESDVWSFGVVLWEIFTYGKQ 259
Query: 275 LDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRP 334
               + ++  +         + Q RE + P     +   I +        C Q  P  R 
Sbjct: 260 PWYQLSNTEAIDC-------ITQGRELERPRACPPEVYAIMRG-------CWQREPQQRH 305
Query: 335 PMNEVIEMLQGSTEALQIPPT 355
            + +V   LQ   +A   PP 
Sbjct: 306 SIKDVHARLQALAQA---PPV 323

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 118/272 (43%), Gaps = 44/272 (16%)
Query: 89  DKLGQGGFGGVYKGR---------------------LLDDFVNEVASISRTSHVNVVTLL 127
           +K+G+G +G VYK R                     +    + E++ +   +H N+V LL
Sbjct: 13  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 72
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                 N   L++EF+ +  L+KF+  +  T  P   ++       +  + +GL + H  
Sbjct: 73  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-----SYLFQLLQGLAFCH-- 124
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            S ++LH D+KP N+L++ +   K++DFGLA+        V +       + Y APE+  
Sbjct: 125 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTYTHEVVTLWYRAPEILL 180
Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
                 S   D++S G +  E+V  +  L  G DS  +  F   I+R +    E   PGV
Sbjct: 181 -GCKYYSTAVDIWSLGCIFAEMV-TRRALFPG-DSEIDQLF--RIFRTLGTPDEVVWPGV 235
Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNE 338
            +  + + +        W  Q      PP++E
Sbjct: 236 TSMPDYKPS-----FPKWARQDFSKVVPPLDE 262

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 119/275 (43%), Gaps = 54/275 (19%)
Query: 89  DKLGQGGFGGVYKG-----------RLLD---------DFVNEVASISRTSHVNVVTLLG 128
           +K+G+G FG V+KG           +++D         D   E+  +S+     V    G
Sbjct: 33  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 92
Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNG--DTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
             L+     +I E++  GS    +  G  D ++    LR          I KGL+YLH  
Sbjct: 93  SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR---------EILKGLDYLH-- 141
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            S K +H DIK  N+LL E    K++DFG+A   T  +   ++ +G      ++APEV  
Sbjct: 142 -SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTP---FWMAPEVIK 197
Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
           ++      K+D++S G+  +EL         G    SE++ P  +   + ++    L G 
Sbjct: 198 QS--AYDSKADIWSLGITAIELA-------RGEPPHSELH-PMKVLFLIPKNNPPTLEGN 247
Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
            ++   E  +        C+   PS RP   E+++
Sbjct: 248 YSKPLKEFVEA-------CLNKEPSFRPTAKELLK 275

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 119/275 (43%), Gaps = 54/275 (19%)
Query: 89  DKLGQGGFGGVYKG-----------RLLD---------DFVNEVASISRTSHVNVVTLLG 128
           +K+G+G FG V+KG           +++D         D   E+  +S+     V    G
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNG--DTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
             L+     +I E++  GS    +  G  D ++    LR          I KGL+YLH  
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR---------EILKGLDYLH-- 121
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            S K +H DIK  N+LL E    K++DFG+A   T  +   ++ +G      ++APEV  
Sbjct: 122 -SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTP---FWMAPEVIK 177
Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
           ++      K+D++S G+  +EL         G    SE++ P  +   + ++    L G 
Sbjct: 178 QS--AYDSKADIWSLGITAIELA-------RGEPPHSELH-PMKVLFLIPKNNPPTLEGN 227
Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
            ++   E  +        C+   PS RP   E+++
Sbjct: 228 YSKPLKEFVEA-------CLNKEPSFRPTAKELLK 255

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 77/168 (45%), Gaps = 15/168 (8%)
Query: 119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
           +H NVV   G   EGN + L  E+   G L       D  +P   +           +  
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLMA 116
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL--CTTKEGIVSSLLGARGI 236
           G+ YLH      I H DIKP N+LLDE    KISDFGLA +     +E +++ + G    
Sbjct: 117 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT--- 170
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE 284
           + Y+APE+  R     +   DV+S G+++  ++  +   D   DS  E
Sbjct: 171 LPYVAPELLKRREFH-AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 77/168 (45%), Gaps = 15/168 (8%)
Query: 119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
           +H NVV   G   EGN + L  E+   G L       D  +P   +           +  
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLMA 116
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL--CTTKEGIVSSLLGARGI 236
           G+ YLH      I H DIKP N+LLDE    KISDFGLA +     +E +++ + G    
Sbjct: 117 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT--- 170
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE 284
           + Y+APE+  R     +   DV+S G+++  ++  +   D   DS  E
Sbjct: 171 LPYVAPELLKRREFH-AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 76/159 (47%), Gaps = 20/159 (12%)
Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEK 168
           NE+A + +  H N+V L      G +  LI + +  G L ++ V  G       +     
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-------FYTERD 117
Query: 169 MYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNIL---LDEDFCPKISDFGLAKLCTTKEG 225
              ++  +   ++YLH      I+H D+KP N+L   LDED    ISDFGL+K+    E 
Sbjct: 118 ASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM----ED 170
Query: 226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMM 264
             S L  A G  GY+APEV ++     S   D +S G++
Sbjct: 171 PGSVLSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVI 207

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 77/168 (45%), Gaps = 15/168 (8%)
Query: 119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
           +H NVV   G   EGN + L  E+   G L       D  +P   +           +  
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLMA 115
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL--CTTKEGIVSSLLGARGI 236
           G+ YLH      I H DIKP N+LLDE    KISDFGLA +     +E +++ + G    
Sbjct: 116 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT--- 169
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE 284
           + Y+APE+  R     +   DV+S G+++  ++  +   D   DS  E
Sbjct: 170 LPYVAPELLKRREFH-AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 118/272 (43%), Gaps = 44/272 (16%)
Query: 89  DKLGQGGFGGVYKGR---------------------LLDDFVNEVASISRTSHVNVVTLL 127
           +K+G+G +G VYK R                     +    + E++ +   +H N+V LL
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 70
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                 N   L++EF+ +  L+KF+  +  T  P   ++       +  + +GL + H  
Sbjct: 71  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-----SYLFQLLQGLAFCH-- 122
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            S ++LH D+KP N+L++ +   K++DFGLA+        V +       + Y APE+  
Sbjct: 123 -SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVP---VRTYXHEVVTLWYRAPEIL- 177
Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
                 S   D++S G +  E+V  +  L  G DS  +  F   I+R +    E   PGV
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMV-TRRALFPG-DSEIDQLFR--IFRTLGTPDEVVWPGV 233
Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNE 338
            +  + + +        W  Q      PP++E
Sbjct: 234 TSMPDYKPS-----FPKWARQDFSKVVPPLDE 260

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 77/168 (45%), Gaps = 15/168 (8%)
Query: 119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
           +H NVV   G   EGN + L  E+   G L       D  +P   +           +  
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLMA 115
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL--CTTKEGIVSSLLGARGI 236
           G+ YLH      I H DIKP N+LLDE    KISDFGLA +     +E +++ + G    
Sbjct: 116 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT--- 169
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE 284
           + Y+APE+  R     +   DV+S G+++  ++  +   D   DS  E
Sbjct: 170 LPYVAPELLKRREFH-AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 77/168 (45%), Gaps = 15/168 (8%)
Query: 119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
           +H NVV   G   EGN + L  E+   G L       D  +P   +           +  
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLMA 115
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL--CTTKEGIVSSLLGARGI 236
           G+ YLH      I H DIKP N+LLDE    KISDFGLA +     +E +++ + G    
Sbjct: 116 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT--- 169
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE 284
           + Y+APE+  R     +   DV+S G+++  ++  +   D   DS  E
Sbjct: 170 LPYVAPELLKRREFH-AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 77/168 (45%), Gaps = 15/168 (8%)
Query: 119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
           +H NVV   G   EGN + L  E+   G L       D  +P   +           +  
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLMA 115
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL--CTTKEGIVSSLLGARGI 236
           G+ YLH      I H DIKP N+LLDE    KISDFGLA +     +E +++ + G    
Sbjct: 116 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT--- 169
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE 284
           + Y+APE+  R     +   DV+S G+++  ++  +   D   DS  E
Sbjct: 170 LPYVAPELLKRREFH-AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 118/272 (43%), Gaps = 44/272 (16%)
Query: 89  DKLGQGGFGGVYKGR---------------------LLDDFVNEVASISRTSHVNVVTLL 127
           +K+G+G +G VYK R                     +    + E++ +   +H N+V LL
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                 N   L++EF+ +  L+KF+  +  T  P   ++       +  + +GL + H  
Sbjct: 70  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK-----SYLFQLLQGLAFCH-- 121
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            S ++LH D+KP N+L++ +   K++DFGLA+        V +       + Y APE+  
Sbjct: 122 -SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVP---VRTYXHEVVTLWYRAPEIL- 176
Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
                 S   D++S G +  E+V  +  L  G DS  +  F   I+R +    E   PGV
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMV-TRRALFPG-DSEIDQLFR--IFRTLGTPDEVVWPGV 232
Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNE 338
            +  + + +        W  Q      PP++E
Sbjct: 233 TSMPDYKPS-----FPKWARQDFSKVVPPLDE 259

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/280 (23%), Positives = 107/280 (38%), Gaps = 68/280 (24%)
Query: 91  LGQGGFGGVYKGR----------------------LLDDFVNEVASISRTSHVNVVTLLG 128
           LG+G FG VY  R                      +      EV   S   H N++ L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 129 FCLEGNNRALIYEFMPNGS-------LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           +  +     LI E+ P G+       L KF    D  +   Y         +  +A  L 
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKF----DEQRTATY---------ITELANALS 125
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           Y H   S +++H DIKP N+LL      KI++FG +    +            G + Y+ 
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLC-----GTLDYLP 177
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE+      +   K D++S G++  E +  K   ++     +        Y+ + +  EF
Sbjct: 178 PEMIEGRMHD--EKVDLWSLGVLCYEFLVGKPPFEANTYQET--------YKRISRV-EF 226
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
             P  VT    ++  ++       ++  PS RP + EV+E
Sbjct: 227 TFPDFVTEGARDLISRL-------LKHNPSQRPMLREVLE 259

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 88/209 (42%), Gaps = 43/209 (20%)
Query: 91  LGQGGFGGVYKGRLLDDFV-------------------NEVASISRTSHVNVVTLLGFCL 131
           LG+G +G VY GR L + V                    E+A      H N+V  LG   
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 132 EGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWE--KMYEIVIG-----IAKGLEYLH 184
           E     +  E +P GSL   + +          +W   K  E  IG     I +GL+YLH
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRS----------KWGPLKDNEQTIGFYTKQILEGLKYLH 125
Query: 185 HGCSTKILHFDIKPHNILLDE-DFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE 243
                +I+H DIK  N+L++      KISDFG +K      GI        G + Y+APE
Sbjct: 126 ---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA---GINPCTETFTGTLQYMAPE 179
Query: 244 VFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
           +  +        +D++S G  I+E+   K
Sbjct: 180 IIDKGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 77/168 (45%), Gaps = 15/168 (8%)
Query: 119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
           +H NVV   G   EGN + L  E+   G L       D  +P   +           +  
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLMA 116
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL--CTTKEGIVSSLLGARGI 236
           G+ YLH      I H DIKP N+LLDE    KISDFGLA +     +E +++ + G    
Sbjct: 117 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT--- 170
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE 284
           + Y+APE+  R     +   DV+S G+++  ++  +   D   DS  E
Sbjct: 171 LPYVAPELLKRREFH-AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 48/214 (22%)
Query: 89  DKLGQGGFGGVYKGR-------------LLDD-------FVNEVASISRTSHVNVVTLLG 128
           +KLG G +  VYKG               LD         + E++ +    H N+V L  
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYD 70
Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYN---GDTSKPCQ-----YLRWEKMYEIVIGIAKGL 180
                N   L++EFM N  L+K++ +   G+T +  +     Y +W+        + +GL
Sbjct: 71  VIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQ--------LLQGL 121
Query: 181 EYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYI 240
            + H     KILH D+KP N+L+++    K+ DFGLA+         SS +     + Y 
Sbjct: 122 AFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVT---LWYR 175
Query: 241 APEVF--SRNFGEVSHKSDVYSFGMMIMELVGCK 272
           AP+V   SR +   S   D++S G ++ E++  K
Sbjct: 176 APDVLMGSRTY---STSIDIWSCGCILAEMITGK 206

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 75/162 (46%), Gaps = 11/162 (6%)
Query: 106 DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLR 165
           ++ + E   + +  +  +V L+G C +     L+ E    G L KF+       P     
Sbjct: 55  EEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVS--- 110
Query: 166 WEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG 225
              + E++  ++ G++YL        +H D+   N+LL      KISDFGL+K     + 
Sbjct: 111 --NVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165
Query: 226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIME 267
             ++    +  + + APE    NF + S +SDV+S+G+ + E
Sbjct: 166 YYTARSAGKWPLKWYAPECI--NFRKFSSRSDVWSYGVTMWE 205

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 100/239 (41%), Gaps = 33/239 (13%)
Query: 119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV-------YNGDTSKPCQYLRWEKMYE 171
            H N+V LLG C  G    +I E+   G L  F+        + +  +P   L    +  
Sbjct: 100 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRP---LELRDLLH 156
Query: 172 IVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK-LCTTKEGIVSSL 230
               +A+G+ +L    S   +H D+   N+LL      KI DFGLA+ +      IV   
Sbjct: 157 FSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG- 212
Query: 231 LGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPH 289
             AR  + ++APE +F   +   + +SDV+S+G+++ E+     N   G+  +S+     
Sbjct: 213 -NARLPVKWMAPESIFDCVY---TVQSDVWSYGILLWEIFSLGLNPYPGILVNSK----- 263
Query: 290 WIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE 348
             Y+ V+   +   P    +    I +        C    P+ RP   ++   LQ   +
Sbjct: 264 -FYKLVKDGYQMAQPAFAPKNIYSIMQA-------CWALEPTHRPTFQQICSFLQEQAQ 314

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 77/168 (45%), Gaps = 15/168 (8%)
Query: 119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
           +H NVV   G   EGN + L  E+   G L       D  +P   +           +  
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLMA 115
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL--CTTKEGIVSSLLGARGI 236
           G+ YLH      I H DIKP N+LLDE    KISDFGLA +     +E +++ + G    
Sbjct: 116 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT--- 169
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE 284
           + Y+APE+  R     +   DV+S G+++  ++  +   D   DS  E
Sbjct: 170 LPYVAPELLKRREFH-AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 118/272 (43%), Gaps = 44/272 (16%)
Query: 89  DKLGQGGFGGVYKGR---------------------LLDDFVNEVASISRTSHVNVVTLL 127
           +K+G+G +G VYK R                     +    + E++ +   +H N+V LL
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                 N   L++EF+ +  L+KF+  +  T  P   ++       +  + +GL + H  
Sbjct: 72  DVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIK-----SYLFQLLQGLAFCH-- 123
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            S ++LH D+KP N+L++ +   K++DFGLA+        V +       + Y APE+  
Sbjct: 124 -SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVP---VRTYXHEVVTLWYRAPEIL- 178
Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
                 S   D++S G +  E+V  +  L  G DS  +  F   I+R +    E   PGV
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMV-TRRALFPG-DSEIDQLFR--IFRTLGTPDEVVWPGV 234
Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNE 338
            +  + + +        W  Q      PP++E
Sbjct: 235 TSMPDYKPS-----FPKWARQDFSKVVPPLDE 261

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 76/159 (47%), Gaps = 20/159 (12%)
Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEK 168
           NE+A + +  H N+V L      G +  LI + +  G L ++ V  G       +     
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-------FYTERD 117
Query: 169 MYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNIL---LDEDFCPKISDFGLAKLCTTKEG 225
              ++  +   ++YLH      I+H D+KP N+L   LDED    ISDFGL+K+    E 
Sbjct: 118 ASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM----ED 170
Query: 226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMM 264
             S L  A G  GY+APEV ++     S   D +S G++
Sbjct: 171 PGSVLSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVI 207

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 76/159 (47%), Gaps = 20/159 (12%)
Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEK 168
           NE+A + +  H N+V L      G +  LI + +  G L ++ V  G       +     
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-------FYTERD 117
Query: 169 MYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNIL---LDEDFCPKISDFGLAKLCTTKEG 225
              ++  +   ++YLH      I+H D+KP N+L   LDED    ISDFGL+K+    E 
Sbjct: 118 ASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM----ED 170
Query: 226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMM 264
             S L  A G  GY+APEV ++     S   D +S G++
Sbjct: 171 PGSVLSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVI 207

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 108/280 (38%), Gaps = 68/280 (24%)
Query: 91  LGQGGFGGVYKGR----------------------LLDDFVNEVASISRTSHVNVVTLLG 128
           LG+G FG VY  R                      +      EV   S   H N++ L G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 129 FCLEGNNRALIYEFMPNGS-------LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           +  +     LI E+ P G+       L KF    D  +   Y         +  +A  L 
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKLSKF----DEQRTATY---------ITELANALS 148
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           Y H   S +++H DIKP N+LL      KI+DFG +    +     S      G + Y+ 
Sbjct: 149 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-----SRRDDLCGTLDYLP 200
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE+      +   K D++S G++  E +  K   ++     +        Y+ + +  EF
Sbjct: 201 PEMIEGRMHD--EKVDLWSLGVLCYEFLVGKPPFEANTYQET--------YKRISR-VEF 249
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
             P  VT    ++  ++       ++  PS RP + EV+E
Sbjct: 250 TFPDFVTEGARDLISRL-------LKHNPSQRPMLREVLE 282

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 118/272 (43%), Gaps = 44/272 (16%)
Query: 89  DKLGQGGFGGVYKGR---------------------LLDDFVNEVASISRTSHVNVVTLL 127
           +K+G+G +G VYK R                     +    + E++ +   +H N+V LL
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                 N   L++EF+ +  L+KF+  +  T  P   ++       +  + +GL + H  
Sbjct: 70  DVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIK-----SYLFQLLQGLAFCH-- 121
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            S ++LH D+KP N+L++ +   K++DFGLA+        V +       + Y APE+  
Sbjct: 122 -SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVP---VRTYXHEVVTLWYRAPEIL- 176
Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
                 S   D++S G +  E+V  +  L  G DS  +  F   I+R +    E   PGV
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMV-TRRALFPG-DSEIDQLFR--IFRTLGTPDEVVWPGV 232
Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNE 338
            +  + + +        W  Q      PP++E
Sbjct: 233 TSMPDYKPS-----FPKWARQDFSKVVPPLDE 259

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 76/159 (47%), Gaps = 20/159 (12%)
Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEK 168
           NE+A + +  H N+V L      G +  LI + +  G L ++ V  G       +     
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-------FYTERD 117
Query: 169 MYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNIL---LDEDFCPKISDFGLAKLCTTKEG 225
              ++  +   ++YLH      I+H D+KP N+L   LDED    ISDFGL+K+    E 
Sbjct: 118 ASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM----ED 170
Query: 226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMM 264
             S L  A G  GY+APEV ++     S   D +S G++
Sbjct: 171 PGSVLSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVI 207

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 75/165 (45%), Gaps = 11/165 (6%)
Query: 108 FVNEVASISRTSHVNVVTLLGFCLEGNNRAL--IYEFMPNGSLEKFVYNGDTSKPCQYLR 165
            V+EV  +    H N+V      ++  N  L  + E+   G L   +  G  +K  QYL 
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKG--TKERQYLD 109
Query: 166 WEKMYEIVIGIAKGLEYLHHGCS--TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK 223
            E +  ++  +   L+  H        +LH D+KP N+ LD     K+ DFGLA++    
Sbjct: 110 EEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD 169
Query: 224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMEL 268
                + +G      Y++PE  +R     + KSD++S G ++ EL
Sbjct: 170 TSFAKTFVGT---PYYMSPEQMNRM--SYNEKSDIWSLGCLLYEL 209

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 75/165 (45%), Gaps = 11/165 (6%)
Query: 108 FVNEVASISRTSHVNVVTLLGFCLEGNNRAL--IYEFMPNGSLEKFVYNGDTSKPCQYLR 165
            V+EV  +    H N+V      ++  N  L  + E+   G L   +  G  +K  QYL 
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKG--TKERQYLD 109
Query: 166 WEKMYEIVIGIAKGLEYLHHGCS--TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK 223
            E +  ++  +   L+  H        +LH D+KP N+ LD     K+ DFGLA++    
Sbjct: 110 EEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD 169
Query: 224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMEL 268
                + +G      Y++PE  +R     + KSD++S G ++ EL
Sbjct: 170 TSFAKAFVGT---PYYMSPEQMNRM--SYNEKSDIWSLGCLLYEL 209

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/280 (23%), Positives = 107/280 (38%), Gaps = 68/280 (24%)
Query: 91  LGQGGFGGVYKGR----------------------LLDDFVNEVASISRTSHVNVVTLLG 128
           LG+G FG VY  R                      +      EV   S   H N++ L G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 129 FCLEGNNRALIYEFMPNGS-------LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           +  +     LI E+ P G+       L KF    D  +   Y         +  +A  L 
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKLSKF----DEQRTATY---------ITELANALS 124
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           Y H   S +++H DIKP N+LL      KI++FG +    +            G + Y+ 
Sbjct: 125 YCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLC-----GTLDYLP 176
Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE+      +   K D++S G++  E +  K   ++     +        Y+ + +  EF
Sbjct: 177 PEMIEGRMHD--EKVDLWSLGVLCYEFLVGKPPFEANTYQET--------YKRISRV-EF 225
Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
             P  VT    ++  ++       ++  PS RP + EV+E
Sbjct: 226 TFPDFVTEGARDLISRL-------LKHNPSQRPMLREVLE 258

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 93/222 (41%), Gaps = 51/222 (22%)
Query: 91  LGQGGFGGVYKGR-------------------------LLDDFVNEVASISRTSHVNVVT 125
           +G+G FG V++ R                         +  DF  E A ++   + N+V 
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 126 LLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQY------------------LRWE 167
           LLG C  G    L++E+M  G L +F+ +      C                    L   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 168 KMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV 227
           +   I   +A G+ YL      K +H D+   N L+ E+   KI+DFGL++   + +   
Sbjct: 175 EQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 228 SSLLGARGI-IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           +   G   I I ++ PE  S  +   + +SDV+++G+++ E+
Sbjct: 232 AD--GNDAIPIRWMPPE--SIFYNRYTTESDVWAYGVVLWEI 269

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 99/207 (47%), Gaps = 42/207 (20%)
Query: 89  DKLGQGGFGGVYK------GRL-----------LDDFVNEVASISRTSHVNVVTLLGFCL 131
           +KLG+G +G VYK      G++           L + + E++ + +    +VV   G   
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 132 EGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKI 191
           +  +  ++ E+   GS+   +   + +     L  +++  I+    KGLEYLH     + 
Sbjct: 95  KNTDLWIVMEYCGAGSVSDIIRLRNKT-----LTEDEIATILQSTLKGLEYLHF---MRK 146
Query: 192 LHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG-IIG---YIAPEVFSR 247
           +H DIK  NILL+ +   K++DFG+A       G ++  +  R  +IG   ++APEV   
Sbjct: 147 IHRDIKAGNILLNTEGHAKLADFGVA-------GQLTDXMAKRNXVIGTPFWMAPEVIQ- 198
Query: 248 NFGEVSHK--SDVYSFGMMIMELVGCK 272
              E+ +   +D++S G+  +E+   K
Sbjct: 199 ---EIGYNCVADIWSLGITAIEMAEGK 222

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 100/239 (41%), Gaps = 33/239 (13%)
Query: 119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV-------YNGDTSKPCQYLRWEKMYE 171
            H N+V LLG C  G    +I E+   G L  F+        + +  +P   L    +  
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRP---LELRDLLH 164
Query: 172 IVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK-LCTTKEGIVSSL 230
               +A+G+ +L    S   +H D+   N+LL      KI DFGLA+ +      IV   
Sbjct: 165 FSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG- 220
Query: 231 LGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPH 289
             AR  + ++APE +F   +   + +SDV+S+G+++ E+     N   G+  +S+     
Sbjct: 221 -NARLPVKWMAPESIFDCVY---TVQSDVWSYGILLWEIFSLGLNPYPGILVNSK----- 271
Query: 290 WIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE 348
             Y+ V+   +   P    +    I +        C    P+ RP   ++   LQ   +
Sbjct: 272 -FYKLVKDGYQMAQPAFAPKNIYSIMQA-------CWALEPTHRPTFQQICSFLQEQAQ 322

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/97 (37%), Positives = 56/97 (57%), Gaps = 10/97 (10%)
Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT--TKEGIVSSLLGA 233
           I   LEYLH      I+H D+KP NILL+ED   +I+DFG AK+ +  +K+   +S +G 
Sbjct: 141 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 197
Query: 234 RGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG 270
                Y++PE+ +      S  SD+++ G +I +LV 
Sbjct: 198 ---AQYVSPELLTEK--SASKSSDLWALGCIIYQLVA 229

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 118/275 (42%), Gaps = 54/275 (19%)
Query: 89  DKLGQGGFGGVYKG-----------RLLD---------DFVNEVASISRTSHVNVVTLLG 128
           +K+G+G FG V+KG           +++D         D   E+  +S+     V    G
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNG--DTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
             L+     +I E++  GS    +  G  D ++    LR          I KGL+YLH  
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR---------EILKGLDYLH-- 121
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            S K +H DIK  N+LL E    K++DFG+A   T  +   +  +G      ++APEV  
Sbjct: 122 -SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTP---FWMAPEVIK 177
Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
           ++      K+D++S G+  +EL         G    SE++ P  +   + ++    L G 
Sbjct: 178 QS--AYDSKADIWSLGITAIELA-------RGEPPHSELH-PMKVLFLIPKNNPPTLEGN 227
Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
            ++   E  +        C+   PS RP   E+++
Sbjct: 228 YSKPLKEFVEA-------CLNKEPSFRPTAKELLK 255

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 77/160 (48%), Gaps = 20/160 (12%)
Query: 115 ISRTSHVNVVTLLGFCLEGNNRALI-YEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEI 172
           +SR  H   V L  FC + + +      +  NG L K++   G   + C      + Y  
Sbjct: 91  MSRLDHPFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----RFY-- 142
Query: 173 VIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT--TKEGIVSSL 230
              I   LEYLH      I+H D+KP NILL+ED   +I+DFG AK+ +  +K+   +  
Sbjct: 143 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 199
Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG 270
           +G      Y++PE+ +         SD+++ G +I +LV 
Sbjct: 200 VGT---AQYVSPELLTEK--SACKSSDLWALGCIIYQLVA 234

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 118/273 (43%), Gaps = 50/273 (18%)
Query: 89  DKLGQGGFGGVYKG-----------RLLD---------DFVNEVASISRTSHVNVVTLLG 128
           +K+G+G FG V+KG           +++D         D   E+  +S+     V    G
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
             L+     +I E++  GS    +  G        L   ++  I+  I KGL+YLH   S
Sbjct: 88  SYLKDTKLWIIMEYLGGGSALDLLEPGP-------LDETQIATILREILKGLDYLH---S 137
Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRN 248
            K +H DIK  N+LL E    K++DFG+A   T  +   +  +G      ++APEV  ++
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTP---FWMAPEVIKQS 194
Query: 249 FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVT 308
                 K+D++S G+  +EL         G    SE++ P  +   + ++    L G  +
Sbjct: 195 --AYDSKADIWSLGITAIELA-------RGEPPHSELH-PMKVLFLIPKNNPPTLEGNYS 244
Query: 309 RKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
           +   E  +        C+   PS RP   E+++
Sbjct: 245 KPLKEFVEA-------CLNKEPSFRPTAKELLK 270

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 79/168 (47%), Gaps = 19/168 (11%)
Query: 101 KGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKP 160
           +G   +D   EV+ +    H NV+TL        +  LI E +  G L  F+   ++   
Sbjct: 54  RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--- 110
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP----KISDFGL 216
              L  E+  E +  I  G+ YLH   S +I HFD+KP NI+L +   P    KI DFGL
Sbjct: 111 ---LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 217 AKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMM 264
           A     K    +      G   ++APE+   N+  +  ++D++S G++
Sbjct: 165 AH----KIDFGNEFKNIFGTPAFVAPEIV--NYEPLGLEADMWSIGVI 206

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 33/202 (16%)
Query: 90  KLGQGGFGGVYKGR-------------------LLDDFVNEVASISRTSHVNVVTLLGFC 130
           +LG G FG VYK +                    L+D++ E+  ++   H N+V LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 131 LEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTK 190
              NN  ++ EF   G+++  +   +  +P   L   ++  +       L YLH     K
Sbjct: 104 YYENNLWILIEFCAGGAVDAVML--ELERP---LTESQIQVVCKQTLDALNYLH---DNK 155
Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVF---SR 247
           I+H D+K  NIL   D   K++DFG++   T       S +G      ++APEV    + 
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTP---YWMAPEVVMCETS 212
Query: 248 NFGEVSHKSDVYSFGMMIMELV 269
                 +K+DV+S G+ ++E+ 
Sbjct: 213 KDRPYDYKADVWSLGITLIEMA 234

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 33/202 (16%)
Query: 90  KLGQGGFGGVYKGR-------------------LLDDFVNEVASISRTSHVNVVTLLGFC 130
           +LG G FG VYK +                    L+D++ E+  ++   H N+V LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 131 LEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTK 190
              NN  ++ EF   G+++  +   +  +P   L   ++  +       L YLH     K
Sbjct: 104 YYENNLWILIEFCAGGAVDAVML--ELERP---LTESQIQVVCKQTLDALNYLH---DNK 155
Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVF---SR 247
           I+H D+K  NIL   D   K++DFG++   T       S +G      ++APEV    + 
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTP---YWMAPEVVMCETS 212
Query: 248 NFGEVSHKSDVYSFGMMIMELV 269
                 +K+DV+S G+ ++E+ 
Sbjct: 213 KDRPYDYKADVWSLGITLIEMA 234

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/272 (23%), Positives = 108/272 (39%), Gaps = 51/272 (18%)
Query: 89  DKLGQGGFGGVYKGRL-------------------------LDDFVNEVASISRTSHVNV 123
           +KLG G FG V +G                           +DDF+ EV ++    H N+
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 124 VTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYL 183
           + L G  L    + ++ E  P GSL   +      K   +     +    + +A+G+ YL
Sbjct: 74  IRLYGVVLTPPMK-MVTELAPLGSLLDRL-----RKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 184 HHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE 243
               S + +H D+   N+LL      KI DFGL +     +         +    + APE
Sbjct: 128 E---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPE 184
Query: 244 VF-SRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK 302
              +R F   SH SD + FG+ + E+         G++ S        I   ++++ E +
Sbjct: 185 SLKTRTF---SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-------ILHKIDKEGE-R 233
Query: 303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRP 334
           LP     +  +  + +  V + C   +P DRP
Sbjct: 234 LP-----RPEDCPQDIYNVMVQCWAHKPEDRP 260

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/272 (23%), Positives = 108/272 (39%), Gaps = 51/272 (18%)
Query: 89  DKLGQGGFGGVYKGRL-------------------------LDDFVNEVASISRTSHVNV 123
           +KLG G FG V +G                           +DDF+ EV ++    H N+
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 124 VTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYL 183
           + L G  L    + ++ E  P GSL   +      K   +     +    + +A+G+ YL
Sbjct: 84  IRLYGVVLTPPMK-MVTELAPLGSLLDRL-----RKHQGHFLLGTLSRYAVQVAEGMGYL 137
Query: 184 HHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE 243
               S + +H D+   N+LL      KI DFGL +     +         +    + APE
Sbjct: 138 E---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPE 194
Query: 244 VF-SRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK 302
              +R F   SH SD + FG+ + E+         G++ S        I   ++++ E +
Sbjct: 195 SLKTRTF---SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-------ILHKIDKEGE-R 243
Query: 303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRP 334
           LP     +  +  + +  V + C   +P DRP
Sbjct: 244 LP-----RPEDCPQDIYNVMVQCWAHKPEDRP 270

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 93/221 (42%), Gaps = 56/221 (25%)
Query: 91  LGQGGFGGVYKGRLLD--------------DFVNE--VASISRTSHVNVVTLLGFCLEGN 134
           +G+G +G VYKG L +              +F+NE  +  +    H N+   +     G+
Sbjct: 21  IGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIV----GD 76
Query: 135 NRA---------LIYEFMPNGSLEKFV--YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYL 183
            R          L+ E+ PNGSL K++  +  D    C+         +   + +GL YL
Sbjct: 77  ERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCR---------LAHSVTRGLAYL 127
Query: 184 H----HGCSTK--ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV-----SSLLG 232
           H     G   K  I H D+   N+L+  D    ISDFGL+   T    +      ++ + 
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAIS 187
Query: 233 ARGIIGYIAPEVFS-----RNFGEVSHKSDVYSFGMMIMEL 268
             G I Y+APEV       R+      + D+Y+ G++  E+
Sbjct: 188 EVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/272 (23%), Positives = 108/272 (39%), Gaps = 51/272 (18%)
Query: 89  DKLGQGGFGGVYKGRL-------------------------LDDFVNEVASISRTSHVNV 123
           +KLG G FG V +G                           +DDF+ EV ++    H N+
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 124 VTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYL 183
           + L G  L    + ++ E  P GSL   +      K   +     +    + +A+G+ YL
Sbjct: 84  IRLYGVVLTPPMK-MVTELAPLGSLLDRL-----RKHQGHFLLGTLSRYAVQVAEGMGYL 137
Query: 184 HHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE 243
               S + +H D+   N+LL      KI DFGL +     +         +    + APE
Sbjct: 138 E---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 194
Query: 244 VF-SRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK 302
              +R F   SH SD + FG+ + E+         G++ S        I   ++++ E +
Sbjct: 195 SLKTRTF---SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-------ILHKIDKEGE-R 243
Query: 303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRP 334
           LP     +  +  + +  V + C   +P DRP
Sbjct: 244 LP-----RPEDCPQDIYNVMVQCWAHKPEDRP 270

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 43/217 (19%)
Query: 87  FKDKLGQGGFG------GVYKG------RLLDDFVNEVASISRTS-------HVNVVTLL 127
           F  KLG+GGF       G++ G      R+L     +     R +       H N++ L+
Sbjct: 33  FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92
Query: 128 GFCLE----GNNRALIYEFMPNGSL----EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
            +CL      +   L+  F   G+L    E+    G+      +L  +++  +++GI +G
Sbjct: 93  AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGN------FLTEDQILWLLLGICRG 146
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFG-LAKLCTTKEGIVSSLL-----GA 233
           LE +H   +    H D+KP NILL ++  P + D G + + C   EG   +L        
Sbjct: 147 LEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ 203
Query: 234 RGIIGYIAPEVFS-RNFGEVSHKSDVYSFGMMIMELV 269
           R  I Y APE+FS ++   +  ++DV+S G ++  ++
Sbjct: 204 RCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMM 240

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/272 (23%), Positives = 108/272 (39%), Gaps = 51/272 (18%)
Query: 89  DKLGQGGFGGVYKGRL-------------------------LDDFVNEVASISRTSHVNV 123
           +KLG G FG V +G                           +DDF+ EV ++    H N+
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 124 VTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYL 183
           + L G  L    + ++ E  P GSL   +      K   +     +    + +A+G+ YL
Sbjct: 78  IRLYGVVLTPPMK-MVTELAPLGSLLDRL-----RKHQGHFLLGTLSRYAVQVAEGMGYL 131
Query: 184 HHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE 243
               S + +H D+   N+LL      KI DFGL +     +         +    + APE
Sbjct: 132 E---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 188
Query: 244 VF-SRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK 302
              +R F   SH SD + FG+ + E+         G++ S        I   ++++ E +
Sbjct: 189 SLKTRTF---SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-------ILHKIDKEGE-R 237
Query: 303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRP 334
           LP     +  +  + +  V + C   +P DRP
Sbjct: 238 LP-----RPEDCPQDIYNVMVQCWAHKPEDRP 264

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/258 (22%), Positives = 109/258 (42%), Gaps = 38/258 (14%)
Query: 105 LDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPC--- 161
           L D ++E   + + +H +V+ L G C +     LI E+   GSL  F+       P    
Sbjct: 70  LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLG 129
Query: 162 ---------------QYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDED 206
                          + L    +      I++G++YL       ++H D+   NIL+ E 
Sbjct: 130 SGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEG 186
Query: 207 FCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIM 266
              KISDFGL++    ++  V    G R  + ++A E    +    + +SDV+SFG+++ 
Sbjct: 187 RKMKISDFGLSRDVYEEDSXVKRSQG-RIPVKWMAIESLFDHI--YTTQSDVWSFGVLLW 243
Query: 267 ELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCI 326
           E+V    N   G+        P  ++  ++     + P       +  +++M  + L C 
Sbjct: 244 EIVTLGGNPYPGIP-------PERLFNLLKTGHRMERP-------DNCSEEMYRLMLQCW 289
Query: 327 QARPSDRPPMNEVIEMLQ 344
           +  P  RP   ++ + L+
Sbjct: 290 KQEPDKRPVFADISKDLE 307

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 97/223 (43%), Gaps = 43/223 (19%)
Query: 91  LGQGGFGGVYKGRLLDD--------------FVN-EVASISRTSHVNVVTLLGFCLEGNN 135
           +G G FG VY+ +L D               F N E+  + +  H N+V L  F      
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGE 87
Query: 136 RA------LIYEFMPNG--SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
           +       L+ +++P     + +       + P  Y++   MY++     + L Y+H   
Sbjct: 88  KKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLF----RSLAYIH--- 139
Query: 188 STKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
           S  I H DIKP N+LLD D    K+ DFG AK     E  VS +        Y APE+  
Sbjct: 140 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY----YRAPELI- 194
Query: 247 RNFGEVSHKS--DVYSFGMMIMELVGCKNNL--DSGVDSSSEV 285
             FG   + S  DV+S G ++ EL+  +     DSGVD   E+
Sbjct: 195 --FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/272 (23%), Positives = 108/272 (39%), Gaps = 51/272 (18%)
Query: 89  DKLGQGGFGGVYKGRL-------------------------LDDFVNEVASISRTSHVNV 123
           +KLG G FG V +G                           +DDF+ EV ++    H N+
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 124 VTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYL 183
           + L G  L    + ++ E  P GSL   +      K   +     +    + +A+G+ YL
Sbjct: 74  IRLYGVVLTPPMK-MVTELAPLGSLLDRL-----RKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 184 HHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE 243
               S + +H D+   N+LL      KI DFGL +     +         +    + APE
Sbjct: 128 E---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 244 VF-SRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK 302
              +R F   SH SD + FG+ + E+         G++ S        I   ++++ E +
Sbjct: 185 SLKTRTF---SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-------ILHKIDKEGE-R 233
Query: 303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRP 334
           LP     +  +  + +  V + C   +P DRP
Sbjct: 234 LP-----RPEDCPQDIYNVMVQCWAHKPEDRP 260

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 97/223 (43%), Gaps = 43/223 (19%)
Query: 91  LGQGGFGGVYKGRLLDD--------------FVN-EVASISRTSHVNVVTLLGFCLEGNN 135
           +G G FG VY+ +L D               F N E+  + +  H N+V L  F      
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGE 87
Query: 136 RA------LIYEFMPNG--SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
           +       L+ +++P     + +       + P  Y++   MY++     + L Y+H   
Sbjct: 88  KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLF----RSLAYIH--- 139
Query: 188 STKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
           S  I H DIKP N+LLD D    K+ DFG AK     E  VS +        Y APE+  
Sbjct: 140 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY----YRAPELI- 194
Query: 247 RNFGEVSHKS--DVYSFGMMIMELVGCKNNL--DSGVDSSSEV 285
             FG   + S  DV+S G ++ EL+  +     DSGVD   E+
Sbjct: 195 --FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 97/223 (43%), Gaps = 43/223 (19%)
Query: 91  LGQGGFGGVYKGRLLDD--------------FVN-EVASISRTSHVNVVTLLGFCLEGNN 135
           +G G FG VY+ +L D               F N E+  + +  H N+V L  F      
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGE 87
Query: 136 RA------LIYEFMPNG--SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
           +       L+ +++P     + +       + P  Y++   MY++     + L Y+H   
Sbjct: 88  KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLF----RSLAYIH--- 139
Query: 188 STKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
           S  I H DIKP N+LLD D    K+ DFG AK     E  VS +        Y APE+  
Sbjct: 140 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY----YRAPELI- 194
Query: 247 RNFGEVSHKS--DVYSFGMMIMELVGCKNNL--DSGVDSSSEV 285
             FG   + S  DV+S G ++ EL+  +     DSGVD   E+
Sbjct: 195 --FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 97/223 (43%), Gaps = 43/223 (19%)
Query: 91  LGQGGFGGVYKGRLLDD--------------FVN-EVASISRTSHVNVVTLLGFCLEGNN 135
           +G G FG VY+ +L D               F N E+  + +  H N+V L  F      
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGE 95
Query: 136 RA------LIYEFMPNG--SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
           +       L+ +++P     + +       + P  Y++   MY++     + L Y+H   
Sbjct: 96  KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLF----RSLAYIH--- 147
Query: 188 STKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
           S  I H DIKP N+LLD D    K+ DFG AK     E  VS +        Y APE+  
Sbjct: 148 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY----YRAPELI- 202
Query: 247 RNFGEVSHKS--DVYSFGMMIMELVGCKNNL--DSGVDSSSEV 285
             FG   + S  DV+S G ++ EL+  +     DSGVD   E+
Sbjct: 203 --FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 243

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 97/223 (43%), Gaps = 43/223 (19%)
Query: 91  LGQGGFGGVYKGRLLDD--------------FVN-EVASISRTSHVNVVTLLGFCLEGNN 135
           +G G FG VY+ +L D               F N E+  + +  H N+V L  F      
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGE 106
Query: 136 RA------LIYEFMPNG--SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
           +       L+ +++P     + +       + P  Y++   MY++     + L Y+H   
Sbjct: 107 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLF----RSLAYIH--- 158
Query: 188 STKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
           S  I H DIKP N+LLD D    K+ DFG AK     E  VS +        Y APE+  
Sbjct: 159 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY----YRAPELI- 213
Query: 247 RNFGEVSHKS--DVYSFGMMIMELVGCKNNL--DSGVDSSSEV 285
             FG   + S  DV+S G ++ EL+  +     DSGVD   E+
Sbjct: 214 --FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 254

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 97/223 (43%), Gaps = 43/223 (19%)
Query: 91  LGQGGFGGVYKGRLLDD--------------FVN-EVASISRTSHVNVVTLLGFCLEGNN 135
           +G G FG VY+ +L D               F N E+  + +  H N+V L  F      
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGE 88
Query: 136 RA------LIYEFMPNG--SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
           +       L+ +++P     + +       + P  Y++   MY++     + L Y+H   
Sbjct: 89  KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLF----RSLAYIH--- 140
Query: 188 STKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
           S  I H DIKP N+LLD D    K+ DFG AK     E  VS +        Y APE+  
Sbjct: 141 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY----YRAPELI- 195
Query: 247 RNFGEVSHKS--DVYSFGMMIMELVGCKNNL--DSGVDSSSEV 285
             FG   + S  DV+S G ++ EL+  +     DSGVD   E+
Sbjct: 196 --FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 236

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/272 (23%), Positives = 108/272 (39%), Gaps = 51/272 (18%)
Query: 89  DKLGQGGFGGVYKGRL-------------------------LDDFVNEVASISRTSHVNV 123
           +KLG G FG V +G                           +DDF+ EV ++    H N+
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 124 VTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYL 183
           + L G  L    + ++ E  P GSL   +      K   +     +    + +A+G+ YL
Sbjct: 74  IRLYGVVLTPPMK-MVTELAPLGSLLDRL-----RKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 184 HHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE 243
               S + +H D+   N+LL      KI DFGL +     +         +    + APE
Sbjct: 128 E---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 244 VF-SRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK 302
              +R F   SH SD + FG+ + E+         G++ S        I   ++++ E +
Sbjct: 185 SLKTRTF---SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-------ILHKIDKEGE-R 233
Query: 303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRP 334
           LP     +  +  + +  V + C   +P DRP
Sbjct: 234 LP-----RPEDCPQDIYNVMVQCWAHKPEDRP 260

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/272 (23%), Positives = 108/272 (39%), Gaps = 51/272 (18%)
Query: 89  DKLGQGGFGGVYKGRL-------------------------LDDFVNEVASISRTSHVNV 123
           +KLG G FG V +G                           +DDF+ EV ++    H N+
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 124 VTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYL 183
           + L G  L    + ++ E  P GSL   +      K   +     +    + +A+G+ YL
Sbjct: 78  IRLYGVVLTPPMK-MVTELAPLGSLLDRL-----RKHQGHFLLGTLSRYAVQVAEGMGYL 131
Query: 184 HHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE 243
               S + +H D+   N+LL      KI DFGL +     +         +    + APE
Sbjct: 132 E---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 188
Query: 244 VF-SRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK 302
              +R F   SH SD + FG+ + E+         G++ S        I   ++++ E +
Sbjct: 189 SLKTRTF---SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-------ILHKIDKEGE-R 237
Query: 303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRP 334
           LP     +  +  + +  V + C   +P DRP
Sbjct: 238 LP-----RPEDCPQDIYNVMVQCWAHKPEDRP 264

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 97/223 (43%), Gaps = 43/223 (19%)
Query: 91  LGQGGFGGVYKGRLLDD--------------FVN-EVASISRTSHVNVVTLLGFCLEGNN 135
           +G G FG VY+ +L D               F N E+  + +  H N+V L  F      
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGE 121
Query: 136 RA------LIYEFMPNG--SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
           +       L+ +++P     + +       + P  Y++   MY++     + L Y+H   
Sbjct: 122 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLF----RSLAYIH--- 173
Query: 188 STKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
           S  I H DIKP N+LLD D    K+ DFG AK     E  VS +        Y APE+  
Sbjct: 174 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY----YRAPELI- 228
Query: 247 RNFGEVSHKS--DVYSFGMMIMELVGCKNNL--DSGVDSSSEV 285
             FG   + S  DV+S G ++ EL+  +     DSGVD   E+
Sbjct: 229 --FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 269

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 97/223 (43%), Gaps = 43/223 (19%)
Query: 91  LGQGGFGGVYKGRLLDD--------------FVN-EVASISRTSHVNVVTLLGFCLEGNN 135
           +G G FG VY+ +L D               F N E+  + +  H N+V L  F      
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGE 99
Query: 136 RA------LIYEFMPNG--SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
           +       L+ +++P     + +       + P  Y++   MY++     + L Y+H   
Sbjct: 100 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLF----RSLAYIH--- 151
Query: 188 STKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
           S  I H DIKP N+LLD D    K+ DFG AK     E  VS +        Y APE+  
Sbjct: 152 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY----YRAPELI- 206
Query: 247 RNFGEVSHKS--DVYSFGMMIMELVGCKNNL--DSGVDSSSEV 285
             FG   + S  DV+S G ++ EL+  +     DSGVD   E+
Sbjct: 207 --FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 247

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 97/223 (43%), Gaps = 43/223 (19%)
Query: 91  LGQGGFGGVYKGRLLDD--------------FVN-EVASISRTSHVNVVTLLGFCLEGNN 135
           +G G FG VY+ +L D               F N E+  + +  H N+V L  F      
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGE 91
Query: 136 RA------LIYEFMPNG--SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
           +       L+ +++P     + +       + P  Y++   MY++     + L Y+H   
Sbjct: 92  KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLF----RSLAYIH--- 143
Query: 188 STKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
           S  I H DIKP N+LLD D    K+ DFG AK     E  VS +        Y APE+  
Sbjct: 144 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY----YRAPELI- 198
Query: 247 RNFGEVSHKS--DVYSFGMMIMELVGCKNNL--DSGVDSSSEV 285
             FG   + S  DV+S G ++ EL+  +     DSGVD   E+
Sbjct: 199 --FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 239

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 99/221 (44%), Gaps = 39/221 (17%)
Query: 91  LGQGGFGGVYKGRLLDD--------------FVN-EVASISRTSHVNVVTLLGFCLEGNN 135
           +G G FG VY+ +L D               F N E+  + +  H N+V L  F      
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGE 87
Query: 136 RA------LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCST 189
           +       L+ +++P  ++ +   +   +K    + + K+Y  +  + + L Y+H   S 
Sbjct: 88  KKDEVYLNLVLDYVP-ATVYRVARHYSRAKQTLPVIYVKLY--MYQLFRSLAYIH---SF 141
Query: 190 KILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRN 248
            I H DIKP N+LLD D    K+ DFG AK     E  VS +        Y APE+    
Sbjct: 142 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY----YRAPELI--- 194
Query: 249 FGEVSHKS--DVYSFGMMIMELVGCKNNL--DSGVDSSSEV 285
           FG   + S  DV+S G ++ EL+  +     DSGVD   E+
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 97/223 (43%), Gaps = 43/223 (19%)
Query: 91  LGQGGFGGVYKGRLLDD--------------FVN-EVASISRTSHVNVVTLLGFCLEGNN 135
           +G G FG VY+ +L D               F N E+  + +  H N+V L  F      
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGE 99
Query: 136 RA------LIYEFMPNG--SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
           +       L+ +++P     + +       + P  Y++   MY++     + L Y+H   
Sbjct: 100 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLF----RSLAYIH--- 151
Query: 188 STKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
           S  I H DIKP N+LLD D    K+ DFG AK     E  VS +        Y APE+  
Sbjct: 152 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY----YRAPELI- 206
Query: 247 RNFGEVSHKS--DVYSFGMMIMELVGCKNNL--DSGVDSSSEV 285
             FG   + S  DV+S G ++ EL+  +     DSGVD   E+
Sbjct: 207 --FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 247

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 35/205 (17%)
Query: 89  DKLGQGGFGGVYK-----GRLL---------------DDFVNEVASISRTSHVNVVTLLG 128
           +K+G+G +G VYK     GR++                  + E++ +    H N+V+L+ 
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
                    L++EFM    L+K +    T      ++   +Y+++ G+A       H   
Sbjct: 87  VIHSERCLTLVFEFM-EKDLKKVLDENKTGLQDSQIKI-YLYQLLRGVA-------HCHQ 137
Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI-VSSLLGARGIIGYIAPEVFSR 247
            +ILH D+KP N+L++ D   K++DFGLA+      GI V S       + Y AP+V   
Sbjct: 138 HRILHRDLKPQNLLINSDGALKLADFGLARAF----GIPVRSYTHEVVTLWYRAPDVLMG 193
Query: 248 NFGEVSHKSDVYSFGMMIMELVGCK 272
           +  + S   D++S G +  E++  K
Sbjct: 194 S-KKYSTSVDIWSIGCIFAEMITGK 217

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 103/236 (43%), Gaps = 37/236 (15%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV--YNGDTSKPCQYLRWEK 168
           EVA ++   H N+V       E  +  ++ ++   G L K +    G   +  Q L W  
Sbjct: 73  EVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW-- 130
Query: 169 MYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVS 228
                + I   L+++H     KILH DIK  NI L +D   ++ DFG+A++        S
Sbjct: 131 ----FVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN------S 177
Query: 229 SLLGARGIIG---YIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
           ++  AR  IG   Y++PE+        ++KSD+++ G ++ EL   K+  ++G   +  +
Sbjct: 178 TVELARACIGTPYYLSPEICENK--PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL 235
Query: 286 YFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
                 +  V     + L  +V++                 +  P DRP +N ++E
Sbjct: 236 KIISGSFPPVSLHYSYDLRSLVSQ---------------LFKRNPRDRPSVNSILE 276

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 117/272 (43%), Gaps = 44/272 (16%)
Query: 89  DKLGQGGFGGVYKGR---------------------LLDDFVNEVASISRTSHVNVVTLL 127
           +K+G+G +G VYK R                     +    + E++ +   +H N+V LL
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                 N   L++EF+ +  L+ F+  +  T  P   ++       +  + +GL + H  
Sbjct: 72  DVIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIK-----SYLFQLLQGLAFCH-- 123
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            S ++LH D+KP N+L++ +   K++DFGLA+        V +       + Y APE+  
Sbjct: 124 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTYXHEVVTLWYRAPEIL- 178
Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
                 S   D++S G +  E+V  +  L  G DS  +  F   I+R +    E   PGV
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMV-TRRALFPG-DSEIDQLFR--IFRTLGTPDEVVWPGV 234
Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNE 338
            +  + + +        W  Q      PP++E
Sbjct: 235 TSMPDYKPS-----FPKWARQDFSKVVPPLDE 261

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 79/168 (47%), Gaps = 19/168 (11%)
Query: 101 KGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKP 160
           +G   +D   EV+ +    H NV+TL        +  LI E +  G L  F+   ++   
Sbjct: 53  RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--- 109
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP----KISDFGL 216
              L  E+  E +  I  G+ YLH   S +I HFD+KP NI+L +   P    KI DFGL
Sbjct: 110 ---LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163
Query: 217 AKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMM 264
           A     K    +      G   ++APE+   N+  +  ++D++S G++
Sbjct: 164 AH----KIDFGNEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVI 205

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 97/223 (43%), Gaps = 43/223 (19%)
Query: 91  LGQGGFGGVYKGRLLDD--------------FVN-EVASISRTSHVNVVTLLGFCLEGNN 135
           +G G FG VY+ +L D               F N E+  + +  H N+V L  F      
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGE 87
Query: 136 RA------LIYEFMPNG--SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
           +       L+ +++P     + +       + P  Y++   MY++     + L Y+H   
Sbjct: 88  KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLF----RSLAYIH--- 139
Query: 188 STKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
           S  I H DIKP N+LLD D    K+ DFG AK     E  VS +        Y APE+  
Sbjct: 140 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY----YRAPELI- 194
Query: 247 RNFGEVSHKS--DVYSFGMMIMELVGCKNNL--DSGVDSSSEV 285
             FG   + S  DV+S G ++ EL+  +     DSGVD   E+
Sbjct: 195 --FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 79/168 (47%), Gaps = 19/168 (11%)
Query: 101 KGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKP 160
           +G   +D   EV+ +    H NV+TL        +  LI E +  G L  F+   ++   
Sbjct: 54  RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--- 110
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP----KISDFGL 216
              L  E+  E +  I  G+ YLH   S +I HFD+KP NI+L +   P    KI DFGL
Sbjct: 111 ---LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 217 AKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMM 264
           A     K    +      G   ++APE+   N+  +  ++D++S G++
Sbjct: 165 AH----KIDFGNEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVI 206

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 35/205 (17%)
Query: 89  DKLGQGGFGGVYK-----GRLL---------------DDFVNEVASISRTSHVNVVTLLG 128
           +K+G+G +G VYK     GR++                  + E++ +    H N+V+L+ 
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
                    L++EFM    L+K +    T      ++   +Y+++ G+A       H   
Sbjct: 87  VIHSERCLTLVFEFM-EKDLKKVLDENKTGLQDSQIKI-YLYQLLRGVA-------HCHQ 137
Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI-VSSLLGARGIIGYIAPEVFSR 247
            +ILH D+KP N+L++ D   K++DFGLA+      GI V S       + Y AP+V   
Sbjct: 138 HRILHRDLKPQNLLINSDGALKLADFGLARAF----GIPVRSYTHEVVTLWYRAPDVLMG 193
Query: 248 NFGEVSHKSDVYSFGMMIMELVGCK 272
           +  + S   D++S G +  E++  K
Sbjct: 194 S-KKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 79/168 (47%), Gaps = 19/168 (11%)
Query: 101 KGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKP 160
           +G   +D   EV+ +    H NV+TL        +  LI E +  G L  F+   ++   
Sbjct: 54  RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--- 110
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP----KISDFGL 216
              L  E+  E +  I  G+ YLH   S +I HFD+KP NI+L +   P    KI DFGL
Sbjct: 111 ---LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 217 AKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMM 264
           A     K    +      G   ++APE+   N+  +  ++D++S G++
Sbjct: 165 AH----KIDFGNEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVI 206

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 79/168 (47%), Gaps = 19/168 (11%)
Query: 101 KGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKP 160
           +G   +D   EV+ +    H NV+TL        +  LI E +  G L  F+   ++   
Sbjct: 53  RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--- 109
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP----KISDFGL 216
              L  E+  E +  I  G+ YLH   S +I HFD+KP NI+L +   P    KI DFGL
Sbjct: 110 ---LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163
Query: 217 AKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMM 264
           A     K    +      G   ++APE+   N+  +  ++D++S G++
Sbjct: 164 AH----KIDFGNEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVI 205

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 79/168 (47%), Gaps = 19/168 (11%)
Query: 101 KGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKP 160
           +G   +D   EV+ +    H NV+TL        +  LI E +  G L  F+   ++   
Sbjct: 54  RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--- 110
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP----KISDFGL 216
              L  E+  E +  I  G+ YLH   S +I HFD+KP NI+L +   P    KI DFGL
Sbjct: 111 ---LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 217 AKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMM 264
           A     K    +      G   ++APE+   N+  +  ++D++S G++
Sbjct: 165 AH----KIDFGNEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVI 206

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 76/164 (46%), Gaps = 11/164 (6%)
Query: 106 DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLR 165
           ++ + E   + +  +  +V L+G C +     L+ E    G L KF+       P     
Sbjct: 381 EEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVS--- 436
Query: 166 WEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG 225
              + E++  ++ G++YL        +H ++   N+LL      KISDFGL+K     + 
Sbjct: 437 --NVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491
Query: 226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             ++    +  + + APE    NF + S +SDV+S+G+ + E +
Sbjct: 492 YYTARSAGKWPLKWYAPECI--NFRKFSSRSDVWSYGVTMWEAL 533

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 97/223 (43%), Gaps = 43/223 (19%)
Query: 91  LGQGGFGGVYKGRLLDD--------------FVN-EVASISRTSHVNVVTLLGFCLEGNN 135
           +G G FG VY+ +L D               F N E+  + +  H N+V L  F      
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGE 87
Query: 136 RA------LIYEFMPNG--SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
           +       L+ +++P     + +       + P  Y++   MY++     + L Y+H   
Sbjct: 88  KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLF----RSLAYIH--- 139
Query: 188 STKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
           S  I H DIKP N+LLD D    K+ DFG AK     E  VS +        Y APE+  
Sbjct: 140 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY----YRAPELI- 194
Query: 247 RNFGEVSHKS--DVYSFGMMIMELVGCKNNL--DSGVDSSSEV 285
             FG   + S  DV+S G ++ EL+  +     DSGVD   E+
Sbjct: 195 --FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 97/223 (43%), Gaps = 43/223 (19%)
Query: 91  LGQGGFGGVYKGRLLDD--------------FVN-EVASISRTSHVNVVTLLGFCLEGNN 135
           +G G FG VY+ +L D               F N E+  + +  H N+V L  F      
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGE 100
Query: 136 RA------LIYEFMPNG--SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
           +       L+ +++P     + +       + P  Y++   MY++     + L Y+H   
Sbjct: 101 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLF----RSLAYIH--- 152
Query: 188 STKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
           S  I H DIKP N+LLD D    K+ DFG AK     E  VS +        Y APE+  
Sbjct: 153 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY----YRAPELI- 207
Query: 247 RNFGEVSHKS--DVYSFGMMIMELVGCKNNL--DSGVDSSSEV 285
             FG   + S  DV+S G ++ EL+  +     DSGVD   E+
Sbjct: 208 --FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 248

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 79/168 (47%), Gaps = 19/168 (11%)
Query: 101 KGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKP 160
           +G   +D   EV+ +    H NV+TL        +  LI E +  G L  F+   ++   
Sbjct: 54  RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--- 110
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP----KISDFGL 216
              L  E+  E +  I  G+ YLH   S +I HFD+KP NI+L +   P    KI DFGL
Sbjct: 111 ---LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 217 AKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMM 264
           A     K    +      G   ++APE+   N+  +  ++D++S G++
Sbjct: 165 AH----KIDFGNEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVI 206

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 79/168 (47%), Gaps = 19/168 (11%)
Query: 101 KGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKP 160
           +G   +D   EV+ +    H NV+TL        +  LI E +  G L  F+   ++   
Sbjct: 54  RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--- 110
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP----KISDFGL 216
              L  E+  E +  I  G+ YLH   S +I HFD+KP NI+L +   P    KI DFGL
Sbjct: 111 ---LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 217 AKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMM 264
           A     K    +      G   ++APE+   N+  +  ++D++S G++
Sbjct: 165 AH----KIDFGNEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVI 206

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 113/271 (41%), Gaps = 42/271 (15%)
Query: 89  DKLGQGGFGGVYKGR---------------------LLDDFVNEVASISRTSHVNVVTLL 127
           +K+G+G +G VYK R                     +    + E++ +   +H N+V LL
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
                 N   L++EF+     +    +  T  P   ++       +  + +GL + H   
Sbjct: 72  DVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIK-----SYLFQLLQGLAFCH--- 123
Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSR 247
           S ++LH D+KP N+L++ +   K++DFGLA+        V +       + Y APE+   
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTYXHEVVTLWYRAPEIL-L 179
Query: 248 NFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVV 307
                S   D++S G +  E+V  +  L  G DS  +  F   I+R +    E   PGV 
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMV-TRRALFPG-DSEIDQLFR--IFRTLGTPDEVVWPGVT 235
Query: 308 TRKENEIAKKMIIVGLWCIQARPSDRPPMNE 338
           +  + + +        W  Q      PP++E
Sbjct: 236 SMPDYKPS-----FPKWARQDFSKVVPPLDE 261

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 97/223 (43%), Gaps = 43/223 (19%)
Query: 91  LGQGGFGGVYKGRLLDD--------------FVN-EVASISRTSHVNVVTLLGFCLEGNN 135
           +G G FG VY+ +L D               F N E+  + +  H N+V L  F      
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGE 115
Query: 136 RA------LIYEFMPNG--SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
           +       L+ +++P     + +       + P  Y++   MY++     + L Y+H   
Sbjct: 116 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLF----RSLAYIH--- 167
Query: 188 STKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
           S  I H DIKP N+LLD D    K+ DFG AK     E  VS +        Y APE+  
Sbjct: 168 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY----YRAPELI- 222
Query: 247 RNFGEVSHKS--DVYSFGMMIMELVGCKNNL--DSGVDSSSEV 285
             FG   + S  DV+S G ++ EL+  +     DSGVD   E+
Sbjct: 223 --FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 263

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 79/168 (47%), Gaps = 19/168 (11%)
Query: 101 KGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKP 160
           +G   +D   EV+ +    H NV+TL        +  LI E +  G L  F+   ++   
Sbjct: 54  RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--- 110
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP----KISDFGL 216
              L  E+  E +  I  G+ YLH   S +I HFD+KP NI+L +   P    KI DFGL
Sbjct: 111 ---LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 217 AKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMM 264
           A     K    +      G   ++APE+   N+  +  ++D++S G++
Sbjct: 165 AH----KIDFGNEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVI 206

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/242 (23%), Positives = 97/242 (40%), Gaps = 35/242 (14%)
Query: 119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
            H N+V LLG C  G    +I E+   G L  F+      +  + L  +  + I    A 
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL-----RRKSRVLETDPAFAIANSTAS 162
Query: 179 GLEYLHHG----------CSTKILHFDIKPHNILLDEDFCPKISDFGLAK-LCTTKEGIV 227
             + LH             S   +H D+   N+LL      KI DFGLA+ +      IV
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 228 SSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVY 286
                AR  + ++APE +F   +   + +SDV+S+G+++ E+     N   G+  +S+  
Sbjct: 223 KG--NARLPVKWMAPESIFDCVY---TVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-- 275
Query: 287 FPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGS 346
                Y+ V+   +   P    +    I +        C    P+ RP   ++   LQ  
Sbjct: 276 ----FYKLVKDGYQMAQPAFAPKNIYSIMQA-------CWALEPTHRPTFQQICSFLQEQ 324
Query: 347 TE 348
            +
Sbjct: 325 AQ 326

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 113/271 (41%), Gaps = 42/271 (15%)
Query: 89  DKLGQGGFGGVYKGR---------------------LLDDFVNEVASISRTSHVNVVTLL 127
           +K+G+G +G VYK R                     +    + E++ +   +H N+V LL
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
                 N   L++EF+     +    +  T  P   ++       +  + +GL + H   
Sbjct: 69  DVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIK-----SYLFQLLQGLAFCH--- 120
Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSR 247
           S ++LH D+KP N+L++ +   K++DFGLA+        V +       + Y APE+   
Sbjct: 121 SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVP---VRTYXHEVVTLWYRAPEIL-L 176
Query: 248 NFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVV 307
                S   D++S G +  E+V  +  L  G DS  +  F   I+R +    E   PGV 
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMV-TRRALFPG-DSEIDQLFR--IFRTLGTPDEVVWPGVT 232
Query: 308 TRKENEIAKKMIIVGLWCIQARPSDRPPMNE 338
           +  + + +        W  Q      PP++E
Sbjct: 233 SMPDYKPS-----FPKWARQDFSKVVPPLDE 258

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 97/223 (43%), Gaps = 43/223 (19%)
Query: 91  LGQGGFGGVYKGRLLDD--------------FVN-EVASISRTSHVNVVTLLGFCLEGNN 135
           +G G FG VY+ +L D               F N E+  + +  H N+V L  F      
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGE 92
Query: 136 RA------LIYEFMPNG--SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
           +       L+ +++P     + +       + P  Y++   MY++     + L Y+H   
Sbjct: 93  KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLF----RSLAYIH--- 144
Query: 188 STKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
           S  I H DIKP N+LLD D    K+ DFG AK     E  VS +        Y APE+  
Sbjct: 145 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY----YRAPELI- 199
Query: 247 RNFGEVSHKS--DVYSFGMMIMELVGCKNNL--DSGVDSSSEV 285
             FG   + S  DV+S G ++ EL+  +     DSGVD   E+
Sbjct: 200 --FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 240

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 97/223 (43%), Gaps = 43/223 (19%)
Query: 91  LGQGGFGGVYKGRLLDD--------------FVN-EVASISRTSHVNVVTLLGFCLEGNN 135
           +G G FG VY+ +L D               F N E+  + +  H N+V L  F      
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGE 87
Query: 136 RA------LIYEFMPNG--SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
           +       L+ +++P     + +       + P  Y++   MY++     + L Y+H   
Sbjct: 88  KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLF----RSLAYIH--- 139
Query: 188 STKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
           S  I H DIKP N+LLD D    K+ DFG AK     E  VS +        Y APE+  
Sbjct: 140 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY----YRAPELI- 194
Query: 247 RNFGEVSHKS--DVYSFGMMIMELVGCKNNL--DSGVDSSSEV 285
             FG   + S  DV+S G ++ EL+  +     DSGVD   E+
Sbjct: 195 --FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 97/223 (43%), Gaps = 43/223 (19%)
Query: 91  LGQGGFGGVYKGRLLDD--------------FVN-EVASISRTSHVNVVTLLGFCLEGNN 135
           +G G FG VY+ +L D               F N E+  + +  H N+V L  F      
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGE 121
Query: 136 RA------LIYEFMPNG--SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
           +       L+ +++P     + +       + P  Y++   MY++     + L Y+H   
Sbjct: 122 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLF----RSLAYIH--- 173
Query: 188 STKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
           S  I H DIKP N+LLD D    K+ DFG AK     E  VS +        Y APE+  
Sbjct: 174 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY----YRAPELI- 228
Query: 247 RNFGEVSHKS--DVYSFGMMIMELVGCKNNL--DSGVDSSSEV 285
             FG   + S  DV+S G ++ EL+  +     DSGVD   E+
Sbjct: 229 --FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 269

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 113/271 (41%), Gaps = 42/271 (15%)
Query: 89  DKLGQGGFGGVYKGR---------------------LLDDFVNEVASISRTSHVNVVTLL 127
           +K+G+G +G VYK R                     +    + E++ +   +H N+V LL
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 70
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
                 N   L++EF+     +    +  T  P   ++       +  + +GL + H   
Sbjct: 71  DVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIK-----SYLFQLLQGLAFCH--- 122
Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSR 247
           S ++LH D+KP N+L++ +   K++DFGLA+        V +       + Y APE+   
Sbjct: 123 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTYXHEVVTLWYRAPEIL-L 178
Query: 248 NFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVV 307
                S   D++S G +  E+V  +  L  G DS  +  F   I+R +    E   PGV 
Sbjct: 179 GCKYYSTAVDIWSLGCIFAEMV-TRRALFPG-DSEIDQLFR--IFRTLGTPDEVVWPGVT 234
Query: 308 TRKENEIAKKMIIVGLWCIQARPSDRPPMNE 338
           +  + + +        W  Q      PP++E
Sbjct: 235 SMPDYKPS-----FPKWARQDFSKVVPPLDE 260

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 93/198 (46%), Gaps = 28/198 (14%)
Query: 91  LGQGGFGGVY---------KGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI-- 139
           LGQG FG V+           +L    V + A++     V         +E N+  ++  
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 140 -YEFMPNGSLE---KFVYNGDT----SKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKI 191
            Y F   G L     F+  GD     SK   +   E +   +  +A  L++LH   S  I
Sbjct: 92  HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTE-EDVKFYLAELALALDHLH---SLGI 147
Query: 192 LHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGE 251
           ++ D+KP NILLDE+   K++DFGL+K     E    S  G    + Y+APEV +R  G 
Sbjct: 148 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGT---VEYMAPEVVNRR-GH 203
Query: 252 VSHKSDVYSFGMMIMELV 269
            +  +D +SFG+++ E++
Sbjct: 204 -TQSADWWSFGVLMFEML 220

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 79/168 (47%), Gaps = 19/168 (11%)
Query: 101 KGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKP 160
           +G   +D   EV+ +    H NV+TL        +  LI E +  G L  F+   ++   
Sbjct: 54  RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--- 110
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP----KISDFGL 216
              L  E+  E +  I  G+ YLH   S +I HFD+KP NI+L +   P    KI DFGL
Sbjct: 111 ---LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 217 AKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMM 264
           A     K    +      G   ++APE+   N+  +  ++D++S G++
Sbjct: 165 AH----KIDFGNEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVI 206

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 92/221 (41%), Gaps = 51/221 (23%)
Query: 91  LGQGGFGGVYKGR------------------LLDDFVNEVASISRTSHVNVVTLLGFCLE 132
           LGQG FG V K R                   L   ++EV  ++  +H  VV      LE
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVVRYYAAWLE 73
Query: 133 GNN----------RALIY---EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
             N          ++ ++   E+  N +L   +++ + ++     + ++ + +   I + 
Sbjct: 74  RRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQ-----QRDEYWRLFRQILEA 128
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV-----------S 228
           L Y+H   S  I+H ++KP NI +DE    KI DFGLAK       I+            
Sbjct: 129 LSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 229 SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
           +L  A G   Y+A EV     G  + K D YS G++  E +
Sbjct: 186 NLTSAIGTAXYVATEVLD-GTGHYNEKIDXYSLGIIFFEXI 225

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 79/168 (47%), Gaps = 19/168 (11%)
Query: 101 KGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKP 160
           +G   +D   EV+ +    H NV+TL        +  LI E +  G L  F+   ++   
Sbjct: 54  RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--- 110
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP----KISDFGL 216
              L  E+  E +  I  G+ YLH   S +I HFD+KP NI+L +   P    KI DFGL
Sbjct: 111 ---LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 217 AKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMM 264
           A     K    +      G   ++APE+   N+  +  ++D++S G++
Sbjct: 165 AH----KIDFGNEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVI 206

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 97/223 (43%), Gaps = 43/223 (19%)
Query: 91  LGQGGFGGVYKGRLLDD--------------FVN-EVASISRTSHVNVVTLLGFCLEGNN 135
           +G G FG VY+ +L D               F N E+  + +  H N+V L  F      
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGE 125
Query: 136 RA------LIYEFMPNG--SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
           +       L+ +++P     + +       + P  Y++   MY++     + L Y+H   
Sbjct: 126 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLF----RSLAYIH--- 177
Query: 188 STKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
           S  I H DIKP N+LLD D    K+ DFG AK     E  VS +        Y APE+  
Sbjct: 178 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY----YRAPELI- 232
Query: 247 RNFGEVSHKS--DVYSFGMMIMELVGCKNNL--DSGVDSSSEV 285
             FG   + S  DV+S G ++ EL+  +     DSGVD   E+
Sbjct: 233 --FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 273

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 69/155 (44%), Gaps = 11/155 (7%)
Query: 120 HVNVVTLLGFCLEG-NNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
           H   +  L +  E   +  L+   M  G +   +YN D   P    +  +       I  
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG--FQEPRAIFYTAQIVS 300
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG 238
           GLE+LH      I++ D+KP N+LLD+D   +ISD GLA     K G   +  G  G  G
Sbjct: 301 GLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKT-KGYAGTPG 354
Query: 239 YIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKN 273
           ++APE+      E     D ++ G+ + E++  + 
Sbjct: 355 FMAPELLLGE--EYDFSVDYFALGVTLYEMIAARG 387

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 79/168 (47%), Gaps = 19/168 (11%)
Query: 101 KGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKP 160
           +G   +D   EV+ +    H NV+TL        +  LI E +  G L  F+   ++   
Sbjct: 54  RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--- 110
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP----KISDFGL 216
              L  E+  E +  I  G+ YLH   S +I HFD+KP NI+L +   P    KI DFGL
Sbjct: 111 ---LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 217 AKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMM 264
           A     K    +      G   ++APE+   N+  +  ++D++S G++
Sbjct: 165 AH----KIDFGNEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVI 206

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 77/160 (48%), Gaps = 20/160 (12%)
Query: 115 ISRTSHVNVVTLLGFCLEGNNRALI-YEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEI 172
           +SR  H   V L  F  + + +      +  NG L K++   G   + C      + Y  
Sbjct: 87  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----RFY-- 138
Query: 173 VIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT--TKEGIVSSL 230
              I   LEYLH      I+H D+KP NILL+ED   +I+DFG AK+ +  +K+   +S 
Sbjct: 139 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 195
Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG 270
           +G      Y++PE+ +         SD+++ G +I +LV 
Sbjct: 196 VGT---AQYVSPELLTEK--SACKSSDLWALGCIIYQLVA 230

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 69/155 (44%), Gaps = 11/155 (7%)
Query: 120 HVNVVTLLGFCLEG-NNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
           H   +  L +  E   +  L+   M  G +   +YN D   P    +  +       I  
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG--FQEPRAIFYTAQIVS 300
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG 238
           GLE+LH      I++ D+KP N+LLD+D   +ISD GLA     K G   +  G  G  G
Sbjct: 301 GLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKT-KGYAGTPG 354
Query: 239 YIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKN 273
           ++APE+      E     D ++ G+ + E++  + 
Sbjct: 355 FMAPELLLGE--EYDFSVDYFALGVTLYEMIAARG 387

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 97/223 (43%), Gaps = 43/223 (19%)
Query: 91  LGQGGFGGVYKGRLLDD--------------FVN-EVASISRTSHVNVVTLLGFCLEGNN 135
           +G G FG VY+ +L D               F N E+  + +  H N+V L  F      
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGE 123
Query: 136 RA------LIYEFMPNG--SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
           +       L+ +++P     + +       + P  Y++   MY++     + L Y+H   
Sbjct: 124 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLF----RSLAYIH--- 175
Query: 188 STKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
           S  I H DIKP N+LLD D    K+ DFG AK     E  VS +        Y APE+  
Sbjct: 176 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY----YRAPELI- 230
Query: 247 RNFGEVSHKS--DVYSFGMMIMELVGCKNNL--DSGVDSSSEV 285
             FG   + S  DV+S G ++ EL+  +     DSGVD   E+
Sbjct: 231 --FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 271

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 69/155 (44%), Gaps = 11/155 (7%)
Query: 120 HVNVVTLLGFCLEG-NNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
           H   +  L +  E   +  L+   M  G +   +YN D   P    +  +       I  
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG--FQEPRAIFYTAQIVS 300
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG 238
           GLE+LH      I++ D+KP N+LLD+D   +ISD GLA     K G   +  G  G  G
Sbjct: 301 GLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKT-KGYAGTPG 354
Query: 239 YIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKN 273
           ++APE+      E     D ++ G+ + E++  + 
Sbjct: 355 FMAPELLLGE--EYDFSVDYFALGVTLYEMIAARG 387

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 42/209 (20%)
Query: 91  LGQGGFGGVYKGR-----------LLDDFVNEVASISR--------TSHVNVVTLLGFCL 131
           +G G +G VYKGR           ++D   +E   I +        + H N+ T  G  +
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91
Query: 132 EGN------NRALIYEFMPNGSLEKFVYN--GDTSKPCQYLRWEKMYEIVIGIAKGLEYL 183
           + N         L+ EF   GS+   + N  G+T      L+ E +  I   I +GL +L
Sbjct: 92  KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT------LKEEWIAYICREILRGLSHL 145
Query: 184 HHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE 243
           H     K++H DIK  N+LL E+   K+ DFG++       G  ++ +G      ++APE
Sbjct: 146 HQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGT---PYWMAPE 199
Query: 244 VFSRNF---GEVSHKSDVYSFGMMIMELV 269
           V + +         KSD++S G+  +E+ 
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEMA 228

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 97/223 (43%), Gaps = 43/223 (19%)
Query: 91  LGQGGFGGVYKGRLLDD--------------FVN-EVASISRTSHVNVVTLLGFCLEGNN 135
           +G G FG VY+ +L D               F N E+  + +  H N+V L  F      
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGE 166
Query: 136 RA------LIYEFMPNG--SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
           +       L+ +++P     + +       + P  Y++   MY++     + L Y+H   
Sbjct: 167 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLF----RSLAYIH--- 218
Query: 188 STKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
           S  I H DIKP N+LLD D    K+ DFG AK     E  VS +        Y APE+  
Sbjct: 219 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY----YRAPELI- 273
Query: 247 RNFGEVSHKS--DVYSFGMMIMELVGCKNNL--DSGVDSSSEV 285
             FG   + S  DV+S G ++ EL+  +     DSGVD   E+
Sbjct: 274 --FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 314

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 69/155 (44%), Gaps = 11/155 (7%)
Query: 120 HVNVVTLLGFCLEG-NNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
           H   +  L +  E   +  L+   M  G +   +YN D   P    +  +       I  
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG--FQEPRAIFYTAQIVS 300
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG 238
           GLE+LH      I++ D+KP N+LLD+D   +ISD GLA     K G   +  G  G  G
Sbjct: 301 GLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKT-KGYAGTPG 354
Query: 239 YIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKN 273
           ++APE+      E     D ++ G+ + E++  + 
Sbjct: 355 FMAPELLLGE--EYDFSVDYFALGVTLYEMIAARG 387

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 79/168 (47%), Gaps = 19/168 (11%)
Query: 101 KGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKP 160
           +G   +D   EV+ +    H NV+TL        +  LI E +  G L  F+   ++   
Sbjct: 54  RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--- 110
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP----KISDFGL 216
              L  E+  E +  I  G+ YLH   S +I HFD+KP NI+L +   P    KI DFGL
Sbjct: 111 ---LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 217 AKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMM 264
           A     K    +      G   ++APE+   N+  +  ++D++S G++
Sbjct: 165 AH----KIDFGNEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVI 206

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 77/160 (48%), Gaps = 20/160 (12%)
Query: 115 ISRTSHVNVVTLLGFCLEGNNRALI-YEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEI 172
           +SR  H   V L  F  + + +      +  NG L K++   G   + C      + Y  
Sbjct: 83  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----RFY-- 134
Query: 173 VIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT--TKEGIVSSL 230
              I   LEYLH      I+H D+KP NILL+ED   +I+DFG AK+ +  +K+   +S 
Sbjct: 135 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 191
Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG 270
           +G      Y++PE+ +         SD+++ G +I +LV 
Sbjct: 192 VGT---AQYVSPELLTEK--SACKSSDLWALGCIIYQLVA 226

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 89/202 (44%), Gaps = 33/202 (16%)
Query: 90  KLGQGGFGGVYKGR-------------------LLDDFVNEVASISRTSHVNVVTLLGFC 130
           +LG G FG VYK +                    L+D++ E+  ++   H N+V LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 131 LEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTK 190
              NN  ++ EF   G+++  +   +  +P   L   ++  +       L YLH     K
Sbjct: 104 YYENNLWILIEFCAGGAVDAVML--ELERP---LTESQIQVVCKQTLDALNYLH---DNK 155
Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVF---SR 247
           I+H D+K  NIL   D   K++DFG++   T         +G      ++APEV    + 
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTP---YWMAPEVVMCETS 212
Query: 248 NFGEVSHKSDVYSFGMMIMELV 269
                 +K+DV+S G+ ++E+ 
Sbjct: 213 KDRPYDYKADVWSLGITLIEMA 234

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 100/239 (41%), Gaps = 33/239 (13%)
Query: 119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY-------- 170
           +H+N+V LLG C  G    +I E+   G L  F+     S  C       M         
Sbjct: 108 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 167
Query: 171 ----EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
                    +AKG+ +L    S   +H D+   NILL      KI DFGLA+        
Sbjct: 168 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNY 224
Query: 227 VSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
           V     AR  + ++APE +F+  +   + +SDV+S+G+ + EL    ++   G+   S+ 
Sbjct: 225 VVK-GNARLPVKWMAPESIFNCVY---TFESDVWSYGIFLWELFSLGSSPYPGMPVDSK- 279
Query: 286 YFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
                 Y+ +++      P     +  +I K        C  A P  RP   +++++++
Sbjct: 280 -----FYKMIKEGFRMLSPEHAPAEMYDIMKT-------CWDADPLKRPTFKQIVQLIE 326

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 93/198 (46%), Gaps = 28/198 (14%)
Query: 91  LGQGGFGGVY---------KGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI-- 139
           LGQG FG V+           +L    V + A++     V         +E N+  ++  
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 140 -YEFMPNGSLE---KFVYNGDT----SKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKI 191
            Y F   G L     F+  GD     SK   +   E +   +  +A  L++LH   S  I
Sbjct: 92  HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTE-EDVKFYLAELALALDHLH---SLGI 147
Query: 192 LHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGE 251
           ++ D+KP NILLDE+   K++DFGL+K     E    S  G    + Y+APEV +R  G 
Sbjct: 148 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGT---VEYMAPEVVNRR-GH 203
Query: 252 VSHKSDVYSFGMMIMELV 269
            +  +D +SFG+++ E++
Sbjct: 204 -TQSADWWSFGVLMFEML 220

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 100/239 (41%), Gaps = 33/239 (13%)
Query: 119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY-------- 170
           +H+N+V LLG C  G    +I E+   G L  F+     S  C       M         
Sbjct: 85  NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 171 ----EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
                    +AKG+ +L    S   +H D+   NILL      KI DFGLA+        
Sbjct: 145 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 227 VSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
           V     AR  + ++APE +F+  +   + +SDV+S+G+ + EL    ++   G+   S+ 
Sbjct: 202 VVK-GNARLPVKWMAPESIFNCVY---TFESDVWSYGIFLWELFSLGSSPYPGMPVDSK- 256
Query: 286 YFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
                 Y+ +++      P     +  +I K        C  A P  RP   +++++++
Sbjct: 257 -----FYKMIKEGFRMLSPEHAPAEMYDIMKT-------CWDADPLKRPTFKQIVQLIE 303

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 93/198 (46%), Gaps = 28/198 (14%)
Query: 91  LGQGGFGGVY---------KGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI-- 139
           LGQG FG V+           +L    V + A++     V         +E N+  ++  
Sbjct: 33  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 92
Query: 140 -YEFMPNGSLE---KFVYNGDT----SKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKI 191
            Y F   G L     F+  GD     SK   +   E +   +  +A  L++LH   S  I
Sbjct: 93  HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTE-EDVKFYLAELALALDHLH---SLGI 148
Query: 192 LHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGE 251
           ++ D+KP NILLDE+   K++DFGL+K     E    S  G    + Y+APEV +R  G 
Sbjct: 149 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGT---VEYMAPEVVNRR-GH 204
Query: 252 VSHKSDVYSFGMMIMELV 269
            +  +D +SFG+++ E++
Sbjct: 205 -TQSADWWSFGVLMFEML 221

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/240 (24%), Positives = 98/240 (40%), Gaps = 31/240 (12%)
Query: 119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGD---TSKPC-----QYLRWEKMY 170
            H N+V LLG C  G    +I E+   G L  F+        + P        L    + 
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLL 167
Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK-LCTTKEGIVSS 229
                +A+G+ +L    S   +H D+   N+LL      KI DFGLA+ +      IV  
Sbjct: 168 HFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 230 LLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFP 288
              AR  + ++APE +F   +   + +SDV+S+G+++ E+     N   G+  +S+    
Sbjct: 225 --NARLPVKWMAPESIFDCVY---TVQSDVWSYGILLWEIFSLGLNPYPGILVNSK---- 275
Query: 289 HWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE 348
              Y+ V+   +   P    +    I +        C    P+ RP   ++   LQ   +
Sbjct: 276 --FYKLVKDGYQMAQPAFAPKNIYSIMQA-------CWALEPTHRPTFQQICSFLQEQAQ 326

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 79/168 (47%), Gaps = 19/168 (11%)
Query: 101 KGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKP 160
           +G   +D   EV+ +    H NV+TL        +  LI E +  G L  F+   ++   
Sbjct: 54  RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKES--- 110
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP----KISDFGL 216
              L  E+  E +  I  G+ YLH   S +I HFD+KP NI+L +   P    KI DFGL
Sbjct: 111 ---LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 217 AKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMM 264
           A     K    +      G   ++APE+   N+  +  ++D++S G++
Sbjct: 165 AH----KIDFGNEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVI 206

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 100/239 (41%), Gaps = 33/239 (13%)
Query: 119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY-------- 170
           +H+N+V LLG C  G    +I E+   G L  F+     S  C       M         
Sbjct: 108 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 167
Query: 171 ----EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
                    +AKG+ +L    S   +H D+   NILL      KI DFGLA+        
Sbjct: 168 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 224
Query: 227 VSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
           V     AR  + ++APE +F+  +   + +SDV+S+G+ + EL    ++   G+   S+ 
Sbjct: 225 VVK-GNARLPVKWMAPESIFNCVY---TFESDVWSYGIFLWELFSLGSSPYPGMPVDSK- 279
Query: 286 YFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
                 Y+ +++      P     +  +I K        C  A P  RP   +++++++
Sbjct: 280 -----FYKMIKEGFRMLSPEHAPAEMYDIMKT-------CWDADPLKRPTFKQIVQLIE 326

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 117/272 (43%), Gaps = 44/272 (16%)
Query: 89  DKLGQGGFGGVYKGR---------------------LLDDFVNEVASISRTSHVNVVTLL 127
           +K+G+G +G VYK R                     +    + E++ +   +H N+V LL
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                 N   L++E + +  L+KF+  +  T  P   ++       +  + +GL + H  
Sbjct: 72  DVIHTENKLYLVFEHV-DQDLKKFMDASALTGIPLPLIK-----SYLFQLLQGLAFCH-- 123
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            S ++LH D+KP N+L++ +   K++DFGLA+        V +       + Y APE+  
Sbjct: 124 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTYXHEVVTLWYRAPEIL- 178
Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
                 S   D++S G +  E+V  +  L  G DS  +  F   I+R +    E   PGV
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMV-TRRALFPG-DSEIDQLFR--IFRTLGTPDEVVWPGV 234
Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNE 338
            +  + + +        W  Q      PP++E
Sbjct: 235 TSMPDYKPS-----FPKWARQDFSKVVPPLDE 261

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 100/239 (41%), Gaps = 33/239 (13%)
Query: 119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY-------- 170
           +H+N+V LLG C  G    +I E+   G L  F+     S  C       M         
Sbjct: 103 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 162
Query: 171 ----EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
                    +AKG+ +L    S   +H D+   NILL      KI DFGLA+        
Sbjct: 163 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 219
Query: 227 VSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
           V     AR  + ++APE +F+  +   + +SDV+S+G+ + EL    ++   G+   S+ 
Sbjct: 220 VVK-GNARLPVKWMAPESIFNCVY---TFESDVWSYGIFLWELFSLGSSPYPGMPVDSK- 274
Query: 286 YFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
                 Y+ +++      P     +  +I K        C  A P  RP   +++++++
Sbjct: 275 -----FYKMIKEGFRMLSPEHAPAEMYDIMKT-------CWDADPLKRPTFKQIVQLIE 321

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 100/249 (40%), Gaps = 40/249 (16%)
Query: 119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYN------GDTSKPCQY--------- 163
            H N+V LLG C  G    +I E+   G L  F+        G +  P Q          
Sbjct: 93  QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDG 152
Query: 164 --LRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK-LC 220
             L    +      +A+G+ +L    S   +H D+   N+LL      KI DFGLA+ + 
Sbjct: 153 RPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 209
Query: 221 TTKEGIVSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGV 279
                IV     AR  + ++APE +F   +   + +SDV+S+G+++ E+     N   G+
Sbjct: 210 NDSNYIVKG--NARLPVKWMAPESIFDCVY---TVQSDVWSYGILLWEIFSLGLNPYPGI 264
Query: 280 DSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEV 339
             +S+       Y+ V+   +   P    +    I +        C    P+ RP   ++
Sbjct: 265 LVNSK------FYKLVKDGYQMAQPAFAPKNIYSIMQA-------CWALEPTHRPTFQQI 311
Query: 340 IEMLQGSTE 348
              LQ   +
Sbjct: 312 CSFLQEQAQ 320

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/257 (23%), Positives = 102/257 (39%), Gaps = 26/257 (10%)
Query: 103 RLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRA--LIYEFMPNGSLEKFVYNGDTSKP 160
           +L   +  E+  +    H ++V   G C +   ++  L+ E++P GSL  ++       P
Sbjct: 53  QLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL-------P 105
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
              +   ++      I +G+ YLH   +   +H  +   N+LLD D   KI DFGLAK  
Sbjct: 106 RHCVGLAQLLLFAQQICEGMAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAV 162
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGV 279
                           + + APE       +  + SDV+SFG+ + EL+  C +N     
Sbjct: 163 PEGHEYYRVREDGDSPVFWYAPECLKEC--KFYYASDVWSFGVTLYELLTYCDSN----- 215
Query: 280 DSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLW-----CIQARPSDRP 334
             S    F   I     Q    +L  ++ R E           ++     C +   S RP
Sbjct: 216 -QSPHTKFTELIGHTQGQMTVLRLTELLERGERLPRPDRCPCEIYHLMKNCWETEASFRP 274
Query: 335 PMNEVIEMLQGSTEALQ 351
               ++ +LQ + E  Q
Sbjct: 275 TFQNLVPILQTAQEKYQ 291

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 72  LKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLLDDF-VNEVASISRTSHVNVVTLLGFC 130
           L R +F +V ++    KDK  Q GF    K   L+ F V E+ + +  S   +V L G  
Sbjct: 80  LGRGSFGEVHRM----KDK--QTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAV 133
Query: 131 LEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTK 190
            EG    +  E +  GSL + +      K    L  ++    +    +GLEYLH   + +
Sbjct: 134 REGPWVNIFMELLEGGSLGQLI------KQMGCLPEDRALYYLGQALEGLEYLH---TRR 184
Query: 191 ILHFDIKPHNILLDEDFC-PKISDFGLAKLCTTKEGIVSSLLGARGIIG---YIAPEVFS 246
           ILH D+K  N+LL  D     + DFG A LC   +G+  SLL    I G   ++APEV  
Sbjct: 185 ILHGDVKADNVLLSSDGSRAALCDFGHA-LCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 243
Query: 247 RNFGEVSHKSDVY-SFGMMIMELVGC 271
                   K D++ S  MM+  L GC
Sbjct: 244 GK--PCDAKVDIWSSCCMMLHMLNGC 267

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/257 (23%), Positives = 102/257 (39%), Gaps = 26/257 (10%)
Query: 103 RLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRA--LIYEFMPNGSLEKFVYNGDTSKP 160
           +L   +  E+  +    H ++V   G C +   ++  L+ E++P GSL  ++       P
Sbjct: 52  QLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL-------P 104
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
              +   ++      I +G+ YLH   +   +H  +   N+LLD D   KI DFGLAK  
Sbjct: 105 RHCVGLAQLLLFAQQICEGMAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAV 161
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGV 279
                           + + APE       +  + SDV+SFG+ + EL+  C +N     
Sbjct: 162 PEGHEYYRVREDGDSPVFWYAPECLKEC--KFYYASDVWSFGVTLYELLTYCDSN----- 214
Query: 280 DSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLW-----CIQARPSDRP 334
             S    F   I     Q    +L  ++ R E           ++     C +   S RP
Sbjct: 215 -QSPHTKFTELIGHTQGQMTVLRLTELLERGERLPRPDRCPCEIYHLMKNCWETEASFRP 273
Query: 335 PMNEVIEMLQGSTEALQ 351
               ++ +LQ + E  Q
Sbjct: 274 TFQNLVPILQTAQEKYQ 290

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 100/239 (41%), Gaps = 33/239 (13%)
Query: 119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY-------- 170
           +H+N+V LLG C  G    +I E+   G L  F+     S  C       M         
Sbjct: 101 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 160
Query: 171 ----EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
                    +AKG+ +L    S   +H D+   NILL      KI DFGLA+        
Sbjct: 161 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 217
Query: 227 VSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
           V     AR  + ++APE +F+  +   + +SDV+S+G+ + EL    ++   G+   S+ 
Sbjct: 218 VVK-GNARLPVKWMAPESIFNCVY---TFESDVWSYGIFLWELFSLGSSPYPGMPVDSK- 272
Query: 286 YFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
                 Y+ +++      P     +  +I K        C  A P  RP   +++++++
Sbjct: 273 -----FYKMIKEGFRMLSPEHAPAEMYDIMKT-------CWDADPLKRPTFKQIVQLIE 319

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 77/160 (48%), Gaps = 20/160 (12%)
Query: 115 ISRTSHVNVVTLLGFCLEGNNRALI-YEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEI 172
           +SR  H   V L  F  + + +      +  NG L K++   G   + C      + Y  
Sbjct: 84  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----RFY-- 135
Query: 173 VIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT--TKEGIVSSL 230
              I   LEYLH      I+H D+KP NILL+ED   +I+DFG AK+ +  +K+   ++ 
Sbjct: 136 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAF 192
Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG 270
           +G      Y++PE+ +         SD+++ G +I +LV 
Sbjct: 193 VGT---AQYVSPELLTEK--SACKSSDLWALGCIIYQLVA 227

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 89/201 (44%), Gaps = 29/201 (14%)
Query: 91  LGQGGFGGV---YKGRLLDDFVNEVASISRTSHVNV------VTLLGFCLEGNNRALIYE 141
           +G G +G V   Y  RL      +  S    S ++       + LL      N   L+  
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 87
Query: 142 FMPNGSLEKF--VY------NGDTSK--PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKI 191
           F P  S+E F  VY        D +    CQ L  E +  +V  + +GL+Y+H   S  I
Sbjct: 88  FTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIH---SAGI 144
Query: 192 LHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGE 251
           +H D+KP N+ ++ED   +I DFGLA+    +      + G      Y APE+   N+  
Sbjct: 145 IHRDLKPSNVAVNEDCELRILDFGLARQADEE------MTGYVATRWYRAPEIM-LNWMH 197
Query: 252 VSHKSDVYSFGMMIMELVGCK 272
            +   D++S G ++ EL+  K
Sbjct: 198 YNQTVDIWSVGCIMAELLQGK 218

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 79/168 (47%), Gaps = 23/168 (13%)
Query: 108 FVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWE 167
            + EVA +    H N++ L  F  +  N  L+ E    G L          +    +++ 
Sbjct: 83  LLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL--------FDEIIHRMKFN 134
Query: 168 KMYEIVI--GIAKGLEYLHHGCSTKILHFDIKPHNILL---DEDFCPKISDFGLAKLCTT 222
           ++   VI   +  G+ YLH      I+H D+KP N+LL   ++D   KI DFGL+ +   
Sbjct: 135 EVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191
Query: 223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG 270
           ++ +   L    G   YIAPEV  + + E   K DV+S G+++  L+ 
Sbjct: 192 QKKMKERL----GTAYYIAPEVLRKKYDE---KCDVWSIGVILFILLA 232

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 77/160 (48%), Gaps = 20/160 (12%)
Query: 115 ISRTSHVNVVTLLGFCLEGNNRALI-YEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEI 172
           +SR  H   V L  F  + + +      +  NG L K++   G   + C      + Y  
Sbjct: 86  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----RFY-- 137
Query: 173 VIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT--TKEGIVSSL 230
              I   LEYLH      I+H D+KP NILL+ED   +I+DFG AK+ +  +K+   +  
Sbjct: 138 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG 270
           +G      Y++PE+ +      S  SD+++ G +I +LV 
Sbjct: 195 VGT---AQYVSPELLTEKSAXKS--SDLWALGCIIYQLVA 229

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 89/201 (44%), Gaps = 29/201 (14%)
Query: 91  LGQGGFGGV---YKGRLLDDFVNEVASISRTSHVNV------VTLLGFCLEGNNRALIYE 141
           +G G +G V   Y  RL      +  S    S ++       + LL      N   L+  
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 142 FMPNGSLEKF--VY------NGDTSK--PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKI 191
           F P  S+E F  VY        D +    CQ L  E +  +V  + +GL+Y+H   S  I
Sbjct: 96  FTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIH---SAGI 152
Query: 192 LHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGE 251
           +H D+KP N+ ++ED   +I DFGLA+    +      + G      Y APE+   N+  
Sbjct: 153 IHRDLKPSNVAVNEDSELRILDFGLARQADEE------MTGYVATRWYRAPEIM-LNWMH 205
Query: 252 VSHKSDVYSFGMMIMELVGCK 272
            +   D++S G ++ EL+  K
Sbjct: 206 YNQTVDIWSVGCIMAELLQGK 226

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 97/211 (45%), Gaps = 29/211 (13%)
Query: 115 ISRTSHVNVVTLLGFCLEGNNRALI-YEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEI 172
           +SR  H   V L  F  + + +      +  NG L K++   G   + C      + Y  
Sbjct: 89  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----RFY-- 140
Query: 173 VIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT--TKEGIVSSL 230
              I   LEYLH      I+H D+KP NILL+ED   +I+DFG AK+ +  +K+   +  
Sbjct: 141 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 197
Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHW 290
           +G      Y++PE+ +         SD+++ G +I +LV       +G +        + 
Sbjct: 198 VGT---AQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPFRAGNE--------YL 244
Query: 291 IYRHVEQDREFKLPGVVTRKENEIAKKMIIV 321
           I++ + +  E+  P     K  ++ +K++++
Sbjct: 245 IFQKIIK-LEYDFPAAFFPKARDLVEKLLVL 274

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 109/243 (44%), Gaps = 37/243 (15%)
Query: 89  DKLGQGGFGGVYKGR--LLDDFV------------------NEVASISRTSHVNVVTLLG 128
           DKLG+G +  VYKG+  L D+ V                   EV+ +    H N+VTL  
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 67
Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
                 +  L++E++ +  L++++   D       +   K++  +  + +GL Y H    
Sbjct: 68  IIHTEKSLTLVFEYL-DKDLKQYL---DDCGNIINMHNVKLF--LFQLLRGLAYCHR--- 118
Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRN 248
            K+LH D+KP N+L++E    K++DFGLA+     + I +       +  +  P      
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGLAR----AKSIPTKTYDNEVVTLWYRPPDILLG 174
Query: 249 FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVT 308
             + S + D++  G +  E+   +  L  G     ++   H+I+R +    E   PG+++
Sbjct: 175 STDYSTQIDMWGVGCIFYEMATGR-PLFPGSTVEEQL---HFIFRILGTPTEETWPGILS 230
Query: 309 RKE 311
            +E
Sbjct: 231 NEE 233

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 78  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 125
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 126 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-- 180
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
                    + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 181 ----HTADEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 224

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 78  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 125
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 126 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-- 180
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
                    + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 181 ----HTADEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 224

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 78  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 125
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 126 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-- 180
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
                    + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 181 ----HTADEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 224

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 78/184 (42%), Gaps = 30/184 (16%)
Query: 101 KGRLLDD----------FVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEK 150
           KGR  DD            NE++ +    H N++ L     +     L+ EF   G L +
Sbjct: 76  KGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFE 135
Query: 151 FVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDED---F 207
            + N      C          I+  I  G+ YLH      I+H DIKP NILL+      
Sbjct: 136 QIINRHKFDECD------AANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLL 186
Query: 208 CPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIME 267
             KI DFGL+   +    +   L    G   YIAPEV  + + E   K DV+S G +IM 
Sbjct: 187 NIKIVDFGLSSFFSKDYKLRDRL----GTAYYIAPEVLKKKYNE---KCDVWSCG-VIMY 238
Query: 268 LVGC 271
           ++ C
Sbjct: 239 ILLC 242

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 89/203 (43%), Gaps = 39/203 (19%)
Query: 91  LGQGGFGGVYKGR----------------------LLDDFVNEVASISRTSHVNVVTLLG 128
           LG+G F GVY+                        ++    NEV    +  H +++ L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKP-CQYLRWEKMYEIVIGIAKGLEYLH-HG 186
           +  + N   L+ E   NG + +++ N    KP  +      M++I+ G+     YLH HG
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGML----YLHSHG 132
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
               ILH D+   N+LL  +   KI+DFGLA           +L G      YI+PE+ +
Sbjct: 133 ----ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTP---NYISPEIAT 185
Query: 247 RNFGEVSHKSDVYSFGMMIMELV 269
           R+   +  +SDV+S G M   L+
Sbjct: 186 RSAHGL--ESDVWSLGCMFYTLL 206

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 88/203 (43%), Gaps = 33/203 (16%)
Query: 90  KLGQGGFGGVYKGR---------------------LLDDFVNEVASISRTS---HVNVVT 125
           ++G G +G VYK R                     L    V EVA + R     H NVV 
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVR 70
Query: 126 LLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
           L+  C        I   +    +++ +       P   L  E + +++    +GL++LH 
Sbjct: 71  LMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA 130
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVF 245
            C   I+H D+KP NIL+      K++DFGLA++ + +  +   ++     + Y APEV 
Sbjct: 131 NC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVV----TLWYRAPEVL 183
Query: 246 SRNFGEVSHKSDVYSFGMMIMEL 268
            ++    +   D++S G +  E+
Sbjct: 184 LQS--TYATPVDMWSVGCIFAEM 204

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 76  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 123
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 124 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHT 180
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 181 DDE------MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 222

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 76/160 (47%), Gaps = 20/160 (12%)
Query: 115 ISRTSHVNVVTLLGFCLEGNNRALI-YEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEI 172
           +SR  H   V L  F  + + +      +  NG L K++   G   + C      + Y  
Sbjct: 63  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----RFY-- 114
Query: 173 VIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT--TKEGIVSSL 230
              I   LEYLH      I+H D+KP NILL+ED   +I+DFG AK+ +  +K+   +  
Sbjct: 115 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 171
Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG 270
           +G      Y++PE+ +         SD+++ G +I +LV 
Sbjct: 172 VGT---AQYVSPELLTEK--SACKSSDLWALGCIIYQLVA 206

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 82  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 129
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 130 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHT 186
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
                    + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 187 D------DEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 228

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 76  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 123
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 124 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHT 180
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 181 DDE------MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 222

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 76/160 (47%), Gaps = 20/160 (12%)
Query: 115 ISRTSHVNVVTLLGFCLEGNNRALI-YEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEI 172
           +SR  H   V L  F  + + +      +  NG L K++   G   + C      + Y  
Sbjct: 61  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----RFY-- 112
Query: 173 VIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT--TKEGIVSSL 230
              I   LEYLH      I+H D+KP NILL+ED   +I+DFG AK+ +  +K+   +  
Sbjct: 113 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 169
Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG 270
           +G      Y++PE+ +         SD+++ G +I +LV 
Sbjct: 170 VGT---AQYVSPELLTEK--SACKSSDLWALGCIIYQLVA 204

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 94/204 (46%), Gaps = 24/204 (11%)
Query: 74  RYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLLDDF-VNEVASISRTSHVNVVTLLGFCLE 132
           R +F +V ++    KDK  Q GF    K   L+ F V E+ + +  S   +V L G   E
Sbjct: 68  RGSFGEVHRM----KDK--QTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVRE 121
Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKIL 192
           G    +  E +  GSL + +      K    L  ++    +    +GLEYLH   + +IL
Sbjct: 122 GPWVNIFMELLEGGSLGQLI------KQMGCLPEDRALYYLGQALEGLEYLH---TRRIL 172
Query: 193 HFDIKPHNILLDEDFC-PKISDFGLAKLCTTKEGIVSSLLGARGIIG---YIAPEVFSRN 248
           H D+K  N+LL  D     + DFG A LC   +G+  SLL    I G   ++APEV    
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHA-LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 249 FGEVSHKSDVY-SFGMMIMELVGC 271
                 K D++ S  MM+  L GC
Sbjct: 232 --PCDAKVDIWSSCCMMLHMLNGC 253

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 76/160 (47%), Gaps = 20/160 (12%)
Query: 115 ISRTSHVNVVTLLGFCLEGNNRALI-YEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEI 172
           +SR  H   V L  F  + + +      +  NG L K++   G   + C      + Y  
Sbjct: 62  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----RFY-- 113
Query: 173 VIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT--TKEGIVSSL 230
              I   LEYLH      I+H D+KP NILL+ED   +I+DFG AK+ +  +K+   +  
Sbjct: 114 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 170
Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG 270
           +G      Y++PE+ +         SD+++ G +I +LV 
Sbjct: 171 VGT---AQYVSPELLTEK--SACKSSDLWALGCIIYQLVA 205

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 76/160 (47%), Gaps = 20/160 (12%)
Query: 115 ISRTSHVNVVTLLGFCLEGNNRALI-YEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEI 172
           +SR  H   V L  F  + + +      +  NG L K++   G   + C      + Y  
Sbjct: 64  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----RFY-- 115
Query: 173 VIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT--TKEGIVSSL 230
              I   LEYLH      I+H D+KP NILL+ED   +I+DFG AK+ +  +K+   +  
Sbjct: 116 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 172
Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG 270
           +G      Y++PE+ +         SD+++ G +I +LV 
Sbjct: 173 VGT---AQYVSPELLTEK--SACKSSDLWALGCIIYQLVA 207

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 91/211 (43%), Gaps = 43/211 (20%)
Query: 79  DVKKLTNSFKDKLGQGGFGGVY------KGRLL--------------DDFVNEVASISRT 118
           D+KK+   FK+ LG G F  V        G+L                   NE+A + + 
Sbjct: 19  DIKKIFE-FKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKI 77
Query: 119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNG-DTSKPCQYLRWEKMYEIVIGI 176
            H N+V L       N+  L+ + +  G L ++ V  G  T K    L        +  +
Sbjct: 78  KHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTL--------IRQV 129
Query: 177 AKGLEYLHHGCSTKILHFDIKPHNILL---DEDFCPKISDFGLAKLCTTKEGIVSSLLGA 233
              + YLH      I+H D+KP N+L    DE+    ISDFGL+K+    EG    +  A
Sbjct: 130 LDAVYYLHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM----EGKGDVMSTA 182
Query: 234 RGIIGYIAPEVFSRNFGEVSHKSDVYSFGMM 264
            G  GY+APEV ++     S   D +S G++
Sbjct: 183 CGTPGYVAPEVLAQK--PYSKAVDCWSIGVI 211

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 94/204 (46%), Gaps = 24/204 (11%)
Query: 74  RYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLLDDF-VNEVASISRTSHVNVVTLLGFCLE 132
           R +F +V ++    KDK  Q GF    K   L+ F V E+ + +  S   +V L G   E
Sbjct: 84  RGSFGEVHRM----KDK--QTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVRE 137
Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKIL 192
           G    +  E +  GSL + +      K    L  ++    +    +GLEYLH   + +IL
Sbjct: 138 GPWVNIFMELLEGGSLGQLI------KQMGCLPEDRALYYLGQALEGLEYLH---TRRIL 188
Query: 193 HFDIKPHNILLDEDFC-PKISDFGLAKLCTTKEGIVSSLLGARGIIG---YIAPEVFSRN 248
           H D+K  N+LL  D     + DFG A LC   +G+  SLL    I G   ++APEV    
Sbjct: 189 HGDVKADNVLLSSDGSRAALCDFGHA-LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 247
Query: 249 FGEVSHKSDVY-SFGMMIMELVGC 271
                 K D++ S  MM+  L GC
Sbjct: 248 --PCDAKVDIWSSCCMMLHMLNGC 269

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 83/205 (40%), Gaps = 36/205 (17%)
Query: 91  LGQGGFGGVYKGRL------------------LDDFVNEVASISRTSHVNVVTLLGFCLE 132
           +G+G FG VY GR                   L  F  EV +  +T H NVV  +G C+ 
Sbjct: 41  IGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100
Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKIL 192
             + A+I       +L   V +         L   K  +I   I KG+ YLH   +  IL
Sbjct: 101 PPHLAIITSLCKGRTLYSVVRDAKI-----VLDVNKTRQIAQEIVKGMGYLH---AKGIL 152
Query: 193 HFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG--IVSSLLGARGIIGYIAPEVFSRNFG 250
           H D+K  N+  D      I+DFGL  +    +       L    G + ++APE+  +   
Sbjct: 153 HKDLKSKNVFYDNGKVV-ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 251 EV-------SHKSDVYSFGMMIMEL 268
           +        S  SDV++ G +  EL
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYEL 236

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 76/160 (47%), Gaps = 20/160 (12%)
Query: 115 ISRTSHVNVVTLLGFCLEGNNRALI-YEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEI 172
           +SR  H   V L  F  + + +      +  NG L K++   G   + C      + Y  
Sbjct: 86  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----RFY-- 137
Query: 173 VIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT--TKEGIVSSL 230
              I   LEYLH      I+H D+KP NILL+ED   +I+DFG AK+ +  +K+   +  
Sbjct: 138 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG 270
           +G      Y++PE+ +         SD+++ G +I +LV 
Sbjct: 195 VGT---AQYVSPELLTEK--SACKSSDLWALGCIIYQLVA 229

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 71  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 119 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 175
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
                    + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 176 D------DEMTGXVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 217

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 76/160 (47%), Gaps = 20/160 (12%)
Query: 115 ISRTSHVNVVTLLGFCLEGNNRALI-YEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEI 172
           +SR  H   V L  F  + + +      +  NG L K++   G   + C      + Y  
Sbjct: 86  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----RFY-- 137
Query: 173 VIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT--TKEGIVSSL 230
              I   LEYLH      I+H D+KP NILL+ED   +I+DFG AK+ +  +K+   +  
Sbjct: 138 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG 270
           +G      Y++PE+ +         SD+++ G +I +LV 
Sbjct: 195 VGT---AQYVSPELLTEK--SACKSSDLWALGCIIYQLVA 229

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 76/160 (47%), Gaps = 20/160 (12%)
Query: 115 ISRTSHVNVVTLLGFCLEGNNRALI-YEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEI 172
           +SR  H   V L  F  + + +      +  NG L K++   G   + C      + Y  
Sbjct: 87  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----RFY-- 138
Query: 173 VIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT--TKEGIVSSL 230
              I   LEYLH      I+H D+KP NILL+ED   +I+DFG AK+ +  +K+   +  
Sbjct: 139 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 195
Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG 270
           +G      Y++PE+ +         SD+++ G +I +LV 
Sbjct: 196 VGT---AQYVSPELLTEK--SACKSSDLWALGCIIYQLVA 230

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 76/160 (47%), Gaps = 20/160 (12%)
Query: 115 ISRTSHVNVVTLLGFCLEGNNRALI-YEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEI 172
           +SR  H   V L  F  + + +      +  NG L K++   G   + C      + Y  
Sbjct: 84  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----RFY-- 135
Query: 173 VIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT--TKEGIVSSL 230
              I   LEYLH      I+H D+KP NILL+ED   +I+DFG AK+ +  +K+   +  
Sbjct: 136 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 192
Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG 270
           +G      Y++PE+ +         SD+++ G +I +LV 
Sbjct: 193 VGT---AQYVSPELLTEK--SACKSSDLWALGCIIYQLVA 227

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 91  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 138
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 139 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 195
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 196 DDE------MXGXVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 237

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 76/160 (47%), Gaps = 20/160 (12%)
Query: 115 ISRTSHVNVVTLLGFCLEGNNRALI-YEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEI 172
           +SR  H   V L  F  + + +      +  NG L K++   G   + C      + Y  
Sbjct: 84  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----RFY-- 135
Query: 173 VIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT--TKEGIVSSL 230
              I   LEYLH      I+H D+KP NILL+ED   +I+DFG AK+ +  +K+   +  
Sbjct: 136 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 192
Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG 270
           +G      Y++PE+ +         SD+++ G +I +LV 
Sbjct: 193 VGT---AQYVSPELLTEK--SACKSSDLWALGCIIYQLVA 227

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 76/160 (47%), Gaps = 20/160 (12%)
Query: 115 ISRTSHVNVVTLLGFCLEGNNRALI-YEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEI 172
           +SR  H   V L  F  + + +      +  NG L K++   G   + C      + Y  
Sbjct: 84  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----RFY-- 135
Query: 173 VIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT--TKEGIVSSL 230
              I   LEYLH      I+H D+KP NILL+ED   +I+DFG AK+ +  +K+   +  
Sbjct: 136 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 192
Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG 270
           +G      Y++PE+ +         SD+++ G +I +LV 
Sbjct: 193 VGT---AQYVSPELLTEK--SACKSSDLWALGCIIYQLVA 227

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 80/179 (44%), Gaps = 31/179 (17%)
Query: 172 IVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSL- 230
           I I IA+ +E+LH   S  ++H D+KP NI    D   K+ DFGL       E   + L 
Sbjct: 169 IFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225
Query: 231 --------LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSS 282
                    G  G   Y++PE    N    SHK D++S G+++ EL+   +     V   
Sbjct: 226 PMPAYATHXGQVGTKLYMSPEQIHGN--NYSHKVDIFSLGLILFELLYSFSTQMERVRII 283
Query: 283 SEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
           ++V             R  K P + T+K  +  + M++  +  +   P++RP   ++IE
Sbjct: 284 TDV-------------RNLKFPLLFTQKYPQ--EHMMVQDM--LSPSPTERPEATDIIE 325

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 76/160 (47%), Gaps = 20/160 (12%)
Query: 115 ISRTSHVNVVTLLGFCLEGNNRALI-YEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEI 172
           +SR  H   V L  F  + + +      +  NG L K++   G   + C      + Y  
Sbjct: 86  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----RFY-- 137
Query: 173 VIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT--TKEGIVSSL 230
              I   LEYLH      I+H D+KP NILL+ED   +I+DFG AK+ +  +K+   +  
Sbjct: 138 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG 270
           +G      Y++PE+ +         SD+++ G +I +LV 
Sbjct: 195 VGT---AQYVSPELLTEK--SACKSSDLWALGCIIYQLVA 229

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 76/160 (47%), Gaps = 20/160 (12%)
Query: 115 ISRTSHVNVVTLLGFCLEGNNRALI-YEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEI 172
           +SR  H   V L  F  + + +      +  NG L K++   G   + C      + Y  
Sbjct: 83  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----RFY-- 134
Query: 173 VIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT--TKEGIVSSL 230
              I   LEYLH      I+H D+KP NILL+ED   +I+DFG AK+ +  +K+   +  
Sbjct: 135 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 191
Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG 270
           +G      Y++PE+ +         SD+++ G +I +LV 
Sbjct: 192 VGT---AQYVSPELLTEK--SACKSSDLWALGCIIYQLVA 226

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 76/160 (47%), Gaps = 20/160 (12%)
Query: 115 ISRTSHVNVVTLLGFCLEGNNRALI-YEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEI 172
           +SR  H   V L  F  + + +      +  NG L K++   G   + C      + Y  
Sbjct: 68  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----RFY-- 119
Query: 173 VIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT--TKEGIVSSL 230
              I   LEYLH      I+H D+KP NILL+ED   +I+DFG AK+ +  +K+   +  
Sbjct: 120 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 176
Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG 270
           +G      Y++PE+ +         SD+++ G +I +LV 
Sbjct: 177 VGT---AQYVSPELLTEK--SACKSSDLWALGCIIYQLVA 211

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 81/168 (48%), Gaps = 19/168 (11%)
Query: 101 KGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKP 160
           +G   ++   EV+ + +  H N++TL        +  LI E +  G L  F+   ++   
Sbjct: 55  RGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES--- 111
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP----KISDFGL 216
              L  E+    +  I  G+ YLH   + KI HFD+KP NI+L +   P    K+ DFGL
Sbjct: 112 ---LSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 217 AKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMM 264
           A     ++G+        G   ++APE+   N+  +  ++D++S G++
Sbjct: 166 AH--EIEDGV--EFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVI 207

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 76/160 (47%), Gaps = 20/160 (12%)
Query: 115 ISRTSHVNVVTLLGFCLEGNNRALI-YEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEI 172
           +SR  H   V L  F  + + +      +  NG L K++   G   + C      + Y  
Sbjct: 86  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----RFY-- 137
Query: 173 VIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT--TKEGIVSSL 230
              I   LEYLH      I+H D+KP NILL+ED   +I+DFG AK+ +  +K+   +  
Sbjct: 138 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG 270
           +G      Y++PE+ +         SD+++ G +I +LV 
Sbjct: 195 VGT---AQYVSPELLTEK--SACKSSDLWALGCIIYQLVA 229

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 88/203 (43%), Gaps = 33/203 (16%)
Query: 90  KLGQGGFGGVYKGR---------------------LLDDFVNEVASISRTS---HVNVVT 125
           ++G G +G VYK R                     L    V EVA + R     H NVV 
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVR 70
Query: 126 LLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
           L+  C        I   +    +++ +       P   L  E + +++    +GL++LH 
Sbjct: 71  LMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA 130
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVF 245
            C   I+H D+KP NIL+      K++DFGLA++ + +  +   ++     + Y APEV 
Sbjct: 131 NC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV----TLWYRAPEVL 183
Query: 246 SRNFGEVSHKSDVYSFGMMIMEL 268
            ++    +   D++S G +  E+
Sbjct: 184 LQS--TYATPVDMWSVGCIFAEM 204

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 81/168 (48%), Gaps = 19/168 (11%)
Query: 101 KGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKP 160
           +G   ++   EV+ + +  H NV+TL        +  LI E +  G L  F+   ++   
Sbjct: 55  RGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES--- 111
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP----KISDFGL 216
              L  E+    +  I  G+ YLH   + KI HFD+KP NI+L +   P    K+ DFGL
Sbjct: 112 ---LSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 217 AKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMM 264
           A     ++G+        G   ++APE+   N+  +  ++D++S G++
Sbjct: 166 AH--EIEDGV--EFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVI 207

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 77  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 124
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 125 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHT 181
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 182 DDE------MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 223

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 71  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 119 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 175
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 176 DDE------MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 217

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 81  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 128
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 129 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 185
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 186 DDE------MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 227

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 71  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 119 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 175
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 176 DDE------MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 217

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 73  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 120
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 121 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHT 177
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 178 DDE------MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 219

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 81/168 (48%), Gaps = 19/168 (11%)
Query: 101 KGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKP 160
           +G   ++   EV+ + +  H NV+TL        +  LI E +  G L  F+   ++   
Sbjct: 55  RGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES--- 111
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP----KISDFGL 216
              L  E+    +  I  G+ YLH   + KI HFD+KP NI+L +   P    K+ DFGL
Sbjct: 112 ---LSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 217 AKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMM 264
           A     ++G+        G   ++APE+   N+  +  ++D++S G++
Sbjct: 166 AH--EIEDGV--EFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVI 207

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 76  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 123
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 124 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 180
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 181 DDE------MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 222

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 71  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 119 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 175
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
                    + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 176 D------DEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 217

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 70  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 117
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 118 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 174
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 175 DDE------MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 216

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 36/203 (17%)
Query: 91  LGQGGFGGVYKGRL--------------------LDD---FVNEVASISRTSHVNVVTLL 127
           LG+G FG VY+G                      LD+   F++E   +    H ++V L+
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
           G  +E     +I E  P G L  ++     S     L+   +    + I K + YL    
Sbjct: 76  GI-IEEEPTWIIMELYPYGELGHYLERNKNS-----LKVLTLVLYSLQICKAMAYLE--- 126
Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSR 247
           S   +H DI   NIL+    C K+ DFGL++    ++   +S+   R  I +++PE  S 
Sbjct: 127 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV--TRLPIKWMSPE--SI 182
Query: 248 NFGEVSHKSDVYSFGMMIMELVG 270
           NF   +  SDV+ F + + E++ 
Sbjct: 183 NFRRFTTASDVWMFAVCMWEILS 205

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 94/205 (45%), Gaps = 39/205 (19%)
Query: 90  KLGQGGFGGVYKGR-------------------LLDDFVNEVASISRTSHVNVVTLLGFC 130
           +LG G FG VYK +                    L+D++ E+  ++   H  +V LLG  
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 131 LEGNNRALIYEFMPNGSLEKFVYNGDT--SKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
                  ++ EF P G+++  +   D   ++P   +   +M E        L +LH   S
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLE-------ALNFLH---S 135
Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGL-AKLCTTKEGIVSSLLGARGIIGYIAPEVF-- 245
            +I+H D+K  N+L+  +   +++DFG+ AK   T +   S +    G   ++APEV   
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI----GTPYWMAPEVVMC 191
Query: 246 -SRNFGEVSHKSDVYSFGMMIMELV 269
            +       +K+D++S G+ ++E+ 
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEMA 216

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 71  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 119 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 175
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 176 DDE------MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 217

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 71  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 119 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 175
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 176 DDE------MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 217

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 83  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 130
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 131 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 187
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 188 DDE------MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 229

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 83  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 130
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 131 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 187
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 188 DDE------MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 229

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 73  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 120
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 121 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 177
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 178 DDE------MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 219

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 73  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 120
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 121 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 177
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 178 DDE------MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 219

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 81/168 (48%), Gaps = 19/168 (11%)
Query: 101 KGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKP 160
           +G   ++   EV+ + +  H NV+TL        +  LI E +  G L  F+   ++   
Sbjct: 55  RGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES--- 111
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP----KISDFGL 216
              L  E+    +  I  G+ YLH   + KI HFD+KP NI+L +   P    K+ DFGL
Sbjct: 112 ---LSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 217 AKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMM 264
           A     ++G+        G   ++APE+   N+  +  ++D++S G++
Sbjct: 166 AH--EIEDGV--EFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVI 207

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 81/168 (48%), Gaps = 19/168 (11%)
Query: 101 KGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKP 160
           +G   ++   EV+ + +  H NV+TL        +  LI E +  G L  F+   ++   
Sbjct: 55  RGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES--- 111
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP----KISDFGL 216
              L  E+    +  I  G+ YLH   + KI HFD+KP NI+L +   P    K+ DFGL
Sbjct: 112 ---LSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 217 AKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMM 264
           A     ++G+        G   ++APE+   N+  +  ++D++S G++
Sbjct: 166 AH--EIEDGV--EFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVI 207

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 83  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 130
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 131 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 187
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 188 DDE------MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 229

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 73  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 120
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 121 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 177
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 178 DDE------MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 219

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 78  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 125
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 126 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
                    + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 183 D------DEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 224

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 81/168 (48%), Gaps = 19/168 (11%)
Query: 101 KGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKP 160
           +G   ++   EV+ + +  H NV+TL        +  LI E +  G L  F+   ++   
Sbjct: 55  RGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES--- 111
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP----KISDFGL 216
              L  E+    +  I  G+ YLH   + KI HFD+KP NI+L +   P    K+ DFGL
Sbjct: 112 ---LSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 217 AKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMM 264
           A     ++G+        G   ++APE+   N+  +  ++D++S G++
Sbjct: 166 AH--EIEDGV--EFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVI 207

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 76  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 123
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 124 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 180
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 181 DDE------MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 222

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 71  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 119 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 175
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 176 DDE------MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 217

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 71  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 119 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 175
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 176 DDE------MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 217

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 94  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 141
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 142 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 198
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 199 DDE------MXGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 240

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 94/205 (45%), Gaps = 39/205 (19%)
Query: 90  KLGQGGFGGVYKGR-------------------LLDDFVNEVASISRTSHVNVVTLLGFC 130
           +LG G FG VYK +                    L+D++ E+  ++   H  +V LLG  
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 131 LEGNNRALIYEFMPNGSLEKFVYNGDT--SKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
                  ++ EF P G+++  +   D   ++P   +   +M E        L +LH   S
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLE-------ALNFLH---S 127
Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGL-AKLCTTKEGIVSSLLGARGIIGYIAPEVF-- 245
            +I+H D+K  N+L+  +   +++DFG+ AK   T +   S +    G   ++APEV   
Sbjct: 128 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI----GTPYWMAPEVVMC 183
Query: 246 -SRNFGEVSHKSDVYSFGMMIMELV 269
            +       +K+D++S G+ ++E+ 
Sbjct: 184 ETMKDTPYDYKADIWSLGITLIEMA 208

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 68  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 115
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 116 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 172
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
                    + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 173 D------DEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 214

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 82  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 129
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 130 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 186
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
                    + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 187 D------DEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 228

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 71  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 119 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 175
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
                    + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 176 D------DEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 217

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 77  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 124
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 125 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 181
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 182 DDE------MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 223

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 69  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 116
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 117 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 173
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 174 DDE------MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 215

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 90  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 137
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 138 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 194
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 195 DDE------MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 236

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 36/203 (17%)
Query: 91  LGQGGFGGVYKGRL--------------------LDD---FVNEVASISRTSHVNVVTLL 127
           LG+G FG VY+G                      LD+   F++E   +    H ++V L+
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
           G  +E     +I E  P G L  ++     S     L+   +    + I K + YL    
Sbjct: 92  GI-IEEEPTWIIMELYPYGELGHYLERNKNS-----LKVLTLVLYSLQICKAMAYLE--- 142
Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSR 247
           S   +H DI   NIL+    C K+ DFGL++    ++   +S+   R  I +++PE  S 
Sbjct: 143 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV--TRLPIKWMSPE--SI 198
Query: 248 NFGEVSHKSDVYSFGMMIMELVG 270
           NF   +  SDV+ F + + E++ 
Sbjct: 199 NFRRFTTASDVWMFAVCMWEILS 221

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 67  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 114
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 115 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
                    + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 172 D------DEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 213

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 90  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 137
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 138 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 194
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 195 DDE------MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 236

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 67  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 114
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 115 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
                    + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 172 D------DEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 213

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 72/162 (44%), Gaps = 14/162 (8%)
Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRAL--IYEFMPNGSLEKFVYNGDTSKPCQYLRWE 167
            E+  +    H +++   G C +   ++L  + E++P GSL  ++       P   +   
Sbjct: 65  QEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL-------PRHSIGLA 117
Query: 168 KMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV 227
           ++      I +G+ YLH   S   +H ++   N+LLD D   KI DFGLAK         
Sbjct: 118 QLLLFAQQICEGMAYLH---SQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY 174
Query: 228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
                    + + APE       +  + SDV+SFG+ + EL+
Sbjct: 175 RVREDGDSPVFWYAPECLKEY--KFYYASDVWSFGVTLYELL 214

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 68  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 115
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 116 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 172
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
                    + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 173 D------DEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 214

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 91  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 138
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 139 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 195
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 196 DDE------MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 237

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 94  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 141
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 142 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 198
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 199 DDE------MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 240

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 91  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 138
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 139 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 195
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 196 DDE------MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 237

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 77  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 124
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 125 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 181
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 182 DDE------MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 223

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 36/206 (17%)
Query: 90  KLGQGGFGGVYKGR------------------------LLDDFVNEVASISRTS---HVN 122
           ++G G +G VYK R                        L    V EVA + R     H N
Sbjct: 16  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 123 VVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 182
           VV L+  C        I   +    +++ +       P   L  E + +++    +GL++
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 135
Query: 183 LHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAP 242
           LH  C   I+H D+KP NIL+      K++DFGLA++ + +  +   ++     + Y AP
Sbjct: 136 LHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV----TLWYRAP 188
Query: 243 EVFSRNFGEVSHKSDVYSFGMMIMEL 268
           EV  ++    +   D++S G +  E+
Sbjct: 189 EVLLQS--TYATPVDMWSVGCIFAEM 212

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 90/215 (41%), Gaps = 44/215 (20%)
Query: 91  LGQGGFGGVYKG-----------------------RLLDDFVNEVASISRTSHVNVVTLL 127
           +G+G FG V++G                        + + F+ E  ++ +  H ++V L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
           G   E N   +I E    G L  F+     S     L    +      ++  L YL    
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFLQVRKFS-----LDLASLILYAYQLSTALAYLE--- 128
Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSR 247
           S + +H DI   N+L+  + C K+ DFGL++         +S    +  I ++APE  S 
Sbjct: 129 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKAS--KGKLPIKWMAPE--SI 184
Query: 248 NFGEVSHKSDVYSFGMMIMELV--------GCKNN 274
           NF   +  SDV+ FG+ + E++        G KNN
Sbjct: 185 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 219

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 71/162 (43%), Gaps = 14/162 (8%)
Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRAL--IYEFMPNGSLEKFVYNGDTSKPCQYLRWE 167
            E+  +    H +++   G C +    +L  + E++P GSL  ++       P   +   
Sbjct: 82  QEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-------PRHSIGLA 134
Query: 168 KMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV 227
           ++      I +G+ YLH   +   +H D+   N+LLD D   KI DFGLAK         
Sbjct: 135 QLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXY 191
Query: 228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
                    + + APE       +  + SDV+SFG+ + EL+
Sbjct: 192 RVREDGDSPVFWYAPECLKEY--KFYYASDVWSFGVTLYELL 231

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 36/203 (17%)
Query: 91  LGQGGFGGVYKGRL--------------------LDD---FVNEVASISRTSHVNVVTLL 127
           LG+G FG VY+G                      LD+   F++E   +    H ++V L+
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
           G  +E     +I E  P G L  ++     S     L+   +    + I K + YL    
Sbjct: 80  GI-IEEEPTWIIMELYPYGELGHYLERNKNS-----LKVLTLVLYSLQICKAMAYLE--- 130
Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSR 247
           S   +H DI   NIL+    C K+ DFGL++    ++   +S+   R  I +++PE  S 
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV--TRLPIKWMSPE--SI 186
Query: 248 NFGEVSHKSDVYSFGMMIMELVG 270
           NF   +  SDV+ F + + E++ 
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILS 209

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 67  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 114
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 115 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 172 DDE------MAGFVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 213

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 77  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 124
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 125 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 181
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 182 DDE------MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 223

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 71  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 119 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 175
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 176 DDE------MAGFVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 217

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 71  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 119 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 175
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 176 DDE------MAGFVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 217

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 92/219 (42%), Gaps = 52/219 (23%)
Query: 91  LGQGGFGGVYKG-----------------------RLLDDFVNEVASISRTSHVNVVTLL 127
           +G+G FG V++G                        + + F+ E  ++ +  H ++V L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV----YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYL 183
           G   E N   +I E    G L  F+    Y+ D +    Y            ++  L YL
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILY---------AYQLSTALAYL 127
Query: 184 HHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE 243
               S + +H DI   N+L+  + C K+ DFGL++         +S    +  I ++APE
Sbjct: 128 E---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS--KGKLPIKWMAPE 182
Query: 244 VFSRNFGEVSHKSDVYSFGMMIMELV--------GCKNN 274
             S NF   +  SDV+ FG+ + E++        G KNN
Sbjct: 183 --SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 219

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 92/219 (42%), Gaps = 52/219 (23%)
Query: 91  LGQGGFGGVYKG-----------------------RLLDDFVNEVASISRTSHVNVVTLL 127
           +G+G FG V++G                        + + F+ E  ++ +  H ++V L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV----YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYL 183
           G   E N   +I E    G L  F+    Y+ D +    Y            ++  L YL
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILY---------AYQLSTALAYL 127
Query: 184 HHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE 243
               S + +H DI   N+L+  + C K+ DFGL++         +S    +  I ++APE
Sbjct: 128 E---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS--KGKLPIKWMAPE 182
Query: 244 VFSRNFGEVSHKSDVYSFGMMIMELV--------GCKNN 274
             S NF   +  SDV+ FG+ + E++        G KNN
Sbjct: 183 --SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 219

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 70  LPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLLDDF-VNEVASISRTSHVNVVTLLG 128
           L L R +F +V ++    +DK  Q GF    K   L+ F   E+ + +  +   +V L G
Sbjct: 99  LRLGRGSFGEVHRM----EDK--QTGFQCAVKKVRLEVFRAEELMACAGLTSPRIVPLYG 152
Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIA-KGLEYLHHGC 187
              EG    +  E +  GSL + V         Q    E      +G A +GLEYLH   
Sbjct: 153 AVREGPWVNIFMELLEGGSLGQLVKE-------QGCLPEDRALYYLGQALEGLEYLH--- 202
Query: 188 STKILHFDIKPHNILLDEDFC-PKISDFGLAKLCTTKEGIVSSLLGARGIIG---YIAPE 243
           S +ILH D+K  N+LL  D     + DFG A +C   +G+  SLL    I G   ++APE
Sbjct: 203 SRRILHGDVKADNVLLSSDGSHAALCDFGHA-VCLQPDGLGKSLLTGDYIPGTETHMAPE 261
Query: 244 -VFSRNFGEVSHKSDVY-SFGMMIMELVGC 271
            V  R+      K DV+ S  MM+  L GC
Sbjct: 262 VVLGRS---CDAKVDVWSSCCMMLHMLNGC 288

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 88/203 (43%), Gaps = 33/203 (16%)
Query: 90  KLGQGGFGGVYKGR---------------------LLDDFVNEVASISRTS---HVNVVT 125
           ++G G +G VYK R                     L    V EVA + R     H NVV 
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVR 70
Query: 126 LLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
           L+  C        I   +    +++ +       P   L  E + +++    +GL++LH 
Sbjct: 71  LMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA 130
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVF 245
            C   I+H D+KP NIL+      K++DFGLA++ + +  +   ++     + Y APEV 
Sbjct: 131 NC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVV----TLWYRAPEVL 183
Query: 246 SRNFGEVSHKSDVYSFGMMIMEL 268
            ++    +   D++S G +  E+
Sbjct: 184 LQS--TYATPVDMWSVGCIFAEM 204

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 92/219 (42%), Gaps = 52/219 (23%)
Query: 91  LGQGGFGGVYKG-----------------------RLLDDFVNEVASISRTSHVNVVTLL 127
           +G+G FG V++G                        + + F+ E  ++ +  H ++V L+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV----YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYL 183
           G   E N   +I E    G L  F+    Y+ D +    Y            ++  L YL
Sbjct: 75  GVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILY---------AYQLSTALAYL 124
Query: 184 HHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE 243
               S + +H DI   N+L+  + C K+ DFGL++         +S    +  I ++APE
Sbjct: 125 E---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS--KGKLPIKWMAPE 179
Query: 244 VFSRNFGEVSHKSDVYSFGMMIMELV--------GCKNN 274
             S NF   +  SDV+ FG+ + E++        G KNN
Sbjct: 180 --SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 216

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/272 (23%), Positives = 116/272 (42%), Gaps = 44/272 (16%)
Query: 89  DKLGQGGFGGVYKGR---------------------LLDDFVNEVASISRTSHVNVVTLL 127
           +K+G+G +G VYK R                     +    + E++ +   +H N+V LL
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                 N   L++E + +  L+ F+  +  T  P   ++       +  + +GL + H  
Sbjct: 68  DVIHTENKLYLVFEHV-HQDLKTFMDASALTGIPLPLIK-----SYLFQLLQGLAFCH-- 119
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            S ++LH D+KP N+L++ +   K++DFGLA+        V +       + Y APE+  
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---VRTYTHEVVTLWYRAPEIL- 174
Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
                 S   D++S G +  E+V  +  L  G DS  +  F   I+R +    E   PGV
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMV-TRRALFPG-DSEIDQLFR--IFRTLGTPDEVVWPGV 230
Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNE 338
            +  + + +        W  Q      PP++E
Sbjct: 231 TSMPDYKPS-----FPKWARQDFSKVVPPLDE 257

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 89/217 (41%), Gaps = 43/217 (19%)
Query: 91  LGQGGFGGVYKGR-LLDD-------------------FVNEVASISRTSHVNVVTLLGFC 130
           LG+GGFG V++ +  +DD                    + EV ++++  H  +V      
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 131 LEGN-------NRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKM--YEIVIGIAKGLE 181
           LE N       +   +Y ++      K       +  C     E+     I + IA+ +E
Sbjct: 73  LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVE 132
Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSL---------LG 232
           +LH   S  ++H D+KP NI    D   K+ DFGL       E   + L          G
Sbjct: 133 FLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189
Query: 233 ARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             G   Y++PE    N    SHK D++S G+++ EL+
Sbjct: 190 QVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFELL 224

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/277 (23%), Positives = 106/277 (38%), Gaps = 62/277 (22%)
Query: 91  LGQGGFGGVYKGR----------------------LLDDFVNEVASISRTSHVNVVTLLG 128
           LG+G FG VY  R                      +      EV   S   H N++ L G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 129 FCLEGNNRALIYEFMPNGSLEKFVY---NGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
           +  +     LI E+ P G++ + +      D  +   Y         +  +A  L Y H 
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATY---------ITELANALSYCH- 129
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVF 245
             S +++H DIKP N+LL  +   KI+DFG +    +            G + Y+ PE+ 
Sbjct: 130 --SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLC-----GTLDYLPPEMI 182
Query: 246 SRNFGEVSHKSDVYSFGMMIME-LVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
                +   K D++S G++  E LVG             E +     YR + +  EF  P
Sbjct: 183 EGRMHD--EKVDLWSLGVLCYEFLVGM---------PPFEAHTYQETYRRISRV-EFTFP 230
Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
             VT    ++  ++       ++   S R  + EV+E
Sbjct: 231 DFVTEGARDLISRL-------LKHNASQRLTLAEVLE 260

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 92/219 (42%), Gaps = 52/219 (23%)
Query: 91  LGQGGFGGVYKG-----------------------RLLDDFVNEVASISRTSHVNVVTLL 127
           +G+G FG V++G                        + + F+ E  ++ +  H ++V L+
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV----YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYL 183
           G   E N   +I E    G L  F+    Y+ D +    Y            ++  L YL
Sbjct: 80  GVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILY---------AYQLSTALAYL 129
Query: 184 HHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE 243
               S + +H DI   N+L+  + C K+ DFGL++         +S    +  I ++APE
Sbjct: 130 E---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS--KGKLPIKWMAPE 184
Query: 244 VFSRNFGEVSHKSDVYSFGMMIMELV--------GCKNN 274
             S NF   +  SDV+ FG+ + E++        G KNN
Sbjct: 185 --SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 221

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 91/206 (44%), Gaps = 50/206 (24%)
Query: 87  FKDKLGQGGFGGVY--KGRLL-----------------DDFVNEVASISRTSHVNVVTLL 127
           F + LG G F  V+  K RL                      NE+A + +  H N+VTL 
Sbjct: 13  FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 128 GFCLEGNNRALIYEFMPNGS-----LEKFVYNGDTSKPCQYLRWEKMYEIVI-GIAKGLE 181
                  +  L+ + +  G      LE+ VY             EK   +VI  +   ++
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDRILERGVYT------------EKDASLVIQQVLSAVK 120
Query: 182 YLHHGCSTKILHFDIKPHNILL---DEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG 238
           YLH      I+H D+KP N+L    +E+    I+DFGL+K+   + GI+S+   A G  G
Sbjct: 121 YLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM--EQNGIMST---ACGTPG 172
Query: 239 YIAPEVFSRNFGEVSHKSDVYSFGMM 264
           Y+APEV ++     S   D +S G++
Sbjct: 173 YVAPEVLAQK--PYSKAVDCWSIGVI 196

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 68/134 (50%), Gaps = 14/134 (10%)
Query: 138 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIK 197
           ++ E+MP G L   + N D  +     +W + Y   + +A  L+ +H   S   +H D+K
Sbjct: 146 MVMEYMPGGDLVNLMSNYDVPE-----KWARFYTAEVVLA--LDAIH---SMGFIHRDVK 195
Query: 198 PHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGE--VSHK 255
           P N+LLD+    K++DFG   +   KEG+V     A G   YI+PEV     G+     +
Sbjct: 196 PDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGDGYYGRE 253
Query: 256 SDVYSFGMMIMELV 269
            D +S G+ + E++
Sbjct: 254 CDWWSVGVFLYEML 267

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 68/134 (50%), Gaps = 14/134 (10%)
Query: 138 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIK 197
           ++ E+MP G L   + N D  +     +W + Y   + +A  L+ +H   S   +H D+K
Sbjct: 151 MVMEYMPGGDLVNLMSNYDVPE-----KWARFYTAEVVLA--LDAIH---SMGFIHRDVK 200
Query: 198 PHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGE--VSHK 255
           P N+LLD+    K++DFG   +   KEG+V     A G   YI+PEV     G+     +
Sbjct: 201 PDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGDGYYGRE 258
Query: 256 SDVYSFGMMIMELV 269
            D +S G+ + E++
Sbjct: 259 CDWWSVGVFLYEML 272

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 92/219 (42%), Gaps = 52/219 (23%)
Query: 91  LGQGGFGGVYKG-----------------------RLLDDFVNEVASISRTSHVNVVTLL 127
           +G+G FG V++G                        + + F+ E  ++ +  H ++V L+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV----YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYL 183
           G   E N   +I E    G L  F+    Y+ D +    Y            ++  L YL
Sbjct: 83  GVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILY---------AYQLSTALAYL 132
Query: 184 HHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE 243
               S + +H DI   N+L+  + C K+ DFGL++         +S    +  I ++APE
Sbjct: 133 E---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS--KGKLPIKWMAPE 187
Query: 244 VFSRNFGEVSHKSDVYSFGMMIMELV--------GCKNN 274
             S NF   +  SDV+ FG+ + E++        G KNN
Sbjct: 188 --SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 224

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 92/219 (42%), Gaps = 52/219 (23%)
Query: 91  LGQGGFGGVYKG-----------------------RLLDDFVNEVASISRTSHVNVVTLL 127
           +G+G FG V++G                        + + F+ E  ++ +  H ++V L+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV----YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYL 183
           G   E N   +I E    G L  F+    Y+ D +    Y            ++  L YL
Sbjct: 106 GVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILY---------AYQLSTALAYL 155
Query: 184 HHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE 243
               S + +H DI   N+L+  + C K+ DFGL++         +S    +  I ++APE
Sbjct: 156 E---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS--KGKLPIKWMAPE 210
Query: 244 VFSRNFGEVSHKSDVYSFGMMIMELV--------GCKNN 274
             S NF   +  SDV+ FG+ + E++        G KNN
Sbjct: 211 --SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 247

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 100 ELRLLKHMKHENVIGLLDV------------FTPATSLEEFNDVYLVTHLMGADLNNIVK 147
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 148 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 204
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 205 DDE------MTGYVATRWYRAPEIM-LNWMHYNMTVDIWSVGCIMAELL 246

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 92/219 (42%), Gaps = 52/219 (23%)
Query: 91  LGQGGFGGVYKG-----------------------RLLDDFVNEVASISRTSHVNVVTLL 127
           +G+G FG V++G                        + + F+ E  ++ +  H ++V L+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV----YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYL 183
           G   E N   +I E    G L  F+    Y+ D +    Y            ++  L YL
Sbjct: 81  GVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILY---------AYQLSTALAYL 130
Query: 184 HHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE 243
               S + +H DI   N+L+  + C K+ DFGL++         +S    +  I ++APE
Sbjct: 131 E---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS--KGKLPIKWMAPE 185
Query: 244 VFSRNFGEVSHKSDVYSFGMMIMELV--------GCKNN 274
             S NF   +  SDV+ FG+ + E++        G KNN
Sbjct: 186 --SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 222

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 68/134 (50%), Gaps = 14/134 (10%)
Query: 138 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIK 197
           ++ E+MP G L   + N D  +     +W + Y   + +A  L+ +H   S   +H D+K
Sbjct: 151 MVMEYMPGGDLVNLMSNYDVPE-----KWARFYTAEVVLA--LDAIH---SMGFIHRDVK 200
Query: 198 PHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGE--VSHK 255
           P N+LLD+    K++DFG   +   KEG+V     A G   YI+PEV     G+     +
Sbjct: 201 PDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGDGYYGRE 258
Query: 256 SDVYSFGMMIMELV 269
            D +S G+ + E++
Sbjct: 259 CDWWSVGVFLYEML 272

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 72/162 (44%), Gaps = 14/162 (8%)
Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRAL--IYEFMPNGSLEKFVYNGDTSKPCQYLRWE 167
            E+  +    H +++   G C +   ++L  + E++P GSL  ++       P   +   
Sbjct: 65  QEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL-------PRHSIGLA 117
Query: 168 KMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV 227
           ++      I +G+ YLH   +   +H ++   N+LLD D   KI DFGLAK         
Sbjct: 118 QLLLFAQQICEGMAYLH---AQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY 174
Query: 228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
                    + + APE       +  + SDV+SFG+ + EL+
Sbjct: 175 RVREDGDSPVFWYAPECLKEY--KFYYASDVWSFGVTLYELL 214

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 78/169 (46%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 71  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI D+GLA+  
Sbjct: 119 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDYGLARHT 175
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 176 DDE------MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 217

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 76/164 (46%), Gaps = 11/164 (6%)
Query: 109 VNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSK--PCQYLRW 166
           + E+  + R  H N++ +         RA   E M +  + + +   D  K   CQ+L  
Sbjct: 73  LREIKILLRFRHENIIGINDII-----RAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSN 127
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
           + +   +  I +GL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++       
Sbjct: 128 DHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184
Query: 227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG 270
              L        Y APE+   + G  +   D++S G ++ E++ 
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLS 227

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 78/170 (45%), Gaps = 18/170 (10%)
Query: 119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
            H N++TL     +G    ++ E M  G L   +         ++    +   ++  I K
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ------KFFSEREASAVLFTITK 127
Query: 179 GLEYLHHGCSTKILHFDIKPHNIL-LDEDFCP---KISDFGLAKLCTTKEGIVSSLLGAR 234
            +EYLH   +  ++H D+KP NIL +DE   P   +I DFG AK    + G+   L+   
Sbjct: 128 TVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL---LMTPC 181
Query: 235 GIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE 284
               ++APEV  R   + +   D++S G+++  ++       +G D + E
Sbjct: 182 YTANFVAPEVLERQGYDAA--CDIWSLGVLLYTMLTGYTPFANGPDDTPE 229

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 71  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 119 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 175
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N    +   D++S G ++ EL+
Sbjct: 176 DDE------MTGYVATRWYRAPEIM-LNAMHYNQTVDIWSVGCIMAELL 217

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/251 (23%), Positives = 111/251 (44%), Gaps = 36/251 (14%)
Query: 109 VNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLE--KFVYNGDTSKPCQYLRW 166
           + E+  + +  H N+V LL  C +     L++EF+ +  L+  +   NG        L +
Sbjct: 72  MREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG--------LDY 123
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
           + + + +  I  G+ + H   S  I+H DIKP NIL+ +    K+ DFG A+       +
Sbjct: 124 QVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 180
Query: 227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKS--DVYSFGMMIMELVGCKNNL--DSGVDSS 282
               +  R    Y APE+     G+V +    DV++ G ++ E+   +     DS +D  
Sbjct: 181 YDDEVATR---WYRAPELL---VGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQL 234
Query: 283 SEVY--FPHWIYRHVEQDRE------FKLPGV-----VTRKENEIAKKMIIVGLWCIQAR 329
             +     + I RH E   +       +LP +     + R+  ++++ +I +   C+   
Sbjct: 235 YHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHID 294
Query: 330 PSDRPPMNEVI 340
           P  RP   E++
Sbjct: 295 PDKRPFCAELL 305

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 90/215 (41%), Gaps = 44/215 (20%)
Query: 91  LGQGGFGGVYKG-----------------------RLLDDFVNEVASISRTSHVNVVTLL 127
           +G+G FG V++G                        + + F+ E  ++ +  H ++V L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
           G   E N   +I E    G L  F+     S     L    +      ++  L YL    
Sbjct: 458 GVITE-NPVWIIMELCTLGELRSFLQVRKFS-----LDLASLILYAYQLSTALAYLE--- 508
Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSR 247
           S + +H DI   N+L+  + C K+ DFGL++         +S    +  I ++APE  S 
Sbjct: 509 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS--KGKLPIKWMAPE--SI 564
Query: 248 NFGEVSHKSDVYSFGMMIMELV--------GCKNN 274
           NF   +  SDV+ FG+ + E++        G KNN
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 599

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 88/193 (45%), Gaps = 27/193 (13%)
Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           I  G +YLH     +++H D+K  N+ L+ED   KI DFGLA           +L G   
Sbjct: 126 IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTP- 181
Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV 295
              YIAPEV S+     S + DV+S G ++  L+  K   ++     +        Y  +
Sbjct: 182 --NYIAPEVLSKKGH--SFEVDVWSIGCIMYTLLVGKPPFETSCLKET--------YLRI 229
Query: 296 EQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI--EMLQGSTEALQIP 353
           +++ E+ +P  +      + +KM       +Q  P+ RP +NE++  E         ++P
Sbjct: 230 KKN-EYSIPKHINPVAASLIQKM-------LQTDPTARPTINELLNDEFFTSGYIPARLP 281
Query: 354 PTPFLSSPPRAPI 366
            T  L+ PPR  I
Sbjct: 282 IT-CLTIPPRFSI 293

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 65/277 (23%), Positives = 106/277 (38%), Gaps = 62/277 (22%)
Query: 91  LGQGGFGGVYKGR----------------------LLDDFVNEVASISRTSHVNVVTLLG 128
           LG+G FG VY  R                      +      EV   S   H N++ L G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 129 FCLEGNNRALIYEFMPNGSLEKFVY---NGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
           +  +     LI E+ P G++ + +      D  +   Y         +  +A  L Y H 
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATY---------ITELANALSYCH- 129
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVF 245
             S +++H DIKP N+LL  +   KI+DFG +    +            G + Y+ PE+ 
Sbjct: 130 --SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLC-----GTLDYLPPEMI 182
Query: 246 SRNFGEVSHKSDVYSFGMMIME-LVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
                +   K D++S G++  E LVG             E +     YR + +  EF  P
Sbjct: 183 EGRMHD--EKVDLWSLGVLCYEFLVGM---------PPFEAHTYQETYRRISRV-EFTFP 230
Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
             VT    ++  ++       ++   S R  + EV+E
Sbjct: 231 DFVTEGARDLISRL-------LKHNASQRLTLAEVLE 260

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 44/223 (19%)
Query: 89  DKLGQGGFGGVYKG--------------RLLDD-------FVNEVASISRTSHVNVVTLL 127
           +K+G+G +G V+K               RL DD        + E+  +    H N+V L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV--YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
                     L++EF  +  L+K+    NGD       L  E +   +  + KGL + H 
Sbjct: 68  DVLHSDKKLTLVFEFC-DQDLKKYFDSCNGD-------LDPEIVKSFLFQLLKGLGFCH- 118
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI-IGYIAPEV 244
             S  +LH D+KP N+L++ +   K++DFGLA+      GI      A  + + Y  P+V
Sbjct: 119 --SRNVLHRDLKPQNLLINRNGELKLADFGLARAF----GIPVRCYSAEVVTLWYRPPDV 172
Query: 245 FSRNFGE--VSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
               FG    S   D++S G +  EL      L  G D   ++
Sbjct: 173 L---FGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQL 212

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 89/215 (41%), Gaps = 44/215 (20%)
Query: 91  LGQGGFGGVYKG-----------------------RLLDDFVNEVASISRTSHVNVVTLL 127
           +G+G FG V++G                        + + F+ E  ++ +  H ++V L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
           G   E N   +I E    G L  F+     S     L    +      ++  L YL    
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFLQVRKFS-----LDLASLILYAYQLSTALAYLE--- 128
Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSR 247
           S + +H DI   N+L+    C K+ DFGL++         +S    +  I ++APE  S 
Sbjct: 129 SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKAS--KGKLPIKWMAPE--SI 184
Query: 248 NFGEVSHKSDVYSFGMMIMELV--------GCKNN 274
           NF   +  SDV+ FG+ + E++        G KNN
Sbjct: 185 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 219

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 73/145 (50%), Gaps = 16/145 (11%)
Query: 129 FCLEGNNRAL--IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
           FC   +++ L  + E+MP G L   + N D  +     +W K Y   + +A  L+ +H  
Sbjct: 141 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE-----KWAKFYTAEVVLA--LDAIH-- 191
Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            S  ++H D+KP N+LLD+    K++DFG   +   + G+V     A G   YI+PEV  
Sbjct: 192 -SMGLIHRDVKPDNMLLDKHGHLKLADFGTC-MKMDETGMVHCDT-AVGTPDYISPEVLK 248
Query: 247 RNFGE--VSHKSDVYSFGMMIMELV 269
              G+     + D +S G+ + E++
Sbjct: 249 SQGGDGYYGRECDWWSVGVFLFEML 273

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 90/193 (46%), Gaps = 27/193 (13%)
Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           I  G +YLH     +++H D+K  N+ L+ED   KI DFGLA      +G    +L   G
Sbjct: 124 IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATK-VEYDGERKKVLC--G 177
Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV 295
              YIAPEV S+     S + DV+S G ++  L+  K   ++     +        Y  +
Sbjct: 178 TPNYIAPEVLSKKGH--SFEVDVWSIGCIMYTLLVGKPPFETSCLKET--------YLRI 227
Query: 296 EQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI--EMLQGSTEALQIP 353
           +++ E+ +P  +      + +KM       +Q  P+ RP +NE++  E         ++P
Sbjct: 228 KKN-EYSIPKHINPVAASLIQKM-------LQTDPTARPTINELLNDEFFTSGYIPARLP 279
Query: 354 PTPFLSSPPRAPI 366
            T  L+ PPR  I
Sbjct: 280 IT-CLTIPPRFSI 291

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 88/193 (45%), Gaps = 27/193 (13%)
Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           I  G +YLH     +++H D+K  N+ L+ED   KI DFGLA           +L G   
Sbjct: 130 IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTP- 185
Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV 295
              YIAPEV S+     S + DV+S G ++  L+  K   ++     +        Y  +
Sbjct: 186 --NYIAPEVLSKKGH--SFEVDVWSIGCIMYTLLVGKPPFETSCLKET--------YLRI 233
Query: 296 EQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI--EMLQGSTEALQIP 353
           +++ E+ +P  +      + +KM       +Q  P+ RP +NE++  E         ++P
Sbjct: 234 KKN-EYSIPKHINPVAASLIQKM-------LQTDPTARPTINELLNDEFFTSGYIPARLP 285
Query: 354 PTPFLSSPPRAPI 366
            T  L+ PPR  I
Sbjct: 286 IT-CLTIPPRFSI 297

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 80/185 (43%), Gaps = 23/185 (12%)
Query: 119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSL--------EKFVYNG---------DTSKPC 161
           SH N+V LLG C       LI+E+   G L        EKF  +          +  +  
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 162 QYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT 221
             L +E +      +AKG+E+L        +H D+   N+L+      KI DFGLA+   
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 223
Query: 222 TKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDS 281
           +    V     AR  + ++APE      G  + KSDV+S+G+++ E+     N   G+  
Sbjct: 224 SDSNYVVR-GNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280
Query: 282 SSEVY 286
            +  Y
Sbjct: 281 DANFY 285

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 75/162 (46%), Gaps = 19/162 (11%)
Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDT-SKPCQYLRWEK 168
           +E   +S  +H  ++ + G   +     +I +++  G L   +        P       K
Sbjct: 55  DERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA-----K 109
Query: 169 MYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVS 228
            Y   + +A  LEYLH   S  I++ D+KP NILLD++   KI+DFG AK       +  
Sbjct: 110 FYAAEVCLA--LEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP---DVTY 161
Query: 229 SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG 270
            L G      YIAPEV S      +   D +SFG++I E++ 
Sbjct: 162 XLCGTP---DYIAPEVVSTK--PYNKSIDWWSFGILIYEMLA 198

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 94/210 (44%), Gaps = 28/210 (13%)
Query: 70  LPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLLDDF-VNEVASISRTSHVNVVTLLG 128
           L L R +F +V ++ +       Q GF    K   L+ F   E+ + +  +   +V L G
Sbjct: 80  LRLGRGSFGEVHRMEDK------QTGFQCAVKKVRLEVFRAEELMACAGLTSPRIVPLYG 133
Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIA-KGLEYLHHGC 187
              EG    +  E +  GSL + V         Q    E      +G A +GLEYLH   
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLVKE-------QGCLPEDRALYYLGQALEGLEYLH--- 183
Query: 188 STKILHFDIKPHNILLDEDFC-PKISDFGLAKLCTTKEGIVSSLLGARGIIG---YIAPE 243
           S +ILH D+K  N+LL  D     + DFG A +C   +G+   LL    I G   ++APE
Sbjct: 184 SRRILHGDVKADNVLLSSDGSHAALCDFGHA-VCLQPDGLGKDLLTGDYIPGTETHMAPE 242
Query: 244 -VFSRNFGEVSHKSDVY-SFGMMIMELVGC 271
            V  R+      K DV+ S  MM+  L GC
Sbjct: 243 VVLGRS---CDAKVDVWSSCCMMLHMLNGC 269

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 88/201 (43%), Gaps = 29/201 (14%)
Query: 91  LGQGGFGGV---YKGRLLDDFVNEVASISRTSHVNV------VTLLGFCLEGNNRALIYE 141
           +G G +G V   Y  RL      +  S    S ++       + LL      N   L+  
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 142 FMPNGSLEKF--VY------NGDTSK--PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKI 191
           F P  S+E F  VY        D +     Q L  E +  +V  + +GL+Y+H   S  I
Sbjct: 96  FTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIH---SAGI 152
Query: 192 LHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGE 251
           +H D+KP N+ ++ED   +I DFGLA+    +      + G      Y APE+   N+  
Sbjct: 153 IHRDLKPSNVAVNEDSELRILDFGLARQADEE------MTGYVATRWYRAPEIM-LNWMH 205
Query: 252 VSHKSDVYSFGMMIMELVGCK 272
            +   D++S G ++ EL+  K
Sbjct: 206 YNQTVDIWSVGCIMAELLQGK 226

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 80/181 (44%), Gaps = 26/181 (14%)
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
           E + +I +   K L +L    + KI+H DIKP NILLD     K+ DFG++        +
Sbjct: 125 EILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISG------QL 176
Query: 227 VSSLLGAR--GIIGYIAPEVFSRNFGEVSH--KSDVYSFGMMIMELVGCKNNLDSGVDSS 282
           V S+   R  G   Y+APE    +     +  +SDV+S G+ + EL            ++
Sbjct: 177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYEL------------AT 224
Query: 283 SEVYFPHW--IYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI 340
               +P W  ++  + Q  +   P +   +E E +   I     C+    S RP   E++
Sbjct: 225 GRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELL 284
Query: 341 E 341
           +
Sbjct: 285 K 285

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 76/169 (44%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 67  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 114
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           C  L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 115 CAKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
                    + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 172 D------DEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 213

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 110/234 (47%), Gaps = 32/234 (13%)
Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-EKFV---YNGDTSKPCQYLR 165
           NE++ +++  H N++ L       N+  L+ E++  G L ++ +   YN        +++
Sbjct: 135 NEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMK 194
Query: 166 WEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNIL-LDEDFCP-KISDFGLAKLCTTK 223
                     I +G+ ++H      ILH D+KP NIL ++ D    KI DFGLA+    +
Sbjct: 195 ---------QICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242
Query: 224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMI-MELVGCKNNL-DSGVDS 281
           E +  +     G   ++APEV + +F  VS  +D++S G++  M L G    L D+  ++
Sbjct: 243 EKLKVNF----GTPEFLAPEVVNYDF--VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET 296
Query: 282 SSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPP 335
            + +    W      +D EF+   +    +  I+K +I    W I A  + + P
Sbjct: 297 LNNILACRWDL----EDEEFQ--DISEEAKEFISKLLIKEKSWRISASEALKHP 344

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 89/215 (41%), Gaps = 44/215 (20%)
Query: 91  LGQGGFGGVYKG-----------------------RLLDDFVNEVASISRTSHVNVVTLL 127
           +G+G FG V++G                        + + F+ E  ++ +  H ++V L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
           G   E N   +I E    G L  F+     S     L    +      ++  L YL    
Sbjct: 458 GVITE-NPVWIIMELCTLGELRSFLQVRKFS-----LDLASLILYAYQLSTALAYLE--- 508
Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSR 247
           S + +H DI   N+L+    C K+ DFGL++         +S    +  I ++APE  S 
Sbjct: 509 SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKAS--KGKLPIKWMAPE--SI 564
Query: 248 NFGEVSHKSDVYSFGMMIMELV--------GCKNN 274
           NF   +  SDV+ FG+ + E++        G KNN
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 599

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 89/190 (46%), Gaps = 27/190 (14%)
Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           I  G +YLH     +++H D+K  N+ L+ED   KI DFGLA      +G    +L   G
Sbjct: 150 IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY-DGERKKVLC--G 203
Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV 295
              YIAPEV S+     S + DV+S G ++  L+  K   ++     +        Y  +
Sbjct: 204 TPNYIAPEVLSKKGH--SFEVDVWSIGCIMYTLLVGKPPFETSCLKET--------YLRI 253
Query: 296 EQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI--EMLQGSTEALQIP 353
           +++ E+ +P  +      + +KM       +Q  P+ RP +NE++  E         ++P
Sbjct: 254 KKN-EYSIPKHINPVAASLIQKM-------LQTDPTARPTINELLNDEFFTSGYIPARLP 305
Query: 354 PTPFLSSPPR 363
            T  L+ PPR
Sbjct: 306 IT-CLTIPPR 314

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 90/193 (46%), Gaps = 27/193 (13%)
Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           I  G +YLH     +++H D+K  N+ L+ED   KI DFGLA      +G    +L   G
Sbjct: 148 IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY-DGERKKVLC--G 201
Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV 295
              YIAPEV S+     S + DV+S G ++  L+  K   ++     +        Y  +
Sbjct: 202 TPNYIAPEVLSKKGH--SFEVDVWSIGCIMYTLLVGKPPFETSCLKET--------YLRI 251
Query: 296 EQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI--EMLQGSTEALQIP 353
           +++ E+ +P  +      + +KM       +Q  P+ RP +NE++  E         ++P
Sbjct: 252 KKN-EYSIPKHINPVAASLIQKM-------LQTDPTARPTINELLNDEFFTSGYIPARLP 303
Query: 354 PTPFLSSPPRAPI 366
            T  L+ PPR  I
Sbjct: 304 IT-CLTIPPRFSI 315

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 95/225 (42%), Gaps = 47/225 (20%)
Query: 72  LKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLL-------------------DDFVNEV 112
           + +++  D K+L  +F  KL +   G ++KGR                      DF  E 
Sbjct: 1   MNKHSGIDFKQL--NFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEEC 58
Query: 113 ASISRTSHVNVVTLLGFCLE--GNNRALIYEFMPNGSLEKFVYNG-----DTSKPCQYLR 165
             +   SH NV+ +LG C      +  LI  +MP GSL   ++ G     D S+  ++  
Sbjct: 59  PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKF-- 116
Query: 166 WEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG 225
                   + +A+G+ +L H     I    +   ++++DED   +IS      +   K  
Sbjct: 117 -------ALDMARGMAFL-HTLEPLIPRHALNSRSVMIDEDMTARIS------MADVKFS 162
Query: 226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKS-DVYSFGMMIMELV 269
             S   G      ++APE   +   + + +S D++SF +++ ELV
Sbjct: 163 FQSP--GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELV 205

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 76/170 (44%), Gaps = 18/170 (10%)
Query: 119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
            H N++TL     +G +  L+ E M  G L   +         ++    +   ++  I K
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQ------KFFSEREASFVLHTIGK 132
Query: 179 GLEYLHHGCSTKILHFDIKPHNIL-LDED---FCPKISDFGLAKLCTTKEGIVSSLLGAR 234
            +EYLH   S  ++H D+KP NIL +DE     C +I DFG AK    + G+   L+   
Sbjct: 133 TVEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGL---LMTPC 186
Query: 235 GIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE 284
               ++APEV  R         D++S G+++  ++       +G   + E
Sbjct: 187 YTANFVAPEVLKRQ--GYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPE 234

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 93/206 (45%), Gaps = 33/206 (16%)
Query: 80  VKKLTNSFKDKLGQGGFGG-VYKG----------RLLDD---FVNEVASISRTS--HVNV 123
           V K++   KD LG G  G  VY+G          R+L +   F +    + R S  H NV
Sbjct: 21  VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNV 80
Query: 124 VTLLGFCLEGNNR-ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 182
           +    FC E + +   I   +   +L+++V   D +    +L  E +  ++     GL +
Sbjct: 81  IRY--FCTEKDRQFQYIAIELCAATLQEYVEQKDFA----HLGLEPI-TLLQQTTSGLAH 133
Query: 183 LHHGCSTKILHFDIKPHNILLDE-----DFCPKISDFGLAKLCTTKEGIVSSLLGARGII 237
           LH   S  I+H D+KPHNIL+            ISDFGL K         S   G  G  
Sbjct: 134 LH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190
Query: 238 GYIAPEVFSRNFGE-VSHKSDVYSFG 262
           G+IAPE+ S +  E  ++  D++S G
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAG 216

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 75/166 (45%), Gaps = 11/166 (6%)
Query: 109 VNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSK--PCQYLRW 166
           + E+  + R  H N++ +         RA   E M +  L   +   D  K    Q+L  
Sbjct: 89  LREIKILLRFRHENIIGINDII-----RAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSN 143
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
           + +   +  I +GL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++       
Sbjct: 144 DHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDH 200
Query: 227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
              L        Y APE+   + G  +   D++S G ++ E++  +
Sbjct: 201 TGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 245

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 77/169 (45%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 71  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI D GLA+  
Sbjct: 119 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDAGLARHT 175
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 176 DDE------MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 217

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 77/169 (45%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 71  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI  FGLA+  
Sbjct: 119 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILGFGLARHT 175
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 176 DDE------MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 217

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 40/221 (18%)
Query: 91  LGQGGFGGVYKGRLLDD-------------FVNEVASISR-TSHVNVVTLLGFCLEGNNR 136
           +G G FG V++ +L++              F N    I R   H NVV L  F     ++
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDK 107
Query: 137 A------LIYEFMPNGSLEKFVYNGDTSKPCQYLRWE-KMYEIVIGIAKGLEYLHHGCST 189
                  L+ E++P        +     +    L  +  MY+++    + L Y+H   S 
Sbjct: 108 KDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLL----RSLAYIH---SI 160
Query: 190 KILHFDIKPHNILLD-EDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRN 248
            I H DIKP N+LLD      K+ DFG AK+    E  VS +        Y APE+    
Sbjct: 161 GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRY----YRAPELI--- 213
Query: 249 FGEVSHKS--DVYSFGMMIMELVGCKNNL--DSGVDSSSEV 285
           FG  ++ +  D++S G ++ EL+  +     +SG+D   E+
Sbjct: 214 FGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEI 254

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 77/169 (45%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 71  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI D GLA+  
Sbjct: 119 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDRGLARHT 175
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 176 DDE------MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 217

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 77/169 (45%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 71  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DF LA+  
Sbjct: 119 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFYLARHT 175
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 176 DDE------MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 217

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 77/165 (46%), Gaps = 24/165 (14%)
Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           I  G +YLH     +++H D+K  N+ L+ED   KI DFGLA           +L G   
Sbjct: 126 IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTP- 181
Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV 295
              YIAPEV S+     S + DV+S G ++  L+  K   ++     +        Y  +
Sbjct: 182 --NYIAPEVLSKKGH--SFEVDVWSIGCIMYTLLVGKPPFETSCLKET--------YLRI 229
Query: 296 EQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI 340
           +++ E+ +P  +      + +KM       +Q  P+ RP +NE++
Sbjct: 230 KKN-EYSIPKHINPVAASLIQKM-------LQTDPTARPTINELL 266

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 76/169 (44%), Gaps = 18/169 (10%)
Query: 120 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
           H N++TL     +G +  L+ E M  G L   +         ++    +   ++  I K 
Sbjct: 80  HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQ------KFFSEREASFVLHTIGKT 133
Query: 180 LEYLHHGCSTKILHFDIKPHNIL-LDEDF---CPKISDFGLAKLCTTKEGIVSSLLGARG 235
           +EYLH   S  ++H D+KP NIL +DE     C +I DFG AK    + G+   L+    
Sbjct: 134 VEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGL---LMTPCY 187
Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE 284
              ++APEV  R         D++S G+++  ++       +G   + E
Sbjct: 188 TANFVAPEVLKRQ--GYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPE 234

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 77/173 (44%), Gaps = 32/173 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 71  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
            Q L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 119 XQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHT 175
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKN 273
                    + G      Y APE+   N+   +   D++S G ++ EL+  + 
Sbjct: 176 D------DEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 78/172 (45%), Gaps = 25/172 (14%)
Query: 102 GRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKP 160
           G LLD    EVA + +  H N++ L  F  +  N  L+ E    G L ++ +     S+ 
Sbjct: 66  GALLD----EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEV 121
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLD---EDFCPKISDFGLA 217
              +       I+  +  G  YLH      I+H D+KP N+LL+    D   KI DFGL+
Sbjct: 122 DAAV-------IMKQVLSGTTYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLS 171
Query: 218 KLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
                   +   L    G   YIAPEV  + + E   K DV+S G+++  L+
Sbjct: 172 AHFEVGGKMKERL----GTAYYIAPEVLRKKYDE---KCDVWSCGVILYILL 216

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/169 (24%), Positives = 80/169 (47%), Gaps = 15/169 (8%)
Query: 101 KGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKP 160
           K  + +  + E+  +   +   +V   G        ++  E M  GSL++ +      K 
Sbjct: 54  KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL------KE 107
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
            + +  E + ++ I + +GL YL      +I+H D+KP NIL++     K+ DFG++   
Sbjct: 108 AKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 165
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
              + + +S +G R    Y+APE        V  +SD++S G+ ++EL 
Sbjct: 166 I--DSMANSFVGTR---SYMAPERLQGTHYSV--QSDIWSMGLSLVELA 207

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 78/169 (46%), Gaps = 21/169 (12%)
Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           +A+G+E+L    S K +H D+   NILL E+   KI DFGLA+        V      R 
Sbjct: 208 VARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRK-GDTRL 263
Query: 236 IIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRH 294
            + ++APE +F + +   S KSDV+S+G+++ E+     +   GV    +          
Sbjct: 264 PLKWMAPESIFDKIY---STKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDF--------- 311
Query: 295 VEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEML 343
             + RE    G+  R       ++  + L C    P +RP   E++E L
Sbjct: 312 CSRLRE----GMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKL 356

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 77/157 (49%), Gaps = 11/157 (7%)
Query: 123 VVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 182
            VT  G      +  +  E M + SL+KF Y     K  Q +  + + +I + I K LE+
Sbjct: 112 TVTFYGALFREGDVWICMELM-DTSLDKF-YKQVIDK-GQTIPEDILGKIAVSIVKALEH 168
Query: 183 LHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAP 242
           LH   S  ++H D+KP N+L++     K+ DFG++         V+  + A G   Y+AP
Sbjct: 169 LHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDS---VAKTIDA-GCKPYMAP 222
Query: 243 EVFSRNFGE--VSHKSDVYSFGMMIMELVGCKNNLDS 277
           E  +    +   S KSD++S G+ ++EL   +   DS
Sbjct: 223 ERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 259

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 76/168 (45%), Gaps = 25/168 (14%)
Query: 102 GRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKP 160
           G LLD    EVA + +  H N++ L  F  +  N  L+ E    G L ++ +     S+ 
Sbjct: 49  GALLD----EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEV 104
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLD---EDFCPKISDFGLA 217
              +       I+  +  G  YLH      I+H D+KP N+LL+    D   KI DFGL+
Sbjct: 105 DAAV-------IMKQVLSGTTYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLS 154
Query: 218 KLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMI 265
                   +   L    G   YIAPEV  + + E   K DV+S G+++
Sbjct: 155 AHFEVGGKMKERL----GTAYYIAPEVLRKKYDE---KCDVWSCGVIL 195

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 77/169 (45%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 71  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           CQ L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI D GLA+  
Sbjct: 119 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDGGLARHT 175
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +      + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 176 DDE------MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 217

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 78/169 (46%), Gaps = 23/169 (13%)
Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRALIYEF---MP--NGSLEKFVYNGDTSKPCQYL 164
            E+  +    H NV+ LL      ++    Y+F   MP     L+K +    + +  QYL
Sbjct: 90  RELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYL 149
Query: 165 RWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE 224
                   V  + KGL+Y+H   S  ++H D+KP N+ ++ED   KI DFGLA+      
Sbjct: 150 --------VYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD--- 195
Query: 225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKN 273
              + + G      Y APEV   ++   +   D++S G ++ E++  K 
Sbjct: 196 ---AEMTGYVVTRWYRAPEVI-LSWMHYNQTVDIWSVGCIMAEMLTGKT 240

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 77/174 (44%), Gaps = 32/174 (18%)
Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV--------YNGDTSKPC 161
            E+  +    H NV+ LL              F P+ +L+ F            D  K  
Sbjct: 73  RELRLLKHMRHENVIGLLDV------------FTPDETLDDFTDFYLVMPFMGTDLGKLM 120
Query: 162 QY--LRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL 219
           ++  L  +++  +V  + KGL Y+H   +  I+H D+KP N+ ++ED   KI DFGLA+ 
Sbjct: 121 KHEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 177
Query: 220 CTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKN 273
                   S + G      Y APEV   N+   +   D++S G ++ E++  K 
Sbjct: 178 AD------SEMXGXVVTRWYRAPEVIL-NWMRYTQTVDIWSVGCIMAEMITGKT 224

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 123/293 (41%), Gaps = 66/293 (22%)
Query: 87  FKDKLGQGGFGGVYKG------------------RLLD--------DFVNEVASISRTSH 120
           F + LGQG F  ++KG                  ++LD         F    + +S+ SH
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 121 VNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGL 180
            ++V   G C+ G+   L+ EF+  GSL+ ++     +K C  + W+   E+   +A  +
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYL---KKNKNCINILWK--LEVAKQLAAAM 126
Query: 181 EYLHHGCSTKILHFDIKPHNILL--DEDFCP------KISDFGLAKLCTTKEGIVSSLLG 232
            +L       ++H ++   NILL  +ED         K+SD G++     K+     +L 
Sbjct: 127 HFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-----ILQ 178
Query: 233 ARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIY 292
            R  I ++ PE    N   ++  +D +SFG  + E+    +   S +DS  ++ F     
Sbjct: 179 ER--IPWVPPECIE-NPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF----- 230
Query: 293 RHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG 345
               +DR  +LP     K  E+A   +I    C+   P  RP    +I  L  
Sbjct: 231 ---YEDRH-QLPA---PKAAELAN--LINN--CMDYEPDHRPSFRAIIRDLNS 272

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 96/209 (45%), Gaps = 44/209 (21%)
Query: 90  KLGQGGFGGVYKGRLLDD----------------------FVNEVASISRTS---HVNVV 124
           ++G+G +G V+K R L +                       + EVA +       H NVV
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 125 TLLGFC-LEGNNR----ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
            L   C +   +R     L++E +     +   Y     +P   +  E + +++  + +G
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQ---DLTTYLDKVPEPG--VPTETIKDMMFQLLRG 132
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
           L++LH   S +++H D+KP NIL+      K++DFGLA++ + +  + S ++     + Y
Sbjct: 133 LDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV----TLWY 185
Query: 240 IAPEVFSRNFGEVSHKSDVYSFGMMIMEL 268
            APEV  ++    +   D++S G +  E+
Sbjct: 186 RAPEVLLQS--SYATPVDLWSVGCIFAEM 212

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 96/209 (45%), Gaps = 44/209 (21%)
Query: 90  KLGQGGFGGVYKGRLLDD----------------------FVNEVASISRTS---HVNVV 124
           ++G+G +G V+K R L +                       + EVA +       H NVV
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 125 TLLGFC-LEGNNR----ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
            L   C +   +R     L++E +     +   Y     +P   +  E + +++  + +G
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQ---DLTTYLDKVPEPG--VPTETIKDMMFQLLRG 132
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
           L++LH   S +++H D+KP NIL+      K++DFGLA++ + +  + S ++     + Y
Sbjct: 133 LDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV----TLWY 185
Query: 240 IAPEVFSRNFGEVSHKSDVYSFGMMIMEL 268
            APEV  ++    +   D++S G +  E+
Sbjct: 186 RAPEVLLQS--SYATPVDLWSVGCIFAEM 212

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 76/166 (45%), Gaps = 11/166 (6%)
Query: 109 VNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSK--PCQYLRW 166
           + E+  + R  H N++ +         RA   E M +  + + +   D  K    Q+L  
Sbjct: 69  LREIKILLRFRHENIIGINDII-----RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN 123
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
           + +   +  I +GL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++       
Sbjct: 124 DHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDH 180
Query: 227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
              L        Y APE+   + G  +   D++S G ++ E++  +
Sbjct: 181 TGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 225

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 76/169 (44%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 71  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
            Q L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+  
Sbjct: 119 XQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 175
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
                    + G      Y APE+   N+   +   D++S G ++ EL+
Sbjct: 176 D------DEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 217

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 78/169 (46%), Gaps = 32/169 (18%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY--------NGDTSKP 160
           E+  +    H NV+ LL              F P  SLE+F  VY        + +    
Sbjct: 71  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
            Q L  + +  ++  I +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFG   LC
Sbjct: 119 SQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFG---LC 172
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
              +  ++  +  R    Y APE+   N+   +   D++S G ++ EL+
Sbjct: 173 RHTDDEMTGYVATR---WYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 217

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 77/171 (45%), Gaps = 25/171 (14%)
Query: 101 KGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDT--- 157
           +G   ++   EV  +    H N++TL        +  LI E +  G L  F+   ++   
Sbjct: 48  RGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTE 107
Query: 158 SKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP----KISD 213
            +  Q+L+          I  G+ YLH   S +I HFD+KP NI+L +   P    K+ D
Sbjct: 108 DEATQFLKQ---------ILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLID 155
Query: 214 FGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMM 264
           FG+A          +      G   ++APE+   N+  +  ++D++S G++
Sbjct: 156 FGIAHKIEAG----NEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVI 200

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/161 (24%), Positives = 70/161 (43%), Gaps = 18/161 (11%)
Query: 138 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIK 197
           ++ E++   +L   V+      P      ++  E++    + L + H      I+H D+K
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTP------KRAIEVIADACQALNFSHQ---NGIIHRDVK 143
Query: 198 PHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSD 257
           P NI++      K+ DFG+A+        V+      G   Y++PE    +   V  +SD
Sbjct: 144 PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSD 201
Query: 258 VYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQD 298
           VYS G ++ E++  +       DS   V      Y+HV +D
Sbjct: 202 VYSLGCVLYEVLTGEPPFTG--DSPDSV-----AYQHVRED 235

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 77/171 (45%), Gaps = 25/171 (14%)
Query: 101 KGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDT--- 157
           +G   ++   EV  +    H N++TL        +  LI E +  G L  F+   ++   
Sbjct: 55  RGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTE 114
Query: 158 SKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP----KISD 213
            +  Q+L+          I  G+ YLH   S +I HFD+KP NI+L +   P    K+ D
Sbjct: 115 DEATQFLKQ---------ILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLID 162
Query: 214 FGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMM 264
           FG+A          +      G   ++APE+   N+  +  ++D++S G++
Sbjct: 163 FGIAHKIEAG----NEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVI 207

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 78/169 (46%), Gaps = 23/169 (13%)
Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRALIYEF---MP--NGSLEKFVYNGDTSKPCQYL 164
            E+  +    H NV+ LL      ++    Y+F   MP     L+K +    + +  QYL
Sbjct: 72  RELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYL 131
Query: 165 RWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE 224
                   V  + KGL+Y+H   S  ++H D+KP N+ ++ED   KI DFGLA+      
Sbjct: 132 --------VYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD--- 177
Query: 225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKN 273
              + + G      Y APEV   ++   +   D++S G ++ E++  K 
Sbjct: 178 ---AEMTGYVVTRWYRAPEVI-LSWMHYNQTVDIWSVGCIMAEMLTGKT 222

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 96/209 (45%), Gaps = 44/209 (21%)
Query: 90  KLGQGGFGGVYKGRLLDD----------------------FVNEVASISRTS---HVNVV 124
           ++G+G +G V+K R L +                       + EVA +       H NVV
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 125 TLLGFC-LEGNNR----ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
            L   C +   +R     L++E +     +   Y     +P   +  E + +++  + +G
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQ---DLTTYLDKVPEPG--VPTETIKDMMFQLLRG 132
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
           L++LH   S +++H D+KP NIL+      K++DFGLA++ + +  + S ++     + Y
Sbjct: 133 LDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV----TLWY 185
Query: 240 IAPEVFSRNFGEVSHKSDVYSFGMMIMEL 268
            APEV  ++    +   D++S G +  E+
Sbjct: 186 RAPEVLLQS--SYATPVDLWSVGCIFAEM 212

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 75/164 (45%), Gaps = 7/164 (4%)
Query: 109 VNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEK 168
           + E+  + R  H NV+ +          A+   ++    +E  +Y    S   Q L  + 
Sbjct: 89  LREIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKS---QQLSNDH 145
Query: 169 MYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVS 228
           +   +  I +GL+Y+H   S  +LH D+KP N+L++     KI DFGLA++   +     
Sbjct: 146 ICYFLYQILRGLKYIH---SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTG 202
Query: 229 SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
            L        Y APE+   + G  +   D++S G ++ E++  +
Sbjct: 203 FLTEXVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 245

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 102/243 (41%), Gaps = 55/243 (22%)
Query: 52  KITKSDKDLEAFIRNYGPLPLKR-----YNFSDVKKLTNSFKDKLGQGGFGGVYK----- 101
           KI   DK  E   + Y P P++      Y++ D+        ++LG G FG V++     
Sbjct: 22  KINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDIL-------EELGSGAFGVVHRCVEKA 74
Query: 102 -GRL-----------LDDFV--NEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS 147
            GR+           LD +   NE++ +++  H  ++ L     +     LI EF+  G 
Sbjct: 75  TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE 134
Query: 148 LEKFV----YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL 203
           L   +    Y    ++   Y+R            +GL+++H      I+H DIKP NI+ 
Sbjct: 135 LFDRIAAEDYKMSEAEVINYMR---------QACEGLKHMHEHS---IVHLDIKPENIMC 182
Query: 204 DEDFCP--KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSF 261
           +       KI DFGLA      E +  +   A     + APE+  R    V   +D+++ 
Sbjct: 183 ETKKASSVKIIDFGLATKLNPDEIVKVTTATAE----FAAPEIVDRE--PVGFYTDMWAI 236
Query: 262 GMM 264
           G++
Sbjct: 237 GVL 239

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 76/166 (45%), Gaps = 11/166 (6%)
Query: 109 VNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSK--PCQYLRW 166
           + E+  + R  H N++ +         RA   E M +  + + +   D  K    Q+L  
Sbjct: 73  LREIKILLRFRHENIIGINDII-----RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN 127
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
           + +   +  I +GL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++       
Sbjct: 128 DHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDH 184
Query: 227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
              L        Y APE+   + G  +   D++S G ++ E++  +
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 229

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 77/171 (45%), Gaps = 25/171 (14%)
Query: 101 KGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDT--- 157
           +G   ++   EV  +    H N++TL        +  LI E +  G L  F+   ++   
Sbjct: 69  RGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTE 128
Query: 158 SKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP----KISD 213
            +  Q+L+          I  G+ YLH   S +I HFD+KP NI+L +   P    K+ D
Sbjct: 129 DEATQFLKQ---------ILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLID 176
Query: 214 FGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMM 264
           FG+A          +      G   ++APE+   N+  +  ++D++S G++
Sbjct: 177 FGIAHKIEAG----NEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVI 221

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 76/166 (45%), Gaps = 11/166 (6%)
Query: 109 VNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSK--PCQYLRW 166
           + E+  + R  H N++ +         RA   E M +  + + +   D  K    Q+L  
Sbjct: 73  LREIKILLRFRHENIIGINDII-----RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN 127
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
           + +   +  I +GL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++       
Sbjct: 128 DHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184
Query: 227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
              L        Y APE+   + G  +   D++S G ++ E++  +
Sbjct: 185 TGFLXEXVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 76/166 (45%), Gaps = 11/166 (6%)
Query: 109 VNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSK--PCQYLRW 166
           + E+  + R  H N++ +         RA   E M +  + + +   D  K    Q+L  
Sbjct: 74  LREIKILLRFRHENIIGINDII-----RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN 128
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
           + +   +  I +GL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++       
Sbjct: 129 DHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 185
Query: 227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
              L        Y APE+   + G  +   D++S G ++ E++  +
Sbjct: 186 TGFLXEXVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 230

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 76/166 (45%), Gaps = 11/166 (6%)
Query: 109 VNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSK--PCQYLRW 166
           + E+  + R  H N++ +         RA   E M +  + + +   D  K    Q+L  
Sbjct: 73  LREIKILLRFRHENIIGINDII-----RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN 127
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
           + +   +  I +GL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++       
Sbjct: 128 DHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDH 184
Query: 227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
              L        Y APE+   + G  +   D++S G ++ E++  +
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 229

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 76/166 (45%), Gaps = 11/166 (6%)
Query: 109 VNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSK--PCQYLRW 166
           + E+  + R  H N++ +         RA   E M +  + + +   D  K    Q+L  
Sbjct: 69  LREIKILLRFRHENIIGINDII-----RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN 123
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
           + +   +  I +GL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++       
Sbjct: 124 DHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDH 180
Query: 227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
              L        Y APE+   + G  +   D++S G ++ E++  +
Sbjct: 181 TGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 225

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 76/166 (45%), Gaps = 11/166 (6%)
Query: 109 VNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSK--PCQYLRW 166
           + E+  + R  H N++ +         RA   E M +  + + +   D  K    Q+L  
Sbjct: 69  LREIKILLRFRHENIIGINDII-----RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN 123
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
           + +   +  I +GL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++       
Sbjct: 124 DHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDH 180
Query: 227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
              L        Y APE+   + G  +   D++S G ++ E++  +
Sbjct: 181 TGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 225

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 44/223 (19%)
Query: 89  DKLGQGGFGGVYKG--------------RLLDD-------FVNEVASISRTSHVNVVTLL 127
           +K+G+G +G V+K               RL DD        + E+  +    H N+V L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 128 GFCLEGNNRALIYEFMPNGSLEKFV--YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
                     L++EF  +  L+K+    NGD       L  E +   +  + KGL + H 
Sbjct: 68  DVLHSDKKLTLVFEFC-DQDLKKYFDSCNGD-------LDPEIVKSFLFQLLKGLGFCH- 118
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI-IGYIAPEV 244
             S  +LH D+KP N+L++ +   K+++FGLA+      GI      A  + + Y  P+V
Sbjct: 119 --SRNVLHRDLKPQNLLINRNGELKLANFGLARAF----GIPVRCYSAEVVTLWYRPPDV 172
Query: 245 FSRNFGE--VSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
               FG    S   D++S G +  EL      L  G D   ++
Sbjct: 173 L---FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 212

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 39/161 (24%), Positives = 70/161 (43%), Gaps = 18/161 (11%)
Query: 138 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIK 197
           ++ E++   +L   V+      P      ++  E++    + L + H      I+H D+K
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTP------KRAIEVIADACQALNFSHQ---NGIIHRDVK 143
Query: 198 PHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSD 257
           P NI++      K+ DFG+A+        V+      G   Y++PE    +   V  +SD
Sbjct: 144 PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSD 201
Query: 258 VYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQD 298
           VYS G ++ E++  +       DS   V      Y+HV +D
Sbjct: 202 VYSLGCVLYEVLTGEPPFTG--DSPVSV-----AYQHVRED 235

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           I  GLE LH     +I++ D+KP NILLD+    +ISD GLA      EG   ++ G  G
Sbjct: 295 ICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEG--QTIKGRVG 347
Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG 270
            +GY+APEV        +   D ++ G ++ E++ 
Sbjct: 348 TVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMIA 380

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 39/161 (24%), Positives = 70/161 (43%), Gaps = 18/161 (11%)
Query: 138 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIK 197
           ++ E++   +L   V+      P      ++  E++    + L + H      I+H D+K
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTP------KRAIEVIADACQALNFSHQ---NGIIHRDVK 143
Query: 198 PHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSD 257
           P NI++      K+ DFG+A+        V+      G   Y++PE    +   V  +SD
Sbjct: 144 PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSD 201
Query: 258 VYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQD 298
           VYS G ++ E++  +       DS   V      Y+HV +D
Sbjct: 202 VYSLGCVLYEVLTGEPPFTG--DSPVSV-----AYQHVRED 235

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 69/161 (42%), Gaps = 18/161 (11%)
Query: 138 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIK 197
           ++ E++   +L   V+      P      ++  E++    + L + H      I+H D+K
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTP------KRAIEVIADACQALNFSHQ---NGIIHRDVK 143
Query: 198 PHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSD 257
           P NIL+      K+ DFG+A+        V       G   Y++PE    +   V  +SD
Sbjct: 144 PANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGD--SVDARSD 201
Query: 258 VYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQD 298
           VYS G ++ E++  +       DS   V      Y+HV +D
Sbjct: 202 VYSLGCVLYEVLTGEPPFTG--DSPVSV-----AYQHVRED 235

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           I  GLE LH     +I++ D+KP NILLD+    +ISD GLA      EG   ++ G  G
Sbjct: 295 ICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEG--QTIKGRVG 347
Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG 270
            +GY+APEV        +   D ++ G ++ E++ 
Sbjct: 348 TVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMIA 380

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 73/153 (47%), Gaps = 35/153 (22%)
Query: 90  KLGQGGFGGVYKG------------RLLDDFVN---------EVASISRTS-HVNVVTLL 127
           KLG+G +G V+K             ++ D F N         E+  ++  S H N+V LL
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLL 75
Query: 128 GFCLEGNNRA--LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
                 N+R   L++++M        V   +  +P       K Y +V  + K ++YLH 
Sbjct: 76  NVLRADNDRDVYLVFDYMETDL--HAVIRANILEPVH-----KQY-VVYQLIKVIKYLHS 127
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAK 218
           G    +LH D+KP NILL+ +   K++DFGL++
Sbjct: 128 GG---LLHRDMKPSNILLNAECHVKVADFGLSR 157

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 122/293 (41%), Gaps = 66/293 (22%)
Query: 87  FKDKLGQGGFGGVYKG------------------RLLD--------DFVNEVASISRTSH 120
           F + LGQG F  ++KG                  ++LD         F    + +S+ SH
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 121 VNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGL 180
            ++V   G C  G+   L+ EF+  GSL+ ++     +K C  + W+   E+   +A  +
Sbjct: 72  KHLVLNYGVCFCGDENILVQEFVKFGSLDTYL---KKNKNCINILWK--LEVAKQLAWAM 126
Query: 181 EYLHHGCSTKILHFDIKPHNILL--DEDFCP------KISDFGLAKLCTTKEGIVSSLLG 232
            +L       ++H ++   NILL  +ED         K+SD G++     K+     +L 
Sbjct: 127 HFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-----ILQ 178
Query: 233 ARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIY 292
            R  I ++ PE    N   ++  +D +SFG  + E+    +   S +DS  ++ F     
Sbjct: 179 ER--IPWVPPECIE-NPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF----- 230
Query: 293 RHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG 345
               +DR  +LP     K  E+A   +I    C+   P  RP    +I  L  
Sbjct: 231 ---YEDRH-QLPAP---KAAELAN--LINN--CMDYEPDHRPSFRAIIRDLNS 272

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/236 (22%), Positives = 107/236 (45%), Gaps = 27/236 (11%)
Query: 106 DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLR 165
           +  + E+  +   +   +V   G        ++  E M  GSL++ +      K    + 
Sbjct: 68  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL------KKAGRIP 121
Query: 166 WEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG 225
            + + ++ I + KGL YL      KI+H D+KP NIL++     K+ DFG++      + 
Sbjct: 122 EQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DS 177
Query: 226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
           + +S +G R    Y++PE        V  +SD++S G+ ++E+   +  + SG  S S  
Sbjct: 178 MANSFVGTR---SYMSPERLQGTHYSV--QSDIWSMGLSLVEMAVGRYPIGSG--SGSMA 230
Query: 286 YFPHWIYRHVEQDREFKLP-GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI 340
            F   +  ++  +   KLP GV + +  +   K       C+   P++R  + +++
Sbjct: 231 IFE--LLDYIVNEPPPKLPSGVFSLEFQDFVNK-------CLIKNPAERADLKQLM 277

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 76/166 (45%), Gaps = 11/166 (6%)
Query: 109 VNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSK--PCQYLRW 166
           + E+  + R  H N++ +         RA   E M +  + + +   D  K    Q+L  
Sbjct: 73  LREIKILLRFRHENIIGINDII-----RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN 127
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
           + +   +  I +GL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++       
Sbjct: 128 DHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184
Query: 227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
              L        Y APE+   + G  +   D++S G ++ E++  +
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 229

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 39/161 (24%), Positives = 70/161 (43%), Gaps = 18/161 (11%)
Query: 138 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIK 197
           ++ E++   +L   V+      P      ++  E++    + L + H      I+H D+K
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTP------KRAIEVIADACQALNFSHQ---NGIIHRDVK 143
Query: 198 PHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSD 257
           P NI++      K+ DFG+A+        V+      G   Y++PE    +   V  +SD
Sbjct: 144 PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSD 201
Query: 258 VYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQD 298
           VYS G ++ E++  +       DS   V      Y+HV +D
Sbjct: 202 VYSLGCVLYEVLTGEPPFTG--DSPVSV-----AYQHVRED 235

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 76/166 (45%), Gaps = 11/166 (6%)
Query: 109 VNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSK--PCQYLRW 166
           + E+  + R  H N++ +         RA   E M +  + + +   D  K    Q+L  
Sbjct: 74  LREIKILLRFRHENIIGINDII-----RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN 128
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
           + +   +  I +GL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++       
Sbjct: 129 DHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 185
Query: 227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
              L        Y APE+   + G  +   D++S G ++ E++  +
Sbjct: 186 TGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 76/166 (45%), Gaps = 11/166 (6%)
Query: 109 VNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSK--PCQYLRW 166
           + E+  + R  H N++ +         RA   E M +  + + +   D  K    Q+L  
Sbjct: 75  LREIKILLRFRHENIIGINDII-----RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN 129
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
           + +   +  I +GL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++       
Sbjct: 130 DHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 186
Query: 227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
              L        Y APE+   + G  +   D++S G ++ E++  +
Sbjct: 187 TGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 76/166 (45%), Gaps = 11/166 (6%)
Query: 109 VNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSK--PCQYLRW 166
           + E+  + R  H N++ +         RA   E M +  + + +   D  K    Q+L  
Sbjct: 66  LREIKILLRFRHENIIGINDII-----RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN 120
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
           + +   +  I +GL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++       
Sbjct: 121 DHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 177
Query: 227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
              L        Y APE+   + G  +   D++S G ++ E++  +
Sbjct: 178 TGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 222

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 39/161 (24%), Positives = 70/161 (43%), Gaps = 18/161 (11%)
Query: 138 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIK 197
           ++ E++   +L   V+      P      ++  E++    + L + H      I+H D+K
Sbjct: 110 IVMEYVDGVTLRDIVHTEGPMTP------KRAIEVIADACQALNFSHQ---NGIIHRDVK 160
Query: 198 PHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSD 257
           P NI++      K+ DFG+A+        V+      G   Y++PE    +   V  +SD
Sbjct: 161 PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSD 218
Query: 258 VYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQD 298
           VYS G ++ E++  +       DS   V      Y+HV +D
Sbjct: 219 VYSLGCVLYEVLTGEPPFTG--DSPVSV-----AYQHVRED 252

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 76/166 (45%), Gaps = 11/166 (6%)
Query: 109 VNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSK--PCQYLRW 166
           + E+  + R  H N++ +         RA   E M +  + + +   D  K    Q+L  
Sbjct: 73  LREIKILLRFRHENIIGINDII-----RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN 127
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
           + +   +  I +GL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++       
Sbjct: 128 DHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184
Query: 227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
              L        Y APE+   + G  +   D++S G ++ E++  +
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 229

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 76/166 (45%), Gaps = 11/166 (6%)
Query: 109 VNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSK--PCQYLRW 166
           + E+  + R  H N++ +         RA   E M +  + + +   D  K    Q+L  
Sbjct: 67  LREIKILLRFRHENIIGINDII-----RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN 121
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
           + +   +  I +GL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++       
Sbjct: 122 DHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 178
Query: 227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
              L        Y APE+   + G  +   D++S G ++ E++  +
Sbjct: 179 TGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 223

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 76/166 (45%), Gaps = 11/166 (6%)
Query: 109 VNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSK--PCQYLRW 166
           + E+  + R  H N++ +         RA   E M +  + + +   D  K    Q+L  
Sbjct: 77  LREIKILLRFRHENIIGINDII-----RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN 131
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
           + +   +  I +GL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++       
Sbjct: 132 DHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 188
Query: 227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
              L        Y APE+   + G  +   D++S G ++ E++  +
Sbjct: 189 TGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 76/166 (45%), Gaps = 11/166 (6%)
Query: 109 VNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSK--PCQYLRW 166
           + E+  + R  H N++ +         RA   E M +  + + +   D  K    Q+L  
Sbjct: 69  LREIKILLRFRHENIIGINDII-----RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN 123
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
           + +   +  I +GL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++       
Sbjct: 124 DHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 180
Query: 227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
              L        Y APE+   + G  +   D++S G ++ E++  +
Sbjct: 181 TGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 225

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 76/166 (45%), Gaps = 11/166 (6%)
Query: 109 VNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSK--PCQYLRW 166
           + E+  + R  H N++ +         RA   E M +  + + +   D  K    Q+L  
Sbjct: 67  LREIKILLRFRHENIIGINDII-----RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN 121
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
           + +   +  I +GL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++       
Sbjct: 122 DHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 178
Query: 227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
              L        Y APE+   + G  +   D++S G ++ E++  +
Sbjct: 179 TGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 223

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 77/155 (49%), Gaps = 17/155 (10%)
Query: 120 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
           H +++TL+      +   L+++ M  G L  ++    T K    L  ++   I+  + + 
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYL----TEKVA--LSEKETRSIMRSLLEA 212
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
           + +LH   +  I+H D+KP NILLD++   ++SDFG +  C  + G    L    G  GY
Sbjct: 213 VSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFS--CHLEPG--EKLRELCGTPGY 265
Query: 240 IAPEVFSRNFGEV----SHKSDVYSFGMMIMELVG 270
           +APE+   +  E       + D+++ G+++  L+ 
Sbjct: 266 LAPEILKCSMDETHPGYGKEVDLWACGVILFTLLA 300

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 43/202 (21%)
Query: 80  VKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI 139
           VKKL+  F++   Q      Y+  +L   VN         H N+++LL            
Sbjct: 54  VKKLSRPFQN---QTHAKRAYRELVLLKCVN---------HKNIISLLNV---------- 91
Query: 140 YEFMPNGSLEKF-----VYNGDTSKPCQY----LRWEKMYEIVIGIAKGLEYLHHGCSTK 190
             F P  +LE+F     V     +  CQ     L  E+M  ++  +  G+++LH   S  
Sbjct: 92  --FTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH---SAG 146
Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFG 250
           I+H D+KP NI++  D   KI DFGLA+   T   +   ++       Y APEV     G
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY----YRAPEVI-LGMG 201
Query: 251 EVSHKSDVYSFGMMIMELV-GC 271
             ++  D++S G ++ ELV GC
Sbjct: 202 YAAN-VDIWSVGCIMGELVKGC 222

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 76/166 (45%), Gaps = 11/166 (6%)
Query: 109 VNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSK--PCQYLRW 166
           + E+  + R  H N++ +         RA   E M +  + + +   D  K    Q+L  
Sbjct: 69  LREIKILLRFRHENIIGINDII-----RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN 123
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
           + +   +  I +GL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++       
Sbjct: 124 DHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 180
Query: 227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
              L        Y APE+   + G  +   D++S G ++ E++  +
Sbjct: 181 TGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 225

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 76/166 (45%), Gaps = 11/166 (6%)
Query: 109 VNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSK--PCQYLRW 166
           + E+  + R  H N++ +         RA   E M +  + + +   D  K    Q+L  
Sbjct: 71  LREIKILLRFRHENIIGINDII-----RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN 125
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
           + +   +  I +GL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++       
Sbjct: 126 DHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 182
Query: 227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
              L        Y APE+   + G  +   D++S G ++ E++  +
Sbjct: 183 TGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 227

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 77/156 (49%), Gaps = 11/156 (7%)
Query: 124 VTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYL 183
           VT  G      +  +  E M + SL+KF Y     K  Q +  + + +I + I K LE+L
Sbjct: 69  VTFYGALFREGDVWICMELM-DTSLDKF-YKQVIDK-GQTIPEDILGKIAVSIVKALEHL 125
Query: 184 HHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE 243
           H   S  ++H D+KP N+L++     K+ DFG++         V+  + A G   Y+APE
Sbjct: 126 HSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDD---VAKDIDA-GCKPYMAPE 179
Query: 244 VFSRNFGE--VSHKSDVYSFGMMIMELVGCKNNLDS 277
             +    +   S KSD++S G+ ++EL   +   DS
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 79/169 (46%), Gaps = 15/169 (8%)
Query: 101 KGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKP 160
           K  + +  + E+  +   +   +V   G        ++  E M  GSL++ +      K 
Sbjct: 106 KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL------KK 159
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
              +  + + ++ I + KGL YL      KI+H D+KP NIL++     K+ DFG++   
Sbjct: 160 AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 217
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
              + + +S +G R    Y++PE        V  +SD++S G+ ++E+ 
Sbjct: 218 I--DSMANSFVGTR---SYMSPERLQGTHYSV--QSDIWSMGLSLVEMA 259

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 76/166 (45%), Gaps = 11/166 (6%)
Query: 109 VNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSK--PCQYLRW 166
           + E+  + R  H N++ +         RA   E M +  + + +   D  K    Q+L  
Sbjct: 89  LREIKILLRFRHENIIGINDII-----RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN 143
Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
           + +   +  I +GL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++       
Sbjct: 144 DHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 200
Query: 227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
              L        Y APE+   + G  +   D++S G ++ E++  +
Sbjct: 201 TGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 245

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 102/231 (44%), Gaps = 31/231 (13%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY 170
           E++ +    H +++ L       +   ++ E+  N  L  ++   D     +  R+ +  
Sbjct: 58  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQ- 115
Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSL 230
                I   +EY H     KI+H D+KP N+LLDE    KI+DFGL+ + T    + +S 
Sbjct: 116 -----IISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC 167
Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHW 290
               G   Y APEV S        + DV+S G+++  ++  +   D   D S  V F + 
Sbjct: 168 ----GSPNYAAPEVISGKL-YAGPEVDVWSCGVILYVMLCRRLPFD---DESIPVLFKNI 219
Query: 291 IYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
                  +  + LP  ++     + K+M+IV        P +R  ++E+++
Sbjct: 220 ------SNGVYTLPKFLSPGAAGLIKRMLIVN-------PLNRISIHEIMQ 257

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 102/231 (44%), Gaps = 31/231 (13%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY 170
           E++ +    H +++ L       +   ++ E+  N  L  ++   D     +  R+ +  
Sbjct: 63  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQ- 120
Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSL 230
                I   +EY H     KI+H D+KP N+LLDE    KI+DFGL+ + T    + +S 
Sbjct: 121 -----IISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC 172
Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHW 290
               G   Y APEV S        + DV+S G+++  ++  +   D   D S  V F + 
Sbjct: 173 ----GSPNYAAPEVISGKL-YAGPEVDVWSCGVILYVMLCRRLPFD---DESIPVLFKNI 224
Query: 291 IYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
                  +  + LP  ++     + K+M+IV        P +R  ++E+++
Sbjct: 225 ------SNGVYTLPKFLSPGAAGLIKRMLIVN-------PLNRISIHEIMQ 262

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 102/231 (44%), Gaps = 31/231 (13%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY 170
           E++ +    H +++ L       +   ++ E+  N  L  ++   D     +  R+ +  
Sbjct: 64  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQ- 121
Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSL 230
                I   +EY H     KI+H D+KP N+LLDE    KI+DFGL+ + T    + +S 
Sbjct: 122 -----IISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC 173
Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHW 290
               G   Y APEV S        + DV+S G+++  ++  +   D   D S  V F + 
Sbjct: 174 ----GSPNYAAPEVISGKL-YAGPEVDVWSCGVILYVMLCRRLPFD---DESIPVLFKNI 225
Query: 291 IYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
                  +  + LP  ++     + K+M+IV        P +R  ++E+++
Sbjct: 226 ------SNGVYTLPKFLSPGAAGLIKRMLIVN-------PLNRISIHEIMQ 263

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 44/200 (22%)
Query: 80  VKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI 139
           +KKL+  F++   Q      Y+  +L   VN         H N++ LL            
Sbjct: 54  IKKLSRPFQN---QTHAKRAYRELVLMKVVN---------HKNIIGLLNV---------- 91
Query: 140 YEFMPNGSLEKF--VY------NGDTSKPCQY-LRWEKMYEIVIGIAKGLEYLHHGCSTK 190
             F P  SLE+F  VY      + + S+  Q  L  E+M  ++  +  G+++LH   S  
Sbjct: 92  --FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLH---SAG 146
Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV-FSRNF 249
           I+H D+KP NI++  D   KI DFGLA+   T   +   ++       Y APEV     +
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRY----YRAPEVILGMGY 202
Query: 250 GEVSHKSDVYSFGMMIMELV 269
            E     D++S G+++ E++
Sbjct: 203 KE---NVDIWSVGVIMGEMI 219

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 102/231 (44%), Gaps = 31/231 (13%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY 170
           E++ +    H +++ L       +   ++ E+  N  L  ++   D     +  R+ +  
Sbjct: 54  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQ- 111
Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSL 230
                I   +EY H     KI+H D+KP N+LLDE    KI+DFGL+ + T    + +S 
Sbjct: 112 -----IISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC 163
Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHW 290
               G   Y APEV S        + DV+S G+++  ++  +   D   D S  V F + 
Sbjct: 164 ----GSPNYAAPEVISGKL-YAGPEVDVWSCGVILYVMLCRRLPFD---DESIPVLFKNI 215
Query: 291 IYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
                  +  + LP  ++     + K+M+IV        P +R  ++E+++
Sbjct: 216 ------SNGVYTLPKFLSPGAAGLIKRMLIVN-------PLNRISIHEIMQ 253

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 56/111 (50%), Gaps = 4/111 (3%)
Query: 162 QYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT 221
           Q+L  + +   +  I +GL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++  
Sbjct: 121 QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTSDLKICDFGLARVAD 177
Query: 222 TKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
                   L        Y APE+   + G  +   D++S G ++ E++  +
Sbjct: 178 PDHDHTGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 227

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 44/200 (22%)
Query: 80  VKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI 139
           +KKL+  F++   Q      Y+  +L   VN         H N++ LL            
Sbjct: 54  IKKLSRPFQN---QTHAKRAYRELVLMKVVN---------HKNIIGLLNV---------- 91
Query: 140 YEFMPNGSLEKF--VY------NGDTSKPCQY-LRWEKMYEIVIGIAKGLEYLHHGCSTK 190
             F P  SLE+F  VY      + + S+  Q  L  E+M  ++  +  G+++LH   S  
Sbjct: 92  --FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLH---SAG 146
Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV-FSRNF 249
           I+H D+KP NI++  D   KI DFGLA+   T   +   ++       Y APEV     +
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRY----YRAPEVILGMGY 202
Query: 250 GEVSHKSDVYSFGMMIMELV 269
            E     D++S G+++ E++
Sbjct: 203 KE---NVDIWSVGVIMGEMI 219

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 38/225 (16%)
Query: 68  GPLPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKG-------------------RLLD-- 106
           GP+  K+ +   VK       D LG G FG V  G                   R LD  
Sbjct: 1   GPMAEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVV 60
Query: 107 -DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYL 164
                E+ ++    H +++ L       ++  ++ E++  G L  ++  NG        L
Sbjct: 61  GKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG-------RL 113
Query: 165 RWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE 224
             ++   +   I  G++Y H      ++H D+KP N+LLD     KI+DFGL+ + +  E
Sbjct: 114 DEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170
Query: 225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            +  S     G   Y APEV S        + D++S G+++  L+
Sbjct: 171 FLRXSC----GSPNYAAPEVISGRL-YAGPEVDIWSSGVILYALL 210

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 37/200 (18%)
Query: 93  QGGFGG--VYKGRLLDDFVN----EVASISRTS-HVNVVTLLGFCLEGNNRALIYEF-MP 144
           QG F G  V   R+L DF +    E+  ++ +  H NV+    +C E  +R L     + 
Sbjct: 34  QGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRY--YCSETTDRFLYIALELC 91
Query: 145 NGSLEKFVYNGDTSKPCQYLRWEKMYE---IVIGIAKGLEYLHHGCSTKILHFDIKPHNI 201
           N +L+  V + + S   + L+ +K Y    ++  IA G+ +LH   S KI+H D+KP NI
Sbjct: 92  NLNLQDLVESKNVSD--ENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNI 146
Query: 202 LLD-------------EDFCPKISDFGL-AKLCTTKEGIVSSLLGARGIIGYIAPEVF-- 245
           L+              E+    ISDFGL  KL + +    ++L    G  G+ APE+   
Sbjct: 147 LVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEE 206
Query: 246 SRNFG---EVSHKSDVYSFG 262
           S N      ++   D++S G
Sbjct: 207 SNNLQTKRRLTRSIDIFSMG 226

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 58/108 (53%), Gaps = 8/108 (7%)
Query: 163 YLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT 222
           + + E +   +  +   L+YL    + +I+H D+KP NILLDE     I+DF +A +   
Sbjct: 111 HFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAML-P 166
Query: 223 KEGIVSSLLGARGIIGYIAPEVFSRNFGE-VSHKSDVYSFGMMIMELV 269
           +E  ++++ G +    Y+APE+FS   G   S   D +S G+   EL+
Sbjct: 167 RETQITTMAGTK---PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELL 211

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 60/113 (53%), Gaps = 5/113 (4%)
Query: 162 QYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK-LC 220
           Q L  E +   +  + +GL+Y+H   S +++H D+KP N+L++E+   KI DFG+A+ LC
Sbjct: 154 QPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 210
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKN 273
           T+       +        Y APE+   +  E +   D++S G +  E++  + 
Sbjct: 211 TSPAEHQYFMTEYVATRWYRAPELML-SLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 79/169 (46%), Gaps = 15/169 (8%)
Query: 101 KGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKP 160
           K  + +  + E+  +   +   +V   G        ++  E M  GSL++ +      K 
Sbjct: 44  KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL------KK 97
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
              +  + + ++ I + KGL YL      KI+H D+KP NIL++     K+ DFG++   
Sbjct: 98  AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
              + + +S +G R    Y++PE        V  +SD++S G+ ++E+ 
Sbjct: 156 I--DSMANSFVGTR---SYMSPERLQGTHYSV--QSDIWSMGLSLVEMA 197

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 56/111 (50%), Gaps = 4/111 (3%)
Query: 162 QYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT 221
           Q+L  + +   +  I +GL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++  
Sbjct: 121 QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 177
Query: 222 TKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
                   L        Y APE+   + G  +   D++S G ++ E++  +
Sbjct: 178 PDHDHTGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 227

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/117 (29%), Positives = 64/117 (54%), Gaps = 11/117 (9%)
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK-L 219
            Q L  E +   +  + +GL+Y+H   S +++H D+KP N+L++E+   KI DFG+A+ L
Sbjct: 152 SQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGL 208
Query: 220 CTT---KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKN 273
           CT+    +  ++  +  R    Y APE+   +  E +   D++S G +  E++  + 
Sbjct: 209 CTSPAEHQYFMTEYVATR---WYRAPELML-SLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 89/200 (44%), Gaps = 44/200 (22%)
Query: 80  VKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI 139
           VKKL+  F++   Q      Y+  +L   VN         H N+++LL            
Sbjct: 52  VKKLSRPFQN---QTHAKRAYRELVLLKCVN---------HKNIISLLNV---------- 89
Query: 140 YEFMPNGSLEKF-----VYNGDTSKPCQY----LRWEKMYEIVIGIAKGLEYLHHGCSTK 190
             F P  +LE+F     V     +  CQ     L  E+M  ++  +  G+++LH   S  
Sbjct: 90  --FTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH---SAG 144
Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV-FSRNF 249
           I+H D+KP NI++  D   KI DFGLA+  +T   +   ++       Y APEV     +
Sbjct: 145 IIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRY----YRAPEVILGMGY 200
Query: 250 GEVSHKSDVYSFGMMIMELV 269
            E     D++S G ++ ELV
Sbjct: 201 KE---NVDIWSVGCIMGELV 217

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 33/196 (16%)
Query: 93  QGGFGG--VYKGRLLDDFVN----EVASISRTS-HVNVVTLLGFCLEGNNRALIYEF-MP 144
           QG F G  V   R+L DF +    E+  ++ +  H NV+    +C E  +R L     + 
Sbjct: 52  QGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRY--YCSETTDRFLYIALELC 109
Query: 145 NGSLEKFVYNGDTSKPCQYLRWEKMYE---IVIGIAKGLEYLHHGCSTKILHFDIKPHNI 201
           N +L+  V + + S   + L+ +K Y    ++  IA G+ +LH   S KI+H D+KP NI
Sbjct: 110 NLNLQDLVESKNVSD--ENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNI 164
Query: 202 LLD-------------EDFCPKISDFGL-AKLCTTKEGIVSSLLGARGIIGYIAPEVFSR 247
           L+              E+    ISDFGL  KL + +     +L    G  G+ APE+   
Sbjct: 165 LVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEE 224
Query: 248 NFGEVSHKS-DVYSFG 262
           +      +S D++S G
Sbjct: 225 STKRRLTRSIDIFSMG 240

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 33/196 (16%)
Query: 93  QGGFGG--VYKGRLLDDFVN----EVASISRTS-HVNVVTLLGFCLEGNNRALIYEF-MP 144
           QG F G  V   R+L DF +    E+  ++ +  H NV+    +C E  +R L     + 
Sbjct: 52  QGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRY--YCSETTDRFLYIALELC 109
Query: 145 NGSLEKFVYNGDTSKPCQYLRWEKMYE---IVIGIAKGLEYLHHGCSTKILHFDIKPHNI 201
           N +L+  V + + S   + L+ +K Y    ++  IA G+ +LH   S KI+H D+KP NI
Sbjct: 110 NLNLQDLVESKNVSD--ENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNI 164
Query: 202 LLD-------------EDFCPKISDFGL-AKLCTTKEGIVSSLLGARGIIGYIAPEVFSR 247
           L+              E+    ISDFGL  KL + +     +L    G  G+ APE+   
Sbjct: 165 LVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEE 224
Query: 248 NFGEVSHKS-DVYSFG 262
           +      +S D++S G
Sbjct: 225 STKRRLTRSIDIFSMG 240

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 79/169 (46%), Gaps = 15/169 (8%)
Query: 101 KGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKP 160
           K  + +  + E+  +   +   +V   G        ++  E M  GSL++ +      K 
Sbjct: 44  KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL------KK 97
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
              +  + + ++ I + KGL YL      KI+H D+KP NIL++     K+ DFG++   
Sbjct: 98  AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
              + + +S +G R    Y++PE        V  +SD++S G+ ++E+ 
Sbjct: 156 I--DSMANSFVGTR---SYMSPERLQGTHYSV--QSDIWSMGLSLVEMA 197

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/170 (24%), Positives = 76/170 (44%), Gaps = 18/170 (10%)
Query: 119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
            H N++TL     +G    ++ E    G L   +         ++    +   ++  I K
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQ------KFFSEREASAVLFTITK 127
Query: 179 GLEYLHHGCSTKILHFDIKPHNIL-LDEDFCP---KISDFGLAKLCTTKEGIVSSLLGAR 234
            +EYLH   +  ++H D+KP NIL +DE   P   +I DFG AK    + G++ +     
Sbjct: 128 TVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYT- 183
Query: 235 GIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE 284
               ++APEV  R   + +   D++S G+++   +       +G D + E
Sbjct: 184 --ANFVAPEVLERQGYDAA--CDIWSLGVLLYTXLTGYTPFANGPDDTPE 229

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 76/162 (46%), Gaps = 18/162 (11%)
Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKM 169
            E+ ++    H +++ L        +  ++ E++  G L  ++        C++ R E+M
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI--------CKHGRVEEM 111
Query: 170 --YEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV 227
               +   I   ++Y H      ++H D+KP N+LLD     KI+DFGL+ + +  E + 
Sbjct: 112 EARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR 168
Query: 228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
           +S     G   Y APEV S        + D++S G+++  L+
Sbjct: 169 TSC----GSPNYAAPEVISGRL-YAGPEVDIWSCGVILYALL 205

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 79/169 (46%), Gaps = 15/169 (8%)
Query: 101 KGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKP 160
           K  + +  + E+  +   +   +V   G        ++  E M  GSL++ +      K 
Sbjct: 71  KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL------KK 124
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
              +  + + ++ I + KGL YL      KI+H D+KP NIL++     K+ DFG++   
Sbjct: 125 AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
              + + +S +G R    Y++PE        V  +SD++S G+ ++E+ 
Sbjct: 183 I--DSMANSFVGTR---SYMSPERLQGTHYSV--QSDIWSMGLSLVEMA 224

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 79/169 (46%), Gaps = 15/169 (8%)
Query: 101 KGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKP 160
           K  + +  + E+  +   +   +V   G        ++  E M  GSL++ +      K 
Sbjct: 44  KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL------KK 97
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
              +  + + ++ I + KGL YL      KI+H D+KP NIL++     K+ DFG++   
Sbjct: 98  AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
              + + +S +G R    Y++PE        V  +SD++S G+ ++E+ 
Sbjct: 156 I--DSMANSFVGTR---SYMSPERLQGTHYSV--QSDIWSMGLSLVEMA 197

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 79/169 (46%), Gaps = 15/169 (8%)
Query: 101 KGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKP 160
           K  + +  + E+  +   +   +V   G        ++  E M  GSL++ +      K 
Sbjct: 44  KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL------KK 97
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
              +  + + ++ I + KGL YL      KI+H D+KP NIL++     K+ DFG++   
Sbjct: 98  AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
              + + +S +G R    Y++PE        V  +SD++S G+ ++E+ 
Sbjct: 156 I--DSMANSFVGTR---SYMSPERLQGTHYSV--QSDIWSMGLSLVEMA 197

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 76/170 (44%), Gaps = 20/170 (11%)
Query: 106 DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLR 165
           +  + EV  + +  H N++ L  F  +     L+ E    G L   + +          R
Sbjct: 77  ESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR 136
Query: 166 WEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLD---EDFCPKISDFGLAKLCTT 222
                 I+  +  G+ Y+H     KI+H D+KP N+LL+   +D   +I DFGL+     
Sbjct: 137 ------IIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 187
Query: 223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV-GC 271
            + +   +    G   YIAPEV    + E   K DV+S G+++  L+ GC
Sbjct: 188 SKKMKDKI----GTAYYIAPEVLHGTYDE---KCDVWSTGVILYILLSGC 230

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 79/169 (46%), Gaps = 15/169 (8%)
Query: 101 KGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKP 160
           K  + +  + E+  +   +   +V   G        ++  E M  GSL++ +      K 
Sbjct: 44  KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL------KK 97
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
              +  + + ++ I + KGL YL      KI+H D+KP NIL++     K+ DFG++   
Sbjct: 98  AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
              + + +S +G R    Y++PE        V  +SD++S G+ ++E+ 
Sbjct: 156 I--DSMANSFVGTR---SYMSPERLQGTHYSV--QSDIWSMGLSLVEMA 197

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/127 (30%), Positives = 61/127 (48%), Gaps = 20/127 (15%)
Query: 166 WEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFG-LAKLCTTKE 224
           W  + + ++ +A    +LH   S  ++H D+KP NI L      K+ DFG L +L T   
Sbjct: 160 WGYLRDTLLALA----HLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA 212
Query: 225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE 284
           G V       G   Y+APE+   ++G     +DV+S G+ I+E V C   L  G +   +
Sbjct: 213 GEVQE-----GDPRYMAPELLQGSYGTA---ADVFSLGLTILE-VACNMELPHGGEGWQQ 263
Query: 285 V---YFP 288
           +   Y P
Sbjct: 264 LRQGYLP 270

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 86/188 (45%), Gaps = 27/188 (14%)
Query: 178 KGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGII 237
           +G++YLH   + +++H D+K  N+ L++D   KI DFGLA           +L G     
Sbjct: 153 QGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTP--- 206
Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQ 297
            YIAPEV  +     S + D++S G ++  L+  K   ++     + +           +
Sbjct: 207 NYIAPEVLCKKGH--SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI---------K 255
Query: 298 DREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI--EMLQGSTEALQIPPT 355
             E+ +P    R  N +A  +I      + A P+ RP + E++  E        +++ PT
Sbjct: 256 KNEYSVP----RHINPVASALI---RRMLHADPTLRPSVAELLTDEFFTSGYAPMRL-PT 307
Query: 356 PFLSSPPR 363
             L+ PPR
Sbjct: 308 SCLTVPPR 315

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 44/203 (21%)
Query: 80  VKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI 139
           +KKL+  F++   Q      Y+  +L   VN         H N+++LL            
Sbjct: 54  IKKLSRPFQN---QTHAKRAYRELVLMKXVN---------HKNIISLLNV---------- 91
Query: 140 YEFMPNGSLEKF--VY------NGDTSKPCQY-LRWEKMYEIVIGIAKGLEYLHHGCSTK 190
             F P  +LE+F  VY      + +  +  Q  L  E+M  ++  +  G+++LH   S  
Sbjct: 92  --FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLH---SAG 146
Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV-FSRNF 249
           I+H D+KP NI++  D   KI DFGLA+   T   +   ++       Y APEV     +
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRY----YRAPEVILGMGY 202
Query: 250 GEVSHKSDVYSFGMMIMELVGCK 272
            E     D++S G ++ E+V  K
Sbjct: 203 KE---NVDIWSVGCIMGEMVRHK 222

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 86/213 (40%), Gaps = 41/213 (19%)
Query: 86  SFKDKLGQGGFGGVYKGRLLDD--------------------FVNEVASISRTSHVNVVT 125
             K++LG GGFG V +    D                     +  E+  + + +H NVV+
Sbjct: 18  EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 77
Query: 126 L------LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
                  L      +   L  E+   G L K++   +    C  L+   +  ++  I+  
Sbjct: 78  AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN---CCGLKEGPIRTLLSDISSA 134
Query: 180 LEYLHHGCSTKILHFDIKPHNILLD---EDFCPKISDFGLAKLCTTKEGIVSSLLGARGI 236
           L YLH     +I+H D+KP NI+L    +    KI D G AK     E     +    G 
Sbjct: 135 LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV----GT 187
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
           + Y+APE+  +    V+   D +SFG +  E +
Sbjct: 188 LQYLAPELLEQKKYTVT--VDYWSFGTLAFECI 218

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 75/162 (46%), Gaps = 18/162 (11%)
Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKM 169
            E+ ++    H +++ L        +  ++ E++  G L  ++        C++ R E+M
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI--------CKHGRVEEM 111
Query: 170 --YEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV 227
               +   I   ++Y H      ++H D+KP N+LLD     KI+DFGL+ + +  E + 
Sbjct: 112 EARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR 168
Query: 228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            S     G   Y APEV S        + D++S G+++  L+
Sbjct: 169 DSC----GSPNYAAPEVISGRL-YAGPEVDIWSCGVILYALL 205

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 88/213 (41%), Gaps = 41/213 (19%)
Query: 86  SFKDKLGQGGFGGVYKGRLLDD--------------------FVNEVASISRTSHVNVVT 125
             K++LG GGFG V +    D                     +  E+  + + +H NVV+
Sbjct: 17  EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 76
Query: 126 LLGF-----CLEGNNRALI-YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
                     L  N+  L+  E+   G L K++   +    C  L+   +  ++  I+  
Sbjct: 77  AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN---CCGLKEGPIRTLLSDISSA 133
Query: 180 LEYLHHGCSTKILHFDIKPHNILLD---EDFCPKISDFGLAKLCTTKEGIVSSLLGARGI 236
           L YLH     +I+H D+KP NI+L    +    KI D G AK     E     +    G 
Sbjct: 134 LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV----GT 186
Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
           + Y+APE+  +    V+   D +SFG +  E +
Sbjct: 187 LQYLAPELLEQKKYTVT--VDYWSFGTLAFECI 217

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 95/222 (42%), Gaps = 52/222 (23%)
Query: 80  VKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI 139
           +KKL+  F++   Q      Y+  +L   VN         H N++ LL            
Sbjct: 54  IKKLSRPFQN---QTHAKRAYRELVLMKCVN---------HKNIIGLLNV---------- 91
Query: 140 YEFMPNGSLEKF-----VYNGDTSKPCQYLRWE----KMYEIVIGIAKGLEYLHHGCSTK 190
             F P  SLE+F     V     +  CQ ++ E    +M  ++  +  G+++LH   S  
Sbjct: 92  --FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAG 146
Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYI-APEV-FSRN 248
           I+H D+KP NI++  D   KI DFGLA+   T     S ++    +  Y  APEV     
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-----SFMMEPEVVTRYYRAPEVILGMG 201
Query: 249 FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHW 290
           + E     D++S G ++ E+V C   L  G D     Y   W
Sbjct: 202 YKE---NVDIWSVGCIMGEMV-CHKILFPGRD-----YIDQW 234

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 75/168 (44%), Gaps = 20/168 (11%)
Query: 108 FVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWE 167
            + EV  + +  H N++ L  F  +     L+ E    G L   + +          R  
Sbjct: 73  LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR-- 130
Query: 168 KMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLD---EDFCPKISDFGLAKLCTTKE 224
               I+  +  G+ Y+H     KI+H D+KP N+LL+   +D   +I DFGL+      +
Sbjct: 131 ----IIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183
Query: 225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMI-MELVGC 271
            +   +    G   YIAPEV    + E   K DV+S G+++ + L GC
Sbjct: 184 KMKDKI----GTAYYIAPEVLHGTYDE---KCDVWSTGVILYILLSGC 224

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 44/203 (21%)
Query: 80  VKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI 139
           +KKL+  F++   Q      Y+  +L   VN         H N+++LL            
Sbjct: 54  IKKLSRPFQN---QTHAKRAYRELVLMKXVN---------HKNIISLLNV---------- 91
Query: 140 YEFMPNGSLEKF-----VYNGDTSKPCQYLRWE----KMYEIVIGIAKGLEYLHHGCSTK 190
             F P  +LE+F     V     +  CQ ++ E    +M  ++  +  G+++LH   S  
Sbjct: 92  --FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAG 146
Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV-FSRNF 249
           I+H D+KP NI++  D   KI DFGLA+   T   +   ++       Y APEV     +
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRY----YRAPEVILGMGY 202
Query: 250 GEVSHKSDVYSFGMMIMELVGCK 272
            E     D++S G ++ E+V  K
Sbjct: 203 KE---NVDIWSVGCIMGEMVRHK 222

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 76/170 (44%), Gaps = 20/170 (11%)
Query: 106 DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLR 165
           +  + EV  + +  H N++ L  F  +     L+ E    G L   + +          R
Sbjct: 94  ESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR 153
Query: 166 WEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLD---EDFCPKISDFGLAKLCTT 222
                 I+  +  G+ Y+H     KI+H D+KP N+LL+   +D   +I DFGL+     
Sbjct: 154 ------IIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 204
Query: 223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMI-MELVGC 271
            + +   +    G   YIAPEV    + E   K DV+S G+++ + L GC
Sbjct: 205 SKKMKDKI----GTAYYIAPEVLHGTYDE---KCDVWSTGVILYILLSGC 247

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 44/200 (22%)
Query: 80  VKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI 139
           +KKL+  F++   Q      Y+  +L   VN         H N++ LL            
Sbjct: 54  IKKLSRPFQN---QTHAKRAYRELVLMKVVN---------HKNIIGLLNV---------- 91
Query: 140 YEFMPNGSLEKF--VY------NGDTSKPCQY-LRWEKMYEIVIGIAKGLEYLHHGCSTK 190
             F P  SLE+F  VY      + + S+  Q  L  E+M  ++  +  G+++LH   S  
Sbjct: 92  --FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLH---SAG 146
Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV-FSRNF 249
           I+H D+KP NI++  D   KI DFGLA+   T   +   ++       Y APEV     +
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRY----YRAPEVILGMGY 202
Query: 250 GEVSHKSDVYSFGMMIMELV 269
            E     D++S G ++ E++
Sbjct: 203 KE---NVDIWSVGCIMGEMI 219

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 85/188 (45%), Gaps = 27/188 (14%)
Query: 178 KGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGII 237
           +G++YLH   + +++H D+K  N+ L++D   KI DFGLA            L G     
Sbjct: 137 QGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTP--- 190
Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQ 297
            YIAPEV  +     S + D++S G ++  L+  K   ++     + +           +
Sbjct: 191 NYIAPEVLCKKGH--SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI---------K 239
Query: 298 DREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI--EMLQGSTEALQIPPT 355
             E+ +P    R  N +A  +I      + A P+ RP + E++  E        +++ PT
Sbjct: 240 KNEYSVP----RHINPVASALI---RRMLHADPTLRPSVAELLTDEFFTSGYAPMRL-PT 291
Query: 356 PFLSSPPR 363
             L+ PPR
Sbjct: 292 SCLTVPPR 299

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 76/170 (44%), Gaps = 20/170 (11%)
Query: 106 DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLR 165
           +  + EV  + +  H N++ L  F  +     L+ E    G L   + +          R
Sbjct: 95  ESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR 154
Query: 166 WEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLD---EDFCPKISDFGLAKLCTT 222
                 I+  +  G+ Y+H     KI+H D+KP N+LL+   +D   +I DFGL+     
Sbjct: 155 ------IIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 205
Query: 223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMI-MELVGC 271
            + +   +    G   YIAPEV    + E   K DV+S G+++ + L GC
Sbjct: 206 SKKMKDKI----GTAYYIAPEVLHGTYDE---KCDVWSTGVILYILLSGC 248

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 85/188 (45%), Gaps = 27/188 (14%)
Query: 178 KGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGII 237
           +G++YLH   + +++H D+K  N+ L++D   KI DFGLA            L G     
Sbjct: 153 QGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTP--- 206
Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQ 297
            YIAPEV  +     S + D++S G ++  L+  K   ++     + +           +
Sbjct: 207 NYIAPEVLCKKGH--SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI---------K 255
Query: 298 DREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI--EMLQGSTEALQIPPT 355
             E+ +P    R  N +A  +I      + A P+ RP + E++  E        +++ PT
Sbjct: 256 KNEYSVP----RHINPVASALI---RRMLHADPTLRPSVAELLTDEFFTSGYAPMRL-PT 307
Query: 356 PFLSSPPR 363
             L+ PPR
Sbjct: 308 SCLTVPPR 315

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 106/271 (39%), Gaps = 54/271 (19%)
Query: 91  LGQGGFGGVYKGR----------------------LLDDFVNEVASISRTSHVNVVTLLG 128
           LG+G FG VY  R                      +      E+   +   H N++ L  
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYN 90
Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
           +  +     LI E+ P G L K     +  K C +   ++   I+  +A  L Y H    
Sbjct: 91  YFYDRRRIYLILEYAPRGELYK-----ELQKSCTFDE-QRTATIMEELADALMYCH---G 141
Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRN 248
            K++H DIKP N+LL      KI+DFG +    +            G + Y+ PE+    
Sbjct: 142 KKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMC-----GTLDYLPPEMIEGR 196
Query: 249 FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVT 308
               + K D++  G++  EL+      +S   S +E Y      R V+ D   K P  V 
Sbjct: 197 MH--NEKVDLWCIGVLCYELLVGNPPFESA--SHNETY-----RRIVKVD--LKFPASVP 245
Query: 309 RKENEIAKKMIIVGLWCIQARPSDRPPMNEV 339
               ++  K+       ++  PS+R P+ +V
Sbjct: 246 TGAQDLISKL-------LRHNPSERLPLAQV 269

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 52/94 (55%), Gaps = 9/94 (9%)
Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           I  GLE++H+     +++ D+KP NILLDE    +ISD GLA   + K+   S      G
Sbjct: 300 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-----G 351
Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             GY+APEV  +     S  +D +S G M+ +L+
Sbjct: 352 THGYMAPEVLQKGVAYDS-SADWFSLGCMLFKLL 384

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 52/94 (55%), Gaps = 9/94 (9%)
Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           I  GLE++H+     +++ D+KP NILLDE    +ISD GLA   + K+   S      G
Sbjct: 301 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-----G 352
Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             GY+APEV  +     S  +D +S G M+ +L+
Sbjct: 353 THGYMAPEVLQKGVAYDS-SADWFSLGCMLFKLL 385

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 85/188 (45%), Gaps = 27/188 (14%)
Query: 178 KGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGII 237
           +G++YLH   + +++H D+K  N+ L++D   KI DFGLA            L G     
Sbjct: 153 QGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTP--- 206
Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQ 297
            YIAPEV  +     S + D++S G ++  L+  K   ++     + +           +
Sbjct: 207 NYIAPEVLCKKGH--SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI---------K 255
Query: 298 DREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI--EMLQGSTEALQIPPT 355
             E+ +P    R  N +A  +I      + A P+ RP + E++  E        +++ PT
Sbjct: 256 KNEYSVP----RHINPVASALI---RRMLHADPTLRPSVAELLTDEFFTSGYAPMRL-PT 307
Query: 356 PFLSSPPR 363
             L+ PPR
Sbjct: 308 SCLTVPPR 315

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 82/187 (43%), Gaps = 18/187 (9%)
Query: 89  DKLGQGGFGGVYKGRLLDDFVNEVASISRTS-HVNVVTLLGFCLEGNNRALIYEFMPNGS 147
           D  G G F       L +  + EV  + + S H N++ L           L+++ M  G 
Sbjct: 51  DVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGE 110
Query: 148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDF 207
           L  ++    T      L  ++  +I+  + + +  LH      I+H D+KP NILLD+D 
Sbjct: 111 LFDYLTEKVT------LSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDM 161
Query: 208 CPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV----FSRNFGEVSHKSDVYSFGM 263
             K++DFG +  C    G    L    G   Y+APE+     + N      + D++S G+
Sbjct: 162 NIKLTDFGFS--CQLDPG--EKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 217
Query: 264 MIMELVG 270
           ++  L+ 
Sbjct: 218 IMYTLLA 224

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 37/200 (18%)
Query: 93  QGGFGG--VYKGRLLDDFVN----EVASISRTS-HVNVVTLLGFCLEGNNRALIYEF-MP 144
           QG F G  V   R+L DF +    E+  ++ +  H NV+    +C E  +R L     + 
Sbjct: 34  QGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRY--YCSETTDRFLYIALELC 91
Query: 145 NGSLEKFVYNGDTSKPCQYLRWEKMYE---IVIGIAKGLEYLHHGCSTKILHFDIKPHNI 201
           N +L+  V + + S   + L+ +K Y    ++  IA G+ +LH   S KI+H D+KP NI
Sbjct: 92  NLNLQDLVESKNVSD--ENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNI 146
Query: 202 LLD-------------EDFCPKISDFGL-AKLCTTKEGIVSSLLGARGIIGYIAPEVF-- 245
           L+              E+    ISDFGL  KL + +     +L    G  G+ APE+   
Sbjct: 147 LVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEE 206
Query: 246 SRNFG---EVSHKSDVYSFG 262
           S N      ++   D++S G
Sbjct: 207 SNNLQTKRRLTRSIDIFSMG 226

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 44/203 (21%)
Query: 80  VKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI 139
           +KKL+  F++   Q      Y+  +L   VN         H N+++LL            
Sbjct: 54  IKKLSRPFQN---QTHAKRAYRELVLMKCVN---------HKNIISLLNV---------- 91
Query: 140 YEFMPNGSLEKF--VY------NGDTSKPCQY-LRWEKMYEIVIGIAKGLEYLHHGCSTK 190
             F P  +LE+F  VY      + +  +  Q  L  E+M  ++  +  G+++LH   S  
Sbjct: 92  --FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLH---SAG 146
Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV-FSRNF 249
           I+H D+KP NI++  D   KI DFGLA+   T   +   ++       Y APEV     +
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRY----YRAPEVILGMGY 202
Query: 250 GEVSHKSDVYSFGMMIMELVGCK 272
            E     D++S G ++ E+V  K
Sbjct: 203 KE---NVDIWSVGCIMGEMVRHK 222

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 52/94 (55%), Gaps = 9/94 (9%)
Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           I  GLE++H+     +++ D+KP NILLDE    +ISD GLA   + K+   S      G
Sbjct: 301 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-----G 352
Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             GY+APEV  +     S  +D +S G M+ +L+
Sbjct: 353 THGYMAPEVLQKGVAYDS-SADWFSLGCMLFKLL 385

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 52/94 (55%), Gaps = 9/94 (9%)
Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           I  GLE++H+     +++ D+KP NILLDE    +ISD GLA   + K+   S      G
Sbjct: 301 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-----G 352
Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             GY+APEV  +     S  +D +S G M+ +L+
Sbjct: 353 THGYMAPEVLQKGVAYDS-SADWFSLGCMLFKLL 385

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 44/203 (21%)
Query: 80  VKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI 139
           +KKL+  F++   Q      Y+  +L   VN         H N+++LL            
Sbjct: 47  IKKLSRPFQN---QTHAKRAYRELVLMKCVN---------HKNIISLLNV---------- 84
Query: 140 YEFMPNGSLEKF--VY------NGDTSKPCQY-LRWEKMYEIVIGIAKGLEYLHHGCSTK 190
             F P  +LE+F  VY      + +  +  Q  L  E+M  ++  +  G+++LH   S  
Sbjct: 85  --FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLH---SAG 139
Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV-FSRNF 249
           I+H D+KP NI++  D   KI DFGLA+   T   +   ++       Y APEV     +
Sbjct: 140 IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRY----YRAPEVILGMGY 195
Query: 250 GEVSHKSDVYSFGMMIMELVGCK 272
            E     D++S G ++ E+V  K
Sbjct: 196 KE---NVDIWSVGCIMGEMVRHK 215

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           I  GL++LH   S  I++ D+K  NILLD+D   KI+DFG+ K     +   +   G   
Sbjct: 128 IILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTP- 183
Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
              YIAPE+      + +H  D +SFG+++ E++
Sbjct: 184 --DYIAPEILLGQ--KYNHSVDWWSFGVLLYEML 213

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 89/200 (44%), Gaps = 44/200 (22%)
Query: 80  VKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI 139
           +KKL+  F++   Q      Y+  +L   VN         H N++ LL            
Sbjct: 56  IKKLSRPFQN---QTHAKRAYRELVLMKCVN---------HKNIIGLLNV---------- 93
Query: 140 YEFMPNGSLEKF-----VYNGDTSKPCQYLRWE----KMYEIVIGIAKGLEYLHHGCSTK 190
             F P  SLE+F     V     +  CQ ++ E    +M  ++  +  G+++LH   S  
Sbjct: 94  --FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAG 148
Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV-FSRNF 249
           I+H D+KP NI++  D   KI DFGLA+   T   +V  ++       Y APEV     +
Sbjct: 149 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRY----YRAPEVILGMGY 204
Query: 250 GEVSHKSDVYSFGMMIMELV 269
            E     D++S G ++ E++
Sbjct: 205 KE---NVDIWSVGCIMGEMI 221

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 95/222 (42%), Gaps = 52/222 (23%)
Query: 80  VKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI 139
           +KKL+  F++   Q      Y+  +L   VN         H N++ LL            
Sbjct: 54  IKKLSRPFQN---QTHAKRAYRELVLMKCVN---------HKNIIGLLNV---------- 91
Query: 140 YEFMPNGSLEKF-----VYNGDTSKPCQYLRWE----KMYEIVIGIAKGLEYLHHGCSTK 190
             F P  SLE+F     V     +  CQ ++ E    +M  ++  +  G+++LH   S  
Sbjct: 92  --FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAG 146
Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYI-APEV-FSRN 248
           I+H D+KP NI++  D   KI DFGLA+   T     S ++    +  Y  APEV     
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-----SFMMEPEVVTRYYRAPEVILGMG 201
Query: 249 FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHW 290
           + E     D++S G ++ E+V C   L  G D     Y   W
Sbjct: 202 YKE---NVDLWSVGCIMGEMV-CHKILFPGRD-----YIDQW 234

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 44/203 (21%)
Query: 80  VKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI 139
           +KKL+  F++   Q      Y+  +L   VN         H N+++LL            
Sbjct: 54  IKKLSRPFQN---QTHAKRAYRELVLMKCVN---------HKNIISLLNV---------- 91
Query: 140 YEFMPNGSLEKF-----VYNGDTSKPCQYLRWE----KMYEIVIGIAKGLEYLHHGCSTK 190
             F P  +LE+F     V     +  CQ ++ E    +M  ++  +  G+++LH   S  
Sbjct: 92  --FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAG 146
Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV-FSRNF 249
           I+H D+KP NI++  D   KI DFGLA+   T   +   ++       Y APEV     +
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY----YRAPEVILGMGY 202
Query: 250 GEVSHKSDVYSFGMMIMELVGCK 272
            E     D++S G ++ E+V  K
Sbjct: 203 KE---NVDIWSVGCIMGEMVRHK 222

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 44/203 (21%)
Query: 80  VKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI 139
           +KKL+  F++   Q      Y+  +L   VN         H N+++LL            
Sbjct: 55  IKKLSRPFQN---QTHAKRAYRELVLMKCVN---------HKNIISLLNV---------- 92
Query: 140 YEFMPNGSLEKF-----VYNGDTSKPCQYLRWE----KMYEIVIGIAKGLEYLHHGCSTK 190
             F P  +LE+F     V     +  CQ ++ E    +M  ++  +  G+++LH   S  
Sbjct: 93  --FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAG 147
Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV-FSRNF 249
           I+H D+KP NI++  D   KI DFGLA+   T   +   ++       Y APEV     +
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY----YRAPEVILGMGY 203
Query: 250 GEVSHKSDVYSFGMMIMELVGCK 272
            E     D++S G ++ E+V  K
Sbjct: 204 KE---NVDIWSVGCIMGEMVRHK 223

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 44/203 (21%)
Query: 80  VKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI 139
           +KKL+  F++   Q      Y+  +L   VN         H N+++LL            
Sbjct: 55  IKKLSRPFQN---QTHAKRAYRELVLMKCVN---------HKNIISLLNV---------- 92
Query: 140 YEFMPNGSLEKF-----VYNGDTSKPCQYLRWE----KMYEIVIGIAKGLEYLHHGCSTK 190
             F P  +LE+F     V     +  CQ ++ E    +M  ++  +  G+++LH   S  
Sbjct: 93  --FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAG 147
Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV-FSRNF 249
           I+H D+KP NI++  D   KI DFGLA+   T   +   ++       Y APEV     +
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY----YRAPEVILGMGY 203
Query: 250 GEVSHKSDVYSFGMMIMELVGCK 272
            E     D++S G ++ E+V  K
Sbjct: 204 KE---NVDIWSVGCIMGEMVRHK 223

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 44/203 (21%)
Query: 80  VKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI 139
           +KKL+  F++   Q      Y+  +L   VN         H N+++LL            
Sbjct: 48  IKKLSRPFQN---QTHAKRAYRELVLMKCVN---------HKNIISLLNV---------- 85
Query: 140 YEFMPNGSLEKF-----VYNGDTSKPCQYLRWE----KMYEIVIGIAKGLEYLHHGCSTK 190
             F P  +LE+F     V     +  CQ ++ E    +M  ++  +  G+++LH   S  
Sbjct: 86  --FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAG 140
Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV-FSRNF 249
           I+H D+KP NI++  D   KI DFGLA+   T   +   ++       Y APEV     +
Sbjct: 141 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY----YRAPEVILGMGY 196
Query: 250 GEVSHKSDVYSFGMMIMELVGCK 272
            E     D++S G ++ E+V  K
Sbjct: 197 KE---NVDIWSVGCIMGEMVRHK 216

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 44/203 (21%)
Query: 80  VKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI 139
           +KKL+  F++   Q      Y+  +L   VN         H N+++LL            
Sbjct: 47  IKKLSRPFQN---QTHAKRAYRELVLMKCVN---------HKNIISLLNV---------- 84
Query: 140 YEFMPNGSLEKF-----VYNGDTSKPCQYLRWE----KMYEIVIGIAKGLEYLHHGCSTK 190
             F P  +LE+F     V     +  CQ ++ E    +M  ++  +  G+++LH   S  
Sbjct: 85  --FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAG 139
Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV-FSRNF 249
           I+H D+KP NI++  D   KI DFGLA+   T   +   ++       Y APEV     +
Sbjct: 140 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY----YRAPEVILGMGY 195
Query: 250 GEVSHKSDVYSFGMMIMELVGCK 272
            E     D++S G ++ E+V  K
Sbjct: 196 KE---NVDIWSVGCIMGEMVRHK 215

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 44/203 (21%)
Query: 80  VKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI 139
           +KKL+  F++   Q      Y+  +L   VN         H N+++LL            
Sbjct: 53  IKKLSRPFQN---QTHAKRAYRELVLMKCVN---------HKNIISLLNV---------- 90
Query: 140 YEFMPNGSLEKF-----VYNGDTSKPCQYLRWE----KMYEIVIGIAKGLEYLHHGCSTK 190
             F P  +LE+F     V     +  CQ ++ E    +M  ++  +  G+++LH   S  
Sbjct: 91  --FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAG 145
Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV-FSRNF 249
           I+H D+KP NI++  D   KI DFGLA+   T   +   ++       Y APEV     +
Sbjct: 146 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY----YRAPEVILGMGY 201
Query: 250 GEVSHKSDVYSFGMMIMELVGCK 272
            E     D++S G ++ E+V  K
Sbjct: 202 KE---NVDIWSVGCIMGEMVRHK 221

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 94/221 (42%), Gaps = 50/221 (22%)
Query: 80  VKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI 139
           +KKL+  F++   Q      Y+  +L   VN         H N++ LL            
Sbjct: 59  IKKLSRPFQN---QTHAKRAYRELVLMKCVN---------HKNIIGLLNV---------- 96
Query: 140 YEFMPNGSLEKF-----VYNGDTSKPCQYLRWE----KMYEIVIGIAKGLEYLHHGCSTK 190
             F P  SLE+F     V     +  CQ ++ E    +M  ++  +  G+++LH   S  
Sbjct: 97  --FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAG 151
Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV-FSRNF 249
           I+H D+KP NI++  D   KI DFGLA+   T   +   ++       Y APEV     +
Sbjct: 152 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY----YRAPEVILGMGY 207
Query: 250 GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHW 290
            E     D++S G ++ E+V C   L  G D     Y   W
Sbjct: 208 KE---NVDLWSVGCIMGEMV-CHKILFPGRD-----YIDQW 239

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 44/203 (21%)
Query: 80  VKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI 139
           +KKL+  F++   Q      Y+  +L   VN         H N+++LL            
Sbjct: 54  IKKLSRPFQN---QTHAKRAYRELVLMKCVN---------HKNIISLLNV---------- 91
Query: 140 YEFMPNGSLEKF-----VYNGDTSKPCQYLRWE----KMYEIVIGIAKGLEYLHHGCSTK 190
             F P  +LE+F     V     +  CQ ++ E    +M  ++  +  G+++LH   S  
Sbjct: 92  --FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAG 146
Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV-FSRNF 249
           I+H D+KP NI++  D   KI DFGLA+   T   +   ++       Y APEV     +
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY----YRAPEVILGMGY 202
Query: 250 GEVSHKSDVYSFGMMIMELVGCK 272
            E     D++S G ++ E+V  K
Sbjct: 203 KE---NVDIWSVGCIMGEMVRHK 222

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 82/187 (43%), Gaps = 18/187 (9%)
Query: 89  DKLGQGGFGGVYKGRLLDDFVNEVASISRTS-HVNVVTLLGFCLEGNNRALIYEFMPNGS 147
           D  G G F       L +  + EV  + + S H N++ L           L+++ M  G 
Sbjct: 38  DVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGE 97
Query: 148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDF 207
           L  ++    T      L  ++  +I+  + + +  LH      I+H D+KP NILLD+D 
Sbjct: 98  LFDYLTEKVT------LSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDM 148
Query: 208 CPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV----FSRNFGEVSHKSDVYSFGM 263
             K++DFG +  C    G    L    G   Y+APE+     + N      + D++S G+
Sbjct: 149 NIKLTDFGFS--CQLDPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 204
Query: 264 MIMELVG 270
           ++  L+ 
Sbjct: 205 IMYTLLA 211

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 44/200 (22%)
Query: 80  VKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI 139
           +KKL+  F++   Q      Y+  +L   VN         H N++ LL            
Sbjct: 54  IKKLSRPFQN---QTHAKRAYRELVLMKVVN---------HKNIIGLLNV---------- 91
Query: 140 YEFMPNGSLEKF--VY------NGDTSKPCQY-LRWEKMYEIVIGIAKGLEYLHHGCSTK 190
             F P  SLE+F  VY      + + S+  Q  L  E+M  ++  +  G+++LH   S  
Sbjct: 92  --FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLH---SAG 146
Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV-FSRNF 249
           I+H D+KP NI++  D   KI DFGLA+   T   +   ++       Y APEV     +
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRY----YRAPEVILGMGY 202
Query: 250 GEVSHKSDVYSFGMMIMELV 269
            E     D++S G ++ E++
Sbjct: 203 KE---NVDIWSVGCIMGEMI 219

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 44/203 (21%)
Query: 80  VKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI 139
           +KKL+  F++   Q      Y+  +L   VN         H N+++LL            
Sbjct: 48  IKKLSRPFQN---QTHAKRAYRELVLMKCVN---------HKNIISLLNV---------- 85
Query: 140 YEFMPNGSLEKF-----VYNGDTSKPCQYLRWE----KMYEIVIGIAKGLEYLHHGCSTK 190
             F P  +LE+F     V     +  CQ ++ E    +M  ++  +  G+++LH   S  
Sbjct: 86  --FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAG 140
Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV-FSRNF 249
           I+H D+KP NI++  D   KI DFGLA+   T   +   ++       Y APEV     +
Sbjct: 141 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY----YRAPEVILGMGY 196
Query: 250 GEVSHKSDVYSFGMMIMELVGCK 272
            E     D++S G ++ E+V  K
Sbjct: 197 KE---NVDIWSVGCIMGEMVRHK 216

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           I  GL++LH   S  I++ D+K  NILLD+D   KI+DFG+ K     +   +   G   
Sbjct: 127 IILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTP- 182
Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
              YIAPE+      + +H  D +SFG+++ E++
Sbjct: 183 --DYIAPEILLGQ--KYNHSVDWWSFGVLLYEML 212

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 44/203 (21%)
Query: 80  VKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI 139
           +KKL+  F++   Q      Y+  +L   VN         H N+++LL            
Sbjct: 92  IKKLSRPFQN---QTHAKRAYRELVLMKCVN---------HKNIISLLNV---------- 129
Query: 140 YEFMPNGSLEKF-----VYNGDTSKPCQYLRWE----KMYEIVIGIAKGLEYLHHGCSTK 190
             F P  +LE+F     V     +  CQ ++ E    +M  ++  +  G+++LH   S  
Sbjct: 130 --FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAG 184
Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV-FSRNF 249
           I+H D+KP NI++  D   KI DFGLA+   T   +   ++       Y APEV     +
Sbjct: 185 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY----YRAPEVILGMGY 240
Query: 250 GEVSHKSDVYSFGMMIMELVGCK 272
            E     D++S G ++ E+V  K
Sbjct: 241 KE---NVDIWSVGCIMGEMVRHK 260

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 82/187 (43%), Gaps = 18/187 (9%)
Query: 89  DKLGQGGFGGVYKGRLLDDFVNEVASISRTS-HVNVVTLLGFCLEGNNRALIYEFMPNGS 147
           D  G G F       L +  + EV  + + S H N++ L           L+++ M  G 
Sbjct: 51  DVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGE 110
Query: 148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDF 207
           L  ++    T      L  ++  +I+  + + +  LH      I+H D+KP NILLD+D 
Sbjct: 111 LFDYLTEKVT------LSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDM 161
Query: 208 CPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV----FSRNFGEVSHKSDVYSFGM 263
             K++DFG +  C    G    L    G   Y+APE+     + N      + D++S G+
Sbjct: 162 NIKLTDFGFS--CQLDPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 217
Query: 264 MIMELVG 270
           ++  L+ 
Sbjct: 218 IMYTLLA 224

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 94/221 (42%), Gaps = 50/221 (22%)
Query: 80  VKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI 139
           +KKL+  F++   Q      Y+  +L   VN         H N++ LL            
Sbjct: 48  IKKLSRPFQN---QTHAKRAYRELVLMKCVN---------HKNIIGLLNV---------- 85
Query: 140 YEFMPNGSLEKF-----VYNGDTSKPCQYLRWE----KMYEIVIGIAKGLEYLHHGCSTK 190
             F P  SLE+F     V     +  CQ ++ E    +M  ++  +  G+++LH   S  
Sbjct: 86  --FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAG 140
Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV-FSRNF 249
           I+H D+KP NI++  D   KI DFGLA+   T   +   ++       Y APEV     +
Sbjct: 141 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY----YRAPEVILGMGY 196
Query: 250 GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHW 290
            E     D++S G ++ E+V C   L  G D     Y   W
Sbjct: 197 KE---NVDLWSVGCIMGEMV-CHKILFPGRD-----YIDQW 228

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 89/213 (41%), Gaps = 37/213 (17%)
Query: 87  FKDKLGQGGFGGVYKGRLLDDFVN-------------EVASISRTSHVNVVTLLGFCLEG 133
            ++ +G+G FG V++G+   + V                A I +T  +    +LGF    
Sbjct: 46  LQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 134 NNRA-------LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH- 185
           N          L+ ++  +GSL  ++     +        E M ++ +  A GL +LH  
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV-------EGMIKLALSTASGLAHLHME 158
Query: 186 --GCSTK--ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGAR-GIIGYI 240
             G   K  I H D+K  NIL+ ++    I+D GLA    +    +      R G   Y+
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 241 APEVFSRNFG----EVSHKSDVYSFGMMIMELV 269
           APEV   +      E   ++D+Y+ G++  E+ 
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 44/203 (21%)
Query: 80  VKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI 139
           +KKL+  F++   Q      Y+  +L   VN         H N+++LL            
Sbjct: 92  IKKLSRPFQN---QTHAKRAYRELVLMKCVN---------HKNIISLLNV---------- 129
Query: 140 YEFMPNGSLEKF-----VYNGDTSKPCQYLRWE----KMYEIVIGIAKGLEYLHHGCSTK 190
             F P  +LE+F     V     +  CQ ++ E    +M  ++  +  G+++LH   S  
Sbjct: 130 --FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAG 184
Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV-FSRNF 249
           I+H D+KP NI++  D   KI DFGLA+   T   +   ++       Y APEV     +
Sbjct: 185 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY----YRAPEVILGMGY 240
Query: 250 GEVSHKSDVYSFGMMIMELVGCK 272
            E     D++S G ++ E+V  K
Sbjct: 241 KE---NVDIWSVGCIMGEMVRHK 260

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 89/213 (41%), Gaps = 37/213 (17%)
Query: 87  FKDKLGQGGFGGVYKGRLLDDFVN-------------EVASISRTSHVNVVTLLGFCLEG 133
            ++ +G+G FG V++G+   + V                A I +T  +    +LGF    
Sbjct: 8   LQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 67
Query: 134 NNRA-------LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH- 185
           N          L+ ++  +GSL  ++     +        E M ++ +  A GL +LH  
Sbjct: 68  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV-------EGMIKLALSTASGLAHLHME 120
Query: 186 --GCSTK--ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGAR-GIIGYI 240
             G   K  I H D+K  NIL+ ++    I+D GLA    +    +      R G   Y+
Sbjct: 121 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 180
Query: 241 APEVFSRNFG----EVSHKSDVYSFGMMIMELV 269
           APEV   +      E   ++D+Y+ G++  E+ 
Sbjct: 181 APEVLDDSINMKHFESFKRADIYAMGLVFWEIA 213

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 40/169 (23%), Positives = 78/169 (46%), Gaps = 15/169 (8%)
Query: 101 KGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKP 160
           K  + +  + E+  +   +   +V   G        ++  E M  GSL++ +      K 
Sbjct: 47  KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL------KK 100
Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
              +  + + ++ I + KGL YL      KI+H D+KP NIL++     K+ DFG++   
Sbjct: 101 AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 158
Query: 221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             +  + +  +G R    Y++PE        V  +SD++S G+ ++E+ 
Sbjct: 159 IDE--MANEFVGTR---SYMSPERLQGTHYSV--QSDIWSMGLSLVEMA 200

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 44/203 (21%)
Query: 80  VKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI 139
           +KKL+  F++   Q      Y+  +L   VN         H N+++LL            
Sbjct: 54  IKKLSRPFQN---QTHAKRAYRELVLMKXVN---------HKNIISLLNV---------- 91
Query: 140 YEFMPNGSLEKF--VY------NGDTSKPCQY-LRWEKMYEIVIGIAKGLEYLHHGCSTK 190
             F P  +LE+F  VY      + +  +  Q  L  E+M  ++  +  G+++LH   S  
Sbjct: 92  --FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLCGIKHLH---SAG 146
Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV-FSRNF 249
           I+H D+KP NI++  D   KI DFGLA+   T   +   ++       Y APEV     +
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRY----YRAPEVILGMGY 202
Query: 250 GEVSHKSDVYSFGMMIMELVGCK 272
            E     D++S G ++ E+V  K
Sbjct: 203 KE---NVDIWSVGCIMGEMVRHK 222

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 44/200 (22%)
Query: 80  VKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI 139
           +KKL+  F++   Q      Y+  +L   VN         H N++ LL            
Sbjct: 54  IKKLSRPFQN---QTHAKRAYRELVLMKCVN---------HKNIIGLLNV---------- 91
Query: 140 YEFMPNGSLEKF-----VYNGDTSKPCQYLRWE----KMYEIVIGIAKGLEYLHHGCSTK 190
             F P  SLE+F     V     +  CQ ++ E    +M  ++  +  G+++LH   S  
Sbjct: 92  --FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAG 146
Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV-FSRNF 249
           I+H D+KP NI++  D   KI DFGLA+   T   +   ++       Y APEV     +
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRY----YRAPEVILGMGY 202
Query: 250 GEVSHKSDVYSFGMMIMELV 269
            E     D++S G ++ E++
Sbjct: 203 KE---NVDIWSVGCIMGEMI 219

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 89/213 (41%), Gaps = 37/213 (17%)
Query: 87  FKDKLGQGGFGGVYKGRLLDDFVN-------------EVASISRTSHVNVVTLLGFCLEG 133
            ++ +G+G FG V++G+   + V                A I +T  +    +LGF    
Sbjct: 33  LQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 92
Query: 134 NNRA-------LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH- 185
           N          L+ ++  +GSL  ++     +        E M ++ +  A GL +LH  
Sbjct: 93  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV-------EGMIKLALSTASGLAHLHME 145
Query: 186 --GCSTK--ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGAR-GIIGYI 240
             G   K  I H D+K  NIL+ ++    I+D GLA    +    +      R G   Y+
Sbjct: 146 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 205
Query: 241 APEVFSRNFG----EVSHKSDVYSFGMMIMELV 269
           APEV   +      E   ++D+Y+ G++  E+ 
Sbjct: 206 APEVLDDSINMKHFESFKRADIYAMGLVFWEIA 238

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 89/213 (41%), Gaps = 37/213 (17%)
Query: 87  FKDKLGQGGFGGVYKGRLLDDFVN-------------EVASISRTSHVNVVTLLGFCLEG 133
            ++ +G+G FG V++G+   + V                A I +T  +    +LGF    
Sbjct: 7   LQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 134 NNRA-------LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH- 185
           N          L+ ++  +GSL  ++     +        E M ++ +  A GL +LH  
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV-------EGMIKLALSTASGLAHLHME 119
Query: 186 --GCSTK--ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGAR-GIIGYI 240
             G   K  I H D+K  NIL+ ++    I+D GLA    +    +      R G   Y+
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 241 APEVFSRNFG----EVSHKSDVYSFGMMIMELV 269
           APEV   +      E   ++D+Y+ G++  E+ 
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 89/213 (41%), Gaps = 37/213 (17%)
Query: 87  FKDKLGQGGFGGVYKGRLLDDFVN-------------EVASISRTSHVNVVTLLGFCLEG 133
            ++ +G+G FG V++G+   + V                A I +T  +    +LGF    
Sbjct: 10  LQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 69
Query: 134 NNRA-------LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH- 185
           N          L+ ++  +GSL  ++     +        E M ++ +  A GL +LH  
Sbjct: 70  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV-------EGMIKLALSTASGLAHLHME 122
Query: 186 --GCSTK--ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGAR-GIIGYI 240
             G   K  I H D+K  NIL+ ++    I+D GLA    +    +      R G   Y+
Sbjct: 123 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 182
Query: 241 APEVFSRNFG----EVSHKSDVYSFGMMIMELV 269
           APEV   +      E   ++D+Y+ G++  E+ 
Sbjct: 183 APEVLDDSINMKHFESFKRADIYAMGLVFWEIA 215

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/272 (21%), Positives = 109/272 (40%), Gaps = 65/272 (23%)
Query: 89  DKLGQGGFGGVYK--GRL-------------LDDFVNEVASISRT-------SHVNVVTL 126
           +K+G G FG V+K   RL             L   V+E  ++           H +VV  
Sbjct: 13  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 72
Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                E ++  +  E+   GSL   +   +  +   Y +  ++ ++++ + +GL Y+H  
Sbjct: 73  FSAWAEDDHMLIQNEYCNGGSLADAI--SENYRIMSYFKEAELKDLLLQVGRGLRYIH-- 128
Query: 187 CSTKILHFDIKPHNILLDEDFCP-------------------KISDFGLAKLCTTKEGIV 227
            S  ++H DIKP NI +     P                   KI D G      T+   +
Sbjct: 129 -SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG----HVTR---I 180
Query: 228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYF 287
           SS     G   ++A EV   N+  +  K+D+++  + ++   G +    +G         
Sbjct: 181 SSPQVEEGDSRFLANEVLQENYTHLP-KADIFALALTVVXAAGAEPLPRNGDQ------- 232
Query: 288 PHWIYRHVEQDREFKLPGVVTRKENEIAKKMI 319
               +  + Q R  ++P V++++  E+ K MI
Sbjct: 233 ----WHEIRQGRLPRIPQVLSQEFTELLKVMI 260

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 99/222 (44%), Gaps = 28/222 (12%)
Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRA--LIYEFMPNGSLEKFVYNGDTS---KPCQYLR 165
           E+A +    H NV++L    L   +R   L++++  +       ++  +    KP Q  R
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 127
Query: 166 WEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL----DEDFCPKISDFGLAKLCT 221
              +  ++  I  G+ YLH   +  +LH D+KP NIL+     E    KI+D G A+L  
Sbjct: 128 -GMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 183
Query: 222 TKEGIVSSLLGARGIIGYIAPEVF--SRNFGEVSHKSDVYSFGMMIMELVGCK---NNLD 276
           +    ++ L        Y APE+   +R++ +     D+++ G +  EL+  +   +   
Sbjct: 184 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKA---IDIWAIGCIFAELLTSEPIFHCRQ 240
Query: 277 SGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKM 318
             + +S+        Y H + DR F + G    K+ E  KKM
Sbjct: 241 EDIKTSNP-------YHHDQLDRIFNVMGFPADKDWEDIKKM 275

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 44/200 (22%)
Query: 80  VKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI 139
           +KKL+  F++   Q      Y+  +L   VN         H N++ LL            
Sbjct: 54  IKKLSRPFQN---QTHAKRAYRELVLMKCVN---------HKNIIGLLNV---------- 91
Query: 140 YEFMPNGSLEKF--VY------NGDTSKPCQY-LRWEKMYEIVIGIAKGLEYLHHGCSTK 190
             F P  SLE+F  VY      + + S+  Q  L  E+M  ++  +  G+++LH   S  
Sbjct: 92  --FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLH---SAG 146
Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV-FSRNF 249
           I+H D+KP NI++  D   KI DFGLA+   T   +   ++       Y APEV     +
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRY----YRAPEVILGMGY 202
Query: 250 GEVSHKSDVYSFGMMIMELV 269
            E     D++S G ++ E++
Sbjct: 203 KE---NVDIWSVGCIMGEMI 219

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 89/213 (41%), Gaps = 37/213 (17%)
Query: 87  FKDKLGQGGFGGVYKGRLLDDFVN-------------EVASISRTSHVNVVTLLGFCLEG 133
            ++ +G+G FG V++G+   + V                A I +T  +    +LGF    
Sbjct: 13  LQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 72
Query: 134 NNRA-------LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH- 185
           N          L+ ++  +GSL  ++     +        E M ++ +  A GL +LH  
Sbjct: 73  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV-------EGMIKLALSTASGLAHLHME 125
Query: 186 --GCSTK--ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGAR-GIIGYI 240
             G   K  I H D+K  NIL+ ++    I+D GLA    +    +      R G   Y+
Sbjct: 126 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 185
Query: 241 APEVFSRNFG----EVSHKSDVYSFGMMIMELV 269
           APEV   +      E   ++D+Y+ G++  E+ 
Sbjct: 186 APEVLDDSINMKHFESFKRADIYAMGLVFWEIA 218

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 44/200 (22%)
Query: 80  VKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI 139
           +KKL+  F++   Q      Y+  +L   VN         H N++ LL            
Sbjct: 54  IKKLSRPFQN---QTHAKRAYRELVLMKCVN---------HKNIIGLLNV---------- 91
Query: 140 YEFMPNGSLEKF--VY------NGDTSKPCQY-LRWEKMYEIVIGIAKGLEYLHHGCSTK 190
             F P  SLE+F  VY      + + S+  Q  L  E+M  ++  +  G+++LH   S  
Sbjct: 92  --FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLH---SAG 146
Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV-FSRNF 249
           I+H D+KP NI++  D   KI DFGLA+   T   +   ++       Y APEV     +
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY----YRAPEVILGMGY 202
Query: 250 GEVSHKSDVYSFGMMIMELV 269
            E     D++S G ++ E++
Sbjct: 203 KE---NVDIWSVGCIMGEMI 219

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 44/200 (22%)
Query: 80  VKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI 139
           +KKL+  F++   Q      Y+  +L   VN         H N++ LL            
Sbjct: 54  IKKLSRPFQN---QTHAKRAYRELVLMKCVN---------HKNIIGLLNV---------- 91
Query: 140 YEFMPNGSLEKF-----VYNGDTSKPCQYLRWE----KMYEIVIGIAKGLEYLHHGCSTK 190
             F P  SLE+F     V     +  CQ ++ E    +M  ++  +  G+++LH   S  
Sbjct: 92  --FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAG 146
Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV-FSRNF 249
           I+H D+KP NI++  D   KI DFGLA+   T   +   ++       Y APEV     +
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY----YRAPEVILGMGY 202
Query: 250 GEVSHKSDVYSFGMMIMELV 269
            E     D++S G ++ E++
Sbjct: 203 KE---NVDIWSVGCIMGEMI 219

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 44/200 (22%)
Query: 80  VKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI 139
           +KKL+  F++   Q      Y+  +L   VN         H N++ LL            
Sbjct: 55  IKKLSRPFQN---QTHAKRAYRELVLMKCVN---------HKNIIGLLNV---------- 92
Query: 140 YEFMPNGSLEKF-----VYNGDTSKPCQYLRWE----KMYEIVIGIAKGLEYLHHGCSTK 190
             F P  SLE+F     V     +  CQ ++ E    +M  ++  +  G+++LH   S  
Sbjct: 93  --FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAG 147
Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV-FSRNF 249
           I+H D+KP NI++  D   KI DFGLA+   T   +   ++       Y APEV     +
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY----YRAPEVILGMGY 203
Query: 250 GEVSHKSDVYSFGMMIMELV 269
            E     D++S G ++ E++
Sbjct: 204 KE---NVDIWSVGCIMGEMI 220

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 73/166 (43%), Gaps = 16/166 (9%)
Query: 105 LDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQY 163
           L     EV  +   +H N+V L           LI E+   G + +  V +G   +    
Sbjct: 58  LQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEAR 117
Query: 164 LRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK 223
            ++ +       I   ++Y H     +I+H D+K  N+LLD D   KI+DFG +   T  
Sbjct: 118 SKFRQ-------IVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167
Query: 224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            G + +  GA     Y APE+F     +   + DV+S G+++  LV
Sbjct: 168 -GKLDAFCGAP---PYAAPELFQGKKYD-GPEVDVWSLGVILYTLV 208

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 8/94 (8%)
Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           I   LEYLH   S  +++ DIK  N++LD+D   KI+DFGL K   +    + +  G   
Sbjct: 114 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP- 169
Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
              Y+APEV   N  +     D +  G+++ E++
Sbjct: 170 --EYLAPEVLEDN--DYGRAVDWWGLGVVMYEMM 199

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 44/200 (22%)
Query: 80  VKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI 139
           +KKL+  F++   Q      Y+  +L   VN         H N++ LL            
Sbjct: 54  IKKLSRPFQN---QTHAKRAYRELVLMKCVN---------HKNIIGLLNV---------- 91
Query: 140 YEFMPNGSLEKF-----VYNGDTSKPCQYLRWE----KMYEIVIGIAKGLEYLHHGCSTK 190
             F P  SLE+F     V     +  CQ ++ E    +M  ++  +  G+++LH   S  
Sbjct: 92  --FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAG 146
Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV-FSRNF 249
           I+H D+KP NI++  D   KI DFGLA+   T   +   ++       Y APEV     +
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY----YRAPEVILGMGY 202
Query: 250 GEVSHKSDVYSFGMMIMELV 269
            E     D++S G ++ E++
Sbjct: 203 KE---NVDIWSVGCIMGEMI 219

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 8/94 (8%)
Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           I   LEYLH   S  +++ DIK  N++LD+D   KI+DFGL K   +    + +  G   
Sbjct: 114 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP- 169
Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
              Y+APEV   N  +     D +  G+++ E++
Sbjct: 170 --EYLAPEVLEDN--DYGRAVDWWGLGVVMYEMM 199

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 77/161 (47%), Gaps = 20/161 (12%)
Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEK 168
            E+  + + +H  ++ +  F  +  +  ++ E M  G L +K V N    +    L +  
Sbjct: 64  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-- 120
Query: 169 MYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL---DEDFCPKISDFGLAKLCTTKEG 225
            Y++++ +    +YLH      I+H D+KP N+LL   +ED   KI+DFG +K+     G
Sbjct: 121 -YQMLLAV----QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----G 168
Query: 226 IVSSLLGARGIIGYIAPEVF-SRNFGEVSHKSDVYSFGMMI 265
             S +    G   Y+APEV  S      +   D +S G+++
Sbjct: 169 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 8/94 (8%)
Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           I   LEYLH   S  +++ DIK  N++LD+D   KI+DFGL K   +    + +  G   
Sbjct: 117 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT-- 171
Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
              Y+APEV   N  +     D +  G+++ E++
Sbjct: 172 -PEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMM 202

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 77/161 (47%), Gaps = 20/161 (12%)
Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEK 168
            E+  + + +H  ++ +  F  +  +  ++ E M  G L +K V N    +    L +  
Sbjct: 63  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-- 119
Query: 169 MYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL---DEDFCPKISDFGLAKLCTTKEG 225
            Y++++ +    +YLH      I+H D+KP N+LL   +ED   KI+DFG +K+     G
Sbjct: 120 -YQMLLAV----QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----G 167
Query: 226 IVSSLLGARGIIGYIAPEVF-SRNFGEVSHKSDVYSFGMMI 265
             S +    G   Y+APEV  S      +   D +S G+++
Sbjct: 168 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 208

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 52/93 (55%), Gaps = 9/93 (9%)
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG 238
            +EY H     KI+H D+KP N+LLD++   KI+DFGL+ + T    + +S     G   
Sbjct: 120 AIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC----GSPN 172
Query: 239 YIAPEVFSRNFGEVSHKSDVYSFGMMI-MELVG 270
           Y APEV +        + DV+S G+++ + LVG
Sbjct: 173 YAAPEVINGKL-YAGPEVDVWSCGIVLYVMLVG 204

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 77/161 (47%), Gaps = 20/161 (12%)
Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEK 168
            E+  + + +H  ++ +  F  +  +  ++ E M  G L +K V N    +    L +  
Sbjct: 64  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-- 120
Query: 169 MYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL---DEDFCPKISDFGLAKLCTTKEG 225
            Y++++ +    +YLH      I+H D+KP N+LL   +ED   KI+DFG +K+     G
Sbjct: 121 -YQMLLAV----QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----G 168
Query: 226 IVSSLLGARGIIGYIAPEVF-SRNFGEVSHKSDVYSFGMMI 265
             S +    G   Y+APEV  S      +   D +S G+++
Sbjct: 169 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 77/161 (47%), Gaps = 20/161 (12%)
Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEK 168
            E+  + + +H  ++ +  F  +  +  ++ E M  G L +K V N    +    L +  
Sbjct: 64  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-- 120
Query: 169 MYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL---DEDFCPKISDFGLAKLCTTKEG 225
            Y++++ +    +YLH      I+H D+KP N+LL   +ED   KI+DFG +K+     G
Sbjct: 121 -YQMLLAV----QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----G 168
Query: 226 IVSSLLGARGIIGYIAPEVF-SRNFGEVSHKSDVYSFGMMI 265
             S +    G   Y+APEV  S      +   D +S G+++
Sbjct: 169 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 52/96 (54%), Gaps = 12/96 (12%)
Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV--SSLLGA 233
           I   LEYLH   S  +++ DIK  N++LD+D   KI+DFGL      KEGI   +++   
Sbjct: 114 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLC-----KEGISDGATMKXF 165
Query: 234 RGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            G   Y+APEV   N  +     D +  G+++ E++
Sbjct: 166 CGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMM 199

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 77/161 (47%), Gaps = 20/161 (12%)
Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEK 168
            E+  + + +H  ++ +  F  +  +  ++ E M  G L +K V N    +    L +  
Sbjct: 70  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-- 126
Query: 169 MYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL---DEDFCPKISDFGLAKLCTTKEG 225
            Y++++ +    +YLH      I+H D+KP N+LL   +ED   KI+DFG +K+     G
Sbjct: 127 -YQMLLAV----QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----G 174
Query: 226 IVSSLLGARGIIGYIAPEVF-SRNFGEVSHKSDVYSFGMMI 265
             S +    G   Y+APEV  S      +   D +S G+++
Sbjct: 175 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 215

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 52/96 (54%), Gaps = 12/96 (12%)
Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV--SSLLGA 233
           I   LEYLH   S  +++ DIK  N++LD+D   KI+DFGL      KEGI   +++   
Sbjct: 119 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLC-----KEGISDGATMKXF 170
Query: 234 RGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            G   Y+APEV   N  +     D +  G+++ E++
Sbjct: 171 CGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMM 204

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/272 (21%), Positives = 109/272 (40%), Gaps = 65/272 (23%)
Query: 89  DKLGQGGFGGVYK--GRL-------------LDDFVNEVASISRT-------SHVNVVTL 126
           +K+G G FG V+K   RL             L   V+E  ++           H +VV  
Sbjct: 15  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 74
Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                E ++  +  E+   GSL   +   +  +   Y +  ++ ++++ + +GL Y+H  
Sbjct: 75  FSAWAEDDHMLIQNEYCNGGSLADAI--SENYRIMSYFKEAELKDLLLQVGRGLRYIH-- 130
Query: 187 CSTKILHFDIKPHNILLDEDFCP-------------------KISDFGLAKLCTTKEGIV 227
            S  ++H DIKP NI +     P                   KI D G      T+   +
Sbjct: 131 -SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG----HVTR---I 182
Query: 228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYF 287
           SS     G   ++A EV   N+  +  K+D+++  + ++   G +    +G         
Sbjct: 183 SSPQVEEGDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAEPLPRNGDQ------- 234
Query: 288 PHWIYRHVEQDREFKLPGVVTRKENEIAKKMI 319
               +  + Q R  ++P V++++  E+ K MI
Sbjct: 235 ----WHEIRQGRLPRIPQVLSQEFTELLKVMI 262

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 52/96 (54%), Gaps = 12/96 (12%)
Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV--SSLLGA 233
           I   LEYLH   S  +++ DIK  N++LD+D   KI+DFGL      KEGI   +++   
Sbjct: 114 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLC-----KEGISDGATMKXF 165
Query: 234 RGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            G   Y+APEV   N  +     D +  G+++ E++
Sbjct: 166 CGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMM 199

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 52/96 (54%), Gaps = 12/96 (12%)
Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV--SSLLGA 233
           I   LEYLH   S  +++ DIK  N++LD+D   KI+DFGL      KEGI   +++   
Sbjct: 114 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLC-----KEGISDGATMKXF 165
Query: 234 RGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            G   Y+APEV   N  +     D +  G+++ E++
Sbjct: 166 CGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMM 199

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 67/159 (42%), Gaps = 44/159 (27%)
Query: 90  KLGQGGFGGVYKGRLLDDFVNEVASISRT-----------------------SHVNVVTL 126
           KLG+G +G VYK   +D   NE  +I R                         H N++ L
Sbjct: 41  KLGEGTYGEVYKA--IDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIEL 98
Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEK--MYEIVIGIAKGLEYLH 184
                  +   LI+E+  N   +    N D S     +R  K  +Y+++     G+ + H
Sbjct: 99  KSVIHHNHRLHLIFEYAENDLKKYMDKNPDVS-----MRVIKSFLYQLI----NGVNFCH 149
Query: 185 HGCSTKILHFDIKPHNILL---DEDFCP--KISDFGLAK 218
              S + LH D+KP N+LL   D    P  KI DFGLA+
Sbjct: 150 ---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/272 (21%), Positives = 109/272 (40%), Gaps = 65/272 (23%)
Query: 89  DKLGQGGFGGVYK--GRL-------------LDDFVNEVASISRT-------SHVNVVTL 126
           +K+G G FG V+K   RL             L   V+E  ++           H +VV  
Sbjct: 15  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 74
Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                E ++  +  E+   GSL   +   +  +   Y +  ++ ++++ + +GL Y+H  
Sbjct: 75  FSAWAEDDHMLIQNEYCNGGSLADAI--SENYRIMSYFKEAELKDLLLQVGRGLRYIH-- 130
Query: 187 CSTKILHFDIKPHNILLDEDFCP-------------------KISDFGLAKLCTTKEGIV 227
            S  ++H DIKP NI +     P                   KI D G      T+   +
Sbjct: 131 -SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG----HVTR---I 182
Query: 228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYF 287
           SS     G   ++A EV   N+  +  K+D+++  + ++   G +    +G         
Sbjct: 183 SSPQVEEGDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAEPLPRNGDQ------- 234
Query: 288 PHWIYRHVEQDREFKLPGVVTRKENEIAKKMI 319
               +  + Q R  ++P V++++  E+ K MI
Sbjct: 235 ----WHEIRQGRLPRIPQVLSQEFTELLKVMI 262

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 85/193 (44%), Gaps = 24/193 (12%)
Query: 87  FKDKLGQGGFGGVY--KGRLLDDFVN-EVASISRTSHVNVVTLLGFCLEGNNRALIYEFM 143
            +DKL +      Y  +G  +D+ V  E+ +     H N+V      L   + A+I E+ 
Sbjct: 39  MRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98
Query: 144 PNGSL-EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNIL 202
             G L E+    G  S+      ++++         G+ Y H   S +I H D+K  N L
Sbjct: 99  SGGELYERICNAGRFSEDEARFFFQQLL-------SGVSYCH---SMQICHRDLKLENTL 148
Query: 203 LDEDFCP--KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHK-SDVY 259
           LD    P  KI DFG +K         S++    G   YIAPEV  R   E   K +DV+
Sbjct: 149 LDGSPAPRLKICDFGYSKSSVLHSQPKSTV----GTPAYIAPEVLLRQ--EYDGKIADVW 202
Query: 260 SFGMMI-MELVGC 271
           S G+ + + LVG 
Sbjct: 203 SCGVTLYVMLVGA 215

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 70/147 (47%), Gaps = 22/147 (14%)
Query: 127 LGFCLEGN-NRALIYEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEIVIGIAKGLEYLH 184
           L F  + N N  ++ E+MP G +   +   G  S+P       + Y   I +    EYLH
Sbjct: 106 LEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHA-----RFYAAQIVLT--FEYLH 158
Query: 185 HGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE- 243
              S  +++ D+KP N+L+D+    K++DFG AK    +   +       G   Y+APE 
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC------GTPEYLAPEI 209
Query: 244 VFSRNFGEVSHKSDVYSFGMMIMELVG 270
           + S+ + +     D ++ G++I E+  
Sbjct: 210 ILSKGYNKA---VDWWALGVLIYEMAA 233

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 37/210 (17%)
Query: 90  KLGQGGFGGVYKGRLLDD-------FVNEVASISRTS---------HVNVVTLLGFCLEG 133
           ++G+G +G V+ G+   +       F  E AS  R +         H N++  +   ++G
Sbjct: 44  QIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKG 103
Query: 134 NNRA----LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC-S 188
                   LI ++  NGSL  ++ +         L  + M ++      GL +LH    S
Sbjct: 104 TGSWTQLYLITDYHENGSLYDYLKSTT-------LDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 189 TK----ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGAR-GIIGYIAPE 243
           T+    I H D+K  NIL+ ++    I+D GLA    +    V      R G   Y+ PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 244 V----FSRNFGEVSHKSDVYSFGMMIMELV 269
           V     +RN  +    +D+YSFG+++ E+ 
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 20/168 (11%)
Query: 108 FVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWE 167
            + EV  + +  H N+  L  F  +     L+ E    G L   + +          R  
Sbjct: 73  LLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR-- 130
Query: 168 KMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLD---EDFCPKISDFGLAKLCTTKE 224
               I+  +  G+ Y H     KI+H D+KP N+LL+   +D   +I DFGL+      +
Sbjct: 131 ----IIRQVLSGITYXH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183
Query: 225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMI-MELVGC 271
                +    G   YIAPEV    + E   K DV+S G+++ + L GC
Sbjct: 184 KXKDKI----GTAYYIAPEVLHGTYDE---KCDVWSTGVILYILLSGC 224

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 70/147 (47%), Gaps = 22/147 (14%)
Query: 127 LGFCLEGN-NRALIYEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEIVIGIAKGLEYLH 184
           L F  + N N  ++ E+MP G +   +   G  S+P       + Y   I +    EYLH
Sbjct: 106 LEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHA-----RFYAAQIVLT--FEYLH 158
Query: 185 HGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE- 243
              S  +++ D+KP N+L+D+    K++DFG AK    +   +       G   Y+APE 
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC------GTPEYLAPEI 209
Query: 244 VFSRNFGEVSHKSDVYSFGMMIMELVG 270
           + S+ + +     D ++ G++I E+  
Sbjct: 210 ILSKGYNKA---VDWWALGVLIYEMAA 233

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 68/137 (49%), Gaps = 10/137 (7%)
Query: 143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNIL 202
           + + SL+KF Y     K  Q +  + + +I + I K LE+LH   S  ++H D+KP N+L
Sbjct: 114 LXDTSLDKF-YKQVIDK-GQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVL 169
Query: 203 LDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGE--VSHKSDVYS 260
           ++     K  DFG++         V+  + A G   Y APE  +    +   S KSD++S
Sbjct: 170 INALGQVKXCDFGISGYLVDD---VAKDIDA-GCKPYXAPERINPELNQKGYSVKSDIWS 225
Query: 261 FGMMIMELVGCKNNLDS 277
            G+  +EL   +   DS
Sbjct: 226 LGITXIELAILRFPYDS 242

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/272 (21%), Positives = 109/272 (40%), Gaps = 65/272 (23%)
Query: 89  DKLGQGGFGGVYK--GRL-------------LDDFVNEVASISRT-------SHVNVVTL 126
           +K+G G FG V+K   RL             L   V+E  ++           H +VV  
Sbjct: 17  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76
Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                E ++  +  E+   GSL   +   +  +   Y +  ++ ++++ + +GL Y+H  
Sbjct: 77  FSAWAEDDHMLIQNEYCNGGSLADAI--SENYRIMSYFKEAELKDLLLQVGRGLRYIH-- 132
Query: 187 CSTKILHFDIKPHNILLDEDFCP-------------------KISDFGLAKLCTTKEGIV 227
            S  ++H DIKP NI +     P                   KI D G      T+   +
Sbjct: 133 -SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG----HVTR---I 184
Query: 228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYF 287
           SS     G   ++A EV   N+  +  K+D+++  + ++   G +    +G         
Sbjct: 185 SSPQVEEGDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAEPLPRNGDQ------- 236
Query: 288 PHWIYRHVEQDREFKLPGVVTRKENEIAKKMI 319
               +  + Q R  ++P V++++  E+ K MI
Sbjct: 237 ----WHEIRQGRLPRIPQVLSQEFTELLKVMI 264

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 81/197 (41%), Gaps = 35/197 (17%)
Query: 89  DKLGQGGFGGVYK-------GRLLDDFV------------NEVASISRTSHVNVVTLLGF 129
           ++LG G FG V++             FV             E+ ++S   H  +V L   
Sbjct: 57  EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 116
Query: 130 CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCST 189
             + N   +IYEFM  G L + V +         +  ++  E +  + KGL ++H     
Sbjct: 117 FEDDNEMVMIYEFMSGGELFEKVADEHNK-----MSEDEAVEYMRQVCKGLCHMH---EN 168
Query: 190 KILHFDIKPHNILLDEDFCP--KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSR 247
             +H D+KP NI+         K+ DFGL      K+ +  +     G   + APEV   
Sbjct: 169 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT----GTAEFAAPEVAEG 224
Query: 248 NFGEVSHKSDVYSFGMM 264
               V + +D++S G++
Sbjct: 225 K--PVGYYTDMWSVGVL 239

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 81/197 (41%), Gaps = 35/197 (17%)
Query: 89  DKLGQGGFGGVYK-------GRLLDDFV------------NEVASISRTSHVNVVTLLGF 129
           ++LG G FG V++             FV             E+ ++S   H  +V L   
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 222
Query: 130 CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCST 189
             + N   +IYEFM  G L + V +         +  ++  E +  + KGL ++H     
Sbjct: 223 FEDDNEMVMIYEFMSGGELFEKVADEHNK-----MSEDEAVEYMRQVCKGLCHMH---EN 274
Query: 190 KILHFDIKPHNILLDEDFCP--KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSR 247
             +H D+KP NI+         K+ DFGL      K+ +  +     G   + APEV   
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT----GTAEFAAPEVAEG 330
Query: 248 NFGEVSHKSDVYSFGMM 264
               V + +D++S G++
Sbjct: 331 K--PVGYYTDMWSVGVL 345

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 77/162 (47%), Gaps = 20/162 (12%)
Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEK 168
            E+  + + +H  ++ +  F  +  +  ++ E M  G L +K V N    +    L +  
Sbjct: 189 TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-- 245
Query: 169 MYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL---DEDFCPKISDFGLAKLCTTKEG 225
            Y++++ +    +YLH      I+H D+KP N+LL   +ED   KI+DFG +K+     G
Sbjct: 246 -YQMLLAV----QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----G 293
Query: 226 IVSSLLGARGIIGYIAPEVF-SRNFGEVSHKSDVYSFGMMIM 266
             S +    G   Y+APEV  S      +   D +S G+++ 
Sbjct: 294 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 335

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 77/162 (47%), Gaps = 20/162 (12%)
Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEK 168
            E+  + + +H  ++ +  F  +  +  ++ E M  G L +K V N    +    L +  
Sbjct: 203 TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-- 259
Query: 169 MYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL---DEDFCPKISDFGLAKLCTTKEG 225
            Y++++ +    +YLH      I+H D+KP N+LL   +ED   KI+DFG +K+     G
Sbjct: 260 -YQMLLAV----QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----G 307
Query: 226 IVSSLLGARGIIGYIAPEVF-SRNFGEVSHKSDVYSFGMMIM 266
             S +    G   Y+APEV  S      +   D +S G+++ 
Sbjct: 308 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 349

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 52/97 (53%), Gaps = 14/97 (14%)
Query: 172 IVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP----KISDFGLAKLCTTKEGIV 227
           ++  I +G+ YLH      I+H D+KP NILL   + P    KI DFG+++    K G  
Sbjct: 136 LIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIY-PLGDIKIVDFGMSR----KIGHA 187
Query: 228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMM 264
             L    G   Y+APE+   N+  ++  +D+++ G++
Sbjct: 188 CELREIMGTPEYLAPEIL--NYDPITTATDMWNIGII 222

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 50/210 (23%)
Query: 91  LGQGGFGGVYK---------GRLLDDFVNEVASISRTS-----------------HVNVV 124
           LG+GG+G V++         G++    V + A I R +                 H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 125 TLLGFCLEGNNRALIYEFMPNGSL-----EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
            L+     G    LI E++  G L      + ++  DT+  C YL           I+  
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA--CFYL---------AEISMA 133
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
           L +LH      I++ D+KP NI+L+     K++DFGL K  +  +G V+      G I Y
Sbjct: 134 LGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFC--GTIEY 187
Query: 240 IAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
           +APE+  R+    +   D +S G ++ +++
Sbjct: 188 MAPEILMRSGH--NRAVDWWSLGALMYDML 215

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 73/166 (43%), Gaps = 16/166 (9%)
Query: 105 LDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQY 163
           L     EV  +   +H N+V L           LI E+   G + +  V +G   +    
Sbjct: 55  LQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEAR 114
Query: 164 LRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK 223
            ++ +       I   ++Y H     +I+H D+K  N+LLD D   KI+DFG +   T  
Sbjct: 115 SKFRQ-------IVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 164
Query: 224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            G + +  G+     Y APE+F     +   + DV+S G+++  LV
Sbjct: 165 -GKLDTFCGSP---PYAAPELFQGKKYD-GPEVDVWSLGVILYTLV 205

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 50/210 (23%)
Query: 91  LGQGGFGGVYK---------GRLLDDFVNEVASISRTS-----------------HVNVV 124
           LG+GG+G V++         G++    V + A I R +                 H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 125 TLLGFCLEGNNRALIYEFMPNGSL-----EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
            L+     G    LI E++  G L      + ++  DT+  C YL           I+  
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA--CFYL---------AEISMA 133
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
           L +LH      I++ D+KP NI+L+     K++DFGL K  +  +G V+      G I Y
Sbjct: 134 LGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHXFC--GTIEY 187
Query: 240 IAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
           +APE+  R+    +   D +S G ++ +++
Sbjct: 188 MAPEILMRSGH--NRAVDWWSLGALMYDML 215

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 54/105 (51%), Gaps = 15/105 (14%)
Query: 171 EIVIGIAKGLEYLH--HGCSTKILHFDIKPHNILLDEDFCPKISDFGLA-KLCTTKEGIV 227
           ++ + I K L YL   HG    ++H D+KP NILLDE    K+ DFG++ +L   K    
Sbjct: 128 KMTVAIVKALYYLKEKHG----VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDR 183
Query: 228 SSLLGARGIIGYIAPEVF---SRNFGEVSHKSDVYSFGMMIMELV 269
           S+     G   Y+APE          +   ++DV+S G+ ++EL 
Sbjct: 184 SA-----GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELA 223

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/205 (21%), Positives = 81/205 (39%), Gaps = 40/205 (19%)
Query: 90  KLGQGGFGGVYKGRLLDD---------------------FVNEVASISRTSHVNVVTLLG 128
           K+G+G +G V+K R  D                       + E+  + +  H N+V LL 
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 129 FCLEGNNRALIYEFMPNGSLEKF--VYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH-H 185
                    L++E+  +  L +      G      + + W+ +        + + + H H
Sbjct: 70  VFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTL--------QAVNFCHKH 121
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVF 245
            C    +H D+KP NIL+ +    K+ DFG A+L T         +  R    Y +PE+ 
Sbjct: 122 NC----IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR---WYRSPELL 174
Query: 246 SRNFGEVSHKSDVYSFGMMIMELVG 270
             +  +     DV++ G +  EL+ 
Sbjct: 175 VGD-TQYGPPVDVWAIGCVFAELLS 198

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 81/192 (42%), Gaps = 25/192 (13%)
Query: 88  KDKLGQGGFG------GVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYE 141
           KD++ Q  +          K +     + EV  + +  H N++ L     + ++  ++ E
Sbjct: 42  KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101
Query: 142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNI 201
               G L   +            R      I+  +  G+ Y+H      I+H D+KP NI
Sbjct: 102 LYTGGELFDEIIKRKRFSEHDAAR------IIKQVFSGITYMH---KHNIVHRDLKPENI 152
Query: 202 LL---DEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDV 258
           LL   ++D   KI DFGL+  C  +   +   +G      YIAPEV    + E   K DV
Sbjct: 153 LLESKEKDCDIKIIDFGLS-TCFQQNTKMKDRIGT---AYYIAPEVLRGTYDE---KCDV 205
Query: 259 YSFGMMIMELVG 270
           +S G+++  L+ 
Sbjct: 206 WSAGVILYILLS 217

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 81/192 (42%), Gaps = 25/192 (13%)
Query: 88  KDKLGQGGFG------GVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYE 141
           KD++ Q  +          K +     + EV  + +  H N++ L     + ++  ++ E
Sbjct: 42  KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101
Query: 142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNI 201
               G L   +            R      I+  +  G+ Y+H      I+H D+KP NI
Sbjct: 102 LYTGGELFDEIIKRKRFSEHDAAR------IIKQVFSGITYMH---KHNIVHRDLKPENI 152
Query: 202 LL---DEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDV 258
           LL   ++D   KI DFGL+  C  +   +   +G      YIAPEV    + E   K DV
Sbjct: 153 LLESKEKDCDIKIIDFGLS-TCFQQNTKMKDRIGT---AYYIAPEVLRGTYDE---KCDV 205
Query: 259 YSFGMMIMELVG 270
           +S G+++  L+ 
Sbjct: 206 WSAGVILYILLS 217

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 47/206 (22%)
Query: 91  LGQGGFGGV-----------YKGRLLDDFVNEVASISRTSH----------VNV--VTLL 127
           LG G FG V           Y  ++LD    +V  + +  H          VN   +T L
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDK--QKVVKLKQIEHTLNEKRILQAVNFPFLTKL 107
Query: 128 GFCLEGN-NRALIYEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
            F  + N N  ++ E+ P G +   +   G  S+P       + Y   I +    EYLH 
Sbjct: 108 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA-----RFYAAQIVLT--FEYLH- 159
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
             S  +++ D+KP N+++D+    K++DFG AK    +   +       G   Y+APE +
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC------GTPEYLAPEII 211
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVG 270
            S+ + +     D ++ G++I E+  
Sbjct: 212 LSKGYNKA---VDWWALGVLIYEMAA 234

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 47/206 (22%)
Query: 91  LGQGGFGGV-----------YKGRLLDDFVNEVASISRTSH----------VNV--VTLL 127
           LG G FG V           Y  ++LD    +V  + +  H          VN   +T L
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDK--QKVVKLKQIEHTLNEKRILQAVNFPFLTKL 107
Query: 128 GFCLEGN-NRALIYEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
            F  + N N  ++ E+ P G +   +   G  S+P       + Y   I +    EYLH 
Sbjct: 108 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA-----RFYAAQIVLT--FEYLH- 159
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
             S  +++ D+KP N+++D+    K++DFG AK    +   +       G   Y+APE +
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC------GTPEYLAPEII 211
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVG 270
            S+ + +     D ++ G++I E+  
Sbjct: 212 LSKGYNKA---VDWWALGVLIYEMAA 234

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 82/167 (49%), Gaps = 20/167 (11%)
Query: 122 NVVTLLGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
           N++TL     +  +R  AL++E + N   ++ +Y   T    ++     MYEI+    K 
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQ-LYQTLTDYDIRFY----MYEIL----KA 143
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIG 238
           L+Y H   S  I+H D+KPHN+L+D +    ++ D+GLA+     +   +  + +R   G
Sbjct: 144 LDYCH---SMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKG 199
Query: 239 YIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
              PE+   ++    +  D++S G M+  ++  K     G D+  ++
Sbjct: 200 ---PELLV-DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 242

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 89/211 (42%), Gaps = 44/211 (20%)
Query: 90  KLGQGGFGGVYKGR-------------LLDD--------FVNEVASISRTSHVNVVTLLG 128
           K+GQG FG V+K R             L+++         + E+  +    H NVV L+ 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 129 FCLEGN---NRA-----LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGL 180
            C       NR      L+++F  +         G  S         ++  ++  +  GL
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHD------LAGLLSNVLVKFTLSEIKRVMQMLLNGL 138
Query: 181 EYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI-IGY 239
            Y+H     KILH D+K  N+L+  D   K++DFGLA+  +  +    +    R + + Y
Sbjct: 139 YYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 240 IAPEVF--SRNFGEVSHKSDVYSFGMMIMEL 268
             PE+    R++G      D++  G ++ E+
Sbjct: 196 RPPELLLGERDYGP---PIDLWGAGCIMAEM 223

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 81/175 (46%), Gaps = 23/175 (13%)
Query: 99  VYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGN-NRALIYEFMPNGSLEKFVYN-GD 156
           V K + ++  +NE   I +  +   +  L F  + N N  ++ E+ P G +   +   G 
Sbjct: 80  VVKLKQIEHTLNE-KRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGR 138
Query: 157 TSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGL 216
            S+P       + Y   I +    EYLH   S  +++ D+KP N+L+D+    K++DFG 
Sbjct: 139 FSEPHA-----RFYAAQIVLT--FEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGF 188
Query: 217 AKLCTTKEGIVSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVG 270
           AK    +   +       G   Y+APE + S+ + +     D ++ G++I E+  
Sbjct: 189 AKRVKGRTWXLC------GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAA 234

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 79/187 (42%), Gaps = 25/187 (13%)
Query: 88  KDKLGQGGFG------GVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYE 141
           KD++ Q  +          K +     + EV  + +  H N++ L     + ++  ++ E
Sbjct: 42  KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101
Query: 142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNI 201
               G L   +            R      I+  +  G+ Y+H      I+H D+KP NI
Sbjct: 102 LYTGGELFDEIIKRKRFSEHDAAR------IIKQVFSGITYMHKH---NIVHRDLKPENI 152
Query: 202 LL---DEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDV 258
           LL   ++D   KI DFGL+  C  +   +   +G      YIAPEV    + E   K DV
Sbjct: 153 LLESKEKDCDIKIIDFGLST-CFQQNTKMKDRIGT---AYYIAPEVLRGTYDE---KCDV 205
Query: 259 YSFGMMI 265
           +S G+++
Sbjct: 206 WSAGVIL 212

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 89/211 (42%), Gaps = 44/211 (20%)
Query: 90  KLGQGGFGGVYKGR-------------LLDD--------FVNEVASISRTSHVNVVTLLG 128
           K+GQG FG V+K R             L+++         + E+  +    H NVV L+ 
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 83
Query: 129 FCLEGN---NRA-----LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGL 180
            C       NR      L+++F  +         G  S         ++  ++  +  GL
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFCEHD------LAGLLSNVLVKFTLSEIKRVMQMLLNGL 137
Query: 181 EYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI-IGY 239
            Y+H     KILH D+K  N+L+  D   K++DFGLA+  +  +    +    R + + Y
Sbjct: 138 YYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 194
Query: 240 IAPEVF--SRNFGEVSHKSDVYSFGMMIMEL 268
             PE+    R++G      D++  G ++ E+
Sbjct: 195 RPPELLLGERDYGP---PIDLWGAGCIMAEM 222

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 82/210 (39%), Gaps = 44/210 (20%)
Query: 87  FKDKLGQGGFGGVYKGRL--------------------LDDFVNEVASISRTSHVNVVTL 126
             D LGQG    V++GR                     +D  + E   + + +H N+V L
Sbjct: 13  LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 127 LGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVI-GIAKGLEYL 183
                E   R   LI EF P GSL    Y         Y   E  + IV+  +  G+ +L
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSL----YTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 184 HHGCSTKILHFDIKPHNILL----DEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
                  I+H +IKP NI+     D     K++DFG A+     E  VS      G   Y
Sbjct: 129 R---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS----LYGTEEY 181
Query: 240 IAPEVFSRNFGEVSHKS------DVYSFGM 263
           + P+++ R      H+       D++S G+
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGV 211

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 89/211 (42%), Gaps = 44/211 (20%)
Query: 90  KLGQGGFGGVYKGR-------------LLDD--------FVNEVASISRTSHVNVVTLLG 128
           K+GQG FG V+K R             L+++         + E+  +    H NVV L+ 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 129 FCLEGN---NRA-----LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGL 180
            C       NR      L+++F  +         G  S         ++  ++  +  GL
Sbjct: 85  ICRTKASPYNRCKASIYLVFDFCEHD------LAGLLSNVLVKFTLSEIKRVMQMLLNGL 138
Query: 181 EYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI-IGY 239
            Y+H     KILH D+K  N+L+  D   K++DFGLA+  +  +    +    R + + Y
Sbjct: 139 YYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 240 IAPEVF--SRNFGEVSHKSDVYSFGMMIMEL 268
             PE+    R++G      D++  G ++ E+
Sbjct: 196 RPPELLLGERDYGP---PIDLWGAGCIMAEM 223

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 87/203 (42%), Gaps = 37/203 (18%)
Query: 89  DKLGQGGFGGVYKGR--------------------LLDDFVNEVASISRTSHVNVVTLLG 128
           +K+G+G +G VYK +                    +    + E++ +    H N+V L  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQY-LRWEKMYEIVIGIAKGLEYLHHGC 187
                    L++E + +  L+K +        C+  L        ++ +  G+ Y H   
Sbjct: 68  VIHTKKRLVLVFEHL-DQDLKKLL------DVCEGGLESVTAKSFLLQLLNGIAYCH--- 117
Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI-VSSLLGARGIIGYIAPEVFS 246
             ++LH D+KP N+L++ +   KI+DFGLA+      GI V         + Y AP+V  
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAF----GIPVRKYTHEVVTLWYRAPDVLM 173
Query: 247 RNFGEVSHKSDVYSFGMMIMELV 269
            +  + S   D++S G +  E+V
Sbjct: 174 GS-KKYSTTIDIWSVGCIFAEMV 195

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 82/167 (49%), Gaps = 20/167 (11%)
Query: 122 NVVTLLGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
           N++TL     +  +R  AL++E + N   ++ +Y   T    ++     MYEI+    K 
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQ-LYQTLTDYDIRFY----MYEIL----KA 143
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIG 238
           L+Y H   S  I+H D+KPHN+++D +    ++ D+GLA+     +   +  + +R   G
Sbjct: 144 LDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKG 199
Query: 239 YIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
              PE+   ++    +  D++S G M+  ++  K     G D+  ++
Sbjct: 200 ---PELLV-DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 242

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 96/228 (42%), Gaps = 45/228 (19%)
Query: 68  GPLPLKRYNFSDVKKLTNSFKDKLGQGGFGG-----------------VYKGRLLDDFVN 110
           GP+ L   + SD  +L       +G G FG                  + +G  +D+ V 
Sbjct: 8   GPMDLPIMHDSDRYELVKD----IGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVK 63
Query: 111 -EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEK 168
            E+ +     H N+V      L   + A++ E+   G L E+    G  S+      +++
Sbjct: 64  REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ 123
Query: 169 MYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP--KISDFGLAKLCTTKEGI 226
           +         G+ Y H   + ++ H D+K  N LLD    P  KI+DFG +K       +
Sbjct: 124 LI-------SGVSYAH---AMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASV----L 169
Query: 227 VSSLLGARGIIGYIAPEVFSRNF--GEVSHKSDVYSFGMMI-MELVGC 271
            S    A G   YIAPEV  +    G+V   +DV+S G+ + + LVG 
Sbjct: 170 HSQPKSAVGTPAYIAPEVLLKKEYDGKV---ADVWSCGVTLYVMLVGA 214

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 82/167 (49%), Gaps = 20/167 (11%)
Query: 122 NVVTLLGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
           N++TL     +  +R  AL++E + N   ++ +Y   T    ++     MYEI+    K 
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQ-LYQTLTDYDIRFY----MYEIL----KA 143
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIG 238
           L+Y H   S  I+H D+KPHN+++D +    ++ D+GLA+     +   +  + +R   G
Sbjct: 144 LDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKG 199
Query: 239 YIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
              PE+   ++    +  D++S G M+  ++  K     G D+  ++
Sbjct: 200 ---PELLV-DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 242

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 82/167 (49%), Gaps = 20/167 (11%)
Query: 122 NVVTLLGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
           N++TL     +  +R  AL++E + N   ++ +Y   T    ++     MYEI+    K 
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQ-LYQTLTDYDIRFY----MYEIL----KA 143
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIG 238
           L+Y H   S  I+H D+KPHN+++D +    ++ D+GLA+     +   +  + +R   G
Sbjct: 144 LDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKG 199
Query: 239 YIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
              PE+   ++    +  D++S G M+  ++  K     G D+  ++
Sbjct: 200 ---PELLV-DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 242

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 84/212 (39%), Gaps = 29/212 (13%)
Query: 72  LKRYNFSDVKKLTNSFKDKLGQGGFGGV-----------YKGRLLDDFVNEVASISRTSH 120
            K+ NF  + KL  +   +L +G + G            +  R   DF  E   +   SH
Sbjct: 9   FKQLNF--LTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 121 VNVVTLLGFCLE--GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 178
            NV+ +LG C      +  LI  + P GSL   ++ G      Q     +  +  +  A+
Sbjct: 67  PNVLPVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQ----SQAVKFALDXAR 122
Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG 238
           G  +L H     I    +   ++ +DED   +IS          K    S   G      
Sbjct: 123 GXAFL-HTLEPLIPRHALNSRSVXIDEDXTARIS------XADVKFSFQSP--GRXYAPA 173
Query: 239 YIAPEVFSRNFGEVSHKS-DVYSFGMMIMELV 269
           ++APE   +   + + +S D +SF +++ ELV
Sbjct: 174 WVAPEALQKKPEDTNRRSADXWSFAVLLWELV 205

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 70/147 (47%), Gaps = 22/147 (14%)
Query: 127 LGFCLEGN-NRALIYEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEIVIGIAKGLEYLH 184
           L F  + N N  ++ E+ P G +   +   G  S+P       + Y   I +    EYLH
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA-----RFYAAQIVLT--FEYLH 158
Query: 185 HGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE- 243
              S  +++ D+KP N+++D+    K++DFGLAK    +   +       G   Y+APE 
Sbjct: 159 ---SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC------GTPEYLAPEI 209
Query: 244 VFSRNFGEVSHKSDVYSFGMMIMELVG 270
           + S+ + +     D ++ G++I E+  
Sbjct: 210 ILSKGYNKA---VDWWALGVLIYEMAA 233

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 89/211 (42%), Gaps = 44/211 (20%)
Query: 90  KLGQGGFGGVYKGR-------------LLDD--------FVNEVASISRTSHVNVVTLLG 128
           K+GQG FG V+K R             L+++         + E+  +    H NVV L+ 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 129 FCLEGN---NRA-----LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGL 180
            C       NR      L+++F  +         G  S         ++  ++  +  GL
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHD------LAGLLSNVLVKFTLSEIKRVMQMLLNGL 138
Query: 181 EYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI-IGY 239
            Y+H     KILH D+K  N+L+  D   K++DFGLA+  +  +    +    R + + Y
Sbjct: 139 YYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 240 IAPEVF--SRNFGEVSHKSDVYSFGMMIMEL 268
             PE+    R++G      D++  G ++ E+
Sbjct: 196 RPPELLLGERDYGP---PIDLWGAGCIMAEM 223

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 82/167 (49%), Gaps = 20/167 (11%)
Query: 122 NVVTLLGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
           N++TL     +  +R  AL++E + N   ++ +Y   T    ++     MYEI+    K 
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQ-LYQTLTDYDIRFY----MYEIL----KA 143
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIG 238
           L+Y H   S  I+H D+KPHN+++D +    ++ D+GLA+     +   +  + +R   G
Sbjct: 144 LDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKG 199
Query: 239 YIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
              PE+   ++    +  D++S G M+  ++  K     G D+  ++
Sbjct: 200 ---PELLV-DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 242

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 87/203 (42%), Gaps = 37/203 (18%)
Query: 89  DKLGQGGFGGVYKGR--------------------LLDDFVNEVASISRTSHVNVVTLLG 128
           +K+G+G +G VYK +                    +    + E++ +    H N+V L  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQY-LRWEKMYEIVIGIAKGLEYLHHGC 187
                    L++E + +  L+K +        C+  L        ++ +  G+ Y H   
Sbjct: 68  VIHTKKRLVLVFEHL-DQDLKKLL------DVCEGGLESVTAKSFLLQLLNGIAYCH--- 117
Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI-VSSLLGARGIIGYIAPEVFS 246
             ++LH D+KP N+L++ +   KI+DFGLA+      GI V         + Y AP+V  
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAF----GIPVRKYTHEVVTLWYRAPDVLM 173
Query: 247 RNFGEVSHKSDVYSFGMMIMELV 269
            +  + S   D++S G +  E+V
Sbjct: 174 GS-KKYSTTIDIWSVGCIFAEMV 195

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 82/167 (49%), Gaps = 20/167 (11%)
Query: 122 NVVTLLGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
           N++TL     +  +R  AL++E + N   ++ +Y   T    ++     MYEI+    K 
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQ-LYQTLTDYDIRFY----MYEIL----KA 143
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIG 238
           L+Y H   S  I+H D+KPHN+++D +    ++ D+GLA+     +   +  + +R   G
Sbjct: 144 LDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKG 199
Query: 239 YIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
              PE+   ++    +  D++S G M+  ++  K     G D+  ++
Sbjct: 200 ---PELLV-DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 242

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 82/167 (49%), Gaps = 20/167 (11%)
Query: 122 NVVTLLGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
           N++TL     +  +R  AL++E + N   ++ +Y   T    ++     MYEI+    K 
Sbjct: 92  NIITLADIVKDPVSRTPALVFEHVNNTDFKQ-LYQTLTDYDIRFY----MYEIL----KA 142
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIG 238
           L+Y H   S  I+H D+KPHN+++D +    ++ D+GLA+     +   +  + +R   G
Sbjct: 143 LDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKG 198
Query: 239 YIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
              PE+   ++    +  D++S G M+  ++  K     G D+  ++
Sbjct: 199 ---PELLV-DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 241

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 82/167 (49%), Gaps = 20/167 (11%)
Query: 122 NVVTLLGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
           N++TL     +  +R  AL++E + N   ++ +Y   T    ++     MYEI+    K 
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQ-LYQTLTDYDIRFY----MYEIL----KA 143
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIG 238
           L+Y H   S  I+H D+KPHN+++D +    ++ D+GLA+     +   +  + +R   G
Sbjct: 144 LDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKG 199
Query: 239 YIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
              PE+   ++    +  D++S G M+  ++  K     G D+  ++
Sbjct: 200 ---PELLV-DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 242

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 82/167 (49%), Gaps = 20/167 (11%)
Query: 122 NVVTLLGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
           N++TL     +  +R  AL++E + N   ++ +Y   T    ++     MYEI+    K 
Sbjct: 91  NIITLADIVKDPVSRTPALVFEHVNNTDFKQ-LYQTLTDYDIRFY----MYEIL----KA 141
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIG 238
           L+Y H   S  I+H D+KPHN+++D +    ++ D+GLA+     +   +  + +R   G
Sbjct: 142 LDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKG 197
Query: 239 YIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
              PE+   ++    +  D++S G M+  ++  K     G D+  ++
Sbjct: 198 ---PELLV-DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 240

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 74/150 (49%), Gaps = 14/150 (9%)
Query: 124 VTLLGFCLEG-NNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 182
           +T L +  +  NN  L+ ++   G L   +   +   P +  R+  + E+VI I   +  
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARF-YLAEMVIAI-DSVHQ 193
Query: 183 LHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAP 242
           LH+      +H DIKP NIL+D +   +++DFG + L   ++G V S + A G   YI+P
Sbjct: 194 LHY------VHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSV-AVGTPDYISP 245
Query: 243 EVFSR---NFGEVSHKSDVYSFGMMIMELV 269
           E+        G    + D +S G+ + E++
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEML 275

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 70/147 (47%), Gaps = 22/147 (14%)
Query: 127 LGFCLEGN-NRALIYEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEIVIGIAKGLEYLH 184
           L F  + N N  ++ E++P G +   +   G  S+P       + Y   I +    EYLH
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA-----RFYAAQIVLT--FEYLH 158
Query: 185 HGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE- 243
              S  +++ D+KP N+L+D+    K++DFG AK    +   +       G   Y+APE 
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC------GTPEYLAPEI 209
Query: 244 VFSRNFGEVSHKSDVYSFGMMIMELVG 270
           + S+ + +     D ++ G++I E+  
Sbjct: 210 ILSKGYNKA---VDWWALGVLIYEMAA 233

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 82/167 (49%), Gaps = 20/167 (11%)
Query: 122 NVVTLLGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
           N++TL     +  +R  AL++E + N   ++ +Y   T    ++     MYEI+    K 
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQ-LYQTLTDYDIRFY----MYEIL----KA 143
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIG 238
           L+Y H   S  I+H D+KPHN+++D +    ++ D+GLA+     +   +  + +R   G
Sbjct: 144 LDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKG 199
Query: 239 YIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
              PE+   ++    +  D++S G M+  ++  K     G D+  ++
Sbjct: 200 ---PELLV-DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 242

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 82/167 (49%), Gaps = 20/167 (11%)
Query: 122 NVVTLLGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
           N++TL     +  +R  AL++E + N   ++ +Y   T    ++     MYEI+    K 
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQ-LYQTLTDYDIRFY----MYEIL----KA 143
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIG 238
           L+Y H   S  I+H D+KPHN+++D +    ++ D+GLA+     +   +  + +R   G
Sbjct: 144 LDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKG 199
Query: 239 YIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
              PE+   ++    +  D++S G M+  ++  K     G D+  ++
Sbjct: 200 ---PELLV-DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 242

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 82/167 (49%), Gaps = 20/167 (11%)
Query: 122 NVVTLLGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
           N++TL     +  +R  AL++E + N   ++ +Y   T    ++     MYEI+    K 
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQ-LYQTLTDYDIRFY----MYEIL----KA 143
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIG 238
           L+Y H   S  I+H D+KPHN+++D +    ++ D+GLA+     +   +  + +R   G
Sbjct: 144 LDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKG 199
Query: 239 YIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
              PE+   ++    +  D++S G M+  ++  K     G D+  ++
Sbjct: 200 ---PELLV-DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 242

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 82/167 (49%), Gaps = 20/167 (11%)
Query: 122 NVVTLLGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
           N++TL     +  +R  AL++E + N   ++ +Y   T    ++     MYEI+    K 
Sbjct: 92  NIITLADIVKDPVSRTPALVFEHVNNTDFKQ-LYQTLTDYDIRFY----MYEIL----KA 142
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIG 238
           L+Y H   S  I+H D+KPHN+++D +    ++ D+GLA+     +   +  + +R   G
Sbjct: 143 LDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKG 198
Query: 239 YIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
              PE+   ++    +  D++S G M+  ++  K     G D+  ++
Sbjct: 199 ---PELLV-DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 241

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 87/203 (42%), Gaps = 37/203 (18%)
Query: 89  DKLGQGGFGGVYKGR--------------------LLDDFVNEVASISRTSHVNVVTLLG 128
           +K+G+G +G VYK +                    +    + E++ +    H N+V L  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQY-LRWEKMYEIVIGIAKGLEYLHHGC 187
                    L++E + +  L+K +        C+  L        ++ +  G+ Y H   
Sbjct: 68  VIHTKKRLVLVFEHL-DQDLKKLL------DVCEGGLESVTAKSFLLQLLNGIAYCH--- 117
Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI-VSSLLGARGIIGYIAPEVFS 246
             ++LH D+KP N+L++ +   KI+DFGLA+      GI V         + Y AP+V  
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAF----GIPVRKYTHEIVTLWYRAPDVLM 173
Query: 247 RNFGEVSHKSDVYSFGMMIMELV 269
            +  + S   D++S G +  E+V
Sbjct: 174 GS-KKYSTTIDIWSVGCIFAEMV 195

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 47/206 (22%)
Query: 91  LGQGGFGGV-----------YKGRLLDDFVNEVASISRTSH----------VNVVTL--L 127
           LG G FG V           Y  ++LD    +V  + +  H          VN   L  L
Sbjct: 35  LGTGSFGRVMLVKHMETGNHYAMKILDK--QKVVKLKQIEHTLNEKRILQAVNFPFLVKL 92
Query: 128 GFCLEGN-NRALIYEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
            F  + N N  ++ E++P G +   +   G  S+P       + Y   I +    EYLH 
Sbjct: 93  EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA-----RFYAAQIVLT--FEYLH- 144
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
             S  +++ D+KP N+L+D+    +++DFG AK    +   +       G   Y+APE +
Sbjct: 145 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC------GTPEYLAPEII 196
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVG 270
            S+ + +     D ++ G++I E+  
Sbjct: 197 LSKGYNKA---VDWWALGVLIYEMAA 219

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 82/167 (49%), Gaps = 20/167 (11%)
Query: 122 NVVTLLGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
           N++TL     +  +R  AL++E + N   ++ +Y   T    ++     MYEI+    K 
Sbjct: 98  NIITLADIVKDPVSRTPALVFEHVNNTDFKQ-LYQTLTDYDIRFY----MYEIL----KA 148
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIG 238
           L+Y H   S  I+H D+KPHN+++D +    ++ D+GLA+     +   +  + +R   G
Sbjct: 149 LDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKG 204
Query: 239 YIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
              PE+   ++    +  D++S G M+  ++  K     G D+  ++
Sbjct: 205 ---PELLV-DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 247

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 47/206 (22%)
Query: 91  LGQGGFGGV-----------YKGRLLDDFVNEVASISRTSH----------VNVVTL--L 127
           LG G FG V           Y  ++LD    +V  + +  H          VN   L  L
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDK--QKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 128 GFCLEGN-NRALIYEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
            F  + N N  ++ E++P G +   +   G  S+P       + Y   I +    EYLH 
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA-----RFYAAQIVLT--FEYLH- 159
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
             S  +++ D+KP N+L+D+    +++DFG AK    +   +       G   Y+APE +
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC------GTPEYLAPEII 211
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVG 270
            S+ + +     D ++ G++I E+  
Sbjct: 212 LSKGYNKA---VDWWALGVLIYEMAA 234

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 47/206 (22%)
Query: 91  LGQGGFGGV-----------YKGRLLDDFVNEVASISRTSH----------VNVVTL--L 127
           LG G FG V           Y  ++LD    +V  + +  H          VN   L  L
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDK--QKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 128 GFCLEGN-NRALIYEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
            F  + N N  ++ E++P G +   +   G  S+P       + Y   I +    EYLH 
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA-----RFYAAQIVLT--FEYLH- 159
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
             S  +++ D+KP N+L+D+    +++DFG AK    +   +       G   Y+APE +
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC------GTPEYLAPEII 211
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVG 270
            S+ + +     D ++ G++I E+  
Sbjct: 212 LSKGYNKA---VDWWALGVLIYEMAA 234

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 86/209 (41%), Gaps = 37/209 (17%)
Query: 91  LGQGGFGGVYKGRLLDDFV----------------NEVASISRTSHVNVVTLLGFCLEGN 134
           +G+G +G V++G    + V                 E+ +     H N++  +   +   
Sbjct: 16  VGKGRYGEVWRGLWHGESVAVKIFSSRDEQSWFRETEIYNTVLLRHDNILGFIASDMTSR 75
Query: 135 NRA----LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH---HGC 187
           N +    LI  +  +GSL  F+    T +P   LR      + +  A GL +LH    G 
Sbjct: 76  NSSTQLWLITHYHEHGSLYDFLQR-QTLEPHLALR------LAVSAACGLAHLHVEIFGT 128
Query: 188 STK--ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGAR-GIIGYIAPEV 244
             K  I H D K  N+L+  +    I+D GLA + +     +      R G   Y+APEV
Sbjct: 129 QGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEV 188
Query: 245 FSRNFG----EVSHKSDVYSFGMMIMELV 269
                     E    +D+++FG+++ E+ 
Sbjct: 189 LDEQIRTDCFESYKWTDIWAFGLVLWEIA 217

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 47/206 (22%)
Query: 91  LGQGGFGGV-----------YKGRLLDDFVNEVASISRTSH----------VNVVTL--L 127
           LG G FG V           Y  ++LD    +V  + +  H          VN   L  L
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDK--QKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 128 GFCLEGN-NRALIYEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
            F  + N N  ++ E++P G +   +   G  S+P       + Y   I +    EYLH 
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA-----RFYAAQIVLT--FEYLH- 159
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
             S  +++ D+KP N+L+D+    +++DFG AK    +   +       G   Y+APE +
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC------GTPEYLAPEII 211
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVG 270
            S+ + +     D ++ G++I E+  
Sbjct: 212 LSKGYNKA---VDWWALGVLIYEMAA 234

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 47/206 (22%)
Query: 91  LGQGGFGGV-----------YKGRLLDDFVNEVASISRTSH----------VNVVTL--L 127
           LG G FG V           Y  ++LD    +V  + +  H          VN   L  L
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDK--QKVVKLKQIEHTLNEKRILQAVNFPFLVKL 99
Query: 128 GFCLEGN-NRALIYEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
            F  + N N  ++ E++P G +   +   G  S+P       + Y   I +    EYLH 
Sbjct: 100 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA-----RFYAAQIVLT--FEYLH- 151
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
             S  +++ D+KP N+L+D+    +++DFG AK    +   +       G   Y+APE +
Sbjct: 152 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC------GTPEYLAPEII 203
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVG 270
            S+ + +     D ++ G++I E+  
Sbjct: 204 LSKGYNKA---VDWWALGVLIYEMAA 226

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 51/96 (53%), Gaps = 11/96 (11%)
Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV--SSLLGA 233
           I   L+YLH      +++ D+K  N++LD+D   KI+DFGL      KEGI   +++   
Sbjct: 257 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLC-----KEGIKDGATMKTF 309
Query: 234 RGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            G   Y+APEV   N  +     D +  G+++ E++
Sbjct: 310 CGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMM 343

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 47/206 (22%)
Query: 91  LGQGGFGGV-----------YKGRLLDDFVNEVASISRTSH----------VNVVTL--L 127
           LG G FG V           Y  ++LD    +V  + +  H          VN   L  L
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDK--QKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 128 GFCLEGN-NRALIYEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
            F  + N N  ++ E++P G +   +   G  S+P       + Y   I +    EYLH 
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA-----RFYAAQIVLT--FEYLH- 158
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
             S  +++ D+KP N+L+D+    +++DFG AK    +   +       G   Y+APE +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC------GTPEYLAPEII 210
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVG 270
            S+ + +     D ++ G++I E+  
Sbjct: 211 LSKGYNKA---VDWWALGVLIYEMAA 233

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 47/206 (22%)
Query: 91  LGQGGFGGV-----------YKGRLLDDFVNEVASISRTSH----------VNVVTL--L 127
           LG G FG V           Y  ++LD    +V  + +  H          VN   L  L
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDK--QKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 128 GFCLEGN-NRALIYEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
            F  + N N  ++ E++P G +   +   G  S+P       + Y   I +    EYLH 
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA-----RFYAAQIVLT--FEYLH- 159
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
             S  +++ D+KP N+L+D+    +++DFG AK    +   +       G   Y+APE +
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC------GTPEYLAPEII 211
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVG 270
            S+ + +     D ++ G++I E+  
Sbjct: 212 LSKGYNKA---VDWWALGVLIYEMAA 234

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 47/206 (22%)
Query: 91  LGQGGFGGV-----------YKGRLLDDFVNEVASISRTSH----------VNVVTL--L 127
           LG G FG V           Y  ++LD    +V  + +  H          VN   L  L
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDK--QKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 128 GFCLEGN-NRALIYEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
            F  + N N  ++ E++P G +   +   G  S+P       + Y   I +    EYLH 
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA-----RFYAAQIVLT--FEYLH- 159
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
             S  +++ D+KP N+L+D+    +++DFG AK    +   +       G   Y+APE +
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC------GTPEYLAPEII 211
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVG 270
            S+ + +     D ++ G++I E+  
Sbjct: 212 LSKGYNKA---VDWWALGVLIYEMAA 234

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 24/75 (32%), Positives = 42/75 (56%), Gaps = 4/75 (5%)
Query: 193 HFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEV 252
           H D+KP NIL+  D    + DFG+A   T ++  ++ L    G + Y APE FS +    
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEK--LTQLGNTVGTLYYXAPERFSES--HA 212
Query: 253 SHKSDVYSFGMMIME 267
           ++++D+Y+   ++ E
Sbjct: 213 TYRADIYALTCVLYE 227

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 51/96 (53%), Gaps = 11/96 (11%)
Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV--SSLLGA 233
           I   L+YLH      +++ D+K  N++LD+D   KI+DFGL      KEGI   +++   
Sbjct: 260 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLC-----KEGIKDGATMKTF 312
Query: 234 RGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            G   Y+APEV   N  +     D +  G+++ E++
Sbjct: 313 CGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMM 346

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 47/206 (22%)
Query: 91  LGQGGFGGV-----------YKGRLLDDFVNEVASISRTSH----------VNVVTL--L 127
           LG G FG V           Y  ++LD    +V  + +  H          VN   L  L
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDK--QKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 128 GFCLEGN-NRALIYEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
            F  + N N  ++ E+ P G +   +   G  S+P       + Y   I +    EYLH 
Sbjct: 108 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA-----RFYAAQIVLT--FEYLH- 159
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
             S  +++ D+KP N+++D+    K++DFG AK    +   +       G   Y+APE +
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC------GTPEYLAPEII 211
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVG 270
            S+ + +     D ++ G++I E+  
Sbjct: 212 LSKGYNKA---VDWWALGVLIYEMAA 234

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 47/206 (22%)
Query: 91  LGQGGFGGV-----------YKGRLLDDFVNEVASISRTSH----------VNVVTL--L 127
           LG G FG V           Y  ++LD    +V  + +  H          VN   L  L
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDK--QKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 128 GFCLEGN-NRALIYEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
            F  + N N  ++ E++P G +   +   G  S+P       + Y   I +    EYLH 
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA-----RFYAAQIVLT--FEYLH- 158
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
             S  +++ D+KP N+L+D+    +++DFG AK    +   +       G   Y+APE +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC------GTPEYLAPEII 210
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVG 270
            S+ + +     D ++ G++I E+  
Sbjct: 211 LSKGYNKA---VDWWALGVLIYEMAA 233

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 47/206 (22%)
Query: 91  LGQGGFGGV-----------YKGRLLDDFVNEVASISRTSH----------VNVVTL--L 127
           LG G FG V           Y  ++LD    +V  + +  H          VN   L  L
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDK--QKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 128 GFCLEGN-NRALIYEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
            F  + N N  ++ E++P G +   +   G  S+P       + Y   I +    EYLH 
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA-----RFYAAQIVLT--FEYLH- 158
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
             S  +++ D+KP N+L+D+    +++DFG AK    +   +       G   Y+APE +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC------GTPEYLAPEII 210
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVG 270
            S+ + +     D ++ G++I E+  
Sbjct: 211 LSKGYNKA---VDWWALGVLIYEMAA 233

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 83/168 (49%), Gaps = 22/168 (13%)
Query: 122 NVVTLLGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
           N+V LL    + +++  +LI+E++ N    K +Y   T    +Y     +YE++    K 
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDF-KVLYPTLTDYDIRYY----IYELL----KA 138
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTT-KEGIVSSLLGARGII 237
           L+Y H   S  I+H D+KPHN+++D +    ++ D+GLA+     KE  V   + +R   
Sbjct: 139 LDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR--VASRYFK 193
Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
           G   PE+   +  +  +  D++S G M   ++  K     G D+  ++
Sbjct: 194 G---PELLV-DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 237

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 83/168 (49%), Gaps = 22/168 (13%)
Query: 122 NVVTLLGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
           N+V LL    + +++  +LI+E++ N    K +Y   T    +Y     +YE++    K 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDF-KVLYPTLTDYDIRYY----IYELL----KA 137
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTT-KEGIVSSLLGARGII 237
           L+Y H   S  I+H D+KPHN+++D +    ++ D+GLA+     KE  V   + +R   
Sbjct: 138 LDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR--VASRYFK 192
Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
           G   PE+   +  +  +  D++S G M   ++  K     G D+  ++
Sbjct: 193 G---PELLV-DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 236

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 83/168 (49%), Gaps = 22/168 (13%)
Query: 122 NVVTLLGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
           N+V LL    + +++  +LI+E++ N    K +Y   T    +Y     +YE++    K 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDF-KVLYPTLTDYDIRYY----IYELL----KA 137
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTT-KEGIVSSLLGARGII 237
           L+Y H   S  I+H D+KPHN+++D +    ++ D+GLA+     KE  V   + +R   
Sbjct: 138 LDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR--VASRYFK 192
Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
           G   PE+   +  +  +  D++S G M   ++  K     G D+  ++
Sbjct: 193 G---PELLV-DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 236

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 47/206 (22%)
Query: 91  LGQGGFGGV-----------YKGRLLDDFVNEVASISRTSH----------VNVVTL--L 127
           LG G FG V           Y  ++LD    +V  + +  H          VN   L  L
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDK--QKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 128 GFCLEGN-NRALIYEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
            F  + N N  ++ E+ P G +   +   G  S+P       + Y   I +    EYLH 
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA-----RFYAAQIVLT--FEYLH- 158
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
             S  +++ D+KP N+++D+    K++DFG AK    +   +       G   Y+APE +
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC------GTPEYLAPEII 210
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVG 270
            S+ + +     D ++ G++I E+  
Sbjct: 211 LSKGYNKA---VDWWALGVLIYEMAA 233

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 83/168 (49%), Gaps = 22/168 (13%)
Query: 122 NVVTLLGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
           N+V LL    + +++  +LI+E++ N    K +Y   T    +Y     +YE++    K 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDF-KVLYPTLTDYDIRYY----IYELL----KA 137
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTT-KEGIVSSLLGARGII 237
           L+Y H   S  I+H D+KPHN+++D +    ++ D+GLA+     KE  V   + +R   
Sbjct: 138 LDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR--VASRYFK 192
Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
           G   PE+   +  +  +  D++S G M   ++  K     G D+  ++
Sbjct: 193 G---PELLV-DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 236

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 83/168 (49%), Gaps = 22/168 (13%)
Query: 122 NVVTLLGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
           N+V LL    + +++  +LI+E++ N    K +Y   T    +Y     +YE++    K 
Sbjct: 108 NIVKLLDIVRDQHSKTPSLIFEYVNNTDF-KVLYPTLTDYDIRYY----IYELL----KA 158
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTT-KEGIVSSLLGARGII 237
           L+Y H   S  I+H D+KPHN+++D +    ++ D+GLA+     KE  V   + +R   
Sbjct: 159 LDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR--VASRYFK 213
Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
           G   PE+   +  +  +  D++S G M   ++  K     G D+  ++
Sbjct: 214 G---PELLV-DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 257

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 83/168 (49%), Gaps = 22/168 (13%)
Query: 122 NVVTLLGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
           N+V LL    + +++  +LI+E++ N    K +Y   T    +Y     +YE++    K 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDF-KVLYPTLTDYDIRYY----IYELL----KA 137
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTT-KEGIVSSLLGARGII 237
           L+Y H   S  I+H D+KPHN+++D +    ++ D+GLA+     KE  V   + +R   
Sbjct: 138 LDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR--VASRYFK 192
Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
           G   PE+   +  +  +  D++S G M   ++  K     G D+  ++
Sbjct: 193 G---PELLV-DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 236

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 83/168 (49%), Gaps = 22/168 (13%)
Query: 122 NVVTLLGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
           N+V LL    + +++  +LI+E++ N    K +Y   T    +Y     +YE++    K 
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDF-KVLYPTLTDYDIRYY----IYELL----KA 138
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTT-KEGIVSSLLGARGII 237
           L+Y H   S  I+H D+KPHN+++D +    ++ D+GLA+     KE  V   + +R   
Sbjct: 139 LDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR--VASRYFK 193
Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
           G   PE+   +  +  +  D++S G M   ++  K     G D+  ++
Sbjct: 194 G---PELLV-DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 237

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 47/206 (22%)
Query: 91  LGQGGFGGV-----------YKGRLLDDFVNEVASISRTSH----------VNV--VTLL 127
           LG G FG V           Y  ++LD    +V  + +  H          VN   +T L
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDK--QKVVKLKQIEHTLNEKRILQAVNFPFLTKL 107
Query: 128 GFCLEGN-NRALIYEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
            F  + N N  ++ E+ P G +   +   G   +P       + Y   I +    EYLH 
Sbjct: 108 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHA-----RFYAAQIVLT--FEYLH- 159
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
             S  +++ D+KP N+++D+    K++DFG AK    +   +       G   Y+APE +
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC------GTPEYLAPEII 211
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVG 270
            S+ + +     D ++ G++I E+  
Sbjct: 212 LSKGYNKA---VDWWALGVLIYEMAA 234

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 47/206 (22%)
Query: 91  LGQGGFGGV-----------YKGRLLDDFVNEVASISRTSH----------VNVVTL--L 127
           LG G FG V           Y  ++LD    +V  + +  H          VN   L  L
Sbjct: 70  LGTGSFGRVMLVKHKETGNHYAMKILDK--QKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 128 GFCLEGN-NRALIYEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
            F  + N N  ++ E++P G +   +   G  S+P       + Y   I +    EYLH 
Sbjct: 128 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA-----RFYAAQIVLT--FEYLH- 179
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
             S  +++ D+KP N+L+D+    +++DFG AK    +   +       G   Y+APE +
Sbjct: 180 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC------GTPEYLAPEII 231
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVG 270
            S+ + +     D ++ G++I E+  
Sbjct: 232 LSKGYNKA---VDWWALGVLIYEMAA 254

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 83/168 (49%), Gaps = 22/168 (13%)
Query: 122 NVVTLLGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
           N+V LL    + +++  +LI+E++ N    K +Y   T    +Y     +YE++    K 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDF-KVLYPTLTDYDIRYY----IYELL----KA 137
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTT-KEGIVSSLLGARGII 237
           L+Y H   S  I+H D+KPHN+++D +    ++ D+GLA+     KE  V   + +R   
Sbjct: 138 LDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR--VASRYFK 192
Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
           G   PE+   +  +  +  D++S G M   ++  K     G D+  ++
Sbjct: 193 G---PELLV-DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 236

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 80/209 (38%), Gaps = 51/209 (24%)
Query: 91  LGQGGFGGVYKGR----------------------LLDDFVNEVASISRTSHVNVVTLLG 128
           LG+G FG VY  R                      +      E+   S   H N++ +  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNG---DTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
           +  +     L+ EF P G L K +      D  +   ++           +A  L Y H 
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME---------ELADALHYCH- 131
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGAR---GIIGYIAP 242
               K++H DIKP N+L+      KI+DFG +        + +  L  R   G + Y+ P
Sbjct: 132 --ERKVIHRDIKPENLLMGYKGELKIADFGWS--------VHAPSLRRRXMCGTLDYLPP 181
Query: 243 EVFSRNFGEVSHKSDVYSFGMMIME-LVG 270
           E+      +   K D++  G++  E LVG
Sbjct: 182 EMIEGKTHD--EKVDLWCAGVLCYEFLVG 208

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/171 (22%), Positives = 74/171 (43%), Gaps = 22/171 (12%)
Query: 109 VNEVASISRTSHVNVVTLLGF----CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL 164
           + E+  +    H N++T+         E  N   I + +    L + +         Q L
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI-------STQML 109
Query: 165 RWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE 224
             + +   +    + ++ LH    + ++H D+KP N+L++ +   K+ DFGLA++     
Sbjct: 110 SDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166
Query: 225 GIVSSLLGAR-GIIGYI------APEVFSRNFGEVSHKSDVYSFGMMIMEL 268
              S   G + G+  Y+      APEV   +  + S   DV+S G ++ EL
Sbjct: 167 ADNSEPTGQQSGMTEYVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAEL 216

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 83/168 (49%), Gaps = 22/168 (13%)
Query: 122 NVVTLLGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
           N+V LL    + +++  +LI+E++ N    K +Y   T    +Y     +YE++    K 
Sbjct: 89  NIVKLLDIVRDQHSKTPSLIFEYVNNTDF-KVLYPTLTDYDIRYY----IYELL----KA 139
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTT-KEGIVSSLLGARGII 237
           L+Y H   S  I+H D+KPHN+++D +    ++ D+GLA+     KE  V   + +R   
Sbjct: 140 LDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR--VASRYFK 194
Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
           G   PE+   +  +  +  D++S G M   ++  K     G D+  ++
Sbjct: 195 G---PELLV-DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 238

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/171 (22%), Positives = 75/171 (43%), Gaps = 22/171 (12%)
Query: 109 VNEVASISRTSHVNVVTLLGF----CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL 164
           + E+  +    H N++T+         E  N   I + +    L + +         Q L
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI-------STQML 109
Query: 165 RWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE 224
             + +   +    + ++ LH    + ++H D+KP N+L++ +   K+ DFGLA++     
Sbjct: 110 SDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166
Query: 225 GIVSSLLGAR-GIIGYI------APEVFSRNFGEVSHKSDVYSFGMMIMEL 268
              S   G + G++ ++      APEV   +  + S   DV+S G ++ EL
Sbjct: 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAEL 216

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 83/168 (49%), Gaps = 22/168 (13%)
Query: 122 NVVTLLGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
           N+V LL    + +++  +LI+E++ N    K +Y   T    +Y     +YE++    K 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDF-KVLYPTLTDYDIRYY----IYELL----KA 137
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTT-KEGIVSSLLGARGII 237
           L+Y H   S  I+H D+KPHN+++D +    ++ D+GLA+     KE  V   + +R   
Sbjct: 138 LDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR--VASRYFK 192
Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
           G   PE+   +  +  +  D++S G M   ++  K     G D+  ++
Sbjct: 193 G---PELLV-DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 236

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 57/138 (41%), Gaps = 27/138 (19%)
Query: 120 HVNVVTLLGFCLEGNNRALIYEFMPNGSL------EKFVYNGDTSKPCQYLRWEKMYEIV 173
           H N+V L     E  +  LI++ +  G L       ++    D S   Q +         
Sbjct: 80  HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQI--------- 130
Query: 174 IGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDF---CPKISDFGLAKLCTTKEGIVSSL 230
                 LE + H     ++H D+KP N+LL         K++DFGLA      EG   + 
Sbjct: 131 ------LEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLA---IEVEGEQQAW 181
Query: 231 LGARGIIGYIAPEVFSRN 248
            G  G  GY++PEV  ++
Sbjct: 182 FGFAGTPGYLSPEVLRKD 199

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 80/209 (38%), Gaps = 51/209 (24%)
Query: 91  LGQGGFGGVYKGR----------------------LLDDFVNEVASISRTSHVNVVTLLG 128
           LG+G FG VY  R                      +      E+   S   H N++ +  
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNG---DTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
           +  +     L+ EF P G L K +      D  +   ++           +A  L Y H 
Sbjct: 83  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME---------ELADALHYCH- 132
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGAR---GIIGYIAP 242
               K++H DIKP N+L+      KI+DFG +        + +  L  R   G + Y+ P
Sbjct: 133 --ERKVIHRDIKPENLLMGYKGELKIADFGWS--------VHAPSLRRRXMCGTLDYLPP 182
Query: 243 EVFSRNFGEVSHKSDVYSFGMMIME-LVG 270
           E+      +   K D++  G++  E LVG
Sbjct: 183 EMIEGKTHD--EKVDLWCAGVLCYEFLVG 209

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 70/147 (47%), Gaps = 22/147 (14%)
Query: 127 LGFCLEGN-NRALIYEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEIVIGIAKGLEYLH 184
           L F  + N N  ++ E+ P G +   +   G  S+P       + Y   I +    EYLH
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA-----RFYAAQIVLT--FEYLH 158
Query: 185 HGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE- 243
              S  +++ D+KP N+++D+    +++DFGLAK    +   +       G   Y+APE 
Sbjct: 159 ---SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC------GTPEYLAPEI 209
Query: 244 VFSRNFGEVSHKSDVYSFGMMIMELVG 270
           + S+ + +     D ++ G++I E+  
Sbjct: 210 ILSKGYNKA---VDWWALGVLIYEMAA 233

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 80/177 (45%), Gaps = 24/177 (13%)
Query: 100 YKGRLLDD---FVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGD 156
           + G LLD    F+++  S  + +   V T +  C E N  A+      NGS+  F  + D
Sbjct: 111 HGGHLLDKLNVFIDD--STGKCAMDVVKTQICPCPECNEEAI------NGSIHGFRESLD 162
Query: 157 TSKPCQYLRWEKMY-EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL--DEDFCPKISD 213
                 +++ EK+   I+  I   L YLH   +  I H DIKP N L   ++ F  K+ D
Sbjct: 163 ------FVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVD 213
Query: 214 FGLAK-LCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
           FGL+K       G    +    G   ++APEV +        K D +S G+++  L+
Sbjct: 214 FGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 81/174 (46%), Gaps = 21/174 (12%)
Query: 99  VYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYN-GDT 157
           V K + ++  +NE   +   +   +V L     + +N  ++ E++P G +   +   G  
Sbjct: 79  VVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF 138
Query: 158 SKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLA 217
           S+P       + Y   I +    EYLH   S  +++ D+KP N+L+D+    +++DFG A
Sbjct: 139 SEPHA-----RFYAAQIVLT--FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 218 KLCTTKEGIVSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVG 270
           K    +   +       G   Y+APE + S+ + +     D ++ G++I E+  
Sbjct: 189 KRVKGRTWXLC------GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAA 233

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 80/180 (44%), Gaps = 34/180 (18%)
Query: 106 DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL---------EKFVYNGD 156
           +D   E +      H ++V LL          +++EFM    L           FVY+  
Sbjct: 71  EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEA 130
Query: 157 TSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL--DEDFCP-KISD 213
            +    Y+R          I + L Y H      I+H D+KP N+LL   E+  P K+ D
Sbjct: 131 VAS--HYMRQ---------ILEALRYCH---DNNIIHRDVKPENVLLASKENSAPVKLGD 176
Query: 214 FGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRN-FGEVSHKSDVYSFGMMIMELV-GC 271
           FG+A +   + G+V+   G  G   ++APEV  R  +G+     DV+  G+++  L+ GC
Sbjct: 177 FGVA-IQLGESGLVAG--GRVGTPHFMAPEVVKREPYGK---PVDVWGCGVILFILLSGC 230

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 81/174 (46%), Gaps = 21/174 (12%)
Query: 99  VYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYN-GDT 157
           V K + ++  +NE   +   +   +V L     + +N  ++ E++P G +   +   G  
Sbjct: 79  VVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF 138
Query: 158 SKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLA 217
           S+P       + Y   I +    EYLH   S  +++ D+KP N+L+D+    +++DFG A
Sbjct: 139 SEPHA-----RFYAAQIVLT--FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 218 KLCTTKEGIVSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVG 270
           K    +   +       G   Y+APE + S+ + +     D ++ G++I E+  
Sbjct: 189 KRVKGRTWXLC------GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAA 233

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 81/174 (46%), Gaps = 21/174 (12%)
Query: 99  VYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYN-GDT 157
           V K + ++  +NE   +   +   +V L     + +N  ++ E++P G +   +   G  
Sbjct: 79  VVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF 138
Query: 158 SKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLA 217
           S+P       + Y   I +    EYLH   S  +++ D+KP N+L+D+    +++DFG A
Sbjct: 139 SEPHA-----RFYAAQIVLT--FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 218 KLCTTKEGIVSSLLGARGIIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVG 270
           K    +   +       G   Y+APE + S+ + +     D ++ G++I E+  
Sbjct: 189 KRVKGRTWXLC------GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAA 233

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 70/166 (42%), Gaps = 16/166 (9%)
Query: 105 LDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQY 163
           L     EV  +   +H N+V L           L+ E+   G + +  V +G   +    
Sbjct: 57  LQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR 116
Query: 164 LRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK 223
            ++ +       I   ++Y H      I+H D+K  N+LLD D   KI+DFG +   T  
Sbjct: 117 AKFRQ-------IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFT-- 164
Query: 224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
               + L    G   Y APE+F     +   + DV+S G+++  LV
Sbjct: 165 --FGNKLDAFCGAPPYAAPELFQGKKYD-GPEVDVWSLGVILYTLV 207

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 49/92 (53%), Gaps = 13/92 (14%)
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
            EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   ++      G   Y
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLA------GTPEY 204
Query: 240 IAPE-VFSRNFGEVSHKSDVYSFGMMIMELVG 270
           +APE + S+ + +     D ++ G++I E+  
Sbjct: 205 LAPEIILSKGYNKA---VDWWALGVLIYEMAA 233

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 51/96 (53%), Gaps = 11/96 (11%)
Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV--SSLLGA 233
           I   L+YLH      +++ D+K  N++LD+D   KI+DFGL      KEGI   +++   
Sbjct: 119 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLC-----KEGIKDGATMKXF 171
Query: 234 RGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            G   Y+APEV   N  +     D +  G+++ E++
Sbjct: 172 CGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMM 205

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 51/96 (53%), Gaps = 11/96 (11%)
Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV--SSLLGA 233
           I   L+YLH      +++ D+K  N++LD+D   KI+DFGL      KEGI   +++   
Sbjct: 117 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLC-----KEGIKDGATMKXF 169
Query: 234 RGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            G   Y+APEV   N  +     D +  G+++ E++
Sbjct: 170 CGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMM 203

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 51/96 (53%), Gaps = 11/96 (11%)
Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV--SSLLGA 233
           I   L+YLH      +++ D+K  N++LD+D   KI+DFGL      KEGI   +++   
Sbjct: 118 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLC-----KEGIKDGATMKXF 170
Query: 234 RGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            G   Y+APEV   N  +     D +  G+++ E++
Sbjct: 171 CGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMM 204

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 86/209 (41%), Gaps = 37/209 (17%)
Query: 91  LGQGGFGGVYKGRLLDDFV--------NEVASISRTSHVNVVTL-----LGFCLE----- 132
           +G+G +G V++G    + V        +E +    T   N V L     LGF        
Sbjct: 16  VGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSR 75
Query: 133 --GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH---HGC 187
                  LI  +   GSL  ++    T      LR      IV+ IA GL +LH    G 
Sbjct: 76  HSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLR------IVLSIASGLAHLHIEIFGT 128
Query: 188 STK--ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGAR-GIIGYIAPEV 244
             K  I H D+K  NIL+ ++    I+D GLA + +     +      R G   Y+APEV
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188
Query: 245 FSRNFG----EVSHKSDVYSFGMMIMELV 269
                     +   + D+++FG+++ E+ 
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 63/140 (45%), Gaps = 18/140 (12%)
Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEK 168
            E+  + R SH N++ L          +L+ E +  G L ++ V  G       Y     
Sbjct: 97  TEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKG-------YYSERD 149
Query: 169 MYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE---DFCPKISDFGLAKLCTTKEG 225
             + V  I + + YLH      I+H D+KP N+L      D   KI+DFGL+K+    + 
Sbjct: 150 AADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI-VEHQV 205
Query: 226 IVSSLLGARGIIGYIAPEVF 245
           ++ ++ G     GY APE+ 
Sbjct: 206 LMKTVCGTP---GYCAPEIL 222

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 86/209 (41%), Gaps = 37/209 (17%)
Query: 91  LGQGGFGGVYKGRLLDDFV--------NEVASISRTSHVNVVTL-----LGFCLE----- 132
           +G+G +G V++G    + V        +E +    T   N V L     LGF        
Sbjct: 16  VGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSR 75
Query: 133 --GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH---HGC 187
                  LI  +   GSL  ++    T      LR      IV+ IA GL +LH    G 
Sbjct: 76  HSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLR------IVLSIASGLAHLHIEIFGT 128
Query: 188 STK--ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGAR-GIIGYIAPEV 244
             K  I H D+K  NIL+ ++    I+D GLA + +     +      R G   Y+APEV
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188
Query: 245 FSRNFG----EVSHKSDVYSFGMMIMELV 269
                     +   + D+++FG+++ E+ 
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           I    EYLH   S  +++ D+KP N+L+DE    +++DFG AK    +   +       G
Sbjct: 137 IVLTFEYLH---SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLC------G 187
Query: 236 IIGYIAPE-VFSRNFGEVSHKSDVYSFGMMIMELVG 270
              Y+APE + S+ + +     D ++ G++I E+  
Sbjct: 188 TPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAA 220

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 81/210 (38%), Gaps = 44/210 (20%)
Query: 87  FKDKLGQGGFGGVYKGRL--------------------LDDFVNEVASISRTSHVNVVTL 126
             D LGQG    V++GR                     +D  + E   + + +H N+V L
Sbjct: 13  LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 127 LGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVI-GIAKGLEYL 183
                E   R   LI EF P GSL    Y         Y   E  + IV+  +  G+ +L
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSL----YTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 184 HHGCSTKILHFDIKPHNILL----DEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
                  I+H +IKP NI+     D     K++DFG A+     E  V       G   Y
Sbjct: 129 R---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVX----LYGTEEY 181
Query: 240 IAPEVFSRNFGEVSHKS------DVYSFGM 263
           + P+++ R      H+       D++S G+
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGV 211

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 52/104 (50%), Gaps = 13/104 (12%)
Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE---DFCPKISDFGLAKLCTTKEGIV 227
           EI+  I + ++YLH   S  I H D+KP N+L      +   K++DFG AK  T+   + 
Sbjct: 126 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 182
Query: 228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGC 271
           +          Y+APEV      + S   D++S G +IM ++ C
Sbjct: 183 TPCYTPY----YVAPEVLGPEKYDKS--CDMWSLG-VIMYILLC 219

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 52/104 (50%), Gaps = 13/104 (12%)
Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE---DFCPKISDFGLAKLCTTKEGIV 227
           EI+  I + ++YLH   S  I H D+KP N+L      +   K++DFG AK  T+   + 
Sbjct: 125 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 181
Query: 228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGC 271
           +          Y+APEV      + S   D++S G +IM ++ C
Sbjct: 182 TPCYTPY----YVAPEVLGPEKYDKS--CDMWSLG-VIMYILLC 218

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 52/104 (50%), Gaps = 13/104 (12%)
Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE---DFCPKISDFGLAKLCTTKEGIV 227
           EI+  I + ++YLH   S  I H D+KP N+L      +   K++DFG AK  T+   + 
Sbjct: 165 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 221
Query: 228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGC 271
           +          Y+APEV      + S   D++S G +IM ++ C
Sbjct: 222 TPCYTPY----YVAPEVLGPEKYDKS--CDMWSLG-VIMYILLC 258

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 52/104 (50%), Gaps = 13/104 (12%)
Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE---DFCPKISDFGLAKLCTTKEGIV 227
           EI+  I + ++YLH   S  I H D+KP N+L      +   K++DFG AK  T+   + 
Sbjct: 127 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 183
Query: 228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGC 271
           +          Y+APEV      + S   D++S G +IM ++ C
Sbjct: 184 TPCYTPY----YVAPEVLGPEKYDKS--CDMWSLG-VIMYILLC 220

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 52/104 (50%), Gaps = 13/104 (12%)
Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE---DFCPKISDFGLAKLCTTKEGIV 227
           EI+  I + ++YLH   S  I H D+KP N+L      +   K++DFG AK  T+   + 
Sbjct: 121 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 177
Query: 228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGC 271
           +          Y+APEV      + S   D++S G +IM ++ C
Sbjct: 178 TPCYTPY----YVAPEVLGPEKYDKS--CDMWSLG-VIMYILLC 214

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 52/104 (50%), Gaps = 13/104 (12%)
Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE---DFCPKISDFGLAKLCTTKEGIV 227
           EI+  I + ++YLH   S  I H D+KP N+L      +   K++DFG AK  T+   + 
Sbjct: 121 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 177
Query: 228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGC 271
           +          Y+APEV      + S   D++S G +IM ++ C
Sbjct: 178 TPCYTPY----YVAPEVLGPEKYDKS--CDMWSLG-VIMYILLC 214

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 51/104 (49%), Gaps = 13/104 (12%)
Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE---DFCPKISDFGLAKLCTTKEGIV 227
           EI+  I + ++YLH   S  I H D+KP N+L      +   K++DFG AK  T+   + 
Sbjct: 135 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 191
Query: 228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGC 271
           +          Y+APEV      +     D++S G +IM ++ C
Sbjct: 192 TPCYTPY----YVAPEVLGPE--KYDKSCDMWSLG-VIMYILLC 228

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 44/94 (46%), Gaps = 8/94 (8%)
Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           IA  L YLH   S  I++ D+KP NILLD      ++DFGL K         S+  G   
Sbjct: 148 IASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTP- 203
Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
              Y+APEV  +         D +  G ++ E++
Sbjct: 204 --EYLAPEVLHKQ--PYDRTVDWWCLGAVLYEML 233

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 52/104 (50%), Gaps = 13/104 (12%)
Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE---DFCPKISDFGLAKLCTTKEGIV 227
           EI+  I + ++YLH   S  I H D+KP N+L      +   K++DFG AK  T+   + 
Sbjct: 119 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 175
Query: 228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGC 271
           +          Y+APEV      + S   D++S G +IM ++ C
Sbjct: 176 TPCYTPY----YVAPEVLGPEKYDKS--CDMWSLG-VIMYILLC 212

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 52/104 (50%), Gaps = 13/104 (12%)
Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE---DFCPKISDFGLAKLCTTKEGIV 227
           EI+  I + ++YLH   S  I H D+KP N+L      +   K++DFG AK  T+   + 
Sbjct: 120 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 176
Query: 228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGC 271
           +          Y+APEV      + S   D++S G +IM ++ C
Sbjct: 177 TPCYTPY----YVAPEVLGPEKYDKS--CDMWSLG-VIMYILLC 213

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 52/104 (50%), Gaps = 13/104 (12%)
Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE---DFCPKISDFGLAKLCTTKEGIV 227
           EI+  I + ++YLH   S  I H D+KP N+L      +   K++DFG AK  T+   + 
Sbjct: 171 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 227
Query: 228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGC 271
           +          Y+APEV      + S   D++S G +IM ++ C
Sbjct: 228 TPCYTPY----YVAPEVLGPEKYDKS--CDMWSLG-VIMYILLC 264

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/171 (22%), Positives = 72/171 (42%), Gaps = 22/171 (12%)
Query: 109 VNEVASISRTSHVNVVTLLGF----CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL 164
           + E+  +    H N++T+         E  N   I + +    L + +         Q L
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI-------STQML 109
Query: 165 RWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC---- 220
             + +   +    + ++ LH    + ++H D+KP N+L++ +   K+ DFGLA++     
Sbjct: 110 SDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166
Query: 221 ---TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMEL 268
              +   G  S +        Y APEV   +  + S   DV+S G ++ EL
Sbjct: 167 ADNSEPTGQQSGMTEXVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAEL 216

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 50/92 (54%), Gaps = 13/92 (14%)
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
            EYLH   S  +++ D+KP N+L+D+    +++DFG AK     +G   +L G      Y
Sbjct: 175 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---KGATWTLCGTP---EY 225
Query: 240 IAPE-VFSRNFGEVSHKSDVYSFGMMIMELVG 270
           +APE + S+ + +     D ++ G++I E+  
Sbjct: 226 LAPEIILSKGYNKA---VDWWALGVLIYEMAA 254

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 47/206 (22%)
Query: 91  LGQGGFGGV-----------YKGRLLDDFVNEVASISRTSH----------VNVVTL--L 127
           LG G FG V           Y  ++LD    +V  + +  H          VN   L  L
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDK--QKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 128 GFCLEGN-NRALIYEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
            F  + N N  ++ E+ P G +   +   G  S+P       + Y   I +    EYLH 
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA-----RFYAAQIVLT--FEYLH- 158
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
             S  +++ D+KP N+++D+    +++DFG AK    +   +       G   Y+APE +
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLC------GTPEYLAPEII 210
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVG 270
            S+ + +     D ++ G++I E+  
Sbjct: 211 LSKGYNKA---VDWWALGVLIYEMAA 233

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 71/166 (42%), Gaps = 16/166 (9%)
Query: 105 LDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQY 163
           L     EV  +   +H N+V L           L+ E+   G + +  V +G   +    
Sbjct: 58  LQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR 117
Query: 164 LRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK 223
            ++ +       I   ++Y H      I+H D+K  N+LLD D   KI+DFG +   T  
Sbjct: 118 AKFRQ-------IVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFT-- 165
Query: 224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             + + L    G   Y APE+F     +   + DV+S G+++  LV
Sbjct: 166 --VGNKLDTFCGSPPYAAPELFQGKKYD-GPEVDVWSLGVILYTLV 208

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 86/209 (41%), Gaps = 37/209 (17%)
Query: 91  LGQGGFGGVYKGRLLDDFV--------NEVASISRTSHVNVVTL-----LGFCLE----- 132
           +G+G +G V++G    + V        +E +    T   N V L     LGF        
Sbjct: 45  VGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSR 104
Query: 133 --GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH---HGC 187
                  LI  +   GSL  ++    T      LR      IV+ IA GL +LH    G 
Sbjct: 105 HSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLR------IVLSIASGLAHLHIEIFGT 157
Query: 188 STK--ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGAR-GIIGYIAPEV 244
             K  I H D+K  NIL+ ++    I+D GLA + +     +      R G   Y+APEV
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 217
Query: 245 FSRNFG----EVSHKSDVYSFGMMIMELV 269
                     +   + D+++FG+++ E+ 
Sbjct: 218 LDETIQVDCFDSYKRVDIWAFGLVLWEVA 246

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 48/92 (52%), Gaps = 13/92 (14%)
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
            EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +       G   Y
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLX------GTPEY 204
Query: 240 IAPE-VFSRNFGEVSHKSDVYSFGMMIMELVG 270
           +APE + S+ + +     D ++ G++I E+  
Sbjct: 205 LAPEIILSKGYNKA---VDWWALGVLIYEMAA 233

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 47/206 (22%)
Query: 91  LGQGGFGGV-----------YKGRLLDDFVNEVASISRTSH----------VNVVTL--L 127
           LG G FG V           Y  ++LD    +V  + +  H          VN   L  L
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDK--QKVVKLKQIEHTLNEKRILQAVNFPFLVKL 99
Query: 128 GFCLEGN-NRALIYEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
            F  + N N  ++ E++P G +   +   G   +P       + Y   I +    EYLH 
Sbjct: 100 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHA-----RFYAAQIVLT--FEYLH- 151
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
             S  +++ D+KP N+L+D+    +++DFG AK    +   +       G   Y+APE +
Sbjct: 152 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC------GTPEYLAPEII 203
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVG 270
            S+ + +     D ++ G++I E+  
Sbjct: 204 LSKGYNKA---VDWWALGVLIYEMAA 226

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 48/92 (52%), Gaps = 13/92 (14%)
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
            EYLH   S  +++ D+KP N+++D+    K++DFG AK    +   +       G   Y
Sbjct: 154 FEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC------GTPEY 204
Query: 240 IAPE-VFSRNFGEVSHKSDVYSFGMMIMELVG 270
           +APE + S+ + +     D ++ G++I E+  
Sbjct: 205 LAPEIILSKGYNKA---VDWWALGVLIYEMAA 233

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 47/206 (22%)
Query: 91  LGQGGFGGV-----------YKGRLLDDFVNEVASISRTSH----------VNVVTL--L 127
           LG G FG V           Y  ++LD    +V  + +  H          VN   L  L
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDK--QKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 128 GFCLEGN-NRALIYEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
            F  + N N  ++ E++P G +   +   G   +P       + Y   I +    EYLH 
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHA-----RFYAAQIVLT--FEYLH- 158
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
             S  +++ D+KP N+L+D+    +++DFG AK    +   +       G   Y+APE +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC------GTPEYLAPEII 210
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVG 270
            S+ + +     D ++ G++I E+  
Sbjct: 211 LSKGYNKA---VDWWALGVLIYEMAA 233

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 47/206 (22%)
Query: 91  LGQGGFGGV-----------YKGRLLDDFVNEVASISRTSH----------VNVVTL--L 127
           LG G FG V           Y  ++LD    +V  + +  H          VN   L  L
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDK--QKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 128 GFCLEGN-NRALIYEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
            F  + N N  ++ E++P G +   +   G   +P       + Y   I +    EYLH 
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHA-----RFYAAQIVLT--FEYLH- 158
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
             S  +++ D+KP N+L+D+    +++DFG AK    +   +       G   Y+APE +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC------GTPEYLAPEII 210
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVG 270
            S+ + +     D ++ G++I E+  
Sbjct: 211 LSKGYNKA---VDWWALGVLIYEMAA 233

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 47/206 (22%)
Query: 91  LGQGGFGGV-----------YKGRLLDDFVNEVASISRTSH----------VNVVTL--L 127
           LG G FG V           Y  ++LD    +V  + +  H          VN   L  L
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDK--QKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 128 GFCLEGN-NRALIYEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
            F  + N N  ++ E++P G +   +   G   +P       + Y   I +    EYLH 
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHA-----RFYAAQIVLT--FEYLH- 159
Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE-V 244
             S  +++ D+KP N+L+D+    +++DFG AK    +   +       G   Y+APE +
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC------GTPEYLAPEII 211
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVG 270
            S+ + +     D ++ G++I E+  
Sbjct: 212 LSKGYNKA---VDWWALGVLIYEMAA 234

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 51/104 (49%), Gaps = 13/104 (12%)
Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE---DFCPKISDFGLAKLCTTKEGIV 227
           EI+  I + ++YLH   S  I H D+KP N+L      +   K++DFG AK  T+   + 
Sbjct: 119 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 175
Query: 228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGC 271
                      Y+APEV      + S   D++S G +IM ++ C
Sbjct: 176 EPCYTPY----YVAPEVLGPEKYDKS--CDMWSLG-VIMYILLC 212

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 70/166 (42%), Gaps = 16/166 (9%)
Query: 105 LDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQY 163
           L     EV  +   +H N+V L           L+ E+   G + +  V +G   +    
Sbjct: 57  LQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR 116
Query: 164 LRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK 223
            ++ +       I   ++Y H      I+H D+K  N+LLD D   KI+DFG +   T  
Sbjct: 117 AKFRQ-------IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFT-- 164
Query: 224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
               + L    G   Y APE+F     +   + DV+S G+++  LV
Sbjct: 165 --FGNKLDTFCGSPPYAAPELFQGKKYD-GPEVDVWSLGVILYTLV 207

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 70/166 (42%), Gaps = 16/166 (9%)
Query: 105 LDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQY 163
           L     EV  +   +H N+V L           L+ E+   G + +  V +G   +    
Sbjct: 57  LQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR 116
Query: 164 LRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK 223
            ++ +       I   ++Y H      I+H D+K  N+LLD D   KI+DFG +   T  
Sbjct: 117 AKFRQ-------IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG 166
Query: 224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             + +      G   Y APE+F     +   + DV+S G+++  LV
Sbjct: 167 NKLDTFC----GSPPYAAPELFQGKKYD-GPEVDVWSLGVILYTLV 207

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 48/92 (52%), Gaps = 13/92 (14%)
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
            EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +       G   Y
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC------GTPEY 204
Query: 240 IAPE-VFSRNFGEVSHKSDVYSFGMMIMELVG 270
           +APE + S+ + +     D ++ G++I E+  
Sbjct: 205 LAPEIILSKGYNKA---VDWWALGVLIYEMAA 233

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 70/166 (42%), Gaps = 16/166 (9%)
Query: 105 LDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQY 163
           L     EV  +   +H N+V L           L+ E+   G + +  V +G   +    
Sbjct: 57  LQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR 116
Query: 164 LRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK 223
            ++ +       I   ++Y H      I+H D+K  N+LLD D   KI+DFG +   T  
Sbjct: 117 AKFRQ-------IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFT-- 164
Query: 224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
               + L    G   Y APE+F     +   + DV+S G+++  LV
Sbjct: 165 --FGNKLDTFCGSPPYAAPELFQGKKYD-GPEVDVWSLGVILYTLV 207

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 48/92 (52%), Gaps = 13/92 (14%)
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
            EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +       G   Y
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC------GTPEY 204
Query: 240 IAPE-VFSRNFGEVSHKSDVYSFGMMIMELVG 270
           +APE + S+ + +     D ++ G++I E+  
Sbjct: 205 LAPEIILSKGYNKA---VDWWALGVLIYEMAA 233

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 42/220 (19%)
Query: 76  NFSDVKKLTNSFKDKLGQGGFGGVYKGRLLDD-------FVNEVASISRT---------- 118
            F D+ KLT+     LG+G +  V     L +        + + A  SR+          
Sbjct: 9   KFEDMYKLTSEL---LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLY 65
Query: 119 ---SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG 175
               + N++ L+ F  +     L++E +  GS+   +         ++    +   +V  
Sbjct: 66  QCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQ------KHFNEREASRVVRD 119
Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLD--EDFCP-KISDFGLA---KLCTTKEGIVS- 228
           +A  L++LH   +  I H D+KP NIL +  E   P KI DF L    KL  +   I + 
Sbjct: 120 VAAALDFLH---TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTP 176
Query: 229 SLLGARGIIGYIAP---EVFSRNFGEVSHKSDVYSFGMMI 265
            L    G   Y+AP   EVF+        + D++S G+++
Sbjct: 177 ELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVL 216

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 69/166 (41%), Gaps = 16/166 (9%)
Query: 105 LDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQY 163
           L     EV      +H N+V L           L+ E+   G + +  V +G   +    
Sbjct: 57  LQKLFREVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEAR 116
Query: 164 LRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK 223
            ++ +       I   ++Y H      I+H D+K  N+LLD D   KI+DFG +   T  
Sbjct: 117 AKFRQ-------IVSAVQYCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFT-- 164
Query: 224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
               + L    G   Y APE+F     +   + DV+S G+++  LV
Sbjct: 165 --FGNKLDAFCGAPPYAAPELFQGKKYD-GPEVDVWSLGVILYTLV 207

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 48/92 (52%), Gaps = 13/92 (14%)
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
            EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +       G   Y
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC------GTPEY 204
Query: 240 IAPE-VFSRNFGEVSHKSDVYSFGMMIMELVG 270
           +APE + S+ + +     D ++ G++I E+  
Sbjct: 205 LAPEIILSKGYNKA---VDWWALGVLIYEMAA 233

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 48/92 (52%), Gaps = 13/92 (14%)
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
            EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +       G   Y
Sbjct: 155 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC------GTPEY 205
Query: 240 IAPE-VFSRNFGEVSHKSDVYSFGMMIMELVG 270
           +APE + S+ + +     D ++ G++I E+  
Sbjct: 206 LAPEIILSKGYNKA---VDWWALGVLIYEMAA 234

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 48/92 (52%), Gaps = 13/92 (14%)
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
            EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +       G   Y
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC------GTPEY 204
Query: 240 IAPE-VFSRNFGEVSHKSDVYSFGMMIMELVG 270
           +APE + S+ + +     D ++ G++I E+  
Sbjct: 205 LAPEIILSKGYNKA---VDWWALGVLIYEMAA 233

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 60/126 (47%), Gaps = 26/126 (20%)
Query: 109 VNEVASISRTSHVNVVTL--------------LGFCLEGNNRALIYEFMPNGSLEKFVYN 154
           + E+  I R  H N+V +              +G   E N+  ++ E+M    L   +  
Sbjct: 56  LREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQ 114
Query: 155 GDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLD-EDFCPKISD 213
           G   +    L    MY+++    +GL+Y+H   S  +LH D+KP N+ ++ ED   KI D
Sbjct: 115 GPLLEEHARLF---MYQLL----RGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGD 164
Query: 214 FGLAKL 219
           FGLA++
Sbjct: 165 FGLARI 170

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 48/92 (52%), Gaps = 13/92 (14%)
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
            EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +       G   Y
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC------GTPEY 204
Query: 240 IAPE-VFSRNFGEVSHKSDVYSFGMMIMELVG 270
           +APE + S+ + +     D ++ G++I E+  
Sbjct: 205 LAPEIILSKGYNKA---VDWWALGVLIYEMAA 233

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 48/92 (52%), Gaps = 13/92 (14%)
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
            EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +       G   Y
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC------GTPEY 204
Query: 240 IAPE-VFSRNFGEVSHKSDVYSFGMMIMELVG 270
           +APE + S+ + +     D ++ G++I E+  
Sbjct: 205 LAPEIILSKGYNKA---VDWWALGVLIYEMAA 233

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 48/92 (52%), Gaps = 13/92 (14%)
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
            EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +       G   Y
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC------GTPEY 204
Query: 240 IAPE-VFSRNFGEVSHKSDVYSFGMMIMELVG 270
           +APE + S+ + +     D ++ G++I E+  
Sbjct: 205 LAPEIILSKGYNKA---VDWWALGVLIYEMAA 233

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 48/92 (52%), Gaps = 13/92 (14%)
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
            EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +       G   Y
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC------GTPEY 204
Query: 240 IAPE-VFSRNFGEVSHKSDVYSFGMMIMELVG 270
           +APE + S+ + +     D ++ G++I E+  
Sbjct: 205 LAPEIILSKGYNKA---VDWWALGVLIYEMAA 233

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 124 VTLLGFCLEGNNRA-LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 182
           +T L +  +  N   L+ ++   G L   +   +   P    R+  + E+V+ I   +  
Sbjct: 136 ITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARF-YIGEMVLAI-DSIHQ 193
Query: 183 LHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAP 242
           LH+      +H DIKP N+LLD +   +++DFG + L    +G V S + A G   YI+P
Sbjct: 194 LHY------VHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSV-AVGTPDYISP 245
Query: 243 EVFSR---NFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDR 299
           E+        G+   + D +S G+ + E++  +    +  +S  E Y    I  H E+  
Sbjct: 246 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA--ESLVETYGK--IMNHEER-- 299
Query: 300 EFKLPGVVTRKENEIAKKMIIVGLWCIQAR 329
            F+ P  VT    E   K +I  L C + R
Sbjct: 300 -FQFPSHVTDVSEE--AKDLIQRLICSRER 326

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 48/92 (52%), Gaps = 13/92 (14%)
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
            EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +       G   Y
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC------GTPEY 204
Query: 240 IAPE-VFSRNFGEVSHKSDVYSFGMMIMELVG 270
           +APE + S+ + +     D ++ G++I E+  
Sbjct: 205 LAPEIILSKGYNKA---VDWWALGVLIYEMAA 233

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 124 VTLLGFCLEGNNRA-LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 182
           +T L +  +  N   L+ ++   G L   +   +   P    R+  + E+V+ I   +  
Sbjct: 152 ITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARF-YIGEMVLAI-DSIHQ 209
Query: 183 LHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAP 242
           LH+      +H DIKP N+LLD +   +++DFG + L    +G V S + A G   YI+P
Sbjct: 210 LHY------VHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSV-AVGTPDYISP 261
Query: 243 EVFSR---NFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDR 299
           E+        G+   + D +S G+ + E++  +    +  +S  E Y    I  H E+  
Sbjct: 262 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA--ESLVETYGK--IMNHEER-- 315
Query: 300 EFKLPGVVTRKENEIAKKMIIVGLWCIQAR 329
            F+ P  VT    E   K +I  L C + R
Sbjct: 316 -FQFPSHVTDVSEE--AKDLIQRLICSRER 342

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 89/211 (42%), Gaps = 62/211 (29%)
Query: 103 RLLDDFVN------EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF----- 151
           R+ +D ++      E+A ++R +H +VV +L   +  +             +EKF     
Sbjct: 88  RVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKD-------------VEKFDELYV 134
Query: 152 ---VYNGDTSKPCQ---YLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE 205
              + + D  K  +   YL    +  ++  +  G++Y+H   S  ILH D+KP N L+++
Sbjct: 135 VLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQ 191
Query: 206 DFCPKISDFGLAKLCTTKEGIVSSLLGA------------------RGIIGYI------A 241
           D   K+ DFGLA+     E   S L  +                  R + G++      A
Sbjct: 192 DCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRA 251
Query: 242 PE--VFSRNFGEVSHKSDVYSFGMMIMELVG 270
           PE  +   N+ E     DV+S G +  EL+ 
Sbjct: 252 PELILLQENYTEA---IDVWSIGCIFAELLN 279

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 48/92 (52%), Gaps = 13/92 (14%)
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
            EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +       G   Y
Sbjct: 175 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC------GTPEY 225
Query: 240 IAPE-VFSRNFGEVSHKSDVYSFGMMIMELVG 270
           +APE + S+ + +     D ++ G++I E+  
Sbjct: 226 LAPEIILSKGYNKA---VDWWALGVLIYEMAA 254

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 48/92 (52%), Gaps = 13/92 (14%)
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
            EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +       G   Y
Sbjct: 149 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC------GTPEY 199
Query: 240 IAPE-VFSRNFGEVSHKSDVYSFGMMIMELVG 270
           +APE + S+ + +     D ++ G++I E+  
Sbjct: 200 LAPEIILSKGYNKA---VDWWALGVLIYEMAA 228

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 70/166 (42%), Gaps = 16/166 (9%)
Query: 105 LDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQY 163
           L     EV  +   +H N+V L           L+ E+   G + +  V +G   +    
Sbjct: 57  LQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR 116
Query: 164 LRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK 223
            ++ +       I   ++Y H      I+H D+K  N+LLD D   KI+DFG +   T  
Sbjct: 117 AKFRQ-------IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFT-- 164
Query: 224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
               + L    G   Y APE+F     +   + DV+S G+++  LV
Sbjct: 165 --FGNKLDEFCGSPPYAAPELFQGKKYD-GPEVDVWSLGVILYTLV 207

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 48/92 (52%), Gaps = 13/92 (14%)
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
            EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +       G   Y
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC------GTPEY 204
Query: 240 IAPE-VFSRNFGEVSHKSDVYSFGMMIMELVG 270
           +APE + S+ + +     D ++ G++I E+  
Sbjct: 205 LAPEIILSKGYNKA---VDWWALGVLIYEMAA 233

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 70/160 (43%), Gaps = 31/160 (19%)
Query: 120 HVNVVTLLGFCLEGNNRALIYEFMPNGSL------EKFVYNGDTSKPCQYLRWEKMYEIV 173
           H N+V L     E  +  LI++ +  G L       ++    D S   Q +         
Sbjct: 69  HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQI--------- 119
Query: 174 IGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDF---CPKISDFGLAKLCTTKEGIVSSL 230
                 LE + H     ++H ++KP N+LL         K++DFGLA      EG   + 
Sbjct: 120 ------LEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLA---IEVEGEQQAW 170
Query: 231 LGARGIIGYIAPEVFSRN-FGEVSHKSDVYSFGMMIMELV 269
            G  G  GY++PEV  ++ +G+     D+++ G+++  L+
Sbjct: 171 FGFAGTPGYLSPEVLRKDPYGK---PVDLWACGVILYILL 207

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLD---EDFCPKISDFGLAKLCTTKEGIVSSLLG 232
           I + LE ++H     I+H D+KP N+LL    +    K++DFGLA      +G   +  G
Sbjct: 136 IHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLA---IEVQGEQQAWFG 192
Query: 233 ARGIIGYIAPEVFSRN-FGEVSHKSDVYSFGMMIMELV 269
             G  GY++PEV  ++ +G+     D+++ G+++  L+
Sbjct: 193 FAGTPGYLSPEVLRKDPYGK---PVDIWACGVILYILL 227

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 67/161 (41%), Gaps = 29/161 (18%)
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIG 238
           LE + H  +  +LH DIK  NIL+D +    K+ DFG   L   K+ + +   G R    
Sbjct: 120 LEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTR---- 173
Query: 239 YIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQD 298
             +P  + R        + V+S G+++ ++V              ++ F H        D
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMV------------CGDIPFEH--------D 213
Query: 299 REFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEV 339
            E     V  R+      + +I   WC+  RPSDRP   E+
Sbjct: 214 EEIIRGQVFFRQRVSXECQHLI--RWCLALRPSDRPTFEEI 252

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 108/275 (39%), Gaps = 60/275 (21%)
Query: 91  LGQGGFGGVYKG-RLLD-----------DFVNEVASISRTSHVNVVTLL------GFCLE 132
           LG GGFG VY G R+ D           D +++   +   + V +  +L      GF   
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 88
Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL------RWEKMYEIVIGI-AKGLEYLHH 185
           G  R L +   P+     FV   +  +P Q L      R     E+      + LE + H
Sbjct: 89  GVIRLLDWFERPD----SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 144
Query: 186 GCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV 244
             +  +LH DIK  NIL+D +    K+ DFG   L   K+ + +   G R      +P  
Sbjct: 145 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTR----VYSPPE 198
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
           + R        + V+S G+++ ++V              ++ F H        D E    
Sbjct: 199 WIRYHRYHGRSAAVWSLGILLYDMV------------CGDIPFEH--------DEEIIRG 238
Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEV 339
            V  R+      + +I   WC+  RPSDRP   E+
Sbjct: 239 QVFFRQRVSXECQHLI--RWCLALRPSDRPTFEEI 271

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 108/275 (39%), Gaps = 60/275 (21%)
Query: 91  LGQGGFGGVYKG-RLLD-----------DFVNEVASISRTSHVNVVTLL------GFCLE 132
           LG GGFG VY G R+ D           D +++   +   + V +  +L      GF   
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 89
Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL------RWEKMYEIVIGI-AKGLEYLHH 185
           G  R L +   P+     FV   +  +P Q L      R     E+      + LE + H
Sbjct: 90  GVIRLLDWFERPD----SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 145
Query: 186 GCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV 244
             +  +LH DIK  NIL+D +    K+ DFG   L   K+ + +   G R      +P  
Sbjct: 146 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTR----VYSPPE 199
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
           + R        + V+S G+++ ++V              ++ F H        D E    
Sbjct: 200 WIRYHRYHGRSAAVWSLGILLYDMV------------CGDIPFEH--------DEEIIRG 239
Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEV 339
            V  R+      + +I   WC+  RPSDRP   E+
Sbjct: 240 QVFFRQRVSXECQHLI--RWCLALRPSDRPTFEEI 272

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 82/212 (38%), Gaps = 51/212 (24%)
Query: 88  KDKLGQGGFGGVYK---------------------GRLLDDFVNEVASISRTSHVNVVTL 126
           K++LG+G F  V +                      R       E     +  H N+V L
Sbjct: 11  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 70
Query: 127 LGFCLEGNNRALIYEFMPNGSL------EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGL 180
                E +   L+++ +  G L       +F    D S   Q             I + +
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ------------QILESI 118
Query: 181 EYLHHGCSTKILHFDIKPHNILL---DEDFCPKISDFGLAKLCTTKEGIVSSLLGARGII 237
            Y H   S  I+H ++KP N+LL    +    K++DFGLA      E    +  G  G  
Sbjct: 119 AYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE----AWHGFAGTP 171
Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
           GY++PEV  ++    S   D+++ G+++  L+
Sbjct: 172 GYLSPEVLKKD--PYSKPVDIWACGVILYILL 201

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 82/212 (38%), Gaps = 51/212 (24%)
Query: 88  KDKLGQGGFGGVYK---------------------GRLLDDFVNEVASISRTSHVNVVTL 126
           K++LG+G F  V +                      R       E     +  H N+V L
Sbjct: 10  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 69
Query: 127 LGFCLEGNNRALIYEFMPNGSL------EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGL 180
                E +   L+++ +  G L       +F    D S   Q             I + +
Sbjct: 70  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ------------QILESI 117
Query: 181 EYLHHGCSTKILHFDIKPHNILL---DEDFCPKISDFGLAKLCTTKEGIVSSLLGARGII 237
            Y H   S  I+H ++KP N+LL    +    K++DFGLA      E    +  G  G  
Sbjct: 118 AYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE----AWHGFAGTP 170
Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
           GY++PEV  ++    S   D+++ G+++  L+
Sbjct: 171 GYLSPEVLKKD--PYSKPVDIWACGVILYILL 200

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 84/214 (39%), Gaps = 52/214 (24%)
Query: 88  KDKLGQGGFGGVYK---------------------GRLLDDFVNEVASISRTSHVNVVTL 126
           K++LG+G F  V +                      R       E     +  H N+V L
Sbjct: 11  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 70
Query: 127 LGFCLEGNNRALIYEFMPNGSL------EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGL 180
                E +   L+++ +  G L       +F    D S   Q             I + +
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ------------QILESI 118
Query: 181 EYLHHGCSTKILHFDIKPHNILL---DEDFCPKISDFGLAKLCTTKEGIVSSLLGARGII 237
            Y H   S  I+H ++KP N+LL    +    K++DFGLA      E    +  G  G  
Sbjct: 119 AYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE----AWHGFAGTP 171
Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMI-MELVG 270
           GY++PEV  ++    S   D+++ G+++ + LVG
Sbjct: 172 GYLSPEVLKKD--PYSKPVDIWACGVILYILLVG 203

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 81/167 (48%), Gaps = 20/167 (11%)
Query: 122 NVVTLLGFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
           N++TL     +  +R  AL++E + N   ++ +    T    ++     MYEI+    K 
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQ-LRQTLTDYDIRFY----MYEIL----KA 143
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIG 238
           L+Y H   S  I+H D+KPHN+++D +    ++ D+GLA+     +   +  + +R   G
Sbjct: 144 LDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKG 199
Query: 239 YIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
              PE+   ++    +  D++S G M+  ++  K     G D+  ++
Sbjct: 200 ---PELLV-DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 242

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 26/76 (34%), Positives = 41/76 (53%), Gaps = 6/76 (7%)
Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILL---DEDFCPKISDFGLAKLCTTKEGIVSSLLG 232
           I + LE ++H     I+H D+KP N+LL    +    K++DFGLA      +G   +  G
Sbjct: 109 IQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA---IEVQGDQQAWFG 165
Query: 233 ARGIIGYIAPEVFSRN 248
             G  GY++PEV  ++
Sbjct: 166 FAGTPGYLSPEVLRKD 181

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 108/275 (39%), Gaps = 60/275 (21%)
Query: 91  LGQGGFGGVYKG-RLLD-----------DFVNEVASISRTSHVNVVTLL------GFCLE 132
           LG GGFG VY G R+ D           D +++   +   + V +  +L      GF   
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 116
Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL------RWEKMYEIVIGI-AKGLEYLHH 185
           G  R L +   P+     FV   +  +P Q L      R     E+      + LE + H
Sbjct: 117 GVIRLLDWFERPDS----FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 172
Query: 186 GCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV 244
             +  +LH DIK  NIL+D +    K+ DFG   L   K+ + +   G R      +P  
Sbjct: 173 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTR----VYSPPE 226
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
           + R        + V+S G+++ ++V              ++ F H        D E    
Sbjct: 227 WIRYHRYHGRSAAVWSLGILLYDMV------------CGDIPFEH--------DEEIIRG 266
Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEV 339
            V  R+      + +I   WC+  RPSDRP   E+
Sbjct: 267 QVFFRQRVSXECQHLI--RWCLALRPSDRPTFEEI 299

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 108/275 (39%), Gaps = 60/275 (21%)
Query: 91  LGQGGFGGVYKG-RLLD-----------DFVNEVASISRTSHVNVVTLL------GFCLE 132
           LG GGFG VY G R+ D           D +++   +   + V +  +L      GF   
Sbjct: 39  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 96
Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL------RWEKMYEIVIGI-AKGLEYLHH 185
           G  R L +   P+     FV   +  +P Q L      R     E+      + LE + H
Sbjct: 97  GVIRLLDWFERPD----SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 152
Query: 186 GCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV 244
             +  +LH DIK  NIL+D +    K+ DFG   L   K+ + +   G R      +P  
Sbjct: 153 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTR----VYSPPE 206
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
           + R        + V+S G+++ ++V              ++ F H        D E    
Sbjct: 207 WIRYHRYHGRSAAVWSLGILLYDMV------------CGDIPFEH--------DEEIIRG 246
Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEV 339
            V  R+      + +I   WC+  RPSDRP   E+
Sbjct: 247 QVFFRQRVSXECQHLI--RWCLALRPSDRPTFEEI 279

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 108/275 (39%), Gaps = 60/275 (21%)
Query: 91  LGQGGFGGVYKG-RLLD-----------DFVNEVASISRTSHVNVVTLL------GFCLE 132
           LG GGFG VY G R+ D           D +++   +   + V +  +L      GF   
Sbjct: 64  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 121
Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL------RWEKMYEIVIGI-AKGLEYLHH 185
           G  R L +   P+     FV   +  +P Q L      R     E+      + LE + H
Sbjct: 122 GVIRLLDWFERPD----SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 177
Query: 186 GCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV 244
             +  +LH DIK  NIL+D +    K+ DFG   L   K+ + +   G R      +P  
Sbjct: 178 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTR----VYSPPE 231
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
           + R        + V+S G+++ ++V              ++ F H        D E    
Sbjct: 232 WIRYHRYHGRSAAVWSLGILLYDMV------------CGDIPFEH--------DEEIIRG 271
Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEV 339
            V  R+      + +I   WC+  RPSDRP   E+
Sbjct: 272 QVFFRQRVSXECQHLI--RWCLALRPSDRPTFEEI 304

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 81/180 (45%), Gaps = 24/180 (13%)
Query: 99  VYKGRLLDDFVN-EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGD 156
           + +G  +D+ V  E+ +     H N+V      L   + A++ E+   G L E+    G 
Sbjct: 51  IERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR 110
Query: 157 TSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP--KISDF 214
            S+      ++++         G+ Y H   + ++ H D+K  N LLD    P  KI DF
Sbjct: 111 FSEDEARFFFQQLI-------SGVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICDF 160
Query: 215 GLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNF--GEVSHKSDVYSFGMMI-MELVGC 271
           G +K         S++    G   YIAPEV  +    G+V   +DV+S G+ + + LVG 
Sbjct: 161 GYSKSSVLHSQPKSTV----GTPAYIAPEVLLKKEYDGKV---ADVWSCGVTLYVMLVGA 213

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 46/88 (52%), Gaps = 10/88 (11%)
Query: 185 HGCSTKILHFDIKPHNILLDE-DFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE 243
           H  S  + H DIKPHN+L++E D   K+ DFG AK  +  E  V+ +        Y APE
Sbjct: 146 HLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY----YRAPE 201
Query: 244 VFSRNFGEVSHKS--DVYSFGMMIMELV 269
           +    FG   + +  D++S G +  E++
Sbjct: 202 LI---FGNQHYTTAVDIWSVGCIFAEMM 226

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 108/275 (39%), Gaps = 60/275 (21%)
Query: 91  LGQGGFGGVYKG-RLLD-----------DFVNEVASISRTSHVNVVTLL------GFCLE 132
           LG GGFG VY G R+ D           D +++   +   + V +  +L      GF   
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 74
Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL------RWEKMYEIVIGI-AKGLEYLHH 185
           G  R L +   P+     FV   +  +P Q L      R     E+      + LE + H
Sbjct: 75  GVIRLLDWFERPD----SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 186 GCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV 244
             +  +LH DIK  NIL+D +    K+ DFG   L   K+ + +   G R      +P  
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTR----VYSPPE 184
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
           + R        + V+S G+++ ++V              ++ F H        D E    
Sbjct: 185 WIRYHRYHGRSAAVWSLGILLYDMV------------CGDIPFEH--------DEEIIRG 224
Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEV 339
            V  R+      + +I   WC+  RPSDRP   E+
Sbjct: 225 QVFFRQRVSSECQHLI--RWCLALRPSDRPTFEEI 257

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 108/275 (39%), Gaps = 60/275 (21%)
Query: 91  LGQGGFGGVYKG-RLLD-----------DFVNEVASISRTSHVNVVTLL------GFCLE 132
           LG GGFG VY G R+ D           D +++   +   + V +  +L      GF   
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 101
Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL------RWEKMYEIVIGI-AKGLEYLHH 185
           G  R L +   P+     FV   +  +P Q L      R     E+      + LE + H
Sbjct: 102 GVIRLLDWFERPDS----FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 157
Query: 186 GCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV 244
             +  +LH DIK  NIL+D +    K+ DFG   L   K+ + +   G R      +P  
Sbjct: 158 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTR----VYSPPE 211
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
           + R        + V+S G+++ ++V              ++ F H        D E    
Sbjct: 212 WIRYHRYHGRSAAVWSLGILLYDMV------------CGDIPFEH--------DEEIIRG 251
Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEV 339
            V  R+      + +I   WC+  RPSDRP   E+
Sbjct: 252 QVFFRQRVSSECQHLI--RWCLALRPSDRPTFEEI 284

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 26/76 (34%), Positives = 41/76 (53%), Gaps = 6/76 (7%)
Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILL---DEDFCPKISDFGLAKLCTTKEGIVSSLLG 232
           I + LE ++H     I+H D+KP N+LL    +    K++DFGLA      +G   +  G
Sbjct: 109 IQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA---IEVQGDQQAWFG 165
Query: 233 ARGIIGYIAPEVFSRN 248
             G  GY++PEV  ++
Sbjct: 166 FAGTPGYLSPEVLRKD 181

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 108/275 (39%), Gaps = 60/275 (21%)
Query: 91  LGQGGFGGVYKG-RLLD-----------DFVNEVASISRTSHVNVVTLL------GFCLE 132
           LG GGFG VY G R+ D           D +++   +   + V +  +L      GF   
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 88
Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL------RWEKMYEIVIGI-AKGLEYLHH 185
           G  R L +   P+     FV   +  +P Q L      R     E+      + LE + H
Sbjct: 89  GVIRLLDWFERPD----SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 144
Query: 186 GCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV 244
             +  +LH DIK  NIL+D +    K+ DFG   L   K+ + +   G R      +P  
Sbjct: 145 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTR----VYSPPE 198
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
           + R        + V+S G+++ ++V              ++ F H        D E    
Sbjct: 199 WIRYHRYHGRSAAVWSLGILLYDMV------------CGDIPFEH--------DEEIIRG 238
Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEV 339
            V  R+      + +I   WC+  RPSDRP   E+
Sbjct: 239 QVFFRQRVSSECQHLI--RWCLALRPSDRPTFEEI 271

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 108/275 (39%), Gaps = 60/275 (21%)
Query: 91  LGQGGFGGVYKG-RLLD-----------DFVNEVASISRTSHVNVVTLL------GFCLE 132
           LG GGFG VY G R+ D           D +++   +   + V +  +L      GF   
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 89
Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL------RWEKMYEIVIGI-AKGLEYLHH 185
           G  R L +   P+     FV   +  +P Q L      R     E+      + LE + H
Sbjct: 90  GVIRLLDWFERPD----SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 145
Query: 186 GCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV 244
             +  +LH DIK  NIL+D +    K+ DFG   L   K+ + +   G R      +P  
Sbjct: 146 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTR----VYSPPE 199
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
           + R        + V+S G+++ ++V              ++ F H        D E    
Sbjct: 200 WIRYHRYHGRSAAVWSLGILLYDMV------------CGDIPFEH--------DEEIIRG 239
Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEV 339
            V  R+      + +I   WC+  RPSDRP   E+
Sbjct: 240 QVFFRQRVSSECQHLI--RWCLALRPSDRPTFEEI 272

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 65/138 (47%), Gaps = 20/138 (14%)
Query: 138 LIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDI 196
           +I E M  G L  +    GD     Q     +  EI+  I   +++LH   S  I H D+
Sbjct: 84  IIMECMEGGELFSRIQERGD-----QAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDV 135
Query: 197 KPHNILL---DEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVS 253
           KP N+L    ++D   K++DFG AK  TT+  + +          Y+APEV      + S
Sbjct: 136 KPENLLYTSKEKDAVLKLTDFGFAKE-TTQNALQTPCYTPY----YVAPEVLGPEKYDKS 190
Query: 254 HKSDVYSFGMMIMELVGC 271
              D++S G +IM ++ C
Sbjct: 191 --CDMWSLG-VIMYILLC 205

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 41/138 (29%), Positives = 64/138 (46%), Gaps = 20/138 (14%)
Query: 138 LIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDI 196
           +I E M  G L  +    GD     Q     +  EI+  I   +++LH   S  I H D+
Sbjct: 103 IIMECMEGGELFSRIQERGD-----QAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDV 154
Query: 197 KPHNILL---DEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVS 253
           KP N+L    ++D   K++DFG AK  TT+  + +          Y+APEV      +  
Sbjct: 155 KPENLLYTSKEKDAVLKLTDFGFAKE-TTQNALQTPCYTPY----YVAPEVLGPE--KYD 207
Query: 254 HKSDVYSFGMMIMELVGC 271
              D++S G +IM ++ C
Sbjct: 208 KSCDMWSLG-VIMYILLC 224

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 71/166 (42%), Gaps = 16/166 (9%)
Query: 105 LDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQY 163
           L     EV  +   +H N+V L           L+ E+   G + +  V +G       +
Sbjct: 50  LQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG-------W 102
Query: 164 LRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK 223
           ++ ++       I   ++Y H      I+H D+K  N+LLD D   KI+DFG +   T  
Sbjct: 103 MKEKEARAKFRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG 159
Query: 224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             + +      G   Y APE+F     +   + DV+S G+++  LV
Sbjct: 160 NKLDTFC----GSPPYAAPELFQGKKYD-GPEVDVWSLGVILYTLV 200

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 108/275 (39%), Gaps = 60/275 (21%)
Query: 91  LGQGGFGGVYKG-RLLD-----------DFVNEVASISRTSHVNVVTLL------GFCLE 132
           LG GGFG VY G R+ D           D +++   +   + V +  +L      GF   
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS-- 102
Query: 133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL------RWEKMYEIVIGI-AKGLEYLHH 185
           G  R L +   P+     FV   +  +P Q L      R     E+      + LE + H
Sbjct: 103 GVIRLLDWFERPD----SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 158
Query: 186 GCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV 244
             +  +LH DIK  NIL+D +    K+ DFG   L   K+ + +   G R      +P  
Sbjct: 159 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTR----VYSPPE 212
Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
           + R        + V+S G+++ ++V              ++ F H        D E    
Sbjct: 213 WIRYHRYHGRSAAVWSLGILLYDMV------------CGDIPFEH--------DEEIIGG 252
Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEV 339
            V  R+      + +I   WC+  RPSDRP   E+
Sbjct: 253 QVFFRQRVSXECQHLI--RWCLALRPSDRPTFEEI 285

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 25/92 (27%), Positives = 48/92 (52%), Gaps = 13/92 (14%)
Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
            EYLH   S  +++ D+KP N+L+D+    +++DFG AK    +   +       G   Y
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC------GTPEY 204
Query: 240 IAPE-VFSRNFGEVSHKSDVYSFGMMIMELVG 270
           +APE + S+ + +     D ++ G++I ++  
Sbjct: 205 LAPEIILSKGYNKA---VDWWALGVLIYQMAA 233

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 79/180 (43%), Gaps = 34/180 (18%)
Query: 106 DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL---------EKFVYNGD 156
           +D   E +      H ++V LL          +++EFM    L           FVY+  
Sbjct: 73  EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEA 132
Query: 157 TSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL--DEDFCP-KISD 213
            +    Y+R          I + L Y H      I+H D+KPH +LL   E+  P K+  
Sbjct: 133 VAS--HYMRQ---------ILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGG 178
Query: 214 FGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRN-FGEVSHKSDVYSFGMMIMELV-GC 271
           FG+A +   + G+V+   G  G   ++APEV  R  +G+     DV+  G+++  L+ GC
Sbjct: 179 FGVA-IQLGESGLVAG--GRVGTPHFMAPEVVKREPYGK---PVDVWGCGVILFILLSGC 232

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	372
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-99
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-86
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	6e-86
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-57
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	7e-56
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-52
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	7e-52
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	7e-51
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-50
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-49
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	5e-49
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-48
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-48
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-47
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-44
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-43
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-43
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	7e-42
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-36
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-32
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-32
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-32
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-32
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-32
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-31
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-31
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-31
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-31
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-31
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-31
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-31
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-31
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-31
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-31
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	5e-31
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	6e-31
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	8e-31
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-30
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-30
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-30
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-30
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-30
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-30
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	6e-30
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	6e-30
3pls_A	298	Macrophage-stimulating protein receptor; protein k	7e-30
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	8e-30
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	8e-30
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-29
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-29
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-29
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-29
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-29
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	5e-29
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	6e-29
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-29
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	9e-29
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-28
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-28
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-28
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-28
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-28
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-28
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-28
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-28
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	9e-28
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-27
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	5e-27
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-26
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-26
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-26
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-26
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-26
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-26
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-26
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	8e-26
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-25
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-25
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-25
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-24
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-24
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	5e-24
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-24
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	7e-24
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-23
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-23
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-23
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-23
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-23
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	6e-23
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	9e-23
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-22
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-22
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-22
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-22
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-22
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-22
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-22
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	7e-22
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	8e-22
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	9e-22
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-21
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-21
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-21
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-21
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	6e-21
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	7e-21
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-20
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-20
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-20
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-20
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-20
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-20
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-20
3an0_A	340	Dual specificity mitogen-activated protein kinase;	6e-20
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-19
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-19
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-19
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-19
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-19
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-19
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-19
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-19
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-19
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-19
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-19
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	7e-19
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	9e-19
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-18
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-18
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-18
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-18
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-18
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-18
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	5e-18
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-18
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	5e-18
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	6e-18
3bhy_A	283	Death-associated protein kinase 3; death associate	6e-18
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-17
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-17
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-17
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-17
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-17
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-17
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-17
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	7e-17
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-16
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-16
3uqc_A	286	Probable conserved transmembrane protein; structur	5e-16
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-16
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	6e-16
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	7e-16
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	8e-16
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	9e-16
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	5e-15
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	6e-15
3niz_A	311	Rhodanese family protein; structural genomics, str	9e-15
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-14
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-14
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-14
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-14
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-14
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-14
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-14
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-14
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-14
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-14
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	5e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	9e-06
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-13
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-13
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-13
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-13
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	9e-13
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-12
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-12
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-12
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-12
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-12
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-12
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	6e-12
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-11
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-11
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-11
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-11
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-11
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-11
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-11
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-11
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-11
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	5e-11
3rp9_A	458	Mitogen-activated protein kinase; structural genom	6e-11
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	8e-11
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	9e-11
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-10
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-10
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-10
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-10
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-10
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-10
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-10
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-10
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-10
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-10
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	9e-10
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-09
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-09
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-09
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-09
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-09
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-09
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-09
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-09
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-09
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-09
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-09
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	5e-09
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	7e-09
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	8e-09
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-08
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-08
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-06
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	6e-06
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-05
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-05
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-05
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-05
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-04
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-04
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	5e-04
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	6e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	7e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  296 bits (761), Expect = 2e-99
 Identities = 108/298 (36%), Positives = 165/298 (55%), Gaps = 30/298 (10%)

Query: 72  LKRYNFSDVKKLTNSF--KDKLGQGGFGGVYKGRLLD-------------------DFVN 110
           LKR++  +++  +++F  K+ LG+GGFG VYKGRL D                    F  
Sbjct: 17  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76

Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY 170
           EV  IS   H N++ L GFC+    R L+Y +M NGS+   +     S+P   L W K  
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP--PLDWPKRQ 134

Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSL 230
            I +G A+GL YLH  C  KI+H D+K  NILLDE+F   + DFGLAKL   K+  V++ 
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 194

Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE-VYFPH 289
           +  RG IG+IAPE  S   G+ S K+DV+ +G+M++EL+  +   D    ++ + V    
Sbjct: 195 V--RGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250

Query: 290 WIYRHVEQDREFKL--PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG 345
           W+   +++ +   L    +    ++E  +++I V L C Q+ P +RP M+EV+ ML+G
Sbjct: 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  262 bits (672), Expect = 3e-86
 Identities = 89/317 (28%), Positives = 146/317 (46%), Gaps = 60/317 (18%)

Query: 72  LKRYNFSDVKKLTNSFKD--------KLGQGGFGGVYKGRL------------------- 104
              ++F ++K +TN+F +        K+G+GGFG VYKG +                   
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE 71

Query: 105 --LDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQ 162
                F  E+  +++  H N+V LLGF  +G++  L+Y +MPNGSL   +   D + P  
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP-- 129

Query: 163 YLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT 222
            L W    +I  G A G+ +LH       +H DIK  NILLDE F  KISDFGLA+    
Sbjct: 130 -LSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEK 185

Query: 223 -KEGIVSSLLGAR--GIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGV 279
             + +++S    R  G   Y+APE      GE++ KSD+YSFG++++E++     +D   
Sbjct: 186 FAQTVMTS----RIVGTTAYMAPEALR---GEITPKSDIYSFGVVLLEIITGLPAVDE-- 236

Query: 280 DSSSEVYFPHWIYRHVEQDREFKLPGVV-------TRKENEIAKKMIIVGLWCIQARPSD 332
                           ++++   +   +               + M  V   C+  + + 
Sbjct: 237 -HREPQLLLDIKEEIEDEEK--TIEDYIDKKMNDADSTS---VEAMYSVASQCLHEKKNK 290

Query: 333 RPPMNEVIEMLQGSTEA 349
           RP + +V ++LQ  T +
Sbjct: 291 RPDIKKVQQLLQEMTAS 307

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  262 bits (671), Expect = 6e-86
 Identities = 99/311 (31%), Positives = 157/311 (50%), Gaps = 44/311 (14%)

Query: 69  PLPLKRYNFSDVKKLTNSFKDK--LGQGGFGGVYKGRLLDD------------------F 108
           P    R    D+++ TN+F  K  +G G FG VYKG L D                   F
Sbjct: 23  PFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEF 82

Query: 109 VNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEK 168
             E+ ++S   H ++V+L+GFC E N   LIY++M NG+L++ +Y   +  P   + WE+
Sbjct: 83  ETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLY--GSDLPTMSMSWEQ 140

Query: 169 MYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI-V 227
             EI IG A+GL YLH      I+H D+K  NILLDE+F PKI+DFG++K  T  +   +
Sbjct: 141 RLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197

Query: 228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYF 287
           S+++  +G +GYI PE F +  G ++ KSDVYSFG+++ E++  ++ +         V  
Sbjct: 198 STVV--KGTLGYIDPEYFIK--GRLTEKSDVYSFGVVLFEVLCARSAIVQS-LPREMVNL 252

Query: 288 PHWIYRHVEQDREF------KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
             W       + +        L   +  +     +K     + C+     DRP M +V+ 
Sbjct: 253 AEWA-VESHNNGQLEQIVDPNLADKIRPES---LRKFGDTAVKCLALSSEDRPSMGDVLW 308

Query: 342 MLQGSTEALQI 352
            L+    AL++
Sbjct: 309 KLEY---ALRL 316

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  188 bits (478), Expect = 5e-57
 Identities = 70/299 (23%), Positives = 111/299 (37%), Gaps = 51/299 (17%)

Query: 86  SFKDKLGQGGFGGVYKGRLLDDFV----------------NEVASISRTSHVNVVTLLGF 129
              +   +G FG V+K +LL+++V                 EV S+    H N++  +G 
Sbjct: 27  QLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGA 86

Query: 130 CLEGNNRA----LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
              G +      LI  F   GSL  F+           + W ++  I   +A+GL YLH 
Sbjct: 87  EKRGTSVDVDLWLITAFHEKGSLSDFLKA-------NVVSWNELCHIAETMARGLAYLHE 139

Query: 186 -------GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG 238
                  G    I H DIK  N+LL  +    I+DFGLA      +    +  G  G   
Sbjct: 140 DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDT-HGQVGTRR 198

Query: 239 YIAPEVFS---RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV 295
           Y+APEV         +   + D+Y+ G+++ EL       D  VD    + F   I +H 
Sbjct: 199 YMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD-EYMLPFEEEIGQHP 257

Query: 296 EQDREFKLPGVVTRK----------ENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
             +   ++  VV +K          ++     +      C       R     V E + 
Sbjct: 258 SLEDMQEV--VVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERIT 314

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  184 bits (469), Expect = 7e-56
 Identities = 70/301 (23%), Positives = 132/301 (43%), Gaps = 53/301 (17%)

Query: 76  NFSDVKKLTNSFKDKLGQGGFGGVYKGR-------------------LLDDFVNEVASIS 116
            + D+       K+K+G G FG V++                      +++F+ EVA + 
Sbjct: 35  PWCDLN-----IKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMK 89

Query: 117 RTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 176
           R  H N+V  +G   +  N +++ E++  GSL + ++     +    L   +   +   +
Sbjct: 90  RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ---LDERRRLSMAYDV 146

Query: 177 AKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI 236
           AKG+ YLH+  +  I+H ++K  N+L+D+ +  K+ DFGL++L   K     S   A G 
Sbjct: 147 AKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL---KASTFLSSKSAAGT 202

Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK---NNLDSGVDSSSEVYFPHWIYR 293
             ++APEV        + KSDVYSFG+++ EL   +    NL+              +  
Sbjct: 203 PEWMAPEVLRDE--PSNEKSDVYSFGVILWELATLQQPWGNLN----------PAQVVAA 250

Query: 294 HVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQIP 353
              + +  ++P  +  +   I +        C    P  RP    ++++L+   ++   P
Sbjct: 251 VGFKCKRLEIPRNLNPQVAAIIEG-------CWTNEPWKRPSFATIMDLLRPLIKSAVPP 303

Query: 354 P 354
           P
Sbjct: 304 P 304

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  175 bits (445), Expect = 2e-52
 Identities = 67/304 (22%), Positives = 120/304 (39%), Gaps = 53/304 (17%)

Query: 76  NFSDVKKLTNSFKDKLGQGGFGGVYKGR---------------LLDDFVNEVASISRTSH 120
           ++ +++      ++ +G+G FG V K +                   F+ E+  +SR +H
Sbjct: 6   DYKEIE-----VEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNH 60

Query: 121 VNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGL 180
            N+V L G CL  N   L+ E+   GSL   ++    ++P  Y          +  ++G+
Sbjct: 61  PNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHG---AEPLPYYTAAHAMSWCLQCSQGV 115

Query: 181 EYLHHGCSTKILHFDIKPHNILLDEDF-CPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
            YLH      ++H D+KP N+LL       KI DFG A    T       +   +G   +
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT------HMTNNKGSAAW 169

Query: 240 IAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK---NNLDSGVDSSSEVYFPHWIYRHVE 296
           +APEVF  +    S K DV+S+G+++ E++  +   + +               I   V 
Sbjct: 170 MAPEVFEGS--NYSEKCDVFSWGIILWEVITRRKPFDEIGGP---------AFRIMWAVH 218

Query: 297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQIPPTP 356
                 L   + +    +  +       C    PS RP M E+++++            P
Sbjct: 219 NGTRPPLIKNLPKPIESLMTR-------CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271

Query: 357 FLSS 360
               
Sbjct: 272 LQYP 275

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  173 bits (440), Expect = 7e-52
 Identities = 71/284 (25%), Positives = 121/284 (42%), Gaps = 53/284 (18%)

Query: 87  FKDKLGQGGFGGVYKG------------------RLLDDFVNEVASISRTSHVNVVTLLG 128
              ++G G FG VYKG                  + L  F NEV  + +T HVN++  +G
Sbjct: 28  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
           +       A++ ++    SL   ++  +T         +K+ +I    A+G++YLH   +
Sbjct: 88  YSTAPQ-LAIVTQWCEGSSLYHHLHASETK-----FEMKKLIDIARQTARGMDYLH---A 138

Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVF-SR 247
             I+H D+K +NI L ED   KI DFGLA    ++           G I ++APEV   +
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATE-KSRWSGSHQFEQLSGSILWMAPEVIRMQ 197

Query: 248 NFGEVSHKSDVYSFGMMIMELVGCK------NNLDSGVDSSSEVYFPHWIYRHVE-QDRE 300
           +    S +SDVY+FG+++ EL+  +      NN D              I   V      
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-------------IIEMVGRGSLS 244

Query: 301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
             L  V +     + + M      C++ +  +RP    ++  ++
Sbjct: 245 PDLSKVRSNCPKRMKRLM----AECLKKKRDERPSFPRILAEIE 284

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  171 bits (436), Expect = 7e-51
 Identities = 66/299 (22%), Positives = 110/299 (36%), Gaps = 61/299 (20%)

Query: 76  NFSDVKKLTNSFKDKLGQGGFGGVYKGR------------------LLDDFVNEVASISR 117
            F  ++       + +G+G FG VY GR                   L  F  EV +  +
Sbjct: 31  PFEQLE-----IGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQ 85

Query: 118 TSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIA 177
           T H NVV  +G C+   + A+I       +L   V +         L   K  +I   I 
Sbjct: 86  TRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV-----LDVNKTRQIAQEIV 140

Query: 178 KGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL--CTTKEGIVSSLLGARG 235
           KG+ YLH   +  ILH D+K  N+  D      I+DFGL  +            L    G
Sbjct: 141 KGMGYLH---AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNG 196

Query: 236 IIGYIAPEVFSRNFGEV-------SHKSDVYSFGMMIMELVGCK---NNLDSGVDSSSEV 285
            + ++APE+  +   +        S  SDV++ G +  EL   +                
Sbjct: 197 WLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP--------- 247

Query: 286 YFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
                I   +    +  L       +  + K++  + L+C      +RP   ++++ML+
Sbjct: 248 --AEAIIWQMGTGMKPNLS------QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  167 bits (425), Expect = 1e-49
 Identities = 56/296 (18%), Positives = 109/296 (36%), Gaps = 64/296 (21%)

Query: 76  NFSDVKKLTNSFKDKLGQGGFGGVYKG-------------------RLLDDFVNEVASIS 116
           +F  +      F  KL +   G ++KG                   R   DF  E   + 
Sbjct: 8   DFKQLN-----FLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLR 62

Query: 117 RTSHVNVVTLLGFCLE--GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVI 174
             SH NV+ +LG C      +  LI  +MP GSL   ++ G        +   +  +  +
Sbjct: 63  IFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV----VDQSQAVKFAL 118

Query: 175 GIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGAR 234
            +A+G+ +LH      I    +   ++++DED   +IS   +     +         G  
Sbjct: 119 DMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP--------GRM 169

Query: 235 GIIGYIAPEVF-SRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPH---- 289
               ++APE    +        +D++SF +++ ELV            + EV F      
Sbjct: 170 YAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELV------------TREVPFADLSNM 217

Query: 290 -WIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
               +   +     +P  ++   +++ K        C+   P+ RP  + ++ +L+
Sbjct: 218 EIGMKVALEGLRPTIPPGISPHVSKLMKI-------CMNEDPAKRPKFDMIVPILE 266

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  165 bits (421), Expect = 5e-49
 Identities = 64/303 (21%), Positives = 122/303 (40%), Gaps = 68/303 (22%)

Query: 76  NFSDVKKLTNSFKDKLGQGGFGGVYKGR--------------------------LLDDFV 109
             ++++     ++ ++G+GGFG V+KGR                             +F 
Sbjct: 17  ADNEIE-----YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQ 71

Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKM 169
            EV  +S  +H N+V L G         ++ EF+P G L   + +         ++W   
Sbjct: 72  REVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD-----KAHPIKWSVK 124

Query: 170 YEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE-----DFCPKISDFGLAKLCTTKE 224
             +++ IA G+EY+ +  +  I+H D++  NI L         C K++DFGL++      
Sbjct: 125 LRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----- 178

Query: 225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK---NNLDSGVDS 281
             V S+ G  G   ++APE         + K+D YSF M++  ++  +   +       S
Sbjct: 179 -SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY-----S 232

Query: 282 SSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
             ++ F + I    E+     +P     +   + +        C    P  RP  + +++
Sbjct: 233 YGKIKFINMI---REEGLRPTIPEDCPPRLRNVIEL-------CWSGDPKKRPHFSYIVK 282

Query: 342 MLQ 344
            L 
Sbjct: 283 ELS 285

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  166 bits (422), Expect = 1e-48
 Identities = 63/327 (19%), Positives = 106/327 (32%), Gaps = 60/327 (18%)

Query: 79  DVKKLTNSFKDKLGQGGFGGVYKGRL--------------LDDFVNE--VASISRTSHVN 122
           D+  L     + +G+G +G VYKG L                +F+NE  +  +    H N
Sbjct: 11  DLDNLK--LLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDN 68

Query: 123 VVTLLGFCLEGN-----NRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIA 177
           +   +               L+ E+ PNGSL K++             W     +   + 
Sbjct: 69  IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-------HTSDWVSSCRLAHSVT 121

Query: 178 KGLEYLH------HGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLL 231
           +GL YLH            I H D+   N+L+  D    ISDFGL+   T    +     
Sbjct: 122 RGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEE 181

Query: 232 -----GARGIIGYIAPEVFS-----RNFGEVSHKSDVYSFGMMIMELV-GCKNNLDSGVD 280
                   G I Y+APEV       R+      + D+Y+ G++  E+   C +       
Sbjct: 182 DNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241

Query: 281 SSSEVYFPHWIYRHVEQDREFKLPGVVTRKE-----------NEIAKKMIIVGLWCIQAR 329
              ++ F   +  H   +    L  V   K+           +   + +      C    
Sbjct: 242 PEYQMAFQTEVGNHPTFEDMQVL--VSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQD 299

Query: 330 PSDRPPMNEVIEMLQGSTEALQIPPTP 356
              R       E +       +   + 
Sbjct: 300 AEARLTAQXAEERMAELMMIWERNKSV 326

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  163 bits (415), Expect = 2e-48
 Identities = 63/301 (20%), Positives = 116/301 (38%), Gaps = 68/301 (22%)

Query: 76  NFSDVKKLTNSFKDKLGQGGFGGVYKG---------------------RLLDDFVNEVAS 114
           +F+++       ++ +G GGFG VY+                      + +++   E   
Sbjct: 5   DFAELT-----LEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKL 59

Query: 115 ISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVI 174
            +   H N++ L G CL+  N  L+ EF   G L + +         + +  + +    +
Sbjct: 60  FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG-------KRIPPDILVNWAV 112

Query: 175 GIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP--------KISDFGLAKLCTTKEGI 226
            IA+G+ YLH      I+H D+K  NIL+ +            KI+DFGLA+        
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR---- 168

Query: 227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK---NNLDSGVDSSS 283
            ++ + A G   ++APEV   +    S  SDV+S+G+++ EL+  +     +D       
Sbjct: 169 -TTKMSAAGAYAWMAPEVIRAS--MFSKGSDVWSYGVLLWELLTGEVPFRGID------- 218

Query: 284 EVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEML 343
                   Y          +P        ++ +        C    P  RP    +++ L
Sbjct: 219 ---GLAVAYGVAMNKLALPIPSTCPEPFAKLMED-------CWNPDPHSRPSFTNILDQL 268

Query: 344 Q 344
            
Sbjct: 269 T 269

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  161 bits (410), Expect = 4e-47
 Identities = 70/326 (21%), Positives = 116/326 (35%), Gaps = 60/326 (18%)

Query: 76  NFSDVKKLTNSFKDKLGQGGFGGVYKGRL-------------------LDDFVNEVASIS 116
             SD+        + LG+G FG   K                         F+ EV  + 
Sbjct: 8   RPSDLI-----HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMR 62

Query: 117 RTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 176
              H NV+  +G   +      I E++  G+L   + + D+        W +       I
Sbjct: 63  CLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ-----YPWSQRVSFAKDI 117

Query: 177 AKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL-----------CTTKEG 225
           A G+ YLH   S  I+H D+  HN L+ E+    ++DFGLA+L            + K+ 
Sbjct: 118 ASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKP 174

Query: 226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV 285
                    G   ++APE+   N      K DV+SFG+++ E++G   N D      +  
Sbjct: 175 DRKKRYTVVGNPYWMAPEMI--NGRSYDEKVDVFSFGIVLCEIIGRV-NADPDYLPRTMD 231

Query: 286 YFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG 345
           +       +V    +   P         I  +       C    P  RP   ++   L+ 
Sbjct: 232 F-----GLNVRGFLDRYCPPNCPPSFFPITVR-------CCDLDPEKRPSFVKLEHWLET 279

Query: 346 STEAL--QIPPTPFLSSPPRAPIDSF 369
               L   +P  P L    R   +++
Sbjct: 280 LRMHLAGHLPLGPQLEQLDRGFWETY 305

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  156 bits (395), Expect = 1e-44
 Identities = 64/325 (19%), Positives = 116/325 (35%), Gaps = 58/325 (17%)

Query: 69  PLPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLLDDFV----------------NEV 112
           PL ++R     ++        ++G+G +G V+ G+   + V                 E+
Sbjct: 28  PLLVQRTIAKQIQ-----MVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEI 82

Query: 113 ASISRTSHVNVVTLLGFCLEGNNR----ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEK 168
                  H N++  +   ++G        LI ++  NGSL  ++ +         L  + 
Sbjct: 83  YQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS-------TTLDAKS 135

Query: 169 MYEIVIGIAKGLEYLH-----HGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT-T 222
           M ++      GL +LH           I H D+K  NIL+ ++    I+D GLA      
Sbjct: 136 MLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISD 195

Query: 223 KEGIVSSLLGARGIIGYIAPEVF----SRNFGEVSHKSDVYSFGMMIMELV-GCKNNLDS 277
              +        G   Y+ PEV     +RN  +    +D+YSFG+++ E+   C +    
Sbjct: 196 TNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG--- 252

Query: 278 GVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKE-----NEIAKKMIIVGLW-----CIQ 327
                 E   P+      +   E     V  +K      N  +    +  +      C  
Sbjct: 253 --GIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWA 310

Query: 328 ARPSDRPPMNEVIEMLQGSTEALQI 352
             P+ R     V + L   +E+  I
Sbjct: 311 HNPASRLTALRVKKTLAKMSESQDI 335

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  150 bits (382), Expect = 4e-43
 Identities = 57/300 (19%), Positives = 107/300 (35%), Gaps = 55/300 (18%)

Query: 87  FKDKLGQGGFGGVYKGRLLDDFV----------------NEVASISRTSHVNVVTLLGFC 130
             + +G+G +G V++G    + V                 E+ +     H N++  +   
Sbjct: 12  LLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASD 71

Query: 131 LEGNNRA----LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH-- 184
           +   + +    LI  +   GSL  ++           L       IV+ IA GL +LH  
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQL-------TTLDTVSCLRIVLSIASGLAHLHIE 124

Query: 185 ---HGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT-TKEGIVSSLLGARGIIGYI 240
                    I H D+K  NIL+ ++    I+D GLA + + +   +        G   Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184

Query: 241 APEVF----SRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRH-- 294
           APEV       +  +   + D+++FG+++ E+        +G+    +  F   +     
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMV--SNGIVEDYKPPFYDVVPNDPS 242

Query: 295 VEQDREFKLPGVVTRKE-----NEIAKKMIIVGLW-----CIQARPSDRPPMNEVIEMLQ 344
            E  R+     V   ++     N       +  L      C    PS R     + + L 
Sbjct: 243 FEDMRK----VVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  148 bits (376), Expect = 7e-42
 Identities = 61/321 (19%), Positives = 116/321 (36%), Gaps = 66/321 (20%)

Query: 69  PLPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLLDDFV----------------NEV 112
           PL ++R     +       ++ +G+G FG V++G+   + V                 E+
Sbjct: 33  PLLVQRTIARTIV-----LQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEI 87

Query: 113 ASISRTSHVNVVTLLGFCLEGNNRA----LIYEFMPNGSLEKFVYNGDTSKPCQYLR--- 165
                  H N++  +    + N       L+ ++  +GSL              YL    
Sbjct: 88  YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL------------FDYLNRYT 135

Query: 166 --WEKMYEIVIGIAKGLEYLH-----HGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK 218
              E M ++ +  A GL +LH           I H D+K  NIL+ ++    I+D GLA 
Sbjct: 136 VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 195

Query: 219 -LCTTKEGIVSSLLGARGIIGYIAPEVF----SRNFGEVSHKSDVYSFGMMIMELVGCKN 273
              +  + I  +     G   Y+APEV     +    E   ++D+Y+ G++  E+    +
Sbjct: 196 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 255

Query: 274 NLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRK----------ENEIAKKMIIVGL 323
               G+    ++ +   +      +   K+  V  +K            E  + M  +  
Sbjct: 256 --IGGIHEDYQLPYYDLVPSDPSVEEMRKV--VCEQKLRPNIPNRWQSCEALRVMAKIMR 311

Query: 324 WCIQARPSDRPPMNEVIEMLQ 344
            C  A  + R     + + L 
Sbjct: 312 ECWYANGAARLTALRIKKTLS 332

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  134 bits (339), Expect = 3e-36
 Identities = 69/291 (23%), Positives = 116/291 (39%), Gaps = 69/291 (23%)

Query: 86  SFKDKLGQGGFGGVYKGRL--------------------LDDFVNEVASISRTSHVNVVT 125
              +++G+G FG V+ GRL                       F+ E   + + SH N+V 
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176

Query: 126 LLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
           L+G C +     ++ E +  G    F+           LR + + ++V   A G+EYL  
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR-----LRVKTLLQMVGDAAAGMEYLE- 230

Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI-IGYIAPEV 244
             S   +H D+   N L+ E    KISDFG+++     +G+ ++  G R + + + APE 
Sbjct: 231 --SKCCIHRDLAARNCLVTEKNVLKISDFGMSRE--EADGVYAASGGLRQVPVKWTAPEA 286

Query: 245 FSRNFGEVSHKSDVYSFGMMIMELV--------GCKNNLDSGVDSSSEVYFPHWIYRHVE 296
              N+G  S +SDV+SFG+++ E             N          +          VE
Sbjct: 287 L--NYGRYSSESDVWSFGILLWETFSLGASPYPNLSN---------QQT------REFVE 329

Query: 297 QDREFKLPGVVTRKEN---EIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
           +    +LP      E     + + M      C    P  RP  + + + LQ
Sbjct: 330 KG--GRLP----CPELCPDAVFRLM----EQCWAYEPGQRPSFSTIYQELQ 370

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  122 bits (308), Expect = 1e-32
 Identities = 64/285 (22%), Positives = 103/285 (36%), Gaps = 76/285 (26%)

Query: 87  FKDKLGQGGFGGVYKG---------------------RLLDDFVNEVASISRTSHVNVVT 125
           F  ++G+G F  VYKG                          F  E   +    H N+V 
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89

Query: 126 LLGFCLEGNNRA----LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG-----I 176
                           L+ E M +G+L+ ++            R++ M   V+      I
Sbjct: 90  FYDSWESTVKGKKCIVLVTELMTSGTLKTYL-----------KRFKVMKIKVLRSWCRQI 138

Query: 177 AKGLEYLHHGCSTKILHFDIKPHNILLD-EDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
            KGL++LH   +  I+H D+K  NI +       KI D GLA L             A+ 
Sbjct: 139 LKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--------AKA 189

Query: 236 IIG---YIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK---NNLDSGVDSSSEVYFPH 289
           +IG   ++APE++   + E     DVY+FGM ++E+   +   +   +            
Sbjct: 190 VIGTPEFMAPEMYEEKYDE---SVDVYAFGMCMLEMATSEYPYSECQN----------AA 236

Query: 290 WIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRP 334
            IYR V        P    +      K++I     CI+    +R 
Sbjct: 237 QIYRRVTSG---VKPASFDKVAIPEVKEII---EGCIRQNKDERY 275

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  126 bits (317), Expect = 2e-32
 Identities = 72/279 (25%), Positives = 124/279 (44%), Gaps = 49/279 (17%)

Query: 87  FKDKLGQGGFGGVYKGRL------------------LDDFVNEVASISRTSHVNVVTLLG 128
            K KLG G +G VY+G                    +++F+ E A +    H N+V LLG
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283

Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
            C       +I EFM  G+L  ++   +     Q +    +  +   I+  +EYL     
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLE---K 336

Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRN 248
              +H ++   N L+ E+   K++DFGL++L T       +  GA+  I + APE     
Sbjct: 337 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA--GAKFPIKWTAPESL--A 392

Query: 249 FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVT 308
           + + S KSDV++FG+++ E+     +   G+   S+V      Y  +E+D  +++     
Sbjct: 393 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQV------YELLEKD--YRME---- 439

Query: 309 RKEN---EIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
           R E    ++ + M      C Q  PSDRP   E+ +  +
Sbjct: 440 RPEGCPEKVYELM----RACWQWNPSDRPSFAEIHQAFE 474

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  123 bits (310), Expect = 2e-32
 Identities = 70/316 (22%), Positives = 130/316 (41%), Gaps = 65/316 (20%)

Query: 87  FKDKLGQGGFGGVYKGRLLD------------------------DFVNEVASISRTSHVN 122
            +  +G G FG VYKG L                          DF+ E   + + SH N
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107

Query: 123 VVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 182
           ++ L G   +     +I E+M NG+L+KF+   D           ++  ++ GIA G++Y
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE-----FSVLQLVGMLRGIAAGMKY 162

Query: 183 LHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAP 242
           L    +   +H D+   NIL++ +   K+SDFGL+++         +  G +  I + AP
Sbjct: 163 LA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 219

Query: 243 EVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHW----IYRHVEQD 298
           E    ++ + +  SDV+SFG+++ E++           +  E  +       + + +   
Sbjct: 220 EAI--SYRKFTSASDVWSFGIVMWEVM-----------TYGERPYWELSNHEVMKAINDG 266

Query: 299 REFKLPGVVTRKEN---EIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG---STEALQI 352
             F+LP       +    I + M    + C Q   + RP   +++ +L     + ++L+ 
Sbjct: 267 --FRLP----TPMDCPSAIYQLM----MQCWQQERARRPKFADIVSILDKLIRAPDSLKT 316

Query: 353 PPTPFLSSPPRAPIDS 368
                     R P  S
Sbjct: 317 LADFDPRVSIRLPSTS 332

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  122 bits (309), Expect = 3e-32
 Identities = 58/209 (27%), Positives = 90/209 (43%), Gaps = 38/209 (18%)

Query: 86  SFKDKLGQGGFGGVYKGRL------------------------LDDFVNEVASISRTSHV 121
                LG G FG VYKG                            + ++E   ++   + 
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 77

Query: 122 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGL 180
           +V  LLG CL  +   LI + MP G L  +V  + D       L W       + IAKG+
Sbjct: 78  HVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGM 130

Query: 181 EYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYI 240
            YL      +++H D+   N+L+      KI+DFGLAKL   +E    +  G +  I ++
Sbjct: 131 NYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIKWM 186

Query: 241 APEVFSRNFGEVSHKSDVYSFGMMIMELV 269
           A E         +H+SDV+S+G+ + EL+
Sbjct: 187 ALESI--LHRIYTHQSDVWSYGVTVWELM 213

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  121 bits (306), Expect = 3e-32
 Identities = 65/294 (22%), Positives = 114/294 (38%), Gaps = 56/294 (19%)

Query: 87  FKDKLGQGGFGGVYKGRL------------------------LDDFVNEVASISRTSHVN 122
               LG+G FG V   R                         + D   E+  +    H N
Sbjct: 25  RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84

Query: 123 VVTLLGFCLEGNNRA--LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGL 180
           +V   G C E       LI EF+P+GSL++++           +  ++  +  + I KG+
Sbjct: 85  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-----INLKQQLKYAVQICKGM 139

Query: 181 EYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYI 240
           +YL    S + +H D+   N+L++ +   KI DFGL K   T +   +        + + 
Sbjct: 140 DYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY 196

Query: 241 APEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHW------IYR 293
           APE       +    SDV+SFG+ + EL+  C ++          +   H       +  
Sbjct: 197 APE--CLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254

Query: 294 HVEQDREFKLPGVVTRKEN---EIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
            +++    +LP       N   E+ + M      C + +PS+R     +IE  +
Sbjct: 255 TLKEG--KRLP----CPPNCPDEVYQLM----RKCWEFQPSNRTSFQNLIEGFE 298

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  120 bits (302), Expect = 1e-31
 Identities = 47/204 (23%), Positives = 85/204 (41%), Gaps = 33/204 (16%)

Query: 88  KDKLGQGGFGGVYKGRL----------------------LDDFVNEVASISRTSHVNVVT 125
             +LG G FG V +G                         ++ + E   + +  +  +V 
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 126 LLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH 185
           L+G C       L+ E    G L KF+         + +    + E++  ++ G++YL  
Sbjct: 75  LIGVCQA-EALMLVMEMAGGGPLHKFL-----VGKREEIPVSNVAELLHQVSMGMKYL-- 126

Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVF 245
                 +H D+   N+LL      KISDFGL+K     +   ++    +  + + APE  
Sbjct: 127 -EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 185

Query: 246 SRNFGEVSHKSDVYSFGMMIMELV 269
             NF + S +SDV+S+G+ + E +
Sbjct: 186 --NFRKFSSRSDVWSYGVTMWEAL 207

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  120 bits (304), Expect = 1e-31
 Identities = 67/330 (20%), Positives = 110/330 (33%), Gaps = 73/330 (22%)

Query: 87  FKDKLGQGGFGGVYKGRL-----------------------LDDFVNEVASISRTSHVNV 123
           +  +LG+G FG V   R                          DF  E+  +       +
Sbjct: 27  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86

Query: 124 VTLLGFCLEGNNRA--LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           V   G       ++  L+ E++P+G L  F+           L   ++      I KG+E
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-----LDASRLLLYSSQICKGME 141

Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           YL    S + +H D+   NIL++ +   KI+DFGLAKL    +         +  I + A
Sbjct: 142 YLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA 198

Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELV--GCKNNLDSGVDSSSEVYFPHWIYRHVEQDR 299
           PE  S +    S +SDV+SFG+++ EL     K                        +  
Sbjct: 199 PE--SLSDNIFSRQSDVWSFGVVLYELFTYCDK---------------SCSPSAEFLRMM 241

Query: 300 EFKLPGVVTRKENEIAKKMIIVG-----------------LWCIQARPSDRPPMNEVIEM 342
             +              +++  G                   C    P DRP  + +   
Sbjct: 242 GCERDVP----ALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297

Query: 343 LQGSTEALQIPPTPFLSSPPRAPIDSFTFS 372
           L       +   T   ++ P     S +FS
Sbjct: 298 LDMLWSGSRGCETHAFTAHPEGKHHSLSFS 327

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  120 bits (302), Expect = 1e-31
 Identities = 67/294 (22%), Positives = 106/294 (36%), Gaps = 56/294 (19%)

Query: 87  FKDKLGQGGFGGVYKGRL-----------------------LDDFVNEVASISRTSHVNV 123
           F  +LG+G FG V   R                        L DF  E+  +    H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 124 VTLLGFCLEGNNRA--LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           V   G C     R   LI E++P GSL  ++           +   K+ +    I KG+E
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQICKGME 128

Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           YL    + + +H D+   NIL++ +   KI DFGL K+    +            I + A
Sbjct: 129 YLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185

Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELV--GCKNNLDSGVDSSSEVYFPHW------IYR 293
           PE       + S  SDV+SFG+++ EL     K+                       +  
Sbjct: 186 PESL--TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243

Query: 294 HVEQDREFKLPGVVTRKEN---EIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
            ++ +   +LP    R +    EI   M      C     + RP   ++   + 
Sbjct: 244 LLKNN--GRLP----RPDGCPDEIYMIM----TECWNNNVNQRPSFRDLALRVD 287

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  118 bits (299), Expect = 2e-31
 Identities = 66/283 (23%), Positives = 119/283 (42%), Gaps = 57/283 (20%)

Query: 86  SFKDKLGQGGFGGVYKGRLL-----------------DDFVNEVASISRTSHVNVVTLLG 128
           +F  ++G G FG V+ G  L                 +DF+ E   + + SH  +V L G
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70

Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
            CLE     L+ EFM +G L  ++              E +  + + + +G+ YL     
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRTQRGL-----FAAETLLGMCLDVCEGMAYL---EE 122

Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRN 248
             ++H D+   N L+ E+   K+SDFG+ +     +   +S  G +  + + +PEVF  +
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRF--VLDDQYTSSTGTKFPVKWASPEVF--S 178

Query: 249 FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHW----IYRHVEQDREFKLP 304
           F   S KSDV+SFG+++ E+            S  ++ + +     +   +     F+L 
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVF-----------SEGKIPYENRSNSEVVEDISTG--FRLY 225

Query: 305 GVVTRKEN---EIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
               +       + + M      C + RP DRP  + ++  L 
Sbjct: 226 ----KPRLASTHVYQIM----NHCWRERPEDRPAFSRLLRQLA 260

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  122 bits (308), Expect = 2e-31
 Identities = 69/278 (24%), Positives = 118/278 (42%), Gaps = 49/278 (17%)

Query: 87  FKDKLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHVNVVTLLGF 129
            + KLGQG FG V+ G                    + F+ E   + +  H  +V L   
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247

Query: 130 CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCST 189
             E     ++ E+M  GSL  F+         +YLR  ++ ++   IA G+ Y+      
Sbjct: 248 VSE-EPIYIVTEYMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVE---RM 299

Query: 190 KILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNF 249
             +H D++  NIL+ E+   K++DFGLA+L   ++   ++  GA+  I + APE     +
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAA--LY 355

Query: 250 GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTR 309
           G  + KSDV+SFG+++ EL         G+  + EV         VE+   +++P     
Sbjct: 356 GRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREV------LDQVERG--YRMP----C 402

Query: 310 KEN---EIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
                  +   M      C +  P +RP    +   L+
Sbjct: 403 PPECPESLHDLM----CQCWRKEPEERPTFEYLQAFLE 436

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  119 bits (301), Expect = 3e-31
 Identities = 61/294 (20%), Positives = 105/294 (35%), Gaps = 58/294 (19%)

Query: 87  FKDKLGQGGFGGVYKGRL------------------------LDDFVNEVASISRTSHVN 122
               LG+G FG V                                +  E+  +    H +
Sbjct: 35  KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94

Query: 123 VVTLLGFCLEGNNRA--LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGL 180
           ++   G C +    +  L+ E++P GSL  ++       P   +   ++      I +G+
Sbjct: 95  IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-------PRHSIGLAQLLLFAQQICEGM 147

Query: 181 EYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYI 240
            YLH   +   +H D+   N+LLD D   KI DFGLAK                  + + 
Sbjct: 148 AYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 204

Query: 241 APEVFSRNFGEVSHKSDVYSFGMMIMELV-GCKNNLDSGVDSSSEVYFPHW------IYR 293
           APE       +  + SDV+SFG+ + EL+  C ++          +           +  
Sbjct: 205 APE--CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262

Query: 294 HVEQDREFKLPGVVTRKEN---EIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
            +E+    +LP    R +    E+   M      C +   S RP    +I +L+
Sbjct: 263 LLERGE--RLP----RPDKCPAEVYHLM----KNCWETEASFRPTFENLIPILK 306

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  123 bits (309), Expect = 3e-31
 Identities = 69/278 (24%), Positives = 118/278 (42%), Gaps = 49/278 (17%)

Query: 87  FKDKLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHVNVVTLLGF 129
            + KLGQG FG V+ G                    + F+ E   + +  H  +V L   
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330

Query: 130 CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCST 189
             E     ++ E+M  GSL  F+         +YLR  ++ ++   IA G+ Y+      
Sbjct: 331 VSE-EPIYIVTEYMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVE---RM 382

Query: 190 KILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNF 249
             +H D++  NIL+ E+   K++DFGLA+L   ++   ++  GA+  I + APE     +
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAA--LY 438

Query: 250 GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTR 309
           G  + KSDV+SFG+++ EL         G+  + EV         VE+   +++P     
Sbjct: 439 GRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREV------LDQVERG--YRMP----C 485

Query: 310 KEN---EIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
                  +   M      C +  P +RP    +   L+
Sbjct: 486 PPECPESLHDLM----CQCWRKEPEERPTFEYLQAFLE 519

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  118 bits (298), Expect = 3e-31
 Identities = 65/287 (22%), Positives = 116/287 (40%), Gaps = 65/287 (22%)

Query: 86  SFKDKLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHVNVVTLLG 128
           +   +LG G FG V  G+                   D+F  E  ++ + SH  +V   G
Sbjct: 11  TLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYG 70

Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
            C +     ++ E++ NG L  ++ +         L   ++ E+   + +G+ +L    S
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYLRSHGKG-----LEPSQLLEMCYDVCEGMAFLE---S 122

Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRN 248
            + +H D+   N L+D D C K+SDFG+ +     +    S +G +  + + APEVF  +
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRY--VLDDQYVSSVGTKFPVKWSAPEVF--H 178

Query: 249 FGEVSHKSDVYSFGMMIMELV--------GCKNNLDSGVDSSSEVYFPHWIYRHVEQDRE 300
           + + S KSDV++FG+++ E+            N         SEV         V Q   
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN---------SEV------VLKVSQG-- 221

Query: 301 FKLPGVVTRKEN---EIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
            +L     R       I + M      C    P  RP   +++  ++
Sbjct: 222 HRLY----RPHLASDTIYQIM----YSCWHELPEKRPTFQQLLSSIE 260

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  119 bits (301), Expect = 3e-31
 Identities = 64/292 (21%), Positives = 114/292 (39%), Gaps = 69/292 (23%)

Query: 87  FKDKLGQGGFGGVYKGRLL-----------------------DDFVNEVASISRTSHVNV 123
            +  +G G  G V  GRL                         DF++E + + +  H N+
Sbjct: 53  IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112

Query: 124 VTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYL 183
           + L G    G    ++ E+M NGSL+ F+   D           ++  ++ G+  G+ YL
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ-----FTIMQLVGMLRGVGAGMRYL 167

Query: 184 HHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE 243
                   +H D+   N+L+D +   K+SDFGL+++         +  G +  I + APE
Sbjct: 168 S---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPE 224

Query: 244 VFSRNFGEVSHKSDVYSFGMMIMELV--------GCKNNLDSGVDSSSEVYFPHWIYRHV 295
                F   S  SDV+SFG+++ E++           N          +V         V
Sbjct: 225 AI--AFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN---------RDV------ISSV 267

Query: 296 EQDREFKLPGVVTRKEN---EIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
           E+   ++LP            + + M    L C     + RP  ++++ +L 
Sbjct: 268 EEG--YRLP----APMGCPHALHQLM----LDCWHKDRAQRPRFSQIVSVLD 309

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  119 bits (301), Expect = 4e-31
 Identities = 68/294 (23%), Positives = 107/294 (36%), Gaps = 56/294 (19%)

Query: 87  FKDKLGQGGFGGVYKGRL-----------------------LDDFVNEVASISRTSHVNV 123
           F  +LG+G FG V   R                        L DF  E+  +    H N+
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104

Query: 124 VTLLGFCLEGNNRA--LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           V   G C     R   LI E++P GSL  ++           +   K+ +    I KG+E
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQICKGME 159

Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           YL    + + +H D+   NIL++ +   KI DFGL K+    +            I + A
Sbjct: 160 YLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA 216

Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELV--GCKNNLDSGVDSSSEVYFPHW------IYR 293
           PE  S    + S  SDV+SFG+++ EL     K+                       +  
Sbjct: 217 PE--SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274

Query: 294 HVEQDREFKLPGVVTRKEN---EIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
            ++ +   +LP    R +    EI   M      C     + RP   ++   + 
Sbjct: 275 LLKNN--GRLP----RPDGCPDEIYMIM----TECWNNNVNQRPSFRDLALRVD 318

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  118 bits (298), Expect = 5e-31
 Identities = 73/288 (25%), Positives = 123/288 (42%), Gaps = 65/288 (22%)

Query: 86  SFKDKLGQGGFGGVYKGRL------------------LDDFVNEVASISRTSHVNVVTLL 127
           + K KLG G +G VY+G                    +++F+ E A +    H N+V LL
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75

Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
           G C       +I EFM  G+L  ++   +     Q +    +  +   I+  +EYL    
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLE--- 128

Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSR 247
               +H D+   N L+ E+   K++DFGL++L T       +  GA+  I + APE    
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA--GAKFPIKWTAPESL-- 184

Query: 248 NFGEVSHKSDVYSFGMMIMELV--------GCKNNLDSGVDSSSEVYFPHWIYRHVEQDR 299
            + + S KSDV++FG+++ E+         G            S+V      Y  +E+D 
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---------SQV------YELLEKD- 228

Query: 300 EFKLPGVVTRKEN---EIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
            +++     R E    ++ + M      C Q  PSDRP   E+ +  +
Sbjct: 229 -YRME----RPEGCPEKVYELM----RACWQWNPSDRPSFAEIHQAFE 267

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  121 bits (305), Expect = 6e-31
 Identities = 74/278 (26%), Positives = 120/278 (43%), Gaps = 49/278 (17%)

Query: 87  FKDKLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHVNVVTLLGF 129
            + KLG G FG V+                     ++ F+ E   +    H  +V L   
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251

Query: 130 CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCST 189
             +     +I EFM  GSL  F+ + +           K+ +    IA+G+ ++      
Sbjct: 252 VTK-EPIYIITEFMAKGSLLDFLKSDEG----SKQPLPKLIDFSAQIAEGMAFIE---QR 303

Query: 190 KILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNF 249
             +H D++  NIL+      KI+DFGLA++    E       GA+  I + APE    NF
Sbjct: 304 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE--GAKFPIKWTAPEAI--NF 359

Query: 250 GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTR 309
           G  + KSDV+SFG+++ME+V        G+ S+ EV       R +E+   +++P    R
Sbjct: 360 GSFTIKSDVWSFGILLMEIVTYGRIPYPGM-SNPEV------IRALERG--YRMP----R 406

Query: 310 KEN---EIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
            EN   E+   M    + C + RP +RP    +  +L 
Sbjct: 407 PENCPEELYNIM----MRCWKNRPEERPTFEYIQSVLD 440

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  117 bits (296), Expect = 8e-31
 Identities = 50/210 (23%), Positives = 79/210 (37%), Gaps = 38/210 (18%)

Query: 86  SFKDKLGQGGFGGVYKGRL-------------------------LDDFVNEVASISRTSH 120
              +KLG G FG V +G                           +DDF+ EV ++    H
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80

Query: 121 VNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKG 179
            N++ L G  L      ++ E  P GSL   +  +          R+       + +A+G
Sbjct: 81  RNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY------AVQVAEG 133

Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
           + YL    S + +H D+   N+LL      KI DFGL +     +         +    +
Sbjct: 134 MGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190

Query: 240 IAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            APE         SH SD + FG+ + E+ 
Sbjct: 191 CAPESL--KTRTFSHASDTWMFGVTLWEMF 218

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  117 bits (296), Expect = 2e-30
 Identities = 58/209 (27%), Positives = 90/209 (43%), Gaps = 38/209 (18%)

Query: 86  SFKDKLGQGGFGGVYKGRL------------------------LDDFVNEVASISRTSHV 121
                LG G FG VYKG                            + ++E   ++   + 
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 77

Query: 122 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGL 180
           +V  LLG CL  +   LI + MP G L  +V  + D       L W       + IAKG+
Sbjct: 78  HVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGM 130

Query: 181 EYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYI 240
            YL      +++H D+   N+L+      KI+DFGLAKL   +E    +  G +  I ++
Sbjct: 131 NYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIKWM 186

Query: 241 APEVFSRNFGEVSHKSDVYSFGMMIMELV 269
           A E         +H+SDV+S+G+ + EL+
Sbjct: 187 ALESI--LHRIYTHQSDVWSYGVTVWELM 213

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  116 bits (293), Expect = 2e-30
 Identities = 62/287 (21%), Positives = 115/287 (40%), Gaps = 65/287 (22%)

Query: 86  SFKDKLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHVNVVTLLG 128
           +F  +LG G FG V  G+                   D+F+ E   +   SH  +V L G
Sbjct: 27  TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86

Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
            C +     +I E+M NG L  ++            + +++ E+   + + +EYL    S
Sbjct: 87  VCTKQRPIFIITEYMANGCLLNYLREMRHR-----FQTQQLLEMCKDVCEAMEYLE---S 138

Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRN 248
            + LH D+   N L+++    K+SDFGL++     +   +S +G++  + +  PEV    
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPPEVL--M 194

Query: 249 FGEVSHKSDVYSFGMMIMELV--------GCKNNLDSGVDSSSEVYFPHWIYRHVEQDRE 300
           + + S KSD+++FG+++ E+            N         SE         H+ Q   
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---------SET------AEHIAQG-- 237

Query: 301 FKLPGVVTRKEN---EIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
            +L     R      ++   M      C   +  +RP    ++  + 
Sbjct: 238 LRLY----RPHLASEKVYTIM----YSCWHEKADERPTFKILLSNIL 276

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  119 bits (300), Expect = 3e-30
 Identities = 63/283 (22%), Positives = 113/283 (39%), Gaps = 63/283 (22%)

Query: 87  FKDKLGQGGFGGVYKGRL---------------LDDFVNEVASISRTSHVNVVTLLGFCL 131
               +G+G FG V  G                    F+ E + +++  H N+V LLG  +
Sbjct: 197 LLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 256

Query: 132 EGNNRALIY---EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
           E   +  +Y   E+M  GSL  ++     S+    L  + + +  + + + +EYL     
Sbjct: 257 E--EKGGLYIVTEYMAKGSLVDYL----RSRGRSVLGGDCLLKFSLDVCEAMEYLE---G 307

Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRN 248
              +H D+   N+L+ ED   K+SDFGL K  ++ +         +  + + APE     
Sbjct: 308 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD------TGKLPVKWTAPEAL--R 359

Query: 249 FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHW----IYRHVEQDREFKLP 304
             + S KSDV+SFG+++ E+            S   V +P      +   VE+   +K+ 
Sbjct: 360 EKKFSTKSDVWSFGILLWEIY-----------SFGRVPYPRIPLKDVVPRVEKG--YKMD 406

Query: 305 GVVTRKEN---EIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
                 +     +   M      C     + RP   ++ E L+
Sbjct: 407 ----APDGCPPAVYDVM----KNCWHLDAATRPTFLQLREQLE 441

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  115 bits (291), Expect = 3e-30
 Identities = 62/282 (21%), Positives = 111/282 (39%), Gaps = 59/282 (20%)

Query: 86  SFKDKLGQGGFGGVYKGRL---------------LDDFVNEVASISRTSHVNVVTLLGFC 130
                +G+G FG V  G                    F+ E + +++  H N+V LLG  
Sbjct: 24  KLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 131 LEGNNRALI-YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCST 189
           +E      I  E+M  GSL  ++ +         L  + + +  + + + +EYL      
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLE---GN 136

Query: 190 KILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNF 249
             +H D+   N+L+ ED   K+SDFGL K  ++ +         +  + + APE      
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD------TGKLPVKWTAPEAL--RE 188

Query: 250 GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHW----IYRHVEQDREFKLPG 305
            + S KSDV+SFG+++ E+            S   V +P      +   VE+   +K+  
Sbjct: 189 KKFSTKSDVWSFGILLWEIY-----------SFGRVPYPRIPLKDVVPRVEKG--YKMD- 234

Query: 306 VVTRKEN---EIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
                +     + + M      C     + RP   ++ E L+
Sbjct: 235 ---APDGCPPAVYEVM----KNCWHLDAAMRPSFLQLREQLE 269

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  117 bits (296), Expect = 4e-30
 Identities = 51/207 (24%), Positives = 92/207 (44%), Gaps = 33/207 (15%)

Query: 86  SFKDKLGQGGFGGVYKGRLL-----------------------DDFVNEVASISRTSHVN 122
           S    +G G FG V  GRL                         DF+ E + + +  H N
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 107

Query: 123 VVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 182
           ++ L G   +     ++ E+M NGSL+ F+   D           ++  ++ GIA G++Y
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-----FTVIQLVGMLRGIASGMKY 162

Query: 183 LHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAP 242
           L        +H D+   NIL++ +   K+SDFGL ++         +  G +  I + +P
Sbjct: 163 LS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSP 219

Query: 243 EVFSRNFGEVSHKSDVYSFGMMIMELV 269
           E     + + +  SDV+S+G+++ E++
Sbjct: 220 EAI--AYRKFTSASDVWSYGIVLWEVM 244

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  115 bits (291), Expect = 4e-30
 Identities = 50/203 (24%), Positives = 83/203 (40%), Gaps = 35/203 (17%)

Query: 90  KLGQGGFGGVYKGRL-----------------------LDDFVNEVASISRTSHVNVVTL 126
           +LG G FG V KG                          D+ + E   + +  +  +V +
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
           +G C    +  L+ E    G L K++      K    +        V  ++ G++YL   
Sbjct: 84  IGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL------VHQVSMGMKYLE-- 134

Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
             +  +H D+   N+LL      KISDFGL+K     E    +    +  + + APE   
Sbjct: 135 -ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI- 192

Query: 247 RNFGEVSHKSDVYSFGMMIMELV 269
            N+ + S KSDV+SFG+++ E  
Sbjct: 193 -NYYKFSSKSDVWSFGVLMWEAF 214

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  116 bits (292), Expect = 6e-30
 Identities = 72/321 (22%), Positives = 111/321 (34%), Gaps = 77/321 (23%)

Query: 86  SFKDKLGQGGFGGVYKGRLLD-------------------------DFVNEVASISRTSH 120
           +    LG G FG VY+G++                           DF+ E   IS+ +H
Sbjct: 33  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 92

Query: 121 VNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKG 179
            N+V  +G  L+   R ++ E M  G L+ F+            L    +  +   IA G
Sbjct: 93  QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152

Query: 180 LEYLHHGCSTKILHFDIKPHNILLD---EDFCPKISDFGLAKL-----CTTKEGIVSSLL 231
            +YL        +H DI   N LL         KI DFG+A+         K G   ++L
Sbjct: 153 CQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG--CAML 207

Query: 232 GARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV--------GCKNNLDSGVDSSS 283
             +    ++ PE F    G  + K+D +SFG+++ E+            N          
Sbjct: 208 PVK----WMPPEAF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------- 252

Query: 284 EVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEML 343
           EV         V        P         I   M      C Q +P DRP    ++E +
Sbjct: 253 EV------LEFVTSGGRMDPPKNCPGPVYRI---M----TQCWQHQPEDRPNFAIILERI 299

Query: 344 QGSTEALQI--PPTPFLSSPP 362
           +  T+   +     P    P 
Sbjct: 300 EYCTQDPDVINTALPIEYGPL 320

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  116 bits (292), Expect = 6e-30
 Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 36/207 (17%)

Query: 87  FKDKLGQGGFGGVYKGRL------------------------LDDFVNEVASISRTSHVN 122
               LG G FG V+KG                               + + +I    H +
Sbjct: 17  KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76

Query: 123 VVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 182
           +V LLG C   ++  L+ +++P GSL   V     +   Q L         + IAKG+ Y
Sbjct: 77  IVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLL-----LNWGVQIAKGMYY 130

Query: 183 LHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAP 242
           L       ++H ++   N+LL      +++DFG+A L    +  +     A+  I ++A 
Sbjct: 131 LE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY-SEAKTPIKWMAL 186

Query: 243 EVFSRNFGEVSHKSDVYSFGMMIMELV 269
           E    +FG+ +H+SDV+S+G+ + EL+
Sbjct: 187 ESI--HFGKYTHQSDVWSYGVTVWELM 211

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  115 bits (290), Expect = 7e-30
 Identities = 65/299 (21%), Positives = 114/299 (38%), Gaps = 71/299 (23%)

Query: 82  KLTNSFKDKLGQGGFGGVYKGRLLD-----------------------DFVNEVASISRT 118
           ++       +G+G FG VY G  +D                        F+ E   +   
Sbjct: 20  RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL 79

Query: 119 SHVNVVTLLGFCLEGNNRALI-YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIA 177
           +H NV+ L+G  L       +   +M +G L +F+ +   +        + +    + +A
Sbjct: 80  NHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN-----PTVKDLISFGLQVA 134

Query: 178 KGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE-GIVSSLLGARGI 236
           +G+EYL      K +H D+   N +LDE F  K++DFGLA+    +E   V     AR  
Sbjct: 135 RGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP 191

Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV--------GCKNNLDSGVDSSSEVYFP 288
           + + A E  S      + KSDV+SFG+++ EL+                      ++   
Sbjct: 192 VKWTALE--SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF---------DL--- 237

Query: 289 HWIYRHVEQDREFKLPGVVTRKEN---EIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
                 + Q R    P      E     + + M      C +A P+ RP    ++  ++
Sbjct: 238 ---THFLAQGRRLPQP------EYCPDSLYQVM----QQCWEADPAVRPTFRVLVGEVE 283

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  116 bits (292), Expect = 8e-30
 Identities = 54/204 (26%), Positives = 85/204 (41%), Gaps = 40/204 (19%)

Query: 88  KDKLGQGGFGGVYKG--------------RLLDDFVNEVASISRTSHVNVVTLLGFCLEG 133
           + ++G+G FG V++               RL    V E+ + +  S   +V L G   EG
Sbjct: 63  QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREG 122

Query: 134 NNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG-----IAKGLEYLHHGCS 188
               +  E +  GSL + +            +   + E           +GLEYLH   +
Sbjct: 123 PWVNIFMELLEGGSLGQLI-----------KQMGCLPEDRALYYLGQALEGLEYLH---T 168

Query: 189 TKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIG---YIAPEV 244
            +ILH D+K  N+LL  D     + DFG A  C   +G+  SLL    I G   ++APEV
Sbjct: 169 RRILHGDVKADNVLLSSDGSRAALCDFGHAL-CLQPDGLGKSLLTGDYIPGTETHMAPEV 227

Query: 245 FSRNFGEVSHKSDVYSFGMMIMEL 268
                     K D++S   M++ +
Sbjct: 228 VMGK--PCDAKVDIWSSCCMMLHM 249

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  115 bits (289), Expect = 8e-30
 Identities = 48/207 (23%), Positives = 84/207 (40%), Gaps = 36/207 (17%)

Query: 86  SFKDKLGQGGFGGVYKGRL-----------------------LDDFVNEVASISRTSHVN 122
                +G+G FG V++G                          + F+ E  ++ +  H +
Sbjct: 18  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 77

Query: 123 VVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 182
           +V L+G   E N   +I E    G L  F+     S     L    +      ++  L Y
Sbjct: 78  IVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAY 131

Query: 183 LHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAP 242
           L    S + +H DI   N+L+  + C K+ DFGL++    ++         +  I ++AP
Sbjct: 132 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAP 186

Query: 243 EVFSRNFGEVSHKSDVYSFGMMIMELV 269
           E    NF   +  SDV+ FG+ + E++
Sbjct: 187 ESI--NFRRFTSASDVWMFGVCMWEIL 211

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  119 bits (299), Expect = 1e-29
 Identities = 49/223 (21%), Positives = 89/223 (39%), Gaps = 33/223 (14%)

Query: 69  PLPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLL----------------------D 106
           P  LK       +        +LG G FG V +G                         +
Sbjct: 322 PEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE 381

Query: 107 DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRW 166
           + + E   + +  +  +V L+G C       L+ E    G L KF+         + +  
Sbjct: 382 EMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFL-----VGKREEIPV 435

Query: 167 EKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI 226
             + E++  ++ G++YL        +H ++   N+LL      KISDFGL+K     +  
Sbjct: 436 SNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY 492

Query: 227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            ++    +  + + APE    NF + S +SDV+S+G+ + E +
Sbjct: 493 YTARSAGKWPLKWYAPECI--NFRKFSSRSDVWSYGVTMWEAL 533

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  114 bits (288), Expect = 2e-29
 Identities = 71/311 (22%), Positives = 124/311 (39%), Gaps = 81/311 (26%)

Query: 86  SFKDKLGQGGFGGVYKGRLLD------------------------DFVNEVASISRTSHV 121
                LG+G FG V +G L                          +F++E A +   SH 
Sbjct: 37  ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP 96

Query: 122 NVVTLLGFCLEGNNRA-----LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 176
           NV+ LLG C+E +++      +I  FM  G L  ++         +++  + + + ++ I
Sbjct: 97  NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156

Query: 177 AKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC-----TTKEGIVSSLL 231
           A G+EYL    +   LH D+   N +L +D    ++DFGL+K         +        
Sbjct: 157 ALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGR------ 207

Query: 232 GARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV--------GCKNNLDSGVDSSS 283
            A+  + +IA E  S      + KSDV++FG+ + E+         G +N+         
Sbjct: 208 IAKMPVKWIAIE--SLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--------- 256

Query: 284 EVYFPHWIYRHVEQDREFKLPGVVTRKEN---EIAKKMIIVGLWCIQARPSDRPPMNEVI 340
           E+      Y ++      K P      E+   E+ + M      C +  P DRP  + + 
Sbjct: 257 EM------YDYLLHGHRLKQP------EDCLDELYEIM----YSCWRTDPLDRPTFSVLR 300

Query: 341 EMLQGSTEALQ 351
             L+   E+L 
Sbjct: 301 LQLEKLLESLP 311

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  113 bits (285), Expect = 2e-29
 Identities = 73/287 (25%), Positives = 126/287 (43%), Gaps = 65/287 (22%)

Query: 86  SFKDKLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHVNVVTLLG 128
              ++LG G FG V+ G                    D F+ E   + +  H  +V L  
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75

Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
              +     +I E+M NGSL  F+      K    L   K+ ++   IA+G+ ++     
Sbjct: 76  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIK----LTINKLLDMAAQIAEGMAFIE---E 127

Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRN 248
              +H D++  NIL+ +    KI+DFGLA+L   ++   ++  GA+  I + APE    N
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARL--IEDNEYTAREGAKFPIKWTAPEAI--N 183

Query: 249 FGEVSHKSDVYSFGMMIMELV--------GCKNNLDSGVDSSSEVYFPHWIYRHVEQDRE 300
           +G  + KSDV+SFG+++ E+V        G  N          EV       +++E+   
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---------PEV------IQNLERG-- 226

Query: 301 FKLPGVVTRKEN---EIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
           +++     R +N   E+ + M      C + RP DRP  + +  +L+
Sbjct: 227 YRMV----RPDNCPEELYQLM----RLCWKERPEDRPTFDYLRSVLE 265

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  114 bits (288), Expect = 5e-29
 Identities = 72/321 (22%), Positives = 111/321 (34%), Gaps = 77/321 (23%)

Query: 86  SFKDKLGQGGFGGVYKGRLLD-------------------------DFVNEVASISRTSH 120
           +    LG G FG VY+G++                           DF+ E   IS+ +H
Sbjct: 74  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 133

Query: 121 VNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKG 179
            N+V  +G  L+   R ++ E M  G L+ F+            L    +  +   IA G
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193

Query: 180 LEYLHHGCSTKILHFDIKPHNILLD---EDFCPKISDFGLAKL-----CTTKEGIVSSLL 231
            +YL        +H DI   N LL         KI DFG+A+         K G   ++L
Sbjct: 194 CQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGG--CAML 248

Query: 232 GARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV--------GCKNNLDSGVDSSS 283
             +    ++ PE F    G  + K+D +SFG+++ E+            N          
Sbjct: 249 PVK----WMPPEAF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------- 293

Query: 284 EVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEML 343
           EV         V        P         I   M      C Q +P DRP    ++E +
Sbjct: 294 EV------LEFVTSGGRMDPPKNCPGPVYRI---M----TQCWQHQPEDRPNFAIILERI 340

Query: 344 QGSTEALQI--PPTPFLSSPP 362
           +  T+   +     P    P 
Sbjct: 341 EYCTQDPDVINTALPIEYGPL 361

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  113 bits (284), Expect = 5e-29
 Identities = 66/309 (21%), Positives = 110/309 (35%), Gaps = 86/309 (27%)

Query: 86  SFKDKLGQGGFGGVYKGRL------------------------LDDFVNEVASISRTSHV 121
             K +LG+G FG V+                              DF  E   ++   H 
Sbjct: 18  VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHE 77

Query: 122 NVVTLLGFCLEGNNRALIYEFMPNGSLEKF----------VYNGDTSKPCQYLRWEKMYE 171
           ++V   G C +G+   +++E+M +G L KF          + +G   +    L   +M  
Sbjct: 78  HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137

Query: 172 IVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC-----TTKEGI 226
           I   IA G+ YL    S   +H D+   N L+  +   KI DFG+++           G 
Sbjct: 138 IASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG- 193

Query: 227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV--------GCKNNLDSG 278
                     I ++ PE     + + + +SDV+SFG+++ E+            N     
Sbjct: 194 -----HTMLPIRWMPPESI--MYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---- 242

Query: 279 VDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKEN---EIAKKMIIVGLWCIQARPSDRPP 335
                EV         + Q R  + P           E+   M    L C Q  P  R  
Sbjct: 243 -----EV------IECITQGRVLERP------RVCPKEVYDVM----LGCWQREPQQRLN 281

Query: 336 MNEVIEMLQ 344
           + E+ ++L 
Sbjct: 282 IKEIYKILH 290

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  113 bits (285), Expect = 5e-29
 Identities = 64/312 (20%), Positives = 112/312 (35%), Gaps = 72/312 (23%)

Query: 86  SFKDKLGQGGFGGVYKGRLLD------------------------DFVNEVASISRTSHV 121
           +    LG+G FG V + +L                          +F+ E A +    H 
Sbjct: 26  TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHP 85

Query: 122 NVVTLLGFCLEGNNRA------LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG 175
           +V  L+G  L    +       +I  FM +G L  F+      +    L  + +   ++ 
Sbjct: 86  HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD 145

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           IA G+EYL    S   +H D+   N +L ED    ++DFGL++   + +        ++ 
Sbjct: 146 IACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD-YYRQGCASKL 201

Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV--------GCKNNLDSGVDSSSEVYF 287
            + ++A E  S      +  SDV++FG+ + E++        G +N          E+  
Sbjct: 202 PVKWLALE--SLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA---------EI-- 248

Query: 288 PHWIYRHVEQDREFKLPGVVTRKEN---EIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
               Y ++      K P           E+   M      C  A P  RP    +   L+
Sbjct: 249 ----YNYLIGGNRLKQP------PECMEEVYDLM----YQCWSADPKQRPSFTCLRMELE 294

Query: 345 GSTEALQIPPTP 356
                L +  T 
Sbjct: 295 NILGHLSVLSTS 306

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  113 bits (285), Expect = 6e-29
 Identities = 73/327 (22%), Positives = 119/327 (36%), Gaps = 81/327 (24%)

Query: 87  FKDKLGQGGFGGVYKGRLLD-------------------------DFVNEVASISRTSHV 121
              +LGQG FG VY+G                             +F+NE + +   +  
Sbjct: 29  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88

Query: 122 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFV----YNGDTSKPCQYLRWEKMYEIVIGIA 177
           +VV LLG   +G    +I E M  G L+ ++         +         KM ++   IA
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148

Query: 178 KGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC-----TTKEGIVSSLLG 232
            G+ YL+   + K +H D+   N ++ EDF  KI DFG+ +         K G       
Sbjct: 149 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG------K 199

Query: 233 ARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV--------GCKNNLDSGVDSSSE 284
               + +++PE  S   G  +  SDV+SFG+++ E+         G  N          +
Sbjct: 200 GLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---------Q 248

Query: 285 VYFPHWIYRHVEQDREFKLPGVVTRKEN---EIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
           V       R V +      P      +N    + + M      C Q  P  RP   E+I 
Sbjct: 249 V------LRFVMEGGLLDKP------DNCPDMLFELM----RMCWQYNPKMRPSFLEIIS 292

Query: 342 MLQGSTEALQIPPTPFLSSPPRAPIDS 368
            ++   E      + + S   + P   
Sbjct: 293 SIKEEMEPGFREVSFYYSEENKLPEPE 319

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  112 bits (282), Expect = 6e-29
 Identities = 51/207 (24%), Positives = 84/207 (40%), Gaps = 36/207 (17%)

Query: 86  SFKDKLGQGGFGGVYKGRLL-----------------------DDFVNEVASISRTSHVN 122
                LG+G FG VY+G                          + F++E   +    H +
Sbjct: 15  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPH 74

Query: 123 VVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 182
           +V L+G   E     +I E  P G L  ++     S     L+   +    + I K + Y
Sbjct: 75  IVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNS-----LKVLTLVLYSLQICKAMAY 128

Query: 183 LHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAP 242
           L    S   +H DI   NIL+    C K+ DFGL++    ++   +S    R  I +++P
Sbjct: 129 LE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS--VTRLPIKWMSP 183

Query: 243 EVFSRNFGEVSHKSDVYSFGMMIMELV 269
           E    NF   +  SDV+ F + + E++
Sbjct: 184 ESI--NFRRFTTASDVWMFAVCMWEIL 208

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  112 bits (282), Expect = 9e-29
 Identities = 68/298 (22%), Positives = 107/298 (35%), Gaps = 67/298 (22%)

Query: 87  FKDKLGQGGFGGVYKGR------------------LLDDFVNEVASISRTSHVNVVTLLG 128
               LGQG FG V K R                   L   ++EV  ++  +H  VV    
Sbjct: 10  EIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYA 69

Query: 129 FCLEGNNRAL----------IY---EFMPNGSL-EKFVYNGDTSKPCQYLRWEKMYEIVI 174
             LE  N             ++   E+  NG+L +         +  +Y R     +I+ 
Sbjct: 70  AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL--FRQIL- 126

Query: 175 GIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGAR 234
              + L Y+H   S  I+H D+KP NI +DE    KI DFGLAK       I+       
Sbjct: 127 ---EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180

Query: 235 GIIG-----------YIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSS 283
                          Y+A EV     G  + K D+YS G++  E++           +  
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMI-------YPFSTGM 232

Query: 284 EVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
           E      I + + +    + P      + ++ KK+I      I   P+ RP    ++ 
Sbjct: 233 ERVN---ILKKL-RSVSIEFPPDFDDNKMKVEKKII---RLLIDHDPNKRPGARTLLN 283

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  112 bits (282), Expect = 1e-28
 Identities = 75/295 (25%), Positives = 122/295 (41%), Gaps = 71/295 (24%)

Query: 86  SFKDKLGQGGFGGVYKGRLLD-----------------------DFVNEVASISRTSHVN 122
            F + +G+G FG VY G LLD                        F+ E   +   SH N
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87

Query: 123 VVTLLGFCLEGNNRAL-IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           V++LLG CL      L +  +M +G L  F+ N   +        + +    + +AKG++
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-----PTVKDLIGFGLQVAKGMK 142

Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE-GIVSSLLGARGIIGYI 240
           YL    S K +H D+   N +LDE F  K++DFGLA+    KE   V +  GA+  + ++
Sbjct: 143 YLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 199

Query: 241 APEVFSRNFGEVSHKSDVYSFGMMIMELV--------GCKNNLDSGVDSSSEVYFPHWIY 292
           A E  S    + + KSDV+SFG+++ EL+                      ++       
Sbjct: 200 ALE--SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---------DI------T 242

Query: 293 RHVEQDREFKLPGVVTRKEN---EIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
            ++ Q R    P      E     + + M    L C   +   RP  +E++  + 
Sbjct: 243 VYLLQGRRLLQP------EYCPDPLYEVM----LKCWHPKAEMRPSFSELVSRIS 287

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  113 bits (285), Expect = 1e-28
 Identities = 73/295 (24%), Positives = 122/295 (41%), Gaps = 71/295 (24%)

Query: 86  SFKDKLGQGGFGGVYKGRLLD-----------------------DFVNEVASISRTSHVN 122
            F + +G+G FG VY G LLD                        F+ E   +   SH N
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151

Query: 123 VVTLLGFCLEGNN-RALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           V++LLG CL       ++  +M +G L  F+ N   +        + +    + +AKG++
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-----PTVKDLIGFGLQVAKGMK 206

Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE-GIVSSLLGARGIIGYI 240
           +L    S K +H D+   N +LDE F  K++DFGLA+    KE   V +  GA+  + ++
Sbjct: 207 FLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 263

Query: 241 APEVFSRNFGEVSHKSDVYSFGMMIMELV--------GCKNNLDSGVDSSSEVYFPHWIY 292
           A E  S    + + KSDV+SFG+++ EL+                      ++       
Sbjct: 264 ALE--SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---------DI------T 306

Query: 293 RHVEQDREFKLPGVVTRKEN---EIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
            ++ Q R    P      E     + + M    L C   +   RP  +E++  + 
Sbjct: 307 VYLLQGRRLLQP------EYCPDPLYEVM----LKCWHPKAEMRPSFSELVSRIS 351

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  112 bits (282), Expect = 2e-28
 Identities = 61/308 (19%), Positives = 105/308 (34%), Gaps = 85/308 (27%)

Query: 86  SFKDKLGQGGFGGVYKGRL------------------------LDDFVNEVASISRTSHV 121
             K +LG+G FG V+                              DF  E   ++   H 
Sbjct: 44  VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQ 103

Query: 122 NVVTLLGFCLEGNNRALIYEFMPNGSLEKF---------VYNGDTSKPCQYLRWEKMYEI 172
           ++V   G C EG    +++E+M +G L +F         +  G        L   ++  +
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163

Query: 173 VIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC-----TTKEGIV 227
              +A G+ YL        +H D+   N L+ +    KI DFG+++           G  
Sbjct: 164 ASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG-- 218

Query: 228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV--------GCKNNLDSGV 279
            ++L  R    ++ PE     + + + +SDV+SFG+++ E+            N      
Sbjct: 219 RTMLPIR----WMPPESI--LYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT----- 267

Query: 280 DSSSEVYFPHWIYRHVEQDREFKLPGVVTRKEN---EIAKKMIIVGLWCIQARPSDRPPM 336
               E          + Q         + R      E+   M      C Q  P  R  +
Sbjct: 268 ----EA------IDCITQG------RELERPRACPPEVYAIM----RGCWQREPQQRHSI 307

Query: 337 NEVIEMLQ 344
            +V   LQ
Sbjct: 308 KDVHARLQ 315

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  111 bits (279), Expect = 2e-28
 Identities = 59/284 (20%), Positives = 108/284 (38%), Gaps = 62/284 (21%)

Query: 90  KLGQGGFGGVYKGRLLDD---------------FVNEVASISRTSHVNVVTLLGFCLEGN 134
            +G GGFG V+K +   D                  EV ++++  HVN+V   G     +
Sbjct: 18  LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFD 77

Query: 135 NRALIYEFMPNGSLEKFVY-------NGD-----TSKPCQYLRWEKMYEIVIGIAKGLEY 182
                     + S  K ++        G        +  + L      E+   I KG++Y
Sbjct: 78  YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDY 137

Query: 183 LHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG---Y 239
           +H   S K+++ D+KP NI L +    KI DFGL          + +        G   Y
Sbjct: 138 IH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVT-------SLKNDGKRTRSKGTLRY 187

Query: 240 IAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDR 299
           ++PE  S    +   + D+Y+ G+++ EL+   +                   +     R
Sbjct: 188 MSPEQISSQ--DYGKEVDLYALGLILAELLHVCDT-------------AFETSKFFTDLR 232

Query: 300 EFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEML 343
           +  +  +  +KE  + +K+       +  +P DRP  +E++  L
Sbjct: 233 DGIISDIFDKKEKTLLQKL-------LSKKPEDRPNTSEILRTL 269

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  111 bits (281), Expect = 2e-28
 Identities = 68/300 (22%), Positives = 115/300 (38%), Gaps = 63/300 (21%)

Query: 86  SFKDKLGQGGFGGVYKGRL-------------------------LDDFVNEVASISR-TS 119
           SF   LG G FG V +                             +  ++E+  +S   +
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85

Query: 120 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF------------VYNGDTSKPCQYLRWE 167
           H+N+V LLG C  G    +I E+   G L  F                        L  E
Sbjct: 86  HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145

Query: 168 KMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV 227
            +      +AKG+ +L    S   +H D+   NILL      KI DFGLA+     +   
Sbjct: 146 DLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARD-IKNDSNY 201

Query: 228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYF 287
                AR  + ++APE  S      + +SDV+S+G+ + EL    ++   G+   S+   
Sbjct: 202 VVKGNARLPVKWMAPE--SIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF-- 257

Query: 288 PHWIYRHVEQDREFKLPGVVTRKEN---EIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
               Y+ +++   F++       E+   E+   M      C  A P  RP   +++++++
Sbjct: 258 ----YKMIKEG--FRML----SPEHAPAEMYDIM----KTCWDADPLKRPTFKQIVQLIE 303

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  111 bits (279), Expect = 2e-28
 Identities = 68/310 (21%), Positives = 112/310 (36%), Gaps = 87/310 (28%)

Query: 86  SFKDKLGQGGFGGVYKGRLLD-------------------------DFVNEVASISRTSH 120
            F ++LG+  FG VYKG L                           +F +E    +R  H
Sbjct: 12  RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 71

Query: 121 VNVVTLLGFCLEGNNRALIYEFMPNGSLEKF----------VYNGDTSKPCQYLRWEKMY 170
            NVV LLG   +    ++I+ +  +G L +F              D       L      
Sbjct: 72  PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131

Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC-----TTKEG 225
            +V  IA G+EYL    S  ++H D+   N+L+ +    KISD GL +           G
Sbjct: 132 HLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188

Query: 226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV--------GCKNNLDS 277
                  +   I ++APE  +  +G+ S  SD++S+G+++ E+         G  N    
Sbjct: 189 ------NSLLPIRWMAPE--AIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--- 237

Query: 278 GVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKEN---EIAKKMIIVGLWCIQARPSDRP 334
                 +V         +       LP      ++    +   M    + C    PS RP
Sbjct: 238 ------DV------VEMIRNR--QVLP----CPDDCPAWVYALM----IECWNEFPSRRP 275

Query: 335 PMNEVIEMLQ 344
              ++   L+
Sbjct: 276 RFKDIHSRLR 285

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  111 bits (281), Expect = 3e-28
 Identities = 64/301 (21%), Positives = 107/301 (35%), Gaps = 69/301 (22%)

Query: 86  SFKDKLGQGGFGGVYKGRLLD-------------------------DFVNEVASISR-TS 119
            F   LG G FG V +                                ++E+  +S    
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108

Query: 120 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--------VYNGDTSKPCQYLRWEKMYE 171
           H N+V LLG C  G    +I E+   G L  F          +   +          +  
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168

Query: 172 IVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT-----TKEGI 226
               +A+G+ +L    S   +H D+   N+LL      KI DFGLA+          +G 
Sbjct: 169 FSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG- 224

Query: 227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVY 286
                 AR  + ++APE  S      + +SDV+S+G+++ E+     N   G+  +S+  
Sbjct: 225 -----NARLPVKWMAPE--SIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF- 276

Query: 287 FPHWIYRHVEQDREFKLPGVVTRKEN---EIAKKMIIVGLWCIQARPSDRPPMNEVIEML 343
                Y+ V+    +++     +       I   M      C    P+ RP   ++   L
Sbjct: 277 -----YKLVKDG--YQMA----QPAFAPKNIYSIM----QACWALEPTHRPTFQQICSFL 321

Query: 344 Q 344
           Q
Sbjct: 322 Q 322

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  111 bits (280), Expect = 3e-28
 Identities = 66/302 (21%), Positives = 121/302 (40%), Gaps = 78/302 (25%)

Query: 87  FKDKLGQGGFGGVYKGRL----------------------LDDFVNEVASISR-TSHVNV 123
           F+D +G+G FG V K R+                        DF  E+  + +   H N+
Sbjct: 29  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88

Query: 124 VTLLGFCLEGNNRALIYEFMPNGSLEKF----------VYNGDTSKPCQYLRWEKMYEIV 173
           + LLG C       L  E+ P+G+L  F                +     L  +++    
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148

Query: 174 IGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGA 233
             +A+G++YL      + +H D+   NIL+ E++  KI+DFGL++     + +       
Sbjct: 149 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMG 201

Query: 234 RGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV--------GCKNNLDSGVDSSSEV 285
           R  + ++A E  S N+   +  SDV+S+G+++ E+V        G            +E+
Sbjct: 202 RLPVRWMAIE--SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---------AEL 250

Query: 286 YFPHWIYRHVEQDREFKLPGVVTRKEN---EIAKKMIIVGLWCIQARPSDRPPMNEVIEM 342
                 Y  + Q   ++L     +  N   E+   M      C + +P +RP   +++  
Sbjct: 251 ------YEKLPQG--YRLE----KPLNCDDEVYDLM----RQCWREKPYERPSFAQILVS 294

Query: 343 LQ 344
           L 
Sbjct: 295 LN 296

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  109 bits (275), Expect = 9e-28
 Identities = 61/294 (20%), Positives = 106/294 (36%), Gaps = 66/294 (22%)

Query: 89  DKLGQGGFGGVYKGRLLDD--------------------FVNEVASISRTSHVNVVTLLG 128
             LG+GGFG V++ +   D                     + EV ++++  H  +V    
Sbjct: 11  QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70

Query: 129 FCLEGNN---------RALIY---EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 176
             LE N          +  +Y   +     +L+ ++   +     +         I + I
Sbjct: 71  AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM---NGRCTIEERERSVCLHIFLQI 127

Query: 177 AKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL------CTTKEGIVSSL 230
           A+ +E+LH   S  ++H D+KP NI    D   K+ DFGL           T    + + 
Sbjct: 128 AEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184

Query: 231 LGARGIIG---YIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYF 287
               G +G   Y++PE    N    SHK D++S G+++ EL+           +  E   
Sbjct: 185 ARHTGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFELL-------YPFSTQMERVR 235

Query: 288 PHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
                  V   +   L       E  + + M       +   P +RP    +IE
Sbjct: 236 ---TLTDVRNLKFPPLFTQKYPCEYVMVQDM-------LSPSPMERPEAINIIE 279

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  113 bits (283), Expect = 2e-27
 Identities = 65/293 (22%), Positives = 107/293 (36%), Gaps = 72/293 (24%)

Query: 86  SFKDKLGQGGFGGVYKGRL-----------------------LDDFVNEVASISRTSHVN 122
                +G+G FG V++G                          + F+ E  ++ +  H +
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 452

Query: 123 VVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 182
           +V L+G   E N   +I E    G L  F+     S     L    +      ++  L Y
Sbjct: 453 IVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFS-----LDLASLILYAYQLSTALAY 506

Query: 183 LHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAP 242
           L    S + +H DI   N+L+  + C K+ DFGL++    ++         +  I ++AP
Sbjct: 507 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAP 561

Query: 243 EVFSRNFGEVSHKSDVYSFGMMIMELV--------GCKNNLDSGVDSSSEVYFPHWIYRH 294
           E  S NF   +  SDV+ FG+ + E++        G KN         ++V         
Sbjct: 562 E--SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---------NDV------IGR 604

Query: 295 VEQDREFKLPGVVTRKEN---EIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
           +E     +LP       N    +   M      C    PS RP   E+   L 
Sbjct: 605 IENG--ERLP----MPPNCPPTLYSLM----TKCWAYDPSRRPRFTELKAQLS 647

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  109 bits (274), Expect = 5e-27
 Identities = 69/334 (20%), Positives = 118/334 (35%), Gaps = 84/334 (25%)

Query: 86  SFKDKLGQGGFGGVYKGRLLD---------------------------DFVNEVASISR- 117
                LG+G FG V     +                            D ++E+  +   
Sbjct: 72  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 131

Query: 118 TSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF----------VYNGDTSKPCQYLRWE 167
             H N++ LLG C +     +I E+   G+L ++               +  P + L  +
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191

Query: 168 KMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT-----T 222
            +      +A+G+EYL    S K +H D+   N+L+ ED   KI+DFGLA+         
Sbjct: 192 DLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 248

Query: 223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV--------GCKNN 274
           K          R  + ++APE  +      +H+SDV+SFG+++ E+         G    
Sbjct: 249 KTT------NGRLPVKWMAPE--ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300

Query: 275 LDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRP 334
                    E+      ++ +++      P   T   NE+   M      C  A PS RP
Sbjct: 301 ---------EL------FKLLKEGHRMDKPSNCT---NELYMMM----RDCWHAVPSQRP 338

Query: 335 PMNEVIEMLQGSTEALQIPPTPFLSSPPRAPIDS 368
              +++E L             +         D 
Sbjct: 339 TFKQLVEDLDRIVALTSNQEMGYYHHHHHHDYDI 372

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  107 bits (270), Expect = 1e-26
 Identities = 66/310 (21%), Positives = 106/310 (34%), Gaps = 78/310 (25%)

Query: 86  SFKDKLGQGGFGGVYKGRLLD-------------------------DFVNEVASISR-TS 119
            F   LG G FG V                                  ++E+  +++  S
Sbjct: 48  EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS 107

Query: 120 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF-----------------VYNGDTSKPCQ 162
           H N+V LLG C       LI+E+   G L  +                     +  +   
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167

Query: 163 YLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT- 221
            L +E +      +AKG+E+L        +H D+   N+L+      KI DFGLA+    
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224

Query: 222 ----TKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDS 277
                  G       AR  + ++APE  S   G  + KSDV+S+G+++ E+     N   
Sbjct: 225 DSNYVVRG------NARLPVKWMAPE--SLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276

Query: 278 GVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKEN---EIAKKMIIVGLWCIQARPSDRP 334
           G+   +        Y+ ++    FK+     +      EI   M      C       RP
Sbjct: 277 GIPVDANF------YKLIQN--GFKMD----QPFYATEEIYIIM----QSCWAFDSRKRP 320

Query: 335 PMNEVIEMLQ 344
               +   L 
Sbjct: 321 SFPNLTSFLG 330

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  108 bits (271), Expect = 1e-26
 Identities = 67/309 (21%), Positives = 116/309 (37%), Gaps = 84/309 (27%)

Query: 87  FKDKLGQGGFGGVYKGRLLD---------------------------DFVNEVASISR-T 118
               LG+G FG V     +                            D V+E+  +    
Sbjct: 85  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144

Query: 119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF----------VYNGDTSKPCQYLRWEK 168
            H N++ LLG C +     +I E+   G+L ++                  P + + ++ 
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204

Query: 169 MYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT-----TK 223
           +      +A+G+EYL    S K +H D+   N+L+ E+   KI+DFGLA+         K
Sbjct: 205 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261

Query: 224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV--------GCKNNL 275
                     R  + ++APE  +      +H+SDV+SFG+++ E+         G     
Sbjct: 262 TT------NGRLPVKWMAPE--ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE- 312

Query: 276 DSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPP 335
                   E+      ++ +++      P   T   NE+   M      C  A PS RP 
Sbjct: 313 --------EL------FKLLKEGHRMDKPANCT---NELYMMM----RDCWHAVPSQRPT 351

Query: 336 MNEVIEMLQ 344
             +++E L 
Sbjct: 352 FKQLVEDLD 360

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  106 bits (268), Expect = 1e-26
 Identities = 64/317 (20%), Positives = 110/317 (34%), Gaps = 95/317 (29%)

Query: 87  FKDKLGQGGFGGVYKGRLLD-------------------------DFVNEVASISRTSHV 121
               LG+G FG V K                              D ++E   + + +H 
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86

Query: 122 NVVTLLGFCLEGNNRALIYEFMPNGSLEKF------------------VYNGDTSKPCQY 163
           +V+ L G C +     LI E+   GSL  F                    +       + 
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146

Query: 164 LRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT-- 221
           L    +      I++G++YL      K++H D+   NIL+ E    KISDFGL++     
Sbjct: 147 LTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203

Query: 222 ---TKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV--------G 270
               K          R  + ++A E  S      + +SDV+SFG+++ E+V        G
Sbjct: 204 DSYVKRS------QGRIPVKWMAIE--SLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255

Query: 271 CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKEN---EIAKKMIIVGLWCIQ 327
                         +      +  ++     + P      +N   E+ + M    L C +
Sbjct: 256 IPPE---------RL------FNLLKTGHRMERP------DNCSEEMYRLM----LQCWK 290

Query: 328 ARPSDRPPMNEVIEMLQ 344
             P  RP   ++ + L+
Sbjct: 291 QEPDKRPVFADISKDLE 307

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  107 bits (269), Expect = 1e-26
 Identities = 69/318 (21%), Positives = 112/318 (35%), Gaps = 95/318 (29%)

Query: 86  SFKDKLGQGGFGGVYKGRLLD-------------------------DFVNEVASISRTSH 120
            +   +G+G FG V++ R                            DF  E A ++   +
Sbjct: 50  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109

Query: 121 VNVVTLLGFCLEGNNRALIYEFMPNGSLEKF------------------VYNGDTSKPCQ 162
            N+V LLG C  G    L++E+M  G L +F                       +S    
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169

Query: 163 YLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT 222
            L   +   I   +A G+ YL      K +H D+   N L+ E+   KI+DFGL++    
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSR---- 222

Query: 223 KEGIVSS---LLGARGI--IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV-------- 269
              I S+            I ++ PE  S  +   + +SDV+++G+++ E+         
Sbjct: 223 --NIYSADYYKADGNDAIPIRWMPPE--SIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278

Query: 270 GCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKEN---EIAKKMIIVGLWCI 326
           G  +          EV        +V        P      EN   E+   M      C 
Sbjct: 279 GMAHE---------EV------IYYVRDGNILACP------ENCPLELYNLM----RLCW 313

Query: 327 QARPSDRPPMNEVIEMLQ 344
              P+DRP    +  +LQ
Sbjct: 314 SKLPADRPSFCSIHRILQ 331

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  106 bits (267), Expect = 2e-26
 Identities = 66/305 (21%), Positives = 116/305 (38%), Gaps = 74/305 (24%)

Query: 86  SFKDKLGQGGFGGVYKGRLLD---------------------------DFVNEVASISR- 117
           +    LG+G FG V     +                            D V+E+  +   
Sbjct: 38  TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97

Query: 118 TSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF----------VYNGDTSKPCQYLRWE 167
             H N++ LLG C +     +I E+   G+L ++                  P + + ++
Sbjct: 98  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157

Query: 168 KMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV 227
            +      +A+G+EYL    S K +H D+   N+L+ E+   KI+DFGLA+         
Sbjct: 158 DLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARD-INNIDYY 213

Query: 228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV--------GCKNNLDSGV 279
                 R  + ++APE  +      +H+SDV+SFG+++ E+         G         
Sbjct: 214 KKTTNGRLPVKWMAPE--ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE----- 266

Query: 280 DSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEV 339
               E+      ++ +++      P   T   NE+   M      C  A PS RP   ++
Sbjct: 267 ----EL------FKLLKEGHRMDKPANCT---NELYMMM----RDCWHAVPSQRPTFKQL 309

Query: 340 IEMLQ 344
           +E L 
Sbjct: 310 VEDLD 314

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  105 bits (264), Expect = 3e-26
 Identities = 55/302 (18%), Positives = 102/302 (33%), Gaps = 84/302 (27%)

Query: 86  SFKDKLGQGGFGGVYKGRLL--------------------------DDFVNEVASISRTS 119
            F + LGQG F  ++KG                             + F    + +S+ S
Sbjct: 11  IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS 70

Query: 120 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
           H ++V   G C+ G+   L+ EF+  GSL+ ++           +      E+   +A  
Sbjct: 71  HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC-----INILWKLEVAKQLAAA 125

Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCP--------KISDFGLAKLCTTKEGIVSSLL 231
           + +L       ++H ++   NILL  +           K+SD G++     K+       
Sbjct: 126 MHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------- 175

Query: 232 GARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV--------GCKNNLDSGVDSSS 283
             +  I ++ PE    N   ++  +D +SFG  + E+            +          
Sbjct: 176 ILQERIPWVPPECIE-NPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS---------Q 225

Query: 284 EVYFPHWIYRHVEQDREFKLPGVVTRKEN-EIAKKMIIVGLWCIQARPSDRPPMNEVIEM 342
                    +  E     +LP      +  E+A  +      C+   P  RP    +I  
Sbjct: 226 RK------LQFYEDR--HQLP----APKAAELANLI----NNCMDYEPDHRPSFRAIIRD 269

Query: 343 LQ 344
           L 
Sbjct: 270 LN 271

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  105 bits (264), Expect = 4e-26
 Identities = 73/307 (23%), Positives = 114/307 (37%), Gaps = 78/307 (25%)

Query: 86  SFKDKLGQGGFGGVYKGRLLD-------------------------DFVNEVASISR-TS 119
                LG+G FG V +                                ++E+  +     
Sbjct: 30  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89

Query: 120 HVNVVTLLGFCL-EGNNRALIYEFMPNGSLEKF----------VYNGDTSKPCQYLRWEK 168
           H+NVV LLG C   G    +I EF   G+L  +                     +L  E 
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149

Query: 169 MYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVS 228
           +      +AKG+E+L    S K +H D+   NILL E    KI DFGLA+    K+    
Sbjct: 150 LICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARD-IYKDPDYV 205

Query: 229 SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV--------GCKNNLDSGVD 280
               AR  + ++APE  +      + +SDV+SFG+++ E+         G K +      
Sbjct: 206 RKGDARLPLKWMAPE--TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------ 257

Query: 281 SSSEVYFPHWIYRHVEQDREFKLPGVVTRKEN---EIAKKMIIVGLWCIQARPSDRPPMN 337
              E        R +++    + P      +    E+ + M    L C    PS RP  +
Sbjct: 258 --EEF------CRRLKEGTRMRAP------DYTTPEMYQTM----LDCWHGEPSQRPTFS 299

Query: 338 EVIEMLQ 344
           E++E L 
Sbjct: 300 ELVEHLG 306

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  104 bits (261), Expect = 8e-26
 Identities = 55/203 (27%), Positives = 82/203 (40%), Gaps = 39/203 (19%)

Query: 91  LGQGGFGGVYKGRLLD--DFV-----------------NEVASISRTSHVNVVTLLGFCL 131
           LG+G +G VY GR L     +                  E+A      H N+V  LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 132 EGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG-----IAKGLEYLHHG 186
           E     +  E +P GSL   + +                E  IG     I +GL+YLH  
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDN--------EQTIGFYTKQILEGLKYLH-- 139

Query: 187 CSTKILHFDIKPHNILLD-EDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVF 245
              +I+H DIK  N+L++      KISDFG +K          +     G + Y+APE+ 
Sbjct: 140 -DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF---TGTLQYMAPEII 195

Query: 246 SRNFGEVSHKSDVYSFGMMIMEL 268
            +        +D++S G  I+E+
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEM 218

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  103 bits (259), Expect = 2e-25
 Identities = 56/280 (20%), Positives = 95/280 (33%), Gaps = 63/280 (22%)

Query: 89  DKLGQGGFGGVYKGRLLDD---------------------FVNEVASISR-TSHVNVVTL 126
            +LG G +G V+K R  +D                      + EV S  +   H   V L
Sbjct: 63  SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122

Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                EG    L  E     SL++             L   +++  +      L +LH  
Sbjct: 123 EQAWEEGGILYLQTELC-GPSLQQHC-----EAWGASLPEAQVWGYLRDTLLALAHLH-- 174

Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG---YIAPE 243
            S  ++H D+KP NI L      K+ DFGL          + +        G   Y+APE
Sbjct: 175 -SQGLVHLDVKPANIFLGPRGRCKLGDFGLLV-------ELGTAGAGEVQEGDPRYMAPE 226

Query: 244 VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQD-REFK 302
           +   ++G     +DV+S G+ I+E+                            Q  R+  
Sbjct: 227 LLQGSYG---TAADVFSLGLTILEVACNM---------------ELPHGGEGWQQLRQGY 268

Query: 303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM 342
           LP   T   +   + ++   +  ++  P  R     ++ +
Sbjct: 269 LPPEFTAGLSSELRSVL---VMMLEPDPKLRATAEALLAL 305

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  104 bits (261), Expect = 2e-25
 Identities = 51/280 (18%), Positives = 109/280 (38%), Gaps = 58/280 (20%)

Query: 89  DKLGQGGFGGVYKGRLLDD---------------------FVNEVASISRTSHVNVVTLL 127
            K+G+G FG     +  +D                        EVA ++   H N+V   
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89

Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
               E  +  ++ ++   G L K +     ++     + +++ +  + I   L+++H   
Sbjct: 90  ESFEENGSLYIVMDYCEGGDLFKRI----NAQKGVLFQEDQILDWFVQICLALKHVH--- 142

Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSR 247
             KILH DIK  NI L +D   ++ DFG+A++  +   +  + +   G   Y++PE+   
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI---GTPYYLSPEICEN 199

Query: 248 NFGEVSHKSDVYSFGMMIMELVGCK-----NNLDSGVDSSSEVYFPHWIYRHVEQDREFK 302
                ++KSD+++ G ++ EL   K      ++ +             +   +       
Sbjct: 200 K--PYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-------------LVLKIISGSFPP 244

Query: 303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM 342
           +    +     +  ++        +  P DRP +N ++E 
Sbjct: 245 VSLHYSYDLRSLVSQL-------FKRNPRDRPSVNSILEK 277

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  103 bits (258), Expect = 3e-25
 Identities = 46/202 (22%), Positives = 88/202 (43%), Gaps = 32/202 (15%)

Query: 89  DKLGQGGFGGVYKGRLLDD----------------------FVNEVASISRTSHVNVVTL 126
            K+G+G F  VY+   L D                       + E+  + + +H NV+  
Sbjct: 38  KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97

Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
               +E N   ++ E    G L + + +    K  + +    +++  + +   LE++H  
Sbjct: 98  YASFIEDNELNIVLELADAGDLSRMIKH--FKKQKRLIPERTVWKYFVQLCSALEHMH-- 153

Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            S +++H DIKP N+ +      K+ D GL +  ++K     SL+G      Y++PE   
Sbjct: 154 -SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGT---PYYMSPERIH 209

Query: 247 RNFGEVSHKSDVYSFGMMIMEL 268
            N    + KSD++S G ++ E+
Sbjct: 210 EN--GYNFKSDIWSLGCLLYEM 229

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  103 bits (258), Expect = 1e-24
 Identities = 55/213 (25%), Positives = 86/213 (40%), Gaps = 33/213 (15%)

Query: 79  DVKKLTNSFKDKLGQGGFGGVYKG-----------RLLDDFV----NEVASISRTS--HV 121
            V K++   KD LG G  G +              R+L +       EV  + R S  H 
Sbjct: 20  IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQ-LLRESDEHP 78

Query: 122 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           NV+       +   + +  E     +L+++V   D +         +   ++     GL 
Sbjct: 79  NVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFA-----HLGLEPITLLQQTTSGLA 132

Query: 182 YLHHGCSTKILHFDIKPHNILLDE-----DFCPKISDFGLAKLCTTKEGIVSSLLGARGI 236
           +LH   S  I+H D+KPHNIL+            ISDFGL K         S   G  G 
Sbjct: 133 HLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189

Query: 237 IGYIAPEVFSRNFGE-VSHKSDVYSFGMMIMEL 268
            G+IAPE+ S +  E  ++  D++S G +   +
Sbjct: 190 EGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYV 222

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =   99 bits (250), Expect = 3e-24
 Identities = 64/310 (20%), Positives = 121/310 (39%), Gaps = 65/310 (20%)

Query: 89  DKLGQGGFGGVYKGR----------------LLDD------FVNEVASISRTSHVNVVTL 126
           DKLG GG   VY                     +       F  EV + S+ SH N+V++
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76

Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH-H 185
           +    E +   L+ E++   +L +++   ++  P   L  +        I  G+++ H  
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGP---LSVDTAINFTNQILDGIKHAHDM 130

Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG---YIAP 242
                I+H DIKP NIL+D +   KI DFG+AK  +      +SL     ++G   Y +P
Sbjct: 131 R----IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE-----TSLTQTNHVLGTVQYFSP 181

Query: 243 EVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGV-----DSSSEVYFPHWIYRHVEQ 297
           E            +D+YS G+++ E++        G      +++  +       +H++ 
Sbjct: 182 EQAKG--EATDECTDIYSIGIVLYEML-------VGEPPFNGETAVSI-----AIKHIQD 227

Query: 298 DREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPP-MNEVIEMLQGSTEALQIPPTP 356
                +P V T    +I + +  V L   +   ++R   + E+ + L       +     
Sbjct: 228 S----VPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANEDV 283

Query: 357 FLSSPPRAPI 366
           +     +   
Sbjct: 284 YELDKMKTIA 293

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  100 bits (251), Expect = 5e-24
 Identities = 35/348 (10%), Positives = 73/348 (20%), Gaps = 74/348 (21%)

Query: 46  SAAVRRKITKSDKDLEAFIRNYGPLPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGR-- 103
             A++      +              +        +KL     + L  G    V+  R  
Sbjct: 27  EEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLK--LVEPLRVGDRSVVFLVRDV 84

Query: 104 --------------------LLDDFVNEVASISRTSHVNVVTLLGFC------------- 130
                                L+       + +R    +                     
Sbjct: 85  ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQS 144

Query: 131 -------------LEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQ-YLRWEKMYEIVIGI 176
                            N  L+     +  LE      D     +       ++ +   +
Sbjct: 145 QPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVFRGDEGILALHILTAQL 203

Query: 177 AKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI 236
            +    L    S  ++H    P N+ +  D    + D         K G           
Sbjct: 204 IRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW----KVGTRGPASS--VP 254

Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGV---DSSSEVYFPHWIYR 293
           + Y   E  + +    +H  + +  G+ I  +                 +      W   
Sbjct: 255 VTYAPREFLNASTATFTHALNAWQLGLSIYRVW-------CLFLPFGLVTPGIKGSWKRP 307

Query: 294 HVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
            +       L         +  K +I      +      R    E +E
Sbjct: 308 SLRVPGTDSLAFGSCTPLPDFVKTLI---GRFLNFDRRRRLLPLEAME 352

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  100 bits (251), Expect = 6e-24
 Identities = 38/212 (17%), Positives = 71/212 (33%), Gaps = 44/212 (20%)

Query: 89  DKLGQG--GFGGVYKGR---------------------LLDDFVNEVASISRTSHVNVVT 125
             +G+G      V   R                     ++     E+      +H N+V 
Sbjct: 31  TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90

Query: 126 LLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG-----IAKGL 180
                +  N   ++  FM  GS +  +              + M E+ I      + K L
Sbjct: 91  YRATFIADNELWVVTSFMAYGSAKDLICTHFM---------DGMNELAIAYILQGVLKAL 141

Query: 181 EYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFG-LAKLCTTKEGIVSSLLGARGIIG- 238
           +Y+H       +H  +K  +IL+  D    +S       + +  +         +  +  
Sbjct: 142 DYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198

Query: 239 --YIAPEVFSRNFGEVSHKSDVYSFGMMIMEL 268
             +++PEV  +N      KSD+YS G+   EL
Sbjct: 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACEL 230

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  100 bits (250), Expect = 7e-24
 Identities = 59/305 (19%), Positives = 103/305 (33%), Gaps = 68/305 (22%)

Query: 89  DKLGQGGFGGVYKGRL--------------------LDDFVNEVASISRTSHVNVVTLLG 128
            +LG G  G V+K                        +  + E+  +   +   +V   G
Sbjct: 39  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98

Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
                   ++  E M  GSL++         P Q L      ++ I + KGL YL     
Sbjct: 99  AFYSDGEISICMEHMDGGSLDQV-LKKAGRIPEQILG-----KVSIAVIKGLTYLRE--K 150

Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG---YIAPEVF 245
            KI+H D+KP NIL++     K+ DFG++        ++ S+  A   +G   Y++PE  
Sbjct: 151 HKIMHRDVKPSNILVNSRGEIKLCDFGVSG------QLIDSM--ANSFVGTRSYMSPERL 202

Query: 246 SRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG 305
                  S +SD++S G+ ++E+                  +P       +      + G
Sbjct: 203 QGT--HYSVQSDIWSMGLSLVEMA--------------VGRYP---IPPPDAKELELMFG 243

Query: 306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQIPPTPFLSSPPRAP 365
                +              +     D  P   + E+L        I        PP+ P
Sbjct: 244 CQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLD------YIVN----EPPPKLP 293

Query: 366 IDSFT 370
              F+
Sbjct: 294 SGVFS 298

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 98.9 bits (247), Expect = 1e-23
 Identities = 47/208 (22%), Positives = 86/208 (41%), Gaps = 36/208 (17%)

Query: 89  DKLGQGGFGGVYKGRL--------------------LDDFVNEVASISRTSHVNVVTLLG 128
           + +G G    V                         +D+ + E+ ++S+  H N+V+   
Sbjct: 21  EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80

Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIA-----KGLEYL 183
             +  +   L+ + +  GS+   +            +   + E  I        +GLEYL
Sbjct: 81  SFVVKDELWLVMKLLSGGSVLDII---KHIVAKGEHKSGVLDESTIATILREVLEGLEYL 137

Query: 184 HHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG---YI 240
           H       +H D+K  NILL ED   +I+DFG++       G ++     +  +G   ++
Sbjct: 138 H---KNGQIHRDVKAGNILLGEDGSVQIADFGVSA-FLATGGDITRNKVRKTFVGTPCWM 193

Query: 241 APEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           APEV  +  G    K+D++SFG+  +EL
Sbjct: 194 APEVMEQVRG-YDFKADIWSFGITAIEL 220

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  100 bits (251), Expect = 2e-23
 Identities = 52/316 (16%), Positives = 95/316 (30%), Gaps = 82/316 (25%)

Query: 89  DKLGQGGFGGVYKGR--LLDD-------------------FVNEVASISRTSHVNVVTLL 127
             +  GG G +Y      ++                     + E   ++   H ++V + 
Sbjct: 86  GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 128 GFCLEGNNRA-----LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 182
            F    +        ++ E++   SL++           Q L   +    ++ I   L Y
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--------QKLPVAEAIAYLLEILPALSY 197

Query: 183 LH-HGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           LH  G    +++ D+KP NI+L E+   K+ D G      +   +        G  G+ A
Sbjct: 198 LHSIG----LVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSFGYLY-------GTPGFQA 245

Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV-EQDRE 300
           PE+        +  +D+Y+ G  +  L                          + E D  
Sbjct: 246 PEIVR---TGPTVATDIYTVGRTLAALT------------LDLPTRNGRYVDGLPEDDPV 290

Query: 301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPP-MNEVIEMLQGSTEAL-------QI 352
            K      R          ++    I   P  R     E+   L G    +         
Sbjct: 291 LKTYDSYGR----------LL-RRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPR 339

Query: 353 PPTPFLSSPPRAPIDS 368
           P    + SP R+    
Sbjct: 340 PGLSTIFSPSRSTFGV 355

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 98.2 bits (245), Expect = 2e-23
 Identities = 56/296 (18%), Positives = 103/296 (34%), Gaps = 64/296 (21%)

Query: 87  FKDKLGQGGFGGVYKGRLLDD-------------------FVNEVASISRTSHVNVVTLL 127
           F  KLG+GGF  V     L D                      E       +H N++ L+
Sbjct: 33  FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92

Query: 128 GFCLEGNNRA----LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYL 183
            +CL          L+  F   G+L   +          +L  +++  +++GI +GLE +
Sbjct: 93  AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKG--NFLTEDQILWLLLGICRGLEAI 150

Query: 184 HHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG----- 238
           H   +    H D+KP NILL ++  P + D G               L  +         
Sbjct: 151 H---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207

Query: 239 -YIAPEVFS-RNFGEVSHKSDVYSFGMMIMELV-------GCKNNLDSGVDS-SSEVYFP 288
            Y APE+FS ++   +  ++DV+S G ++  ++             DS   +  +++  P
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIP 267

Query: 289 HWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
                                       +++      +   P  RP +  ++  L+
Sbjct: 268 --QSPRHSSA----------------LWQLLN---SMMTVDPHQRPHIPLLLSQLE 302

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 97.3 bits (243), Expect = 2e-23
 Identities = 59/283 (20%), Positives = 104/283 (36%), Gaps = 57/283 (20%)

Query: 90  KLGQGGFGGVYKGRLLDD---------------------FVNEVASISRTSHVNVVTLLG 128
            +G G +G   K R   D                      V+EV  +    H N+V    
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 129 -FCLEGNNRALIY-EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH-- 184
                 N    I  E+   G L   +  G   +  QYL  E +  ++  +   L+  H  
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKER--QYLDEEFVLRVMTQLTLALKECHRR 130

Query: 185 HGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV 244
                 +LH D+KP N+ LD     K+ DFGLA++         + +G      Y++PE 
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGT---PYYMSPEQ 187

Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCK-----NNLDSGVDSSSEVYFPHWIYRHVEQDR 299
            +R     + KSD++S G ++ EL          +                +   + + +
Sbjct: 188 MNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------------LAGKIREGK 232

Query: 300 EFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM 342
             ++P   + + NEI  +M+ +       +   RP + E++E 
Sbjct: 233 FRRIPYRYSDELNEIITRMLNL-------KDYHRPSVEEILEN 268

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 96.6 bits (241), Expect = 4e-23
 Identities = 42/218 (19%), Positives = 85/218 (38%), Gaps = 40/218 (18%)

Query: 89  DKLGQGGFGGVYKGRLLDD---------------------FVNEVASISRTS-HVNVVTL 126
           +K+G G FG V+K     D                      + EV + +    H +VV  
Sbjct: 17  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76

Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                E ++  +  E+   GSL   +   +  +   Y +  ++ ++++ + +GL Y+H  
Sbjct: 77  FSAWAEDDHMLIQNEYCNGGSLADAI--SENYRIMSYFKEAELKDLLLQVGRGLRYIH-- 132

Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE---------GIVSSLLGARGII 237
            S  ++H DIKP NI +     P  +     +               G V+ +   +   
Sbjct: 133 -SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE 191

Query: 238 G---YIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
           G   ++A EV   N+     K+D+++  + ++   G +
Sbjct: 192 GDSRFLANEVLQENYTH-LPKADIFALALTVVCAAGAE 228

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 96.7 bits (241), Expect = 6e-23
 Identities = 54/209 (25%), Positives = 87/209 (41%), Gaps = 52/209 (24%)

Query: 89  DKLGQGGFGGVYKGR-------------------LLDDFVNEVASISRTSHVNVVTLLGF 129
            K+G+G  G V   R                     +   NEV  +    H NVV +   
Sbjct: 51  VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110

Query: 130 CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG-----IAKGLEYLH 184
            L G    ++ EF+  G+L   V               ++ E  I      + + L YLH
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIVSQV------------RLNEEQIATVCEAVLQALAYLH 158

Query: 185 HGCSTKILHFDIKPHNILLDEDFCPKISDFGL-AKLCTTKEGIVSSLLGARGIIG---YI 240
              +  ++H DIK  +ILL  D   K+SDFG  A++        S       ++G   ++
Sbjct: 159 ---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS-------LVGTPYWM 208

Query: 241 APEVFSRNFGEVSHKSDVYSFGMMIMELV 269
           APEV SR+    + + D++S G+M++E+V
Sbjct: 209 APEVISRS--LYATEVDIWSLGIMVIEMV 235

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 95.8 bits (239), Expect = 9e-23
 Identities = 53/208 (25%), Positives = 85/208 (40%), Gaps = 52/208 (25%)

Query: 90  KLGQGGFGGVYKGR-------------------LLDDFVNEVASISRTSHVNVVTLLGFC 130
           K+GQG  G VY                        +  +NE+  +    + N+V  L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 131 LEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG-----IAKGLEYLHH 185
           L G+   ++ E++  GSL   V                M E  I        + LE+LH 
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTET------------CMDEGQIAAVCRECLQALEFLH- 133

Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG-IIG---YIA 241
             S +++H DIK  NILL  D   K++DFG           ++     R  ++G   ++A
Sbjct: 134 --SNQVIHRDIKSDNILLGMDGSVKLTDFGFC-------AQITPEQSKRSTMVGTPYWMA 184

Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELV 269
           PEV +R       K D++S G+M +E++
Sbjct: 185 PEVVTRK--AYGPKVDIWSLGIMAIEMI 210

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 97.8 bits (244), Expect = 2e-22
 Identities = 51/233 (21%), Positives = 86/233 (36%), Gaps = 54/233 (23%)

Query: 64  IRNYGPLPLKRYNFSDVKKLTN--SFKDKLGQGGFGGVYK-------------------- 101
           + ++      R N           +    LG+G FG V K                    
Sbjct: 1   MHHHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA 60

Query: 102 -GRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-----EKFVYNG 155
             +     + EV  + +  H N++ L     + ++  ++ E    G L     ++  ++ 
Sbjct: 61  KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS- 119

Query: 156 DTSKPCQYLRWEKM-YEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL---DEDFCPKI 211
                      E     I+  +  G+ Y+H      I+H D+KP NILL   ++D   KI
Sbjct: 120 -----------EHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKI 165

Query: 212 SDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMM 264
            DFGL+        +   +    G   YIAPEV    + E   K DV+S G++
Sbjct: 166 IDFGLSTCFQQNTKMKDRI----GTAYYIAPEVLRGTYDE---KCDVWSAGVI 211

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 95.7 bits (238), Expect = 2e-22
 Identities = 50/213 (23%), Positives = 83/213 (38%), Gaps = 38/213 (17%)

Query: 141 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHN 200
           +     +L+ ++         +         I I IA+ +E+LH   S  ++H D+KP N
Sbjct: 141 QLCRKENLKDWMNRR---CSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSN 194

Query: 201 ILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGAR------GIIG---YIAPEVFSRNFGE 251
           I    D   K+ DFGL       E   + L          G +G   Y++PE    N   
Sbjct: 195 IFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGN--N 252

Query: 252 VSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFP--HWIYRHVEQDREFKLPGVVTR 309
            SHK D++S G+++ EL+                 F       R +   R  K P + T+
Sbjct: 253 YSHKVDIFSLGLILFELL---------------YSFSTQMERVRIITDVRNLKFPLLFTQ 297

Query: 310 KENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM 342
           K  +    M+      +   P++RP   ++IE 
Sbjct: 298 KYPQ-EHMMV---QDMLSPSPTERPEATDIIEN 326

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 97.5 bits (243), Expect = 2e-22
 Identities = 50/207 (24%), Positives = 82/207 (39%), Gaps = 45/207 (21%)

Query: 86  SFKDKLGQGGFGGVYKGR----------------------LLDDFVNEVASISRTSHVNV 123
             +  LG+G FG V   +                        +  + EV  + +  H N+
Sbjct: 29  KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88

Query: 124 VTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEKM-YEIVIGIAKGLE 181
           + L  F  +     L+ E    G L ++ +     S        E     I+  +  G+ 
Sbjct: 89  MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFS--------EVDAARIIRQVLSGIT 140

Query: 182 YLHHGCSTKILHFDIKPHNILL---DEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG 238
           Y+H     KI+H D+KP N+LL    +D   +I DFGL+      + +   +    G   
Sbjct: 141 YMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI----GTAY 193

Query: 239 YIAPEVFSRNFGEVSHKSDVYSFGMMI 265
           YIAPEV    + E   K DV+S G+++
Sbjct: 194 YIAPEVLHGTYDE---KCDVWSTGVIL 217

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 95.4 bits (238), Expect = 2e-22
 Identities = 77/311 (24%), Positives = 115/311 (36%), Gaps = 75/311 (24%)

Query: 91  LGQGGFGGVY----------------------KGRLLDDFVNEVASISRTSHVNVVTLLG 128
           LG+GGF   +                      K    +    E++     +H +VV   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 129 FCLEGNNRA-LIYEFMPNGSL-EKFVYNGDTSKP--CQYLRWEKMYEIVIGIAKGLEYLH 184
              E N+   ++ E     SL E        ++P    YLR          I  G +YLH
Sbjct: 109 -FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR---------QIVLGCQYLH 158

Query: 185 HGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV 244
                +++H D+K  N+ L+ED   KI DFGLA            L G      YIAPEV
Sbjct: 159 ---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGT---PNYIAPEV 212

Query: 245 FSRNFGEVSHKSDVYSFGMMIME-LVGC----KNNLDSGVDSSSEVYFPHWIYRHVEQDR 299
            S+     S + DV+S G ++   LVG      + L                Y  +++  
Sbjct: 213 LSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-------------TYLRIKK-N 256

Query: 300 EFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE---MLQGSTEALQIPPTP 356
           E+ +P  +       A  +I      +Q  P+ RP +NE++       G   A    P  
Sbjct: 257 EYSIPKHINPV----AASLIQ---KMLQTDPTARPTINELLNDEFFTSGYIPAR--LPIT 307

Query: 357 FLSSPPRAPID 367
            L+ PPR  I 
Sbjct: 308 CLTIPPRFSIA 318

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 95.0 bits (237), Expect = 3e-22
 Identities = 67/318 (21%), Positives = 116/318 (36%), Gaps = 76/318 (23%)

Query: 89  DKLGQGGFGGVYKGR----------------LLDD------FVNEVASISRTSHVNVVTL 126
           + LG GG   V+  R                L  D      F  E  + +  +H  +V +
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77

Query: 127 L--GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLR------WEKMYEIVIGIAK 178
              G   E     L Y  M      ++V +G T +    +        ++  E++    +
Sbjct: 78  YDTG-EAETPAGPLPYIVM------EYV-DGVTLR--DIVHTEGPMTPKRAIEVIADACQ 127

Query: 179 GLEYLH-HGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGII 237
            L + H +G    I+H D+KP NI++      K+ DFG+A+         +S+     +I
Sbjct: 128 ALNFSHQNG----IIHRDVKPANIMISATNAVKVMDFGIARAIADSG---NSVTQTAAVI 180

Query: 238 G---YIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGV-----DSSSEVYFPH 289
           G   Y++PE        V  +SDVYS G ++ E++       +G      DS   V    
Sbjct: 181 GTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVL-------TGEPPFTGDSPVSV---- 227

Query: 290 WIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPP-MNEVIEMLQGSTE 348
             Y+HV +D     P   + +   ++  +  V L  +   P +R     E+   L     
Sbjct: 228 -AYQHVRED-----PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281

Query: 349 ALQIPPTPFLSSPPRAPI 366
                    L+   R  +
Sbjct: 282 GEPPEAPKVLTDAERTSL 299

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 96.4 bits (240), Expect = 3e-22
 Identities = 51/226 (22%), Positives = 84/226 (37%), Gaps = 40/226 (17%)

Query: 76  NFSDVKKLTNSFKDKLGQGGFGGVYK-----GRL----------LDDFVNEVASISRTS- 119
           NF    K     +  LG G  G V       GR            D  + E+  ++ +  
Sbjct: 8   NFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDD 67

Query: 120 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAK 178
           H NV+             +  E   N +L+  V     + +  +  +      ++  IA 
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126

Query: 179 GLEYLHHGCSTKILHFDIKPHNILLD-------------EDFCPKISDFGLAKLCTTKEG 225
           G+ +LH   S KI+H D+KP NIL+              E+    ISDFGL K   + + 
Sbjct: 127 GVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183

Query: 226 IVSSLLGAR-GIIGYIAPEVFSRNFGEVSHKS-----DVYSFGMMI 265
              + L    G  G+ APE+   +    + +      D++S G + 
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 96.7 bits (241), Expect = 3e-22
 Identities = 53/206 (25%), Positives = 84/206 (40%), Gaps = 44/206 (21%)

Query: 86  SFKDKLGQGGFGGVYK---------------------GRLLDDFVNEVASISRTSHVNVV 124
               KLG G +G V                              + EVA +    H N++
Sbjct: 40  QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99

Query: 125 TLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEKM-YEIVIGIAKGLEY 182
            L  F  +  N  L+ E    G L ++ ++    +        E     I+  +  G+ Y
Sbjct: 100 KLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFN--------EVDAAVIIKQVLSGVTY 151

Query: 183 LHHGCSTKILHFDIKPHNILL---DEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
           LH      I+H D+KP N+LL   ++D   KI DFGL+ +   ++ +   L    G   Y
Sbjct: 152 LH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL----GTAYY 204

Query: 240 IAPEVFSRNFGEVSHKSDVYSFGMMI 265
           IAPEV  + + E   K DV+S G+++
Sbjct: 205 IAPEVLRKKYDE---KCDVWSIGVIL 227

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 93.4 bits (233), Expect = 7e-22
 Identities = 75/316 (23%), Positives = 116/316 (36%), Gaps = 85/316 (26%)

Query: 91  LGQGGFGGVYKGR----------------------LLDDFVNEVASISRTSHVNVVTLLG 128
           LG+GGF   ++                          +    E++     +H +VV   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 129 FCLEGNNRALIY---EFMPNGSL-EKFVYNGDTSKP--CQYLRWEKMYEIVIGIAKGLEY 182
              E N+   ++   E     SL E        ++P    YLR          I  G +Y
Sbjct: 83  -FFEDNDF--VFVVLELCRRRSLLELHKRRKALTEPEARYYLR---------QIVLGCQY 130

Query: 183 LHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG---Y 239
           LH     +++H D+K  N+ L+ED   KI DFGLA                + + G   Y
Sbjct: 131 LH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD----GERK--KVLCGTPNY 181

Query: 240 IAPEVFSRNFGEVSHKSDVYSFGMMIME-LVGC----KNNLDSGVDSSSEVYFPHWIYRH 294
           IAPEV S+     S + DV+S G ++   LVG      + L                Y  
Sbjct: 182 IAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-------------TYLR 226

Query: 295 VEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE---MLQGSTEALQ 351
           +++  E+ +P  +       A  +I      +Q  P+ RP +NE++       G   A  
Sbjct: 227 IKK-NEYSIPKHINPV----AASLIQ---KMLQTDPTARPTINELLNDEFFTSGYIPAR- 277

Query: 352 IPPTPFLSSPPRAPID 367
             P   L+ PPR  I 
Sbjct: 278 -LPITCLTIPPRFSIA 292

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 93.2 bits (232), Expect = 8e-22
 Identities = 53/208 (25%), Positives = 86/208 (41%), Gaps = 51/208 (24%)

Query: 89  DKLGQGGFGGVYKGR--------------------LLDDFVNEVASISRTSHVNVVTLLG 128
           +K+G+G FG V+KG                      ++D   E+  +S+     V    G
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87

Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI-----AKGLEYL 183
             L+     +I E++  GS    +  G             + E  I        KGL+YL
Sbjct: 88  SYLKDTKLWIIMEYLGGGSALDLLEPG------------PLDETQIATILREILKGLDYL 135

Query: 184 HHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG---YI 240
           H   S K +H DIK  N+LL E    K++DFG+A        +  + +     +G   ++
Sbjct: 136 H---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQ------LTDTQIKRNTFVGTPFWM 186

Query: 241 APEVFSRNFGEVSHKSDVYSFGMMIMEL 268
           APEV  +       K+D++S G+  +EL
Sbjct: 187 APEVIKQ--SAYDSKADIWSLGITAIEL 212

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 93.2 bits (232), Expect = 9e-22
 Identities = 48/206 (23%), Positives = 92/206 (44%), Gaps = 41/206 (19%)

Query: 89  DKLGQGGFGGVYKGR-------------------LLDDFVNEVASISRTSHVNVVTLLGF 129
            +LG G FG VYK +                    L+D++ E+  ++   H  +V LLG 
Sbjct: 25  GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84

Query: 130 CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCST 189
                   ++ EF P G+++  +   D       L   ++  +   + + L +LH   S 
Sbjct: 85  YYHDGKLWIMIEFCPGGAVDAIMLELDRG-----LTEPQIQVVCRQMLEALNFLH---SK 136

Query: 190 KILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG-IIG---YIAPEVF 245
           +I+H D+K  N+L+  +   +++DFG++             L  R   IG   ++APEV 
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVS-------AKNLKTLQKRDSFIGTPYWMAPEVV 189

Query: 246 SRNFGEVS---HKSDVYSFGMMIMEL 268
                + +   +K+D++S G+ ++E+
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEM 215

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 93.3 bits (232), Expect = 1e-21
 Identities = 47/217 (21%), Positives = 76/217 (35%), Gaps = 44/217 (20%)

Query: 86  SFKDKLGQGGFGGVYKGR--------------------LLDDFVNEVASISRTSHVNVVT 125
              D LGQG    V++GR                     +D  + E   + + +H N+V 
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 126 LLGFCLEGNNRALIY---EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 182
           L     E           EF P GSL   +   +       L   +   ++  +  G+ +
Sbjct: 72  LFAI-EEETTTRHKVLIMEFCPCGSLYTVL---EEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 183 LHHGCSTKILHFDIKPHNILL----DEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG 238
           L       I+H +IKP NI+     D     K++DFG A+     E  VS      G   
Sbjct: 128 LR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY----GTEE 180

Query: 239 YIAPEVFSRNFGEV------SHKSDVYSFGMMIMELV 269
           Y+ P+++ R               D++S G+      
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA 217

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 92.8 bits (231), Expect = 2e-21
 Identities = 49/211 (23%), Positives = 82/211 (38%), Gaps = 47/211 (22%)

Query: 89  DKLGQGGFGGVYKGRL--------------------LDDFVNEVASISRTS-HVNVVTLL 127
            ++G+G +G V K                           + ++  + R+S    +V   
Sbjct: 28  GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87

Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG-----IAKGLEY 182
           G      +  +  E M + S +KF       K    +  + + E ++G       K L +
Sbjct: 88  GALFREGDCWICMELM-STSFDKFY------KYVYSVLDDVIPEEILGKITLATVKALNH 140

Query: 183 LHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG---Y 239
           L    + KI+H DIKP NILLD     K+ DFG++       G +   +      G   Y
Sbjct: 141 LKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGIS-------GQLVDSIAKTRDAGCRPY 191

Query: 240 IAPEVFSRNFGEV--SHKSDVYSFGMMIMEL 268
           +APE    +        +SDV+S G+ + EL
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYEL 222

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 92.3 bits (230), Expect = 2e-21
 Identities = 66/322 (20%), Positives = 104/322 (32%), Gaps = 100/322 (31%)

Query: 89  DKLGQGGFGGVYKGR----------------LLDD------FVNEVASISRTSHVNVVTL 126
             +G+GG G VY+                  L  D         E  +  R    +VV  
Sbjct: 40  RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP- 98

Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVY------NGDTSKPCQYLR------WEKMYEIVI 174
                       I++F   G ++  +Y      NG        LR        +   IV 
Sbjct: 99  ------------IHDF---GEIDGQLYVDMRLINGVDLA--AMLRRQGPLAPPRAVAIVR 141

Query: 175 GIAKGLEYLH-HGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGA 233
            I   L+  H  G      H D+KP NIL+  D    + DFG+A   T        L   
Sbjct: 142 QIGSALDAAHAAG----ATHRDVKPENILVSADDFAYLVDFGIASATTD-----EKLTQL 192

Query: 234 RGIIG---YIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGV-----DSSSEV 285
              +G   Y+APE FS      ++++D+Y+   ++ E +       +G      D  S  
Sbjct: 193 GNTVGTLYYMAPERFSE--SHATYRADIYALTCVLYECL-------TGSPPYQGDQLSV- 242

Query: 286 YFPHWIYRHVEQD----REFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
                +  H+ Q        + PG+    +  IA+ M           P DR       +
Sbjct: 243 -----MGAHINQAIPRPSTVR-PGIPVAFDAVIARGM--------AKNPEDRYV--TCGD 286

Query: 342 MLQGSTEALQIPPTPFLSSPPR 363
           +   +  AL        +   R
Sbjct: 287 LSAAAHAALATADQDRATDILR 308

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 91.7 bits (228), Expect = 4e-21
 Identities = 50/202 (24%), Positives = 92/202 (45%), Gaps = 38/202 (18%)

Query: 89  DKLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHVNVVTLLGFCL 131
           +KLG+G +G VYK                    L + + E++ + +    +VV   G   
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYF 94

Query: 132 EGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKI 191
           +  +  ++ E+   GS+   +         + L  +++  I+    KGLEYLH     + 
Sbjct: 95  KNTDLWIVMEYCGAGSVSDII-----RLRNKTLTEDEIATILQSTLKGLEYLH---FMRK 146

Query: 192 LHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG-IIG---YIAPEVFSR 247
           +H DIK  NILL+ +   K++DFG+A       G ++  +  R  +IG   ++APEV   
Sbjct: 147 IHRDIKAGNILLNTEGHAKLADFGVA-------GQLTDTMAKRNTVIGTPFWMAPEVIQE 199

Query: 248 NFGEVSHKSDVYSFGMMIMELV 269
                +  +D++S G+  +E+ 
Sbjct: 200 --IGYNCVADIWSLGITAIEMA 219

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 90.8 bits (226), Expect = 6e-21
 Identities = 52/218 (23%), Positives = 83/218 (38%), Gaps = 46/218 (21%)

Query: 73  KRYNFSDVKKLTN--SFKDKLGQGGFGGVYK---------------------GRLLDDFV 109
            R N           +    LG+G FG V K                      +     +
Sbjct: 10  GRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL 69

Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEK 168
            EV  + +  H N++ L     + ++  ++ E    G L ++ +     S        E 
Sbjct: 70  REVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS--------EH 121

Query: 169 M-YEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL---DEDFCPKISDFGLAKLCTTKE 224
               I+  +  G+ Y+H      I+H D+KP NILL   ++D   KI DFGL+     ++
Sbjct: 122 DAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQ 176

Query: 225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFG 262
              + +    G   YIAPEV    + E   K DV+S G
Sbjct: 177 N--TKMKDRIGTAYYIAPEVLRGTYDE---KCDVWSAG 209

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 92.2 bits (229), Expect = 7e-21
 Identities = 48/217 (22%), Positives = 77/217 (35%), Gaps = 44/217 (20%)

Query: 86  SFKDKLGQGGFGGVYKGR--------------------LLDDFVNEVASISRTSHVNVVT 125
              D LGQG    V++GR                     +D  + E   + + +H N+V 
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 126 LLGFCLEGNNRALIY---EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 182
           L     E           EF P GSL   +   +       L   +   ++  +  G+ +
Sbjct: 72  LFAI-EEETTTRHKVLIMEFCPCGSLYTVL---EEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 183 LHHGCSTKILHFDIKPHNILL----DEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG 238
           L       I+H +IKP NI+     D     K++DFG A+     E  VS      G   
Sbjct: 128 LR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY----GTEE 180

Query: 239 YIAPEVFSRNFGEVSH------KSDVYSFGMMIMELV 269
           Y+ P+++ R      H        D++S G+      
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA 217

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 91.7 bits (228), Expect = 2e-20
 Identities = 54/216 (25%), Positives = 79/216 (36%), Gaps = 55/216 (25%)

Query: 86  SFKDKLGQGGFGGVYKGR--------------------------------LLDDFVNEVA 113
               KLG G +G V   +                                  ++  NE++
Sbjct: 39  FKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEIS 98

Query: 114 SISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEKM-YE 171
            +    H N++ L     +     L+ EF   G L E+ +              E     
Sbjct: 99  LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFD--------ECDAAN 150

Query: 172 IVIGIAKGLEYLHHGCSTKILHFDIKPHNILL---DEDFCPKISDFGLAKLCTTKEGIVS 228
           I+  I  G+ YLH      I+H DIKP NILL   +     KI DFGL+   +    +  
Sbjct: 151 IMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD 207

Query: 229 SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMM 264
            L    G   YIAPEV  + + E   K DV+S G++
Sbjct: 208 RL----GTAYYIAPEVLKKKYNE---KCDVWSCGVI 236

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 89.2 bits (222), Expect = 2e-20
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 44/209 (21%)

Query: 89  DKLGQGGFGGVYKGRL--------------------LDDFVNEVASISRTS-HVNVVTLL 127
            +LG+G +G V K R                         + ++    RT      VT  
Sbjct: 13  MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72

Query: 128 GFCLEGNNRALIYEFMPNGSLEKF---VYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH 184
           G      +  +  E M + SL+KF   V +   + P   L      +I + I K LE+LH
Sbjct: 73  GALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILG-----KIAVSIVKALEHLH 126

Query: 185 HGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG---YIA 241
                 ++H D+KP N+L++     K+ DFG++       G +   +      G   Y+A
Sbjct: 127 S--KLSVIHRDVKPSNVLINALGQVKMCDFGIS-------GYLVDDVAKDIDAGCKPYMA 177

Query: 242 PEVFSRNFGEV--SHKSDVYSFGMMIMEL 268
           PE  +    +   S KSD++S G+ ++EL
Sbjct: 178 PERINPELNQKGYSVKSDIWSLGITMIEL 206

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 88.8 bits (221), Expect = 2e-20
 Identities = 54/230 (23%), Positives = 83/230 (36%), Gaps = 49/230 (21%)

Query: 64  IRNYGPLPLKRYNFSDVKKLTN--SFKDKLGQGGFGGVYKGRL----------------- 104
           + ++      R N      + +   FK KLG G FG V+                     
Sbjct: 1   MHHHHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS 60

Query: 105 ---LDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-----EKFVYNGD 156
              ++    E+  +    H N++ +     + +N  ++ E    G L             
Sbjct: 61  QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKA 120

Query: 157 TSKPCQYLRWEKM-YEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL---DEDFCPKIS 212
            S        E    E++  +   L Y H   S  ++H D+KP NIL          KI 
Sbjct: 121 LS--------EGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKII 169

Query: 213 DFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFG 262
           DFGLA+L  + E        A G   Y+APEVF R+      K D++S G
Sbjct: 170 DFGLAELFKSDE----HSTNAAGTALYMAPEVFKRDVTF---KCDIWSAG 212

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 89.0 bits (221), Expect = 4e-20
 Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 56/217 (25%)

Query: 89  DKLGQGGFGGVYKGR------------------LLDDFVNEVASISRTS-HVNVVTLLGF 129
           + +G G +G VYKGR                    ++   E+  + + S H N+ T  G 
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89

Query: 130 CLEGNNRA------LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG-----IAK 178
            ++ N         L+ EF   GS+   +         +  +   + E  I      I +
Sbjct: 90  FIKKNPPGMDDQLWLVMEFCGAGSVTDLI---------KNTKGNTLKEEWIAYICREILR 140

Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG-II 237
           GL +LH     K++H DIK  N+LL E+   K+ DFG++         +   +G R   I
Sbjct: 141 GLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS-------AQLDRTVGRRNTFI 190

Query: 238 G---YIAPEVFSRNFGEVS---HKSDVYSFGMMIMEL 268
           G   ++APEV + +    +    KSD++S G+  +E+
Sbjct: 191 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 89.0 bits (221), Expect = 4e-20
 Identities = 46/298 (15%), Positives = 103/298 (34%), Gaps = 84/298 (28%)

Query: 89  DKLGQGGFGGVYKGR--------------------LLDDFVNEVASISRTSH--VNVVTL 126
            ++G GG   V++                       LD + NE+A +++       ++ L
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG-----IAKGLE 181
             + +      ++ E   N  L  ++              + +           + + + 
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWLKKK-----------KSIDPWERKSYWKNMLEAVH 122

Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT--TKEGIVSSLLGARGIIGY 239
            +H      I+H D+KP N L+ +    K+ DFG+A      T   +  S +G    + Y
Sbjct: 123 TIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGT---VNY 175

Query: 240 IAPEVFSR---------NFGEVSHKSDVYSFGMMIMELV-------GCKNNLDSGVDSSS 283
           + PE             +  ++S KSDV+S G ++  +           N +        
Sbjct: 176 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK------ 229

Query: 284 EVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
                  ++  ++ + E + P +      +  + ++     C++  P  R  + E++ 
Sbjct: 230 -------LHAIIDPNHEIEFPDIP----EKDLQDVL---KCCLKRDPKQRISIPELLA 273

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 88.5 bits (220), Expect = 5e-20
 Identities = 45/296 (15%), Positives = 98/296 (33%), Gaps = 80/296 (27%)

Query: 89  DKLGQGGFGGVYKGR--------------------LLDDFVNEVASISRTSH--VNVVTL 126
            ++G GG   V++                       LD + NE+A +++       ++ L
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG-----IAKGLE 181
             + +      ++ E   N  L  ++              + +           + + + 
Sbjct: 94  YDYEITDQYIYMVMECG-NIDLNSWLKKK-----------KSIDPWERKSYWKNMLEAVH 141

Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
            +H      I+H D+KP N L+ +    K+ DFG+A         V       G + Y+ 
Sbjct: 142 TIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSV-VKDSQVGTVNYMP 196

Query: 242 PEVFSRNFGE---------VSHKSDVYSFGMMIMELV-------GCKNNLDSGVDSSSEV 285
           PE                 +S KSDV+S G ++  +           N +          
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-------- 248

Query: 286 YFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
                ++  ++ + E + P +      +  + ++     C++  P  R  + E++ 
Sbjct: 249 -----LHAIIDPNHEIEFPDIP----EKDLQDVL---KCCLKRDPKQRISIPELLA 292

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 89.0 bits (221), Expect = 5e-20
 Identities = 59/250 (23%), Positives = 96/250 (38%), Gaps = 59/250 (23%)

Query: 46  SAAVRRKITKSDKDLEAFIRNYGPLPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGR-- 103
             A  R  +  D D+        P  L    FSD++++        G G FG VY  R  
Sbjct: 29  MPAGGRAGSLKDPDVAELFFKDDPEKL----FSDLREI--------GHGSFGAVYFARDV 76

Query: 104 --------------------LLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM 143
                                  D + EV  + +  H N +   G  L  +   L+ E+ 
Sbjct: 77  RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC 136

Query: 144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL 203
              + +    +         L+  ++  +  G  +GL YLH   S  ++H D+K  NILL
Sbjct: 137 LGSASDLLEVHKKP------LQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILL 187

Query: 204 DEDFCPKISDFGLAKLCTTKEGIVSSLLGARG-IIG---YIAPEV-FSRNFGEVSHKSDV 258
            E    K+ DFG            +S++      +G   ++APEV  + + G+   K DV
Sbjct: 188 SEPGLVKLGDFG-----------SASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDV 236

Query: 259 YSFGMMIMEL 268
           +S G+  +EL
Sbjct: 237 WSLGITCIEL 246

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 89.7 bits (222), Expect = 1e-19
 Identities = 50/213 (23%), Positives = 85/213 (39%), Gaps = 43/213 (20%)

Query: 87  FKDKLGQGGFGGVYKGR--------------------LLDDFVNEVASISRTSHVNVVTL 126
            K++LG GGFG V +                        + +  E+  + + +H NVV+ 
Sbjct: 18  MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77

Query: 127 L------GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGL 180
                        +   L  E+   G L K++   +  + C  L+   +  ++  I+  L
Sbjct: 78  REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL---NQFENCCGLKEGPIRTLLSDISSAL 134

Query: 181 EYLHHGCSTKILHFDIKPHNILLD---EDFCPKISDFGLAKLCTTKEGIVSSLLGARGII 237
            YLH     +I+H D+KP NI+L    +    KI D G AK     E     +    G +
Sbjct: 135 RYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV----GTL 187

Query: 238 GYIAPEVFS-RNFGEVSHKSDVYSFGMMIMELV 269
            Y+APE+   + +       D +SFG +  E +
Sbjct: 188 QYLAPELLEQKKYTV---TVDYWSFGTLAFECI 217

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 86.5 bits (215), Expect = 1e-19
 Identities = 49/210 (23%), Positives = 79/210 (37%), Gaps = 56/210 (26%)

Query: 91  LGQGGFGGVY----------------------KGRLLDDFVNEVASISRTSHVNVVTLLG 128
           LG+G FG VY                      K  +      EV   S   H N++ L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76

Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
           +  +     LI E+ P G++ + +      +       ++    +  +A  L Y H   S
Sbjct: 77  YFHDATRVYLILEYAPLGTVYREL------QKLSKFDEQRTATYITELANALSYCH---S 127

Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAK---------LCTTKEGIVSSLLGARGIIGY 239
            +++H DIKP N+LL      KI+DFG +          LC T +              Y
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLD--------------Y 173

Query: 240 IAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
           + PE+          K D++S G++  E +
Sbjct: 174 LPPEMIEGR--MHDEKVDLWSLGVLCYEFL 201

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 86.4 bits (215), Expect = 2e-19
 Identities = 65/278 (23%), Positives = 109/278 (39%), Gaps = 61/278 (21%)

Query: 91  LGQGGFGGVY----------------------KGRLLDDFVNEVASISRTSHVNVVTLLG 128
           LG+G F GVY                      K  ++    NEV    +  H +++ L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 129 FCLEGNNRA-LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
              E +N   L+ E   NG + +++         +     +    +  I  G+ YLH   
Sbjct: 79  -YFEDSNYVYLVLEMCHNGEMNRYL-----KNRVKPFSENEARHFMHQIITGMLYLH--- 129

Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSR 247
           S  ILH D+   N+LL  +   KI+DFGLA           +L G      YI+PE+ +R
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGT---PNYISPEIATR 186

Query: 248 NFGEVSHKSDVYSFGMMIME-LVGCKNNL---DSGVDSSSEVYFPHWIYRHVEQDREFKL 303
           +      +SDV+S G M    L+G           V +             V    ++++
Sbjct: 187 S--AHGLESDVWSLGCMFYTLLIG---RPPFDTDTVKN---------TLNKVVL-ADYEM 231

Query: 304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
           P  ++ +    AK +I   L   +  P+DR  ++ V++
Sbjct: 232 PSFLSIE----AKDLIHQLL---RRNPADRLSLSSVLD 262

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 86.5 bits (215), Expect = 2e-19
 Identities = 41/200 (20%), Positives = 70/200 (35%), Gaps = 42/200 (21%)

Query: 87  FKDKLGQGGFGGVYKGRL-------------------LDDFVNEVASISRTSHVNVVTLL 127
            ++ +G+G +G V                        +D F  E+  +    H N++ L 
Sbjct: 13  LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLY 72

Query: 128 GFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEKM-YEIVIGIAKGLEYLHH 185
               +  +  L+ E    G L E+ V+             E     I+  +   + Y H 
Sbjct: 73  ETFEDNTDIYLVMELCTGGELFERVVHKRVFR--------ESDAARIMKDVLSAVAYCH- 123

Query: 186 GCSTKILHFDIKPHNILL---DEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAP 242
                + H D+KP N L      D   K+ DFGLA      +     +    G   Y++P
Sbjct: 124 --KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK----MMRTKVGTPYYVSP 177

Query: 243 EVFSRNFGEVSHKSDVYSFG 262
           +V    +G    + D +S G
Sbjct: 178 QVLEGLYGP---ECDEWSAG 194

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 87.3 bits (217), Expect = 2e-19
 Identities = 55/233 (23%), Positives = 86/233 (36%), Gaps = 66/233 (28%)

Query: 68  GPLPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYK-------------------------G 102
           G  P K+    D   +     ++LG G F  V K                         G
Sbjct: 1   GMEPFKQQKVEDFYDI----GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRG 56

Query: 103 RLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-----EKFVYNGDT 157
              ++   EV+ + +  H NV+TL        +  LI E +  G L     +K   +   
Sbjct: 57  VSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS--- 113

Query: 158 SKPCQYLRWEKMYEIVIG-IAKGLEYLHHGCSTKILHFDIKPHNILL---DEDFCP-KIS 212
                    E+     I  I  G+ YLH   + KI HFD+KP NI+L   +      K+ 
Sbjct: 114 ---------EEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLI 161

Query: 213 DFGLAKLCTTKEGIVSSLLGARGIIG---YIAPEVFSRNFGEVSHKSDVYSFG 262
           DFGLA                + I G   ++APE+ +     +  ++D++S G
Sbjct: 162 DFGLAHEIEDGVEF-------KNIFGTPEFVAPEIVNYEP--LGLEADMWSIG 205

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 87.0 bits (216), Expect = 2e-19
 Identities = 45/207 (21%), Positives = 76/207 (36%), Gaps = 42/207 (20%)

Query: 89  DKLGQGGFGGVYKGRL--------------------LDDFVNEVASISRTS-HVNVVTLL 127
            ++G G  G V+K R                         + ++  + ++     +V   
Sbjct: 31  GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCF 90

Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
           G  +   +  +  E M     EK         P + L      ++ + I K L YL    
Sbjct: 91  GTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILG-----KMTVAIVKALYYLKE-- 142

Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG---YIAPEV 244
              ++H D+KP NILLDE    K+ DFG++       G +          G   Y+APE 
Sbjct: 143 KHGVIHRDVKPSNILLDERGQIKLCDFGIS-------GRLVDDKAKDRSAGCAAYMAPER 195

Query: 245 FSRNFGEV---SHKSDVYSFGMMIMEL 268
                        ++DV+S G+ ++EL
Sbjct: 196 IDPPDPTKPDYDIRADVWSLGISLVEL 222

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 87.8 bits (217), Expect = 2e-19
 Identities = 34/332 (10%), Positives = 85/332 (25%), Gaps = 87/332 (26%)

Query: 91  LGQGGFGGVYKGR----------------------LLDDFVNEVASISRTSHV------- 121
           LGQ       +                         +     EV  +     +       
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 122 ---------NVVTLLGFCLEGN-----------NRALIYEFMPNGSLEKFVYNGDTSKPC 161
                    ++V                     +R  +Y  M +            S   
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 162 QYLRWEKMYEIVIGIAKGLEYLH-HGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
           + L      ++ + + + L  LH +G    ++H  ++P +I+LD+     ++ F      
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 221 -TTKEGIVSSLLGARGIIGYIAPEVFSR---NFGEVSHKSDVYSFGMMIMELVGCKNNLD 276
             +    +             A  +      +   ++   D ++ G+ I  +        
Sbjct: 262 GASAVSPIGRGFAPP---ETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW------- 311

Query: 277 SGV---DSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDR 333
                    + +    WI+R  +      +P        +  + ++      ++    DR
Sbjct: 312 CADLPNTDDAALGGSEWIFRSCKN-----IP--------QPVRALL---EGFLRYPKEDR 355

Query: 334 PPMNEVIEMLQGSTEALQIPPTPFLSSPPRAP 365
               + +E  +      ++     L      P
Sbjct: 356 LLPLQAMETPEYEQLRTELSAALPLYQTDGEP 387

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 87.2 bits (216), Expect = 3e-19
 Identities = 47/298 (15%), Positives = 102/298 (34%), Gaps = 84/298 (28%)

Query: 89  DKLGQGGFGGVYKGR--------------------LLDDFVNEVASISRTSH--VNVVTL 126
            ++G GG   V++                       LD + NE+A +++       ++ L
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG-----IAKGLE 181
             + +      ++ E   N  L  ++              + +           + + + 
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKK-----------KSIDPWERKSYWKNMLEAVH 169

Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL--CTTKEGIVSSLLGARGIIGY 239
            +H      I+H D+KP N L+ +    K+ DFG+A      T   +  S +GA   + Y
Sbjct: 170 TIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGA---VNY 222

Query: 240 IAPEVFSRNFGE---------VSHKSDVYSFGMMIMELV-------GCKNNLDSGVDSSS 283
           + PE                 +S KSDV+S G ++  +           N +        
Sbjct: 223 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK------ 276

Query: 284 EVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
                  ++  ++ + E + P +      +  + ++     C++  P  R  + E++ 
Sbjct: 277 -------LHAIIDPNHEIEFPDIP----EKDLQDVL---KCCLKRDPKQRISIPELLA 320

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 86.8 bits (215), Expect = 3e-19
 Identities = 50/237 (21%), Positives = 72/237 (30%), Gaps = 64/237 (27%)

Query: 87  FKDKLGQGGFGGVYKGR------------------------LLDDFVNEVASISRTSHVN 122
            K  +GQG +G V                             ++    EV  + +  H N
Sbjct: 30  LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89

Query: 123 VVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEKMY----------- 170
           +  L     +     L+ E    G L +K     D S     +   K             
Sbjct: 90  IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149

Query: 171 ----------------------EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL--DED 206
                                  I+  I   L YLH   +  I H DIKP N L   ++ 
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKS 206

Query: 207 FCPKISDFGLAKLCT-TKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFG 262
           F  K+ DFGL+K       G    +    G   ++APEV +        K D +S G
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 87.0 bits (215), Expect = 4e-19
 Identities = 31/248 (12%), Positives = 81/248 (32%), Gaps = 47/248 (18%)

Query: 108 FVNEVASISRTSHVNVVTLLGFCLEGN--NRALIYEFMPNGSLEKFVYNGDTSKPCQYLR 165
           F+     +       ++ +     +    +R  +Y  M +            S   + L 
Sbjct: 145 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLV 204

Query: 166 WEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG 225
                ++ + + + L  LH      ++H  ++P +I+LD+     ++ F        ++G
Sbjct: 205 HHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV----RDG 257

Query: 226 IVSSLLGARGIIGYIAPEVFSRNFGE---------VSHKSDVYSFGMMIMELVGCKNNLD 276
                  +R   G+  PE+ +R             ++   D ++ G++I  +        
Sbjct: 258 ARVVSSVSR---GFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW------- 307

Query: 277 SGV---DSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDR 333
                    + +    WI+R  +      +P        +  + ++      ++    DR
Sbjct: 308 CADLPITKDAALGGSEWIFRSCKN-----IP--------QPVRALL---EGFLRYPKEDR 351

Query: 334 PPMNEVIE 341
               + +E
Sbjct: 352 LLPLQAME 359

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 86.3 bits (214), Expect = 5e-19
 Identities = 55/241 (22%), Positives = 96/241 (39%), Gaps = 51/241 (21%)

Query: 50  RRKITKSDKDLEAFIRNYGPLPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYK------GR 103
           R      D        ++  +  K+   +    ++    + LG G FG V+K      G 
Sbjct: 58  RTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSK--TEILGGGRFGQVHKCEETATGL 115

Query: 104 LL-------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-- 148
            L             ++  NE++ +++  H N++ L       N+  L+ E++  G L  
Sbjct: 116 KLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFD 175

Query: 149 ----EKFVYNGDTSKPCQYLRWEKM-YEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL 203
               E +               E      +  I +G+ ++H      ILH D+KP NIL 
Sbjct: 176 RIIDESYNLT------------ELDTILFMKQICEGIRHMH---QMYILHLDLKPENILC 220

Query: 204 --DEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSF 261
              +    KI DFGLA+    +E +  +     G   ++APEV + +F  VS  +D++S 
Sbjct: 221 VNRDAKQIKIIDFGLARRYKPREKLKVNF----GTPEFLAPEVVNYDF--VSFPTDMWSV 274

Query: 262 G 262
           G
Sbjct: 275 G 275

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 85.8 bits (212), Expect = 7e-19
 Identities = 32/217 (14%), Positives = 62/217 (28%), Gaps = 42/217 (19%)

Query: 87  FKDKLGQGGFGGVYKGRLLDDF------------------------VNEVASISRTSHVN 122
               LG+G F  VY+    D                             +  +  +    
Sbjct: 69  VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM 128

Query: 123 VVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 182
            +      L  N   L+ E    G+L     N   + P + +    +    + +   +E 
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLN-AINLYKNTPEKVMPQGLVISFAMRMLYMIEQ 187

Query: 183 LHHGCSTKILHFDIKPHNILLDEDFCP-----------KISDFGLAKLCTTKEGIVSSLL 231
           +H     +I+H DIKP N +L   F              + D G +          +   
Sbjct: 188 VH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI-DMKLFPKGTIFT 243

Query: 232 GARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMEL 268
                 G+   E+ S      +++ D +     +  +
Sbjct: 244 AKCETSGFQCVEMLSNK--PWNYQIDYFGVAATVYCM 278

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 85.0 bits (211), Expect = 9e-19
 Identities = 47/229 (20%), Positives = 85/229 (37%), Gaps = 52/229 (22%)

Query: 72  LKRYNFSDVKKLTNSFKDKLGQGGFGGVYKG----------------RLLDDFVNEVASI 115
           +K   F     L +     LG+G F    K                 R+  +   E+ ++
Sbjct: 1   MKDSPFYQHYDL-DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITAL 59

Query: 116 SRTS-HVNVVTLLGFCLEGNNRALIYEFMPNGSL-----EKFVYNGDTSKPCQYLRWEKM 169
                H N+V L     +  +  L+ E +  G L     +K  ++            E  
Sbjct: 60  KLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFS------------ETE 107

Query: 170 -YEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL---DEDFCPKISDFGLAKLCTTKEG 225
              I+  +   + ++H      ++H D+KP N+L    +++   KI DFG A+L      
Sbjct: 108 ASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164

Query: 226 IVSSLLGARGIIGYIAPEVFSRNF-GEVSHKSDVYSFG--MMIMELVGC 271
            + +       + Y APE+ ++N   E     D++S G  +  M L G 
Sbjct: 165 PLKTPCFT---LHYAAPELLNQNGYDE---SCDLWSLGVILYTM-LSGQ 206

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 84.8 bits (210), Expect = 2e-18
 Identities = 49/216 (22%), Positives = 82/216 (37%), Gaps = 43/216 (19%)

Query: 90  KLGQGGFGGVYKGR----------------------------------LLDDFVNEVASI 115
            L QG F  +                                        DDF NE+  I
Sbjct: 38  TLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 116 SRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEKMY-EIV 173
           +   +   +T  G     +   +IYE+M N S+ +   Y     K        ++   I+
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157

Query: 174 IGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGA 233
             +     Y+H+     I H D+KP NIL+D++   K+SDFG ++    K+     + G+
Sbjct: 158 KSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK-----IKGS 210

Query: 234 RGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
           RG   ++ PE FS        K D++S G+ +  + 
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMF 246

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 84.3 bits (209), Expect = 2e-18
 Identities = 50/212 (23%), Positives = 79/212 (37%), Gaps = 56/212 (26%)

Query: 86  SFKDKLGQGGFGGVYK-------------------------GRLLDDFVNEVASISRTSH 120
              ++LG G F  V K                         G   ++   EV+ + +  H
Sbjct: 15  DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74

Query: 121 VNVVTLLGFCLEGNNRALIYEFMPNGSL-----EKFVYNGDTSKPCQYLRWEKMYEIVIG 175
            N++TL        +  LI E +  G L     +K   +            E+     I 
Sbjct: 75  PNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS------------EEEATSFIK 122

Query: 176 -IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP----KISDFGLAKLCTTKEGIVSSL 230
            I  G+ YLH   + KI HFD+KP NI+L +   P    K+ DFGLA             
Sbjct: 123 QILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV----EF 175

Query: 231 LGARGIIGYIAPEVFSRNFGEVSHKSDVYSFG 262
               G   ++APE+ +     +  ++D++S G
Sbjct: 176 KNIFGTPEFVAPEIVNYEP--LGLEADMWSIG 205

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 83.0 bits (206), Expect = 2e-18
 Identities = 44/207 (21%), Positives = 78/207 (37%), Gaps = 53/207 (25%)

Query: 87  FKDKLGQGGFGGVYK---------------------GRLLDDFVNEVASISRTSHVNVVT 125
            K++LG+G F  V +                      R       E     +  H N+V 
Sbjct: 10  VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 69

Query: 126 LLGFCLEGNNRALIYEFMPNGSL-----EKFVYNGDTSKPCQYLRWEKM-YEIVIGIAKG 179
           L     E +   L+++ +  G L      +  Y+            E      +  I + 
Sbjct: 70  LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYS------------EADASHCIQQILES 117

Query: 180 LEYLHHGCSTKILHFDIKPHNILL---DEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI 236
           + Y H   S  I+H ++KP N+LL    +    K++DFGLA      +    +  G  G 
Sbjct: 118 IAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDS--EAWHGFAGT 170

Query: 237 IGYIAPEVFSRN-FGEVSHKSDVYSFG 262
            GY++PEV  ++ + +     D+++ G
Sbjct: 171 PGYLSPEVLKKDPYSK---PVDIWACG 194

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 83.9 bits (208), Expect = 3e-18
 Identities = 44/207 (21%), Positives = 78/207 (37%), Gaps = 53/207 (25%)

Query: 87  FKDKLGQGGFGGVYK---------------------GRLLDDFVNEVASISRTSHVNVVT 125
            K++LG+G F  V +                      R       E     +  H N+V 
Sbjct: 33  VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92

Query: 126 LLGFCLEGNNRALIYEFMPNGSL-----EKFVYNGDTSKPCQYLRWEKM-YEIVIGIAKG 179
           L     E +   L+++ +  G L      +  Y+            E      +  I + 
Sbjct: 93  LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYS------------EADASHCIQQILES 140

Query: 180 LEYLHHGCSTKILHFDIKPHNILL---DEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI 236
           + Y H   S  I+H ++KP N+LL    +    K++DFGLA      +    +  G  G 
Sbjct: 141 IAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDS--EAWHGFAGT 193

Query: 237 IGYIAPEVFSRN-FGEVSHKSDVYSFG 262
            GY++PEV  ++ + +     D+++ G
Sbjct: 194 PGYLSPEVLKKDPYSK---PVDIWACG 217

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 84.0 bits (208), Expect = 4e-18
 Identities = 56/243 (23%), Positives = 92/243 (37%), Gaps = 55/243 (22%)

Query: 50  RRKITKSDKDLEAFIRNYGPLP--LKRYNFSDVKKLTNSFKDKLGQGGFGGVYK------ 101
             KI   DK  E   + Y P P  +K+ +  D         ++LG G FG V++      
Sbjct: 20  GPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDY----YDILEELGSGAFGVVHRCVEKAT 75

Query: 102 GRLL-------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL 148
           GR+                  NE++ +++  H  ++ L     +     LI EF+  G L
Sbjct: 76  GRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL 135

Query: 149 ------EKFVYNGDTSKPCQYLRWEKMYEIVIG-IAKGLEYLHHGCSTKILHFDIKPHNI 201
                 E +  +            E      +    +GL+++H      I+H DIKP NI
Sbjct: 136 FDRIAAEDYKMS------------EAEVINYMRQACEGLKHMH---EHSIVHLDIKPENI 180

Query: 202 LL--DEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVY 259
           +    +    KI DFGLA      E +  +         + APE+  R    V   +D++
Sbjct: 181 MCETKKASSVKIIDFGLATKLNPDEIVKVTT----ATAEFAAPEIVDREP--VGFYTDMW 234

Query: 260 SFG 262
           + G
Sbjct: 235 AIG 237

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 83.1 bits (206), Expect = 4e-18
 Identities = 47/207 (22%), Positives = 75/207 (36%), Gaps = 54/207 (26%)

Query: 86  SFKDKLGQGGFGGVY------------------KGRLLDDFVNEVASISRTSHVNVVTLL 127
              + LG+G FG V+                  KG        E++ ++   H N++ L 
Sbjct: 8   MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLH 67

Query: 128 GFCLEGNNRALIYEFMPNGSL------EKFVYNGDTSKPCQYLRWEKM-YEIVIGIAKGL 180
                     +I+EF+    +        F  N            E+     V  + + L
Sbjct: 68  ESFESMEELVMIFEFISGLDIFERINTSAFELN------------EREIVSYVHQVCEAL 115

Query: 181 EYLHHGCSTKILHFDIKPHNILL--DEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG 238
           ++LH   S  I HFDI+P NI+         KI +FG A+     +         R +  
Sbjct: 116 QFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF-------RLLFT 165

Query: 239 ---YIAPEVFSRNFGEVSHKSDVYSFG 262
              Y APEV   +   VS  +D++S G
Sbjct: 166 APEYYAPEVHQHDV--VSTATDMWSLG 190

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 84.5 bits (209), Expect = 5e-18
 Identities = 48/205 (23%), Positives = 76/205 (37%), Gaps = 49/205 (23%)

Query: 86  SFKDKLGQGGFGGVYK------GRLL-------------DDFVNEVASISRTSHVNVVTL 126
              ++LG G FG V++      G                +    E+ ++S   H  +V L
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 219

Query: 127 LGFCLEGNNRALIYEFMPNGSL------EKFVYNGDTSKPCQYLRWEKM-YEIVIGIAKG 179
                + N   +IYEFM  G L      E    +            E    E +  + KG
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMS------------EDEAVEYMRQVCKG 267

Query: 180 LEYLHHGCSTKILHFDIKPHNILL--DEDFCPKISDFGLAKLCTTKEGIVSSLLGARGII 237
           L ++H       +H D+KP NI+         K+ DFGL      K+ +  +     G  
Sbjct: 268 LCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT----GTA 320

Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFG 262
            + APEV       V + +D++S G
Sbjct: 321 EFAAPEVA--EGKPVGYYTDMWSVG 343

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 83.3 bits (206), Expect = 5e-18
 Identities = 52/314 (16%), Positives = 102/314 (32%), Gaps = 66/314 (21%)

Query: 90  KLGQGGFGGVYKGR-------------------LLDDFVNEVASISR-TSHVNVVTLLGF 129
            L +GGF  VY+ +                        + EV  + + + H N+V     
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 130 CLEGNNRA-------LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 182
              G   +       L+   +  G L +F+      +    L  + + +I     + +++
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKK---MESRGPLSCDTVLKIFYQTCRAVQH 151

Query: 183 LHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI------ 236
           +H      I+H D+K  N+LL      K+ DFG A   +       S      +      
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210

Query: 237 ---IGYIAPEVFSRNFGE-VSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIY 292
                Y  PE+        +  K D+++ G ++  L                 +  H   
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLL----------------CFRQHPFE 254

Query: 293 RHVE---QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA 349
              +    + ++ +P      +  +   +I      +Q  P +R  + EV+  LQ    A
Sbjct: 255 DGAKLRIVNGKYSIP--PHDTQYTVFHSLIR---AMLQVNPEERLSIAEVVHQLQEIAAA 309

Query: 350 LQI-PPTPFLSSPP 362
             + P +P      
Sbjct: 310 RNVNPKSPITELLE 323

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 83.1 bits (206), Expect = 5e-18
 Identities = 43/205 (20%), Positives = 69/205 (33%), Gaps = 41/205 (20%)

Query: 87  FKDKLGQGGFGGVYK------------------------GRLLDDFVNEVASISRTSHVN 122
             + +G+G F  V +                        G   +D   E +      H +
Sbjct: 28  LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87

Query: 123 VVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEKM-YEIVIGIAKGL 180
           +V LL          +++EFM    L  + V          Y   E +    +  I + L
Sbjct: 88  IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRA--DAGFVYS--EAVASHYMRQILEAL 143

Query: 181 EYLHHGCSTKILHFDIKPHNILL---DEDFCPKISDFGLAKLCTTKEGIVSSLLGARGII 237
            Y H      I+H D+KPH +LL   +     K+  FG+A        +    +G     
Sbjct: 144 RYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGT---P 197

Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFG 262
            ++APEV  R         DV+  G
Sbjct: 198 HFMAPEVVKRE--PYGKPVDVWGCG 220

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 82.2 bits (204), Expect = 6e-18
 Identities = 50/201 (24%), Positives = 86/201 (42%), Gaps = 44/201 (21%)

Query: 87  FKDKLGQGGFGGVYKG----------------RLL---DDFVNEVASISRTSHVNVVTLL 127
           F + LG G F  V+                            NE+A + +  H N+VTL 
Sbjct: 13  FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72

Query: 128 GFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEKM-YEIVIGIAKGLEYLHH 185
                  +  L+ + +  G L ++ +  G  +        EK    ++  +   ++YLH 
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDRILERGVYT--------EKDASLVIQQVLSAVKYLH- 123

Query: 186 GCSTKILHFDIKPHNILL---DEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAP 242
                I+H D+KP N+L    +E+    I+DFGL+K+   + GI+S+  G     GY+AP
Sbjct: 124 --ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM--EQNGIMSTACGT---PGYVAP 176

Query: 243 EVFSRN-FGEVSHKSDVYSFG 262
           EV ++  + +     D +S G
Sbjct: 177 EVLAQKPYSK---AVDCWSIG 194

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 81.8 bits (203), Expect = 6e-18
 Identities = 49/215 (22%), Positives = 77/215 (35%), Gaps = 62/215 (28%)

Query: 86  SFKDKLGQGGFGGVYK-------------------------GRLLDDFVNEVASISRTSH 120
              ++LG G F  V K                         G   ++   EV  +    H
Sbjct: 8   EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67

Query: 121 VNVVTLLGFCLEGNNRALIYEFMPNGSL-----EKFVYNGDTSKPCQYLRWEKM-YEIVI 174
            N++TL        +  LI E +  G L     EK                E    + + 
Sbjct: 68  PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLT------------EDEATQFLK 115

Query: 175 GIAKGLEYLHHGCSTKILHFDIKPHNILL----DEDFCPKISDFGLAKLCTTKEGIVSSL 230
            I  G+ YLH   S +I HFD+KP NI+L      +   K+ DFG+A             
Sbjct: 116 QILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---- 168

Query: 231 LGARGIIG---YIAPEVFSRNFGEVSHKSDVYSFG 262
              + I G   ++APE+ +     +  ++D++S G
Sbjct: 169 ---KNIFGTPEFVAPEIVNYEP--LGLEADMWSIG 198

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 82.4 bits (204), Expect = 1e-17
 Identities = 50/203 (24%), Positives = 78/203 (38%), Gaps = 49/203 (24%)

Query: 87  FKDKLGQGGFGGVY-----------------KGRLLDDFVNEVASISRTSHVNVVTLLGF 129
            + +LG+G    VY                 K         E+  + R SH N++ L   
Sbjct: 57  VESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEI 116

Query: 130 CLEGNNRALIYEFMPNGSL-----EKFVYNGDTSKPCQYLRWEKM-YEIVIGIAKGLEYL 183
                  +L+ E +  G L     EK  Y+            E+   + V  I + + YL
Sbjct: 117 FETPTEISLVLELVTGGELFDRIVEKGYYS------------ERDAADAVKQILEAVAYL 164

Query: 184 HHGCSTKILHFDIKPHNILL---DEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYI 240
           H      I+H D+KP N+L      D   KI+DFGL+K+   +      +    G  GY 
Sbjct: 165 H---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQ--VLMKTVCGTPGYC 217

Query: 241 APEVFSR-NFGEVSHKSDVYSFG 262
           APE+     +G    + D++S G
Sbjct: 218 APEILRGCAYGP---EVDMWSVG 237

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 81.5 bits (202), Expect = 2e-17
 Identities = 56/230 (24%), Positives = 82/230 (35%), Gaps = 66/230 (28%)

Query: 71  PLKRYNFSDVKKLTNSFKDKLGQGGFGGVYK-------------------------GRLL 105
             ++ N  D         ++LG G F  V K                         G   
Sbjct: 3   VFRQENVDDYYDT----GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR 58

Query: 106 DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-----EKFVYNGDTSKP 160
           +D   EV+ +    H NV+TL        +  LI E +  G L     EK          
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLT------ 112

Query: 161 CQYLRWEKM-YEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL----DEDFCPKISDFG 215
                 E+   E +  I  G+ YLH   S +I HFD+KP NI+L          KI DFG
Sbjct: 113 ------EEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163

Query: 216 LAKLCTTKEGIVSSLLGARGIIG---YIAPEVFSRNFGEVSHKSDVYSFG 262
           LA                + I G   ++APE+ +     +  ++D++S G
Sbjct: 164 LAHKIDFGNEF-------KNIFGTPEFVAPEIVNYEP--LGLEADMWSIG 204

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 40/208 (19%), Positives = 74/208 (35%), Gaps = 52/208 (25%)

Query: 86  SFKDKLGQGGFGGVYKGRL---------------------LDDFVNEVASISRTSHVNVV 124
              ++LG+G F  V +                              E        H N+V
Sbjct: 14  QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIV 73

Query: 125 TLLGFCLEGNNRALIYEFMPNGSL-----EKFVYNGDTSKPCQYLRWEKM-YEIVIGIAK 178
            L     E  +  LI++ +  G L      +  Y+            E      +  I +
Sbjct: 74  RLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYS------------EADASHCIQQILE 121

Query: 179 GLEYLHHGCSTKILHFDIKPHNILL---DEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
            + + H      ++H ++KP N+LL    +    K++DFGLA     ++       G   
Sbjct: 122 AVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGT-- 176

Query: 236 IIGYIAPEVFSRN-FGEVSHKSDVYSFG 262
             GY++PEV  ++ +G+     D+++ G
Sbjct: 177 -PGYLSPEVLRKDPYGK---PVDLWACG 200

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 80.8 bits (200), Expect = 2e-17
 Identities = 51/226 (22%), Positives = 83/226 (36%), Gaps = 61/226 (26%)

Query: 87  FKDKLGQGGFGGVYKGR----------------------------LLDDFVNEVASISRT 118
            K+ LG+G    V +                              L +  + EV  + + 
Sbjct: 21  PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80

Query: 119 S-HVNVVTLLGFCLEGNNRALIYEFMPNGSL-----EKFVYN-GDTSKPCQYLRWEKMYE 171
           S H N++ L           L+++ M  G L     EK   +  +T K            
Sbjct: 81  SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK------------ 128

Query: 172 IVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLL 231
           I+  + + +  LH      I+H D+KP NILLD+D   K++DFG +       G    L 
Sbjct: 129 IMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPG--EKLR 181

Query: 232 GARGIIGYIAPEVFSRNFGEVSH----KSDVYSFG--MMIMELVGC 271
              G   Y+APE+   +  +       + D++S G  M  + L G 
Sbjct: 182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTL-LAGS 226

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 58/221 (26%), Positives = 90/221 (40%), Gaps = 64/221 (28%)

Query: 89  DKLGQGGFGGVYKGRLLDDFVNEVA---------------SISRT-SHVNVVTLLGFCLE 132
             +G G FG V++ +L++   +EVA                I R   H NVV L  F   
Sbjct: 46  KVIGNGSFGVVFQAKLVES--DEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYS 103

Query: 133 GNNRA------LIYEFMPNGSLEKFVYNGDTSKP------CQYLRWEKMYEIVIGIAKGL 180
             ++       L+ E++P  ++ +   +    K        +      MY++     + L
Sbjct: 104 NGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLY----MYQL----LRSL 154

Query: 181 EYLHHGCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
            Y+H   S  I H DIKP N+LLD      K+ DFG AK+    E  VS          Y
Sbjct: 155 AYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS----------Y 201

Query: 240 I------APEVFSRNFG--EVSHKSDVYSFGMMIMELVGCK 272
           I      APE+    FG    +   D++S G ++ EL+  +
Sbjct: 202 ICSRYYRAPELI---FGATNYTTNIDIWSTGCVMAELMQGQ 239

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 82.1 bits (203), Expect = 2e-17
 Identities = 58/220 (26%), Positives = 90/220 (40%), Gaps = 61/220 (27%)

Query: 89  DKLGQGGFGGVYKGRLLDD--------------FVN-EVASISRTSHVNVVTLLGFCLEG 133
             +G G FG VY+ +L D               F N E+  + +  H N+V L  F    
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSS 119

Query: 134 NNRA------LIYEFMPNGSLEKFVYNGDTSKP------CQYLRWEKMYEIVIGIAKGLE 181
             +       L+ +++P  ++ +   +   +K        +      MY++     + L 
Sbjct: 120 GEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLY----MYQL----FRSLA 170

Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIGYI 240
           Y+H   S  I H DIKP N+LLD D    K+ DFG AK     E  VS          YI
Sbjct: 171 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS----------YI 217

Query: 241 ------APEVFSRNFG--EVSHKSDVYSFGMMIMELVGCK 272
                 APE+    FG  + +   DV+S G ++ EL+  +
Sbjct: 218 CSRYYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 254

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 80.8 bits (200), Expect = 3e-17
 Identities = 59/233 (25%), Positives = 88/233 (37%), Gaps = 57/233 (24%)

Query: 76  NFSDVKKLTNSFKDKLGQGGFGGVY-------------------KGRLLDDFVNEVASIS 116
            F DV +L    +D LG+G    V                     G +      EV  + 
Sbjct: 9   RFEDVYQLQ---EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLY 65

Query: 117 R-TSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-----EKFVYNGDTSKPCQYLRWEKM- 169
           +   H NV+ L+ F  E +   L++E M  GS+     ++  +N            E   
Sbjct: 66  QCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFN------------ELEA 113

Query: 170 YEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL---DEDFCPKISDFGLAKLC----TT 222
             +V  +A  L++LH   +  I H D+KP NIL    ++    KI DF L          
Sbjct: 114 SVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170

Query: 223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSH---KSDVYSFG--MMIMELVG 270
                  LL   G   Y+APEV      E S    + D++S G  + I+ L G
Sbjct: 171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYIL-LSG 222

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 79.6 bits (197), Expect = 7e-17
 Identities = 45/234 (19%), Positives = 86/234 (36%), Gaps = 49/234 (20%)

Query: 58  KDLEAFIRNYGPLPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGR-------------- 103
                 +           NF++   LT     +LG+G F  V +                
Sbjct: 7   HSSGVDLGTENLYFQSMENFNNFYILT---SKELGRGKFAVVRQCISKSTGQEYAAKFLK 63

Query: 104 -------LLDDFVNEVASISRTSHV-NVVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYN 154
                     + ++E+A +        V+ L       +   LI E+   G +    +  
Sbjct: 64  KRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCL-- 121

Query: 155 GDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL---DEDFCPKI 211
               +  + +    +  ++  I +G+ YLH      I+H D+KP NILL         KI
Sbjct: 122 ---PELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKI 175

Query: 212 SDFGLAKLCTTKEGIVSSLLGARGIIG---YIAPEVFSRNFGEVSHKSDVYSFG 262
            DFG+++       +       R I+G   Y+APE+ + +   ++  +D+++ G
Sbjct: 176 VDFGMSRKIGHACEL-------REIMGTPEYLAPEILNYDP--ITTATDMWNIG 220

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 79.4 bits (196), Expect = 1e-16
 Identities = 42/214 (19%), Positives = 81/214 (37%), Gaps = 57/214 (26%)

Query: 87  FKDKLGQGGFGGVYKGR---------------------------LLDDFVNEVASISRTS 119
            KD +G+G    V +                             + +    E   + + +
Sbjct: 98  PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157

Query: 120 -HVNVVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNG-----DTSKPCQYLRWEKMYEI 172
            H +++TL+      +   L+++ M  G L +           +T              I
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRS------------I 205

Query: 173 VIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLG 232
           +  + + + +LH   +  I+H D+KP NILLD++   ++SDFG +     + G    L  
Sbjct: 206 MRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL--EPG--EKLRE 258

Query: 233 ARGIIGYIAPEVFSRNFGEV----SHKSDVYSFG 262
             G  GY+APE+   +  E       + D+++ G
Sbjct: 259 LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACG 292

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 78.4 bits (194), Expect = 1e-16
 Identities = 45/210 (21%), Positives = 75/210 (35%), Gaps = 56/210 (26%)

Query: 91  LGQGGFGGVY----------------------KGRLLDDFVNEVASISRTSHVNVVTLLG 128
           LG+G FG VY                      K  +      E+   S   H N++ +  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
           +  +     L+ EF P G L K +      +       ++    +  +A  L Y H    
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKEL------QKHGRFDEQRSATFMEELADALHYCH---E 132

Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAK---------LCTTKEGIVSSLLGARGIIGY 239
            K++H DIKP N+L+      KI+DFG +          +C T +              Y
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLD--------------Y 178

Query: 240 IAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
           + PE+          K D++  G++  E +
Sbjct: 179 LPPEMIEGK--THDEKVDLWCAGVLCYEFL 206

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 76.3 bits (188), Expect = 5e-16
 Identities = 34/301 (11%), Positives = 71/301 (23%), Gaps = 78/301 (25%)

Query: 89  DKLGQGGFGGVYKGR--LLD--------------------DFVNEVASISRTSHVNVVTL 126
              G       ++     LD                    + ++    +SR     V  +
Sbjct: 37  IFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96

Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH-H 185
           L          ++ E++  GSL++                      +  +A   +  H  
Sbjct: 97  LDVVHTRAGGLVVAEWIRGGSLQEVADTS--------PSPVGAIRAMQSLAAAADAAHRA 148

Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVF 245
           G    +      P  + +  D        G   L                    +     
Sbjct: 149 G----VALSIDHPSRVRVSID--------GDVVL---------------AYPATMPD--- 178

Query: 246 SRNFGEVSHKSDVYSFGMMIMELV-GCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
                  + + D+   G  +  L+       ++GV S           R          P
Sbjct: 179 ------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP-----AERDTAGQ-----P 222

Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQIPPTPFLSSPPRA 364
                 + +I  ++  V    +Q     R     +  M Q +  A +      +   P +
Sbjct: 223 IEPADIDRDIPFQISAVAARSVQGDGGIRSASTLLNLMQQATAVADRTEVLGPIDEAPVS 282

Query: 365 P 365
            
Sbjct: 283 A 283

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 77.3 bits (191), Expect = 5e-16
 Identities = 43/184 (23%), Positives = 73/184 (39%), Gaps = 36/184 (19%)

Query: 87  FKDKLGQGGFGGVYKG---------------RLLDDFVNEVASISRTS-HVNVVTLLGFC 130
            K+ +G G +    +                +   D   E+  + R   H N++TL    
Sbjct: 26  VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVY 85

Query: 131 LEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEKM-YEIVIGIAKGLEYLHHGCS 188
            +G    ++ E M  G L +K +     S        E+    ++  I K +EYLH   +
Sbjct: 86  DDGKYVYVVTELMKGGELLDKILRQKFFS--------EREASAVLFTITKTVEYLH---A 134

Query: 189 TKILHFDIKPHNILL---DEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV 244
             ++H D+KP NIL      +    +I DFG AK    + G++ +         ++APEV
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYT---ANFVAPEV 191

Query: 245 FSRN 248
             R 
Sbjct: 192 LERQ 195

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 77.3 bits (191), Expect = 6e-16
 Identities = 48/239 (20%), Positives = 86/239 (35%), Gaps = 65/239 (27%)

Query: 76  NFSDVKKLTNSFKD--KLGQGGFGGVYKGRLLDDFVNEVASI------------------ 115
                +K  + F+     GQG FG V  G+          +I                  
Sbjct: 14  ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKST--GMSVAIKKVIQDPRFRNRELQIMQ 71

Query: 116 --SRTSHVNVVTLLGFCLEGNNRA-------LIYEFMPNGSLEKFVYNGDTSKP------ 160
             +   H N+V L  +      R        ++ E++P+ +L +   N    +       
Sbjct: 72  DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPIL 130

Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKL 219
            +      ++++     + +  LH   S  + H DIKPHN+L++E     K+ DFG AK 
Sbjct: 131 IKVF----LFQL----IRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKK 181

Query: 220 CTTKEGIVSSLLGARGIIGYI------APEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
            +  E  V+          YI      APE+        +   D++S G +  E++  +
Sbjct: 182 LSPSEPNVA----------YICSRYYRAPELIF-GNQHYTTAVDIWSVGCIFAEMMLGE 229

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 77.4 bits (191), Expect = 7e-16
 Identities = 44/229 (19%), Positives = 73/229 (31%), Gaps = 61/229 (26%)

Query: 76  NFSDVKKLTNSFKDK------LGQGGFGGVYKGR-------------------------- 103
              D      + +D+      LG G  G V                              
Sbjct: 122 TVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREA 181

Query: 104 -LLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-----EKFVYNGDT 157
               +   E+  + + +H  ++ +  F  +  +  ++ E M  G L             T
Sbjct: 182 DPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEAT 240

Query: 158 SKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL---DEDFCPKISDF 214
            K                +   ++YLH      I+H D+KP N+LL   +ED   KI+DF
Sbjct: 241 CK-----------LYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDF 286

Query: 215 GLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEV-SHKSDVYSFG 262
           G +K+          +    G   Y+APEV         +   D +S G
Sbjct: 287 GHSKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG 331

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 76.6 bits (189), Expect = 8e-16
 Identities = 55/225 (24%), Positives = 89/225 (39%), Gaps = 48/225 (21%)

Query: 73  KRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLL--------------DDFVNEVASISRT 118
           K+Y  +D  +L+   K  LG G  G V +                       EV    + 
Sbjct: 22  KKYAVTDDYQLS---KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQA 78

Query: 119 S-HVNVVTLLGFCLEGNNRA----LIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEKM-YE 171
           S   ++V +L      ++      +I E M  G L  +    GD +        E+   E
Sbjct: 79  SGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFT------EREAAE 132

Query: 172 IVIGIAKGLEYLHHGCSTKILHFDIKPHNILL---DEDFCPKISDFGLAKLCTTKEGIVS 228
           I+  I   +++LH   S  I H D+KP N+L    ++D   K++DFG AK     +  + 
Sbjct: 133 IMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNALQ 187

Query: 229 SLLGARGIIGYIAPEVFSR-NFGEVSHKSDVYSFG--MMIMELVG 270
           +         Y+APEV     + +     D++S G  M I+ L G
Sbjct: 188 TPCYTP---YYVAPEVLGPEKYDK---SCDMWSLGVIMYIL-LCG 225

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 76.5 bits (189), Expect = 9e-16
 Identities = 52/167 (31%), Positives = 74/167 (44%), Gaps = 37/167 (22%)

Query: 79  DVKKLTNSFK--DKLGQGGFGGVYKGR-------------LLDDFVNEVASISRTS---- 119
           DVK     ++  D LG+G F  VYK R              L         I+RT+    
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63

Query: 120 -------HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTS-KPCQYLRWEKMYE 171
                  H N++ LL      +N +L+++FM    LE  + +      P     +  M  
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLM-- 120

Query: 172 IVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK 218
                 +GLEYLH      ILH D+KP+N+LLDE+   K++DFGLAK
Sbjct: 121 ----TLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAK 160

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 74.2 bits (183), Expect = 5e-15
 Identities = 41/149 (27%), Positives = 65/149 (43%), Gaps = 24/149 (16%)

Query: 89  DKLGQGGFGGVYKGR--LLDDFV------------------NEVASISRTSHVNVVTLLG 128
           +KLG G +  VYKG       +V                   E++ +    H N+V L  
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYD 70

Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
                N   L++EFM N  L+K++ +       + L    +      + +GL + H    
Sbjct: 71  VIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN-- 127

Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLA 217
            KILH D+KP N+L+++    K+ DFGLA
Sbjct: 128 -KILHRDLKPQNLLINKRGQLKLGDFGLA 155

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 73.5 bits (181), Expect = 6e-15
 Identities = 45/158 (28%), Positives = 72/158 (45%), Gaps = 22/158 (13%)

Query: 111 EVASISRTSHVNVVTLLGFCLEGNNRALIY---EFMPNGSLEKFVYNG--DTSKPCQYLR 165
           E+A + +  H NVV L+   L+  N   +Y   E +  G + +          +   Y +
Sbjct: 86  EIAILKKLDHPNVVKLVEV-LDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQ 144

Query: 166 WEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG 225
                     + KG+EYLH     KI+H DIKP N+L+ ED   KI+DFG++      + 
Sbjct: 145 ---------DLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192

Query: 226 IVSSLLGARGIIGYIAPEVFSRNFGEVS-HKSDVYSFG 262
           ++S+     G   ++APE  S      S    DV++ G
Sbjct: 193 LLSN---TVGTPAFMAPESLSETRKIFSGKALDVWAMG 227

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 73.4 bits (181), Expect = 9e-15
 Identities = 42/176 (23%), Positives = 79/176 (44%), Gaps = 30/176 (17%)

Query: 64  IRNYGPLPLKRYNFSDVKKLTNSFK-DKLGQGGFGGVYKGR------------LLDDF-- 108
           + ++      R N      +    K +K+G+G +G VYK +             LD    
Sbjct: 1   MHHHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDE 60

Query: 109 ------VNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQ 162
                 + E++ +    H N+V+L+          L++EFM    L+K +    T     
Sbjct: 61  GIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDS 119

Query: 163 YLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK 218
            ++   +Y+++    +G+ + H     +ILH D+KP N+L++ D   K++DFGLA+
Sbjct: 120 QIK-IYLYQLL----RGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLAR 167

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 73.6 bits (181), Expect = 1e-14
 Identities = 54/228 (23%), Positives = 84/228 (36%), Gaps = 47/228 (20%)

Query: 70  LPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLL--------------DDFVNEVASI 115
           L +K+    D  K+       LG G  G V +                       EV   
Sbjct: 52  LQIKKNAIIDDYKV---TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELH 108

Query: 116 SRTS-HVNVVTLLGFCLEGNNRA----LIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEKM 169
            R S   ++V ++              ++ E +  G L  +    GD +        E+ 
Sbjct: 109 WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT------ERE 162

Query: 170 -YEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL---DEDFCPKISDFGLAKLCTTKEG 225
             EI+  I + ++YLH   S  I H D+KP N+L      +   K++DFG AK  T+   
Sbjct: 163 ASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 219

Query: 226 IVSSLLGARGIIGYIAPEVFSR-NFGEVSHKSDVYSFG--MMIMELVG 270
               L        Y+APEV     + +     D++S G  M I+ L G
Sbjct: 220 ----LTTPCYTPYYVAPEVLGPEKYDK---SCDMWSLGVIMYIL-LCG 259

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 46/213 (21%), Positives = 75/213 (35%), Gaps = 57/213 (26%)

Query: 87  FKDKLGQGGFGGVYKGR---------------------------LLDDFVNEVASISRTS 119
               LG G  G V                                  +   E+  + + +
Sbjct: 14  MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73

Query: 120 HVNVVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEKMYE-----IV 173
           H  ++ +  F  +  +  ++ E M  G L +K V N             ++ E       
Sbjct: 74  HPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNK------------RLKEATCKLYF 120

Query: 174 IGIAKGLEYLHHGCSTKILHFDIKPHNILL---DEDFCPKISDFGLAKLCTTKEGIVSSL 230
             +   ++YLH      I+H D+KP N+LL   +ED   KI+DFG +K+    E   S +
Sbjct: 121 YQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GET--SLM 173

Query: 231 LGARGIIGYIAPEVFSRNFGEV-SHKSDVYSFG 262
               G   Y+APEV         +   D +S G
Sbjct: 174 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG 206

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 71.5 bits (176), Expect = 3e-14
 Identities = 57/196 (29%), Positives = 82/196 (41%), Gaps = 39/196 (19%)

Query: 91  LGQGGFGGVY-----------------KGRLLDDFVN---EVASISRTSHVNVVTLLGFC 130
           LG+G +G V                    R +D   N   E+      +H NVV   G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 131 LEGNNRALIYEFMPNGSL-EKFVYNGDTSKP--CQYLRWEKMYEIVIGIAKGLEYLHHGC 187
            EGN + L  E+   G L ++   +    +P   ++       +++ G+     YLH   
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-----QLMAGV----VYLH--- 122

Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGAR-GIIGYIAPEVFS 246
              I H DIKP N+LLDE    KISDFGLA +   +      LL    G + Y+APE+  
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATV--FRYNNRERLLNKMCGTLPYVAPELLK 180

Query: 247 RNFGEVSHKSDVYSFG 262
           R     +   DV+S G
Sbjct: 181 RR-EFHAEPVDVWSCG 195

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 72.5 bits (178), Expect = 3e-14
 Identities = 39/163 (23%), Positives = 70/163 (42%), Gaps = 38/163 (23%)

Query: 88  KDKLGQGGFGGVYKGRLLDDFVNEVASISRT-------------------SHVNVVTLLG 128
             K+G+G +G VYK +  D   ++  ++ +                     H NV++L  
Sbjct: 26  GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQK 85

Query: 129 FCLEGNNRA--LIYEFMPN---GSLEKFVYNGDTSKPCQYLRWEK---MYEIVIGIAKGL 180
             L   +R   L++++  +     ++    +    KP Q  R      +Y+I+     G+
Sbjct: 86  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL----DGI 141

Query: 181 EYLHHGCSTKILHFDIKPHNILLDEDF----CPKISDFGLAKL 219
            YLH   +  +LH D+KP NIL+  +       KI+D G A+L
Sbjct: 142 HYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 71.8 bits (177), Expect = 3e-14
 Identities = 30/150 (20%), Positives = 60/150 (40%), Gaps = 30/150 (20%)

Query: 89  DKLGQGGFGGVYKGR-------------LLDDF--------VNEVASISRTSHVNVVTLL 127
            K+G+G +G V+K R             L  +         + E+  + +  H N+V LL
Sbjct: 9   GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68

Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
                     L++E+  + ++   +       P   ++    ++ +    + + + H   
Sbjct: 69  EVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVK-SITWQTL----QAVNFCH--- 119

Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLA 217
               +H D+KP NIL+ +    K+ DFG A
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFA 149

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 71.4 bits (176), Expect = 3e-14
 Identities = 34/150 (22%), Positives = 66/150 (44%), Gaps = 29/150 (19%)

Query: 89  DKLGQGGFGGVYKGR------------LLDDF--------VNEVASISRTSHVNVVTLLG 128
           +K+G+G +G VYK +             L+          + E++ +    H N+V L  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
                    L++E +    L+K +   +        +   + +++     G+ Y H    
Sbjct: 68  VIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAK-SFLLQLL----NGIAYCH---D 118

Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAK 218
            ++LH D+KP N+L++ +   KI+DFGLA+
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLAR 148

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 71.4 bits (176), Expect = 4e-14
 Identities = 40/151 (26%), Positives = 72/151 (47%), Gaps = 29/151 (19%)

Query: 89  DKLGQGGFGGVYKGR-------------LLDDF--------VNEVASISRTSHVNVVTLL 127
           +K+G+G +G VYK R              LD          + E++ +   +H N+V LL
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68

Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
                 N   L++EF+    L+KF+     +     +    +   +  + +GL + H   
Sbjct: 69  DVIHTENKLYLVFEFLHQ-DLKKFM----DASALTGIPLPLIKSYLFQLLQGLAFCH--- 120

Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAK 218
           S ++LH D+KP N+L++ +   K++DFGLA+
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 71.0 bits (175), Expect = 4e-14
 Identities = 36/151 (23%), Positives = 71/151 (47%), Gaps = 30/151 (19%)

Query: 89  DKLGQGGFGGVYKGR-------------LLDDF--------VNEVASISRTSHVNVVTLL 127
           +K+G+G +G V+K +              LDD         + E+  +    H N+V L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
                     L++EF     L+K+  + +     + ++   +++++    KGL + H   
Sbjct: 68  DVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVK-SFLFQLL----KGLGFCH--- 118

Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAK 218
           S  +LH D+KP N+L++ +   K+++FGLA+
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLAR 149

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 71.2 bits (175), Expect = 5e-14
 Identities = 57/196 (29%), Positives = 82/196 (41%), Gaps = 39/196 (19%)

Query: 91  LGQGGFGGVY-----------------KGRLLDDFVN---EVASISRTSHVNVVTLLGFC 130
           LG+G +G V                    R +D   N   E+      +H NVV   G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 131 LEGNNRALIYEFMPNGSL-EKFVYNGDTSKP--CQYLRWEKMYEIVIGIAKGLEYLHHGC 187
            EGN + L  E+   G L ++   +    +P   ++       +++ G+     YLH   
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-----QLMAGV----VYLH--- 122

Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGAR-GIIGYIAPEVFS 246
              I H DIKP N+LLDE    KISDFGLA +   +      LL    G + Y+APE+  
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATV--FRYNNRERLLNKMCGTLPYVAPELLK 180

Query: 247 RNFGEVSHKSDVYSFG 262
           R     +   DV+S G
Sbjct: 181 RR-EFHAEPVDVWSCG 195

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 71.1 bits (175), Expect = 5e-14
 Identities = 49/216 (22%), Positives = 92/216 (42%), Gaps = 47/216 (21%)

Query: 90  KLGQGGFGGVYKGRLLDDFVNEVASI--------SRT-----------SHVNVVTLLGFC 130
           KLG+G +  V++    +   NE   +         +               N++TL    
Sbjct: 43  KLGRGKYSEVFEAI--NITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIV 100

Query: 131 LEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
            +  +R  AL++E + N   ++ +Y   T    ++     MYEI+    K L+Y H   S
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQ-LYQTLTDYDIRFY----MYEIL----KALDYCH---S 148

Query: 189 TKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKE---GIVSSLLGARGIIGYIAPEV 244
             I+H D+KPHN+++D +    ++ D+GLA+     +     V+S         +  PE+
Sbjct: 149 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-------FKGPEL 201

Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVD 280
              ++    +  D++S G M+  ++  K     G D
Sbjct: 202 LV-DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 236

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 71.6 bits (176), Expect = 5e-14
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 8/94 (8%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           +   L+YL    + +I+H D+KP NILLDE     I+DF +A +   +  I +      G
Sbjct: 124 LVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA----G 176

Query: 236 IIGYIAPEVFSRNFGEVSHKS-DVYSFGMMIMEL 268
              Y+APE+FS   G     + D +S G+   EL
Sbjct: 177 TKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYEL 210

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 69.6 bits (170), Expect = 2e-13
 Identities = 52/174 (29%), Positives = 80/174 (45%), Gaps = 19/174 (10%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           +AKG+E+L    S K +H D+   NILL E    KI DFGLA+        V     AR 
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK-GDARL 257

Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV 295
            + ++APE  +      + +SDV+SFG+++ E+     +   GV    E        R +
Sbjct: 258 PLKWMAPE--TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF------CRRL 309

Query: 296 EQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA 349
           ++    + P   T    E+ + M    L C    PS RP  +E++E L    +A
Sbjct: 310 KEGTRMRAPDYTT---PEMYQTM----LDCWHGEPSQRPTFSELVEHLGNLLQA 356

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 46.1 bits (109), Expect = 9e-06
 Identities = 21/96 (21%), Positives = 33/96 (34%), Gaps = 27/96 (28%)

Query: 86  SFKDKLGQGGFGGVYKGRL-------------------------LDDFVNEVAS-ISRTS 119
                LG+G FG V +                                ++E+   I    
Sbjct: 25  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 84

Query: 120 HVNVVTLLGFCLEGNNRA-LIYEFMPNGSLEKFVYN 154
           H+NVV LLG C +      +I EF   G+L  ++ +
Sbjct: 85  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 120

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 69.2 bits (170), Expect = 2e-13
 Identities = 38/150 (25%), Positives = 65/150 (43%), Gaps = 30/150 (20%)

Query: 89  DKLGQGGFGGVYKGR-------------LLDDFVNEVASIS--------RTSHVNVVTLL 127
             +G+G +G V K R             L  D    V  I+        +  H N+V LL
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90

Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
             C +     L++EF+ + ++   +         Q ++ + +++I+     G+ + H   
Sbjct: 91  EVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQ-KYLFQII----NGIGFCH--- 141

Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLA 217
           S  I+H DIKP NIL+ +    K+ DFG A
Sbjct: 142 SHNIIHRDIKPENILVSQSGVVKLCDFGFA 171

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 68.8 bits (169), Expect = 3e-13
 Identities = 39/150 (26%), Positives = 73/150 (48%), Gaps = 29/150 (19%)

Query: 89  DKLGQGGFGGVYKGRL-------------LDD-------FVNEVASISRTSHVNVVTLLG 128
           DKLG+G +  VYKG+              L+         + EV+ +    H N+VTL  
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 67

Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
                 +  L++E++    L++++ +         ++   +++++    +GL Y H    
Sbjct: 68  IIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVK-LFLFQLL----RGLAYCH---R 118

Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAK 218
            K+LH D+KP N+L++E    K++DFGLA+
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGLAR 148

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 51/208 (24%), Positives = 80/208 (38%), Gaps = 46/208 (22%)

Query: 91  LGQGGFGGVY-----------------KGRLLDDFVNEVASI-------SRTSHVNVVTL 126
           LG+GGFG V+                 K RL                  ++     +V+L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKR--KGYQGAMVEKKILAKVHSRFIVSL 250

Query: 127 LGFCLEGNNRA-LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY--EIVIGIAKGLEYL 183
             +  E      L+   M  G +   +YN D   P         Y  +IV G    LE+L
Sbjct: 251 A-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG----LEHL 305

Query: 184 HHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE 243
           H      I++ D+KP N+LLD+D   +ISD GLA      +       G     G++APE
Sbjct: 306 H---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGT---PGFMAPE 359

Query: 244 VFSRNFGEVSHKSDV--YSFGMMIMELV 269
           +         +   V  ++ G+ + E++
Sbjct: 360 LLLGE----EYDFSVDYFALGVTLYEMI 383

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 68.4 bits (168), Expect = 3e-13
 Identities = 37/162 (22%), Positives = 65/162 (40%), Gaps = 40/162 (24%)

Query: 89  DKLGQGGFGGVYKGR-------------LLDDFVNEVASISRTS--------------HV 121
            ++G G +G VYK R              + +       +  ++              H 
Sbjct: 15  AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74

Query: 122 NVVTLLGFCLEGNNRA-----LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 176
           NVV L+  C            L++E +    L  ++       P   L  E + +++   
Sbjct: 75  NVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL----DKAPPPGLPAETIKDLMRQF 129

Query: 177 AKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK 218
            +GL++LH   +  I+H D+KP NIL+      K++DFGLA+
Sbjct: 130 LRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLAR 168

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 67.7 bits (166), Expect = 9e-13
 Identities = 39/156 (25%), Positives = 66/156 (42%), Gaps = 36/156 (23%)

Query: 89  DKLGQGGFGGVYKGR--LLDDFV--------NEVASISRTS-----------HVNVVTLL 127
            KLG+G +G VYK    + ++ V        +E   +  T+           H N++ L 
Sbjct: 40  TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELK 99

Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
                 +   LI+E+  N  L+K++             +  +Y+++     G+ + H   
Sbjct: 100 SVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSF--LYQLI----NGVNFCH--- 149

Query: 188 STKILHFDIKPHNILLDEDFCP-----KISDFGLAK 218
           S + LH D+KP N+LL           KI DFGLA+
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 68.4 bits (167), Expect = 1e-12
 Identities = 51/212 (24%), Positives = 84/212 (39%), Gaps = 56/212 (26%)

Query: 91  LGQGGFGGVY-----------------KGRLLDDFVNEVAS----------ISRTSHVNV 123
           +G+GGFG VY                 K R+                    +S      +
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK--QGETLALNERIMLSLVSTGDCPFI 254

Query: 124 VTLLGFCLEGNNRA-LIYEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMY--EIVIGIAKG 179
           V +  +     ++   I + M  G L   +   G  S+        + Y  EI++G    
Sbjct: 255 VCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DMRFYAAEIILG---- 304

Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
           LE++H   +  +++ D+KP NILLDE    +ISD GLA      +    + +G     GY
Sbjct: 305 LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACD--FSKKKPHASVGT---HGY 356

Query: 240 IAPEVFSRNFGEVSHKSDV--YSFGMMIMELV 269
           +APEV  +      + S    +S G M+ +L+
Sbjct: 357 MAPEVLQKGVA---YDSSADWFSLGCMLFKLL 385

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 58/249 (23%), Positives = 98/249 (39%), Gaps = 54/249 (21%)

Query: 55  KSDKDLEAFIRNYGPLPLK----RYNFSD--VKKLTNSFKDKLGQGGFGGVY-------- 100
           + +K+++ F+  Y     K    R    D  V K+       +G+G FG V         
Sbjct: 42  RKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKV-------IGRGAFGEVQLVRHKSTR 94

Query: 101 ---------KGRLLDD-----FVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG 146
                    K  ++       F  E   ++  +   VV L     +     ++ E+MP G
Sbjct: 95  KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGG 154

Query: 147 SLEKFVYNGDTSKPCQYLRWEKMY--EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLD 204
            L   + N D  +      W + Y  E+V+     L+ +H   S   +H D+KP N+LLD
Sbjct: 155 DLVNLMSNYDVPEK-----WARFYTAEVVLA----LDAIH---SMGFIHRDVKPDNMLLD 202

Query: 205 EDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDV--YSFG 262
           +    K++DFG       +  +        G   YI+PEV     G+  +  +   +S G
Sbjct: 203 KSGHLKLADFGTCMKMNKEGMVRCDTAV--GTPDYISPEVLKSQGGDGYYGRECDWWSVG 260

Query: 263 MMIME-LVG 270
           + + E LVG
Sbjct: 261 VFLYEMLVG 269

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 67.5 bits (165), Expect = 1e-12
 Identities = 37/148 (25%), Positives = 62/148 (41%), Gaps = 36/148 (24%)

Query: 138 LIYEFMPNGSLEKFVYNGDTSKP------CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKI 191
           +I E++P+ +L K + +   S                +Y++     + + ++H   S  I
Sbjct: 115 VIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIY----IYQL----FRAVGFIH---SLGI 162

Query: 192 LHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIGYI------APEV 244
            H DIKP N+L++      K+ DFG AK     E  V+          YI      APE+
Sbjct: 163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVA----------YICSRFYRAPEL 212

Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCK 272
                 E +   D++S G +  EL+  K
Sbjct: 213 ML-GATEYTPSIDLWSIGCVFGELILGK 239

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 66.8 bits (164), Expect = 1e-12
 Identities = 39/163 (23%), Positives = 69/163 (42%), Gaps = 44/163 (26%)

Query: 89  DKLGQGGFGGVYKGRLLDDFVNEVA-------------------------SISRTSHVNV 123
            ++G+G +G V+K R L +    VA                          +    H NV
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 76

Query: 124 VTLLGFCLEGNNRA-----LIYEFMPN---GSLEKFVYNGDTSKPCQYLRWEKMYEIVIG 175
           V L   C            L++E +       L+K    G  ++  + +    M++++  
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM----MFQLL-- 130

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK 218
             +GL++LH   S +++H D+KP NIL+      K++DFGLA+
Sbjct: 131 --RGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 52/197 (26%), Positives = 78/197 (39%), Gaps = 40/197 (20%)

Query: 91  LGQGGFGGVY-----------------KGRLLDDFVN-EVASISRTSHVNVVTLLGFCLE 132
           +G G FG                    +G  +D+ V  E+ +     H N+V      L 
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87

Query: 133 GNNRALIYEFMPNGSL-EKFVYNGDTSKP--CQYLRWEKMYEIVIGIAKGLEYLHHGCST 189
             + A+I E+   G L E+    G  S+     + +     +++ G+     Y H   S 
Sbjct: 88  PTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQ-----QLLSGV----SYCH---SM 135

Query: 190 KILHFDIKPHNILLDEDFCP--KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSR 247
           +I H D+K  N LLD    P  KI DFG +K         S++    G   YIAPEV  R
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV----GTPAYIAPEVLLR 191

Query: 248 NFGEVSHKSDVYSFGMM 264
                   +DV+S G+ 
Sbjct: 192 Q-EYDGKIADVWSCGVT 207

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 65.0 bits (159), Expect = 4e-12
 Identities = 44/204 (21%), Positives = 70/204 (34%), Gaps = 48/204 (23%)

Query: 91  LGQGGFGGVYKGR-----------------------LLDDFVNEVASISRTSHVNVVTLL 127
           LG+G +G V +                            +   E+  + R  H NV+ L+
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 128 GFCLEGNNRALIY---EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIV-----IGIAKG 179
              L    +  +Y   E+   G  E              +  ++            +  G
Sbjct: 73  DV-LYNEEKQKMYMVMEYCVCGMQEML----------DSVPEKRFPVCQAHGYFCQLIDG 121

Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLG-ARGIIG 238
           LEYLH   S  I+H DIKP N+LL      KIS  G+A+               ++G   
Sbjct: 122 LEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEA--LHPFAADDTCRTSQGSPA 176

Query: 239 YIAPEVFSRNFGEVSHKSDVYSFG 262
           +  PE+ +        K D++S G
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAG 200

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 65.3 bits (160), Expect = 6e-12
 Identities = 44/159 (27%), Positives = 63/159 (39%), Gaps = 40/159 (25%)

Query: 89  DKLGQGGFGGVYKGRLLD--DFV--------NEVASISRTS-----------HVNVVTLL 127
            K+GQG FG V+K R       V        NE      T+           H NVV L+
Sbjct: 23  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 82

Query: 128 GFCLEGNNRA--------LIYEFMPNGSLEKFVYNGDTS-KPCQYLRWEKMYEIVIGIAK 178
             C    +          L+++F  +  L   + N        +  R   M  ++     
Sbjct: 83  EICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV--MQMLL----N 135

Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLA 217
           GL Y+H     KILH D+K  N+L+  D   K++DFGLA
Sbjct: 136 GLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 171

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 64.6 bits (158), Expect = 1e-11
 Identities = 38/159 (23%), Positives = 68/159 (42%), Gaps = 19/159 (11%)

Query: 120 HVNVVTLLGFCLEGNNRA-----LIYEFMPNGSLEKFVYNGD-TSKPCQYLRWEKMYEIV 173
           H N++ +                ++ + M    L K +     ++    Y     +Y+I+
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYF----LYQIL 138

Query: 174 IGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGA 233
               +GL+Y+H   S  +LH D+KP N+LL+     KI DFGLA++          L   
Sbjct: 139 ----RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 191

Query: 234 RGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
                Y APE+   N    +   D++S G ++ E++  +
Sbjct: 192 VATRWYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNR 229

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 41/197 (20%), Positives = 74/197 (37%), Gaps = 38/197 (19%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGAR 234
           +   +++ H   S  ++H DIK  NIL+D      K+ DFG   L    +          
Sbjct: 148 VVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL--LHDEP---YTDFD 199

Query: 235 GIIGYIAPEVFSRN--FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIY 292
           G   Y  PE  SR+         + V+S G+++ ++V C                P    
Sbjct: 200 GTRVYSPPEWISRHQYHAL---PATVWSLGILLYDMV-CG-------------DIPFERD 242

Query: 293 RHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM--LQGSTEAL 350
           + +  + E   P  V+         +I     C+  +PS RP + E++    +Q   E +
Sbjct: 243 QEI-LEAELHFPAHVSPD----CCALI---RRCLAPKPSSRPSLEEILLDPWMQTPAEDV 294

Query: 351 QIPPTPFLSSPPRAPID 367
            + P+    +P    + 
Sbjct: 295 PLNPSKGGPAPLAWSLL 311

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 51/206 (24%), Positives = 87/206 (42%), Gaps = 50/206 (24%)

Query: 80  VKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRA-- 137
           +KKL   F+ +        ++  R       E+  +    H NV+ LL            
Sbjct: 55  IKKLYRPFQSE--------LFAKRAY----RELRLLKHMRHENVIGLLDVFTPDETLDDF 102

Query: 138 ----LIYEFMPNGSLEKFVYNGD-TSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKIL 192
               L+  FM    L K + +        Q+L    +Y+++    KGL Y+H   +  I+
Sbjct: 103 TDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFL----VYQML----KGLRYIH---AAGII 150

Query: 193 HFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYI------APEVFS 246
           H D+KP N+ ++ED   KI DFGLA+   ++            + GY+      APEV  
Sbjct: 151 HRDLKPGNLAVNEDCELKILDFGLARQADSE------------MTGYVVTRWYRAPEVIL 198

Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCK 272
            N+   +   D++S G ++ E++  K
Sbjct: 199 -NWMRYTQTVDIWSVGCIMAEMITGK 223

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 52/260 (20%), Positives = 89/260 (34%), Gaps = 69/260 (26%)

Query: 55  KSDKDLEAFIRNYGP-------LPLKRYNFSDVKKLTNSFKDKLGQGGFGGVY------- 100
             DK +  F++   P       + L+R +F ++ K+       +G+G F  V        
Sbjct: 34  AQDKYVADFLQWAEPIVVRLKEVRLQRDDF-EILKV-------IGRGAFSEVAVVKMKQT 85

Query: 101 ----------KGRLLDDFVNEVASI-------SRTSHVNVVTLLGFCLEGNNRA-LIYEF 142
                     K  +L     EV+                +  L  F  +  N   L+ E+
Sbjct: 86  GQVYAMKIMNKWDMLKR--GEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEY 142

Query: 143 MPNGSLEKFVYNGDTSKPCQYLRWEKMY--EIVIGIAKGLEYLHHGCSTKILHFDIKPHN 200
              G L   +       P       + Y  EIV+     ++ +H       +H DIKP N
Sbjct: 143 YVGGDLLTLLSKFGERIP---AEMARFYLAEIVMA----IDSVH---RLGYVHRDIKPDN 192

Query: 201 ILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG---YIAPEVFSRNFGEVSHKS- 256
           ILLD     +++DFG        +      + +   +G   Y++PE+     G     S 
Sbjct: 193 ILLDRCGHIRLADFGSC-----LKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSY 247

Query: 257 ----DVYSFGMMIME-LVGC 271
               D ++ G+   E   G 
Sbjct: 248 GPECDWWALGVFAYEMFYGQ 267

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 63.0 bits (154), Expect = 2e-11
 Identities = 56/213 (26%), Positives = 85/213 (39%), Gaps = 58/213 (27%)

Query: 91  LGQGGFGGVYKGRLLD------------DFV---NEVASI-------SRTSHVNVVTLLG 128
           LG+G F  V   R L               +   N+V  +       SR  H   V L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97

Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY----------EIVIGIAK 178
              +         +  NG L             +Y+R    +          EIV     
Sbjct: 98  TFQDDEKLYFGLSYAKNGEL--L----------KYIRKIGSFDETCTRFYTAEIVSA--- 142

Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT--TKEGIVSSLLGARGI 236
            LEYLH      I+H D+KP NILL+ED   +I+DFG AK+ +  +K+   +S +G    
Sbjct: 143 -LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT--- 195

Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
             Y++PE+ +         SD+++ G +I +LV
Sbjct: 196 AQYVSPELLTEK--SACKSSDLWALGCIIYQLV 226

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 63.4 bits (155), Expect = 2e-11
 Identities = 30/119 (25%), Positives = 56/119 (47%), Gaps = 19/119 (15%)

Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
            QY     +Y+ +    + ++ LH    + ++H D+KP N+L++ +   K+ DFGLA++ 
Sbjct: 114 IQYF----IYQTL----RAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162

Query: 221 TTKEGIVSSLLGARGII-GYI------APEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
                  S   G +  +  ++      APEV      + S   DV+S G ++ EL   +
Sbjct: 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVML-TSAKYSRAMDVWSCGCILAELFLRR 220

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 63.2 bits (154), Expect = 2e-11
 Identities = 51/204 (25%), Positives = 77/204 (37%), Gaps = 50/204 (24%)

Query: 91  LGQGGFGGVY-----------------KGRLLDDFVN----------EVASISRTSHVNV 123
           LG G FG V+                 K ++L+D             E+A +SR  H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 124 VTLLGFCLEGNNRALIYEFMPNGSLEKFVY---NGDTSKP--CQYLRWEKMYEIVIGIAK 178
           + +L          L+ E   +G L+ F +   +    +P      R          +  
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSG-LDLFAFIDRHPRLDEPLASYIFR---------QLVS 141

Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG 238
            + YL       I+H DIK  NI++ EDF  K+ DFG A     + G         G I 
Sbjct: 142 AVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY--LERG--KLFYTFCGTIE 194

Query: 239 YIAPEVFSRNFGEVSHKSDVYSFG 262
           Y APEV   N      + +++S G
Sbjct: 195 YCAPEVLMGN-PYRGPELEMWSLG 217

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 63.1 bits (154), Expect = 3e-11
 Identities = 40/141 (28%), Positives = 70/141 (49%), Gaps = 31/141 (21%)

Query: 138 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIK 197
           L+  FM    L+K +    + +  QYL    +Y+++    KGL+Y+H   S  ++H D+K
Sbjct: 106 LVMPFMQT-DLQKIMGLKFSEEKIQYL----VYQML----KGLKYIH---SAGVVHRDLK 153

Query: 198 PHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYI------APEVFSRNFGE 251
           P N+ ++ED   KI DFGLA+    +            + GY+      APEV   ++  
Sbjct: 154 PGNLAVNEDCELKILDFGLARHADAE------------MTGYVVTRWYRAPEVIL-SWMH 200

Query: 252 VSHKSDVYSFGMMIMELVGCK 272
            +   D++S G ++ E++  K
Sbjct: 201 YNQTVDIWSVGCIMAEMLTGK 221

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 63.7 bits (155), Expect = 4e-11
 Identities = 52/208 (25%), Positives = 81/208 (38%), Gaps = 49/208 (23%)

Query: 91  LGQGGFGGVY-----------------KGRLLDDFVNEVASI-------SRTSHVNVVTL 126
           LG+GGFG V                  K R+        A          + +   VV+L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR--KGEAMALNEKQILEKVNSRFVVSL 249

Query: 127 LGFCLEGNNRA-LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY--EIVIGIAKGLEYL 183
             +  E  +   L+   M  G L+  +Y+    +          Y  EI  G    LE L
Sbjct: 250 -AYAYETKDALCLVLTLMNGGDLKFHIYH--MGQAGFPEARAVFYAAEICCG----LEDL 302

Query: 184 HHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE 243
           H     +I++ D+KP NILLD+    +ISD GLA      + I   +    G +GY+APE
Sbjct: 303 H---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV----GTVGYMAPE 355

Query: 244 VFSRNFGEVSHKSDV--YSFGMMIMELV 269
           V         +      ++ G ++ E++
Sbjct: 356 VVKNE----RYTFSPDWWALGCLLYEMI 379

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 62.3 bits (152), Expect = 5e-11
 Identities = 40/167 (23%), Positives = 65/167 (38%), Gaps = 37/167 (22%)

Query: 120 HVNVVTLLGFCLEGNNRA-----LIYEFMPNGSLEKFVYNGD---TSKPCQYLRWEKMYE 171
           H N++ L    +     A     L+ E M    L + +++     + +  QY     MY 
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYF----MYH 142

Query: 172 IVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLL 231
           I+     GL  LH      ++H D+ P NILL ++    I DF LA+  T          
Sbjct: 143 IL----LGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKT---- 191

Query: 232 GARGIIGYI------APEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
                  Y+      APE+    F   +   D++S G ++ E+   K
Sbjct: 192 ------HYVTHRWYRAPELVM-QFKGFTKLVDMWSAGCVMAEMFNRK 231

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 62.5 bits (152), Expect = 6e-11
 Identities = 35/159 (22%), Positives = 64/159 (40%), Gaps = 42/159 (26%)

Query: 88  KDKLGQGGFGGVYKG------------RLLDDFVNEVASISRT----------SHVNVVT 125
           +  +G G +G V +             ++L  F + +    R           +H +VV 
Sbjct: 58  RHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDC-KRILREIAILNRLNHDHVVK 116

Query: 126 LLGFCLEGNNRA-----LIYEFMPNGSLEKFVYNGD--TSKPCQYLRWEKMYEIVIGIAK 178
           +L   +  +        ++ E   +   +K        T    + L    +Y ++     
Sbjct: 117 VLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTL----LYNLL----V 167

Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLA 217
           G++Y+H   S  ILH D+KP N L+++D   K+ DFGLA
Sbjct: 168 GVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLA 203

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 62.1 bits (151), Expect = 8e-11
 Identities = 29/104 (27%), Positives = 50/104 (48%), Gaps = 13/104 (12%)

Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSL 230
           E+VI     ++ +H       +H DIKP NIL+D +   +++DFG          + SS+
Sbjct: 183 EMVIA----IDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV 235

Query: 231 LGARGIIGYIAPEVF-SRNFGEVSHKSDV--YSFGMMIME-LVG 270
               G   YI+PE+  +   G+  +  +   +S G+ + E L G
Sbjct: 236 AV--GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 61.6 bits (150), Expect = 9e-11
 Identities = 45/166 (27%), Positives = 73/166 (43%), Gaps = 38/166 (22%)

Query: 120 HVNVVTLLGFCLEGNNRA------LIYEFMPNGSLEKFVYNGD-TSKPCQYLRWEKMYEI 172
           H NV+ LL       +        L+   M    L   V     T    Q+L    +Y+I
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFL----IYQI 141

Query: 173 VIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLG 232
           +    +GL+Y+H   S  I+H D+KP N+ ++ED   KI DFGLA+    +         
Sbjct: 142 L----RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE--------- 185

Query: 233 ARGIIGYI------APEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
              + GY+      APE+   N+   +   D++S G ++ EL+  +
Sbjct: 186 ---MTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 227

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 41/174 (23%), Positives = 77/174 (44%), Gaps = 34/174 (19%)

Query: 120 HVNVVTLLGFCLEGNNRA--LIYEFMPNGSLEKFVYNGD-TSKPCQYLRWEKMYEIVIGI 176
           H N+V LL      N+R   L++++M    L   +          QY+    +Y+++   
Sbjct: 68  HENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQYV----VYQLI--- 119

Query: 177 AKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI 236
            K ++YLH   S  +LH D+KP NILL+ +   K++DFGL++       + +++  +   
Sbjct: 120 -KVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINE 175

Query: 237 IG------------------YIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
                               Y APE+      + +   D++S G ++ E++  K
Sbjct: 176 NTENFDDDQPILTDYVATRWYRAPEILL-GSTKYTKGIDMWSLGCILGEILCGK 228

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 61.1 bits (149), Expect = 1e-10
 Identities = 31/137 (22%), Positives = 61/137 (44%), Gaps = 15/137 (10%)

Query: 138 LIYEFMPNGSLEKFVYNGD-TSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDI 196
           ++ E+M    L   +  G    +  +      MY+++    +GL+Y+H   S  +LH D+
Sbjct: 99  IVQEYMET-DLANVLEQGPLLEEHARLF----MYQLL----RGLKYIH---SANVLHRDL 146

Query: 197 KPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHK 255
           KP N+ ++ +    KI DFGLA++          L        Y +P +   +    +  
Sbjct: 147 KPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLL-SPNNYTKA 205

Query: 256 SDVYSFGMMIMELVGCK 272
            D+++ G +  E++  K
Sbjct: 206 IDMWAAGCIFAEMLTGK 222

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 61.8 bits (150), Expect = 1e-10
 Identities = 42/166 (25%), Positives = 70/166 (42%), Gaps = 38/166 (22%)

Query: 120 HVNVVTLLGFCLEGNNRA------LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIV 173
           H N+++LL                L+ E M   +L + +      +   YL    +Y+++
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYL----LYQML 174

Query: 174 IGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGA 233
                G+++LH   S  I+H D+KP NI++  D   KI DFGLA+   T           
Sbjct: 175 ----CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--------- 218

Query: 234 RGIIGYI------APEV-FSRNFGEVSHKSDVYSFGMMIMELVGCK 272
             +  Y+      APEV     +       D++S G ++ E+V  K
Sbjct: 219 -MMTPYVVTRYYRAPEVILGMGY---KENVDIWSVGCIMGEMVRHK 260

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 60.8 bits (148), Expect = 1e-10
 Identities = 65/311 (20%), Positives = 107/311 (34%), Gaps = 84/311 (27%)

Query: 91  LGQGGFGGVYKGRLLDD-------FVN------------------EVASISRTSHV--NV 123
           LG GGFG VY G  + D        V                   EV  + + S     V
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 124 VTLLGFCLEGNNRALIYEFMPNGSLEKFVY---NG--DTSKPCQYLRWEKMYEIVIGIAK 178
           + LL +    ++  LI E  P    + F +    G         +            + +
Sbjct: 111 IRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFW---------QVLE 160

Query: 179 GLEYLHHGCSTKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGII 237
            + + H   +  +LH DIK  NIL+D +    K+ DFG   L   K+ + +   G R   
Sbjct: 161 AVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL--LKDTVYTDFDGTR--- 212

Query: 238 GYIAPEVFSRN--FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVD--SSSEVYFPHWIYR 293
            Y  PE    +   G     + V+S G+++ ++V C +      +     +V+F   +  
Sbjct: 213 VYSPPEWIRYHRYHG---RSAAVWSLGILLYDMV-CGDIPFEHDEEIIRGQVFFRQRV-- 266

Query: 294 HVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM--LQGSTEALQ 351
                             +   + +I    WC+  RPSDRP   E+     +Q      +
Sbjct: 267 ------------------SSECQHLI---RWCLALRPSDRPTFEEIQNHPWMQDVLLPQE 305

Query: 352 IPPTPFLSSPP 362
                  S  P
Sbjct: 306 TAEIHLHSLSP 316

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 39/165 (23%), Positives = 68/165 (41%), Gaps = 36/165 (21%)

Query: 120 HVNVVTLLGFCLEGNNRA------LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIV 173
           H N++ LL       +        ++ E M   +L + +      +   YL    +Y+++
Sbjct: 83  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYL----LYQML 137

Query: 174 IGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGA 233
                G+++LH   S  I+H D+KP NI++  D   KI DFGLA+   T           
Sbjct: 138 ----CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--------- 181

Query: 234 RGIIGYI------APEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 272
             +  Y+      APEV            D++S G ++ E++   
Sbjct: 182 -MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGG 223

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 60.4 bits (147), Expect = 2e-10
 Identities = 29/87 (33%), Positives = 40/87 (45%), Gaps = 8/87 (9%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           I   ++Y H     +I+H D+K  N+LLD D   KI+DFG +   T        L    G
Sbjct: 123 IVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG----KLDAFCG 175

Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFG 262
              Y APE+F         + DV+S G
Sbjct: 176 APPYAAPELFQGK-KYDGPEVDVWSLG 201

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 31/145 (21%), Positives = 61/145 (42%), Gaps = 31/145 (21%)

Query: 80  VKKLTNSFKDKLGQGGFGGVYKGRLLDDFVNEVASISRTSHVNVVTLLGFCLEGNNRA-- 137
           +KK+   F+D         +   R+L     E+  ++R     ++ L    +  +     
Sbjct: 56  IKKVNRMFEDL--------IDCKRIL----REITILNRLKSDYIIRLYDLIIPDDLLKFD 103

Query: 138 ---LIYEFMPNGSLEKFVYNGD--TSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKIL 192
              ++ E   +  L+K        T +  + +    +Y ++     G  ++H    + I+
Sbjct: 104 ELYIVLEIADS-DLKKLFKTPIFLTEEHIKTI----LYNLL----LGENFIH---ESGII 151

Query: 193 HFDIKPHNILLDEDFCPKISDFGLA 217
           H D+KP N LL++D   K+ DFGLA
Sbjct: 152 HRDLKPANCLLNQDCSVKVCDFGLA 176

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 59.6 bits (145), Expect = 3e-10
 Identities = 39/179 (21%), Positives = 62/179 (34%), Gaps = 46/179 (25%)

Query: 69  PLPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRL--------------LDDFVNEVAS 114
            L +K+    D  K+       LG G  G V +                       EV  
Sbjct: 7   GLQIKKNAIIDDYKV---TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVEL 63

Query: 115 ISRTS-HVNVVTLLGFC----LEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEK 168
             R S   ++V ++              ++ E +  G L  +    GD           +
Sbjct: 64  HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD-----------Q 112

Query: 169 MY------EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL---DEDFCPKISDFGLAK 218
            +      EI+  I + ++YLH   S  I H D+KP N+L      +   K++DFG AK
Sbjct: 113 AFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 59.5 bits (145), Expect = 3e-10
 Identities = 37/98 (37%), Positives = 54/98 (55%), Gaps = 13/98 (13%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           +A  L++LH   S  I++ D+KP NILLDE+   K++DFGL+K     E    S  G   
Sbjct: 135 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGT-- 189

Query: 236 IIGYIAPEVFSRNFGEVSHKSDV--YSFGMMIME-LVG 270
            + Y+APEV +R      H      +SFG+++ E L G
Sbjct: 190 -VEYMAPEVVNRR----GHTQSADWWSFGVLMFEMLTG 222

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 59.1 bits (144), Expect = 5e-10
 Identities = 30/98 (30%), Positives = 48/98 (48%), Gaps = 13/98 (13%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           I+  L +LH      I++ D+KP NI+L+     K++DFGL K       +  +  G   
Sbjct: 130 ISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGT-- 184

Query: 236 IIGYIAPEVFSRNFGEVSHKSDV--YSFGMMIME-LVG 270
            I Y+APE+  R+     H   V  +S G ++ + L G
Sbjct: 185 -IEYMAPEILMRS----GHNRAVDWWSLGALMYDMLTG 217

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 58.5 bits (142), Expect = 9e-10
 Identities = 31/96 (32%), Positives = 46/96 (47%), Gaps = 11/96 (11%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGAR- 234
           I   LE+LH      I++ DIK  NILLD +    ++DFGL+     KE +      A  
Sbjct: 168 IVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLS-----KEFVADETERAYD 219

Query: 235 --GIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMEL 268
             G I Y+AP++            D +S G+++ EL
Sbjct: 220 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYEL 255

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 58.4 bits (142), Expect = 1e-09
 Identities = 32/98 (32%), Positives = 49/98 (50%), Gaps = 13/98 (13%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           I   LEYLH   S  +++ DIK  N++LD+D   KI+DFGL K   +    + +     G
Sbjct: 114 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC---G 167

Query: 236 IIGYIAPEVFSRNFGEVSHKSDV--YSFGMMIME-LVG 270
              Y+APEV   N     +   V  +  G+++ E + G
Sbjct: 168 TPEYLAPEVLEDN----DYGRAVDWWGLGVVMYEMMCG 201

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 58.4 bits (142), Expect = 1e-09
 Identities = 33/98 (33%), Positives = 45/98 (45%), Gaps = 13/98 (13%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           IA  L YLH   S  I++ D+KP NILLD      ++DFGL K         S+     G
Sbjct: 148 IASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC---G 201

Query: 236 IIGYIAPEVFSRNFGEVSHKSDV--YSFGMMIME-LVG 270
              Y+APEV  +      +   V  +  G ++ E L G
Sbjct: 202 TPEYLAPEVLHKQ----PYDRTVDWWCLGAVLYEMLYG 235

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 58.0 bits (141), Expect = 1e-09
 Identities = 35/97 (36%), Positives = 54/97 (55%), Gaps = 11/97 (11%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDED-FCPKISDFGLAKLCTTKEGIVSSLLGAR 234
           I  GL++LH   S  I++ D+K  NILLD+D    KI+DFG+ K     +   ++     
Sbjct: 127 IILGLQFLH---SKGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFC--- 179

Query: 235 GIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIME-LVG 270
           G   YIAPE+      + +H  D +SFG+++ E L+G
Sbjct: 180 GTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIG 214

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 29/96 (30%), Positives = 48/96 (50%), Gaps = 8/96 (8%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           I   L+YLH   +  +++ D+K  N++LD+D   KI+DFGL K        + +  G   
Sbjct: 257 IVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGT-- 312

Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIME-LVG 270
              Y+APEV   N  +     D +  G+++ E + G
Sbjct: 313 -PEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCG 345

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 57.2 bits (139), Expect = 2e-09
 Identities = 42/106 (39%), Positives = 54/106 (50%), Gaps = 32/106 (30%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK--------LCTTKEGIV 227
           +   LEYLH   S  I++ D+KP NILLD++   KI+DFG AK        LC T +   
Sbjct: 115 VCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPD--- 168

Query: 228 SSLLGARGIIGYIAPEVFSRNFGEVSH-KS-DVYSFGMMIME-LVG 270
                      YIAPEV S       + KS D +SFG++I E L G
Sbjct: 169 -----------YIAPEVVSTK----PYNKSIDWWSFGILIYEMLAG 199

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 57.3 bits (139), Expect = 2e-09
 Identities = 29/104 (27%), Positives = 48/104 (46%), Gaps = 31/104 (29%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK--------LCTTKEGIV 227
           I    EYLH   S  +++ D+KP N+L+D+    +++DFG AK        LC T E   
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPE--- 203

Query: 228 SSLLGARGIIGYIAPEVFSRNFGEVSH-KS-DVYSFGMMIMELV 269
                       +APE+         + K+ D ++ G++I E+ 
Sbjct: 204 -----------ALAPEIILSK----GYNKAVDWWALGVLIYEMA 232

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 57.2 bits (139), Expect = 2e-09
 Identities = 27/98 (27%), Positives = 46/98 (46%), Gaps = 13/98 (13%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           I   L +LH      I++ D+K  N+LLD +   K++DFG+ K         ++     G
Sbjct: 133 IISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC---G 186

Query: 236 IIGYIAPEVFSRNFGEVSH-KS-DVYSFGMMIME-LVG 270
              YIAPE+         +  + D ++ G+++ E L G
Sbjct: 187 TPDYIAPEILQEM----LYGPAVDWWAMGVLLYEMLCG 220

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 56.1 bits (136), Expect = 4e-09
 Identities = 32/87 (36%), Positives = 46/87 (52%), Gaps = 8/87 (9%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           I   +EY H     KI+H D+KP N+LLD++   KI+DFGL+ + T    + +S     G
Sbjct: 117 IICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC----G 169

Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFG 262
              Y APEV +        + DV+S G
Sbjct: 170 SPNYAAPEVINGK-LYAGPEVDVWSCG 195

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 55.7 bits (135), Expect = 4e-09
 Identities = 29/87 (33%), Positives = 44/87 (50%), Gaps = 8/87 (9%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           I   ++Y H      ++H D+KP N+LLD     KI+DFGL+ + +  E + +S     G
Sbjct: 120 ILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC----G 172

Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFG 262
              Y APEV S        + D++S G
Sbjct: 173 SPNYAAPEVISGR-LYAGPEVDIWSCG 198

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 56.5 bits (137), Expect = 5e-09
 Identities = 30/98 (30%), Positives = 48/98 (48%), Gaps = 13/98 (13%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           IA GL +L    S  I++ D+K  N++LD +   KI+DFG+ K          +     G
Sbjct: 130 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC---G 183

Query: 236 IIGYIAPEVFSRNFGEVSHKSDV--YSFGMMIME-LVG 270
              YIAPE+ +       +   V  ++FG+++ E L G
Sbjct: 184 TPDYIAPEIIAYQ----PYGKSVDWWAFGVLLYEMLAG 217

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 56.1 bits (136), Expect = 5e-09
 Identities = 28/98 (28%), Positives = 47/98 (47%), Gaps = 13/98 (13%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           I+  L YLH      I++ D+K  N+LLD +   K++D+G+ K         S+     G
Sbjct: 119 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---G 172

Query: 236 IIGYIAPEVFSRNFGEVSH-KS-DVYSFGMMIME-LVG 270
              YIAPE+         +  S D ++ G+++ E + G
Sbjct: 173 TPNYIAPEILRGE----DYGFSVDWWALGVLMFEMMAG 206

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 57.0 bits (137), Expect = 5e-09
 Identities = 30/96 (31%), Positives = 47/96 (48%), Gaps = 9/96 (9%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARG 235
           IA GL +L    S  I++ D+K  N++LD +   KI+DFG+ K          +     G
Sbjct: 451 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC---G 504

Query: 236 IIGYIAPEVFSRNFGEVSHKSDVYSFGMMIME-LVG 270
              YIAPE+ +          D ++FG+++ E L G
Sbjct: 505 TPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAG 538

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 55.8 bits (135), Expect = 7e-09
 Identities = 30/103 (29%), Positives = 49/103 (47%), Gaps = 23/103 (22%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGAR- 234
           I+  L YLH      I++ D+K  N+LLD +   K++D+G+      KEG+     G   
Sbjct: 162 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC-----KEGLRP---GDTT 210

Query: 235 ----GIIGYIAPEVFSRNFGEVSH-KS-DVYSFGMMIME-LVG 270
               G   YIAPE+         +  S D ++ G+++ E + G
Sbjct: 211 STFCGTPNYIAPEILRGE----DYGFSVDWWALGVLMFEMMAG 249

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 30/88 (34%), Positives = 43/88 (48%), Gaps = 10/88 (11%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGAR- 234
           I  G++Y H      ++H D+KP N+LLD     KI+DFGL+ + +  E      L    
Sbjct: 125 ILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-----FLRTSC 176

Query: 235 GIIGYIAPEVFSRNFGEVSHKSDVYSFG 262
           G   Y APEV S        + D++S G
Sbjct: 177 GSPNYAAPEVISGR-LYAGPEVDIWSSG 203

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 53.6 bits (129), Expect = 4e-08
 Identities = 30/99 (30%), Positives = 47/99 (47%), Gaps = 18/99 (18%)

Query: 178 KGLEYLHHGCSTKILHFDIKPHNILLDEDFCP------KISDFGLAKLCTTKEGIVSSLL 231
            GL+Y+H  C   I+H DIKP N+L++    P      KI+D G A      +   ++ +
Sbjct: 142 LGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---CWYDEHYTNSI 196

Query: 232 GARGIIGYIAPEVFSRNFG-EVSHKSDVYSFGMMIMELV 269
             R    Y +PEV     G      +D++S   +I EL+
Sbjct: 197 QTR---EYRSPEVL---LGAPWGCGADIWSTACLIFELI 229

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 31/96 (32%), Positives = 47/96 (48%), Gaps = 15/96 (15%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP--KISDFGLAKLCTTKEGIVSSLLGA 233
           I + L+ LH     +I+H D+KP NILL +      K+ DFG +  C   +  V + + +
Sbjct: 209 ILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQ-RVYTYIQS 262

Query: 234 RGIIGYIAPEVFSRNFG-EVSHKSDVYSFGMMIMEL 268
           R    Y APEV     G       D++S G ++ EL
Sbjct: 263 R---FYRAPEVI---LGARYGMPIDMWSLGCILAEL 292

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 46.6 bits (111), Expect = 6e-06
 Identities = 32/170 (18%), Positives = 59/170 (34%), Gaps = 53/170 (31%)

Query: 90  KLGQGGFGGVYKGRLLD---------------------------------DFVNEVASIS 116
           K+G GGFG +Y     +                                 D + +     
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 117 RTSHVNVVTLLGF----CLEGNNRALIYEFMPNG-SLEK-FVYNGDTSKPCQYLRWEKMY 170
           +  ++ +    G         + R ++ E +  G  L+K    NG   K         + 
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTFKKST-------VL 154

Query: 171 EIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKI--SDFGLAK 218
           ++ I +   LEY+H     + +H DIK  N+LL      ++  +D+GL+ 
Sbjct: 155 QLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 45.5 bits (108), Expect = 1e-05
 Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 13/96 (13%)

Query: 176 IAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP--KISDFGLAKLCTTKEGIVSSLLGA 233
           +   L +L       I+H D+KP NILL        KI DFG +  C   +  +   + +
Sbjct: 166 MCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQ-RIYQYIQS 221

Query: 234 RGIIGYIAPEVFSRNFG-EVSHKSDVYSFGMMIMEL 268
           R    Y +PEV     G       D++S G +++E+
Sbjct: 222 R---FYRSPEVL---LGMPYDLAIDMWSLGCILVEM 251

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 45.3 bits (106), Expect = 2e-05
 Identities = 22/194 (11%), Positives = 44/194 (22%), Gaps = 75/194 (38%)

Query: 90  KLGQGGFGGVYKGRL-------------------------LDDFVNEVA---------SI 115
           K+G+G FG V++                             ++ + E+            
Sbjct: 27  KIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86

Query: 116 SRTSHVNVVTLLGFCL------------------------------EGNNRALIYEFMPN 145
                   + L                                   + +   ++ EF   
Sbjct: 87  VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146

Query: 146 G-SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLD 204
           G  LE+      +              I+  +   L         +  H D+   N+LL 
Sbjct: 147 GIDLEQMRTKLSS--------LATAKSILHQLTASLAVAEASL--RFEHRDLHWGNVLLK 196

Query: 205 EDFCPKISDFGLAK 218
           +    K+      K
Sbjct: 197 KTSLKKLHYTLNGK 210

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 44.5 bits (105), Expect = 4e-05
 Identities = 45/210 (21%), Positives = 70/210 (33%), Gaps = 80/210 (38%)

Query: 120 HVNVVTLLG-FCLEGNN---RALIYEFMPNG-SLEKFV-YNGDTSKPCQYLRWEKMYEIV 173
              VV LL  F + G N     +++E +  G  L K++  +     P   ++      I+
Sbjct: 100 REMVVQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQGLPLPCVKK-----II 152

Query: 174 IGIAKGLEYLHHGCSTKILHFDIKPHNILL------------------------------ 203
             + +GL+YLH  C  +I+H DIKP NILL                              
Sbjct: 153 QQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210

Query: 204 -------------------DEDFCPKISDFGLAKLCTTKE---GIVSSLLGARGIIGYIA 241
                               E    KI+D G A  C   +     + +         Y +
Sbjct: 211 STAPATAGNFLVNPLEPKNAEKLKVKIADLGNA--CWVHKHFTEDIQTR-------QYRS 261

Query: 242 PEVFSRNFG-EVSHKSDVYSFGMMIMELVG 270
            EV     G   +  +D++S   M  EL  
Sbjct: 262 LEVL---IGSGYNTPADIWSTACMAFELAT 288

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 44.0 bits (104), Expect = 5e-05
 Identities = 23/181 (12%), Positives = 55/181 (30%), Gaps = 55/181 (30%)

Query: 90  KLGQGGFGGVYKGRLLDDFVN-------EVA----------------------------- 113
              +   G +Y+                + +                             
Sbjct: 49  FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKW 108

Query: 114 -SISRTSHVNVVTLLGF-CLEGNNRALIYEFMPNG-SLEK-FVYNGDTSKPCQYLRWEKM 169
             +  T  + + T +GF   +   R L+   +  G SL+     +            E+ 
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLS------ERS 160

Query: 170 -YEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKI--SDFGLAKL-CTTKEG 225
             ++   +   LE+LH     + +H ++   NI +D +   ++  + +G A   C + + 
Sbjct: 161 VLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKH 217

Query: 226 I 226
           +
Sbjct: 218 V 218

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 42.1 bits (99), Expect = 2e-04
 Identities = 36/164 (21%), Positives = 64/164 (39%), Gaps = 38/164 (23%)

Query: 90  KLGQGGFGGVYKGRLLD-----DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 144
            +GQGGFG +Y   +            V  +  + +  + T L F         I +++ 
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 145 NGSLE-----KFVYNGDTSKPCQYLRW----------EKMYEI---------VIGIA--- 177
              L+     K+  +G   K  +  R+          +K+YE          V+ ++   
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRI 161

Query: 178 -KGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKI--SDFGLAK 218
              LEY+H     + +H DIK  N+LL+     ++   D+GLA 
Sbjct: 162 LDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 41.6 bits (98), Expect = 2e-04
 Identities = 32/159 (20%), Positives = 57/159 (35%), Gaps = 46/159 (28%)

Query: 90  KLGQGGFGGVYKGRLLDDFVNEVASISRTSH--------------------VNVVTLLGF 129
           ++G+G FG +++G  L +  N+  +I                           +  +  F
Sbjct: 17  RIGEGSFGVIFEGTNLLN--NQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 74

Query: 130 CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKM-YEIVIGIAK----GLEYLH 184
             EG +  L+ + +   SLE      D    C      K   + V   AK     ++ +H
Sbjct: 75  GQEGLHNVLVIDLLGP-SLE------DLLDLCG----RKFSVKTVAMAAKQMLARVQSIH 123

Query: 185 HGCSTKILHFDIKPHNILLDEDFCPK-----ISDFGLAK 218
                 +++ DIKP N L+            + DFG+ K
Sbjct: 124 ---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 40.8 bits (96), Expect = 5e-04
 Identities = 37/160 (23%), Positives = 54/160 (33%), Gaps = 48/160 (30%)

Query: 90  KLGQGGFGGVYKGRLLDDFVNEVA-------------------SISRTSHVNVVTLLGFC 130
           K+G G FG +  G+ L      VA                        S   +  +  F 
Sbjct: 16  KIGCGNFGELRLGKNLYTN-EYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFG 74

Query: 131 LEGNNRALIYEFMPNG-SLEK-FVYNGDTSKPCQYLRWEKM-YEIVIGIAK----GLEYL 183
             G   A++ E +  G SLE  F                    + V+ IA      +EY+
Sbjct: 75  PCGKYNAMVLELL--GPSLEDLFDLCD-----------RTFSLKTVLMIAIQLISRMEYV 121

Query: 184 HHGCSTKILHFDIKPHNILLDEDFCPK-----ISDFGLAK 218
           H   S  +++ D+KP N L+            I DF LAK
Sbjct: 122 H---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 40.0 bits (94), Expect = 6e-04
 Identities = 36/154 (23%), Positives = 56/154 (36%), Gaps = 38/154 (24%)

Query: 90  KLGQGGFGGVYKGRLLDDFVNEVASISRTSH--------------------VNVVTLLGF 129
           K+G G FG +Y G  +     E  +I                         V + T+   
Sbjct: 16  KIGSGSFGDIYLGTDIAA--GEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 73

Query: 130 CLEGNNRALIYEFMPNG-SLEK-FVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
             EG+   ++ E +  G SLE  F +             + +  +   +   +EY+H   
Sbjct: 74  GAEGDYNVMVMELL--GPSLEDLFNFCSRK------FSLKTVLLLADQMISRIEYIH--- 122

Query: 188 STKILHFDIKPHNILLDEDFCPK---ISDFGLAK 218
           S   +H D+KP N L+          I DFGLAK
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 40.4 bits (94), Expect = 7e-04
 Identities = 38/154 (24%), Positives = 60/154 (38%), Gaps = 38/154 (24%)

Query: 90  KLGQGGFGGVYKGRLLDDFVNEVASISRTSH--------------------VNVVTLLGF 129
           K+G G FG +Y G  +    NE  +I   +                       +  +  F
Sbjct: 14  KIGSGSFGEIYLGTNIQT--NEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWF 71

Query: 130 CLEGNNRALIYEFMPNG-SLEK-FVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
            +EG+   L+ + +  G SLE  F +        + L  + +  +   +   +E++H   
Sbjct: 72  GVEGDYNVLVMDLL--GPSLEDLFNFCS------RKLSLKTVLMLADQMINRVEFVH--- 120

Query: 188 STKILHFDIKPHNILLDEDFCPK---ISDFGLAK 218
           S   LH DIKP N L+          I DFGLAK
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	372
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.85
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.71
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.56
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.19
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.02
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.02
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.83
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.49
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.27
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.2
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.04
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.98
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.88
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.53
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.4
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.22
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.16
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.8
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.44
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.26
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.15
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.12
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.64
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	94.54
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	92.97
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	91.44
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	91.06
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	90.83
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	90.28
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	89.87
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	89.67
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	89.12
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	87.71
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	80.98

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=6.8e-57  Score=409.95  Aligned_cols=245  Identities=28%  Similarity=0.470  Sum_probs=191.3

Q ss_pred             hhhhhcCCCCceEEEEEEecc------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS  147 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~  147 (372)
                      .+.++||+|+||+||+|++.+                  +|.+|+.++++++|||||+++|+|.+ +..+||||||++|+
T Consensus        39 ~l~~~iG~G~fG~Vy~~~~~~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGs  117 (307)
T 3omv_A           39 MLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSS  117 (307)
T ss_dssp             CEEEECCCCSSSEEEEEESSSEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCB
T ss_pred             EEeeEEeeCCCcEEEEEEECCcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCC
Confidence            456789999999999997632                  58999999999999999999999865 56899999999999


Q ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCee
Q 036435          148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV  227 (372)
Q Consensus       148 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  227 (372)
                      |.++|.....     .++|.+++.++.|+|+||+|||   +.+||||||||+|||+++++.+||+|||+|+.........
T Consensus       118 L~~~l~~~~~-----~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~  189 (307)
T 3omv_A          118 LYKHLHVQET-----KFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ  189 (307)
T ss_dssp             HHHHHHTSCC-----CCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred             HHHHHhhcCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence            9999976542     2999999999999999999999   7899999999999999999999999999998754332221


Q ss_pred             eeecccccccccccccccccc-cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCcc
Q 036435          228 SSLLGARGIIGYIAPEVFSRN-FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV  306 (372)
Q Consensus       228 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (372)
                       ......||+.|||||++.+. .+.++.++|||||||++|||+||+.||......       ..+...+......  |. 
T Consensus       190 -~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~-------~~~~~~~~~~~~~--p~-  258 (307)
T 3omv_A          190 -QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR-------DQIIFMVGRGYAS--PD-  258 (307)
T ss_dssp             -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------HHHHHHHHTTCCC--CC-
T ss_pred             -eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH-------HHHHHHHhcCCCC--CC-
Confidence             12345699999999999653 246899999999999999999999999754321       1122222222111  11 


Q ss_pred             CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccC
Q 036435          307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEAL  350 (372)
Q Consensus       307 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~  350 (372)
                      ......+++..+.+++.+||+.||++||||+||++.|+.+..+.
T Consensus       259 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l  302 (307)
T 3omv_A          259 LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL  302 (307)
T ss_dssp             STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred             cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence            11112234567888999999999999999999999998776543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.4e-57  Score=414.44  Aligned_cols=247  Identities=25%  Similarity=0.401  Sum_probs=200.9

Q ss_pred             HHHHHHhhhhhhcCCCCceEEEEEEec-------------------------chHHHHHHHHhccCCCceeeeEeEEecC
Q 036435           79 DVKKLTNSFKDKLGQGGFGGVYKGRLL-------------------------DDFVNEVASISRTSHVNVVTLLGFCLEG  133 (372)
Q Consensus        79 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~  133 (372)
                      ++...+.+|.++||+|+||+||+|++.                         ++|.+|+.++++++|||||+++|+|.++
T Consensus        22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~  101 (308)
T 4gt4_A           22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD  101 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence            333445567889999999999999752                         1689999999999999999999999999


Q ss_pred             CceeEEEEecCCCChhhhhhcCCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE
Q 036435          134 NNRALIYEFMPNGSLEKFVYNGDTS----------KPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL  203 (372)
Q Consensus       134 ~~~~lV~e~~~~g~L~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill  203 (372)
                      +..+||||||++|+|.++|......          .....++|.+++.++.|||+||+|||   +.+||||||||+|||+
T Consensus       102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl  178 (308)
T 4gt4_A          102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLV  178 (308)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEE
Confidence            9999999999999999999764321          11234999999999999999999999   7999999999999999


Q ss_pred             CCCCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCC
Q 036435          204 DEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSS  282 (372)
Q Consensus       204 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~  282 (372)
                      ++++.+||+|||+|+......... ......||+.|||||++.+.  .++.++|||||||++|||+| |..||.....  
T Consensus       179 ~~~~~~Ki~DFGlar~~~~~~~~~-~~~~~~gt~~ymAPE~l~~~--~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~--  253 (308)
T 4gt4_A          179 YDKLNVKISDLGLFREVYAADYYK-LLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--  253 (308)
T ss_dssp             CGGGCEEECCSCCBCGGGGGGCBC-SSSSSCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--
T ss_pred             CCCCCEEECCcccceeccCCCcee-EecccccCCcccCHHHHhCC--CCCccchhhhHHHHHHHHHhCCCCCCCCCCH--
Confidence            999999999999998765433221 12345689999999999875  89999999999999999998 8889875421  


Q ss_pred             CccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 036435          283 SEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGS  346 (372)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~  346 (372)
                            ..+...+..+.....|.       +++..+.+++.+||+.||++||||+||++.|+..
T Consensus       254 ------~~~~~~i~~~~~~~~p~-------~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          254 ------QDVVEMIRNRQVLPCPD-------DCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             ------HHHHHHHHTTCCCCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             ------HHHHHHHHcCCCCCCcc-------cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                  12334444443333332       2345678899999999999999999999999854

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=6.3e-57  Score=409.92  Aligned_cols=243  Identities=26%  Similarity=0.436  Sum_probs=198.0

Q ss_pred             hhhhhcCCCCceEEEEEEec------------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYE  141 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  141 (372)
                      .+.++||+|+||+||+|++.                        ++|.+|+++|++++|||||+++|+|.+++..+||||
T Consensus        16 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E   95 (299)
T 4asz_A           16 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFE   95 (299)
T ss_dssp             EEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             EEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEE
Confidence            45678999999999999752                        158999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhcCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeec
Q 036435          142 FMPNGSLEKFVYNGDT-------SKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDF  214 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~-------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  214 (372)
                      ||++|+|.++|.....       ......++|.+++.++.|+++||+|||   +.+|+||||||+|||+++++.+||+||
T Consensus        96 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki~DF  172 (299)
T 4asz_A           96 YMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGDF  172 (299)
T ss_dssp             CCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             cCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEECCc
Confidence            9999999999976431       112234999999999999999999999   799999999999999999999999999


Q ss_pred             CCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHH
Q 036435          215 GLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYR  293 (372)
Q Consensus       215 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  293 (372)
                      |+|+.......... .....||+.|||||++.+.  .++.++|||||||++|||+| |+.||.....        ..+..
T Consensus       173 Gla~~~~~~~~~~~-~~~~~gt~~ymAPE~~~~~--~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--------~~~~~  241 (299)
T 4asz_A          173 GMSRDVYSTDYYRV-GGHTMLPIRWMPPESIMYR--KFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--------NEVIE  241 (299)
T ss_dssp             SCHHHHTGGGCEEE-TTTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------HHHHH
T ss_pred             ccceecCCCCceee-cCceecChhhcCHHHHcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHH
Confidence            99987654433222 2334589999999999875  89999999999999999998 8999975421        12334


Q ss_pred             HhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 036435          294 HVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~  349 (372)
                      .+..+.....|..       ++.++.+++.+||+.||++|||++++++.|+++..+
T Consensus       242 ~i~~~~~~~~p~~-------~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          242 CITQGRVLQRPRT-------CPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             HHHHTCCCCCCTT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHcCCCCCCCcc-------chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            4444444444432       345678899999999999999999999999987654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.2e-56  Score=411.73  Aligned_cols=243  Identities=24%  Similarity=0.399  Sum_probs=192.7

Q ss_pred             hhhhhcCCCCceEEEEEEec------------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYE  141 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  141 (372)
                      .+.++||+|+||+||+|++.                        ++|.+|+++|++++|||||+++|+|.+++..+||||
T Consensus        44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E  123 (329)
T 4aoj_A           44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE  123 (329)
T ss_dssp             EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            34578999999999999752                        168999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhcCCCCC---------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEe
Q 036435          142 FMPNGSLEKFVYNGDTSK---------PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKIS  212 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~---------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  212 (372)
                      ||++|+|.++++......         ....++|.+++.++.|+++||+|||   +.+|+||||||+|||+++++.+||+
T Consensus       124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~Ki~  200 (329)
T 4aoj_A          124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIG  200 (329)
T ss_dssp             CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEEC
T ss_pred             cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcEEEc
Confidence            999999999998754211         1234999999999999999999999   7999999999999999999999999


Q ss_pred             ecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHH
Q 036435          213 DFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWI  291 (372)
Q Consensus       213 Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  291 (372)
                      |||+|+.......... .....||+.|||||++.+.  .++.++|||||||++|||+| |+.||.....        ..+
T Consensus       201 DFGla~~~~~~~~~~~-~~~~~gt~~ymAPE~~~~~--~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~--------~~~  269 (329)
T 4aoj_A          201 DFGMSRDIYSTDYYRV-GGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQPWYQLSN--------TEA  269 (329)
T ss_dssp             CCC-----------------CCCCGGGCCHHHHTTC--CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH--------HHH
T ss_pred             ccccceeccCCCccee-cCcccccccccChhhhcCC--CCCccccccchHHHHHHHHcCCCCCCCCCCH--------HHH
Confidence            9999987654332221 2345689999999999875  89999999999999999999 8999975421        123


Q ss_pred             HHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 036435          292 YRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~  349 (372)
                      ...+..+.....|..       ++..+.+++.+||+.||++|||++||++.|+.+.+.
T Consensus       270 ~~~i~~g~~~~~p~~-------~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          270 IDCITQGRELERPRA-------CPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             HHHHHHTCCCCCCTT-------CCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHcCCCCCCccc-------ccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            344444444444432       345678899999999999999999999999988754

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.1e-54  Score=399.17  Aligned_cols=238  Identities=21%  Similarity=0.236  Sum_probs=189.4

Q ss_pred             hhhhcCCCCceEEEEEEecc--------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCChhhhh
Q 036435           87 FKDKLGQGGFGGVYKGRLLD--------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV  152 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~--------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~~~l  152 (372)
                      +.++||+|+||.||+|++..              ...+|+.++++++|||||++++++.+++..|||||||+||+|.+++
T Consensus        62 ~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l  141 (336)
T 4g3f_A           62 HQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI  141 (336)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHH
T ss_pred             eCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHH
Confidence            34679999999999998643              2468999999999999999999999999999999999999999999


Q ss_pred             hcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC-ceEEeecCCcccccCCCCeee--e
Q 036435          153 YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDF-CPKISDFGLAKLCTTKEGIVS--S  229 (372)
Q Consensus       153 ~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgla~~~~~~~~~~~--~  229 (372)
                      .+.+.      +++.++..++.||+.||+|||   +.+|+||||||+|||++.++ .+||+|||+|+..........  .
T Consensus       142 ~~~~~------l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~  212 (336)
T 4g3f_A          142 KQMGC------LPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT  212 (336)
T ss_dssp             HHHSS------CCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----------
T ss_pred             HHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceec
Confidence            76542      999999999999999999999   89999999999999999887 699999999987654332111  1


Q ss_pred             ecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCCc
Q 036435          230 LLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTR  309 (372)
Q Consensus       230 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (372)
                      .....||+.|||||++.+.  .++.++|||||||++|||+||+.||........        ...+..... ...    .
T Consensus       213 ~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--------~~~i~~~~~-~~~----~  277 (336)
T 4g3f_A          213 GDYIPGTETHMAPEVVMGK--PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL--------CLKIASEPP-PIR----E  277 (336)
T ss_dssp             -CCCCCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC--------HHHHHHSCC-GGG----G
T ss_pred             CCccccCccccCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH--------HHHHHcCCC-Cch----h
Confidence            2234699999999999875  789999999999999999999999976543221        111111111 000    1


Q ss_pred             chHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 036435          310 KENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE  348 (372)
Q Consensus       310 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~  348 (372)
                      ....+...+.+++.+||++||.+|||+.|+++.|.....
T Consensus       278 ~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~  316 (336)
T 4g3f_A          278 IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ  316 (336)
T ss_dssp             SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            112334667788999999999999999999988866553

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2e-53  Score=384.44  Aligned_cols=225  Identities=25%  Similarity=0.426  Sum_probs=181.1

Q ss_pred             hhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEec----CCceeEEEE
Q 036435           87 FKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLE----GNNRALIYE  141 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~----~~~~~lV~e  141 (372)
                      |.++||+|+||+||+|.+..                     .|.+|+.+|++++|||||+++++|.+    ++..|||||
T Consensus        30 ~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmE  109 (290)
T 3fpq_A           30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE  109 (290)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred             eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEe
Confidence            45679999999999997642                     58899999999999999999999875    346899999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCceEEC-CCCceEEeecCCcc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTK--ILHFDIKPHNILLD-EDFCPKISDFGLAK  218 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~--ivH~dlk~~Nill~-~~~~~kl~Dfgla~  218 (372)
                      ||++|+|.+++.+...      +++..+..++.||+.||+|||   +.+  |+||||||+|||++ .++.+||+|||+|+
T Consensus       110 y~~gg~L~~~l~~~~~------l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~  180 (290)
T 3fpq_A          110 LMTSGTLKTYLKRFKV------MKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             CCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             CCCCCCHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence            9999999999976542      899999999999999999999   666  99999999999998 47999999999998


Q ss_pred             cccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhc
Q 036435          219 LCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQD  298 (372)
Q Consensus       219 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (372)
                      ......     .....||+.|||||++.+   .++.++|||||||++|||+||+.||......       ..+...+...
T Consensus       181 ~~~~~~-----~~~~~GTp~YmAPE~~~~---~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-------~~~~~~i~~~  245 (290)
T 3fpq_A          181 LKRASF-----AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNA-------AQIYRRVTSG  245 (290)
T ss_dssp             GCCTTS-----BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-------HHHHHHHTTT
T ss_pred             eCCCCc-----cCCcccCccccCHHHcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-------HHHHHHHHcC
Confidence            644322     123469999999999864   6899999999999999999999999753221       1123333322


Q ss_pred             ccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          299 REFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ..   |...   ......++.+++.+||+.||++|||++|+++
T Consensus       246 ~~---~~~~---~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          246 VK---PASF---DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             CC---CGGG---GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CC---CCCC---CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11   1111   1112345778999999999999999999986

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.8e-53  Score=389.20  Aligned_cols=254  Identities=21%  Similarity=0.282  Sum_probs=189.7

Q ss_pred             hhhhcCCCCceEEEEEEecc--------------hH--HHHHHHHhccCCCceeeeEeEEecCC----ceeEEEEecCCC
Q 036435           87 FKDKLGQGGFGGVYKGRLLD--------------DF--VNEVASISRTSHVNVVTLLGFCLEGN----NRALIYEFMPNG  146 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~--------------~~--~~E~~~l~~l~h~nIv~l~g~~~~~~----~~~lV~e~~~~g  146 (372)
                      +.++||+|+||+||+|++.+              ++  ..|+..+.+++|||||+++|+|.+++    .++||||||++|
T Consensus         7 L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~g   86 (303)
T 3hmm_A            7 LQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG   86 (303)
T ss_dssp             EEEEEEECSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTC
T ss_pred             EEEEEeeCCCeEEEEEEECCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCC
Confidence            45789999999999998743              23  34566667889999999999998764    579999999999


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG-----CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-----~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      +|.++++...       ++|..+++++.|++.||+|||+.     ...+|+||||||+|||+|+++.+||+|||+|+...
T Consensus        87 sL~~~l~~~~-------l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  159 (303)
T 3hmm_A           87 SLFDYLNRYT-------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD  159 (303)
T ss_dssp             BHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred             cHHHHHHhCC-------CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence            9999998653       89999999999999999999942     12399999999999999999999999999998766


Q ss_pred             CCCCeee-eeccccccccccccccccccc----CCCCccccchhHHHHHHHHhcCCCCCCCCCCCCC--------ccchH
Q 036435          222 TKEGIVS-SLLGARGIIGYIAPEVFSRNF----GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSS--------EVYFP  288 (372)
Q Consensus       222 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~--------~~~~~  288 (372)
                      ....... ......||+.|||||++.+..    ..++.++|||||||++|||+||++|+........        .....
T Consensus       160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~  239 (303)
T 3hmm_A          160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE  239 (303)
T ss_dssp             TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred             CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH
Confidence            5443322 123346999999999987531    1467899999999999999999988754322110        01111


Q ss_pred             HHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 036435          289 HWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~  349 (372)
                      ...........+...|....  ..+....+.+++.+||+.||++||||.||++.|+++.+.
T Consensus       240 ~~~~~~~~~~~rp~~p~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          240 EMRKVVCEQKLRPNIPNRWQ--SCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             HHHHHHTTSCCCCCCCGGGG--SSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHhcccCCCCCCcccc--chHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            11111122222222332221  224567788999999999999999999999999887643

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=6.4e-54  Score=395.30  Aligned_cols=228  Identities=23%  Similarity=0.325  Sum_probs=189.1

Q ss_pred             hhhhhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      ++.++||+|+||+||+|+...                   .+.+|+.+|++++|||||++++++.+++.+|||||||++|
T Consensus        77 ~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg  156 (346)
T 4fih_A           77 DNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG  156 (346)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTE
T ss_pred             EEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCC
Confidence            335679999999999997642                   5889999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      +|.+++.+..       +++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+........
T Consensus       157 ~L~~~l~~~~-------l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~  226 (346)
T 4fih_A          157 ALTDIVTHTR-------MNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR  226 (346)
T ss_dssp             EHHHHHHHSC-------CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred             cHHHHHHcCC-------CCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence            9999997643       899999999999999999999   799999999999999999999999999999876544322


Q ss_pred             eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCcc
Q 036435          227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV  306 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (372)
                         .....||+.|||||++.+.  .++.++|||||||++|||++|+.||.....        ......+........+  
T Consensus       227 ---~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~~~i~~~~~~~~~--  291 (346)
T 4fih_A          227 ---RKSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------LKAMKMIRDNLPPRLK--  291 (346)
T ss_dssp             ---BCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHSSCCCCS--
T ss_pred             ---ccccccCcCcCCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHHcCCCCCCC--
Confidence               2345699999999999875  789999999999999999999999975321        1122222222111111  


Q ss_pred             CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       307 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                         ....+...+.+++.+||+.||++|||++|+++
T Consensus       292 ---~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          292 ---NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             ---CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               12234567788999999999999999999986

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=7.8e-54  Score=397.87  Aligned_cols=246  Identities=28%  Similarity=0.429  Sum_probs=199.2

Q ss_pred             HhhhhhhcCCCCceEEEEEEec-------------------------chHHHHHHHHhccCC-CceeeeEeEEecC-Cce
Q 036435           84 TNSFKDKLGQGGFGGVYKGRLL-------------------------DDFVNEVASISRTSH-VNVVTLLGFCLEG-NNR  136 (372)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-------------------------~~~~~E~~~l~~l~h-~nIv~l~g~~~~~-~~~  136 (372)
                      .+.+.+.||+|+||+||+|++.                         ++|.+|+.+|.+++| ||||+++|+|.+. +.+
T Consensus        65 ~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~  144 (353)
T 4ase_A           65 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL  144 (353)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCC
T ss_pred             HeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEE
Confidence            3445678999999999999642                         158899999999965 8999999999764 568


Q ss_pred             eEEEEecCCCChhhhhhcCCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC
Q 036435          137 ALIYEFMPNGSLEKFVYNGDTS----------KPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDED  206 (372)
Q Consensus       137 ~lV~e~~~~g~L~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~  206 (372)
                      ++|||||++|+|.++|+.....          .....+++.+++.++.|||+||+|||   +.+||||||||+|||++++
T Consensus       145 ~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~  221 (353)
T 4ase_A          145 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEK  221 (353)
T ss_dssp             EEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGG
T ss_pred             EEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCccceeeCCC
Confidence            9999999999999999764321          11234899999999999999999999   7999999999999999999


Q ss_pred             CceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCcc
Q 036435          207 FCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEV  285 (372)
Q Consensus       207 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~  285 (372)
                      +.+||+|||+|+.......... .....||+.|||||++.+.  .++.++|||||||++|||+| |+.||......    
T Consensus       222 ~~vKi~DFGlar~~~~~~~~~~-~~~~~gt~~ymAPE~l~~~--~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~----  294 (353)
T 4ase_A          222 NVVKICDFGLARDIYKDPDYVR-KGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----  294 (353)
T ss_dssp             GCEEECCCGGGSCTTTCTTSEE-ETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS----
T ss_pred             CCEEECcchhhhhcccCCCcee-eccccccccccCHHHHhcC--CCCCcccEeehHHHHHHHHhCCCCCCCCCCHH----
Confidence            9999999999997655443322 3445689999999999875  89999999999999999998 89999754321    


Q ss_pred             chHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 036435          286 YFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~  349 (372)
                         ..+...+..+..+..|...       ..++.+++.+||+.||++|||++|+++.|+.+.++
T Consensus       295 ---~~~~~~i~~g~~~~~p~~~-------~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          295 ---EEFCRRLKEGTRMRAPDYT-------TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             ---HHHHHHHHHTCCCCCCTTC-------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---HHHHHHHHcCCCCCCCccC-------CHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence               2244455555555555432       34677889999999999999999999999876543

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.9e-54  Score=396.67  Aligned_cols=230  Identities=22%  Similarity=0.360  Sum_probs=183.3

Q ss_pred             hhhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      +.+.+.||+|+||+||+++...                     .+.+|+.+|++++|||||++++++.+++..|||||||
T Consensus        26 Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~  105 (350)
T 4b9d_A           26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYC  105 (350)
T ss_dssp             EEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             eEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            3456789999999999997632                     5889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      +||+|.+++......    .+++.+++.++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+|+.....
T Consensus       106 ~gg~L~~~i~~~~~~----~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          106 EGGDLFKRINAQKGV----LFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             TTCBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred             CCCcHHHHHHHcCCC----CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence            999999999765432    2789999999999999999999   799999999999999999999999999999876432


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                      ...   .....||+.|||||++.+.  .++.++|||||||++|||+||+.||.....       .. +...+........
T Consensus       179 ~~~---~~~~~GT~~YmAPE~l~~~--~y~~~~DiwSlGvilyemltG~~PF~~~~~-------~~-~~~~i~~~~~~~~  245 (350)
T 4b9d_A          179 VEL---ARACIGTPYYLSPEICENK--PYNNKSDIWALGCVLYELCTLKHAFEAGSM-------KN-LVLKIISGSFPPV  245 (350)
T ss_dssp             HHH---HHHHHSCCTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HH-HHHHHHHTCCCCC
T ss_pred             ccc---ccccCCCccccCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------HH-HHHHHHcCCCCCC
Confidence            211   1234699999999999875  789999999999999999999999975421       11 2222222221111


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      +       ..+...+.+++.+||++||++|||++|+++
T Consensus       246 ~-------~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          246 S-------LHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             C-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             C-------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            2       123456788999999999999999999985

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.8e-53  Score=384.62  Aligned_cols=228  Identities=25%  Similarity=0.348  Sum_probs=189.6

Q ss_pred             hhhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEe
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      +.+.+.||+|+||+||+++...                      .+.+|+++|++++|||||++++++.+++..|+||||
T Consensus        34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy  113 (311)
T 4aw0_A           34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY  113 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence            4567889999999999997632                      578999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      |+||+|.+++.+.+.      +++.++..++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+|+....
T Consensus       114 ~~gG~L~~~i~~~~~------l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~  184 (311)
T 4aw0_A          114 AKNGELLKYIRKIGS------FDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  184 (311)
T ss_dssp             CTTEEHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             CCCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence            999999999976543      999999999999999999999   79999999999999999999999999999997654


Q ss_pred             CCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      ..... ......||+.|||||++.+.  .++.++||||+||++|||++|+.||.....        ..+...+... .+.
T Consensus       185 ~~~~~-~~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~~~i~~~-~~~  252 (311)
T 4aw0_A          185 ESKQA-RANSFVGTAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPFRAGNE--------GLIFAKIIKL-EYD  252 (311)
T ss_dssp             TTTCC-CBCCCCSCGGGCCHHHHHHS--CBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHT-CCC
T ss_pred             CCCcc-cccCcccCcccCCHHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcC-CCC
Confidence            33221 12345799999999999875  789999999999999999999999975421        1122222222 233


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI  340 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl  340 (372)
                      .|..       +..++.+++.+||++||++|||++|++
T Consensus       253 ~p~~-------~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          253 FPEK-------FFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             CCTT-------CCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             CCcc-------cCHHHHHHHHHHccCCHhHCcChHHHc
Confidence            3332       234677899999999999999999863

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1e-52  Score=396.58  Aligned_cols=227  Identities=23%  Similarity=0.325  Sum_probs=188.3

Q ss_pred             hhhhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCC
Q 036435           87 FKDKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS  147 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~  147 (372)
                      +.++||+|+||.||+|+...                   .+.+|+.+|++++|||||++++++.+++.+|||||||+||+
T Consensus       155 ~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~  234 (423)
T 4fie_A          155 NFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA  234 (423)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred             eeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCc
Confidence            34679999999999997642                   58899999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCee
Q 036435          148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV  227 (372)
Q Consensus       148 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  227 (372)
                      |.+++....       +++.++..++.||+.||+|||   +.+|+||||||+||||+.++.+||+|||+|+........ 
T Consensus       235 L~~~i~~~~-------l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~-  303 (423)
T 4fie_A          235 LTDIVTHTR-------MNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-  303 (423)
T ss_dssp             HHHHHHHSC-------CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC-
T ss_pred             HHHHHhccC-------CCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc-
Confidence            999997643       899999999999999999999   799999999999999999999999999999876543322 


Q ss_pred             eeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccC
Q 036435          228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVV  307 (372)
Q Consensus       228 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (372)
                        .....||+.|||||++.+.  .++.++|||||||++|||++|+.||.....        ..+...+........+   
T Consensus       304 --~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~~~i~~~~~~~~~---  368 (423)
T 4fie_A          304 --RKSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------LKAMKMIRDNLPPRLK---  368 (423)
T ss_dssp             --BCCCEECTTTCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHSCCCCCS---
T ss_pred             --ccccccCcCcCCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHHcCCCCCCc---
Confidence              2345699999999999875  789999999999999999999999975321        1122223222111111   


Q ss_pred             CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          308 TRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       308 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                        ....+...+.+++.+||+.||++|||++|+++
T Consensus       369 --~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          369 --NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             --CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              11123456788999999999999999999986

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=4.6e-52  Score=372.38  Aligned_cols=226  Identities=23%  Similarity=0.382  Sum_probs=175.6

Q ss_pred             hhhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEe
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      +.+.+.||+|+||+||+++...                      .+.+|+.++++++|||||++++++.+++..|+||||
T Consensus        15 Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   94 (275)
T 3hyh_A           15 YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY   94 (275)
T ss_dssp             CEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeC
Confidence            4556889999999999996532                      588999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      + +|+|.+++.+...      +++.++..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+|+....
T Consensus        95 ~-~g~L~~~l~~~~~------l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  164 (275)
T 3hyh_A           95 A-GNELFDYIVQRDK------MSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD  164 (275)
T ss_dssp             C-CEEHHHHHHHSCS------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred             C-CCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence            9 6899999977543      999999999999999999999   79999999999999999999999999999986544


Q ss_pred             CCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      ...    .....||+.|||||++.+. ...+.++||||+||++|||+||+.||.....        ..+...+... ...
T Consensus       165 ~~~----~~~~~GT~~Y~APE~~~~~-~y~~~~~DiwSlGvily~lltg~~PF~~~~~--------~~~~~~i~~~-~~~  230 (275)
T 3hyh_A          165 GNF----LKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYVMLCRRLPFDDESI--------PVLFKNISNG-VYT  230 (275)
T ss_dssp             --------------CTTSCHHHHSSS-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHT-CCC
T ss_pred             CCc----cCCeeECcccCChhhhcCC-CCCCChhhhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHcC-CCC
Confidence            321    2335699999999999875 2346899999999999999999999975321        1122222222 222


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .|..       +...+.+++.+||+.||++|||++|+++
T Consensus       231 ~p~~-------~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          231 LPKF-------LSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             CCTT-------SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCC-------CCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            3322       3356778899999999999999999987

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.6e-52  Score=378.95  Aligned_cols=227  Identities=24%  Similarity=0.324  Sum_probs=180.1

Q ss_pred             hhhhhhcCCCCceEEEEEEec------------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIY  140 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~  140 (372)
                      +++.+.||+|+||+||+++..                        ..+.+|+.+|++++|||||++++++.+++..|+||
T Consensus        26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm  105 (304)
T 3ubd_A           26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLIL  105 (304)
T ss_dssp             EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEE
T ss_pred             cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            455688999999999998642                        15888999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccc
Q 036435          141 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC  220 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~  220 (372)
                      |||+||+|.+++.+...      +++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+..
T Consensus       106 Ey~~gg~L~~~l~~~~~------l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          106 DFLRGGDLFTRLSKEVM------FTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             CCCTTCEEHHHHHHHCC------CCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             EcCCCCCHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            99999999999987543      899999999999999999999   799999999999999999999999999999865


Q ss_pred             cCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccc
Q 036435          221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDRE  300 (372)
Q Consensus       221 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (372)
                      ......   .....||+.|||||++.+.  .++.++||||+||++|||+||+.||.....        ..+...+... .
T Consensus       177 ~~~~~~---~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~~~i~~~-~  242 (304)
T 3ubd_A          177 IDHEKK---AYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGTLPFQGKDR--------KETMTMILKA-K  242 (304)
T ss_dssp             ----CC---CCSCCCCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHC-C
T ss_pred             cCCCcc---ccccccCcccCCHHHhccC--CCCCCCcccchHHHHHHHHhCCCCCCCcCH--------HHHHHHHHcC-C
Confidence            433221   2345699999999999875  789999999999999999999999975421        1122222221 2


Q ss_pred             ccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 036435          301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPP-----MNEVIE  341 (372)
Q Consensus       301 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~  341 (372)
                      ...|..       ++.++.+++.+||++||++|||     ++|+++
T Consensus       243 ~~~p~~-------~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          243 LGMPQF-------LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             CCCCTT-------SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             CCCCCc-------CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            233322       3456778999999999999998     467764

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.6e-50  Score=368.27  Aligned_cols=232  Identities=25%  Similarity=0.389  Sum_probs=172.2

Q ss_pred             hhhhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecCC----------
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEGN----------  134 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~----------  134 (372)
                      +++.+.||+|+||+||+|+...                    .+.+|+.+|++++|||||++++++.+.+          
T Consensus         7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~   86 (299)
T 4g31_A            7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP   86 (299)
T ss_dssp             EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred             CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence            3446789999999999997632                    5889999999999999999999987654          


Q ss_pred             --ceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEe
Q 036435          135 --NRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKIS  212 (372)
Q Consensus       135 --~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  212 (372)
                        ..|+|||||++|+|.+++.......   ...+..++.++.|+++||+|||   +.+|+||||||+|||++.++.+||+
T Consensus        87 ~~~l~ivmE~~~gg~L~~~l~~~~~~~---~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           87 KVYLYIQMQLCRKENLKDWMNGRCTIE---ERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             CEEEEEEEECCCSCCHHHHHHTCCSGG---GSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CcEEEEEEecCCCCcHHHHHHhcCCCC---hhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEc
Confidence              3689999999999999998754322   2567778999999999999999   7999999999999999999999999


Q ss_pred             ecCCcccccCCCCeee---------eecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCC
Q 036435          213 DFGLAKLCTTKEGIVS---------SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSS  283 (372)
Q Consensus       213 Dfgla~~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~  283 (372)
                      |||+|+..........         ......||+.|||||++.+.  .++.++|||||||++|||++   ||....    
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyell~---Pf~~~~----  231 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFELLY---PFSTQM----  231 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTC--CCCTHHHHHHHHHHHHHHHS---CCSSHH----
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCC--CCCCHHHHHHHHHHHHHHcc---CCCCcc----
Confidence            9999987654332111         12334699999999999875  88999999999999999996   654211    


Q ss_pred             ccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          284 EVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                           + ....+........|    ....+......+++.+||++||++|||+.|+++
T Consensus       232 -----~-~~~~~~~~~~~~~p----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          232 -----E-RVRTLTDVRNLKFP----PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             -----H-HHHHHHHHHTTCCC----HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----H-HHHHHHHHhcCCCC----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                 0 01111111111222    222334455678999999999999999999986

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-48  Score=366.53  Aligned_cols=242  Identities=19%  Similarity=0.258  Sum_probs=182.4

Q ss_pred             hhhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEec------CCcee
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLE------GNNRA  137 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~------~~~~~  137 (372)
                      +.+.+.||+|+||+||+|+...                     .+.+|+.+|++++|||||++++++..      .+..|
T Consensus        56 Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~  135 (398)
T 4b99_A           56 YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY  135 (398)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEE
T ss_pred             eEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEE
Confidence            3456789999999999997632                     47889999999999999999999864      35789


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCc
Q 036435          138 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLA  217 (372)
Q Consensus       138 lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla  217 (372)
                      ||||||+ |+|.+++....      .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|
T Consensus       136 ivmE~~~-g~L~~~i~~~~------~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          136 VVLDLME-SDLHQIIHSSQ------PLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             EEEECCS-EEHHHHHTSSS------CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEeCCC-CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeeccee
Confidence            9999995 68999997654      2999999999999999999999   899999999999999999999999999999


Q ss_pred             ccccCCCCe-eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhh
Q 036435          218 KLCTTKEGI-VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE  296 (372)
Q Consensus       218 ~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  296 (372)
                      +........ ........||+.|||||++.+. ..++.++||||+||++|||++|+.||.......    ....+.....
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~-~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~----~l~~I~~~~g  280 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSL-HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH----QLQLIMMVLG  280 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH----HHHHHHHHHC
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCC-CCCCChhheehhHHHHHHHHHCCCCCCCCCHHH----HHHHHHHhcC
Confidence            876443211 1223445799999999998764 357899999999999999999999997643211    0000110000


Q ss_pred             hcc---------------cccCCccCCcch----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          297 QDR---------------EFKLPGVVTRKE----NEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       297 ~~~---------------~~~~~~~~~~~~----~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ...               ....+.......    ......+.+++.+||+.||.+|||++|+++
T Consensus       281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          281 TPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             CCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            000               000111111111    112456788999999999999999999986

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=5.4e-47  Score=353.90  Aligned_cols=182  Identities=21%  Similarity=0.349  Sum_probs=154.2

Q ss_pred             hhhhhhcCCCCceEEEEEEec--------------------chHHHHHHHHhcc-CCCceeeeEeEEecCCceeEEEEec
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL--------------------DDFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~--------------------~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      +.+.++||+|+||+||+|+..                    .++.+|+++|+.+ +||||+++++++.++++.|+||||+
T Consensus        23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~  102 (361)
T 4f9c_A           23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYL  102 (361)
T ss_dssp             CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECC
T ss_pred             EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCC
Confidence            345678999999999999642                    1578999999998 6999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC-CceEEeecCCcccccC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDED-FCPKISDFGLAKLCTT  222 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgla~~~~~  222 (372)
                      ++|+|.+++..         +++.++..++.|++.||+|||   +.+|+||||||+|||++.+ +.+||+|||+|+....
T Consensus       103 ~g~~L~~~~~~---------l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~  170 (361)
T 4f9c_A          103 EHESFLDILNS---------LSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD  170 (361)
T ss_dssp             CCCCHHHHHTT---------CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred             CcccHHHHHcC---------CCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence            99999999832         889999999999999999999   8999999999999999876 7999999999986543


Q ss_pred             CCCe-------------------------eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCC
Q 036435          223 KEGI-------------------------VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDS  277 (372)
Q Consensus       223 ~~~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~  277 (372)
                      ....                         ........||+.|||||++.+. ..++.++||||+||++|||++|+.||..
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~y~~~~DiWSlG~il~ell~G~~Pf~~  249 (361)
T 4f9c_A          171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC-PNQTTAIDMWSAGVIFLSLLSGRYPFYK  249 (361)
T ss_dssp             CSCGGGGGC--------------------------CCCCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence            2110                         0112234699999999999764 3588999999999999999999999976


Q ss_pred             CC
Q 036435          278 GV  279 (372)
Q Consensus       278 ~~  279 (372)
                      ..
T Consensus       250 ~~  251 (361)
T 4f9c_A          250 AS  251 (361)
T ss_dssp             CS
T ss_pred             CC
Confidence            54

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.7e-46  Score=368.25  Aligned_cols=226  Identities=27%  Similarity=0.330  Sum_probs=181.9

Q ss_pred             hhhcCCCCceEEEEEEecc----------------------hHHH---HHHHHhccCCCceeeeEeEEecCCceeEEEEe
Q 036435           88 KDKLGQGGFGGVYKGRLLD----------------------DFVN---EVASISRTSHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~----------------------~~~~---E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      .+.||+|+||.||+++...                      .+.+   ++.+++.++|||||++++++.+++.+|+||||
T Consensus       194 ~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy  273 (689)
T 3v5w_A          194 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL  273 (689)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEec
Confidence            4679999999999997642                      1233   35677788999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      |+||+|.+++.+.+.      +++..+..++.||+.||+|||   +.+||||||||+||||+.+|.+||+|||+|+....
T Consensus       274 ~~GGdL~~~l~~~~~------l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          274 MNGGDLHYHLSQHGV------FSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             CCSCBHHHHHHHHCC------CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             CCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence            999999999987543      999999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      ..     .....||+.|||||++.+. ..++.++|+||+||++|||++|..||........     ..+..... .....
T Consensus       345 ~~-----~~t~~GTp~YmAPEvl~~~-~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~-----~~i~~~i~-~~~~~  412 (689)
T 3v5w_A          345 KK-----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRMTL-TMAVE  412 (689)
T ss_dssp             CC-----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH-----HHHHHHHH-HCCCC
T ss_pred             CC-----CCCccCCcCccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHhhc-CCCCC
Confidence            33     2345799999999999642 2689999999999999999999999975433221     11111111 11222


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPP-----MNEVIE  341 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~  341 (372)
                      .|..       +...+.+++.+||++||.+|++     ++|+++
T Consensus       413 ~p~~-------~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          413 LPDS-------FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             CCTT-------SCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             CCcc-------CCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            3322       3456778899999999999998     677774

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.9e-46  Score=370.31  Aligned_cols=231  Identities=24%  Similarity=0.344  Sum_probs=188.7

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      +.+.+.||+|+||+||+++...                   .+.+|+.+|++++|||||++++++.+++.+|+|||||+|
T Consensus       159 Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~g  238 (573)
T 3uto_A          159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG  238 (573)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred             cEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCC
Confidence            3456789999999999997632                   578899999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC--CceEEeecCCcccccCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDED--FCPKISDFGLAKLCTTK  223 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfgla~~~~~~  223 (372)
                      |+|.+++.....     .+++.++..++.||+.||+|||   +.+|+||||||+|||++.+  +.+||+|||+|+.....
T Consensus       239 g~L~~~i~~~~~-----~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          239 GELFEKVADEHN-----KMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CBHHHHHTCTTS-----CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             CcHHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            999999965432     2899999999999999999999   7999999999999999854  89999999999987654


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                      ...    ....||+.|||||++.+.  .++.++||||+||++|||++|..||......        .....+... ....
T Consensus       311 ~~~----~~~~GT~~y~APEv~~~~--~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~--------~~~~~i~~~-~~~~  375 (573)
T 3uto_A          311 QSV----KVTTGTAEFAAPEVAEGK--PVGYYTDMWSVGVLSYILLSGLSPFGGENDD--------ETLRNVKSC-DWNM  375 (573)
T ss_dssp             SEE----EEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHHTT-CCCC
T ss_pred             Cce----eeeEECccccCHHHhCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--------HHHHHHHhC-CCCC
Confidence            422    234699999999999885  7899999999999999999999999754221        122222221 1111


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      +.   .....+...+.+++.+||+.||.+|||++|+++
T Consensus       376 ~~---~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          376 DD---SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             CS---GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             Cc---ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11   112234456778999999999999999999987

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.2e-45  Score=338.53  Aligned_cols=271  Identities=38%  Similarity=0.699  Sum_probs=213.6

Q ss_pred             CCccccHHHHHHHHhhhh--hhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeE
Q 036435           71 PLKRYNFSDVKKLTNSFK--DKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGF  129 (372)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~--~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~  129 (372)
                      ....+++.++.....+|.  +.||+|+||.||+|+..+                   .+.+|+.++++++||||++++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            356788888888777664  679999999999996531                   57899999999999999999999


Q ss_pred             EecCCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCce
Q 036435          130 CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP  209 (372)
Q Consensus       130 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~  209 (372)
                      +.+++..++||||+++|+|.+++.......  ..+++..+..++.|++.||+|||+.+..+++||||||+|||++.++.+
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~  173 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQ--PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA  173 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTC--CCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence            999999999999999999999998764322  348999999999999999999994222399999999999999999999


Q ss_pred             EEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCC-CCCccchH
Q 036435          210 KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVD-SSSEVYFP  288 (372)
Q Consensus       210 kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~-~~~~~~~~  288 (372)
                      ||+|||++...........  ....||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||..... ........
T Consensus       174 kl~Dfg~~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  249 (326)
T 3uim_A          174 VVGDFGLAKLMDYKDTHVT--TAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL  249 (326)
T ss_dssp             EECCCSSCEECCSSSSCEE--CCCCSCGGGCCHHHHHHS--EECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHH
T ss_pred             EeccCccccccCccccccc--ccccCCcCccCHHHhccC--CCCccccchhHHHHHHHHHhCCCcccccccccccchhHH
Confidence            9999999987654433222  334589999999999764  789999999999999999999999963211 11222333


Q ss_pred             HHHHHHhhhcc--cccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          289 HWIYRHVEQDR--EFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       289 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                      .|+........  .............+....+.+++.+||+.||.+|||++++++.|++..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  310 (326)
T 3uim_A          250 DWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG  310 (326)
T ss_dssp             HHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred             HHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence            33332222211  111122223445667789999999999999999999999999998754

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.1e-45  Score=338.73  Aligned_cols=240  Identities=25%  Similarity=0.436  Sum_probs=193.9

Q ss_pred             hhhhhhcCCCCceEEEEEEec-----------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL-----------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYE  141 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-----------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  141 (372)
                      +.+.+.||+|+||.||+|++.                       +.+.+|+.++++++||||+++++++.+++..++|||
T Consensus        51 y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  130 (325)
T 3kul_A           51 IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTE  130 (325)
T ss_dssp             EEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEE
T ss_pred             eEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEee
Confidence            344578999999999999763                       158889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      |+++|+|.+++.....     .+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       131 ~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          131 YMENGSLDTFLRTHDG-----QFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             CCTTCBHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             CCCCCcHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            9999999999976532     2899999999999999999999   7999999999999999999999999999998776


Q ss_pred             CCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhccc
Q 036435          222 TKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDRE  300 (372)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (372)
                      .............+|+.|+|||.+.+.  .++.++||||||+++|||++ |..||.....        ......+.....
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~--------~~~~~~~~~~~~  272 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWNMTN--------RDVISSVEEGYR  272 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTSCH--------HHHHHHHHTTCC
T ss_pred             cCccceeeccCCCCcccccCHhHhcCC--CCCcHHHHHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHHHcCCC
Confidence            544333333444567889999999764  78999999999999999999 9999865422        112233333322


Q ss_pred             ccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 036435          301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       301 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~  349 (372)
                      ...+.       .+...+.+++.+||+.||.+|||++++++.|+.+...
T Consensus       273 ~~~~~-------~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~  314 (325)
T 3kul_A          273 LPAPM-------GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS  314 (325)
T ss_dssp             CCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             CCCCC-------CcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence            22222       2345678899999999999999999999999988755

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.5e-44  Score=331.13  Aligned_cols=264  Identities=33%  Similarity=0.579  Sum_probs=210.2

Q ss_pred             CCccccHHHHHHHHhhhh--------hhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCC
Q 036435           71 PLKRYNFSDVKKLTNSFK--------DKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHV  121 (372)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~--------~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~  121 (372)
                      ....|++.++..++.+|.        +.||+|+||.||+|+..+                     .+.+|+.++++++||
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            356789999999998886        459999999999986521                     578999999999999


Q ss_pred             ceeeeEeEEecCCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCce
Q 036435          122 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNI  201 (372)
Q Consensus       122 nIv~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Ni  201 (372)
                      ||+++++++.+++..++||||+++|+|.+++......   ..+++..++.++.|++.||+|||   +.+++|+||||+||
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Ni  164 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT---PPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANI  164 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGC---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGE
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCC---CCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHE
Confidence            9999999999999999999999999999999754321   23899999999999999999999   78999999999999


Q ss_pred             EECCCCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCC
Q 036435          202 LLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDS  281 (372)
Q Consensus       202 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~  281 (372)
                      +++.++.+||+|||++........... .....||+.|+|||.+.+   .++.++||||||+++|+|++|..||......
T Consensus       165 li~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~  240 (307)
T 2nru_A          165 LLDEAFTAKISDFGLARASEKFAQTVM-TSRIVGTTAYMAPEALRG---EITPKSDIYSFGVVLLEIITGLPAVDEHREP  240 (307)
T ss_dssp             EECTTCCEEECCCTTCEECCSCSSCEE-CSSCCSCGGGCCHHHHTT---EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS
T ss_pred             EEcCCCcEEEeeccccccccccccccc-ccccCCCcCcCChHHhcC---CCCccchhHHHHHHHHHHHHCCCCcccCcch
Confidence            999999999999999987654332221 233468999999999865   5789999999999999999999999865443


Q ss_pred             CCccchHHHHHHHhhhcccc--cCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          282 SSEVYFPHWIYRHVEQDREF--KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                      ...   ..+..........+  ................+.+++.+||+.||.+|||++++++.|+++.
T Consensus       241 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          241 QLL---LDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             SBT---THHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             HHH---HHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            211   11111111111000  0112223344566788999999999999999999999999998765

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=9.4e-45  Score=333.12  Aligned_cols=240  Identities=26%  Similarity=0.477  Sum_probs=184.9

Q ss_pred             hhhhhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      .+.+.||+|+||.||+++..+                   ++.+|+.++++++||||+++++++.+.+..++||||+++|
T Consensus        40 ~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~  119 (309)
T 3p86_A           40 NIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG  119 (309)
T ss_dssp             EEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTC
T ss_pred             eeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCC
Confidence            445789999999999997532                   5788999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTK--ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      +|.+++......   ..+++..++.++.|++.||+|||   +.+  ++||||||+|||++.++.+||+|||+++......
T Consensus       120 ~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~  193 (309)
T 3p86_A          120 SLYRLLHKSGAR---EQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF  193 (309)
T ss_dssp             BHHHHHHSTTHH---HHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred             cHHHHHhhcCCC---CCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc
Confidence            999999865421   23899999999999999999999   788  9999999999999999999999999997544322


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCC
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP  304 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (372)
                      .   ......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||......       ...............+
T Consensus       194 ~---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~-------~~~~~~~~~~~~~~~~  261 (309)
T 3p86_A          194 L---SSKSAAGTPEWMAPEVLRDE--PSNEKSDVYSFGVILWELATLQQPWGNLNPA-------QVVAAVGFKCKRLEIP  261 (309)
T ss_dssp             -----------CCTTSCHHHHTTC--CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH-------HHHHHHHHSCCCCCCC
T ss_pred             c---ccccCCCCccccChhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhcCCCCCCC
Confidence            1   12334589999999999875  7899999999999999999999999754211       1111111112222222


Q ss_pred             ccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccC
Q 036435          305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEAL  350 (372)
Q Consensus       305 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~  350 (372)
                      .       .+...+.+++.+||+.||.+|||++++++.|+.+....
T Consensus       262 ~-------~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          262 R-------NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             T-------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             c-------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence            2       23356778999999999999999999999999888654

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.2e-44  Score=334.39  Aligned_cols=250  Identities=26%  Similarity=0.360  Sum_probs=192.4

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------hHHHHHHHHhccCCCceeeeEeEEecCCc----eeEEEEecCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------DFVNEVASISRTSHVNVVTLLGFCLEGNN----RALIYEFMPN  145 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~----~~lV~e~~~~  145 (372)
                      .+.+.||+|+||.||+|+..+                .+.+|+.++++++||||+++++++.+...    .++||||+++
T Consensus        27 ~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~  106 (322)
T 3soc_A           27 QLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEK  106 (322)
T ss_dssp             EEEEEEECSTTCEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred             hhhheecccCceEEEEEEECCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCC
Confidence            446789999999999997643                45668889999999999999999987543    6999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC----------CeeecCCCCCceEECCCCceEEeecC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCST----------KILHFDIKPHNILLDEDFCPKISDFG  215 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~----------~ivH~dlk~~Nill~~~~~~kl~Dfg  215 (372)
                      |+|.+++....       +++..++.++.|++.||+|||   +.          +++||||||+|||++.++.+||+|||
T Consensus       107 g~L~~~l~~~~-------~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg  176 (322)
T 3soc_A          107 GSLSDFLKANV-------VSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG  176 (322)
T ss_dssp             CBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CCHHHHHHhcC-------CCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence            99999997643       899999999999999999999   67          99999999999999999999999999


Q ss_pred             CcccccCCCCeeeeeccccccccccccccccccc---CCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccc------
Q 036435          216 LAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNF---GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVY------  286 (372)
Q Consensus       216 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~------  286 (372)
                      +++......... ......||+.|+|||.+.+..   ..++.++|||||||++|||++|+.||...........      
T Consensus       177 ~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  255 (322)
T 3soc_A          177 LALKFEAGKSAG-DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ  255 (322)
T ss_dssp             TCEEECTTSCCC-CCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred             cccccccccCcc-ccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence            998765443221 123346899999999987521   2456789999999999999999999986544321111      


Q ss_pred             ---hHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 036435          287 ---FPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE  348 (372)
Q Consensus       287 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~  348 (372)
                         ...+.............+...  ........+.+++.+||+.||++|||++|+++.|+++..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~  318 (322)
T 3soc_A          256 HPSLEDMQEVVVHKKKRPVLRDYW--QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR  318 (322)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGG--GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCchhhhhhhhhcccCCCCccccc--cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence               111111111111111111111  122345678999999999999999999999999987653

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3.7e-44  Score=330.81  Aligned_cols=263  Identities=36%  Similarity=0.650  Sum_probs=205.8

Q ss_pred             HHHHHHHHhhh--hhhcCCCCceEEEEEEecc------------------hHHHHHHHHhccCCCceeeeEeEEecCCce
Q 036435           77 FSDVKKLTNSF--KDKLGQGGFGGVYKGRLLD------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNR  136 (372)
Q Consensus        77 ~~~~~~~~~~~--~~~lg~G~~g~V~~~~~~~------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~  136 (372)
                      +.++...+.+|  .+.||+|+||.||+|++.+                  .+.+|+.++++++||||+++++++.+++..
T Consensus        31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  110 (321)
T 2qkw_B           31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM  110 (321)
T ss_dssp             CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred             HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence            33333334333  4679999999999997632                  578999999999999999999999999999


Q ss_pred             eEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCC
Q 036435          137 ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGL  216 (372)
Q Consensus       137 ~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  216 (372)
                      ++||||+++|+|.+++......  ...+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+
T Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  185 (321)
T 2qkw_B          111 ILIYKYMENGNLKRHLYGSDLP--TMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGI  185 (321)
T ss_dssp             EEEEECCTTCBTGGGSSSSCCC--SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred             EEEEEcCCCCcHHHHHhccCCC--ccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence            9999999999999999765421  234899999999999999999999   79999999999999999999999999999


Q ss_pred             cccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhh
Q 036435          217 AKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE  296 (372)
Q Consensus       217 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  296 (372)
                      +........... .....||+.|+|||.+.+.  .++.++||||||+++|||++|+.||....... ......|......
T Consensus       186 ~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~p~~~~~~~~-~~~~~~~~~~~~~  261 (321)
T 2qkw_B          186 SKKGTELDQTHL-STVVKGTLGYIDPEYFIKG--RLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE-MVNLAEWAVESHN  261 (321)
T ss_dssp             CEECSSSSCCCC-BCCCEEETTTCCHHHHHHC--BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSS-CCCHHHHTHHHHT
T ss_pred             cccccccccccc-ccccCCCccccCHHHhcCC--CCCcccchHhHHHHHHHHHhCCCcccccCcHH-HHHHHHHhhhccc
Confidence            986543222111 1233588999999998764  78999999999999999999999998654432 2223333332222


Q ss_pred             hcc--cccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 036435          297 QDR--EFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE  348 (372)
Q Consensus       297 ~~~--~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~  348 (372)
                      ...  ....+........+....+.+++.+||+.||++|||++|+++.|+.+..
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            211  1112333334456778889999999999999999999999999987664

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.3e-44  Score=337.59  Aligned_cols=242  Identities=25%  Similarity=0.458  Sum_probs=194.2

Q ss_pred             hhhhhcCCCCceEEEEEEec---------------------------chHHHHHHHHhcc-CCCceeeeEeEEecCCcee
Q 036435           86 SFKDKLGQGGFGGVYKGRLL---------------------------DDFVNEVASISRT-SHVNVVTLLGFCLEGNNRA  137 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~---------------------------~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~  137 (372)
                      .+.+.||+|+||.||+|+..                           +++.+|+.+++++ +||||++++++|.+++..+
T Consensus        84 ~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  163 (370)
T 2psq_A           84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY  163 (370)
T ss_dssp             EEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCE
T ss_pred             EeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEE
Confidence            44578999999999999642                           1578999999999 8999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC
Q 036435          138 LIYEFMPNGSLEKFVYNGDTS----------KPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDF  207 (372)
Q Consensus       138 lV~e~~~~g~L~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~  207 (372)
                      +||||+++|+|.+++......          .....+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++
T Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~  240 (370)
T 2psq_A          164 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENN  240 (370)
T ss_dssp             EEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTC
T ss_pred             EEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEECCCC
Confidence            999999999999999875421          11234899999999999999999999   79999999999999999999


Q ss_pred             ceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccc
Q 036435          208 CPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVY  286 (372)
Q Consensus       208 ~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~  286 (372)
                      .+||+|||+++.......... .....+|+.|+|||.+.+.  .++.++|||||||++|||++ |+.||.......    
T Consensus       241 ~~kl~DFG~a~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~----  313 (370)
T 2psq_A          241 VMKIADFGLARDINNIDYYKK-TTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----  313 (370)
T ss_dssp             CEEECCCSSCEETTCCCTTCT-TTTTTSCGGGCCHHHHHTC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----
T ss_pred             CEEEccccCCcccCcccceec-ccCCCcccceECHhHhcCC--CCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH----
Confidence            999999999986654332211 2334577899999999774  78999999999999999999 889887542211    


Q ss_pred             hHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 036435          287 FPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE  348 (372)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~  348 (372)
                          +...+........+.       .+...+.+++.+||+.||.+|||+.|+++.|+++..
T Consensus       314 ----~~~~~~~~~~~~~~~-------~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~  364 (370)
T 2psq_A          314 ----LFKLLKEGHRMDKPA-------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  364 (370)
T ss_dssp             ----HHHHHHTTCCCCCCT-------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----HHHHHhcCCCCCCCC-------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                223333332222222       234567889999999999999999999999988653

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.1e-44  Score=330.76  Aligned_cols=242  Identities=24%  Similarity=0.424  Sum_probs=192.2

Q ss_pred             hhhhhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      .+.+.||+|+||.||+++...                   .+.+|+.++++++||||+++++++.+++..++||||+++|
T Consensus        13 ~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~   92 (310)
T 3s95_A           13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGG   92 (310)
T ss_dssp             EEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred             eccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCC
Confidence            345789999999999997642                   5889999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      +|.+++.....     .+++.+++.++.|+++||+|||   +.+++||||||+|||++.++.+||+|||++.........
T Consensus        93 ~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  164 (310)
T 3s95_A           93 TLRGIIKSMDS-----QYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ  164 (310)
T ss_dssp             BHHHHHHHCCT-----TSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred             cHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence            99999987532     2899999999999999999999   799999999999999999999999999999876443321


Q ss_pred             ee-----------eecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHh
Q 036435          227 VS-----------SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV  295 (372)
Q Consensus       227 ~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  295 (372)
                      ..           ......||+.|+|||.+.+.  .++.++||||||+++|||++|..|+.............  .....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~--~~~~~  240 (310)
T 3s95_A          165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR--SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN--VRGFL  240 (310)
T ss_dssp             ---------------CCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC--HHHHH
T ss_pred             ccccccccccccccccccCCCcceeCHHHhcCC--CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh--hhccc
Confidence            11           11134689999999999875  78999999999999999999999987644322111100  01111


Q ss_pred             hhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccC
Q 036435          296 EQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEAL  350 (372)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~  350 (372)
                      ..    ..+.       .+...+.+++.+||+.||++|||++++++.|+.+....
T Consensus       241 ~~----~~~~-------~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~  284 (310)
T 3s95_A          241 DR----YCPP-------NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL  284 (310)
T ss_dssp             HH----TCCT-------TCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             cc----cCCC-------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            11    0111       12245777889999999999999999999999887553

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.4e-44  Score=340.42  Aligned_cols=239  Identities=25%  Similarity=0.457  Sum_probs=181.0

Q ss_pred             hhhhhhcCCCCceEEEEEEec-----------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL-----------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYE  141 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-----------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  141 (372)
                      +.+.+.||+|+||.||+|++.                       +++.+|+.++++++||||+++++++.+++..++|||
T Consensus        47 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (373)
T 2qol_A           47 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTE  126 (373)
T ss_dssp             CCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             ceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEe
Confidence            344578999999999998653                       158899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      |+++|+|.+++.....     .+++.+++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++...
T Consensus       127 ~~~~~sL~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          127 YMENGSLDSFLRKHDA-----QFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             CCTTCBHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             CCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            9999999999976532     2899999999999999999999   7899999999999999999999999999998765


Q ss_pred             CCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhccc
Q 036435          222 TKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDRE  300 (372)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (372)
                      .............+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.||.....        ..+...+.....
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~--------~~~~~~i~~~~~  268 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWEMSN--------QDVIKAVDEGYR  268 (373)
T ss_dssp             ---------------CTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH--------HHHHHHHHTTEE
T ss_pred             cCCccceeccCCCcCCCccChhhhccC--CcCchhcHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCC
Confidence            433222222233457789999999864  78999999999999999998 9999865421        112233333222


Q ss_pred             ccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 036435          301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE  348 (372)
Q Consensus       301 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~  348 (372)
                      ...+.       .....+.+++.+||+.||.+||+++++++.|+++..
T Consensus       269 ~~~~~-------~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  309 (373)
T 2qol_A          269 LPPPM-------DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR  309 (373)
T ss_dssp             CCCCT-------TCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCc-------cccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence            22221       234568889999999999999999999999987754

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.1e-44  Score=333.41  Aligned_cols=237  Identities=27%  Similarity=0.446  Sum_probs=190.1

Q ss_pred             hhhhhhcCCCCceEEEEEEec------------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIY  140 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~  140 (372)
                      +.+.+.||+|+||.||+|++.                        +.+.+|+.++++++||||++++++|.++. .++|+
T Consensus        17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~   95 (327)
T 3poz_A           17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIT   95 (327)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEE
T ss_pred             cccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEE
Confidence            344678999999999999752                        15888999999999999999999998754 78999


Q ss_pred             EecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccc
Q 036435          141 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC  220 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~  220 (372)
                      ||+++|+|.+++.....     .+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++..
T Consensus        96 e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           96 QLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             ECCTTCBHHHHHHHSTT-----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             EecCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            99999999999987542     2899999999999999999999   789999999999999999999999999999876


Q ss_pred             cCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcc
Q 036435          221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDR  299 (372)
Q Consensus       221 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (372)
                      ........ .....+|+.|+|||.+.+.  .++.++|||||||++|||++ |+.||.......        +...+....
T Consensus       168 ~~~~~~~~-~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------~~~~~~~~~  236 (327)
T 3poz_A          168 GAEEKEYH-AEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------ISSILEKGE  236 (327)
T ss_dssp             TTTCC--------CCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHHTTC
T ss_pred             cCCccccc-ccCCCccccccChHHhccC--CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--------HHHHHHcCC
Confidence            54433222 2334568899999999875  78999999999999999999 999987543211        223333332


Q ss_pred             cccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 036435          300 EFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE  348 (372)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~  348 (372)
                      ....+..       ....+.+++.+||+.||.+|||++++++.|+.+..
T Consensus       237 ~~~~~~~-------~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          237 RLPQPPI-------CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             CCCCCTT-------BCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             CCCCCcc-------CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            2222221       23567789999999999999999999999987654

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.4e-44  Score=331.71  Aligned_cols=236  Identities=25%  Similarity=0.391  Sum_probs=189.1

Q ss_pred             hhhhhcCCCCceEEEEEEec------------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYE  141 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  141 (372)
                      .+.+.||+|+||.||+|++.                        ..+.+|+.++++++||||+++++++. ++..++|+|
T Consensus        16 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e   94 (325)
T 3kex_A           16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQ   94 (325)
T ss_dssp             EEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEE
T ss_pred             eeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEE
Confidence            34578999999999999752                        15778999999999999999999986 567899999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      |+++|+|.+++.....     .+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++...
T Consensus        95 ~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           95 YLPLGSLLDHVRQHRG-----ALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             CCTTCBSHHHHHSSGG-----GSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             eCCCCCHHHHHHHccc-----cCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            9999999999976532     3889999999999999999999   7899999999999999999999999999998765


Q ss_pred             CCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhccc
Q 036435          222 TKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDRE  300 (372)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (372)
                      ....... .....+|..|+|||.+.+.  .++.++||||||+++|+|++ |+.||.......        +...+.....
T Consensus       167 ~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~  235 (325)
T 3kex_A          167 PDDKQLL-YSEAKTPIKWMALESIHFG--KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--------VPDLLEKGER  235 (325)
T ss_dssp             CCTTCCC------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--------HHHHHHTTCB
T ss_pred             ccccccc-ccCCCCcccccChHHhccC--CCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--------HHHHHHcCCC
Confidence            4432221 2334577899999999864  78999999999999999999 999997643221        2233333333


Q ss_pred             ccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 036435          301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE  348 (372)
Q Consensus       301 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~  348 (372)
                      ...+...+       ..+.+++.+||+.||.+|||++++++.|+++..
T Consensus       236 ~~~~~~~~-------~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          236 LAQPQICT-------IDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             CCCCTTBC-------TTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             CCCCCcCc-------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            33333322       346678889999999999999999999988764

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4e-44  Score=327.14  Aligned_cols=228  Identities=24%  Similarity=0.376  Sum_probs=186.2

Q ss_pred             hhhhhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      .+.+.||+|+||.||+++...                   .+.+|+.++++++||||+++++++.+++..++||||+++|
T Consensus        23 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~  102 (297)
T 3fxz_A           23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG  102 (297)
T ss_dssp             CCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred             eeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCC
Confidence            345789999999999997532                   4789999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      +|.+++....       +++.++..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++.........
T Consensus       103 ~L~~~~~~~~-------~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  172 (297)
T 3fxz_A          103 SLTDVVTETC-------MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (297)
T ss_dssp             BHHHHHHHSC-------CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             CHHHHHhhcC-------CCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc
Confidence            9999997653       899999999999999999999   789999999999999999999999999999876544322


Q ss_pred             eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCcc
Q 036435          227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV  306 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (372)
                         .....||+.|+|||.+.+.  .++.++|||||||++|||++|+.||......       ..... .........   
T Consensus       173 ---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~-~~~~~~~~~---  236 (297)
T 3fxz_A          173 ---RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALYL-IATNGTPEL---  236 (297)
T ss_dssp             ---BCCCCSCGGGCCHHHHHCS--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHH-HHHHCSCCC---
T ss_pred             ---cCCccCCcCccChhhhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHH-HHhCCCCCC---
Confidence               2334689999999999875  7899999999999999999999999753211       11111 111111111   


Q ss_pred             CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       307 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                        .........+.+++.+||+.||.+|||++|+++
T Consensus       237 --~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          237 --QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             --SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence              111223456788999999999999999999986

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=7.9e-44  Score=320.00  Aligned_cols=238  Identities=26%  Similarity=0.477  Sum_probs=194.1

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-----------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-----------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS  147 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-----------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~  147 (372)
                      +.+.+.||+|+||.||+++..+                 ++.+|+.++++++||||+++++++.+++..++||||+++++
T Consensus        10 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   89 (268)
T 3sxs_A           10 ITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGC   89 (268)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred             eeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCc
Confidence            3456789999999999997632                 58899999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCee
Q 036435          148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV  227 (372)
Q Consensus       148 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  227 (372)
                      |.+++.....     .+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++......... 
T Consensus        90 L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-  160 (268)
T 3sxs_A           90 LLNYLRSHGK-----GLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV-  160 (268)
T ss_dssp             HHHHHHHHGG-----GCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE-
T ss_pred             HHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhhhh-
Confidence            9999976432     3899999999999999999999   799999999999999999999999999999876544322 


Q ss_pred             eeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCcc
Q 036435          228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV  306 (372)
Q Consensus       228 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (372)
                       ......+|+.|+|||.+.+.  .++.++||||||+++|+|++ |+.||......        ..............+..
T Consensus       161 -~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~  229 (268)
T 3sxs_A          161 -SSVGTKFPVKWSAPEVFHYF--KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS--------EVVLKVSQGHRLYRPHL  229 (268)
T ss_dssp             -ECCSCCCCGGGCCHHHHHHS--EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH--------HHHHHHHTTCCCCCCTT
T ss_pred             -cccCCCcCcccCCHHHHhcc--CCchhhhhHHHHHHHHHHHcCCCCCccccChH--------HHHHHHHcCCCCCCCCc
Confidence             22344567889999999774  78899999999999999999 99998653221        12222222222222222


Q ss_pred             CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 036435          307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       307 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~  349 (372)
                             ....+.+++.+||+.||.+|||++++++.|+.+.+.
T Consensus       230 -------~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          230 -------ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             -------SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             -------ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence                   234677899999999999999999999999987753

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.1e-44  Score=339.84  Aligned_cols=236  Identities=26%  Similarity=0.424  Sum_probs=191.3

Q ss_pred             hhhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      .+.+.||+|+||.||+|++..                    ++.+|+.++++++||||+++++++.+++..++||||+++
T Consensus       117 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  196 (377)
T 3cbl_A          117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG  196 (377)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             EEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCC
Confidence            445789999999999998741                    578899999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      |+|.+++.....     .+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++.......
T Consensus       197 g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~  268 (377)
T 3cbl_A          197 GDFLTFLRTEGA-----RLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY  268 (377)
T ss_dssp             CBHHHHHHHHGG-----GCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred             CCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence            999999976432     2899999999999999999999   79999999999999999999999999999986443211


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCC
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP  304 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (372)
                       ........+++.|+|||.+.+.  .++.++|||||||++|||++ |..||.....        ......+........|
T Consensus       269 -~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~  337 (377)
T 3cbl_A          269 -AASGGLRQVPVKWTAPEALNYG--RYSSESDVWSFGILLWETFSLGASPYPNLSN--------QQTREFVEKGGRLPCP  337 (377)
T ss_dssp             -ECCSSCCEEEGGGSCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH--------HHHHHHHHTTCCCCCC
T ss_pred             -eecCCCCCCCcCcCCHhHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCCCC
Confidence             1111122357789999999764  78999999999999999998 8888865321        1223333333333333


Q ss_pred             ccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       305 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                      ..       .+..+.+++.+||+.||++|||++++++.|+.+.
T Consensus       338 ~~-------~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~  373 (377)
T 3cbl_A          338 EL-------CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR  373 (377)
T ss_dssp             TT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CC-------CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            22       2356778999999999999999999999998765

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5e-44  Score=321.54  Aligned_cols=236  Identities=28%  Similarity=0.520  Sum_probs=192.1

Q ss_pred             hhhhhcCCCCceEEEEEEecc-----------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCCh
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD-----------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL  148 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~-----------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L  148 (372)
                      .+.+.||+|+||.||+++..+                 ++.+|+.++++++||||+++++++.+++..++||||+++|+|
T Consensus        13 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   92 (269)
T 4hcu_A           13 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCL   92 (269)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBH
T ss_pred             eeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcH
Confidence            445789999999999997632                 588999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeee
Q 036435          149 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVS  228 (372)
Q Consensus       149 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  228 (372)
                      .+++.....     .+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++........  .
T Consensus        93 ~~~l~~~~~-----~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~  162 (269)
T 4hcu_A           93 SDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY--T  162 (269)
T ss_dssp             HHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH--H
T ss_pred             HHHHHhcCc-----ccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecccccccccccccc--c
Confidence            999976442     2899999999999999999999   79999999999999999999999999999986543221  1


Q ss_pred             eecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccC
Q 036435          229 SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVV  307 (372)
Q Consensus       229 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (372)
                      ......+|+.|+|||.+.+.  .++.++||||+|+++|+|++ |+.||.....        ......+........+.. 
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~-  231 (269)
T 4hcu_A          163 SSTGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEVVEDISTGFRLYKPRL-  231 (269)
T ss_dssp             STTSTTCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTTCCCCCCTT-
T ss_pred             cccCcccccccCCHHHhcCC--CCCchhhhHHHHHHHHHHhcCCCCCCCCCCH--------HHHHHHHhcCccCCCCCc-
Confidence            12334467789999999764  78999999999999999999 8888875321        112222322222222222 


Q ss_pred             CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 036435          308 TRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE  348 (372)
Q Consensus       308 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~  348 (372)
                            ....+.+++.+||+.||++|||++++++.|+++.+
T Consensus       232 ------~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          232 ------ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             ------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------CCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence                  23567789999999999999999999999987764

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=6.8e-44  Score=325.01  Aligned_cols=248  Identities=25%  Similarity=0.419  Sum_probs=188.7

Q ss_pred             hhhhhhcCCCCceEEEEEEec-----------------------chHHHHHHHHhccCCCceeeeEeEEecC--CceeEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL-----------------------DDFVNEVASISRTSHVNVVTLLGFCLEG--NNRALI  139 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-----------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~--~~~~lV  139 (372)
                      +.+.+.||+|+||.||++++.                       +.+.+|+.++++++||||+++++++...  ...++|
T Consensus        12 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   91 (295)
T 3ugc_A           12 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI   91 (295)
T ss_dssp             EEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEE
T ss_pred             hhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEE
Confidence            345678999999999999731                       1578999999999999999999998654  568999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccc
Q 036435          140 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL  219 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  219 (372)
                      |||+++|+|.+++.....     .+++.+++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++..
T Consensus        92 ~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           92 MEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             EECCTTCBHHHHHHHCGG-----GCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             EEeCCCCCHHHHHHhccc-----ccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            999999999999977542     2899999999999999999999   79999999999999999999999999999987


Q ss_pred             ccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCC--------CCccchHHHH
Q 036435          220 CTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDS--------SSEVYFPHWI  291 (372)
Q Consensus       220 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~--------~~~~~~~~~~  291 (372)
                      ...............+|..|+|||.+.+.  .++.++||||||+++|||++|..|+......        ..........
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  241 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCC--CCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence            65543332323344577889999999875  7899999999999999999999988642110        0000011112


Q ss_pred             HHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 036435          292 YRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~  349 (372)
                      ............+.       .+...+.+++.+||+.||++|||++|+++.|+.+.+.
T Consensus       242 ~~~~~~~~~~~~~~-------~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          242 IELLKNNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HHHHHTTCCCCCCT-------TCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHhccCcCCCCc-------CcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            22222222222222       2345688899999999999999999999999987654

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.2e-43  Score=346.01  Aligned_cols=239  Identities=29%  Similarity=0.464  Sum_probs=196.2

Q ss_pred             HhhhhhhcCCCCceEEEEEEecc------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           84 TNSFKDKLGQGGFGGVYKGRLLD------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~~------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      .+.+.+.||+|+||.||+|++.+                  +|.+|+.++++++||||++++++|.+++..++||||+++
T Consensus       221 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~  300 (495)
T 1opk_A          221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY  300 (495)
T ss_dssp             GEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             HceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCC
Confidence            34456789999999999997642                  688999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      |+|.+++......    .+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... 
T Consensus       301 g~L~~~l~~~~~~----~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  372 (495)
T 1opk_A          301 GNLLDYLRECNRQ----EVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-  372 (495)
T ss_dssp             CBHHHHHHHSCTT----TSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-
T ss_pred             CCHHHHHHhcCcC----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCc-
Confidence            9999999865432    2899999999999999999999   7999999999999999999999999999998764332 


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCC
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP  304 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (372)
                       ........+|..|+|||.+.+.  .++.++|||||||++|||++ |..||......        .+...+........+
T Consensus       373 -~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~~  441 (495)
T 1opk_A          373 -YTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------QVYELLEKDYRMERP  441 (495)
T ss_dssp             -EECCTTCCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--------GHHHHHHTTCCCCCC
T ss_pred             -eeecCCCcCCcceeCHhHHhcC--CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCCCC
Confidence             1222344567889999999764  78999999999999999999 88888754321        123333333333323


Q ss_pred             ccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 036435          305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE  348 (372)
Q Consensus       305 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~  348 (372)
                      .       .+...+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       442 ~-------~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          442 E-------GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             T-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             C-------CCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence            2       234567889999999999999999999999998764

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=8.3e-44  Score=324.53  Aligned_cols=240  Identities=25%  Similarity=0.399  Sum_probs=188.1

Q ss_pred             hhhhhcCCCCceEEEEEEec----------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLL----------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~----------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      .+.+.||+|+||.||+++..                      +.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus        14 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   93 (294)
T 4eqm_A           14 KIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYI   93 (294)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCC
Confidence            44678999999999999753                      15789999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      ++|+|.+++.....      +++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++......
T Consensus        94 ~g~~L~~~l~~~~~------~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  164 (294)
T 4eqm_A           94 EGPTLSEYIESHGP------LSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET  164 (294)
T ss_dssp             CSCBHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred             CCCCHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence            99999999976542      899999999999999999999   799999999999999999999999999999865433


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                      ....  .....||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||......       ..........    .
T Consensus       165 ~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-------~~~~~~~~~~----~  229 (294)
T 4eqm_A          165 SLTQ--TNHVLGTVQYFSPEQAKGE--ATDECTDIYSIGIVLYEMLVGEPPFNGETAV-------SIAIKHIQDS----V  229 (294)
T ss_dssp             ------------CCSSCCHHHHHTC--CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH-------HHHHHHHSSC----C
T ss_pred             cccc--cCccccCccccCHhHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhhcc----C
Confidence            2111  2234589999999999875  7889999999999999999999999754211       1111111111    1


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhhcCccc
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRP-PMNEVIEMLQGSTEA  349 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~evl~~L~~~~~~  349 (372)
                      +........+++..+.+++.+||+.||.+|| +++++.+.|+.....
T Consensus       230 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~  276 (294)
T 4eqm_A          230 PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE  276 (294)
T ss_dssp             CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred             CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence            1111111122346788899999999999999 899999999887644

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1e-43  Score=329.22  Aligned_cols=243  Identities=19%  Similarity=0.245  Sum_probs=190.6

Q ss_pred             hhhhhcCCCCceEEEEEEec-----------------chHHHHHHHHhcc-CCCceeeeEeEEecCCceeEEEEecCCCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLL-----------------DDFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNGS  147 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~-----------------~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~~~~g~  147 (372)
                      .+.+.||+|+||.||+|+..                 +.+.+|+.+++++ +||||+++++++.+++..++||||+ +++
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~   90 (330)
T 2izr_A           12 RVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPS   90 (330)
T ss_dssp             EEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCB
T ss_pred             EEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCC
Confidence            34578999999999999752                 2589999999999 9999999999999999999999999 999


Q ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCc-----eEEeecCCcccccC
Q 036435          148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFC-----PKISDFGLAKLCTT  222 (372)
Q Consensus       148 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Dfgla~~~~~  222 (372)
                      |.+++.....     .+++..++.++.|++.||+|||   +.+++||||||+|||++.++.     +||+|||+++....
T Consensus        91 L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~  162 (330)
T 2izr_A           91 LEDLFDLCDR-----TFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID  162 (330)
T ss_dssp             HHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred             HHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence            9999986532     2999999999999999999999   789999999999999998887     99999999987654


Q ss_pred             CCCeee----eecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhc
Q 036435          223 KEGIVS----SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQD  298 (372)
Q Consensus       223 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (372)
                      ......    ......||+.|+|||.+.+.  .++.++|||||||++|||++|+.||........    .. ....+...
T Consensus       163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~----~~-~~~~i~~~  235 (330)
T 2izr_A          163 PETKKHIPYREHKSLTGTARYMSINTHLGK--EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL----KE-RYQKIGDT  235 (330)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH----HH-HHHHHHHH
T ss_pred             CCCCccccccccCCcCCCccccChHHHcCC--CCCchhHHHHHHHHHHHHhcCCCCccccccccH----HH-HHHHHHhh
Confidence            332211    12345689999999999875  789999999999999999999999986533221    11 11111111


Q ss_pred             ccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 036435          299 REFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE  348 (372)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~  348 (372)
                      .. ..+.  .......+ .+.+++..||+.||.+||+++++++.|+.+..
T Consensus       236 ~~-~~~~--~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~  281 (330)
T 2izr_A          236 KR-ATPI--EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD  281 (330)
T ss_dssp             HH-HSCH--HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             hc-cCCH--HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence            10 0010  00001123 78889999999999999999999999876653

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-43  Score=334.07  Aligned_cols=252  Identities=24%  Similarity=0.415  Sum_probs=199.8

Q ss_pred             HhhhhhhcCCCCceEEEEEEec---------------------------chHHHHHHHHhcc-CCCceeeeEeEEecCCc
Q 036435           84 TNSFKDKLGQGGFGGVYKGRLL---------------------------DDFVNEVASISRT-SHVNVVTLLGFCLEGNN  135 (372)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~---------------------------~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~  135 (372)
                      .+.+.+.||+|+||.||+++..                           .++.+|+++++++ +||||+++++++.+++.
T Consensus        70 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  149 (382)
T 3tt0_A           70 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP  149 (382)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             heEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCc
Confidence            4455678999999999999741                           1578999999999 99999999999999999


Q ss_pred             eeEEEEecCCCChhhhhhcCCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC
Q 036435          136 RALIYEFMPNGSLEKFVYNGDTS----------KPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE  205 (372)
Q Consensus       136 ~~lV~e~~~~g~L~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~  205 (372)
                      .++||||+++|+|.+++......          .....+++.+++.++.|++.||+|||   +.+++||||||+|||++.
T Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~  226 (382)
T 3tt0_A          150 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTE  226 (382)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECT
T ss_pred             eEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEEcC
Confidence            99999999999999999875421          11234899999999999999999999   789999999999999999


Q ss_pred             CCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCc
Q 036435          206 DFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSE  284 (372)
Q Consensus       206 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~  284 (372)
                      ++.+||+|||+++.......... .....+|+.|+|||.+.+.  .++.++|||||||++|||++ |..||.....    
T Consensus       227 ~~~~kL~DFG~a~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~ellt~g~~p~~~~~~----  299 (382)
T 3tt0_A          227 DNVMKIADFGLARDIHHIDYYKK-TTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----  299 (382)
T ss_dssp             TCCEEECSCSCCCCSSCCCTTCC-CTTCCCGGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----
T ss_pred             CCcEEEcccCccccccccccccc-ccCCCCCcceeCHHHhcCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCCH----
Confidence            99999999999987654332211 2334578899999999874  78999999999999999999 8898865321    


Q ss_pred             cchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccCCCCCCC
Q 036435          285 VYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQIPPTP  356 (372)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~~p  356 (372)
                          ..+...+........+..       ....+.+++.+||+.||++|||++|+++.|+++.........+
T Consensus       300 ----~~~~~~~~~~~~~~~~~~-------~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~  360 (382)
T 3tt0_A          300 ----EELFKLLKEGHRMDKPSN-------CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMG  360 (382)
T ss_dssp             ----HHHHHHHHTTCCCCCCSS-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC--
T ss_pred             ----HHHHHHHHcCCCCCCCcc-------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCC
Confidence                122333333333333322       2356788999999999999999999999999887654433333

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-43  Score=323.86  Aligned_cols=241  Identities=27%  Similarity=0.454  Sum_probs=183.7

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCChhh
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEK  150 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~~  150 (372)
                      .+.+.||+|+||.||+++..+               .+.+|+.++++++||||+++++++.+  ..++||||+++|+|.+
T Consensus        11 ~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~   88 (307)
T 2eva_A           11 EVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYN   88 (307)
T ss_dssp             EEEEEEECCSSSEEEEEEETTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHH
T ss_pred             eeeeEeecCCCceEEEEEECCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHH
Confidence            345789999999999997632               58899999999999999999999874  4799999999999999


Q ss_pred             hhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCc-eEEeecCCcccccCCCCeeee
Q 036435          151 FVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFC-PKISDFGLAKLCTTKEGIVSS  229 (372)
Q Consensus       151 ~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-~kl~Dfgla~~~~~~~~~~~~  229 (372)
                      ++......   ..+++..++.++.|+++||+|||+....+++||||||+|||++.++. +||+|||++.......     
T Consensus        89 ~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~-----  160 (307)
T 2eva_A           89 VLHGAEPL---PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-----  160 (307)
T ss_dssp             HHHCSSSE---ECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------------
T ss_pred             HHhccCCC---CccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc-----
Confidence            99865431   23789999999999999999999322279999999999999998876 7999999997654322     


Q ss_pred             ecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCCc
Q 036435          230 LLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTR  309 (372)
Q Consensus       230 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (372)
                       ....||+.|+|||.+.+.  .++.++||||||+++|||++|+.||.......     .. .............+     
T Consensus       161 -~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~-~~~~~~~~~~~~~~-----  226 (307)
T 2eva_A          161 -TNNKGSAAWMAPEVFEGS--NYSEKCDVFSWGIILWEVITRRKPFDEIGGPA-----FR-IMWAVHNGTRPPLI-----  226 (307)
T ss_dssp             -----CCTTSSCHHHHTCC--CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH-----HH-HHHHHHTTCCCCCB-----
T ss_pred             -ccCCCCCceEChhhhCCC--CCCcHHHHHHHHHHHHHHHHCCCCchhhCccH-----HH-HHHHHhcCCCCCcc-----
Confidence             223489999999999874  78999999999999999999999997543211     01 11111111111111     


Q ss_pred             chHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccCCC
Q 036435          310 KENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQI  352 (372)
Q Consensus       310 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  352 (372)
                        ......+.+++.+||+.||.+|||++++++.|+.+......
T Consensus       227 --~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  267 (307)
T 2eva_A          227 --KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG  267 (307)
T ss_dssp             --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred             --cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence              12345677899999999999999999999999887755433

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=4.8e-45  Score=337.60  Aligned_cols=250  Identities=26%  Similarity=0.371  Sum_probs=193.5

Q ss_pred             hhhhhhcCCCCceEEEEEEec-----------------------chHHHHHHHHhccCCCceeeeEeEEe--cCCceeEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL-----------------------DDFVNEVASISRTSHVNVVTLLGFCL--EGNNRALI  139 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-----------------------~~~~~E~~~l~~l~h~nIv~l~g~~~--~~~~~~lV  139 (372)
                      +.+.+.||+|+||.||++++.                       +.+.+|+.++++++||||+++++++.  +.+..++|
T Consensus        25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv  104 (327)
T 3lxl_A           25 LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLV  104 (327)
T ss_dssp             EEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEE
T ss_pred             hhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEE
Confidence            345678999999999999831                       14889999999999999999999987  44568999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccc
Q 036435          140 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL  219 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  219 (372)
                      |||+++++|.+++.....     .+++..++.++.|++.||+|||   +.+++|+||||+|||++.++.+||+|||++..
T Consensus       105 ~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A          105 MEYLPSGCLRDFLQRHRA-----RLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             EECCTTCBHHHHHHHHGG-----GCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             EeecCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEccccccee
Confidence            999999999999976432     2899999999999999999999   79999999999999999999999999999987


Q ss_pred             ccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCC-------CCccchHHHHH
Q 036435          220 CTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDS-------SSEVYFPHWIY  292 (372)
Q Consensus       220 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~-------~~~~~~~~~~~  292 (372)
                      ...............+|..|+|||.+.+.  .++.++||||||+++|+|++|+.||......       ...........
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  254 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDN--IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL  254 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccC--CCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence            76555444434445688889999999775  7899999999999999999999998643210       00001111112


Q ss_pred             HHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccCC
Q 036435          293 RHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQ  351 (372)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~  351 (372)
                      ...........+       ..+...+.+++.+||+.||.+|||++++++.|+.+.....
T Consensus       255 ~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  306 (327)
T 3lxl_A          255 ELLEEGQRLPAP-------PACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR  306 (327)
T ss_dssp             HHHHTTCCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred             HHhhcccCCCCC-------CcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            222222222222       2234667889999999999999999999999998876543

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3e-43  Score=339.46  Aligned_cols=233  Identities=25%  Similarity=0.434  Sum_probs=190.4

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------hHHHHHHHHhccCCCceeeeEeEEecCC-ceeEEEEecCCCChh
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------DFVNEVASISRTSHVNVVTLLGFCLEGN-NRALIYEFMPNGSLE  149 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~-~~~lV~e~~~~g~L~  149 (372)
                      .+.+.||+|+||.||+|++.+               .|.+|+.++++++||||+++++++.+.+ ..++||||+++|+|.
T Consensus       196 ~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~  275 (450)
T 1k9a_A          196 KLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV  275 (450)
T ss_dssp             EEEEEEEECSSEEEEEEEETTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHH
T ss_pred             EEEeeecCcCCeeEEEEEecCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHH
Confidence            345789999999999997642               6899999999999999999999987765 789999999999999


Q ss_pred             hhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeeee
Q 036435          150 KFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSS  229 (372)
Q Consensus       150 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  229 (372)
                      +++......    .+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++......     
T Consensus       276 ~~l~~~~~~----~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-----  343 (450)
T 1k9a_A          276 DYLRSRGRS----VLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----  343 (450)
T ss_dssp             HHHHHHCTT----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred             HHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-----
Confidence            999865432    2789999999999999999999   7999999999999999999999999999998543221     


Q ss_pred             ecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCC
Q 036435          230 LLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVT  308 (372)
Q Consensus       230 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (372)
                       ....+++.|+|||.+.+.  .++.++||||||+++|||++ |+.||.......        +...+..+.....|.   
T Consensus       344 -~~~~~~~~y~aPE~~~~~--~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--------~~~~i~~~~~~~~p~---  409 (450)
T 1k9a_A          344 -DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRVEKGYKMDAPD---  409 (450)
T ss_dssp             ----CCCTTTSCHHHHHSS--CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--------HHHHHHTTCCCCCCT---
T ss_pred             -cCCCCCcceeCHHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCCCCC---
Confidence             122467889999999764  78999999999999999998 999987653322        233333333333332   


Q ss_pred             cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 036435          309 RKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE  348 (372)
Q Consensus       309 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~  348 (372)
                          .+...+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       410 ----~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          410 ----GCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             ----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence                234567889999999999999999999999987654

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.2e-44  Score=337.35  Aligned_cols=244  Identities=26%  Similarity=0.392  Sum_probs=192.9

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-------------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-------------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALI  139 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV  139 (372)
                      +.+.+.||+|+||.||+|++..                         ++.+|+.++++++||||+++++++.+++..++|
T Consensus        73 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  152 (367)
T 3l9p_A           73 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFIL  152 (367)
T ss_dssp             EEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEE
Confidence            4456789999999999998421                         578899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC---ceEEeecC
Q 036435          140 YEFMPNGSLEKFVYNGDTS-KPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDF---CPKISDFG  215 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~-~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg  215 (372)
                      |||+++|+|.+++...... .....+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++   .+||+|||
T Consensus       153 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG  229 (367)
T 3l9p_A          153 LELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFG  229 (367)
T ss_dssp             EECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred             EEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEECCCc
Confidence            9999999999999764421 11234899999999999999999999   79999999999999999554   59999999


Q ss_pred             CcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHH
Q 036435          216 LAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRH  294 (372)
Q Consensus       216 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  294 (372)
                      +++......... ......+|+.|+|||.+.+.  .++.++|||||||++|||++ |..||.....        ......
T Consensus       230 ~a~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt~g~~pf~~~~~--------~~~~~~  298 (367)
T 3l9p_A          230 MARDIYRAGYYR-KGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------QEVLEF  298 (367)
T ss_dssp             HHHHHHHHSSCT-TCCGGGSCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHHHH
T ss_pred             cccccccccccc-cCCCcCCcccEECHHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHH
Confidence            998543222111 11234578899999999775  78999999999999999998 8899875421        112233


Q ss_pred             hhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 036435          295 VEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~  349 (372)
                      +........+.       .....+.+++.+||+.||.+|||++++++.|+.+...
T Consensus       299 i~~~~~~~~~~-------~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          299 VTSGGRMDPPK-------NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             HHTTCCCCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHcCCCCCCCc-------cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence            33332222222       2235677899999999999999999999999887654

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-43  Score=326.84  Aligned_cols=230  Identities=21%  Similarity=0.302  Sum_probs=186.6

Q ss_pred             hhhhhcCCCCceEEEEEEecc------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS  147 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~  147 (372)
                      .+.+.||+|+||.||+++...                  .+.+|+.++++++||||+++++++.+.+..++||||+++|+
T Consensus         8 ~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~   87 (321)
T 1tki_A            8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLD   87 (321)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCB
T ss_pred             EeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCC
Confidence            345789999999999997632                  47889999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC--CCceEEeecCCcccccCCCC
Q 036435          148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE--DFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       148 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgla~~~~~~~~  225 (372)
                      |.+++.....     .+++.++..++.|++.||+|||   +.+++||||||+|||++.  ++.+||+|||++........
T Consensus        88 L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~  159 (321)
T 1tki_A           88 IFERINTSAF-----ELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             HHHHHTSSSC-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             HHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence            9999976432     2899999999999999999999   799999999999999987  78999999999987654432


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                      .    ....||+.|+|||.+.+.  .++.++|||||||++|+|++|..||......       . ....+.... ...+ 
T Consensus       160 ~----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~-~~~~i~~~~-~~~~-  223 (321)
T 1tki_A          160 F----RLLFTAPEYYAPEVHQHD--VVSTATDMWSLGTLVYVLLSGINPFLAETNQ-------Q-IIENIMNAE-YTFD-  223 (321)
T ss_dssp             E----EEEESCGGGSCHHHHTTC--EECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------H-HHHHHHHTC-CCCC-
T ss_pred             c----ccccCChhhcCcHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-------H-HHHHHHcCC-CCCC-
Confidence            2    223588999999999874  6789999999999999999999999754211       1 112221111 1111 


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                        ......+...+.+++.+||+.||.+|||+.|+++
T Consensus       224 --~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          224 --EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             --HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              1111233567888999999999999999999997

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3.2e-43  Score=324.67  Aligned_cols=242  Identities=24%  Similarity=0.319  Sum_probs=193.3

Q ss_pred             ccccHHHHHHHHhh------------hhhhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCC
Q 036435           73 KRYNFSDVKKLTNS------------FKDKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHV  121 (372)
Q Consensus        73 ~~~~~~~~~~~~~~------------~~~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~  121 (372)
                      ..+++++++.++..            ..+.||+|+||.||+|+...                   .+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            45677777777653            23579999999999997642                   478999999999999


Q ss_pred             ceeeeEeEEecCCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCce
Q 036435          122 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNI  201 (372)
Q Consensus       122 nIv~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Ni  201 (372)
                      ||+++++++..++..++||||+++|+|.+++....       +++..+..++.|++.||+|||   +.+++||||||+||
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NI  172 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR-------LNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSI  172 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTCC-------CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGE
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhcC-------CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHE
Confidence            99999999999999999999999999999986532       899999999999999999999   78999999999999


Q ss_pred             EECCCCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCC
Q 036435          202 LLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDS  281 (372)
Q Consensus       202 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~  281 (372)
                      |++.++.+||+|||++.........   .....||+.|+|||.+.+.  .++.++||||||+++|||++|+.||..... 
T Consensus       173 ll~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~pf~~~~~-  246 (321)
T 2c30_A          173 LLTLDGRVKLSDFGFCAQISKDVPK---RKSLVGTPYWMAPEVISRS--LYATEVDIWSLGIMVIEMVDGEPPYFSDSP-  246 (321)
T ss_dssp             EECTTCCEEECCCTTCEECCSSSCC---BCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-
T ss_pred             EECCCCcEEEeeeeeeeecccCccc---cccccCCccccCHhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-
Confidence            9999999999999999876543221   1234689999999999764  789999999999999999999999975321 


Q ss_pred             CCccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          282 SSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                             ......+.........     ........+.+++.+||+.||++|||++++++.
T Consensus       247 -------~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          247 -------VQAMKRLRDSPPPKLK-----NSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             -------HHHHHHHHHSSCCCCT-----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             -------HHHHHHHhcCCCCCcC-----ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                   1112222221111111     112234567889999999999999999999873

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.1e-43  Score=343.04  Aligned_cols=239  Identities=26%  Similarity=0.434  Sum_probs=192.5

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-----------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-----------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS  147 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-----------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~  147 (372)
                      +.+.+.||+|+||.||+|++.+                 ++.+|+.++++++||||+++++++. .+..++||||+++|+
T Consensus       190 ~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~  268 (454)
T 1qcf_A          190 LKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGS  268 (454)
T ss_dssp             EEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCB
T ss_pred             eEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCc
Confidence            3445789999999999997642                 6899999999999999999999986 567899999999999


Q ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCee
Q 036435          148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV  227 (372)
Q Consensus       148 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  227 (372)
                      |.+++.....    ..+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++........ 
T Consensus       269 L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~-  340 (454)
T 1qcf_A          269 LLDFLKSDEG----SKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-  340 (454)
T ss_dssp             HHHHHHSHHH----HTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH-
T ss_pred             HHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee-
Confidence            9999975432    12889999999999999999999   789999999999999999999999999999875432111 


Q ss_pred             eeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCcc
Q 036435          228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV  306 (372)
Q Consensus       228 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (372)
                       ......+|..|+|||.+.+.  .++.++|||||||++|||++ |+.||.....        ..+...+........+. 
T Consensus       341 -~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~t~g~~P~~~~~~--------~~~~~~i~~~~~~~~~~-  408 (454)
T 1qcf_A          341 -AREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--------PEVIRALERGYRMPRPE-  408 (454)
T ss_dssp             -TTCSSSSCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHHHHHHHTCCCCCCT-
T ss_pred             -ccCCCcccccccCHHHhccC--CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCCCCC-
Confidence             11233467889999999764  78999999999999999999 9999875321        11223333332322222 


Q ss_pred             CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccC
Q 036435          307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEAL  350 (372)
Q Consensus       307 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~  350 (372)
                            .++..+.+++.+||+.||++|||++++++.|+.+....
T Consensus       409 ------~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~  446 (454)
T 1qcf_A          409 ------NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT  446 (454)
T ss_dssp             ------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred             ------CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence                  23456888999999999999999999999999887543

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=6e-43  Score=319.37  Aligned_cols=250  Identities=21%  Similarity=0.308  Sum_probs=187.6

Q ss_pred             hhhhhcCCCCceEEEEEEecc--------------hHHHHHHHHhc--cCCCceeeeEeEEecC----CceeEEEEecCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD--------------DFVNEVASISR--TSHVNVVTLLGFCLEG----NNRALIYEFMPN  145 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~--------------~~~~E~~~l~~--l~h~nIv~l~g~~~~~----~~~~lV~e~~~~  145 (372)
                      .+.+.||+|+||.||+|+..+              .+.+|.+++..  ++||||+++++++.+.    ...++||||+++
T Consensus        11 ~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~   90 (301)
T 3q4u_A           11 TLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEM   90 (301)
T ss_dssp             EEEEEEEECSSEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTT
T ss_pred             EEEEeeccCCCcEEEEEEECCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccC
Confidence            345789999999999997643              45667777766  7999999999997653    458999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeeecCCCCCceEECCCCceEEeecCCcccc
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC-----STKILHFDIKPHNILLDEDFCPKISDFGLAKLC  220 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-----~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~  220 (372)
                      |+|.+++....       +++..++.++.|++.||+|||+..     +.+++||||||+|||++.++.+||+|||+++..
T Consensus        91 g~L~~~l~~~~-------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  163 (301)
T 3q4u_A           91 GSLYDYLQLTT-------LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH  163 (301)
T ss_dssp             CBHHHHHTTCC-------BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             CCHHHHHhhcc-------cCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeec
Confidence            99999995432       899999999999999999999321     479999999999999999999999999999876


Q ss_pred             cCCCCeee-eecccccccccccccccccccC----CCCccccchhHHHHHHHHhcC----------CCCCCCCCCCCCcc
Q 036435          221 TTKEGIVS-SLLGARGIIGYIAPEVFSRNFG----EVSHKSDVYSFGMMIMELVGC----------KNNLDSGVDSSSEV  285 (372)
Q Consensus       221 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~----~~~~~~DvwslG~il~elltg----------~~p~~~~~~~~~~~  285 (372)
                      ........ ......||+.|+|||.+.+...    .++.++|||||||++|||++|          +.||......... 
T Consensus       164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~-  242 (301)
T 3q4u_A          164 SQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS-  242 (301)
T ss_dssp             ETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC-
T ss_pred             ccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcc-
Confidence            55443322 1223468999999999876411    345799999999999999999          7777654332211 


Q ss_pred             chHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 036435          286 YFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGS  346 (372)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~  346 (372)
                       .................+.  ..........+.+++.+||+.||++|||++++++.|+++
T Consensus       243 -~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          243 -FEDMRKVVCVDQQRPNIPN--RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             -HHHHHHHHTTSCCCCCCCG--GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             -hhhhhHHHhccCCCCCCCh--hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence             1111111111111111121  112234567899999999999999999999999999864

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.4e-43  Score=319.22  Aligned_cols=235  Identities=23%  Similarity=0.385  Sum_probs=179.1

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYE  141 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  141 (372)
                      +.+.+.||+|+||.||+|+...                       .+.+|+.++++++||||+++++++. ++..++|||
T Consensus        17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e   95 (281)
T 1mp8_A           17 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIME   95 (281)
T ss_dssp             EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             eEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEe
Confidence            3456789999999999987521                       4788999999999999999999984 567899999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      |+++|+|.+++.....     .+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++....
T Consensus        96 ~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           96 LCTLGELRSFLQVRKY-----SLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             CCTTEEHHHHHHHTTT-----TSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             cCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccC
Confidence            9999999999976532     2899999999999999999999   7899999999999999999999999999998765


Q ss_pred             CCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhccc
Q 036435          222 TKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDRE  300 (372)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (372)
                      ......  .....+|+.|+|||.+.+.  .++.++||||||+++|||++ |..||.......        ....+.....
T Consensus       168 ~~~~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--------~~~~i~~~~~  235 (281)
T 1mp8_A          168 DSTYYK--ASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--------VIGRIENGER  235 (281)
T ss_dssp             -------------CCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHHTTCC
T ss_pred             cccccc--cccCCCcccccChhhcccC--CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--------HHHHHHcCCC
Confidence            433221  1233467889999999764  78999999999999999996 888987543221        1222222222


Q ss_pred             ccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       301 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                      ...+.       .....+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       236 ~~~~~-------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  275 (281)
T 1mp8_A          236 LPMPP-------NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  275 (281)
T ss_dssp             CCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCC-------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            22221       23456778999999999999999999999998764

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.7e-43  Score=325.95  Aligned_cols=227  Identities=22%  Similarity=0.343  Sum_probs=185.7

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      .+.+.||+|+||.||+++...                     .+.+|+.++++++||||+++++++.+++..++||||++
T Consensus        18 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~   97 (328)
T 3fe3_A           18 RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYAS   97 (328)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCC
Confidence            445789999999999997631                     47789999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      +|+|.+++.....      +++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++.......
T Consensus        98 ~~~L~~~l~~~~~------l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  168 (328)
T 3fe3_A           98 GGEVFDYLVAHGR------MKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG  168 (328)
T ss_dssp             TCBHHHHHHHHCC------CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred             CCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence            9999999976543      899999999999999999999   7999999999999999999999999999998665432


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCC
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP  304 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (372)
                      .    .....||+.|+|||.+.+. ...+.++||||+||++|+|++|+.||.....        ......+... ....|
T Consensus       169 ~----~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~-~~~~p  234 (328)
T 3fe3_A          169 K----LDAFCGAPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQNL--------KELRERVLRG-KYRIP  234 (328)
T ss_dssp             G----GGTTSSSGGGCCHHHHHTC-CCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHC-CCCCC
T ss_pred             c----cccccCCcceeCcccccCC-CcCCchhhhhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhC-CCCCC
Confidence            2    2345689999999999875 2235899999999999999999999975421        1122222221 22223


Q ss_pred             ccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       305 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                      ..       ....+.+++.+||+.||.+|||++|+++.
T Consensus       235 ~~-------~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          235 FY-------MSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             TT-------SCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             CC-------CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            22       23557788999999999999999999863

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-43  Score=326.15  Aligned_cols=237  Identities=27%  Similarity=0.475  Sum_probs=184.5

Q ss_pred             hhhcCCCCceEEEEEEecc------------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           88 KDKLGQGGFGGVYKGRLLD------------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      .+.||+|+||.||+|+...                        .+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        49 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  128 (333)
T 1mqb_A           49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM  128 (333)
T ss_dssp             EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             ccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCC
Confidence            4679999999999986421                        4788999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      ++|+|.+++.....     .+++.+++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++......
T Consensus       129 ~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  200 (333)
T 1mqb_A          129 ENGALDKFLREKDG-----EFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  200 (333)
T ss_dssp             TTEEHHHHHHHTTT-----CSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             CCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence            99999999976532     2899999999999999999999   789999999999999999999999999999876543


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      ...........+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.||.....        ..+...+.......
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~~~~~~~~~~~~~~  270 (333)
T 1mqb_A          201 PEATYTTSGGKIPIRWTAPEAISYR--KFTSASDVWSFGIVMWEVMTYGERPYWELSN--------HEVMKAINDGFRLP  270 (333)
T ss_dssp             ----------CCCGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTTCCCC
T ss_pred             cccccccCCCCccccccCchhcccC--CCCchhhhHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHHHCCCcCC
Confidence            3222222333467889999999764  78999999999999999998 9999865321        11223333222222


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~  349 (372)
                      .+.       .....+.+++.+||+.||.+||++.++++.|+++...
T Consensus       271 ~~~-------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  310 (333)
T 1mqb_A          271 TPM-------DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  310 (333)
T ss_dssp             CCT-------TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             Ccc-------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            221       2345678899999999999999999999999876644

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-42  Score=319.78  Aligned_cols=254  Identities=22%  Similarity=0.313  Sum_probs=188.0

Q ss_pred             HHHHhhhhhhcCCCCceEEEEEEecc--------------hHHHHHHHHhcc--CCCceeeeEeEEecC----CceeEEE
Q 036435           81 KKLTNSFKDKLGQGGFGGVYKGRLLD--------------DFVNEVASISRT--SHVNVVTLLGFCLEG----NNRALIY  140 (372)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~~--------------~~~~E~~~l~~l--~h~nIv~l~g~~~~~----~~~~lV~  140 (372)
                      ....+.+.+.||+|+||.||+|+..+              .+.+|.+++..+  +||||+++++++.+.    ...++||
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~  114 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLIT  114 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEE
T ss_pred             cccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEE
Confidence            33445566889999999999997643              355666666655  899999999999887    6789999


Q ss_pred             EecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC--------CeeecCCCCCceEECCCCceEEe
Q 036435          141 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCST--------KILHFDIKPHNILLDEDFCPKIS  212 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~--------~ivH~dlk~~Nill~~~~~~kl~  212 (372)
                      ||+++|+|.+++....       +++..++.++.|++.||+|||   ..        +++||||||+|||++.++.+||+
T Consensus       115 e~~~~g~L~~~l~~~~-------~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~  184 (337)
T 3mdy_A          115 DYHENGSLYDYLKSTT-------LDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA  184 (337)
T ss_dssp             CCCTTCBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred             eccCCCcHHHHhhccC-------CCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence            9999999999997643       899999999999999999999   66        99999999999999999999999


Q ss_pred             ecCCcccccCCCCeee-eecccccccccccccccccccCCCCc------cccchhHHHHHHHHhcC----------CCCC
Q 036435          213 DFGLAKLCTTKEGIVS-SLLGARGIIGYIAPEVFSRNFGEVSH------KSDVYSFGMMIMELVGC----------KNNL  275 (372)
Q Consensus       213 Dfgla~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~------~~DvwslG~il~elltg----------~~p~  275 (372)
                      |||++........... ......||+.|+|||.+.+.  ..+.      ++|||||||++|||++|          ..||
T Consensus       185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~  262 (337)
T 3mdy_A          185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES--LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY  262 (337)
T ss_dssp             CCTTCEECC---------CCSSCSCGGGCCHHHHTTC--CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             eCCCceeeccccccccCCCCCCccCcceeChhhcccc--cCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence            9999976644332211 12234689999999999764  3333      49999999999999999          4444


Q ss_pred             CCCCCCCCccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccC
Q 036435          276 DSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEAL  350 (372)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~  350 (372)
                      ........  ..................+.  .....+....+.+++.+||+.||++|||++++++.|+++.+..
T Consensus       263 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          263 HDLVPSDP--SYEDMREIVCIKKLRPSFPN--RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             TTTSCSSC--CHHHHHHHHTTSCCCCCCCG--GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             hhhcCCCC--chhhhHHHHhhhccCccccc--cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            43322211  11111111111111111111  1122356788999999999999999999999999999877653

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.7e-43  Score=325.37  Aligned_cols=233  Identities=26%  Similarity=0.357  Sum_probs=186.1

Q ss_pred             hhhhhcCCCCceEEEEEEec--------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLL--------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~--------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      .+.+.||+|+||.||+++..                    +.+.+|+.++++++||||+++++++.+++..++||||+++
T Consensus        10 ~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~   89 (323)
T 3tki_A           10 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG   89 (323)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             eeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCC
Confidence            34578999999999999653                    2578999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      |+|.+++....      .+++.++..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++........
T Consensus        90 ~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  160 (323)
T 3tki_A           90 GELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (323)
T ss_dssp             EEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             CcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence            99999996543      2899999999999999999999   79999999999999999999999999999986543322


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                      . .......||+.|+|||.+.+. ...+.++|||||||++|+|++|+.||........       ........... .  
T Consensus       161 ~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------~~~~~~~~~~~-~--  228 (323)
T 3tki_A          161 E-RLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-------EYSDWKEKKTY-L--  228 (323)
T ss_dssp             E-CCBCSCCSCGGGSCHHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-------HHHHHHTTCTT-S--
T ss_pred             c-cccCCCccCcCccCcHHhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-------HHHHHhccccc-C--
Confidence            1 112345689999999999764 2347899999999999999999999976543221       01111111111 0  


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                         .....+...+.+++.+||+.||.+|||++|+++.
T Consensus       229 ---~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          229 ---NPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             ---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ---CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence               1112234567789999999999999999999863

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.8e-43  Score=318.91  Aligned_cols=236  Identities=25%  Similarity=0.453  Sum_probs=188.9

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-----------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-----------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS  147 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-----------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~  147 (372)
                      +.+.+.||+|+||.||++++.+                 ++.+|++++++++||||+++++++.+++..++||||+++|+
T Consensus        26 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  105 (283)
T 3gen_A           26 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC  105 (283)
T ss_dssp             EEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCB
T ss_pred             HHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCc
Confidence            3446789999999999997642                 58899999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCee
Q 036435          148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV  227 (372)
Q Consensus       148 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  227 (372)
                      |.+++.....     .+++.+++.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++........  
T Consensus       106 L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~--  175 (283)
T 3gen_A          106 LLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY--  175 (283)
T ss_dssp             HHHHHHCGGG-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH--
T ss_pred             HHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcccccccccccccc--
Confidence            9999976332     2899999999999999999999   79999999999999999999999999999986543221  


Q ss_pred             eeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCcc
Q 036435          228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV  306 (372)
Q Consensus       228 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (372)
                      .......+|+.|+|||.+.+.  .++.++||||||+++|+|++ |+.||......        .....+........+..
T Consensus       176 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~  245 (283)
T 3gen_A          176 TSSVGSKFPVRWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--------ETAEHIAQGLRLYRPHL  245 (283)
T ss_dssp             HSTTSTTSCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--------HHHHHHHTTCCCCCCTT
T ss_pred             ccccCCccCcccCCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCccccChh--------HHHHHHhcccCCCCCCc
Confidence            112334467889999999865  78999999999999999998 99998754221        12222333222222222


Q ss_pred             CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       307 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                             ....+.+++.+||+.||.+|||++++++.|+++.
T Consensus       246 -------~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~  279 (283)
T 3gen_A          246 -------ASEKVYTIMYSCWHEKADERPTFKILLSNILDVM  279 (283)
T ss_dssp             -------CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -------CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence                   2356778999999999999999999999998765

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.6e-43  Score=340.10  Aligned_cols=238  Identities=28%  Similarity=0.463  Sum_probs=187.8

Q ss_pred             hhhhhcCCCCceEEEEEEecc-----------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCCh
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD-----------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL  148 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~-----------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L  148 (372)
                      .+.+.||+|+||.||+|++.+                 +|.+|+.++++++||||+++++++.+ +..++||||+++|+|
T Consensus       187 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL  265 (452)
T 1fmk_A          187 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL  265 (452)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBH
T ss_pred             eeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCH
Confidence            445789999999999997642                 58999999999999999999999876 678999999999999


Q ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeee
Q 036435          149 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVS  228 (372)
Q Consensus       149 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  228 (372)
                      .+++.....    ..+++.+++.++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++........  
T Consensus       266 ~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~--  336 (452)
T 1fmk_A          266 LDFLKGETG----KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT--  336 (452)
T ss_dssp             HHHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred             HHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCcee--
Confidence            999975321    12899999999999999999999   799999999999999999999999999999876433211  


Q ss_pred             eecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccC
Q 036435          229 SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVV  307 (372)
Q Consensus       229 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (372)
                      ......+|..|+|||.+.+.  .++.++||||||+++|||++ |+.||.....        ..+...+..+.....+.  
T Consensus       337 ~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--------~~~~~~i~~~~~~~~~~--  404 (452)
T 1fmk_A          337 ARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVERGYRMPCPP--  404 (452)
T ss_dssp             ------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTTCCCCCCT--
T ss_pred             cccCCcccccccCHhHHhcC--CCCccccHHhHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCCCCC--
Confidence            12233467889999999764  78999999999999999999 8888865321        11233333333322222  


Q ss_pred             CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccC
Q 036435          308 TRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEAL  350 (372)
Q Consensus       308 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~  350 (372)
                           .++..+.+++.+||+.||++|||++++++.|+.+....
T Consensus       405 -----~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~  442 (452)
T 1fmk_A          405 -----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  442 (452)
T ss_dssp             -----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             -----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence                 23456788999999999999999999999999887553

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.9e-43  Score=324.94  Aligned_cols=244  Identities=24%  Similarity=0.404  Sum_probs=183.5

Q ss_pred             hhhhhhcCCCCceEEEEEEec------------------------chHHHHHHHHhccCCCceeeeEeEEecCCce----
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNR----  136 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~----  136 (372)
                      +.+.+.||+|+||.||+++..                        +.+.+|+.++++++||||+++++++.+....    
T Consensus        25 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (323)
T 3qup_A           25 FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLP  104 (323)
T ss_dssp             CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------
T ss_pred             eEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCC
Confidence            344678999999999998642                        1578999999999999999999999887655    


Q ss_pred             --eEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeec
Q 036435          137 --ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDF  214 (372)
Q Consensus       137 --~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  214 (372)
                        ++|+||+++|+|.+++...........+++.+++.++.|++.||+|||   +.+++||||||+|||++.++.+||+||
T Consensus       105 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~kl~Df  181 (323)
T 3qup_A          105 IPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADF  181 (323)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred             ccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEEEeec
Confidence              999999999999999965432222234899999999999999999999   789999999999999999999999999


Q ss_pred             CCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHH
Q 036435          215 GLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYR  293 (372)
Q Consensus       215 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  293 (372)
                      |++........... .....+|+.|+|||.+.+.  .++.++|||||||++|||++ |..||.......        ...
T Consensus       182 g~a~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--------~~~  250 (323)
T 3qup_A          182 GLSRKIYSGDYYRQ-GCASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE--------IYN  250 (323)
T ss_dssp             CC------------------CCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHH
T ss_pred             cccccccccccccc-cccccCcccccCchhhcCC--CCCCccchhhHHHHHHHHHhCCCCCccccChHH--------HHH
Confidence            99987654332221 2234467889999999875  78999999999999999999 888887543221        222


Q ss_pred             HhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 036435          294 HVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~  349 (372)
                      .+........+.       .....+.+++.+||+.||++|||+.++++.|+++...
T Consensus       251 ~~~~~~~~~~~~-------~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~  299 (323)
T 3qup_A          251 YLIGGNRLKQPP-------ECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH  299 (323)
T ss_dssp             HHHTTCCCCCCT-------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHhcCCCCCCCC-------ccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            222222222221       2345678899999999999999999999999987754

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-43  Score=330.32  Aligned_cols=239  Identities=29%  Similarity=0.480  Sum_probs=180.1

Q ss_pred             hhhhcCCCCceEEEEEEec-----------------------chHHHHHHHHhccCCCceeeeEeEEec-CCceeEEEEe
Q 036435           87 FKDKLGQGGFGGVYKGRLL-----------------------DDFVNEVASISRTSHVNVVTLLGFCLE-GNNRALIYEF  142 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~-----------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~-~~~~~lV~e~  142 (372)
                      +.+.||+|+||.||+|++.                       +++.+|+.++++++||||+++++++.+ ++..++||||
T Consensus        93 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~  172 (373)
T 3c1x_A           93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY  172 (373)
T ss_dssp             EEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEEC
T ss_pred             cCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEEC
Confidence            4568999999999998752                       157899999999999999999998764 4678999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      +++|+|.+++.....     .+++.+++.++.|+++||+|||   +.+++||||||+|||++.++.+||+|||+++....
T Consensus       173 ~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          173 MKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             CTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             CCCCCHHHHHhhccc-----CCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccccccc
Confidence            999999999976442     2889999999999999999999   78999999999999999999999999999986543


Q ss_pred             CCCee-eeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhccc
Q 036435          223 KEGIV-SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDRE  300 (372)
Q Consensus       223 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (372)
                      ..... .......+|+.|+|||.+.+.  .++.++||||||+++|||++ |.+||.......        ....+.....
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--------~~~~~~~~~~  314 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--------ITVYLLQGRR  314 (373)
T ss_dssp             -------------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--------HHHHHHTTCC
T ss_pred             cccccccccCCCCCcccccChHHhcCC--CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--------HHHHHHcCCC
Confidence            32211 112334577889999999874  78999999999999999999 556665433221        1222223322


Q ss_pred             ccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccC
Q 036435          301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEAL  350 (372)
Q Consensus       301 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~  350 (372)
                      ...+..       ....+.+++.+||+.||.+|||++++++.|+.+....
T Consensus       315 ~~~p~~-------~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~  357 (373)
T 3c1x_A          315 LLQPEY-------CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  357 (373)
T ss_dssp             CCCCTT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             CCCCCC-------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            222221       2356788999999999999999999999998877543

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=4.6e-43  Score=328.29  Aligned_cols=230  Identities=23%  Similarity=0.334  Sum_probs=185.9

Q ss_pred             hhhhhhcCCCCceEEEEEEec-------------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL-------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI  139 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV  139 (372)
                      +.+.+.||+|+||.||+++..                         +.+.+|+.++++++||||+++++++.+++..++|
T Consensus        14 y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   93 (361)
T 2yab_A           14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLI   93 (361)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEE
Confidence            345678999999999998653                         1478999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC----ceEEeecC
Q 036435          140 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDF----CPKISDFG  215 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg  215 (372)
                      |||+++|+|.+++....      .+++..+..++.|++.||.|||   +.+|+||||||+|||++.++    .+||+|||
T Consensus        94 ~e~~~gg~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           94 LELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EECCCSCBHHHHHTTCS------CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            99999999999997643      2899999999999999999999   79999999999999998776    79999999


Q ss_pred             CcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHh
Q 036435          216 LAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV  295 (372)
Q Consensus       216 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  295 (372)
                      ++........    .....||+.|+|||++.+.  .++.++|||||||++|+|++|..||......        .....+
T Consensus       165 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~--------~~~~~i  230 (361)
T 2yab_A          165 LAHEIEDGVE----FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLANI  230 (361)
T ss_dssp             SCEECCTTCC----CCCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHH
T ss_pred             CceEcCCCCc----cccCCCCccEECchHHcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHH
Confidence            9987654332    1334589999999999764  7899999999999999999999999754211        112222


Q ss_pred             hhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          296 EQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ... ....+   ..........+.+++.+||+.||.+|||+.|+++
T Consensus       231 ~~~-~~~~~---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          231 TAV-SYDFD---EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HTT-CCCCC---HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             Hhc-CCCCC---chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            111 11111   0111223456788999999999999999999985

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-43  Score=326.38  Aligned_cols=244  Identities=25%  Similarity=0.405  Sum_probs=193.3

Q ss_pred             hhhhhcCCCCceEEEEEEec-------------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLL-------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIY  140 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~-------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~  140 (372)
                      .+.+.||+|+||.||+++..                         +.+.+|+.++++++||||+++++++.+++..++||
T Consensus        50 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  129 (343)
T 1luf_A           50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLF  129 (343)
T ss_dssp             EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             eeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEE
Confidence            34578999999999999763                         14788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhcCCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceE
Q 036435          141 EFMPNGSLEKFVYNGDTSK------------------PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNIL  202 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~------------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nil  202 (372)
                      ||+++|+|.+++.......                  ....+++.+++.++.|+++||+|||   +.+++||||||+|||
T Consensus       130 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl  206 (343)
T 1luf_A          130 EYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCL  206 (343)
T ss_dssp             ECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred             ecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEE
Confidence            9999999999998743211                  0134899999999999999999999   789999999999999


Q ss_pred             ECCCCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCC
Q 036435          203 LDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDS  281 (372)
Q Consensus       203 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~  281 (372)
                      ++.++.+||+|||++.......... ......+|+.|+|||.+.+.  .++.++||||||+++|||++ |..||..... 
T Consensus       207 ~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~-  282 (343)
T 1luf_A          207 VGENMVVKIADFGLSRNIYSADYYK-ADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGLQPYYGMAH-  282 (343)
T ss_dssp             ECGGGCEEECCCSCHHHHTGGGCBC-----CCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-
T ss_pred             ECCCCeEEEeecCCCcccccCcccc-ccCCCcccceecChhhhccC--CcCcccccHHHHHHHHHHHhcCCCcCCCCCh-
Confidence            9999999999999998654332211 12334578899999998865  78999999999999999999 9989875321 


Q ss_pred             CCccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccC
Q 036435          282 SSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEAL  350 (372)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~  350 (372)
                             ......+........+.       .+...+.+++.+||+.||.+|||+.++++.|+++....
T Consensus       283 -------~~~~~~~~~~~~~~~~~-------~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~  337 (343)
T 1luf_A          283 -------EEVIYYVRDGNILACPE-------NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA  337 (343)
T ss_dssp             -------HHHHHHHHTTCCCCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred             -------HHHHHHHhCCCcCCCCC-------CCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence                   11222232222222222       23456788999999999999999999999999887643

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=6.9e-43  Score=335.45  Aligned_cols=231  Identities=20%  Similarity=0.317  Sum_probs=185.5

Q ss_pred             hhhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      +.+.+.||+|+||.||++....                     .+.+|+.++++++||||+++++++.+++..++||||+
T Consensus        13 Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~   92 (444)
T 3soa_A           13 YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLV   92 (444)
T ss_dssp             EEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCC
T ss_pred             eEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeC
Confidence            4456789999999999986531                     4789999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC---CCCceEEeecCCcccc
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLD---EDFCPKISDFGLAKLC  220 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgla~~~  220 (372)
                      ++|+|.+++.....      +++..+..++.|++.||+|||   +.+|+||||||+|||++   .++.+||+|||++...
T Consensus        93 ~gg~L~~~i~~~~~------~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~  163 (444)
T 3soa_A           93 TGGELFEDIVAREY------YSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV  163 (444)
T ss_dssp             BCCBHHHHHHHCSC------CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred             CCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence            99999999987543      899999999999999999999   78999999999999998   5678999999999876


Q ss_pred             cCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccc
Q 036435          221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDRE  300 (372)
Q Consensus       221 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (372)
                      ......   .....||+.|+|||.+.+.  .++.++||||+||++|+|++|..||.....        ......+.... 
T Consensus       164 ~~~~~~---~~~~~gt~~Y~APE~l~~~--~~~~~~DIwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~~-  229 (444)
T 3soa_A          164 EGEQQA---WFGFAGTPGYLSPEVLRKD--PYGKPVDLWACGVILYILLVGYPPFWDEDQ--------HRLYQQIKAGA-  229 (444)
T ss_dssp             CTTCCB---CCCSCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHTC-
T ss_pred             cCCCce---eecccCCcccCCHHHhcCC--CCCCccccHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHHhCC-
Confidence            543322   2334689999999999874  789999999999999999999999975421        11222222221 


Q ss_pred             ccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       301 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ...+.   .....+...+.+++.+||+.||.+|||+.|+++
T Consensus       230 ~~~~~---~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          230 YDFPS---PEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             CCCCT---TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCCc---cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            11111   111223456788999999999999999999987

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=4.6e-43  Score=328.26  Aligned_cols=244  Identities=28%  Similarity=0.433  Sum_probs=193.3

Q ss_pred             hhhhhcCCCCceEEEEEEec-------------------------chHHHHHHHHhcc-CCCceeeeEeEEecCC-ceeE
Q 036435           86 SFKDKLGQGGFGGVYKGRLL-------------------------DDFVNEVASISRT-SHVNVVTLLGFCLEGN-NRAL  138 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~-------------------------~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~-~~~l  138 (372)
                      .+.+.||+|+||.||+|++.                         +.+.+|++++.++ +||||+++++++.+.+ ..++
T Consensus        25 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~i  104 (359)
T 3vhe_A           25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV  104 (359)
T ss_dssp             EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEE
T ss_pred             eeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEE
Confidence            44578999999999999731                         1488999999999 7999999999998765 4899


Q ss_pred             EEEecCCCChhhhhhcCCCCC-----------------------------------------------------------
Q 036435          139 IYEFMPNGSLEKFVYNGDTSK-----------------------------------------------------------  159 (372)
Q Consensus       139 V~e~~~~g~L~~~l~~~~~~~-----------------------------------------------------------  159 (372)
                      ||||+++|+|.+++.......                                                           
T Consensus       105 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  184 (359)
T 3vhe_A          105 IVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPED  184 (359)
T ss_dssp             EEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------C
T ss_pred             EEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccc
Confidence            999999999999998754210                                                           


Q ss_pred             -CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeeeeecccccccc
Q 036435          160 -PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIG  238 (372)
Q Consensus       160 -~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  238 (372)
                       ....+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++........... .....||+.
T Consensus       185 ~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~~~t~~  260 (359)
T 3vhe_A          185 LYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR-KGDARLPLK  260 (359)
T ss_dssp             TTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEE-C--CEECGG
T ss_pred             hhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchh-ccccCCCce
Confidence             0122899999999999999999999   78999999999999999999999999999987654333222 234568889


Q ss_pred             cccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCCcchHHHHHH
Q 036435          239 YIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKK  317 (372)
Q Consensus       239 y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (372)
                      |+|||.+.+.  .++.++||||||+++|||++ |..||......       ......+........+..       ....
T Consensus       261 y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~-------~~~~  324 (359)
T 3vhe_A          261 WMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-------EEFCRRLKEGTRMRAPDY-------TTPE  324 (359)
T ss_dssp             GCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-------HHHHHHHHHTCCCCCCTT-------CCHH
T ss_pred             eEChhhhcCC--CCCchhhhhhHHHHHHHHHhcCCCCCCccchh-------HHHHHHHHcCCCCCCCCC-------CCHH
Confidence            9999999874  78999999999999999998 99998754322       112333333333333322       2346


Q ss_pred             HHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 036435          318 MIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       318 l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~  349 (372)
                      +.+++.+||+.||.+|||++|+++.|+.+..+
T Consensus       325 l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          325 MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence            77889999999999999999999999877643

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=7.9e-43  Score=320.48  Aligned_cols=243  Identities=25%  Similarity=0.411  Sum_probs=195.0

Q ss_pred             hhhhhhcCCCCceEEEEEEec-------------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL-------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI  139 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV  139 (372)
                      +.+.+.||+|+||.||+++..                         +.+.+|+.++++++||||+++++++.+++..++|
T Consensus        25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  104 (314)
T 2ivs_A           25 LVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLI  104 (314)
T ss_dssp             EEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEE
Confidence            344578999999999999651                         1578899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCce
Q 036435          140 YEFMPNGSLEKFVYNGDTSK------------------PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNI  201 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~------------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Ni  201 (372)
                      |||+++|+|.+++.......                  ....+++.+++.++.|+++||+|||   +.+++||||||+||
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp~NI  181 (314)
T 2ivs_A          105 VEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNI  181 (314)
T ss_dssp             EECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGE
T ss_pred             EeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccchheE
Confidence            99999999999998754311                  1134899999999999999999999   78999999999999


Q ss_pred             EECCCCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCC
Q 036435          202 LLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVD  280 (372)
Q Consensus       202 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~  280 (372)
                      +++.++.+||+|||++........... .....+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.||.....
T Consensus       182 li~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          182 LVAEGRKMKISDFGLSRDVYEEDSYVK-RSQGRIPVKWMAIESLFDH--IYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             EEETTTEEEECCCTTCEECTTTSCEEC-SSCCCSCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             EEcCCCCEEEcccccccccccccccee-ccCCCCcccccChhhhcCC--CcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999987654433222 2334577889999999774  78999999999999999999 9999875432


Q ss_pred             CCCccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 036435          281 SSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE  348 (372)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~  348 (372)
                      ..        ....+........+.       .....+.+++.+||+.||.+|||++++++.|+++..
T Consensus       259 ~~--------~~~~~~~~~~~~~~~-------~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          259 ER--------LFNLLKTGHRMERPD-------NCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             GG--------HHHHHHTTCCCCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HH--------HHHHhhcCCcCCCCc-------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            11        223333332222221       234567889999999999999999999999987653

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.4e-42  Score=328.17  Aligned_cols=234  Identities=20%  Similarity=0.293  Sum_probs=185.4

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhcc-CCCceeeeEeEEecCCceeEEEEe
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      .+.+.||+|+||.||+++..+                      .+.+|..++.++ +||||+++++++.+++..++||||
T Consensus        55 ~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~  134 (396)
T 4dc2_A           55 DLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY  134 (396)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEc
Confidence            446789999999999997632                      477899999887 899999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      +++|+|.+++.....      +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       135 ~~gg~L~~~l~~~~~------l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          135 VNGGDLMFHMQRQRK------LPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             CTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             CCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence            999999999976532      899999999999999999999   79999999999999999999999999999986332


Q ss_pred             CCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCc-cchHHHHHHHhhhcccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE-VYFPHWIYRHVEQDREF  301 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~  301 (372)
                      ....   .....||+.|+|||++.+.  .++.++|+|||||++|||++|+.||......... ......+...+.. ...
T Consensus       206 ~~~~---~~~~~gt~~Y~aPE~l~~~--~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~-~~~  279 (396)
T 4dc2_A          206 PGDT---TSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-KQI  279 (396)
T ss_dssp             TTCC---BCCCCBCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH-CCC
T ss_pred             CCCc---cccccCCcccCCchhhcCC--CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc-ccc
Confidence            2211   2345699999999999875  7899999999999999999999999754322111 1111222222222 222


Q ss_pred             cCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 036435          302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPM------NEVIE  341 (372)
Q Consensus       302 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~------~evl~  341 (372)
                      ..|..       +...+.+++.+||+.||.+||++      +|+++
T Consensus       280 ~~p~~-------~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~  318 (396)
T 4dc2_A          280 RIPRS-------LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  318 (396)
T ss_dssp             CCCTT-------SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred             CCCCc-------CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence            33322       23567788999999999999985      56664

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.8e-43  Score=319.25  Aligned_cols=243  Identities=28%  Similarity=0.467  Sum_probs=180.9

Q ss_pred             hhhhhhcCCCCceEEEEEEecc------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      +.+.+.||+|+||.||+|+..+                  .+.+|+.++++++||||+++++++ ..+..++||||++++
T Consensus        26 y~~~~~lG~G~~g~Vy~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~  104 (289)
T 3og7_A           26 ITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGS  104 (289)
T ss_dssp             CEEEEEEEECSSEEEEEEESSSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEE
T ss_pred             eeeeeEecCCCCeEEEEEEEcCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCC
Confidence            4456789999999999997532                  588999999999999999999965 556789999999999


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      +|.+++.....     .+++.+++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++.........
T Consensus       105 ~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  176 (289)
T 3og7_A          105 SLYHHLHASET-----KFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS  176 (289)
T ss_dssp             EHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred             cHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccccccccc
Confidence            99999965432     2899999999999999999999   799999999999999999999999999999765432211


Q ss_pred             eeeecccccccccccccccccc-cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          227 VSSLLGARGIIGYIAPEVFSRN-FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                      . ......||+.|+|||.+... ...++.++||||||+++|+|++|+.||......       ...............  
T Consensus       177 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~--  246 (289)
T 3og7_A          177 H-QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-------DQIIEMVGRGSLSPD--  246 (289)
T ss_dssp             --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH-------HHHHHHHHHTSCCCC--
T ss_pred             c-cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH-------HHHHHHhcccccCcc--
Confidence            1 12334589999999998621 136788999999999999999999999754321       112222222211111  


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                       .......++..+.+++.+||+.||.+|||++++++.|+++.
T Consensus       247 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          247 -LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             -TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             -hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence             11111223467888999999999999999999999998865

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3.8e-43  Score=318.75  Aligned_cols=239  Identities=29%  Similarity=0.463  Sum_probs=195.5

Q ss_pred             HhhhhhhcCCCCceEEEEEEecc------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           84 TNSFKDKLGQGGFGGVYKGRLLD------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~~------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      .+.+.+.||+|+||.||+++..+                  .+.+|+.++++++||||+++++++.+++..++||||+++
T Consensus        14 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~   93 (288)
T 3kfa_A           14 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY   93 (288)
T ss_dssp             GEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred             ceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCC
Confidence            34456789999999999997642                  588999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      ++|.+++......    .+++..++.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++........
T Consensus        94 ~~L~~~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  166 (288)
T 3kfa_A           94 GNLLDYLRECNRQ----EVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  166 (288)
T ss_dssp             EEHHHHHHHCCTT----TSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred             CcHHHHHHhcccC----CccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence            9999999875432    3899999999999999999999   78999999999999999999999999999987654432


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCC
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP  304 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (372)
                      ..  .....+|+.|+|||.+.+.  .++.++||||||+++|+|++ |..||.......        ....+........+
T Consensus       167 ~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~  234 (288)
T 3kfa_A          167 TA--HAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------VYELLEKDYRMERP  234 (288)
T ss_dssp             EE--ETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--------HHHHHHTTCCCCCC
T ss_pred             cc--ccCCccccCcCChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHhccCCCCCC
Confidence            22  2344577889999999775  78999999999999999999 888887543211        22233332222222


Q ss_pred             ccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 036435          305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE  348 (372)
Q Consensus       305 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~  348 (372)
                      .       .....+.+++.+||+.||.+|||++++++.|+.+..
T Consensus       235 ~-------~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~  271 (288)
T 3kfa_A          235 E-------GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  271 (288)
T ss_dssp             T-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             C-------CCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence            2       234567889999999999999999999999987653

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-42  Score=315.88  Aligned_cols=238  Identities=23%  Similarity=0.400  Sum_probs=193.1

Q ss_pred             hcCCCCceEEEEEEec----------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCC
Q 036435           90 KLGQGGFGGVYKGRLL----------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS  147 (372)
Q Consensus        90 ~lg~G~~g~V~~~~~~----------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~  147 (372)
                      .||+|+||.||+|.+.                      +.+.+|+.++++++||||+++++++ +.+..++||||+++++
T Consensus        17 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~   95 (287)
T 1u59_A           17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGP   95 (287)
T ss_dssp             EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEE
T ss_pred             cccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCC
Confidence            7999999999999742                      1578999999999999999999999 5567899999999999


Q ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCee
Q 036435          148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV  227 (372)
Q Consensus       148 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  227 (372)
                      |.+++.....     .+++..++.++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++..........
T Consensus        96 L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  167 (287)
T 1u59_A           96 LHKFLVGKRE-----EIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY  167 (287)
T ss_dssp             HHHHHTTCTT-----TSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred             HHHHHHhCCc-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccCccee
Confidence            9999965432     2899999999999999999999   7899999999999999999999999999998776544433


Q ss_pred             eeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCcc
Q 036435          228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV  306 (372)
Q Consensus       228 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (372)
                      .......+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.||......        .....+........+. 
T Consensus       168 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------~~~~~i~~~~~~~~~~-  236 (287)
T 1u59_A          168 TARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------EVMAFIEQGKRMECPP-  236 (287)
T ss_dssp             CCCCSSCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--------HHHHHHHTTCCCCCCT-
T ss_pred             eccccccccccccCHHHhccC--CCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--------HHHHHHhcCCcCCCCC-
Confidence            333444578899999999764  78999999999999999998 99998754321        1222333322222222 


Q ss_pred             CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccCCCC
Q 036435          307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQIP  353 (372)
Q Consensus       307 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~  353 (372)
                            .....+.+++.+||+.||.+||++.++++.|+.+......+
T Consensus       237 ------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~  277 (287)
T 1u59_A          237 ------ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK  277 (287)
T ss_dssp             ------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred             ------CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence                  23457788999999999999999999999998887654433

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=5.8e-43  Score=319.01  Aligned_cols=247  Identities=15%  Similarity=0.220  Sum_probs=195.2

Q ss_pred             hhhhhcCCCCceEEEEEEec-----------------chHHHHHHHHhcc-CCCceeeeEeEEecCCceeEEEEecCCCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLL-----------------DDFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNGS  147 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~-----------------~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~~~~g~  147 (372)
                      .+.+.||+|+||.||+|+..                 +.+.+|+.+++++ +|+|++++++++.++...++||||+ +++
T Consensus        13 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~   91 (298)
T 1csn_A           13 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPS   91 (298)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred             EEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCC
Confidence            34578999999999999752                 2688999999999 8999999999999999999999999 999


Q ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCc-----eEEeecCCcccccC
Q 036435          148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFC-----PKISDFGLAKLCTT  222 (372)
Q Consensus       148 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Dfgla~~~~~  222 (372)
                      |.+++.....     .+++..+..++.|++.||+|||   +.+++||||||+|||++.++.     +||+|||++.....
T Consensus        92 L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~  163 (298)
T 1csn_A           92 LEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  163 (298)
T ss_dssp             HHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             HHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence            9999986532     2899999999999999999999   899999999999999987766     99999999987654


Q ss_pred             CCCee----eeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhc
Q 036435          223 KEGIV----SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQD  298 (372)
Q Consensus       223 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (372)
                      .....    .......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||.........     .....+...
T Consensus       164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-----~~~~~~~~~  236 (298)
T 1csn_A          164 PVTKQHIPYREKKNLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK-----QKYERIGEK  236 (298)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH-----HHHHHHHHH
T ss_pred             ccccccccccCccCCCCCcccCCchhhcCC--CCChHHHHHHHHHHHHHHHcCCCCcchhhccccH-----HHHHHHHhh
Confidence            43221    112345689999999999775  7899999999999999999999999875433211     111111111


Q ss_pred             -ccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccCCC
Q 036435          299 -REFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQI  352 (372)
Q Consensus       299 -~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  352 (372)
                       .....+.    ....+...+.+++.+||+.||++|||++++++.|+++......
T Consensus       237 ~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~  287 (298)
T 1csn_A          237 KQSTPLRE----LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT  287 (298)
T ss_dssp             HHHSCHHH----HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             ccCccHHH----HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence             1111010    0112346788899999999999999999999999988765443

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.9e-43  Score=324.90  Aligned_cols=237  Identities=27%  Similarity=0.445  Sum_probs=185.0

Q ss_pred             hhhhhcCCCCceEEEEEEec------------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYE  141 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  141 (372)
                      .+.+.||+|+||.||+|++.                        +.+.+|+.++++++||||+++++++.++. .++|+|
T Consensus        18 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~   96 (327)
T 3lzb_A           18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQ   96 (327)
T ss_dssp             EEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEEC
T ss_pred             eEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEE
Confidence            44578999999999999752                        15889999999999999999999998764 789999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      |+++|+|.+++.....     .+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++....
T Consensus        97 ~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           97 LMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             CCSSCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             ecCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            9999999999987542     2899999999999999999999   7899999999999999999999999999998765


Q ss_pred             CCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhccc
Q 036435          222 TKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDRE  300 (372)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (372)
                      ....... .....+|+.|+|||.+.+.  .++.++|||||||++|||++ |..||.......        ....+.....
T Consensus       169 ~~~~~~~-~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--------~~~~~~~~~~  237 (327)
T 3lzb_A          169 AEEKEYH-AEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------ISSILEKGER  237 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHHTTCC
T ss_pred             Ccccccc-ccCCCccccccCHHHHcCC--CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--------HHHHHHcCCC
Confidence            4332221 2334467889999999875  78999999999999999999 999987543221        2233333322


Q ss_pred             ccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 036435          301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       301 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~  349 (372)
                      ...+..       ....+.+++.+||+.||.+|||++|+++.|+.+...
T Consensus       238 ~~~~~~-------~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          238 LPQPPI-------CTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             CCCCTT-------BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             CCCCcc-------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            222222       234677899999999999999999999999887643

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1e-42  Score=316.60  Aligned_cols=235  Identities=25%  Similarity=0.424  Sum_probs=190.0

Q ss_pred             hhh-hcCCCCceEEEEEEec-----------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEe
Q 036435           87 FKD-KLGQGGFGGVYKGRLL-----------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        87 ~~~-~lg~G~~g~V~~~~~~-----------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      +.+ .||+|+||.||+|.+.                       +++.+|+.++++++||||+++++++ +.+..++||||
T Consensus        20 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~   98 (291)
T 1xbb_A           20 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEM   98 (291)
T ss_dssp             EEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEEC
T ss_pred             hccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEe
Confidence            345 7999999999999431                       1578899999999999999999999 66788999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      +++++|.+++.....      +++..++.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++.....
T Consensus        99 ~~~~~L~~~l~~~~~------~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (291)
T 1xbb_A           99 AELGPLNKYLQQNRH------VKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  169 (291)
T ss_dssp             CTTEEHHHHHHHCTT------CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             CCCCCHHHHHHhCcC------CCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence            999999999987542      899999999999999999999   78999999999999999999999999999987765


Q ss_pred             CCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREF  301 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (372)
                      ............+|+.|+|||.+.+.  .++.++||||||+++|+|++ |+.||.....        ......+......
T Consensus       170 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~  239 (291)
T 1xbb_A          170 DENYYKAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVTAMLEKGERM  239 (291)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTTCCC
T ss_pred             CCCcccccccCCCCceeeChHHhccC--CCChhhhHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCC
Confidence            55443333344567889999999764  78899999999999999999 9999875422        1122333333222


Q ss_pred             cCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 036435          302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE  348 (372)
Q Consensus       302 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~  348 (372)
                      ..+.       .....+.+++.+||+.||.+||++.++++.|+++-.
T Consensus       240 ~~~~-------~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  279 (291)
T 1xbb_A          240 GCPA-------GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  279 (291)
T ss_dssp             CCCT-------TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCC-------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            2221       234568889999999999999999999999987654

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=7e-43  Score=319.18  Aligned_cols=246  Identities=25%  Similarity=0.405  Sum_probs=193.1

Q ss_pred             hhhhhhcCCCCceEEEEEEec------------------------chHHHHHHHHhccCCCceeeeEeEEecC--CceeE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTLLGFCLEG--NNRAL  138 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~--~~~~l  138 (372)
                      +.+.+.||+|+||.||++++.                        +.+.+|+.++++++||||+++++++.+.  +..++
T Consensus        23 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l  102 (302)
T 4e5w_A           23 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL  102 (302)
T ss_dssp             EEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEE
T ss_pred             hhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEE
Confidence            445678999999999999731                        1578999999999999999999999876  67899


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          139 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       139 V~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      ||||+++|+|.+++.....     .+++..++.++.|++.||+|||   +.+++|+||||+|||++.++.+||+|||++.
T Consensus       103 v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A          103 IMEFLPSGSLKEYLPKNKN-----KINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             EEECCTTCBHHHHHHHHTT-----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEeCCCCcHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccccc
Confidence            9999999999999965432     2899999999999999999999   7999999999999999999999999999998


Q ss_pred             cccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCC-------CCCccchHHHH
Q 036435          219 LCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVD-------SSSEVYFPHWI  291 (372)
Q Consensus       219 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~-------~~~~~~~~~~~  291 (372)
                      ................+|..|+|||.+.+.  .++.++||||||+++|+|++|+.|+.....       ...........
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  252 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQS--KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL  252 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCC--CCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence            876655444444455688889999999775  788999999999999999999988643210       00000111112


Q ss_pred             HHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          292 YRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                      ............+.       .+...+.+++.+||+.||.+|||++++++.|+.+.
T Consensus       253 ~~~~~~~~~~~~~~-------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          253 VNTLKEGKRLPCPP-------NCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHHTTCCCCCCT-------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHhccCCCCCCC-------CCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            22222222222221       23457888999999999999999999999998653

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=5.3e-42  Score=311.18  Aligned_cols=234  Identities=26%  Similarity=0.484  Sum_probs=185.6

Q ss_pred             hhhhhhcCCCCceEEEEEEec--------------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL--------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRAL  138 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~--------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~l  138 (372)
                      +.+.+.||+|+||.||+++..                          +.+.+|+.++++++||||+++++++.+..  ++
T Consensus        21 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~l   98 (287)
T 4f0f_A           21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RM   98 (287)
T ss_dssp             EEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EE
T ss_pred             ceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eE
Confidence            344678999999999999762                          25788999999999999999999987655  79


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCceEECCCCc-----eEE
Q 036435          139 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTK--ILHFDIKPHNILLDEDFC-----PKI  211 (372)
Q Consensus       139 V~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~--ivH~dlk~~Nill~~~~~-----~kl  211 (372)
                      ||||+++|+|.+++.....     .+++..++.++.|++.||+|||   +.+  ++||||||+|||++.++.     +||
T Consensus        99 v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl  170 (287)
T 4f0f_A           99 VMEFVPCGDLYHRLLDKAH-----PIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKV  170 (287)
T ss_dssp             EEECCTTCBHHHHHHCTTS-----CCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred             EEEecCCCCHHHHHhcccC-----CccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence            9999999999999876542     3899999999999999999999   778  999999999999987776     999


Q ss_pred             eecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHH
Q 036435          212 SDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWI  291 (372)
Q Consensus       212 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  291 (372)
                      +|||++......      .....||+.|+|||.+.+....++.++||||||+++|||++|+.||.......     ....
T Consensus       171 ~Dfg~~~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~~~~  239 (287)
T 4f0f_A          171 ADFGLSQQSVHS------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-----IKFI  239 (287)
T ss_dssp             CCCTTCBCCSSC------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH-----HHHH
T ss_pred             CCCCcccccccc------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH-----HHHH
Confidence            999999754332      23345899999999985433467899999999999999999999997543321     1111


Q ss_pred             HHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 036435          292 YRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGS  346 (372)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~  346 (372)
                      ............+.       .....+.+++.+||+.||.+|||++++++.|+++
T Consensus       240 ~~~~~~~~~~~~~~-------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          240 NMIREEGLRPTIPE-------DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHHHHSCCCCCCCT-------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             HHHhccCCCCCCCc-------ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            11111121222221       2345678899999999999999999999999864

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.1e-43  Score=322.30  Aligned_cols=230  Identities=25%  Similarity=0.349  Sum_probs=185.7

Q ss_pred             hhhhhhcCCCCceEEEEEEec-------------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL-------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI  139 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV  139 (372)
                      +.+.+.||+|+||.||+++..                         +.+.+|+.++++++||||+++++++.+++..++|
T Consensus        13 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   92 (326)
T 2y0a_A           13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILI   92 (326)
T ss_dssp             EEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            455678999999999998653                         1478999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC----ceEEeecC
Q 036435          140 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDF----CPKISDFG  215 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg  215 (372)
                      |||+++|+|.+++....      .+++..+..++.|++.||.|||   +.+++||||||+|||++.++    .+||+|||
T Consensus        93 ~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           93 LELVAGGELFDFLAEKE------SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EECCCSCBHHHHHTTSS------CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEcCCCCCHHHHHHhcC------CcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            99999999999996543      2899999999999999999999   79999999999999999877    89999999


Q ss_pred             CcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHh
Q 036435          216 LAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV  295 (372)
Q Consensus       216 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  295 (372)
                      ++........    .....||+.|+|||.+.+.  .++.++|||||||++|+|++|..||......       . ....+
T Consensus       164 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~-~~~~~  229 (326)
T 2y0a_A          164 LAHKIDFGNE----FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQ-------E-TLANV  229 (326)
T ss_dssp             TCEECCTTSC----CCCCCSCTTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-------H-HHHHH
T ss_pred             CCeECCCCCc----cccccCCcCcCCceeecCC--CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-------H-HHHHH
Confidence            9987654332    1234589999999999764  7899999999999999999999999753211       1 11111


Q ss_pred             hhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          296 EQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ... ....+   ..........+.+++.+||+.||.+|||++|+++
T Consensus       230 ~~~-~~~~~---~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          230 SAV-NYEFE---DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HHT-CCCCC---HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             Hhc-CCCcC---ccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            111 11111   1111123456788999999999999999999997

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.9e-44  Score=330.34  Aligned_cols=247  Identities=23%  Similarity=0.360  Sum_probs=193.3

Q ss_pred             hhhhhcCCCCceEEEEEEec------------------------chHHHHHHHHhccCCCceeeeEeEEecC--CceeEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTLLGFCLEG--NNRALI  139 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~--~~~~lV  139 (372)
                      .+.+.||+|+||.||++.+.                        +.+.+|+.++++++||||+++++++.+.  ...++|
T Consensus        34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv  113 (318)
T 3lxp_A           34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV  113 (318)
T ss_dssp             EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred             hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence            44578999999999887531                        1478999999999999999999999874  578999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccc
Q 036435          140 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL  219 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  219 (372)
                      |||+++|+|.+++....       +++..++.++.|++.||+|||   +.+++|+||||+|||++.++.+||+|||++..
T Consensus       114 ~e~~~~~~L~~~l~~~~-------~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  183 (318)
T 3lxp_A          114 MEYVPLGSLRDYLPRHS-------IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  183 (318)
T ss_dssp             ECCCTTCBHHHHGGGSC-------CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EecccCCcHHHHHhhCC-------CCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence            99999999999997653       899999999999999999999   78999999999999999999999999999998


Q ss_pred             ccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCC-------CccchHHHHH
Q 036435          220 CTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSS-------SEVYFPHWIY  292 (372)
Q Consensus       220 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~-------~~~~~~~~~~  292 (372)
                      ...............+|..|+|||.+.+.  .++.++||||||+++|+|++|+.||.......       ..........
T Consensus       184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  261 (318)
T 3lxp_A          184 VPEGHEYYRVREDGDSPVFWYAPECLKEY--KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT  261 (318)
T ss_dssp             CCTTCSEEEC---CCCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHH
T ss_pred             ccccccccccccCCCCCceeeChHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHH
Confidence            76655443333445678889999999875  78899999999999999999999986431100       0000000111


Q ss_pred             HHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccCC
Q 036435          293 RHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQ  351 (372)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~  351 (372)
                      ...........+       ..+...+.+++.+||+.||.+|||++++++.|+.+.....
T Consensus       262 ~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  313 (318)
T 3lxp_A          262 ELLERGERLPRP-------DKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ  313 (318)
T ss_dssp             HHHHTTCCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHhcccCCCCC-------ccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence            222222222222       2234678889999999999999999999999998876543

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=346.69  Aligned_cols=235  Identities=23%  Similarity=0.399  Sum_probs=187.0

Q ss_pred             hcCCCCceEEEEEEec----------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCC
Q 036435           90 KLGQGGFGGVYKGRLL----------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS  147 (372)
Q Consensus        90 ~lg~G~~g~V~~~~~~----------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~  147 (372)
                      .||+|+||.||+|.+.                      +++.+|+.++++++||||++++++|.+ +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            6999999999998652                      158899999999999999999999976 56899999999999


Q ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCee
Q 036435          148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV  227 (372)
Q Consensus       148 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  227 (372)
                      |.+++.....     .+++..++.++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++.........
T Consensus       422 L~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~  493 (613)
T 2ozo_A          422 LHKFLVGKRE-----EIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY  493 (613)
T ss_dssp             HHHHHTTCTT-----TSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred             HHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence            9999975432     3899999999999999999999   7899999999999999999999999999998765443322


Q ss_pred             eeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCcc
Q 036435          228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV  306 (372)
Q Consensus       228 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (372)
                      .......+|+.|+|||++.+.  .++.++|||||||++|||++ |+.||......        .+...+..+.....+. 
T Consensus       494 ~~~~~~~~~~~y~APE~~~~~--~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--------~~~~~i~~~~~~~~p~-  562 (613)
T 2ozo_A          494 TARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------EVMAFIEQGKRMECPP-  562 (613)
T ss_dssp             --------CCTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--------HHHHHHHTTCCCCCCT-
T ss_pred             eeccCCCCccceeCHhhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--------HHHHHHHcCCCCCCCC-
Confidence            222333466889999999764  88999999999999999998 99999764321        1333344443333332 


Q ss_pred             CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccC
Q 036435          307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEAL  350 (372)
Q Consensus       307 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~  350 (372)
                            .+...+.+++..||+.||++||+++++++.|+......
T Consensus       563 ------~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~  600 (613)
T 2ozo_A          563 ------ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  600 (613)
T ss_dssp             ------TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             ------cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence                  23467888999999999999999999999998876443

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-42  Score=316.08  Aligned_cols=240  Identities=27%  Similarity=0.439  Sum_probs=190.8

Q ss_pred             hhhcCCCCceEEEEEEec-----------------------chHHHHHHHHhccCCCceeeeEeEEecCCce-eEEEEec
Q 036435           88 KDKLGQGGFGGVYKGRLL-----------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNR-ALIYEFM  143 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~-----------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~-~lV~e~~  143 (372)
                      .+.||+|+||.||+|++.                       +.+.+|+.++++++||||+++++++.+.+.. ++|+||+
T Consensus        26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~  105 (298)
T 3pls_A           26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM  105 (298)
T ss_dssp             EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred             CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence            467999999999999742                       1578999999999999999999999877655 9999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      .+|+|.+++.....     .+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++......
T Consensus       106 ~~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  177 (298)
T 3pls_A          106 CHGDLLQFIRSPQR-----NPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR  177 (298)
T ss_dssp             TTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred             cCCCHHHHHhcccc-----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence            99999999976432     2899999999999999999999   789999999999999999999999999999865433


Q ss_pred             CCe-eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          224 EGI-VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       224 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      ... ........+|+.|+|||.+.+.  .++.++||||||+++|+|++|+.|+........       ............
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~-------~~~~~~~~~~~~  248 (298)
T 3pls_A          178 EYYSVQQHRHARLPVKWTALESLQTY--RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-------LTHFLAQGRRLP  248 (298)
T ss_dssp             GGGCSCCSSCTTCGGGGSCHHHHTTC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG-------HHHHHHTTCCCC
T ss_pred             cccccccCcCCCCCccccChhhhccC--CCChhhchhhHHHHHHHHhhCCCCCCccCCHHH-------HHHHhhcCCCCC
Confidence            211 1112334578899999999774  789999999999999999997776654332211       222222322222


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccCC
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQ  351 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~  351 (372)
                      .+..       ....+.+++.+||+.||.+|||++++++.|+++.....
T Consensus       249 ~~~~-------~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~  290 (298)
T 3pls_A          249 QPEY-------CPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL  290 (298)
T ss_dssp             CCTT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             CCcc-------chHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence            2221       23567889999999999999999999999998876643

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.3e-42  Score=320.73  Aligned_cols=226  Identities=24%  Similarity=0.324  Sum_probs=185.2

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      .+.+.||+|+||.||+++...                      .+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         8 ~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~   87 (337)
T 1o6l_A            8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA   87 (337)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCC
Confidence            345789999999999997632                      4778999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      ++|+|.+++.....      +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        88 ~gg~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  158 (337)
T 1o6l_A           88 NGGELFFHLSRERV------FTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             TTCBHHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             CCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            99999999976432      899999999999999999999   799999999999999999999999999999864332


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                      ...   .....||+.|+|||.+.+.  .++.++|+|||||++|||++|+.||.....        ......+.. .....
T Consensus       159 ~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~-~~~~~  224 (337)
T 1o6l_A          159 GAT---MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILM-EEIRF  224 (337)
T ss_dssp             TCC---BCCCEECGGGCCGGGGSSS--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHH-CCCCC
T ss_pred             CCc---ccccccChhhCChhhhcCC--CCCchhhcccchhHHHHHhcCCCCCCCCCH--------HHHHHHHHc-CCCCC
Confidence            211   2334689999999999875  789999999999999999999999975321        111222221 12222


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRP-----PMNEVIE  341 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~  341 (372)
                      |..       ....+.+++.+||+.||.+||     +++|+++
T Consensus       225 p~~-------~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          225 PRT-------LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CTT-------SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCC-------CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence            322       345677889999999999999     8999986

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.8e-42  Score=315.89  Aligned_cols=240  Identities=30%  Similarity=0.502  Sum_probs=187.2

Q ss_pred             hhhhhcCCCCceEEEEEEec-----------------------chHHHHHHHHhccCCCceeeeEeEEe-cCCceeEEEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLL-----------------------DDFVNEVASISRTSHVNVVTLLGFCL-EGNNRALIYE  141 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~-----------------------~~~~~E~~~l~~l~h~nIv~l~g~~~-~~~~~~lV~e  141 (372)
                      .+.+.||+|+||.||+|++.                       +.+.+|+.++++++||||+++++++. +++..++|||
T Consensus        28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e  107 (298)
T 3f66_A           28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  107 (298)
T ss_dssp             EEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEE
T ss_pred             hhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEe
Confidence            44578999999999998742                       15789999999999999999999865 4567899999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      |+++|+|.+++.....     .+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++....
T Consensus       108 ~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~  179 (298)
T 3f66_A          108 YMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  179 (298)
T ss_dssp             CCTTCBHHHHHHCTTC-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred             CCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccccccc
Confidence            9999999999976432     2899999999999999999999   7999999999999999999999999999998664


Q ss_pred             CCCCe-eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccc
Q 036435          222 TKEGI-VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDRE  300 (372)
Q Consensus       222 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (372)
                      ..... ........+|+.|+|||.+.+.  .++.++||||||+++|+|++|+.|+........       ..........
T Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~-------~~~~~~~~~~  250 (298)
T 3f66_A          180 DKEYYSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQGRR  250 (298)
T ss_dssp             CGGGCBC-----CCBCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT-------HHHHHHTTCC
T ss_pred             ccchhccccccCCCCCccccChHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH-------HHHHHhcCCC
Confidence            43221 1122334578899999999775  789999999999999999995554433322211       1122222222


Q ss_pred             ccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 036435          301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       301 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~  349 (372)
                      ...+..       ....+.+++.+||+.||.+|||++++++.|+++...
T Consensus       251 ~~~~~~-------~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  292 (298)
T 3f66_A          251 LLQPEY-------CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  292 (298)
T ss_dssp             CCCCTT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCCcc-------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            222222       234678899999999999999999999999987754

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-42  Score=318.69  Aligned_cols=248  Identities=21%  Similarity=0.302  Sum_probs=193.6

Q ss_pred             hhhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecCC--ceeEEEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEGN--NRALIYEFM  143 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~--~~~lV~e~~  143 (372)
                      .+.+.||+|+||.||+|+...                    .+.+|++++++++||||+++++++.+..  ..++||||+
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~   91 (319)
T 4euu_A           12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC   91 (319)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred             EEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCC
Confidence            346789999999999997642                    4679999999999999999999998765  779999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE----CCCCceEEeecCCccc
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL----DEDFCPKISDFGLAKL  219 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfgla~~  219 (372)
                      ++|+|.+++......   ..+++.+++.++.|++.||+|||   +.+++||||||+|||+    +.++.+||+|||+++.
T Consensus        92 ~~~~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           92 PCGSLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             TTCBHHHHHHSGGGT---TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             CCCCHHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            999999999865432   22899999999999999999999   7899999999999999    7888899999999987


Q ss_pred             ccCCCCeeeeecccccccccccccccccc------cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHH
Q 036435          220 CTTKEGIVSSLLGARGIIGYIAPEVFSRN------FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYR  293 (372)
Q Consensus       220 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  293 (372)
                      .......    ....||+.|+|||.+...      ...++.++|||||||++|||++|+.||.........   ......
T Consensus       166 ~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~~~~~  238 (319)
T 4euu_A          166 LEDDEQF----VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN---KEVMYK  238 (319)
T ss_dssp             CCTTCCB----CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC---HHHHHH
T ss_pred             cCCCCce----eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh---HHHHHH
Confidence            6544322    234589999999988621      137889999999999999999999999754432221   111222


Q ss_pred             Hhhhccc-------------c----cCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          294 HVEQDRE-------------F----KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       294 ~~~~~~~-------------~----~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                      .......             .    ..+ ............+.+++.+||+.||++|||++|+++......
T Consensus       239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          239 IITGKPSGAISGVQKAENGPIDWSGDMP-VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             HHHHCCTTCCEEEECSTTCCEEEESSCC-TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             HhcCCCcccchhhhcccCCccccCccCC-cccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            2211100             0    001 111234567778889999999999999999999999887654

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-42  Score=322.06  Aligned_cols=245  Identities=24%  Similarity=0.386  Sum_probs=194.6

Q ss_pred             hhhhhhcCCCCceEEEEEEec-------------------------chHHHHHHHHhcc-CCCceeeeEeEEecCCceeE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL-------------------------DDFVNEVASISRT-SHVNVVTLLGFCLEGNNRAL  138 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-------------------------~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~l  138 (372)
                      +.+.+.||+|+||.||+|+..                         +.+.+|+.+++++ +||||+++++++.+++..++
T Consensus        47 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  126 (344)
T 1rjb_A           47 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYL  126 (344)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             ceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEE
Confidence            345678999999999999751                         1588999999999 99999999999999999999


Q ss_pred             EEEecCCCChhhhhhcCCCCC-----------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCce
Q 036435          139 IYEFMPNGSLEKFVYNGDTSK-----------------PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNI  201 (372)
Q Consensus       139 V~e~~~~g~L~~~l~~~~~~~-----------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Ni  201 (372)
                      ||||+++|+|.+++.......                 ....+++..++.++.|++.||+|||   +.+++||||||+||
T Consensus       127 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NI  203 (344)
T 1rjb_A          127 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNV  203 (344)
T ss_dssp             EEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGGGE
T ss_pred             EEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhE
Confidence            999999999999998754210                 1123899999999999999999999   79999999999999


Q ss_pred             EECCCCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCC
Q 036435          202 LLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVD  280 (372)
Q Consensus       202 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~  280 (372)
                      |++.++.+||+|||++........... .....+|+.|+|||.+.+.  .++.++||||||+++|+|+| |..||.....
T Consensus       204 ll~~~~~~kL~Dfg~~~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~  280 (344)
T 1rjb_A          204 LVTHGKVVKICDFGLARDIMSDSNYVV-RGNARLPVKWMAPESLFEG--IYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  280 (344)
T ss_dssp             EEETTTEEEECCCGGGSCGGGCTTSEE-ETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             EEcCCCcEEeCCCccCcccccCcccee-ccCccCccCccCHHHhccC--CCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence            999999999999999987654433222 2344578899999998764  78999999999999999998 9999876432


Q ss_pred             CCCccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 036435          281 SSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~  349 (372)
                      ..       .....+........+.       .....+.+++.+||+.||.+|||++++++.|+.+...
T Consensus       281 ~~-------~~~~~~~~~~~~~~~~-------~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  335 (344)
T 1rjb_A          281 DA-------NFYKLIQNGFKMDQPF-------YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD  335 (344)
T ss_dssp             SH-------HHHHHHHTTCCCCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             HH-------HHHHHHhcCCCCCCCC-------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            21       1222233322222222       1245678899999999999999999999999887654

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.3e-42  Score=317.50  Aligned_cols=239  Identities=23%  Similarity=0.335  Sum_probs=184.1

Q ss_pred             hhhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      .+.+.||+|+||+||+++..+                    .+.+|+.++++++||||+++++++.+++..++||||++ 
T Consensus        24 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-  102 (311)
T 3niz_A           24 QKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-  102 (311)
T ss_dssp             EEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-
T ss_pred             HhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-
Confidence            345789999999999997632                    47889999999999999999999999999999999997 


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      |+|.+++.....     .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++........
T Consensus       103 ~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  174 (311)
T 3niz_A          103 KDLKKVLDENKT-----GLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR  174 (311)
T ss_dssp             EEHHHHHHTCTT-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred             CCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence            488888876542     2899999999999999999999   79999999999999999999999999999987643322


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                      .   .....+|+.|+|||.+.+. ..++.++|||||||++|+|++|+.||........   + ..+............+.
T Consensus       175 ~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~-~~i~~~~~~~~~~~~~~  246 (311)
T 3niz_A          175 S---YTHEVVTLWYRAPDVLMGS-KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ---L-PKIFSILGTPNPREWPQ  246 (311)
T ss_dssp             ------CCCCCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH---H-HHHHHHHCCCCTTTSGG
T ss_pred             c---ccCCcccCCcCCHHHhcCC-CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH---H-HHHHHHHCCCChHHhhh
Confidence            2   2234578999999998764 3679999999999999999999999976543321   1 11111111100000000


Q ss_pred             -------------cCC-----cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          306 -------------VVT-----RKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       306 -------------~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                                   ...     ........++.+++.+||+.||.+|||++|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                         000     001112356788999999999999999999986

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4.2e-43  Score=315.69  Aligned_cols=230  Identities=27%  Similarity=0.479  Sum_probs=177.7

Q ss_pred             hhhhhcCCCCceEEEEEEec---------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           86 SFKDKLGQGGFGGVYKGRLL---------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~---------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      .+.+.||+|+||.||++++.                     +.+.+|+.++++++||||+++++++.+++..++||||++
T Consensus        10 ~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   89 (271)
T 3dtc_A           10 TLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFAR   89 (271)
T ss_dssp             EEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCT
T ss_pred             eeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCC
Confidence            34578999999999999653                     257789999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC---eeecCCCCCceEECC--------CCceEEee
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTK---ILHFDIKPHNILLDE--------DFCPKISD  213 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~---ivH~dlk~~Nill~~--------~~~~kl~D  213 (372)
                      +++|.+++...       .+++..+..++.|++.||+|||   +.+   ++||||||+|||++.        ++.+||+|
T Consensus        90 ~~~L~~~~~~~-------~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           90 GGPLNRVLSGK-------RIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             TEEHHHHHTSS-------CCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             CCCHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            99999998643       2899999999999999999999   566   999999999999986        77899999


Q ss_pred             cCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHH
Q 036435          214 FGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYR  293 (372)
Q Consensus       214 fgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  293 (372)
                      ||++........     ....||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||......       .....
T Consensus       160 fg~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~  225 (271)
T 3dtc_A          160 FGLAREWHRTTK-----MSAAGAYAWMAPEVIRAS--MFSKGSDVWSYGVLLWELLTGEVPFRGIDGL-------AVAYG  225 (271)
T ss_dssp             CCC------------------CCGGGSCHHHHHHC--CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH-------HHHHH
T ss_pred             CCcccccccccc-----cCCCCccceeCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHh
Confidence            999986543322     233588999999999775  7899999999999999999999999753211       11111


Q ss_pred             HhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 036435          294 HVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGS  346 (372)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~  346 (372)
                      ..........+       ......+.+++.+||+.||.+|||++|+++.|+++
T Consensus       226 ~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          226 VAMNKLALPIP-------STCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             HHTSCCCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             hhcCCCCCCCC-------cccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            11111111222       12245678899999999999999999999999863

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=321.77  Aligned_cols=256  Identities=23%  Similarity=0.348  Sum_probs=187.3

Q ss_pred             hhhhhcCCCCceEEEEEEecc--------------hHHHHHHH--HhccCCCceeeeEeEEec-----CCceeEEEEecC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD--------------DFVNEVAS--ISRTSHVNVVTLLGFCLE-----GNNRALIYEFMP  144 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~--------------~~~~E~~~--l~~l~h~nIv~l~g~~~~-----~~~~~lV~e~~~  144 (372)
                      .+.+.||+|+||.||+|+..+              .+..|.++  +..++||||+++++.+..     ....++||||++
T Consensus        16 ~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~   95 (336)
T 3g2f_A           16 KLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYP   95 (336)
T ss_dssp             EEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCT
T ss_pred             heeeecccCCCeEEEEEEECCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCC
Confidence            345789999999999997632              34445554  445899999999986542     235689999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC---------CeeecCCCCCceEECCCCceEEeecC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCST---------KILHFDIKPHNILLDEDFCPKISDFG  215 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~---------~ivH~dlk~~Nill~~~~~~kl~Dfg  215 (372)
                      +|+|.+++....       .++..+..++.|++.||+|||   +.         +|+||||||+|||++.++.+||+|||
T Consensus        96 ~g~L~~~l~~~~-------~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG  165 (336)
T 3g2f_A           96 NGSLXKYLSLHT-------SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG  165 (336)
T ss_dssp             TCBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred             CCcHHHHHhhcc-------cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence            999999997654       688999999999999999999   67         99999999999999999999999999


Q ss_pred             CcccccCCCCe-----eeeeccccccccccccccccccc-----CCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCcc
Q 036435          216 LAKLCTTKEGI-----VSSLLGARGIIGYIAPEVFSRNF-----GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV  285 (372)
Q Consensus       216 la~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~  285 (372)
                      ++.........     ........||+.|+|||.+.+..     ..++.++|||||||++|||++|+.|+..........
T Consensus       166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~  245 (336)
T 3g2f_A          166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ  245 (336)
T ss_dssp             TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred             ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence            99876543211     11122346899999999987521     245678999999999999999988876544322111


Q ss_pred             -ch----------HHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccCCC
Q 036435          286 -YF----------PHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQI  352 (372)
Q Consensus       286 -~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~  352 (372)
                       .+          ..+.............+..... .......+.+++.+||+.||++|||++|+++.|+++......
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~  322 (336)
T 3g2f_A          246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKE-NSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWER  322 (336)
T ss_dssp             CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCC-CSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC
T ss_pred             HhhhcccCCCchHHHHHhhhcccccCCCCCccccc-ccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHh
Confidence             10          0110111111112222222222 233567799999999999999999999999999988866443

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.7e-43  Score=332.05  Aligned_cols=256  Identities=15%  Similarity=0.181  Sum_probs=187.4

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-----------------------------------hHHHHHHHHhccCCCceeeeEeE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-----------------------------------DFVNEVASISRTSHVNVVTLLGF  129 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-----------------------------------~~~~E~~~l~~l~h~nIv~l~g~  129 (372)
                      +.+.+.||+|+||.||+|++..                                   .+.+|+..++.++||||++++++
T Consensus        37 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~  116 (364)
T 3op5_A           37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGS  116 (364)
T ss_dssp             EEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEE
T ss_pred             EEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEee
Confidence            4456789999999999996521                                   13334555666789999999999


Q ss_pred             EecC----CceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC-
Q 036435          130 CLEG----NNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLD-  204 (372)
Q Consensus       130 ~~~~----~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~-  204 (372)
                      +.+.    ...++||||+ +++|.+++.....     .+++.+++.++.|++.||+|||   +.+|+||||||+|||++ 
T Consensus       117 ~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~  187 (364)
T 3op5_A          117 GLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK-----RFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNY  187 (364)
T ss_dssp             EEEEETTEEEEEEEEECE-EEEHHHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEES
T ss_pred             eeeccCCcceEEEEEeCC-CCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEec
Confidence            9875    4589999999 9999999987532     2999999999999999999999   78999999999999999 


Q ss_pred             -CCCceEEeecCCcccccCCCCeee----eecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCC
Q 036435          205 -EDFCPKISDFGLAKLCTTKEGIVS----SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGV  279 (372)
Q Consensus       205 -~~~~~kl~Dfgla~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~  279 (372)
                       .++.+||+|||+++..........    ......||+.|+|||.+.+.  .++.++|||||||++|||++|+.||....
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~Pf~~~~  265 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV--APSRRGDLEILGYCMIQWLTGHLPWEDNL  265 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC--CCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence             889999999999987654322111    11233489999999999875  78999999999999999999999998533


Q ss_pred             CCCCccchHHHHHHHhhhc-ccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccCCCCCCCC
Q 036435          280 DSSSEVYFPHWIYRHVEQD-REFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQIPPTPF  357 (372)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~~p~  357 (372)
                      ...   ............. .....+...   ....+..+.+++..||+.||.+||+++++++.|+.+...........
T Consensus       266 ~~~---~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~  338 (364)
T 3op5_A          266 KDP---KYVRDSKIRYRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGK  338 (364)
T ss_dssp             TCH---HHHHHHHHHHHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCC
T ss_pred             cCH---HHHHHHHHHhhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCc
Confidence            221   1111111111000 000000000   01124567889999999999999999999999987765544444333

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.4e-43  Score=325.55  Aligned_cols=239  Identities=22%  Similarity=0.360  Sum_probs=177.7

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCce----eEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNR----ALI  139 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~----~lV  139 (372)
                      .+.+.||+|+||.||+++...                      .+.+|+.++++++||||+++++++......    ++|
T Consensus        15 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv   94 (311)
T 3ork_A           15 ELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIV   94 (311)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEE
Confidence            446789999999999997521                      478899999999999999999999876544    999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccc
Q 036435          140 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL  219 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  219 (372)
                      |||+++|+|.+++.....      +++.+++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++..
T Consensus        95 ~e~~~g~~L~~~l~~~~~------~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  165 (311)
T 3ork_A           95 MEYVDGVTLRDIVHTEGP------MTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARA  165 (311)
T ss_dssp             EECCCEEEHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred             EecCCCCCHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence            999999999999976542      899999999999999999999   78999999999999999999999999999987


Q ss_pred             ccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcc
Q 036435          220 CTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDR  299 (372)
Q Consensus       220 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (372)
                      ...............||+.|+|||.+.+.  .++.++||||||+++|||++|+.||......       ...........
T Consensus       166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-------~~~~~~~~~~~  236 (311)
T 3ork_A          166 IADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-------SVAYQHVREDP  236 (311)
T ss_dssp             ----------------CCTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHCCC
T ss_pred             ccccccccccccccCcCcccCCHHHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhcCCC
Confidence            65443332223344689999999999875  7899999999999999999999999754211       11112111111


Q ss_pred             cccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHH-HHhhcCc
Q 036435          300 EFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI-EMLQGST  347 (372)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl-~~L~~~~  347 (372)
                      .   +  .......+...+.+++.+||+.||.+||+..+++ +.+.+..
T Consensus       237 ~---~--~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          237 I---P--PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             C---C--HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             C---C--cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence            0   0  0001112346678899999999999999766544 5555543

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=9.7e-43  Score=326.57  Aligned_cols=231  Identities=21%  Similarity=0.363  Sum_probs=186.1

Q ss_pred             HhhhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEe
Q 036435           84 TNSFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      .+.+.+.||+|+||.||++....                     .+.+|+.++++++||||+++++++.+++..++||||
T Consensus        30 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~  109 (362)
T 2bdw_A           30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL  109 (362)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             CeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence            34556789999999999997531                     477899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC---CceEEeecCCccc
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDED---FCPKISDFGLAKL  219 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfgla~~  219 (372)
                      +++|+|.+++....      .+++..+..++.|++.||+|||   +.+|+||||||+|||++.+   +.+||+|||++..
T Consensus       110 ~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          110 VTGGELFEDIVARE------FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             CCSCBHHHHHTTCS------CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             CCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            99999999997643      2899999999999999999999   7899999999999999864   4599999999987


Q ss_pred             ccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcc
Q 036435          220 CTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDR  299 (372)
Q Consensus       220 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (372)
                      ......    .....||+.|+|||++.+.  .++.++|||||||++|+|++|..||.....        ......+... 
T Consensus       181 ~~~~~~----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--------~~~~~~i~~~-  245 (362)
T 2bdw_A          181 VNDSEA----WHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HRLYAQIKAG-  245 (362)
T ss_dssp             CTTCCS----CCCSCSCTTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHT-
T ss_pred             ecCCcc----cccCCCCccccCHHHHccC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhC-
Confidence            654332    1234689999999999874  789999999999999999999999975421        1122222221 


Q ss_pred             cccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          300 EFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ....+.   .....+...+.+++.+||+.||.+|||+.++++
T Consensus       246 ~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          246 AYDYPS---PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             CCCCCT---TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCCCCc---ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            111111   111233466788999999999999999999875

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.1e-42  Score=348.03  Aligned_cols=232  Identities=25%  Similarity=0.413  Sum_probs=185.3

Q ss_pred             hhcCCCCceEEEEEEec-----------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           89 DKLGQGGFGGVYKGRLL-----------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~-----------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      +.||+|+||.||+|.+.                       +++.+|+.++++++||||+++++++.+ +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            36999999999998441                       258899999999999999999999964 568999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      |+|.+++.....      +++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus       454 g~L~~~l~~~~~------l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~  524 (635)
T 4fl3_A          454 GPLNKYLQQNRH------VKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN  524 (635)
T ss_dssp             EEHHHHHHHCTT------CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred             CCHHHHHhhCCC------CCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence            999999976532      899999999999999999999   78999999999999999999999999999987655443


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCC
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP  304 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (372)
                      .........+|+.|+|||++.+.  .++.++|||||||++|||++ |+.||.....        ..+...+........+
T Consensus       525 ~~~~~~~~~~t~~y~APE~~~~~--~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--------~~~~~~i~~~~~~~~p  594 (635)
T 4fl3_A          525 YYKAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVTAMLEKGERMGCP  594 (635)
T ss_dssp             ----------CGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTTCCCCCC
T ss_pred             ccccccCCCCceeeeChhhhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCCCC
Confidence            33323334577889999999764  78999999999999999998 9999975432        1233444444333333


Q ss_pred             ccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       305 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                      .       .+...+.+++..||+.||++||+++++++.|+...
T Consensus       595 ~-------~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  630 (635)
T 4fl3_A          595 A-------GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  630 (635)
T ss_dssp             T-------TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             C-------CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            2       23467788999999999999999999999998653

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=7.5e-42  Score=327.28  Aligned_cols=233  Identities=20%  Similarity=0.253  Sum_probs=186.8

Q ss_pred             hhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           88 KDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      .+.||+|+||.||+++..+                      .+.+|..++..++||||++++++|.+++..++||||+++
T Consensus        79 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~g  158 (437)
T 4aw2_A           79 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVG  158 (437)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             EEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCC
Confidence            4789999999999997642                      378899999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      |+|.+++.+...     .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus       159 g~L~~~l~~~~~-----~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~  230 (437)
T 4aw2_A          159 GDLLTLLSKFED-----RLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  230 (437)
T ss_dssp             CBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred             CcHHHHHHHccC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence            999999986432     2899999999999999999999   79999999999999999999999999999986654433


Q ss_pred             eeeeecccccccccccccccccc---cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRN---FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      ..  .....||+.|+|||++...   ...++.++|||||||++|||++|+.||......       ............+.
T Consensus       231 ~~--~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~-------~~~~~i~~~~~~~~  301 (437)
T 4aw2_A          231 VQ--SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-------ETYGKIMNHKERFQ  301 (437)
T ss_dssp             EE--CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTHHHHCC
T ss_pred             cc--cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh-------HHHHhhhhcccccc
Confidence            22  2335699999999998621   136899999999999999999999999754211       11112222222333


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSD--RPPMNEVIE  341 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~evl~  341 (372)
                      .|.....    +...+.+++.+||..+|.+  ||+++|+++
T Consensus       302 ~p~~~~~----~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          302 FPTQVTD----VSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             CCSSCCC----SCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             CCccccc----CCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            3433221    2356677888899888887  999999986

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=7.8e-43  Score=315.36  Aligned_cols=240  Identities=27%  Similarity=0.453  Sum_probs=191.1

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-----------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-----------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS  147 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-----------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~  147 (372)
                      +.+.+.||+|+||.||+|+..+                 .+.+|++++++++||||+++++++.+ +..++||||+++++
T Consensus        15 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~   93 (279)
T 1qpc_A           15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGS   93 (279)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCB
T ss_pred             hhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCC
Confidence            3456789999999999997532                 58899999999999999999999864 56899999999999


Q ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCee
Q 036435          148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV  227 (372)
Q Consensus       148 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  227 (372)
                      |.+++.....    ..+++.+++.++.|++.||+|||   +.+++|+||||+||++++++.+||+|||++........  
T Consensus        94 L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  164 (279)
T 1qpc_A           94 LVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY--  164 (279)
T ss_dssp             HHHHTTSHHH----HTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE--
T ss_pred             HHHHHhcCCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc--
Confidence            9999965321    13899999999999999999999   79999999999999999999999999999987654321  


Q ss_pred             eeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCcc
Q 036435          228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV  306 (372)
Q Consensus       228 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (372)
                      .......++..|+|||.+.+.  .++.++||||||+++|||++ |+.||.....        ......+........+. 
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~-  233 (279)
T 1qpc_A          165 TAREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--------PEVIQNLERGYRMVRPD-  233 (279)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTTCCCCCCT-
T ss_pred             ccccCCCCccCccChhhhccC--CCCchhhhHHHHHHHHHHHhCCCCCCcccCH--------HHHHHHHhcccCCCCcc-
Confidence            112334567889999999764  78899999999999999999 8888865321        11222222222222221 


Q ss_pred             CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccCC
Q 036435          307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQ  351 (372)
Q Consensus       307 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~  351 (372)
                            .....+.+++.+||+.||++|||++++++.|+.+.....
T Consensus       234 ------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  272 (279)
T 1qpc_A          234 ------NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE  272 (279)
T ss_dssp             ------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             ------cccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence                  234567889999999999999999999999998875543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.4e-42  Score=324.30  Aligned_cols=235  Identities=20%  Similarity=0.280  Sum_probs=185.7

Q ss_pred             HhhhhhhcCCCCceEEEEEEecc------------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEE
Q 036435           84 TNSFKDKLGQGGFGGVYKGRLLD------------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALI  139 (372)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~~------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV  139 (372)
                      .+.+.+.||+|+||.||+++...                        .+.+|+.++++++||||+++++++.+++..++|
T Consensus        25 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  104 (351)
T 3c0i_A           25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMV  104 (351)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            35556889999999999996531                        478999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCc---eEEeecCC
Q 036435          140 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFC---PKISDFGL  216 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfgl  216 (372)
                      |||+++|+|.+++......  ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.   +||+|||+
T Consensus       105 ~e~~~g~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          105 FEFMDGADLCFEIVKRADA--GFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EECCSSCBHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EeCCCCCCHHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999888653211  123899999999999999999999   799999999999999986554   99999999


Q ss_pred             cccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhh
Q 036435          217 AKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE  296 (372)
Q Consensus       217 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  296 (372)
                      +.........   .....||+.|+|||.+.+.  .++.++|||||||++|+|++|+.||....         ......+.
T Consensus       180 a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~---------~~~~~~i~  245 (351)
T 3c0i_A          180 AIQLGESGLV---AGGRVGTPHFMAPEVVKRE--PYGKPVDVWGCGVILFILLSGCLPFYGTK---------ERLFEGII  245 (351)
T ss_dssp             CEECCTTSCB---CCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCSSH---------HHHHHHHH
T ss_pred             eeEecCCCee---ecCCcCCcCccCHHHHcCC--CCCchHhhHHHHHHHHHHHHCCCCCCCcH---------HHHHHHHH
Confidence            9876543321   1234589999999999875  78999999999999999999999997531         11122221


Q ss_pred             hcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ... ...+   ......+...+.+++.+||+.||++|||+.++++
T Consensus       246 ~~~-~~~~---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          246 KGK-YKMN---PRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HTC-CCCC---HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cCC-CCCC---ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            111 1111   0111123467888999999999999999999985

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=8.3e-43  Score=323.43  Aligned_cols=225  Identities=23%  Similarity=0.356  Sum_probs=183.3

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      .+.+.||+|+||.||+|+...                      .+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus        12 ~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~   91 (336)
T 3h4j_B           12 IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA   91 (336)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC
Confidence            446789999999999997621                      5789999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                       +|+|.+++.....      +++.++..++.|++.||+|||   +.+++||||||+|||+++++.+||+|||++......
T Consensus        92 -~g~l~~~l~~~~~------l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           92 -GGELFDYIVEKKR------MTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             -CEEHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             -CCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence             7899999876542      899999999999999999999   789999999999999999999999999999866543


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                      ...    ....||+.|+|||.+.+. ...+.++|||||||++|+|++|+.||..........        .+. ......
T Consensus       162 ~~~----~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~--------~i~-~~~~~~  227 (336)
T 3h4j_B          162 NFL----KTSCGSPNYAAPEVINGK-LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK--------KVN-SCVYVM  227 (336)
T ss_dssp             BTT----CCCTTSTTTSCGGGSCCS-GGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC--------CCC-SSCCCC
T ss_pred             ccc----ccccCCcCcCCHHHHcCC-CCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH--------HHH-cCCCCC
Confidence            321    234589999999999875 223789999999999999999999997643322110        000 011111


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      |.       .....+.+++.+||+.||.+|||++|+++
T Consensus       228 p~-------~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          228 PD-------FLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             CT-------TSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             cc-------cCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            21       13456778999999999999999999986

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.2e-42  Score=316.32  Aligned_cols=245  Identities=27%  Similarity=0.425  Sum_probs=195.5

Q ss_pred             hhhhhhcCCCCceEEEEEEec-------------------------chHHHHHHHHhcc-CCCceeeeEeEEecCCceeE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL-------------------------DDFVNEVASISRT-SHVNVVTLLGFCLEGNNRAL  138 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-------------------------~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~l  138 (372)
                      +.+.+.||+|+||.||+++..                         +.+.+|+.+++++ +||||+++++++.+++..++
T Consensus        25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l  104 (313)
T 1t46_A           25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLV  104 (313)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             hhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEE
Confidence            445678999999999999741                         1578999999999 99999999999999999999


Q ss_pred             EEEecCCCChhhhhhcCCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC
Q 036435          139 IYEFMPNGSLEKFVYNGDTS------------KPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDED  206 (372)
Q Consensus       139 V~e~~~~g~L~~~l~~~~~~------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~  206 (372)
                      ||||+++|+|.+++......            .....+++.+++.++.|++.||+|||   +.+++||||||+||+++.+
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~  181 (313)
T 1t46_A          105 ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHG  181 (313)
T ss_dssp             EEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEETT
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEcCC
Confidence            99999999999999875421            11124899999999999999999999   7899999999999999999


Q ss_pred             CceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCcc
Q 036435          207 FCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEV  285 (372)
Q Consensus       207 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~  285 (372)
                      +.+||+|||++........... .....+|+.|+|||.+.+.  .++.++||||||+++|+|++ |+.||.......   
T Consensus       182 ~~~kl~Dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---  255 (313)
T 1t46_A          182 RITKICDFGLARDIKNDSNYVV-KGNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS---  255 (313)
T ss_dssp             TEEEECCCGGGSCTTSCTTSEE-CSSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH---
T ss_pred             CCEEEcccccccccccccccee-ccCCCCcceeeChHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCCCcccchh---
Confidence            9999999999987665443222 2334577889999998764  78999999999999999998 999987543221   


Q ss_pred             chHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 036435          286 YFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~  349 (372)
                          ..............+.       .....+.+++.+||+.||.+|||++++++.|++....
T Consensus       256 ----~~~~~~~~~~~~~~~~-------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  308 (313)
T 1t46_A          256 ----KFYKMIKEGFRMLSPE-------HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (313)
T ss_dssp             ----HHHHHHHHTCCCCCCT-------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----HHHHHhccCCCCCCcc-------cCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence                1222222222222121       2345678899999999999999999999999876643

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=5.4e-42  Score=308.05  Aligned_cols=233  Identities=22%  Similarity=0.393  Sum_probs=186.8

Q ss_pred             hhhhhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEecC--CceeEEEEecC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLEG--NNRALIYEFMP  144 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~--~~~~lV~e~~~  144 (372)
                      .+.+.||+|+||.||+|++.+                   .+.+|+.++++++||||+++++++.+.  +..++||||++
T Consensus        13 ~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~   92 (271)
T 3kmu_A           13 NFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMP   92 (271)
T ss_dssp             EEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCT
T ss_pred             HHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccC
Confidence            446789999999999997642                   588999999999999999999999887  78899999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTK--ILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      +|+|.+++......    .+++.+++.++.|++.||+|||   +.+  ++||||||+||+++.++.++|+|||++.....
T Consensus        93 ~~~L~~~l~~~~~~----~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~  165 (271)
T 3kmu_A           93 YGSLYNVLHEGTNF----VVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS  165 (271)
T ss_dssp             TCBHHHHHHSCSSC----CCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred             CCcHHHHHhhcccC----CCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence            99999999875432    3899999999999999999999   778  99999999999999999999999888764322


Q ss_pred             CCCeeeeecccccccccccccccccc-cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRN-FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF  301 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (372)
                              ....||+.|+|||.+.+. ...++.++||||||+++|||++|+.||......       .............
T Consensus       166 --------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~  230 (271)
T 3kmu_A          166 --------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM-------EIGMKVALEGLRP  230 (271)
T ss_dssp             --------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH-------HHHHHHHHSCCCC
T ss_pred             --------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH-------HHHHHHHhcCCCC
Confidence                    223578999999998764 123344899999999999999999999753211       1112222222222


Q ss_pred             cCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       302 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                      ..+.       .....+.+++.+||+.||++|||++++++.|+++.
T Consensus       231 ~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          231 TIPP-------GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             CCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             CCCC-------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            2222       23456788999999999999999999999998765

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.3e-42  Score=321.14  Aligned_cols=234  Identities=19%  Similarity=0.272  Sum_probs=167.8

Q ss_pred             hhcCCCCceEEEEEEecc----------------hHHHHHHHHhccC-CCceeeeEeEEecCCceeEEEEecCCCChhhh
Q 036435           89 DKLGQGGFGGVYKGRLLD----------------DFVNEVASISRTS-HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF  151 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~----------------~~~~E~~~l~~l~-h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~~~  151 (372)
                      +.||+|+||.||+++...                .+.+|+.+++++. ||||+++++++.+++..++||||+++|+|.++
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~   96 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFER   96 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHH
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHH
Confidence            579999999999997642                5788999999997 99999999999999999999999999999999


Q ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC---ceEEeecCCcccccCCCCeee
Q 036435          152 VYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDF---CPKISDFGLAKLCTTKEGIVS  228 (372)
Q Consensus       152 l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfgla~~~~~~~~~~~  228 (372)
                      +.....      +++.++..++.|++.||+|||   +.+|+||||||+|||++.++   .+||+|||++.........  
T Consensus        97 l~~~~~------~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~--  165 (325)
T 3kn6_A           97 IKKKKH------FSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP--  165 (325)
T ss_dssp             HHHCSC------CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred             HHhcCC------CCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc--
Confidence            987542      899999999999999999999   79999999999999997665   8999999999865443221  


Q ss_pred             eecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCC
Q 036435          229 SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVT  308 (372)
Q Consensus       229 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (372)
                       .....||+.|+|||.+.+.  .++.++|||||||++|+|++|+.||............ ......+.... ..   ...
T Consensus       166 -~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~-~~~~~~i~~~~-~~---~~~  237 (325)
T 3kn6_A          166 -LKTPCFTLHYAAPELLNQN--GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSA-VEIMKKIKKGD-FS---FEG  237 (325)
T ss_dssp             -------------------C--CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCH-HHHHHHHTTTC-CC---CCS
T ss_pred             -ccccCCCcCccCHHHhcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccH-HHHHHHHHcCC-CC---CCc
Confidence             2234578999999999775  7899999999999999999999999865432211111 11222222211 11   111


Q ss_pred             cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          309 RKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       309 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .....+...+.+++.+||+.||.+|||++++++
T Consensus       238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            122334567888999999999999999999875

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.4e-42  Score=319.85  Aligned_cols=244  Identities=23%  Similarity=0.350  Sum_probs=176.4

Q ss_pred             hhhhhcCCCCceEEEEEEec--------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLL--------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~--------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      .+.+.||+|+||.||+|+..                    +.+.+|+.++++++||||+++++++.+++..++||||++ 
T Consensus         8 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-   86 (317)
T 2pmi_A            8 KQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-   86 (317)
T ss_dssp             -----------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-
T ss_pred             eEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-
Confidence            44578999999999999653                    157899999999999999999999999999999999997 


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      |+|.+++...........+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++........
T Consensus        87 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  163 (317)
T 2pmi_A           87 NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN  163 (317)
T ss_dssp             CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC
T ss_pred             CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcc
Confidence            599999876432222234899999999999999999999   78999999999999999999999999999987643322


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcc------
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDR------  299 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------  299 (372)
                      .   .....||+.|+|||.+.+. ..++.++|||||||++|||++|+.||.......    ....+........      
T Consensus       164 ~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~  235 (317)
T 2pmi_A          164 T---FSSEVVTLWYRAPDVLMGS-RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE----QLKLIFDIMGTPNESLWPS  235 (317)
T ss_dssp             C---CCCCCSCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCSCCTTTCGG
T ss_pred             c---CCCCcccccccCchHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCChhHhhh
Confidence            1   1234588999999998763 367899999999999999999999997543211    1111111110000      


Q ss_pred             -----cc--cCCccCCcc---------hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          300 -----EF--KLPGVVTRK---------ENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       300 -----~~--~~~~~~~~~---------~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                           ..  ..+......         .......+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence                 00  000000000         0113457889999999999999999999986

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.3e-42  Score=327.31  Aligned_cols=253  Identities=18%  Similarity=0.219  Sum_probs=188.4

Q ss_pred             hhhhhhcCCC--CceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEE
Q 036435           85 NSFKDKLGQG--GFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYE  141 (372)
Q Consensus        85 ~~~~~~lg~G--~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  141 (372)
                      +.+.+.||+|  +||.||+++...                     .+.+|+.++++++||||+++++++.+++..++|||
T Consensus        27 y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  106 (389)
T 3gni_B           27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS  106 (389)
T ss_dssp             EEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             EEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEE
Confidence            3456789999  999999997642                     46779999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      |+++|+|.+++......    .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||.+....
T Consensus       107 ~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          107 FMAYGSAKDLICTHFMD----GMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             CCTTCBHHHHHHHTCTT----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             ccCCCCHHHHHhhhccc----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            99999999999875332    2899999999999999999999   7999999999999999999999999999987543


Q ss_pred             CCCCee----eeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhh
Q 036435          222 TKEGIV----SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQ  297 (372)
Q Consensus       222 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (372)
                      ......    .......||+.|+|||.+.+....++.++|||||||++|||++|+.||..........   .........
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~---~~~~~~~~~  256 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL---EKLNGTVPC  256 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH---HC-------
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH---HHhcCCCCc
Confidence            322111    1112235889999999998743478999999999999999999999997643322100   000000000


Q ss_pred             ---c-----ccc---------------------cCC----ccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--
Q 036435          298 ---D-----REF---------------------KLP----GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM--  342 (372)
Q Consensus       298 ---~-----~~~---------------------~~~----~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~--  342 (372)
                         .     ...                     ..+    .........+...+.+++.+||+.||++|||++|+++.  
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~  336 (389)
T 3gni_B          257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF  336 (389)
T ss_dssp             -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred             cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHH
Confidence               0     000                     000    00001122334668889999999999999999999864  


Q ss_pred             hhcCc
Q 036435          343 LQGST  347 (372)
Q Consensus       343 L~~~~  347 (372)
                      +++..
T Consensus       337 f~~~~  341 (389)
T 3gni_B          337 FKQIK  341 (389)
T ss_dssp             GGGC-
T ss_pred             HHHHh
Confidence            44443

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.4e-42  Score=324.45  Aligned_cols=230  Identities=23%  Similarity=0.351  Sum_probs=186.0

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      .+.+.||+|+||.||+++...                      .+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        18 ~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~   97 (384)
T 4fr4_A           18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLL   97 (384)
T ss_dssp             EEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecC
Confidence            446789999999999997632                      4778999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      ++|+|.+++.....      +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++......
T Consensus        98 ~gg~L~~~l~~~~~------l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           98 LGGDLRYHLQQNVH------FKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             TTEEHHHHHHTTCC------CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             CCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            99999999986532      899999999999999999999   799999999999999999999999999999876443


Q ss_pred             CCeeeeecccccccccccccccccc-cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRN-FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      ..    .....||+.|+|||++.+. ...++.++|+|||||++|||++|+.||........     ......... ....
T Consensus       169 ~~----~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~-----~~~~~~~~~-~~~~  238 (384)
T 4fr4_A          169 TQ----ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-----KEIVHTFET-TVVT  238 (384)
T ss_dssp             CC----BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH-----HHHHHHHHH-CCCC
T ss_pred             Cc----eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH-----HHHHHHHhh-cccC
Confidence            22    2344699999999998743 13578999999999999999999999975433221     111111111 1122


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPP-MNEVIE  341 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~evl~  341 (372)
                      .|.       .+...+.+++.+||+.||.+||+ ++++.+
T Consensus       239 ~p~-------~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          239 YPS-------AWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             CCT-------TSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             CCC-------cCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            222       23456788999999999999998 777764

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.1e-42  Score=312.21  Aligned_cols=236  Identities=28%  Similarity=0.510  Sum_probs=191.1

Q ss_pred             hhhhhcCCCCceEEEEEEecc-----------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCCh
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD-----------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL  148 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~-----------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L  148 (372)
                      .+.+.||+|+||.||+++..+                 ++.+|+.++++++||||+++++++.+++..++||||+++++|
T Consensus        11 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   90 (267)
T 3t9t_A           11 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCL   90 (267)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBH
T ss_pred             eeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcH
Confidence            445789999999999997632                 588999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeee
Q 036435          149 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVS  228 (372)
Q Consensus       149 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  228 (372)
                      .+++.....     .+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++........  .
T Consensus        91 ~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~  160 (267)
T 3t9t_A           91 SDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY--T  160 (267)
T ss_dssp             HHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH--H
T ss_pred             HHHHhhCcc-----cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccccccccccc--c
Confidence            999976532     2899999999999999999999   79999999999999999999999999999986543211  1


Q ss_pred             eecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccC
Q 036435          229 SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVV  307 (372)
Q Consensus       229 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (372)
                      ......+|..|+|||.+.+.  .++.++||||||+++|+|++ |+.||.....        ......+........+.. 
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~i~~~~~~~~~~~-  229 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEVVEDISTGFRLYKPRL-  229 (267)
T ss_dssp             STTSTTCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTTCCCCCCTT-
T ss_pred             ccccccccccccChhhhcCC--CccchhchhhhHHHHHHHhccCCCCCCCCCH--------HHHHHHHhcCCcCCCCcc-
Confidence            11234467889999999764  78999999999999999999 8888865321        112222222222222221 


Q ss_pred             CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 036435          308 TRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE  348 (372)
Q Consensus       308 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~  348 (372)
                            ....+.+++.+||+.||++|||++++++.|+++.+
T Consensus       230 ------~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          230 ------ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             ------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------CcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                  23567789999999999999999999999988764

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-42  Score=326.09  Aligned_cols=232  Identities=22%  Similarity=0.324  Sum_probs=186.4

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      +.+.+.||+|+||.||++....                   .+.+|+.++++++||||+++++++.+++..++||||+++
T Consensus        53 y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~g  132 (387)
T 1kob_A           53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG  132 (387)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCC
Confidence            4456789999999999997632                   578899999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC--CCceEEeecCCcccccCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE--DFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgla~~~~~~  223 (372)
                      |+|.+++.....     .+++..+..++.|++.||+|||   +.+|+||||||+|||++.  ++.+||+|||++......
T Consensus       133 g~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          133 GELFDRIAAEDY-----KMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CBHHHHTTCTTC-----CBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CcHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            999999976432     2899999999999999999999   799999999999999974  578999999999876544


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                      ....    ...||+.|+|||++.+.  .++.++|||||||++|||++|..||......       . ....+... ....
T Consensus       205 ~~~~----~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-------~-~~~~i~~~-~~~~  269 (387)
T 1kob_A          205 EIVK----VTTATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-------E-TLQNVKRC-DWEF  269 (387)
T ss_dssp             SCEE----EECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------H-HHHHHHHC-CCCC
T ss_pred             ccee----eeccCCCccCchhccCC--CCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-------H-HHHHHHhC-CCCC
Confidence            3222    23589999999999874  7899999999999999999999999754211       1 11112111 1111


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                      +.   .....+...+.+++.+||+.||.+|||++|+++.
T Consensus       270 ~~---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          270 DE---DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             CS---STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             Cc---cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            11   1112234567889999999999999999999973

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.9e-42  Score=319.96  Aligned_cols=245  Identities=24%  Similarity=0.445  Sum_probs=195.6

Q ss_pred             HhhhhhhcCCCCceEEEEEEec---------------------------chHHHHHHHHhcc-CCCceeeeEeEEecCCc
Q 036435           84 TNSFKDKLGQGGFGGVYKGRLL---------------------------DDFVNEVASISRT-SHVNVVTLLGFCLEGNN  135 (372)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~---------------------------~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~  135 (372)
                      .+.+.+.||+|+||.||+++..                           +.+.+|+.+++++ +||||+++++++.+++.
T Consensus        36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  115 (334)
T 2pvf_A           36 KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP  115 (334)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSC
T ss_pred             HeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCc
Confidence            3455678999999999999752                           1478899999999 89999999999999999


Q ss_pred             eeEEEEecCCCChhhhhhcCCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC
Q 036435          136 RALIYEFMPNGSLEKFVYNGDTSK----------PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE  205 (372)
Q Consensus       136 ~~lV~e~~~~g~L~~~l~~~~~~~----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~  205 (372)
                      .++||||+++|+|.+++.......          ....+++.+++.++.|++.||+|||   +.+++||||||+|||++.
T Consensus       116 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~  192 (334)
T 2pvf_A          116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTE  192 (334)
T ss_dssp             CEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECT
T ss_pred             eEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEEcC
Confidence            999999999999999998754211          1123899999999999999999999   789999999999999999


Q ss_pred             CCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCc
Q 036435          206 DFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSE  284 (372)
Q Consensus       206 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~  284 (372)
                      ++.+||+|||++........... .....+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.||.....    
T Consensus       193 ~~~~kL~Dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~----  265 (334)
T 2pvf_A          193 NNVMKIADFGLARDINNIDYYKK-TTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----  265 (334)
T ss_dssp             TCCEEECCCTTCEECTTTSSEEC-CSCCCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTCCH----
T ss_pred             CCCEEEccccccccccccccccc-cCCCCcccceeChHHhcCC--CcChHHHHHHHHHHHHHHHhCCCCCcCcCCH----
Confidence            99999999999987654432222 2334577889999998764  78999999999999999999 9998865321    


Q ss_pred             cchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 036435          285 VYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~  349 (372)
                          ..+...+........+.       .....+.+++.+||+.||.+|||++++++.|+++...
T Consensus       266 ----~~~~~~~~~~~~~~~~~-------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~  319 (334)
T 2pvf_A          266 ----EELFKLLKEGHRMDKPA-------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  319 (334)
T ss_dssp             ----HHHHHHHHHTCCCCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----HHHHHHHhcCCCCCCCc-------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence                11222333322222222       2335678899999999999999999999999988754

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=6.3e-42  Score=315.36  Aligned_cols=223  Identities=26%  Similarity=0.354  Sum_probs=184.7

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      .+.+.||+|+||.||+++...                      .+.+|..+++.++||||+++++++.+.+..++||||+
T Consensus         9 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   88 (318)
T 1fot_A            9 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYI   88 (318)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCC
Confidence            445789999999999987632                      4667999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      ++|+|.+++.....      +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        89 ~gg~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~  159 (318)
T 1fot_A           89 EGGELFSLLRKSQR------FPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  159 (318)
T ss_dssp             CSCBHHHHHHHTSS------CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             CCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence            99999999986542      899999999999999999999   899999999999999999999999999999865432


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                      .      ....||+.|+|||.+.+.  .++.++|+|||||++|||++|+.||......       . ....+... ....
T Consensus       160 ~------~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~-~~~~i~~~-~~~~  222 (318)
T 1fot_A          160 T------YTLCGTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-------K-TYEKILNA-ELRF  222 (318)
T ss_dssp             B------CCCCSCTTTCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------H-HHHHHHHC-CCCC
T ss_pred             c------ccccCCccccCHhHhcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------H-HHHHHHhC-CCCC
Confidence            2      234689999999999875  7899999999999999999999999753211       1 12222221 2222


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRP-----PMNEVIE  341 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~  341 (372)
                      |..       ....+.+++.+||+.||++||     +++++++
T Consensus       223 p~~-------~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          223 PPF-------FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             CTT-------SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCC-------CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            322       235677889999999999999     8899885

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=6.3e-42  Score=318.93  Aligned_cols=234  Identities=20%  Similarity=0.292  Sum_probs=184.5

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhcc-CCCceeeeEeEEecCCceeEEEEe
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      .+.+.||+|+||.||+++...                      .+.+|..++.++ +||||+++++++.+++..++||||
T Consensus        12 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~   91 (345)
T 3a8x_A           12 DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY   91 (345)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeC
Confidence            445789999999999997632                      367899999988 899999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      +++|+|.+++.....      +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        92 ~~gg~L~~~l~~~~~------l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           92 VNGGDLMFHMQRQRK------LPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             CCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             CCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            999999999976432      899999999999999999999   79999999999999999999999999999986433


Q ss_pred             CCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCc-cchHHHHHHHhhhcccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE-VYFPHWIYRHVEQDREF  301 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~  301 (372)
                      ....   .....||+.|+|||.+.+.  .++.++|+|||||++|||++|+.||......... ..........+... ..
T Consensus       163 ~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~-~~  236 (345)
T 3a8x_A          163 PGDT---TSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QI  236 (345)
T ss_dssp             TTCC---BCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC-CC
T ss_pred             CCCc---ccccCCCccccCccccCCC--CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC-CC
Confidence            2211   2344689999999999875  7899999999999999999999999753322111 01112222222221 22


Q ss_pred             cCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 036435          302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPM------NEVIE  341 (372)
Q Consensus       302 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~------~evl~  341 (372)
                      ..|.       .....+.+++.+||+.||.+||++      +++++
T Consensus       237 ~~p~-------~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~  275 (345)
T 3a8x_A          237 RIPR-------SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  275 (345)
T ss_dssp             CCCT-------TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred             CCCC-------CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence            2332       234567788999999999999995      66664

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=4.3e-42  Score=315.74  Aligned_cols=243  Identities=26%  Similarity=0.438  Sum_probs=183.3

Q ss_pred             hhhhhcCCCCceEEEEEEecc------------------------hHHHHHHHHhccCCCceeeeEeEEecCC-----ce
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD------------------------DFVNEVASISRTSHVNVVTLLGFCLEGN-----NR  136 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~-----~~  136 (372)
                      .+.+.||+|+||.||+|+...                        .+.+|+.++++++||||+++++++.+.+     ..
T Consensus        37 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  116 (313)
T 3brb_A           37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKP  116 (313)
T ss_dssp             EEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CE
T ss_pred             eeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCccc
Confidence            345789999999999986521                        4788999999999999999999998765     34


Q ss_pred             eEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCC
Q 036435          137 ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGL  216 (372)
Q Consensus       137 ~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  216 (372)
                      ++|+||+++|+|.+++...........+++..++.++.|+++||.|||   +.+++||||||+||+++.++.+||+|||+
T Consensus       117 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl~Dfg~  193 (313)
T 3brb_A          117 MVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGL  193 (313)
T ss_dssp             EEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEEECSCSC
T ss_pred             EEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEEeecCc
Confidence            999999999999999965432222345999999999999999999999   89999999999999999999999999999


Q ss_pred             cccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHh
Q 036435          217 AKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHV  295 (372)
Q Consensus       217 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  295 (372)
                      +........... .....+++.|+|||.+.+.  .++.++||||||+++|+|++ |..||.......        .....
T Consensus       194 ~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--------~~~~~  262 (313)
T 3brb_A          194 SKKIYSGDYYRQ-GRIAKMPVKWIAIESLADR--VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE--------MYDYL  262 (313)
T ss_dssp             C-----------------CCGGGSCHHHHHSS--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--------HHHHH
T ss_pred             ceecccccccCc-ccccCCCccccCchhhcCC--CccchhhhHHHHHHHHHHHhcCCCCCccCCHHH--------HHHHH
Confidence            987654332211 2233467889999999764  78999999999999999999 888886543211        12222


Q ss_pred             hhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 036435          296 EQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~  349 (372)
                      ........+       ......+.+++.+||+.||.+|||++++++.|+.+...
T Consensus       263 ~~~~~~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~  309 (313)
T 3brb_A          263 LHGHRLKQP-------EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES  309 (313)
T ss_dssp             HTTCCCCCB-------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HcCCCCCCC-------ccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            222222222       12345678899999999999999999999999887654

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.9e-42  Score=311.99  Aligned_cols=234  Identities=25%  Similarity=0.406  Sum_probs=185.6

Q ss_pred             hhhhhcCCCCceEEEEEEec-----------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEe
Q 036435           86 SFKDKLGQGGFGGVYKGRLL-----------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~-----------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      .+.+.||+|+||.||+|+..                       +.+.+|+.++++++||||+++++++.+ +..++||||
T Consensus        15 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   93 (281)
T 3cc6_A           15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMEL   93 (281)
T ss_dssp             EEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             EEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEec
Confidence            34578999999999998642                       157889999999999999999999865 457899999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      +++++|.+++.....     .+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++.....
T Consensus        94 ~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  165 (281)
T 3cc6_A           94 YPYGELGHYLERNKN-----SLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIED  165 (281)
T ss_dssp             CTTCBHHHHHHHHTT-----TCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred             CCCCCHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence            999999999976432     2899999999999999999999   79999999999999999999999999999987654


Q ss_pred             CCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREF  301 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (372)
                      .....  .....+|+.|+|||.+.+.  .++.++||||||+++|+|++ |+.||.......        ....+......
T Consensus       166 ~~~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--------~~~~~~~~~~~  233 (281)
T 3cc6_A          166 EDYYK--ASVTRLPIKWMSPESINFR--RFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--------VIGVLEKGDRL  233 (281)
T ss_dssp             ---------CCCCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--------HHHHHHHTCCC
T ss_pred             ccccc--cccCCCCcceeCchhhccC--CCCchhccHHHHHHHHHHHhCCCCCcccCChHH--------HHHHHhcCCCC
Confidence            33221  2334577889999999764  78999999999999999998 999997543221        12222222222


Q ss_pred             cCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       302 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                      ..+..       ....+.+++.+||+.||.+|||++++++.|+.+.
T Consensus       234 ~~~~~-------~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~  272 (281)
T 3cc6_A          234 PKPDL-------CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY  272 (281)
T ss_dssp             CCCTT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCC-------CCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence            22222       2356778999999999999999999999998765

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=7.2e-43  Score=317.08  Aligned_cols=233  Identities=24%  Similarity=0.391  Sum_probs=185.7

Q ss_pred             hhhhhhcCCCCceEEEEEEec--------------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL--------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRAL  138 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~--------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~l  138 (372)
                      +.+.+.||+|+||.||+|+..                          +.+.+|+.++++++||||+++++++.+++..++
T Consensus        10 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   89 (289)
T 4fvq_A           10 LIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENIL   89 (289)
T ss_dssp             EEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEE
T ss_pred             eeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEE
Confidence            345678999999999998542                          157899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCc--------eE
Q 036435          139 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFC--------PK  210 (372)
Q Consensus       139 V~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--------~k  210 (372)
                      ||||+++|+|.+++.....     .+++..++.++.|++.||+|||   +.+++||||||+|||++.++.        +|
T Consensus        90 v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           90 VQEFVKFGSLDTYLKKNKN-----CINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             EEECCTTCBHHHHHHHTGG-----GCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             EEECCCCCCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceee
Confidence            9999999999999987542     2899999999999999999999   799999999999999998877        99


Q ss_pred             EeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHH
Q 036435          211 ISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHW  290 (372)
Q Consensus       211 l~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~  290 (372)
                      |+|||++......       ....+|+.|+|||.+.+. ..++.++||||||+++|||++|+.|+.......       .
T Consensus       162 l~Dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~-------~  226 (289)
T 4fvq_A          162 LSDPGISITVLPK-------DILQERIPWVPPECIENP-KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ-------R  226 (289)
T ss_dssp             ECCCCSCTTTSCH-------HHHHHTTTTSCHHHHHCG-GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-------H
T ss_pred             eccCcccccccCc-------cccCCcCcccCHHHhCCC-CCCCchhHHHHHHHHHHHHHcCCCCCccccchH-------H
Confidence            9999998754322       123478889999999763 368999999999999999999766655432211       0


Q ss_pred             HHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 036435          291 IYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~  349 (372)
                      .......  ....+...       ...+.+++.+||+.||.+|||++++++.|+++..+
T Consensus       227 ~~~~~~~--~~~~~~~~-------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          227 KLQFYED--RHQLPAPK-------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             HHHHHHT--TCCCCCCS-------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             HHHHhhc--cCCCCCCC-------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence            1111111  11122222       23467788899999999999999999999988864

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.4e-42  Score=326.46  Aligned_cols=231  Identities=23%  Similarity=0.297  Sum_probs=186.4

Q ss_pred             hhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           87 FKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      +.+.||+|+||.||+++...                      .+.+|..+++.++||||+++++++.+++..++||||++
T Consensus        73 ~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~  152 (410)
T 3v8s_A           73 VVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMP  152 (410)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             EEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence            35789999999999997642                      37789999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      +|+|.+++.+..       +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus       153 gg~L~~~l~~~~-------~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~  222 (410)
T 3v8s_A          153 GGDLVNLMSNYD-------VPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG  222 (410)
T ss_dssp             TEEHHHHHHHCC-------CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             CCcHHHHHHcCC-------CCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence            999999997643       899999999999999999999   7999999999999999999999999999998765433


Q ss_pred             Ceeeeeccccccccccccccccccc--CCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhh-cccc
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNF--GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQ-DREF  301 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~  301 (372)
                      ..  ......||+.|+|||++.+..  +.++.++|+|||||++|||++|+.||......       . ....+.. ...+
T Consensus       223 ~~--~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~-~~~~i~~~~~~~  292 (410)
T 3v8s_A          223 MV--RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------G-TYSKIMNHKNSL  292 (410)
T ss_dssp             EE--ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH-------H-HHHHHHTHHHHC
T ss_pred             cc--cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh-------h-HHHHHHhccccc
Confidence            21  223456999999999997641  12788999999999999999999999754211       1 1222221 1122


Q ss_pred             cCCccCCcchHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 036435          302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSD--RPPMNEVIEM  342 (372)
Q Consensus       302 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~evl~~  342 (372)
                      ..|..     ..+...+.+++.+||+.+|.+  ||+++|+++.
T Consensus       293 ~~p~~-----~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          293 TFPDD-----NDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             CCCTT-----CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             cCCCc-----ccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            22221     112456778889999999988  9999999974

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.1e-42  Score=317.85  Aligned_cols=244  Identities=25%  Similarity=0.410  Sum_probs=191.8

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-------------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-------------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALI  139 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV  139 (372)
                      +.+.+.||+|+||.||+|+...                         .+.+|+.++++++||||+++++++.+++..++|
T Consensus        27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  106 (322)
T 1p4o_A           27 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI  106 (322)
T ss_dssp             EEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEE
Confidence            3446789999999999986431                         478899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCC----CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecC
Q 036435          140 YEFMPNGSLEKFVYNGDT----SKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFG  215 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~----~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  215 (372)
                      |||+++|+|.+++.....    ......+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||
T Consensus       107 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~~~kl~Dfg  183 (322)
T 1p4o_A          107 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFG  183 (322)
T ss_dssp             EECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred             EEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCCeEEECcCc
Confidence            999999999999975321    001123789999999999999999999   7899999999999999999999999999


Q ss_pred             CcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHH
Q 036435          216 LAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRH  294 (372)
Q Consensus       216 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  294 (372)
                      ++.......... ......+|+.|+|||.+.+.  .++.++||||||+++|+|++ |..||.....        ......
T Consensus       184 ~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~~~~  252 (322)
T 1p4o_A          184 MTRDIYETDYYR-KGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--------EQVLRF  252 (322)
T ss_dssp             CCCGGGGGGCEE-GGGSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--------HHHHHH
T ss_pred             cccccccccccc-cccCCCCCCCccChhhhccC--CCCchhhHHHHHHHHHHHHhcCCCccccCCH--------HHHHHH
Confidence            998654433221 12233468889999999764  78999999999999999999 7888864321        112222


Q ss_pred             hhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 036435          295 VEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~  349 (372)
                      +........+       ......+.+++.+||+.||.+|||+.++++.|++....
T Consensus       253 ~~~~~~~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~  300 (322)
T 1p4o_A          253 VMEGGLLDKP-------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  300 (322)
T ss_dssp             HHTTCCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             HHcCCcCCCC-------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence            2222221222       12345678899999999999999999999999887643

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=324.76  Aligned_cols=227  Identities=20%  Similarity=0.287  Sum_probs=181.9

Q ss_pred             hhhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhcc-CCCceeeeEeEEecCCceeEEEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYE  141 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e  141 (372)
                      +.+.+.||+|+||.||+++...                      .+.+|..+++.+ +||||+++++++.+++..++|||
T Consensus        25 y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E  104 (353)
T 3txo_A           25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVME  104 (353)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEe
Confidence            3456789999999999997642                      367899999988 79999999999999999999999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      |+++|+|.+++.....      +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       105 ~~~gg~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          105 FVNGGDLMFHIQKSRR------FDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             CCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             CCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            9999999999976542      899999999999999999999   7899999999999999999999999999998543


Q ss_pred             CCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccc
Q 036435          222 TKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF  301 (372)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (372)
                      ....   ......||+.|+|||++.+.  .++.++|+|||||++|||++|+.||.....        ......+... ..
T Consensus       176 ~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~-~~  241 (353)
T 3txo_A          176 CNGV---TTATFCGTPDYIAPEILQEM--LYGPAVDWWAMGVLLYEMLCGHAPFEAENE--------DDLFEAILND-EV  241 (353)
T ss_dssp             C------------CCGGGCCHHHHHHH--HCTTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHC-CC
T ss_pred             cCCc---cccccCCCcCeEChhhcCCC--CcCCccCCCcchHHHHHHHhCCCCCCCCCH--------HHHHHHHHcC-CC
Confidence            3221   12344699999999999875  789999999999999999999999975422        1122222221 22


Q ss_pred             cCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 036435          302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPM------NEVIE  341 (372)
Q Consensus       302 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~------~evl~  341 (372)
                      ..|..       ....+.+++.+||+.||.+||++      +++++
T Consensus       242 ~~p~~-------~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          242 VYPTW-------LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             CCCTT-------SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             CCCCC-------CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            22222       23567788999999999999998      77775

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=5.9e-42  Score=319.65  Aligned_cols=223  Identities=20%  Similarity=0.272  Sum_probs=185.7

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      .+.+.||+|+||.||+++...                      .+.+|+.++++++||||+++++++.+++..++||||+
T Consensus        44 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~  123 (350)
T 1rdq_E           44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV  123 (350)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCC
Confidence            445789999999999997632                      4678999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      ++|+|.+++.....      +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       124 ~gg~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          124 AGGEMFSHLRRIGR------FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             TTCBHHHHHHHHCC------CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             CCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence            99999999976532      899999999999999999999   799999999999999999999999999999876443


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                      .      ....||+.|+|||.+.+.  .++.++|+|||||++|||++|+.||.....        ......+... ....
T Consensus       195 ~------~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~-~~~~  257 (350)
T 1rdq_E          195 T------WTLCGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYEKIVSG-KVRF  257 (350)
T ss_dssp             B------CCCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHC-CCCC
T ss_pred             c------ccccCCccccCHHHhcCC--CCCCcCCEecccHhHhHHhhCCCCCCCCCH--------HHHHHHHHcC-CCCC
Confidence            2      234589999999999875  789999999999999999999999975321        1122222222 2222


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPP-----MNEVIE  341 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~  341 (372)
                      |..       +...+.+++.+||+.||.+||+     ++++++
T Consensus       258 p~~-------~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          258 PSH-------FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CTT-------CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCC-------CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            322       3456778999999999999998     888875

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=7.6e-43  Score=325.35  Aligned_cols=246  Identities=17%  Similarity=0.233  Sum_probs=182.7

Q ss_pred             HhhhhhhcCCCCceEEEEEEecc---------------------------------hHHHHHHHHhccCCCceeeeEeEE
Q 036435           84 TNSFKDKLGQGGFGGVYKGRLLD---------------------------------DFVNEVASISRTSHVNVVTLLGFC  130 (372)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~~---------------------------------~~~~E~~~l~~l~h~nIv~l~g~~  130 (372)
                      .+.+.+.||+|+||.||+|+...                                 .+.+|+..++.++||||+++++++
T Consensus        38 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~  117 (345)
T 2v62_A           38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSG  117 (345)
T ss_dssp             EEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEE
T ss_pred             eEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccc
Confidence            34556789999999999997631                                 255677888888999999999999


Q ss_pred             ec----CCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC
Q 036435          131 LE----GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDED  206 (372)
Q Consensus       131 ~~----~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~  206 (372)
                      .+    +...++||||+ +++|.+++....      .+++.+++.++.|++.||+|||   +.+++||||||+|||++.+
T Consensus       118 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          118 LTEFKGRSYRFMVMERL-GIDLQKISGQNG------TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYK  187 (345)
T ss_dssp             EEESSSCEEEEEEEECE-EEEHHHHCBGGG------BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESS
T ss_pred             ccccCCCcEEEEEEecc-CCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccC
Confidence            88    67899999999 999999997654      2899999999999999999999   7899999999999999887


Q ss_pred             C--ceEEeecCCcccccCCCCee----eeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCC
Q 036435          207 F--CPKISDFGLAKLCTTKEGIV----SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVD  280 (372)
Q Consensus       207 ~--~~kl~Dfgla~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~  280 (372)
                      +  .+||+|||+++.........    .......||+.|+|||.+.+.  .++.++|||||||++|||++|+.||.....
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~  265 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV--ALSRRSDVEILGYCMLRWLCGKLPWEQNLK  265 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCTTGGGTT
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence            7  99999999998764332111    111334689999999999875  789999999999999999999999964322


Q ss_pred             CCCccchHHHHHHHhhhcccccCCccCCcc--hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 036435          281 SSSEVYFPHWIYRHVEQDREFKLPGVVTRK--ENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE  348 (372)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~  348 (372)
                      ...  .. .......    ....+......  .......+.+++.+||+.||++|||++++++.|+....
T Consensus       266 ~~~--~~-~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          266 DPV--AV-QTAKTNL----LDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             CHH--HH-HHHHHHH----HHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             ccH--HH-HHHHHhh----cccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            110  00 0001111    11111100000  00234578889999999999999999999999987664

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=6.3e-42  Score=316.69  Aligned_cols=231  Identities=24%  Similarity=0.379  Sum_probs=179.6

Q ss_pred             hhhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecCCc----------
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEGNN----------  135 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~----------  135 (372)
                      .+.+.||+|+||.||+++...                    .+.+|+.++++++||||+++++++.+...          
T Consensus         9 ~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~   88 (332)
T 3qd2_B            9 EPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEI   88 (332)
T ss_dssp             EEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC-
T ss_pred             ceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhh
Confidence            445789999999999997641                    58899999999999999999999866542          


Q ss_pred             -----------------------------------------------eeEEEEecCCCChhhhhhcCCCCCCCCCCCHHH
Q 036435          136 -----------------------------------------------RALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEK  168 (372)
Q Consensus       136 -----------------------------------------------~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~  168 (372)
                                                                     .++||||+++|+|.+++......   ...++..
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~---~~~~~~~  165 (332)
T 3qd2_B           89 WLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL---EDREHGV  165 (332)
T ss_dssp             -------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG---GGSCHHH
T ss_pred             hhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc---cchhhHH
Confidence                                                           79999999999999999876532   2367788


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCee---------eeeccccccccc
Q 036435          169 MYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV---------SSLLGARGIIGY  239 (372)
Q Consensus       169 ~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~---------~~~~~~~gt~~y  239 (372)
                      ++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++..........         .......||+.|
T Consensus       166 ~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  242 (332)
T 3qd2_B          166 CLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY  242 (332)
T ss_dssp             HHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred             HHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence            9999999999999999   7999999999999999999999999999998765543211         112334689999


Q ss_pred             ccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCCcchHHHHHHHH
Q 036435          240 IAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMI  319 (372)
Q Consensus       240 ~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  319 (372)
                      +|||.+.+.  .++.++||||||+++|||++|..|+...             ............    ..........+.
T Consensus       243 ~aPE~~~~~--~~~~~~Di~slG~il~el~~~~~~~~~~-------------~~~~~~~~~~~~----~~~~~~~~~~~~  303 (332)
T 3qd2_B          243 MSPEQIHGN--NYSHKVDIFSLGLILFELLYSFSTQMER-------------VRIITDVRNLKF----PLLFTQKYPQEH  303 (332)
T ss_dssp             SCHHHHHCC--CCCTHHHHHHHHHHHHHHHSCCCCHHHH-------------HHHHHHHHTTCC----CHHHHHHCHHHH
T ss_pred             cChHHhcCC--CCcchhhHHHHHHHHHHHHHcCCChhHH-------------HHHHHHhhccCC----CcccccCChhHH
Confidence            999999875  7899999999999999999986553210             111111111111    122334456678


Q ss_pred             HHHHHcccCCCCCCCCHHHHHH
Q 036435          320 IVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       320 ~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      +++.+||+.||.+|||++|+++
T Consensus       304 ~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          304 MMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCCCCcCCCHHHHhh
Confidence            8999999999999999999986

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.8e-42  Score=320.95  Aligned_cols=243  Identities=25%  Similarity=0.420  Sum_probs=192.1

Q ss_pred             hhhhhhcCCCCceEEEEEEec-------------------------chHHHHHHHHhcc-CCCceeeeEeEEecCCceeE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL-------------------------DDFVNEVASISRT-SHVNVVTLLGFCLEGNNRAL  138 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-------------------------~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~l  138 (372)
                      +.+.+.||+|+||.||+|+..                         +.+.+|+.+++++ +||||+++++++.+++..++
T Consensus        48 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l  127 (333)
T 2i1m_A           48 LQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLV  127 (333)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             ceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEE
Confidence            344578999999999999752                         1478999999999 89999999999999999999


Q ss_pred             EEEecCCCChhhhhhcCCCC--------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceE
Q 036435          139 IYEFMPNGSLEKFVYNGDTS--------KPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPK  210 (372)
Q Consensus       139 V~e~~~~g~L~~~l~~~~~~--------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  210 (372)
                      ||||+++|+|.+++......        .....+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+|
T Consensus       128 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~k  204 (333)
T 2i1m_A          128 ITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAK  204 (333)
T ss_dssp             EEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEGGGEEE
T ss_pred             EEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECCCCeEE
Confidence            99999999999999753210        00123899999999999999999999   78999999999999999999999


Q ss_pred             EeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHH
Q 036435          211 ISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPH  289 (372)
Q Consensus       211 l~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~  289 (372)
                      |+|||++........... .....+|+.|+|||.+.+.  .++.++||||||+++|||++ |..||.......       
T Consensus       205 l~Dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------  274 (333)
T 2i1m_A          205 IGDFGLARDIMNDSNYIV-KGNARLPVKWMAPESIFDC--VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-------  274 (333)
T ss_dssp             BCCCGGGCCGGGCTTSEE-CSSCEECGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH-------
T ss_pred             ECccccccccccccceee-cCCCCCCccccCHHHhccC--CCChHHHHHHHHHHHHHHHcCCCCCCcccchhH-------
Confidence            999999986654432221 2334577889999998764  78999999999999999998 888887543221       


Q ss_pred             HHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          290 WIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                      ..............+..       ....+.+++.+||+.||.+|||++++++.|+...
T Consensus       275 ~~~~~~~~~~~~~~~~~-------~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  325 (333)
T 2i1m_A          275 KFYKLVKDGYQMAQPAF-------APKNIYSIMQACWALEPTHRPTFQQICSFLQEQA  325 (333)
T ss_dssp             HHHHHHHHTCCCCCCTT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHhcCCCCCCCCC-------CCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence            12222222222222221       2356778999999999999999999999998754

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.8e-42  Score=314.84  Aligned_cols=229  Identities=24%  Similarity=0.356  Sum_probs=178.8

Q ss_pred             hhhhhcCCCCceEEEEEEec---------------------------------------------chHHHHHHHHhccCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLL---------------------------------------------DDFVNEVASISRTSH  120 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~---------------------------------------------~~~~~E~~~l~~l~h  120 (372)
                      .+.+.||+|+||.||+++..                                             +.+.+|+.++++++|
T Consensus        16 ~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   95 (298)
T 2zv2_A           16 TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDH   95 (298)
T ss_dssp             EEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCC
T ss_pred             EEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCC
Confidence            44678999999999999642                                             236789999999999


Q ss_pred             CceeeeEeEEec--CCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCC
Q 036435          121 VNVVTLLGFCLE--GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKP  198 (372)
Q Consensus       121 ~nIv~l~g~~~~--~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~  198 (372)
                      |||+++++++.+  ++..++||||+++++|.+++...       .+++.++..++.|++.||+|||   +.+++||||||
T Consensus        96 ~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp  165 (298)
T 2zv2_A           96 PNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK-------PLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKP  165 (298)
T ss_dssp             TTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS-------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCG
T ss_pred             CCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCH
Confidence            999999999987  56789999999999998865432       2899999999999999999999   78999999999


Q ss_pred             CceEECCCCceEEeecCCcccccCCCCeeeeecccccccccccccccccccC-CCCccccchhHHHHHHHHhcCCCCCCC
Q 036435          199 HNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFG-EVSHKSDVYSFGMMIMELVGCKNNLDS  277 (372)
Q Consensus       199 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~DvwslG~il~elltg~~p~~~  277 (372)
                      +|||++.++.+||+|||++.........   .....||+.|+|||.+.+... ..+.++|||||||++|+|++|+.||..
T Consensus       166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          166 SNLLVGEDGHIKIADFGVSNEFKGSDAL---LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSSSCE---ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             HHEEECCCCCEEEecCCCcccccccccc---ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            9999999999999999999876543322   233468999999999976411 147889999999999999999999975


Q ss_pred             CCCCCCccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          278 GVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ...        ......+... ....+..     ......+.+++.+||+.||++|||++|+++
T Consensus       243 ~~~--------~~~~~~~~~~-~~~~~~~-----~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          243 ERI--------MCLHSKIKSQ-ALEFPDQ-----PDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SSH--------HHHHHHHHHC-CCCCCSS-----SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccH--------HHHHHHHhcc-cCCCCCc-----cccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            321        1111222111 1111211     123456788999999999999999999875

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.2e-42  Score=342.04  Aligned_cols=237  Identities=28%  Similarity=0.469  Sum_probs=191.5

Q ss_pred             hhhhhcCCCCceEEEEEEecc-----------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCCh
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD-----------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL  148 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~-----------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L  148 (372)
                      .+.+.||+|+||.||+|++.+                 +|.+|+.+|++++||||+++++++.+ +..++||||+++|+|
T Consensus       270 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL  348 (535)
T 2h8h_A          270 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL  348 (535)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEH
T ss_pred             hhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcH
Confidence            445789999999999997642                 68999999999999999999999876 678999999999999


Q ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeee
Q 036435          149 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVS  228 (372)
Q Consensus       149 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  228 (372)
                      .+++.....    ..+++.+++.++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++.......  .
T Consensus       349 ~~~l~~~~~----~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~--~  419 (535)
T 2h8h_A          349 LDFLKGETG----KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY--T  419 (535)
T ss_dssp             HHHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH--H
T ss_pred             HHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce--e
Confidence            999975321    12899999999999999999999   79999999999999999999999999999986543211  1


Q ss_pred             eecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccC
Q 036435          229 SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVV  307 (372)
Q Consensus       229 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (372)
                      ......++..|+|||.+.+.  .++.++|||||||++|||++ |+.||.....        ..+...+..+.....+.  
T Consensus       420 ~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~--------~~~~~~i~~~~~~~~~~--  487 (535)
T 2h8h_A          420 ARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVERGYRMPCPP--  487 (535)
T ss_dssp             TTCSTTSCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH--------HHHHHHHHTTCCCCCCT--
T ss_pred             cccCCcCcccccCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCCCCC--
Confidence            11233467889999998764  78999999999999999999 8888865321        11233333333322222  


Q ss_pred             CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 036435          308 TRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       308 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~  349 (372)
                           .+...+.+++.+||+.||++|||++++++.|+.+...
T Consensus       488 -----~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          488 -----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             -----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             -----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence                 2345678899999999999999999999999987754

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.1e-42  Score=321.65  Aligned_cols=230  Identities=22%  Similarity=0.316  Sum_probs=173.9

Q ss_pred             hhhhhcCCCCceEEEEEEecc-----------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCCh
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD-----------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL  148 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~-----------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L  148 (372)
                      .+.+.||+|+||.||+++...                 .+.+|+.++++++||||+++++++.+++..++||||+++|+|
T Consensus        56 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  135 (349)
T 2w4o_A           56 EVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL  135 (349)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             EEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCH
Confidence            345789999999999997642                 477899999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC---CCceEEeecCCcccccCCCC
Q 036435          149 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE---DFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       149 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgla~~~~~~~~  225 (372)
                      .+++....      .+++.++..++.|++.||+|||   +.+++||||||+|||++.   ++.+||+|||++........
T Consensus       136 ~~~l~~~~------~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~  206 (349)
T 2w4o_A          136 FDRIVEKG------YYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL  206 (349)
T ss_dssp             HHHHTTCS------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred             HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc
Confidence            99997643      2899999999999999999999   789999999999999975   88999999999986543221


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                          .....||+.|+|||.+.+.  .++.++|||||||++|||++|+.||......       ......+..... ..+ 
T Consensus       207 ----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~~i~~~~~-~~~-  271 (349)
T 2w4o_A          207 ----MKTVCGTPGYCAPEILRGC--AYGPEVDMWSVGIITYILLCGFEPFYDERGD-------QFMFRRILNCEY-YFI-  271 (349)
T ss_dssp             ----------CGGGSCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-------HHHHHHHHTTCC-CCC-
T ss_pred             ----cccccCCCCccCHHHhcCC--CCCcccchHHHHHHHHHHHhCCCCCCCCccc-------HHHHHHHHhCCC-ccC-
Confidence                1234589999999999875  7899999999999999999999999754321       112222222111 111 


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                        .....+....+.+++.+||+.||++|||+.++++
T Consensus       272 --~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          272 --SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             --TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              1111233467788999999999999999999987

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1e-41  Score=319.56  Aligned_cols=233  Identities=24%  Similarity=0.342  Sum_probs=175.9

Q ss_pred             hhhhhhcCCCCceEEEEEEec------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      +.+.+.||+|+||+||+++..                  +.+.+|+.++++++||||+++++++.+++..++||||+++|
T Consensus        22 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~  101 (361)
T 3uc3_A           22 YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGG  101 (361)
T ss_dssp             EEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred             EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCC
Confidence            345678999999999999763                  25889999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCc--eEEeecCCcccccCCC
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFC--PKISDFGLAKLCTTKE  224 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfgla~~~~~~~  224 (372)
                      +|.+++.....      +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.  +||+|||+++......
T Consensus       102 ~L~~~l~~~~~------~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~  172 (361)
T 3uc3_A          102 ELYERICNAGR------FSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  172 (361)
T ss_dssp             BHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             CHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence            99999976432      899999999999999999999   799999999999999987765  9999999997433222


Q ss_pred             CeeeeecccccccccccccccccccCCCC-ccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVS-HKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                      .    .....||+.|+|||.+.+.  .++ .++|||||||++|+|++|+.||........   ............  ...
T Consensus       173 ~----~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~~~~~~~~~~--~~~  241 (361)
T 3uc3_A          173 Q----PKSTVGTPAYIAPEVLLRQ--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD---YRKTIQRILSVK--YSI  241 (361)
T ss_dssp             ------------CTTSCHHHHHCS--SCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC---HHHHHHHHHTTC--CCC
T ss_pred             C----CCCCcCCCCcCChhhhcCC--CCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH---HHHHHHHHhcCC--CCC
Confidence            1    1234589999999999764  554 448999999999999999999986543321   111112211111  111


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                      +...     .....+.+++.+||+.||.+|||+.|+++.
T Consensus       242 ~~~~-----~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          242 PDDI-----RISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             CTTS-----CCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CCcC-----CCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            1111     123567789999999999999999999963

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=4.8e-42  Score=312.38  Aligned_cols=240  Identities=22%  Similarity=0.318  Sum_probs=181.8

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      .+.+.||+|+||+||+++...                     .+.+|+.++++++||||+++++++.+++..++||||++
T Consensus         5 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   84 (292)
T 3o0g_A            5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD   84 (292)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             eeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCC
Confidence            345789999999999997632                     57789999999999999999999999999999999997


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      + +|.+++.....     .+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++.......
T Consensus        85 ~-~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           85 Q-DLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             E-EHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             C-CHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            5 66666654332     2899999999999999999999   7899999999999999999999999999998764332


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC-
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL-  303 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  303 (372)
                      ..   .....||+.|+|||.+.+. ..++.++|||||||++|||++|+.|+.......   .....+............ 
T Consensus       156 ~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~---~~~~~i~~~~~~~~~~~~~  228 (292)
T 3o0g_A          156 RC---YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD---DQLKRIFRLLGTPTEEQWP  228 (292)
T ss_dssp             SC---CCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH---HHHHHHHHHHCCCCTTTCT
T ss_pred             cc---ccCCccccCCcChHHHcCC-CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH---HHHHHHHHHhCCCChhhhh
Confidence            21   1234588999999998764 347999999999999999999998875443211   011111111100000000 


Q ss_pred             ----------------CccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          304 ----------------PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       304 ----------------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                                      ..............+.+++.+||+.||++|||++|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                            00001111223466788999999999999999999986

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=4.8e-42  Score=323.05  Aligned_cols=227  Identities=24%  Similarity=0.316  Sum_probs=179.0

Q ss_pred             hhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCChh
Q 036435           89 DKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLE  149 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~  149 (372)
                      +.||+|+||.||+++...                   .+.+|+.++++++||||+++++++.+.+..++||||+++|+|.
T Consensus        95 ~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~  174 (373)
T 2x4f_A           95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF  174 (373)
T ss_dssp             EECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEH
T ss_pred             eEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHH
Confidence            469999999999997532                   5889999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE--CCCCceEEeecCCcccccCCCCee
Q 036435          150 KFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL--DEDFCPKISDFGLAKLCTTKEGIV  227 (372)
Q Consensus       150 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill--~~~~~~kl~Dfgla~~~~~~~~~~  227 (372)
                      +++.....     .+++..++.++.|++.||+|||   +.+|+||||||+|||+  +.++.+||+|||+++........ 
T Consensus       175 ~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~-  245 (373)
T 2x4f_A          175 DRIIDESY-----NLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL-  245 (373)
T ss_dssp             HHHHHTGG-----GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC-
T ss_pred             HHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc-
Confidence            99876432     2899999999999999999999   7999999999999999  56789999999999876543321 


Q ss_pred             eeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccC
Q 036435          228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVV  307 (372)
Q Consensus       228 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (372)
                         ....||+.|+|||.+.+.  .++.++|||||||++|||++|+.||......       ...........  ..+   
T Consensus       246 ---~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~-------~~~~~i~~~~~--~~~---  308 (373)
T 2x4f_A          246 ---KVNFGTPEFLAPEVVNYD--FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-------ETLNNILACRW--DLE---  308 (373)
T ss_dssp             ---CCCCSSCTTCCHHHHTTC--BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHTCC--CSC---
T ss_pred             ---ccccCCCcEeChhhccCC--CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhccC--CCC---
Confidence               233589999999999764  7899999999999999999999999754221       11111111111  111   


Q ss_pred             CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          308 TRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       308 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ......+...+.+++.+||+.||.+|||++|+++
T Consensus       309 ~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          309 DEEFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            1111234567888999999999999999999997

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.4e-41  Score=322.88  Aligned_cols=233  Identities=21%  Similarity=0.300  Sum_probs=177.6

Q ss_pred             hhcCCCCceEEEEEEecc--------------hHHHHHHHHhc-cCCCceeeeEeEEec----CCceeEEEEecCCCChh
Q 036435           89 DKLGQGGFGGVYKGRLLD--------------DFVNEVASISR-TSHVNVVTLLGFCLE----GNNRALIYEFMPNGSLE  149 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~--------------~~~~E~~~l~~-l~h~nIv~l~g~~~~----~~~~~lV~e~~~~g~L~  149 (372)
                      +.||+|+||+||++....              .+.+|+.++.+ .+||||+++++++..    ++..++||||+++|+|.
T Consensus        68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~  147 (400)
T 1nxk_A           68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELF  147 (400)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHH
T ss_pred             ceeeeccCeEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHH
Confidence            579999999999997642              57889998754 489999999999875    56789999999999999


Q ss_pred             hhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC---CCceEEeecCCcccccCCCCe
Q 036435          150 KFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE---DFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       150 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      +++.....    ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.   ++.+||+|||+++....... 
T Consensus       148 ~~l~~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~-  219 (400)
T 1nxk_A          148 SRIQDRGD----QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-  219 (400)
T ss_dssp             HHHHCC-------CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----
T ss_pred             HHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecccccccCCCCc-
Confidence            99987543    23899999999999999999999   799999999999999997   78999999999986543221 


Q ss_pred             eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCcc
Q 036435          227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV  306 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (372)
                         .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||............    ...+... ....+..
T Consensus       220 ---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~----~~~i~~~-~~~~~~~  289 (400)
T 1nxk_A          220 ---LTTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----KTRIRMG-QYEFPNP  289 (400)
T ss_dssp             ----------CTTCCGGGSCCC--CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSH----HHHHHHT-CCCCCTT
T ss_pred             ---cccCCCCCCccCHhhcCCC--CCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHH----HHHHHcC-cccCCCc
Confidence               2334589999999999764  7899999999999999999999999865433211111    1111111 1111111


Q ss_pred             CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       307 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                         ....+...+.+++.+||+.||.+|||++|+++.
T Consensus       290 ---~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          290 ---EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             ---TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ---ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence               112234668889999999999999999999973

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.5e-41  Score=313.34  Aligned_cols=264  Identities=21%  Similarity=0.285  Sum_probs=198.6

Q ss_pred             ccHHHHHHHHhhhhhhcCCCCceEEEEEEecc--------------hHHHHHHHHhc--cCCCceeeeEeEEecCC----
Q 036435           75 YNFSDVKKLTNSFKDKLGQGGFGGVYKGRLLD--------------DFVNEVASISR--TSHVNVVTLLGFCLEGN----  134 (372)
Q Consensus        75 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~--------------~~~~E~~~l~~--l~h~nIv~l~g~~~~~~----  134 (372)
                      +...+.....+.+.+.||+|+||.||+|+..+              .+.+|.+++..  ++||||+++++++.+..    
T Consensus        34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~  113 (342)
T 1b6c_B           34 LLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT  113 (342)
T ss_dssp             HHHHHHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred             eeecccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence            33344444555667899999999999997643              46788888887  79999999999998876    


Q ss_pred             ceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeeecCCCCCceEECCCCce
Q 036435          135 NRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC-----STKILHFDIKPHNILLDEDFCP  209 (372)
Q Consensus       135 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-----~~~ivH~dlk~~Nill~~~~~~  209 (372)
                      ..++||||+++|+|.+++.+..       +++.+++.++.|++.||+|||...     +.+++||||||+|||++.++.+
T Consensus       114 ~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~  186 (342)
T 1b6c_B          114 QLWLVSDYHEHGSLFDYLNRYT-------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  186 (342)
T ss_dssp             CEEEEECCCTTCBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCE
T ss_pred             eeEEEEeecCCCcHHHHHhccC-------ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCE
Confidence            7899999999999999997643       899999999999999999999311     3789999999999999999999


Q ss_pred             EEeecCCcccccCCCCeee-eecccccccccccccccccccC----CCCccccchhHHHHHHHHhcC----------CCC
Q 036435          210 KISDFGLAKLCTTKEGIVS-SLLGARGIIGYIAPEVFSRNFG----EVSHKSDVYSFGMMIMELVGC----------KNN  274 (372)
Q Consensus       210 kl~Dfgla~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~----~~~~~~DvwslG~il~elltg----------~~p  274 (372)
                      ||+|||++........... ......||+.|+|||.+.+...    .++.++||||||+++|||++|          ..|
T Consensus       187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p  266 (342)
T 1b6c_B          187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  266 (342)
T ss_dssp             EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence            9999999987655443321 2234468999999999876311    233689999999999999999          566


Q ss_pred             CCCCCCCCCccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 036435          275 LDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~  349 (372)
                      |........  ....+.............+...  ...+....+.+++.+||+.||++|||+.++++.|+++...
T Consensus       267 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~  337 (342)
T 1b6c_B          267 YYDLVPSDP--SVEEMRKVVCEQKLRPNIPNRW--QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  337 (342)
T ss_dssp             TTTTSCSSC--CHHHHHHHHTTSCCCCCCCGGG--GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ccccCcCcc--cHHHHHHHHHHHHhCCCCcccc--cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence            655432221  1111111111222122222111  1234567889999999999999999999999999987654

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.4e-42  Score=312.79  Aligned_cols=239  Identities=21%  Similarity=0.308  Sum_probs=180.8

Q ss_pred             hhhhhcCCCCceEEEEEEec--------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLL--------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~--------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      .+.+.||+|+||.||+++..                    +.+.+|+.++++++||||+++++++.+++..++||||+++
T Consensus         5 ~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (288)
T 1ob3_A            5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ   84 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE
T ss_pred             hhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC
Confidence            34578999999999999753                    1577999999999999999999999999999999999975


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                       +|.+++.....     .+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++........
T Consensus        85 -~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (288)
T 1ob3_A           85 -DLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (288)
T ss_dssp             -EHHHHHHTSTT-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             -CHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence             99999876432     2899999999999999999999   78999999999999999999999999999986543221


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC--
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL--  303 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  303 (372)
                      .   .....+|+.|+|||.+.+. ..++.++|||||||++|||++|+.||.......    ....+............  
T Consensus       156 ~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~  227 (288)
T 1ob3_A          156 K---YTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD----QLMRIFRILGTPNSKNWPN  227 (288)
T ss_dssp             ---------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCCCCTTTSTT
T ss_pred             c---cccccccccccCchheeCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHHCCCChhhchh
Confidence            1   1233578999999998764 368999999999999999999999997542211    00011111100000000  


Q ss_pred             ---------------CccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          304 ---------------PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       304 ---------------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                                     +.............+.+++.+||+.||++|||++|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                           00000111223466788999999999999999999985

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=4.8e-42  Score=319.34  Aligned_cols=234  Identities=24%  Similarity=0.391  Sum_probs=185.3

Q ss_pred             hhhhhhcCCCCceEEEEEEecc---------------hHHHHHHHHhcc-CCCceeeeEeEEecCCceeEEEEecCCCCh
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD---------------DFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNGSL  148 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~---------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L  148 (372)
                      +.+.+.||+|+||.||+++...               ...+|++++.++ +||||+++++++.+++..++||||+++|+|
T Consensus        24 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L  103 (342)
T 2qr7_A           24 YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL  103 (342)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcH
Confidence            4456789999999999997642               467899999988 799999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC----CceEEeecCCcccccCCC
Q 036435          149 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDED----FCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       149 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfgla~~~~~~~  224 (372)
                      .+++.....      +++..+..++.|++.||+|||   +.+|+||||||+|||+.++    +.+||+|||++.......
T Consensus       104 ~~~i~~~~~------~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~  174 (342)
T 2qr7_A          104 LDKILRQKF------FSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN  174 (342)
T ss_dssp             HHHHHTCTT------CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred             HHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence            999976542      899999999999999999999   7899999999999998533    359999999998765433


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCC
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP  304 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (372)
                      ..   .....||+.|+|||.+.+.  .++.++|||||||++|||++|..||.......     ...+...+.... ...+
T Consensus       175 ~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-----~~~~~~~i~~~~-~~~~  243 (342)
T 2qr7_A          175 GL---LMTPCYTANFVAPEVLERQ--GYDAACDIWSLGVLLYTMLTGYTPFANGPDDT-----PEEILARIGSGK-FSLS  243 (342)
T ss_dssp             CC---BCCSSCCSSCCCHHHHHHH--HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC-----HHHHHHHHHHCC-CCCC
T ss_pred             Cc---eeccCCCccccCHHHhcCC--CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC-----HHHHHHHHccCC-cccC
Confidence            22   1234689999999999874  68899999999999999999999997543221     112222232221 1111


Q ss_pred             ccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       305 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ..   ....+...+.+++.+||+.||++|||+.++++
T Consensus       244 ~~---~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          244 GG---YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             ST---TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             cc---ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            11   11223456788999999999999999999986

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.6e-41  Score=326.77  Aligned_cols=226  Identities=24%  Similarity=0.401  Sum_probs=185.6

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      .+.+.||+|+||.||+|+...                      .+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus        19 ~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~   98 (476)
T 2y94_A           19 ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYV   98 (476)
T ss_dssp             EEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            446789999999999997631                      4778999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      ++|+|.+++....      .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++......
T Consensus        99 ~gg~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           99 SGGELFDYICKNG------RLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             SSEEHHHHTTSSS------SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             CCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            9999999997543      2899999999999999999999   899999999999999999999999999999876543


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                      ..    .....||+.|+|||.+.+. ...+.++|||||||++|+|++|+.||......       . ....+... ....
T Consensus       170 ~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-------~-~~~~i~~~-~~~~  235 (476)
T 2y94_A          170 EF----LRTSCGSPNYAAPEVISGR-LYAGPEVDIWSSGVILYALLCGTLPFDDDHVP-------T-LFKKICDG-IFYT  235 (476)
T ss_dssp             CC----BCCCCSCSTTCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH-------H-HHHHHHTT-CCCC
T ss_pred             cc----ccccCCCcCeEChhhccCC-CCCCCcceehhhHHHHHHHhhCCCCCCCCCHH-------H-HHHHHhcC-CcCC
Confidence            32    1234689999999999874 23478999999999999999999999754221       1 22222221 1222


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      |..       ....+.+++.+||+.||.+|||++++++
T Consensus       236 p~~-------~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          236 PQY-------LNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             CTT-------CCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             Ccc-------CCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence            221       2346778999999999999999999997

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-41  Score=314.41  Aligned_cols=248  Identities=25%  Similarity=0.418  Sum_probs=192.2

Q ss_pred             hhhhhhcCCCCceEEEEEEec-----------------------chHHHHHHHHhccCCCceeeeEeEEecCC--ceeEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL-----------------------DDFVNEVASISRTSHVNVVTLLGFCLEGN--NRALI  139 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-----------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~--~~~lV  139 (372)
                      +.+.+.||+|+||.||+++..                       +.+.+|+.++++++||||+++++++...+  ..++|
T Consensus        43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv  122 (326)
T 2w1i_A           43 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI  122 (326)
T ss_dssp             EEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEE
T ss_pred             ceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEE
Confidence            345678999999999999731                       15889999999999999999999987654  78999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccc
Q 036435          140 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL  219 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  219 (372)
                      |||+++++|.+++.....     .+++.+++.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++..
T Consensus       123 ~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          123 MEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             ECCCTTCBHHHHHHHSTT-----SSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             EECCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            999999999999987542     2899999999999999999999   79999999999999999999999999999987


Q ss_pred             ccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCC--------CCCccchHHHH
Q 036435          220 CTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVD--------SSSEVYFPHWI  291 (372)
Q Consensus       220 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~--------~~~~~~~~~~~  291 (372)
                      ...............++..|+|||.+.+.  .++.++||||||+++|||++|..|+.....        ..........+
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  272 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             ccccccccccccCCCCceeEECchhhcCC--CCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence            76544333323334577889999999775  788999999999999999999988763210        00000011111


Q ss_pred             HHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 036435          292 YRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~  349 (372)
                      ...+........+       ..+...+.+++.+||+.||++|||+.++++.|+++.+.
T Consensus       273 ~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~  323 (326)
T 2w1i_A          273 IELLKNNGRLPRP-------DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ  323 (326)
T ss_dssp             HHHHHTTCCCCCC-------TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHhhcCCCCCCC-------CcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            2222222222222       12345688899999999999999999999999887643

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=4.4e-41  Score=307.68  Aligned_cols=237  Identities=20%  Similarity=0.284  Sum_probs=182.8

Q ss_pred             hhhhhcCCCCceEEEEEEecc-----------------------hHHHHHHHHhccCCCceeeeEeEEe--cCCceeEEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD-----------------------DFVNEVASISRTSHVNVVTLLGFCL--EGNNRALIY  140 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~-----------------------~~~~E~~~l~~l~h~nIv~l~g~~~--~~~~~~lV~  140 (372)
                      .+.+.||+|+||.||++...+                       .+.+|+.++++++||||+++++++.  +.+..++||
T Consensus         8 ~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~   87 (305)
T 2wtk_C            8 LMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVM   87 (305)
T ss_dssp             CCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEE
T ss_pred             eEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEe
Confidence            446789999999999997632                       4778999999999999999999984  456889999


Q ss_pred             EecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccc
Q 036435          141 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC  220 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~  220 (372)
                      ||++++ |.+++......    .+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++...
T Consensus        88 e~~~~~-l~~~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           88 EYCVCG-MQEMLDSVPEK----RFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             ECCSEE-HHHHHHHSTTC----SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             hhccCC-HHHHHHhCccc----ccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            999876 77777664432    3899999999999999999999   789999999999999999999999999999876


Q ss_pred             cCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccc
Q 036435          221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDRE  300 (372)
Q Consensus       221 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (372)
                      ....... ......||+.|+|||.+.+.....+.++||||||+++|||++|+.||.....        ......+... .
T Consensus       160 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~i~~~-~  229 (305)
T 2wtk_C          160 HPFAADD-TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI--------YKLFENIGKG-S  229 (305)
T ss_dssp             CTTCSSC-EECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHC-C
T ss_pred             Ccccccc-ccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH--------HHHHHHHhcC-C
Confidence            5332221 1234458999999999876423457899999999999999999999975321        1122222222 1


Q ss_pred             ccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhhcCc
Q 036435          301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE--MLQGST  347 (372)
Q Consensus       301 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~--~L~~~~  347 (372)
                      ...+..       ....+.+++.+||+.||.+|||++++++  .+.+..
T Consensus       230 ~~~~~~-------~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  271 (305)
T 2wtk_C          230 YAIPGD-------CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH  271 (305)
T ss_dssp             CCCCSS-------SCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred             CCCCCc-------cCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence            222221       2356778899999999999999999996  355444

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=9.2e-42  Score=315.58  Aligned_cols=241  Identities=25%  Similarity=0.455  Sum_probs=190.9

Q ss_pred             hhhhhhcCCCCceEEEEEEec----------------------chHHHHHHHHhcc-CCCceeeeEeEEecCCceeEEEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL----------------------DDFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYE  141 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~----------------------~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e  141 (372)
                      +.+.+.||+|+||.||+++..                      +.+.+|+.+++++ +||||+++++++.+++..++|||
T Consensus        27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e  106 (327)
T 1fvr_A           27 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE  106 (327)
T ss_dssp             CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEe
Confidence            345678999999999998642                      1588899999999 99999999999999999999999


Q ss_pred             ecCCCChhhhhhcCCC----------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEE
Q 036435          142 FMPNGSLEKFVYNGDT----------SKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKI  211 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~----------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  211 (372)
                      |+++|+|.+++.....          ......+++.+++.++.|+++||+|||   +.+++||||||+|||++.++.+||
T Consensus       107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kL  183 (327)
T 1fvr_A          107 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKI  183 (327)
T ss_dssp             CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEE
T ss_pred             cCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeEEE
Confidence            9999999999976530          011124899999999999999999999   799999999999999999999999


Q ss_pred             eecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHH
Q 036435          212 SDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHW  290 (372)
Q Consensus       212 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~  290 (372)
                      +|||++.......    ......+++.|+|||.+.+.  .++.++||||||+++|||++ |+.||.....        ..
T Consensus       184 ~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~~  249 (327)
T 1fvr_A          184 ADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AE  249 (327)
T ss_dssp             CCTTCEESSCEEC----CC----CCTTTCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HH
T ss_pred             cccCcCccccccc----cccCCCCCccccChhhhccc--cCCchhcchHHHHHHHHHHcCCCCCCCCCcH--------HH
Confidence            9999997432211    11223467889999999764  78999999999999999998 9999865421        11


Q ss_pred             HHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 036435          291 IYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~  349 (372)
                      ....+........+.       .....+.+++.+||+.||.+|||++++++.|+.+...
T Consensus       250 ~~~~~~~~~~~~~~~-------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  301 (327)
T 1fvr_A          250 LYEKLPQGYRLEKPL-------NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  301 (327)
T ss_dssp             HHHHGGGTCCCCCCT-------TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHHHhhcCCCCCCCC-------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            223333322222221       2235678899999999999999999999999877654

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3e-41  Score=307.21  Aligned_cols=250  Identities=18%  Similarity=0.249  Sum_probs=193.6

Q ss_pred             hhhhhhcCCCCceEEEEEEec-----------------chHHHHHHHHhccCCCceeeeEeEE-ecCCceeEEEEecCCC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL-----------------DDFVNEVASISRTSHVNVVTLLGFC-LEGNNRALIYEFMPNG  146 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-----------------~~~~~E~~~l~~l~h~nIv~l~g~~-~~~~~~~lV~e~~~~g  146 (372)
                      +.+.+.||+|+||.||+++..                 +++.+|+.++++++|+|++..++.+ .+++..++||||+ ++
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~   89 (296)
T 4hgt_A           11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GP   89 (296)
T ss_dssp             CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred             eEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CC
Confidence            344678999999999999752                 2689999999999988877777666 5667789999999 99


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE---CCCCceEEeecCCcccccCC
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL---DEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgla~~~~~~  223 (372)
                      +|.+++.....     .+++..++.++.|++.||+|||   +.+++||||||+|||+   +.++.+||+|||++......
T Consensus        90 ~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~  161 (296)
T 4hgt_A           90 SLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             BHHHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence            99999975432     2899999999999999999999   7999999999999999   78899999999999876554


Q ss_pred             CCee----eeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcc
Q 036435          224 EGIV----SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDR  299 (372)
Q Consensus       224 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (372)
                      ....    .......||+.|+|||.+.+.  .++.++|||||||++|+|++|+.||...........+..........  
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--  237 (296)
T 4hgt_A          162 RTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST--  237 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCGGGCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS--
T ss_pred             ccCccCCCCcccccCCCccccchHHhcCC--CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc--
Confidence            3221    112344689999999999875  78999999999999999999999998754433222221111111110  


Q ss_pred             cccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccCCCC
Q 036435          300 EFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQIP  353 (372)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~  353 (372)
                        ..+    .....++..+.+++.+||+.||++|||++++++.|+.+......+
T Consensus       238 --~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~  285 (296)
T 4hgt_A          238 --PIE----VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS  285 (296)
T ss_dssp             --CHH----HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred             --hhh----hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCC
Confidence              000    000112457888999999999999999999999999887655433

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3e-42  Score=320.77  Aligned_cols=225  Identities=23%  Similarity=0.324  Sum_probs=183.1

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhcc-CCCceeeeEeEEecCCceeEEEEe
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      .+.+.||+|+||.||+++...                      .+.+|..++..+ +||||+++++++.+.+..++||||
T Consensus        20 ~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~   99 (345)
T 1xjd_A           20 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEY   99 (345)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeC
Confidence            445789999999999997642                      366788999887 999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      +++|+|.+++.....      +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       100 ~~gg~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  170 (345)
T 1xjd_A          100 LNGGDLMYHIQSCHK------FDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML  170 (345)
T ss_dssp             CTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             CCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence            999999999976432      899999999999999999999   78999999999999999999999999999986433


Q ss_pred             CCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      ....   .....||+.|+|||.+.+.  .++.++|+|||||++|||++|+.||.....        ..+...+... ...
T Consensus       171 ~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~-~~~  236 (345)
T 1xjd_A          171 GDAK---TNTFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--------EELFHSIRMD-NPF  236 (345)
T ss_dssp             TTCC---BCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHC-CCC
T ss_pred             CCCc---ccCCCCCcccCChhhhcCC--CCCChhhhHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHhC-CCC
Confidence            2211   2345689999999999875  789999999999999999999999975321        1122222221 122


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMN-EVI  340 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-evl  340 (372)
                      .|..       ....+.+++.+||+.||++||++. +++
T Consensus       237 ~p~~-------~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          237 YPRW-------LEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             CCTT-------SCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             CCcc-------cCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence            2221       345677889999999999999997 665

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.1e-41  Score=307.56  Aligned_cols=229  Identities=21%  Similarity=0.312  Sum_probs=185.3

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      +.+.+.||+|+||.||+++...                   .+.+|++++++++||||+++++++.+++..++||||+++
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   90 (277)
T 3f3z_A           11 YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTG   90 (277)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred             EEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCC
Confidence            3446789999999999997632                   588999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE---CCCCceEEeecCCcccccC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL---DEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgla~~~~~  222 (372)
                      ++|.+++.....      +++..+..++.|++.||+|||   +.+++|+||||+||++   +.++.+||+|||++.....
T Consensus        91 ~~L~~~~~~~~~------~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           91 GELFERVVHKRV------FRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             CBHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             CcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            999999876432      899999999999999999999   7999999999999999   7889999999999987654


Q ss_pred             CCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      ....    ....||+.|+|||.+.+   .++.++||||||+++|+|++|+.||......        .....+... ...
T Consensus       162 ~~~~----~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~-~~~  225 (277)
T 3f3z_A          162 GKMM----RTKVGTPYYVSPQVLEG---LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS--------EVMLKIREG-TFT  225 (277)
T ss_dssp             TSCB----CCCCSCTTTCCHHHHTT---CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHC-CCC
T ss_pred             ccch----hccCCCCCccChHHhcc---cCCchhhehhHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhC-CCC
Confidence            3322    23458899999999865   5889999999999999999999999753211        112222221 111


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .+.   .........+.+++.+||+.||.+|||+.++++
T Consensus       226 ~~~---~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          226 FPE---KDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             CCH---HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCc---hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            111   011123467888999999999999999999985

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.8e-41  Score=318.85  Aligned_cols=182  Identities=27%  Similarity=0.390  Sum_probs=145.1

Q ss_pred             hhhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccC-CCceeeeEeEEecCC--ceeEEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTS-HVNVVTLLGFCLEGN--NRALIY  140 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~-h~nIv~l~g~~~~~~--~~~lV~  140 (372)
                      +.+.+.||+|+||.||++....                     .+.+|+.+++++. ||||+++++++..++  ..++||
T Consensus        11 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~   90 (388)
T 3oz6_A           11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVF   90 (388)
T ss_dssp             EEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEE
T ss_pred             eEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEe
Confidence            3446789999999999996532                     4678999999997 999999999997544  789999


Q ss_pred             EecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccc
Q 036435          141 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC  220 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~  220 (372)
                      ||++ |+|.+++....       +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        91 e~~~-~~L~~~~~~~~-------~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           91 DYME-TDLHAVIRANI-------LEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSF  159 (388)
T ss_dssp             ECCS-EEHHHHHHHTC-------CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred             cccC-cCHHHHHHcCC-------CCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence            9997 69999997642       899999999999999999999   799999999999999999999999999999865


Q ss_pred             cCCCC------------------eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCC
Q 036435          221 TTKEG------------------IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSG  278 (372)
Q Consensus       221 ~~~~~------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~  278 (372)
                      .....                  .........||+.|+|||++.+. ..++.++|||||||++|||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~  234 (388)
T 3oz6_A          160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGIDMWSLGCILGEILCGKPIFPGS  234 (388)
T ss_dssp             SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence            33110                  01112334689999999998763 37899999999999999999999999754

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-41  Score=317.31  Aligned_cols=248  Identities=21%  Similarity=0.200  Sum_probs=186.0

Q ss_pred             hhhhhhcCCCCceEEEEEEecc------------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD------------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIY  140 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~  140 (372)
                      +.+.+.||+|+||.||+++...                        .+.+|+.++++++||||+++++++.+++..++||
T Consensus        28 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  107 (345)
T 3hko_A           28 YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVM  107 (345)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEE
Confidence            4446789999999999996521                        4778999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhcCCCC----------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 036435          141 EFMPNGSLEKFVYNGDTS----------------------------------KPCQYLRWEKMYEIVIGIAKGLEYLHHG  186 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~~----------------------------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~  186 (372)
                      ||+++|+|.+++......                                  .....+++..+..++.|++.||+|||  
T Consensus       108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--  185 (345)
T 3hko_A          108 ELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH--  185 (345)
T ss_dssp             ECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH--
T ss_pred             eCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH--
Confidence            999999999998531100                                  00112467788899999999999999  


Q ss_pred             CCCCeeecCCCCCceEECCCC--ceEEeecCCcccccCCCCe-eeeecccccccccccccccccccCCCCccccchhHHH
Q 036435          187 CSTKILHFDIKPHNILLDEDF--CPKISDFGLAKLCTTKEGI-VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGM  263 (372)
Q Consensus       187 ~~~~ivH~dlk~~Nill~~~~--~~kl~Dfgla~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~  263 (372)
                       +.+++||||||+|||++.++  .+||+|||++......... ........||+.|+|||.+.+....++.++||||||+
T Consensus       186 -~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~  264 (345)
T 3hko_A          186 -NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV  264 (345)
T ss_dssp             -HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred             -HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence             78999999999999998776  8999999999865432221 1122345689999999998753347889999999999


Q ss_pred             HHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--
Q 036435          264 MIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE--  341 (372)
Q Consensus       264 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~--  341 (372)
                      ++|||++|+.||......       ...............     .........+.+++.+||+.||.+|||+.++++  
T Consensus       265 il~el~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp  332 (345)
T 3hko_A          265 LLHLLLMGAVPFPGVNDA-------DTISQVLNKKLCFEN-----PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHP  332 (345)
T ss_dssp             HHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCCTTS-----GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSH
T ss_pred             HHHHHHHCCCCCCCCChH-------HHHHHHHhcccccCC-----cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCh
Confidence            999999999999754221       112222222111111     111223467788999999999999999999987  


Q ss_pred             HhhcCc
Q 036435          342 MLQGST  347 (372)
Q Consensus       342 ~L~~~~  347 (372)
                      .+++..
T Consensus       333 ~~~~~~  338 (345)
T 3hko_A          333 WISQFS  338 (345)
T ss_dssp             HHHTTS
T ss_pred             hhccCh
Confidence            344433

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=7.5e-42  Score=314.06  Aligned_cols=228  Identities=24%  Similarity=0.299  Sum_probs=177.8

Q ss_pred             HHHHhhhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhcc-CCCceeeeEeEEecCCceeE
Q 036435           81 KKLTNSFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRT-SHVNVVTLLGFCLEGNNRAL  138 (372)
Q Consensus        81 ~~~~~~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~l  138 (372)
                      ....+.+.++||+|+||+||+|+...                     .+..|+..+.++ +||||++++++|.+++..++
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l  134 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL  134 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence            33445556789999999999997642                     345566555555 89999999999999999999


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          139 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       139 V~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      ||||+ +++|.+++.....     .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++.
T Consensus       135 v~e~~-~~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~  205 (311)
T 3p1a_A          135 QTELC-GPSLQQHCEAWGA-----SLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLV  205 (311)
T ss_dssp             EEECC-CCBHHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCE
T ss_pred             EEecc-CCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeee
Confidence            99999 6799999876542     2999999999999999999999   7899999999999999999999999999998


Q ss_pred             cccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhc
Q 036435          219 LCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQD  298 (372)
Q Consensus       219 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (372)
                      .......    .....||+.|+|||++.+   .++.++|||||||++|||++|..++....           ....+...
T Consensus       206 ~~~~~~~----~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~el~~g~~~~~~~~-----------~~~~~~~~  267 (311)
T 3p1a_A          206 ELGTAGA----GEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGGE-----------GWQQLRQG  267 (311)
T ss_dssp             ECC----------CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-----------HHHHHTTT
T ss_pred             ecccCCC----CcccCCCccccCHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCcc-----------HHHHHhcc
Confidence            6543321    123458999999999875   68899999999999999999977665321           11111111


Q ss_pred             ccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          299 REFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .   .+   ..........+.+++.+||+.||++|||++|+++
T Consensus       268 ~---~~---~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          268 Y---LP---PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             C---CC---HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             C---CC---cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            0   11   0111223467888999999999999999999985

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.2e-41  Score=312.49  Aligned_cols=240  Identities=21%  Similarity=0.284  Sum_probs=182.0

Q ss_pred             hhhhhhcCCCCceEEEEEEec----------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEe
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL----------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~----------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      +.+.+.||+|+||.||+++..                      +.+.+|+.++++++||||+++++++.+++..++|+||
T Consensus        36 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  115 (309)
T 2h34_A           36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRL  115 (309)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEe
Confidence            344678999999999999753                      1477899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      +++++|.+++.....      +++.+++.++.|++.||+|||   +.+++|+||||+|||++.++.+||+|||++.....
T Consensus       116 ~~~~~L~~~l~~~~~------~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          116 INGVDLAAMLRRQGP------LAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             CCCEEHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             cCCCCHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            999999999976532      899999999999999999999   78999999999999999999999999999976544


Q ss_pred             CCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      ....  ......||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||.....        ......+.....  
T Consensus       187 ~~~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~~~~~~~--  252 (309)
T 2h34_A          187 EKLT--QLGNTVGTLYYMAPERFSES--HATYRADIYALTCVLYECLTGSPPYQGDQL--------SVMGAHINQAIP--  252 (309)
T ss_dssp             ------------CCGGGCCGGGTCC------CCCHHHHHHHHHHHHHHSSCSSCSCHH--------HHHHHHHHSCCC--
T ss_pred             cccc--cccccCCCcCccCHHHHcCC--CCCchHhHHHHHHHHHHHHHCCCCCCCchH--------HHHHHHhccCCC--
Confidence            3211  12234588999999999764  788999999999999999999999975321        111222211110  


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhhcCcccC
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRP-PMNEVIEMLQGSTEAL  350 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~evl~~L~~~~~~~  350 (372)
                      .+   ......+...+.+++.+||+.||++|| +++++++.|+......
T Consensus       253 ~~---~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          253 RP---STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             CG---GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             Cc---cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence            01   011122345677899999999999999 9999999998876543

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.8e-41  Score=312.82  Aligned_cols=230  Identities=23%  Similarity=0.334  Sum_probs=185.9

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-------------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-------------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALI  139 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV  139 (372)
                      +.+.+.||+|+||.||+++...                         .+.+|+.++++++||||+++++++.+++..++|
T Consensus        14 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (321)
T 2a2a_A           14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLI   93 (321)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             EEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            4556889999999999997531                         478999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC----ceEEeecC
Q 036435          140 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDF----CPKISDFG  215 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg  215 (372)
                      |||+++++|.+++....      .+++..+..++.|++.||+|||   +.+++||||||+||+++.++    .+||+|||
T Consensus        94 ~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           94 LELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             ECCCCSCBHHHHHHTCS------CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            99999999999997643      2899999999999999999999   78999999999999999887    79999999


Q ss_pred             CcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHh
Q 036435          216 LAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV  295 (372)
Q Consensus       216 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  295 (372)
                      ++.........    ....||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||......       . ....+
T Consensus       165 ~~~~~~~~~~~----~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~-~~~~i  230 (321)
T 2a2a_A          165 LAHEIEDGVEF----KNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQ-------E-TLANI  230 (321)
T ss_dssp             TCEECCTTCCC----CCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-------H-HHHHH
T ss_pred             cceecCccccc----cccCCCCCccCcccccCC--CCCCccccHHHHHHHHHHHHCCCCCCCCCHH-------H-HHHHH
Confidence            99876543321    234589999999999764  7899999999999999999999999753211       1 11111


Q ss_pred             hhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          296 EQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ... ....+.   .........+.+++.+||+.||.+|||++|+++
T Consensus       231 ~~~-~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          231 TSV-SYDFDE---EFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HTT-CCCCCH---HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             Hhc-ccccCh---hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            111 111110   111123456788999999999999999999986

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4.6e-41  Score=305.53  Aligned_cols=225  Identities=25%  Similarity=0.431  Sum_probs=179.4

Q ss_pred             hhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEec----CCceeEEEE
Q 036435           87 FKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLE----GNNRALIYE  141 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~----~~~~~lV~e  141 (372)
                      +.+.||+|+||.||+|....                     .+.+|+.++++++||||+++++++.+    +...++|||
T Consensus        30 ~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e  109 (290)
T 1t4h_A           30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE  109 (290)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEE
T ss_pred             eeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEE
Confidence            45679999999999997632                     47889999999999999999999875    356899999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCceEEC-CCCceEEeecCCcc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTK--ILHFDIKPHNILLD-EDFCPKISDFGLAK  218 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~--ivH~dlk~~Nill~-~~~~~kl~Dfgla~  218 (372)
                      |+++|+|.+++.....      +++..+..++.|++.||+|||   +.+  ++|+||||+|||++ .++.+||+|||++.
T Consensus       110 ~~~~~~L~~~l~~~~~------~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          110 LMTSGTLKTYLKRFKV------MKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             CCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             ecCCCCHHHHHHHccC------CCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            9999999999976432      899999999999999999999   677  99999999999998 78999999999997


Q ss_pred             cccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhc
Q 036435          219 LCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQD  298 (372)
Q Consensus       219 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (372)
                      .......     ....||+.|+|||.+.+   .++.++||||||+++|+|++|+.||.......       .........
T Consensus       181 ~~~~~~~-----~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-------~~~~~~~~~  245 (290)
T 1t4h_A          181 LKRASFA-----KAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-------QIYRRVTSG  245 (290)
T ss_dssp             GCCTTSB-----EESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-------HHHHHHTTT
T ss_pred             ccccccc-----ccccCCcCcCCHHHHhc---cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH-------HHHHHHhcc
Confidence            5543321     22358899999998864   68899999999999999999999997542211       112222211


Q ss_pred             ccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          299 REFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ..   +...   .......+.+++.+||+.||.+|||++++++
T Consensus       246 ~~---~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          246 VK---PASF---DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             CC---CGGG---GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CC---cccc---CCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            11   1111   1112346788999999999999999999986

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.5e-41  Score=308.24  Aligned_cols=232  Identities=25%  Similarity=0.352  Sum_probs=178.9

Q ss_pred             hhhhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      +.+.+.||+|+||.||+++...                    .+.+|++++++++||||+++++++.+.+..++||||++
T Consensus        24 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~  103 (285)
T 3is5_A           24 FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCE  103 (285)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             eeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCC
Confidence            4556889999999999987532                    57899999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE---CCCCceEEeecCCccccc
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL---DEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgla~~~~  221 (372)
                      +|+|.+++......  ...+++..+..++.|++.||+|||   +.+++||||||+||++   +.++.+||+|||++....
T Consensus       104 ~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          104 GGELLERIVSAQAR--GKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CCBHHHHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCcHHHHHHhhhhc--ccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            99999998653210  122899999999999999999999   7999999999999999   456789999999998654


Q ss_pred             CCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccc
Q 036435          222 TKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF  301 (372)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (372)
                      ....    .....||+.|+|||.+.+   .++.++||||||+++|||++|+.||......        ......... ..
T Consensus       179 ~~~~----~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~il~~ll~g~~pf~~~~~~--------~~~~~~~~~-~~  242 (285)
T 3is5_A          179 SDEH----STNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE--------EVQQKATYK-EP  242 (285)
T ss_dssp             ------------CTTGGGCCHHHHTT---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHC-CC
T ss_pred             Cccc----CcCcccccCcCChHHhcc---CCCcccCeehHHHHHHHHHhCCCCCCCCCHH--------HHHhhhccC-Cc
Confidence            4322    123458999999999864   6789999999999999999999999753211        111111111 11


Q ss_pred             cCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       302 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ..+....    .....+.+++.+||+.||++|||+.|+++
T Consensus       243 ~~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          243 NYAVECR----PLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             CCCC--C----CCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ccccccC----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1111111    12356778999999999999999999985

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.6e-41  Score=306.79  Aligned_cols=224  Identities=26%  Similarity=0.448  Sum_probs=181.5

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      .+.+.||+|+||.||+++...                      .+.+|+.++++++||||+++++++.+++..++||||+
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (279)
T 3fdn_A           12 EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYA   91 (279)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecC
Confidence            345789999999999997632                      4778999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      ++|+|.+++.....      +++..+..++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++......
T Consensus        92 ~~~~l~~~l~~~~~------~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           92 PLGTVYRELQKLSK------FDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             TTEEHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred             CCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence            99999999976532      899999999999999999999   899999999999999999999999999998654332


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                      .     .....||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||.....        ......+.. .....
T Consensus       163 ~-----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~-~~~~~  226 (279)
T 3fdn_A          163 R-----RTDLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRISR-VEFTF  226 (279)
T ss_dssp             ----------CCCCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHH-TCCCC
T ss_pred             c-----ccccCCCCCccCHhHhccC--CCCccchhHhHHHHHHHHHHCCCCCCCCcH--------HHHHHHHHh-CCCCC
Confidence            2     1234588999999999775  778999999999999999999999974321        111222211 11122


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      +..       ....+.+++.+||+.||.+|||++|+++
T Consensus       227 ~~~-------~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          227 PDF-------VTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             CTT-------SCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CCc-------CCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            221       2356778899999999999999999997

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=311.10  Aligned_cols=240  Identities=25%  Similarity=0.362  Sum_probs=182.8

Q ss_pred             HhhhhhhcCCCCceEEEEEEecc------------------------hHHHHHHHHhccC---CCceeeeEeEEecCC--
Q 036435           84 TNSFKDKLGQGGFGGVYKGRLLD------------------------DFVNEVASISRTS---HVNVVTLLGFCLEGN--  134 (372)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~~------------------------~~~~E~~~l~~l~---h~nIv~l~g~~~~~~--  134 (372)
                      .+.+.+.||+|+||+||+++...                        .+.+|+.++++++   ||||+++++++.+..  
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~   89 (308)
T 3g33_A           10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTD   89 (308)
T ss_dssp             CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSS
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCC
Confidence            34556889999999999997421                        4678888888775   999999999998765  


Q ss_pred             ---ceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEE
Q 036435          135 ---NRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKI  211 (372)
Q Consensus       135 ---~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  211 (372)
                         ..++||||+. |+|.+++......    .+++.++..++.|++.||+|||   +.+++||||||+|||++.++.+||
T Consensus        90 ~~~~~~lv~e~~~-~~L~~~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           90 REIKVTLVFEHVD-QDLRTYLDKAPPP----GLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             SEEEEEEEEECCC-CBHHHHHHTCCTT----CSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEE
T ss_pred             CceeEEEEehhhh-cCHHHHHhhccCC----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEE
Confidence               4789999996 5999999876532    2899999999999999999999   789999999999999999999999


Q ss_pred             eecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHH
Q 036435          212 SDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWI  291 (372)
Q Consensus       212 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  291 (372)
                      +|||++........    .....||+.|+|||.+.+.  .++.++|||||||++|||++|+.||.......    ....+
T Consensus       162 ~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~i  231 (308)
T 3g33_A          162 ADFGLARIYSYQMA----LTPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD----QLGKI  231 (308)
T ss_dssp             CSCSCTTTSTTCCC----SGGGGCCCSSCCHHHHHTS--CCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH----HHHHH
T ss_pred             eeCccccccCCCcc----cCCccccccccCchHHcCC--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHH
Confidence            99999986543322    2334689999999999775  78999999999999999999999997543211    11111


Q ss_pred             HHHhhhcccccCCc-----------cCCc----chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          292 YRHVEQDREFKLPG-----------VVTR----KENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       292 ~~~~~~~~~~~~~~-----------~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ............+.           ....    ...+....+.+++.+||+.||++|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          232 FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            11111000000000           0000    01123467788999999999999999999986

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=6.1e-42  Score=309.43  Aligned_cols=233  Identities=25%  Similarity=0.428  Sum_probs=182.5

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------hHHHHHHHHhccCCCceeeeEeEEecC-CceeEEEEecCCCChh
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------DFVNEVASISRTSHVNVVTLLGFCLEG-NNRALIYEFMPNGSLE  149 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------~~~~E~~~l~~l~h~nIv~l~g~~~~~-~~~~lV~e~~~~g~L~  149 (372)
                      .+.+.||+|+||.||+++..+               .+.+|+.++++++||||+++++++.+. +..++||||+++|+|.
T Consensus        24 ~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~  103 (278)
T 1byg_A           24 KLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV  103 (278)
T ss_dssp             EEEEEEEECSSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHH
T ss_pred             eEEeEEecCCCceEEEEEEcCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHH
Confidence            446789999999999997632               588999999999999999999997654 4789999999999999


Q ss_pred             hhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeeee
Q 036435          150 KFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSS  229 (372)
Q Consensus       150 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  229 (372)
                      +++.....    ..+++..++.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++.......     
T Consensus       104 ~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-----  171 (278)
T 1byg_A          104 DYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----  171 (278)
T ss_dssp             HHHHHHHH----HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred             HHHHhccc----ccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccccccc-----
Confidence            99976432    12788999999999999999999   7899999999999999999999999999997654322     


Q ss_pred             ecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCC
Q 036435          230 LLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVT  308 (372)
Q Consensus       230 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (372)
                       ....+++.|+|||.+.+.  .++.++||||||+++|+|++ |+.||.......        ....+........+.   
T Consensus       172 -~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~---  237 (278)
T 1byg_A          172 -DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRVEKGYKMDAPD---  237 (278)
T ss_dssp             -----CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--------HHHHHTTTCCCCCCT---
T ss_pred             -cCCCccccccCHHHhCCC--CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHhcCCCCCCcc---
Confidence             122467889999999764  78999999999999999998 999987542211        222232222222221   


Q ss_pred             cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 036435          309 RKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE  348 (372)
Q Consensus       309 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~  348 (372)
                          .....+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       238 ----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          238 ----GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             ----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----cCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence                234567889999999999999999999999987653

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.4e-41  Score=307.73  Aligned_cols=229  Identities=21%  Similarity=0.341  Sum_probs=184.0

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      .+.+.||+|+||.||++....                     .+.+|+.++++++||||+++++++.+++..++||||++
T Consensus         9 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   88 (284)
T 3kk8_A            9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVT   88 (284)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             hhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCC
Confidence            345789999999999996532                     47789999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCc---eEEeecCCccccc
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFC---PKISDFGLAKLCT  221 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfgla~~~~  221 (372)
                      +++|.+++.....      +++..+..++.|++.||+|||   +.+++||||||+||+++.++.   +||+|||++....
T Consensus        89 ~~~l~~~~~~~~~------~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           89 GGELFEDIVAREF------YSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             SCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             CCCHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            9999998876532      899999999999999999999   789999999999999986655   9999999997665


Q ss_pred             CCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccc
Q 036435          222 TKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF  301 (372)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (372)
                      .....    ....||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||......        .....+... ..
T Consensus       160 ~~~~~----~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--------~~~~~~~~~-~~  224 (284)
T 3kk8_A          160 DSEAW----HGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQH--------RLYAQIKAG-AY  224 (284)
T ss_dssp             SSCBC----CCSCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHT-CC
T ss_pred             cCccc----cCCCCCcCCcCchhhcCC--CCCcccchHHHHHHHHHHHHCCCCCCCCchh--------HHHHHHHhc-cc
Confidence            43321    234589999999999875  7899999999999999999999999753211        112222211 11


Q ss_pred             cCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       302 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ..+..   ........+.+++.+||+.||++|||++|+++
T Consensus       225 ~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          225 DYPSP---EWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             CCCTT---TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cCCch---hhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            11111   11123456788999999999999999999987

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.5e-41  Score=315.33  Aligned_cols=221  Identities=25%  Similarity=0.334  Sum_probs=182.0

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeE
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRAL  138 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~l  138 (372)
                      .+.+.||+|+||.||+++...                           .+.+|+.++++++||||+++++++.+++..++
T Consensus        27 ~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l  106 (335)
T 3dls_A           27 STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQL  106 (335)
T ss_dssp             EEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             EEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEE
Confidence            345679999999999996521                           46679999999999999999999999999999


Q ss_pred             EEEecCCC-ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCc
Q 036435          139 IYEFMPNG-SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLA  217 (372)
Q Consensus       139 V~e~~~~g-~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla  217 (372)
                      ||||+.+| +|.+++.....      +++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++
T Consensus       107 v~e~~~~g~~l~~~~~~~~~------l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  177 (335)
T 3dls_A          107 VMEKHGSGLDLFAFIDRHPR------LDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSA  177 (335)
T ss_dssp             EEECCTTSCBHHHHHHTCCC------CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEeCCCCccHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence            99999777 99999976543      899999999999999999999   789999999999999999999999999999


Q ss_pred             ccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhh
Q 036435          218 KLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQ  297 (372)
Q Consensus       218 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (372)
                      .........    ....||+.|+|||.+.+. ...+.++|||||||++|+|++|+.||.......               
T Consensus       178 ~~~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---------------  237 (335)
T 3dls_A          178 AYLERGKLF----YTFCGTIEYCAPEVLMGN-PYRGPELEMWSLGVTLYTLVFEENPFCELEETV---------------  237 (335)
T ss_dssp             EECCTTCCB----CEECSCGGGCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT---------------
T ss_pred             eECCCCCce----eccCCCccccChhhhcCC-CCCCCcccchhHHHHHHHHHhCCCchhhHHHHH---------------
Confidence            876544322    223589999999999875 233889999999999999999999997521110               


Q ss_pred             cccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          298 DREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                      ......+..       ....+.+++.+||+.||.+|||++++++.
T Consensus       238 ~~~~~~~~~-------~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          238 EAAIHPPYL-------VSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             TTCCCCSSC-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             hhccCCCcc-------cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            001111111       23567889999999999999999999974

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.7e-41  Score=311.82  Aligned_cols=245  Identities=28%  Similarity=0.427  Sum_probs=193.2

Q ss_pred             hhhhhhcCCCCceEEEEEEec-------------------------chHHHHHHHHhcc-CCCceeeeEeEEecCC-cee
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL-------------------------DDFVNEVASISRT-SHVNVVTLLGFCLEGN-NRA  137 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-------------------------~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~-~~~  137 (372)
                      +.+.+.||+|+||.||+++..                         ..+.+|+.++.++ +||||+++++++.+.+ ..+
T Consensus        29 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~  108 (316)
T 2xir_A           29 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM  108 (316)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCE
T ss_pred             eeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceE
Confidence            344578999999999999731                         1478899999999 7999999999988755 589


Q ss_pred             EEEEecCCCChhhhhhcCCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC
Q 036435          138 LIYEFMPNGSLEKFVYNGDTSK----------PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDF  207 (372)
Q Consensus       138 lV~e~~~~g~L~~~l~~~~~~~----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~  207 (372)
                      +||||+++|+|.+++.......          ....+++..++.++.|++.||+|||   +.+++||||||+||+++.++
T Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~  185 (316)
T 2xir_A          109 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKN  185 (316)
T ss_dssp             EEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCC
Confidence            9999999999999998754310          0123789999999999999999999   78999999999999999999


Q ss_pred             ceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccc
Q 036435          208 CPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVY  286 (372)
Q Consensus       208 ~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~  286 (372)
                      .+||+|||++........... .....+|+.|+|||.+.+.  .++.++||||||+++|+|++ |..||......     
T Consensus       186 ~~kl~Dfg~~~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-----  257 (316)
T 2xir_A          186 VVKICDFGLARDIYKDPDYVR-KGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-----  257 (316)
T ss_dssp             CEEECCCGGGSCTTTCTTSEE-ETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-----
T ss_pred             CEEECCCccccccccCcccee-ccCCCcceeecCchhhccc--cccchhHHHHHHHHHHHHHhCCCCCCcccchh-----
Confidence            999999999987654433222 2344578899999999774  78999999999999999998 99998654321     


Q ss_pred             hHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 036435          287 FPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~  349 (372)
                        ......+........+..       ....+.+++.+||+.||.+|||+.++++.|+.+.++
T Consensus       258 --~~~~~~~~~~~~~~~~~~-------~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  311 (316)
T 2xir_A          258 --EEFCRRLKEGTRMRAPDY-------TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  311 (316)
T ss_dssp             --HHHHHHHHHTCCCCCCTT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --HHHHHHhccCccCCCCCC-------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence              112233333322222222       235677889999999999999999999999887643

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.4e-41  Score=311.95  Aligned_cols=248  Identities=21%  Similarity=0.390  Sum_probs=182.2

Q ss_pred             hhhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEe
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      +.+.+.||+|+||.||+++...                      .+.+|+.++++++||||+++++++.+++..++||||
T Consensus        34 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  113 (310)
T 2wqm_A           34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL  113 (310)
T ss_dssp             EEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             eEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEec
Confidence            4456789999999999997521                      478899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      +++|+|.+++......  ...+++..++.++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++.....
T Consensus       114 ~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          114 ADAGDLSRMIKHFKKQ--KRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             CCSCBHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             CCCCCHHHHHHHhccc--ccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            9999999998652211  123899999999999999999999   78999999999999999999999999999986544


Q ss_pred             CCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      ....   .....||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||.......     .. ....+....   
T Consensus       189 ~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~-~~~~~~~~~---  254 (310)
T 2wqm_A          189 KTTA---AHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-----YS-LCKKIEQCD---  254 (310)
T ss_dssp             -------------CCSSCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-----HH-HHHHHHTTC---
T ss_pred             CCcc---ccccCCCeeEeChHHhCCC--CCCchhhHHHHHHHHHHHHhCCCCCcccchhH-----HH-HHHHhhccc---
Confidence            3221   1233588899999998764  78999999999999999999999997542211     11 112222211   


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccCCCCC
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQIPP  354 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~  354 (372)
                      .+...   .......+.+++.+||+.||.+|||++++++.|+++......|+
T Consensus       255 ~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~  303 (310)
T 2wqm_A          255 YPPLP---SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL  303 (310)
T ss_dssp             SCCCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred             CCCCc---ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence            11111   11234567889999999999999999999999999887654443

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.6e-41  Score=316.90  Aligned_cols=227  Identities=20%  Similarity=0.279  Sum_probs=183.9

Q ss_pred             hhhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhcc-CCCceeeeEeEEecCCceeEEEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYE  141 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e  141 (372)
                      +.+.+.||+|+||.||+++...                      .+.+|..++..+ +||||+++++++.+.+..++|||
T Consensus        22 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E  101 (353)
T 2i0e_A           22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME  101 (353)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEe
Confidence            3446789999999999997632                      367899999988 89999999999999999999999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      |+++|+|.+++.....      +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       102 ~~~gg~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A          102 YVNGGDLMYHIQQVGR------FKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             CCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             CCCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            9999999999976432      899999999999999999999   7899999999999999999999999999998643


Q ss_pred             CCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccc
Q 036435          222 TKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF  301 (372)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (372)
                      .....   .....||+.|+|||.+.+.  .++.++|+|||||++|||++|+.||.....        ..+...+... ..
T Consensus       173 ~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~-~~  238 (353)
T 2i0e_A          173 WDGVT---TKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIMEH-NV  238 (353)
T ss_dssp             CTTCC---BCCCCSCGGGCCHHHHTTC--CBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHC-CC
T ss_pred             cCCcc---cccccCCccccChhhhcCC--CcCCcccccchHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhC-CC
Confidence            22211   2344699999999999875  789999999999999999999999975321        1122222221 22


Q ss_pred             cCCccCCcchHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 036435          302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPP-----MNEVIE  341 (372)
Q Consensus       302 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~  341 (372)
                      ..|.       .....+.+++.+||+.||.+||+     ++++++
T Consensus       239 ~~p~-------~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          239 AYPK-------SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             CCCT-------TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             CCCC-------CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            2232       23456778999999999999995     577764

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=4.5e-42  Score=312.06  Aligned_cols=239  Identities=24%  Similarity=0.394  Sum_probs=184.3

Q ss_pred             hhhhhhcCCCCceEEEEEEec-------------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL-------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI  139 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV  139 (372)
                      +.+.+.||+|+||.||+|++.                         +.+.+|+.++++++||||+++++++.+++ .++|
T Consensus        20 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v   98 (291)
T 1u46_A           20 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMV   98 (291)
T ss_dssp             EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEE
T ss_pred             eeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceee
Confidence            345678999999999998741                         14678999999999999999999998765 8999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccc
Q 036435          140 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL  219 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  219 (372)
                      +||+++|+|.+++....     ..+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++..
T Consensus        99 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           99 TELAPLGSLLDRLRKHQ-----GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EECCTTCBHHHHHHHHG-----GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             EecccCCCHHHHHHhcc-----CCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEcccccccc
Confidence            99999999999997643     22899999999999999999999   78999999999999999999999999999987


Q ss_pred             ccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhc
Q 036435          220 CTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQD  298 (372)
Q Consensus       220 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (372)
                      ...............+|..|+|||.+.+.  .++.++||||||+++|+|++ |+.||......       ..........
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~  241 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTR--TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-------QILHKIDKEG  241 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHTSC
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCcccCCHH-------HHHHHHHccC
Confidence            76554433333344577889999999764  78899999999999999999 99998754211       1111111111


Q ss_pred             ccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 036435          299 REFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE  348 (372)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~  348 (372)
                      .....+       ......+.+++.+||+.||.+|||++++++.|+++..
T Consensus       242 ~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          242 ERLPRP-------EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             CCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             CCCCCC-------cCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence            111111       1234678889999999999999999999999987663

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=8.9e-42  Score=315.70  Aligned_cols=245  Identities=26%  Similarity=0.389  Sum_probs=189.4

Q ss_pred             HhhhhhhcCCCCceEEEEEEec-------------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeE
Q 036435           84 TNSFKDKLGQGGFGGVYKGRLL-------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRAL  138 (372)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~-------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~l  138 (372)
                      .+.+.+.||+|+||.||+|++.                         .++.+|+.++++++||||+++++++.+++..++
T Consensus        31 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (327)
T 2yfx_A           31 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFI  110 (327)
T ss_dssp             GCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             heEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEE
Confidence            3455678999999999999731                         157889999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhcCCCCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC---CCceEEeec
Q 036435          139 IYEFMPNGSLEKFVYNGDTSK-PCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE---DFCPKISDF  214 (372)
Q Consensus       139 V~e~~~~g~L~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Df  214 (372)
                      ||||+++|+|.+++....... ....+++..++.++.|++.||.|||   +.+++||||||+|||++.   +..+||+||
T Consensus       111 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~Df  187 (327)
T 2yfx_A          111 LMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDF  187 (327)
T ss_dssp             EEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred             EEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEECcc
Confidence            999999999999998754321 1234899999999999999999999   789999999999999984   456999999


Q ss_pred             CCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHH
Q 036435          215 GLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYR  293 (372)
Q Consensus       215 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  293 (372)
                      |++.......... ......+|+.|+|||.+.+.  .++.++||||||+++|+|++ |..||.....        .....
T Consensus       188 g~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~~~  256 (327)
T 2yfx_A          188 GMARDIYRASYYR-KGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------QEVLE  256 (327)
T ss_dssp             HHHHHHHC-------CCGGGSCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHHH
T ss_pred             ccccccccccccc-cCCCcCCCcceeCHhHhcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--------HHHHH
Confidence            9998654332211 12234578899999998764  78999999999999999998 8888865321        11222


Q ss_pred             HhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 036435          294 HVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~  349 (372)
                      .+........+.       .....+.+++.+||+.||.+||++.++++.|+.....
T Consensus       257 ~~~~~~~~~~~~-------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          257 FVTSGGRMDPPK-------NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             HHHTTCCCCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHhcCCCCCCCC-------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence            222222222221       2345677899999999999999999999999877644

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.6e-41  Score=305.24  Aligned_cols=227  Identities=26%  Similarity=0.414  Sum_probs=165.4

Q ss_pred             hhhhhcCCCCceEEEEEEec----------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLL----------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~----------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      .+.+.||+|+||.||+++..                      +.+.+|+.++++++||||+++++++.+++..++|+||+
T Consensus        14 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   93 (278)
T 3cok_A           14 KVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMC   93 (278)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             eeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecC
Confidence            34578999999999999752                      14778999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      ++++|.+++.....     .+++..+..++.|+++||+|||   +.+++|+||||+||+++.++.+||+|||++......
T Consensus        94 ~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           94 HNGEMNRYLKNRVK-----PFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             TTEEHHHHHHTCSS-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             CCCcHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            99999999986532     2899999999999999999999   789999999999999999999999999999865433


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                      ...   .....||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||........        ..... ......
T Consensus       166 ~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------~~~~~-~~~~~~  231 (278)
T 3cok_A          166 HEK---HYTLCGTPNYISPEIATRS--AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT--------LNKVV-LADYEM  231 (278)
T ss_dssp             -------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------CC-SSCCCC
T ss_pred             CCc---ceeccCCCCcCCcchhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH--------HHHHh-hcccCC
Confidence            221   1234588999999999764  778999999999999999999999976432210        01000 011111


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      +.       .....+.+++.+||+.||++|||++++++
T Consensus       232 ~~-------~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          232 PS-------FLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             CT-------TSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cc-------ccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            21       12356778999999999999999999986

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=3.3e-41  Score=310.17  Aligned_cols=240  Identities=23%  Similarity=0.313  Sum_probs=179.4

Q ss_pred             hhcCCCCceEEEEEEec-------------------chHHHHHHHHhcc-CCCceeeeEeEEecCCceeEEEEecCCCCh
Q 036435           89 DKLGQGGFGGVYKGRLL-------------------DDFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNGSL  148 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~-------------------~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L  148 (372)
                      +.||+|+||.||+++..                   +.+.+|+.++.++ +||||+++++++.+++..++||||+++|+|
T Consensus        19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   98 (316)
T 2ac3_A           19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI   98 (316)
T ss_dssp             CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred             ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence            56999999999999653                   2588999999985 799999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCc---eEEeecCCcccccCCCC
Q 036435          149 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFC---PKISDFGLAKLCTTKEG  225 (372)
Q Consensus       149 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfgla~~~~~~~~  225 (372)
                      .+++.....      +++..+..++.|++.||+|||   +.+++||||||+|||++.++.   +||+|||++........
T Consensus        99 ~~~l~~~~~------~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~  169 (316)
T 2ac3_A           99 LSHIHKRRH------FNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD  169 (316)
T ss_dssp             HHHHHHHSS------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred             HHHHhccCC------CCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence            999976532      899999999999999999999   789999999999999998776   99999999976543221


Q ss_pred             e----eeeecccccccccccccccccc---cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccch-------HHHH
Q 036435          226 I----VSSLLGARGIIGYIAPEVFSRN---FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYF-------PHWI  291 (372)
Q Consensus       226 ~----~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~-------~~~~  291 (372)
                      .    ........||+.|+|||.+.+.   ...++.++|||||||++|||++|+.||............       ....
T Consensus       170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  249 (316)
T 2ac3_A          170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML  249 (316)
T ss_dssp             ------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHH
T ss_pred             cccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHH
Confidence            1    1112234589999999998641   125788999999999999999999999865433211100       0111


Q ss_pred             HHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          292 YRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ...+... ....+.   .........+.+++.+||+.||.+|||++|+++
T Consensus       250 ~~~i~~~-~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          250 FESIQEG-KYEFPD---KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHC-CCCCCH---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHhcc-CcccCc---hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            2222211 111111   111123467888999999999999999999997

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.9e-41  Score=304.37  Aligned_cols=233  Identities=26%  Similarity=0.346  Sum_probs=185.4

Q ss_pred             hhhhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      +.+.+.||+|+||.||+++...                    .+.+|+.++++++||||+++++++.+++..++|+||++
T Consensus         9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (276)
T 2yex_A            9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS   88 (276)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             eEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecC
Confidence            3456789999999999997631                    57889999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      +++|.+++....      .+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++.......
T Consensus        89 ~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           89 GGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             TEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             CCcHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            999999986543      2899999999999999999999   7999999999999999999999999999998654332


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCC
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP  304 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (372)
                      .. .......||+.|+|||.+.+. ...+.++||||||+++|+|++|+.||........  .     .......... .+
T Consensus       160 ~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~-----~~~~~~~~~~-~~  229 (276)
T 2yex_A          160 RE-RLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--E-----YSDWKEKKTY-LN  229 (276)
T ss_dssp             EE-CCBCCCCSCGGGCCGGGGTCS-SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH--H-----HHHHHTTCTT-ST
T ss_pred             ch-hcccCCccccCccChHHHhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--H-----HHHhhhcccc-cC
Confidence            11 112334588999999999764 2347899999999999999999999976543221  1     1111111110 00


Q ss_pred             ccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       305 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                           ........+.+++.+||+.||.+|||++|+++
T Consensus       230 -----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          230 -----PWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             -----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence                 11223456778999999999999999999886

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.8e-41  Score=325.44  Aligned_cols=226  Identities=20%  Similarity=0.309  Sum_probs=178.2

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      .+.+.||+|+||.||+++...                      .+.+|+.++++++||||+++++++.+++..++||||+
T Consensus       151 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~  230 (446)
T 4ejn_A          151 EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYA  230 (446)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCC
T ss_pred             EEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeC
Confidence            345789999999999987532                      4677999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS-TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      ++|+|.+++.....      +++..+..++.|++.||+|||   + .+|+||||||+|||++.++.+||+|||+++....
T Consensus       231 ~~~~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          231 NGGELFFHLSRERV------FSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  301 (446)
T ss_dssp             SSCBHHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred             CCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence            99999999976542      899999999999999999999   6 8999999999999999999999999999986433


Q ss_pred             CCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      ...   ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||......       . ....+.. ....
T Consensus       302 ~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~-~~~~i~~-~~~~  367 (446)
T 4ejn_A          302 DGA---TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------K-LFELILM-EEIR  367 (446)
T ss_dssp             --------CCSSSCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------H-HHHHHHH-CCCC
T ss_pred             CCc---ccccccCCccccCHhhcCCC--CCCCccchhhhHHHHHHHhhCCCCCCCCCHH-------H-HHHHHHh-CCCC
Confidence            221   12345689999999999774  7899999999999999999999999753211       1 1122111 1222


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRP-----PMNEVIE  341 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~  341 (372)
                      .|..       ....+.+++.+||+.||.+||     +++|+++
T Consensus       368 ~p~~-------~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          368 FPRT-------LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             CCTT-------SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCcc-------CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            2222       235677899999999999999     9999986

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=8.2e-41  Score=304.48  Aligned_cols=249  Identities=18%  Similarity=0.252  Sum_probs=192.1

Q ss_pred             hhhhhcCCCCceEEEEEEec-----------------chHHHHHHHHhccCCCceeeeEeEE-ecCCceeEEEEecCCCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLL-----------------DDFVNEVASISRTSHVNVVTLLGFC-LEGNNRALIYEFMPNGS  147 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~-----------------~~~~~E~~~l~~l~h~nIv~l~g~~-~~~~~~~lV~e~~~~g~  147 (372)
                      .+.+.||+|+||.||+|+..                 +++.+|+.++++++|+|++..++++ .+++..++||||+ +++
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~   90 (296)
T 3uzp_A           12 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPS   90 (296)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred             EEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCC
Confidence            34578999999999999752                 2689999999999998877766665 5566789999999 899


Q ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE---CCCCceEEeecCCcccccCCC
Q 036435          148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL---DEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       148 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      |.+++.....     .+++..++.++.|++.||+|||   +.+++||||||+|||+   +.++.+||+|||++.......
T Consensus        91 L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~  162 (296)
T 3uzp_A           91 LEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             HHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             HHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence            9999975432     2899999999999999999999   7999999999999999   488899999999998765543


Q ss_pred             Cee----eeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccc
Q 036435          225 GIV----SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDRE  300 (372)
Q Consensus       225 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (372)
                      ...    .......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||...........+..........   
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---  237 (296)
T 3uzp_A          163 THQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST---  237 (296)
T ss_dssp             TCCBCCCCCSCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS---
T ss_pred             cccccccccccccccccccCChhhhcCC--CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC---
Confidence            221    112344689999999999875  78999999999999999999999998754433222221111111110   


Q ss_pred             ccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccCCCC
Q 036435          301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQIP  353 (372)
Q Consensus       301 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~  353 (372)
                       ..+    .....++..+.+++.+||+.||.+|||++++++.|+.+......+
T Consensus       238 -~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~  285 (296)
T 3uzp_A          238 -PIE----VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS  285 (296)
T ss_dssp             -CHH----HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             -chH----HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence             000    001123456888999999999999999999999999887665443

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.3e-41  Score=313.99  Aligned_cols=232  Identities=21%  Similarity=0.334  Sum_probs=177.7

Q ss_pred             hhhhhcCCCCceEEEEEEec--------------------chHHHHHHHHhccCC--CceeeeEeEEecCCceeEEEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLL--------------------DDFVNEVASISRTSH--VNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~--------------------~~~~~E~~~l~~l~h--~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      .+.+.||+|+||.||++...                    +.+.+|+.++++++|  |||+++++++.+++..++|||+ 
T Consensus        12 ~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-   90 (343)
T 3dbq_A           12 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-   90 (343)
T ss_dssp             EEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-
T ss_pred             EEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-
Confidence            44678999999999998652                    257889999999986  9999999999999999999995 


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      .+|+|.+++.....      +++.++..++.|++.||+|||   +.+|+||||||+|||++ ++.+||+|||++......
T Consensus        91 ~~~~L~~~l~~~~~------~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~  160 (343)
T 3dbq_A           91 GNIDLNSWLKKKKS------IDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  160 (343)
T ss_dssp             CSEEHHHHHHHSCC------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred             CCCCHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence            58899999987543      899999999999999999999   78999999999999997 578999999999876543


Q ss_pred             CCeeeeecccccccccccccccccc---------cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHH
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRN---------FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRH  294 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  294 (372)
                      ..... .....||+.|+|||++.+.         ...++.++|||||||++|||++|+.||......      .......
T Consensus       161 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~~  233 (343)
T 3dbq_A          161 TTSVV-KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------ISKLHAI  233 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH------HHHHHHH
T ss_pred             ccccc-CCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH------HHHHHHH
Confidence            32211 2234689999999998641         136788999999999999999999999753221      1112222


Q ss_pred             hhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          295 VEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                      .........+...       ...+.+++.+||+.||.+|||+.|+++.
T Consensus       234 ~~~~~~~~~~~~~-------~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          234 IDPNHEIEFPDIP-------EKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             HCTTSCCCCCCCS-------CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hcCCcccCCcccC-------CHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            2222222223222       2457788999999999999999999863

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.3e-41  Score=312.68  Aligned_cols=246  Identities=22%  Similarity=0.364  Sum_probs=182.9

Q ss_pred             hhhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      .+.+.||+|+||.||+++...                    .+.+|+.++++++||||+++++++.+++..++||||++ 
T Consensus         5 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-   83 (324)
T 3mtl_A            5 IKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-   83 (324)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-
T ss_pred             EEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-
Confidence            345789999999999997642                    35579999999999999999999999999999999997 


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      |+|.+++.....     .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++........
T Consensus        84 ~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  155 (324)
T 3mtl_A           84 KDLKQYLDDCGN-----IINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  155 (324)
T ss_dssp             EEHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             cCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence            599999876543     2899999999999999999999   79999999999999999999999999999986543322


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                      .   .....||+.|+|||.+.+. ..++.++|||||||++|+|++|+.||.......    ....+............+.
T Consensus       156 ~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~  227 (324)
T 3mtl_A          156 T---YDNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE----QLHFIFRILGTPTEETWPG  227 (324)
T ss_dssp             ----------CGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCCCCTTTSTT
T ss_pred             c---cccccCcccccChhhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCChHhchh
Confidence            1   2234578999999998764 367999999999999999999999997643211    1111111111110001111


Q ss_pred             cC--------------C----cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhhcCcc
Q 036435          306 VV--------------T----RKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE--MLQGSTE  348 (372)
Q Consensus       306 ~~--------------~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~--~L~~~~~  348 (372)
                      ..              .    .....+...+.+++.+||+.||.+|||++|+++  .+.+...
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  290 (324)
T 3mtl_A          228 ILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE  290 (324)
T ss_dssp             GGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred             hhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence            00              0    001123456788999999999999999999997  3555443

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.1e-42  Score=321.29  Aligned_cols=262  Identities=16%  Similarity=0.191  Sum_probs=197.7

Q ss_pred             hhhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceee---------------eE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVT---------------LL  127 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~---------------l~  127 (372)
                      +.+.+.||+|+||.||+++...                      .+.+|+.++++++||||++               ++
T Consensus        44 y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~  123 (352)
T 2jii_A           44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCM  123 (352)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTSTHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCC
T ss_pred             EEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccchHHHHHHHHHHhcccchhhhhhhhccCCccCccchh
Confidence            3456789999999999997632                      4889999999999999998               67


Q ss_pred             eEEec-CCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC
Q 036435          128 GFCLE-GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDED  206 (372)
Q Consensus       128 g~~~~-~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~  206 (372)
                      +++.. ++..++||||+ +++|.+++.....    ..+++.+++.++.|++.||+|||   +.+++||||||+|||++.+
T Consensus       124 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~----~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl~~~~  195 (352)
T 2jii_A          124 GFGVHQDKYRFLVLPSL-GRSLQSALDVSPK----HVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPE  195 (352)
T ss_dssp             EEEEETTTEEEEEEECC-CEEHHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEEEETT
T ss_pred             hccccCCcEEEEEecCC-CcCHHHHHHhCCc----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEEcCC
Confidence            77776 67889999999 9999999987521    23999999999999999999999   7899999999999999998


Q ss_pred             C--ceEEeecCCcccccCCCCeee----eecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCC
Q 036435          207 F--CPKISDFGLAKLCTTKEGIVS----SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVD  280 (372)
Q Consensus       207 ~--~~kl~Dfgla~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~  280 (372)
                      +  .+||+|||+++..........    ......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||.....
T Consensus       196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~  273 (352)
T 2jii_A          196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC--GPSRRSDLQSLGYCMLKWLYGFLPWTNCLP  273 (352)
T ss_dssp             EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence            8  999999999986654322111    11234689999999999875  789999999999999999999999986432


Q ss_pred             CCCccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccCCCCCCCCCCC
Q 036435          281 SSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQIPPTPFLSS  360 (372)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~~~p~~~~  360 (372)
                      ...  .+.............+......   .......+.+++.+||+.||.+|||++++++.|+++..........+..+
T Consensus       274 ~~~--~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~dw  348 (352)
T 2jii_A          274 NTE--DIMKQKQKFVDKPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIGL  348 (352)
T ss_dssp             CHH--HHHHHHHHHHHSCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCCCC
T ss_pred             CHH--HHHHHHHhccCChhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCccccC
Confidence            211  1111111111111111100000   01124668889999999999999999999999999887765555544444


Q ss_pred             C
Q 036435          361 P  361 (372)
Q Consensus       361 ~  361 (372)
                      +
T Consensus       349 ~  349 (352)
T 2jii_A          349 P  349 (352)
T ss_dssp             C
T ss_pred             c
Confidence            3

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=7.1e-41  Score=303.38  Aligned_cols=224  Identities=24%  Similarity=0.384  Sum_probs=184.3

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      .+.+.||+|+||.||+++...                      .+.+|+.++++++||||+++++++.+++..++||||+
T Consensus        17 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   96 (284)
T 2vgo_A           17 DIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFA   96 (284)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             eeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeC
Confidence            445789999999999997632                      4778999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      ++|+|.+++.....      +++..+..++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++......
T Consensus        97 ~~~~L~~~l~~~~~------~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           97 PRGELYKELQKHGR------FDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             TTEEHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred             CCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence            99999999976532      899999999999999999999   899999999999999999999999999999765432


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                      .     .....||+.|+|||.+.+.  .++.++||||||+++|+|++|..||......       . ....+.. .....
T Consensus       168 ~-----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~-~~~~~~~-~~~~~  231 (284)
T 2vgo_A          168 R-----RRTMCGTLDYLPPEMIEGK--THDEKVDLWCAGVLCYEFLVGMPPFDSPSHT-------E-THRRIVN-VDLKF  231 (284)
T ss_dssp             C-----BCCCCSCGGGCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------H-HHHHHHT-TCCCC
T ss_pred             c-----cccccCCCCcCCHHHhccC--CCCcccchhhHHHHHHHHHHCCCCCCCCCHh-------H-HHHHHhc-cccCC
Confidence            2     1234588999999999875  7899999999999999999999999753211       1 1111111 11222


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      +.       .....+.+++.+||+.||.+|||++++++
T Consensus       232 ~~-------~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          232 PP-------FLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             CT-------TSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CC-------cCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            21       12356778999999999999999999996

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-41  Score=323.46  Aligned_cols=233  Identities=19%  Similarity=0.222  Sum_probs=184.4

Q ss_pred             hhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           87 FKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      +.+.||+|+||.||+++...                      .+.+|..++.+++||||+++++++.+++..|+||||++
T Consensus        65 ~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~  144 (412)
T 2vd5_A           65 ILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYV  144 (412)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCC
Confidence            34789999999999997632                      37789999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      +|+|.+++.+...     .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus       145 gg~L~~~l~~~~~-----~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~  216 (412)
T 2vd5_A          145 GGDLLTLLSKFGE-----RIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG  216 (412)
T ss_dssp             SCBHHHHHHHHSS-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             CCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence            9999999976431     2899999999999999999999   7999999999999999999999999999998765443


Q ss_pred             Ceeeeecccccccccccccccccc-----cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcc
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRN-----FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDR  299 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (372)
                      ...  .....||+.|+|||++.+.     ...++.++|+|||||++|||++|+.||......       ...........
T Consensus       217 ~~~--~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~~~~i~~~~~  287 (412)
T 2vd5_A          217 TVR--SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA-------ETYGKIVHYKE  287 (412)
T ss_dssp             CEE--CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTHHH
T ss_pred             ccc--cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH-------HHHHHHHhccc
Confidence            221  2335699999999998731     136789999999999999999999999754221       11111111111


Q ss_pred             cccCCccCCcchHHHHHHHHHHHHHcccCCCCCC---CCHHHHHH
Q 036435          300 EFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDR---PPMNEVIE  341 (372)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R---Ps~~evl~  341 (372)
                      ....|..    ...+...+.+++.+||+ +|.+|   |+++|+++
T Consensus       288 ~~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          288 HLSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             CcCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            2222211    12234567889999999 99998   58999986

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=5e-41  Score=318.02  Aligned_cols=232  Identities=21%  Similarity=0.331  Sum_probs=178.9

Q ss_pred             hhhhhhcCCCCceEEEEEEec--------------------chHHHHHHHHhccC--CCceeeeEeEEecCCceeEEEEe
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL--------------------DDFVNEVASISRTS--HVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~--------------------~~~~~E~~~l~~l~--h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      +.+.+.||+|+||.||++...                    +.+.+|+.++++++  ||||+++++++..++..++||| 
T Consensus        58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-  136 (390)
T 2zmd_A           58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-  136 (390)
T ss_dssp             EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred             eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence            344678999999999998652                    15789999999996  5999999999999999999999 


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      +.+++|.+++.....      +++.++..++.||+.||+|||   +.+|+||||||+|||++ ++.+||+|||+++....
T Consensus       137 ~~~~~L~~~l~~~~~------~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          137 CGNIDLNSWLKKKKS------IDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             CCSEEHHHHHHHCSS------CCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             cCCCCHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            568899999987542      889999999999999999999   89999999999999996 57899999999987654


Q ss_pred             CCCeeeeecccccccccccccccccc---------cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHH
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRN---------FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYR  293 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  293 (372)
                      ..... ......||+.|+|||++.+.         ...++.++|||||||++|||++|+.||......      ...+..
T Consensus       207 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~~~~~~  279 (390)
T 2zmd_A          207 DTTSV-VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------ISKLHA  279 (390)
T ss_dssp             --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHH
T ss_pred             CCccc-cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH------HHHHHH
Confidence            33221 12344699999999998641         125789999999999999999999999753221      111222


Q ss_pred             HhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          294 HVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ..........+...       ...+.+++.+||+.||.+|||+.|+++
T Consensus       280 ~~~~~~~~~~~~~~-------~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          280 IIDPNHEIEFPDIP-------EKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             HHCTTSCCCCCCCS-------CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HhCccccCCCCccc-------hHHHHHHHHHHcccChhhCCCHHHHhh
Confidence            22222222222221       346778999999999999999999986

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.3e-41  Score=331.97  Aligned_cols=229  Identities=25%  Similarity=0.342  Sum_probs=187.0

Q ss_pred             hhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           88 KDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      .+.||+|+||.||+++...                      .+.+|+.+|++++||||+++++++.+++..++||||+++
T Consensus       189 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~g  268 (576)
T 2acx_A          189 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG  268 (576)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCC
Confidence            4679999999999997632                      367899999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      |+|.+++......    .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus       269 g~L~~~l~~~~~~----~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~  341 (576)
T 2acx_A          269 GDLKFHIYHMGQA----GFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  341 (576)
T ss_dssp             CBHHHHHHSSSSC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred             CcHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecccCcc
Confidence            9999999875432    2899999999999999999999   78999999999999999999999999999987654332


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                      .    ....||+.|+|||++.+.  .++.++|+|||||++|||++|+.||.........    ..+...+... ....+.
T Consensus       342 ~----~~~~GT~~Y~APEvl~~~--~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~----~~i~~~i~~~-~~~~p~  410 (576)
T 2acx_A          342 I----KGRVGTVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR----EEVERLVKEV-PEEYSE  410 (576)
T ss_dssp             E----ECCCSCGGGCCHHHHTTC--EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH----HHHHHHHHHC-CCCCCT
T ss_pred             c----cccCCCccccCHHHHcCC--CCCccchHHHHHHHHHHHHhCCCCCcccccchhH----HHHHHHhhcc-cccCCc
Confidence            2    234699999999999874  7899999999999999999999999865432211    1122222211 111221


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRP-----PMNEVIE  341 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~  341 (372)
                             .+...+.+++.+||+.||.+||     +++|+++
T Consensus       411 -------~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          411 -------RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             -------TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             -------cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence                   2345677899999999999999     7888885

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.6e-42  Score=314.13  Aligned_cols=243  Identities=20%  Similarity=0.293  Sum_probs=180.9

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      .+.+.||+|+||.||+++...                     .+.+|+.++++++||||+++++++.+++..++||||++
T Consensus         6 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (311)
T 4agu_A            6 EKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCD   85 (311)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             eEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCC
Confidence            345789999999999997632                     46789999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      +++|.+++.....      +++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.......
T Consensus        86 ~~~l~~~~~~~~~------~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           86 HTVLHELDRYQRG------VPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             EEHHHHHHHTSSC------CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             CchHHHHHhhhcC------CCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            9999998875432      899999999999999999999   7899999999999999999999999999998765332


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHH-------HHHHhhh
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHW-------IYRHVEQ  297 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~~~  297 (372)
                      ..   .....||+.|+|||.+.+. ..++.++||||||+++|+|++|+.||...............       .......
T Consensus       157 ~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (311)
T 4agu_A          157 DY---YDDEVATRWYRSPELLVGD-TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST  232 (311)
T ss_dssp             ------------GGGCCHHHHHTC-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred             cc---cCCCcCCccccChHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence            22   1234588999999998764 36799999999999999999999999764321100000000       0000000


Q ss_pred             c---ccccCCc--cCCc---chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          298 D---REFKLPG--VVTR---KENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       298 ~---~~~~~~~--~~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .   .....+.  ....   ........+.+++.+||+.||.+|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0   0011111  1110   01123456888999999999999999999996

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.6e-41  Score=305.82  Aligned_cols=235  Identities=25%  Similarity=0.416  Sum_probs=188.2

Q ss_pred             HHhhhhhhcCCCCceEEEEEEec---------------chHHHHHHHHhccCCCceeeeEeEEec---------------
Q 036435           83 LTNSFKDKLGQGGFGGVYKGRLL---------------DDFVNEVASISRTSHVNVVTLLGFCLE---------------  132 (372)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~---------------~~~~~E~~~l~~l~h~nIv~l~g~~~~---------------  132 (372)
                      ..+.+.+.||+|+||.||+++..               +.+.+|++++++++||||+++++++..               
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~   90 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRS   90 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CC
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccccc
Confidence            34455678999999999999764               268899999999999999999998864               


Q ss_pred             -CCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEE
Q 036435          133 -GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKI  211 (372)
Q Consensus       133 -~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  211 (372)
                       ....++||||+++|+|.+++.....    ..+++..++.++.|++.||.|||   +.+++|+||||+||+++.++.+||
T Consensus        91 ~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl  163 (284)
T 2a19_B           91 KTKCLFIQMEFCDKGTLEQWIEKRRG----EKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKI  163 (284)
T ss_dssp             EEEEEEEEECCCCSCBHHHHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEE
T ss_pred             CcceEEEEEeccCCCCHHHHHhhccC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCEEE
Confidence             4457999999999999999976432    22899999999999999999999   789999999999999999999999


Q ss_pred             eecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHH
Q 036435          212 SDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWI  291 (372)
Q Consensus       212 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  291 (372)
                      +|||++........    .....||+.|+|||.+.+.  .++.++||||||+++|+|++|..|+...          ...
T Consensus       164 ~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~~~~~~~~----------~~~  227 (284)
T 2a19_B          164 GDFGLVTSLKNDGK----RTRSKGTLRYMSPEQISSQ--DYGKEVDLYALGLILAELLHVCDTAFET----------SKF  227 (284)
T ss_dssp             CCCTTCEESSCCSC----CCCCCSCCTTSCHHHHHCS--CCCTHHHHHHHHHHHHHHHSCCSSHHHH----------HHH
T ss_pred             Ccchhheecccccc----ccccCCcccccChhhhccC--CCcchhhhHHHHHHHHHHHhcCCcchhH----------HHH
Confidence            99999987654332    1234588999999999774  7899999999999999999998876421          001


Q ss_pred             HHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccC
Q 036435          292 YRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEAL  350 (372)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~  350 (372)
                      .......   ..+..       ....+.+++.+||+.||.+|||+.|+++.|......+
T Consensus       228 ~~~~~~~---~~~~~-------~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~  276 (284)
T 2a19_B          228 FTDLRDG---IISDI-------FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP  276 (284)
T ss_dssp             HHHHHTT---CCCTT-------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred             HHHhhcc---ccccc-------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence            1111111   11111       2345678899999999999999999999998877543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.1e-41  Score=317.61  Aligned_cols=227  Identities=28%  Similarity=0.403  Sum_probs=180.7

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      ...+.||+|+||.||+|+...                      ++.+|+.++++++||||+++++++.+++..++||||+
T Consensus        57 ~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  136 (348)
T 1u5q_A           57 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC  136 (348)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             eeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecC
Confidence            345679999999999997521                      4789999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      . |+|.+++.....     .+++.++..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++......
T Consensus       137 ~-g~l~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  207 (348)
T 1u5q_A          137 L-GSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  207 (348)
T ss_dssp             S-EEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             C-CCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence            7 688888864332     2899999999999999999999   789999999999999999999999999999865432


Q ss_pred             CCeeeeeccccccccccccccccc-ccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSR-NFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                             ....||+.|+|||.+.+ ..+.++.++|||||||++|||++|+.||.....       ......... ...  
T Consensus       208 -------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-------~~~~~~~~~-~~~--  270 (348)
T 1u5q_A          208 -------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQ-NES--  270 (348)
T ss_dssp             -------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHH-SCC--
T ss_pred             -------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHh-cCC--
Confidence                   23358999999999853 124788999999999999999999999875421       111122211 111  


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                       +....   ......+.+++.+||+.||++|||++++++.
T Consensus       271 -~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          271 -PALQS---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             -CCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             -CCCCC---CCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence             11111   1123567789999999999999999999863

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.6e-41  Score=328.78  Aligned_cols=229  Identities=26%  Similarity=0.377  Sum_probs=182.0

Q ss_pred             hhhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      +.+.+.||+|+||.||+++...                     .+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        39 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  118 (494)
T 3lij_A           39 YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECY  118 (494)
T ss_dssp             EEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             eEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecC
Confidence            4556789999999999987631                     5789999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC---CCceEEeecCCcccc
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE---DFCPKISDFGLAKLC  220 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgla~~~  220 (372)
                      ++|+|.+++.....      +++..+..++.|++.||+|||   +.+|+||||||+|||++.   ++.+||+|||++...
T Consensus       119 ~~g~L~~~~~~~~~------~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          119 KGGELFDEIIHRMK------FNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             CSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             CCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            99999998876532      899999999999999999999   789999999999999976   455999999999876


Q ss_pred             cCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccc
Q 036435          221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDRE  300 (372)
Q Consensus       221 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (372)
                      .....    .....||+.|+|||++.+   .++.++||||+||++|+|++|..||.....        ......+.....
T Consensus       190 ~~~~~----~~~~~gt~~y~aPE~l~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~~~~~  254 (494)
T 3lij_A          190 ENQKK----MKERLGTAYYIAPEVLRK---KYDEKCDVWSIGVILFILLAGYPPFGGQTD--------QEILRKVEKGKY  254 (494)
T ss_dssp             BTTBC----BCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTCC
T ss_pred             CCCcc----ccccCCCcCeeCHHHHcc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCC
Confidence            54332    123458999999999864   688999999999999999999999975422        112222222211


Q ss_pred             ccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       301 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                       ..+   ......+...+.+++.+||+.||.+|||+.++++
T Consensus       255 -~~~---~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          255 -TFD---SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             -CCC---SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -CCC---chhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence             111   1111233466788999999999999999999985

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.6e-41  Score=322.31  Aligned_cols=249  Identities=20%  Similarity=0.302  Sum_probs=192.9

Q ss_pred             hhhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecCC--ceeEEEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEGN--NRALIYEFM  143 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~--~~~lV~e~~  143 (372)
                      .+.+.||+|+||.||+|+...                    .+.+|++++++++||||+++++++.+.+  ..++||||+
T Consensus        12 ~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~   91 (396)
T 4eut_A           12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC   91 (396)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCC
T ss_pred             EEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecC
Confidence            346789999999999997642                    4679999999999999999999998765  679999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE----CCCCceEEeecCCccc
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL----DEDFCPKISDFGLAKL  219 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfgla~~  219 (372)
                      ++|+|.+++......   ..+++..++.++.|++.||+|||   +.+|+||||||+|||+    +.++.+||+|||+++.
T Consensus        92 ~~g~L~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           92 PCGSLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             TTEEHHHHTTSGGGT---TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             CCCCHHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            999999999764322   22899999999999999999999   7899999999999999    7788899999999987


Q ss_pred             ccCCCCeeeeecccccccccccccccccc------cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHH
Q 036435          220 CTTKEGIVSSLLGARGIIGYIAPEVFSRN------FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYR  293 (372)
Q Consensus       220 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  293 (372)
                      ......    .....||+.|+|||.+.+.      ...++.++|||||||++|||++|+.||..........   .....
T Consensus       166 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~---~~~~~  238 (396)
T 4eut_A          166 LEDDEQ----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK---EVMYK  238 (396)
T ss_dssp             CCCGGG----SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH---HHHHH
T ss_pred             ccCCCc----cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH---HHHHH
Confidence            644322    1234589999999998641      0256789999999999999999999997654333221   11222


Q ss_pred             Hhhhccc-------------c----cCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 036435          294 HVEQDRE-------------F----KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE  348 (372)
Q Consensus       294 ~~~~~~~-------------~----~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~  348 (372)
                      .......             .    ..+ ........+...+.+++.+||+.||++||+++++++.++.+..
T Consensus       239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          239 IITGKPSGAISGVQKAENGPIDWSGDMP-VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             HHHSCCTTCCEEEECSTTCCEEEESSCC-TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             HhcCCCcccchhheeccCCCcccCccCC-cccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            2211100             0    001 1112235667788899999999999999999999988876654

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.2e-41  Score=327.78  Aligned_cols=242  Identities=19%  Similarity=0.275  Sum_probs=187.9

Q ss_pred             hhhhhcCCCCceEEEEEEec-----------------chHHHHHHHHhccCC-CceeeeEeEEecCCceeEEEEecCCCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLL-----------------DDFVNEVASISRTSH-VNVVTLLGFCLEGNNRALIYEFMPNGS  147 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~-----------------~~~~~E~~~l~~l~h-~nIv~l~g~~~~~~~~~lV~e~~~~g~  147 (372)
                      .+.+.||+|+||.||+|+..                 .++.+|+++++.++| +++..+..++.+++..++||||+ +++
T Consensus        10 ~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~s   88 (483)
T 3sv0_A           10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPS   88 (483)
T ss_dssp             ECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred             EEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCC
Confidence            34678999999999999763                 268999999999987 55666666777788889999999 999


Q ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE---CCCCceEEeecCCcccccCCC
Q 036435          148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL---DEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       148 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      |.+++.....     .+++.+++.++.||+.||+|||   ..+|+||||||+|||+   +.++.+||+|||+++......
T Consensus        89 L~~ll~~~~~-----~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (483)
T 3sv0_A           89 LEDLFNFCSR-----KLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS  160 (483)
T ss_dssp             HHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             HHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence            9999975432     2999999999999999999999   7899999999999999   688999999999998765543


Q ss_pred             Cee----eeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccc
Q 036435          225 GIV----SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDRE  300 (372)
Q Consensus       225 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (372)
                      ...    .......||+.|+|||.+.+.  .++.++|||||||++|||++|+.||...........+...........  
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~--  236 (483)
T 3sv0_A          161 THQHIPYRENKNLTGTARYASVNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS--  236 (483)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC--
T ss_pred             cccccccccccccCCCccccCHHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc--
Confidence            221    112245689999999999875  789999999999999999999999987544321111111111111100  


Q ss_pred             ccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 036435          301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGS  346 (372)
Q Consensus       301 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~  346 (372)
                            .......+..++.+++..||+.||.+||++++|++.|+.+
T Consensus       237 ------~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          237 ------IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             ------HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             ------HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence                  0001112346788899999999999999999999988776

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=6.5e-42  Score=315.21  Aligned_cols=245  Identities=26%  Similarity=0.388  Sum_probs=183.8

Q ss_pred             hhhhhcCCCCceEEEEEEecc------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS  147 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~  147 (372)
                      .+.+.||+|+||.||+|+..+                  .+.+|+.++++++||||+++++++.+++..++|+||+++++
T Consensus        36 ~~~~~lg~G~~g~V~~~~~~~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~  115 (319)
T 2y4i_B           36 EIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRT  115 (319)
T ss_dssp             ECCCBCCCSSSSEEEEEEESSSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEE
T ss_pred             EEeeEeccCCceEEEEEEEcCeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCc
Confidence            446789999999999997532                  57789999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe-
Q 036435          148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI-  226 (372)
Q Consensus       148 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-  226 (372)
                      |.+++.....     .+++..++.++.|++.||+|||   +.+++||||||+|||++ ++.+||+|||++......... 
T Consensus       116 L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~  186 (319)
T 2y4i_B          116 LYSVVRDAKI-----VLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGR  186 (319)
T ss_dssp             HHHHTTSSCC-----CCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC---------
T ss_pred             HHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCccccccccccc
Confidence            9999976432     3889999999999999999999   78999999999999998 679999999998765322111 


Q ss_pred             -eeeecccccccccccccccccc-------cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhc
Q 036435          227 -VSSLLGARGIIGYIAPEVFSRN-------FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQD  298 (372)
Q Consensus       227 -~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (372)
                       ........||+.|+|||.+.+.       ...++.++||||||+++|||++|+.||.....        ......+...
T Consensus       187 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------~~~~~~~~~~  258 (319)
T 2y4i_B          187 REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA--------EAIIWQMGTG  258 (319)
T ss_dssp             -CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH--------HHHHHHHHTT
T ss_pred             cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHhccC
Confidence             1112234588999999998642       13578899999999999999999999975321        1112222222


Q ss_pred             ccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccCCCC
Q 036435          299 REFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQIP  353 (372)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~  353 (372)
                      .......      ......+.+++.+||+.||.+|||++++++.|+.+.......
T Consensus       259 ~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~  307 (319)
T 2y4i_B          259 MKPNLSQ------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRL  307 (319)
T ss_dssp             CCCCCCC------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-------
T ss_pred             CCCCCCc------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccC
Confidence            1111111      012345778889999999999999999999999988664433

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.6e-41  Score=326.82  Aligned_cols=176  Identities=26%  Similarity=0.407  Sum_probs=137.9

Q ss_pred             hhhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecC-----CceeE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEG-----NNRAL  138 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~-----~~~~l  138 (372)
                      +.+.+.||+|+||+||+++...                     ++.+|+.+|++++||||+++++++...     +..|+
T Consensus        55 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  134 (458)
T 3rp9_A           55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYV  134 (458)
T ss_dssp             EEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred             eEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEE
Confidence            3456789999999999996531                     578999999999999999999999543     57899


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          139 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       139 V~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      ||||+ +|+|.+++.....      +++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       135 v~e~~-~~~L~~~~~~~~~------l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          135 VLEIA-DSDFKKLFRTPVY------LTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EECCC-SEEHHHHHHSSCC------CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEecc-ccchhhhcccCCC------CCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccch
Confidence            99998 5799999976432      899999999999999999999   7899999999999999999999999999998


Q ss_pred             cccCCCCe------------------------eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcC
Q 036435          219 LCTTKEGI------------------------VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGC  271 (372)
Q Consensus       219 ~~~~~~~~------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg  271 (372)
                      ........                        ........||+.|+|||++... ..++.++|||||||++|||++|
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC-CCCCcHhHHHHHHHHHHHHHHh
Confidence            76432211                        0112334689999999986443 3789999999999999999993

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3e-41  Score=312.28  Aligned_cols=227  Identities=22%  Similarity=0.297  Sum_probs=177.6

Q ss_pred             hhhhhhcCCCCceEEEEEEec--------------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL--------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRAL  138 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~--------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~l  138 (372)
                      +.+.+.||+|+||.||+++..                          ..+.+|+.++++++||||+++++++.+++..++
T Consensus        19 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   98 (327)
T 3a62_A           19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYL   98 (327)
T ss_dssp             EEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEE
T ss_pred             eEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEE
Confidence            345678999999999998752                          136779999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          139 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       139 V~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      ||||+++|+|.+++.....      +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus        99 v~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           99 ILEYLSGGELFMQLEREGI------FMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEECCTTEEHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEeCCCCCcHHHHHHhCCC------CCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            9999999999999976432      889999999999999999999   7899999999999999999999999999997


Q ss_pred             cccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhc
Q 036435          219 LCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQD  298 (372)
Q Consensus       219 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (372)
                      .......   ......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||......       . ....+...
T Consensus       170 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~-~~~~i~~~  236 (327)
T 3a62_A          170 ESIHDGT---VTHTFCGTIEYMAPEILMRS--GHNRAVDWWSLGALMYDMLTGAPPFTGENRK-------K-TIDKILKC  236 (327)
T ss_dssp             ------------CTTSSCCTTSCHHHHTTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------H-HHHHHHHT
T ss_pred             ccccCCc---cccccCCCcCccCHhhCcCC--CCCCcccchhHHHHHHHHHHCCCCCCCCCHH-------H-HHHHHHhC
Confidence            5433221   12334689999999999774  7899999999999999999999999754211       1 11222111


Q ss_pred             ccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 036435          299 REFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRP-----PMNEVIE  341 (372)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~  341 (372)
                       ....|.       .....+.+++.+||+.||.+||     ++.++++
T Consensus       237 -~~~~p~-------~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          237 -KLNLPP-------YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             -CCCCCT-------TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             -CCCCCC-------CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence             122222       1345677899999999999999     7788876

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=5.4e-41  Score=314.47  Aligned_cols=178  Identities=28%  Similarity=0.346  Sum_probs=155.7

Q ss_pred             hhhhhhcCCCCceEEEEEEecc------------------hHHHHHHHHhccC-----CCceeeeEeEEecCCceeEEEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD------------------DFVNEVASISRTS-----HVNVVTLLGFCLEGNNRALIYE  141 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~------------------~~~~E~~~l~~l~-----h~nIv~l~g~~~~~~~~~lV~e  141 (372)
                      +.+.++||+|+||.||+++...                  .+..|+.++++++     ||||+++++++...+..++|||
T Consensus        37 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e  116 (360)
T 3llt_A           37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFE  116 (360)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEEC
T ss_pred             EEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEc
Confidence            3445789999999999997632                  4677999999996     9999999999999999999999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC----------------
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE----------------  205 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~----------------  205 (372)
                      |+ +++|.+++......    .+++..+..++.|++.||+|||   +.+|+||||||+|||++.                
T Consensus       117 ~~-~~~L~~~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~  188 (360)
T 3llt_A          117 PL-GPSLYEIITRNNYN----GFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDG  188 (360)
T ss_dssp             CC-CCBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEEEEEEECTTTC
T ss_pred             CC-CCCHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccccccccchhccccc
Confidence            99 89999999876532    2899999999999999999999   799999999999999975                


Q ss_pred             ---------CCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCC
Q 036435          206 ---------DFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLD  276 (372)
Q Consensus       206 ---------~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~  276 (372)
                               ++.+||+|||++.......      ....||+.|+|||.+.+.  .++.++|||||||++|+|++|+.||.
T Consensus       189 ~~~~~~~~~~~~~kl~DFG~a~~~~~~~------~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~  260 (360)
T 3llt_A          189 KKIQIYRTKSTGIKLIDFGCATFKSDYH------GSIINTRQYRAPEVILNL--GWDVSSDMWSFGCVLAELYTGSLLFR  260 (360)
T ss_dssp             CEEEEEEESCCCEEECCCTTCEETTSCC------CSCCSCGGGCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred             ccccccccCCCCEEEEeccCceecCCCC------cCccCcccccCcHHHcCC--CCCCccchHHHHHHHHHHHHCCCCCC
Confidence                     7899999999998654322      234589999999999875  78999999999999999999999997


Q ss_pred             CC
Q 036435          277 SG  278 (372)
Q Consensus       277 ~~  278 (372)
                      ..
T Consensus       261 ~~  262 (360)
T 3llt_A          261 TH  262 (360)
T ss_dssp             CS
T ss_pred             CC
Confidence            54

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3e-41  Score=322.51  Aligned_cols=233  Identities=20%  Similarity=0.286  Sum_probs=176.2

Q ss_pred             HhhhhhhcCCCCceEEEEEEecc---------------------------hHHHHHHHHhccCCCceeeeEeEEecCCce
Q 036435           84 TNSFKDKLGQGGFGGVYKGRLLD---------------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNR  136 (372)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~~---------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~  136 (372)
                      .+.+.+.||+|+||.||+|....                           .+.+|+.+|++++||||+++++++.. +..
T Consensus       136 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~  214 (419)
T 3i6u_A          136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDY  214 (419)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SEE
T ss_pred             cEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-Cce
Confidence            34456789999999999996532                           37889999999999999999999854 557


Q ss_pred             eEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC---CceEEee
Q 036435          137 ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDED---FCPKISD  213 (372)
Q Consensus       137 ~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~D  213 (372)
                      ++||||+++|+|.+++.....      +++..+..++.|++.||+|||   +.+++||||||+|||++.+   +.+||+|
T Consensus       215 ~lv~e~~~~g~L~~~l~~~~~------~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~D  285 (419)
T 3i6u_A          215 YIVLELMEGGELFDKVVGNKR------LKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITD  285 (419)
T ss_dssp             EEEEECCTTCBGGGGTSSSCC------CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred             EEEEEcCCCCcHHHHHhccCC------CCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEee
Confidence            999999999999999875432      899999999999999999999   7899999999999999754   4599999


Q ss_pred             cCCcccccCCCCeeeeeccccccccccccccccc-ccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHH
Q 036435          214 FGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSR-NFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIY  292 (372)
Q Consensus       214 fgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  292 (372)
                      ||+++.......    .....||+.|+|||++.+ ....++.++|||||||++|+|++|..||........       ..
T Consensus       286 FG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-------~~  354 (419)
T 3i6u_A          286 FGHSKILGETSL----MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-------LK  354 (419)
T ss_dssp             SSTTTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC-------HH
T ss_pred             cccceecCCCcc----ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH-------HH
Confidence            999987643321    123458999999999853 123678899999999999999999999976433221       11


Q ss_pred             HHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          293 RHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ..+.......    ...........+.+++.+||+.||.+|||++|+++
T Consensus       355 ~~i~~~~~~~----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          355 DQITSGKYNF----IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             HHHHTTCCCC----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHhcCCCCC----CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            2222211111    11111223567888999999999999999999986

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=6.1e-41  Score=326.54  Aligned_cols=230  Identities=26%  Similarity=0.365  Sum_probs=185.4

Q ss_pred             HhhhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEe
Q 036435           84 TNSFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      .+.+.+.||+|+||+||+++...                     .+.+|+.++++++||||+++++++.+.+..++|+||
T Consensus        23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  102 (486)
T 3mwu_A           23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL  102 (486)
T ss_dssp             HEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             ceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEc
Confidence            35567889999999999997631                     578999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC---CCCceEEeecCCccc
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLD---EDFCPKISDFGLAKL  219 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgla~~  219 (372)
                      +++|+|.+++.....      +++..+..++.|++.||.|||   +.+|+||||||+|||++   .++.+||+|||++..
T Consensus       103 ~~~~~L~~~~~~~~~------~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A          103 YTGGELFDEIIKRKR------FSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             CCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             CCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            999999999876532      899999999999999999999   79999999999999995   456799999999986


Q ss_pred             ccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcc
Q 036435          220 CTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDR  299 (372)
Q Consensus       220 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (372)
                      ......    .....||+.|+|||++.+   .++.++||||+||++|+|++|..||......        .....+....
T Consensus       174 ~~~~~~----~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~~~~  238 (486)
T 3mwu_A          174 FQQNTK----MKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--------DILKRVETGK  238 (486)
T ss_dssp             BCCC--------CCTTGGGGCCGGGGGS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTC
T ss_pred             CCCCCc----cCCCcCCCCCCCHHHhCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCC
Confidence            644322    233468999999999875   5889999999999999999999999754211        1122222211


Q ss_pred             -cccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          300 -EFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       300 -~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                       ....+     ....+...+.+++.+||+.||.+|||+.++++.
T Consensus       239 ~~~~~~-----~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          239 YAFDLP-----QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             CCSCSG-----GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             CCCCCc-----ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             11111     122345667889999999999999999999973

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=4.9e-41  Score=304.06  Aligned_cols=230  Identities=22%  Similarity=0.349  Sum_probs=182.7

Q ss_pred             hhhhhhcCCCCceEEEEEEec-------------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL-------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALI  139 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV  139 (372)
                      +.+.+.||+|+||.||+++..                         +.+.+|+.++++++||||+++++++.+++..++|
T Consensus         7 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   86 (283)
T 3bhy_A            7 YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLI   86 (283)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEE
Confidence            455678999999999999653                         1478999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC----ceEEeecC
Q 036435          140 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDF----CPKISDFG  215 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg  215 (372)
                      |||+++++|.+++....      .+++.++..++.|++.||+|||   +.+++|+||||+||+++.++    .+||+|||
T Consensus        87 ~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           87 LELVSGGELFDFLAEKE------SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EeecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            99999999999997643      2899999999999999999999   78999999999999998877    89999999


Q ss_pred             CcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHh
Q 036435          216 LAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV  295 (372)
Q Consensus       216 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  295 (372)
                      ++........    .....+|+.|+|||.+.+.  .++.++||||||+++|+|++|+.||......        .....+
T Consensus       158 ~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~  223 (283)
T 3bhy_A          158 IAHKIEAGNE----FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGETKQ--------ETLTNI  223 (283)
T ss_dssp             TCEECC------------CCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHH
T ss_pred             cceeccCCCc----ccccCCCcCccCcceecCC--CCCcchhhhhHHHHHHHHHHCCCCCCCcchH--------HHHHHh
Confidence            9986644322    1234588999999999764  7899999999999999999999999753211        111111


Q ss_pred             hhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          296 EQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ... ....+   ..........+.+++.+||+.||.+|||+.++++
T Consensus       224 ~~~-~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          224 SAV-NYDFD---EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             HTT-CCCCC---HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             Hhc-ccCCc---chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            111 11111   1111123456788999999999999999999997

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=7e-41  Score=310.80  Aligned_cols=226  Identities=27%  Similarity=0.385  Sum_probs=184.7

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      .+.+.||+|+||.||+++..+                      .+.+|+.++++++||||+++++++.+++..++||||+
T Consensus        44 ~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  123 (335)
T 2owb_A           44 VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELC  123 (335)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecC
Confidence            445789999999999987532                      4778999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      ++++|.+++.....      +++.+++.++.|++.||+|||   +.+++|+||||+|||++.++.+||+|||++......
T Consensus       124 ~~~~L~~~~~~~~~------l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          124 RRRSLLELHKRRKA------LTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             TTCBHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             CCCCHHHHHhccCC------CCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence            99999999876432      899999999999999999999   789999999999999999999999999999876433


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                      ...   .....||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||.....       .. ....+... ....
T Consensus       195 ~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~-~~~~~~~~-~~~~  260 (335)
T 2owb_A          195 GER---KKVLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCL-------KE-TYLRIKKN-EYSI  260 (335)
T ss_dssp             TCC---BCCCCSCCSSCCHHHHHTS--CBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-------HH-HHHHHHHT-CCCC
T ss_pred             ccc---ccccCCCccccCHHHhccC--CCCchhhHHHHHHHHHHHHHCcCCCCCCCH-------HH-HHHHHhcC-CCCC
Confidence            221   1234588999999999775  788999999999999999999999975321       11 11111111 1222


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      +..       ....+.+++.+||+.||++|||++|+++
T Consensus       261 ~~~-------~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          261 PKH-------INPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             CTT-------SCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             Ccc-------CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            221       2345778899999999999999999996

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-41  Score=318.17  Aligned_cols=236  Identities=24%  Similarity=0.290  Sum_probs=185.2

Q ss_pred             hhhhhhcCCCCceEEEEEEec--------------------------chHHHHHHHHhcc-CCCceeeeEeEEecCCcee
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL--------------------------DDFVNEVASISRT-SHVNVVTLLGFCLEGNNRA  137 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~--------------------------~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~  137 (372)
                      +.+.+.||+|+||.||+++..                          +.+.+|+.+++++ +||||+++++++.+++..+
T Consensus        56 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~  135 (355)
T 1vzo_A           56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH  135 (355)
T ss_dssp             EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred             eEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEE
Confidence            345678999999999998752                          1467799999999 6999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCc
Q 036435          138 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLA  217 (372)
Q Consensus       138 lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla  217 (372)
                      +||||+++|+|.+++.....      +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       136 lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          136 LILDYINGGELFTHLSQRER------FTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEECCCCSCBHHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             EEeecCCCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            99999999999999976532      899999999999999999999   789999999999999999999999999999


Q ss_pred             ccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhh
Q 036435          218 KLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQ  297 (372)
Q Consensus       218 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (372)
                      +.........  .....||+.|+|||.+.+....++.++|||||||++|||++|+.||.........   .. +......
T Consensus       207 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~---~~-~~~~~~~  280 (355)
T 1vzo_A          207 KEFVADETER--AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ---AE-ISRRILK  280 (355)
T ss_dssp             EECCGGGGGG--GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH---HH-HHHHHHH
T ss_pred             eecccCCCCc--ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH---HH-HHHHHhc
Confidence            8654322211  1234589999999999764335789999999999999999999999765433211   11 1111111


Q ss_pred             cccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHh
Q 036435          298 DREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRP-----PMNEVIEML  343 (372)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~~L  343 (372)
                      . ....+       .+....+.+++.+||+.||.+||     +++|+++..
T Consensus       281 ~-~~~~~-------~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          281 S-EPPYP-------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             C-CCCCC-------TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             c-CCCCC-------cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence            1 11112       12345677899999999999999     999998753

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.2e-40  Score=303.46  Aligned_cols=226  Identities=27%  Similarity=0.386  Sum_probs=184.5

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      .+.+.||+|+||.||+++..+                      .+.+|+.++++++||||+++++++.+++..++||||+
T Consensus        18 ~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   97 (294)
T 2rku_A           18 VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELC   97 (294)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecC
Confidence            345789999999999987632                      4778999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      ++++|.+++.....      +++.++..++.|+++||+|||   +.+++|+||||+||+++.++.+||+|||++......
T Consensus        98 ~~~~L~~~~~~~~~------~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A           98 RRRSLLELHKRRKA------LTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  168 (294)
T ss_dssp             TTCBHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             CCCCHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence            99999999876432      899999999999999999999   789999999999999999999999999999876433


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                      ...   .....||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||......       . ....+.. .....
T Consensus       169 ~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~-~~~~~~~-~~~~~  234 (294)
T 2rku_A          169 GER---KKVLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-------E-TYLRIKK-NEYSI  234 (294)
T ss_dssp             TCC---BCCCCSCCSSCCHHHHTTS--CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------H-HHHHHHT-TCCCC
T ss_pred             ccc---cccccCCCCcCCcchhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------H-HHHHHhh-ccCCC
Confidence            221   1234588999999999764  7889999999999999999999999753211       1 1111111 11222


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      +.       .....+.+++.+||+.||++|||++++++
T Consensus       235 ~~-------~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          235 PK-------HINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             CT-------TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             cc-------ccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            22       12346778899999999999999999997

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=4.1e-41  Score=309.70  Aligned_cols=247  Identities=23%  Similarity=0.358  Sum_probs=185.2

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEe----cCCceeEEEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCL----EGNNRALIYE  141 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~----~~~~~~lV~e  141 (372)
                      +.+.+.||+|+||.||+++...                   .+.+|+.++++++||||+++++++.    .....++|+|
T Consensus        31 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e  110 (317)
T 2buj_A           31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLP  110 (317)
T ss_dssp             EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEE
T ss_pred             EEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEE
Confidence            4456789999999999997521                   5789999999999999999999997    3447899999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      |+++|+|.+++......  ...+++.+++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++....
T Consensus       111 ~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~  185 (317)
T 2buj_A          111 FFKRGTLWNEIERLKDK--GNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC  185 (317)
T ss_dssp             CCTTCBHHHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred             eCCCCcHHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence            99999999999763211  123899999999999999999999   7899999999999999999999999999987543


Q ss_pred             CCCCee------eeecccccccccccccccccc-cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHH
Q 036435          222 TKEGIV------SSLLGARGIIGYIAPEVFSRN-FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRH  294 (372)
Q Consensus       222 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  294 (372)
                      ......      .......||+.|+|||.+.+. ...++.++||||||+++|+|++|+.||.........      ....
T Consensus       186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~  259 (317)
T 2buj_A          186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS------VALA  259 (317)
T ss_dssp             EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC------HHHH
T ss_pred             cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch------hhHH
Confidence            211000      001123468999999998653 123688999999999999999999998642111110      1111


Q ss_pred             hhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 036435          295 VEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~  349 (372)
                      ....  ...+.     .......+.+++.+||+.||.+|||++++++.|+.+..+
T Consensus       260 ~~~~--~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  307 (317)
T 2buj_A          260 VQNQ--LSIPQ-----SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP  307 (317)
T ss_dssp             HHCC----CCC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred             hhcc--CCCCc-----cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence            1111  11111     112345688899999999999999999999999987643

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=5.2e-41  Score=310.66  Aligned_cols=229  Identities=21%  Similarity=0.326  Sum_probs=180.2

Q ss_pred             hhcCCCCceEEEEEEecc---------------------hHHHHHHHHhcc-CCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           89 DKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      +.||+|+||.||+++...                     .+.+|+.++.++ +||||+++++++.+++..++||||+++|
T Consensus        35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~  114 (327)
T 3lm5_A           35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG  114 (327)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred             ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCC
Confidence            679999999999996532                     578899999999 5699999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC---CCceEEeecCCcccccCC
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE---DFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgla~~~~~~  223 (372)
                      +|.+++.....    ..+++.+++.++.|++.||+|||   +.+++||||||+|||++.   ++.+||+|||++......
T Consensus       115 ~L~~~~~~~~~----~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~  187 (327)
T 3lm5_A          115 EIFSLCLPELA----EMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA  187 (327)
T ss_dssp             EGGGGGSSCC-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred             cHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence            99999865432    23899999999999999999999   789999999999999987   789999999999876433


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                      ..    .....||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||......       . ....+.... ...
T Consensus       188 ~~----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~-~~~~i~~~~-~~~  252 (327)
T 3lm5_A          188 CE----LREIMGTPEYLAPEILNYD--PITTATDMWNIGIIAYMLLTHTSPFVGEDNQ-------E-TYLNISQVN-VDY  252 (327)
T ss_dssp             ----------CCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------H-HHHHHHHTC-CCC
T ss_pred             cc----cccccCCcCccCCeeecCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCch-------H-HHHHHHhcc-ccc
Confidence            22    1234589999999999764  7899999999999999999999999753221       1 111111111 111


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                      +.   .........+.+++.+||+.||.+|||++++++.
T Consensus       253 ~~---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          253 SE---ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             CT---TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             Cc---hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            11   1112234567789999999999999999999863

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.7e-41  Score=318.95  Aligned_cols=224  Identities=22%  Similarity=0.271  Sum_probs=175.3

Q ss_pred             hhhhhhcCCCCceEEEEEEecc----------------------hHHHHHHH-HhccCCCceeeeEeEEecCCceeEEEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVAS-ISRTSHVNVVTLLGFCLEGNNRALIYE  141 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~-l~~l~h~nIv~l~g~~~~~~~~~lV~e  141 (372)
                      +.+.+.||+|+||.||+++...                      .+.+|..+ ++.++||||+++++++.+.+..|+|||
T Consensus        40 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E  119 (373)
T 2r5t_A           40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLD  119 (373)
T ss_dssp             EEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEe
Confidence            3456789999999999997632                      34556665 567899999999999999999999999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      |+++|+|.+++.+...      +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       120 ~~~gg~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          120 YINGGELFYHLQRERC------FLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             CCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             CCCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            9999999999976432      889999999999999999999   7999999999999999999999999999998643


Q ss_pred             CCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccc
Q 036435          222 TKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF  301 (372)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (372)
                      ....   ......||+.|+|||++.+.  .++.++|+|||||++|||++|..||.....        ......+... ..
T Consensus       191 ~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~-~~  256 (373)
T 2r5t_A          191 EHNS---TTSTFCGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--------AEMYDNILNK-PL  256 (373)
T ss_dssp             CCCC---CCCSBSCCCCCCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCSBH--------HHHHHHHHHS-CC
T ss_pred             cCCC---ccccccCCccccCHHHhCCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhc-cc
Confidence            3221   12345689999999999875  789999999999999999999999975321        1122222221 12


Q ss_pred             cCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 036435          302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNE  338 (372)
Q Consensus       302 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  338 (372)
                      ..+..       +...+.+++.+||+.||.+||++.+
T Consensus       257 ~~~~~-------~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          257 QLKPN-------ITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             CCCSS-------SCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             CCCCC-------CCHHHHHHHHHHcccCHHhCCCCCC
Confidence            22221       2356778899999999999999853

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=5.8e-41  Score=336.82  Aligned_cols=235  Identities=23%  Similarity=0.379  Sum_probs=186.7

Q ss_pred             hhhhhhcCCCCceEEEEEEec-----------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL-----------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYE  141 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-----------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  141 (372)
                      +.+.+.||+|+||.||+|++.                       +.+.+|+.++++++||||+++++++. ++..++|||
T Consensus       392 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E  470 (656)
T 2j0j_A          392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIME  470 (656)
T ss_dssp             EEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             EEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEE
Confidence            344578999999999999752                       25788999999999999999999985 457899999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      |+++|+|.+++.....     .+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++...
T Consensus       471 ~~~~g~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          471 LCTLGELRSFLQVRKF-----SLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  542 (656)
T ss_dssp             CCTTCBHHHHHHHTTT-----TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred             cCCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence            9999999999976532     2899999999999999999999   7899999999999999999999999999998765


Q ss_pred             CCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhccc
Q 036435          222 TKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDRE  300 (372)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (372)
                      ......  .....+|+.|+|||.+.+.  .++.++||||||+++|||++ |..||......        .....+.....
T Consensus       543 ~~~~~~--~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--------~~~~~i~~~~~  610 (656)
T 2j0j_A          543 DSTYYK--ASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--------DVIGRIENGER  610 (656)
T ss_dssp             C------------CCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHHTCC
T ss_pred             CCccee--ccCCCCCcceeCHHHhcCC--CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHHcCCC
Confidence            433221  1233467889999999764  78999999999999999997 88888753211        12223333333


Q ss_pred             ccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       301 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                      ...+.       .+...+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       611 ~~~~~-------~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il  650 (656)
T 2j0j_A          611 LPMPP-------NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  650 (656)
T ss_dssp             CCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCc-------cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            32332       23456788999999999999999999999998764

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.6e-41  Score=313.12  Aligned_cols=244  Identities=20%  Similarity=0.284  Sum_probs=170.5

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccC-CCceeeeEeEEe--------cCCce
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTS-HVNVVTLLGFCL--------EGNNR  136 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~-h~nIv~l~g~~~--------~~~~~  136 (372)
                      +.+.+.||+|+||.||+++...                   .+.+|+.++.++. ||||+++++++.        .....
T Consensus        30 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~  109 (337)
T 3ll6_A           30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEF  109 (337)
T ss_dssp             EEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEE
T ss_pred             EEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceE
Confidence            4456789999999999998632                   5788999999996 999999999994        33457


Q ss_pred             eEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCceEECCCCceEEeec
Q 036435          137 ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTK--ILHFDIKPHNILLDEDFCPKISDF  214 (372)
Q Consensus       137 ~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl~Df  214 (372)
                      ++|+||+. |+|.+++......   ..+++.+++.++.|++.||+|||   +.+  ++||||||+|||++.++.+||+||
T Consensus       110 ~lv~e~~~-g~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Df  182 (337)
T 3ll6_A          110 LLLTELCK-GQLVEFLKKMESR---GPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDF  182 (337)
T ss_dssp             EEEEECCS-EEHHHHHHHHHTT---CSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred             EEEEEecC-CCHHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecC
Confidence            89999995 7999998652211   12899999999999999999999   777  999999999999999999999999


Q ss_pred             CCcccccCCCCeee---------eeccccccccccccccccc-ccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCc
Q 036435          215 GLAKLCTTKEGIVS---------SLLGARGIIGYIAPEVFSR-NFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE  284 (372)
Q Consensus       215 gla~~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~  284 (372)
                      |++...........         ......||+.|+|||.+.. ....++.++||||||+++|+|++|+.||.......  
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--  260 (337)
T 3ll6_A          183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR--  260 (337)
T ss_dssp             TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH--
Confidence            99987654332110         1113358899999999832 11367899999999999999999999997543211  


Q ss_pred             cchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccCCCC
Q 036435          285 VYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQIP  353 (372)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~  353 (372)
                               ..........+...       ...+.+++.+||+.||.+|||++|+++.|+.+.......
T Consensus       261 ---------~~~~~~~~~~~~~~-------~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~  313 (337)
T 3ll6_A          261 ---------IVNGKYSIPPHDTQ-------YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN  313 (337)
T ss_dssp             --------------CCCCTTCCS-------SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred             ---------hhcCcccCCccccc-------chHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCC
Confidence                     11111111111111       234667889999999999999999999998887654433

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.5e-40  Score=318.93  Aligned_cols=180  Identities=23%  Similarity=0.373  Sum_probs=148.1

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecC-----CceeEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEG-----NNRALI  139 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~-----~~~~lV  139 (372)
                      .+.+.||+|+||.||+++...                     .+.+|+.+|++++||||+++++++...     +..|+|
T Consensus        29 ~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv  108 (432)
T 3n9x_A           29 IIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIV  108 (432)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEE
T ss_pred             EEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEE
Confidence            446789999999999997532                     578999999999999999999999876     578999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccc
Q 036435          140 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL  219 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  219 (372)
                      |||+. |+|.+++.....      +++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       109 ~e~~~-~~L~~~~~~~~~------l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          109 LEIAD-SDLKKLFKTPIF------LTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             EECCS-EEHHHHHHSSCC------CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EecCC-cCHHHHHhccCC------CCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence            99996 699999976432      899999999999999999999   78999999999999999999999999999987


Q ss_pred             ccCCCCee-------------------eeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCC
Q 036435          220 CTTKEGIV-------------------SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLD  276 (372)
Q Consensus       220 ~~~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~  276 (372)
                      ........                   .......||+.|+|||++... ..++.++||||+||++|||++|..|+.
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC-CCCCcccccchHHHHHHHHHhcccccc
Confidence            65432110                   112345689999999986443 378999999999999999998655543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=8.9e-41  Score=311.99  Aligned_cols=243  Identities=21%  Similarity=0.299  Sum_probs=182.3

Q ss_pred             hhhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecC--------Cc
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEG--------NN  135 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~--------~~  135 (372)
                      +.+.+.||+|+||.||+++...                     .+.+|+.++++++||||+++++++.+.        +.
T Consensus        19 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   98 (351)
T 3mi9_A           19 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS   98 (351)
T ss_dssp             EEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CE
T ss_pred             eeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCce
Confidence            3456789999999999997632                     578999999999999999999999873        46


Q ss_pred             eeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecC
Q 036435          136 RALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFG  215 (372)
Q Consensus       136 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  215 (372)
                      .++||||+++ +|.+.+.....     .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||
T Consensus        99 ~~lv~e~~~~-~l~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           99 IYLVFDFCEH-DLAGLLSNVLV-----KFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             EEEEEECCSE-EHHHHHHCTTS-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEeccCC-CHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccch
Confidence            8999999975 88888766432     2899999999999999999999   7899999999999999999999999999


Q ss_pred             CcccccCCCCe-eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHH
Q 036435          216 LAKLCTTKEGI-VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRH  294 (372)
Q Consensus       216 la~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  294 (372)
                      ++......... ........||+.|+|||.+.+. ..++.++|||||||++|||++|+.||.......    ....+...
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~~i~~~  244 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH----QLALISQL  244 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHH
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCC-CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHH
Confidence            99876532211 1122344689999999998764 367999999999999999999999997542211    00111111


Q ss_pred             hhhccc--------------ccCCccCCcchHH------HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          295 VEQDRE--------------FKLPGVVTRKENE------IAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       295 ~~~~~~--------------~~~~~~~~~~~~~------~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ......              ............+      ....+.+++.+||+.||++|||++|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             HCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            100000              0000000011111      1245788999999999999999999997

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-40  Score=310.32  Aligned_cols=241  Identities=26%  Similarity=0.331  Sum_probs=184.0

Q ss_pred             hhhhhhcCCCCceEEEEEEecc------------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD------------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIY  140 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~  140 (372)
                      +.+.+.||+|+||.||+++...                        .+.+|+.++++++||||+++++++.+++..++||
T Consensus        12 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   91 (346)
T 1ua2_A           12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVF   91 (346)
T ss_dssp             -CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEE
T ss_pred             cEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEE
Confidence            3445789999999999996531                        4678999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccc
Q 036435          141 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC  220 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~  220 (372)
                      ||+++ +|.+++.....     .+++..+..++.|+++||+|||   +.+++||||||+|||++.++.+||+|||++...
T Consensus        92 e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           92 DFMET-DLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSF  162 (346)
T ss_dssp             ECCSE-EHHHHHTTCCS-----SCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             EcCCC-CHHHHHHhcCc-----CCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence            99975 89988876432     2888999999999999999999   799999999999999999999999999999876


Q ss_pred             cCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccc
Q 036435          221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDRE  300 (372)
Q Consensus       221 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (372)
                      ......   .....||+.|+|||.+.+. ..++.++|||||||++|||++|.+||.......    ....+.........
T Consensus       163 ~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~----~~~~i~~~~~~~~~  234 (346)
T 1ua2_A          163 GSPNRA---YTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD----QLTRIFETLGTPTE  234 (346)
T ss_dssp             TSCCCC---CCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHHCCCCT
T ss_pred             cCCccc---CCcccccccccCchHhhCC-CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH----HHHHHHHHcCCCCh
Confidence            443221   2234589999999998754 357899999999999999999999987542211    00111111110000


Q ss_pred             ccCCccC-----------Cc-----chHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          301 FKLPGVV-----------TR-----KENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       301 ~~~~~~~-----------~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                      ...+...           ..     ........+.+++.+||+.||.+|||++|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            0001000           00     002234678889999999999999999999974

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1e-40  Score=326.46  Aligned_cols=231  Identities=23%  Similarity=0.345  Sum_probs=185.4

Q ss_pred             hhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           89 DKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      +.||+|+||.||+++...                      .+.+|+.++++++||||+++++++.+.+..|+||||+++|
T Consensus       191 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg  270 (543)
T 3c4z_A          191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGG  270 (543)
T ss_dssp             EEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred             EEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCC
Confidence            469999999999997632                      4678999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      +|.+++.......  ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++........
T Consensus       271 ~L~~~l~~~~~~~--~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~  345 (543)
T 3c4z_A          271 DIRYHIYNVDEDN--PGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK  345 (543)
T ss_dssp             BHHHHHHTSSTTS--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC
T ss_pred             CHHHHHHHhhccc--ccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc
Confidence            9999997654211  23899999999999999999999   799999999999999999999999999999876543322


Q ss_pred             eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCcc
Q 036435          227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV  306 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (372)
                         .....||+.|+|||++.+.  .++.++|+|||||++|||++|+.||.........    ..+...+... ....|. 
T Consensus       346 ---~~~~~GT~~Y~APE~l~~~--~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~----~~~~~~i~~~-~~~~p~-  414 (543)
T 3c4z_A          346 ---TKGYAGTPGFMAPELLLGE--EYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN----KELKQRVLEQ-AVTYPD-  414 (543)
T ss_dssp             ---BCCCCSCTTTSCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH----HHHHHHHHHC-CCCCCT-
T ss_pred             ---cccccCCccccChhhhcCC--CCChHHhcCcchHHHHHHHhCCCCCCCCccchhH----HHHHHHHhhc-ccCCCc-
Confidence               1234699999999999875  7899999999999999999999999865432211    1122222111 112222 


Q ss_pred             CCcchHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 036435          307 VTRKENEIAKKMIIVGLWCIQARPSDRPPM-----NEVIE  341 (372)
Q Consensus       307 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~-----~evl~  341 (372)
                            .+...+.+++.+||+.||.+||++     +++++
T Consensus       415 ------~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          415 ------KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             ------TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             ------ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence                  234567788999999999999975     66664

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=5.7e-41  Score=324.30  Aligned_cols=239  Identities=23%  Similarity=0.255  Sum_probs=174.4

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCC------ceeE
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGN------NRAL  138 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~------~~~l  138 (372)
                      .+.+.||+|+||.||++....                     ++.+|+.++++++||||+++++++...+      ..++
T Consensus        65 ~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~l  144 (464)
T 3ttj_A           65 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL  144 (464)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEE
T ss_pred             EEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEE
Confidence            345789999999999996532                     5778999999999999999999997653      4699


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          139 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       139 V~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      ||||+++ +|.+.+...        +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       145 v~E~~~~-~l~~~~~~~--------l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~  212 (464)
T 3ttj_A          145 VMELMDA-NLCQVIQME--------LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (464)
T ss_dssp             EEECCSE-EHHHHHTSC--------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred             EEeCCCC-CHHHHHhhc--------CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence            9999975 577766431        889999999999999999999   7899999999999999999999999999998


Q ss_pred             cccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccch--------HH-
Q 036435          219 LCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYF--------PH-  289 (372)
Q Consensus       219 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~--------~~-  289 (372)
                      .......    .....||+.|+|||++.+.  .++.++||||+||++|||++|+.||...........+        +. 
T Consensus       213 ~~~~~~~----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~  286 (464)
T 3ttj_A          213 TAGTSFM----MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  286 (464)
T ss_dssp             ----CCC----C----CCCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             ecCCCcc----cCCCcccccccCHHHHcCC--CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            6644321    1234689999999999875  7899999999999999999999999754311000000        00 


Q ss_pred             ------HHHHHhhhccc---cc----CCcc----CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          290 ------WIYRHVEQDRE---FK----LPGV----VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       290 ------~~~~~~~~~~~---~~----~~~~----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                            ...........   ..    .+..    ...........+.+++.+||+.||++|||++|+++.
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                  00000000000   00    0000    011112235678899999999999999999999963

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.5e-40  Score=304.07  Aligned_cols=227  Identities=28%  Similarity=0.390  Sum_probs=184.9

Q ss_pred             hhhhhcCCCCceEEEEEEec--------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLL--------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~--------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      ...+.||+|+||.||+|+..                    +.+.+|+.++++++||||+++++++.+++..++||||+++
T Consensus        25 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  104 (303)
T 3a7i_A           25 TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGG  104 (303)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             HHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCC
Confidence            34578999999999999653                    2578999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      ++|.+++...       .+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++........
T Consensus       105 ~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~  174 (303)
T 3a7i_A          105 GSALDLLEPG-------PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  174 (303)
T ss_dssp             EEHHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred             CcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence            9999999653       2899999999999999999999   78999999999999999999999999999987654332


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                      .   .....||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||.....        ......+........+.
T Consensus       175 ~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~  241 (303)
T 3a7i_A          175 K---RNTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIELARGEPPHSELHP--------MKVLFLIPKNNPPTLEG  241 (303)
T ss_dssp             C---BCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHSCCCCCCS
T ss_pred             c---cCccCCCcCccCHHHHhcC--CCCchhhhHHHHHHHHHHccCCCCCCCcCH--------HHHHHHhhcCCCCCCcc
Confidence            1   1334588999999999764  788999999999999999999999865321        11112222221111111


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                             .....+.+++.+||+.||.+|||++++++.
T Consensus       242 -------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          242 -------NYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             -------SCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             -------ccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                   123567789999999999999999999863

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=8.4e-41  Score=305.93  Aligned_cols=229  Identities=22%  Similarity=0.360  Sum_probs=185.0

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      +.+.+.||+|+||.||+++...                   .+.+|+.++++++||||+++++++.+++..++||||+++
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   90 (304)
T 2jam_A           11 FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSG   90 (304)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             ceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCC
Confidence            4456789999999999987531                   478999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE---CCCCceEEeecCCcccccC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL---DEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgla~~~~~  222 (372)
                      ++|.+++.....      +++..+..++.|++.||+|||   +.+++|+||||+||++   +.++.+||+|||++.....
T Consensus        91 ~~L~~~l~~~~~------~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           91 GELFDRILERGV------YTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             CBHHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred             ccHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence            999999876432      899999999999999999999   7899999999999999   7889999999999975433


Q ss_pred             CCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      ..     .....||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||.....        ......+.... ..
T Consensus       162 ~~-----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~i~~~~-~~  225 (304)
T 2jam_A          162 GI-----MSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVITYILLCGYPPFYEETE--------SKLFEKIKEGY-YE  225 (304)
T ss_dssp             BT-----THHHHSCCCBCCTTTBSSC--SCCHHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHCC-CC
T ss_pred             Cc-----cccccCCCCccChHHhccC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHcCC-CC
Confidence            21     1223588999999999764  789999999999999999999999975321        11222222221 11


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .+.   .....+...+.+++.+||+.||.+|||++++++
T Consensus       226 ~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          226 FES---PFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             CCT---TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCc---cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            111   111223466788999999999999999999986

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2e-40  Score=311.29  Aligned_cols=236  Identities=14%  Similarity=0.125  Sum_probs=183.9

Q ss_pred             hhhhhcCCCCceEEEEEEec---------------------chHHHHHHHHhccC---CCceeeeEeEEecCCceeEEEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLL---------------------DDFVNEVASISRTS---HVNVVTLLGFCLEGNNRALIYE  141 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~---------------------~~~~~E~~~l~~l~---h~nIv~l~g~~~~~~~~~lV~e  141 (372)
                      .+.+.||+|+||.||+|...                     .++.+|+.++.+++   |+||+++++++..++..++|||
T Consensus        68 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e  147 (365)
T 3e7e_A           68 YVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGE  147 (365)
T ss_dssp             EEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEEC
T ss_pred             EEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEe
Confidence            34567999999999999421                     15788888888886   9999999999999999999999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC-----------CCceE
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE-----------DFCPK  210 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~-----------~~~~k  210 (372)
                      |+++|+|.+++...... ....+++..++.++.|++.||+|||   +.+|+||||||+|||++.           ++.+|
T Consensus       148 ~~~~g~L~~~l~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~k  223 (365)
T 3e7e_A          148 LYSYGTLLNAINLYKNT-PEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLA  223 (365)
T ss_dssp             CCCSCBHHHHHHHHHTS-TTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC------CTTEE
T ss_pred             ccCCCcHHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccccccccCCEE
Confidence            99999999999753211 1123999999999999999999999   899999999999999998           89999


Q ss_pred             EeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHH
Q 036435          211 ISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHW  290 (372)
Q Consensus       211 l~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~  290 (372)
                      |+|||+++......... ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||.........      
T Consensus       224 l~DFG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~------  294 (365)
T 3e7e_A          224 LIDLGQSIDMKLFPKGT-IFTAKCETSGFQCVEMLSNK--PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK------  294 (365)
T ss_dssp             ECCCTTCEEGGGSCTTE-EECCSSCTTSCCCHHHHTTC--CBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE------
T ss_pred             EeeCchhhhhhccCCCc-eeeeecCCCCCCChHHhcCC--CCCccccHHHHHHHHHHHHhCCCccccCCCCcee------
Confidence            99999997654322211 22445699999999999875  6899999999999999999999998643221100      


Q ss_pred             HHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCC-CCHHHHHHHhhcCcc
Q 036435          291 IYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDR-PPMNEVIEMLQGSTE  348 (372)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R-Ps~~evl~~L~~~~~  348 (372)
                              ........   .   ....+.+++..|++.+|.+| |+++++.+.|++...
T Consensus       295 --------~~~~~~~~---~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~  339 (365)
T 3e7e_A          295 --------PEGLFRRL---P---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ  339 (365)
T ss_dssp             --------ECSCCTTC---S---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred             --------echhcccc---C---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence                    00000000   1   13445567788999999999 578888887776553

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.8e-41  Score=312.67  Aligned_cols=236  Identities=21%  Similarity=0.308  Sum_probs=176.9

Q ss_pred             hhhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      +.+.+.||+|+||.||+++...                     .+.+|+.++++++||||+++++++.+++..++||||+
T Consensus        36 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  115 (329)
T 3gbz_A           36 YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA  115 (329)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecC
Confidence            3445789999999999996531                     4678999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE-----CCCCceEEeecCCcc
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL-----DEDFCPKISDFGLAK  218 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill-----~~~~~~kl~Dfgla~  218 (372)
                      + |+|.+++.....      +++..+..++.|++.||+|||   +.+|+||||||+|||+     +.++.+||+|||++.
T Consensus       116 ~-~~L~~~~~~~~~------~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~  185 (329)
T 3gbz_A          116 E-NDLKKYMDKNPD------VSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR  185 (329)
T ss_dssp             S-EEHHHHHHHCTT------CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred             C-CCHHHHHhhcCC------CCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence            7 599999987643      899999999999999999999   7899999999999999     455569999999998


Q ss_pred             cccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhc
Q 036435          219 LCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQD  298 (372)
Q Consensus       219 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (372)
                      ........   .....+|+.|+|||.+.+. ..++.++|||||||++|||++|+.||.......       .........
T Consensus       186 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------~~~~~~~~~  254 (329)
T 3gbz_A          186 AFGIPIRQ---FTHEIITLWYRPPEILLGS-RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID-------QLFKIFEVL  254 (329)
T ss_dssp             HHC--------------CCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHHH
T ss_pred             ccCCcccc---cCCCcCCccccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH-------HHHHHHHHh
Confidence            76433221   1233578999999999764 357999999999999999999999997542211       111111110


Q ss_pred             cc----------------ccCCccCCcchHH-----HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          299 RE----------------FKLPGVVTRKENE-----IAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       299 ~~----------------~~~~~~~~~~~~~-----~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ..                ...+.........     ....+.+++.+||+.||.+|||++|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          255 GLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             CCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            00                0001111111111     2356788999999999999999999986

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.6e-40  Score=316.36  Aligned_cols=249  Identities=21%  Similarity=0.276  Sum_probs=167.9

Q ss_pred             hhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEec--CCceeEEEEecCCCC
Q 036435           89 DKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLE--GNNRALIYEFMPNGS  147 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~--~~~~~lV~e~~~~g~  147 (372)
                      ++||+|+||.||+++..+                   .+.+|+.+|++++||||+++++++.+  +...++||||+. |+
T Consensus        27 ~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~  105 (405)
T 3rgf_A           27 CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HD  105 (405)
T ss_dssp             CCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EE
T ss_pred             cEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CC
Confidence            579999999999998541                   58899999999999999999999954  678899999996 58


Q ss_pred             hhhhhhcCCC---CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE----CCCCceEEeecCCcccc
Q 036435          148 LEKFVYNGDT---SKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL----DEDFCPKISDFGLAKLC  220 (372)
Q Consensus       148 L~~~l~~~~~---~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfgla~~~  220 (372)
                      |.+++.....   ......+++..+..++.|++.||+|||   +.+|+||||||+|||+    +.++.+||+|||+++..
T Consensus       106 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~  182 (405)
T 3rgf_A          106 LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF  182 (405)
T ss_dssp             HHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC--
T ss_pred             HHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceec
Confidence            8888753211   111123899999999999999999999   7999999999999999    67889999999999876


Q ss_pred             cCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCC--ccchHHHHHHHhhhc
Q 036435          221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSS--EVYFPHWIYRHVEQD  298 (372)
Q Consensus       221 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~  298 (372)
                      ..............||+.|+|||++.+. ..++.++|||||||++|||++|+.||........  .......+.......
T Consensus       183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~  261 (405)
T 3rgf_A          183 NSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM  261 (405)
T ss_dssp             --------------CCCTTCCHHHHTTC-CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHH
T ss_pred             CCCCcccccCCCceecCcccCchhhcCC-CcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhh
Confidence            5433222223445689999999998764 3589999999999999999999999976543210  000011111111100


Q ss_pred             cc---ccCCcc------------------CCcchHH--------HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          299 RE---FKLPGV------------------VTRKENE--------IAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       299 ~~---~~~~~~------------------~~~~~~~--------~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                      ..   ..++..                  .......        ....+.+++.+||+.||.+|||++|+++.
T Consensus       262 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h  334 (405)
T 3rgf_A          262 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  334 (405)
T ss_dssp             CCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            00   000000                  0000000        03457789999999999999999999973

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2e-41  Score=306.08  Aligned_cols=235  Identities=22%  Similarity=0.351  Sum_probs=183.4

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEec--CCceeEEEEe
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLE--GNNRALIYEF  142 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~--~~~~~lV~e~  142 (372)
                      .+.+.||+|+||.||+++...                     .+.+|+.++++++||||+++++++.+  ++..++||||
T Consensus         9 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~   88 (279)
T 2w5a_A            9 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY   88 (279)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEEC
T ss_pred             eeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeC
Confidence            345789999999999997632                     47889999999999999999998854  5688999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----eeecCCCCCceEECCCCceEEeecCCc
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTK-----ILHFDIKPHNILLDEDFCPKISDFGLA  217 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~-----ivH~dlk~~Nill~~~~~~kl~Dfgla  217 (372)
                      +++|+|.+++......  ...+++..++.++.|++.||+|||   +.+     ++|+||||+||+++.++.+||+|||++
T Consensus        89 ~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~  163 (279)
T 2w5a_A           89 CEGGDLASVITKGTKE--RQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  163 (279)
T ss_dssp             CTTEEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred             CCCCCHHHHHHhhccc--CCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence            9999999999764321  123899999999999999999999   566     999999999999999999999999999


Q ss_pred             ccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhh
Q 036435          218 KLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQ  297 (372)
Q Consensus       218 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (372)
                      .........   .....||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||.....        ......+..
T Consensus       164 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~i~~  230 (279)
T 2w5a_A          164 RILNHDTSF---AKTFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------KELAGKIRE  230 (279)
T ss_dssp             HHC---CHH---HHHHHSCCTTCCHHHHHCC---CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHH
T ss_pred             eeecccccc---ccccCCCccccChHHhccC--CCCchhhHHHHHHHHHHHHHCCCCCcccCH--------HHHHHHHhh
Confidence            865433211   1223578899999999774  789999999999999999999999875421        112222222


Q ss_pred             cccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 036435          298 DREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG  345 (372)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~  345 (372)
                      ......+.       .....+.+++.+||+.||.+|||++|+++.+..
T Consensus       231 ~~~~~~~~-------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          231 GKFRRIPY-------RYSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             TCCCCCCT-------TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             cccccCCc-------ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence            22212221       234567889999999999999999999986654

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=4.9e-41  Score=327.13  Aligned_cols=229  Identities=24%  Similarity=0.352  Sum_probs=186.8

Q ss_pred             HhhhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEE
Q 036435           84 TNSFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYE  141 (372)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  141 (372)
                      .+.+.+.||+|+||.||+++...                      .+.+|+.++++++||||+++++++.+.+..++|+|
T Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  106 (484)
T 3nyv_A           27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGE  106 (484)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence            34556789999999999987631                      47899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE---CCCCceEEeecCCcc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL---DEDFCPKISDFGLAK  218 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgla~  218 (372)
                      |+.+|+|.+++.....      +++..+..++.|++.||+|||   +.+|+||||||+|||+   +.++.+||+|||++.
T Consensus       107 ~~~~~~L~~~~~~~~~------~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          107 VYTGGELFDEIISRKR------FSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             CCCSCBHHHHHHTCSC------CBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             cCCCCCHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            9999999999976542      899999999999999999999   7899999999999999   567899999999998


Q ss_pred             cccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhc
Q 036435          219 LCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQD  298 (372)
Q Consensus       219 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (372)
                      .......    .....||+.|+|||.+.+   .++.++||||+||++|+|++|..||......        .....+...
T Consensus       178 ~~~~~~~----~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~~~  242 (484)
T 3nyv_A          178 HFEASKK----MKDKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPFNGANEY--------DILKKVEKG  242 (484)
T ss_dssp             HBCCCCS----HHHHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHC
T ss_pred             Ecccccc----cccCCCCccccCceeecC---CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHcC
Confidence            7654332    223458999999999875   6789999999999999999999999754211        122222222


Q ss_pred             c-cccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          299 R-EFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       299 ~-~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      . .+..     +....+...+.+++.+||+.||.+|||++|+++
T Consensus       243 ~~~~~~-----~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          243 KYTFEL-----PQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             CCCCCS-----GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCCC-----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            1 1111     112234567788999999999999999999986

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.2e-40  Score=325.89  Aligned_cols=229  Identities=26%  Similarity=0.353  Sum_probs=182.5

Q ss_pred             hhhhhhcCCCCceEEEEEEecc--------------------------------hHHHHHHHHhccCCCceeeeEeEEec
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD--------------------------------DFVNEVASISRTSHVNVVTLLGFCLE  132 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~--------------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~  132 (372)
                      +.+.+.||+|+||+||+++...                                .+.+|+.++++++||||+++++++.+
T Consensus        38 Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  117 (504)
T 3q5i_A           38 YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFED  117 (504)
T ss_dssp             EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             eEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            3445789999999999986521                                36789999999999999999999999


Q ss_pred             CCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC---ce
Q 036435          133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDF---CP  209 (372)
Q Consensus       133 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~  209 (372)
                      ++..++||||+++|+|.+++.....      +++..+..++.|++.||+|||   +.+|+||||||+|||++.++   .+
T Consensus       118 ~~~~~lv~e~~~gg~L~~~l~~~~~------~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~  188 (504)
T 3q5i_A          118 KKYFYLVTEFYEGGELFEQIINRHK------FDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNI  188 (504)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSE
T ss_pred             CCEEEEEEecCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccE
Confidence            9999999999999999999976532      899999999999999999999   78999999999999998775   69


Q ss_pred             EEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHH
Q 036435          210 KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPH  289 (372)
Q Consensus       210 kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~  289 (372)
                      ||+|||++........    .....||+.|+|||.+.+   .++.++||||+||++|+|++|..||.....        .
T Consensus       189 kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~  253 (504)
T 3q5i_A          189 KIVDFGLSSFFSKDYK----LRDRLGTAYYIAPEVLKK---KYNEKCDVWSCGVIMYILLCGYPPFGGQND--------Q  253 (504)
T ss_dssp             EECCCTTCEECCTTSC----BCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------H
T ss_pred             EEEECCCCEEcCCCCc----cccccCCcCCCCHHHhcc---CCCchHHHHHHHHHHHHHHhCCCCCCCCCH--------H
Confidence            9999999987654332    123458999999999864   688999999999999999999999975422        1


Q ss_pred             HHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          290 WIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .....+..... ..+   ......+...+.+++.+||+.||.+|||++|+++
T Consensus       254 ~~~~~i~~~~~-~~~---~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          254 DIIKKVEKGKY-YFD---FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HHHHHHHHCCC-CCC---HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHcCCC-CCC---ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            12222222211 111   0111223467888999999999999999999986

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.3e-40  Score=311.96  Aligned_cols=233  Identities=21%  Similarity=0.327  Sum_probs=182.0

Q ss_pred             hhhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      .+.+.||+|+||.||+++...                    .+.+|+.++++++||||+++++++.+++..++||||+++
T Consensus        36 ~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  115 (360)
T 3eqc_A           36 EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG  115 (360)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred             eeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCC
Confidence            445789999999999997642                    578999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCST-KILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      |+|.+++.....      +++..+..++.|++.||+|||   +. +++||||||+|||++.++.+||+|||++.......
T Consensus       116 ~~L~~~l~~~~~------~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  186 (360)
T 3eqc_A          116 GSLDQVLKKAGR------IPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  186 (360)
T ss_dssp             CBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC
T ss_pred             CCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCccccccc
Confidence            999999976542      899999999999999999999   54 89999999999999999999999999997553221


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCcc-------------------
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV-------------------  285 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~-------------------  285 (372)
                           .....||+.|+|||.+.+.  .++.++|||||||++|+|++|+.||..........                   
T Consensus       187 -----~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (360)
T 3eqc_A          187 -----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT  259 (360)
T ss_dssp             ---------CCCCTTCCHHHHTTC--CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------
T ss_pred             -----ccCCCCCCCeECHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCccc
Confidence                 1233588999999999875  78999999999999999999999997532110000                   


Q ss_pred             ----------------chHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          286 ----------------YFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       286 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                                      ..... ........   .+..   ....+...+.+++.+||+.||++|||++|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~---~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          260 PGRPLNKFGMDSRPPMAIFEL-LDYIVNEP---PPKL---PSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             --------------CCCHHHH-HHHHHHSC---CCCC---CTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCCcccccccCCCCcccchhh-hhHHhccC---CCCC---CcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                            00000 00000000   0000   01112456888999999999999999999986

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3.6e-40  Score=298.65  Aligned_cols=226  Identities=22%  Similarity=0.382  Sum_probs=180.1

Q ss_pred             hhhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhcc-CCCceeeeEeEEecCCceeEEEEe
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      +.+.+.||+|+||.||+++...                     ++.+|+..+.++ +||||+++++++.+++..++||||
T Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~   92 (289)
T 1x8b_A           13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEY   92 (289)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEe
Confidence            3445789999999999997641                     578899999999 999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC-----------------
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE-----------------  205 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~-----------------  205 (372)
                      +++|+|.+++......  ...+++..+..++.|++.||+|||   +.+++||||||+|||++.                 
T Consensus        93 ~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~  167 (289)
T 1x8b_A           93 CNGGSLADAISENYRI--MSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA  167 (289)
T ss_dssp             CTTCBHHHHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC------------------
T ss_pred             cCCCcHHHHHHhhccc--ccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence            9999999999764211  022899999999999999999999   799999999999999984                 


Q ss_pred             --CCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCC
Q 036435          206 --DFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSS  283 (372)
Q Consensus       206 --~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~  283 (372)
                        ...+||+|||++.......       ...||+.|+|||.+.+. ..++.++||||||+++|+|++|.+++....    
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~-------~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~----  235 (289)
T 1x8b_A          168 SNKVMFKIGDLGHVTRISSPQ-------VEEGDSRFLANEVLQEN-YTHLPKADIFALALTVVCAAGAEPLPRNGD----  235 (289)
T ss_dssp             --CCCEEECCCTTCEETTCSC-------CCCCCGGGCCHHHHTTC-CTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----
T ss_pred             CCceEEEEcccccccccCCcc-------ccCCCccccChhHhcCC-CCCCchhhHHHHHHHHHHHhcCCCCCcchh----
Confidence              4479999999998765432       22488999999999764 356689999999999999999988764321    


Q ss_pred             ccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          284 EVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                             ....+........+.       .....+.+++.+||+.||++|||+.++++
T Consensus       236 -------~~~~~~~~~~~~~~~-------~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          236 -------QWHEIRQGRLPRIPQ-------VLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             -------HHHHHHTTCCCCCSS-------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -------HHHHHHcCCCCCCCc-------ccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence                   112222222222221       12356778999999999999999999985

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.1e-40  Score=304.71  Aligned_cols=233  Identities=20%  Similarity=0.285  Sum_probs=181.6

Q ss_pred             HhhhhhhcCCCCceEEEEEEecc---------------------------hHHHHHHHHhccCCCceeeeEeEEecCCce
Q 036435           84 TNSFKDKLGQGGFGGVYKGRLLD---------------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNR  136 (372)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~~---------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~  136 (372)
                      .+.+.+.||+|+||.||+++...                           .+.+|+.++++++||||+++++++..++ .
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~   89 (322)
T 2ycf_A           11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-Y   89 (322)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-E
T ss_pred             ceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-e
Confidence            44556889999999999996532                           3778999999999999999999987654 8


Q ss_pred             eEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCc---eEEee
Q 036435          137 ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFC---PKISD  213 (372)
Q Consensus       137 ~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~D  213 (372)
                      ++||||+++|+|.+++....      .+++..+..++.|++.||+|||   +.+++||||||+|||++.++.   +||+|
T Consensus        90 ~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           90 YIVLELMEGGELFDKVVGNK------RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             EEEEECCTTEETHHHHSTTC------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             EEEEecCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEcc
Confidence            99999999999999997543      2899999999999999999999   799999999999999987654   99999


Q ss_pred             cCCcccccCCCCeeeeeccccccccccccccccc-ccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHH
Q 036435          214 FGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSR-NFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIY  292 (372)
Q Consensus       214 fgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  292 (372)
                      ||++........    .....||+.|+|||.+.+ ....++.++|||||||++|+|++|..||........       ..
T Consensus       161 fg~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~  229 (322)
T 2ycf_A          161 FGHSKILGETSL----MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-------LK  229 (322)
T ss_dssp             CTTCEECCCCHH----HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC-------HH
T ss_pred             Cccceecccccc----cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH-------HH
Confidence            999986543221    123358899999999742 123678999999999999999999999976433221       11


Q ss_pred             HHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          293 RHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ..+........+    .........+.+++.+||+.||.+|||+.++++
T Consensus       230 ~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          230 DQITSGKYNFIP----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HHHHHTCCCCCH----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHhCccccCc----hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            112111111011    111223567888999999999999999999984

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=4.1e-40  Score=299.73  Aligned_cols=231  Identities=26%  Similarity=0.353  Sum_probs=181.5

Q ss_pred             hhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCChh
Q 036435           89 DKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLE  149 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~  149 (372)
                      ..||+|+||.||+|+...                   .+.+|+.++++++||||+++++++.+++..++||||+++++|.
T Consensus        28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  107 (295)
T 2clq_A           28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS  107 (295)
T ss_dssp             CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred             EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence            379999999999997532                   5789999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC-CCceEEeecCCcccccCCCCeee
Q 036435          150 KFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE-DFCPKISDFGLAKLCTTKEGIVS  228 (372)
Q Consensus       150 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgla~~~~~~~~~~~  228 (372)
                      +++......   ..+++..+..++.|++.||+|||   +.+++|+||||+||+++. ++.+||+|||++.........  
T Consensus       108 ~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~--  179 (295)
T 2clq_A          108 ALLRSKWGP---LKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC--  179 (295)
T ss_dssp             HHHHHTTCC---CTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------
T ss_pred             HHHHhhccC---CCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc--
Confidence            999875322   22778999999999999999999   789999999999999987 899999999999865432211  


Q ss_pred             eecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCC
Q 036435          229 SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVT  308 (372)
Q Consensus       229 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (372)
                       .....||+.|+|||.+.+....++.++||||||+++|+|++|+.||.......      ...............+    
T Consensus       180 -~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~----  248 (295)
T 2clq_A          180 -TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ------AAMFKVGMFKVHPEIP----  248 (295)
T ss_dssp             --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH------HHHHHHHHHCCCCCCC----
T ss_pred             -ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh------HHHHhhcccccccccc----
Confidence             12345889999999987642247899999999999999999999996432211      0011111111111112    


Q ss_pred             cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          309 RKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       309 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                         ......+.+++.+||+.||++||+++++++
T Consensus       249 ---~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          249 ---ESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             ---TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ---ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence               123456778999999999999999999985

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-40  Score=312.79  Aligned_cols=239  Identities=22%  Similarity=0.272  Sum_probs=177.5

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCC------ceeE
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGN------NRAL  138 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~------~~~l  138 (372)
                      .+.+.||+|+||.||+|+...                     ++.+|+.++++++||||+++++++..+.      ..++
T Consensus        28 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~l  107 (367)
T 1cm8_A           28 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYL  107 (367)
T ss_dssp             EEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEE
T ss_pred             EEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEE
Confidence            345789999999999997632                     4778999999999999999999998763      4599


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          139 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       139 V~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      ||||+ +++|.+++....       +++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++
T Consensus       108 v~e~~-~~~L~~~~~~~~-------l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  176 (367)
T 1cm8_A          108 VMPFM-GTDLGKLMKHEK-------LGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR  176 (367)
T ss_dssp             EEECC-SEEHHHHHHHCC-------CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEecC-CCCHHHHHhcCC-------CCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence            99999 889999997632       899999999999999999999   7999999999999999999999999999998


Q ss_pred             cccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHh---
Q 036435          219 LCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV---  295 (372)
Q Consensus       219 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---  295 (372)
                      ......      ....+|+.|+|||.+.+. ..++.++||||+||++|||++|+.||.......    ....+....   
T Consensus       177 ~~~~~~------~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~l~~i~~~~g~~  245 (367)
T 1cm8_A          177 QADSEM------TGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD----QLKEIMKVTGTP  245 (367)
T ss_dssp             ECCSSC------CSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHHCCC
T ss_pred             cccccc------CcCcCCCCcCCHHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHhcCCC
Confidence            754322      234588999999998763 378999999999999999999999997543211    000000000   


Q ss_pred             -----------------hhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhhcCc
Q 036435          296 -----------------EQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE--MLQGST  347 (372)
Q Consensus       296 -----------------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~--~L~~~~  347 (372)
                                       ....... ..............+.+++.+||+.||.+|||++|+++  .++...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~  315 (367)
T 1cm8_A          246 PAEFVQRLQSDEAKNYMKGLPELE-KKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  315 (367)
T ss_dssp             CHHHHHTCSCHHHHHHHHHSCCCC-CCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             CHHHHHHhhhHHHHHHHHhCCCCC-CCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence                             0000000 00001111223456788999999999999999999997  355444

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=8.2e-41  Score=309.78  Aligned_cols=243  Identities=23%  Similarity=0.371  Sum_probs=180.9

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      .+.+.||+|+||.||+++...                     .+.+|+.++++++||||+++++++.+++..++||||++
T Consensus        28 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  107 (331)
T 4aaa_A           28 ENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVD  107 (331)
T ss_dssp             EEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             eeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCC
Confidence            345789999999999997642                     36789999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      +++|.+++.....      +++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++.......
T Consensus       108 ~~~l~~~~~~~~~------~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  178 (331)
T 4aaa_A          108 HTILDDLELFPNG------LDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  178 (331)
T ss_dssp             EEHHHHHHHSTTC------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             cchHHHHHhhccC------CCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence            9999888765432      899999999999999999999   7899999999999999999999999999998654432


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchH-------HHHHHHhhh
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFP-------HWIYRHVEQ  297 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~-------~~~~~~~~~  297 (372)
                      ..   .....||+.|+|||.+.+. ..++.++|||||||++|+|++|+.||.............       .........
T Consensus       179 ~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (331)
T 4aaa_A          179 EV---YDDEVATRWYRAPELLVGD-VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK  254 (331)
T ss_dssp             --------CCCCCTTCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred             cc---cCCCcCCccccCcccccCC-CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence            21   1234588999999998764 367899999999999999999999997643211000000       000000000


Q ss_pred             c---ccccCCccCCcc-----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          298 D---REFKLPGVVTRK-----ENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       298 ~---~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .   .....+......     .......+.+++.+||+.||.+|||++|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0   011111111111     1123567889999999999999999999885

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=8.8e-41  Score=313.65  Aligned_cols=240  Identities=20%  Similarity=0.281  Sum_probs=182.9

Q ss_pred             hhhhhcCCCCceEEEEEEec--------------------chHHHHHHHHhccCCCceeeeEeEEecC-----CceeEEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLL--------------------DDFVNEVASISRTSHVNVVTLLGFCLEG-----NNRALIY  140 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~--------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~-----~~~~lV~  140 (372)
                      .+.+.||+|+||.||+++..                    +.+.+|++++++++||||+++++++...     ...++|+
T Consensus        30 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~  109 (364)
T 3qyz_A           30 TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQ  109 (364)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEE
T ss_pred             EEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEE
Confidence            44578999999999999653                    2578999999999999999999999765     3689999


Q ss_pred             EecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccc
Q 036435          141 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC  220 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~  220 (372)
                      ||+. |+|.+++....       +++.++..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++...
T Consensus       110 e~~~-~~L~~~l~~~~-------~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  178 (364)
T 3qyz_A          110 DLME-TDLYKLLKTQH-------LSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  178 (364)
T ss_dssp             ECCS-EEHHHHHHHCC-------CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cccC-cCHHHHHHhCC-------CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence            9996 59999997643       899999999999999999999   799999999999999999999999999999876


Q ss_pred             cCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhc--
Q 036435          221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQD--  298 (372)
Q Consensus       221 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--  298 (372)
                      ..............||+.|+|||.+.+. ..++.++|||||||++|+|++|+.||........    ...+.......  
T Consensus       179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----~~~i~~~~~~~~~  253 (364)
T 3qyz_A          179 DPDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ----LNHILGILGSPSQ  253 (364)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCHHHHHTB-CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH----HHHHHHHHCSCCH
T ss_pred             CCCCCccccccccccccCCCCCHHhcCC-CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH----HHHHHHHhCCCCH
Confidence            5433222222344689999999987654 3589999999999999999999999976432211    00011000000  


Q ss_pred             -------------ccccCCccCCc----chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          299 -------------REFKLPGVVTR----KENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       299 -------------~~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                                   .....+.....    ........+.+++.+||+.||.+|||++|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                         00000100000    01122456788999999999999999999997

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2e-40  Score=304.64  Aligned_cols=231  Identities=23%  Similarity=0.354  Sum_probs=181.6

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-----------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-----------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS  147 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-----------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~  147 (372)
                      +.+.+.||+|+||.||+|+...                 .+.+|+.++++++||||+++++++.+++..++||||+++++
T Consensus        31 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  110 (314)
T 3com_A           31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGS  110 (314)
T ss_dssp             EEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred             hhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCC
Confidence            3445789999999999997642                 58899999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCee
Q 036435          148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV  227 (372)
Q Consensus       148 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  227 (372)
                      |.+++.....     .+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++......... 
T Consensus       111 L~~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~-  181 (314)
T 3com_A          111 VSDIIRLRNK-----TLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK-  181 (314)
T ss_dssp             HHHHHHHHTC-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSC-
T ss_pred             HHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccc-
Confidence            9999974321     2899999999999999999999   799999999999999999999999999999866543221 


Q ss_pred             eeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccC
Q 036435          228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVV  307 (372)
Q Consensus       228 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (372)
                        .....||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||......       . .............    
T Consensus       182 --~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~-~~~~~~~~~~~~~----  245 (314)
T 3com_A          182 --RNTVIGTPFWMAPEVIQEI--GYNCVADIWSLGITAIEMAEGKPPYADIHPM-------R-AIFMIPTNPPPTF----  245 (314)
T ss_dssp             --BCCCCSCGGGCCHHHHSSS--CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-------H-HHHHHHHSCCCCC----
T ss_pred             --cCccCCCCCccChhhcCCC--CCCccccHHHHHHHHHHHHhCCCCCCCCChH-------H-HHHHHhcCCCccc----
Confidence              1234588999999999774  7899999999999999999999999753211       0 1111111111110    


Q ss_pred             CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          308 TRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       308 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                       .....+...+.+++.+||+.||.+|||+.++++
T Consensus       246 -~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          246 -RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             -SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence             011223456788999999999999999999986

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.2e-40  Score=316.01  Aligned_cols=249  Identities=22%  Similarity=0.269  Sum_probs=181.6

Q ss_pred             hhhhhhcCCCCceEEEEEEecc--------------hHHHHHHHHhccCCCceeeeEeEEecCCc------eeEEEEecC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD--------------DFVNEVASISRTSHVNVVTLLGFCLEGNN------RALIYEFMP  144 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~--------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~------~~lV~e~~~  144 (372)
                      +.+.+.||+|+||.||+++..+              ...+|+.+++.++||||+++++++...+.      .++||||++
T Consensus        42 Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~  121 (394)
T 4e7w_A           42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP  121 (394)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCS
T ss_pred             EEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccC
Confidence            3456789999999999997643              34579999999999999999999965443      789999997


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC-CCCceEEeecCCcccccCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLD-EDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgla~~~~~~  223 (372)
                      ++ +.+.+......  ...+++..+..++.|++.||+|||   +.+|+||||||+|||++ .++.+||+|||+++.....
T Consensus       122 ~~-l~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~  195 (394)
T 4e7w_A          122 ET-VYRASRHYAKL--KQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG  195 (394)
T ss_dssp             EE-HHHHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             cc-HHHHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence            74 44333221100  123899999999999999999999   79999999999999999 7999999999999876443


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHH---------
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRH---------  294 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~---------  294 (372)
                      ...    ....+|+.|+|||.+.+. ..++.++|||||||++|||++|+.||.......   .+.. +...         
T Consensus       196 ~~~----~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~l~~-i~~~~g~p~~~~~  266 (394)
T 4e7w_A          196 EPN----VSYICSRYYRAPELIFGA-TNYTTNIDIWSTGCVMAELMQGQPLFPGESGID---QLVE-IIKVLGTPSREQI  266 (394)
T ss_dssp             CCC----CSSCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH-HHHHHCCCCHHHH
T ss_pred             CCC----cccccCcCccCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH-HHHHhCCCCHHHH
Confidence            322    234578999999998764 368999999999999999999999997643211   0000 0000         


Q ss_pred             --h-hhcccccCCccCCcch-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hhcCcc
Q 036435          295 --V-EQDREFKLPGVVTRKE-----NEIAKKMIIVGLWCIQARPSDRPPMNEVIEM--LQGSTE  348 (372)
Q Consensus       295 --~-~~~~~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~--L~~~~~  348 (372)
                        . ........+.......     ......+.+++.+||+.||.+|||+.|+++.  ++++..
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (394)
T 4e7w_A          267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT  330 (394)
T ss_dssp             HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred             HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence              0 0000111121111111     1134578899999999999999999999974  555543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1e-40  Score=316.29  Aligned_cols=243  Identities=23%  Similarity=0.270  Sum_probs=183.5

Q ss_pred             HHhhhhhhcCCCCceEEEEEEecc------------------hHHHHHHHHhccC--------CCceeeeEeEEe----c
Q 036435           83 LTNSFKDKLGQGGFGGVYKGRLLD------------------DFVNEVASISRTS--------HVNVVTLLGFCL----E  132 (372)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~~------------------~~~~E~~~l~~l~--------h~nIv~l~g~~~----~  132 (372)
                      ..+.+.+.||+|+||.||+++...                  .+.+|+.++++++        |+||+++++++.    +
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~  116 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVN  116 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETT
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCC
Confidence            345566789999999999997532                  5778999999995        888999999998    5


Q ss_pred             CCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCceEECCCC----
Q 036435          133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCST-KILHFDIKPHNILLDEDF----  207 (372)
Q Consensus       133 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~-~ivH~dlk~~Nill~~~~----  207 (372)
                      +...++||||+ +++|.+++.....    ..+++..+..++.|++.||+|||   +. +|+||||||+|||++.++    
T Consensus       117 ~~~~~lv~e~~-~~~l~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~  188 (397)
T 1wak_A          117 GTHICMVFEVL-GHHLLKWIIKSNY----QGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIR  188 (397)
T ss_dssp             EEEEEEEECCC-CCBHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHH
T ss_pred             CceEEEEEecc-CccHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhh
Confidence            66889999999 5677777765432    22899999999999999999999   67 999999999999999775    


Q ss_pred             ---------------------------------------------ceEEeecCCcccccCCCCeeeeecccccccccccc
Q 036435          208 ---------------------------------------------CPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAP  242 (372)
Q Consensus       208 ---------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aP  242 (372)
                                                                   .+||+|||++.......      ....||+.|+||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~------~~~~gt~~y~aP  262 (397)
T 1wak_A          189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF------TEDIQTRQYRSL  262 (397)
T ss_dssp             HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS------CSCCSCGGGCCH
T ss_pred             hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC------ccCCCCCcccCC
Confidence                                                         79999999998764332      233589999999


Q ss_pred             cccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccc--hHHHHHHHhhhc-----------cc-c-------
Q 036435          243 EVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVY--FPHWIYRHVEQD-----------RE-F-------  301 (372)
Q Consensus       243 E~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~--~~~~~~~~~~~~-----------~~-~-------  301 (372)
                      |++.+.  .++.++|||||||++|||++|+.||...........  ....+.......           .. +       
T Consensus       263 E~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  340 (397)
T 1wak_A          263 EVLIGS--GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLK  340 (397)
T ss_dssp             HHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBS
T ss_pred             hhhcCC--CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccc
Confidence            999875  789999999999999999999999986543321110  000011100000           00 0       


Q ss_pred             cCCcc-----------CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          302 KLPGV-----------VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       302 ~~~~~-----------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .....           ......+....+.+++.+||+.||++|||++|+++
T Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            00000           00123456678899999999999999999999985

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.8e-41  Score=307.60  Aligned_cols=244  Identities=23%  Similarity=0.335  Sum_probs=172.2

Q ss_pred             hhhhhcCCCCceEEEEEEec--------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLL--------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~--------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      .+.+.||+|+||.||+++..                    +++.+|+.++++++||||+++++++.+++..++||||+++
T Consensus        18 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   97 (303)
T 2vwi_A           18 ELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSG   97 (303)
T ss_dssp             EEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTT
T ss_pred             hhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccC
Confidence            34678999999999999652                    1477899999999999999999999999999999999999


Q ss_pred             CChhhhhhcCC--CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          146 GSLEKFVYNGD--TSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       146 g~L~~~l~~~~--~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      ++|.+++....  .......+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++......
T Consensus        98 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  174 (303)
T 2vwi_A           98 GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG  174 (303)
T ss_dssp             CBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC--
T ss_pred             CchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccchheeccC
Confidence            99999986411  0011234899999999999999999999   789999999999999999999999999999765433


Q ss_pred             CCee--eeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccc
Q 036435          224 EGIV--SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF  301 (372)
Q Consensus       224 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (372)
                      ....  .......||+.|+|||.+.+. ..++.++||||||+++|+|++|+.||.......       ......... ..
T Consensus       175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~-~~  245 (303)
T 2vwi_A          175 GDITRNKVRKTFVGTPCWMAPEVMEQV-RGYDFKADIWSFGITAIELATGAAPYHKYPPMK-------VLMLTLQND-PP  245 (303)
T ss_dssp             -------------CCCTTCCHHHHHHH-HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-------HHHHHHTSS-CC
T ss_pred             CCccchhhhcccCCCccccCHHHhccc-cCCCchhhHHHHHHHHHHHHhCCCCCccCchhh-------HHHHHhccC-CC
Confidence            2111  111234588999999998652 257899999999999999999999997643211       111111111 00


Q ss_pred             cCCc--cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          302 KLPG--VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       302 ~~~~--~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ....  ............+.+++.+||+.||.+|||+.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          246 SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            0000  000011123356788999999999999999999986

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.6e-40  Score=310.53  Aligned_cols=229  Identities=20%  Similarity=0.341  Sum_probs=182.9

Q ss_pred             hhhcCCCCceEEEEEEecc---------------------------hHHHHHHHHhcc-CCCceeeeEeEEecCCceeEE
Q 036435           88 KDKLGQGGFGGVYKGRLLD---------------------------DFVNEVASISRT-SHVNVVTLLGFCLEGNNRALI  139 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~---------------------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV  139 (372)
                      .+.||+|+||.||++++..                           .+.+|+.+++++ +||||+++++++...+..++|
T Consensus        99 ~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  178 (365)
T 2y7j_A           99 KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV  178 (365)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEE
T ss_pred             ceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEE
Confidence            4689999999999997631                           367899999999 799999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccc
Q 036435          140 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKL  219 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  219 (372)
                      |||+++++|.+++....      .+++..+..++.|++.||.|||   +.+++|+||||+|||++.++.+||+|||++..
T Consensus       179 ~e~~~g~~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~  249 (365)
T 2y7j_A          179 FDLMRKGELFDYLTEKV------ALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCH  249 (365)
T ss_dssp             ECCCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEecCcccc
Confidence            99999999999997643      2899999999999999999999   78999999999999999999999999999987


Q ss_pred             ccCCCCeeeeecccccccccccccccccc----cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHh
Q 036435          220 CTTKEGIVSSLLGARGIIGYIAPEVFSRN----FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV  295 (372)
Q Consensus       220 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  295 (372)
                      ......    .....||+.|+|||++.+.    ...++.++|||||||++|+|++|+.||......        .....+
T Consensus       250 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--------~~~~~i  317 (365)
T 2y7j_A          250 LEPGEK----LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI--------LMLRMI  317 (365)
T ss_dssp             CCTTCC----BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHH
T ss_pred             cCCCcc----cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH--------HHHHHH
Confidence            654332    1234689999999998642    125788999999999999999999999753210        111111


Q ss_pred             hhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          296 EQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .... ...+   ..........+.+++.+||+.||++|||++++++
T Consensus       318 ~~~~-~~~~---~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          318 MEGQ-YQFS---SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHTC-CCCC---HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HhCC-CCCC---CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1111 1110   0011123456788999999999999999999986

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.5e-40  Score=298.37  Aligned_cols=226  Identities=23%  Similarity=0.394  Sum_probs=176.8

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      .+.+.||+|+||.||+++...                      .+.+|+.++++++||||+++++++.+++..++||||+
T Consensus        14 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   93 (276)
T 2h6d_A           14 VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYV   93 (276)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEecc
Confidence            345789999999999997631                      4678999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      ++++|.+++.....      +++..+..++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++......
T Consensus        94 ~~~~L~~~l~~~~~------~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           94 SGGELFDYICKHGR------VEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             CSCBHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             CCCcHHHHHhccCC------CCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence            99999999976532      899999999999999999999   789999999999999999999999999999876443


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                      ..    .....+|+.|+|||.+.+. ...+.++||||||+++|+|++|+.||.....        ......+... ....
T Consensus       165 ~~----~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~-~~~~  230 (276)
T 2h6d_A          165 EF----LRTSCGSPNYAAPEVISGR-LYAGPEVDIWSCGVILYALLCGTLPFDDEHV--------PTLFKKIRGG-VFYI  230 (276)
T ss_dssp             ----------------CCTGGGTTS-CCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHC-CCCC
T ss_pred             cc----eecccCCccccCHHHHcCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCcH--------HHHHHHhhcC-cccC
Confidence            21    1233588899999999764 2336899999999999999999999965321        1122222221 1112


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      +..       ....+.+++.+||+.||.+|||++++++
T Consensus       231 ~~~-------~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          231 PEY-------LNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             CTT-------SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             chh-------cCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            221       2356778999999999999999999997

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.1e-40  Score=306.59  Aligned_cols=240  Identities=19%  Similarity=0.291  Sum_probs=182.4

Q ss_pred             hhhhhhcCCCCceEEEEEEec----------------chHHHHHHHHhccC-CCceeeeEeEEec--CCceeEEEEecCC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL----------------DDFVNEVASISRTS-HVNVVTLLGFCLE--GNNRALIYEFMPN  145 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~----------------~~~~~E~~~l~~l~-h~nIv~l~g~~~~--~~~~~lV~e~~~~  145 (372)
                      +.+.+.||+|+||.||+++..                +.+.+|+.++++++ ||||+++++++.+  ....++||||+++
T Consensus        38 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~  117 (330)
T 3nsz_A           38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN  117 (330)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCC
T ss_pred             eEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCc
Confidence            344578999999999999763                26889999999997 9999999999988  6678999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC-ceEEeecCCcccccCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDF-CPKISDFGLAKLCTTKE  224 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgla~~~~~~~  224 (372)
                      ++|.+++..         +++.++..++.|++.||+|||   +.+++||||||+|||++.++ .+||+|||++.......
T Consensus       118 ~~l~~~~~~---------~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~  185 (330)
T 3nsz_A          118 TDFKQLYQT---------LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  185 (330)
T ss_dssp             CCHHHHGGG---------CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred             hhHHHHHHh---------CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence            999999843         788999999999999999999   79999999999999999766 89999999998765433


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccch------HHHHHHHhhhc
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYF------PHWIYRHVEQD  298 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~------~~~~~~~~~~~  298 (372)
                      ..    ....+|..|+|||.+.+. ..++.++|||||||++|+|++|+.||............      .......+...
T Consensus       186 ~~----~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  260 (330)
T 3nsz_A          186 EY----NVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  260 (330)
T ss_dssp             CC----CSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             cc----ccccccccccChhhhcCC-CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHh
Confidence            22    234588899999998763 36899999999999999999999999654322110000      00000000000


Q ss_pred             ccc---------------cCCc-cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          299 REF---------------KLPG-VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       299 ~~~---------------~~~~-~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ...               .... ........+...+.+++.+||+.||++|||++|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            000               0000 000111123567889999999999999999999986

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3.5e-40  Score=310.37  Aligned_cols=238  Identities=22%  Similarity=0.248  Sum_probs=172.3

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCC------ceeE
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGN------NRAL  138 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~------~~~l  138 (372)
                      .+.+.||+|+||.||++....                     .+.+|+.+++.++||||+++++++...+      ..++
T Consensus        28 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~l  107 (371)
T 2xrw_A           28 QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI  107 (371)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEE
T ss_pred             eEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEE
Confidence            345789999999999996531                     4778999999999999999999998665      6799


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          139 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       139 V~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      ||||++ |+|.+++...        +++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++
T Consensus       108 v~e~~~-~~l~~~~~~~--------~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  175 (371)
T 2xrw_A          108 VMELMD-ANLCQVIQME--------LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  175 (371)
T ss_dssp             EEECCS-EEHHHHHHSC--------CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred             EEEcCC-CCHHHHHhhc--------cCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence            999996 5888888531        889999999999999999999   7899999999999999999999999999998


Q ss_pred             cccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCc--------cchHH-
Q 036435          219 LCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE--------VYFPH-  289 (372)
Q Consensus       219 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~--------~~~~~-  289 (372)
                      .......    .....||+.|+|||.+.+.  .++.++|||||||++|+|++|+.||.........        ...+. 
T Consensus       176 ~~~~~~~----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  249 (371)
T 2xrw_A          176 TAGTSFM----MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF  249 (371)
T ss_dssp             ------------------CTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHH
T ss_pred             ccccccc----cCCceecCCccCHHHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            6543221    1234588999999999875  7899999999999999999999999764321000        00000 


Q ss_pred             ------HHHHHhhhccccc-------CCc----cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          290 ------WIYRHVEQDREFK-------LPG----VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       290 ------~~~~~~~~~~~~~-------~~~----~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                            .............       .+.    ............+.+++.+||+.||.+|||++|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             HTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence                  0000000000000       000    001112234667899999999999999999999997

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.4e-40  Score=317.21  Aligned_cols=178  Identities=23%  Similarity=0.301  Sum_probs=153.8

Q ss_pred             hhhhhhcCCCCceEEEEEEecc------------------hHHHHHHHHhcc------CCCceeeeEeEEecCCceeEEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD------------------DFVNEVASISRT------SHVNVVTLLGFCLEGNNRALIY  140 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~------------------~~~~E~~~l~~l------~h~nIv~l~g~~~~~~~~~lV~  140 (372)
                      +.+.+.||+|+||.||+|....                  ++.+|+.+++.+      +|+||+++++++...+..++||
T Consensus        99 y~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~  178 (429)
T 3kvw_A           99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTF  178 (429)
T ss_dssp             EEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEE
T ss_pred             EEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEE
Confidence            3445789999999999996632                  467788888887      5779999999999999999999


Q ss_pred             EecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCc--eEEeecCCcc
Q 036435          141 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFC--PKISDFGLAK  218 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfgla~  218 (372)
                      ||+. ++|.+++......    .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.  +||+|||++.
T Consensus       179 e~~~-~~L~~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          179 ELLS-MNLYELIKKNKFQ----GFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             CCCC-CBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             eccC-CCHHHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence            9995 6999999876532    2899999999999999999999   789999999999999999887  9999999997


Q ss_pred             cccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCC
Q 036435          219 LCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSG  278 (372)
Q Consensus       219 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~  278 (372)
                      ......      ....||+.|+|||++.+.  .++.++|||||||++|||++|..||...
T Consensus       251 ~~~~~~------~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          251 YEHQRV------YTYIQSRFYRAPEVILGA--RYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             ETTCCC------CSSCSCGGGCCHHHHHTB--CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ecCCcc------cccCCCCCccChHHHhCC--CCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            654322      234589999999999875  7899999999999999999999999764

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=4.4e-40  Score=307.28  Aligned_cols=240  Identities=22%  Similarity=0.302  Sum_probs=179.2

Q ss_pred             hhhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecC-----CceeEEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEG-----NNRALIY  140 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~-----~~~~lV~  140 (372)
                      .+.+.||+|+||.||+|+...                    .+.+|+.++++++||||+++++++..+     ...++|+
T Consensus        14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~   93 (353)
T 2b9h_A           14 QLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQ   93 (353)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEE
T ss_pred             EEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEE
Confidence            345789999999999997642                    467899999999999999999998764     6789999


Q ss_pred             EecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccc
Q 036435          141 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC  220 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~  220 (372)
                      ||+. |+|.+++....       +++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++...
T Consensus        94 e~~~-~~L~~~~~~~~-------~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           94 ELMQ-TDLHRVISTQM-------LSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARII  162 (353)
T ss_dssp             CCCS-EEHHHHHHHCC-------CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eccC-ccHHHHHhhcC-------CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence            9996 69999987642       899999999999999999999   789999999999999999999999999999876


Q ss_pred             cCCCCeee-------eecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHH
Q 036435          221 TTKEGIVS-------SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYR  293 (372)
Q Consensus       221 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  293 (372)
                      ........       ......||+.|+|||.+.+. ..++.++|||||||++|+|++|+.||.......    ....+..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~  237 (353)
T 2b9h_A          163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH----QLLLIFG  237 (353)
T ss_dssp             C----------------CCCCCCGGGCCHHHHHSC-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHH
T ss_pred             ccccccccCccccccchhhccccccccCCeeeccC-CCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH----HHHHHHH
Confidence            53321111       11234589999999987653 378999999999999999999999997543110    0000000


Q ss_pred             Hhhhcc---c-------------ccCCccC----CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          294 HVEQDR---E-------------FKLPGVV----TRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       294 ~~~~~~---~-------------~~~~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ......   .             ...+...    ..........+.+++.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            000000   0             0000000    0001123466788999999999999999999997

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3.1e-40  Score=332.48  Aligned_cols=227  Identities=20%  Similarity=0.281  Sum_probs=185.3

Q ss_pred             hhhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhcc-CCCceeeeEeEEecCCceeEEEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYE  141 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e  141 (372)
                      +.+.+.||+|+||.||+++...                      .+..|..++..+ +||||+++++++.+.+..|+|||
T Consensus       343 f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E  422 (674)
T 3pfq_A          343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME  422 (674)
T ss_dssp             EEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEE
T ss_pred             eEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEe
Confidence            3445789999999999997632                      467799999988 79999999999999999999999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      |+++|+|.+++.....      +++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       423 ~~~gg~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          423 YVNGGDLMYHIQQVGR------FKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  493 (674)
T ss_dssp             CCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred             CcCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence            9999999999987542      899999999999999999999   7999999999999999999999999999998643


Q ss_pred             CCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccc
Q 036435          222 TKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF  301 (372)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (372)
                      .....   .....||+.|+|||++.+.  .++.++|+|||||++|||++|+.||.....        ..+...+... ..
T Consensus       494 ~~~~~---~~~~~GT~~Y~APE~l~~~--~~~~~~DvwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~~-~~  559 (674)
T 3pfq_A          494 WDGVT---TKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIMEH-NV  559 (674)
T ss_dssp             CTTCC---BCCCCSCSSSCCHHHHTCC--CBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHSS-CC
T ss_pred             cCCcc---cccccCCCcccCHhhhcCC--CCCccceEechHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhC-CC
Confidence            32221   2345699999999999875  889999999999999999999999976421        1122222221 22


Q ss_pred             cCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 036435          302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPM-----NEVIE  341 (372)
Q Consensus       302 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~-----~evl~  341 (372)
                      ..|.       .+...+.+++.+||+.||++||++     +|+++
T Consensus       560 ~~p~-------~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          560 AYPK-------SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             CCCT-------TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             CCCc-------cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence            2232       234567889999999999999997     77764

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=9.6e-42  Score=321.71  Aligned_cols=223  Identities=14%  Similarity=0.158  Sum_probs=168.4

Q ss_pred             hhhcCCCCceEEEEEEec----------------------chHHHHH---HHHhccCCCceeeeE-------eEEecCC-
Q 036435           88 KDKLGQGGFGGVYKGRLL----------------------DDFVNEV---ASISRTSHVNVVTLL-------GFCLEGN-  134 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~----------------------~~~~~E~---~~l~~l~h~nIv~l~-------g~~~~~~-  134 (372)
                      .+.||+|+||.||+|+..                      +.+.+|+   ..+++++||||++++       +++.+.+ 
T Consensus        78 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  157 (377)
T 3byv_A           78 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK  157 (377)
T ss_dssp             EEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTS
T ss_pred             cceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCC
Confidence            578999999999999752                      1477899   556666899999998       6665543 


Q ss_pred             ----------------ceeEEEEecCCCChhhhhhcCCCCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC
Q 036435          135 ----------------NRALIYEFMPNGSLEKFVYNGDTSKP-CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIK  197 (372)
Q Consensus       135 ----------------~~~lV~e~~~~g~L~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk  197 (372)
                                      ..++||||+ +|+|.+++........ ...+++..++.++.|++.||+|||   +.+|+|||||
T Consensus       158 ~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDik  233 (377)
T 3byv_A          158 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLR  233 (377)
T ss_dssp             CSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTEECSCCC
T ss_pred             ccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence                            278999999 6899999976432111 123556888999999999999999   7899999999


Q ss_pred             CCceEECCCCceEEeecCCcccccCCCCeeeeecccccccccccccccccc---------cCCCCccccchhHHHHHHHH
Q 036435          198 PHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRN---------FGEVSHKSDVYSFGMMIMEL  268 (372)
Q Consensus       198 ~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~~~DvwslG~il~el  268 (372)
                      |+|||++.++.+||+|||+++....      ......| +.|+|||.+.+.         ...++.++|||||||++|||
T Consensus       234 p~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el  306 (377)
T 3byv_A          234 PVDIVLDQRGGVFLTGFEHLVRDGA------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI  306 (377)
T ss_dssp             GGGEEECTTCCEEECCGGGCEETTC------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred             HHHEEEcCCCCEEEEechhheecCC------cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence            9999999999999999999985332      1123346 889999998753         01578999999999999999


Q ss_pred             hcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          269 VGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       269 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ++|+.||..........        ..     ....       ..+...+.+++.+||+.||++|||+.++++
T Consensus       307 ltg~~Pf~~~~~~~~~~--------~~-----~~~~-------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          307 WCADLPITKDAALGGSE--------WI-----FRSC-------KNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHSSCCC------CCSG--------GG-----GSSC-------CCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHCCCCCcccccccchh--------hh-----hhhc-------cCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            99999997543322100        00     0001       112356788999999999999999999986

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.2e-40  Score=304.43  Aligned_cols=232  Identities=21%  Similarity=0.353  Sum_probs=179.6

Q ss_pred             hhhhhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      .+.+.||+|+||.||+++...                   .+.+|+.++++++||||+++++++.+++..++||||++++
T Consensus        22 ~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~  101 (302)
T 2j7t_A           22 EIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGG  101 (302)
T ss_dssp             EEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTE
T ss_pred             eecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCC
Confidence            345789999999999997642                   5788999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      +|.+++.....     .+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++........ 
T Consensus       102 ~l~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  172 (302)
T 2j7t_A          102 AVDAIMLELDR-----GLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ-  172 (302)
T ss_dssp             EHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH-
T ss_pred             cHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccc-
Confidence            99999876332     2899999999999999999999   78999999999999999999999999998764321110 


Q ss_pred             eeeeccccccccccccccccc---ccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          227 VSSLLGARGIIGYIAPEVFSR---NFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                        ......||+.|+|||.+..   ....++.++||||||+++|+|++|+.||......       ... ........   
T Consensus       173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~-~~~~~~~~---  239 (302)
T 2j7t_A          173 --KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------RVL-LKIAKSDP---  239 (302)
T ss_dssp             --C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHH-HHHHHSCC---
T ss_pred             --ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH-------HHH-HHHhccCC---
Confidence              0122358899999999841   1136789999999999999999999998753211       111 11111111   


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      +..  .....+...+.+++.+||+.||.+|||+.++++
T Consensus       240 ~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          240 PTL--LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             CCC--SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             ccc--CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            110  111223456788999999999999999999885

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=9.1e-40  Score=304.59  Aligned_cols=235  Identities=24%  Similarity=0.391  Sum_probs=184.7

Q ss_pred             hhhhhcCCCCceEEEEEEec----------------------------------chHHHHHHHHhccCCCceeeeEeEEe
Q 036435           86 SFKDKLGQGGFGGVYKGRLL----------------------------------DDFVNEVASISRTSHVNVVTLLGFCL  131 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~----------------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~  131 (372)
                      .+.+.||+|+||.||+++..                                  +.+.+|+.++++++||||+++++++.
T Consensus        34 ~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~  113 (348)
T 2pml_X           34 RIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIIT  113 (348)
T ss_dssp             EEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEE
T ss_pred             EEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            44578999999999998641                                  45789999999999999999999999


Q ss_pred             cCCceeEEEEecCCCChhhh------hhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeecCCCCCceEEC
Q 036435          132 EGNNRALIYEFMPNGSLEKF------VYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS-TKILHFDIKPHNILLD  204 (372)
Q Consensus       132 ~~~~~~lV~e~~~~g~L~~~------l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~-~~ivH~dlk~~Nill~  204 (372)
                      +++..++||||+++|+|.++      +.....    ..+++..+..++.|++.||+|||   + .+++|+||||+||+++
T Consensus       114 ~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~~  186 (348)
T 2pml_X          114 NYDEVYIIYEYMENDSILKFDEYFFVLDKNYT----CFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILMD  186 (348)
T ss_dssp             SSSEEEEEEECCTTCBSSEESSSEESSCSSSC----CCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEEC
T ss_pred             eCCeEEEEEeccCCCcHHHHHHHhhhhhhccc----cCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEEc
Confidence            99999999999999999999      543211    33999999999999999999999   6 9999999999999999


Q ss_pred             CCCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCc-cccchhHHHHHHHHhcCCCCCCCCCCCCC
Q 036435          205 EDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSH-KSDVYSFGMMIMELVGCKNNLDSGVDSSS  283 (372)
Q Consensus       205 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~DvwslG~il~elltg~~p~~~~~~~~~  283 (372)
                      .++.+||+|||++......     ......||..|+|||.+.+. ..++. ++||||||+++|||++|..||....... 
T Consensus       187 ~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-  259 (348)
T 2pml_X          187 KNGRVKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNE-SSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV-  259 (348)
T ss_dssp             TTSCEEECCCTTCEECBTT-----EECSSCSCGGGCCGGGGSSC-CCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH-
T ss_pred             CCCcEEEeccccccccccc-----cccCCCCCcCccCchhhcCC-CCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH-
Confidence            9999999999999875443     12345689999999999764 24555 9999999999999999999997643311 


Q ss_pred             ccchHHHHHHHhhhcccccCCccC------------CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          284 EVYFPHWIYRHVEQDREFKLPGVV------------TRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                           . ....+... ....+...            ..........+.+++.+||+.||.+|||++|+++
T Consensus       260 -----~-~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          260 -----E-LFNNIRTK-NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             -----H-HHHHHTSC-CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             -----H-HHHHHhcc-CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                 1 12222211 11111100            0001234567888999999999999999999986

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.9e-40  Score=309.66  Aligned_cols=242  Identities=22%  Similarity=0.278  Sum_probs=178.6

Q ss_pred             hhhhhhcCCCCceEEEEEEecc---------------hHHHHHHHHhccCCCceeeeEeEEecC----------------
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD---------------DFVNEVASISRTSHVNVVTLLGFCLEG----------------  133 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~---------------~~~~E~~~l~~l~h~nIv~l~g~~~~~----------------  133 (372)
                      +.+.+.||+|+||.||+++...               ...+|+.+++.++||||+++++++...                
T Consensus         9 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~   88 (383)
T 3eb0_A            9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNK   88 (383)
T ss_dssp             EEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC----------------
T ss_pred             EEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCccccccccccccccc
Confidence            3446789999999999997632               356899999999999999999998543                


Q ss_pred             ----------------------CceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 036435          134 ----------------------NNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKI  191 (372)
Q Consensus       134 ----------------------~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i  191 (372)
                                            ...++||||++ |+|.+.+......  ...+++..+..++.|++.||+|||   +.+|
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~gi  162 (383)
T 3eb0_A           89 LGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS--GRSIPMNLISIYIYQLFRAVGFIH---SLGI  162 (383)
T ss_dssp             ---------------------CCEEEEEECCCS-EEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHH---TTTE
T ss_pred             ccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCcC
Confidence                                  34789999997 5887777542110  123899999999999999999999   8999


Q ss_pred             eecCCCCCceEEC-CCCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc
Q 036435          192 LHFDIKPHNILLD-EDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG  270 (372)
Q Consensus       192 vH~dlk~~Nill~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt  270 (372)
                      +||||||+|||++ .++.+||+|||+++........    ....+|+.|+|||.+.+. ..++.++||||+||++|||++
T Consensus       163 ~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~  237 (383)
T 3eb0_A          163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS----VAYICSRFYRAPELMLGA-TEYTPSIDLWSIGCVFGELIL  237 (383)
T ss_dssp             ECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC----CCCCCCSSCCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHH
T ss_pred             ccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC----cCcccCCCccCHHHhcCC-CCCCcchhhhhHHHHHHHHHh
Confidence            9999999999997 6889999999999876443322    233578899999998764 358999999999999999999


Q ss_pred             CCCCCCCCCCCCCccchHHHHHHHh------------hhcccccCCccCCcc-----hHHHHHHHHHHHHHcccCCCCCC
Q 036435          271 CKNNLDSGVDSSSEVYFPHWIYRHV------------EQDREFKLPGVVTRK-----ENEIAKKMIIVGLWCIQARPSDR  333 (372)
Q Consensus       271 g~~p~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~~p~~R  333 (372)
                      |+.||.......   .+.. +....            ........+......     .......+.+++.+||+.||.+|
T Consensus       238 g~~pf~~~~~~~---~~~~-i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  313 (383)
T 3eb0_A          238 GKPLFSGETSID---QLVR-IIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR  313 (383)
T ss_dssp             SSCSSCCSSHHH---HHHH-HHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred             CCCCCCCCChHH---HHHH-HHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence            999997643211   0000 00000            000111112111111     11134568889999999999999


Q ss_pred             CCHHHHHH
Q 036435          334 PPMNEVIE  341 (372)
Q Consensus       334 Ps~~evl~  341 (372)
                      ||+.|+++
T Consensus       314 ~t~~e~l~  321 (383)
T 3eb0_A          314 INPYEAMA  321 (383)
T ss_dssp             CCHHHHHT
T ss_pred             CCHHHHhc
Confidence            99999985

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=5.3e-40  Score=308.49  Aligned_cols=235  Identities=22%  Similarity=0.270  Sum_probs=163.1

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecC------CceeE
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEG------NNRAL  138 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~------~~~~l  138 (372)
                      .+.+.||+|+||.||+|....                     .+.+|+.++++++||||+++++++...      ...++
T Consensus        32 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~l  111 (367)
T 2fst_X           32 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL  111 (367)
T ss_dssp             EEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEE
T ss_pred             EEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEE
Confidence            345789999999999996532                     567899999999999999999999754      56799


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          139 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       139 V~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      |+||+ +++|.+++...       .+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++
T Consensus       112 v~e~~-~~~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~  180 (367)
T 2fst_X          112 VTHLM-GADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR  180 (367)
T ss_dssp             EEECC-CEECC-----C-------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred             Eeccc-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence            99999 78999988652       2899999999999999999999   7999999999999999999999999999998


Q ss_pred             cccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhc
Q 036435          219 LCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQD  298 (372)
Q Consensus       219 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (372)
                      ......      ....||+.|+|||.+.+. ..++.++|||||||++|||++|+.||.......    ....+.......
T Consensus       181 ~~~~~~------~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~l~~i~~~~g~p  249 (367)
T 2fst_X          181 HTADEM------TGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID----QLKLILRLVGTP  249 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTC-CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCSC
T ss_pred             cccccC------CCcCcCcCccChHHHcCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCC
Confidence            654321      234588999999998763 378999999999999999999999997543211    000011100000


Q ss_pred             cc---------------ccCCccCCcch----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          299 RE---------------FKLPGVVTRKE----NEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       299 ~~---------------~~~~~~~~~~~----~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                      ..               ...+.......    ......+.+++.+||+.||.+|||++|+++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            00               00000000011    1123567889999999999999999999973

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=9e-40  Score=297.98  Aligned_cols=231  Identities=21%  Similarity=0.308  Sum_probs=184.0

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------------hHHHHHHHHhccC-CCceeeeEeEEecCCce
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------------DFVNEVASISRTS-HVNVVTLLGFCLEGNNR  136 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------------~~~~E~~~l~~l~-h~nIv~l~g~~~~~~~~  136 (372)
                      .+.+.||+|+||.||+++...                            .+.+|+.+++++. ||||+++++++.+++..
T Consensus        20 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   99 (298)
T 1phk_A           20 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF   99 (298)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             ceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeE
Confidence            345789999999999987531                            3678999999995 99999999999999999


Q ss_pred             eEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCC
Q 036435          137 ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGL  216 (372)
Q Consensus       137 ~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  216 (372)
                      ++||||+++++|.+++.....      +++..+..++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||+
T Consensus       100 ~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A          100 FLVFDLMKKGELFDYLTEKVT------LSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             EEEEECCTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEEeccCCCcHHHHHhccCC------CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecccc
Confidence            999999999999999976432      899999999999999999999   79999999999999999999999999999


Q ss_pred             cccccCCCCeeeeecccccccccccccccccc----cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHH
Q 036435          217 AKLCTTKEGIVSSLLGARGIIGYIAPEVFSRN----FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIY  292 (372)
Q Consensus       217 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  292 (372)
                      +.........    ....+|+.|+|||.+.+.    ...++.++||||||+++|+|++|+.||......       . ..
T Consensus       171 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~-~~  238 (298)
T 1phk_A          171 SCQLDPGEKL----REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-------L-ML  238 (298)
T ss_dssp             CEECCTTCCB----CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------H-HH
T ss_pred             hhhcCCCccc----ccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH-------H-HH
Confidence            9876543321    234588999999998521    236788999999999999999999999653211       1 11


Q ss_pred             HHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          293 RHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ..+.... ...+   ..........+.+++.+||+.||.+|||+.++++
T Consensus       239 ~~~~~~~-~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          239 RMIMSGN-YQFG---SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHHHHTC-CCCC---TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHhcCC-cccC---cccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            2221111 1111   1111234567888999999999999999999985

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.5e-40  Score=303.41  Aligned_cols=237  Identities=24%  Similarity=0.323  Sum_probs=172.5

Q ss_pred             hhhhhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEe--------------c
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCL--------------E  132 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~--------------~  132 (372)
                      ...+.||+|+||.||+|+...                   ++.+|+.++++++||||+++++++.              +
T Consensus        14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~   93 (320)
T 2i6l_A           14 MDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTE   93 (320)
T ss_dssp             EEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCS
T ss_pred             eEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccc
Confidence            345789999999999997642                   5788999999999999999999874              3


Q ss_pred             CCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC-CCCceEE
Q 036435          133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLD-EDFCPKI  211 (372)
Q Consensus       133 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl  211 (372)
                      .+..++||||++ |+|.+++....       +++..+..++.|++.||+|||   +.+++||||||+|||++ +++.+||
T Consensus        94 ~~~~~lv~e~~~-~~L~~~~~~~~-------~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl  162 (320)
T 2i6l_A           94 LNSVYIVQEYME-TDLANVLEQGP-------LLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKI  162 (320)
T ss_dssp             CSEEEEEEECCS-EEHHHHHTTCC-------CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred             cCceeEEeeccC-CCHHHHhhcCC-------ccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEE
Confidence            467899999997 69999996532       889999999999999999999   78999999999999997 6779999


Q ss_pred             eecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHH
Q 036435          212 SDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWI  291 (372)
Q Consensus       212 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  291 (372)
                      +|||++.................+|..|+|||.+.+. ..++.++||||||+++|||++|+.||.......       ..
T Consensus       163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-------~~  234 (320)
T 2i6l_A          163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE-------QM  234 (320)
T ss_dssp             CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HH
T ss_pred             ccCccccccCCCcccccccccccccccccCcHHhcCc-ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH-------HH
Confidence            9999998765432222223344578899999988653 378999999999999999999999997643211       00


Q ss_pred             HHHhhhcc--------------------cccCCc-cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          292 YRHVEQDR--------------------EFKLPG-VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       292 ~~~~~~~~--------------------~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ........                    ....+. ............+.+++.+||+.||.+|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            00000000                    000000 000011123567889999999999999999999986

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.4e-40  Score=313.16  Aligned_cols=234  Identities=12%  Similarity=0.038  Sum_probs=161.8

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhcc--CCCceeeeE-------eEEecC-
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRT--SHVNVVTLL-------GFCLEG-  133 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l--~h~nIv~l~-------g~~~~~-  133 (372)
                      .+.+.||+|+||.||+|++..                      .+.+|+.+++.+  +||||++++       +++... 
T Consensus        65 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~  144 (371)
T 3q60_A           65 KLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQS  144 (371)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETT
T ss_pred             eeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCC
Confidence            345789999999999997642                      356774444444  699988755       444432 


Q ss_pred             ----------------CceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHH------HHHHHHHHHHHHHHhcCCCCCe
Q 036435          134 ----------------NNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKM------YEIVIGIAKGLEYLHHGCSTKI  191 (372)
Q Consensus       134 ----------------~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~------~~i~~qi~~~l~~LH~~~~~~i  191 (372)
                                      ...++||||++ |+|.+++.....     .+.+..+      +.++.|++.||+|||   +.+|
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-----~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~i  215 (371)
T 3q60_A          145 QPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-----VYVFRGDEGILALHILTAQLIRLAANLQ---SKGL  215 (371)
T ss_dssp             SCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-----SCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             CCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-----ccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCC
Confidence                            23799999998 899999986432     1444555      678899999999999   7999


Q ss_pred             eecCCCCCceEECCCCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcC
Q 036435          192 LHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGC  271 (372)
Q Consensus       192 vH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg  271 (372)
                      +||||||+|||++.++.+||+|||+++......      ....+|+.|+|||.+.+....++.++|||||||++|||++|
T Consensus       216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg  289 (371)
T 3q60_A          216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG------PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL  289 (371)
T ss_dssp             EETTCSGGGEEECTTSCEEECCGGGEEETTCEE------EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred             ccCcCCHHHEEECCCCCEEEEecceeeecCCCc------cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence            999999999999999999999999998653211      13446799999999976223789999999999999999999


Q ss_pred             CCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          272 KNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       272 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      +.||............ .. ............+     ....+...+.+++.+||+.||++|||+.++++
T Consensus       290 ~~Pf~~~~~~~~~~~~-~~-~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          290 FLPFGLVTPGIKGSWK-RP-SLRVPGTDSLAFG-----SCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             SCSTTBCCTTCTTCCC-BC-CTTSCCCCSCCCT-----TSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCCCcCcccccchh-hh-hhhhccccccchh-----hccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            9999876432211000 00 0000000011111     11133567888999999999999999999874

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.2e-39  Score=295.93  Aligned_cols=230  Identities=25%  Similarity=0.363  Sum_probs=184.1

Q ss_pred             HHhhhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEE
Q 036435           83 LTNSFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYE  141 (372)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  141 (372)
                      ..+.+.+.||+|+||.||+++...                     .+.+|+.++++++||||+++++++.+.+..++|+|
T Consensus        22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  101 (287)
T 2wei_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (287)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence            344556889999999999997631                     57899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC---CceEEeecCCcc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDED---FCPKISDFGLAK  218 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfgla~  218 (372)
                      |+++++|.+++.....      +++.+++.++.|++.||+|||   +.+++|+||||+||+++.+   +.+||+|||++.
T Consensus       102 ~~~~~~L~~~l~~~~~------~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~  172 (287)
T 2wei_A          102 LYTGGELFDEIIKRKR------FSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (287)
T ss_dssp             CCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred             ccCCCCHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence            9999999999876432      899999999999999999999   7899999999999999754   479999999998


Q ss_pred             cccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhc
Q 036435          219 LCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQD  298 (372)
Q Consensus       219 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (372)
                      ........    ....+|+.|+|||.+.+   .++.++||||||+++|+|++|+.||......       . ....+...
T Consensus       173 ~~~~~~~~----~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~-~~~~~~~~  237 (287)
T 2wei_A          173 CFQQNTKM----KDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-------D-ILKRVETG  237 (287)
T ss_dssp             TBCCCSSC----SCHHHHHTTCCHHHHTT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------H-HHHHHHHC
T ss_pred             eecCCCcc----ccccCcccccChHHhcC---CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH-------H-HHHHHHcC
Confidence            66443221    22347889999999875   5789999999999999999999999754211       1 12222221


Q ss_pred             c-cccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          299 R-EFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       299 ~-~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      . ....+     ....+...+.+++.+||+.||++|||++++++
T Consensus       238 ~~~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          238 KYAFDLP-----QWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             CCCCCSG-----GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCch-----hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            1 11111     11223456788999999999999999999997

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=5e-40  Score=314.15  Aligned_cols=242  Identities=24%  Similarity=0.308  Sum_probs=177.3

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------hHHHHHHHHhccCCCceeeeEeEEecC------CceeEEEEecC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------DFVNEVASISRTSHVNVVTLLGFCLEG------NNRALIYEFMP  144 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------~~~~E~~~l~~l~h~nIv~l~g~~~~~------~~~~lV~e~~~  144 (372)
                      ...+.||+|+||.||+|++..               ...+|++++++++||||+++++++...      ...++||||++
T Consensus        57 ~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~  136 (420)
T 1j1b_A           57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP  136 (420)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCC
T ss_pred             EeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhccc
Confidence            445789999999999998742               355899999999999999999998642      23679999997


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC-CceEEeecCCcccccCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDED-FCPKISDFGLAKLCTTK  223 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgla~~~~~~  223 (372)
                      + +|.+.+......  ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.+ +.+||+|||+++.....
T Consensus       137 ~-~l~~~~~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~  210 (420)
T 1j1b_A          137 E-TVYRVARHYSRA--KQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG  210 (420)
T ss_dssp             E-EHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             c-cHHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhhhcccC
Confidence            5 676665431100  123899999999999999999999   8999999999999999955 67899999999876443


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHH-------HHhh
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIY-------RHVE  296 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~~  296 (372)
                      ...    ....+|+.|+|||++.+. ..++.++|||||||++|||++|+.||.......   .+...+.       ..+.
T Consensus       211 ~~~----~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~---~l~~i~~~lg~p~~~~~~  282 (420)
T 1j1b_A          211 EPN----VSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD---QLVEIIKVLGTPTREQIR  282 (420)
T ss_dssp             CCC----CSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCSCCHHHHH
T ss_pred             CCc----eeeeeCCCcCCHHHHcCC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHHH
Confidence            321    234588999999998763 368999999999999999999999997643211   1111100       0000


Q ss_pred             h----cccccCCccCCcch-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          297 Q----DREFKLPGVVTRKE-----NEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       297 ~----~~~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .    ...+..+.......     ......+.+++.+||+.||.+|||+.|+++
T Consensus       283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            0    01112222111111     122467889999999999999999999986

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=4e-40  Score=304.21  Aligned_cols=231  Identities=26%  Similarity=0.391  Sum_probs=175.8

Q ss_pred             hhhhcCCCCceEEEEEEecc------------------hHHHHHHHHhcc-CCCceeeeEeEEec------CCceeEEEE
Q 036435           87 FKDKLGQGGFGGVYKGRLLD------------------DFVNEVASISRT-SHVNVVTLLGFCLE------GNNRALIYE  141 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~------------------~~~~E~~~l~~l-~h~nIv~l~g~~~~------~~~~~lV~e  141 (372)
                      +.+.||+|+||.||+|+...                  .+.+|+.+++++ +||||+++++++..      .+..++|||
T Consensus        28 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e  107 (326)
T 2x7f_A           28 LVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVME  107 (326)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEE
T ss_pred             EEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEE
Confidence            45789999999999997632                  588999999999 89999999999987      467899999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      |+++|+|.+++.....    ..+++..+..++.|++.||+|||   +.+++|+||||+|||++.++.+||+|||++....
T Consensus       108 ~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  180 (326)
T 2x7f_A          108 FCGAGSVTDLIKNTKG----NTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  180 (326)
T ss_dssp             CCTTEEHHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCTTTC---
T ss_pred             cCCCCcHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEeeCcCceecC
Confidence            9999999999986532    23899999999999999999999   7899999999999999999999999999998654


Q ss_pred             CCCCeeeeecccccccccccccccccc---cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhc
Q 036435          222 TKEGIVSSLLGARGIIGYIAPEVFSRN---FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQD  298 (372)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (372)
                      .....   .....||+.|+|||.+...   ...++.++|||||||++|+|++|+.||......       . ....+...
T Consensus       181 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~-~~~~~~~~  249 (326)
T 2x7f_A          181 RTVGR---RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-------R-ALFLIPRN  249 (326)
T ss_dssp             -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-------H-HHHHHHHS
T ss_pred             cCccc---cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-------H-HHHHhhcC
Confidence            32211   1233588999999998631   136789999999999999999999999653211       0 11111111


Q ss_pred             ccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          299 REFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .   .+....   ..+...+.+++.+||+.||.+||+++++++
T Consensus       250 ~---~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          250 P---APRLKS---KKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             C---CCCCSC---SCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             c---cccCCc---cccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            1   111111   112356778999999999999999999986

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.1e-39  Score=295.81  Aligned_cols=233  Identities=28%  Similarity=0.424  Sum_probs=174.0

Q ss_pred             hhhhhcCCCCceEEEEEEecc------------------hHHHHHHHHhccCCCceeeeEeEEec-------------CC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD------------------DFVNEVASISRTSHVNVVTLLGFCLE-------------GN  134 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~------------------~~~~E~~~l~~l~h~nIv~l~g~~~~-------------~~  134 (372)
                      .+.+.||+|+||.||+|+...                  .+.+|+.++++++||||+++++++.+             .+
T Consensus         9 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~   88 (303)
T 1zy4_A            9 EEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKS   88 (303)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEE
T ss_pred             hhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCC
Confidence            445789999999999997632                  57889999999999999999998865             35


Q ss_pred             ceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeec
Q 036435          135 NRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDF  214 (372)
Q Consensus       135 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  214 (372)
                      ..++||||+++|+|.+++.....     .+++..++.++.|++.||+|||   +.+++|+||||+|||++.++.+||+||
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~df  160 (303)
T 1zy4_A           89 TLFIQMEYCENGTLYDLIHSENL-----NQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDF  160 (303)
T ss_dssp             EEEEEEECCCSCBHHHHHHHSCG-----GGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred             ceEEEEecCCCCCHHHhhhcccc-----ccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEeeC
Confidence            67999999999999999976432     2788999999999999999999   789999999999999999999999999


Q ss_pred             CCcccccCCCCe-----------eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCC
Q 036435          215 GLAKLCTTKEGI-----------VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSS  283 (372)
Q Consensus       215 gla~~~~~~~~~-----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~  283 (372)
                      |++.........           ........||+.|+|||.+.+. +.++.++||||||+++|+|++   ||.....   
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~---p~~~~~~---  233 (303)
T 1zy4_A          161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIY---PFSTGME---  233 (303)
T ss_dssp             CCCSCTTC-------------------------CTTSCHHHHTSC-SCCCTHHHHHHHHHHHHHHHS---CCSSHHH---
T ss_pred             cchhhcccccchhccccccccccccccccCCCcccccCcccccCC-CCCcchhhHHHHHHHHHHHHh---ccCCchh---
Confidence            999865432110           1112334588999999998764 468899999999999999998   4432100   


Q ss_pred             ccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          284 EVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                          .......+.. .....+....   ......+.+++.+||+.||.+|||++++++
T Consensus       234 ----~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          234 ----RVNILKKLRS-VSIEFPPDFD---DNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             ----HHHHHHHHHS-TTCCCCTTCC---TTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----HHHHHHhccc-cccccCcccc---ccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence                0011111111 1112222221   223456778999999999999999999986

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=8.2e-40  Score=303.74  Aligned_cols=231  Identities=22%  Similarity=0.308  Sum_probs=156.4

Q ss_pred             hhcCCCCceEEEEEEecc--------------hHHHHHH-HHhccCCCceeeeEeEEec----CCceeEEEEecCCCChh
Q 036435           89 DKLGQGGFGGVYKGRLLD--------------DFVNEVA-SISRTSHVNVVTLLGFCLE----GNNRALIYEFMPNGSLE  149 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~--------------~~~~E~~-~l~~l~h~nIv~l~g~~~~----~~~~~lV~e~~~~g~L~  149 (372)
                      +.||+|+||.||+++...              ...+|+. .++.++||||+++++++..    +...++||||+++|+|.
T Consensus        35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~  114 (336)
T 3fhr_A           35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELF  114 (336)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHH
T ss_pred             eeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHH
Confidence            469999999999997752              2344444 4566799999999999976    44589999999999999


Q ss_pred             hhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC---CCceEEeecCCcccccCCCCe
Q 036435          150 KFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE---DFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       150 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      +++......    .+++.+++.++.|++.||+|||   +.+++||||||+|||++.   ++.+||+|||++.......  
T Consensus       115 ~~l~~~~~~----~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~--  185 (336)
T 3fhr_A          115 SRIQERGDQ----AFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--  185 (336)
T ss_dssp             HHHHTC-CC----CCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC------
T ss_pred             HHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccceeccccc--
Confidence            999875432    3899999999999999999999   789999999999999976   4559999999998654322  


Q ss_pred             eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCcc
Q 036435          227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV  306 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (372)
                         .....+|+.|+|||.+.+.  .++.++||||||+++|+|++|+.||...........    ....... .....+. 
T Consensus       186 ---~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----~~~~~~~-~~~~~~~-  254 (336)
T 3fhr_A          186 ---LQTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG----MKRRIRL-GQYGFPN-  254 (336)
T ss_dssp             ---------------------C--HHHHHHHHHHHHHHHHHHHHSSCCC--------------------------CCCT-
T ss_pred             ---cccCCCCcCccChhhhCCC--CCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh----HHHhhhc-cccccCc-
Confidence               1234578999999998764  788999999999999999999999976533221000    0000100 0111111 


Q ss_pred             CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       307 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                        .....+...+.+++.+||+.||.+|||++|+++
T Consensus       255 --~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          255 --PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             --TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             --hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence              111223456788999999999999999999997

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.2e-39  Score=301.07  Aligned_cols=238  Identities=24%  Similarity=0.398  Sum_probs=181.5

Q ss_pred             hhhhhcCCCCceEEEEEEec-c---------------------hHHHHHHHHhcc---CCCceeeeEeEEe-----cCCc
Q 036435           86 SFKDKLGQGGFGGVYKGRLL-D---------------------DFVNEVASISRT---SHVNVVTLLGFCL-----EGNN  135 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~-~---------------------~~~~E~~~l~~l---~h~nIv~l~g~~~-----~~~~  135 (372)
                      .+.+.||+|+||.||+++.. .                     .+.+|+.+++.+   +||||+++++++.     ....
T Consensus        14 ~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   93 (326)
T 1blx_A           14 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK   93 (326)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEE
T ss_pred             eeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCce
Confidence            34578999999999999763 1                     467888888877   8999999999997     5567


Q ss_pred             eeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecC
Q 036435          136 RALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFG  215 (372)
Q Consensus       136 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  215 (372)
                      .++|+||++ |+|.+++......    .+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||
T Consensus        94 ~~lv~e~~~-~~L~~~l~~~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Dfg  165 (326)
T 1blx_A           94 LTLVFEHVD-QDLTTYLDKVPEP----GVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFG  165 (326)
T ss_dssp             EEEEEECCS-CBHHHHHHHSCTT----CSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             EEEEEecCC-CCHHHHHHhcccC----CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecCc
Confidence            899999997 6999999875432    2899999999999999999999   7899999999999999999999999999


Q ss_pred             CcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHh
Q 036435          216 LAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV  295 (372)
Q Consensus       216 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  295 (372)
                      ++........    .....||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||.......    ....+....
T Consensus       166 ~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~i~~~~  235 (326)
T 1blx_A          166 LARIYSFQMA----LTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD----QLGKILDVI  235 (326)
T ss_dssp             SCCCCCGGGG----GCCCCCCCTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHH
T ss_pred             ccccccCCCC----ccccccccceeCHHHHhcC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHHHHc
Confidence            9986543221    1234588999999999774  78999999999999999999999997543211    001111111


Q ss_pred             hhcccccCC---------------ccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          296 EQDREFKLP---------------GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       296 ~~~~~~~~~---------------~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ........+               .........+...+.+++.+||+.||.+|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            000000000               0001111224466788999999999999999999995

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=9.3e-40  Score=296.61  Aligned_cols=233  Identities=26%  Similarity=0.334  Sum_probs=168.6

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      .+.+.||+|+||.||+++...                     .+.++...++.++||||+++++++.+++..++||||++
T Consensus        10 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~   89 (290)
T 3fme_A           10 EPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD   89 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS
T ss_pred             hhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc
Confidence            445789999999999997632                     23344555788899999999999999999999999997


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCST-KILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                       |+|.+++......  ...+++..+..++.|++.||+|||   +. +++||||||+||+++.++.+||+|||++......
T Consensus        90 -~~l~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  163 (290)
T 3fme_A           90 -TSLDKFYKQVIDK--GQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD  163 (290)
T ss_dssp             -EEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC---------
T ss_pred             -cchHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccccccc
Confidence             5888877542110  123899999999999999999999   66 9999999999999999999999999999865443


Q ss_pred             CCeeeeeccccccccccccccccc--ccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccc
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSR--NFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF  301 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (372)
                      ...    ....||+.|+|||.+..  ....++.++||||||+++|+|++|+.||.......      .......... ..
T Consensus       164 ~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~-~~  232 (290)
T 3fme_A          164 VAK----DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF------QQLKQVVEEP-SP  232 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH------HHHHHHHHSC-CC
T ss_pred             ccc----cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH------HHHHHHhccC-CC
Confidence            221    22358899999999732  11367899999999999999999999997532211      1111111111 11


Q ss_pred             cCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       302 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ..+      .......+.+++.+||+.||++|||++|+++
T Consensus       233 ~~~------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          233 QLP------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             CCC------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             Ccc------cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            111      1123456788999999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.9e-39  Score=300.76  Aligned_cols=237  Identities=20%  Similarity=0.283  Sum_probs=182.5

Q ss_pred             hhhhhhcCCCCceEEEEEEec-------------------chHHHHHHHHhccCCCc------eeeeEeEEecCCceeEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL-------------------DDFVNEVASISRTSHVN------VVTLLGFCLEGNNRALI  139 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-------------------~~~~~E~~~l~~l~h~n------Iv~l~g~~~~~~~~~lV  139 (372)
                      +.+.+.||+|+||.||++...                   +.+.+|+.++++++|+|      ++++++++.+++..++|
T Consensus        16 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv   95 (339)
T 1z57_A           16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIV   95 (339)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEE
T ss_pred             eEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEE
Confidence            345678999999999999752                   14778999999997665      99999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC--------------
Q 036435          140 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE--------------  205 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~--------------  205 (372)
                      |||+ +++|.+++......    .+++..+..++.|++.||+|||   +.+++||||||+|||++.              
T Consensus        96 ~e~~-~~~l~~~l~~~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           96 FELL-GLSTYDFIKENGFL----PFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             EECC-CCBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             EcCC-CCCHHHHHHhcCCC----CCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence            9999 88999999876532    2899999999999999999999   789999999999999987              


Q ss_pred             -----CCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCC
Q 036435          206 -----DFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVD  280 (372)
Q Consensus       206 -----~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~  280 (372)
                           ++.+||+|||++.......      ....||+.|+|||.+.+.  .++.++|||||||++|||++|..||.....
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~  239 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDEHH------STLVSTRHYRAPEVILAL--GWSQPCDVWSIGCILIEYYLGFTVFPTHDS  239 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTSCC------CSSCSCGGGCCHHHHTTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred             cccccCCCceEeeCcccccCcccc------ccccCCccccChHHhhCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence                 6689999999998654322      234589999999999874  789999999999999999999999975432


Q ss_pred             CCCccchHHHHHHHhh-----------hcc-----cccCCc----------------cCCcchHHHHHHHHHHHHHcccC
Q 036435          281 SSSEVYFPHWIYRHVE-----------QDR-----EFKLPG----------------VVTRKENEIAKKMIIVGLWCIQA  328 (372)
Q Consensus       281 ~~~~~~~~~~~~~~~~-----------~~~-----~~~~~~----------------~~~~~~~~~~~~l~~l~~~cl~~  328 (372)
                      ..    ....+.....           ...     ....+.                ............+.+++.+||+.
T Consensus       240 ~~----~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~  315 (339)
T 1z57_A          240 KE----HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY  315 (339)
T ss_dssp             HH----HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred             HH----HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc
Confidence            11    0000000000           000     000000                00011123457788999999999


Q ss_pred             CCCCCCCHHHHHH
Q 036435          329 RPSDRPPMNEVIE  341 (372)
Q Consensus       329 ~p~~RPs~~evl~  341 (372)
                      ||.+|||++|+++
T Consensus       316 dP~~Rpt~~ell~  328 (339)
T 1z57_A          316 DPAKRITLREALK  328 (339)
T ss_dssp             STTTSCCHHHHTT
T ss_pred             CcccccCHHHHhc
Confidence            9999999999985

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3e-39  Score=303.85  Aligned_cols=246  Identities=20%  Similarity=0.244  Sum_probs=182.3

Q ss_pred             HhhhhhhcCCCCceEEEEEEecc------------------hHHHHHHHHhccC-----------CCceeeeEeEEecCC
Q 036435           84 TNSFKDKLGQGGFGGVYKGRLLD------------------DFVNEVASISRTS-----------HVNVVTLLGFCLEGN  134 (372)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~~------------------~~~~E~~~l~~l~-----------h~nIv~l~g~~~~~~  134 (372)
                      .+.+.+.||+|+||.||+++...                  .+.+|+.++++++           ||||+++++++...+
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~   99 (373)
T 1q8y_A           20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG   99 (373)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred             eEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccC
Confidence            34556789999999999997532                  4778999999886           899999999998654


Q ss_pred             ----ceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCceEEC-----
Q 036435          135 ----NRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCST-KILHFDIKPHNILLD-----  204 (372)
Q Consensus       135 ----~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~-~ivH~dlk~~Nill~-----  204 (372)
                          ..++||||+ +++|.+++......    .+++..+..++.|++.||+|||   +. +|+||||||+|||++     
T Consensus       100 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~----~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A          100 PNGVHVVMVFEVL-GENLLALIKKYEHR----GIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             TTEEEEEEEECCC-CEEHHHHHHHTTTS----CCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETT
T ss_pred             CCCceEEEEEecC-CCCHHHHHHHhhcc----CCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCC
Confidence                789999999 88999999875432    2899999999999999999999   66 999999999999994     


Q ss_pred             -CCCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCC
Q 036435          205 -EDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSS  283 (372)
Q Consensus       205 -~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~  283 (372)
                       ..+.+||+|||++.......      ....||+.|+|||.+.+.  .++.++|||||||++|||++|+.||........
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~~------~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  243 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEHY------TNSIQTREYRSPEVLLGA--PWGCGADIWSTACLIFELITGDFLFEPDEGHSY  243 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBCC------CSCCSCGGGCCHHHHHTC--CCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             cCcceEEEcccccccccCCCC------CCCCCCccccCcHHHhCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCccccc
Confidence             44589999999998664332      233589999999999875  789999999999999999999999986542211


Q ss_pred             ccchHHHHHHHhhhcc---------------------cccC-Cc-----------cCCcchHHHHHHHHHHHHHcccCCC
Q 036435          284 EVYFPHWIYRHVEQDR---------------------EFKL-PG-----------VVTRKENEIAKKMIIVGLWCIQARP  330 (372)
Q Consensus       284 ~~~~~~~~~~~~~~~~---------------------~~~~-~~-----------~~~~~~~~~~~~l~~l~~~cl~~~p  330 (372)
                      ... ...+........                     .... ..           ............+.+++.+||+.||
T Consensus       244 ~~~-~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  322 (373)
T 1q8y_A          244 TKD-DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP  322 (373)
T ss_dssp             -CH-HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred             CCh-HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCc
Confidence            100 000011000000                     0000 00           0011224567788999999999999


Q ss_pred             CCCCCHHHHHH--HhhcC
Q 036435          331 SDRPPMNEVIE--MLQGS  346 (372)
Q Consensus       331 ~~RPs~~evl~--~L~~~  346 (372)
                      .+|||++|+++  .+.+.
T Consensus       323 ~~Rpt~~ell~hp~f~~~  340 (373)
T 1q8y_A          323 RKRADAGGLVNHPWLKDT  340 (373)
T ss_dssp             TTCBCHHHHHTCGGGTTC
T ss_pred             cccCCHHHHhhChhhhcc
Confidence            99999999997  34443

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=8.9e-40  Score=307.58  Aligned_cols=231  Identities=23%  Similarity=0.275  Sum_probs=175.6

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCce------eE
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNR------AL  138 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~------~l  138 (372)
                      .+.+.||+|+||.||+++...                     .+.+|+.++++++||||+++++++...+..      ++
T Consensus        45 ~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l  124 (371)
T 4exu_A           45 VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYL  124 (371)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEE
T ss_pred             EEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEE
Confidence            345679999999999996532                     577899999999999999999999887655      99


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          139 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       139 V~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      ||||+. ++|.+++..        .+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++
T Consensus       125 v~e~~~-~~l~~~~~~--------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  192 (371)
T 4exu_A          125 VMPFMQ-TDLQKIMGM--------EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR  192 (371)
T ss_dssp             EEECCC-EEHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred             EEcccc-ccHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence            999996 689888732        1899999999999999999999   7899999999999999999999999999998


Q ss_pred             cccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhc
Q 036435          219 LCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQD  298 (372)
Q Consensus       219 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (372)
                      ......      ....||+.|+|||.+.+. ..++.++|||||||++|+|++|+.||.......       .........
T Consensus       193 ~~~~~~------~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------~~~~i~~~~  258 (371)
T 4exu_A          193 HADAEM------TGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-------QLTQILKVT  258 (371)
T ss_dssp             -------------CTTCCCTTSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHHH
T ss_pred             ccccCc------CCcccCccccCHHHhcCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH-------HHHHHHHHh
Confidence            654321      334589999999998763 378999999999999999999999997542111       011110000


Q ss_pred             cc------------------ccCCccCCcc----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          299 RE------------------FKLPGVVTRK----ENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       299 ~~------------------~~~~~~~~~~----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                      ..                  ...+......    .......+.+++.+||+.||++|||++|+++.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          259 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             CCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            00                  0000000000    11234678889999999999999999999973

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=8.4e-40  Score=306.59  Aligned_cols=236  Identities=19%  Similarity=0.221  Sum_probs=171.7

Q ss_pred             hhhcCCCCceEEEEEEec-----------------------------chHHHHHHHHhccCCCceeeeEeEEec-----C
Q 036435           88 KDKLGQGGFGGVYKGRLL-----------------------------DDFVNEVASISRTSHVNVVTLLGFCLE-----G  133 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~-----------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~-----~  133 (372)
                      .+.||+|+||.||++...                             +.+.+|+.++++++||||+++++++..     .
T Consensus        27 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (362)
T 3pg1_A           27 QRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAM  106 (362)
T ss_dssp             EEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTC
T ss_pred             eEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCc
Confidence            478999999999998542                             357899999999999999999999854     3


Q ss_pred             CceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEee
Q 036435          134 NNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISD  213 (372)
Q Consensus       134 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  213 (372)
                      ...++||||++ |+|.+++.....     .+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|
T Consensus       107 ~~~~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~D  177 (362)
T 3pg1_A          107 HKLYLVTELMR-TDLAQVIHDQRI-----VISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICD  177 (362)
T ss_dssp             CEEEEEEECCS-EEHHHHHHCTTS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             ceEEEEEccCC-CCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEEcCCCCEEEEe
Confidence            36799999997 689888875432     3899999999999999999999   78999999999999999999999999


Q ss_pred             cCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHH
Q 036435          214 FGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYR  293 (372)
Q Consensus       214 fgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  293 (372)
                      ||++........    .....+|+.|+|||.+.+. ..++.++|||||||++|+|++|+.||.......    ....+..
T Consensus       178 fg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~i~~  248 (362)
T 3pg1_A          178 FNLAREDTADAN----KTHYVTHRWYRAPELVMQF-KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN----QLNKIVE  248 (362)
T ss_dssp             TTC-------------------CGGGCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHH
T ss_pred             cCcccccccccc----cceecccceecCcHHhcCC-CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH----HHHHHHH
Confidence            999975433221    1234588899999998763 368999999999999999999999997543111    0000000


Q ss_pred             Hhhh-------------------cccccCCc-cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          294 HVEQ-------------------DREFKLPG-VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       294 ~~~~-------------------~~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ....                   ......+. ............+.+++.+||+.||.+|||++|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          249 VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            0000                   00000000 000011122456788999999999999999999996

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3e-39  Score=310.04  Aligned_cols=239  Identities=22%  Similarity=0.296  Sum_probs=171.7

Q ss_pred             hhhcCCCCceEEEEEEec---------------chHHHHHHHHhcc-CCCceeeeEeEEecCCceeEEEEecCCCChhhh
Q 036435           88 KDKLGQGGFGGVYKGRLL---------------DDFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF  151 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~---------------~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~~~  151 (372)
                      .+.||+|+||+||.+...               +.+.+|+.+++++ +||||+++++++.+++..++||||+. |+|.++
T Consensus        20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~   98 (434)
T 2rio_A           20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDL   98 (434)
T ss_dssp             EEEEEECSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHH
T ss_pred             cCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHH
Confidence            367999999999754221               2467899999987 89999999999999999999999995 699999


Q ss_pred             hhcCCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC-------------CceEEeecCCc
Q 036435          152 VYNGDTSKPC-QYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDED-------------FCPKISDFGLA  217 (372)
Q Consensus       152 l~~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-------------~~~kl~Dfgla  217 (372)
                      +......... ...++..++.++.|++.||+|||   +.+|+||||||+|||++.+             +.+||+|||++
T Consensus        99 l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a  175 (434)
T 2rio_A           99 VESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC  175 (434)
T ss_dssp             HHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTC
T ss_pred             HhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccc
Confidence            9875432211 11234456789999999999999   7899999999999999754             48999999999


Q ss_pred             ccccCCCCee-eeecccccccccccccccccc-----cCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHH
Q 036435          218 KLCTTKEGIV-SSLLGARGIIGYIAPEVFSRN-----FGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHW  290 (372)
Q Consensus       218 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~  290 (372)
                      .......... .......||+.|+|||++.+.     ...++.++|||||||++|||++ |+.||.......        
T Consensus       176 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--------  247 (434)
T 2rio_A          176 KKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--------  247 (434)
T ss_dssp             EECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--------
T ss_pred             eecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--------
Confidence            8765433221 112344689999999998651     1367899999999999999998 889986532110        


Q ss_pred             HHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          291 IYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                       ......  ....+.............+.+++.+||+.||.+|||+.++++
T Consensus       248 -~~i~~~--~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 -SNIIRG--IFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             -HHHHHT--CCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -HHHhcC--CCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence             111111  111122222223456778899999999999999999999985

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=4.8e-39  Score=295.50  Aligned_cols=231  Identities=20%  Similarity=0.326  Sum_probs=176.0

Q ss_pred             hhhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccC--CCceeeeEeEEecCCceeEEEEec
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTS--HVNVVTLLGFCLEGNNRALIYEFM  143 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~--h~nIv~l~g~~~~~~~~~lV~e~~  143 (372)
                      .+.+.||+|+||.||+++..+                    .+.+|+.++.+++  ||||+++++++.+++..++||| +
T Consensus        31 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~  109 (313)
T 3cek_A           31 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-C  109 (313)
T ss_dssp             EEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-C
T ss_pred             EEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-c
Confidence            445789999999999986532                    5788999999997  5999999999999999999999 5


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      .+++|.+++.....      +++..+..++.|+++||+|||   +.+++||||||+|||+++ +.+||+|||++......
T Consensus       110 ~~~~L~~~l~~~~~------~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~  179 (313)
T 3cek_A          110 GNIDLNSWLKKKKS------IDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPD  179 (313)
T ss_dssp             CSEEHHHHHHHCSS------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC----
T ss_pred             CCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccccccccCc
Confidence            58899999987542      899999999999999999999   789999999999999965 89999999999876543


Q ss_pred             CCeeeeecccccccccccccccccc---------cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHH
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRN---------FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRH  294 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  294 (372)
                      ..... .....||+.|+|||.+.+.         ...++.++||||||+++|||++|+.||......      .......
T Consensus       180 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------~~~~~~~  252 (313)
T 3cek_A          180 TTSVV-KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------ISKLHAI  252 (313)
T ss_dssp             -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH------HHHHHHH
T ss_pred             ccccc-ccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH------HHHHHHH
Confidence            32111 1234589999999998641         126788999999999999999999999754221      1112222


Q ss_pred             hhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          295 VEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .........+...       ...+.+++.+||+.||.+|||++|+++
T Consensus       253 ~~~~~~~~~~~~~-------~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          253 IDPNHEIEFPDIP-------EKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             HCTTSCCCCCCCS-------CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HhcccccCCcccc-------hHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            2222222222221       346778899999999999999999996

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.9e-39  Score=299.96  Aligned_cols=237  Identities=23%  Similarity=0.305  Sum_probs=159.7

Q ss_pred             hhhhhcCCCCceEEEEEEecc--------------------hHHHHHH-HHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD--------------------DFVNEVA-SISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~-~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      .+.+.||+|+||.||++....                    ++.+|+. +++.++||||+++++++.+++..++||||++
T Consensus        25 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~  104 (327)
T 3aln_A           25 KDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS  104 (327)
T ss_dssp             EC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             hehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecC
Confidence            345779999999999997642                    3455665 7778899999999999999999999999997


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCST-KILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      + +|.+++...... ....+++..+..++.|++.||.|||   .. +++||||||+|||++.++.+||+|||++......
T Consensus       105 ~-~l~~~~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  179 (327)
T 3aln_A          105 T-SFDKFYKYVYSV-LDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS  179 (327)
T ss_dssp             E-EHHHHHHHHHHT-TCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC----
T ss_pred             C-ChHHHHHHHHhh-hcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccc
Confidence            5 888777531100 0123899999999999999999999   66 9999999999999999999999999999865433


Q ss_pred             CCeeeeecccccccccccccccccc--cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccc
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRN--FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF  301 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (372)
                      ..    .....||+.|+|||.+...  ...++.++||||||+++|+|++|+.||.......          .........
T Consensus       180 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----------~~~~~~~~~  245 (327)
T 3aln_A          180 IA----KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF----------DQLTQVVKG  245 (327)
T ss_dssp             ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------------CCCCCS
T ss_pred             cc----cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH----------HHHHHHhcC
Confidence            21    1223588999999998421  1367899999999999999999999997542211          001111010


Q ss_pred             cCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       302 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ..+.............+.+++.+||+.||.+|||++++++
T Consensus       246 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          246 DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            1111111111223457888999999999999999999975

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=5.3e-39  Score=300.80  Aligned_cols=251  Identities=21%  Similarity=0.252  Sum_probs=171.2

Q ss_pred             hhhhhcCCCCceEEEEEEecc------------------hHHHHHHHHhccCCCceeeeEeEEecCCc-------eeEEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD------------------DFVNEVASISRTSHVNVVTLLGFCLEGNN-------RALIY  140 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~-------~~lV~  140 (372)
                      .+.+.||+|+||.||+|+...                  .+.+|+..++.++||||+++++++...+.       .++||
T Consensus        26 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~  105 (360)
T 3e3p_A           26 QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVM  105 (360)
T ss_dssp             EEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEE
T ss_pred             EEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEe
Confidence            345789999999999997632                  57788888899999999999999976443       78999


Q ss_pred             EecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC-CCceEEeecCCccc
Q 036435          141 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE-DFCPKISDFGLAKL  219 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgla~~  219 (372)
                      ||+++ +|.+.+.....  ....+++..+..++.|++.||.|||.. +.+|+||||||+|||++. ++.+||+|||++..
T Consensus       106 e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~  181 (360)
T 3e3p_A          106 EYVPD-TLHRCCRNYYR--RQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKK  181 (360)
T ss_dssp             ECCSC-BHHHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEEEECCCTTCBC
T ss_pred             ecccc-cHHHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcEEEeeCCCcee
Confidence            99976 55544432110  012388999999999999999999932 589999999999999996 89999999999987


Q ss_pred             ccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHH-------
Q 036435          220 CTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIY-------  292 (372)
Q Consensus       220 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-------  292 (372)
                      .......    ....||+.|+|||.+.+. ..++.++|||||||++|||++|+.||.......   .+.....       
T Consensus       182 ~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~~  253 (360)
T 3e3p_A          182 LSPSEPN----VAYICSRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG---QLHEIVRVLGCPSR  253 (360)
T ss_dssp             CCTTSCC----CSTTSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCH
T ss_pred             cCCCCCc----ccccCCcceeCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH---HHHHHHHHcCCCCH
Confidence            6543322    234588999999998664 358999999999999999999999997643211   0000000       


Q ss_pred             ---HHhhh-cccccCCc--------cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hhcCcc
Q 036435          293 ---RHVEQ-DREFKLPG--------VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM--LQGSTE  348 (372)
Q Consensus       293 ---~~~~~-~~~~~~~~--------~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~--L~~~~~  348 (372)
                         ..... ........        ............+.+++.+||+.||.+|||+.|+++.  +++...
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  323 (360)
T 3e3p_A          254 EVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD  323 (360)
T ss_dssp             HHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred             HHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence               00000 00000000        0011111135678899999999999999999999973  555443

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.7e-39  Score=301.33  Aligned_cols=232  Identities=22%  Similarity=0.261  Sum_probs=175.4

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCc------eeE
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNN------RAL  138 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~------~~l  138 (372)
                      .+.+.||+|+||.||+|+...                     .+.+|+.++++++||||+++++++...+.      .++
T Consensus        27 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l  106 (353)
T 3coi_A           27 VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYL  106 (353)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEE
T ss_pred             EEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEE
Confidence            345779999999999997532                     47789999999999999999999987654      499


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          139 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       139 V~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      ||||+. |+|.+++..        .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.
T Consensus       107 v~e~~~-~~l~~~~~~--------~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  174 (353)
T 3coi_A          107 VMPFMQ-TDLQKIMGL--------KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR  174 (353)
T ss_dssp             EEECCS-EEGGGTTTS--------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred             Eecccc-CCHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeeccccc
Confidence            999997 689887742        2899999999999999999999   7899999999999999999999999999998


Q ss_pred             cccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHH----
Q 036435          219 LCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRH----  294 (372)
Q Consensus       219 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~----  294 (372)
                      ......      ....+|+.|+|||.+.+. ..++.++||||||+++|+|++|+.||.......   .+ ..+...    
T Consensus       175 ~~~~~~------~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~-~~i~~~~~~~  243 (353)
T 3coi_A          175 HADAEM------TGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QL-TQILKVTGVP  243 (353)
T ss_dssp             C--------------CCSBCCSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH---HH-HHHHHHHCBC
T ss_pred             CCCCCc------cccccCcCcCCHHHHhCc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH-HHHHHHhCCC
Confidence            654321      234578999999998763 378899999999999999999999997543110   00 000000    


Q ss_pred             ----------------hhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          295 ----------------VEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       295 ----------------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                                      ....... ...............+.+++.+||+.||++|||++++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          244 GTEFVQKLNDKAAKSYIQSLPQT-PRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             CHHHHTTCSCHHHHHHHHTSCBC-SSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CHHHHHHHhhHHHHHHHHhCcCC-CCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                            0000000 000011111233567888999999999999999999986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.7e-39  Score=296.02  Aligned_cols=222  Identities=25%  Similarity=0.408  Sum_probs=175.4

Q ss_pred             HHhhhhhhcCCCCceEEEEEEecc-------------------------hHHHHHHHHhcc----CCCceeeeEeEEecC
Q 036435           83 LTNSFKDKLGQGGFGGVYKGRLLD-------------------------DFVNEVASISRT----SHVNVVTLLGFCLEG  133 (372)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~~-------------------------~~~~E~~~l~~l----~h~nIv~l~g~~~~~  133 (372)
                      ..+.+.+.||+|+||.||+++...                         .+.+|+.++.++    +||||+++++++.+.
T Consensus        31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~  110 (312)
T 2iwi_A           31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ  110 (312)
T ss_dssp             --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred             hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC
Confidence            345556889999999999996521                         345699999999    899999999999999


Q ss_pred             CceeEEEEe-cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC-CCCceEE
Q 036435          134 NNRALIYEF-MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLD-EDFCPKI  211 (372)
Q Consensus       134 ~~~~lV~e~-~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl  211 (372)
                      +..++|+|| +.+++|.+++.....      +++..++.++.|++.||+|||   +.+++||||||+||+++ +++.+||
T Consensus       111 ~~~~~v~e~~~~~~~L~~~l~~~~~------~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl  181 (312)
T 2iwi_A          111 EGFMLVLERPLPAQDLFDYITEKGP------LGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKL  181 (312)
T ss_dssp             --CEEEEECCSSEEEHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEE
T ss_pred             CeEEEEEEecCCCCCHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEE
Confidence            999999999 789999999976432      899999999999999999999   78999999999999999 8899999


Q ss_pred             eecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHH
Q 036435          212 SDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWI  291 (372)
Q Consensus       212 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  291 (372)
                      +|||++.......     .....||..|+|||.+.+. ...+.++||||||+++|+|++|+.||....            
T Consensus       182 ~dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------  243 (312)
T 2iwi_A          182 IDFGSGALLHDEP-----YTDFDGTRVYSPPEWISRH-QYHALPATVWSLGILLYDMVCGDIPFERDQ------------  243 (312)
T ss_dssp             CCCSSCEECCSSC-----BCCCCSCTTTSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------
T ss_pred             EEcchhhhcccCc-----ccccCCcccccCceeeecC-CCCCccchHHHHHHHHHHHHHCCCCCCChH------------
Confidence            9999998765432     1234588999999998764 233568999999999999999999986421            


Q ss_pred             HHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          292 YRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                       .....  ....+.       .....+.+++.+||+.||++|||++|+++
T Consensus       244 -~~~~~--~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          244 -EILEA--ELHFPA-------HVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             -HHHHT--CCCCCT-------TSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -HHhhh--ccCCcc-------cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             11111  111221       12356778999999999999999999997

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=6.1e-39  Score=295.85  Aligned_cols=220  Identities=25%  Similarity=0.371  Sum_probs=179.3

Q ss_pred             hhhhhhcCCCCceEEEEEEec-------------------------chHHHHHHHHhccC--CCceeeeEeEEecCCcee
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL-------------------------DDFVNEVASISRTS--HVNVVTLLGFCLEGNNRA  137 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-------------------------~~~~~E~~~l~~l~--h~nIv~l~g~~~~~~~~~  137 (372)
                      +.+.+.||+|+||.||+|+..                         +.+.+|+.++++++  |+||+++++++.+++..+
T Consensus        45 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~  124 (320)
T 3a99_A           45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV  124 (320)
T ss_dssp             EEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEE
Confidence            344678999999999999652                         13667999999996  599999999999999999


Q ss_pred             EEEEecCC-CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC-CCCceEEeecC
Q 036435          138 LIYEFMPN-GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLD-EDFCPKISDFG  215 (372)
Q Consensus       138 lV~e~~~~-g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg  215 (372)
                      +|+|++.+ ++|.+++.....      +++..+..++.|+++||+|||   +.+++||||||+|||++ +++.+||+|||
T Consensus       125 lv~e~~~~~~~L~~~l~~~~~------l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg  195 (320)
T 3a99_A          125 LILERPEPVQDLFDFITERGA------LQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG  195 (320)
T ss_dssp             EEEECCSSEEEHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEEcCCCCccHHHHHhccCC------CCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence            99999976 899999976432      899999999999999999999   79999999999999999 78999999999


Q ss_pred             CcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHh
Q 036435          216 LAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV  295 (372)
Q Consensus       216 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  295 (372)
                      ++.......     .....||+.|+|||.+.+. ...+.++||||||+++|||++|+.||....             ...
T Consensus       196 ~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~-------------~~~  256 (320)
T 3a99_A          196 SGALLKDTV-----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------------EII  256 (320)
T ss_dssp             TCEECCSSC-----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------HHH
T ss_pred             ccccccccc-----ccCCCCCccCCChHHhccC-CCCCccchHHhHHHHHHHHHHCCCCCCChh-------------hhh
Confidence            998765432     1234589999999998764 234788999999999999999999986421             111


Q ss_pred             hhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          296 EQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                       .. ....+.       .....+.+++.+||+.||++|||++++++
T Consensus       257 -~~-~~~~~~-------~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          257 -RG-QVFFRQ-------RVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             -HC-CCCCSS-------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -cc-cccccc-------cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             11 111111       12356778999999999999999999997

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1e-38  Score=297.77  Aligned_cols=237  Identities=15%  Similarity=0.225  Sum_probs=180.7

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCc------eeeeEeEEecCCceeEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVN------VVTLLGFCLEGNNRALI  139 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~n------Iv~l~g~~~~~~~~~lV  139 (372)
                      +.+.+.||+|+||.||++....                   .+.+|+.++++++|+|      ++.+++++...+..++|
T Consensus        21 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv  100 (355)
T 2eu9_A           21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIA  100 (355)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEE
T ss_pred             EEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEE
Confidence            4456789999999999996531                   4778999999998766      99999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEE----------------
Q 036435          140 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILL----------------  203 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill----------------  203 (372)
                      |||+ +++|.+++......    .+++.++..++.|++.||+|||   +.+|+||||||+|||+                
T Consensus       101 ~e~~-~~~l~~~l~~~~~~----~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A          101 FELL-GKNTFEFLKENNFQ----PYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             EECC-CCBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             Eecc-CCChHHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccccccc
Confidence            9999 66887887665422    2899999999999999999999   8999999999999999                


Q ss_pred             ---CCCCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCC
Q 036435          204 ---DEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVD  280 (372)
Q Consensus       204 ---~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~  280 (372)
                         +.++.+||+|||++.......      ....||+.|+|||.+.+.  .++.++|||||||++|||++|+.||.....
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~  244 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHEHH------TTIVATRHYRPPEVILEL--GWAQPCDVWSIGCILFEYYRGFTLFQTHEN  244 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTSCC------CSSCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccCCCcEEEeecCccccccccc------cCCcCCCcccCCeeeecC--CCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence               567899999999998654332      234589999999999875  789999999999999999999999975432


Q ss_pred             CCCccchHHHHHHHhh-----------hccc-----ccCCcc----------------CCcchHHHHHHHHHHHHHcccC
Q 036435          281 SSSEVYFPHWIYRHVE-----------QDRE-----FKLPGV----------------VTRKENEIAKKMIIVGLWCIQA  328 (372)
Q Consensus       281 ~~~~~~~~~~~~~~~~-----------~~~~-----~~~~~~----------------~~~~~~~~~~~l~~l~~~cl~~  328 (372)
                      ..    ....+.....           ....     ...+..                ...........+.+++.+||+.
T Consensus       245 ~~----~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~  320 (355)
T 2eu9_A          245 RE----HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF  320 (355)
T ss_dssp             HH----HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred             HH----HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence            11    0000000000           0000     000000                0011122345788999999999


Q ss_pred             CCCCCCCHHHHHH
Q 036435          329 RPSDRPPMNEVIE  341 (372)
Q Consensus       329 ~p~~RPs~~evl~  341 (372)
                      ||++|||++|+++
T Consensus       321 dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          321 DPAQRITLAEALL  333 (355)
T ss_dssp             STTTSCCHHHHTT
T ss_pred             ChhhCcCHHHHhc
Confidence            9999999999985

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=9.8e-39  Score=301.66  Aligned_cols=179  Identities=22%  Similarity=0.267  Sum_probs=151.3

Q ss_pred             hhhhhcCCCCceEEEEEEecc------------------hHHHHHHHHhccC-CC-----ceeeeEeEEecCCceeEEEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD------------------DFVNEVASISRTS-HV-----NVVTLLGFCLEGNNRALIYE  141 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~------------------~~~~E~~~l~~l~-h~-----nIv~l~g~~~~~~~~~lV~e  141 (372)
                      .+.+.||+|+||.||+|+...                  ++.+|+.+++.++ |+     +|+++++++...+..++|||
T Consensus        57 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e  136 (382)
T 2vx3_A           57 EIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE  136 (382)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEE
T ss_pred             EEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEe
Confidence            445789999999999997632                  4667888888885 44     49999999999999999999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC--CCCceEEeecCCccc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLD--EDFCPKISDFGLAKL  219 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfgla~~  219 (372)
                      |++ |+|.+++......    .+++..+..++.|++.||.|||.. ..+|+||||||+|||++  .++.+||+|||++..
T Consensus       137 ~~~-~~L~~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~  210 (382)
T 2vx3_A          137 MLS-YNLYDLLRNTNFR----GVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ  210 (382)
T ss_dssp             CCC-CBHHHHHHHTTTS----CCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             cCC-CCHHHHHhhcCcC----CCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCcee
Confidence            996 5999999875432    289999999999999999999932 46899999999999995  578899999999987


Q ss_pred             ccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCC
Q 036435          220 CTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSG  278 (372)
Q Consensus       220 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~  278 (372)
                      .....      ....||+.|+|||++.+.  .++.++|||||||++|||++|+.||...
T Consensus       211 ~~~~~------~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          211 LGQRI------YQYIQSRFYRSPEVLLGM--PYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             TTCCC------CSSCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccccc------ccccCCccccChHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            64322      234588999999999875  7899999999999999999999999854

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.7e-39  Score=306.68  Aligned_cols=233  Identities=24%  Similarity=0.315  Sum_probs=169.6

Q ss_pred             hhhhcCCCCceEE-EEEEec--------------chHHHHHHHHhcc-CCCceeeeEeEEecCCceeEEEEecCCCChhh
Q 036435           87 FKDKLGQGGFGGV-YKGRLL--------------DDFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEK  150 (372)
Q Consensus        87 ~~~~lg~G~~g~V-~~~~~~--------------~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~~  150 (372)
                      ..+.||+|+||+| |++...              +.+.+|+.+|+++ +||||+++++++.+++..++||||+. |+|.+
T Consensus        28 ~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~  106 (432)
T 3p23_A           28 PKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQE  106 (432)
T ss_dssp             EEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHH
T ss_pred             cCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHH
Confidence            3568999999985 444321              2478999999999 89999999999999999999999996 69999


Q ss_pred             hhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC-----CCceEEeecCCcccccCCCC
Q 036435          151 FVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE-----DFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       151 ~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfgla~~~~~~~~  225 (372)
                      ++......     +.+..++.++.|++.||+|||   +.+|+||||||+|||++.     ...+||+|||+++.......
T Consensus       107 ~l~~~~~~-----~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~  178 (432)
T 3p23_A          107 YVEQKDFA-----HLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH  178 (432)
T ss_dssp             HHHSSSCC-----CCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred             HHHhcCCC-----ccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence            99875432     344456789999999999999   789999999999999953     33588999999987654432


Q ss_pred             eeeeecccccccccccccccccc-cCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRN-FGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                      .........||+.|+|||++.+. ...++.++|||||||++|||++ |..||......        .. ........  .
T Consensus       179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~--------~~-~~~~~~~~--~  247 (432)
T 3p23_A          179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR--------QA-NILLGACS--L  247 (432)
T ss_dssp             -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH--------HH-HHHTTCCC--C
T ss_pred             ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH--------HH-HHHhccCC--c
Confidence            22223445699999999999742 2366889999999999999999 88888543211        01 11111111  1


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      +..  .........+.+++.+||+.||.+|||++++++
T Consensus       248 ~~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          248 DCL--HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             TTS--CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccc--CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            111  111223455778999999999999999999984

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.5e-38  Score=288.48  Aligned_cols=212  Identities=12%  Similarity=0.082  Sum_probs=166.3

Q ss_pred             hhhhhhcCCCCceEEEEEEec----------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEe
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL----------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~----------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      +.+.+.||+|+||.||+++..                      +.+.+|+..+.+++||||+++++++.+++..++||||
T Consensus        33 y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  112 (286)
T 3uqc_A           33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEW  112 (286)
T ss_dssp             EEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEe
Confidence            445678999999999999763                      2588999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      +++++|.+++...        ....++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+++|       
T Consensus       113 ~~g~~L~~~l~~~--------~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~-------  174 (286)
T 3uqc_A          113 IRGGSLQEVADTS--------PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA-------  174 (286)
T ss_dssp             CCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred             cCCCCHHHHHhcC--------CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc-------
Confidence            9999999999542        345678899999999999999   7999999999999999999999997442       


Q ss_pred             CCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                                      |++         .++.++|||||||++|||++|+.||............    ......  .  
T Consensus       175 ----------------~~~---------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~----~~~~~~--~--  221 (286)
T 3uqc_A          175 ----------------TMP---------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA----ERDTAG--Q--  221 (286)
T ss_dssp             ----------------CCT---------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC----CBCTTS--C--
T ss_pred             ----------------ccC---------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH----HHHhcc--C--
Confidence                            333         3578999999999999999999999865432210000    000000  0  


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~  349 (372)
                       +........++...+.+++.+||+.||.+| |+.|+++.|+++...
T Consensus       222 -~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          222 -PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             -BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             -CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence             000001112234668889999999999999 999999999887644

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=6.6e-38  Score=288.18  Aligned_cols=231  Identities=23%  Similarity=0.323  Sum_probs=160.9

Q ss_pred             hhhhhcCCCCceEEEEEEecc--------------------h-HHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD--------------------D-FVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~--------------------~-~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      .+.+.||+|+||.||+++...                    + +.++..+++.++||||+++++++.+++..++||||+ 
T Consensus        28 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-  106 (318)
T 2dyl_A           28 ENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-  106 (318)
T ss_dssp             EEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-
T ss_pred             cccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-
Confidence            345789999999999997642                    1 333445678889999999999999999999999999 


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeecCCCCCceEECCCCceEEeecCCcccccCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCST-KILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~  223 (372)
                      ++.+........     ..+++..+..++.|++.||.|||   .. +++|+||||+||+++.++.+||+|||++......
T Consensus       107 ~~~~~~l~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  178 (318)
T 2dyl_A          107 GTCAEKLKKRMQ-----GPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD  178 (318)
T ss_dssp             SEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             CCcHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence            555655554322     12899999999999999999999   64 9999999999999999999999999999765443


Q ss_pred             CCeeeeecccccccccccccccccc---cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccc
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRN---FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDRE  300 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (372)
                      ..    .....+|+.|+|||.+.+.   ...++.++||||||+++|||++|+.||......      .. ..........
T Consensus       179 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~-~~~~~~~~~~  247 (318)
T 2dyl_A          179 KA----KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD------FE-VLTKVLQEEP  247 (318)
T ss_dssp             ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH------HH-HHHHHHHSCC
T ss_pred             cc----ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc------HH-HHHHHhccCC
Confidence            21    1233588999999998531   136788999999999999999999999753221      11 1111212211


Q ss_pred             ccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       301 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ...+..     ......+.+++.+||+.||.+||+++++++
T Consensus       248 ~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          248 PLLPGH-----MGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             CCCCSS-----SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCCcc-----CCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            111111     113456778999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=5.6e-38  Score=311.20  Aligned_cols=243  Identities=23%  Similarity=0.283  Sum_probs=178.9

Q ss_pred             HhhhhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEec------CCcee
Q 036435           84 TNSFKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLE------GNNRA  137 (372)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~------~~~~~  137 (372)
                      .+.+.+.||+|+||.||++....                    .+.+|+.++++++||||+++++++..      ++..+
T Consensus        15 rY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~   94 (676)
T 3qa8_A           15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL   94 (676)
T ss_dssp             --CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCC
T ss_pred             CeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEE
Confidence            34567889999999999986521                    57889999999999999999999866      67889


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCc---eEEeec
Q 036435          138 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFC---PKISDF  214 (372)
Q Consensus       138 lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Df  214 (372)
                      +||||+++|+|.+++......   ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.   +||+||
T Consensus        95 LVmEy~~ggsL~~~L~~~~~~---~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           95 LAMEYCEGGDLRKYLNQFENC---CGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             CEEECCSSCBHHHHHHSSSCT---TCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             EEEEeCCCCCHHHHHHhcccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEccc
Confidence            999999999999999875432   23888999999999999999999   799999999999999987665   999999


Q ss_pred             CCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCcc-chHHHHHH
Q 036435          215 GLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV-YFPHWIYR  293 (372)
Q Consensus       215 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~-~~~~~~~~  293 (372)
                      |++.........    ....||+.|+|||.+.+.  .++.++||||||+++|+|++|..||.......... ........
T Consensus       169 G~a~~~~~~~~~----~~~~gt~~Y~APE~l~~~--~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~  242 (676)
T 3qa8_A          169 GYAKELDQGELC----TEFVGTLQYLAPELLEQK--KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE  242 (676)
T ss_dssp             CCCCBTTSCCCC----CCCCSCCTTCSSCSSCCS--CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-----
T ss_pred             cccccccccccc----ccccCCcccCChHHhccC--CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccch
Confidence            999876543321    234689999999999764  78999999999999999999999997532110000 00000000


Q ss_pred             Hhhh----cccccCCcc---CCcchHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 036435          294 HVEQ----DREFKLPGV---VTRKENEIAKKMIIVGLWCIQARPSDRPPMNE  338 (372)
Q Consensus       294 ~~~~----~~~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  338 (372)
                      ....    ......+..   .......+...+.+++.+||+.||++|||+++
T Consensus       243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e  294 (676)
T 3qa8_A          243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ  294 (676)
T ss_dssp             -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred             hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence            0000    000001100   11122335678889999999999999999977

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.9e-37  Score=283.12  Aligned_cols=217  Identities=20%  Similarity=0.252  Sum_probs=165.6

Q ss_pred             hhcCCCCceEEEEEEecc--------------hHHHHHHHH-hccCCCceeeeEeEEec----CCceeEEEEecCCCChh
Q 036435           89 DKLGQGGFGGVYKGRLLD--------------DFVNEVASI-SRTSHVNVVTLLGFCLE----GNNRALIYEFMPNGSLE  149 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~--------------~~~~E~~~l-~~l~h~nIv~l~g~~~~----~~~~~lV~e~~~~g~L~  149 (372)
                      +.||+|+||.||++....              .+.+|+.++ +..+||||+++++++.+    ++..++||||+++|+|.
T Consensus        24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~  103 (299)
T 3m2w_A           24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELF  103 (299)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHH
T ss_pred             cccccCCCeEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHH
Confidence            569999999999997632              678899988 55699999999999987    67889999999999999


Q ss_pred             hhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC---CCceEEeecCCcccccCCCCe
Q 036435          150 KFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE---DFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       150 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      +++......    .+++..+..++.|++.||+|||   +.+++||||||+|||++.   ++.+||+|||++.....    
T Consensus       104 ~~l~~~~~~----~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~----  172 (299)
T 3m2w_A          104 SRIQDRGDQ----AFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG----  172 (299)
T ss_dssp             HHHHHCTTC----CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT----
T ss_pred             HHHHhccCC----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEecccccccccc----
Confidence            999875432    3899999999999999999999   799999999999999997   78999999999864221    


Q ss_pred             eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCcc
Q 036435          227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV  306 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (372)
                                             ..++.++|||||||++|||++|+.||..........        .............
T Consensus       173 -----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~--------~~~~~~~~~~~~~  221 (299)
T 3m2w_A          173 -----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--------GMKTRIRMGQYEF  221 (299)
T ss_dssp             -----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C--------CSCCSSCTTCCSS
T ss_pred             -----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH--------HHHHHHhhccccC
Confidence                                   256789999999999999999999997543221000        0000000000000


Q ss_pred             CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhhcCc
Q 036435          307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE--MLQGST  347 (372)
Q Consensus       307 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~--~L~~~~  347 (372)
                      .......+...+.+++.+||+.||.+|||++|+++  .+.+..
T Consensus       222 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          222 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             CchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence            00111224567888999999999999999999997  344433

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.7e-37  Score=312.46  Aligned_cols=219  Identities=21%  Similarity=0.273  Sum_probs=174.6

Q ss_pred             HhhhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCc-----ee
Q 036435           84 TNSFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNN-----RA  137 (372)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~-----~~  137 (372)
                      .+.+.+.||+|+||.||++.+..                     .+.+|+.++++++||||+++++++.+.+.     .|
T Consensus        81 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~  160 (681)
T 2pzi_A           81 QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGY  160 (681)
T ss_dssp             TEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred             ceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeE
Confidence            34556789999999999997631                     46789999999999999999999988765     69


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCc
Q 036435          138 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLA  217 (372)
Q Consensus       138 lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla  217 (372)
                      +||||+++++|.+++..        .+++.+++.++.|++.||.|||   +.+|+||||||+|||++.+ .+||+|||++
T Consensus       161 lv~E~~~g~~L~~~~~~--------~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a  228 (681)
T 2pzi_A          161 IVMEYVGGQSLKRSKGQ--------KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAV  228 (681)
T ss_dssp             EEEECCCCEECC----C--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred             EEEEeCCCCcHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccc
Confidence            99999999999987754        2899999999999999999999   7899999999999999986 8999999999


Q ss_pred             ccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhh
Q 036435          218 KLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQ  297 (372)
Q Consensus       218 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (372)
                      +.....       ....||+.|+|||.+.+   ..+.++|||||||++|+|++|..|+.......               
T Consensus       229 ~~~~~~-------~~~~gt~~y~aPE~~~~---~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------------  283 (681)
T 2pzi_A          229 SRINSF-------GYLYGTPGFQAPEIVRT---GPTVATDIYTVGRTLAALTLDLPTRNGRYVDG---------------  283 (681)
T ss_dssp             EETTCC-------SCCCCCTTTSCTTHHHH---CSCHHHHHHHHHHHHHHHHSCCCEETTEECSS---------------
T ss_pred             hhcccC-------CccCCCccccCHHHHcC---CCCCceehhhhHHHHHHHHhCCCCCccccccc---------------
Confidence            876443       23358999999999876   34889999999999999999988876421110               


Q ss_pred             cccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHHhhcC
Q 036435          298 DREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPP-MNEVIEMLQGS  346 (372)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~evl~~L~~~  346 (372)
                           .+.  ..........+.+++.+||+.||.+||+ ++++.+.|.+.
T Consensus       284 -----~~~--~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          284 -----LPE--DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             -----CCT--TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             -----ccc--cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence                 000  0111223456788999999999999995 56666666544

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.2e-36  Score=290.07  Aligned_cols=222  Identities=15%  Similarity=0.138  Sum_probs=158.9

Q ss_pred             hhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCC-Ccee--------------------
Q 036435           88 KDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSH-VNVV--------------------  124 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h-~nIv--------------------  124 (372)
                      .+.||+|+||.||+|++..                      .+.+|+.+++.++| +|..                    
T Consensus        83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (413)
T 3dzo_A           83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK  162 (413)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred             ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence            4679999999999998641                      57799999999977 2211                    


Q ss_pred             -eeEeEEec-----CCceeEEEEecCCCChhhhhhcCCC-CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC
Q 036435          125 -TLLGFCLE-----GNNRALIYEFMPNGSLEKFVYNGDT-SKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIK  197 (372)
Q Consensus       125 -~l~g~~~~-----~~~~~lV~e~~~~g~L~~~l~~~~~-~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk  197 (372)
                       .+..++..     ....+++|+++ +++|.+++..... ......+++..++.++.|+++||+|||   +.+|+|||||
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~iiHrDiK  238 (413)
T 3dzo_A          163 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLR  238 (413)
T ss_dssp             --------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEECSCCC
T ss_pred             CccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcc
Confidence             11111111     12456777766 6799998852100 011133888999999999999999999   7999999999


Q ss_pred             CCceEECCCCceEEeecCCcccccCCCCeeeeeccccccccccccccccc--------ccCCCCccccchhHHHHHHHHh
Q 036435          198 PHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSR--------NFGEVSHKSDVYSFGMMIMELV  269 (372)
Q Consensus       198 ~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~~DvwslG~il~ell  269 (372)
                      |+|||++.++.+||+|||+++.....      .....| +.|+|||.+.+        ....++.++|||||||++|||+
T Consensus       239 p~NILl~~~~~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell  311 (413)
T 3dzo_A          239 PVDIVLDQRGGVFLTGFEHLVRDGAS------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW  311 (413)
T ss_dssp             GGGEEECTTCCEEECCGGGCEETTEE------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred             cceEEEecCCeEEEEeccceeecCCc------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence            99999999999999999998864432      233456 89999999831        1125788999999999999999


Q ss_pred             cCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 036435          270 GCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI  340 (372)
Q Consensus       270 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl  340 (372)
                      +|+.||.........        ..     .+....       .++..+.+++.+||+.||.+||++.+++
T Consensus       312 tg~~Pf~~~~~~~~~--------~~-----~~~~~~-------~~~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          312 CADLPNTDDAALGGS--------EW-----IFRSCK-------NIPQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HSSCCCCTTGGGSCS--------GG-----GGSSCC-------CCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HCCCCCCCcchhhhH--------HH-----HHhhcc-------cCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            999999754321110        00     000000       1235688899999999999999976664

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=9.6e-36  Score=276.27  Aligned_cols=222  Identities=15%  Similarity=0.141  Sum_probs=167.8

Q ss_pred             HHhhhhhhcCCCCceEEEEEEec-------------------------chHHHHHHHHhccC---------CCceeeeEe
Q 036435           83 LTNSFKDKLGQGGFGGVYKGRLL-------------------------DDFVNEVASISRTS---------HVNVVTLLG  128 (372)
Q Consensus        83 ~~~~~~~~lg~G~~g~V~~~~~~-------------------------~~~~~E~~~l~~l~---------h~nIv~l~g  128 (372)
                      ..+.+.+.||+|+||.||+|+..                         +.+.+|+.++++++         ||||+++.+
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~   99 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNS   99 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEE
T ss_pred             ccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcc
Confidence            34556788999999999999652                         35788999999886         777777666


Q ss_pred             EE-----------------ec-------------CCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHH
Q 036435          129 FC-----------------LE-------------GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK  178 (372)
Q Consensus       129 ~~-----------------~~-------------~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~  178 (372)
                      ++                 .+             ++..++||||+++|++.+.+.+.       .+++..+..++.|++.
T Consensus       100 ~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~-------~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A          100 VHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK-------LSSLATAKSILHQLTA  172 (336)
T ss_dssp             EEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT-------CCCHHHHHHHHHHHHH
T ss_pred             eeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc-------CCCHHHHHHHHHHHHH
Confidence            54                 22             67899999999999877777442       2899999999999999


Q ss_pred             HHHHHhcCCCCCeeecCCCCCceEECCCC--------------------ceEEeecCCcccccCCCCeeeeecccccccc
Q 036435          179 GLEYLHHGCSTKILHFDIKPHNILLDEDF--------------------CPKISDFGLAKLCTTKEGIVSSLLGARGIIG  238 (372)
Q Consensus       179 ~l~~LH~~~~~~ivH~dlk~~Nill~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  238 (372)
                      ||+|||+  +.+|+||||||+|||++.++                    .+||+|||+|+.....        ...||+.
T Consensus       173 aL~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--------~~~gt~~  242 (336)
T 2vuw_A          173 SLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--------IVVFCDV  242 (336)
T ss_dssp             HHHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--------EEECCCC
T ss_pred             HHHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--------cEEEeec
Confidence            9999993  37999999999999999887                    8999999999876532        2258999


Q ss_pred             cccccccccccCCCCccccchhHHHH-HHHHhcCCCCCCCCCCCCCccchHHH---HHHHhhhcccccCCccCCcchHHH
Q 036435          239 YIAPEVFSRNFGEVSHKSDVYSFGMM-IMELVGCKNNLDSGVDSSSEVYFPHW---IYRHVEQDREFKLPGVVTRKENEI  314 (372)
Q Consensus       239 y~aPE~~~~~~~~~~~~~DvwslG~i-l~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  314 (372)
                      |+|||.+.+.   .+.++||||+|++ .+++++|..||...          .|   ....+....... ..........+
T Consensus       243 y~aPE~~~g~---~~~~~Diwsl~~~~~~~~~~g~~p~~~~----------~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  308 (336)
T 2vuw_A          243 SMDEDLFTGD---GDYQFDIYRLMKKENNNRWGEYHPYSNV----------LWLHYLTDKMLKQMTFK-TKCNTPAMKQI  308 (336)
T ss_dssp             TTCSGGGCCC---SSHHHHHHHHHHHHHTTCTTSCCTHHHH----------HHHHHHHHHHHHTCCCS-SCCCSHHHHHH
T ss_pred             ccChhhhcCC---CccceehhhhhCCCCcccccccCCCcch----------hhhhHHHHhhhhhhccC-cccchhhhhhc
Confidence            9999999874   3889999998777 67788888877421          11   111111111111 11122234567


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHH
Q 036435          315 AKKMIIVGLWCIQARPSDRPPMNEVI  340 (372)
Q Consensus       315 ~~~l~~l~~~cl~~~p~~RPs~~evl  340 (372)
                      ...+.+++.+||+.|     |++|++
T Consensus       309 s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          309 KRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             CHHHHHHHHHHhccC-----CHHHHH
Confidence            888999999999976     899888

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=6.7e-32  Score=266.44  Aligned_cols=151  Identities=17%  Similarity=0.215  Sum_probs=114.9

Q ss_pred             hHHHHHHHHhcc-CCCceeeeEeEEecCCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 036435          107 DFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH  185 (372)
Q Consensus       107 ~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~  185 (372)
                      +|.+|+++|+++ .|+||+++++++.+++..||||||++|++|.+++...+.      ++..   +|+.||++||+|+| 
T Consensus       287 ~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~------l~~~---~I~~QIl~AL~ylH-  356 (569)
T 4azs_A          287 ELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEE------IDRE---KILGSLLRSLAALE-  356 (569)
T ss_dssp             HHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCC------CCHH---HHHHHHHHHHHHHH-
T ss_pred             HHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCC------CCHH---HHHHHHHHHHHHHH-
Confidence            589999999999 799999999999999999999999999999999987653      5553   58899999999999 


Q ss_pred             CCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHH
Q 036435          186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMI  265 (372)
Q Consensus       186 ~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il  265 (372)
                        +.+||||||||+|||+++++.+||+|||+|+........   .....||+.|||||.+.+   .+..++|+||+|+++
T Consensus       357 --~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~---~~t~vGTp~YmAPE~l~g---~~~~~~d~~s~g~~~  428 (569)
T 4azs_A          357 --KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSW---PTNLVQSFFVFVNELFAE---NKSWNGFWRSAPVHP  428 (569)
T ss_dssp             --HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CC---SHHHHHHHHHHHHHHC--------------------
T ss_pred             --HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcc---ccCceechhhccHHHhCC---CCCCcccccccccch
Confidence              899999999999999999999999999999876543322   234569999999999976   567789999999999


Q ss_pred             HHHhcCCCCC
Q 036435          266 MELVGCKNNL  275 (372)
Q Consensus       266 ~elltg~~p~  275 (372)
                      +++.++..++
T Consensus       429 ~~l~~~~~~~  438 (569)
T 4azs_A          429 FNLPQPWSNW  438 (569)
T ss_dssp             CCCCTTHHHH
T ss_pred             hhhccccchh
Confidence            8887665443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=2.6e-28  Score=239.56  Aligned_cols=169  Identities=16%  Similarity=0.232  Sum_probs=133.1

Q ss_pred             hhhcCCCCceEEEEEEecc-------------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEe
Q 036435           88 KDKLGQGGFGGVYKGRLLD-------------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~~-------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      .+.||+|+||.||+++...                         ++.+|++++++++||||+++..++...+..++||||
T Consensus       341 ~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~  420 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSY  420 (540)
T ss_dssp             -------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEEC
T ss_pred             CCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEEC
Confidence            3579999999999885421                         378999999999999999766666677888999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      +++++|.+++..              ++.++.|+++||+|||   +.+|+||||||+|||+++  .+||+|||+++....
T Consensus       421 ~~ggsL~~~l~~--------------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          421 INGKLAKDVIED--------------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             CCSEEHHHHSTT--------------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             CCCCCHHHHHHH--------------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999865              3478999999999999   799999999999999999  999999999997654


Q ss_pred             CCCeee----eecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCC
Q 036435          223 KEGIVS----SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNL  275 (372)
Q Consensus       223 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~  275 (372)
                      ......    ......||+.|||||++.+....++..+|+||...-.++-+-++.+|
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            322110    01234689999999999863336788899999998888877666554

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.85  E-value=5.6e-22  Score=178.83  Aligned_cols=122  Identities=18%  Similarity=0.165  Sum_probs=100.0

Q ss_pred             hhcCCCCceEEEEEEecc------------------------------------hHHHHHHHHhccCCCceeeeEeEEec
Q 036435           89 DKLGQGGFGGVYKGRLLD------------------------------------DFVNEVASISRTSHVNVVTLLGFCLE  132 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~------------------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~  132 (372)
                      +.||+|+||.||+|+..+                                    .+.+|+.++++++  | +++.+++. 
T Consensus        96 ~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~-  171 (282)
T 1zar_A           96 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYA-  171 (282)
T ss_dssp             EEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEE-
T ss_pred             CEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEe-
Confidence            789999999999997521                                    2678999999999  5 66666553 


Q ss_pred             CCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEe
Q 036435          133 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKIS  212 (372)
Q Consensus       133 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  212 (372)
                      .+..++||||+++|+|.+ +..            .....++.|++.||.|||   +.+++||||||+|||++ ++.+||+
T Consensus       172 ~~~~~lvmE~~~g~~L~~-l~~------------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-~~~vkl~  234 (282)
T 1zar_A          172 WEGNAVLMELIDAKELYR-VRV------------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-EEGIWII  234 (282)
T ss_dssp             EETTEEEEECCCCEEGGG-CCC------------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-TTEEEEC
T ss_pred             ccceEEEEEecCCCcHHH-cch------------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-CCcEEEE
Confidence            356799999999999998 421            123469999999999999   79999999999999999 9999999


Q ss_pred             ecCCcccccCCCCeeeeeccccccccccccccccc
Q 036435          213 DFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSR  247 (372)
Q Consensus       213 Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  247 (372)
                      |||+++.                +..++|||++.+
T Consensus       235 DFG~a~~----------------~~~~~a~e~l~r  253 (282)
T 1zar_A          235 DFPQSVE----------------VGEEGWREILER  253 (282)
T ss_dssp             CCTTCEE----------------TTSTTHHHHHHH
T ss_pred             ECCCCeE----------------CCCCCHHHHHHH
Confidence            9999863                234788888753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.71  E-value=8.8e-18  Score=149.43  Aligned_cols=117  Identities=16%  Similarity=0.191  Sum_probs=91.1

Q ss_pred             hhhhcCCCCceEEEEEEe--c--------c-----------------------------------hHHHHHHHHhccCCC
Q 036435           87 FKDKLGQGGFGGVYKGRL--L--------D-----------------------------------DFVNEVASISRTSHV  121 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~--~--------~-----------------------------------~~~~E~~~l~~l~h~  121 (372)
                      +.+.||+|+||.||+|+.  .        +                                   .+.+|+..|.+++|+
T Consensus        51 i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~  130 (258)
T 1zth_A           51 MGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEA  130 (258)
T ss_dssp             EEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhC
Confidence            346799999999999865  1        0                                   256799999999888


Q ss_pred             ce--eeeEeEEecCCceeEEEEecCC-C----ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 036435          122 NV--VTLLGFCLEGNNRALIYEFMPN-G----SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHF  194 (372)
Q Consensus       122 nI--v~l~g~~~~~~~~~lV~e~~~~-g----~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~  194 (372)
                      |+  ...+++    +..++||||+.+ |    +|.++...         .++..+..++.|++.||.|||.  ..+++||
T Consensus       131 ~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~--~~givHr  195 (258)
T 1zth_A          131 GVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---------LKELDVEGIFNDVVENVKRLYQ--EAELVHA  195 (258)
T ss_dssp             TCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---------GGGSCHHHHHHHHHHHHHHHHH--TSCEECS
T ss_pred             CCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---------cChHHHHHHHHHHHHHHHHHHH--HCCEEeC
Confidence            64  344442    367899999942 4    66665432         2234567899999999999994  4799999


Q ss_pred             CCCCCceEECCCCceEEeecCCcccc
Q 036435          195 DIKPHNILLDEDFCPKISDFGLAKLC  220 (372)
Q Consensus       195 dlk~~Nill~~~~~~kl~Dfgla~~~  220 (372)
                      ||||+|||++.  .++|+|||+|...
T Consensus       196 Dlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          196 DLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCHHHEEEcC--cEEEEECcccccC
Confidence            99999999998  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.56  E-value=8.6e-16  Score=142.59  Aligned_cols=117  Identities=12%  Similarity=0.100  Sum_probs=83.0

Q ss_pred             hhhhcCCCCceEEEEEEecc--------------------------------h--------HHHHHHHHhccCCCceeee
Q 036435           87 FKDKLGQGGFGGVYKGRLLD--------------------------------D--------FVNEVASISRTSHVNVVTL  126 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~--------------------------------~--------~~~E~~~l~~l~h~nIv~l  126 (372)
                      +.+.||+|+||.||+|...+                                .        ..+|...|.++.+.++.-.
T Consensus        99 I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp  178 (397)
T 4gyi_A           99 VGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVP  178 (397)
T ss_dssp             EEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCC
T ss_pred             ecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCC
Confidence            45679999999999986421                                0        1245556666644443211


Q ss_pred             EeEEecCCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC
Q 036435          127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDED  206 (372)
Q Consensus       127 ~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~  206 (372)
                      .-+.  ....+|||||++|++|......            .....++.|++.+|.+||   ..++|||||||.|||++++
T Consensus       179 ~p~~--~~~~~LVME~i~G~~L~~l~~~------------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~d  241 (397)
T 4gyi_A          179 EPIA--QSRHTIVMSLVDALPMRQVSSV------------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREE  241 (397)
T ss_dssp             CEEE--EETTEEEEECCSCEEGGGCCCC------------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEE
T ss_pred             eeee--ccCceEEEEecCCccHhhhccc------------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCC
Confidence            1111  1234799999999888654321            123567899999999999   7899999999999999877


Q ss_pred             C----------ceEEeecCCcccc
Q 036435          207 F----------CPKISDFGLAKLC  220 (372)
Q Consensus       207 ~----------~~kl~Dfgla~~~  220 (372)
                      +          .+.|+||+.+...
T Consensus       242 gd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          242 KDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             ECSSCTTSEEEEEEECCCTTCEET
T ss_pred             CCcccccccccceEEEEeCCcccC
Confidence            6          3899999988654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.19  E-value=3.3e-11  Score=106.89  Aligned_cols=120  Identities=15%  Similarity=0.020  Sum_probs=93.5

Q ss_pred             hhhcCCCCceEEEEEEec-----------------chHHHHHHHHhccC-CCceeeeEeEEecCCceeEEEEecCCCChh
Q 036435           88 KDKLGQGGFGGVYKGRLL-----------------DDFVNEVASISRTS-HVNVVTLLGFCLEGNNRALIYEFMPNGSLE  149 (372)
Q Consensus        88 ~~~lg~G~~g~V~~~~~~-----------------~~~~~E~~~l~~l~-h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~  149 (372)
                      ...++.|+.+.||+....                 ..+.+|+.+++.+. +.++.++++++.+.+..++||||++|.+|.
T Consensus        19 ~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   98 (263)
T 3tm0_A           19 VKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCS   98 (263)
T ss_dssp             EECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHH
T ss_pred             EeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehh
Confidence            345777788889987421                 15889999999994 678889999999888999999999999998


Q ss_pred             hhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC------------------------------------------
Q 036435          150 KFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC------------------------------------------  187 (372)
Q Consensus       150 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~------------------------------------------  187 (372)
                      +.+..           ......++.+++++|+.||+-.                                          
T Consensus        99 ~~~~~-----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (263)
T 3tm0_A           99 EEYED-----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP  167 (263)
T ss_dssp             HHCCT-----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred             hccCC-----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence            76421           1123467889999999999510                                          


Q ss_pred             --------------CCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          188 --------------STKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       188 --------------~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                                    ...++|+|+++.||+++++..+.|+||+.+.
T Consensus       168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                          1459999999999999876666799998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.02  E-value=1.1e-09  Score=96.50  Aligned_cols=114  Identities=18%  Similarity=0.148  Sum_probs=84.6

Q ss_pred             cC-CCCceEEEEEEec---------------chHHHHHHHHhccCCCc--eeeeEeEEecCCceeEEEEecCCCChhhhh
Q 036435           91 LG-QGGFGGVYKGRLL---------------DDFVNEVASISRTSHVN--VVTLLGFCLEGNNRALIYEFMPNGSLEKFV  152 (372)
Q Consensus        91 lg-~G~~g~V~~~~~~---------------~~~~~E~~~l~~l~h~n--Iv~l~g~~~~~~~~~lV~e~~~~g~L~~~l  152 (372)
                      ++ .|..+.||+....               ..+.+|+.+++.+.+.+  +.+++++..+++..++||||++|.+|.  .
T Consensus        27 ~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~  104 (264)
T 1nd4_A           27 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--S  104 (264)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--T
T ss_pred             cccCCCCceEEEEecCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--c
Confidence            44 5556889987532               25789999999996545  456889888888899999999998884  2


Q ss_pred             hcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------------------------
Q 036435          153 YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC---------------------------------------------  187 (372)
Q Consensus       153 ~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---------------------------------------------  187 (372)
                      ..         .+   ...++.++++.|+.||...                                             
T Consensus       105 ~~---------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (264)
T 1nd4_A          105 SH---------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA  172 (264)
T ss_dssp             SC---------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred             Cc---------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence            11         11   1256777888888888421                                             


Q ss_pred             ----------CCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          188 ----------STKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       188 ----------~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                                ...++|+|++|.||++++++.+.|+||+.+.
T Consensus       173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                      1129999999999999887667799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.02  E-value=1.1e-09  Score=101.75  Aligned_cols=123  Identities=16%  Similarity=0.172  Sum_probs=95.3

Q ss_pred             hhcCCCCceEEEEEEec--------------------chHHHHHHHHhccC--CCceeeeEeEEecC---CceeEEEEec
Q 036435           89 DKLGQGGFGGVYKGRLL--------------------DDFVNEVASISRTS--HVNVVTLLGFCLEG---NNRALIYEFM  143 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~--------------------~~~~~E~~~l~~l~--h~nIv~l~g~~~~~---~~~~lV~e~~  143 (372)
                      +.|+.|.++.||+.+..                    ..+.+|..+++.+.  +.++.++++++.+.   +..++||||+
T Consensus        44 ~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v  123 (359)
T 3dxp_A           44 EQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFV  123 (359)
T ss_dssp             EECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECC
T ss_pred             EEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEec
Confidence            45888988889876421                    25778999999997  45688999998876   4589999999


Q ss_pred             CCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC------------------------------------
Q 036435          144 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC------------------------------------  187 (372)
Q Consensus       144 ~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~------------------------------------  187 (372)
                      +|..+.+...        ..++..++..++.++++.|+.||...                                    
T Consensus       124 ~G~~l~~~~~--------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          124 SGRVLWDQSL--------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             CCBCCCCTTC--------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             CCeecCCCcc--------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            9988754211        11678888899999999999999620                                    


Q ss_pred             -------------------CCCeeecCCCCCceEECCCCc--eEEeecCCccc
Q 036435          188 -------------------STKILHFDIKPHNILLDEDFC--PKISDFGLAKL  219 (372)
Q Consensus       188 -------------------~~~ivH~dlk~~Nill~~~~~--~kl~Dfgla~~  219 (372)
                                         ...++|+|+++.||+++.++.  +.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               257999999999999987653  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.83  E-value=1.5e-09  Score=98.38  Aligned_cols=175  Identities=18%  Similarity=0.178  Sum_probs=110.1

Q ss_pred             hhcCCCCceEEEEEE------e------cchHHHHHHHHhccC-CCc--eeeeEeEEecCC---ceeEEEEecCCCChhh
Q 036435           89 DKLGQGGFGGVYKGR------L------LDDFVNEVASISRTS-HVN--VVTLLGFCLEGN---NRALIYEFMPNGSLEK  150 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~------~------~~~~~~E~~~l~~l~-h~n--Iv~l~g~~~~~~---~~~lV~e~~~~g~L~~  150 (372)
                      +.++.|....||+..      .      ...+.+|..+|+.+. +..  +.+.+.....++   ..|+|||+++|.+|.+
T Consensus        26 ~~~~~G~~n~v~~v~~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~  105 (304)
T 3sg8_A           26 EISGEGNDCIAYEINRDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTP  105 (304)
T ss_dssp             CEEEECSSEEEEESTTSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCH
T ss_pred             EecCCCCcceEEEECCEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCc
Confidence            347888888888642      1      125788999998883 332  445555544333   3489999999988875


Q ss_pred             hhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 036435          151 FVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG--------------------------------------------  186 (372)
Q Consensus       151 ~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~--------------------------------------------  186 (372)
                      .....        ++..++..++.++++.++.||..                                            
T Consensus       106 ~~~~~--------l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  177 (304)
T 3sg8_A          106 LLLNN--------LPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFY  177 (304)
T ss_dssp             HHHHT--------SCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHH
T ss_pred             ccccc--------CCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHH
Confidence            43211        66777778888888888888841                                            


Q ss_pred             -----------CCCCeeecCCCCCceEECC--CCceEEeecCCcccccCCCCeeeeecc-----------ccccccccc-
Q 036435          187 -----------CSTKILHFDIKPHNILLDE--DFCPKISDFGLAKLCTTKEGIVSSLLG-----------ARGIIGYIA-  241 (372)
Q Consensus       187 -----------~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgla~~~~~~~~~~~~~~~-----------~~gt~~y~a-  241 (372)
                                 ....++|+|+++.||++++  +..+.++||+.+...............           .....+... 
T Consensus       178 ~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~  257 (304)
T 3sg8_A          178 RDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDI  257 (304)
T ss_dssp             HHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCH
T ss_pred             HHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCc
Confidence                       0145899999999999998  556789999988653221100000000           000001111 


Q ss_pred             ccccccccCCCCccccchhHHHHHHHHhcCCCCC
Q 036435          242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNL  275 (372)
Q Consensus       242 PE~~~~~~~~~~~~~DvwslG~il~elltg~~p~  275 (372)
                      |+...    ......+.|++|.++|.+.+|..++
T Consensus       258 ~~~~~----r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          258 PTVLE----KYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHH----HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHH----HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            22211    1122358999999999999998654

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.27  E-value=4.2e-06  Score=74.02  Aligned_cols=102  Identities=19%  Similarity=0.173  Sum_probs=74.0

Q ss_pred             hHHHHHHHHhccC-CCceeeeEeEEecCCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 036435          107 DFVNEVASISRTS-HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH  185 (372)
Q Consensus       107 ~~~~E~~~l~~l~-h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~  185 (372)
                      ++.+|...|+.+. +-.+.++++++.+++..++|||+++|.++.+......          .....+..++++.|+-||.
T Consensus        65 ~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~~----------~~~~~~~~~l~~~L~~Lh~  134 (272)
T 4gkh_A           65 DVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYP----------DSGENIVDALAVFLRRLHS  134 (272)
T ss_dssp             HHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHCG----------GGHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCCH----------HHHHHHHHHHHHHHHHhcC
Confidence            5788999998884 3346788899999899999999999988776543211          1223445555555555553


Q ss_pred             C-------------------------------------------------------CCCCeeecCCCCCceEECCCCceE
Q 036435          186 G-------------------------------------------------------CSTKILHFDIKPHNILLDEDFCPK  210 (372)
Q Consensus       186 ~-------------------------------------------------------~~~~ivH~dlk~~Nill~~~~~~k  210 (372)
                      .                                                       ....++|+|+.+.||+++.++.+-
T Consensus       135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~  214 (272)
T 4gkh_A          135 IPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIG  214 (272)
T ss_dssp             SCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEE
T ss_pred             CCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEE
Confidence            1                                                       012489999999999999877778


Q ss_pred             EeecCCcc
Q 036435          211 ISDFGLAK  218 (372)
Q Consensus       211 l~Dfgla~  218 (372)
                      |+||+.+.
T Consensus       215 viDwe~a~  222 (272)
T 4gkh_A          215 CIDVGRVG  222 (272)
T ss_dssp             ECCCTTCE
T ss_pred             EEECcccc
Confidence            99998775

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.20  E-value=8.2e-06  Score=73.72  Aligned_cols=122  Identities=18%  Similarity=0.162  Sum_probs=80.8

Q ss_pred             hcCCCCceEEEEE------Ee------cchHHHHHHHHhccCCC---ceeeeEeEEe-cCCceeEEEEecCCCChhhhhh
Q 036435           90 KLGQGGFGGVYKG------RL------LDDFVNEVASISRTSHV---NVVTLLGFCL-EGNNRALIYEFMPNGSLEKFVY  153 (372)
Q Consensus        90 ~lg~G~~g~V~~~------~~------~~~~~~E~~~l~~l~h~---nIv~l~g~~~-~~~~~~lV~e~~~~g~L~~~l~  153 (372)
                      .++.|....||+.      +.      ...+.+|..+|+.+.+.   .+.+.+.++. ..+..++|||+++|.+|.+...
T Consensus        26 ~l~~G~~n~v~~vg~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~  105 (306)
T 3tdw_A           26 SLGEGFRNYAILVNGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGM  105 (306)
T ss_dssp             EEEECSSEEEEEETTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHH
T ss_pred             ecCCCcceeEEEECCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhh
Confidence            4677777777765      11      12578999999999653   3566676664 4556789999999988866321


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----------------------------------------------
Q 036435          154 NGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG-----------------------------------------------  186 (372)
Q Consensus       154 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-----------------------------------------------  186 (372)
                      ..        ++..+...++.++++.|+.||..                                               
T Consensus       106 ~~--------l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~  177 (306)
T 3tdw_A          106 AV--------LPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQ  177 (306)
T ss_dssp             TT--------SCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHH
T ss_pred             hh--------CCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHH
Confidence            10        33344444444444444444421                                               


Q ss_pred             ----------CCCCeeecCCCCCceEECC---CCc-eEEeecCCccc
Q 036435          187 ----------CSTKILHFDIKPHNILLDE---DFC-PKISDFGLAKL  219 (372)
Q Consensus       187 ----------~~~~ivH~dlk~~Nill~~---~~~-~kl~Dfgla~~  219 (372)
                                ....++|+|+++.||+++.   ++. ..|+||+.+..
T Consensus       178 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          178 SYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                      1346799999999999987   455 48999998754

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.98  E-value=2.5e-05  Score=71.96  Aligned_cols=44  Identities=9%  Similarity=0.085  Sum_probs=33.3

Q ss_pred             hHHHHHHHHhccCC---CceeeeEeEEecC---CceeEEEEecCCCChhh
Q 036435          107 DFVNEVASISRTSH---VNVVTLLGFCLEG---NNRALIYEFMPNGSLEK  150 (372)
Q Consensus       107 ~~~~E~~~l~~l~h---~nIv~l~g~~~~~---~~~~lV~e~~~~g~L~~  150 (372)
                      .+.+|..+++.+..   -.+.++++++.++   +..++||||++|.++.+
T Consensus        73 ~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A           73 RLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             CHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCCB
T ss_pred             HHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChhh
Confidence            46789999998843   3577888887665   35689999999877653

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.53  E-value=0.00072  Score=61.45  Aligned_cols=31  Identities=26%  Similarity=0.229  Sum_probs=28.0

Q ss_pred             CCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          188 STKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       188 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      ...++|+|+++.||+++.++.+.|+||+.+.
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            5789999999999999888899999998764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.40  E-value=0.00076  Score=62.97  Aligned_cols=31  Identities=23%  Similarity=0.295  Sum_probs=26.6

Q ss_pred             CCCeeecCCCCCceEECCCCceEEeecCCccc
Q 036435          188 STKILHFDIKPHNILLDEDFCPKISDFGLAKL  219 (372)
Q Consensus       188 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  219 (372)
                      ...++|+|+.+.||+++.+ .++++||..+..
T Consensus       226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~  256 (397)
T 2olc_A          226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFY  256 (397)
T ss_dssp             CCEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             CCceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence            5789999999999999876 489999987764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.22  E-value=0.0032  Score=53.00  Aligned_cols=101  Identities=13%  Similarity=0.056  Sum_probs=65.7

Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      -+|.+.|...+.     ++++++++.++.|.+.+|.-+-.  ...-..+=+.|..|++..+|.+-+.+ +.+.       
T Consensus        33 vSL~eIL~~~~~-----PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------   97 (229)
T 2yle_A           33 LSLEEILRLYNQ-----PINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------   97 (229)
T ss_dssp             EEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C----------
T ss_pred             ccHHHHHHHcCC-----CcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc-------
Confidence            378999977653     39999999999999999887621  11112334457899999999887764 1110       


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCC
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK  272 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~  272 (372)
                              .....+.|||...   ...+.+.=|||+|+++|..+--.
T Consensus        98 --------~~~~~~~~pe~~~---~~~te~~~IysLG~tLY~ALDyg  133 (229)
T 2yle_A           98 --------AGEPPPVAGKLGY---SQCMETEVIESLGIIIYKALDYG  133 (229)
T ss_dssp             -----------------CCSS---SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred             --------ccccCCCChhhcc---ccchHHHHHHHHHHHHHHHhhcC
Confidence                    0112367888763   25578889999999999998433

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.16  E-value=0.002  Score=58.06  Aligned_cols=126  Identities=17%  Similarity=0.157  Sum_probs=79.9

Q ss_pred             hhcCCCCceEEEEEEec--------------chHHHHHHHHhccC---CCceeeeEeEEecCCceeEEEEecCCCChhh-
Q 036435           89 DKLGQGGFGGVYKGRLL--------------DDFVNEVASISRTS---HVNVVTLLGFCLEGNNRALIYEFMPNGSLEK-  150 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~--------------~~~~~E~~~l~~l~---h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~~-  150 (372)
                      +.|+.|....+|+....              ..+.+|...|+.|.   ...+.+.++++...+..++||||+++..+.. 
T Consensus        42 ~~l~gG~~n~~y~v~~~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~~~~  121 (312)
T 3jr1_A           42 EKLYSGEMNEIWLINDEVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKNKQS  121 (312)
T ss_dssp             EEECCSSSSEEEEEESSSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCCCTT
T ss_pred             EEeCCccceeeeEEEECCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCCCch
Confidence            35788888888876431              24788999998884   3668889998888888999999999876521 


Q ss_pred             ----------hhhcCCC-CCCC---------------CCCCHHHHH---HHH----------------HHHHHHH-HHHh
Q 036435          151 ----------FVYNGDT-SKPC---------------QYLRWEKMY---EIV----------------IGIAKGL-EYLH  184 (372)
Q Consensus       151 ----------~l~~~~~-~~~~---------------~~l~~~~~~---~i~----------------~qi~~~l-~~LH  184 (372)
                                .|+.... ....               -.-+|....   ++.                .++++.+ ..|.
T Consensus       122 ~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~~L~  201 (312)
T 3jr1_A          122 SFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVADTLS  201 (312)
T ss_dssp             HHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHHHHT
T ss_pred             hHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHHHhc
Confidence                      2333221 0000               012454321   011                1122222 2342


Q ss_pred             -cCCCCCeeecCCCCCceEECCCCceEEeecC
Q 036435          185 -HGCSTKILHFDIKPHNILLDEDFCPKISDFG  215 (372)
Q Consensus       185 -~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  215 (372)
                       ......++|+|+.+.|++++.++ +.|.|++
T Consensus       202 ~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          202 KHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             TCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             cCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence             12357899999999999999887 8888974

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.80  E-value=0.0055  Score=54.73  Aligned_cols=31  Identities=23%  Similarity=0.149  Sum_probs=26.0

Q ss_pred             CCCeeecCCCCCceEECCCCceEEeecCCccc
Q 036435          188 STKILHFDIKPHNILLDEDFCPKISDFGLAKL  219 (372)
Q Consensus       188 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  219 (372)
                      ...++|+|+.+.||+ ..++.+.++||..+..
T Consensus       172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            456999999999999 5667789999988764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.44  E-value=0.0097  Score=53.86  Aligned_cols=32  Identities=28%  Similarity=0.313  Sum_probs=27.9

Q ss_pred             CCCeeecCCCCCceEECCC----CceEEeecCCccc
Q 036435          188 STKILHFDIKPHNILLDED----FCPKISDFGLAKL  219 (372)
Q Consensus       188 ~~~ivH~dlk~~Nill~~~----~~~kl~Dfgla~~  219 (372)
                      ...++|+|+.+.||+++.+    +.+.|+||+.+..
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            5689999999999999874    6789999998864

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.26  E-value=0.0058  Score=57.65  Aligned_cols=38  Identities=21%  Similarity=0.323  Sum_probs=26.2

Q ss_pred             hHHHHHHHHhccCCCce-eeeEeEEecCCceeEEEEecCCCCh
Q 036435          107 DFVNEVASISRTSHVNV-VTLLGFCLEGNNRALIYEFMPNGSL  148 (372)
Q Consensus       107 ~~~~E~~~l~~l~h~nI-v~l~g~~~~~~~~~lV~e~~~~g~L  148 (372)
                      .+.+|..+++.+...++ .++++.+.+    .+|+||++|.+|
T Consensus       121 ~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~l  159 (429)
T 1nw1_A          121 HLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL  159 (429)
T ss_dssp             HHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred             HHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCccc
Confidence            46679999988854444 567776643    289999986444

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=96.15  E-value=0.015  Score=51.50  Aligned_cols=56  Identities=20%  Similarity=0.256  Sum_probs=39.5

Q ss_pred             hhcCCCCceEEEEEEecc------------------hHHHHHHHHhccCC---CceeeeEeEEecCCceeEEEEecCCCC
Q 036435           89 DKLGQGGFGGVYKGRLLD------------------DFVNEVASISRTSH---VNVVTLLGFCLEGNNRALIYEFMPNGS  147 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~------------------~~~~E~~~l~~l~h---~nIv~l~g~~~~~~~~~lV~e~~~~g~  147 (372)
                      +.+|.|..+.||+.+..+                  .|.+|...|+.|.-   -.+.+.+++.    ..++||||++++.
T Consensus        21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~   96 (288)
T 3f7w_A           21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERP   96 (288)
T ss_dssp             EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCC
T ss_pred             EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccC
Confidence            458899999999986532                  47889999998842   2344555542    3479999998765


Q ss_pred             h
Q 036435          148 L  148 (372)
Q Consensus       148 L  148 (372)
                      .
T Consensus        97 ~   97 (288)
T 3f7w_A           97 P   97 (288)
T ss_dssp             C
T ss_pred             C
Confidence            3

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.12  E-value=0.01  Score=54.83  Aligned_cols=107  Identities=19%  Similarity=0.192  Sum_probs=64.5

Q ss_pred             hHHHHHHHHhccCCCc-eeeeEeEEecCCceeEEEEecCCCChhhh-----------------hhcCCCCCCCCCC--CH
Q 036435          107 DFVNEVASISRTSHVN-VVTLLGFCLEGNNRALIYEFMPNGSLEKF-----------------VYNGDTSKPCQYL--RW  166 (372)
Q Consensus       107 ~~~~E~~~l~~l~h~n-Iv~l~g~~~~~~~~~lV~e~~~~g~L~~~-----------------l~~~~~~~~~~~l--~~  166 (372)
                      ...+|..+++.+.-.+ ..++++++.++    +|+||++|.+|..-                 |+...... ....  -|
T Consensus        99 ~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~-~~~~~~l~  173 (379)
T 3feg_A           99 SLVLESVMFAILAERSLGPQLYGVFPEG----RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPF-TKEPHWLF  173 (379)
T ss_dssp             HHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSS-CCSCCHHH
T ss_pred             HHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCC-CCCcccHH
Confidence            4668999998884222 35677776542    99999997655311                 12221110 1112  24


Q ss_pred             HHHHHHHHHHHH-------------------HHHH----Hhc-CCCCCeeecCCCCCceEECCC----CceEEeecCCcc
Q 036435          167 EKMYEIVIGIAK-------------------GLEY----LHH-GCSTKILHFDIKPHNILLDED----FCPKISDFGLAK  218 (372)
Q Consensus       167 ~~~~~i~~qi~~-------------------~l~~----LH~-~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfgla~  218 (372)
                      .++.++..++..                   .+..    |.. .....++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       174 ~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          174 GTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            455555544322                   2233    321 124579999999999999876    789999998775

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=94.54  E-value=0.035  Score=51.98  Aligned_cols=81  Identities=12%  Similarity=0.079  Sum_probs=47.0

Q ss_pred             CCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeeeeeccccccccccccccccccc-CCCCccccchhHHHHHH
Q 036435          188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNF-GEVSHKSDVYSFGMMIM  266 (372)
Q Consensus       188 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~DvwslG~il~  266 (372)
                      ...++|+|+++.|||++.++ ++++||+.+..-...........  .-...|.+|+...... .......++.+....+|
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLG--NLILAFFAQDGHATQENDRKEYKQWILRTIEQTW  307 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHH--HHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHH--HHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence            68899999999999998776 99999998875322111000000  0112356655442110 01122345557777777


Q ss_pred             HHhcC
Q 036435          267 ELVGC  271 (372)
Q Consensus       267 elltg  271 (372)
                      +.+.+
T Consensus       308 ~~y~~  312 (420)
T 2pyw_A          308 NLFNK  312 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            77654

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=92.97  E-value=0.11  Score=31.28  Aligned_cols=30  Identities=10%  Similarity=0.299  Sum_probs=19.4

Q ss_pred             CCCCceeehhHHHHHHHHHHHHHHHHHHhh
Q 036435           10 SDGSELCYGLIVGIIGITTACITICIFTSK   39 (372)
Q Consensus        10 ~~~~~~~~g~iv~ii~~~~~~~~~~~~~~~   39 (372)
                      +....|..|+++|++++++++++++++.++
T Consensus         8 s~~~~IA~gVVgGv~~~~ii~~~~~~~~RR   37 (44)
T 2ks1_B            8 PKIPSIATGMVGALLLLLVVALGIGLFMRR   37 (44)
T ss_dssp             SCSSSSTHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CCcceEEeehhHHHHHHHHHHHHHHHHhhh
Confidence            556678888888777766666554444443

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=91.44  E-value=0.21  Score=44.63  Aligned_cols=29  Identities=34%  Similarity=0.375  Sum_probs=25.4

Q ss_pred             CCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          188 STKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       188 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      ...++|+|+++.||+++ + .+.++||+.+.
T Consensus       194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             CCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             CeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence            46789999999999999 4 89999998765

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=91.06  E-value=0.21  Score=47.37  Aligned_cols=55  Identities=18%  Similarity=0.088  Sum_probs=36.0

Q ss_pred             hcCCCCceEEEEEEecc------------------hHHHHHHHHhccCCCce-eeeEeEEecCCceeEEEEecCCCCh
Q 036435           90 KLGQGGFGGVYKGRLLD------------------DFVNEVASISRTSHVNV-VTLLGFCLEGNNRALIYEFMPNGSL  148 (372)
Q Consensus        90 ~lg~G~~g~V~~~~~~~------------------~~~~E~~~l~~l~h~nI-v~l~g~~~~~~~~~lV~e~~~~g~L  148 (372)
                      .|+.|-...+|+....+                  +-.+|..+++.|...++ .++++.+.+    .+|+||++|.+|
T Consensus       115 ~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l  188 (458)
T 2qg7_A          115 IINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYAL  188 (458)
T ss_dssp             EECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEEC
T ss_pred             EcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccC
Confidence            46677777888765321                  12589999999975555 467777632    259999987544

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=90.83  E-value=0.072  Score=47.65  Aligned_cols=31  Identities=23%  Similarity=0.312  Sum_probs=26.2

Q ss_pred             CCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          188 STKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       188 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      ...++|+|+.+.||+++.+..+.++||+.+.
T Consensus       186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            4579999999999999887666899998764

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=90.28  E-value=1.5  Score=36.77  Aligned_cols=115  Identities=9%  Similarity=0.108  Sum_probs=76.1

Q ss_pred             CCCceeeeEeEEecCCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHH-HHhcCCCCCeeecCCC
Q 036435          119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE-YLHHGCSTKILHFDIK  197 (372)
Q Consensus       119 ~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~-~LH~~~~~~ivH~dlk  197 (372)
                      .||++  =..+-.+++.+.+.++.-+++.=...+..         ++...+++++.+++.... +++     .-+|--|.
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~---------~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~  111 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK---------TTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVC  111 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT---------SCHHHHHHHHHHHHHHHSSCCS-----SSEECCCC
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh---------cCHHHHHHHHHHHHHHHHHhhh-----CceeEEEe
Confidence            57777  33344566666666665544322233322         778889999999887655 444     56888999


Q ss_pred             CCceEECCCCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCC
Q 036435          198 PHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLD  276 (372)
Q Consensus       198 ~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~  276 (372)
                      |+|+++|.++.+++.-.|+-.                    -++|.-       .+...=.-++=|++..++.++..|+
T Consensus       112 P~NL~f~~~~~p~i~hRGi~~--------------------~lpP~e-------~~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          112 PENLMFNRALEPFFLHVGVKE--------------------SLPPDE-------WDDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             GGGEEECTTCCEEESCCEETT--------------------TBSSCS-------CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             CceEEEeCCCcEEEEEcCCcc--------------------cCCCCC-------CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            999999999999998766532                    345542       2223334567788888888876654

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=89.87  E-value=1.2  Score=37.30  Aligned_cols=116  Identities=13%  Similarity=0.159  Sum_probs=77.6

Q ss_pred             CCCceeeeEeEEecCCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCC
Q 036435          119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKP  198 (372)
Q Consensus       119 ~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~  198 (372)
                      .||+.+.. .+-.+++...+.++.-+  +..++-.-       +.++...+++++.+|+....+++     .-+|--|.|
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~i-------k~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P  107 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDNI-------KSFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAP  107 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGGG-------GGSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHHH-------HhcCHHHHHHHHHHHHHHHHHhc-----CceEEEEec
Confidence            68888876 45556665555554443  33322211       12778899999999988775555     357889999


Q ss_pred             CceEECCCCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCC
Q 036435          199 HNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLD  276 (372)
Q Consensus       199 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~  276 (372)
                      +|+++|.++.+++.-.|+-.                    -++|.       ..+...=.-.+=|++..+++++..|+
T Consensus       108 ~NL~f~~~~~p~i~~RGik~--------------------~l~P~-------~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          108 DELFFTRDGLPIAKTRGLQN--------------------VVDPL-------PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             GGEEECTTSCEEESCCEETT--------------------TBSCC-------CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             ceEEEcCCCCEEEEEccCcc--------------------CCCCC-------CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999999998766532                    23343       22333345567888899998887765

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=89.67  E-value=0.17  Score=30.41  Aligned_cols=28  Identities=14%  Similarity=0.363  Sum_probs=15.3

Q ss_pred             CCceeehhHHHHHHHHHHHHHHHHHHhh
Q 036435           12 GSELCYGLIVGIIGITTACITICIFTSK   39 (372)
Q Consensus        12 ~~~~~~g~iv~ii~~~~~~~~~~~~~~~   39 (372)
                      ...|..|+++|++++++++++++++.++
T Consensus         9 ~~aIA~gVVgGv~~v~ii~~~~~~~~RR   36 (44)
T 2l2t_A            9 TPLIAAGVIGGLFILVIVGLTFAVYVRR   36 (44)
T ss_dssp             SHHHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             cceEEEeehHHHHHHHHHHHHHHHHhhh
Confidence            3446677777666655555444444333

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=89.12  E-value=0.15  Score=46.18  Aligned_cols=32  Identities=25%  Similarity=0.291  Sum_probs=28.0

Q ss_pred             CCCeeecCCCCCceEECCCCceEEeecCCccc
Q 036435          188 STKILHFDIKPHNILLDEDFCPKISDFGLAKL  219 (372)
Q Consensus       188 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  219 (372)
                      ...++|+|+.+.||+++.++.+.++||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            46799999999999999888899999987653

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=87.71  E-value=0.24  Score=45.26  Aligned_cols=30  Identities=20%  Similarity=0.355  Sum_probs=25.0

Q ss_pred             CCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          188 STKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       188 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      ...++|+|+.+.|||++++. +.++||..+.
T Consensus       211 ~~~l~HgDl~~~Nil~~~~~-~~lID~e~a~  240 (369)
T 3c5i_A          211 TIVFCHNDLQENNIINTNKC-LRLIDFEYSG  240 (369)
T ss_dssp             CEEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred             CeEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence            45799999999999998655 8999998775

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=80.98  E-value=0.76  Score=42.55  Aligned_cols=30  Identities=30%  Similarity=0.316  Sum_probs=25.0

Q ss_pred             CeeecCCCCCceEE------CCCCceEEeecCCccc
Q 036435          190 KILHFDIKPHNILL------DEDFCPKISDFGLAKL  219 (372)
Q Consensus       190 ~ivH~dlk~~Nill------~~~~~~kl~Dfgla~~  219 (372)
                      .++|+|+.+.|||+      +++..+.++||..|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            46799999999999      4567799999988753

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	372
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-58
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-51
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-51
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-51
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-51
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	9e-51
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-50
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-50
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-50
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-50
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-48
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-48
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-47
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-47
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-47
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-47
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-46
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-46
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-46
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-45
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-45
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-44
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	7e-44
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-43
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-43
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-42
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	7e-42
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	9e-42
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-41
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-40
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-39
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	7e-38
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	8e-37
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-35
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	9e-34
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-33
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	5e-33
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	7e-33
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-32
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	7e-32
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-31
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-31
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-31
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-30
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-30
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-29
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-29
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	9e-29
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-28
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-28
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-27
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-26
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-26
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-25
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-24
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	8e-24
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	8e-23
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-22
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-22
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-18
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-17
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-17
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-14

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 4e-58
 Identities = 72/283 (25%), Positives = 126/283 (44%), Gaps = 39/283 (13%)

Query: 87  FKDKLGQGGFGGVYKGRL------------------LDDFVNEVASISRTSHVNVVTLLG 128
              ++G G FG VYKG+                   L  F NEV  + +T HVN++  +G
Sbjct: 12  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71

Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
           +       A++ ++    SL   ++  +T          K+ +I    A+G++YLH    
Sbjct: 72  YS-TAPQLAIVTQWCEGSSLYHHLHIIETK-----FEMIKLIDIARQTAQGMDYLHAKS- 124

Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVF-SR 247
             I+H D+K +NI L ED   KI DFGLA + +   G         G I ++APEV   +
Sbjct: 125 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS-HQFEQLSGSILWMAPEVIRMQ 181

Query: 248 NFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVV 307
           +    S +SDVY+FG+++ EL+       +G    S +     I   V +     L   +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELM-------TGQLPYSNINNRDQIIFMVGRGY---LSPDL 231

Query: 308 TRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEAL 350
           ++  +   K M  +   C++ +  +RP   +++  ++    +L
Sbjct: 232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 1e-51
 Identities = 68/287 (23%), Positives = 113/287 (39%), Gaps = 43/287 (14%)

Query: 87  FKDKLGQGGFGGVYKGRLLD-----------------DFVNEVASISRTSHVNVVTLLGF 129
            + KLGQG FG V+ G                      F+ E   + +  H  +V L   
Sbjct: 21  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80

Query: 130 CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCST 189
                   ++ E+M  GSL  F+      +  +YLR  ++ ++   IA G+ Y+      
Sbjct: 81  V-SEEPIYIVTEYMSKGSLLDFLKG----ETGKYLRLPQLVDMAAQIASGMAYVERMN-- 133

Query: 190 KILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNF 249
             +H D++  NIL+ E+   K++DFGLA+L    E       GA+  I + APE      
Sbjct: 134 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ--GAKFPIKWTAPEAALY-- 188

Query: 250 GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTR 309
           G  + KSDV+SFG+++ EL         G+           +   VE+      P     
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGMV-------NREVLDQVERGYRMPCP----- 236

Query: 310 KENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQIPPTP 356
              E  + +  +   C +  P +RP    +   L+    + +    P
Sbjct: 237 --PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 2e-51
 Identities = 58/275 (21%), Positives = 110/275 (40%), Gaps = 43/275 (15%)

Query: 87  FKDKLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHVNVVTLLGF 129
           F  +LG G FG V  G+                   D+F+ E   +   SH  +V L G 
Sbjct: 8   FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 67

Query: 130 CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCST 189
           C +     +I E+M NG L  ++            + +++ E+   + + +EYL      
Sbjct: 68  CTKQRPIFIITEYMANGCLLNYLRE-----MRHRFQTQQLLEMCKDVCEAMEYLES---K 119

Query: 190 KILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNF 249
           + LH D+   N L+++    K+SDFGL++     E   +S +G++  + +  PEV     
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMY-- 175

Query: 250 GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTR 309
            + S KSD+++FG+++ E+                         H+ Q      P     
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-------NSETAEHIAQGLRLYRP----- 223

Query: 310 KENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
             +  ++K+  +   C   +  +RP    ++  + 
Sbjct: 224 --HLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 2e-51
 Identities = 70/282 (24%), Positives = 121/282 (42%), Gaps = 46/282 (16%)

Query: 87  FKDKLGQGGFGGVYKGRL-----------------LDDFVNEVASISRTSHVNVVTLLGF 129
             ++LG G FG V+ G                    D F+ E   + +  H  +V L   
Sbjct: 17  LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76

Query: 130 CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCST 189
             +     +I E+M NGSL  F+      K    L   K+ ++   IA+G+ ++      
Sbjct: 77  VTQ-EPIYIITEYMENGSLVDFLKTPSGIK----LTINKLLDMAAQIAEGMAFIEERN-- 129

Query: 190 KILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNF 249
             +H D++  NIL+ +    KI+DFGLA+L    E       GA+  I + APE    N+
Sbjct: 130 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE--GAKFPIKWTAPEAI--NY 184

Query: 250 GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTR 309
           G  + KSDV+SFG+++ E+V        G+           + +++E+      P     
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-------NPEVIQNLERGYRMVRP----- 232

Query: 310 KENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG---STE 348
             +   +++  +   C + RP DRP  + +  +L+    +TE
Sbjct: 233 --DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 3e-51
 Identities = 65/280 (23%), Positives = 114/280 (40%), Gaps = 43/280 (15%)

Query: 87  FKDKLGQGGFGGVYKGRLLD-----------------DFVNEVASISRTSHVNVVTLLGF 129
           F  ++G G FG V+ G  L+                 DF+ E   + + SH  +V L G 
Sbjct: 9   FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68

Query: 130 CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCST 189
           CLE     L++EFM +G L  ++              E +  + + + +G+ YL   C  
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYLR-----TQRGLFAAETLLGMCLDVCEGMAYLEEAC-- 121

Query: 190 KILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNF 249
            ++H D+   N L+ E+   K+SDFG+ +     +   +S  G +  + + +PEVF  +F
Sbjct: 122 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASPEVF--SF 176

Query: 250 GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTR 309
              S KSDV+SFG+++ E+                      +   +        P     
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-------NSEVVEDISTGFRLYKP----- 224

Query: 310 KENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA 349
                +  +  +   C + RP DRP  + ++  L    E+
Sbjct: 225 --RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 9e-51
 Identities = 58/274 (21%), Positives = 108/274 (39%), Gaps = 45/274 (16%)

Query: 87  FKDKLGQGGFGGVYKGRL---------------LDDFVNEVASISRTSHVNVVTLLGFCL 131
               +G+G FG V  G                    F+ E + +++  H N+V LLG  +
Sbjct: 11  LLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 70

Query: 132 EGNNR-ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTK 190
           E      ++ E+M  GSL  ++ +    +    L  + + +  + + + +EYL       
Sbjct: 71  EEKGGLYIVTEYMAKGSLVDYLRS----RGRSVLGGDCLLKFSLDVCEAMEYLE---GNN 123

Query: 191 ILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFG 250
            +H D+   N+L+ ED   K+SDFGL K  ++ +         +  + + APE       
Sbjct: 124 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG------KLPVKWTAPEALRE--K 175

Query: 251 EVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRK 310
           + S KSDV+SFG+++ E+          +           +   VE+  +   P      
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIP-------LKDVVPRVEKGYKMDAP------ 222

Query: 311 ENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
            +     +  V   C     + RP   ++ E L+
Sbjct: 223 -DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  169 bits (429), Expect = 1e-50
 Identities = 68/306 (22%), Positives = 121/306 (39%), Gaps = 60/306 (19%)

Query: 75  YNFSDVKKLTNSF-----------KDKLGQGGFGGVYKGRL------------------- 104
           + F D  +    F           +  +G G FG V  G L                   
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 105 ----LDDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKP 160
                 DF++E + + +  H NV+ L G   +     +I EFM NGSL+ F+      + 
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR-----QN 121

Query: 161 CQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC 220
                  ++  ++ GIA G++YL        +H D+   NIL++ +   K+SDFGL++  
Sbjct: 122 DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFL 178

Query: 221 T--TKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSG 278
              T +   +S LG +  I + APE     + + +  SDV+S+G+++ E++         
Sbjct: 179 EDDTSDPTYTSALGGKIPIRWTAPEAI--QYRKFTSASDVWSYGIVMWEVMSYGERPYWD 236

Query: 279 VDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNE 338
           +           +   +EQD     P        +    +  + L C Q   + RP   +
Sbjct: 237 MT-------NQDVINAIEQDYRLPPP-------MDCPSALHQLMLDCWQKDRNHRPKFGQ 282

Query: 339 VIEMLQ 344
           ++  L 
Sbjct: 283 IVNTLD 288

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 1e-50
 Identities = 57/294 (19%), Positives = 107/294 (36%), Gaps = 43/294 (14%)

Query: 87  FKDKLGQGGFGGVYKGRLLDDFV----------------NEVASISRTSHVNVVTLLGFC 130
            ++ +G+G FG V++G+   + V                 E+       H N++  +   
Sbjct: 7   LQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 66

Query: 131 LEGNNRA----LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
            + N       L+ ++  +GSL  ++           +  E M ++ +  A GL +LH  
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-------VTVEGMIKLALSTASGLAHLHME 119

Query: 187 C-----STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGAR-GIIGYI 240
                    I H D+K  NIL+ ++    I+D GLA    +    +      R G   Y+
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179

Query: 241 APEVFSRNF----GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE 296
           APEV   +      E   ++D+Y+ G++  E+    +      D     Y        VE
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239

Query: 297 QDREFKLPGVV------TRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
           + R+      +        +  E  + M  +   C  A  + R     + + L 
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 1e-50
 Identities = 61/297 (20%), Positives = 112/297 (37%), Gaps = 54/297 (18%)

Query: 70  LPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRL----------------------LDD 107
           L LKR N             +LG G FG V +G                         ++
Sbjct: 3   LFLKRDNLLIADI-------ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE 55

Query: 108 FVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWE 167
            + E   + +  +  +V L+G C +     L+ E    G L KF+         + +   
Sbjct: 56  MMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLV-----GKREEIPVS 109

Query: 168 KMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV 227
            + E++  ++ G++YL        +H D+   N+LL      KISDFGL+K     +   
Sbjct: 110 NVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166

Query: 228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYF 287
           ++    +  + + APE    NF + S +SDV+S+G+ + E +         +        
Sbjct: 167 TARSAGKWPLKWYAPECI--NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK------- 217

Query: 288 PHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
              +   +EQ +  + P        E   ++  +   C   +  DRP    V + ++
Sbjct: 218 GPEVMAFIEQGKRMECP-------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  167 bits (425), Expect = 3e-50
 Identities = 71/277 (25%), Positives = 120/277 (43%), Gaps = 43/277 (15%)

Query: 86  SFKDKLGQGGFGGVYKGRL------------------LDDFVNEVASISRTSHVNVVTLL 127
           + K KLG G +G VY+G                    +++F+ E A +    H N+V LL
Sbjct: 20  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 79

Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
           G C       +I EFM  G+L  ++         Q +    +  +   I+  +EYL    
Sbjct: 80  GVCTREPPFYIITEFMTYGNLLDYLRE----CNRQEVSAVVLLYMATQISSAMEYLE--- 132

Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSR 247
               +H D+   N L+ E+   K++DFGL++L T       +  GA+  I + APE  + 
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA--GAKFPIKWTAPESLAY 190

Query: 248 NFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVV 307
              + S KSDV++FG+++ E+     +   G+D          +Y  +E+D   + P   
Sbjct: 191 --NKFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQVYELLEKDYRMERP--- 238

Query: 308 TRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
                   +K+  +   C Q  PSDRP   E+ +  +
Sbjct: 239 ----EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 1e-48
 Identities = 64/291 (21%), Positives = 113/291 (38%), Gaps = 50/291 (17%)

Query: 77  FSDVKKLTNSFKDKLGQGGFGGVYKGRL-----------------------LDDFVNEVA 113
           + D K LT   K +LG G FG V KG                          D+ + E  
Sbjct: 2   YLDRKLLTLEDK-ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN 60

Query: 114 SISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIV 173
            + +  +  +V ++G C E  +  L+ E    G L K++         ++++ + + E+V
Sbjct: 61  VMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ------NRHVKDKNIIELV 113

Query: 174 IGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGA 233
             ++ G++YL     +  +H D+   N+LL      KISDFGL+K     E    +    
Sbjct: 114 HQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170

Query: 234 RGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYR 293
           +  + + APE  +    + S KSDV+SFG+++ E          G+           +  
Sbjct: 171 KWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-------GSEVTA 221

Query: 294 HVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
            +E+      P           ++M  +   C      +RP    V   L+
Sbjct: 222 MLEKGERMGCP-------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 1e-48
 Identities = 73/291 (25%), Positives = 118/291 (40%), Gaps = 49/291 (16%)

Query: 79  DVKKLTNSFKDKLGQGGFGGVYKGRLLD-----------------------DFVNEVASI 115
               L   F + +G+G FG VY G LLD                        F+ E   +
Sbjct: 23  GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 82

Query: 116 SRTSHVNVVTLLGFCLEGNNRA-LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVI 174
              SH NV++LLG CL       ++  +M +G L  F+ N   +        + +    +
Sbjct: 83  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-----PTVKDLIGFGL 137

Query: 175 GIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG-IVSSLLGA 233
            +AKG+       S K +H D+   N +LDE F  K++DFGLA+    KE   V +  GA
Sbjct: 138 QVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 194

Query: 234 RGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYR 293
           +  + ++A E       + + KSDV+SFG+++ EL+         V+          I  
Sbjct: 195 KLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-------TFDITV 245

Query: 294 HVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
           ++ Q R    P             +  V L C   +   RP  +E++  + 
Sbjct: 246 YLLQGRRLLQP-------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 2e-47
 Identities = 61/294 (20%), Positives = 120/294 (40%), Gaps = 51/294 (17%)

Query: 86  SFKDKLGQGGFGGVYKGRLLD------------------------DFVNEVASISRTSHV 121
           + +  +G G FG VYKG L                          DF+ E   + + SH 
Sbjct: 10  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 69

Query: 122 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           N++ L G   +     +I E+M NG+L+KF+      +        ++  ++ GIA G+ 
Sbjct: 70  NIIRLEGVISKYKPMMIITEYMENGALDKFLR-----EKDGEFSVLQLVGMLRGIAAGM- 123

Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
              +  +   +H D+   NIL++ +   K+SDFGL+++         +  G +  I + A
Sbjct: 124 --KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE  S    + +  SDV+SFG+++ E++         +         H + + +      
Sbjct: 182 PEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELS-------NHEVMKAINDGFRL 232

Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQIPPT 355
             P        +    +  + + C Q   + RP   +++ +L    + ++ P +
Sbjct: 233 PTP-------MDCPSAIYQLMMQCWQQERARRPKFADIVSILD---KLIRAPDS 276

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  160 bits (405), Expect = 3e-47
 Identities = 61/301 (20%), Positives = 109/301 (36%), Gaps = 63/301 (20%)

Query: 87  FKDKLGQGGFGGVYKGRL-------------------------LDDFVNEVASISRTSHV 121
           +   +G+G FG V++ R                            DF  E A ++   + 
Sbjct: 17  YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 76

Query: 122 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQY------------------ 163
           N+V LLG C  G    L++E+M  G L +F+ +      C                    
Sbjct: 77  NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136

Query: 164 LRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK 223
           L   +   I   +A G+ YL      K +H D+   N L+ E+   KI+DFGL++   + 
Sbjct: 137 LSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193

Query: 224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSS 283
           +   +        I ++ PE    N    + +SDV+++G+++ E+         G+    
Sbjct: 194 DYYKAD-GNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGLQPYYGMA--- 247

Query: 284 EVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEML 343
                  +  +V        P            ++  +   C    P+DRP    +  +L
Sbjct: 248 ----HEEVIYYVRDGNILACP-------ENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296

Query: 344 Q 344
           Q
Sbjct: 297 Q 297

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 4e-47
 Identities = 59/280 (21%), Positives = 106/280 (37%), Gaps = 47/280 (16%)

Query: 87  FKDKLGQGGFGGVYKGRLLDD---------------------FVNEVASISRTSHVNVVT 125
               +G G +G   K R   D                      V+EV  +    H N+V 
Sbjct: 8   VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR 67

Query: 126 LLGFCLEGNNRAL--IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYL 183
                ++  N  L  + E+   G L   +  G  +K  QYL  E +  ++  +   L+  
Sbjct: 68  YYDRIIDRTNTTLYIVMEYCEGGDLASVITKG--TKERQYLDEEFVLRVMTQLTLALKEC 125

Query: 184 H--HGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           H        +LH D+KP N+ LD     K+ DFGLA++         +     G   Y++
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAF---VGTPYYMS 182

Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE  +R     + KSD++S G ++ EL        +        +    +   + + +  
Sbjct: 183 PEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTA--------FSQKELAGKIREGKFR 232

Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
           ++P   + + NEI  +        +  +   RP + E++E
Sbjct: 233 RIPYRYSDELNEIITR-------MLNLKDYHRPSVEEILE 265

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 4e-47
 Identities = 62/301 (20%), Positives = 108/301 (35%), Gaps = 62/301 (20%)

Query: 87  FKDKLGQGGFGGVYKGRLLD-------------------------DFVNEVASISR-TSH 120
           F   LG G FG V                                  ++E+  +++  SH
Sbjct: 41  FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100

Query: 121 VNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYN-----------------GDTSKPCQY 163
            N+V LLG C       LI+E+   G L  ++ +                  +  +    
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160

Query: 164 LRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTK 223
           L +E +      +AKG+E+L        +H D+   N+L+      KI DFGLA+   + 
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217

Query: 224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSS 283
              V     AR  + ++APE      G  + KSDV+S+G+++ E+     N   G+   +
Sbjct: 218 SNYVVR-GNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274

Query: 284 EVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEML 343
                   Y+ ++   +   P           +++ I+   C       RP    +   L
Sbjct: 275 N------FYKLIQNGFKMDQP-------FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321

Query: 344 Q 344
            
Sbjct: 322 G 322

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 2e-46
 Identities = 68/298 (22%), Positives = 112/298 (37%), Gaps = 57/298 (19%)

Query: 86  SFKDKLGQGGFGGVYKGRLL-------------------------DDFVNEVASISR-TS 119
           SF   LG G FG V +                             +  ++E+  +S   +
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85

Query: 120 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQY------------LRWE 167
           H+N+V LLG C  G    +I E+   G L  F+     S  C              L  E
Sbjct: 86  HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145

Query: 168 KMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV 227
            +      +AKG+ +L    S   +H D+   NILL      KI DFGLA+        V
Sbjct: 146 DLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202

Query: 228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYF 287
                AR  + ++APE         + +SDV+S+G+ + EL    ++   G+   S    
Sbjct: 203 VK-GNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS---- 255

Query: 288 PHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG 345
               Y+ +++      P            +M  +   C  A P  RP   +++++++ 
Sbjct: 256 --KFYKMIKEGFRMLSP-------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  158 bits (401), Expect = 2e-46
 Identities = 62/275 (22%), Positives = 106/275 (38%), Gaps = 53/275 (19%)

Query: 90  KLGQGGFGGVYKGRLLDD----------------------FVNEVASISRTSHVNVVTLL 127
           ++G G FG VY  R + +                       + EV  + +  H N +   
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
           G  L  +   L+ E+    + +    +       + L+  ++  +  G  +GL YLH   
Sbjct: 82  GCYLREHTAWLVMEYCLGSASDLLEVHK------KPLQEVEIAAVTHGALQGLAYLH--- 132

Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVF-S 246
           S  ++H D+K  NILL E    K+ DFG A +       V       G   ++APEV  +
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-------GTPYWMAPEVILA 185

Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
            + G+   K DV+S G+  +EL   K  L +    S        +Y   + +      G 
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIAQNESPALQSGH 238

Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
            +    E  +  +     C+Q  P DRP    +++
Sbjct: 239 WS----EYFRNFV---DSCLQKIPQDRPTSEVLLK 266

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 2e-46
 Identities = 64/309 (20%), Positives = 122/309 (39%), Gaps = 61/309 (19%)

Query: 69  PLPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLLDD--------------------- 107
           P      +++D+K     F+D +G+G FG V K R+  D                     
Sbjct: 1   PTIYPVLDWNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR 55

Query: 108 -FVNEVASISR-TSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYN----------G 155
            F  E+  + +   H N++ LLG C       L  E+ P+G+L  F+             
Sbjct: 56  DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 115

Query: 156 DTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFG 215
             +     L  +++      +A+G++YL      + +H D+   NIL+ E++  KI+DFG
Sbjct: 116 IANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFG 172

Query: 216 LAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNL 275
           L++               R  + ++A E    N+   +  SDV+S+G+++ E+V      
Sbjct: 173 LSRGQEVY----VKKTMGRLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIVSLGGTP 226

Query: 276 DSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPP 335
             G+           +Y  + Q    + P            ++  +   C + +P +RP 
Sbjct: 227 YCGMT-------CAELYEKLPQGYRLEKP-------LNCDDEVYDLMRQCWREKPYERPS 272

Query: 336 MNEVIEMLQ 344
             +++  L 
Sbjct: 273 FAQILVSLN 281

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 1e-45
 Identities = 60/283 (21%), Positives = 104/283 (36%), Gaps = 49/283 (17%)

Query: 87  FKDKLGQGGFGGVYKGRL-------------------------LDDFVNEVASISRTSHV 121
             +KLG G FG V +G                           +DDF+ EV ++    H 
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71

Query: 122 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           N++ L G  L    + ++ E  P GSL   +      K   +     +    + +A+G+ 
Sbjct: 72  NLIRLYGVVLTPPMK-MVTELAPLGSLLDRLR-----KHQGHFLLGTLSRYAVQVAEGMG 125

Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           YL    S + +H D+   N+LL      KI DFGL +     +         +    + A
Sbjct: 126 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182

Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
           PE         SH SD + FG+ + E+         G++ S        +++  ++    
Sbjct: 183 PESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------ILHKIDKEGERL 234

Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
             P        +  + +  V + C   +P DRP    + + L 
Sbjct: 235 PRP-------EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 6e-45
 Identities = 61/281 (21%), Positives = 103/281 (36%), Gaps = 54/281 (19%)

Query: 87  FKDKLGQGGFGGVYKGRLLDD---------------------FVNEVASISRTSHVNVVT 125
           F  ++G+G F  VYKG   +                      F  E   +    H N+V 
Sbjct: 13  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72

Query: 126 LLGFCLE----GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
                           L+ E M +G+L+ ++         + ++ + +      I KGL+
Sbjct: 73  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQ 126

Query: 182 YLHHGCSTKILHFDIKPHNILL-DEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYI 240
           +LH   +  I+H D+K  NI +       KI D GLA L        S      G   ++
Sbjct: 127 FLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-----SFAKAVIGTPEFM 180

Query: 241 APEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDRE 300
           APE++     +     DVY+FGM ++E+        +     SE      IYR V     
Sbjct: 181 APEMYE---EKYDESVDVYAFGMCMLEMA-------TSEYPYSECQNAAQIYRRVTSG-- 228

Query: 301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
              P    +      K++I     CI+    +R  + +++ 
Sbjct: 229 -VKPASFDKVAIPEVKEII---EGCIRQNKDERYSIKDLLN 265

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 2e-44
 Identities = 53/323 (16%), Positives = 107/323 (33%), Gaps = 77/323 (23%)

Query: 70  LPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLLDD--------------------FV 109
           + LK  +F  + +L        G G  G V+K                           +
Sbjct: 1   MELKDDDFEKISEL--------GAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII 52

Query: 110 NEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKM 169
            E+  +   +   +V   G        ++  E M  GSL++ +           +  + +
Sbjct: 53  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA------GRIPEQIL 106

Query: 170 YEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSS 229
            ++ I + KGL YL      KI+H D+KP NIL++     K+ DFG++          S 
Sbjct: 107 GKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-----SM 159

Query: 230 LLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV-------------------- 269
                G   Y++PE         S +SD++S G+ ++E+                     
Sbjct: 160 ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGC 217

Query: 270 -----------GCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKM 318
                        +           +   P  I+  ++       P + +   +   +  
Sbjct: 218 QVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDF 277

Query: 319 IIVGLWCIQARPSDRPPMNEVIE 341
           +     C+   P++R  + +++ 
Sbjct: 278 V---NKCLIKNPAERADLKQLMV 297

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 7e-44
 Identities = 61/305 (20%), Positives = 113/305 (37%), Gaps = 59/305 (19%)

Query: 87  FKDKLGQGGFGGVYKGRL-------------------LDDFVNEVASISRTSHVNVVTLL 127
              +LG G FG VYK +                    L+D++ E+  ++   H N+V LL
Sbjct: 16  IIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 75

Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
                 NN  ++ EF   G+++  +   +     + L   ++  +       L YLH   
Sbjct: 76  DAFYYENNLWILIEFCAGGAVDAVMLELE-----RPLTESQIQVVCKQTLDALNYLH--- 127

Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVF-- 245
             KI+H D+K  NIL   D   K++DFG++   T       S     G   ++APEV   
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF---IGTPYWMAPEVVMC 184

Query: 246 -SRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
            +       +K+DV+S G+ ++E+   +               P  +   + +     L 
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE--------LNPMRVLLKIAKSEPPTLA 236

Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQIPPTPFLSSPPRA 364
                + +   K  +     C++     R   +++++              PF++     
Sbjct: 237 --QPSRWSSNFKDFL---KKCLEKNVDARWTTSQLLQH-------------PFVTVDSNK 278

Query: 365 PIDSF 369
           PI   
Sbjct: 279 PIREL 283

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 2e-43
 Identities = 63/277 (22%), Positives = 104/277 (37%), Gaps = 54/277 (19%)

Query: 87  FKDKLGQGGFGGVYKGRLLDD----------------------FVNEVASISRTSHVNVV 124
               LG+G FG VY  R                             EV   S   H N++
Sbjct: 10  IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 69

Query: 125 TLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH 184
            L G+  +     LI E+ P G++ + +      +       ++    +  +A  L Y H
Sbjct: 70  RLYGYFHDATRVYLILEYAPLGTVYREL------QKLSKFDEQRTATYITELANALSYCH 123

Query: 185 HGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV 244
              S +++H DIKP N+LL      KI+DFG +    +     S      G + Y+ PE+
Sbjct: 124 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-----SRRTTLCGTLDYLPPEM 175

Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
                     K D++S G++  E +  K   ++  ++  E Y             EF  P
Sbjct: 176 IEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEA--NTYQETYKRI-------SRVEFTFP 224

Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
             VT    ++  +        ++  PS RP + EV+E
Sbjct: 225 DFVTEGARDLISR-------LLKHNPSQRPMLREVLE 254

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (378), Expect = 5e-43
 Identities = 68/313 (21%), Positives = 114/313 (36%), Gaps = 56/313 (17%)

Query: 86  SFKDKLGQGGFGGVYKGRLLDD------------------------FVNEVASISRTSHV 121
                LG G FG VYKG  + +                         ++E   ++   + 
Sbjct: 12  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 71

Query: 122 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
           +V  LLG CL    + LI + MP G L  +V     +        + +    + IAKG+ 
Sbjct: 72  HVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIG-----SQYLLNWCVQIAKGMN 125

Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           YL      +++H D+   N+L+      KI+DFGLAKL   +E    +  G +  I ++A
Sbjct: 126 YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIKWMA 181

Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
            E         +H+SDV+S+G+ + EL+   +    G+           I   +E+    
Sbjct: 182 LESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-------ASEISSILEKGERL 232

Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE------ALQIPPT 355
             P             + ++ + C       RP   E+I               +Q    
Sbjct: 233 PQP-------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDER 285

Query: 356 PFLSSPPRAPIDS 368
             L SP  +    
Sbjct: 286 MHLPSPTDSNFYR 298

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 4e-42
 Identities = 60/281 (21%), Positives = 101/281 (35%), Gaps = 50/281 (17%)

Query: 87  FKDKLGQGGFGGVYKGRLLDD-----------------------FVNEVASISRTSHVNV 123
               +G+G FG V++G  +                         F+ E  ++ +  H ++
Sbjct: 11  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70

Query: 124 VTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYL 183
           V L+G   E N   +I E    G L  F+           L    +      ++  L YL
Sbjct: 71  VKLIGVITE-NPVWIIMELCTLGELRSFLQ-----VRKYSLDLASLILYAYQLSTALAYL 124

Query: 184 HHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE 243
               S + +H DI   N+L+  + C K+ DFGL++         +S    +  I ++APE
Sbjct: 125 E---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS--KGKLPIKWMAPE 179

Query: 244 VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL 303
               NF   +  SDV+ FG+ + E++        GV         + +   +E      +
Sbjct: 180 SI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-------NNDVIGRIENGERLPM 230

Query: 304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
           P         +  K       C    PS RP   E+   L 
Sbjct: 231 PPNCPPTLYSLMTK-------CWAYDPSRRPRFTELKAQLS 264

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 7e-42
 Identities = 64/296 (21%), Positives = 118/296 (39%), Gaps = 58/296 (19%)

Query: 87  FKDKLGQGGFGGVYKGRL---------------------------LDDFVNEVASISR-T 118
               LG+G FG V                                L D ++E+  +    
Sbjct: 17  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76

Query: 119 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYN----------GDTSKPCQYLRWEK 168
            H N++ LLG C +     +I E+   G+L +++              +  P + L  + 
Sbjct: 77  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136

Query: 169 MYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVS 228
           +      +A+G+EYL    S K +H D+   N+L+ ED   KI+DFGLA+     +    
Sbjct: 137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193

Query: 229 SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFP 288
           +    R  + ++APE         +H+SDV+SFG+++ E+     +   GV         
Sbjct: 194 T-TNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-------V 243

Query: 289 HWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
             +++ +++      P       +    ++ ++   C  A PS RP   +++E L 
Sbjct: 244 EELFKLLKEGHRMDKP-------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 9e-42
 Identities = 65/292 (22%), Positives = 111/292 (38%), Gaps = 49/292 (16%)

Query: 86  SFKDKLGQGGFGGVYKGRL-------------------------LDDFVNEVASISRTSH 120
           +   +LGQG FG VY+G                             +F+NE + +   + 
Sbjct: 23  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 82

Query: 121 VNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYN----GDTSKPCQYLRWEKMYEIVIGI 176
            +VV LLG   +G    +I E M  G L+ ++ +       +         KM ++   I
Sbjct: 83  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 142

Query: 177 AKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI 236
           A G+ YL    + K +H D+   N ++ EDF  KI DFG+ +     +       G    
Sbjct: 143 ADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG-LLP 198

Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE 296
           + +++PE      G  +  SDV+SFG+++ E+         G+           + R V 
Sbjct: 199 VRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-------NEQVLRFVM 249

Query: 297 QDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE 348
           +      P       +     +  +   C Q  P  RP   E+I  ++   E
Sbjct: 250 EGGLLDKP-------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 2e-41
 Identities = 72/300 (24%), Positives = 114/300 (38%), Gaps = 56/300 (18%)

Query: 87  FKDKLGQGGFGGVYKGRLLD-------------------------DFVNEVASISRTSH- 120
               LG+G FG V +                                ++E+  +    H 
Sbjct: 17  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76

Query: 121 VNVVTLLGFCLE-GNNRALIYEFMPNGSLEKFVYN----------GDTSKPCQYLRWEKM 169
           +NVV LLG C + G    +I EF   G+L  ++ +                  +L  E +
Sbjct: 77  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136

Query: 170 YEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSS 229
                 +AKG+E+L    S K +H D+   NILL E    KI DFGLA+        V  
Sbjct: 137 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193

Query: 230 LLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPH 289
              AR  + ++APE         + +SDV+SFG+++ E+     +   GV          
Sbjct: 194 -GDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVK------IDE 244

Query: 290 WIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA 349
              R +++    + P       +    +M    L C    PS RP  +E++E L    +A
Sbjct: 245 EFCRRLKEGTRMRAP-------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 2e-40
 Identities = 61/275 (22%), Positives = 96/275 (34%), Gaps = 44/275 (16%)

Query: 87  FKDKLGQGGFGGVYKGRLLDD--------------------FVNEVASISRTSHVNVVTL 126
               LG+G +G V                               E+      +H NVV  
Sbjct: 9   LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 68

Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
            G   EGN + L  E+   G L   +      +P   +           +  G+ YLH  
Sbjct: 69  YGHRREGNIQYLFLEYCSGGELFDRI------EPDIGMPEPDAQRFFHQLMAGVVYLH-- 120

Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
               I H DIKP N+LLDE    KISDFGLA +          L    G + Y+APE+  
Sbjct: 121 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRY-NNRERLLNKMCGTLPYVAPELLK 178

Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
           R     +   DV+S G+++  ++  +   D    S S   +  W  +    +   K+   
Sbjct: 179 RR-EFHAEPVDVWSCGIVLTAMLAGELPWDQ--PSDSCQEYSDWKEKKTYLNPWKKID-- 233

Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
                      ++      +   PS R  + ++ +
Sbjct: 234 ------SAPLALL---HKILVENPSARITIPDIKK 259

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 3e-39
 Identities = 61/291 (20%), Positives = 114/291 (39%), Gaps = 59/291 (20%)

Query: 71  PLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLLDD-------------------FVNE 111
           P K+Y          +  +K+GQG  G VY    +                      +NE
Sbjct: 18  PKKKY----------TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE 67

Query: 112 VASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYE 171
           +  +    + N+V  L   L G+   ++ E++  GSL   V               ++  
Sbjct: 68  ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD-------EGQIAA 120

Query: 172 IVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLL 231
           +     + LE+LH   S +++H DIK  NILL  D   K++DFG     T ++   S+++
Sbjct: 121 VCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 177

Query: 232 GARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWI 291
           G      ++APEV +R       K D++S G+M +E++  +    +  ++         +
Sbjct: 178 GTP---YWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLN--ENPLRA-----L 225

Query: 292 YRHVEQDR-EFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
           Y        E + P  ++     I +  +     C+      R    E+++
Sbjct: 226 YLIATNGTPELQNPEKLS----AIFRDFL---NRCLDMDVEKRGSAKELLQ 269

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  137 bits (345), Expect = 7e-38
 Identities = 55/276 (19%), Positives = 102/276 (36%), Gaps = 47/276 (17%)

Query: 87  FKDKLGQGGFGGVYKGRLLDD-------------------FVNEVASISRTSHVNVVTLL 127
             ++LG G FG V++                            E+ ++S   H  +V L 
Sbjct: 30  IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 89

Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
               + N   +IYEFM  G L + V           +  ++  E +  + KGL ++H   
Sbjct: 90  DAFEDDNEMVMIYEFMSGGELFEKVA-----DEHNKMSEDEAVEYMRQVCKGLCHMH--- 141

Query: 188 STKILHFDIKPHNILLDEDFCP--KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVF 245
               +H D+KP NI+         K+ DFGL      K+ +  +     G   + APEV 
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT----TGTAEFAAPEVA 197

Query: 246 SRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG 305
                 V + +D++S G++   L+   +      ++  E            +  ++ +  
Sbjct: 198 EG--KPVGYYTDMWSVGVLSYILLSGLSPFGG--ENDDETLRNV-------KSCDWNMDD 246

Query: 306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
                 +E  K  I      + A P+ R  +++ +E
Sbjct: 247 SAFSGISEDGKDFI---RKLLLADPNTRMTIHQALE 279

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  134 bits (338), Expect = 8e-37
 Identities = 65/338 (19%), Positives = 123/338 (36%), Gaps = 57/338 (16%)

Query: 53  ITKSDKDLEAFIRNYGPLP--LKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLLDD--- 107
           I   DK  E   + Y P P  +K+ +  D   +     ++LG G FG V++         
Sbjct: 1   INDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDI----LEELGSGAFGVVHRCVEKATGRV 56

Query: 108 ----------------FVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF 151
                             NE++ +++  H  ++ L     +     LI EF+  G L   
Sbjct: 57  FVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDR 116

Query: 152 VYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP-- 209
           +     +     +   ++   +    +GL+++H      I+H DIKP NI+ +       
Sbjct: 117 I-----AAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSV 168

Query: 210 KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
           KI DFGLA      E     +        + APE+  R    V   +D+++ G++   L+
Sbjct: 169 KIIDFGLATKLNPDE----IVKVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLL 222

Query: 270 GCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQAR 329
              +      +   E            +  +++         +  AK  I      +Q  
Sbjct: 223 SGLSPFAG--EDDLETLQNV-------KRCDWEFDEDAFSSVSPEAKDFI---KNLLQKE 270

Query: 330 PSDRPPMNEVIEM--LQGSTEAL--QIPPTPFLSSPPR 363
           P  R  +++ +E   L+G    L  +IP + +     +
Sbjct: 271 PRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQK 308

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 3e-35
 Identities = 60/276 (21%), Positives = 91/276 (32%), Gaps = 52/276 (18%)

Query: 87  FKDKLGQGGFGGVYKGRLLDD----------------------FVNEVASISRTSHVNVV 124
           F   LG+G F  V   R L                           E   +SR  H   V
Sbjct: 12  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71

Query: 125 TLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH 184
            L     +         +  NG L K++                       I   LEYLH
Sbjct: 72  KLYFTFQDDEKLYFGLSYAKNGELLKYIRK------IGSFDETCTRFYTAEIVSALEYLH 125

Query: 185 HGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV 244
                 I+H D+KP NILL+ED   +I+DFG AK+ +  E   +      G   Y++PE+
Sbjct: 126 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP-ESKQARANSFVGTAQYVSPEL 181

Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQ-DREFKL 303
            +         SD+++ G +I +LV       +G         P           +  KL
Sbjct: 182 LTE--KSACKSSDLWALGCIIYQLV-------AG-------LPPFRAGNEYLIFQKIIKL 225

Query: 304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEV 339
                 K    A+ ++      +    + R    E+
Sbjct: 226 EYDFPEKFFPKARDLV---EKLLVLDATKRLGCEEM 258

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  124 bits (312), Expect = 9e-34
 Identities = 55/293 (18%), Positives = 103/293 (35%), Gaps = 52/293 (17%)

Query: 81  KKLTNSFK--DKLGQGGFGGVYKGRLLDD----------------------FVNEVASIS 116
             L++ ++  + LG GG   V+  R L                        F  E  + +
Sbjct: 3   SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62

Query: 117 RTSHVNVVTLLGFCLEGNNRA----LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEI 172
             +H  +V +               ++ E++   +L   V+          +  ++  E+
Sbjct: 63  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT------EGPMTPKRAIEV 116

Query: 173 VIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLG 232
           +    + L +        I+H D+KP NI++      K+ DFG+A+        V+    
Sbjct: 117 IADACQALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 173

Query: 233 ARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIY 292
             G   Y++PE        V  +SDVYS G ++ E++  +       DS   V      Y
Sbjct: 174 VIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTG--DSPVSV-----AY 224

Query: 293 RHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPP-MNEVIEMLQ 344
           +HV +D     P       +     ++   L  +   P +R     E+   L 
Sbjct: 225 QHVREDPIP--PSARHEGLSADLDAVV---LKALAKNPENRYQTAAEMRADLV 272

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  123 bits (311), Expect = 2e-33
 Identities = 55/275 (20%), Positives = 92/275 (33%), Gaps = 44/275 (16%)

Query: 87  FKDKLGQGGFGGVYKGRLLDD--------------------FVNEVASISRTSHVNVVTL 126
           F+D LG G F  V                              NE+A + +  H N+V L
Sbjct: 13  FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVAL 72

Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                 G +  LI + +  G L   +          +        ++  +   ++YLH  
Sbjct: 73  DDIYESGGHLYLIMQLVSGGELFDRIVE------KGFYTERDASRLIFQVLDAVKYLHDL 126

Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
                           LDED    ISDFGL+K+        S L  A G  GY+APEV +
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG----SVLSTACGTPGYVAPEVLA 182

Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
           +     S   D +S G++   L+        G     +        + ++ + EF  P  
Sbjct: 183 Q--KPYSKAVDCWSIGVIAYILL-------CGYPPFYDENDAKLFEQILKAEYEFDSP-- 231

Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
                ++I+          ++  P  R    + ++
Sbjct: 232 ---YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  124 bits (312), Expect = 5e-33
 Identities = 57/293 (19%), Positives = 97/293 (33%), Gaps = 58/293 (19%)

Query: 86  SFKDKLGQGGFGGVYKGRLLDD-------------------------FVNEVASISRTSH 120
           S    +G+GGFG VY  R  D                              ++ +S    
Sbjct: 7   SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66

Query: 121 VNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGL 180
             +V +       +  + I + M  G L   +                M      I  GL
Sbjct: 67  PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL------SQHGVFSEADMRFYAAEIILGL 120

Query: 181 EYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYI 240
           E++H   +  +++ D+KP NILLDE    +ISD GLA   +           + G  GY+
Sbjct: 121 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-----KKPHASVGTHGYM 172

Query: 241 APEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDRE 300
           APEV  +        +D +S G M+ +L+   +                 +   VE    
Sbjct: 173 APEVLQKGVA-YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS 231

Query: 301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQIP 353
           F          +   + ++      +Q   + R        + +G+ E  + P
Sbjct: 232 F----------SPELRSLL---EGLLQRDVNRRLGC-----LGRGAQEVKESP 266

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  122 bits (306), Expect = 7e-33
 Identities = 52/288 (18%), Positives = 98/288 (34%), Gaps = 58/288 (20%)

Query: 87  FKDKLGQGGFGGVYKGRLLDD----------------------------FVNEVASISRT 118
            K+ LG+G    V +                                   + EV  + + 
Sbjct: 7   PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66

Query: 119 S-HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIA 177
           S H N++ L           L+++ M  G L  ++           L  ++  +I+  + 
Sbjct: 67  SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK------VTLSEKETRKIMRALL 120

Query: 178 KGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGII 237
           + +  LH      I+H D+KP NILLD+D   K++DFG +      E     L    G  
Sbjct: 121 EVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE----KLREVCGTP 173

Query: 238 GYIAPEVFS----RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYR 293
            Y+APE+       N      + D++S G+++  L+               +        
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH--RKQMLMLR-----M 226

Query: 294 HVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
            +  + +F  P       ++  K ++      +  +P  R    E + 
Sbjct: 227 IMSGNYQFGSP--EWDDYSDTVKDLV---SRFLVVQPQKRYTAEEALA 269

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 3e-32
 Identities = 48/275 (17%), Positives = 98/275 (35%), Gaps = 46/275 (16%)

Query: 87  FKDKLGQGGFGGVYKGRLLDD------------------FVNEVASISRTSHVNVVTLLG 128
             + LG+G FG V++                           E++ ++   H N++ L  
Sbjct: 9   IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHE 68

Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
                    +I+EF+    + + +     +     L   ++   V  + + L++LH   S
Sbjct: 69  SFESMEELVMIFEFISGLDIFERI-----NTSAFELNEREIVSYVHQVCEALQFLH---S 120

Query: 189 TKILHFDIKPHNILLDEDFCP--KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
             I HFDI+P NI+         KI +FG A+     +              Y APEV  
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL----FTAPEYYAPEVHQ 176

Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
                VS  +D++S G ++  L+   N   +  +++ ++            + E+     
Sbjct: 177 H--DVVSTATDMWSLGTLVYVLLSGINPFLA--ETNQQIIENI-------MNAEYTFDEE 225

Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
             ++ +  A   +      +      R   +E ++
Sbjct: 226 AFKEISIEAMDFV---DRLLVKERKSRMTASEALQ 257

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  119 bits (300), Expect = 7e-32
 Identities = 46/283 (16%), Positives = 86/283 (30%), Gaps = 44/283 (15%)

Query: 87  FKDKLGQGGFGGVYKGRLL-----------------DDFVNEVASISRTSHVNVVTLLGF 129
              K+G G FG +Y G  +                      E            +  + +
Sbjct: 11  LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRW 70

Query: 130 CL-EGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
           C  EG+   ++ E +     + F +        +    + +  +   +   +EY+H   S
Sbjct: 71  CGAEGDYNVMVMELLGPSLEDLFNFCS------RKFSLKTVLLLADQMISRIEYIH---S 121

Query: 189 TKILHFDIKPHNIL---LDEDFCPKISDFGLAKLC----TTKEGIVSSLLGARGIIGYIA 241
              +H D+KP N L     +     I DFGLAK      T +           G   Y +
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181

Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF 301
                    E S + D+ S G ++M                          +  E+  E 
Sbjct: 182 INTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQ--------GLKAATKRQKYERISEK 231

Query: 302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ 344
           K+   +         +      +C   R  D+P  + + ++ +
Sbjct: 232 KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (298), Expect = 2e-31
 Identities = 56/297 (18%), Positives = 107/297 (36%), Gaps = 44/297 (14%)

Query: 88  KDKLGQGGFGGVYKGRLLDD--------------FVNEVASISRTS-HVNVVTLLGFC-- 130
              LG G  G V +                       EV    R S   ++V ++     
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYEN 76

Query: 131 --LEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
                    ++ E +  G L   + +    +  Q     +  EI+  I + ++YLH   S
Sbjct: 77  LYAGRKCLLIVMECLDGGELFSRIQD----RGDQAFTEREASEIMKSIGEAIQYLH---S 129

Query: 189 TKILHFDIKPHNILLDEDFCP---KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVF 245
             I H D+KP N+L          K++DFG AK  T+   + +          Y+APEV 
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP----CYTPYYVAPEVL 185

Query: 246 SRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG 305
                +     D++S G+++  L+           S+  +     +   +    +++ P 
Sbjct: 186 GP--EKYDKSCDMWSLGVIMYILLCGYPPF----YSNHGLAISPGMKTRIRMG-QYEFPN 238

Query: 306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQIPPTPFLSSPP 362
               + +E  K +I      ++  P+ R  + E +       ++ ++P TP  +S  
Sbjct: 239 PEWSEVSEEVKMLI---RNLLKTEPTQRMTITEFMNH-PWIMQSTKVPQTPLHTSRV 291

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 4e-31
 Identities = 76/343 (22%), Positives = 122/343 (35%), Gaps = 60/343 (17%)

Query: 67  YGPLPLKRYNFSDVKKLTNSFKDKLGQGGFGGVYKGRLLDD---------------FVNE 111
            GP   +  +++D K +        G G FG VY+ +L D                   E
Sbjct: 12  QGPDRPQEVSYTDTKVI--------GNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE 63

Query: 112 VASISRTSHVNVVTLLGFCLEGNNR------ALIYEFMPNGSLEKFVYNGDTSKPCQYLR 165
           +  + +  H N+V L  F      +       L+ +++P        +    S+  Q L 
Sbjct: 64  LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY---SRAKQTLP 120

Query: 166 WEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDED-FCPKISDFGLAKLCTTKE 224
              +   +  + + L Y+H   S  I H DIKP N+LLD D    K+ DFG AK     E
Sbjct: 121 VIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

Query: 225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKN--NLDSGVDSS 282
             VS +        Y APE+        +   DV+S G ++ EL+  +     DSGVD  
Sbjct: 178 PNVSYI----CSRYYRAPELIFGATD-YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 232

Query: 283 SEVY------FPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGL-----WCIQARPS 331
            E+           I        EFK P +      ++ +              ++  P+
Sbjct: 233 VEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 292

Query: 332 DRPPMNEVI------EMLQGSTEALQIPPTPFLSSPPRAPIDS 368
            R    E        E+   + +      TP L +     + S
Sbjct: 293 ARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSS 335

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  117 bits (293), Expect = 5e-31
 Identities = 37/295 (12%), Positives = 84/295 (28%), Gaps = 46/295 (15%)

Query: 87  FKDKLGQGGFGGVYKGRLLDD-----------------FVNEVASISRTSHVN-VVTLLG 128
              ++G+G FG +++G  L +                   +E  +    +    +  +  
Sbjct: 9   VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYY 68

Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
           F  EG +  L+ + +     +     G      +    + +      +   ++ +H    
Sbjct: 69  FGQEGLHNVLVIDLLGPSLEDLLDLCG------RKFSVKTVAMAAKQMLARVQSIH---E 119

Query: 189 TKILHFDIKPHNILLDEDFCP-----KISDFGLAKLC----TTKEGIVSSLLGARGIIGY 239
             +++ DIKP N L+            + DFG+ K      T +           G   Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179

Query: 240 IAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDR 299
           ++         E S + D+ + G + M  +                       +  E+  
Sbjct: 180 MSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQG--------LKAATNKQKYERIG 229

Query: 300 EFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQIPP 354
           E K    +        ++      +         P  + +  +     E L    
Sbjct: 230 EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE 284

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 2e-30
 Identities = 50/291 (17%), Positives = 100/291 (34%), Gaps = 48/291 (16%)

Query: 89  DKLGQGGFGGVYKGRLLDD--------------------FVNEVASISRTSHVNVVTLLG 128
             +G+G +G V       +                     + E+  + R  H N++ +  
Sbjct: 14  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73

Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
                    +   ++    +   +Y    ++    L  + +   +  I +GL+Y+H   S
Sbjct: 74  IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH---LSNDHICYFLYQILRGLKYIH---S 127

Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRN 248
             +LH D+KP N+LL+     KI DFGLA++          L        Y APE+   +
Sbjct: 128 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 187

Query: 249 FGEVSHKSDVYSFGMMIMELV------GCKNNLD------------SGVDSSSEVYFPHW 290
            G  +   D++S G ++ E++        K+ LD            S  D +  +     
Sbjct: 188 KG-YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246

Query: 291 IYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
            Y      +       +    +  A  ++      +   P  R  + + + 
Sbjct: 247 NYLLSLPHKNKVPWNRLFPNADSKALDLL---DKMLTFNPHKRIEVEQALA 294

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 2e-30
 Identities = 59/290 (20%), Positives = 105/290 (36%), Gaps = 49/290 (16%)

Query: 89  DKLGQGGFGGVYKGRLLDD------------------------FVNEVASISRTSHVNVV 124
           D LG+G F  VYK R  +                          + E+  +   SH N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 125 TLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH 184
            LL      +N +L+++FM          N         L    +   ++   +GLEYLH
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDNS------LVLTPSHIKAYMLMTLQGLEYLH 117

Query: 185 HGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV 244
                 ILH D+KP+N+LLDE+   K++DFGLAK   +     +  +  R    Y APE+
Sbjct: 118 QHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR---WYRAPEL 171

Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCK------------NNLDSGVDSSSEVYFPHWIY 292
                       D+++ G ++ EL+                 +   + + +E  +P    
Sbjct: 172 L-FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230

Query: 293 RHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM 342
                  +      +    +     ++ +        P  R    + ++M
Sbjct: 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 1e-29
 Identities = 56/292 (19%), Positives = 110/292 (37%), Gaps = 51/292 (17%)

Query: 89  DKLGQGGFGGVYKGRLLDD----------------------FVNEVA---SISRTSHVNV 123
            ++G+G +G V+K R L +                       + EVA    +    H NV
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 124 VTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYL 183
           V L   C            +    +++ +       P   +  E + +++  + +GL++L
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132

Query: 184 HHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE 243
           H   S +++H D+KP NIL+      K++DFGLA++ + +  + S        + Y APE
Sbjct: 133 H---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV----VVTLWYRAPE 185

Query: 244 VFSRNFGEVSHKSDVYSFGMMIMELVGCK------------NNLDSGVDSSSEVYFPHWI 291
           V  +     +   D++S G +  E+   K              +   +    E  +P  +
Sbjct: 186 VLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243

Query: 292 Y--RHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
              R     +  +         +E+ K ++   L C+   P+ R      + 
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLL---LKCLTFNPAKRISAYSALS 292

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 1e-29
 Identities = 54/277 (19%), Positives = 97/277 (35%), Gaps = 53/277 (19%)

Query: 87  FKDKLGQGGFGGVYKGRLLDD----------------------FVNEVASISRT-SHVNV 123
               LG+G FG V+                              + E   +S    H  +
Sbjct: 6   LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65

Query: 124 VTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYL 183
             +        N   + E++  G L   +      + C      +       I  GL++L
Sbjct: 66  THMFCTFQTKENLFFVMEYLNGGDLMYHI------QSCHKFDLSRATFYAAEIILGLQFL 119

Query: 184 HHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPE 243
               S  I++ D+K  NILLD+D   KI+DFG+ K     +   ++     G   YIAPE
Sbjct: 120 ---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF---CGTPDYIAPE 173

Query: 244 VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL 303
           +      + +H  D +SFG+++ E++  ++          E      ++  +  D  F  
Sbjct: 174 ILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHG--QDEEE------LFHSIRMDNPFYP 223

Query: 304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI 340
             +      + AK ++   +      P  R  +   I
Sbjct: 224 RWL-----EKEAKDLL---VKLFVREPEKRLGVRGDI 252

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  111 bits (279), Expect = 9e-29
 Identities = 53/271 (19%), Positives = 91/271 (33%), Gaps = 55/271 (20%)

Query: 87  FKDKLGQGGFGGVYKGRLLDD----------------------FVNEVASISRTSHVNVV 124
               LG G FG V+  R   +                        +E   +S  +H  ++
Sbjct: 8   ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFII 67

Query: 125 TLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH 184
            + G   +     +I +++  G L   +             +          A+    L 
Sbjct: 68  RMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY---------AAEVCLALE 118

Query: 185 HGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV 244
           +  S  I++ D+KP NILLD++   KI+DFG AK        +       G   YIAPEV
Sbjct: 119 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL------CGTPDYIAPEV 172

Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
            S      +   D +SFG++I E++           ++ + Y           + E + P
Sbjct: 173 VST--KPYNKSIDWWSFGILIYEMLAGYTPFYD--SNTMKTYEKI-------LNAELRFP 221

Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPP 335
                   ++  +        I    S R  
Sbjct: 222 PFFNEDVKDLLSR-------LITRDLSQRLG 245

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (277), Expect = 1e-28
 Identities = 51/287 (17%), Positives = 100/287 (34%), Gaps = 46/287 (16%)

Query: 89  DKLGQGGFGGVYKGRLLDD---------------------FVNEVASISRTSHVNVVTLL 127
           +K+G+G +G VYK R                          + E++ +   +H N+V LL
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67

Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
                 N   L++EF+     +        +     +    +   +  + +GL + H   
Sbjct: 68  DVIHTENKLYLVFEFLHQDLKKFMD-----ASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122

Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSR 247
              +LH D+KP N+L++ +   K++DFGLA+         +  +       Y APE+   
Sbjct: 123 ---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTL---WYRAPEILLG 176

Query: 248 NFGEVSHKSDVYSFGMMIMELVGCK---------NNLDSGVDSSSEVYFPHWIYRHVEQD 298
                S   D++S G +  E+V  +         + L     +        W       D
Sbjct: 177 C-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235

Query: 299 REFKLPGVVTRKENEIAKKMIIVGL----WCIQARPSDRPPMNEVIE 341
            +   P    +  +++   +   G       +   P+ R      + 
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (277), Expect = 1e-28
 Identities = 62/298 (20%), Positives = 107/298 (35%), Gaps = 60/298 (20%)

Query: 73  KRYNFSDVKKLTNSFKDKLGQGGFGGVYKGR-------------------------LLDD 107
           ++ N  D         ++LG G F  V K R                           +D
Sbjct: 4   RQENVDDYYDT----GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 59

Query: 108 FVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWE 167
              EV+ +    H NV+TL        +  LI E +  G L  F+         + L  E
Sbjct: 60  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK------ESLTEE 113

Query: 168 KMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCP----KISDFGLAKLCTTK 223
           +  E +  I  G   +++  S +I HFD+KP NI+L +   P    KI DFGLA      
Sbjct: 114 EATEFLKQILNG---VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 170

Query: 224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSS 283
               +      G   ++APE+   N+  +  ++D++S G++   L+   +      D+  
Sbjct: 171 ----NEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLG--DTKQ 222

Query: 284 EVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
           E                ++         + +AK  I      +   P  R  + + ++
Sbjct: 223 ETLANV-------SAVNYEFEDEYFSNTSALAKDFI---RRLLVKDPKKRMTIQDSLQ 270

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  107 bits (267), Expect = 2e-27
 Identities = 49/286 (17%), Positives = 93/286 (32%), Gaps = 46/286 (16%)

Query: 89  DKLGQGGFGGVYKGRL--------------------LDDFVNEVASISRTSHVNVVTLLG 128
           +K+G+G +G VYK +                         + E++ +    H N+V L  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 129 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCS 188
                    L++E +     +              L        ++ +  G+ Y H    
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCE------GGLESVTAKSFLLQLLNGIAYCH---D 118

Query: 189 TKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRN 248
            ++LH D+KP N+L++ +   KI+DFGLA+                  + Y AP+V    
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV---RKYTHEIVTLWYRAPDVL-MG 174

Query: 249 FGEVSHKSDVYSFGMMIMELVGCK---------NNLDSGVDSSSEVYFPHWIYRHVEQDR 299
             + S   D++S G +  E+V            + L             +W         
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234

Query: 300 EFKLPGVVTRKENEIAKKMIIVGL----WCIQARPSDRPPMNEVIE 341
           +               K +   G+      ++  P+ R    + +E
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (260), Expect = 2e-26
 Identities = 57/283 (20%), Positives = 90/283 (31%), Gaps = 64/283 (22%)

Query: 87  FKDKLGQGGFGGVYKGRLLDD-------------------------FVNEVASISRTS-- 119
               LG GGFG VY G  + D                            EV  + + S  
Sbjct: 8   VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67

Query: 120 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
              V+ LL +    ++  LI E                      L+ E        + + 
Sbjct: 68  FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-----TERGALQEELARSFFWQVLEA 122

Query: 180 LEYLHHGCSTKILHFDIKPHNILLDED-FCPKISDFGLAKLCTTKEGIVSSLLGARGIIG 238
           + +     +  +LH DIK  NIL+D +    K+ DFG   L        +      G   
Sbjct: 123 VRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-----TVYTDFDGTRV 174

Query: 239 YIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQD 298
           Y  PE   R        + V+S G+++ ++V                  P      + + 
Sbjct: 175 YSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGD--------------IPFEHDEEIIRG 219

Query: 299 REFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
           + F    V     +   + +I    WC+  RPSDRP   E+  
Sbjct: 220 QVFFRQRV-----SSECQHLI---RWCLALRPSDRPTFEEIQN 254

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (259), Expect = 5e-26
 Identities = 50/291 (17%), Positives = 98/291 (33%), Gaps = 40/291 (13%)

Query: 89  DKLGQGGFGGVYKGRLLDD---------------------FVNEVASISRTSHVNVVTLL 127
            K+GQG FG V+K R                          + E+  +    H NVV L+
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
             C    +     +       + F  +         L    + EI   +   L  L++  
Sbjct: 76  EICRTKASPYNRCKGSIYLVFD-FCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 134

Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAK-LCTTKEGIVSSLLGARGIIGYIAPEVFS 246
             KILH D+K  N+L+  D   K++DFGLA+     K    +        + Y  PE+  
Sbjct: 135 RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL- 193

Query: 247 RNFGEVSHKSDVYSFGMMIMELV-------GCKNNLDSGVDSSSEVYFPHWIYRHVEQDR 299
               +     D++  G ++ E+        G        + S         ++ +V+   
Sbjct: 194 LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYE 253

Query: 300 EFKLPGVVTRKENEIAKKMIIVGL---------WCIQARPSDRPPMNEVIE 341
            ++   +V  ++ ++  ++                +   P+ R   ++ + 
Sbjct: 254 LYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 1e-25
 Identities = 50/291 (17%), Positives = 96/291 (32%), Gaps = 54/291 (18%)

Query: 89  DKLGQGGFGGVYKGRLLDD---------------------FVNEVASISRTSHVNVVTLL 127
           +K+G+G +G V+K +  +                       + E+  +    H N+V L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
                     L++EF      + F            L  E +   +  + KGL + H   
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSC------NGDLDPEIVKSFLFQLLKGLGFCHS-- 119

Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSR 247
              +LH D+KP N+L++ +   K+++FGLA+              A  +  +  P     
Sbjct: 120 -RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP----VRCYSAEVVTLWYRPPDVLF 174

Query: 248 NFGEVSHKSDVYSFGMMIMELVGCK-------------NNLDSGVDSSSEVYFPHWI--- 291
                S   D++S G +  EL                   +   + + +E  +P      
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234

Query: 292 -YRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE 341
            Y+             V  K N   + ++      ++  P  R    E ++
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLL---QNLLKCNPVQRISAEEALQ 282

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.9 bits (248), Expect = 3e-24
 Identities = 50/289 (17%), Positives = 93/289 (32%), Gaps = 57/289 (19%)

Query: 87  FKDKLGQGGFGGVYKGRLLDD----------------------FVNEVASISRTSHVNVV 124
           +   LG+G FG V   R                           V E   +  T H  + 
Sbjct: 9   YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68

Query: 125 TLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH 184
            L       +    + E+   G L   +         +    E+       I   L    
Sbjct: 69  ALKYAFQTHDRLCFVMEYANGGELFFHL------SRERVFTEERARFYGAEIVSAL---E 119

Query: 185 HGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEV 244
           +  S  +++ DIK  N++LD+D   KI+DFGL K   +     +++    G   Y+APEV
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG---ATMKTFCGTPEYLAPEV 176

Query: 245 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP 304
                 +     D +  G+++ E++  +    +       ++             E + P
Sbjct: 177 LED--NDYGRAVDWWGLGVVMYEMMCGRLPFYN--QDHERLFELIL-------MEEIRFP 225

Query: 305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQIP 353
               R  +  AK ++      ++  P  R            + E ++  
Sbjct: 226 ----RTLSPEAKSLL---AGLLKKDPKQRLGGGP-----SDAKEVMEHR 262

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 98.7 bits (245), Expect = 8e-24
 Identities = 43/269 (15%), Positives = 88/269 (32%), Gaps = 55/269 (20%)

Query: 89  DKLGQGGFGGVYKGRLLDD----------------------FVNEVASISRTSHVNVVTL 126
             LG G FG V   +  +                        +NE   +   +   +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 127 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG 186
                + +N  ++ E++  G +   +                       I    EYLH  
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRR------IGRFSEPHARFYAAQIVLTFEYLH-- 158

Query: 187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
            S  +++ D+KP N+L+D+    +++DFG AK    +   +       G    +APE+  
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL------CGTPEALAPEIIL 211

Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV 306
                 +   D ++ G++I E+        +  D   ++Y             + + P  
Sbjct: 212 S--KGYNKAVDWWALGVLIYEMAAGYPPFFA--DQPIQIYEKIV-------SGKVRFP-- 258

Query: 307 VTRKENEIAKKMIIVGLWCIQARPSDRPP 335
                +  +  +  +    +Q   + R  
Sbjct: 259 -----SHFSSDLKDLLRNLLQVDLTKRFG 282

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.3 bits (236), Expect = 8e-23
 Identities = 50/294 (17%), Positives = 90/294 (30%), Gaps = 55/294 (18%)

Query: 87  FKDKLGQGGFGGVYKGRLLDD--------------------------FVNEVASISRTSH 120
               LG G +G V+  R +                               E   +     
Sbjct: 28  LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 87

Query: 121 V-NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 179
              +VTL           LI +++  G L   +   +     +   +         + + 
Sbjct: 88  SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY---------VGEI 138

Query: 180 LEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGY 239
           +  L H     I++ DIK  NILLD +    ++DFGL+K     E          G I Y
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET--ERAYDFCGTIEY 196

Query: 240 IAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDR 299
           +AP++            D +S G+++ EL+   +          E      I R + +  
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF----TVDGEKNSQAEISRRILKSE 252

Query: 300 EFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEALQIP 353
                 +     + +AK +I      +   P  R          + + E  +  
Sbjct: 253 PPYPQEM-----SALAKDLI---QRLLMKDPKKRLGCGP-----RDADEIKEHL 293

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 94.1 bits (233), Expect = 2e-22
 Identities = 47/297 (15%), Positives = 105/297 (35%), Gaps = 59/297 (19%)

Query: 87  FKDKLGQGGFGGVYKGRLLDD----------------FVNEVASISRTS-HVNVVTLLGF 129
              KLG+G +  V++   + +                   E+  +       N++TL   
Sbjct: 39  LVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADI 98

Query: 130 CLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
             +  +R  AL++E + N   ++           Q L    +   +  I K L+Y H   
Sbjct: 99  VKDPVSRTPALVFEHVNNTDFKQLY---------QTLTDYDIRFYMYEILKALDYCH--- 146

Query: 188 STKILHFDIKPHNILLDEDFCP-KISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFS 246
           S  I+H D+KPHN+++D +    ++ D+GLA+     +     +        +  PE+  
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV----ASRYFKGPELL- 201

Query: 247 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVY---------FPHWIYRHVEQ 297
            ++    +  D++S G M+  ++  K     G D+  ++            +        
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261

Query: 298 DREFKLPGVVTRKENEIAKKMIIVGLW-------------CIQARPSDRPPMNEVIE 341
           + + +   ++ R   +  ++ +                   ++     R    E +E
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.5 bits (234), Expect = 2e-22
 Identities = 52/289 (17%), Positives = 95/289 (32%), Gaps = 48/289 (16%)

Query: 89  DKLGQGGFGGVYKGRLLDD---------------------FVNEVASISRTSHVNVVTLL 127
             +G G +G V                                E+  +    H NV+ LL
Sbjct: 24  QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 83

Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC 187
                        +F     +     +       + L  +++  +V  + KGL Y+H   
Sbjct: 84  DVFTPDETLDDFTDFYLV--MPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH--- 138

Query: 188 STKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSR 247
           +  I+H D+KP N+ ++ED   KI DFGLA+   ++      + G      Y APEV   
Sbjct: 139 AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE------MTGYVVTRWYRAPEVI-L 191

Query: 248 NFGEVSHKSDVYSFGMMIMELVGCK-----------NNLDSGVDSSSEVYFPHWIYRHVE 296
           N+   +   D++S G ++ E++  K                 V  +    F   +     
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251

Query: 297 QDREFKLPGVVTRKENEIAKKMIIVGL----WCIQARPSDRPPMNEVIE 341
           ++    LP +  +    I      + +      +      R    E + 
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 82.0 bits (201), Expect = 5e-18
 Identities = 39/212 (18%), Positives = 71/212 (33%), Gaps = 34/212 (16%)

Query: 87  FKDKLGQGGFGGVYKGRLLDD------------------FVNEVASISRTSHVNVVTLLG 128
              KLG G F  V+  + + +                    +E+  + R +  +      
Sbjct: 17  LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76

Query: 129 FCLEGNNRALIY--EFMPNGSLEKFVYNGDTSKPCQYLR--------WEKMYEIVIGIAK 178
                  + L +     PNG     V+          ++           + +I   +  
Sbjct: 77  MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136

Query: 179 GLEYLHHGCSTKILHFDIKPHNILLD-EDFCPKISDFGLAKLCTTKEGIVSSLLGARGII 237
           GL+Y+H  C   I+H DIKP N+L++  D    +    +A L             +    
Sbjct: 137 GLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW-YDEHYTNSIQTR 193

Query: 238 GYIAPEVFSRNFGEVSHKSDVYSFGMMIMELV 269
            Y +PEV           +D++S   +I EL+
Sbjct: 194 EYRSPEVLLG--APWGCGADIWSTACLIFELI 223

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.1 bits (199), Expect = 1e-17
 Identities = 45/208 (21%), Positives = 73/208 (35%), Gaps = 45/208 (21%)

Query: 89  DKLGQGGFGGVYKGRLLDD---------------------FVNEVASISRTSHVNVVTLL 127
             +G G  G V                                E+  +   +H N+++LL
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82

Query: 128 GFCL------EGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 181
                     E  +  L+ E M     +      D          E+M  ++  +  G++
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD---------HERMSYLLYQMLCGIK 133

Query: 182 YLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIA 241
           +LH      I+H D+KP NI++  D   KI DFGLA+   T       +        Y A
Sbjct: 134 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF----MMTPYVVTRYYRA 186

Query: 242 PEVFSRNFGEVSHKSDVYSFGMMIMELV 269
           PEV            D++S G ++ E+V
Sbjct: 187 PEVILGM--GYKENVDIWSVGCIMGEMV 212

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.8 bits (193), Expect = 5e-17
 Identities = 46/204 (22%), Positives = 77/204 (37%), Gaps = 37/204 (18%)

Query: 89  DKLGQGGFGGVYKGRLLDD---------------------FVNEVASISRTSHVNVVTLL 127
             +G G +G V                                E+  +    H NV+ LL
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83

Query: 128 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPC--QYLRWEKMYEIVIGIAKGLEYLHH 185
                  +     +      L   +   D +     Q L  + +  ++  I +GL+Y+H 
Sbjct: 84  DVFTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 138

Query: 186 GCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVF 245
             S  I+H D+KP N+ ++ED   KI DFGLA+    +        G      Y APE+ 
Sbjct: 139 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT------GYVATRWYRAPEIM 190

Query: 246 SRNFGEVSHKSDVYSFGMMIMELV 269
             N+   +   D++S G ++ EL+
Sbjct: 191 -LNWMHYNQTVDIWSVGCIMAELL 213

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 68.3 bits (166), Expect = 4e-14
 Identities = 33/211 (15%), Positives = 63/211 (29%), Gaps = 49/211 (23%)

Query: 85  NSFKDKLGQGGFGGVYKGRLLDD----------------------------FVNEVASIS 116
           ++    +G+G    V+                                   F       +
Sbjct: 2   DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61

Query: 117 RTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 176
           R     +  L G  +        Y +  N  L + +           +R E   E++  I
Sbjct: 62  RNEFRALQKLQGLAVPKV-----YAWEGNAVLMELIDAK----ELYRVRVENPDEVLDMI 112

Query: 177 AKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGI 236
            + +   +H     I+H D+  +N+L+  +    I DF  +     +          R I
Sbjct: 113 LEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNI 168

Query: 237 IGYIAPEVFSRNFGEVSHKSDVYSFGMMIME 267
           I Y     FSR +     + D+ S    I++
Sbjct: 169 ITY-----FSRTYRT---EKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	372
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.85
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.21
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.76
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.2
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.19
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	93.09
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	88.61

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.8e-54  Score=392.85  Aligned_cols=250  Identities=27%  Similarity=0.474  Sum_probs=191.4

Q ss_pred             cccHHHHHHHHhhh-----------hhhcCCCCceEEEEEEecc-----------------------hHHHHHHHHhccC
Q 036435           74 RYNFSDVKKLTNSF-----------KDKLGQGGFGGVYKGRLLD-----------------------DFVNEVASISRTS  119 (372)
Q Consensus        74 ~~~~~~~~~~~~~~-----------~~~lg~G~~g~V~~~~~~~-----------------------~~~~E~~~l~~l~  119 (372)
                      .++++++.+++.+|           .+.||+|+||+||+|++..                       +|.+|+++|++++
T Consensus         6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~   85 (299)
T d1jpaa_           6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD   85 (299)
T ss_dssp             GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred             CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC
Confidence            45556666665555           3569999999999997631                       5899999999999


Q ss_pred             CCceeeeEeEEecCCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCC
Q 036435          120 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPH  199 (372)
Q Consensus       120 h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~  199 (372)
                      |||||+++|+|.+++..++|||||++|+|.+++.....     .+++.+++.++.|+++||+|||   +.+++||||||+
T Consensus        86 HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~-----~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~  157 (299)
T d1jpaa_          86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG-----QFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAAR  157 (299)
T ss_dssp             CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGG
T ss_pred             CCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccC-----CCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccc
Confidence            99999999999999999999999999999999876542     2899999999999999999999   799999999999


Q ss_pred             ceEECCCCceEEeecCCcccccCCCCeee--eecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCC
Q 036435          200 NILLDEDFCPKISDFGLAKLCTTKEGIVS--SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLD  276 (372)
Q Consensus       200 Nill~~~~~~kl~Dfgla~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~  276 (372)
                      |||++.++.+||+|||+++..........  ......||+.|||||.+.+.  .++.++|||||||++|||+| |+.||.
T Consensus       158 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~sDvwS~Gvvl~el~t~g~~Pf~  235 (299)
T d1jpaa_         158 NILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR--KFTSASDVWSYGIVMWEVMSYGERPYW  235 (299)
T ss_dssp             GEEECTTCCEEECCC-----------------------CGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             eEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcC--CCCcccccccchHHHHHHHhCCCCCCC
Confidence            99999999999999999987654332211  12234578999999999764  88999999999999999998 888887


Q ss_pred             CCCCCCCccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 036435          277 SGVDSSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE  348 (372)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~  348 (372)
                      ....        ..+...+..+.....+.       +.+..+.+++.+||+.||.+|||++||++.|+++.+
T Consensus       236 ~~~~--------~~~~~~i~~~~~~~~~~-------~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         236 DMTN--------QDVINAIEQDYRLPPPM-------DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             TCCH--------HHHHHHHHTTCCCCCCT-------TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCH--------HHHHHHHHcCCCCCCCc-------cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            5422        11333344433333332       234567889999999999999999999999987654

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-54  Score=387.32  Aligned_cols=244  Identities=28%  Similarity=0.460  Sum_probs=189.8

Q ss_pred             hhhhhcCCCCceEEEEEEecc------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS  147 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~  147 (372)
                      .+.+.||+|+||+||+|++.+                  .|.+|+.++++++||||++++|++.+ +..++||||+++|+
T Consensus        11 ~~~~~lG~G~fg~Vy~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~   89 (276)
T d1uwha_          11 TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSS   89 (276)
T ss_dssp             CCCSEEEECSSCEEEEEESSSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEE
T ss_pred             EEEEEEeeCCCcEEEEEEECCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCC
Confidence            346789999999999997632                  68899999999999999999999754 56899999999999


Q ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCee
Q 036435          148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV  227 (372)
Q Consensus       148 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  227 (372)
                      |.+++.....     .+++.+++.++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+|+.........
T Consensus        90 L~~~l~~~~~-----~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~  161 (276)
T d1uwha_          90 LYHHLHIIET-----KFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH  161 (276)
T ss_dssp             HHHHHHTSCC-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred             HHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence            9999976542     2899999999999999999999   7899999999999999999999999999998765433221


Q ss_pred             eeecccccccccccccccccc-cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCcc
Q 036435          228 SSLLGARGIIGYIAPEVFSRN-FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV  306 (372)
Q Consensus       228 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (372)
                       ......||+.|||||++.+. .+.++.++|||||||++|||+||+.||......       ..+...+......  | .
T Consensus       162 -~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~-------~~~~~~~~~~~~~--p-~  230 (276)
T d1uwha_         162 -QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-------DQIIFMVGRGYLS--P-D  230 (276)
T ss_dssp             -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------HHHHHHHHHTSCC--C-C
T ss_pred             -cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH-------HHHHHHHhcCCCC--C-c
Confidence             12345689999999998653 235799999999999999999999999754221       1122222222111  1 1


Q ss_pred             CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 036435          307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       307 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~  349 (372)
                      ......+++..+.+++.+||+.||.+|||++|+++.|+.+...
T Consensus       231 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence            1111223346788899999999999999999999999987754

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-53  Score=380.59  Aligned_cols=237  Identities=27%  Similarity=0.494  Sum_probs=185.5

Q ss_pred             hhhhhcCCCCceEEEEEEecc-----------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCCh
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD-----------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL  148 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~-----------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L  148 (372)
                      .+.+.||+|+||+||+|++.+                 +|.+|++++++++||||++++|+|.+++..++||||+++|+|
T Consensus         8 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L   87 (263)
T d1sm2a_           8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCL   87 (263)
T ss_dssp             EEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcH
Confidence            346789999999999997742                 689999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeee
Q 036435          149 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVS  228 (372)
Q Consensus       149 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  228 (372)
                      .+++.....     .+++..++.++.|++.||+|||   +.+|+||||||+|||+|+++.+||+|||+++......... 
T Consensus        88 ~~~l~~~~~-----~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~-  158 (263)
T d1sm2a_          88 SDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-  158 (263)
T ss_dssp             HHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred             HHHhhcccc-----CCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCcee-
Confidence            999876542     2899999999999999999999   7999999999999999999999999999998765443222 


Q ss_pred             eecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCC
Q 036435          229 SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVT  308 (372)
Q Consensus       229 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (372)
                       .....||+.|+|||.+.+.  .++.++|||||||++|||+|++.|+......       ..+...+..+.....|... 
T Consensus       159 -~~~~~gt~~y~aPE~l~~~--~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-------~~~~~~i~~~~~~~~p~~~-  227 (263)
T d1sm2a_         159 -STGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-------SEVVEDISTGFRLYKPRLA-  227 (263)
T ss_dssp             -------CTTSCCHHHHTTC--CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-------HHHHHHHHHTCCCCCCTTS-
T ss_pred             -ecceecCcccCChHHhcCC--CCCchhhhcchHHHHHHHHHCCCCCCCCCCH-------HHHHHHHHhcCCCCCcccc-
Confidence             2334688999999999875  8999999999999999999976655433211       1123334444333333322 


Q ss_pred             cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 036435          309 RKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE  348 (372)
Q Consensus       309 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~  348 (372)
                            ..++.+++.+||+.||++|||++|+++.|+++.+
T Consensus       228 ------~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         228 ------STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             ------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence                  3567889999999999999999999999987653

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-53  Score=379.34  Aligned_cols=230  Identities=25%  Similarity=0.419  Sum_probs=190.2

Q ss_pred             hhcCCCCceEEEEEEec-----------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           89 DKLGQGGFGGVYKGRLL-----------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~-----------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      ++||+|+||+||+|.+.                       ++|.+|+.+|++++|||||+++|+|.+ +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            46999999999999642                       158899999999999999999999965 567899999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      |+|.+++.....      +++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus        92 g~L~~~l~~~~~------l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~  162 (277)
T d1xbba_          92 GPLNKYLQQNRH------VKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN  162 (277)
T ss_dssp             EEHHHHHHHCTT------CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred             CcHHHHHhhccC------CCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence            999999987543      899999999999999999999   78999999999999999999999999999998766555


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCC
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLP  304 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (372)
                      .........||+.|||||.+.+.  .++.++|||||||++|||+| |+.||.....        ..+...+..+.....|
T Consensus       163 ~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--------~~~~~~i~~~~~~~~p  232 (277)
T d1xbba_         163 YYKAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVTAMLEKGERMGCP  232 (277)
T ss_dssp             EEEC----CCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTTCCCCCC
T ss_pred             ccccccccCCCceecCchhhcCC--CCCchhhhccchhhhhHHhhCCCCCCCCCCH--------HHHHHHHHcCCCCCCC
Confidence            54444556789999999999874  78999999999999999998 8999875321        1233444444444444


Q ss_pred             ccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 036435          305 GVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG  345 (372)
Q Consensus       305 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~  345 (372)
                      ..       ++..+.+++.+||+.||++|||+++|++.|+.
T Consensus       233 ~~-------~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         233 AG-------CPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             TT-------CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             cc-------cCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence            32       34567789999999999999999999988865

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.4e-53  Score=382.27  Aligned_cols=239  Identities=30%  Similarity=0.480  Sum_probs=198.1

Q ss_pred             hhhhhhcCCCCceEEEEEEecc------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      +.+.+.||+|+||+||+|++.+                  +|.+|+.+|++++|||||+++|+|.+++..++||||+++|
T Consensus        19 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g   98 (287)
T d1opja_          19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG   98 (287)
T ss_dssp             EEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred             eEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCc
Confidence            4456789999999999997742                  6899999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      +|.+++......    .+++..++.++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+|+........
T Consensus        99 ~l~~~l~~~~~~----~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~  171 (287)
T d1opja_          99 NLLDYLRECNRQ----EVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  171 (287)
T ss_dssp             BHHHHHHHSCTT----TSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE
T ss_pred             chHHHhhhcccc----chHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCCCce
Confidence            999999765432    3899999999999999999999   789999999999999999999999999999876554332


Q ss_pred             eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCcc
Q 036435          227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV  306 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (372)
                      .  .....||+.|+|||++.+.  .++.++|||||||++|||++|+.|+......       ..+...+..+.....+..
T Consensus       172 ~--~~~~~g~~~y~aPE~~~~~--~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~-------~~~~~~i~~~~~~~~~~~  240 (287)
T d1opja_         172 A--HAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------SQVYELLEKDYRMERPEG  240 (287)
T ss_dssp             E--ETTEEECGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHHHHHTTCCCCCCTT
T ss_pred             e--eccccccccccChHHHcCC--CCCchhhhhhHHHHHHHHHhCCCCCCCcchH-------HHHHHHHhcCCCCCCCcc
Confidence            2  2344588899999999875  8899999999999999999988877654321       113334444333333322


Q ss_pred             CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 036435          307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE  348 (372)
Q Consensus       307 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~  348 (372)
                             .+..+.+++.+||+.||++|||++|+++.|+.+.+
T Consensus       241 -------~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         241 -------CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             -------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             -------chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                   34567889999999999999999999999987654

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-52  Score=378.38  Aligned_cols=232  Identities=23%  Similarity=0.397  Sum_probs=193.1

Q ss_pred             hcCCCCceEEEEEEec----------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCC
Q 036435           90 KLGQGGFGGVYKGRLL----------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS  147 (372)
Q Consensus        90 ~lg~G~~g~V~~~~~~----------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~  147 (372)
                      +||+|+||.||+|.+.                      ++|.+|+++|++++|||||+++|+|.+ +..++||||+++|+
T Consensus        16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~   94 (285)
T d1u59a_          16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP   94 (285)
T ss_dssp             EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred             EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence            4999999999999652                      158899999999999999999999865 56899999999999


Q ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCee
Q 036435          148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV  227 (372)
Q Consensus       148 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  227 (372)
                      |.+++.....     .+++.+++.++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++.........
T Consensus        95 L~~~l~~~~~-----~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~  166 (285)
T d1u59a_          95 LHKFLVGKRE-----EIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY  166 (285)
T ss_dssp             HHHHHTTCTT-----TSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred             HHHHhhcccc-----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhccccccccc
Confidence            9999865432     2899999999999999999999   7999999999999999999999999999999877655544


Q ss_pred             eeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCcc
Q 036435          228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV  306 (372)
Q Consensus       228 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (372)
                      .......||+.|+|||++.+.  .++.++|||||||++|||+| |+.||......        .+...+..+.....|..
T Consensus       167 ~~~~~~~gt~~y~aPE~~~~~--~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--------~~~~~i~~~~~~~~p~~  236 (285)
T d1u59a_         167 TARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------EVMAFIEQGKRMECPPE  236 (285)
T ss_dssp             CCCCSSCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--------HHHHHHHTTCCCCCCTT
T ss_pred             ccccccccCccccChHHHhCC--CCCccchhhcchHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCCCCCc
Confidence            444455689999999999764  88999999999999999998 89999754321        13344444444444432


Q ss_pred             CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       307 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                             ++..+.+++.+||+.||++|||+.+|++.|+...
T Consensus       237 -------~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~  270 (285)
T d1u59a_         237 -------CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  270 (285)
T ss_dssp             -------CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -------CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                   3456778999999999999999999999887654

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-52  Score=377.34  Aligned_cols=239  Identities=27%  Similarity=0.471  Sum_probs=187.9

Q ss_pred             hhhhcCCCCceEEEEEEecc------------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEe
Q 036435           87 FKDKLGQGGFGGVYKGRLLD------------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      ..+.||+|+||.||+|++..                        +|.+|+.++++++|||||+++|++.+++..++||||
T Consensus        11 ~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~   90 (283)
T d1mqba_          11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY   90 (283)
T ss_dssp             EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             eeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEe
Confidence            35679999999999986521                        588999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      +.+|+|.+++.....     .+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        91 ~~~~~l~~~~~~~~~-----~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          91 MENGALDKFLREKDG-----EFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             CTTEEHHHHHHHTTT-----CSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             cccCcchhhhhcccc-----cccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence            999999998876543     2899999999999999999999   79999999999999999999999999999987655


Q ss_pred             CCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      ............||+.|||||++.+.  .++.++|||||||++|||++|+.|+......       ..+...+..+....
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~--~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-------~~~~~~i~~~~~~~  233 (283)
T d1mqba_         163 DPEATYTTSGGKIPIRWTAPEAISYR--KFTSASDVWSFGIVMWEVMTYGERPYWELSN-------HEVMKAINDGFRLP  233 (283)
T ss_dssp             -----------CCCGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTTCCCC
T ss_pred             CCccceEeccCCCCccccCHHHHccC--CCCCcccccccHHHHHHHHhCCCCccccCCH-------HHHHHHHhccCCCC
Confidence            44333333445689999999999775  8999999999999999999987776543221       12333444443333


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~  349 (372)
                      .+.       +.+..+.+++.+||+.||++|||++||++.|+++.+.
T Consensus       234 ~~~-------~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         234 TPM-------DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             CCT-------TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             Cch-------hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence            332       2345678899999999999999999999999887653

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-53  Score=376.61  Aligned_cols=232  Identities=26%  Similarity=0.343  Sum_probs=186.9

Q ss_pred             hhhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      .+.+.||+|+||+||+|+...                    ++.+|+.++++++||||+++++++.+++..++||||+++
T Consensus         8 ~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g   87 (271)
T d1nvra_           8 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG   87 (271)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCC
Confidence            446789999999999997632                    588999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      |+|.+++....      .+++.++..++.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+|+.......
T Consensus        88 g~L~~~l~~~~------~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          88 GELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             EEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             CcHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            99999996543      2999999999999999999999   79999999999999999999999999999987654332


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                      .. ......||+.|||||++.+. ...+.++||||+||++|||++|+.||........       ............   
T Consensus       159 ~~-~~~~~~GT~~Y~APE~~~~~-~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-------~~~~~~~~~~~~---  226 (271)
T d1nvra_         159 ER-LLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-------EYSDWKEKKTYL---  226 (271)
T ss_dssp             EC-CBCCCCSCGGGSCTHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-------HHHHHHTTCTTS---
T ss_pred             cc-cccceeeCcCccCHhHhcCC-CCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH-------HHHHHhcCCCCC---
Confidence            21 12345699999999999775 2346789999999999999999999976543221       111111111111   


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                         .....+...+.+++.+||+.||++|||++|+++
T Consensus       227 ---~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         227 ---NPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             ---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               111223456778899999999999999999864

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-52  Score=372.74  Aligned_cols=225  Identities=26%  Similarity=0.440  Sum_probs=188.3

Q ss_pred             hhhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEe
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      +.+.+.||+|+||+||+++...                      .+.+|+.++++++||||+++++++.+++..++||||
T Consensus         8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy   87 (263)
T d2j4za1           8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY   87 (263)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence            4556889999999999997642                      478899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      +++|+|.+++.....      +++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+|.....
T Consensus        88 ~~~g~L~~~l~~~~~------l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~  158 (263)
T d2j4za1          88 APLGTVYRELQKLSK------FDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  158 (263)
T ss_dssp             CTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred             cCCCcHHHHHhhcCC------CCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCC
Confidence            999999999976542      899999999999999999999   79999999999999999999999999999986554


Q ss_pred             CCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      ...     ....||+.|||||++.+.  .++.++|||||||++|||++|+.||.....        ......+... ...
T Consensus       159 ~~~-----~~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~-~~~  222 (263)
T d2j4za1         159 SRR-----TTLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRISRV-EFT  222 (263)
T ss_dssp             CCC-----EETTEEGGGCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHTT-CCC
T ss_pred             Ccc-----cccCCCCcccCHHHHcCC--CCCchhhhhhHhHHHHHHhcCCCCCCCCCH--------HHHHHHHHcC-CCC
Confidence            321     234699999999999875  789999999999999999999999965321        1122222221 222


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .|..       ....+.+++.+||++||++|||++|+++
T Consensus       223 ~p~~-------~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         223 FPDF-------VTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             CCTT-------SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCcc-------CCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            3322       3456778899999999999999999986

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-52  Score=374.90  Aligned_cols=236  Identities=27%  Similarity=0.458  Sum_probs=191.7

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-----------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-----------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS  147 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-----------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~  147 (372)
                      +.+.+.||+|+||.||+|++.+                 +|.+|+.++++++|||||+++|++.+ +..++||||+++|+
T Consensus        15 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~   93 (272)
T d1qpca_          15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGS   93 (272)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCB
T ss_pred             eEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCc
Confidence            3456789999999999998743                 68999999999999999999998855 56799999999999


Q ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCee
Q 036435          148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV  227 (372)
Q Consensus       148 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  227 (372)
                      |.+++.....    ..+++.+++.++.||++||+|||   +.+|+||||||+|||+++++.+||+|||+|+........ 
T Consensus        94 L~~~~~~~~~----~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~-  165 (272)
T d1qpca_          94 LVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-  165 (272)
T ss_dssp             HHHHTTSHHH----HTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-
T ss_pred             HHHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCccc-
Confidence            9998765432    23899999999999999999999   799999999999999999999999999999976543322 


Q ss_pred             eeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccC
Q 036435          228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVV  307 (372)
Q Consensus       228 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (372)
                       ......||+.|||||++.+.  .++.++|||||||++|||+||+.|+......       ..+...+..+.....|.. 
T Consensus       166 -~~~~~~gt~~y~APE~~~~~--~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-------~~~~~~i~~~~~~~~p~~-  234 (272)
T d1qpca_         166 -AREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-------PEVIQNLERGYRMVRPDN-  234 (272)
T ss_dssp             -CCTTCCCCTTTSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCCCCCCTT-
T ss_pred             -cccccCCcccccChHHHhCC--CCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHhcCCCCCccc-
Confidence             22445688999999999864  7899999999999999999977766543221       123334444433333322 


Q ss_pred             CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 036435          308 TRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGS  346 (372)
Q Consensus       308 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~  346 (372)
                            ++..+.+++.+||+.||++|||+++|++.|+..
T Consensus       235 ------~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         235 ------CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             ------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------ChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence                  345678899999999999999999999998753

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-52  Score=380.39  Aligned_cols=240  Identities=25%  Similarity=0.405  Sum_probs=194.5

Q ss_pred             hhhhhhcCCCCceEEEEEEec-------------------------chHHHHHHHHhcc-CCCceeeeEeEEecCCceeE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL-------------------------DDFVNEVASISRT-SHVNVVTLLGFCLEGNNRAL  138 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~-------------------------~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~l  138 (372)
                      +.+.+.||+|+||+||+|++.                         ..+.+|+.++.++ +|||||+++|++.+.+..++
T Consensus        39 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l  118 (325)
T d1rjba_          39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYL  118 (325)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             eEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEE
Confidence            345678999999999999752                         1588999999998 89999999999999999999


Q ss_pred             EEEecCCCChhhhhhcCCCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCce
Q 036435          139 IYEFMPNGSLEKFVYNGDTS-----------------KPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNI  201 (372)
Q Consensus       139 V~e~~~~g~L~~~l~~~~~~-----------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Ni  201 (372)
                      |||||++|+|.+++......                 .....+++..++.++.|++.||+|||   +.+|+||||||+||
T Consensus       119 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp~Ni  195 (325)
T d1rjba_         119 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNV  195 (325)
T ss_dssp             EEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGGGE
T ss_pred             EEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCchhcc
Confidence            99999999999999765321                 11134899999999999999999999   78999999999999


Q ss_pred             EECCCCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCC
Q 036435          202 LLDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVD  280 (372)
Q Consensus       202 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~  280 (372)
                      |++.++.+||+|||+|+.......... .....||+.|||||.+.+.  .++.++|||||||++|||+| |+.||.....
T Consensus       196 ll~~~~~~Kl~DFGla~~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~--~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         196 LVTHGKVVKICDFGLARDIMSDSNYVV-RGNARLPVKWMAPESLFEG--IYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             EEETTTEEEECCCGGGSCGGGCTTSEE-ETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             ccccCCeEEEeeccccccccCCCceee-eccccCCCccCChHHHcCC--CCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999987665443322 2345589999999999875  88999999999999999998 8999875432


Q ss_pred             CCCccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 036435          281 SSSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQ  344 (372)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~  344 (372)
                      .       ..+...+.....+..|..       .+..+.+++.+||+.||++|||++||++.|.
T Consensus       273 ~-------~~~~~~~~~~~~~~~p~~-------~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 D-------ANFYKLIQNGFKMDQPFY-------ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             S-------HHHHHHHHTTCCCCCCTT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             H-------HHHHHHHhcCCCCCCCCc-------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            1       112333444433333332       2356788999999999999999999999984

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-52  Score=367.40  Aligned_cols=233  Identities=25%  Similarity=0.455  Sum_probs=195.2

Q ss_pred             hhhhhcCCCCceEEEEEEecc-----------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCCh
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD-----------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL  148 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~-----------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~L  148 (372)
                      .+.++||+|+||+||+|++.+                 +|.+|+.++++++||||++++|+|.+++..++||||+++|+|
T Consensus         7 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l   86 (258)
T d1k2pa_           7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL   86 (258)
T ss_dssp             CCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEH
T ss_pred             EEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcH
Confidence            356889999999999998742                 689999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeee
Q 036435          149 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVS  228 (372)
Q Consensus       149 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  228 (372)
                      .+++.....     .+++..+..++.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++......... 
T Consensus        87 ~~~~~~~~~-----~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~-  157 (258)
T d1k2pa_          87 LNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-  157 (258)
T ss_dssp             HHHHHSGGG-----CCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC-
T ss_pred             HHhhhcccc-----CCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCcee-
Confidence            999766542     2889999999999999999999   7899999999999999999999999999998765443222 


Q ss_pred             eecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccC
Q 036435          229 SLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVV  307 (372)
Q Consensus       229 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (372)
                       .....||+.|+|||.+.+.  .++.++|||||||++|||+| |+.||.....        ..+...+..+.....|.. 
T Consensus       158 -~~~~~~t~~y~aPE~~~~~--~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~--------~~~~~~i~~~~~~~~p~~-  225 (258)
T d1k2pa_         158 -SVGSKFPVRWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--------SETAEHIAQGLRLYRPHL-  225 (258)
T ss_dssp             -CCCSCCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH--------HHHHHHHHTTCCCCCCTT-
T ss_pred             -ecccCCCCCcCCcHHhcCC--CCCcceeecccchhhHhHHhcCCCCCCCCCH--------HHHHHHHHhCCCCCCccc-
Confidence             2345689999999999875  88999999999999999998 7888865422        123344444444444432 


Q ss_pred             CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 036435          308 TRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQG  345 (372)
Q Consensus       308 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~  345 (372)
                            ....+.+++.+||+.||++|||++++++.|.+
T Consensus       226 ------~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         226 ------ASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             ------CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             ------ccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence                  23567889999999999999999999999865

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-51  Score=372.82  Aligned_cols=229  Identities=24%  Similarity=0.361  Sum_probs=187.9

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      +.+.+.||+|+||+||+|+...                   .+.+|+.++++++||||+++++++.+++..|+||||+++
T Consensus        22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g  101 (293)
T d1yhwa1          22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG  101 (293)
T ss_dssp             BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             cEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCC
Confidence            3446789999999999997632                   588999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      |+|.+++.+..       +++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.......
T Consensus       102 g~L~~~~~~~~-------l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~  171 (293)
T d1yhwa1         102 GSLTDVVTETC-------MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (293)
T ss_dssp             CBHHHHHHHSC-------CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CcHHHHhhccC-------CCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence            99999887643       899999999999999999999   79999999999999999999999999999987654332


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                      .   .....||+.|+|||.+.+.  .++.++||||+||++|||++|+.||......       ......... .....  
T Consensus       172 ~---~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-------~~~~~~~~~-~~~~~--  236 (293)
T d1yhwa1         172 K---RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALYLIATN-GTPEL--  236 (293)
T ss_dssp             C---BCCCCSCGGGCCHHHHSSS--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHH-CSCCC--
T ss_pred             c---ccccccCCCccChhhhcCC--CCCchhceehHhHHHHHHhhCCCCCCCCCHH-------HHHHHHHhC-CCCCC--
Confidence            2   2344699999999999875  7899999999999999999999999753211       111222211 11111  


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                         .....+...+.+++.+||++||.+|||++|+++
T Consensus       237 ---~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         237 ---QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             ---SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ---CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               111234466788999999999999999999875

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-51  Score=365.09  Aligned_cols=226  Identities=25%  Similarity=0.426  Sum_probs=181.1

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEec----CCceeEEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLE----GNNRALIY  140 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~----~~~~~lV~  140 (372)
                      +|.++||+|+||+||+|++..                     .+.+|+++|++++||||+++++++.+    +...++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            345679999999999997642                     57899999999999999999999875    34679999


Q ss_pred             EecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCceEEC-CCCceEEeecCCc
Q 036435          141 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTK--ILHFDIKPHNILLD-EDFCPKISDFGLA  217 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~--ivH~dlk~~Nill~-~~~~~kl~Dfgla  217 (372)
                      ||+++|+|.+++.+...      +++..+..++.|++.||+|||   +.+  |+||||||+|||++ +++.+||+|||+|
T Consensus        92 E~~~~g~L~~~l~~~~~------~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla  162 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFKV------MKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  162 (270)
T ss_dssp             ECCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             eCCCCCcHHHHHhcccc------ccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence            99999999999976532      899999999999999999999   666  99999999999996 5789999999999


Q ss_pred             ccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhh
Q 036435          218 KLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQ  297 (372)
Q Consensus       218 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (372)
                      +.......     ....||+.|||||++.+   .++.++|||||||++|||++|+.||......       ..+...+..
T Consensus       163 ~~~~~~~~-----~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-------~~~~~~i~~  227 (270)
T d1t4ha_         163 TLKRASFA-----KAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNA-------AQIYRRVTS  227 (270)
T ss_dssp             GGCCTTSB-----EESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-------HHHHHHHTT
T ss_pred             eeccCCcc-----CCcccCccccCHHHhCC---CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-------HHHHHHHHc
Confidence            86543321     23469999999999865   6899999999999999999999999743221       112233322


Q ss_pred             cccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          298 DREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      +..   +...   ......++.+++.+||+.||++|||++|+++
T Consensus       228 ~~~---~~~~---~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         228 GVK---PASF---DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             TCC---CGGG---GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCC---Cccc---CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            211   1111   1112345778999999999999999999985

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-51  Score=371.26  Aligned_cols=232  Identities=23%  Similarity=0.324  Sum_probs=186.0

Q ss_pred             hhhhhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      .+.+.||+|+||.||+|+...                   .+.+|+++|++++|||||++++++.+++..++||||+++|
T Consensus        15 ~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g   94 (288)
T d2jfla1          15 EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG   94 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred             EEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCC
Confidence            445789999999999997632                   6889999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      +|.+++.+...     .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|........ 
T Consensus        95 ~L~~~~~~~~~-----~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-  165 (288)
T d2jfla1          95 AVDAVMLELER-----PLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-  165 (288)
T ss_dssp             EHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-
T ss_pred             cHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCcc-
Confidence            99999865432     2899999999999999999999   79999999999999999999999999999976433211 


Q ss_pred             eeeecccccccccccccccccc---cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          227 VSSLLGARGIIGYIAPEVFSRN---FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                        ......||+.|||||++...   ...++.++|||||||++|||+||+.||.......        ....+........
T Consensus       166 --~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~--------~~~~i~~~~~~~~  235 (288)
T d2jfla1         166 --RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR--------VLLKIAKSEPPTL  235 (288)
T ss_dssp             --HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--------HHHHHHHSCCCCC
T ss_pred             --cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH--------HHHHHHcCCCCCC
Confidence              12234699999999998532   1357899999999999999999999997543211        1122222211111


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                           .....+...+.+++.+||+.||++|||++|+++
T Consensus       236 -----~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         236 -----AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             -----SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 111234467788999999999999999999875

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-52  Score=369.78  Aligned_cols=234  Identities=22%  Similarity=0.370  Sum_probs=174.8

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEec--CCceeEEEEe
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLE--GNNRALIYEF  142 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~--~~~~~lV~e~  142 (372)
                      ++.+.||+|+||+||+++...                     .+.+|++++++++||||+++++++.+  ++..|+||||
T Consensus         7 ~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy   86 (269)
T d2java1           7 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY   86 (269)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEEC
T ss_pred             EEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEec
Confidence            456789999999999997642                     48899999999999999999999865  4568999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeeecCCCCCceEECCCCceEEeecCCcccc
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGC--STKILHFDIKPHNILLDEDFCPKISDFGLAKLC  220 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~  220 (372)
                      +++|+|.+++.+....  ...+++..++.++.|++.||+|||+..  ..+|+||||||+|||++.++.+||+|||+|+..
T Consensus        87 ~~~g~L~~~i~~~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~  164 (269)
T d2java1          87 CEGGDLASVITKGTKE--RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL  164 (269)
T ss_dssp             CTTEEHHHHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC
T ss_pred             CCCCcHHHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeec
Confidence            9999999998653211  123999999999999999999999411  235999999999999999999999999999876


Q ss_pred             cCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccc
Q 036435          221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDRE  300 (372)
Q Consensus       221 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (372)
                      ......   .....||+.|||||++.+.  .++.++|||||||++|||+||+.||.....        ..+...+.....
T Consensus       165 ~~~~~~---~~~~~gt~~Y~APE~l~~~--~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--------~~~~~~i~~~~~  231 (269)
T d2java1         165 NHDTSF---AKAFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------KELAGKIREGKF  231 (269)
T ss_dssp             --------------CCCSCCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHTCC
T ss_pred             ccCCCc---cccCCCCcccCCHHHHcCC--CCChHHHHHhhCHHHHHHhhCCCCCCCCCH--------HHHHHHHHcCCC
Confidence            543322   1234689999999999775  789999999999999999999999975321        112333333322


Q ss_pred             ccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       301 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ...|.       .++.++.+++.+||+.||.+|||++|+++
T Consensus       232 ~~~~~-------~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         232 RRIPY-------RYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             CCCCT-------TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCc-------ccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            22222       23456788999999999999999999875

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-51  Score=366.24  Aligned_cols=239  Identities=28%  Similarity=0.450  Sum_probs=188.1

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-----------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-----------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS  147 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-----------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~  147 (372)
                      +.+.+.||+|+||.||+|++.+                 .|.+|+.++++++|||||+++|+|.+ +..++||||+++|+
T Consensus        19 ~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~   97 (285)
T d1fmka3          19 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGS   97 (285)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCB
T ss_pred             EEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCc
Confidence            4556789999999999997643                 69999999999999999999999854 56899999999999


Q ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCee
Q 036435          148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIV  227 (372)
Q Consensus       148 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  227 (372)
                      |..++......    .++|.+++.++.||+.||+|||   +.+|+||||||+|||+|+++.+||+|||+++.........
T Consensus        98 l~~~~~~~~~~----~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~  170 (285)
T d1fmka3          98 LLDFLKGETGK----YLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  170 (285)
T ss_dssp             HHHHHSHHHHT----TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             hhhhhhhcccc----cchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence            99998764321    2899999999999999999999   7899999999999999999999999999998765433221


Q ss_pred             eeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccC
Q 036435          228 SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVV  307 (372)
Q Consensus       228 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (372)
                        .....||+.|+|||++.+.  .++.++|||||||++|||++|+.|+......       ..+...+..+.....+.  
T Consensus       171 --~~~~~gt~~y~aPE~~~~~--~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-------~~~~~~i~~~~~~~~~~--  237 (285)
T d1fmka3         171 --RQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REVLDQVERGYRMPCPP--  237 (285)
T ss_dssp             -------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCCCCCCT--
T ss_pred             --eccccccccccChHHHhCC--CCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-------HHHHHHHHhcCCCCCCc--
Confidence              2334689999999999874  8899999999999999999987776654321       11233333333333332  


Q ss_pred             CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 036435          308 TRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       308 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~  349 (372)
                           .+.+++.+++.+||+.||++|||+++|++.|+.....
T Consensus       238 -----~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         238 -----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             -----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             -----ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence                 2345678899999999999999999999999886644

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-50  Score=363.48  Aligned_cols=235  Identities=23%  Similarity=0.385  Sum_probs=181.7

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYE  141 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  141 (372)
                      +++.+.||+|+||.||+|++..                       .+.+|+.++++++||||++++|++. ++..++|||
T Consensus         9 ~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E   87 (273)
T d1mp8a_           9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIME   87 (273)
T ss_dssp             EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             eEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEE
Confidence            3456789999999999997531                       5889999999999999999999996 467899999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      |+++|+|.+++.....     .+++.+++.++.|+++||+|||   +.+++||||||+||++++++.+||+|||+|+...
T Consensus        88 ~~~~g~l~~~~~~~~~-----~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          88 LCTLGELRSFLQVRKY-----SLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             CCTTEEHHHHHHHTTT-----TSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             eccCCcHHhhhhccCC-----CCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheecc
Confidence            9999999998876542     2899999999999999999999   7999999999999999999999999999998765


Q ss_pred             CCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhccc
Q 036435          222 TKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDRE  300 (372)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (372)
                      ......  .....||+.|+|||.+.+.  .++.++|||||||++|||++ |.+||.......        +...+..+..
T Consensus       160 ~~~~~~--~~~~~gt~~y~apE~l~~~--~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~--------~~~~i~~~~~  227 (273)
T d1mp8a_         160 DSTYYK--ASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--------VIGRIENGER  227 (273)
T ss_dssp             -------------CCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHHTTCC
T ss_pred             CCccee--ccceecCcccchhhHhccC--CCCCccccccchHHHHHHHhcCCCCCCCCCHHH--------HHHHHHcCCC
Confidence            433222  2334588999999999875  88999999999999999998 788886543221        2333444433


Q ss_pred             ccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       301 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                      ...+.       .++..+.+++.+||+.||.+|||++||++.|+.+.
T Consensus       228 ~~~~~-------~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~  267 (273)
T d1mp8a_         228 LPMPP-------NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  267 (273)
T ss_dssp             CCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCC-------CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            33332       23456788999999999999999999999987654

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-51  Score=377.27  Aligned_cols=238  Identities=21%  Similarity=0.318  Sum_probs=184.2

Q ss_pred             hhhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      .+.+.||+|+||+||+|+...                    ++.+|+.+|++++|||||+++++|.+++..++||||+++
T Consensus         9 ~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~g   88 (322)
T d1s9ja_           9 EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG   88 (322)
T ss_dssp             EEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             EEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence            345789999999999997632                    588999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                      |+|.+++.+...      +++..+..++.|++.||.|||+  ..+|+||||||+|||+++++.+||+|||+|+.......
T Consensus        89 g~L~~~l~~~~~------l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~  160 (322)
T d1s9ja_          89 GSLDQVLKKAGR------IPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA  160 (322)
T ss_dssp             EEHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC
T ss_pred             CcHHHHHhhcCC------CCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCcc
Confidence            999999976542      8999999999999999999993  24899999999999999999999999999986543221


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHH-------------
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIY-------------  292 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-------------  292 (372)
                           ....||+.|+|||++.+.  .++.++||||+||++|||++|+.||.................             
T Consensus       161 -----~~~~GT~~Y~APEvl~~~--~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (322)
T d1s9ja_         161 -----NSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  233 (322)
T ss_dssp             --------CCSSCCCCHHHHHCS--CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred             -----ccccCCccccCchHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence                 234699999999999885  899999999999999999999999976432210000000000             


Q ss_pred             ------------------HHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          293 ------------------RHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       293 ------------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                                        +..........+...   ......++.+++.+||+.||.+|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLP---SGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             ------------CCCCHHHHHHHHHTSCCCCCC---BTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccccchhHHHHHhhhhccCCccCc---cccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                              000000000000000   0112356788999999999999999999986

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-50  Score=369.11  Aligned_cols=230  Identities=24%  Similarity=0.368  Sum_probs=175.8

Q ss_pred             hhhhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      +.+.+.||+|+||+||+++...                    .+.+|+.+|++++||||+++++++.+++..|+|||||+
T Consensus        11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~   90 (307)
T d1a06a_          11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS   90 (307)
T ss_dssp             EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             eEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence            4556889999999999997632                    46789999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC---CCCceEEeecCCccccc
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLD---EDFCPKISDFGLAKLCT  221 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgla~~~~  221 (372)
                      +|+|.+++.....      +++.++..++.|++.||+|||   +.+|+||||||+|||++   +++.+||+|||+|+...
T Consensus        91 gg~L~~~l~~~~~------l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          91 GGELFDRIVEKGF------YTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             SCBHHHHHHTCSC------CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             CCcHHHhhhcccC------CCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            9999999976542      999999999999999999999   79999999999999994   57899999999998654


Q ss_pred             CCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccc
Q 036435          222 TKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF  301 (372)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (372)
                      ....    .....||+.|||||++.+.  .++.++|||||||++|||++|+.||......        .....+.... .
T Consensus       162 ~~~~----~~~~~GT~~y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--------~~~~~i~~~~-~  226 (307)
T d1a06a_         162 PGSV----LSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCGYPPFYDENDA--------KLFEQILKAE-Y  226 (307)
T ss_dssp             ---------------CTTSCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHTTC-C
T ss_pred             CCCe----eeeeeeCccccCcHHHcCC--CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH--------HHHHHHhccC-C
Confidence            4332    2234699999999999875  7899999999999999999999999753211        1222222211 1


Q ss_pred             cCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       302 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ..+.   ....+++..+.+++.+||++||++|||++|+++
T Consensus       227 ~~~~---~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         227 EFDS---PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             CCCT---TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCC---ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            1111   111234466788999999999999999999987

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-51  Score=365.79  Aligned_cols=228  Identities=25%  Similarity=0.350  Sum_probs=185.7

Q ss_pred             hhhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEe
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      +.+.+.||+|+||+||+|+...                      .+.+|++++++++||||+++++++.+++..|+||||
T Consensus        10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy   89 (288)
T d1uu3a_          10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY   89 (288)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred             CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence            4556889999999999997632                      478999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      +++|+|.+++...+.      +++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+|+....
T Consensus        90 ~~gg~L~~~~~~~~~------l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          90 AKNGELLKYIRKIGS------FDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             CTTEEHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             cCCCCHHHhhhccCC------CCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceeccc
Confidence            999999999876543      899999999999999999999   79999999999999999999999999999987654


Q ss_pred             CCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      ...... .....||+.|||||++.+.  .++.++||||+||++|||++|+.||.....        ..+...+... .+.
T Consensus       161 ~~~~~~-~~~~~GT~~Y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~~i~~~-~~~  228 (288)
T d1uu3a_         161 ESKQAR-ANSFVGTAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPFRAGNE--------YLIFQKIIKL-EYD  228 (288)
T ss_dssp             ----------CCCCGGGCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHTT-CCC
T ss_pred             CCcccc-cccccCCccccCceeeccC--CCCcccceehhhHHHHHHhhCCCCCCCcCH--------HHHHHHHHcC-CCC
Confidence            332211 2344699999999999875  789999999999999999999999975321        1122222222 222


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVI  340 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl  340 (372)
                      .|..       +...+.+++.+||+.||.+|||++|++
T Consensus       229 ~p~~-------~s~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         229 FPEK-------FFPKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             CCTT-------CCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             CCcc-------CCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence            3322       345677899999999999999999864

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.9e-50  Score=366.24  Aligned_cols=227  Identities=27%  Similarity=0.376  Sum_probs=184.3

Q ss_pred             hhhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEe
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      +...+.||+|+||+||+|+...                      .+.+|+.+|++++|||||++++++.+++..++||||
T Consensus        17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   96 (309)
T d1u5ra_          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY   96 (309)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEe
Confidence            3445789999999999997632                      588999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      |++|+|..++.....      +++.++..++.||+.||.|||   +.+|+||||||+|||+++++.+||+|||+|.....
T Consensus        97 ~~~g~l~~~~~~~~~------l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (309)
T d1u5ra_          97 CLGSASDLLEVHKKP------LQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (309)
T ss_dssp             CSEEHHHHHHHHTSC------CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             cCCCchHHHHHhCCC------CCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence            999999877765432      899999999999999999999   79999999999999999999999999999986543


Q ss_pred             CCCeeeeecccccccccccccccccc-cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRN-FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF  301 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (372)
                      .       ....||+.|||||++.+. .+.++.++|||||||++|||++|+.||.....       ........ .....
T Consensus       168 ~-------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~-------~~~~~~i~-~~~~~  232 (309)
T d1u5ra_         168 A-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIA-QNESP  232 (309)
T ss_dssp             B-------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHH-HSCCC
T ss_pred             C-------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH-------HHHHHHHH-hCCCC
Confidence            2       234599999999998652 24689999999999999999999999975321       11112222 22111


Q ss_pred             cCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       302 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ..   ..   ..++..+.+++.+||+.||.+|||++|+++
T Consensus       233 ~~---~~---~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         233 AL---QS---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             CC---SC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CC---CC---CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            11   11   123456788999999999999999999986

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-50  Score=365.02  Aligned_cols=241  Identities=25%  Similarity=0.474  Sum_probs=193.1

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhcc-CCCceeeeEeEEecCCceeEEEEe
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRT-SHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      ++.+.||+|+||.||+|++.+                      +|.+|+++|+++ +||||++++|+|.+++..++||||
T Consensus        13 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey   92 (309)
T d1fvra_          13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY   92 (309)
T ss_dssp             EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             EEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEe
Confidence            345789999999999997532                      589999999999 799999999999999999999999


Q ss_pred             cCCCChhhhhhcCCC----------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEe
Q 036435          143 MPNGSLEKFVYNGDT----------SKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKIS  212 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~----------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  212 (372)
                      +++|+|.+++.....          ......+++..++.++.||+.||.|||   +.+++||||||+|||++.++.+||+
T Consensus        93 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~kl~  169 (309)
T d1fvra_          93 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIA  169 (309)
T ss_dssp             CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEEC
T ss_pred             cCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCceEEc
Confidence            999999999976521          111234999999999999999999999   7999999999999999999999999


Q ss_pred             ecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHH
Q 036435          213 DFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIY  292 (372)
Q Consensus       213 Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  292 (372)
                      |||+++.......    .....||..|+|||.+.+.  .++.++|||||||++|||++|..|+.....       ...+.
T Consensus       170 DfG~a~~~~~~~~----~~~~~gt~~y~aPE~l~~~--~~~~~sDvwSfGvil~ell~~~~~p~~~~~-------~~~~~  236 (309)
T d1fvra_         170 DFGLSRGQEVYVK----KTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-------CAELY  236 (309)
T ss_dssp             CTTCEESSCEECC----C----CCTTTCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHH
T ss_pred             ccccccccccccc----ccceecCCcccchHHhccC--CCCccceeehhHHHHHHHHhcCCCCCCCCC-------HHHHH
Confidence            9999986543221    1234588999999999874  889999999999999999998765432221       11233


Q ss_pred             HHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 036435          293 RHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~  349 (372)
                      ..+..+..+..+.       .+...+.+++.+||+.||++||||+||++.|+++.+.
T Consensus       237 ~~i~~~~~~~~~~-------~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         237 EKLPQGYRLEKPL-------NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             HHGGGTCCCCCCT-------TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHHHhcCCCCCCc-------cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            4444443333332       2345678899999999999999999999999888754

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-50  Score=360.05  Aligned_cols=232  Identities=25%  Similarity=0.426  Sum_probs=183.2

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------hHHHHHHHHhccCCCceeeeEeEEec-CCceeEEEEecCCCChh
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------DFVNEVASISRTSHVNVVTLLGFCLE-GNNRALIYEFMPNGSLE  149 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------~~~~E~~~l~~l~h~nIv~l~g~~~~-~~~~~lV~e~~~~g~L~  149 (372)
                      .+.+.||+|+||.||+|++.+               ++.+|++++++++||||++++|+|.+ ++..++||||+++|+|.
T Consensus        10 ~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~   89 (262)
T d1byga_          10 KLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV   89 (262)
T ss_dssp             EEEEEEEECSSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHH
T ss_pred             EEeEEEecCCCeEEEEEEECCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHH
Confidence            456789999999999998743               68999999999999999999999965 45689999999999999


Q ss_pred             hhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCeeee
Q 036435          150 KFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGIVSS  229 (372)
Q Consensus       150 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  229 (372)
                      +++.....    ..+++..+++++.||+.||+|||   +.+++||||||+|||++.++.+|++|||+++......     
T Consensus        90 ~~l~~~~~----~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-----  157 (262)
T d1byga_          90 DYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----  157 (262)
T ss_dssp             HHHHHHHH----HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred             HHHHhcCC----CCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCCC-----
Confidence            99976432    23899999999999999999999   7999999999999999999999999999998654332     


Q ss_pred             ecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcccccCCccCC
Q 036435          230 LLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGVVT  308 (372)
Q Consensus       230 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (372)
                       ....+|..|+|||++.+.  .++.++|||||||++|||+| |+.||.......        +...+..+.....+..  
T Consensus       158 -~~~~~~~~y~aPE~l~~~--~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~--------~~~~i~~~~~~~~~~~--  224 (262)
T d1byga_         158 -DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRVEKGYKMDAPDG--  224 (262)
T ss_dssp             -----CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--------HHHHHTTTCCCCCCTT--
T ss_pred             -ccccccccCCChHHHhCC--CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH--------HHHHHHcCCCCCCCcc--
Confidence             223478899999999874  88999999999999999998 566665432111        2333444433333332  


Q ss_pred             cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          309 RKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       309 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                           ....+.+++.+||+.||.+|||+.++++.|+++.
T Consensus       225 -----~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         225 -----CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             -----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----CCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence                 2356778999999999999999999999998765

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-50  Score=367.90  Aligned_cols=236  Identities=28%  Similarity=0.448  Sum_probs=189.1

Q ss_pred             hhhhhhcCCCCceEEEEEEec------------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIY  140 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~  140 (372)
                      +++.+.||+|+||+||+|++.                        ++|.+|+.++++++|||||+++|+|.++ ..++++
T Consensus        11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~   89 (317)
T d1xkka_          11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT   89 (317)
T ss_dssp             EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred             CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence            344678999999999999652                        1589999999999999999999999865 568889


Q ss_pred             EecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccc
Q 036435          141 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC  220 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~  220 (372)
                      ||+.+|+|.+++.....     .+++..+++++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+..
T Consensus        90 e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          90 QLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  161 (317)
T ss_dssp             ECCTTCBHHHHHHHTSS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred             EeccCCccccccccccc-----CCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceec
Confidence            99999999998876542     3899999999999999999999   789999999999999999999999999999977


Q ss_pred             cCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcc
Q 036435          221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDR  299 (372)
Q Consensus       221 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (372)
                      ........ .....||+.|+|||.+.+.  .++.++|||||||++|||+| |..||.......        +...+..+.
T Consensus       162 ~~~~~~~~-~~~~~gt~~y~APE~l~~~--~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--------~~~~i~~~~  230 (317)
T d1xkka_         162 GAEEKEYH-AEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------ISSILEKGE  230 (317)
T ss_dssp             TTTCC---------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--------HHHHHHHTC
T ss_pred             cccccccc-ccccccCccccChHHHhcC--CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--------HHHHHHcCC
Confidence            65443222 2334589999999999875  88999999999999999998 677776432111        334444444


Q ss_pred             cccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          300 EFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                      .+..|..       +...+.+++.+||+.||.+|||++|+++.|+.+.
T Consensus       231 ~~~~p~~-------~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~  271 (317)
T d1xkka_         231 RLPQPPI-------CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  271 (317)
T ss_dssp             CCCCCTT-------BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCcc-------cCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence            4433322       2356778999999999999999999999887654

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.1e-50  Score=364.32  Aligned_cols=241  Identities=24%  Similarity=0.404  Sum_probs=192.3

Q ss_pred             hhhhhcCCCCceEEEEEEec-------------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLL-------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIY  140 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~-------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~  140 (372)
                      .+.+.||+|+||+||+|+..                         ++|.+|+.+|++++||||++++++|.+.+..++|+
T Consensus        16 ~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~   95 (301)
T d1lufa_          16 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLF   95 (301)
T ss_dssp             EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             EEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEE
Confidence            44678999999999999752                         15899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhcCCCC------------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceE
Q 036435          141 EFMPNGSLEKFVYNGDTS------------------KPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNIL  202 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~~------------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nil  202 (372)
                      ||+++|+|.+++......                  .....+++..++.++.|++.||+|||   +.+++||||||+|||
T Consensus        96 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrDlKp~NIL  172 (301)
T d1lufa_          96 EYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCL  172 (301)
T ss_dssp             ECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred             EecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEeeEEcccceE
Confidence            999999999999754321                  11234899999999999999999999   799999999999999


Q ss_pred             ECCCCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCC-CCCCCCCC
Q 036435          203 LDEDFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKN-NLDSGVDS  281 (372)
Q Consensus       203 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~-p~~~~~~~  281 (372)
                      +|.++.+||+|||+|+.......... .....||+.|+|||.+.+.  .++.++|||||||++|||++|.. ||..... 
T Consensus       173 ld~~~~~Kl~DFGls~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~-  248 (301)
T d1lufa_         173 VGENMVVKIADFGLSRNIYSADYYKA-DGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGLQPYYGMAH-  248 (301)
T ss_dssp             ECGGGCEEECCCSCHHHHTGGGCBC-----CCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-
T ss_pred             ECCCCcEEEccchhheeccCCccccc-cCCCCcCcCcCCHHHHccC--CCChhhhhccchhhHHHHHccCCCCCCCCCH-
Confidence            99999999999999986644332221 2344588999999999875  89999999999999999999975 5543211 


Q ss_pred             CCccchHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          282 SSEVYFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                             ..+...+........|.       .++.++.+++.+||+.||++||||.||++.|+++.
T Consensus       249 -------~e~~~~v~~~~~~~~p~-------~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         249 -------EEVIYYVRDGNILACPE-------NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             -------HHHHHHHHTTCCCCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             -------HHHHHHHHcCCCCCCCc-------cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence                   11223333333333332       23356788999999999999999999999999865

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-50  Score=363.71  Aligned_cols=240  Identities=30%  Similarity=0.492  Sum_probs=193.2

Q ss_pred             hhhhhcCCCCceEEEEEEecc-----------------------hHHHHHHHHhccCCCceeeeEeEEec-CCceeEEEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD-----------------------DFVNEVASISRTSHVNVVTLLGFCLE-GNNRALIYE  141 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~-----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~-~~~~~lV~e  141 (372)
                      +|.++||+|+||+||+|++.+                       +|.+|+++|++++||||++++|++.+ ++..++|||
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E  109 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence            456789999999999997521                       58999999999999999999999875 468899999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      ||++|+|.+++.....     .+++..++.++.|++.||.|||   +.+|+||||||+|||+++++.+||+|||+++...
T Consensus       110 ~~~~g~l~~~~~~~~~-----~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~  181 (311)
T d1r0pa_         110 YMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  181 (311)
T ss_dssp             CCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTT
T ss_pred             EeecCchhhhhccccc-----cchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhcc
Confidence            9999999999876543     2788999999999999999999   7999999999999999999999999999998765


Q ss_pred             CCCCee-eeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccc
Q 036435          222 TKEGIV-SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDRE  300 (372)
Q Consensus       222 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (372)
                      ...... .......||+.|+|||.+.+.  .++.++||||||+++|||+||+.||........       +...+..+..
T Consensus       182 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~-------~~~~i~~g~~  252 (311)
T d1r0pa_         182 DKEFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQGRR  252 (311)
T ss_dssp             TTTCCCTTCTTCSSCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHHHHTTCC
T ss_pred             ccccccceecccccccccccChHHHhcC--CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCCC
Confidence            443221 112334689999999998874  889999999999999999999888876433221       1222233333


Q ss_pred             ccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 036435          301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       301 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~  349 (372)
                      ...|..       ....+.+++.+||+.||++||+++||++.|+++...
T Consensus       253 ~~~p~~-------~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         253 LLQPEY-------CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             CCCCTT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCccc-------CcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            333322       235678899999999999999999999999888754

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-50  Score=357.40  Aligned_cols=236  Identities=25%  Similarity=0.402  Sum_probs=185.0

Q ss_pred             hhhhhcCCCCceEEEEEEec-------------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLL-------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIY  140 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~-------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~  140 (372)
                      ++.+.||+|+||.||+|++.                         ++|.+|+.+|++++||||++++|+|.+ +..++||
T Consensus        11 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~   89 (273)
T d1u46a_          11 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVT   89 (273)
T ss_dssp             EEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             EEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheee
Confidence            45678999999999999642                         158899999999999999999999976 4778999


Q ss_pred             EecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccc
Q 036435          141 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC  220 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~  220 (372)
                      ||+++|+|.+++.....     .+++..++.++.|+++||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        90 e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          90 ELAPLGSLLDRLRKHQG-----HFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             ECCTTCBHHHHHHHHGG-----GSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeecCcchhhhhhcccC-----CCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhc
Confidence            99999999998876432     2999999999999999999999   799999999999999999999999999999987


Q ss_pred             cCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCccchHHHHHHHhhhcc
Q 036435          221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEVYFPHWIYRHVEQDR  299 (372)
Q Consensus       221 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (372)
                      ..............||..|+|||.+.+.  .++.++|||||||++|||+| |+.||......       ...........
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~-------~~~~~i~~~~~  232 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTR--TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-------QILHKIDKEGE  232 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHTSCC
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCC--CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH-------HHHHHHHhCCC
Confidence            6655544444455678899999999875  78999999999999999998 89998643211       11222222222


Q ss_pred             cccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcC
Q 036435          300 EFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGS  346 (372)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~  346 (372)
                      .+..+.       .++..+.+++.+||+.||.+|||+++|++.|+++
T Consensus       233 ~~~~~~-------~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         233 RLPRPE-------DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             CCCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCcc-------cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            222222       2335678899999999999999999999998764

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=360.87  Aligned_cols=230  Identities=25%  Similarity=0.344  Sum_probs=187.2

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-------------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-------------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALI  139 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV  139 (372)
                      +.+.+.||+|+||+||+|+...                         .+.+|+.+|++++|||||++++++.+++..++|
T Consensus        12 Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (293)
T d1jksa_          12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILI   91 (293)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             EEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            4556889999999999997632                         478999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC----ceEEeecC
Q 036435          140 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDF----CPKISDFG  215 (372)
Q Consensus       140 ~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg  215 (372)
                      ||||++|+|.+++.....      +++..+..++.|++.||+|||   +.+|+||||||+|||++.++    .+|++|||
T Consensus        92 ~E~~~gg~L~~~i~~~~~------l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          92 LELVAGGELFDFLAEKES------LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EECCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEcCCCccccchhccccc------cchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchh
Confidence            999999999999976542      999999999999999999999   79999999999999998776    59999999


Q ss_pred             CcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHh
Q 036435          216 LAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV  295 (372)
Q Consensus       216 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  295 (372)
                      ++........    .....||+.|+|||++.+.  .++.++||||+||++|||++|+.||......        .....+
T Consensus       163 ~a~~~~~~~~----~~~~~~t~~y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--------~~~~~i  228 (293)
T d1jksa_         163 LAHKIDFGNE----FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLANV  228 (293)
T ss_dssp             TCEECTTSCB----CSCCCCCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHH
T ss_pred             hhhhcCCCcc----ccccCCCCcccCHHHHcCC--CCCCcccchhhhHHHHHHHcCCCCCCCCCHH--------HHHHHH
Confidence            9987654332    2334589999999999875  7899999999999999999999999753211        112222


Q ss_pred             hhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          296 EQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .... ...+   .......+..+.+++.+||+.||++|||++|+++
T Consensus       229 ~~~~-~~~~---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         229 SAVN-YEFE---DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HTTC-CCCC---HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HhcC-CCCC---chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            2111 1111   1111223456788999999999999999999986

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.8e-49  Score=367.00  Aligned_cols=232  Identities=24%  Similarity=0.343  Sum_probs=188.4

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      +.+.+.||+|+||.||+++...                   .+.+|+.+|++++|||||++++++.+++..++|||||++
T Consensus        28 Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g  107 (350)
T d1koaa2          28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG  107 (350)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred             eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence            4556889999999999997642                   578999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC--CCCceEEeecCCcccccCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLD--EDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfgla~~~~~~  223 (372)
                      |+|.+++.+...     .+++..+..++.||+.||+|||   +.+|+||||||+|||++  .++.+||+|||+++.....
T Consensus       108 g~L~~~l~~~~~-----~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         108 GELFEKVADEHN-----KMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             CBHHHHHTCTTS-----CBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             CCHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            999999965432     2999999999999999999999   79999999999999996  4678999999999876554


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                      ...    ....||+.|||||++.+.  .++.++|||||||++|||++|+.||......       . ....+.... ...
T Consensus       180 ~~~----~~~~gT~~Y~aPEv~~~~--~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~-~~~~i~~~~-~~~  244 (350)
T d1koaa2         180 QSV----KVTTGTAEFAAPEVAEGK--PVGYYTDMWSVGVLSYILLSGLSPFGGENDD-------E-TLRNVKSCD-WNM  244 (350)
T ss_dssp             SCE----EEECSCTTTCCHHHHHTC--CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------H-HHHHHHHTC-CCS
T ss_pred             ccc----ceecCcccccCHHHHcCC--CCChhHhhhhhhHHHHHHHhCCCCCCCCCHH-------H-HHHHHHhCC-CCC
Confidence            432    234589999999999875  7899999999999999999999999753211       1 122222111 111


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                      +   ......+...+.+++.+||+.||++|||++|+++.
T Consensus       245 ~---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         245 D---DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             C---CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             C---cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1   11122344667889999999999999999999874

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-49  Score=358.51  Aligned_cols=254  Identities=22%  Similarity=0.288  Sum_probs=189.0

Q ss_pred             hhhhcCCCCceEEEEEEecc--------------hHHH--HHHHHhccCCCceeeeEeEEecCC----ceeEEEEecCCC
Q 036435           87 FKDKLGQGGFGGVYKGRLLD--------------DFVN--EVASISRTSHVNVVTLLGFCLEGN----NRALIYEFMPNG  146 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~--------------~~~~--E~~~l~~l~h~nIv~l~g~~~~~~----~~~lV~e~~~~g  146 (372)
                      +.+.||+|+||.||+|++.+              ++.+  |+..+.+++||||++++|+|.+.+    ..++||||+++|
T Consensus         7 l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g   86 (303)
T d1vjya_           7 LQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG   86 (303)
T ss_dssp             EEEEEECCSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTC
T ss_pred             EEEEEeeCCCeEEEEEEECCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCC
Confidence            35679999999999998643              3444  444556789999999999998654    578999999999


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHG-----CSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-----~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      +|.+++++..       ++|.++++++.|++.||+|||+.     ..++|+||||||+|||++.++.+||+|||+++...
T Consensus        87 ~L~~~l~~~~-------l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~  159 (303)
T d1vjya_          87 SLFDYLNRYT-------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD  159 (303)
T ss_dssp             BHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred             CHHHHHhcCC-------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccccc
Confidence            9999998643       89999999999999999999942     13699999999999999999999999999999776


Q ss_pred             CCCCeee-eeccccccccccccccccccc----CCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCc-------cchHH
Q 036435          222 TKEGIVS-SLLGARGIIGYIAPEVFSRNF----GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSE-------VYFPH  289 (372)
Q Consensus       222 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~-------~~~~~  289 (372)
                      ....... ......||+.|+|||++.+..    ..++.++|||||||++|||+||..|+.........       .....
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~  239 (303)
T d1vjya_         160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE  239 (303)
T ss_dssp             TTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred             CCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHH
Confidence            5443322 233456999999999987531    13577999999999999999999887543322110       01111


Q ss_pred             HHHHHh-hhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCccc
Q 036435          290 WIYRHV-EQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEA  349 (372)
Q Consensus       290 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~  349 (372)
                      ...... ........+...  ...+....+.+++.+||+.||++|||+.||++.|+++.+.
T Consensus       240 ~~~~~~~~~~~~p~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         240 EMRKVVCEQKLRPNIPNRW--QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             HHHHHHTTSCCCCCCCGGG--GGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHhccccCCCCCccc--CChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence            122211 111112222211  1234567788999999999999999999999999877643

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.7e-49  Score=365.98  Aligned_cols=232  Identities=22%  Similarity=0.322  Sum_probs=188.8

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      +.+.+.||+|+||+||+|+...                   .+.+|+.+|++++||||+++++++.+++..|+|||||++
T Consensus        31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g  110 (352)
T d1koba_          31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG  110 (352)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence            4556889999999999997632                   578899999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC--CCCceEEeecCCcccccCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLD--EDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfgla~~~~~~  223 (372)
                      |+|.+++.....     .+++.++..++.||+.||+|||   +.+|+||||||+|||++  .++.+||+|||+|......
T Consensus       111 g~L~~~~~~~~~-----~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         111 GELFDRIAAEDY-----KMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CBHHHHTTCTTC-----CBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             ChHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence            999988765432     2999999999999999999999   79999999999999998  6789999999999987654


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL  303 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (372)
                      ...    ....||+.|+|||++.+.  .++.++||||+||++|||+||+.||......       . ....+... ....
T Consensus       183 ~~~----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~-~~~~i~~~-~~~~  247 (352)
T d1koba_         183 EIV----KVTTATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-------E-TLQNVKRC-DWEF  247 (352)
T ss_dssp             SCE----EEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------H-HHHHHHHC-CCCC
T ss_pred             Cce----eeccCcccccCHHHHcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHH-------H-HHHHHHhC-CCCC
Confidence            432    233589999999999875  7899999999999999999999999753211       1 11222221 1111


Q ss_pred             CccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          304 PGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       304 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                      +..   ....+...+.+++.+||+.||.+|||++|+++.
T Consensus       248 ~~~---~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         248 DED---AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             CSS---TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             Ccc---cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111   112234567889999999999999999999873

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-49  Score=358.23  Aligned_cols=244  Identities=28%  Similarity=0.426  Sum_probs=185.5

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-------------------------hHHHHHHHHhcc-CCCceeeeEeEEecC-Ccee
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-------------------------DFVNEVASISRT-SHVNVVTLLGFCLEG-NNRA  137 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-------------------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~-~~~~  137 (372)
                      +.+.++||+|+||.||+|++..                         .+.+|...+.++ +|+||+.+++++.+. +..+
T Consensus        15 y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~   94 (299)
T d1ywna1          15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM   94 (299)
T ss_dssp             EEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCE
T ss_pred             EEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEE
Confidence            4556889999999999987421                         467788888877 689999999998765 4689


Q ss_pred             EEEEecCCCChhhhhhcCCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC
Q 036435          138 LIYEFMPNGSLEKFVYNGDTS----------KPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDF  207 (372)
Q Consensus       138 lV~e~~~~g~L~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~  207 (372)
                      +|||||++|+|.+++......          .....+++.+++.++.|+++||+|||   +.+|+||||||+|||+++++
T Consensus        95 iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~~~~  171 (299)
T d1ywna1          95 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKN  171 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGG
T ss_pred             EEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeECCCC
Confidence            999999999999999764310          11234899999999999999999999   79999999999999999999


Q ss_pred             ceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCC-CCCCCCCCCCccc
Q 036435          208 CPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKN-NLDSGVDSSSEVY  286 (372)
Q Consensus       208 ~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~-p~~~~~~~~~~~~  286 (372)
                      .+||+|||+|+.......... .....||+.|+|||.+.+.  .++.++|||||||++|||+||.. ||..... .    
T Consensus       172 ~~Kl~DFGla~~~~~~~~~~~-~~~~~gt~~y~APE~l~~~--~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~-~----  243 (299)
T d1ywna1         172 VVKICDFGLARDIYKDPDYVR-KGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-D----  243 (299)
T ss_dssp             CEEECC------CCSCTTSCC-TTSCCCGGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC-S----
T ss_pred             cEEEccCcchhhccccccccc-cCceeeCccccchhHhhcC--CCCcccceeehHHHHHHHHhCCCCCCCCCCH-H----
Confidence            999999999987654332221 2345689999999999875  88999999999999999999765 5543321 1    


Q ss_pred             hHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 036435          287 FPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE  348 (372)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~  348 (372)
                        ..+...+..+.....|..       ...++.+++.+||+.||++|||++|+++.|+++.+
T Consensus       244 --~~~~~~~~~~~~~~~~~~-------~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         244 --EEFCRRLKEGTRMRAPDY-------TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             --HHHHHHHHHTCCCCCCTT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HHHHHHHhcCCCCCCCcc-------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence              223344444444444432       23467789999999999999999999999987653

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-48  Score=356.37  Aligned_cols=227  Identities=24%  Similarity=0.316  Sum_probs=188.4

Q ss_pred             hhhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEe
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      +++.+.||+|+||.||+++...                      .+.+|+.+|++++||||+++++++.+++..|+||||
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey   86 (337)
T d1o6la_           7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY   86 (337)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence            3456789999999999997632                      478899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      +++|+|.+++.....      +++..+..++.|++.||+|||   +.+|+||||||+|||++.+|.+||+|||+|+....
T Consensus        87 ~~gg~L~~~~~~~~~------~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          87 ANGGELFFHLSRERV------FTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             CTTCBHHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             cCCCchhhhhhcccC------CcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            999999999987543      899999999999999999999   89999999999999999999999999999987544


Q ss_pred             CCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      ....   .....||+.|+|||++.+.  .++.++|+||+||++|||++|+.||.....        ..+...... ....
T Consensus       158 ~~~~---~~~~~GT~~Y~aPE~~~~~--~y~~~~DiwSlGvilyeml~G~~pf~~~~~--------~~~~~~i~~-~~~~  223 (337)
T d1o6la_         158 DGAT---MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILM-EEIR  223 (337)
T ss_dssp             TTCC---BCCCEECGGGCCGGGGSSS--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHH-CCCC
T ss_pred             CCcc---cccceeCHHHhhhhhccCC--CCChhhcccchhhHHHHHHHCCCCCCCcCH--------HHHHHHHhc-CCCC
Confidence            3322   2335699999999999875  789999999999999999999999976432        112222222 2233


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPP-----MNEVIE  341 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~  341 (372)
                      .|..       +...+.+++.+||++||.+||+     ++|+++
T Consensus       224 ~p~~-------~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         224 FPRT-------LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CCTT-------SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCcc-------CCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            3433       2345678899999999999995     788876

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-48  Score=355.25  Aligned_cols=243  Identities=25%  Similarity=0.442  Sum_probs=192.6

Q ss_pred             hhhhhhcCCCCceEEEEEEec---------------------------chHHHHHHHHhcc-CCCceeeeEeEEecCCce
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL---------------------------DDFVNEVASISRT-SHVNVVTLLGFCLEGNNR  136 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~---------------------------~~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~  136 (372)
                      +.+.+.||+|+||.||+|+..                           .++.+|...+.++ +|||||+++++|.+++..
T Consensus        15 ~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~   94 (299)
T d1fgka_          15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL   94 (299)
T ss_dssp             EEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             eEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeE
Confidence            345678999999999998641                           1578899999888 799999999999999999


Q ss_pred             eEEEEecCCCChhhhhhcCCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCC
Q 036435          137 ALIYEFMPNGSLEKFVYNGDTS----------KPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDED  206 (372)
Q Consensus       137 ~lV~e~~~~g~L~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~  206 (372)
                      ++||||+++|+|.+++......          .....+++.+++.++.|++.||+|||   +.+++||||||+|||++.+
T Consensus        95 ~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl~~~  171 (299)
T d1fgka_          95 YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTED  171 (299)
T ss_dssp             EEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTT
T ss_pred             EEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceeecCC
Confidence            9999999999999999765321          12234899999999999999999999   8999999999999999999


Q ss_pred             CceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhc-CCCCCCCCCCCCCcc
Q 036435          207 FCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDSSSEV  285 (372)
Q Consensus       207 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~  285 (372)
                      +.+||+|||+++.......... .....+|+.|+|||.+.+.  .++.++|||||||++|||++ |..||.....     
T Consensus       172 ~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~l~~~--~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~-----  243 (299)
T d1fgka_         172 NVMKIADFGLARDIHHIDYYKK-TTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-----  243 (299)
T ss_dssp             CCEEECSTTCCCCGGGCCTTCC-CTTSCCGGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred             CCeEeccchhhccccccccccc-cccCCCChhhhhhhHhcCC--CCCchhhhHHhHHHHHHhccCCCCCCCCCCH-----
Confidence            9999999999987765443322 2445688999999999874  89999999999999999998 5677654321     


Q ss_pred             chHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 036435          286 YFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE  348 (372)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~  348 (372)
                         ..+...+..+..+..|..       .+..+.+++.+||+.||.+|||++||++.|+++.+
T Consensus       244 ---~~~~~~i~~~~~~~~p~~-------~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         244 ---EELFKLLKEGHRMDKPSN-------CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             ---HHHHHHHHTTCCCCCCSS-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---HHHHHHHHcCCCCCCCcc-------chHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence               224455555544444432       23567889999999999999999999999988753

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.3e-49  Score=354.90  Aligned_cols=240  Identities=22%  Similarity=0.351  Sum_probs=184.2

Q ss_pred             hhhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCC----ceeE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGN----NRAL  138 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~----~~~l  138 (372)
                      +.+.+.||+|+||+||+|+...                      .+.+|+.++++++||||+++++++.+.+    ..|+
T Consensus         9 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~l   88 (277)
T d1o6ya_           9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI   88 (277)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             eEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEE
Confidence            3456789999999999997632                      5889999999999999999999998654    3789


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          139 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       139 V~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      ||||+++|+|.+++.....      +++.+++.++.|++.||+|||   +.+|+||||||+|||++.++..+++|||.+.
T Consensus        89 vmE~~~g~~L~~~~~~~~~------l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          89 VMEYVDGVTLRDIVHTEGP------MTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEECCCEEEHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEECCCCCEehhhhcccCC------CCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhh
Confidence            9999999999999876543      899999999999999999999   7999999999999999999999999999998


Q ss_pred             cccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhc
Q 036435          219 LCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQD  298 (372)
Q Consensus       219 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (372)
                      ................||+.|+|||.+.+.  .++.++|||||||++|||+||+.||.....       .......+...
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~~DiwSlGvilyelltG~~Pf~~~~~-------~~~~~~~~~~~  230 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTGDSP-------VSVAYQHVRED  230 (277)
T ss_dssp             ECC----------------TTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHCC
T ss_pred             hhccccccccccccccCcccccCHHHHcCC--CCCcceecccchHHHHHHHhCCCCCCCcCH-------HHHHHHHHhcC
Confidence            665444333334455699999999999874  789999999999999999999999975321       11122222222


Q ss_pred             ccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhhcCc
Q 036435          299 REFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRP-PMNEVIEMLQGST  347 (372)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~evl~~L~~~~  347 (372)
                      ...  +.   ....+++..+.+++.+||++||.+|| |++++++.|.++.
T Consensus       231 ~~~--~~---~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         231 PIP--PS---ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             CCC--GG---GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CCC--Cc---hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            111  11   11122346778899999999999999 8999999887653

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-48  Score=357.56  Aligned_cols=232  Identities=20%  Similarity=0.282  Sum_probs=183.4

Q ss_pred             hhcCCCCceEEEEEEecc--------------hHHHHHHHHhcc-CCCceeeeEeEEec----CCceeEEEEecCCCChh
Q 036435           89 DKLGQGGFGGVYKGRLLD--------------DFVNEVASISRT-SHVNVVTLLGFCLE----GNNRALIYEFMPNGSLE  149 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~--------------~~~~E~~~l~~l-~h~nIv~l~g~~~~----~~~~~lV~e~~~~g~L~  149 (372)
                      +.||+|+||+||+|+...              .+.+|+.++.++ +||||+++++++.+    +...|+|||||+||+|.
T Consensus        18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~   97 (335)
T d2ozaa1          18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELF   97 (335)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHH
T ss_pred             EEeeeccCeEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHH
Confidence            459999999999997642              688999987665 89999999999875    45789999999999999


Q ss_pred             hhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC---CCceEEeecCCcccccCCCCe
Q 036435          150 KFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE---DFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       150 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      +++.+....    .+++.++..++.|++.||+|||   +.+|+||||||+|||+++   ++.+||+|||+|+........
T Consensus        98 ~~i~~~~~~----~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~  170 (335)
T d2ozaa1          98 SRIQDRGDQ----AFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL  170 (335)
T ss_dssp             HHHHSCSCC----CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCC
T ss_pred             HHHHhcCCC----CcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccccceeeeccCCCcc
Confidence            999865432    3999999999999999999999   799999999999999985   567999999999876544322


Q ss_pred             eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCcc
Q 036435          227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPGV  306 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (372)
                          ....||+.|||||++.+.  .++.++|||||||++|+|+||+.||.........    ..+..... ......   
T Consensus       171 ----~~~~gt~~y~aPE~~~~~--~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~----~~~~~~i~-~~~~~~---  236 (335)
T d2ozaa1         171 ----TTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----PGMKTRIR-MGQYEF---  236 (335)
T ss_dssp             ----CCCSCCCSSCCCCCCCGG--GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCC-SCSSSC---
T ss_pred             ----ccccCCcccCCcHHHcCC--CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH----HHHHHHHh-cCCCCC---
Confidence                334699999999999875  7899999999999999999999999765332210    00011110 011111   


Q ss_pred             CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          307 VTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       307 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .......+...+.+++.+||+.||++|||+.|+++
T Consensus       237 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            11223345678889999999999999999999987

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.4e-48  Score=354.76  Aligned_cols=224  Identities=25%  Similarity=0.342  Sum_probs=187.0

Q ss_pred             hhhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEe
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      +++.+.||+|+||+||+++...                      .+.+|+.++++++||||+++++++.+++..|+||||
T Consensus         6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~   85 (316)
T d1fota_           6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY   85 (316)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred             eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence            3456889999999999997632                      478899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      ++||+|..++.....      +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+....
T Consensus        86 ~~gg~l~~~~~~~~~------~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~  156 (316)
T d1fota_          86 IEGGELFSLLRKSQR------FPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  156 (316)
T ss_dssp             CCSCBHHHHHHHTSS------CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             cCCcccccccccccc------ccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEecc
Confidence            999999999987653      788999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      ..      ....||+.|||||++.+.  .++.++||||+||++|||++|+.||.....        ......+... ...
T Consensus       157 ~~------~~~~Gt~~Y~APE~l~~~--~y~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~i~~~-~~~  219 (316)
T d1fota_         157 VT------YTLCGTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYDSNT--------MKTYEKILNA-ELR  219 (316)
T ss_dssp             CB------CCCCSCTTTCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHC-CCC
T ss_pred             cc------ccccCcccccCHHHHcCC--CCCchhhccccchhHHHHHhCCCCCCCcCH--------HHHHHHHHcC-CCC
Confidence            33      234699999999999875  789999999999999999999999975321        1122222222 222


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRP-----PMNEVIE  341 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~  341 (372)
                      .|..       +...+.+++.+||++||.+|+     |++++++
T Consensus       220 ~p~~-------~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         220 FPPF-------FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             CCTT-------SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCC-------CCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            2322       235677889999999999996     8999986

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-48  Score=352.61  Aligned_cols=245  Identities=27%  Similarity=0.430  Sum_probs=196.7

Q ss_pred             HhhhhhhcCCCCceEEEEEEecc-------------------------hHHHHHHHHhcc-CCCceeeeEeEEecCCcee
Q 036435           84 TNSFKDKLGQGGFGGVYKGRLLD-------------------------DFVNEVASISRT-SHVNVVTLLGFCLEGNNRA  137 (372)
Q Consensus        84 ~~~~~~~lg~G~~g~V~~~~~~~-------------------------~~~~E~~~l~~l-~h~nIv~l~g~~~~~~~~~  137 (372)
                      .+.+.+.||+|+||.||+|++..                         .+.+|+.+++++ +|||||+++|+|.+++..+
T Consensus        24 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~  103 (311)
T d1t46a_          24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL  103 (311)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEE
Confidence            34556789999999999997521                         588999999999 6999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC
Q 036435          138 LIYEFMPNGSLEKFVYNGDTS------------KPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE  205 (372)
Q Consensus       138 lV~e~~~~g~L~~~l~~~~~~------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~  205 (372)
                      +|||||++|+|.+++......            .....+++..++.++.||+.||+|||   +.+++||||||+|||++.
T Consensus       104 lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~~~  180 (311)
T d1t46a_         104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTH  180 (311)
T ss_dssp             EEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEET
T ss_pred             EEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccccccc
Confidence            999999999999999765321            11234899999999999999999999   799999999999999999


Q ss_pred             CCceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCcc
Q 036435          206 DFCPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEV  285 (372)
Q Consensus       206 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~  285 (372)
                      ++.+|++|||+++.......... .....||+.|+|||.+.+.  .++.++|||||||++|||+|++.|+.......   
T Consensus       181 ~~~~ki~DfG~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~--~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~---  254 (311)
T d1t46a_         181 GRITKICDFGLARDIKNDSNYVV-KGNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLWELFSLGSSPYPGMPVD---  254 (311)
T ss_dssp             TTEEEECCCGGGSCTTSCTTSEE-CSSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS---
T ss_pred             cCcccccccchheeccCCCcceE-eeecccChHHcCHHHhcCC--CCCCcccccchHHHHHHHHhCCCCCCCCCCHH---
Confidence            99999999999997765443332 3445689999999999764  88999999999999999999665554433222   


Q ss_pred             chHHHHHHHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          286 YFPHWIYRHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                         ..+...+..+.....+..       .+..+.+++.+||+.||.+|||++++++.|++..
T Consensus       255 ---~~~~~~i~~~~~~~~~~~-------~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i  306 (311)
T d1t46a_         255 ---SKFYKMIKEGFRMLSPEH-------APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (311)
T ss_dssp             ---HHHHHHHHHTCCCCCCTT-------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---HHHHHHHhcCCCCCCccc-------ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence               112333444433333322       2456888999999999999999999999998754

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-48  Score=353.71  Aligned_cols=242  Identities=26%  Similarity=0.405  Sum_probs=193.5

Q ss_pred             hhhhhcCCCCceEEEEEEec-------------------------chHHHHHHHHhccCCCceeeeEeEEecCCceeEEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLL-------------------------DDFVNEVASISRTSHVNVVTLLGFCLEGNNRALIY  140 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~-------------------------~~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~  140 (372)
                      .+.+.||+|+||+||+|.+.                         ..|.+|+.++++++||||++++|+|..++..++||
T Consensus        23 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~  102 (308)
T d1p4oa_          23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM  102 (308)
T ss_dssp             EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             EEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEE
Confidence            44678999999999998652                         14889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhcCC----CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCC
Q 036435          141 EFMPNGSLEKFVYNGD----TSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGL  216 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~----~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  216 (372)
                      ||+++|+|.+++....    .......+++..+..++.|+++||.|||   +.+|+||||||+|||+|+++.+||+|||+
T Consensus       103 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~DFGl  179 (308)
T d1p4oa_         103 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGM  179 (308)
T ss_dssp             ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred             eecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEeeccc
Confidence            9999999999986431    0111123799999999999999999999   78999999999999999999999999999


Q ss_pred             cccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCC-CCCCCCCCCCCccchHHHHHHHh
Q 036435          217 AKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCK-NNLDSGVDSSSEVYFPHWIYRHV  295 (372)
Q Consensus       217 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~  295 (372)
                      ++.......... .....||+.|+|||.+.+.  .++.++||||||+++|||+||+ .||... ..      .+ +...+
T Consensus       180 a~~~~~~~~~~~-~~~~~~t~~y~aPe~l~~~--~~~~~~Dv~S~G~il~El~t~~~~p~~~~-~~------~~-~~~~i  248 (308)
T d1p4oa_         180 TRDIYETDYYRK-GGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGL-SN------EQ-VLRFV  248 (308)
T ss_dssp             CCGGGGGGCEEG-GGSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTS-CH------HH-HHHHH
T ss_pred             ceeccCCcceee-ccceecccccCCHHHHccC--CCCcccccccHHHHHHHHHhCCCCCCCCC-CH------HH-HHHHH
Confidence            987655433222 2334589999999999875  7899999999999999999986 455432 11      11 23333


Q ss_pred             hhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcc
Q 036435          296 EQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTE  348 (372)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~  348 (372)
                      ........|..       .+..+.+++.+||+.||.+|||+++|++.|++..+
T Consensus       249 ~~~~~~~~p~~-------~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         249 MEGGLLDKPDN-------CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             HTTCCCCCCTT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HhCCCCCCccc-------chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            33333333322       23568889999999999999999999999988764

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-48  Score=353.96  Aligned_cols=236  Identities=25%  Similarity=0.293  Sum_probs=181.0

Q ss_pred             hhcCCCCceEEEEEEecc------------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           89 DKLGQGGFGGVYKGRLLD------------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        89 ~~lg~G~~g~V~~~~~~~------------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      +.||+|+||+||+|+...                        .+.+|+.++++++||||+++++++.+++..++||||+.
T Consensus         4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~   83 (299)
T d1ua2a_           4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME   83 (299)
T ss_dssp             EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred             eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence            579999999999997532                        47889999999999999999999999999999999998


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      ++++........      .+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        84 ~~~~~~~~~~~~------~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~  154 (299)
T d1ua2a_          84 TDLEVIIKDNSL------VLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  154 (299)
T ss_dssp             EEHHHHHTTCCS------SCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             chHHhhhhhccc------CCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCc
Confidence            877766654332      2888999999999999999999   7999999999999999999999999999998765433


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccC-
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKL-  303 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  303 (372)
                      ..   .....||+.|+|||++.+. ..++.++|||||||++|||++|..||....+.+    ....+.+.......... 
T Consensus       155 ~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~----~l~~i~~~~~~~~~~~~~  226 (299)
T d1ua2a_         155 RA---YTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD----QLTRIFETLGTPTEEQWP  226 (299)
T ss_dssp             CC---CCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHHCCCCTTTSS
T ss_pred             cc---ccceecChhhccHHHHccC-CCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH----HHHHHHHhcCCCChhhcc
Confidence            22   1234589999999998654 367999999999999999999999987543211    00001111100000000 


Q ss_pred             -----------CccCCcc----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          304 -----------PGVVTRK----ENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       304 -----------~~~~~~~----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                                 .......    .......+.+++.+||+.||++|||++|+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         227 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             chhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence                       0000000    1123457889999999999999999999986

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=6.4e-48  Score=358.56  Aligned_cols=228  Identities=27%  Similarity=0.334  Sum_probs=182.5

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHH---HHHHHhccCCCceeeeEeEEecCCceeEEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVN---EVASISRTSHVNVVTLLGFCLEGNNRALIY  140 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~---E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~  140 (372)
                      .+.+.||+|+||.||+|+...                      .+.+   |+.+++.++||||+++++++.+++..|+||
T Consensus         7 ~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivm   86 (364)
T d1omwa3           7 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL   86 (364)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEE
Confidence            446789999999999997642                      1333   467777888999999999999999999999


Q ss_pred             EecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccc
Q 036435          141 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLC  220 (372)
Q Consensus       141 e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~  220 (372)
                      ||+++|+|.+++.+...      +++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+..
T Consensus        87 E~~~gg~L~~~l~~~~~------~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          87 DLMNGGDLHYHLSQHGV------FSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             CCCCSCBHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EecCCCcHHHHHHhccc------ccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            99999999999976543      889999999999999999999   899999999999999999999999999999876


Q ss_pred             cCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccc
Q 036435          221 TTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDRE  300 (372)
Q Consensus       221 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (372)
                      ....     .....||+.|+|||++.+. ..++.++|||||||++|||+||+.||........     ..+.... ....
T Consensus       158 ~~~~-----~~~~~GT~~y~APE~~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-----~~~~~~~-~~~~  225 (364)
T d1omwa3         158 SKKK-----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRMT-LTMA  225 (364)
T ss_dssp             SSSC-----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-----HHHHHHS-SSCC
T ss_pred             CCCc-----ccccccccccchhHHhhcC-CCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhc-ccCC
Confidence            5433     2334699999999998653 3689999999999999999999999976543221     1111111 1111


Q ss_pred             ccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 036435          301 FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPP-----MNEVIE  341 (372)
Q Consensus       301 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~  341 (372)
                      ...+.       .+...+.+++.+||+.||.+|||     ++|+++
T Consensus       226 ~~~~~-------~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         226 VELPD-------SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             CCCCS-------SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             CCCCC-------CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            12222       13456778999999999999999     688875

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.9e-48  Score=346.91  Aligned_cols=231  Identities=21%  Similarity=0.310  Sum_probs=187.7

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------------hHHHHHHHHhccC-CCceeeeEeEEecCCce
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------------DFVNEVASISRTS-HVNVVTLLGFCLEGNNR  136 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------------~~~~E~~~l~~l~-h~nIv~l~g~~~~~~~~  136 (372)
                      .+.+.||+|+||+||+++...                            .+.+|+.++++++ ||||+++++++.+++..
T Consensus         6 ~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~   85 (277)
T d1phka_           6 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF   85 (277)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             EEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcce
Confidence            446789999999999997632                            4788999999997 99999999999999999


Q ss_pred             eEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCC
Q 036435          137 ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGL  216 (372)
Q Consensus       137 ~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  216 (372)
                      |+||||+++|+|.+++.....      +++.++..++.||+.||+|||   +.+++||||||+|||++.++.+||+|||+
T Consensus        86 ~ivmE~~~~g~L~~~l~~~~~------l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          86 FLVFDLMKKGELFDYLTEKVT------LSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             EEEEECCTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEcCCCchHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchh
Confidence            999999999999999976542      999999999999999999999   79999999999999999999999999999


Q ss_pred             cccccCCCCeeeeecccccccccccccccccc----cCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHH
Q 036435          217 AKLCTTKEGIVSSLLGARGIIGYIAPEVFSRN----FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIY  292 (372)
Q Consensus       217 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  292 (372)
                      ++........    ....||+.|+|||.+.+.    ...++.++||||+||++|||++|+.||.....        ....
T Consensus       157 a~~~~~~~~~----~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~--------~~~~  224 (277)
T d1phka_         157 SCQLDPGEKL----REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--------MLML  224 (277)
T ss_dssp             CEECCTTCCB----CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHH
T ss_pred             eeEccCCCce----eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH--------HHHH
Confidence            9876543321    334689999999998642    13568899999999999999999999975421        1122


Q ss_pred             HHhhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          293 RHVEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ..+.... ...+   ......++.++.+++.+||+.||++|||++|+++
T Consensus       225 ~~i~~~~-~~~~---~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         225 RMIMSGN-YQFG---SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHHHHTC-CCCC---TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHhCC-CCCC---CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            2222221 1111   1122234567888999999999999999999875

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-48  Score=352.86  Aligned_cols=230  Identities=22%  Similarity=0.300  Sum_probs=186.5

Q ss_pred             hhhhhcCCCCceEEEEEEecc------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCCC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS  147 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g~  147 (372)
                      .+.+.||+|+||+||+|....                  .+.+|+++|++++||||+++++++.+++..|+|||||++|+
T Consensus         8 ~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~   87 (321)
T d1tkia_           8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLD   87 (321)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCB
T ss_pred             EEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCc
Confidence            456789999999999997642                  47899999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC--CCceEEeecCCcccccCCCC
Q 036435          148 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE--DFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       148 L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgla~~~~~~~~  225 (372)
                      |.+++.....     .+++.++..++.||+.||+|||   +.+|+||||||+|||++.  ...+||+|||+++.......
T Consensus        88 L~~~i~~~~~-----~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~  159 (321)
T d1tkia_          88 IFERINTSAF-----ELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             HHHHHTSSSC-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             HHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence            9999976532     2899999999999999999999   799999999999999984  45899999999987654332


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccccCCc
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFKLPG  305 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (372)
                      .    ....+|+.|+|||.+.+.  .++.++||||+||++|+|++|+.||......        .+...+... ....+.
T Consensus       160 ~----~~~~~t~~y~ape~~~~~--~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~--------~~~~~i~~~-~~~~~~  224 (321)
T d1tkia_         160 F----RLLFTAPEYYAPEVHQHD--VVSTATDMWSLGTLVYVLLSGINPFLAETNQ--------QIIENIMNA-EYTFDE  224 (321)
T ss_dssp             E----EEEESCGGGSCHHHHTTC--EECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHT-CCCCCH
T ss_pred             c----cccccccccccchhccCC--CCCchhhcccHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhC-CCCCCh
Confidence            2    223588999999998875  7899999999999999999999999764221        122222221 111111


Q ss_pred             cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          306 VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       306 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                         .....+...+.+++.+||+.||.+|||++|+++
T Consensus       225 ---~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         225 ---EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             ---HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---hhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               111123456788999999999999999999987

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.2e-47  Score=354.75  Aligned_cols=224  Identities=20%  Similarity=0.269  Sum_probs=187.0

Q ss_pred             hhhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEe
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEF  142 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  142 (372)
                      +.+.+.||+|+||.||+++...                      .+.+|+.+|++++||||+++++++.+.+..++|+||
T Consensus        43 y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~  122 (350)
T d1rdqe_          43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY  122 (350)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccc
Confidence            3456789999999999997642                      478899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccC
Q 036435          143 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTT  222 (372)
Q Consensus       143 ~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~  222 (372)
                      +.+|+|.+++.....      +++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+....
T Consensus       123 ~~~g~l~~~l~~~~~------l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         123 VAGGEMFSHLRRIGR------FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             CTTCBHHHHHHHHCC------CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             ccccchhhhHhhcCC------CCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence            999999999976543      899999999999999999999   79999999999999999999999999999987654


Q ss_pred             CCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 036435          223 KEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREFK  302 (372)
Q Consensus       223 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (372)
                      ..      ....||+.|||||++.+.  .++.++|||||||++|||+||+.||.....        ......+... ...
T Consensus       194 ~~------~~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~i~~~-~~~  256 (350)
T d1rdqe_         194 RT------WTLCGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYEKIVSG-KVR  256 (350)
T ss_dssp             CB------CCCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHC-CCC
T ss_pred             cc------ccccCccccCCHHHHcCC--CCCccccccchhHHHHHHHhCCCCCCCcCH--------HHHHHHHhcC-CCC
Confidence            33      234599999999999875  789999999999999999999999975321        1122222222 122


Q ss_pred             CCccCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 036435          303 LPGVVTRKENEIAKKMIIVGLWCIQARPSDRP-----PMNEVIE  341 (372)
Q Consensus       303 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~evl~  341 (372)
                      .|.       .+...+.+++.+||+.||.+|+     |++++++
T Consensus       257 ~p~-------~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         257 FPS-------HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CCT-------TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCc-------cCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            222       2345677899999999999994     8999986

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-47  Score=350.09  Aligned_cols=227  Identities=22%  Similarity=0.318  Sum_probs=185.1

Q ss_pred             hhhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHh-ccCCCceeeeEeEEecCCceeEEEE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASIS-RTSHVNVVTLLGFCLEGNNRALIYE  141 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~-~l~h~nIv~l~g~~~~~~~~~lV~e  141 (372)
                      +.+.+.||+|+||+||+|+...                      .+.+|..++. .++||||+++++++.+++..|+|||
T Consensus         4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE   83 (320)
T d1xjda_           4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME   83 (320)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence            3456889999999999997742                      3566777665 6899999999999999999999999


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      |+++|+|.+++.....      +++.++..++.||+.||+|||   +.+++||||||+|||+++++.+||+|||+++...
T Consensus        84 y~~~g~L~~~i~~~~~------~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~  154 (320)
T d1xjda_          84 YLNGGDLMYHIQSCHK------FDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM  154 (320)
T ss_dssp             CCTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             ecCCCcHHHHhhccCC------CCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhcc
Confidence            9999999999976543      889999999999999999999   7899999999999999999999999999998655


Q ss_pred             CCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcccc
Q 036435          222 TKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDREF  301 (372)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (372)
                      ......   ....||+.|+|||++.+.  .++.++||||+||++|||++|+.||.....        ..+...+... ..
T Consensus       155 ~~~~~~---~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~~~i~~~-~~  220 (320)
T d1xjda_         155 LGDAKT---NTFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--------EELFHSIRMD-NP  220 (320)
T ss_dssp             CTTCCB---CCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHC-CC
T ss_pred             cccccc---cccCCCCCcCCHHHHcCC--CCCchhhhhhhhHHHHHHHhCCCCCCCCCH--------HHHHHHHHcC-CC
Confidence            433222   334699999999999875  789999999999999999999999975321        1223333222 22


Q ss_pred             cCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 036435          302 KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMN-EVIE  341 (372)
Q Consensus       302 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-evl~  341 (372)
                      ..|..       +...+.+++.+||+.||.+|||+. ++++
T Consensus       221 ~~p~~-------~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         221 FYPRW-------LEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             CCCTT-------SCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             CCCcc-------CCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            23322       345677899999999999999995 6753

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-47  Score=343.15  Aligned_cols=245  Identities=22%  Similarity=0.348  Sum_probs=184.7

Q ss_pred             hhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCC
Q 036435           87 FKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN  145 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  145 (372)
                      ..+.||+|+||+||+|+...                     ++.+|++++++++||||+++++++.+++..|+||||+.+
T Consensus         6 ~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~   85 (298)
T d1gz8a_           6 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ   85 (298)
T ss_dssp             EEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred             eccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC
Confidence            45789999999999997632                     588999999999999999999999999999999999965


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEG  225 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  225 (372)
                       ++.+++......    .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.......
T Consensus        86 -~~~~~~~~~~~~----~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~  157 (298)
T d1gz8a_          86 -DLKKFMDASALT----GIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  157 (298)
T ss_dssp             -EHHHHHHHTTTT----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred             -chhhhhhhhccc----CCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence             555555443322    2999999999999999999999   79999999999999999999999999999987654332


Q ss_pred             eeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhc-------
Q 036435          226 IVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQD-------  298 (372)
Q Consensus       226 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------  298 (372)
                      .   .....||+.|+|||.+... ...+.++|+||+||++|+|++|+.||.......   .+.. ........       
T Consensus       158 ~---~~~~~gt~~y~apE~~~~~-~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~---~~~~-i~~~~~~~~~~~~~~  229 (298)
T d1gz8a_         158 T---YTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID---QLFR-IFRTLGTPDEVVWPG  229 (298)
T ss_dssp             C---TTCCBCCCTTCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHH-HHHHHCCCCTTTSTT
T ss_pred             c---ceeecccceeeehhhhccc-cCCCccccccccchhhhHHhhCCCCCCCCCHHH---HHHH-HHHhcCCCchhhccc
Confidence            2   2334689999999988764 356889999999999999999999997542110   0000 00000000       


Q ss_pred             ------ccccCCccCCcc----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hhcCc
Q 036435          299 ------REFKLPGVVTRK----ENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM--LQGST  347 (372)
Q Consensus       299 ------~~~~~~~~~~~~----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~--L~~~~  347 (372)
                            .....+......    .......+.+++.+||+.||++|||++|+++.  ++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~  290 (298)
T d1gz8a_         230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT  290 (298)
T ss_dssp             GGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             cccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence                  000001111111    11234567889999999999999999999974  55443

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-46  Score=336.71  Aligned_cols=220  Identities=25%  Similarity=0.361  Sum_probs=178.9

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-------------------------hHHHHHHHHhccC--CCceeeeEeEEecCCcee
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-------------------------DFVNEVASISRTS--HVNVVTLLGFCLEGNNRA  137 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-------------------------~~~~E~~~l~~l~--h~nIv~l~g~~~~~~~~~  137 (372)
                      +.+.+.||+|+||+||+|+...                         ++.+|+.++++++  ||||+++++++.+++..+
T Consensus         6 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~   85 (273)
T d1xwsa_           6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV   85 (273)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred             EEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEE
Confidence            3456789999999999997632                         3678999999996  999999999999999999


Q ss_pred             EEEEecCC-CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC-CCceEEeecC
Q 036435          138 LIYEFMPN-GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE-DFCPKISDFG  215 (372)
Q Consensus       138 lV~e~~~~-g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg  215 (372)
                      +||||+.+ +++.+++.....      +++.++..++.|+++||+|||   +.+|+||||||+|||++. ++.+||+|||
T Consensus        86 lv~e~~~~~~~l~~~~~~~~~------l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          86 LILERPEPVQDLFDFITERGA------LQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEECCSSEEEHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEEeccCcchHHHHHhccCC------CCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccc
Confidence            99999976 678888866432      899999999999999999999   799999999999999985 5799999999


Q ss_pred             CcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHh
Q 036435          216 LAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV  295 (372)
Q Consensus       216 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  295 (372)
                      +|+......     .....||+.|+|||++.+. ..++.++||||+||++|||++|+.||....              .+
T Consensus       157 ~a~~~~~~~-----~~~~~GT~~y~aPE~~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------------~i  216 (273)
T d1xwsa_         157 SGALLKDTV-----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------------EI  216 (273)
T ss_dssp             TCEECCSSC-----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------------HH
T ss_pred             cceeccccc-----ccccccCCCcCCHHHHcCC-CCCCcccccccceeeehhHhhCCCCCCCch--------------HH
Confidence            998654332     1334699999999999764 234678999999999999999999996421              11


Q ss_pred             hhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          296 EQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ... ....+..       ++.++.+++.+||+.||++|||++|+++
T Consensus       217 ~~~-~~~~~~~-------~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         217 IRG-QVFFRQR-------VSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             HHC-CCCCSSC-------CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhc-ccCCCCC-------CCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            111 1112221       2356778999999999999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=8.2e-46  Score=334.29  Aligned_cols=238  Identities=21%  Similarity=0.293  Sum_probs=180.0

Q ss_pred             hhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecCCC
Q 036435           87 FKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      ..++||+|+||+||+|+..+                    ++.+|+.+|++++||||+++++++.+++..++++||+.++
T Consensus         6 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~   85 (286)
T d1ob3a_           6 GLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQD   85 (286)
T ss_dssp             EEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEE
T ss_pred             eccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhh
Confidence            45789999999999997632                    6889999999999999999999999999999999999877


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCCCe
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKEGI  226 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  226 (372)
                      .+..+.....      .+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+|++|||++.........
T Consensus        86 ~~~~~~~~~~------~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~  156 (286)
T d1ob3a_          86 LKKLLDVCEG------GLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK  156 (286)
T ss_dssp             HHHHHHTSTT------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             hHHHHHhhcC------CcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCccc
Confidence            6666654433      2999999999999999999999   789999999999999999999999999999876543322


Q ss_pred             eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhh----------
Q 036435          227 VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVE----------  296 (372)
Q Consensus       227 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------  296 (372)
                         .....+++.|+|||.+.+. ..++.++||||+||++|||++|+.||.......   .+.+ ......          
T Consensus       157 ---~~~~~~~~~y~~pE~~~~~-~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~---~~~~-i~~~~~~~~~~~~~~~  228 (286)
T d1ob3a_         157 ---YTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMR-IFRILGTPNSKNWPNV  228 (286)
T ss_dssp             --------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHH-HHHHHCCCCTTTSTTG
T ss_pred             ---cceecccchhhhHHHHhCC-CCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH---HHHH-HHHhhCCCChhhccch
Confidence               1233578899999998764 367899999999999999999999997542211   0000 000000          


Q ss_pred             -hcccc------cCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          297 -QDREF------KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       297 -~~~~~------~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                       .....      ..+.............+.+++.+||+.||++|||++|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             00000      0000001111223456788999999999999999999984

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-45  Score=334.68  Aligned_cols=238  Identities=24%  Similarity=0.362  Sum_probs=178.3

Q ss_pred             hhhhhcCCCCceEEEEEEecc----------------------hHHHHHHHHhcc---CCCceeeeEeEEec-----CCc
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD----------------------DFVNEVASISRT---SHVNVVTLLGFCLE-----GNN  135 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~----------------------~~~~E~~~l~~l---~h~nIv~l~g~~~~-----~~~  135 (372)
                      ++.++||+|+||+||+|+...                      .+.+|+.+++.+   +||||++++++|..     ...
T Consensus        10 ~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~   89 (305)
T d1blxa_          10 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK   89 (305)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEE
T ss_pred             EEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCce
Confidence            446789999999999997631                      477898888777   79999999999863     346


Q ss_pred             eeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecC
Q 036435          136 RALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFG  215 (372)
Q Consensus       136 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  215 (372)
                      .++++||++++++.........     .+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||
T Consensus        90 ~~~~~e~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg  161 (305)
T d1blxa_          90 LTLVFEHVDQDLTTYLDKVPEP-----GVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFG  161 (305)
T ss_dssp             EEEEEECCSCBHHHHHHHSCTT-----CSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             EEEEEEeccCCchhhhhhccCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchh
Confidence            7999999988777655443332     2899999999999999999999   7999999999999999999999999999


Q ss_pred             CcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHh
Q 036435          216 LAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV  295 (372)
Q Consensus       216 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  295 (372)
                      +++.......    .....||+.|+|||++.+.  .++.++||||+||++|||++|+.||.......    ....+....
T Consensus       162 ~~~~~~~~~~----~~~~~gT~~Y~APE~~~~~--~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~----~~~~i~~~~  231 (305)
T d1blxa_         162 LARIYSFQMA----LTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD----QLGKILDVI  231 (305)
T ss_dssp             SCCCCCGGGG----GCCCCCCCTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHH
T ss_pred             hhhhhccccc----CCCcccChhhcCcchhcCC--CCChhehhhchHHHHHHHHHCCCCCCCCCHHH----HHHHHHHhh
Confidence            9986543321    2345699999999999875  88999999999999999999999997542211    000011110


Q ss_pred             hhccccc---------------CCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          296 EQDREFK---------------LPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       296 ~~~~~~~---------------~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      .......               .+.............+.+++.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0000000               000001111223456778999999999999999999986

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-45  Score=336.64  Aligned_cols=242  Identities=19%  Similarity=0.269  Sum_probs=179.6

Q ss_pred             hhhhhcCCCCceEEEEEEecc--------------------hHHHHHHHHhccCCCceeeeEeEEecCC----ceeEEEE
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD--------------------DFVNEVASISRTSHVNVVTLLGFCLEGN----NRALIYE  141 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~--------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~----~~~lV~e  141 (372)
                      .+.++||+|+||+||+|+...                    ++.+|+.+|++++||||+++++++....    ..+++++
T Consensus        11 ~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~   90 (345)
T d1pmea_          11 TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVT   90 (345)
T ss_dssp             EEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEE
T ss_pred             EEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEE
Confidence            345789999999999997632                    5788999999999999999999997653    2355566


Q ss_pred             ecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCccccc
Q 036435          142 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCT  221 (372)
Q Consensus       142 ~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~  221 (372)
                      |+.+|+|.+++....       +++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||++....
T Consensus        91 ~~~~g~L~~~l~~~~-------l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~  160 (345)
T d1pmea_          91 HLMGADLYKLLKTQH-------LSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  160 (345)
T ss_dssp             ECCCEEHHHHHHHCC-------CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             eecCCchhhhhhcCC-------CCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence            777999999997643       899999999999999999999   7999999999999999999999999999998765


Q ss_pred             CCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhh----
Q 036435          222 TKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQ----  297 (372)
Q Consensus       222 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----  297 (372)
                      .............||+.|+|||.+... ..++.++||||+||++|||++|+.||........    ..........    
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~----~~~~~~~~~~~~~~  235 (345)
T d1pmea_         161 PDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ----LNHILGILGSPSQE  235 (345)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCGGGTTTB-CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCSCCHH
T ss_pred             CCCccceeeccccccceechHHHhhcC-CCCCchhhhhccCceehHHhhCCCCCCCCCHHHH----HHHHhhhccCCChh
Confidence            544333333445689999999998654 3678999999999999999999999975432110    0000000000    


Q ss_pred             -----------cccccCCccCCcc----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 036435          298 -----------DREFKLPGVVTRK----ENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM  342 (372)
Q Consensus       298 -----------~~~~~~~~~~~~~----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~  342 (372)
                                 ......+......    ......++.+++.+||+.||.+|||++|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                       0000011111110    11223467889999999999999999999974

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-44  Score=333.78  Aligned_cols=244  Identities=21%  Similarity=0.275  Sum_probs=177.4

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCC------ceeE
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGN------NRAL  138 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~------~~~l  138 (372)
                      .+.++||+|+||+||+|+...                     .+.+|+.+|++++|||||+++++|...+      ..++
T Consensus        21 ~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l  100 (346)
T d1cm8a_          21 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYL  100 (346)
T ss_dssp             EEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEE
T ss_pred             EEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEE
Confidence            345789999999999997632                     5788999999999999999999998654      5699


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          139 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       139 V~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      ||||+ +++|........       +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+|++|||+|+
T Consensus       101 v~e~~-~~~l~~~~~~~~-------l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~  169 (346)
T d1cm8a_         101 VMPFM-GTDLGKLMKHEK-------LGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR  169 (346)
T ss_dssp             EEECC-SEEHHHHHHHCC-------CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEecc-cccHHHHHHhcc-------ccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhccccccccccccccee
Confidence            99999 668888776543       999999999999999999999   7999999999999999999999999999998


Q ss_pred             cccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccch-------HHHH
Q 036435          219 LCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYF-------PHWI  291 (372)
Q Consensus       219 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~-------~~~~  291 (372)
                      ......      ....||+.|+|||.+.+. ..++.++||||+||++|||++|+.||............       +...
T Consensus       170 ~~~~~~------~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  242 (346)
T d1cm8a_         170 QADSEM------TGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF  242 (346)
T ss_dssp             ECCSSC------CSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             ccCCcc------ccccccccccCHHHHcCC-CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence            765432      334589999999998764 36789999999999999999999999764221100000       0000


Q ss_pred             HHH---------hhhcccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hhcCcc
Q 036435          292 YRH---------VEQDREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM--LQGSTE  348 (372)
Q Consensus       292 ~~~---------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~--L~~~~~  348 (372)
                      ...         ........ ..............+.+++.+||+.||++|||++|+++.  ++++.+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~  309 (346)
T d1cm8a_         243 VQRLQSDEAKNYMKGLPELE-KKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  309 (346)
T ss_dssp             HHTCSCHHHHHHHHHSCCCC-CCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             HhhhcchhhhhhhccCCccc-ccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence            000         00000000 000011111233567789999999999999999999974  665543

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.6e-44  Score=325.15  Aligned_cols=246  Identities=15%  Similarity=0.225  Sum_probs=191.5

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-----------------hHHHHHHHHhccCC-CceeeeEeEEecCCceeEEEEecCCC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-----------------DFVNEVASISRTSH-VNVVTLLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-----------------~~~~E~~~l~~l~h-~nIv~l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      +.+.+.||+|+||+||+|++..                 ++.+|++.++.++| +|++.+++++.++...++||||+ +|
T Consensus         7 Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~   85 (293)
T d1csna_           7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GP   85 (293)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CC
Confidence            3456789999999999997642                 58899999999975 89999999999999999999999 78


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECC-----CCceEEeecCCccccc
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDE-----DFCPKISDFGLAKLCT  221 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfgla~~~~  221 (372)
                      +|.+++.....     .+++.++..++.|++.||+|||   +.+|+||||||+|||++.     ++.+||+|||+|+...
T Consensus        86 ~l~~~~~~~~~-----~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          86 SLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             BHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             CHHHHHHhhcc-----chhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            99999876542     2899999999999999999999   899999999999999974     5789999999998765


Q ss_pred             CCCCee----eeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhh
Q 036435          222 TKEGIV----SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQ  297 (372)
Q Consensus       222 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (372)
                      ......    .......||+.|||||.+.+.  .++.++|||||||++|||++|+.||..........     ....+..
T Consensus       158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~--~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~-----~~~~i~~  230 (293)
T d1csna_         158 DPVTKQHIPYREKKNLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ-----KYERIGE  230 (293)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH-----HHHHHHH
T ss_pred             cCccccceeecccCceEEchhhcCHHHhcCC--CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH-----HHHHHHh
Confidence            432221    112345699999999999875  78999999999999999999999998654433111     1111111


Q ss_pred             ccc-ccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCcccC
Q 036435          298 DRE-FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGSTEAL  350 (372)
Q Consensus       298 ~~~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~  350 (372)
                      ... ...+..    ...+++++.+++..|++.+|++||+++.+.+.|+++....
T Consensus       231 ~~~~~~~~~l----~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~  280 (293)
T d1csna_         231 KKQSTPLREL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  280 (293)
T ss_dssp             HHHHSCHHHH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             ccCCCChHHh----cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence            110 000000    1123456788889999999999999999988887765443

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-44  Score=335.45  Aligned_cols=252  Identities=24%  Similarity=0.265  Sum_probs=180.0

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------hHHHHHHHHhccCCCceeeeEeEEecC------CceeEEEEecC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------DFVNEVASISRTSHVNVVTLLGFCLEG------NNRALIYEFMP  144 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------~~~~E~~~l~~l~h~nIv~l~g~~~~~------~~~~lV~e~~~  144 (372)
                      +..++||+|+||+||+|+..+               ...+|+.+|++++||||++++++|...      .+.++||||++
T Consensus        23 ~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~  102 (350)
T d1q5ka_          23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP  102 (350)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCS
T ss_pred             EeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccC
Confidence            345679999999999998743               367899999999999999999998643      24789999997


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC-ceEEeecCCcccccCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDF-CPKISDFGLAKLCTTK  223 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgla~~~~~~  223 (372)
                      ++.+.........   ...+++.++..++.|++.||+|||   +.+|+||||||+|||++.++ .+||+|||++......
T Consensus       103 ~~~~~~l~~~~~~---~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~  176 (350)
T d1q5ka_         103 ETVYRVARHYSRA---KQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG  176 (350)
T ss_dssp             EEHHHHHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT
T ss_pred             CccHHHHHhhhhc---cCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhccCC
Confidence            6543333221111   123999999999999999999999   89999999999999999765 8999999999876544


Q ss_pred             CCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccc--------hHHHHHHHh
Q 036435          224 EGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVY--------FPHWIYRHV  295 (372)
Q Consensus       224 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~--------~~~~~~~~~  295 (372)
                      ...    ....||+.|+|||.+.+. ..++.++||||+||++|||++|+.||...........        ...+.....
T Consensus       177 ~~~----~~~~gt~~y~aPE~~~~~-~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~  251 (350)
T d1q5ka_         177 EPN----VSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN  251 (350)
T ss_dssp             SCC----CSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             ccc----ccccccccccChHHhhcc-cCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence            322    234588999999988754 3789999999999999999999999975432110000        000000000


Q ss_pred             hhcccccCCccCC-----cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hhcCcc
Q 036435          296 EQDREFKLPGVVT-----RKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEM--LQGSTE  348 (372)
Q Consensus       296 ~~~~~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~--L~~~~~  348 (372)
                      ........+....     .........+.+++.+||+.||++|||++|+++.  ++++..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence            0001111111110     0111234567889999999999999999999963  555543

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-44  Score=327.87  Aligned_cols=244  Identities=18%  Similarity=0.224  Sum_probs=182.2

Q ss_pred             hhhhhhcCCCCceEEEEEEecc-----------------hHHHHHHHHhccCCCceee-eEeEEecCCceeEEEEecCCC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD-----------------DFVNEVASISRTSHVNVVT-LLGFCLEGNNRALIYEFMPNG  146 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~-----------------~~~~E~~~l~~l~h~nIv~-l~g~~~~~~~~~lV~e~~~~g  146 (372)
                      +.+.+.||+|+||+||+|++..                 ++.+|++++++++|+|++. +.++..+++..++||||+ +|
T Consensus         9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~   87 (299)
T d1ckia_           9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GP   87 (299)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred             EEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CC
Confidence            3456889999999999997642                 6889999999998776555 455567778889999999 55


Q ss_pred             ChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEEC---CCCceEEeecCCcccccCC
Q 036435          147 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLD---EDFCPKISDFGLAKLCTTK  223 (372)
Q Consensus       147 ~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgla~~~~~~  223 (372)
                      +|.+.+.....     .+++..++.++.|++.||+|||   +.+|+||||||+|||++   .+..+||+|||+|+.....
T Consensus        88 ~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          88 SLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             BHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             chhhhhhhccC-----CCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            77776655432     2899999999999999999999   79999999999999986   4567999999999977544


Q ss_pred             CCee----eeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcc
Q 036435          224 EGIV----SSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDR  299 (372)
Q Consensus       224 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  299 (372)
                      ....    .......||+.|||||.+.+.  .++.++|||||||++|||++|+.||.....................   
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~---  234 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS---  234 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTB--CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH---
T ss_pred             ccccceeccccCCcCCCccccCHHHHhCC--CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC---
Confidence            3221    122345699999999999875  7899999999999999999999999865443322111111111110   


Q ss_pred             cccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcCc
Q 036435          300 EFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIEMLQGST  347 (372)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~~L~~~~  347 (372)
                       ...+    .....++.++.+++..||+.||++||+++++.+.|+...
T Consensus       235 -~~~~----~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~  277 (299)
T d1ckia_         235 -TPIE----VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  277 (299)
T ss_dssp             -SCHH----HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred             -CChh----HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence             0000    001123456788999999999999999999988887654

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-44  Score=331.21  Aligned_cols=234  Identities=24%  Similarity=0.276  Sum_probs=185.2

Q ss_pred             hhhhhhcCCCCceEEEEEEec--------------------------chHHHHHHHHhccCC-CceeeeEeEEecCCcee
Q 036435           85 NSFKDKLGQGGFGGVYKGRLL--------------------------DDFVNEVASISRTSH-VNVVTLLGFCLEGNNRA  137 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~--------------------------~~~~~E~~~l~~l~h-~nIv~l~g~~~~~~~~~  137 (372)
                      +++.+.||+|+||+||+|+..                          +.+.+|++++++++| |||+++++++.+....+
T Consensus        26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~  105 (322)
T d1vzoa_          26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH  105 (322)
T ss_dssp             EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred             eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence            455788999999999998541                          147789999999976 89999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCc
Q 036435          138 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLA  217 (372)
Q Consensus       138 lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla  217 (372)
                      +|+||+.+|+|.+++.....      ++...+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       106 ~v~e~~~~~~L~~~i~~~~~------~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a  176 (322)
T d1vzoa_         106 LILDYINGGELFTHLSQRER------FTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLS  176 (322)
T ss_dssp             EEECCCCSCBHHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eeeecccccHHHHHHHhccc------ccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccch
Confidence            99999999999999977653      778899999999999999999   799999999999999999999999999999


Q ss_pred             ccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhh
Q 036435          218 KLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQ  297 (372)
Q Consensus       218 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  297 (372)
                      +.........  .....|++.|++||.+.+....++.++|||||||++|||++|+.||.........    ..+..... 
T Consensus       177 ~~~~~~~~~~--~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~----~~i~~~~~-  249 (322)
T d1vzoa_         177 KEFVADETER--AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ----AEISRRIL-  249 (322)
T ss_dssp             EECCGGGGGG--GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH----HHHHHHHH-
T ss_pred             hhhccccccc--ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHHhcc-
Confidence            8664433222  2344688999999999765345788999999999999999999999876443321    11111111 


Q ss_pred             cccccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 036435          298 DREFKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPP-----MNEVIE  341 (372)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~evl~  341 (372)
                      ......+.       .....+.+++.+||++||.+|||     ++|+++
T Consensus       250 ~~~~~~~~-------~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         250 KSEPPYPQ-------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             HCCCCCCT-------TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             cCCCCCcc-------cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            11112221       23467788999999999999994     788886

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-44  Score=326.65  Aligned_cols=242  Identities=20%  Similarity=0.278  Sum_probs=177.6

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEec--------CCce
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLE--------GNNR  136 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~--------~~~~  136 (372)
                      ++.++||+|+||+||+|+..+                     ++.+|+.+|++++||||+++++++..        ++..
T Consensus        13 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~   92 (318)
T d3blha1          13 EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSI   92 (318)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CE
T ss_pred             EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceE
Confidence            446789999999999997642                     57899999999999999999999865        3468


Q ss_pred             eEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCC
Q 036435          137 ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGL  216 (372)
Q Consensus       137 ~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl  216 (372)
                      ++||||+.++.+..+.....      .++...+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        93 ~iv~e~~~~~~~~~~~~~~~------~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          93 YLVFDFCEHDLAGLLSNVLV------KFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             EEEEECCCEEHHHHHTCTTC------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEeccCCCccchhhhccc------ccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeecce
Confidence            99999998876665543332      2889999999999999999999   79999999999999999999999999999


Q ss_pred             cccccCCCCe-eeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHh
Q 036435          217 AKLCTTKEGI-VSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHV  295 (372)
Q Consensus       217 a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  295 (372)
                      +......... ........||+.|+|||.+.+. ..++.++||||+||++|||++|+.||......    ..........
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~----~~~~~i~~~~  238 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ----HQLALISQLC  238 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHHH
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCC-CCCCcHHHcccCCceeeeHhhCCCCCCCCCHH----HHHHHHHHhc
Confidence            9866533222 1122334689999999998764 36789999999999999999999999753211    0001111111


Q ss_pred             hhcc--------------cccCCccCCcchHH------HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          296 EQDR--------------EFKLPGVVTRKENE------IAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       296 ~~~~--------------~~~~~~~~~~~~~~------~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                      ....              .............+      ....+.+++.+||+.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            0000              00000000111111      1345678999999999999999999986

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-44  Score=321.65  Aligned_cols=240  Identities=21%  Similarity=0.306  Sum_probs=184.6

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecCCceeEEEEecC
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEGNNRALIYEFMP  144 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  144 (372)
                      +..++||+|+||+||+|++..                     ++.+|+.++++++||||+++++++.+....++|+|++.
T Consensus         5 ~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~   84 (292)
T d1unla_           5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD   84 (292)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCS
T ss_pred             EeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecc
Confidence            345789999999999997632                     57899999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcccccCCC
Q 036435          145 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAKLCTTKE  224 (372)
Q Consensus       145 ~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  224 (372)
                      +++|..++.....      +++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||.++......
T Consensus        85 ~~~l~~~~~~~~~------~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          85 QDLKKYFDSCNGD------LDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             EEHHHHHHHTTTC------CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             ccccccccccccc------cchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            9999888765543      889999999999999999999   7999999999999999999999999999998765443


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhcc-----
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQDR-----  299 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----  299 (372)
                      ...   ....++..|+|||.+.+. ..++.++||||+||++|||++|+.||........   ....+........     
T Consensus       156 ~~~---~~~~~~~~~~~pe~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~  228 (292)
T d1unla_         156 RCY---SAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD---QLKRIFRLLGTPTEEQWP  228 (292)
T ss_dssp             SCC---CSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH---HHHHHHHHHCCCCTTTCT
T ss_pred             ccc---eeeccccchhhhhHhccC-CCCCchhhccccchHHHHHhhCCCCCCCCCCHHH---HHHHHHhhcCCCChhhhh
Confidence            222   223467789999998764 3568999999999999999999999865432211   0000111000000     


Q ss_pred             ---------c---ccCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          300 ---------E---FKLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       300 ---------~---~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                               .   .................+.+++.+||+.||.+|||++|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                     0   00000111112223456778999999999999999999986

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.7e-43  Score=323.82  Aligned_cols=240  Identities=20%  Similarity=0.321  Sum_probs=180.2

Q ss_pred             hhhhhhcCCCCceEEEEEEecc----------------hHHHHHHHHhccC-CCceeeeEeEEec--CCceeEEEEecCC
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD----------------DFVNEVASISRTS-HVNVVTLLGFCLE--GNNRALIYEFMPN  145 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~----------------~~~~E~~~l~~l~-h~nIv~l~g~~~~--~~~~~lV~e~~~~  145 (372)
                      +.+.++||+|+||+||+|+...                ++.+|+.+|++++ ||||+++++++..  ....++||||+++
T Consensus        37 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~  116 (328)
T d3bqca1          37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN  116 (328)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCS
T ss_pred             eEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCC
Confidence            4556889999999999997642                6889999999995 9999999999974  4568999999999


Q ss_pred             CChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC-ceEEeecCCcccccCCC
Q 036435          146 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDF-CPKISDFGLAKLCTTKE  224 (372)
Q Consensus       146 g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgla~~~~~~~  224 (372)
                      ++|..+..         .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++ .+||+|||+|+......
T Consensus       117 ~~L~~~~~---------~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         117 TDFKQLYQ---------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             CBGGGTTT---------SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             CcHHHHhc---------CCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            99977642         2899999999999999999999   89999999999999998654 69999999998765443


Q ss_pred             CeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccc-hHH-----HHHHHhhh-
Q 036435          225 GIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVY-FPH-----WIYRHVEQ-  297 (372)
Q Consensus       225 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~-~~~-----~~~~~~~~-  297 (372)
                      ..    ....+|+.|+|||.+.+. ..++.++|+||+||++||+++|+.||........... +..     ........ 
T Consensus       185 ~~----~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  259 (328)
T d3bqca1         185 EY----NVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  259 (328)
T ss_dssp             CC----CSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             cc----cccccCccccCcccccCC-CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence            22    334588999999998764 3578999999999999999999999976543211000 000     00000000 


Q ss_pred             --cc--ccc--C--------Cc-cCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          298 --DR--EFK--L--------PG-VVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       298 --~~--~~~--~--------~~-~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                        ..  ...  .        .. ........+..++.+++.+||+.||++|||++|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              00  000  0        00 001111223456788999999999999999999986

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-43  Score=323.16  Aligned_cols=242  Identities=21%  Similarity=0.242  Sum_probs=178.4

Q ss_pred             hhhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEecC-----CceeE
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLEG-----NNRAL  138 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~~-----~~~~l  138 (372)
                      +...+.||+|+||+||+|+...                     ++.+|+.+|++++||||+++++++...     ...++
T Consensus        20 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~   99 (348)
T d2gfsa1          20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY   99 (348)
T ss_dssp             EEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCE
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEE
Confidence            3445789999999999997632                     578999999999999999999998643     34577


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          139 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       139 V~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      +++|+.+|+|.+++....       +++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+|++|||++.
T Consensus       100 i~~~~~gg~L~~~~~~~~-------l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1         100 LVTHLMGADLNNIVKCQK-------LTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             EEEECCSEEHHHHHTTCC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             EEEeecCCchhhhccccc-------ccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhc
Confidence            788888999999996432       999999999999999999999   7999999999999999999999999999997


Q ss_pred             cccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccchHHHHHHHhhhc
Q 036435          219 LCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVYFPHWIYRHVEQD  298 (372)
Q Consensus       219 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  298 (372)
                      ......      ....||+.|+|||.+.+. ..++.++||||+||++|+|++|+.||.......    ....+.......
T Consensus       170 ~~~~~~------~~~~g~~~y~apE~~~~~-~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~----~~~~i~~~~~~~  238 (348)
T d2gfsa1         170 HTDDEM------TGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID----QLKLILRLVGTP  238 (348)
T ss_dssp             CCTGGG------SSSCHHHHTSCHHHHTTC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCCC
T ss_pred             ccCccc------ccccccccccCchhhcCC-ccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH----HHHHHHHhcCCC
Confidence            654322      334588999999987764 356899999999999999999999997542211    000000000000


Q ss_pred             ---------------ccccCCccCCcc----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhhcCc
Q 036435          299 ---------------REFKLPGVVTRK----ENEIAKKMIIVGLWCIQARPSDRPPMNEVIE--MLQGST  347 (372)
Q Consensus       299 ---------------~~~~~~~~~~~~----~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~--~L~~~~  347 (372)
                                     .....+......    .......+.+++.+||+.||.+|||++|+++  .+++..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~  308 (348)
T d2gfsa1         239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  308 (348)
T ss_dssp             CHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             ChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence                           000000000000    0122456788999999999999999999997  355443

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-42  Score=317.74  Aligned_cols=238  Identities=23%  Similarity=0.239  Sum_probs=170.2

Q ss_pred             hhhhhcCCCCceEEEEEEecc---------------------hHHHHHHHHhccCCCceeeeEeEEec------CCceeE
Q 036435           86 SFKDKLGQGGFGGVYKGRLLD---------------------DFVNEVASISRTSHVNVVTLLGFCLE------GNNRAL  138 (372)
Q Consensus        86 ~~~~~lg~G~~g~V~~~~~~~---------------------~~~~E~~~l~~l~h~nIv~l~g~~~~------~~~~~l  138 (372)
                      ++.++||+|+||+||+|.+..                     ++.+|+.++++++||||+++++++..      ....|+
T Consensus        20 ~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~i   99 (355)
T d2b1pa1          20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL   99 (355)
T ss_dssp             EEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEE
T ss_pred             EEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEE
Confidence            345789999999999997642                     47899999999999999999999964      367899


Q ss_pred             EEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          139 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       139 V~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      ||||+.+ ++.+.+..        .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+|++|||+++
T Consensus       100 v~Ey~~~-~l~~~~~~--------~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1         100 VMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEECCSE-EHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             EEeccch-HHHHhhhc--------CCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhh
Confidence            9999966 45455532        2899999999999999999999   7999999999999999999999999999988


Q ss_pred             cccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccc--------hHH-
Q 036435          219 LCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVY--------FPH-  289 (372)
Q Consensus       219 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~--------~~~-  289 (372)
                      .......    .....+|+.|+|||++.+.  .++.++||||+||++|||++|+.||...........        .+. 
T Consensus       168 ~~~~~~~----~~~~~~t~~y~aPE~l~~~--~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~  241 (355)
T d2b1pa1         168 TAGTSFM----MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  241 (355)
T ss_dssp             -----------------CCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             ccccccc----cccccccccccChhhhcCC--CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHH
Confidence            6544322    2334588999999999875  789999999999999999999999975421100000        000 


Q ss_pred             ------HHHHHhhhcccc-----------cCCccCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 036435          290 ------WIYRHVEQDREF-----------KLPGVVTRKENEIAKKMIIVGLWCIQARPSDRPPMNEVIE  341 (372)
Q Consensus       290 ------~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~evl~  341 (372)
                            ............           ................+.+++.+||+.||++|||++|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                  000000100000           0001111223445678899999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.7e-37  Score=284.00  Aligned_cols=244  Identities=20%  Similarity=0.220  Sum_probs=170.9

Q ss_pred             hhhhhhcCCCCceEEEEEEecc------------------hHHHHHHHHhccC-----------CCceeeeEeEEecC--
Q 036435           85 NSFKDKLGQGGFGGVYKGRLLD------------------DFVNEVASISRTS-----------HVNVVTLLGFCLEG--  133 (372)
Q Consensus        85 ~~~~~~lg~G~~g~V~~~~~~~------------------~~~~E~~~l~~l~-----------h~nIv~l~g~~~~~--  133 (372)
                      +.+.++||+|+||+||+|+...                  .+.+|+.++++++           |+||+++++++...  
T Consensus        15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~   94 (362)
T d1q8ya_          15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGP   94 (362)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEET
T ss_pred             EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccc
Confidence            4557889999999999997632                  4678999988875           57899999988653  


Q ss_pred             CceeEEEEecCCCChh-hhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCC-----
Q 036435          134 NNRALIYEFMPNGSLE-KFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDF-----  207 (372)
Q Consensus       134 ~~~~lV~e~~~~g~L~-~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-----  207 (372)
                      ...+++++++..+... ........    ..+++..+..++.|++.||+|||+  ..+|+||||||+|||++.++     
T Consensus        95 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          95 NGVHVVMVFEVLGENLLALIKKYEH----RGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             TEEEEEEEECCCCEEHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             cceeeeeeecccccccccccccccc----cCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCccccc
Confidence            4566777776555433 33332222    238899999999999999999994  48999999999999997654     


Q ss_pred             -ceEEeecCCcccccCCCCeeeeecccccccccccccccccccCCCCccccchhHHHHHHHHhcCCCCCCCCCCCCCccc
Q 036435          208 -CPKISDFGLAKLCTTKEGIVSSLLGARGIIGYIAPEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDSSSEVY  286 (372)
Q Consensus       208 -~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~  286 (372)
                       .++++|||.+.......      ....||+.|+|||.+.+.  .++.++|+||+||++++|++|+.||...........
T Consensus       169 ~~~kl~dfg~s~~~~~~~------~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~  240 (362)
T d1q8ya_         169 IQIKIADLGNACWYDEHY------TNSIQTREYRSPEVLLGA--PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  240 (362)
T ss_dssp             EEEEECCCTTCEETTBCC------CSCCSCGGGCCHHHHHTC--CCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             ceeeEeeccccccccccc------ccccccccccChhhcccc--CCCccccccchHHHHHHHHHCCCCCCCCccccccch
Confidence             39999999998654332      334589999999998864  789999999999999999999999975433211100


Q ss_pred             ---hHHHH----------HHHhhh-------ccc-ccCCcc-----------CCcchHHHHHHHHHHHHHcccCCCCCCC
Q 036435          287 ---FPHWI----------YRHVEQ-------DRE-FKLPGV-----------VTRKENEIAKKMIIVGLWCIQARPSDRP  334 (372)
Q Consensus       287 ---~~~~~----------~~~~~~-------~~~-~~~~~~-----------~~~~~~~~~~~l~~l~~~cl~~~p~~RP  334 (372)
                         +...+          ......       ... ......           ...........+.+++.+||+.||.+||
T Consensus       241 ~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp  320 (362)
T d1q8ya_         241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  320 (362)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             hHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCc
Confidence               00000          000000       000 000000           1112345677899999999999999999


Q ss_pred             CHHHHHHH
Q 036435          335 PMNEVIEM  342 (372)
Q Consensus       335 s~~evl~~  342 (372)
                      |++|+++.
T Consensus       321 ta~e~L~H  328 (362)
T d1q8ya_         321 DAGGLVNH  328 (362)
T ss_dssp             CHHHHHTC
T ss_pred             CHHHHhcC
Confidence            99999873

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.85  E-value=7.9e-23  Score=171.77  Aligned_cols=144  Identities=19%  Similarity=0.186  Sum_probs=106.5

Q ss_pred             hhhhcCCCCceEEEEEEecc------------------------------------hHHHHHHHHhccCCCceeeeEeEE
Q 036435           87 FKDKLGQGGFGGVYKGRLLD------------------------------------DFVNEVASISRTSHVNVVTLLGFC  130 (372)
Q Consensus        87 ~~~~lg~G~~g~V~~~~~~~------------------------------------~~~~E~~~l~~l~h~nIv~l~g~~  130 (372)
                      +.++||+|+||+||+|+..+                                    ...+|...+.++.|.|++..+++.
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence            35789999999999997532                                    234688889999999999988763


Q ss_pred             ecCCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCceEECCCCceE
Q 036435          131 LEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHHGCSTKILHFDIKPHNILLDEDFCPK  210 (372)
Q Consensus       131 ~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  210 (372)
                          ..+++|||++++.+.+             ++......++.|++++|+|||   ..+|+||||||+|||++++ .++
T Consensus        84 ----~~~lvme~~~~~~~~~-------------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~  142 (191)
T d1zara2          84 ----GNAVLMELIDAKELYR-------------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIW  142 (191)
T ss_dssp             ----TTEEEEECCCCEEGGG-------------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEE
T ss_pred             ----CCEEEEEeeccccccc-------------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEE
Confidence                2379999998765532             333445678999999999999   7999999999999999965 589


Q ss_pred             EeecCCcccccCCCCeeeeeccccccccccc------ccccccccCCCCccccchhHHHHH
Q 036435          211 ISDFGLAKLCTTKEGIVSSLLGARGIIGYIA------PEVFSRNFGEVSHKSDVYSFGMMI  265 (372)
Q Consensus       211 l~Dfgla~~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~~~DvwslG~il  265 (372)
                      |+|||+|.........           .|..      .+.+.   ..++.++|+||..--+
T Consensus       143 liDFG~a~~~~~~~~~-----------~~l~rd~~~~~~~f~---r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         143 IIDFPQSVEVGEEGWR-----------EILERDVRNIITYFS---RTYRTEKDINSAIDRI  189 (191)
T ss_dssp             ECCCTTCEETTSTTHH-----------HHHHHHHHHHHHHHH---HHHCCCCCHHHHHHHH
T ss_pred             EEECCCcccCCCCCcH-----------HHHHHHHHHHHHHHc---CCCCCcccHHHHHHHH
Confidence            9999999765432211           0111      11222   2577899999975433

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.21  E-value=3.5e-06  Score=71.99  Aligned_cols=101  Identities=15%  Similarity=0.076  Sum_probs=70.3

Q ss_pred             hHHHHHHHHhccC-CCceeeeEeEEecCCceeEEEEecCCCChhhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 036435          107 DFVNEVASISRTS-HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHH  185 (372)
Q Consensus       107 ~~~~E~~~l~~l~-h~nIv~l~g~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~  185 (372)
                      .+.+|...+..+. +--+.+++.+..+++..++||++++|.++.+......        .   ...++.++++.++.||+
T Consensus        55 ~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~~--------~---~~~~~~~l~~~l~~lH~  123 (263)
T d1j7la_          55 DVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDEQ--------S---PEKIIELYAECIRLFHS  123 (263)
T ss_dssp             CHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTCS--------C---HHHHHHHHHHHHHHHHT
T ss_pred             hHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccccc--------c---HHHHHHHHHHHHHHHhc
Confidence            4788999988774 4346778888888888999999999988765432111        1   12234444455555553


Q ss_pred             C--------------------------------------------------------CCCCeeecCCCCCceEECCCCce
Q 036435          186 G--------------------------------------------------------CSTKILHFDIKPHNILLDEDFCP  209 (372)
Q Consensus       186 ~--------------------------------------------------------~~~~ivH~dlk~~Nill~~~~~~  209 (372)
                      .                                                        ....++|+|+.|.||++++++..
T Consensus       124 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~  203 (263)
T d1j7la_         124 IDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVS  203 (263)
T ss_dssp             SCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEE
T ss_pred             cCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceE
Confidence            1                                                        01248999999999999987667


Q ss_pred             EEeecCCcc
Q 036435          210 KISDFGLAK  218 (372)
Q Consensus       210 kl~Dfgla~  218 (372)
                      -|+||+.+.
T Consensus       204 ~lIDwe~a~  212 (263)
T d1j7la_         204 GFIDLGRSG  212 (263)
T ss_dssp             EECCCTTCE
T ss_pred             EEeechhcc
Confidence            799998765

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.76  E-value=3.9e-05  Score=64.81  Aligned_cols=43  Identities=21%  Similarity=0.276  Sum_probs=33.9

Q ss_pred             hHHHHHHHHhccCC--CceeeeEeEEecCCceeEEEEecCCCChh
Q 036435          107 DFVNEVASISRTSH--VNVVTLLGFCLEGNNRALIYEFMPNGSLE  149 (372)
Q Consensus       107 ~~~~E~~~l~~l~h--~nIv~l~g~~~~~~~~~lV~e~~~~g~L~  149 (372)
                      .+.+|...++.+..  -.+.+++++..+++..++||++++|.++.
T Consensus        50 ~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~   94 (255)
T d1nd4a_          50 ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL   94 (255)
T ss_dssp             CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence            57889999988743  33567788888888999999999886653

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.20  E-value=0.00068  Score=61.04  Aligned_cols=31  Identities=23%  Similarity=0.285  Sum_probs=26.3

Q ss_pred             CCCeeecCCCCCceEECCCCceEEeecCCccc
Q 036435          188 STKILHFDIKPHNILLDEDFCPKISDFGLAKL  219 (372)
Q Consensus       188 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  219 (372)
                      ...++|+|+.+.|||++++. ++|+||..+..
T Consensus       222 ~~~LiHGDl~~gNIlv~~~~-~~vID~E~a~~  252 (392)
T d2pula1         222 AETLIHGDLHTGSIFASEHE-TKVIDPEFAFY  252 (392)
T ss_dssp             CCEEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred             CcceeccCCcCCceeEcCCc-eEEechhhccc
Confidence            34699999999999998764 89999988764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.19  E-value=0.0048  Score=55.28  Aligned_cols=38  Identities=21%  Similarity=0.323  Sum_probs=27.2

Q ss_pred             hHHHHHHHHhccCCCce-eeeEeEEecCCceeEEEEecCCCCh
Q 036435          107 DFVNEVASISRTSHVNV-VTLLGFCLEGNNRALIYEFMPNGSL  148 (372)
Q Consensus       107 ~~~~E~~~l~~l~h~nI-v~l~g~~~~~~~~~lV~e~~~~g~L  148 (372)
                      +..+|..+++.+.-.++ .++++++.+    .+|+||++|.+|
T Consensus        90 dr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l  128 (395)
T d1nw1a_          90 HLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL  128 (395)
T ss_dssp             HHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred             HHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence            45678899888854444 477887753    589999987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=93.09  E-value=0.03  Score=47.94  Aligned_cols=32  Identities=22%  Similarity=0.287  Sum_probs=27.9

Q ss_pred             CCCCeeecCCCCCceEECCCCceEEeecCCcc
Q 036435          187 CSTKILHFDIKPHNILLDEDFCPKISDFGLAK  218 (372)
Q Consensus       187 ~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~  218 (372)
                      ...++||+|+.+.||+++.+...-++||+.+.
T Consensus       181 L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         181 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccccCCcchhhhhcccccceeEecccccc
Confidence            35689999999999999988777899999774

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=88.61  E-value=0.23  Score=42.37  Aligned_cols=30  Identities=30%  Similarity=0.330  Sum_probs=24.4

Q ss_pred             CCCeeecCCCCCceEECCCCceEEeecCCccc
Q 036435          188 STKILHFDIKPHNILLDEDFCPKISDFGLAKL  219 (372)
Q Consensus       188 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~  219 (372)
                      ..+++|+|+.+.|||++++  ..++||+-+..
T Consensus       191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             CceeecCCCCcccEEEeCC--ceEEechhccc
Confidence            4679999999999999753  45899987753